Citrus Sinensis ID: 003156
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 843 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LRT1 | 1016 | Probably inactive leucine | yes | no | 0.988 | 0.819 | 0.617 | 0.0 | |
| C0LGE4 | 882 | Probable LRR receptor-lik | no | no | 0.912 | 0.871 | 0.357 | 1e-124 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.934 | 0.777 | 0.331 | 1e-112 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.931 | 0.658 | 0.331 | 1e-109 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.927 | 0.710 | 0.346 | 1e-109 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.940 | 0.765 | 0.323 | 1e-105 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.940 | 0.695 | 0.315 | 1e-105 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.932 | 0.692 | 0.313 | 1e-104 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.963 | 0.650 | 0.332 | 1e-104 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.943 | 0.730 | 0.326 | 1e-104 |
| >sp|Q9LRT1|Y3804_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At3g28040 OS=Arabidopsis thaliana GN=At3g28040 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1025 bits (2651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/873 (61%), Positives = 668/873 (76%), Gaps = 40/873 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ +++ LDL+ N SG + LF NC+SLRYLSL+ N L+G I CS LN+LNLS
Sbjct: 147 ITSLQHLDLTGNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQIPSTLFRCSVLNSLNLSR 206
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N FSG+ F SG IW L+RLR LDLS N SGSIP G+ +LH LKEL LQ NQFSG LP
Sbjct: 207 NRFSGNPSFVSG--IWRLERLRALDLSSNSLSGSIPLGILSLHNLKELQLQRNQFSGALP 264
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+DIG CPHL +DLS+N F+G+LP +L+ L S+ VSNN L+GD P WIG+++ L L
Sbjct: 265 SDIGLCPHLNRVDLSSNHFSGELPRTLQKLKSLNHFDVSNNLLSGDFPPWIGDMTGLVHL 324
Query: 181 DFSNNHLTGSLPSSLFN------------------------CKKLSVIRLRGNSLNGNIP 216
DFS+N LTG LPSS+ N CK+L +++L+GN +GNIP
Sbjct: 325 DFSSNELTGKLPSSISNLRSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSGNIP 384
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
+G FDLGL+E+D S NG GSIP GSS LF++L LDLS N+L G IP E+GLF
Sbjct: 385 DGFFDLGLQEMDFSGNGLTGSIPRGSSR-----LFESLIRLDLSHNSLTGSIPGEVGLFI 439
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
++RYLNLS NH +R+PPE+ + +L LDLRN+AL GS+P ++CES+SL ILQLDGNSL
Sbjct: 440 HMRYLNLSWNHFNTRVPPEIEFLQNLTVLDLRNSALIGSVPADICESQSLQILQLDGNSL 499
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
TG IP+ I NC+SL LLSLSHN+L+G IPKS+SNL +LKILKLE N+LSGEIP+ELG L
Sbjct: 500 TGSIPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQELKILKLEANKLSGEIPKELGDLQ 559
Query: 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 456
+LL VNVS+NRLIGRLP+G VF +LDQS++QGNLGICSPLL+GPC +NVPKPLV++P++Y
Sbjct: 560 NLLLVNVSFNRLIGRLPLGDVFQSLDQSAIQGNLGICSPLLRGPCTLNVPKPLVINPNSY 619
Query: 457 -NSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVE 515
N N M G+ S + H MF SVS IVAI AAILI GV++I+LLN S RRRL FV+
Sbjct: 620 GNGNNMPGNRASGGSGTFHRRMFLSVSVIVAISAAILIFSGVIIITLLNASVRRRLAFVD 679
Query: 516 TTLESMCSSSSRS-VNLAAGKVILFDSRSSSL-----DCSIDPETLLEKAAEVGEGVFGT 569
LES+ S SS+S +L GK++L +SR+S + +PE+LL KA+ +GEGVFGT
Sbjct: 680 NALESIFSGSSKSGRSLMMGKLVLLNSRTSRSSSSSQEFERNPESLLNKASRIGEGVFGT 739
Query: 570 VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629
VYK G QGR LAVKKLV S I+Q EDF+REVR+L KA+HPNL+S++GY+WTP L LL
Sbjct: 740 VYKAPLGEQGRNLAVKKLVPSPILQNLEDFDREVRILAKAKHPNLVSIKGYFWTPDLHLL 799
Query: 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689
VS+Y PNG+LQ+KLHER PSTPPLSW R+K+ILGTAKGLA+LHH+FRP IH+NLKP+N
Sbjct: 800 VSEYIPNGNLQSKLHEREPSTPPLSWDVRYKIILGTAKGLAYLHHTFRPTTIHFNLKPTN 859
Query: 690 ILLDDNYNPRISDFGLARLLTRLDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGF 748
ILLD+ NP+ISDFGL+RLLT D + M +NRFQ+ALGYVAPEL CQ+LRVNEKCD+YGF
Sbjct: 860 ILLDEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQNLRVNEKCDVYGF 919
Query: 749 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD-YPEDEVLPVLKL 807
GVLILELVTGRRPVEYGED+ VILS+HVRV+LE+GNVL+C+DP M + Y EDEVLPVLKL
Sbjct: 920 GVLILELVTGRRPVEYGEDSFVILSDHVRVMLEQGNVLECIDPVMEEQYSEDEVLPVLKL 979
Query: 808 ALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 840
ALVCT IPS+RP+MAE+VQILQVI +P+P R+
Sbjct: 980 ALVCTSQIPSNRPTMAEIVQILQVINSPVPHRI 1012
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGE4|Y1124_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g12460 OS=Arabidopsis thaliana GN=At1g12460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1146), Expect = e-124, Method: Compositional matrix adjust.
Identities = 311/870 (35%), Positives = 455/870 (52%), Gaps = 101/870 (11%)
Query: 31 YLSLAGNILQGPIGKIFNYCSS-----LNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD 85
Y SLA + G + FN + ++ + L N +G L G+ +LK +R L+
Sbjct: 42 YNSLASWVSDGDLCNSFNGITCNPQGFVDKIVLWNTSLAGTL----APGLSNLKFIRVLN 97
Query: 86 LSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPV 145
L N F+G++P L L + + N SGP+P I L LDLS N FTG++PV
Sbjct: 98 LFGNRFTGNLPLDYFKLQTLWTINVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPV 157
Query: 146 SL-RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 204
SL + + F+S+++N + G IP I N + L DFS N+L G LP + + L I
Sbjct: 158 SLFKFCDKTKFVSLAHNNIFGSIPASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYI 217
Query: 205 RLRGNSLNGNIPEG--------LFDLG--------------------------------- 223
+R N L+G++ E L DLG
Sbjct: 218 SVRNNLLSGDVSEEIQKCQRLILVDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIG 277
Query: 224 --------LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 275
LE +D S N G IP G S L++LDL SN L G IP +G
Sbjct: 278 EIVDCSESLEFLDASSNELTGRIPTGVMGCKS------LKLLDLESNKLNGSIPGSIGKM 331
Query: 276 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 335
+L + L +N + IP ++G L L+L N L G +P+++ R L L + GN
Sbjct: 332 ESLSVIRLGNNSIDGVIPRDIGSLEFLQVLNLHNLNLIGEVPEDISNCRVLLELDVSGND 391
Query: 336 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 395
L G I + + N T++ +L L N L+GSIP + NL+K++ L L N LSG IP LG L
Sbjct: 392 LEGKISKKLLNLTNIKILDLHRNRLNGSIPPELGNLSKVQFLDLSQNSLSGPIPSSLGSL 451
Query: 396 ASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDA 455
+L NVSYN L G +P + S+ N +C L PC
Sbjct: 452 NTLTHFNVSYNNLSGVIPPVPMIQAFGSSAFSNNPFLCGDPLVTPCNSR----------- 500
Query: 456 YNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVE 515
+ + S N + SV ++ A IL GV ++ LN+ R+R E
Sbjct: 501 ----------GAAAKSRNSDALSISVIIVIIAAAVILF--GVCIVLALNLRARKRRKDEE 548
Query: 516 T-TLESM-CSSSSRSVNLAAGKVILFDSR--SSSLDCSIDPETLLEKAAEVGEGVFGTVY 571
T+E+ +SS S + GK++LF S D + LL+K +G G G+VY
Sbjct: 549 ILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALLDKENIIGMGSIGSVY 608
Query: 572 KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631
+ SF G +AVKKL T I+ E+FE+E+ LG +HPNL S +GYY++ ++L++S
Sbjct: 609 RASF-EGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSFQGYYFSSTMQLILS 667
Query: 632 DYAPNGSLQAKLHERL-PSTPP------LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYN 684
++ PNGSL LH R+ P T L+W RF++ LGTAK L+ LH+ +P I+H N
Sbjct: 668 EFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKALSFLHNDCKPAILHLN 727
Query: 685 LKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCD 744
+K +NILLD+ Y ++SD+GL + L +D ++ +F +A+GY+APEL QSLR +EKCD
Sbjct: 728 VKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAPELAQQSLRASEKCD 787
Query: 745 IYGFGVLILELVTGRRPVEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLP 803
+Y +GV++LELVTGR+PVE E+ V+IL ++VR LLE G+ DC D + ++ E+E++
Sbjct: 788 VYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCFDRRLREFEENELIQ 847
Query: 804 VLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
V+KL L+CT P RPSMAEVVQ+L+ I+
Sbjct: 848 VMKLGLLCTSENPLKRPSMAEVVQVLESIR 877
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 405 bits (1040), Expect = e-112, Method: Compositional matrix adjust.
Identities = 289/872 (33%), Positives = 456/872 (52%), Gaps = 84/872 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+++++ LDL N G +P F+N LR+L L+GN L G + + SL T L
Sbjct: 163 LVSLEVLDLRGNFFQGSLPSS-FKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGY 221
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N F G + G ++ L+ LDL+ SG IP + L L+ LLL N F+G +P
Sbjct: 222 NEFKGPIPPEFG----NINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIP 277
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+IG L LD S+N TG++P+ + L ++ +++ N L+G IP I +++ L+ L
Sbjct: 278 REIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVL 337
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIP 239
+ NN L+G LPS L L + + NS +G IP L + G L ++ L N F G IP
Sbjct: 338 ELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIP 397
Query: 240 PGSSSSSSSTL------------------FQTLRILDLSSNNLVGDIPAEMGLFANLRYL 281
S+ S + L+ L+L+ N L G IP ++ +L ++
Sbjct: 398 ATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFI 457
Query: 282 NLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP 341
+ S N +RS +P + H+L + +N + G +P + + SL L L N+LTG IP
Sbjct: 458 DFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIP 517
Query: 342 QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAV 401
I +C L L+L +N+L+G IP+ I+ ++ L +L L N L+G +P+ +G +L +
Sbjct: 518 SSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELL 577
Query: 402 NVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQM 461
NVSYN+L G +P+ G T++ L+GN G+C +L PC ++
Sbjct: 578 NVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLP-PC-----------------SKF 619
Query: 462 DGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIA-GGVLVISLLNVSTRRRLTFVETTLES 520
SHS S H I+A LI VL + +L + TR + +
Sbjct: 620 QRATSSHS--SLHGKR---------IVAGWLIGIASVLALGILTIVTRT--LYKKWYSNG 666
Query: 521 MCSSSSRSVNLAAGKVILFD----SRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFG 576
C + S +++ F + S L C ++++ +G G G VYK
Sbjct: 667 FCGDETASKGEWPWRLMAFHRLGFTASDILAC-------IKESNMIGMGATGIVYKAEMS 719
Query: 577 TQGRMLAVKKLVTS--DIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633
+LAVKKL S DI DF EV +LGK RH N++ L G+ + + ++V ++
Sbjct: 720 RSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEF 779
Query: 634 APNGSLQAKLHERLPSTPPL-SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692
NG+L +H + + L W +R+ + LG A GLA+LHH PP+IH ++K +NILL
Sbjct: 780 MLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILL 839
Query: 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLI 752
D N + RI+DFGLAR++ R + V + + GY+APE +L+V+EK DIY +GV++
Sbjct: 840 DANLDARIADFGLARMMARKKETV--SMVAGSYGYIAPEYG-YTLKVDEKIDIYSYGVVL 896
Query: 753 LELVTGRRPV--EYGEDNVVILSEHVRVLLEEGNVL-DCVDPSMGD--YPEDEVLPVLKL 807
LEL+TGRRP+ E+GE V + E VR + + L + +DP++G+ Y ++E+L VL++
Sbjct: 897 LELLTGRRPLEPEFGES--VDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQI 954
Query: 808 ALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 839
AL+CT +P RPSM +V+ +L K P+R
Sbjct: 955 ALLCTTKLPKDRPSMRDVISMLGEAK---PRR 983
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1020), Expect = e-109, Method: Compositional matrix adjust.
Identities = 292/882 (33%), Positives = 433/882 (49%), Gaps = 97/882 (10%)
Query: 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF 63
+K L L++NLLSG +P +L SL + L+GN+L G I ++F+ CSSL L L+NN
Sbjct: 355 LKHLSLASNLLSGSIPRELC-GSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQI 413
Query: 64 SG--------------DLDFASGYG-----IWSLKRLRTLDLSHNLFSGSIPQGVAALHY 104
+G DLD + G +W L S+N G +P +
Sbjct: 414 NGSIPEDLWKLPLMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAAS 473
Query: 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164
LK L+L NQ +G +P +IG L+ L+L+ N+F G++PV L S+ + + +N L
Sbjct: 474 LKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQ 533
Query: 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSS------LFNCKKLSVIRLRG------NSLN 212
G IP I ++ L+ L S N+L+GS+PS LS ++ G N L+
Sbjct: 534 GQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLS 593
Query: 213 GNIPEGLFD-LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAE 271
G IPE L + L L EI LS N G IP +S + L ILDLS N L G IP E
Sbjct: 594 GPIPEELGECLVLVEISLSNNHLSGEIP------ASLSRLTNLTILDLSGNALTGSIPKE 647
Query: 272 MGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL 331
MG L+ LNL++N L IP G SL+ L+L N L G +P + + L + L
Sbjct: 648 MGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDL 707
Query: 332 DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE 391
N+L+G + + L L + N +G IP + NL +L+ L + N LSGEIP +
Sbjct: 708 SFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTK 767
Query: 392 LGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVL 451
+ L +L +N++ N L G +P GV ++ L GN +C ++ CK+ K
Sbjct: 768 ICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTK---- 823
Query: 452 DPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRL 511
S I ++ I V V SL + +R+
Sbjct: 824 --------------------------LRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRV 857
Query: 512 T---------------FVETTLESMCSSSSR---SVNLAAGKVILFDSRSSSLDCSIDPE 553
FV+ L + S SR S+N+A + L R + ++
Sbjct: 858 KQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDI---VEAT 914
Query: 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN 613
K +G+G FGTVYK + + +AVKKL + Q +F E+ LGK +HPN
Sbjct: 915 DHFSKKNIIGDGGFGTVYKACLPGE-KTVAVKKLSEAK-TQGNREFMAEMETLGKVKHPN 972
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
L+SL GY + KLLV +Y NGSL L + L W+ R K+ +G A+GLA LH
Sbjct: 973 LVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLH 1032
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
H F P IIH ++K SNILLD ++ P+++DFGLARL++ + HV S GY+ PE
Sbjct: 1033 HGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHV-STVIAGTFGYIPPEYG 1091
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPV--EYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
QS R K D+Y FGV++LELVTG+ P ++ E L + +G +D +DP
Sbjct: 1092 -QSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDP 1150
Query: 792 SMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+ ++ L +L++A++C P+ RP+M +V++ L+ I
Sbjct: 1151 LLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 290/838 (34%), Positives = 425/838 (50%), Gaps = 56/838 (6%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ MK L L N L+G +P ++ N + + N L G I K F + +L L+L
Sbjct: 282 LTKMKRLYLYTNQLTGEIPREI-GNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFE 340
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N G + G L L LDLS N +G+IPQ + L YL +L L NQ G +P
Sbjct: 341 NILLGPIPRELG----ELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIP 396
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
IGF + + LD+S N +G +P ++I +S+ +N L+G+IP + +L L
Sbjct: 397 PLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKL 456
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIP 239
+N LTGSLP LFN + L+ + L N L+GNI L L LE + L+ N F G IP
Sbjct: 457 MLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIP 516
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
P + + F ++SSN L G IP E+G ++ L+LS N I ELG
Sbjct: 517 PEIGNLTKIVGF------NISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQL 570
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYL-LSLSHN 358
L L L +N L G IP + L LQL GN L+ IP + TSL + L++SHN
Sbjct: 571 VYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHN 630
Query: 359 HLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVF 418
+LSG+IP S+ NL L+IL L N+LSGEIP +G L SLL N+S N L+G +P VF
Sbjct: 631 NLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVF 690
Query: 419 PTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMF 478
+D S+ GN G+C+ + C +PLV D+ + ++G +
Sbjct: 691 QRMDSSNFAGNHGLCNS-QRSHC-----QPLVPHSDSKLNWLING---------SQRQKI 735
Query: 479 FSVSAIVAIIAAILIAGGVLVISLLNVS---TRRRLTFVETTLESMCSSSSRSVNLAAGK 535
+++ IV G V +I+ L + RR FV LE
Sbjct: 736 LTITCIV--------IGSVFLITFLGLCWTIKRREPAFV--ALEDQTKPD-------VMD 778
Query: 536 VILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVT-SDIIQ 594
F + + +D + +G G GTVYK + G ++AVKKL + +
Sbjct: 779 SYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEM-SGGEVIAVKKLNSRGEGAS 837
Query: 595 YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS 654
F E+ LGK RH N++ L G+ + LL+ +Y GSL +L +R L
Sbjct: 838 SDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQL-QRGEKNCLLD 896
Query: 655 WTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714
W R+++ LG A+GL +LHH RP I+H ++K +NILLD+ + + DFGLA+L+
Sbjct: 897 WNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYS 956
Query: 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR---RPVEYGEDNVVI 771
MS + GY+APE +++V EKCDIY FGV++LEL+TG+ +P+E G D V
Sbjct: 957 KSMS-AVAGSYGYIAPEYA-YTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNW 1014
Query: 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
+ +R ++ + D + E+ VLK+AL CT + P+SRP+M EVV ++
Sbjct: 1015 VRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (982), Expect = e-105, Method: Compositional matrix adjust.
Identities = 290/896 (32%), Positives = 438/896 (48%), Gaps = 103/896 (11%)
Query: 6 FLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSG 65
L++SNNL G + +L + ++ L L+ N L G + ++N S+ L++ +N +G
Sbjct: 163 MLNVSNNLFEGEIHPELCSSSGGIQVLDLSMNRLVGNLDGLYNCSKSIQQLHIDSNRLTG 222
Query: 66 DL-DFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIG 124
L D+ ++S++ L L LS N SG + + ++ L LK LL+ N+FS +P G
Sbjct: 223 QLPDY-----LYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLLISENRFSDVIPDVFG 277
Query: 125 FCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN 184
L LD+S+N F+G+ P SL + + + + NN+L+G I + L LD ++
Sbjct: 278 NLTQLEHLDVSSNKFSGRFPPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLCVLDLAS 337
Query: 185 NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL---------GLEEIDLSE---- 231
NH +G LP SL +C K+ ++ L N G IP+ +L +D SE
Sbjct: 338 NHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDFSETMNV 397
Query: 232 -------------NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL 278
F+G P ++ T F L IL L + L G IP+ + L
Sbjct: 398 LQHCRNLSTLILSKNFIGEEIP-----NNVTGFDNLAILALGNCGLRGQIPSWLLNCKKL 452
Query: 279 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSL------------ 326
L+LS NH IP +G SL ++D NN L G+IP + E ++L
Sbjct: 453 EVLDLSWNHFYGTIPHWIGKMESLFYIDFSNNTLTGAIPVAITELKNLIRLNGTASQMTD 512
Query: 327 --GI------------------------LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL 360
GI + L+ N L G I I L++L LS N+
Sbjct: 513 SSGIPLYVKRNKSSNGLPYNQVSRFPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNF 572
Query: 361 SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPT 420
+G+IP SIS L+ L++L L +N L G IP L L +V+YNRL G +P GG F +
Sbjct: 573 TGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYS 632
Query: 421 LDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFS 480
SS +GNLG+C + PC D SN ++ S N++ F
Sbjct: 633 FPHSSFEGNLGLCRAI-DSPC------------DVLMSNMLNPKGSSRR---NNNGGKFG 676
Query: 481 VSAIVAIIAAILIAGGVLV-ISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILF 539
S+IV + ++ I +L+ + LL +S + + E S S++ L K++LF
Sbjct: 677 RSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVDEETISGVSKA--LGPSKIVLF 734
Query: 540 DS---RSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP 596
S + S++ + +A +G G FG VYK +F G AVK+L + D Q
Sbjct: 735 HSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANF-PDGSKAAVKRL-SGDCGQME 792
Query: 597 EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656
+F+ EV L +A H NL+SL+GY +LL+ + NGSL LHER+ L W
Sbjct: 793 REFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWD 852
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
R K+ G A+GLA+LH P +IH ++K SNILLD+ + ++DFGLARLL D HV
Sbjct: 853 VRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARLLRPYDTHV 912
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE-DNVVILSEH 775
++ LGY+ PE + QSL + D+Y FGV++LELVTGRRPVE + + L
Sbjct: 913 TTD-LVGTLGYIPPEYS-QSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSR 970
Query: 776 VRVLLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
V + E + +D ++ + E VL +L++A C H P RP + EVV L+
Sbjct: 971 VFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCIDHEPRRRPLIEEVVTWLE 1026
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (980), Expect = e-105, Method: Compositional matrix adjust.
Identities = 277/877 (31%), Positives = 429/877 (48%), Gaps = 84/877 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ ++ L + ++SG +P L NC+ L L L N L G I + + L L L
Sbjct: 249 LKKLETLSIYTTMISGEIPSDL-GNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQ 307
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N G + G + L+ +DLS NL SGSIP + L +L+E ++ N+FSG +P
Sbjct: 308 NSLVGGIPEEIG----NCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIP 363
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
I C L L L N +G +P L L + +N L G IP + + + L+ L
Sbjct: 364 TTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQAL 423
Query: 181 DFSNNHLTGSLPSSLF------------------------NCKKLSVIRLRGNSLNGNIP 216
D S N LTG++PS LF NC L +RL N + G IP
Sbjct: 424 DLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIP 483
Query: 217 EGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 275
G+ L + +D S N G +P S S L+++DLS+N+L G +P +
Sbjct: 484 SGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE------LQMIDLSNNSLEGSLPNPVSSL 537
Query: 276 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 335
+ L+ L++S+N +IP LG SL L L N GSIP + L +L L N
Sbjct: 538 SGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNE 597
Query: 336 LTGPIPQVIRNCTSLYL-LSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGK 394
L+G IP + + +L + L+LS N L+G IP I++LNKL IL L N L G++ L
Sbjct: 598 LSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LAN 656
Query: 395 LASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPD 454
+ +L+++N+SYN G LP +F L L+GN +CS + C + K L D
Sbjct: 657 IENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSST-QDSCFLTYRKGNGLGDD 715
Query: 455 AYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVI-SLLNVSTRRRLTF 513
+S + +++ ++ + ++I G V VI + N+ R
Sbjct: 716 GD--------------ASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSEL 761
Query: 514 VETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKV 573
ET + + +N + ++I C ++P +G+G G VY+
Sbjct: 762 GETYKWQF--TPFQKLNFSVDQII---------RCLVEPNV-------IGKGCSGVVYRA 803
Query: 574 SFGTQGRMLAVKKLVTSDI--------IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 625
G ++AVKKL + + + F EV+ LG RH N++ G W
Sbjct: 804 DV-DNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRN 862
Query: 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNL 685
+LL+ DY PNGSL + LHER S+ L W R++++LG A+GLA+LHH PPI+H ++
Sbjct: 863 TRLLMYDYMPNGSLGSLLHERRGSS--LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDI 920
Query: 686 KPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDI 745
K +NIL+ ++ P I+DFGLA+L+ D SN + GY+APE S+++ EK D+
Sbjct: 921 KANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYG-YSMKITEKSDV 979
Query: 746 YGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVL 805
Y +GV++LE++TG++P++ + L + VR VLD S + DE++ VL
Sbjct: 980 YSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVL 1039
Query: 806 KLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEV 842
AL+C P RP+M +V +L+ IK + +V
Sbjct: 1040 GTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKV 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (974), Expect = e-104, Method: Compositional matrix adjust.
Identities = 275/877 (31%), Positives = 434/877 (49%), Gaps = 91/877 (10%)
Query: 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF 63
++ L + + +LSG +P +L NC+ L L L N L G + K +L + L N+
Sbjct: 253 LQSLSVYSTMLSGEIPKEL-GNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNL 311
Query: 64 SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI 123
G + G+ +K L +DLS N FSG+IP+ L L+EL+L N +G +P+ +
Sbjct: 312 HGPIPEEIGF----MKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSIL 367
Query: 124 GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
C L + N +G +P + LL + N L G+IP + L+ LD S
Sbjct: 368 SNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLS 427
Query: 184 NNHLTGSLPSSLF------------------------NCKKLSVIRLRGNSLNGNIPEGL 219
N+LTGSLP+ LF NC L +RL N + G IP+G+
Sbjct: 428 QNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGI 487
Query: 220 -FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL 278
F L +DLSEN G +P S+ + L++L+LS+N L G +P + L
Sbjct: 488 GFLQNLSFLDLSENNLSGPVPLEISNC------RQLQMLNLSNNTLQGYLPLSLSSLTKL 541
Query: 279 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 338
+ L++SSN L +IP LG+ SL L L N+ G IP + +L +L L N+++G
Sbjct: 542 QVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISG 601
Query: 339 PIPQVIRNCTSLYL-LSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLAS 397
IP+ + + L + L+LS N L G IP+ IS LN+L +L + N LSG++ L L +
Sbjct: 602 TIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL-SALSGLEN 660
Query: 398 LLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYN 457
L+++N+S+NR G LP VF L + ++GN G+CS + C ++ N
Sbjct: 661 LVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRS-CFVS------------N 707
Query: 458 SNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETT 517
S+Q+ HS H + ++ ++++ A + + G + VI + +
Sbjct: 708 SSQLTTQRGVHS-----HRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGEN 762
Query: 518 LESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGT 577
L + + + +N V L C ++ +G+G G VYK
Sbjct: 763 LWTWQFTPFQKLNFTVEHV---------LKCLVEGNV-------IGKGCSGIVYKAEMPN 806
Query: 578 QGRMLAVKKLVTSDIIQYPED---------FEREVRVLGKARHPNLISLEGYYWTPQLKL 628
+ ++AVKKL + E F EV+ LG RH N++ G W +L
Sbjct: 807 R-EVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRL 865
Query: 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPS 688
L+ DY NGSL + LHER L W R+K+ILG A+GLA+LHH PPI+H ++K +
Sbjct: 866 LMYDYMSNGSLGSLLHER-SGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKAN 924
Query: 689 NILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 748
NIL+ ++ P I DFGLA+L+ D SN + GY+APE S+++ EK D+Y +
Sbjct: 925 NILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYG-YSMKITEKSDVYSY 983
Query: 749 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEV---LPVL 805
GV++LE++TG++P+ D + H+ +++ + +D + PE EV + L
Sbjct: 984 GVVVLEVLTGKQPI----DPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTL 1039
Query: 806 KLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEV 842
+AL+C IP RP+M +V +L I + M+V
Sbjct: 1040 GVALLCINPIPEDRPTMKDVAAMLSEICQEREESMKV 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (974), Expect = e-104, Method: Compositional matrix adjust.
Identities = 304/914 (33%), Positives = 448/914 (49%), Gaps = 102/914 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N++ L LS LSG +P +L C SL+ L L+ N L G I + L L L NN
Sbjct: 337 NLEQLVLSGTQLSGEIPVEL-SKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNT 395
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
G L + I +L L+ L L HN G +P+ ++AL L+ L L N+FSG +P +
Sbjct: 396 LEGTLSPS----ISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQE 451
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
IG C L +D+ N F G++P S+ L + + + N L G +P +GN L LD
Sbjct: 452 IGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDL 511
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPG 241
++N L+GS+PSS K L + L NSL GN+P+ L L L I+LS N G+I P
Sbjct: 512 ADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPL 571
Query: 242 SSSSSSSTL-----------------------------------------FQTLRILDLS 260
SSS + + L +LD+S
Sbjct: 572 CGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMS 631
Query: 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320
SN L G IP ++ L L +++L++N L IPP LG L L L +N S+P E+
Sbjct: 632 SNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTEL 691
Query: 321 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLE 380
L +L LDGNSL G IPQ I N +L +L+L N SGS+P+++ L+KL L+L
Sbjct: 692 FNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLS 751
Query: 381 FNELSGEIPQELGKLASLL-AVNVSYNRLIGRLP--VGGV--FPTLDQSSLQ------GN 429
N L+GEIP E+G+L L A+++SYN G +P +G + TLD S Q G+
Sbjct: 752 RNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGS 811
Query: 430 LGICSPL---------LKGPCKMNVPKPLVLDPDAYNSNQ-MDGHIHS--HSFSSNHHHM 477
+G L L G K + D++ N + G S + SN+
Sbjct: 812 VGDMKSLGYLNVSFNNLGGKLKKQFSR---WPADSFLGNTGLCGSPLSRCNRVRSNNKQQ 868
Query: 478 FFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVI 537
S ++V I A + L+I ++ + ++R F + + +S S + A
Sbjct: 869 GLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKP 928
Query: 538 LFDSRSSSLDCSIDPETLLEKAAE------VGEGVFGTVYKVSFGTQGRMLAVKKLVTSD 591
LF + +S D I E ++E +G G G VYK G +AVKK++ D
Sbjct: 929 LFRNGASKSD--IRWEDIMEATHNLSEEFMIGSGGSGKVYKAEL-ENGETVAVKKILWKD 985
Query: 592 IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ--LKLLVSDYAPNGSLQAKLHERLP- 648
+ + F REV+ LG+ RH +L+ L GY + L LL+ +Y NGS+ LHE P
Sbjct: 986 DLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPV 1045
Query: 649 ---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705
L W R ++ +G A+G+ +LHH PPI+H ++K SN+LLD N + DFGL
Sbjct: 1046 LEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGL 1105
Query: 706 ARLLTR-LDKHVMSNR-FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763
A++LT D + SN F + GY+APE SL+ EK D+Y G++++E+VTG+ P +
Sbjct: 1106 AKVLTENCDTNTDSNTWFACSYGYIAPEY-AYSLKATEKSDVYSMGIVLMEIVTGKMPTD 1164
Query: 764 --YGE--DNVVILSEHVRVLLEEGNVLD-CVDPSMG---DYPEDEVLPVLKLALVCTCHI 815
+G D V + H+ V G+ D +DP + + ED VL++AL CT
Sbjct: 1165 SVFGAEMDMVRWVETHLEV---AGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTS 1221
Query: 816 PSSRPSMAEVVQIL 829
P RPS + L
Sbjct: 1222 PQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (971), Expect = e-104, Method: Compositional matrix adjust.
Identities = 282/863 (32%), Positives = 419/863 (48%), Gaps = 68/863 (7%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYL------------------------SLAGNILQGP 42
LDLS N G VP ++ NC+SL L L+ N L G
Sbjct: 249 LDLSFNDFQGGVPPEI-GNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGN 307
Query: 43 IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL 102
I + CSSL TL L++N G++ A + LK+L++L+L N SG IP G+ +
Sbjct: 308 IPQELGNCSSLETLKLNDNQLQGEIPPA----LSKLKKLQSLELFFNKLSGEIPIGIWKI 363
Query: 103 HYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162
L ++L+ N +G LP ++ HL L L NN F G +P+SL L S+ + + N
Sbjct: 364 QSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNR 423
Query: 163 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 222
TG+IP + + L +N L G +P+S+ CK L +RL N L+G +PE L
Sbjct: 424 FTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGVLPEFPESL 483
Query: 223 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLN 282
L ++L N F GSIP S + L +DLS N L G IP E+G +L LN
Sbjct: 484 SLSYVNLGSNSFEGSIPRSLGSC------KNLLTIDLSQNKLTGLIPPELGNLQSLGLLN 537
Query: 283 LSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ 342
LS N+L +P +L L++ D+ +N+L GSIP +SL L L N+ G IPQ
Sbjct: 538 LSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQ 597
Query: 343 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI-LKLEFNELSGEIPQELGKLASLLAV 401
+ L L ++ N G IP S+ L L+ L L N +GEIP LG L +L +
Sbjct: 598 FLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGALINLERL 657
Query: 402 NVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQM 461
N+S N+L G L V +L+Q + N GP +P L+ + ++ N
Sbjct: 658 NISNNKLTGPLSVLQSLKSLNQVDVSYNQ------FTGP----IPVNLLSNSSKFSGNPD 707
Query: 462 DGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESM 521
S+S S+ F S V + I+L+ + + + L +
Sbjct: 708 LCIQASYSVSAIIRKEFKSCKGQVKL--------STWKIALIAAGSSLSVLALLFALFLV 759
Query: 522 CSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRM 581
R ++ + S L+ + L+ +G G G VY+ S G+ G
Sbjct: 760 LCRCKRGTKTEDANILAEEGLSLLLNKVLAATDNLDDKYIIGRGAHGVVYRASLGS-GEE 818
Query: 582 LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQA 641
AVKKL+ ++ I+ ++ +RE+ +G RH NLI LE ++ + L++ Y PNGSL
Sbjct: 819 YAVKKLIFAEHIRANQNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHD 878
Query: 642 KLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701
LH L W+ RF + LG + GLA+LHH PPIIH ++KP NIL+D + P I
Sbjct: 879 VLHRGNQGEAVLDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIG 938
Query: 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
DFGLAR+L D V + GY+APE +++R E D+Y +GV++LELVTG+R
Sbjct: 939 DFGLARILD--DSTVSTATVTGTTGYIAPENAYKTVRSKES-DVYSYGVVLLELVTGKRA 995
Query: 762 VEYGEDNVVILSEHVRVLL-----EEGNVLDCVDPSMGDYPED-----EVLPVLKLALVC 811
++ + + VR +L E+ VDP + D D + + V LAL C
Sbjct: 996 LDRSFPEDINIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRC 1055
Query: 812 TCHIPSSRPSMAEVVQILQVIKT 834
T P +RPSM +VV+ L +++
Sbjct: 1056 TDKRPENRPSMRDVVKDLTDLES 1078
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 843 | ||||||
| 255554367 | 1007 | receptor protein kinase, putative [Ricin | 0.989 | 0.828 | 0.713 | 0.0 | |
| 224131472 | 1006 | predicted protein [Populus trichocarpa] | 0.988 | 0.828 | 0.721 | 0.0 | |
| 225433686 | 1012 | PREDICTED: probably inactive leucine-ric | 0.989 | 0.824 | 0.701 | 0.0 | |
| 224069080 | 985 | predicted protein [Populus trichocarpa] | 0.988 | 0.845 | 0.714 | 0.0 | |
| 356499695 | 1007 | PREDICTED: probably inactive leucine-ric | 0.988 | 0.827 | 0.677 | 0.0 | |
| 356568921 | 1007 | PREDICTED: probably inactive leucine-ric | 0.988 | 0.827 | 0.675 | 0.0 | |
| 449469172 | 1007 | PREDICTED: probably inactive leucine-ric | 0.984 | 0.824 | 0.673 | 0.0 | |
| 449484810 | 1007 | PREDICTED: LOW QUALITY PROTEIN: probably | 0.984 | 0.824 | 0.672 | 0.0 | |
| 357502883 | 1016 | Probably inactive leucine-rich repeat re | 0.988 | 0.819 | 0.673 | 0.0 | |
| 297815072 | 1014 | hypothetical protein ARALYDRAFT_484589 [ | 0.985 | 0.819 | 0.618 | 0.0 |
| >gi|255554367|ref|XP_002518223.1| receptor protein kinase, putative [Ricinus communis] gi|223542628|gb|EEF44166.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1209 bits (3127), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 622/872 (71%), Positives = 722/872 (82%), Gaps = 38/872 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M ++FLDLS N LSGP+P LF+NC SLRY+SLAGN LQGP+ CSSLNTLNLS+
Sbjct: 145 MTTVRFLDLSENSLSGPLPDNLFQNCLSLRYISLAGNSLQGPLPSTLARCSSLNTLNLSS 204
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
NHFSG+ DF SG IWSLKRLRTLDLS+N FSGS+P GV++LH LK+L LQGN+FSG LP
Sbjct: 205 NHFSGNPDFFSG--IWSLKRLRTLDLSNNEFSGSLPIGVSSLHNLKDLQLQGNRFSGTLP 262
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
D G C HL LDLSNNLFTG LP SL+ L S+ FIS+SNN T D P WIGNI LE+L
Sbjct: 263 VDTGLCTHLLRLDLSNNLFTGALPDSLKWLGSLTFISLSNNMFTDDFPQWIGNIRNLEYL 322
Query: 181 DFSNNHLTGSLPSSLFNCK------------------------KLSVIRLRGNSLNGNIP 216
DFS+N LTGSLPSS+ + K KLSVIRLRGNS G IP
Sbjct: 323 DFSSNLLTGSLPSSISDLKSLYFINLSNNKFTGQIPTSMVQFSKLSVIRLRGNSFIGTIP 382
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
EGLF+LGLEE+D S+N +GSIP GSS + +L+ILDLS NNL G+I AEMGL +
Sbjct: 383 EGLFNLGLEEVDFSDNKLIGSIPAGSSK-----FYGSLQILDLSRNNLTGNIRAEMGLSS 437
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
NLRYLNLS N+L+SR+P ELGYF +L LDLRN+A+ GSIP ++CES SL ILQLDGNS+
Sbjct: 438 NLRYLNLSWNNLQSRMPQELGYFQNLTVLDLRNSAISGSIPADICESGSLSILQLDGNSI 497
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
G IP+ I NC+++YLLSLSHN+LSG IPKSI+ LN LKILKLEFN+LSGEIP ELGKL
Sbjct: 498 VGSIPEEIGNCSTMYLLSLSHNNLSGPIPKSIAKLNNLKILKLEFNKLSGEIPLELGKLE 557
Query: 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 456
+LLAVN+SYN LIGRLP GG+FP+LDQS+LQGNLGICSPLLKGPCKMNVPKPLVLDP AY
Sbjct: 558 NLLAVNISYNMLIGRLPSGGIFPSLDQSALQGNLGICSPLLKGPCKMNVPKPLVLDPFAY 617
Query: 457 NSNQMDGHI---HSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTF 513
NQM+GH S + +H+HM SVS+I+AI AA+ I GV++ISLLN+S R+RL F
Sbjct: 618 -GNQMEGHRPRNESPDSTRSHNHMLLSVSSIIAISAAVFIVFGVIIISLLNISARKRLAF 676
Query: 514 VETTLESMCSSSSRSVNLAA-GKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYK 572
V+ LES+ SSSSRS NLAA GK++LFDS+SS + + +PE+LL KAAE+GEGVFGTVYK
Sbjct: 677 VDHALESLFSSSSRSGNLAAAGKLVLFDSKSSPDEIN-NPESLLNKAAEIGEGVFGTVYK 735
Query: 573 VSFG-TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631
VS G + GRM+A+KKLV+S+IIQYPEDFEREV++LGKARHPNLISL GYYWTPQL+LLVS
Sbjct: 736 VSLGGSHGRMVAIKKLVSSNIIQYPEDFEREVQILGKARHPNLISLTGYYWTPQLQLLVS 795
Query: 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 691
++AP+GSLQAKLH R PSTPPLSW NRFK++LGTAKGLAHLHHSFRPPIIHYN+KPSNIL
Sbjct: 796 EFAPSGSLQAKLHGRPPSTPPLSWANRFKIVLGTAKGLAHLHHSFRPPIIHYNIKPSNIL 855
Query: 692 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVL 751
LD+N NP+ISDFGL+RLLT+LDKHV++NRFQSALGYVAPEL CQSLRVNEKCD+YGFG+L
Sbjct: 856 LDENNNPKISDFGLSRLLTKLDKHVINNRFQSALGYVAPELACQSLRVNEKCDVYGFGIL 915
Query: 752 ILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVC 811
ILELVTGRRP+EYGEDNVVIL++HVRVLLE+GN LDCVDPSMGDYPEDEVLPVLKLALVC
Sbjct: 916 ILELVTGRRPIEYGEDNVVILNDHVRVLLEQGNALDCVDPSMGDYPEDEVLPVLKLALVC 975
Query: 812 TCHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 843
T IPSSRPSM EVVQILQVIKTP+PQRME+F
Sbjct: 976 TSQIPSSRPSMGEVVQILQVIKTPVPQRMEIF 1007
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131472|ref|XP_002321093.1| predicted protein [Populus trichocarpa] gi|222861866|gb|EEE99408.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1196 bits (3094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 628/871 (72%), Positives = 723/871 (83%), Gaps = 38/871 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M ++KFLDLS N +GP+P LF N SLRYLSLAGN+LQGPI CSSLNT+NLSN
Sbjct: 146 MSSLKFLDLSENSFTGPLPDDLFRNSFSLRYLSLAGNLLQGPIPSSLFSCSSLNTINLSN 205
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N FSGD DF +G WSL+RLR LDLSHN FSGS+PQGV+A+H LKEL LQGN+FSGPLP
Sbjct: 206 NQFSGDPDFVTG--TWSLERLRKLDLSHNEFSGSVPQGVSAIHNLKELHLQGNRFSGPLP 263
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
DIG C HL LDLS+NLF+G LP SL+ L+S+ + S+S N LTG+ P WIG++S LE+L
Sbjct: 264 VDIGLCRHLNRLDLSSNLFSGALPESLQGLSSINYFSLSKNMLTGEFPRWIGSLSNLEYL 323
Query: 181 DFSNNHLTGSL------------------------PSSLFNCKKLSVIRLRGNSLNGNIP 216
D S+N LTGS+ P+S+ +C LS IRLRGNS NG+IP
Sbjct: 324 DLSSNALTGSISSSIGDLKSLRYLSLSNNKLLGNIPASIVSCTMLSAIRLRGNSFNGSIP 383
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
EGLFDLGLEE+D S NG +GSIP GSS T F +L LDLS NNL G IPAEMGL +
Sbjct: 384 EGLFDLGLEEVDFSHNGLIGSIPSGSS-----TFFTSLHTLDLSRNNLTGHIPAEMGLSS 438
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
+LRYLNLS N+L SR+PPELGYF +L LDLR+NAL GSIP ++CES SL ILQLDGNSL
Sbjct: 439 DLRYLNLSWNNLESRMPPELGYFQNLTVLDLRSNALAGSIPADICESGSLNILQLDGNSL 498
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
G +P+ I NC+SLYLLSLS N+LSGSIPKSIS L+KLKILKLEFNEL+GE+PQELGKL
Sbjct: 499 VGQVPEEIGNCSSLYLLSLSQNNLSGSIPKSISRLDKLKILKLEFNELTGEVPQELGKLE 558
Query: 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 456
+LLAVN+SYN+LIGRLPV G+FP+LDQS+LQGNLGICSPLLKGPCKMNVPKPLVLDP+AY
Sbjct: 559 NLLAVNISYNKLIGRLPVRGIFPSLDQSALQGNLGICSPLLKGPCKMNVPKPLVLDPNAY 618
Query: 457 NSNQMDGHIHSHSFSSN----HHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLT 512
NQ DG S SS HHHMF SVSAI+AI AAI I GV++ISLLNVS R+RL
Sbjct: 619 -GNQGDGQ-KPRSASSRPARFHHHMFLSVSAIIAISAAIFIMFGVILISLLNVSVRKRLA 676
Query: 513 FVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYK 572
FV+ LESMCSSSS+S NL GK++LFDS+SS D PE+LL KAAE+G+GVFGTVYK
Sbjct: 677 FVDHALESMCSSSSKSGNLVTGKLVLFDSKSSP-DWINSPESLLNKAAEIGQGVFGTVYK 735
Query: 573 VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632
VS G++ RM+A+KKL+TS+IIQYPEDF+REVRVLGKARHPNL+SL+GYYWTPQL+LLVS+
Sbjct: 736 VSLGSEARMVAIKKLITSNIIQYPEDFDREVRVLGKARHPNLLSLKGYYWTPQLQLLVSE 795
Query: 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692
YAPNGSLQ+KLHERL STPPLSW NR K++LGTAKGLAHLHHSFRPPIIHYN+KPSNILL
Sbjct: 796 YAPNGSLQSKLHERLTSTPPLSWANRLKIVLGTAKGLAHLHHSFRPPIIHYNIKPSNILL 855
Query: 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLI 752
D+N+NP+ISDFGLARLLT+LD+HVMS+RFQSALGYVAPEL CQSLR+NEKCDIYGFGVLI
Sbjct: 856 DENFNPKISDFGLARLLTKLDRHVMSSRFQSALGYVAPELACQSLRINEKCDIYGFGVLI 915
Query: 753 LELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCT 812
LELVTGRRPVEYGEDNVVI ++HVRVLLE+GN LDCVDPSMGDYPEDEV+PVLKLALVCT
Sbjct: 916 LELVTGRRPVEYGEDNVVIQNDHVRVLLEQGNALDCVDPSMGDYPEDEVMPVLKLALVCT 975
Query: 813 CHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 843
IPSSRPSMAEVVQILQVI+TP+PQRME+F
Sbjct: 976 SQIPSSRPSMAEVVQILQVIRTPVPQRMEIF 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433686|ref|XP_002265846.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1165 bits (3013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/871 (70%), Positives = 714/871 (81%), Gaps = 37/871 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M +++FLDLS+N L+GP+P ++FEN +SLR LSL+ N L+GPI C++L+ LNLS+
Sbjct: 151 MTSIRFLDLSHNSLAGPIPDEMFENYSSLRSLSLSMNFLEGPIPSALLRCTTLSNLNLSS 210
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N FSG+LDF+SG IW+L RLRTLDLSHN+FSGS+P GVAA+H LKEL LQGN+FSGPLP
Sbjct: 211 NQFSGNLDFSSG--IWTLNRLRTLDLSHNVFSGSVPDGVAAIHNLKELQLQGNRFSGPLP 268
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
DIG CPHL LD +NLFTG LP SL+ LNS++F VSNN L GD P WIG++S++E++
Sbjct: 269 VDIGLCPHLRRLDFCHNLFTGSLPDSLQRLNSLVFFGVSNNLLAGDFPQWIGSMSSVEYV 328
Query: 181 DFS------------------------NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 216
DFS +N LTGS+P SLF C KLSVIRLRGN +G+IP
Sbjct: 329 DFSGNGFTGSLPASMGNLKSLQFLSLSDNRLTGSIPGSLFYCPKLSVIRLRGNGFSGSIP 388
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
EGLFDLGL+E+DLS N G IPPGSS LF++L LDLS N L G IPAE+GLF+
Sbjct: 389 EGLFDLGLDEVDLSGNELEGPIPPGSS-----RLFESLHSLDLSRNKLTGSIPAEIGLFS 443
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
+LRYLNLS N LRSR+PPELGYF +L LDLRN L+GSIP ++C+S SLGILQLDGNSL
Sbjct: 444 SLRYLNLSWNSLRSRMPPELGYFQNLTVLDLRNTFLFGSIPGDICDSGSLGILQLDGNSL 503
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
TGPIP NC+SLYLLS+SHN L+GSIPKS + L KL+IL+LEFNELSGEIP+ELG L
Sbjct: 504 TGPIPDEFGNCSSLYLLSMSHNELNGSIPKSFAMLKKLEILRLEFNELSGEIPRELGSLE 563
Query: 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 456
+LLAVNVSYNRLIGRLPVGG+F +LDQS+LQGNLGICSPLLKGPCK+NV KPLVLDP +
Sbjct: 564 NLLAVNVSYNRLIGRLPVGGIFQSLDQSALQGNLGICSPLLKGPCKLNVSKPLVLDPYDF 623
Query: 457 NSNQMDGHIHSHSFSSN----HHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLT 512
++G + ++ HHMF SVSAI+AI AA I GV+VISLLNVS RRRL
Sbjct: 624 -GKPINGQNRRNESTTTPMRFRHHMFLSVSAIIAITAAAFILIGVVVISLLNVSARRRLA 682
Query: 513 FVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYK 572
F++T LESMCSSSSRS + GK+ILFDSR+S D +PE LL KAAE+G GVFGTVYK
Sbjct: 683 FIDTALESMCSSSSRSGSPPTGKLILFDSRASQ-DWIANPENLLNKAAEIGGGVFGTVYK 741
Query: 573 VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632
VS G RM+A+KKLVTS+IIQYPEDF+REVR+LGKARH NLISL+GYYWTPQL+LLV+D
Sbjct: 742 VSLGGGARMVAIKKLVTSNIIQYPEDFDREVRILGKARHQNLISLKGYYWTPQLQLLVTD 801
Query: 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692
YAPNGSLQA+LHER P+TPPLSW NRF++ILGTAKGLAHLHHSFRPPIIHYNLKPSNILL
Sbjct: 802 YAPNGSLQARLHERPPTTPPLSWPNRFRIILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 861
Query: 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLI 752
D+N NP ISD+GLARLLT+LDKHV+S+RFQSALGYVAPEL CQSLRVNEKCDIYGFGV+I
Sbjct: 862 DENCNPMISDYGLARLLTKLDKHVISSRFQSALGYVAPELACQSLRVNEKCDIYGFGVMI 921
Query: 753 LELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCT 812
LE+VTGRRPVEYGEDNVVIL++HVRVLLE+GNVL+CVDPSM +YPE+EVLPVLKLALVCT
Sbjct: 922 LEIVTGRRPVEYGEDNVVILNDHVRVLLEQGNVLECVDPSMNEYPEEEVLPVLKLALVCT 981
Query: 813 CHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 843
IPSSRP+MAEVVQILQVIKTP+PQRME F
Sbjct: 982 SQIPSSRPTMAEVVQILQVIKTPIPQRMEAF 1012
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069080|ref|XP_002302895.1| predicted protein [Populus trichocarpa] gi|222844621|gb|EEE82168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1158 bits (2996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 622/871 (71%), Positives = 716/871 (82%), Gaps = 38/871 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M ++KFLDLS N SGP+P LF N SLRYLSLAGN+LQGPI CSSLNT+NLSN
Sbjct: 125 MSSIKFLDLSENSFSGPLPDNLFRNSQSLRYLSLAGNLLQGPIPSSLLSCSSLNTINLSN 184
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
NHFSGD DF+SG IWSLKRLR LDLSHN FSGS+PQGV+A+H+LKEL LQGN+FSGPLP
Sbjct: 185 NHFSGDPDFSSG--IWSLKRLRKLDLSHNEFSGSVPQGVSAIHFLKELQLQGNRFSGPLP 242
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
DIG CPHL LDLS NLF+G LP SL+ L+SM S+S N L G+ P WIG+++ LE+L
Sbjct: 243 GDIGLCPHLNRLDLSRNLFSGALPESLQRLSSMSLFSLSKNMLAGEFPRWIGSLTNLEYL 302
Query: 181 DFSNNHLTGSLPSS------------------------LFNCKKLSVIRLRGNSLNGNIP 216
D S+N LTGS+PSS + +C LSVIRLRGNS NG+IP
Sbjct: 303 DLSSNALTGSIPSSIGDLKSLRYLSLSNNKLFGIIPTSMVSCTMLSVIRLRGNSFNGSIP 362
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
EGLFDL LEE+D S+NG +GSIP GS T F +L LDLS NNL G IPAE GL +
Sbjct: 363 EGLFDLRLEEVDFSDNGLVGSIPSGSI-----TFFSSLHTLDLSKNNLTGHIPAERGLSS 417
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
NLRYLNLS N+L SR+P ELGYF +L LDLRN+AL G IP ++CES SL ILQLDGNSL
Sbjct: 418 NLRYLNLSWNNLESRMPLELGYFQNLTVLDLRNSALVGLIPADICESGSLNILQLDGNSL 477
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
G IP+ I NC+SLYLLSLS N+LSGSIP+SIS LNKLKILKLEFNEL+GEIPQELGKL
Sbjct: 478 VGQIPEEIGNCSSLYLLSLSQNNLSGSIPESISRLNKLKILKLEFNELTGEIPQELGKLE 537
Query: 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 456
+LLAVNVSYN+L+GRLPVGG+FP+LD+S+LQGNLG+CSPLLKGPCKMNVPKPLVLDP AY
Sbjct: 538 NLLAVNVSYNKLVGRLPVGGIFPSLDRSALQGNLGLCSPLLKGPCKMNVPKPLVLDPYAY 597
Query: 457 NSNQMDG----HIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLT 512
+ NQ DG ++ SH + HHHMF SVS I+AI AAI I GV+++SLLNVS R+RL
Sbjct: 598 D-NQGDGKKPRNVSSHP-ARFHHHMFLSVSTIIAISAAIFILFGVILVSLLNVSVRKRLA 655
Query: 513 FVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYK 572
FV+ LESMCSSSSRS NL+ GK++LFDS+SS D +PE LL KAAE+G GVFGTVYK
Sbjct: 656 FVDHALESMCSSSSRSGNLSTGKLVLFDSKSSP-DWISNPEALLNKAAEIGHGVFGTVYK 714
Query: 573 VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632
VS G++ RM+A+KKL T +IIQYPEDF+REV+VLGKARHPNL+SL+GYYWTPQL+LLVS+
Sbjct: 715 VSLGSEARMVAIKKLFTLNIIQYPEDFDREVQVLGKARHPNLLSLKGYYWTPQLQLLVSE 774
Query: 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692
YAPNGSLQAKLHER+PS P LSW NR K++LGTAKGLAHLHHSFRPPIIH ++KPSNILL
Sbjct: 775 YAPNGSLQAKLHERIPSAPRLSWANRLKIVLGTAKGLAHLHHSFRPPIIHCDIKPSNILL 834
Query: 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLI 752
D+N+NP+ISDFGLAR L +LD+HV+S RFQSALGYVAPEL+CQSLR+NEKCDIYGFG+LI
Sbjct: 835 DENFNPKISDFGLARFLAKLDRHVISTRFQSALGYVAPELSCQSLRINEKCDIYGFGILI 894
Query: 753 LELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCT 812
LELVTGRRPVEYGEDNV+IL +HVR LLE+GNV DCVDPSMGDYPEDEVLPVLKLALVCT
Sbjct: 895 LELVTGRRPVEYGEDNVLILKDHVRFLLEQGNVFDCVDPSMGDYPEDEVLPVLKLALVCT 954
Query: 813 CHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 843
HIPSSRPSMAEVVQILQVIKTP+PQR E F
Sbjct: 955 SHIPSSRPSMAEVVQILQVIKTPVPQRTEFF 985
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499695|ref|XP_003518672.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1125 bits (2909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 589/870 (67%), Positives = 699/870 (80%), Gaps = 37/870 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M +++FLDLS N SGPVP FE+C+SL ++SLA NI GPI + CSSLN++NLSN
Sbjct: 148 MNSIRFLDLSENSFSGPVPESFFESCSSLHHISLARNIFDGPIPGSLSRCSSLNSINLSN 207
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N FSG++DF+ GIWSL RLRTLDLS+N SGS+P G++++H KE+LLQGNQFSGPL
Sbjct: 208 NRFSGNVDFS---GIWSLNRLRTLDLSNNALSGSLPNGISSIHNFKEILLQGNQFSGPLS 264
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
DIGFC HL+ LD S+N +G+LP SL +L+S+ + SNN + P WIGN++ LE+L
Sbjct: 265 TDIGFCLHLSRLDFSDNQLSGELPESLGMLSSLSYFKASNNHFNSEFPQWIGNMTNLEYL 324
Query: 181 DFSNNHLTGSLP------------------------SSLFNCKKLSVIRLRGNSLNGNIP 216
+ SNN TGS+P SSL +C KLSV++LRGN NG IP
Sbjct: 325 ELSNNQFTGSIPQSIGELRSLTHLSISNNKLVGTIPSSLSSCTKLSVVQLRGNGFNGTIP 384
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
E LF LGLE+IDLS NG GSIPPGSS L +TL LDLS N+L G+IPAE GL +
Sbjct: 385 EALFGLGLEDIDLSHNGLSGSIPPGSS-----RLLETLTNLDLSDNHLQGNIPAETGLLS 439
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
LRYLNLS N L S++PPE G +L LDLRN+AL+GSIP ++C+S +L +LQLDGNS
Sbjct: 440 KLRYLNLSWNDLHSQMPPEFGLLQNLTVLDLRNSALHGSIPADICDSGNLAVLQLDGNSF 499
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
G IP I NC+SLYLLS SHN+L+GSIPKS++ LNKLKILKLEFNELSGEIP ELG L
Sbjct: 500 EGNIPSEIGNCSSLYLLSSSHNNLTGSIPKSMAKLNKLKILKLEFNELSGEIPMELGMLQ 559
Query: 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 456
SLLAVN+SYNRL GRLP +F LD+SSL+GNLG+CSPLLKGPCKMNVPKPLVLDP+AY
Sbjct: 560 SLLAVNISYNRLTGRLPTSSIFQNLDKSSLEGNLGLCSPLLKGPCKMNVPKPLVLDPNAY 619
Query: 457 NSNQMDGHIHSHSFSSN---HHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTF 513
N NQ+ + S + H H F SVSAIVAI A+ +I GV+ +SLLNVS RRRLTF
Sbjct: 620 N-NQISPQRQRNESSESGQVHRHRFLSVSAIVAISASFVIVLGVIAVSLLNVSVRRRLTF 678
Query: 514 VETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKV 573
V+ LESMCSSSSRS + A GK+ILFDS SS D +PE+LL KA+E+GEGVFGT+YKV
Sbjct: 679 VDNALESMCSSSSRSGSPATGKLILFDSHSSP-DWISNPESLLNKASEIGEGVFGTLYKV 737
Query: 574 SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633
G+QGRM+A+KKL++S+IIQYPEDF+REVR+LGKARHPNLI+L+GYYWTPQL+LLV+++
Sbjct: 738 PLGSQGRMVAIKKLISSNIIQYPEDFDREVRILGKARHPNLIALKGYYWTPQLQLLVTEF 797
Query: 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693
APNGSLQAKLHERLPS+PPLSW RFK++LGTAKGLAHLHHSFRPPIIHYN+KPSNILLD
Sbjct: 798 APNGSLQAKLHERLPSSPPLSWAIRFKILLGTAKGLAHLHHSFRPPIIHYNIKPSNILLD 857
Query: 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLIL 753
+NYN +ISDFGLARLLT+LD+HVMSNRFQSALGYVAPEL CQSLRVNEKCD+YGFGV+IL
Sbjct: 858 ENYNAKISDFGLARLLTKLDRHVMSNRFQSALGYVAPELACQSLRVNEKCDVYGFGVMIL 917
Query: 754 ELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTC 813
ELVTGRRPVEYGEDNV+IL++HVRVLLE GNVL+CVD SM +YPEDEVLPVLKLA+VCT
Sbjct: 918 ELVTGRRPVEYGEDNVLILNDHVRVLLEHGNVLECVDQSMSEYPEDEVLPVLKLAMVCTS 977
Query: 814 HIPSSRPSMAEVVQILQVIKTPLPQRMEVF 843
IPSSRP+MAEVVQILQVIKTP+PQRMEVF
Sbjct: 978 QIPSSRPTMAEVVQILQVIKTPVPQRMEVF 1007
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568921|ref|XP_003552656.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1123 bits (2904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/870 (67%), Positives = 703/870 (80%), Gaps = 37/870 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M ++KFLDLS N SGP+P FE+C+SL ++SLA N+ GP+ + CSSLN++NLSN
Sbjct: 148 MNSIKFLDLSENSFSGPMPESFFESCSSLHHISLARNMFDGPVPGSLSRCSSLNSINLSN 207
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
NHFSG++DF+ GIWSL RLRTLDLS+N SGS+P G++++H KE+LLQGNQFSGPL
Sbjct: 208 NHFSGNVDFS---GIWSLNRLRTLDLSNNALSGSLPNGISSVHNFKEILLQGNQFSGPLS 264
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
DIGFC HL LD S+N F+G+LP SL +L+S+ + SNN + P WIGN+++LE+L
Sbjct: 265 TDIGFCLHLNRLDFSDNQFSGELPESLGMLSSLSYFKASNNHFNSEFPQWIGNMTSLEYL 324
Query: 181 DFSNNHLTGSLP------------------------SSLFNCKKLSVIRLRGNSLNGNIP 216
+ SNN TGS+P SSL C KLSV++LRGN NG IP
Sbjct: 325 ELSNNQFTGSIPQSIGELRSLTHLSISNNMLVGTIPSSLSFCTKLSVVQLRGNGFNGTIP 384
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
EGLF LGLEEIDLS N GSIPPGSS L +TL LDLS N+L G+IPAE GL +
Sbjct: 385 EGLFGLGLEEIDLSHNELSGSIPPGSS-----RLLETLTHLDLSDNHLQGNIPAETGLLS 439
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
L +LNLS N L S++PPE G +L LDLRN+AL+GSIP ++C+S +L +LQLDGNS
Sbjct: 440 KLTHLNLSWNDLHSQMPPEFGLLQNLAVLDLRNSALHGSIPADICDSGNLAVLQLDGNSF 499
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
G IP I NC+SLYLLSLSHN+L+GSIPKS+S LNKLKILKLEFNELSGEIP ELG L
Sbjct: 500 EGNIPSEIGNCSSLYLLSLSHNNLTGSIPKSMSKLNKLKILKLEFNELSGEIPMELGMLQ 559
Query: 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 456
SLLAVN+SYNRL GRLP +F LD+SSL+GNLG+CSPLLKGPCKMNVPKPLVLDP+AY
Sbjct: 560 SLLAVNISYNRLTGRLPTSSIFQNLDKSSLEGNLGLCSPLLKGPCKMNVPKPLVLDPNAY 619
Query: 457 NSNQMDGHIHSHSFSSN---HHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTF 513
N NQ+ ++ S + H H F SVSAIVAI A+ +I GV+ +SLLNVS RRRLTF
Sbjct: 620 N-NQISPQRQTNESSESGPVHRHRFLSVSAIVAISASFVIVLGVIAVSLLNVSVRRRLTF 678
Query: 514 VETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKV 573
++ LESMCSSSSRS + A GK+ILFDS+SS D +PE+LL KA+E+GEGVFGT+YKV
Sbjct: 679 LDNALESMCSSSSRSGSPATGKLILFDSQSSP-DWISNPESLLNKASEIGEGVFGTLYKV 737
Query: 574 SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633
G+QGRM+A+KKL++++IIQYPEDF+REVR+LGKARHPNLI+L+GYYWTPQL+LLV+++
Sbjct: 738 PLGSQGRMVAIKKLISTNIIQYPEDFDREVRILGKARHPNLIALKGYYWTPQLQLLVTEF 797
Query: 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693
APNGSLQAKLHERLPS+PPLSW RFK++LGTAKGLAHLHHSFRPPIIHYN+KPSNILLD
Sbjct: 798 APNGSLQAKLHERLPSSPPLSWAIRFKILLGTAKGLAHLHHSFRPPIIHYNIKPSNILLD 857
Query: 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLIL 753
+NYN +ISDFGLARLLT+LD+HVMSNRFQSALGYVAPEL CQSLRVNEKCD+YGFGV+IL
Sbjct: 858 ENYNAKISDFGLARLLTKLDRHVMSNRFQSALGYVAPELACQSLRVNEKCDVYGFGVMIL 917
Query: 754 ELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTC 813
ELVTGRRPVEYGEDNV+IL++HVRVLLE+GNVL+CVD SM +YPEDEVLPVLKLA+VCT
Sbjct: 918 ELVTGRRPVEYGEDNVLILNDHVRVLLEQGNVLECVDQSMSEYPEDEVLPVLKLAMVCTS 977
Query: 814 HIPSSRPSMAEVVQILQVIKTPLPQRMEVF 843
IPSSRP+MAEVVQILQVIKTP+PQRMEVF
Sbjct: 978 QIPSSRPTMAEVVQILQVIKTPVPQRMEVF 1007
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469172|ref|XP_004152295.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1117 bits (2890), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 587/871 (67%), Positives = 693/871 (79%), Gaps = 41/871 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIF-NYCSSLNTLNLS 59
M +++FLD S+NLLSGP+P ++F NC+SL YLSLA N+LQGP+ C LNTLNLS
Sbjct: 147 MSSIRFLDFSDNLLSGPLPDEMFVNCSSLHYLSLASNMLQGPVPNTLPTRCLYLNTLNLS 206
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
N FSG L+FA G IWSL RLRTLDLS N FSG +PQG++A+H LKEL LQ NQFSGPL
Sbjct: 207 TNQFSGSLNFAPG--IWSLARLRTLDLSKNDFSGVLPQGISAIHNLKELKLQNNQFSGPL 264
Query: 120 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
P+D+G C HL TLD+S N TG LP S+RLL S+ F+++ N+ + ++P WIGN+ LE+
Sbjct: 265 PSDLGLCVHLATLDVSGNRLTGPLPNSMRLLTSLTFLNIGFNSFSDELPQWIGNMGRLEY 324
Query: 180 LDFS------------------------NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 215
+DFS NN LTG++P +L C +LSVI+L GNSLNG +
Sbjct: 325 MDFSSNGFTGSLPLTMGGLRSVKYMSFSNNKLTGNIPETLMECSELSVIKLEGNSLNGRV 384
Query: 216 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 275
PEGLF+LGLEE+DLS+N +GSIP GSS L++ L +DLSSN L G+ PAEMGL+
Sbjct: 385 PEGLFELGLEEMDLSKNELIGSIPVGSS-----RLYEKLTRMDLSSNRLEGNFPAEMGLY 439
Query: 276 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 335
NLRYLNLS N +++IPPE+G F +L LD+R++ LYGSIP E+C+S SL ILQLDGNS
Sbjct: 440 RNLRYLNLSWNEFKAKIPPEMGLFENLNVLDIRSSDLYGSIPGELCDSGSLKILQLDGNS 499
Query: 336 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 395
L GPIP I NC SLYLLSLSHN+LSG IPKSIS L+KL+IL+LE NELSGEIPQELG L
Sbjct: 500 LVGPIPDEIGNCLSLYLLSLSHNNLSGEIPKSISKLSKLEILRLESNELSGEIPQELGIL 559
Query: 396 ASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDA 455
+LLAVN+SYN L GRLPVGG+FP+LDQS+LQGNLG+CSPLLKGPCKMNVPKPLVLDP+A
Sbjct: 560 QNLLAVNISYNMLTGRLPVGGIFPSLDQSALQGNLGLCSPLLKGPCKMNVPKPLVLDPNA 619
Query: 456 YNSNQMDGHIHSHSFS--SNH--HHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRR- 510
Y NQM G + S SNH HH+FFSVSAIVAI AA LIA GVLVI+LLNVS RRR
Sbjct: 620 Y-PNQMGGQSSRNRPSQLSNHSSHHVFFSVSAIVAISAATLIALGVLVITLLNVSARRRS 678
Query: 511 LTFVETTLESMCSSSSRSVNLAAGKVILFDSRS-SSLDCSIDPETLLEKAAEVGEGVFGT 569
L FV+ LES SSS + AGK+ILFDS S +SL+ + E LL KA+E+G GVFGT
Sbjct: 679 LAFVDNALESCSSSSKSGT-VTAGKLILFDSNSKASLNWVSNHEALLNKASEIGGGVFGT 737
Query: 570 VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629
VYKVS G G + A+KKLV SDIIQ PEDF+RE+RVLGK +HPNLISL+GYYWT Q +LL
Sbjct: 738 VYKVSLGDGGDV-AMKKLVKSDIIQNPEDFDREIRVLGKVKHPNLISLKGYYWTVQTQLL 796
Query: 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689
V +YA NGSLQ +LH RLPS PPLSW NRFK++LGTAKGLAHLHHSFRPPI+HYNLKP+N
Sbjct: 797 VMEYANNGSLQTQLHGRLPSAPPLSWDNRFKIVLGTAKGLAHLHHSFRPPIVHYNLKPTN 856
Query: 690 ILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFG 749
ILLD+N+NP+ISD+GLARLLT+LDKHVM+NRFQSALGYVAPEL CQS+RVNEKCD++GFG
Sbjct: 857 ILLDENFNPKISDYGLARLLTKLDKHVMNNRFQSALGYVAPELACQSIRVNEKCDVHGFG 916
Query: 750 VLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLAL 809
V+ILE+VTGRRPVEYGEDNVVIL++HVR LLE GNVLDCVDPSM Y EDEV+P+LKLAL
Sbjct: 917 VMILEIVTGRRPVEYGEDNVVILTDHVRYLLERGNVLDCVDPSMTQYSEDEVVPILKLAL 976
Query: 810 VCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 840
VCT IPSSRPSMAEVVQILQVIK PLPQR+
Sbjct: 977 VCTSQIPSSRPSMAEVVQILQVIKAPLPQRI 1007
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449484810|ref|XP_004156987.1| PREDICTED: LOW QUALITY PROTEIN: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1115 bits (2883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/871 (67%), Positives = 692/871 (79%), Gaps = 41/871 (4%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIF-NYCSSLNTLNLS 59
M +++FLD S+NLLSGP+P ++F NC+SL YLSLA N+LQGP+ C LNTLNLS
Sbjct: 147 MSSIRFLDFSDNLLSGPLPDEMFVNCSSLHYLSLASNMLQGPVPNTLPTRCLYLNTLNLS 206
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
N FSG L+FA G IWSL RLRTLDLS N FSG +PQG++A+H LKEL LQ NQFSGPL
Sbjct: 207 TNQFSGSLNFAPG--IWSLARLRTLDLSKNDFSGVLPQGISAIHNLKELKLQNNQFSGPL 264
Query: 120 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
P+D+G C HL TLD+S N TG LP S+RLL S+ F+++ N+ + ++P WIGN+ LE+
Sbjct: 265 PSDLGLCVHLATLDVSGNRLTGPLPNSMRLLTSLTFLNIGFNSFSDELPQWIGNMGRLEY 324
Query: 180 LDFS------------------------NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 215
+DFS NN LTG++P +L C +LSVI+L GNSLNG +
Sbjct: 325 MDFSSNGFTGSLPLTMGGLRSVKYMSFSNNKLTGNIPETLMECSELSVIKLEGNSLNGRV 384
Query: 216 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 275
PEGLF+LGLEE+DLS+N +GSIP GSS L++ L +DLSSN L G+ PAEMGL+
Sbjct: 385 PEGLFELGLEEMDLSKNELIGSIPVGSS-----RLYEKLTRMDLSSNRLEGNFPAEMGLY 439
Query: 276 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 335
NLRYLNLS N +++IPPE+G F +L LD+R++ LYGSIP E+C+S SL ILQLDGNS
Sbjct: 440 RNLRYLNLSWNEFKAKIPPEMGLFENLNVLDIRSSDLYGSIPGELCDSGSLKILQLDGNS 499
Query: 336 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 395
L GPIP I NC SLYLLSLSHN+LSG IPKSIS L+KL+IL+LE NELSGEIPQELG L
Sbjct: 500 LVGPIPDEIGNCLSLYLLSLSHNNLSGEIPKSISKLSKLEILRLESNELSGEIPQELGIL 559
Query: 396 ASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDA 455
+LLAVN+SYN L GRLPVGG+FP+LDQS+LQGNLG+CSPLLKGPCKMNVPKPLVLDP+A
Sbjct: 560 QNLLAVNISYNMLTGRLPVGGIFPSLDQSALQGNLGLCSPLLKGPCKMNVPKPLVLDPNA 619
Query: 456 YNSNQMDGHIHSHSFS--SNH--HHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRR- 510
Y NQM G + S SNH HH+FFSVSAIVAI AA LIA GVLVI+LLNVS RRR
Sbjct: 620 Y-PNQMGGQSSRNRPSQLSNHSSHHVFFSVSAIVAISAATLIALGVLVITLLNVSARRRS 678
Query: 511 LTFVETTLESMCSSSSRSVNLAAGKVILFDSRS-SSLDCSIDPETLLEKAAEVGEGVFGT 569
L FV+ LES SSS + AGK+ILFDS S +SL+ + E LL KA+E+G GVFGT
Sbjct: 679 LAFVDNALESCSSSSKSGT-VTAGKLILFDSNSKASLNWVSNHEALLNKASEIGGGVFGT 737
Query: 570 VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629
VYKVS G G + A+KKLV SDIIQ PEDF+RE+RVLGK +HPNLISL+GYYWT Q +LL
Sbjct: 738 VYKVSLGDGGDV-AMKKLVKSDIIQNPEDFDREIRVLGKVKHPNLISLKGYYWTVQTQLL 796
Query: 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689
V +YA NGSLQ +LH RLPS PPLSW NRFK++LGTAKGLAHLHHSF PPI+HYNLKP+N
Sbjct: 797 VMEYANNGSLQTQLHGRLPSAPPLSWDNRFKIVLGTAKGLAHLHHSFXPPIVHYNLKPTN 856
Query: 690 ILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFG 749
ILLD+N+NP+ISD+GLARLLT+LDKHVM+NRFQSALGYVAPEL CQS+RVNEKCD++GFG
Sbjct: 857 ILLDENFNPKISDYGLARLLTKLDKHVMNNRFQSALGYVAPELACQSIRVNEKCDVHGFG 916
Query: 750 VLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLAL 809
V+ILE+VTGRRPVEYGEDNVVIL++HVR LLE GNVLDCVDPSM Y EDEV+P+LKLAL
Sbjct: 917 VMILEIVTGRRPVEYGEDNVVILTDHVRYLLERGNVLDCVDPSMTQYSEDEVVPILKLAL 976
Query: 810 VCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 840
VCT IPSSRPSMAEVVQILQVIK PLPQR+
Sbjct: 977 VCTSQIPSSRPSMAEVVQILQVIKAPLPQRI 1007
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357502883|ref|XP_003621730.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355496745|gb|AES77948.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1091 bits (2821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 572/849 (67%), Positives = 693/849 (81%), Gaps = 16/849 (1%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M +++F+DLS+N +G +P FENC SLR +SL+ N+ +G I + CS LN+++LSN
Sbjct: 178 MSSIRFIDLSHNSFAGQMPDGFFENCFSLRRVSLSMNLFEGQIPTTLSKCSLLNSVDLSN 237
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
NHFSG++DF+ +WSL RLR+LDLS+N SG++ G+++LH LKELLL+ NQFSG LP
Sbjct: 238 NHFSGNVDFSR---VWSLNRLRSLDLSNNALSGNLVNGISSLHNLKELLLENNQFSGQLP 294
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
DIGFC HL +DLS N F+G+LP S LNS+ ++ VSNN L G+ P WIGN+ +LE L
Sbjct: 295 NDIGFCLHLNRVDLSTNQFSGELPESFGRLNSLSYLRVSNNLLFGEFPQWIGNLISLEDL 354
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240
D S+N G++P SL +C KLS I LRGNS NG IPEGLF LGLEEID S N +GSIP
Sbjct: 355 DLSHNQFYGNIPLSLVSCTKLSKIFLRGNSFNGTIPEGLFGLGLEEIDFSHNELIGSIPA 414
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH 300
GS+ L +TL LDLS N+L G+IPAE+GL + LR+LNLS N L S+IPPE G
Sbjct: 415 GSNR-----LLETLTKLDLSVNHLQGNIPAEIGLLSKLRFLNLSWNDLHSQIPPEFGLLQ 469
Query: 301 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL 360
+L LDLRN+AL+GSIP++ C+S +L +LQLDGNSL G IP+ I NC+SLYLL LSHN+L
Sbjct: 470 NLEVLDLRNSALFGSIPEDTCDSGNLAVLQLDGNSLKGSIPEKIGNCSSLYLLGLSHNNL 529
Query: 361 SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPT 420
+G +PKS+SNLNKLKILKLEFNELSGE+P ELGKL +LLAVN+S+N L GRLP+G +F
Sbjct: 530 TGPVPKSMSNLNKLKILKLEFNELSGELPMELGKLQNLLAVNISHNSLTGRLPIGSIFQN 589
Query: 421 LDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHI----HSHSFSSNHHH 476
LD+SSL+GN G+CSPLL GPCKMNVPKPLVLDP YN +QM+ I S S S HHH
Sbjct: 590 LDKSSLEGNYGLCSPLLTGPCKMNVPKPLVLDPHGYN-DQMNPRIPRNESSESSSPIHHH 648
Query: 477 MFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKV 536
F S+SAI+AI A I+I GV+ ISL+N S RR+L FVE LESMCSSSSRS A GK+
Sbjct: 649 RFLSISAIIAISAIIVIVIGVIAISLVNASVRRKLAFVENALESMCSSSSRSGAPATGKL 708
Query: 537 ILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQ-GRMLAVKKLVTSDIIQY 595
ILFDS+SS D +PE LL KA+E+GEGVFGTV+KV G+Q GR +A+KKL+TS+I+QY
Sbjct: 709 ILFDSQSSP-DWISNPENLLNKASEIGEGVFGTVFKVPLGSQQGRNVAIKKLITSNILQY 767
Query: 596 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSW 655
PEDF+REVR+LG ARHPNLI+L+GYYWTPQL+LLVS++APNG+LQ+KLHE+LPS+PPLSW
Sbjct: 768 PEDFDREVRILGNARHPNLIALKGYYWTPQLQLLVSEFAPNGNLQSKLHEKLPSSPPLSW 827
Query: 656 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715
NRFK++LGTAKGLAHLHHSFRPPIIHYN+KPSNILLD+N+N +ISDFGLARLLT+LDKH
Sbjct: 828 PNRFKILLGTAKGLAHLHHSFRPPIIHYNIKPSNILLDENFNAKISDFGLARLLTKLDKH 887
Query: 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775
VMSNRFQSALGYVAPEL CQSLRVNEKCD+YGFGV+ILE+VTGRRPVEYGEDNV+IL++H
Sbjct: 888 VMSNRFQSALGYVAPELACQSLRVNEKCDVYGFGVMILEIVTGRRPVEYGEDNVLILNDH 947
Query: 776 VRVLLEEGNVLDCVDPS-MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
VRVLLE GN L+CVDPS M +YPEDEVLPVLKLA+VCT IPSSRP+MAEVVQILQVIKT
Sbjct: 948 VRVLLEHGNALECVDPSLMNEYPEDEVLPVLKLAMVCTSQIPSSRPTMAEVVQILQVIKT 1007
Query: 835 PLPQRMEVF 843
P+PQRMEVF
Sbjct: 1008 PVPQRMEVF 1016
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297815072|ref|XP_002875419.1| hypothetical protein ARALYDRAFT_484589 [Arabidopsis lyrata subsp. lyrata] gi|297321257|gb|EFH51678.1| hypothetical protein ARALYDRAFT_484589 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1027 bits (2655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 541/874 (61%), Positives = 671/874 (76%), Gaps = 43/874 (4%)
Query: 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF 63
++ LDL+ N SG + F NC+SLRYLSL+ N L+G I CS LN+LNLS N F
Sbjct: 150 LQHLDLTGNSFSGTLSDDFFNNCSSLRYLSLSHNHLEGQIPSTLFQCSVLNSLNLSRNRF 209
Query: 64 SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI 123
SG F SG+ W L+RLR LDLS N SGSIP G+ +LH LKEL LQ NQFSG LP+DI
Sbjct: 210 SGS--FVSGF--WRLERLRALDLSSNSLSGSIPLGILSLHNLKELQLQRNQFSGSLPSDI 265
Query: 124 GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
G CPHL +DLS NLF+G+LP +L+ L S+ +S N L+GD P WIG+++ L LDFS
Sbjct: 266 GLCPHLNRVDLSFNLFSGELPRTLQKLRSLNHFDLSKNLLSGDFPAWIGDMTGLVHLDFS 325
Query: 184 NNHLTGSLPS------------------------SLFNCKKLSVIRLRGNSLNGNIPEGL 219
+N LTG LPS SL +C++L +++L+GN +G+IP+GL
Sbjct: 326 SNELTGELPSLIGNLRSLKDLILSENKISGEIPESLESCQELMIVQLKGNGFSGSIPDGL 385
Query: 220 FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLR 279
FDLGL+E+D S NGF GSIP GSS LF++L+ LDLS NNL G IP E+GLF N+R
Sbjct: 386 FDLGLQEMDFSGNGFTGSIPRGSS-----RLFESLKRLDLSRNNLTGSIPGEVGLFINMR 440
Query: 280 YLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGP 339
YLNLS NH +R+PPE+ + +LI LDLR +AL GS+P ++CES+SL ILQLDGNSLTG
Sbjct: 441 YLNLSWNHFNTRVPPEIEFLQNLIVLDLRYSALIGSVPADICESQSLQILQLDGNSLTGS 500
Query: 340 IPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLL 399
IP+ I NC+SL LLSLSHN+L+G IPKS+SNL +LKILKLE N+LSGEIP+ELG+L +LL
Sbjct: 501 IPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQELKILKLEANKLSGEIPKELGELQNLL 560
Query: 400 AVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY-NS 458
VNVS+NRLIGRLPVGGVF +LDQS++QGNLGICSPLL+GPC +NVPKPLV+DP++Y +
Sbjct: 561 LVNVSFNRLIGRLPVGGVFQSLDQSAIQGNLGICSPLLRGPCTLNVPKPLVIDPNSYGHG 620
Query: 459 NQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTL 518
N M G+ S HH MF SVS IVAI AAILI GV++I+LLN S RRRL FV+ L
Sbjct: 621 NNMPGNRGSSGSGKFHHRMFLSVSVIVAISAAILIFSGVIIITLLNASVRRRLAFVDNAL 680
Query: 519 ESMCSSSSRS-VNLAAGKVILFDSRSSSL-----DCSIDPETLLEKAAEVGEGVFGTVYK 572
ES+ S SS+S +L GK++L +SR+S + +P++LL KA+ +GEGVFGTVYK
Sbjct: 681 ESIFSGSSKSGRSLMMGKLVLLNSRTSRSSSSSQEFERNPDSLLNKASRIGEGVFGTVYK 740
Query: 573 VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632
G QGR LAVKKLV S I+Q EDF+REVR+L KA+HPNL+S++GY+WTP+L LLVS+
Sbjct: 741 APLGEQGRNLAVKKLVPSPILQNLEDFDREVRILAKAKHPNLVSIKGYFWTPELHLLVSE 800
Query: 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692
Y PNG+LQ+KLHER PSTPPLSW R+++ILGTAKGLA+LHH+FRP IH+NLKP+NILL
Sbjct: 801 YIPNGNLQSKLHEREPSTPPLSWDVRYRIILGTAKGLAYLHHTFRPATIHFNLKPTNILL 860
Query: 693 DDNYNPRISDFGLARLLTRLDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVL 751
D+ NP+ISDFGL+RLLT D + M +NRFQ+ALGYVAPEL CQ+LRVNEKCD+YGFGVL
Sbjct: 861 DEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQNLRVNEKCDVYGFGVL 920
Query: 752 ILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALV 810
ILELVTGRRPVEYGED+ VILS+HVRV+LE+GNVL+C+DP M + Y EDEVLPVLKLALV
Sbjct: 921 ILELVTGRRPVEYGEDSFVILSDHVRVMLEQGNVLECIDPVMEEQYSEDEVLPVLKLALV 980
Query: 811 CTCHIPSSRPSMAEVVQILQVIKTPLP-QRMEVF 843
CT IPS+RP+MAE+VQILQVI +P+P Q M+ F
Sbjct: 981 CTSQIPSNRPTMAEIVQILQVINSPVPHQIMDSF 1014
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 843 | ||||||
| TAIR|locus:2091353 | 1016 | AT3G28040 [Arabidopsis thalian | 0.988 | 0.819 | 0.529 | 7.8e-229 | |
| TAIR|locus:2102499 | 964 | AT3G56370 [Arabidopsis thalian | 0.976 | 0.853 | 0.389 | 1.5e-152 | |
| TAIR|locus:2181042 | 967 | AT5G01890 [Arabidopsis thalian | 0.964 | 0.840 | 0.365 | 3.7e-135 | |
| TAIR|locus:2034725 | 882 | AT1G12460 [Arabidopsis thalian | 0.391 | 0.374 | 0.440 | 1e-111 | |
| TAIR|locus:2015504 | 890 | AT1G62950 [Arabidopsis thalian | 0.378 | 0.358 | 0.428 | 7.1e-109 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.516 | 0.429 | 0.293 | 2.8e-97 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.371 | 0.262 | 0.371 | 2.8e-92 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.514 | 0.394 | 0.334 | 5.2e-91 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.473 | 0.412 | 0.338 | 6.8e-89 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.520 | 0.454 | 0.320 | 7.5e-89 |
| TAIR|locus:2091353 AT3G28040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2208 (782.3 bits), Expect = 7.8e-229, P = 7.8e-229
Identities = 451/851 (52%), Positives = 577/851 (67%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXXXH 62
++++L LS+N L G +P LF C+ L L+L+ N G +
Sbjct: 174 SLRYLSLSHNHLEGQIPSTLFR-CSVLNSLNLSRNRFSGNPSFVSGIWRLERLRALDLS- 231
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
S L + GI SL L+ L L N FSG++P + +L + L N FSG LP
Sbjct: 232 -SNSLSGSIPLGILSLHNLKELQLQRNQFSGALPSDIGLCPHLNRVDLSSNHFSGELPRT 290
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+ L D+SNNL +G P + + ++ + S+N LTG +P I N+ +L+ L+
Sbjct: 291 LQKLKSLNHFDVSNNLLSGDFPPWIGDMTGLVHLDFSSNELTGKLPSSISNLRSLKDLNL 350
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGX 242
S N L+G +P SL +CK+L +++L+GN +GNIP+G FDLGL+E+D S NG GSIP G
Sbjct: 351 SENKLSGEVPESLESCKELMIVQLKGNDFSGNIPDGFFDLGLQEMDFSGNGLTGSIPRGS 410
Query: 243 XXXXXXTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302
LF++L LDLS N+L G IP E+GLF ++RYLNLS NH +R+PPE+ + +L
Sbjct: 411 SR-----LFESLIRLDLSHNSLTGSIPGEVGLFIHMRYLNLSWNHFNTRVPPEIEFLQNL 465
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTXXXXXXXXXXXXXX 362
LDLRN+AL GS+P ++CES+SL ILQLDGNSLTG IP+ I NC+
Sbjct: 466 TVLDLRNSALIGSVPADICESQSLQILQLDGNSLTGSIPEGIGNCSSLKLLSLSHNNLTG 525
Query: 363 XIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLD 422
IP E N+LSGEIP+ELG L +LL VNVS+NRLIGRLP+G VF +LD
Sbjct: 526 PIPKSLSNLQELKILKLEANKLSGEIPKELGDLQNLLLVNVSFNRLIGRLPLGDVFQSLD 585
Query: 423 QSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY-NSNQMDGXXXXXXXXXXXXXXXXXX 481
QS++QGNLGICSPLL+GPC +NVPKPLV++P++Y N N M G
Sbjct: 586 QSAIQGNLGICSPLLRGPCTLNVPKPLVINPNSYGNGNNMPGNRASGGSGTFHRRMFLSV 645
Query: 482 XXXXXXXXXXXXXXXXXXXSLLNVSTRRRLTFVETTLESMCSSSSRSV-NLAAGKVILFD 540
+LLN S RRRL FV+ LES+ S SS+S +L GK++L +
Sbjct: 646 SVIVAISAAILIFSGVIIITLLNASVRRRLAFVDNALESIFSGSSKSGRSLMMGKLVLLN 705
Query: 541 SR-----SSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY 595
SR SSS + +PE+LL KA+ +GEGVFGTVYK G QGR LAVKKLV S I+Q
Sbjct: 706 SRTSRSSSSSQEFERNPESLLNKASRIGEGVFGTVYKAPLGEQGRNLAVKKLVPSPILQN 765
Query: 596 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSW 655
EDF+REVR+L KA+HPNL+S++GY+WTP L LLVS+Y PNG+LQ+KLHER PSTPPLSW
Sbjct: 766 LEDFDREVRILAKAKHPNLVSIKGYFWTPDLHLLVSEYIPNGNLQSKLHEREPSTPPLSW 825
Query: 656 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715
R+K+ILGTAKGLA+LHH+FRP IH+NLKP+NILLD+ NP+ISDFGL+RLLT D +
Sbjct: 826 DVRYKIILGTAKGLAYLHHTFRPTTIHFNLKPTNILLDEKNNPKISDFGLSRLLTTQDGN 885
Query: 716 VMSN-RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
M+N RFQ+ALGYVAPEL CQ+LRVNEKCD+YGFGVLILELVTGRRPVEYGED+ VILS+
Sbjct: 886 TMNNNRFQNALGYVAPELECQNLRVNEKCDVYGFGVLILELVTGRRPVEYGEDSFVILSD 945
Query: 775 HVRVLLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
HVRV+LE+GNVL+C+DP M + Y EDEVLPVLKLALVCT IPS+RP+MAE+VQILQVI
Sbjct: 946 HVRVMLEQGNVLECIDPVMEEQYSEDEVLPVLKLALVCTSQIPSNRPTMAEIVQILQVIN 1005
Query: 834 TPLPQR-MEVF 843
+P+P R M+ F
Sbjct: 1006 SPVPHRIMDSF 1016
|
|
| TAIR|locus:2102499 AT3G56370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1488 (528.9 bits), Expect = 1.5e-152, P = 1.5e-152
Identities = 331/850 (38%), Positives = 467/850 (54%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXX 60
++N+K +DLS+N LSG +P + F C SLR LSLA N L G I + C
Sbjct: 117 LVNLKVVDLSSNGLSGSLPDEFFRQCGSLRVLSLAKNKLTGKIPVSISSCSSLAALNLSS 176
Query: 61 XHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
FSG + GIWSL LR+LDLS N G P+ + L+ L+ L L N+ SGP+P
Sbjct: 177 NGFSGSMPL----GIWSLNTLRSLDLSRNELEGEFPEKIDRLNNLRALDLSRNRLSGPIP 232
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
++IG C L T+DLS N +G LP + + L+ +++ N L G++P WIG + +LE L
Sbjct: 233 SEIGSCMLLKTIDLSENSLSGSLPNTFQQLSLCYSLNLGKNALEGEVPKWIGEMRSLETL 292
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGFMGSIP 239
D S N +G +P S+ N L V+ GN L G++P + + L +DLS N G +P
Sbjct: 293 DLSMNKFSGQVPDSIGNLLALKVLNFSGNGLIGSLPVSTANCINLLALDLSGNSLTGKLP 352
Query: 240 PGXXXXXXXTL-----------FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHL 288
+ + +++LDLS N G+I A +G +L L+LS N L
Sbjct: 353 MWLFQDGSRDVSALKNDNSTGGIKKIQVLDLSHNAFSGEIGAGLGDLRDLEGLHLSRNSL 412
Query: 289 RSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCT 348
IP +G L LD+ +N L G IP+E + SL L+L+ N L G IP I+NC+
Sbjct: 413 TGPIPSTIGELKHLSVLDVSHNQLNGMIPRETGGAVSLEELRLENNLLEGNIPSSIKNCS 472
Query: 349 XXXXXXXXXXXXXXXIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLASLLAVNVSYNRL 408
IP FNEL+G +P++L L L N+S+N L
Sbjct: 473 SLRSLILSHNKLLGSIPPELAKLTRLEEVDLSFNELAGTLPKQLANLGYLHTFNISHNHL 532
Query: 409 IGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGXXXXX 468
G LP GG+F L SS+ GN GIC ++ C PKP+VL+P+A + +G
Sbjct: 533 FGELPAGGIFNGLSPSSVSGNPGICGAVVNKSCPAISPKPIVLNPNA-TFDPYNGEIVPP 591
Query: 469 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXSLLNV--STRRRLTFVETTLESMCSSSS 526
L V ST R T S S
Sbjct: 592 GAGHKRILLSISSLIAISAAAAIVVGVIAITVLNLRVRASTVSRSAVPLTFSGGDDFSRS 651
Query: 527 RSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKK 586
+ + +GK+++F S D S LL K E+G G FG VY+ G +A+KK
Sbjct: 652 PTTDSNSGKLVMF---SGEPDFSTGTHALLNKDCELGRGGFGAVYRTVI-RDGYPVAIKK 707
Query: 587 LVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHER 646
L S +++ ++FEREV+ LGK RH NL+ LEGYYWT L+LL+ ++ GSL +LHE
Sbjct: 708 LTVSSLVKSQDEFEREVKKLGKLRHSNLVKLEGYYWTTSLQLLIYEFLSGGSLYKQLHEA 767
Query: 647 LPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706
LSW +RF +ILGTAK LA+LH S IIHYN+K SN+LLD + P++ D+GLA
Sbjct: 768 PGGNSSLSWNDRFNIILGTAKCLAYLHQS---NIIHYNIKSSNVLLDSSGEPKVGDYGLA 824
Query: 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 766
RLL LD++V+S++ QSALGY+APE C+++++ EKCD+YGFGVL+LE+VTG++PVEY E
Sbjct: 825 RLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKKPVEYME 884
Query: 767 DNVVILSEHVRVLLEEGNVLDCVDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 825
D+VV+L + VR LE+G +C+DP + G +P +E + V+KL L+CT +PSSRP M E
Sbjct: 885 DDVVVLCDMVREALEDGRADECIDPRLQGKFPVEEAVAVIKLGLICTSQVPSSRPHMGEA 944
Query: 826 VQILQVIKTP 835
V IL++I+ P
Sbjct: 945 VNILRMIRCP 954
|
|
| TAIR|locus:2181042 AT5G01890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1324 (471.1 bits), Expect = 3.7e-135, P = 3.7e-135
Identities = 307/841 (36%), Positives = 453/841 (53%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXXXH 62
+++ + L+NN L+G +P L C++L +L+L+ N L G + + +
Sbjct: 142 SLRSVSLANNKLTGSIPVSL-SYCSTLTHLNLSSNQLSGRLPRDIWFLKSLKSLDFSHNF 200
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
GD+ G G++ L R ++LS N FSG +P + LK L L N FSG LP
Sbjct: 201 LQGDIPDGLG-GLYDL---RHINLSRNWFSGDVPSDIGRCSSLKSLDLSENYFSGNLPDS 256
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+ +++ L N G++P + + ++ + +S N TG +P +GN+ L+ L+
Sbjct: 257 MKSLGSCSSIRLRGNSLIGEIPDWIGDIATLEILDLSANNFTGTVPFSLGNLEFLKDLNL 316
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGX 242
S N L G LP +L NC L I + NS G++ + +F E LS F G
Sbjct: 317 SANMLAGELPQTLSNCSNLISIDVSKNSFTGDVLKWMFTGNSESSSLSR--FSLHKRSGN 374
Query: 243 XXXXXXTLF-QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
F Q LR+LDLSSN G++P+ + + +L LN+S+N L IP +G
Sbjct: 375 DTIMPIVGFLQGLRVLDLSSNGFTGELPSNIWILTSLLQLNMSTNSLFGSIPTGIGGLKV 434
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTXXXXXXXXXXXXX 361
LDL +N L G++P E+ + SL L L N L+G IP I NC+
Sbjct: 435 AEILDLSSNLLNGTLPSEIGGAVSLKQLHLHRNRLSGQIPAKISNCSALNTINLSENELS 494
Query: 362 XXIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTL 421
IP N LSG +P+E+ KL+ LL N+S+N + G LP GG F T+
Sbjct: 495 GAIPGSIGSLSNLEYIDLSRNNLSGSLPKEIEKLSHLLTFNISHNNITGELPAGGFFNTI 554
Query: 422 DQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGXXXXXXXXXXXXXXXXXX 481
S++ GN +C ++ C PKP+VL+P++ SN +G
Sbjct: 555 PLSAVTGNPSLCGSVVNRSCLSVHPKPIVLNPNS--SNPTNGPALTGQIRKSVLSISALI 612
Query: 482 XXXXXXXXXXXXXXXXXXXSLLNVSTRRRLTFVETTLESMCS-----SSSRSVNLAAGKV 536
+LLNV R ++ + S S S S + GK+
Sbjct: 613 AIGAAAVIAIGVVAV----TLLNVHARSSVSRHDAAAALALSVGETFSCSPSKDQEFGKL 668
Query: 537 ILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP 596
++F D + + LL K +E+G G FG VYK S GR +AVKKL S +I+
Sbjct: 669 VMFSGEVDVFDTT-GADALLNKDSELGRGGFGVVYKTSL-QDGRPVAVKKLTVSGLIKSQ 726
Query: 597 EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656
E+FERE+R LGK RH N++ ++GYYWT L+LL+ ++ GSL LH + L+W
Sbjct: 727 EEFEREMRKLGKLRHKNVVEIKGYYWTQSLQLLIHEFVSGGSLYRHLHG--DESVCLTWR 784
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDKH 715
RF +ILG A+GLA LH S I HYN+K +N+L+D ++SDFGLARLL + LD+
Sbjct: 785 QRFSIILGIARGLAFLHSS---NITHYNMKATNVLIDAAGEAKVSDFGLARLLASALDRC 841
Query: 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775
V+S + QSALGY APE C+++++ ++CD+YGFG+L+LE+VTG+RPVEY ED+VV+L E
Sbjct: 842 VLSGKVQSALGYTAPEFACRTVKITDRCDVYGFGILVLEVVTGKRPVEYAEDDVVVLCET 901
Query: 776 VRVLLEEGNVLDCVDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
VR LEEG V +CVDP + G++P +E +PV+KL LVC +PS+RP M EVV+IL++I+
Sbjct: 902 VREGLEEGRVEECVDPRLRGNFPAEEAIPVIKLGLVCGSQVPSNRPEMEEVVKILELIQC 961
Query: 835 P 835
P
Sbjct: 962 P 962
|
|
| TAIR|locus:2034725 AT1G12460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 708 (254.3 bits), Expect = 1.0e-111, Sum P(2) = 1.0e-111
Identities = 151/343 (44%), Positives = 223/343 (65%)
Query: 503 LNVSTRRRLTFVET-TLESM-CSSSSRSVNLAAGKVILFDSRSSSL--DCSIDPETLLEK 558
LN+ R+R E T+E+ +SS S + GK++LF S D + LL+K
Sbjct: 536 LNLRARKRRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALLDK 595
Query: 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+G G G+VY+ SF G +AVKKL T I+ E+FE+E+ LG +HPNL S +
Sbjct: 596 ENIIGMGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSFQ 654
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERL-PSTPP------LSWTNRFKVILGTAKGLAH 671
GYY++ ++L++S++ PNGSL LH R+ P T L+W RF++ LGTAK L+
Sbjct: 655 GYYFSSTMQLILSEFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKALSF 714
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
LH+ +P I+H N+K +NILLD+ Y ++SD+GL + L +D ++ +F +A+GY+APE
Sbjct: 715 LHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAPE 774
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-VVILSEHVRVLLEEGNVLDCVD 790
L QSLR +EKCD+Y +GV++LELVTGR+PVE +N V+IL ++VR LLE G+ DC D
Sbjct: 775 LAQQSLRASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCFD 834
Query: 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
+ ++ E+E++ V+KL L+CT P RPSMAEVVQ+L+ I+
Sbjct: 835 RRLREFEENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIR 877
|
|
| TAIR|locus:2015504 AT1G62950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 7.1e-109, Sum P(2) = 7.1e-109
Identities = 144/336 (42%), Positives = 215/336 (63%)
Query: 511 LTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSL--DCSIDPETLLEKAAEVGEGVFG 568
+TF +TT + S+ S + + GK++LF S D + LL+K +G G G
Sbjct: 554 VTF-DTTTPTQASTESGNGGVTFGKLVLFSKSLPSKYEDWEAGTKALLDKDNIIGIGSIG 612
Query: 569 TVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628
VY+ SF G +AVKKL T I+ E+FE+E+ LG HPNL S +GYY++ ++L
Sbjct: 613 AVYRASF-EGGVSIAVKKLETLGRIRNQEEFEQEIGRLGSLSHPNLASFQGYYFSSTMQL 671
Query: 629 LVSDYAPNGSLQAKLHERLP----------STPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
++S++ NGSL LH R+ L+W RF++ +GTAK L+ LH+ +P
Sbjct: 672 ILSEFVTNGSLYDNLHPRVSHRTSSSSSSHGNTELNWHRRFQIAVGTAKALSFLHNDCKP 731
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
I+H N+K +NILLD+ Y ++SD+GL + L L+ ++ +F +A+GY+APEL QSLR
Sbjct: 732 AILHLNVKSTNILLDERYEAKLSDYGLEKFLPVLNSSGLT-KFHNAVGYIAPELA-QSLR 789
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDN-VVILSEHVRVLLEEGNVLDCVDPSMGDYP 797
V++KCD+Y +GV++LELVTGR+PVE +N VVIL +HVR LLE G+ DC D + +
Sbjct: 790 VSDKCDVYSYGVVLLELVTGRKPVESPSENEVVILRDHVRNLLETGSASDCFDRRLRGFE 849
Query: 798 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
E+E++ V+KL L+CT P RPS+AEVVQ+L++I+
Sbjct: 850 ENELIQVMKLGLICTTENPLKRPSIAEVVQVLELIR 885
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 2.8e-97, Sum P(2) = 2.8e-97
Identities = 135/460 (29%), Positives = 215/460 (46%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXX 60
+++++ LDL N G +P F+N LR+L L+GN L G + +
Sbjct: 163 LVSLEVLDLRGNFFQGSLPSS-FKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGY 221
Query: 61 XHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
F G + G ++ L+ LDL+ SG IP + L L+ LLL N F+G +P
Sbjct: 222 NEFKGPIPPEFG----NINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIP 277
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+IG L LD S+N TG++P+ + L ++ +++ N L+G IP I +++ L+ L
Sbjct: 278 REIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVL 337
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIP 239
+ NN L+G LPS L L + + NS +G IP L + G L ++ L N F G IP
Sbjct: 338 ELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIP 397
Query: 240 PGXXXXXXXTL------------------FQTLRILDLSSNNLVGDIPAEMGLFANLRYL 281
+ L+ L+L+ N L G IP ++ +L ++
Sbjct: 398 ATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFI 457
Query: 282 NLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP 341
+ S N +RS +P + H+L + +N + G +P + + SL L L N+LTG IP
Sbjct: 458 DFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIP 517
Query: 342 QVIRNCTXXXXXXXXXXXXXXXIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLASLLAV 401
I +C IP N L+G +P+ +G +L +
Sbjct: 518 SSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELL 577
Query: 402 NVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 441
NVSYN+L G +P+ G T++ L+GN G+C +L PC
Sbjct: 578 NVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLP-PC 616
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 2.8e-92, Sum P(2) = 2.8e-92
Identities = 121/326 (37%), Positives = 181/326 (55%)
Query: 513 FVETTLESMCSSSSR---SVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGT 569
FV+ L + S SR S+N+A + L R + ++ K +G+G FGT
Sbjct: 874 FVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDI---VEATDHFSKKNIIGDGGFGT 930
Query: 570 VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629
VYK + + +AVKKL + Q +F E+ LGK +HPNL+SL GY + KLL
Sbjct: 931 VYKACLPGE-KTVAVKKLSEAKT-QGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLL 988
Query: 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689
V +Y NGSL L + L W+ R K+ +G A+GLA LHH F P IIH ++K SN
Sbjct: 989 VYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASN 1048
Query: 690 ILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFG 749
ILLD ++ P+++DFGLARL++ + HV S GY+ PE QS R K D+Y FG
Sbjct: 1049 ILLDGDFEPKVADFGLARLISACESHV-STVIAGTFGYIPPEYG-QSARATTKGDVYSFG 1106
Query: 750 VLILELVTGRRPV--EYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP-EDEVLPVLK 806
V++LELVTG+ P ++ E L + +G +D +DP + ++ L +L+
Sbjct: 1107 VILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQ 1166
Query: 807 LALVCTCHIPSSRPSMAEVVQILQVI 832
+A++C P+ RP+M +V++ L+ I
Sbjct: 1167 IAMLCLAETPAKRPNMLDVLKALKEI 1192
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 523 (189.2 bits), Expect = 5.2e-91, Sum P(2) = 5.2e-91
Identities = 150/448 (33%), Positives = 206/448 (45%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXX 60
+ MK L L N L+G +P ++ N + + N L G I K F +
Sbjct: 282 LTKMKRLYLYTNQLTGEIPREI-GNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFE 340
Query: 61 XHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
G + G L L LDLS N +G+IPQ + L YL +L L NQ G +P
Sbjct: 341 NILLGPIPRELG----ELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIP 396
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
IGF + + LD+S N +G +P ++I +S+ +N L+G+IP + +L L
Sbjct: 397 PLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKL 456
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIP 239
+N LTGSLP LFN + L+ + L N L+GNI L L LE + L+ N F G IP
Sbjct: 457 MLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIP 516
Query: 240 PGXXXXXXXTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
P F ++SSN L G IP E+G ++ L+LS N I ELG
Sbjct: 517 PEIGNLTKIVGF------NISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQL 570
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTXXXXXXXXXXX 359
L L L +N L G IP + L LQL GN L+ IP + T
Sbjct: 571 VYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHN 630
Query: 360 XXX-XIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVF 418
IP N+LSGEIP +G L SLL N+S N L+G +P VF
Sbjct: 631 NLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVF 690
Query: 419 PTLDQSSLQGNLGICSPLLKGPCKMNVP 446
+D S+ GN G+C+ + C+ VP
Sbjct: 691 QRMDSSNFAGNHGLCNSQ-RSHCQPLVP 717
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 6.8e-89, Sum P(2) = 6.8e-89
Identities = 140/414 (33%), Positives = 191/414 (46%)
Query: 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXXX 61
+N+ L+LSN L G + L + +L+ + L GN L G I C
Sbjct: 73 LNVVSLNLSNLNLGGEISSALGD-LMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTN 131
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPA 121
GD+ F+ I LK+L L+L +N +G IP + + LK L L NQ +G +P
Sbjct: 132 LLFGDIPFS----ISKLKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDLARNQLTGEIPR 187
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
+ + L L L N+ TG L + L + + V N LTG IP IGN ++ E LD
Sbjct: 188 LLYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILD 247
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE--GLFDLGLEEIDLSENGFMGSIP 239
S N +TG +P ++ +++ + L+GN L G IPE GL L +DLS+N G IP
Sbjct: 248 VSYNQITGVIPYNI-GFLQVATLSLQGNKLTGRIPEVIGLMQ-ALAVLDLSDNELTGPIP 305
Query: 240 PGXXXXXXXTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
P L T ++ L N L G IP E+G + L YL L+ N L +IPPELG
Sbjct: 306 P-----ILGNLSFTGKLY-LHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKL 359
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTXXXXXXXXXXX 359
L L+L NN L G IP + +L + GN L+G +P RN
Sbjct: 360 EQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNS 419
Query: 360 XXXXIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413
IP N SG IP LG L LL +N+S N L G LP
Sbjct: 420 FKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLP 473
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 7.5e-89, Sum P(2) = 7.5e-89
Identities = 147/459 (32%), Positives = 210/459 (45%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXXXHFSGD 66
L+LS+ L G + + + +L+ + L GN L G I C GD
Sbjct: 76 LNLSSLNLGGEISPAIGD-LRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGD 134
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 126
+ F+ I LK+L TL+L +N +G +P + + LK L L GN +G + + +
Sbjct: 135 IPFS----ISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWN 190
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186
L L L N+ TG L + L + + V N LTG IP IGN ++ + LD S N
Sbjct: 191 EVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQ 250
Query: 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE--GLFDLGLEEIDLSENGFMGSIPPGXXX 244
+TG +P ++ +++ + L+GN L G IPE GL L +DLS+N +G IPP
Sbjct: 251 ITGEIPYNI-GFLQVATLSLQGNRLTGRIPEVIGLMQ-ALAVLDLSDNELVGPIPP---- 304
Query: 245 XXXXTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIH 304
L T ++ L N L G IP+E+G + L YL L+ N L IPPELG L
Sbjct: 305 -ILGNLSFTGKLY-LHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFE 362
Query: 305 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTXXXXXXXXXXXXXXXI 364
L+L NN L G IP + +L + GN L+G IP RN I
Sbjct: 363 LNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKI 422
Query: 365 PXXXXXXXXXXXXXXEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQS 424
P N SG IP LG L LL +N+S N L G+LP F L
Sbjct: 423 PVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAE--FGNL--R 478
Query: 425 SLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDG 463
S+Q + + LL G + + L+ N+N++ G
Sbjct: 479 SIQ-MIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHG 516
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LRT1 | Y3804_ARATH | No assigned EC number | 0.6174 | 0.9881 | 0.8198 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 843 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-91 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-52 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.003 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.004 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.004 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = 1e-91
Identities = 256/839 (30%), Positives = 392/839 (46%), Gaps = 91/839 (10%)
Query: 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF 63
++FL L++N L G +P +L + SL+++ L N L G I +SLN L+L N+
Sbjct: 190 LEFLTLASNQLVGQIPRELGQ-MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 64 SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI 123
+G + + G +LK L+ L L N SG IP + +L L L L N SG +P +
Sbjct: 249 TGPIPSSLG----NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304
Query: 124 GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
+L L L +N FTG++PV+L L + + + +N +G+IP +G + L LD S
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364
Query: 184 NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGS 242
N+LTG +P L + L + L NSL G IP+ L L + L +N F G +P
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP--- 421
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302
S T + LD+S+NNL G I + +L+ L+L+ N +P G L
Sbjct: 422 ---SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRL 477
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG 362
+LDL N G++P+++ L L+L N L+G IP + +C L L LSHN LSG
Sbjct: 478 ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537
Query: 363 SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLD 422
IP S S + L L L N+LSGEIP+ LG + SL+ VN+S+N L G LP G F ++
Sbjct: 538 QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAIN 597
Query: 423 QSSLQGNLGICSPLLKG---PCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFF 479
S++ GN+ +C PCK P F+
Sbjct: 598 ASAVAGNIDLCGGDTTSGLPPCKRVRKTPS--------------------------WWFY 631
Query: 480 SVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILF 539
+ A + L+A G + I N +R+ + T E F
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQ----------------FF 675
Query: 540 DSRSSSLDCSIDPETLLEKAAE---VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP 596
DS+ S SI +L E + G G YK G VK++ + I P
Sbjct: 676 DSKVSK---SITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--P 730
Query: 597 EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656
+ +GK +HPN++ L G + + L+ +Y +L L LSW
Sbjct: 731 SSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWE 780
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
R K+ +G AK L LH P ++ NL P I++D P + L LL
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------C 833
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP--VEYGEDNVVILSE 774
+ + YVAPE T ++ + EK DIYGFG++++EL+TG+ P E+G ++ E
Sbjct: 834 TDTKCFISSAYVAPE-TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--E 890
Query: 775 HVRVLLEEGNVLDCVDPSMGDYP---EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
R + ++ +DPS+ ++E++ V+ LAL CT P++RP +V++ L+
Sbjct: 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 3e-52
Identities = 124/373 (33%), Positives = 188/373 (50%), Gaps = 60/373 (16%)
Query: 44 GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH 103
G N S + +++LS + SG + A I+ L ++T++LS+N SG IP +
Sbjct: 62 GITCNNSSRVVSIDLSGKNISGKISSA----IFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 104 Y-LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162
L+ L L N F+G +P G P+L TLDLSNN+ +G++P + +S+ + + N
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
Query: 163 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 222
L G IP+ + N+++LEFL ++N L G +P L K L I L N+L+G IP + L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 223 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLN 282
+L LDL NNL G IP+ +G NL+YL
Sbjct: 236 -----------------------------TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
Query: 283 LSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ 342
L N L IPP + LI LDL +N+L G IP+ V + ++L IL L N+ TG
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTG---- 322
Query: 343 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVN 402
IP ++++L +L++L+L N+ SGEIP+ LGK +L ++
Sbjct: 323 --------------------KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362
Query: 403 VSYNRLIGRLPVG 415
+S N L G +P G
Sbjct: 363 LSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 9e-51
Identities = 134/406 (33%), Positives = 193/406 (47%), Gaps = 59/406 (14%)
Query: 25 NCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84
N + + + L+G + G I + T+NLSNN SG + S LR L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSS---LRYL 123
Query: 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP 144
+LS+N F+GSIP+ G P+L TLDLSNN+ +G++P
Sbjct: 124 NLSNNNFTGSIPR--------------------------GSIPNLETLDLSNNMLSGEIP 157
Query: 145 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 204
+ +S+ + + N L G IP+ + N+++LEFL ++N L G +P L K L I
Sbjct: 158 NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217
Query: 205 RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 264
L N+L+G IP + L +L LDL NNL
Sbjct: 218 YLGYNNLSGEIPYEIGGL-----------------------------TSLNHLDLVYNNL 248
Query: 265 VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESR 324
G IP+ +G NL+YL L N L IPP + LI LDL +N+L G IP+ V + +
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308
Query: 325 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384
+L IL L N+ TG IP + + L +L L N SG IPK++ N L +L L N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 385 SGEIPQELGKLASLLAVNVSYNRLIGRLPVG-GVFPTLDQSSLQGN 429
+GEIP+ L +L + + N L G +P G +L + LQ N
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+GEG FGTVY G+ +A+K + D E+ RE+ +L K HPN++ L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 681
LV +Y GSL+ L E LS +++L +GL +LH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 682 HYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
H +LKP NILLD DN +++DFGL++LLT + Y+APE+ +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 741 EKCDIYGFGVLILEL 755
EK DI+ GV++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 74/267 (27%), Positives = 121/267 (45%), Gaps = 22/267 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
++GEG FG VY G+++A+K + I + E RE+++L K +HPN++ L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ LV +Y G L L +R + + + L +LH I
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLHSKG---I 118
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
+H +LKP NILLD++ + +++DFGLAR LD F Y+APE+
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEV-LLGKGYG 174
Query: 741 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 800
+ DI+ GV++ EL+TG+ P G+D ++ L + + P D E
Sbjct: 175 KAVDIWSLGVILYELLTGKPPF-PGDDQLLELFKKIGKPKPP------FPPPEWDIS-PE 226
Query: 801 VLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+++ LV P R + E +Q
Sbjct: 227 AKDLIRKLLVKD---PEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 18/267 (6%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G FGTVYK G+++AVK L + + RE+R+L + HPN++ L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ LV +Y G L L PLS K+ L +GL +LH + I
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
IH +LKP NILLD+N +I+DFGLA+ L + + + F Y+APE+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177
Query: 741 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 800
K D++ GV++ EL+TG+ P + +N++ + +R +L
Sbjct: 178 PKVDVWSLGVILYELLTGKPP--FSGENILDQLQLIR------RILGPPLEFDEPKWSSG 229
Query: 801 VLPVLKLALVCTCHIPSSRPSMAEVVQ 827
L C PS RP+ E++Q
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 27/279 (9%)
Query: 561 EVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
++GEG FG VYK + +AVK L + +DF +E RV+ K HPN++ L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHER-----LPSTPPLSWTNRFKVILGTAKGLAHL 672
G + LV +Y G L L + P LS + + AKG+ +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
+H +L N L+ ++ +ISDFGL+R + D + + + ++APE
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE- 177
Query: 733 TCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
+ + K D++ FGVL+ E+ T G P Y + +E V L +G L P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPG----LSNEEVLEYLRKGYRLPK--P 229
Query: 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
P++ + +L L C P RP+ +E+V+ L+
Sbjct: 230 E--YCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 85/281 (30%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 554 TLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
TL +K +GEG FG VYK + +AVK L Q E+F RE R++ K
Sbjct: 2 TLGKK---LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
HPN++ L G + ++V +Y P G L L + P LS ++ L A+G+
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGM 116
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
+L IH +L N L+ +N +ISDFGL+R L D + + + + ++A
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMA 172
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
PE + + + K D++ FGVL+ E+ T G P Y + + V L++G L
Sbjct: 173 PE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPG----MSNAEVLEYLKKGYRLPK 225
Query: 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
P + + KL L C P RP+ +E+V+IL
Sbjct: 226 --------PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 85/281 (30%), Positives = 130/281 (46%), Gaps = 30/281 (10%)
Query: 554 TLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
TL +K +GEG FG VYK G + +AVK L Q E+F RE R++ K
Sbjct: 2 TLGKK---LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
HPN++ L G + +V +Y G L + L + P LS ++ L A+G+
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGM 115
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
+L IH +L N L+ +N +ISDFGL+R L D + + + ++A
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMA 171
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
PE + + + K D++ FGVL+ E+ T G +P Y + E V L+ G L
Sbjct: 172 PE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSN----EEVLEYLKNGYRLPQ 224
Query: 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
P + + L L C P RP+ +E+V+IL
Sbjct: 225 --------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 79/274 (28%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 561 EVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
++GEG FG VYK +AVK L + E+F E ++ K HPN++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
L G + +V++Y P G L L + L+ + ++ L AKG+ +L
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
+H +L N L+ +N +ISDFGL+R + D + + + ++APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL-KD 178
Query: 737 LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795
+ K D++ FGVL+ E+ T G +P G N E V LLE+G L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSN-----EEVLELLEDGYRLPR------- 225
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
PE+ + +L L C + P RP+ +E+V+ L
Sbjct: 226 -PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G FG+VY G ++AVK + ++ D + E ERE+R+L +HPN++ G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 621 YWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSF 676
+ + +Y GSL + L + P+ +T + IL +GLA+LH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ---IL---EGLAYLH--- 118
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
I+H ++K +NIL+D + +++DFG A+ L ++ + + ++APE+ +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRG 177
Query: 737 LRVNEKCDIYGFGVLILELVTGRRP 761
DI+ G ++E+ TG+ P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL 614
L E ++G+G FG VYK G+ +A+K + + E E+++L K +HPN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNI 59
Query: 615 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
+ G Y + +L +V ++ GSL+ L L+ + V KGL +LH
Sbjct: 60 VKYYGSY-LKKDELWIVMEFCSGGSLKDLLKSTNQ---TLTESQIAYVCKELLKGLEYLH 115
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 732
S IIH ++K +NILL + ++ DFGL+ +L N ++APE +
Sbjct: 116 -SNG--IIHRDIKAANILLTSDGEVKLIDFGLS---AQLSDTKARNTMVGTPYWMAPEVI 169
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 768
+ + K DI+ G+ +EL G+ P Y E
Sbjct: 170 NGK--PYDYKADIWSLGITAIELAEGKPP--YSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
++G+G FG VY V + G++ +K++ +++ + ED EV++L K HPN+I
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ +V +YA G L K+ ++ P + L +LH S +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRK-- 123
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
I+H ++KP NI L N ++ DFG++++L+ ++ Y++PEL CQ+
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPEL-CQNKPY 180
Query: 740 NEKCDIYGFGVLILELVTGRRP 761
N K DI+ G ++ EL T + P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 9/212 (4%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G+G FG V+KV R+ A+K++ ++ + E+ E RVL K +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ +V +YA NG L L + PL ++ + GLAHLH I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGR--PLPEDQVWRFFIQILLGLAHLHSK---KI 122
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
+H ++K N+ LD N +I D G+A+LL+ D +N Y++PEL C+ N
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPEL-CEDKPYN 179
Query: 741 EKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
EK D++ GV++ E TG+ P + +IL
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 22/219 (10%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLI 615
EK A++GEG +G VYK G ++A+KK+ + + +P RE+++L K RHPN++
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 616 SLEGYYWTPQLK--LLVSDYAP---NGSLQAKLHERLPSTPPL--SWTNRFKVILGTAKG 668
L+ + +V +Y G L + T + K +L +G
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLL---DSPEVKFTESQIKCY---MKQLL---EG 112
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
L +LH + I+H ++K SNIL++++ +++DFGLAR T+ + +NR + L Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT-LWYR 168
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
PEL + R + D++ G ++ EL G +P+ G
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
LE+ +G+G G VYKV G++ A+KK+ ++ + RE++ L P ++
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
G ++ +V +Y GSL A L +++ P + IL KGL +LH
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQIL---KGLDYLHTK 118
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
IIH ++KPSN+L++ +I+DFG++++L N F + Y++PE
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPE---- 170
Query: 736 SLRVNEK-----CDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790
R+ + DI+ G+ +LE G+ P L++ + D
Sbjct: 171 --RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF------ELMQA--ICDGPP 220
Query: 791 PSMGDYPEDEVLPVLK--LALVCTCHIPSSRPSMAEVVQ 827
PS+ P +E P + ++ C P RPS AE++Q
Sbjct: 221 PSL---PAEEFSPEFRDFISA-CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 19/277 (6%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHP-NLISL 617
++GEG FG VY +++A+K L + E F RE+++L HP N++ L
Sbjct: 7 KLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
++ LV +Y GSL+ L +++ PLS + ++ L +LH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQILSALEYLHSK-- 120
Query: 678 PPIIHYNLKPSNILLDDNYN-PRISDFGLARLLTRLDKHVMSNRFQSA----LGYVAPEL 732
IIH ++KP NILLD + ++ DFGLA+LL S GY+APE+
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 733 T--CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790
+ DI+ G+ + EL+TG P E GE N S+ ++++LE
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELPTPSLASP 238
Query: 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
S PE L P +R S + +
Sbjct: 239 LSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 619
+G+G FG V V G++ A+K L II+ E E +L + HP ++ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 620 YYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 675
Y + + KL LV +YAP G L + L + + + RF +++L L +LH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA---RFYAAEIVLA----LEYLH-- 110
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
II+ +LKP NILLD + + +++DFGLA+ L+ + F Y+APE+
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVL-L 166
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 771
+ D + GVL+ E++TG+ P Y ED I
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 38/300 (12%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRM----LAVKKLVTSDIIQYPEDFEREVRV 605
I ET LEK +G G FGTVYK + +G +A+K L + ++ E V
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVI 662
+ HP+++ L G + Q+ L++ P G L + + S L+W +
Sbjct: 63 MASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI--- 118
Query: 663 LGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720
AKG+++L ++H +L N+L+ + +I+DFGLA+LL +K +
Sbjct: 119 ---AKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 721 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 779
+ + ++A E + K D++ +GV + EL+T G +P E G V I L
Sbjct: 171 GKVPIKWMALE-SILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPD-----L 223
Query: 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 839
LE+G L P + V + + C SRP+ E++ + PQR
Sbjct: 224 LEKGERL--------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD-PQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 80/297 (26%), Positives = 131/297 (44%), Gaps = 37/297 (12%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
+ L+ ++GEG FG V + G +AVK L S Q+ DFERE+ +L
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61
Query: 608 KARHPNLISLEGYYWTPQLK--LLVSDYAPNGSLQA---KLHERLPSTPPLSWTNRFKVI 662
H N++ +G P + L+ +Y P+GSL+ + +++ L ++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS------ 115
Query: 663 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRF 721
KG+ +L IH +L NIL++ +ISDFGLA++L D + +
Sbjct: 116 SQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP---------VEYGEDNVVIL 772
+S + + APE S + + D++ FGV + EL T P G ++
Sbjct: 173 ESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
+ LL+EG L DEV ++KL C P RPS A+++ I+
Sbjct: 232 VTRLLELLKEGERLPRPPSC-----PDEVYDLMKL---CWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVLGKA 609
P+ E +G G +G VYK G ++A+K KL D E ++E+ +L +
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF---EIIQQEISMLKEC 57
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
RHPN+++ G Y +V +Y GSLQ + PLS V T KGL
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGL 114
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 726
A+LH + + IH ++K +NILL ++ + +++DFG++ LT ++ R +S +G
Sbjct: 115 AYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKR-KSFIGTPY 166
Query: 727 YVAPELTCQSLRV--NEKCDIYGFGVLILELVTGRRP 761
++APE+ + + KCDI+ G+ +EL + P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 27/275 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQ-GRML--AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
++G+G FG V + + T G+++ AVK L + + +DF +E ++ H NLI L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
G T L +V++ AP GSL +L + +S + V + A G+ +L
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI--ANGMRYLESK-- 116
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQSALGYVAPELTCQS 736
IH +L NILL + +I DFGL R L + + H VM + + APE + ++
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRT 174
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS--EHVRVLLEEGNVLDCVDPSMG 794
+ D++ FGV + E+ T YGE+ LS + ++ + +EG L
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT------YGEEPWAGLSGSQILKKIDKEGERL-------- 220
Query: 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
+ PE + + L C H P+ RP+ A + + L
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 34/221 (15%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKAR 610
PE + + ++GEG +G+VYK G+++A+K + V D+ ++ +E+ +L +
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL----QEIIKEISILKQCD 56
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-------QAKLHERLPSTPPLSWTNRFKVIL 663
P ++ G Y+ +V +Y GS+ L E + ++
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA----------ILY 106
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
T KGL +LH + IH ++K NILL++ +++DFG++ LT M+ R +
Sbjct: 107 QTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT----DTMAKR-NT 158
Query: 724 ALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+G ++APE+ Q + N K DI+ G+ +E+ G+ P
Sbjct: 159 VIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEG 619
+G G FG VYK G +A+K++ I + + +E+ +L +HPN++ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 620 YYWTPQLKLLVSDYAPNGSLQ--AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
T ++ +YA NGSL+ K P + L ++V+ +GLA+LH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPES--LVAVYVYQVL----QGLAYLH---E 117
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTC 734
+IH ++K +NIL + +++DFG+A T+L+ +S S +G ++APE+
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVA---TKLND--VSKDDASVVGTPYWMAPEVIE 172
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRP 761
S + DI+ G ++EL+TG P
Sbjct: 173 MS-GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 68/230 (29%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK-ARHPNLISL 617
+GEG F TV + A+K L +I+ + + E VL + HP +I L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 618 EGYYWTPQ--LKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
Y+T Q L V +YAPNG L + + S L L +LH
Sbjct: 68 ---YYTFQDEENLYFVLEYAPNGELLQYIR-KYGS---LDEKCTRFYAAEILLALEYLH- 119
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN--------------- 719
IIH +LKP NILLD + + +I+DFG A++L +
Sbjct: 120 --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 720 RFQSALG---YVAPELTCQSLRVNEKC-----DIYGFGVLILELVTGRRP 761
RF S +G YV+PEL +NEK D++ G +I +++TG+ P
Sbjct: 178 RFASFVGTAEYVSPEL------LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
++P + E E+G+G FG VYK G A K + + EDF E+ +L +
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-EDFMVEIDILSEC 59
Query: 610 RHPNLISL-EGYYWTPQLKLLVSDYAPNGSLQA---KLHERLPSTPPLSWTNRFKVILGT 665
+HPN++ L E Y++ +L +L+ ++ G+L + +L ER + P + + R
Sbjct: 60 KHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQ-----M 112
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL-ARLLTRLDKHVMSNRFQSA 724
+ L LH +IH +LK NILL + + +++DFG+ A+ + L K + F
Sbjct: 113 LEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGT 166
Query: 725 LGYVAPELT-CQSLR---VNEKCDIYGFGVLILELVTGRRP 761
++APE+ C++ + + K DI+ G+ ++EL P
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 24/218 (11%)
Query: 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--------FEREVRVLGKA 609
K A +G G FG+VY + G ++AVK++ + +D RE+ +L +
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
+H N++ G + +Y P GS+ A L+ L N + IL KGL
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV-RNFVRQIL---KGL 119
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR------LLTRLDKHVMSNRFQS 723
+LH+ IIH ++K +NIL+D+ +ISDFG+++ L T+ + S Q
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--LQG 174
Query: 724 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++ ++APE+ Q+ K DI+ G L++E++TG+ P
Sbjct: 175 SVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYY 621
G+G +G+VYKV + + A+K++ + Q ED E+R+L HPN+IS + +
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 681
+V +YAP G L + +R + +++ + +GL LH I+
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KIL 125
Query: 682 HYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
H +LK +NILL N +I D G++++L + K + Y+APE+ + +
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH-----YMAPEV-WKGRPYS 179
Query: 741 EKCDIYGFGVLILELVTGRRPVE 763
K DI+ G L+ E+ T P E
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE------REVRVLGKAR 610
E VGEG +G V K G ++A+KK S+ +D + REV+VL + R
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-----DDEDVKKTALREVKVLRQLR 58
Query: 611 HPNLISL-EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
H N+++L E + +L LV +Y L+ L E P P + I + +
Sbjct: 59 HENIVNLKEAFRRKGRL-YLVFEYVERTLLE--LLEASPGGLPPDAVRSY--IWQLLQAI 113
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-----RLDKHVMSNRFQSA 724
A+ H IIH ++KP NIL+ ++ ++ DFG AR L L +V + R+
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRW--- 166
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
Y APEL + D++ G ++ EL+ G
Sbjct: 167 --YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 34/227 (14%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 609
EK ++GEG + VYK GR++A+KK+ + + E + RE+++L +
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQEL 59
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHER-LPSTPP--LSWTNRFKVILGTA 666
+HPN+I L + LV ++ L+ + ++ + TP S+ +L T
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSY------MLMTL 112
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS--- 723
+GL +LH ++ I+H +LKP+N+L+ + +++DFGLAR NR +
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKMTHQV 163
Query: 724 -ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
Y APEL + D++ G + EL+ R P G+ ++
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
+G G FG VY G ++AVK ++ +D E E++VL +HPNL+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVKYYG 66
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + +Y G+L+ L + + L +GLA+LH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQL--LEGLAYLHSH---G 119
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQS 736
I+H ++KP+NI LD N ++ DFG A L + M QS G Y+APE+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-NTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 737 LRVNE--KCDIYGFGVLILELVTGRRP 761
DI+ G ++LE+ TG+RP
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 72/287 (25%), Positives = 130/287 (45%), Gaps = 30/287 (10%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVL 606
IDP + + +G G FG V + G+ +A+K L + DF E ++
Sbjct: 1 IDP-SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM 59
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
G+ HPN+I LEG + +++++Y NGSL L E + ++ G A
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIA 116
Query: 667 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
G+ +L ++ +H +L NIL++ N ++SDFGL+R L + + + +
Sbjct: 117 SGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGE-DNVVILSEHVRVLLEEG 783
+ APE + D++ FG+++ E+++ G RP Y + N ++ +E+G
Sbjct: 173 RWTAPE-AIAYRKFTSASDVWSFGIVMWEVMSYGERP--YWDMSNQDVIKA-----VEDG 224
Query: 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
L P D P + +L L C + RP+ +++V L
Sbjct: 225 YRL----PPPMDCPS----ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DPE L K ++G+G FG V+K +++A+K + + ED ++E+ VL +
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
P + G Y ++ +Y GS L P PL T ++ KGL
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PG--PLDETQIATILREILKGLD 115
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
+LH + IH ++K +N+LL ++ +++DFG+A LT D + N F ++AP
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790
E+ QS + K DI+ G+ +EL G P + + V L+ + N
Sbjct: 171 EVIKQS-AYDSKADIWSLGITAIELAKGEPP------HSELHPMKVLFLIPKNN-----P 218
Query: 791 PSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P++ G+Y + P+ + C PS RP+ E+++
Sbjct: 219 PTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKK-LVTSDIIQYPE---DFEREVRVLGKARHPNLISL 617
+G G FG+VY+ G AVK+ + D E E+E+ +L K +HPN++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66
Query: 618 EGYYWTPQL--KLLVS-DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
Y T + L + + P GSL AKL ++ S P + IL GL +LH
Sbjct: 67 --YLGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQIL---LGLEYLHD 120
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF-QSALG---YVAP 730
+H ++K +NIL+D N +++DFG+A K V+ F +S G ++AP
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAP 170
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790
E+ Q DI+ G +LE+ TG+ P + + E V + + G
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP--WSQ------LEGVAAVFKIGRS----- 217
Query: 791 PSMGDYPE--DEVLPVLKL-ALVCTCHIPSSRPSMAEVVQ 827
+ P D + K L C PS RP+ AE+++
Sbjct: 218 ---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKK-LVTSD------IIQYPEDFEREVRVLGK 608
LE E+G G G V KV G+++AVK + + I+ RE+ +L K
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL-------RELDILHK 55
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGT 665
P ++ G ++ + +Y GSL L E R+P L K+ +
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP-ERILG-----KIAVAV 109
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
KGL +LH + IIH ++KPSNIL++ ++ DFG++ L + ++ F
Sbjct: 110 LKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTS 163
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
Y+APE Q + K DI+ G+ ++EL TGR P
Sbjct: 164 SYMAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 609
EK ++GEG +G VYK G ++A+KK I E+ E RE+ +L +
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKK-----IRLDNEE-EGIPSTALREISLLKEL 55
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KVILGTAKG 668
+HPN++ L T + LV +Y L+ K ++ P + +L +G
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLK-KYLDKRPGPLSPNLIKSIMYQLL---RG 110
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT----RLDKHVMSNRFQSA 724
LA+ H I+H +LKP NIL++ + +++DFGLAR V++
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT------ 161
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
L Y APE+ S + DI+ G + E++TG+
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEG 619
+G G FG V V ++ R A+K + I++ E E +L + HP ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHER--LPSTPPLSWTNRF---KVILGTAKGLAHLHH 674
+ + ++ +Y G L L +R +T RF V+L +LH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-----YTARFYIACVVLA----FEYLHN 111
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
II+ +LKP N+LLD N ++ DFG A+ L K + F YVAPE+
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEI-I 164
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 768
+ + D + G+L+ EL+TGR P +GED+
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP--FGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFER--------EVRVLGKARHP 612
+G+G +G VY T G M+AVK++ + + I + ++ E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPL--SWTNRFKVILGTAKGLA 670
N++ G+ T + + +Y P GS+ + L L +T + +GLA
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ------VLEGLA 122
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
+LH I+H +LK N+L+D + +ISDFG+++ + + + Q ++ ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 731 E-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
E + S + K DI+ G ++LE+ GRRP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 25/246 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL----VTSDIIQYPEDFEREVRVLGKARHPNLISL 617
+GEG G V+K G +A+KK+ + I P RE++ L +HP ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI---PNQALREIKALQACQHPYVVKL 64
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ +LV +Y P L L + P + +++L KG+A++H +
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN-- 118
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
I+H +LKP+N+L+ + +I+DFGLARL + + + S++ + Y APEL +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT-RWYRAPELLYGAR 176
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 797
+ + D++ G + EL+ G P+ GE+++ L+ R L G P+ +P
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTL---GT------PNEETWP 226
Query: 798 EDEVLP 803
LP
Sbjct: 227 GLTSLP 232
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 48/289 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRML-----AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+GEG FG VYK L A+K L + + ++F +E ++ +HPN++
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---------------WTNRF- 659
L G Q ++ +Y +G L HE L P S + F
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 660 KVILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717
+ + A G+ +L HH +H +L N L+ + +ISDFGL+R + D + +
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV 776
++ + ++ PE + + DI+ FGV++ E+ + G +P YG N + V
Sbjct: 183 QSKSLLPVRWMPPE-AILYGKFTTESDIWSFGVVLWEIFSYGLQPY-YGFSN-----QEV 235
Query: 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 825
++ +L C PED V L + C IP+ RP ++
Sbjct: 236 IEMIRSRQLLPC--------PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 68/269 (25%), Positives = 111/269 (41%), Gaps = 21/269 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G+G FG VYK +AVK ++ F +E +L + HPN++ L G
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 681
Q +V + P GSL L + L+ ++ L A G+ +L I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCI 115
Query: 682 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE 741
H +L N L+ +N +ISDFG++R V Q + + APE R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYTS 174
Query: 742 KCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEV 801
+ D++ +G+L+ E + G N + R +E G + P+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIESGYRMPA--------PQLCP 221
Query: 802 LPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ +L L C + P +RPS +E+ LQ
Sbjct: 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLI 615
+K ++GEG +G VYK G ++A+KK+ + P+ RE+++L + HPN+I
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 674
L + LV ++ + + K L +GLA H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPES-----LIKSYLYQLLQGLAFCH- 115
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---TRLDKHVMSNRFQSALGYVAPE 731
I+H +LKP N+L++ +++DFGLAR R H + R+ Y APE
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPE 168
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGR 759
L + DI+ G + EL++ R
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 535 KVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DI 592
K ++ D + L DPE + E+G G FG VY + ++AVKK+ S
Sbjct: 2 KGVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT 61
Query: 593 IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTP 651
+ +D +EV+ L + +HPN I +G Y LV +Y + S ++H++
Sbjct: 62 NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK----- 116
Query: 652 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711
PL + G +GLA+LH +IH ++K NILL + +++DFG A +
Sbjct: 117 PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173
Query: 712 LDKHVMSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
+N F ++APE L + + K D++ G+ +EL + P+
Sbjct: 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DPE L K +G+G FG VYK ++A+K + + ED ++E+ VL +
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
P + G Y ++ +Y GS L PL T ++ KGL
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
+LH + IH ++K +N+LL + + +++DFG+A LT D + N F ++AP
Sbjct: 116 YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
E+ QS + K DI+ G+ +EL G P
Sbjct: 171 EVIKQS-AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
L+ A +G+G FG V G +G+ +AVK L D + F E V+ R
Sbjct: 4 NSKELKLGATIGKGEFGDVML---GDYRGQKVAVKCL--KDDSTAAQAFLAEASVMTTLR 58
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
HPNL+ L G +V++Y GSL L R + ++ + L +G+
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGME 116
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
+L +H +L N+L+ ++ ++SDFGLA+ + + S + + + AP
Sbjct: 117 YLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS---QGQDSGKL--PVKWTAP 168
Query: 731 ELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
E +LR + K D++ FG+L+ E+ + GR P Y + + HV E+G +
Sbjct: 169 E----ALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHV----EKGYRM 218
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+ PE V K+ C P+ RP+ ++ + L +I
Sbjct: 219 EA--------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 42/303 (13%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 606
P +E ++G+G FG V++ M+AVK L DF+RE ++
Sbjct: 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM 62
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---------------- 650
+ HPN++ L G + L+ +Y G L L R P
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 651 --PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708
PLS T + + A G+A+L +H +L N L+ +N +I+DFGL+R
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGED 767
+ D + S + ++ PE + R + D++ +GV++ E+ + G +P YG
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPY-YGMA 237
Query: 768 NVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+ E V + +GNVL C P++ L + L +C +PS RPS A + +
Sbjct: 238 H-----EEVIYYVRDGNVLSC--------PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284
Query: 828 ILQ 830
ILQ
Sbjct: 285 ILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 53/275 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRM-----LAVKKLV--TSDIIQYPEDFEREVRVLGKARHPNL 614
+G G FG V+ +G +AVK L T D P+DF E +++ K RHP L
Sbjct: 14 LGAGQFGEVW------EGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKL 63
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH- 673
I L + +V++ GSL L L + A G+A+L
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEA 121
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------Y 727
++ IH +L N+L+ +N +++DFGLAR++ + +++ G +
Sbjct: 122 QNY----IHRDLAARNVLVGENNICKVADFGLARVI-------KEDIYEAREGAKFPIKW 170
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
APE R + K D++ FG+L+ E+VT GR P G N +L + +++G +
Sbjct: 171 TAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMPYP-GMTNAEVLQQ-----VDQGYRM 223
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS 821
C P + + L C P RP+
Sbjct: 224 PC--------PPGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 19/228 (8%)
Query: 540 DSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DIIQYPE 597
D + L DPE L E+G G FG VY ++A+KK+ S + +
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 598 DFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWT 656
D +EVR L K RHPN I G Y LV +Y + S ++H++ PL
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEV 115
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
V G +GLA+LH +IH ++K NILL + ++ DFG A ++
Sbjct: 116 EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167
Query: 717 MSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
+N F ++APE L + + K D++ G+ +EL + P+
Sbjct: 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER-------EVRVLGKA 609
E +G+G FGTV KV + G++L K+ I Y E+ EV +L +
Sbjct: 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKE------IDYGNMTEKEKQQLVSEVNILREL 56
Query: 610 RHPNLISLEGYY-----WTPQLKLLVSDYAPNGSLQA------KLHERLPSTPPLSWTNR 658
+HPN++ YY + Q +V +Y G L K + + W
Sbjct: 57 KHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE--EFIW--- 108
Query: 659 FKVILGTAKGLAHLHH--SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
+++ L H+ ++H +LKP+NI LD N N ++ DFGLA++L
Sbjct: 109 -RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSS 165
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + Y++PE + +EK DI+ G LI EL P
Sbjct: 166 FAKTYVGTPYYMSPEQ-LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 6e-17
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
+G G +G V GR +A+KK+ S++ D + RE+++L RH N+I L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 619 GYYWTPQLKL------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA-KGLAH 671
P +V++ ++ LH+ + S PL+ + + L +GL +
Sbjct: 66 DIL-RPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLT-DDHIQYFLYQILRGLKY 118
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT--RLDKHVMSNRFQSALGYV- 728
LH + +IH +LKPSNIL++ N + +I DFGLAR + +K ++ YV
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-------EYVV 168
Query: 729 -----APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
APEL S R + DI+ G + EL+T R+P+ G D +
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYI 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS---DIIQYPEDFEREVRV 605
T EK +GEG +G VY+ T G ++A+KK+ D I P RE+ +
Sbjct: 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI--PISSLREITL 59
Query: 606 LGKARHPNLISLEGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 663
L RHPN++ L+ L LV +Y A L + +P+ P S + ++L
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQD--LASLLDNMPT--PFSESQVKCLML 115
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
+GL +LH +F IIH +LK SN+LL D +I+DFGLAR K M+ + +
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVVT 171
Query: 724 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
L Y APEL D++ G ++ EL+ +
Sbjct: 172 -LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 28/275 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+G G FG V++ GR +A+K L + +DF E ++G+ H N+I LE
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
G + +++++Y NG+L L + + I K L+ +++
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY---- 128
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALGYVAPELTCQSL 737
+H +L NIL++ N ++SDFGL+R+L + + + + + APE
Sbjct: 129 --VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR- 185
Query: 738 RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH-VRVLLEEGNVLDCVDPSMGD 795
+ D++ FG+++ E+++ G RP Y + +S H V + +G L P+ D
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP--YWD-----MSNHEVMKAINDGFRL----PAPMD 234
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
P V +L L C + RP ++V +L
Sbjct: 235 CPS----AVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 78/289 (26%), Positives = 139/289 (48%), Gaps = 39/289 (13%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
+DP + E E+G+G FG VYK G LA K++ + + ED+ E+ +L
Sbjct: 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATC 66
Query: 610 RHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTA 666
HP ++ L G +YW +L +++ ++ P G++ A + E R + P + +VI
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP------QIQVICRQM 119
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL-ARLLTRLDKHVMSNRFQSAL 725
HS + IIH +LK N+LL + + +++DFG+ A+ + L + + F
Sbjct: 120 LEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR---DSFIGTP 174
Query: 726 GYVAPELT-CQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781
++APE+ C++++ + K DI+ G+ ++E+ P + E N +RVLL+
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP--HHELN------PMRVLLK 226
Query: 782 EGNVLDCVDPSMGDYPED---EVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+P P E LK AL P +RPS A++++
Sbjct: 227 IAK----SEPPTLSQPSKWSMEFRDFLKTALD---KHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 42/281 (14%)
Query: 561 EVGEGVFGTVYKVSFGTQGRM---LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
E+G G FG+V K + + +AVK L I ++F RE V+ + HP ++ L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
G L +LV + AP G L + L + ++ ++ A G+A+L
Sbjct: 62 IGVCKGEPL-MLVMELAPLGPL----LKYLKKRREIPVSDLKELAHQVAMGMAYLESK-- 114
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------YVAPE 731
+H +L N+LL + + +ISDFG++R L S+ +++ + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRAL-----GAGSDYYRATTAGRWPLKWYAPE 168
Query: 732 LTCQSL-RVNEKCDIYGFGVLILELVT-GRRPVEYGE-DNVVILSEHVRVLLEEGNVLDC 788
C + + + K D++ +GV + E + G +P YGE +++ +LE G L
Sbjct: 169 --CINYGKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIA-----MLESGERLPR 219
Query: 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
PE+ + + L C + P RP+ +E+
Sbjct: 220 --------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DPE L K +G+G FG V+K +++A+K + + ED ++E+ VL +
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
P + G Y ++ +Y GS L R K IL KGL
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLD 115
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
+LH + IH ++K +N+LL + + +++DFG+A LT D + N F ++AP
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
E+ QS + K DI+ G+ +EL G P
Sbjct: 171 EVIQQS-AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 34/289 (11%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DIIQYPEDFEREVRVLGK 608
DPE L E+G G FG VY ++A+KK+ S + +D +EV+ L +
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+HPN I +G Y LV +Y + S ++H++ PL + G +
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQ 136
Query: 668 GLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
GLA+LH H+ +IH ++K NILL + +++DFG A + + +N F
Sbjct: 137 GLAYLHSHN----MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPY 186
Query: 727 YVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784
++APE L + + K D++ G+ +EL R+P + N+ +S + E
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLF---NMNAMSALYHIAQNESP 242
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
L + S DY + V C IP RP+ E+++ + V++
Sbjct: 243 TLQSNEWS--DYFRNFVDS-------CLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISL 617
+G G VY +A+K++ D+ + + +EV+ + + HPN++
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 618 EGYYWTPQLKLLVSDYAPNGSL---------QAKLHERLPSTPPLSWTNRFKVILGTAKG 668
+ LV Y GSL + L E + +T V+ KG
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT----------VLKEVLKG 114
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL-ARLLTRLD-KHVMSNRFQSALG 726
L +LH IH ++K NILL ++ + +I+DFG+ A L D + F
Sbjct: 115 LEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ Q + K DI+ FG+ +EL TG P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVT--SDIIQYPEDFEREVRVLGKARHPNLISLEG 619
VG G FG V G+ +A+KK++ S + + RE+++L RH N+ISL
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ +P L Y L LH RL ++ PL + +GL ++H +
Sbjct: 77 IFISP----LEDIYFVTELLGTDLH-RLLTSRPLEKQFIQYFLYQILRGLKYVHSA---G 128
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
++H +LKPSNIL+++N + +I DFGLAR+ +S R+ Y APE+ +
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKY 183
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
+ + DI+ G + E++ G +P+ G+D+V
Sbjct: 184 DVEVDIWSAGCIFAEMLEG-KPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 615
K ++GEG +G VYK G+++A+KK+ + S+ P RE+ +L + +HPN++
Sbjct: 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L+ L+ ++ L L + L S P + + V + L +
Sbjct: 63 CLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---TRLDKHVMSNRFQSALGYVAPEL 732
++H +LKP N+L+D+ +++DFGLAR R+ H + L Y APE+
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV-----VTLWYRAPEV 172
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
S R + DI+ G + E+ T ++P+ +G+ + L R+L
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRIL 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 23/238 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 619
+G+G FG V V +M A+K + ++ + E R+L + HP L++L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + LV D G L+ L +++ + +F I L +LH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKF-WICEIVLALEYLHSK---G 120
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ---S 736
IIH ++KP NILLD+ + I+DF +A +T ++ GY+APE+ C+ S
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEY----GEDNVVILSEHVRVLLEEGNVLDCVD 790
+ V D + GV E + G+RP D + E VL + +D
Sbjct: 178 VAV----DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 28/222 (12%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDF---EREVRV 605
+P+ E VG G +G VYK G + AVK KL D DF ++E+ +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD------DFSLIQQEIFM 59
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+ + +H N+++ G Y + + + +Y GSLQ H T PLS V T
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRET 115
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+GLA+LH + +H ++K +NILL DN + +++DFG+A +T ++ R +S +
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITA----TIAKR-KSFI 167
Query: 726 G---YVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPV 762
G ++APE+ ++ N+ CDI+ G+ +EL + P+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE----DFEREVRVLGKARHPNLIS 616
+ +G FG+VY + G A+K L SD+I + ER + ++ + P +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAK 61
Query: 617 LEGYYWTPQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
L Y++ Q K LV +Y G A L + L P W ++ I G+ LH
Sbjct: 62 L---YYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLP-EDWAKQY--IAEVVLGVEDLH 114
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
IIH ++KP N+L+D + +++DFGL+R + + +F Y+APE T
Sbjct: 115 QR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE-T 164
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVE 763
+ ++ D + G +I E + G P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FEREVRVLGKARHPNLI 615
EK VG G FG V+ +++ +K++ + + + E +VL HPN+I
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
+ + ++V +YAP G+L + +R S F V + L LHH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----LLALHHV 117
Query: 676 FRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 731
I+H +LK NILLD + +I DFG++++L+ K + +G Y++PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA------YTVVGTPCYISPE 171
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763
L C+ N+K DI+ G ++ EL + +R E
Sbjct: 172 L-CEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-16
Identities = 52/143 (36%), Positives = 70/143 (48%), Gaps = 18/143 (12%)
Query: 305 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 364
L L N L G IP ++ + R L + L GNS+ G IP + + TSL +L LS+N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 365 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQS 424
P+S+ L L+IL L N LSG +P LG GRL F D +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG----------------GRLLHRASFNFTDNA 526
Query: 425 SLQGNLGI--CSPLLKGPCKMNV 445
L G G+ C P L K+ +
Sbjct: 527 GLCGIPGLRACGPHLSVGAKIGI 549
|
Length = 623 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS---------DIIQYPEDFER 601
DPE L E+G G FG VY ++A+KK+ S DII +
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII-------K 64
Query: 602 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNRFK 660
EVR L + RHPN I +G Y LV +Y + S ++H++ PL
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAA 119
Query: 661 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720
+ G +GLA+LH R IH ++K NILL + +++DFG A L++ +N
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANS 170
Query: 721 FQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
F ++APE L + + K D++ G+ +EL R+P
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLG 607
+P+ E +G G +G VYK G + A+K + ++ EDF ++E+ ++
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMK 61
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+H N+++ G Y + ++ GSLQ H T PLS + V T +
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQ 117
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 726
GL +LH + +H ++K +NILL DN + +++DFG++ +T ++ R +S +G
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA----TIAKR-KSFIGT 169
Query: 727 --YVAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRPV 762
++APE+ + N+ CDI+ G+ +EL + P+
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 87/311 (27%), Positives = 134/311 (43%), Gaps = 66/311 (21%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGK- 608
E+ AE+GEG +GTVYK GR +A+KK ++ P E RE+ +L +
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQL 55
Query: 609 --ARHPNLISL----EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPST--PPLSWTNRF 659
HPN++ L G +LKL LV ++ + L L + P PP + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLM 113
Query: 660 KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719
+ +L +G+ L HS R I+H +LKP NIL+ + +I+DFGLAR+ +
Sbjct: 114 RQLL---RGVDFL-HSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYS--------- 158
Query: 720 RFQSALG-------YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
F+ AL Y APE+ QS D++ G + EL RRP+ G L
Sbjct: 159 -FEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQL 215
Query: 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+ V+ G PS ++P + LP + + S V +
Sbjct: 216 DKIFDVI---GL------PSEEEWPRNVSLPR-------SSFPSYTPRSFKSFVPEICEE 259
Query: 833 KTPLPQRMEVF 843
L ++M F
Sbjct: 260 GLDLLKKMLTF 270
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 555 LLEKAAEVGEGVFGTVYKVSF-GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN 613
L K +G G FG V+ ++ GT +AVK L + PE F +E +++ K RH
Sbjct: 10 LERK---LGAGQFGEVWMGTWNGTT--KVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDK 62
Query: 614 LISL-------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
L+ L E Y +V++Y GSL L L + A
Sbjct: 63 LVQLYAVCSEEEPIY-------IVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIA 113
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA-- 724
+G+A+L IH +L NIL+ +N +I+DFGLARL+ D + + A
Sbjct: 114 EGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAR--EGAKF 166
Query: 725 -LGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
+ + APE R K D++ FG+L+ E+VT GR P
Sbjct: 167 PIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF----EREVRV-LGKARHPNLIS 616
+G+G FG VY+V R+ A+K L +I+ E ER + V P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKV-ILGTAKGLAHLH 673
L+ + T LV+DY G L L + R +R K I L HLH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE-------DRAKFYIAELVLALEHLH 113
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
+ I++ +LKP NILLD + + DFGL++ L + +N F Y+APE+
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ D + GVL+ E+ G P Y ED
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPF-YAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL--VTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
+G G FG V+ V+ G+ +A+KK+ V +++ F RE+++L +H N++S
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSFRP 678
P + Y +Q+ LH+ + S PLS ++ KV L +GL +LH +
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA--- 122
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
I+H ++KP N+L++ N +I DFGLAR+ + M+ + Y APE+ S
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRH 181
Query: 739 VNEKCDIYGFGVLILELVTGR 759
DI+ G + EL+ R
Sbjct: 182 YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKA 609
DP L + ++GEG G VYK + G+ +A+KK+ + + E+ ++
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDC 72
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-------KVI 662
+HPN++ Y +V +Y GSL T ++ V
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSL----------TDIITQNFVRMNEPQIAYVC 122
Query: 663 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722
+GL +LH S +IH ++K NILL + + +++DFG A LT+ S R
Sbjct: 123 REVLQGLEYLH-SQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE----KSKR-N 174
Query: 723 SALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
S +G ++APE+ + K DI+ G++ +E+ G P
Sbjct: 175 SVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 69/239 (28%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 541 SRSSSLDCSIDPETL--LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED 598
S S+S ++L LE+ +G G GTVYKV GR+ A+K + +
Sbjct: 59 SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ 118
Query: 599 FEREVRVLGKARHPNLISLEGYY-WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTN 657
RE+ +L HPN++ + ++++L+ ++ GSL+ + L+
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGT---HIADEQFLADVA 174
Query: 658 RFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHV 716
R IL G+A+LH R I+H ++KPSN+L++ N +I+DFG++R+L + +D
Sbjct: 175 R--QIL---SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-- 224
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKC----------DIYGFGVLILELVTGRRPVEYG 765
N + Y++PE R+N DI+ GV ILE GR P G
Sbjct: 225 -CNSSVGTIAYMSPE------RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 19/219 (8%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
++PE E E+G+G FG VYK + +LA K++ + + ED+ E+ +L
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELEDYMVEIDILASC 59
Query: 610 RHPNLIS-LEGYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPPLSWTNRFKVILG-TA 666
HPN++ L+ +Y+ L +L+ ++ G++ A + E P T P + +V+ T
Sbjct: 60 DHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEP-----QIRVVCKQTL 113
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+ L +LH + IIH +LK NIL + + +++DFG++ TR + + F
Sbjct: 114 EALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPY 168
Query: 727 YVAPELT-CQSLR---VNEKCDIYGFGVLILELVTGRRP 761
++APE+ C++ + + K D++ G+ ++E+ P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE------REVRVLGKAR 610
EK +++GEG +G V+K G+++A+KK V S+ +D RE+R+L + +
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-----DDPVIKKIALREIRMLKQLK 58
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
HPNL++L + + LV +Y + ++ +L + P K+I T + +
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK---KIIWQTLQAVN 114
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV---MSNRFQSALGY 727
H IH ++KP NIL+ ++ DFG AR+LT ++ R+ Y
Sbjct: 115 FCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-----Y 166
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTG 758
APEL + D++ G + EL+TG
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 70/243 (28%), Positives = 120/243 (49%), Gaps = 27/243 (11%)
Query: 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 608
ET L++ +G G FGTVYK + +G + A+K L + + +F E ++
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHER---LPSTPPLSWTNRFKVILGT 665
HP+L+ L G +P ++L V+ P+G L +HE + S L+W +
Sbjct: 66 MDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQI 118
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
AKG+ +L ++H +L N+L+ + +I+DFGLARLL +K ++ + +
Sbjct: 119 AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 726 GYVAPELTCQSLR-VNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEG 783
++A L C R + D++ +GV I EL+T G +P + I + + LLE+G
Sbjct: 176 KWMA--LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG------IPTREIPDLLEKG 227
Query: 784 NVL 786
L
Sbjct: 228 ERL 230
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 40/279 (14%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
++G G +G VY+ + +AVK L D ++ E+F +E V+ + +HPNL+ L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-----GTAKGLAHLHHS 675
+++++ G+L L E V+L + + +L
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVN-------AVVLLYMATQISSAMEYLE-- 121
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
+ IH +L N L+ +N+ +++DFGL+RL+T D + + + + APE
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE---- 175
Query: 736 SLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
SL N+ K D++ FGVL+ E+ T G P G D LS V LLE+G +
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GID----LS-QVYELLEKGYRM----- 224
Query: 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ PE V +L C PS RPS AE+ Q +
Sbjct: 225 ---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 611
P L ++G+G FG V+ ++ R +A+K L + PE F +E +V+ K RH
Sbjct: 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKKLRH 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGT 665
L+ L + + +V++Y GSL + + RLP ++
Sbjct: 61 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ--------I 111
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
A G+A++ R +H +L+ +NIL+ +N +++DFGLARL+ +++ + +
Sbjct: 112 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPI 167
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
+ APE R K D++ FG+L+ EL T GR P
Sbjct: 168 KWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPN 613
LE+ VG G FG V+ V A+K + ++I + + E RVL + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
+I L + ++ +Y P G L + L + + T F ++ + L
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS---NSTGLFY----ASEIVCALE 115
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAP 730
+ I++ +LKP NILLD + +++DFG A+ L +R + G Y+AP
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--------RDRTWTLCGTPEYLAP 167
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
E+ QS N+ D + G+LI E++ G P
Sbjct: 168 EVI-QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 13/215 (6%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
I P L E+G G FG V+ + + R +A+K + + + EDF E +V+ K
Sbjct: 1 IHPSEL-TLVQEIGSGQFGLVWLGYW-LEKRKVAIKTIREGAMSE--EDFIEEAQVMMKL 56
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
HP L+ L G LV ++ +G L L + S + L +G+
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGM 113
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
A+L S +IH +L N L+ +N ++SDFG+ R + D++ S + + + +
Sbjct: 114 AYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSS 169
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 763
PE+ S + + K D++ FGVL+ E+ + G+ P E
Sbjct: 170 PEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVLGKARH 611
+L ++ +G G +G VY+ GR++A+K L T D D +REV +L + R
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQ 58
Query: 612 ---PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
PN+ G Y ++ +YA GS++ L P++ +I
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-----LMKAGPIAEKYISVIIREVLVA 113
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 726
L ++H +IH ++K +NIL+ + N ++ DFG+A LL S++ + +G
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTP 165
Query: 727 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ + + K DI+ G+ I E+ TG P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 41/292 (14%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRM---LAVKKLVTSDIIQYPEDFEREVRV 605
ID + +EK +G G FG V G+ +A+K L + DF E +
Sbjct: 1 IDASCIKIEKV--IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI 58
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-- 663
+G+ HPN+I LEG + ++V++Y NGSL A L + +F VI
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH---------DGQFTVIQLV 109
Query: 664 ----GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719
G A G+ +L +H +L NIL++ N ++SDFGL+R+L + +
Sbjct: 110 GMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 720 R-FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777
R + + + APE + D++ +G+++ E+++ G RP + VI +
Sbjct: 167 RGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA---- 221
Query: 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
+EEG L P+ D P + +L L C + RP ++V IL
Sbjct: 222 --IEEGYRL----PAPMDCP----AALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 42/278 (15%)
Query: 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN 613
TL K +G G FG V++ + + R +A+K ++ SD + +DF++EV+ L + RH +
Sbjct: 9 TLERK---LGSGYFGEVWEGLWKNRVR-VAIK-ILKSDDLLKQQDFQKEVQALKRLRHKH 63
Query: 614 LISL-------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
LISL E Y ++++ GSL A L R P L + + A
Sbjct: 64 LISLFAVCSVGEPVY-------IITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVA 114
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+G+A+L IH +L NIL+ ++ +++DFGLARL+ + +S+ +
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYK 169
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 785
+ APE + K D++ FG+L+ E+ T G+ P G +N V + G
Sbjct: 170 WTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYP-GMNN-----HEVYDQITAGYR 222
Query: 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 823
+ P P++ + K+ L C P RPS
Sbjct: 223 M----PCPAKCPQE----IYKIMLECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 62/207 (29%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 617
+G+G FG V G+M A KKL + + + E+++ L K ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHH 674
+ T LV G L K H P + I A+ GL HLH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEA---RAIFYAAQIICGLEHLHQ 113
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
I++ +LKP N+LLDD+ N RISD GLA L K GY+APE+
Sbjct: 114 RR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVL- 166
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRP 761
Q + D + G + E++ GR P
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 72/282 (25%), Positives = 127/282 (45%), Gaps = 29/282 (10%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
I+P L E+G G FG V+ + Q + +A+K + + EDF E +V+ K
Sbjct: 1 INPSEL-TFMKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAM--SEEDFIEEAKVMMKL 56
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
HP L+ L G + +V+++ NG L L +R LS + +G+
Sbjct: 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGM 113
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
+L R IH +L N L+ ++SDFG+ R + D++ S+ + + +
Sbjct: 114 EYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSP 169
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
PE+ S + + K D++ FGVL+ E+ T G+ P E + N ++ + G L
Sbjct: 170 PEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFE-KKSNYEVVEM-----ISRGFRL-- 220
Query: 789 VDPSMGDY-PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
Y P+ + V ++ C P RP+ AE+++ +
Sbjct: 221 -------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 562 VGEGVFGTVYK-VSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
+GEG FG V K +F +GR +AVK L + D E +L + HP++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERL--------------------PSTPPLSWT 656
L G LL+ +YA GSL++ L E P L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
+ ++G+ +L ++H +L N+L+ + +ISDFGL+R + D +V
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 775
++ + + ++A E + + D++ FGVL+ E+VT G P I E
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPG------IAPER 237
Query: 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ LL+ G + + PE+ + L L C P RP+ A++ + L+
Sbjct: 238 LFNLLKTGYRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
EK ++GEG + TVYK G+++A+K + + P RE +L +H N++
Sbjct: 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHS 675
L T + LV +Y + L + + P K+ L +GL+++H
Sbjct: 68 LHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
+ I+H +LKP N+L+ D +++DFGLAR + + H SN + L Y P++
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLARAKS-VPSHTYSNEVVT-LWYRPPDVLLG 177
Query: 736 SLRVNEKCDIYGFGVLILELVTG 758
S + D++G G + +E++ G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 84/293 (28%), Positives = 142/293 (48%), Gaps = 41/293 (13%)
Query: 562 VGEGVFGTVYKVSFG----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
+G+G FG+V + G ++AVKKL S ++ DFERE+ +L +H N++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKY 70
Query: 618 EGYYWTP-QLKL-LVSDYAPNGSLQAKL---HERLPSTPPLSWTNRFKVILGTAKGLAHL 672
+G ++ + L LV +Y P GSL+ L ERL L + ++ KG+ +L
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYL 124
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK--HVMSNRFQSALGYVAP 730
S R +H +L NIL++ +I DFGL ++L DK + + +S + + AP
Sbjct: 125 G-SKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAP 180
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVT-----GRRPVEY----GED-NVVILSEHVRVLL 780
E +S + + D++ FGV++ EL T P E+ G D ++ H+ LL
Sbjct: 181 ESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
+ L P+ P E+ ++K C + PS RPS +E+ ++ I+
Sbjct: 240 KNNGRL----PAPPGCP-AEIYAIMKE---CWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 38/286 (13%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 611
P L+ ++G G FG V+ ++ + +AVK L + PE F E +++ K RH
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM--SPESFLEEAQIMKKLRH 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE------RLPSTPPLSWTNRFKVILGT 665
L+ L + + +V++Y GSL L + +LP N +
Sbjct: 61 DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP--------NLVDMAAQV 111
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
A G+A++ R IH +L+ +NIL+ D +I+DFGLARL+ +++ + +
Sbjct: 112 AAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPI 167
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784
+ APE R K D++ FG+L+ ELVT GR P G +N +L + +E G
Sbjct: 168 KWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYP-GMNNREVLEQ-----VERGY 220
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ C P+D + + +L L C P RP+ + L+
Sbjct: 221 RMPC--------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 611
P L ++G+G FG V+ ++ + +A+K L ++ PE F +E +++ K RH
Sbjct: 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMM--PEAFLQEAQIMKKLRH 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE------RLPSTPPLSWTNRFKVILGT 665
L+ L + + +V+++ GSL L E +LP ++
Sbjct: 61 DKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ--------I 111
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
A G+A++ R IH +L+ +NIL+ DN +I+DFGLARL+ +++ + +
Sbjct: 112 ADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPI 167
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
+ APE R K D++ FG+L+ ELVT GR P
Sbjct: 168 KWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+G G FG V + G+ +A+K L + + DF E ++G+ HPN+I LE
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
G + ++++++ NG+L + L + + + I K L+ +++
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY---- 127
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------YVAPEL 732
+H +L NIL++ N ++SDFGL+R L+ + S+LG + APE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAPE- 181
Query: 733 TCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
+ D++ +G+++ E+++ G RP
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 42/286 (14%)
Query: 561 EVGEGVFGTVYKVS-FGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+GE FG VYK FGT Q + +A+K L E+F+ E + + +HPN++
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPLSWTNRFKVIL 663
L G Q ++ Y + L L R P + L + ++
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 664 GTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 721
A G+ L HH ++H +L N+L+ D N +ISD GL R + D + +
Sbjct: 132 QIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP-VEYGEDNVVILSEHVRVL 779
+ +++PE + + DI+ +GV++ E+ + G +P Y +V+ E +R
Sbjct: 187 LLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---EMIR-- 240
Query: 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 825
VL C P+D V L L C PS RP ++
Sbjct: 241 --NRQVLPC--------PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVL---GKARHPNL 614
A +G G FG V + G + A+K L DII E E R+ RHP L
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 671
++L + T V +YA G L +H + S P F V+L GL +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----RAVFYAACVVL----GLQY 116
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM--SNRFQSALG--- 726
LH + I++ +LK N+LLD +I+DFGL K M +R + G
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPE 166
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
++APE+ ++ D +G GVLI E++ G P G+D
Sbjct: 167 FLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFP-GDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 65/291 (22%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
+ E L E +++G G G+V KV G ++A K + + RE++++ +
Sbjct: 2 LRNEDL-ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
R P ++S G + + ++ GSL + P + K+ + +GL
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG----KIAVAVVEGL 116
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
+L++ R I+H ++KPSNIL++ ++ DFG++ L + +++ F Y++
Sbjct: 117 TYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMS 170
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
PE Q + K D++ G+ I+EL G+ P + + + + +L ++L +
Sbjct: 171 PE-RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----DLLQQI 225
Query: 790 --DPS----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
+P D+PED V C P+ RP+ ++ + I+
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDA----CLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
VGEG FG V + A+K++ ED +E +L K +HPN+++ + +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+V +Y G L K+ + P L W + + G+ H+H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH---E 118
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
++H ++K NI L N ++ DFG ARLLT + + + YV PE+ +++
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEI-WENM 175
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
N K DI+ G ++ EL T + P + +IL
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 16/204 (7%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 622
GEG G+V K G + A+K + T + RE+ + + P ++ G +
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 623 TPQ---LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + + +Y GSL + + + K+ KGL++LH
Sbjct: 70 DESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---K 125
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLA-RLLTRLDKHVMSNRFQSALGYVAPE-LTCQSL 737
IIH ++KPSNILL ++ DFG++ L+ L F Y+APE + +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-----YMAPERIQGKPY 180
Query: 738 RVNEKCDIYGFGVLILELVTGRRP 761
+ D++ G+ +LE+ R P
Sbjct: 181 SI--TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 36/283 (12%)
Query: 561 EVGEGVFGTVYKVSFGTQG----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
E+GE FG +YK G +++A+K L + Q +F++E ++ + HPN++
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST-------------PPLSWTNRFKVIL 663
L G Q ++ +Y G L L R P + L + + +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
A G+ +L F +H +L NIL+ + + +ISD GL+R + D + + +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 724 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEE 782
+ ++ PE + + DI+ FGV++ E+ + G +P YG N + V ++ +
Sbjct: 189 PIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPY-YGFSN-----QEVIEMVRK 241
Query: 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 825
+L C ED + L C PS RP ++
Sbjct: 242 RQLLPC--------SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLISLEG 619
+G G FG V V G+ A+K L + I++ E E R+L RHP L++L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 676
+ LV +Y P G L + L R P RF +V+L L +LH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVA-RFYAAQVVLA----LEYLHSL- 120
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 733
I++ +LKP N+LLD + +I+DFG A K V R + G Y+APE+
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIKITDFGFA-------KRV-KGRTYTLCGTPEYLAPEII 170
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRP 761
S + D + G+LI E++ G P
Sbjct: 171 -LSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 44/235 (18%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK- 608
DP + E +GEG +G VYK G+++A+K + + D E+ + E +L K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKY 59
Query: 609 ARHPNLISLEGYY-----WTPQLKL-LVSDYAPNGS---LQAKLHERLPSTPPLSWTNRF 659
+ HPN+ + G + +L LV + GS L L ++ R
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK---------GKRL 110
Query: 660 K------VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713
K ++ T +GLA+LH +IH ++K NILL N ++ DFG++ L
Sbjct: 111 KEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-- 165
Query: 714 KHVMSNRFQSALG---YVAPE-LTC-QSLRV--NEKCDIYGFGVLILELVTGRRP 761
R + +G ++APE + C + + + D++ G+ +EL G+ P
Sbjct: 166 ---TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 67/242 (27%), Positives = 113/242 (46%), Gaps = 25/242 (10%)
Query: 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 608
ET L K +G GVFGTV+K + +G + A+K + Q ++ + +G
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILGT 665
H ++ L G L+L V+ +P GSL + + S P L+W +
Sbjct: 66 LDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWC------VQI 118
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
AKG+ +L ++H NL NILL + +I+DFG+A LL DK + ++ +
Sbjct: 119 AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH-VRVLLEEGN 784
++A E + R + D++ +GV + E+++ YG + + H V LLE+G
Sbjct: 176 KWMALE-SILFGRYTHQSDVWSYGVTVWEMMS------YGAEPYAGMRPHEVPDLLEKGE 228
Query: 785 VL 786
L
Sbjct: 229 RL 230
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLI 615
K ++GEG FG V G+ +K++ S + + E+ +EV VL +HPN++
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAH 671
+ + +V DY G L K++ + P L W + L H
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKH 116
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 728
+H I+H ++K NI L + ++ DFG+AR+L + ++ +G Y+
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYL 168
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 765
+PE+ C++ N K DI+ G ++ E+ T + E G
Sbjct: 169 SPEI-CENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 615
+K ++GEG +G VYK G ++A+KK+ + ++ P RE+ +L + HPN++
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L T LV ++ + L+ + S PL + L +GLA H S
Sbjct: 63 KLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH-S 118
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---LLTRLDKHVMSNRFQSALGYVAPEL 732
R ++H +LKP N+L++ +++DFGLAR + R H + L Y APE+
Sbjct: 119 HR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-----VTLWYRAPEI 171
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGR 759
+ DI+ G + E+VT R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
VG G +G V GR +A+KKL S Q + RE+R+L H N+I L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 619 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV--ILGTAKGL 669
+ TP L LV+ A L+ + +F V IL +GL
Sbjct: 81 DVF-TPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQFLVYQIL---RGL 131
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV- 728
++H + IIH +LKPSNI ++++ +I DFGLAR M+ GYV
Sbjct: 132 KYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMT-------GYVA 177
Query: 729 -----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
APE+ + N+ DI+ G ++ EL+TG+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 59/240 (24%), Positives = 106/240 (44%), Gaps = 40/240 (16%)
Query: 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----------------R 601
K A +GEG +G V K G+++A+KK+ II+ D R
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKV---KIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 602 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV 661
E++++ + +H N++ L Y LV D + + L + + L+ + +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCI 124
Query: 662 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL--------TRLD 713
+L GL LH + +H +L P+NI ++ +I+DFGLAR D
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 714 KHVMSNRFQSA----LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
+ + ++ L Y APEL + + + D++ G + EL+TG +P+ GE+ +
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLV--TSDIIQYPEDFER---EVRVLGKA 609
K +G+G +GTVY QG+++AVK++ TS+++ +++E+ EV +L
Sbjct: 1 EWTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
+H N++ G + ++ P GS+ + L R P + K IL G+
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQIL---DGV 115
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM-SNRFQSALG-- 726
A+LH++ ++H ++K +N++L N ++ DFG AR L + H SN +S G
Sbjct: 116 AYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 727 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ +S K DI+ G + E+ TG+ P
Sbjct: 173 YWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLV-TSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G +G V G+ +A+KK+ D+ + RE+++L +H N+I++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA-KGLAHLHHSFRPP 679
P Y +++ LH + S PL+ + L +GL ++H +
Sbjct: 73 LRPPG-ADFKDVYVVMDLMESDLHHIIHSDQPLT-EEHIRYFLYQLLRGLKYIHSA---N 127
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDKH--VMSNRFQSALGYVAPELTCQS 736
+IH +LKPSN+L++++ RI DFG+AR L + +H M+ + + Y APEL
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT-EYVATRWYRAPELLLSL 186
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
D++ G + E++ GRR + G++ V
Sbjct: 187 PEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+GEG FG +Y + +K++ +T ++ E ++EV +L K +HPN+++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
+ +V +Y G L +++ + LSW + + GL H+H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDR- 120
Query: 677 RPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
I+H ++K NI L N ++ DFG+AR L D ++ Y++PE+ CQ
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEI-CQ 175
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRPVE 763
+ N K DI+ G ++ EL T + P E
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL--------VTSDIIQYPEDFEREVRVLGK 608
+K ++GEG +G VYK G ++A+KK+ V S I RE+ +L +
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKE 54
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF--KVILGTA 666
HPN++ L + LV ++ L L + + S+P +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---LLTRLDKH-VMSNRFQ 722
+G+A+ H S R ++H +LKP N+L+D +++DFGLAR + R H V++
Sbjct: 110 QGIAYCH-SHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT---- 162
Query: 723 SALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
L Y APE+ S + + DI+ G + E+V RRP
Sbjct: 163 --LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 47/298 (15%)
Query: 556 LEKAAEVGEGVFGTV----YKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 611
L+K +GEG FG V Y + G M+AVK L Q +++E+ +L H
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 612 PNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL---GTA 666
N++ +G + L+ +Y P GSL+ L P N +++L
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKHKLNLAQLLLFAQQIC 117
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDKHVMSNRFQSAL 725
+G+A+LH IH +L N+LLD++ +I DFGLA+ + + + + S +
Sbjct: 118 EGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP-------------VEYGEDNVVIL 772
+ A E + + + D++ FGV + EL+T + G+ VV L
Sbjct: 175 FWYAVE-CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
E LLE G L C P++ V L C RP+ ++ IL+
Sbjct: 234 IE----LLERGMRLPC--------PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 34/231 (14%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKL---VTSDIIQYPEDFEREVRVLGKARHPNLISL 617
+VG G +GTV G +A+KKL S++ + + RE+R+L +H N+I L
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMKHENVIGL 79
Query: 618 EGYYWTPQLKL-------LVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFK-VILGTAK 667
+ TP L L LV + G+ KL HE+L +R + ++ K
Sbjct: 80 LDVF-TPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSE-------DRIQFLVYQMLK 129
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
GL ++H + IIH +LKP N+ ++++ +I DFGLAR + R+ Y
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW-----Y 181
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 778
APE+ + + DI+ G ++ E++TG +P+ G D++ L E ++V
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEIMKV 231
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE------REVRVLGKARHPNLI 615
VGEG +G V K G+++A+KK + S +D RE+R+L + RH NL+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR--FKVILGTAKGLAHLH 673
+L + + LV ++ + L E+ P+ S + F+++ G H H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGI--EFCHSH 119
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVMSNRFQSALGYVAP 730
+ IIH ++KP NIL+ + ++ DFG AR L + ++ R+ Y AP
Sbjct: 120 N-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW-----YRAP 169
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTG 758
EL + DI+ G L+ E++TG
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 68/230 (29%), Positives = 100/230 (43%), Gaps = 32/230 (13%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKA-RHPNLISL 617
+G+G FG V + AVK L I+Q +D E E RVL A +HP L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRF---KVILGTAKGLAHL 672
+ T V +Y G L + R RF +++LG L L
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLG----LQFL 112
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR--LLTRLDKHVMSNRFQSALGYVAP 730
H II+ +LK N+LLD + +I+DFG+ + +L V ++ F Y+AP
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAP 165
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE-YGEDNV--VILSEHVR 777
E+ D + GVL+ E++ G+ P E ED + IL + VR
Sbjct: 166 EIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
K ++GEG + TV+K ++A+K++ P REV +L +H N+++L
Sbjct: 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSF 676
T + LV +Y L + L + L + L + K+ + +GL++ H
Sbjct: 69 HDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR- 122
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
I+H +LKP N+L+++ +++DFGLAR + K SN + L Y P++ S
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVT-LWYRPPDVLLGS 178
Query: 737 LRVNEKCDIYGFGVLILELVTGR 759
+ D++G G ++ E+ TGR
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 562 VGEGVFGTVYK------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G G FG VY+ + G+ +AVK L Q ++F +E ++ HPN++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPP--LSWTNRFKVILGTAKGLAHL 672
L G + + ++ + G L + L + R+ P L+ + L AKG +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 673 HHSFRPPIIHYNLKPSNILLD--DNYNPR---ISDFGLARLLTRLDKHVMSNRFQSALGY 727
+ IH +L N L+ R I DFGLAR + + D + + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
+APE + D++ FGVL+ E++T G++P +N +L +HV G L
Sbjct: 180 MAPESLLDGKFTTQS-DVWSFGVLMWEILTLGQQPYP-ALNNQEVL-QHVT----AGGRL 232
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
P P+ + +L C PS RP+ + +ILQ
Sbjct: 233 Q--KPEN--CPDK----IYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G+G +G VY + +A+K++ D +Y + E+ + +H N++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF--KVILGTAKGLAHLHHSFRPP 679
+ + P GSL A L + T F K IL +GL +LH +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLKYLHDN---Q 128
Query: 680 IIHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
I+H ++K N+L++ Y+ +ISDFG ++ L ++ + F L Y+APE+ +
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGP 185
Query: 738 R-VNEKCDIYGFGVLILELVTGRRP-VEYGE 766
R DI+ G I+E+ TG+ P +E GE
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
K ++GEG + TVYK ++A+K++ P REV +L +H N+++L
Sbjct: 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSF 676
T + LV +Y L L + L + K+ L +GL + H
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
R ++H +LKP N+L+++ +++DFGLAR + + SN + L Y P++ S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEVVT-LWYRPPDILLGS 179
Query: 737 LRVNEKCDIYGFGVLILELVTGR 759
+ + D++G G + E+ TGR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 52/295 (17%)
Query: 561 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+GEG FG V+ + ++AVK L + +DFERE +L +H N++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSL---------QAKLHERLPSTP-PLSWTNRFKVILGT 665
G ++V +Y +G L A + S L+ + ++ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 666 AKG---LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722
A G LA H +H +L N L+ + +I DFG++R + D + +
Sbjct: 132 ASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 723 SALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 775
+ ++ PE T +S D++ FGV++ E+ T G++P YG N E
Sbjct: 186 LPIRWMPPESIMYRKFTTES-------DVWSFGVVLWEIFTYGKQPW-YGLSN-----EE 232
Query: 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
V + +G +L P V + L C P R ++ ++ + LQ
Sbjct: 233 VIECITQGRLLQR--------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 43/262 (16%)
Query: 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLE 618
++GEG +G VYK G ++A+KK+ + + +P RE+++L + H N+++L+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 619 GYYWTPQLKL----------LVSDYAPN---GSLQAKL----HERLPSTPPLSWTNRFKV 661
Q L LV +Y + G L++ L + + S K
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF--------MKQ 124
Query: 662 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 721
+L +GL + H + +H ++K SNILL++ +++DFGLARL + +N+
Sbjct: 125 LL---EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781
+ L Y PEL R D++ G ++ EL T ++P+ + L R+
Sbjct: 179 IT-LWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISRL--- 233
Query: 782 EGNVLDCVDPSMGDYPEDEVLP 803
C P +P+ LP
Sbjct: 234 ------CGSPCPAVWPDVIKLP 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 561 EVGEGVFGTVYKV--SFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKARH 611
+G G +G VYK G G+ A+KK E + RE+ +L + +H
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-----KEQYTGISQSACREIALLRELKH 61
Query: 612 PNLISLEGYYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKG 668
N++SL + K L+ DYA + Q R + + K +L G
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP-PSMVKSLLWQILNG 120
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPR----ISDFGLARL-------LTRLDKHVM 717
+ +LH ++ ++H +LKP+NIL+ R I D GLARL L LD V+
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
+ + Y APEL + + DI+ G + EL+T
Sbjct: 178 T------IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 619
+G+G FG V G+M A KKL I + + E ++L K ++SL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHSF 676
Y T LV G L+ ++ + + A+ GL LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE-----RAVFYAAEITCGLEDLH--- 119
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
R I++ +LKP NILLDD + RISD GLA + + + R +GY+APE+ ++
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRV-GTVGYMAPEVV-KN 175
Query: 737 LRVNEKCDIYGFGVLILELVTGRRP 761
R D +G G LI E++ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 75/302 (24%), Positives = 134/302 (44%), Gaps = 39/302 (12%)
Query: 552 PETLLEKAAEVGEGVFGTVYKV-SFGT------QGRMLAVKKLVTSDIIQYPEDFEREVR 604
P L +GEG FG V + ++G Q +AVK L + + D E+
Sbjct: 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEME 69
Query: 605 VLG-KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP------------ 651
++ +H N+I+L G ++ +YA G+L+ L R P P
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 652 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711
LS+ + A+G+ +L S R IH +L N+L+ ++ +I+DFGLAR +
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLE-SRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 770
+D + ++ + + ++APE + ++ D++ FG+L+ E+ T G P
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQS-DVWSFGILMWEIFTLGGSPYP------G 239
Query: 771 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
I E + LL EG+ +D P + + L C +P+ RP+ ++V+ L
Sbjct: 240 IPVEELFKLLREGHRMDK--------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
Query: 831 VI 832
+
Sbjct: 292 KV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 28/230 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G G FG VY+ +A+KK ++Q P+ RE+ ++ H N+I L+ YY
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKK-----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 622 WTPQLKL--------LVSDYAPNGSLQ-AKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 672
+T K +V ++ P + K + R PL + L + LA++
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186
Query: 673 HHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRLDKHV--MSNRFQSALGYVA 729
H F I H +LKP N+L+D N + ++ DFG A+ L + V + +RF Y A
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRA 238
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
PEL + D++ G +I E++ G P+ G+ +V L ++VL
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRIIQVL 287
|
Length = 440 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 36/290 (12%)
Query: 556 LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
+ E+G+G FG VY+ V G +A+K + + ++ +F E V+ +
Sbjct: 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN 67
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------PPLSWTNRFKVILG 664
+++ L G T Q L+V + G L++ L R P P + ++
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 665 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724
A G+A+L +H +L N ++ ++ +I DFG+ R + D + +
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 725 LGYVAPELTCQSLR---VNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780
+ ++APE SL+ K D++ FGV++ E+ T +P + G N E V +
Sbjct: 185 VRWMAPE----SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSN-----EEVLKFV 234
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+G L D PE+ +L+L +C + P RP+ E+V L+
Sbjct: 235 IDGGHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 30/281 (10%)
Query: 562 VGEGVFGTVYKVSF----GTQGRM-LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
+G G FG VY+ + G + +AVK L S Q DF E ++ K H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---PPLSWTNRFKVILGTAKGLAHLH 673
L G + + ++ + G L++ L E P L+ + AKG +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL- 132
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPR---ISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
IH ++ N LL R I+DFG+AR + R + R + ++ P
Sbjct: 133 EENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
E + K D++ FGVL+ E+ + G P G N + V + G L
Sbjct: 191 EAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYP-GRTN-----QEVMEFVTGGGRL--- 240
Query: 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
D P+ PV ++ C H P RP+ A +++ +Q
Sbjct: 241 -----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 35/226 (15%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGT-QGRM-LAVKKLVTSDIIQYPEDFEREVRV 605
IDP+ T L+ E+G G FG V +G +G+ +A+K + + + ++F E +V
Sbjct: 1 IDPKDLTFLK---ELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKV 52
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+ K H L+ L G + +V++Y NG L L E P K +
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV--- 109
Query: 666 AKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724
+G+A+L F IH +L N L+DD ++SDFGL+R +V+ + + S+
Sbjct: 110 CEGMAYLESKQF----IHRDLAARNCLVDDQGCVKVSDFGLSR-------YVLDDEYTSS 158
Query: 725 LG------YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 763
+G + PE+ S + + K D++ FGVL+ E+ + G+ P E
Sbjct: 159 VGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 33/218 (15%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLA-------VKKLVTSDIIQYPEDFEREVRVLGK 608
EK E+G G G V KV G ++A +K + + II RE++VL +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQII-------RELKVLHE 55
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTA 666
P ++ G +++ + ++ GSL L + R+P L K+ +
Sbjct: 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-NILG-----KISIAVL 109
Query: 667 KGLAHLH--HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724
+GL +L H I+H ++KPSNIL++ ++ DFG++ L +D M+N F
Sbjct: 110 RGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS--MANSFVGT 161
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
Y++PE Q + DI+ G+ ++E+ GR P+
Sbjct: 162 RSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 9e-13
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 36/213 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVT-----SDIIQYPEDFEREVRVLGK-ARHPNL 614
++G+G FG+VY G ++A+KK+ + + REV+ L K HPN+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNEHPNI 60
Query: 615 ISL-EGYYWTPQLKLLVSDYAPNGSL--QAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
+ L E + +L V +Y G+L K + P + + +I +GLAH
Sbjct: 61 VKLKEVFRENDEL-YFVFEYM-EGNLYQLMKDRKGKPFSESVI----RSIIYQILQGLAH 114
Query: 672 LH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR----FQSALG 726
+H H F H +LKP N+L+ +I+DFGLAR + S + S
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRW 163
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
Y APE+ +S + DI+ G ++ EL T R
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 66/230 (28%), Positives = 112/230 (48%), Gaps = 21/230 (9%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 615
EK ++GEG +G VYK +A+KK+ + + P RE+ +L + +H N++
Sbjct: 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KVIL-GTAKGLAHLH 673
L+ + + LV +Y L L + + S+P + R K L +G+A+
Sbjct: 65 RLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC- 118
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLL---TRLDKHVMSNRFQSALGYVA 729
HS R ++H +LKP N+L+D N +++DFGLAR R H + L Y A
Sbjct: 119 HSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV-----VTLWYRA 171
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
PE+ S + DI+ G + E+V ++P+ G+ + L + R+L
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRIL 220
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 38/85 (44%), Positives = 52/85 (61%)
Query: 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 316
L L + L G IP ++ +L+ +NLS N +R IPP LG SL LDL N+ GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 317 PQEVCESRSLGILQLDGNSLTGPIP 341
P+ + + SL IL L+GNSL+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 14/212 (6%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 611
P L+ ++G G FG V+ + + +A+K L + PE F E ++ + +H
Sbjct: 4 PRETLKLVKKLGAGQFGEVW-MGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQH 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
P L+ L T + ++++Y NGSL L + P L+ + A+G+A
Sbjct: 61 PRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+ R IH +L+ +NIL+ + +I+DFGLARL+ +++ + + + APE
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE 173
Query: 732 -LTCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
+ + + K D++ FG+L+ E+VT GR P
Sbjct: 174 AINYGTFTI--KSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 618
+G+G FG V G++ A KKL ++ + +E E R+L K ++SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL-NKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHS 675
+ T LV G L+ ++ P + TA+ GL HLH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEHLHQR 116
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
II+ +LKP N+LLD++ N RISD GLA L D + + G++APEL Q
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELL-Q 170
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRP 761
+ D + GV + E++ R P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL---VTSDIIQYPEDFEREVRVLGKARH 611
L +G+G FG VYK +++A+K + D I ED ++E++ L + R
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI---EDIQQEIQFLSQCRS 58
Query: 612 PNLISLEGYYWTPQLKL-LVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 665
P + G + KL ++ +Y GS KL E + ++
Sbjct: 59 PYITKYYGSF-LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF----------ILREV 107
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
GL +LH + IH ++K +NILL + + +++DFG++ LT MS R + +
Sbjct: 108 LLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKR-NTFV 159
Query: 726 G---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
G ++APE+ QS +EK DI+ G+ +EL G P
Sbjct: 160 GTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 64/283 (22%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-----VTSDIIQYPEDFEREVRVLGKARHP 612
K ++G G F + Y+ G ++AVK++ +S+ + E +E+R++ + HP
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 672
++I + G L ++ GS+ L + + +GL++L
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYL 119
Query: 673 HHSFRPPIIHYNLKPSNILLDDN-YNPRISDFG----LARLLTRLDKHVMSNRFQSALGY 727
H + IIH ++K +N+L+D RI+DFG LA T + + + +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAF 174
Query: 728 VAPELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784
+APE+ LR CD++ G +I+E+ T + P + + S H+ ++ + +
Sbjct: 175 MAPEV----LRGEQYGRSCDVWSVGCVIIEMATAKPP--WNAEKH---SNHLALIFKIAS 225
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
PS+ PE + + L C P RP E+++
Sbjct: 226 ATT--APSI---PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 561 EVGEGVFGTVY--KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
E+G G FG V + G + VK+L S F +EV+ + HPN++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKL-----HERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
G LLV ++ P G L+ L + + ++ A GL LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMACEVASGLLWLH 117
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
+ IH +L N L + + +I D+GLA D ++ + L ++APEL
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 734 C---QSLRV---NEKCDIYGFGVLILELVT-GRRP 761
Q L +K +I+ GV + EL T +P
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FEREVRVLGKARHPNL 614
E+ +E+G G G V KV G ++A +KL+ +I + RE++VL + P +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHL 672
+ G +++ + ++ GSL L E R+P KV + +GLA+L
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI------LGKVSIAVLRGLAYL 119
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
+ I+H ++KPSNIL++ ++ DFG++ L +D M+N F Y++PE
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS--MANSFVGTRSYMSPE- 172
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
Q + + DI+ G+ ++EL GR P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 31/229 (13%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 619
+G+G FG V V G+ A+K L II E E RVL RHP L +L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 675
+ T V +YA G L L ER+ S RF +++ L +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAEIVSA----LGYLH-- 112
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
+++ +LK N++LD + + +I+DFGL + + F Y+APE+
Sbjct: 113 -SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV--- 166
Query: 736 SLRVNE---KCDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVR 777
L N+ D +G GV++ E++ GR P Y +D+ IL E +R
Sbjct: 167 -LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 11/223 (4%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 619
+G+G FG V G+M A K+L I + + E ++L K +++L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
Y T LV G L K H P + + A+ L L R
Sbjct: 68 AYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFE---EERALFYAAEILCGLEDLHREN 122
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
++ +LKP NILLDD + RISD GLA + + + R +GY+APE+ + R
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRV-GTVGYMAPEVL-NNQRY 178
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782
D +G G LI E++ G+ P ++ V RVL E
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-12
Identities = 34/88 (38%), Positives = 51/88 (57%)
Query: 132 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSL 191
L L N G +P + L + I++S N++ G+IP +G+I++LE LD S N GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 192 PSSLFNCKKLSVIRLRGNSLNGNIPEGL 219
P SL L ++ L GNSL+G +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FEREVRVLGKARHPNL 614
EK +E+G G G V+KVS G ++A +KL+ +I + RE++VL + P +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHL 672
+ G +++ + ++ GSL L + R+P KV + KGL +L
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI------LGKVSIAVIKGLTYL 119
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
+ I+H ++KPSNIL++ ++ DFG++ L +D M+N F Y++PE
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS--MANSFVGTRSYMSPE- 172
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
Q + + DI+ G+ ++E+ GR P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKK-LVTSDIIQYPEDFEREVRVLGKARHPNLI 615
EK A++G+G FG V+K +++A+KK L+ ++ +P RE+++L +H N++
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV 74
Query: 616 SLEGYYWTPQLK--------LLVSDYAPNGSLQAKLHE--RLPSTPPLSWT--NRFKVIL 663
+L T LV ++ H+ L S + +T KV+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---LLTRLDKHVMSNR 720
GL ++H R I+H ++K +NIL+ + +++DFGLAR L + +NR
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 721 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 765
+ L Y PEL D++G G ++ E+ T R P+ G
Sbjct: 184 VVT-LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 32/258 (12%)
Query: 557 EKAAEVGEGVFGTVYKV-SFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKAR---H 611
E AE+GEG +G V+K GR +A+K++ V + P REV VL H
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 612 PNLISLEGYYWTP----QLKLLVSDYAPNGSLQAKLHERL-PSTPPLSWTNRFKVILGTA 666
PN++ L + KL + + L L + P P + + ++
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---MMFQLL 120
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+GL LH S R ++H +LKP NIL+ + +++DFGLAR+ + + L
Sbjct: 121 RGLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
Y APE+ QS D++ G + E+ R+P+ G +V L G +L
Sbjct: 175 YRAPEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL----------GKIL 222
Query: 787 DCVD-PSMGDYPEDEVLP 803
D + P D+P D LP
Sbjct: 223 DVIGLPGEEDWPRDVALP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G+G FG V A+K L D++ +D E E RVL A HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL-KKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T + V +Y G L + + ++I G L LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKKG- 116
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
II+ +LK N+LLD + + +I+DFG+ + + ++ F Y+APE+ +
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEIL-KGQ 171
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ NE D + FGVL+ E++ G+ P +GED
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
K ++GEG + TV+K ++A+K++ P REV +L +H N+++L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSF 676
T + LV +Y L L + + + + K+ L +GLA+ H
Sbjct: 70 HDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--- 121
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
R ++H +LKP N+L+++ +++DFGLAR + K SN + L Y P++ S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVT-LWYRPPDVLLGS 179
Query: 737 LRVNEKCDIYGFGVLILELVTGR 759
+ + D++G G + E+ +GR
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 44/249 (17%)
Query: 534 GKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII 593
GK I+FDS DP E +G+G +G V+KV G AVK L I
Sbjct: 5 GKTIIFDSFP-------DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIH 55
Query: 594 QYPEDFEREVRVLGK-ARHPNLISLEGYYWTPQLK-----LLVSDYAPNGSLQ------A 641
E+ E E +L + HPN++ G Y+ +K LV + GS+
Sbjct: 56 DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115
Query: 642 KLHERLPSTPPLSWTNRFKVILGTA-KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 700
K ER+ P +++ IL A GL HLH + IH ++K +NILL ++
Sbjct: 116 KRGERM-EEPIIAY------ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165
Query: 701 SDFGLARLLTRLDKHVMSNRFQSALG---YVAPE-LTCQS---LRVNEKCDIYGFGVLIL 753
DFG++ LT R +++G ++APE + C+ + +CD++ G+ +
Sbjct: 166 VDFGVSAQLTS-----TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI 220
Query: 754 ELVTGRRPV 762
EL G P+
Sbjct: 221 ELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 34/277 (12%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
L +GEG FG V + + G+ +AVK + D+ + F E V+ K H NL+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEY--TGQKVAVK-NIKCDVTA--QAFLEETAVMTKLHHKNLV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L G L + V + G+L L R + + +F L A+G+ +L
Sbjct: 63 RLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLESK 119
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRFQSALGYVAPELTC 734
++H +L NIL+ ++ ++SDFGLAR+ + +D + + + APE
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL------PVKWTAPE-AL 169
Query: 735 QSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793
+ + + K D++ +GVL+ E+ + GR P Y + ++ + E V E+G + +P
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECV----EKGYRM---EP-- 218
Query: 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
PE V L C P RPS ++ + L+
Sbjct: 219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVT--SDIIQYPEDFEREVRVLGKARHPNLISLEG 619
VG G +G+V G +AVKKL II + RE+R+L +H N+I L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 620 YYWTP--QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ TP L+ Y + A L+ + +F +I +GL ++H +
Sbjct: 84 VF-TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSA-- 139
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
IIH +LKPSN+ ++++ +I DFGLAR ++ R+ Y APE+ +
Sbjct: 140 -DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRAPEIMLNWM 193
Query: 738 RVNEKCDIYGFGVLILELVTGR 759
N+ DI+ G ++ EL+TGR
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 34/298 (11%)
Query: 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 608
ET L+K +G G FGTVYK + G + A+K L + + ++ E V+
Sbjct: 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 65
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGT 665
P + L G T ++L V+ P G L + E R+ S L+W +
Sbjct: 66 VGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC------VQI 118
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
AKG+++L ++H +L N+L+ + +I+DFGLARLL + ++ + +
Sbjct: 119 AKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784
++A E R + D++ +GV + EL+T G +P + I + + LLE+G
Sbjct: 176 KWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDG------IPAREIPDLLEKGE 228
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEV 842
L P + V + + C RP E+V + P R V
Sbjct: 229 RL--------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD-PSRFVV 277
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 59/303 (19%)
Query: 562 VGEGVFGTVYKV-SFGTQGR----MLAVKKLVTSDIIQYPEDF--EREV-RVLGKARHPN 613
+GEG FG V K + G +AVK L + D E E+ +++GK H N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 614 LISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHER------------LPSTPPLSWTNRFK 660
+I+L G T + L +V +YA +G+L+ L R P L+ +
Sbjct: 78 IINLLGVC-TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 661 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720
A+G+ L IH +L N+L+ +++ +I+DFGLAR + +D + +
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 721 FQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILS 773
+ + ++APE T QS D++ FGVL+ E+ T G P I
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLLWEIFTLGGSPYP------GIPV 240
Query: 774 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTC--HIPSSRPSMAEVVQILQV 831
E + LL+EG ++ P E+ L+ C +PS RP+ ++V+ L
Sbjct: 241 EELFKLLKEGYRME--KPQ---NCTQEL-----YHLMRDCWHEVPSQRPTFKQLVEDLDR 290
Query: 832 IKT 834
+ T
Sbjct: 291 MLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVT----SDIIQYPEDFEREVRVLGKARHPNLISL 617
+G+G FG VY GR LAVK++ + + E E+++L +H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
G + + +Y P GS+ ++L + L+ T K +G+ +LH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEGVEYLH---S 122
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG----YVAPELT 733
I+H ++K +NIL D N ++ DFG + RL S ++ +++PE+
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGAS---KRLQTICSSGTGMKSVTGTPYWMSPEV- 178
Query: 734 CQSLRVN-----EKCDIYGFGVLILELVTGRRP 761
++ K D++ G ++E++T + P
Sbjct: 179 -----ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 562 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNL 614
+G G +G V+ KVS G++ A+K L + I+Q + E E +VL R P L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKGLAHLH 673
++L + T L+ DY G L L +R ++ G L HLH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHLH 122
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
+ II+ ++K NILLD N + ++DFGL++ D+ + F + Y+AP++
Sbjct: 123 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIV 178
Query: 734 CQSLRVNEKC-DIYGFGVLILELVTGRRPVEY-GEDN 768
++K D + GVL+ EL+TG P GE N
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVL----GKARHPNLIS 616
+G G FG VY G+M A+K L I ++ E R++ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
+ + TP + D G L L + + ++ILG L H+H+ F
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEHMHNRF 117
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
+++ +LKP+NILLD++ + RISD GLA ++ H GY+APE+ +
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH----GYMAPEVLQKG 170
Query: 737 LRVNEKCDIYGFGVLILELVTGRRP 761
+ D + G ++ +L+ G P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 565 GVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE----DFEREVRVLGKARHPNLISLEGY 620
G +G V+ + G + A+K + +D+I+ + ER++ L +A+ P ++ L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL--- 58
Query: 621 YWTPQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
Y++ Q K LV +Y P G L A L E + S I+ L +LH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIV---LALEYLH---S 111
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLA------RLLTRLDKHVMSNRFQSALGYVAPE 731
IIH +LKP NIL+D N + +++DFGL+ R + D R Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 732 -LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ Q ++ D + G ++ E + G P
Sbjct: 172 VILGQG--HSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 72/294 (24%), Positives = 127/294 (43%), Gaps = 39/294 (13%)
Query: 562 VGEGVFGTVYKV-SFG------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPN 613
+GEG FG V + G + +AVK L + D E+ ++ +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKV 661
+I+L G ++ +YA G+L+ L R P +++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 662 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 721
A+G+ +L IH +L N+L+ +N +I+DFGLAR + +D + +
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780
+ + ++APE + ++ D++ FGVL+ E+ T G P I E + LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGGSPYPG------IPVEELFKLL 252
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
+EG+ + D P + + + C IPS RP+ ++V+ L I T
Sbjct: 253 KEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 77/285 (27%), Positives = 131/285 (45%), Gaps = 42/285 (14%)
Query: 562 VGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+G+G FG VY + Q AVK L ++ E F +E ++ HPN++SL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 619 GYYWTPQ-LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG----TAKGLAHLH 673
G + L+V Y +G L+ + R + P K ++G AKG+ +L
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNP-----TVKDLIGFGLQVAKGMEYLA 115
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYVAPE 731
+H +L N +LD+++ +++DFGLAR + + + + N + L ++A E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE----DNVVILSEHVRVLLEEGNVLD 787
+ Q+ + K D++ FGVL+ EL+T R Y + D V L + R+L E
Sbjct: 173 -SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPEY---- 226
Query: 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
C D P+ ++ L C P RP+ +E+V ++ I
Sbjct: 227 CPD------------PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 26/228 (11%)
Query: 552 PETLLEKAAEVGEGVFGTVY--------------KVSFGTQGRMLAVKKLVTSDIIQYPE 597
P L ++GEG FG V+ F Q ++AVK L
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN 62
Query: 598 DFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHER-LPST------ 650
DF +E++++ + ++PN+I L G + ++++Y NG L L +R + ST
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 651 -PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709
P +S N + + A G+ +L +H +L N L+ ++Y +I+DFG++R L
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
D + + R + ++A E + D++ FGV + E+ T
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPN 613
+EK +G+G F VYK GR++A+KK+ +++ + +D +E+ +L + HPN
Sbjct: 6 IEKK--IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 614 LIS-LEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGTAK 667
+I L + +L +V + A G L K +RL + W K +
Sbjct: 64 VIKYLASFIENNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTI-W----KYFVQLCS 117
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 726
L H+H S R I+H ++KP+N+ + ++ D GL R + + S +G
Sbjct: 118 ALEHMH-SKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----KTTAAHSLVGT 169
Query: 727 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784
Y++PE N K DI+ G L+ E+ + P + N+ L
Sbjct: 170 PYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------------ 216
Query: 785 VLDCVDPSMGDYP----EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828
C DYP + + L C P RP ++ V+Q+
Sbjct: 217 ---CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-A 609
DP E +G+G +G VYKV+ G + AVK + I E+ E E +L
Sbjct: 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK--ILDPISDVDEEIEAEYNILQSLP 76
Query: 610 RHPNLISLEGYYWTP------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 663
HPN++ G ++ QL LV + GS+ + L L ++
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT--RLDKHVMSNRF 721
G GL HLH++ IIH ++K +NILL ++ DFG++ LT RL R
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-------RR 185
Query: 722 QSALG---YVAPE-LTCQS---LRVNEKCDIYGFGVLILELVTGRRPV 762
+++G ++APE + C+ + +CD++ G+ +EL G P+
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKA-RHPNLISL 617
+G+G FG V+ + A+K L D++ +D E E RVL A HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T + V +Y G L + P + ++I G L LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK-- 115
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
I++ +LK NILLD + + +I+DFG+ + + + F Y+APE+
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQ- 171
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ N D + FGVL+ E++ G+ P +G D
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 69/282 (24%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 608
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 65
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGT 665
+P++ L G T ++L ++ P G L + E + S L+W +
Sbjct: 66 VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQI 118
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
AKG+ +L ++H +L N+L+ + +I+DFGLA+LL +K + + +
Sbjct: 119 AKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784
++A E + ++ D++ +GV + EL+T G +P + I + + +LE+G
Sbjct: 176 KWMALESILHRIYTHQS-DVWSYGVTVWELMTFGSKPYDG------IPASEISSILEKGE 228
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 826
L P P + V + + C SRP E++
Sbjct: 229 RL----PQ----PPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 66/271 (24%), Positives = 107/271 (39%), Gaps = 22/271 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G FG V+ +AVK + F +E R+L + HPN++ L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
Q +V + G L P L +++ A G+ +L
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
IH +L N L+ + +ISDFG++R Q + + APE R +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYS 174
Query: 741 EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799
+ D++ FG+L+ E + G P + ++ R +E+G L C + P+
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPY------ANLSNQQTREAIEQGVRLPCPE----LCPDA 224
Query: 800 EVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
V +L C + P RPS + V Q LQ
Sbjct: 225 ----VYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DP T L+ ++GEG G V + + G+++AVKK+ Q E EV ++ +
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQ 75
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 665
H N++ + Y +V ++ G+L +++E + V L
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA----------VCLAV 125
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
K L+ LH +IH ++K +ILL + ++SDFG ++ K V R +S +
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV--PRRKSLV 177
Query: 726 G---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
G ++APEL + L + DI+ G++++E+V G P
Sbjct: 178 GTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 87/268 (32%), Positives = 120/268 (44%), Gaps = 22/268 (8%)
Query: 23 FENCASLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81
SL LS +G L G + L +L+L+ N ++ L L
Sbjct: 66 LSRLLSLDLLSPSGISSLDGS--ENLLNLLPLPSLDLNLNRLRSNISELL-----ELTNL 118
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
+LDL +N + P LKEL L N+ LP+ + P+L LDLS N +
Sbjct: 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 142 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKL 201
LP L L+++ + +S N ++ D+P I +S LE LD SNN + L SSL N K L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 202 SVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
S + L N L ++PE + +L LE +DLS N SS SS LR LDLS
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNN--------QISSISSLGSLTNLRELDLS 285
Query: 261 SNNLVGDIPAEMGLFANLRYLNLSSNHL 288
N+L +P L L L L
Sbjct: 286 GNSLSNALPLIALLLLLLELLLNLLLTL 313
|
Length = 394 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 19/227 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 619
+G+G FG V G+M A KKL I + + E ++L K ++SL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHSF 676
Y T LV G L+ ++ + + + A+ GL LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-----RAVFYAAEICCGLEDLH--- 119
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
+ I++ +LKP NILLDD+ + RISD GLA + + + R +GY+APE+ ++
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYMAPEVV-KN 175
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783
R D + G L+ E++ G+ P + + I E V L++E
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--IKREEVERLVKEV 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 66/247 (26%), Positives = 115/247 (46%), Gaps = 22/247 (8%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
LEK +GEG + TVYK T G ++A+K++ P RE+ ++ + +H N++
Sbjct: 5 LEK---LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHER-LPSTPPLSWTNRFKVILGTAKGLAHLHH 674
L T +LV +Y + L+ + + + F L KG+A H
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHE 118
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---ALGYVAPE 731
+ ++H +LKP N+L++ +++DFGLAR + N F + L Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG-----IPVNTFSNEVVTLWYRAPD 170
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
+ S + DI+ G ++ E++TG RP+ G +N L + R++ G + P
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIFRIM---GTPTESTWP 226
Query: 792 SMGDYPE 798
+ PE
Sbjct: 227 GISQLPE 233
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 43/230 (18%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
IDP T L+ E+G G FG V+ + + +A+K + + + +DF E +V+
Sbjct: 1 IDPSELTFLK---ELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE--DDFIEEAKVMM 54
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK--VILGT 665
K HPNL+ L G + +V++Y NG L L ER + +L
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER---------KGKLGTEWLLDM 105
Query: 666 A----KGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720
+ + +L + F IH +L N L+ ++ ++SDFGLAR +V+ ++
Sbjct: 106 CSDVCEAMEYLESNGF----IHRDLAARNCLVGEDNVVKVSDFGLAR-------YVLDDQ 154
Query: 721 FQSALG------YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 763
+ S+ G + PE+ S R + K D++ FGVL+ E+ + G+ P E
Sbjct: 155 YTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK- 608
DP + E VG G +G VYK G++ A+K + VT D E+ ++E+ +L K
Sbjct: 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKY 59
Query: 609 ARHPNLISLEGYYWT---PQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KV 661
+ H N+ + G + P + LV ++ GS+ + +T W +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 662 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSNR 720
IL +GL+HLH +IH ++K N+LL +N ++ DFG++ +LD+ V N
Sbjct: 120 IL---RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNT 170
Query: 721 FQSALGYVAPE-LTCQS---LRVNEKCDIYGFGVLILELVTGRRPV 762
F ++APE + C + K D++ G+ +E+ G P+
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 562 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISL 617
+G+G FG V+ K++ G++ A+K L + + ++ + E +L + HP ++ L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT-AKGLAHLHHSF 676
+ T L+ D+ G L +L + + T K L A L HLH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVKFYLAELALALDHLH--- 115
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
II+ +LKP NILLD+ + +++DFGL++ +K S F + Y+APE+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV---- 169
Query: 737 LRVNEK-----CDIYGFGVLILELVTGRRPVEYGED 767
VN + D + FGVL+ E++TG P + G+D
Sbjct: 170 --VNRRGHTQSADWWSFGVLMFEMLTGSLPFQ-GKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 31/246 (12%)
Query: 552 PETLLEKAAEVGEGVFGTVY-KVSFGTQG---------------RMLAVKKLVTSDIIQY 595
P L ++GEG FG V+ + G Q ++AVK L
Sbjct: 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62
Query: 596 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST----- 650
EDF +EV++L + PN+ L G ++ +Y NG L L + + T
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 651 --PPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707
LS++ + A G+ +L +F +H +L N L+ NY +I+DFG++R
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNF----VHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYG 765
L D + + R + ++A E + K D++ FGV + E++T +P E+
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
Query: 766 EDNVVI 771
D VI
Sbjct: 238 TDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNL 614
L+ E+G G FGTV K+ G ++AVK++ ++ + + ++ V+ ++ P +
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 615 ISL------EGYYWT-PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+ EG W +L + D ++E L S P K+ + T K
Sbjct: 66 VKFYGALFREGDCWICMELMDISLD-----KFYKYVYEVLKSVIPEEILG--KIAVATVK 118
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
L +L + IIH ++KPSNILLD N N ++ DFG++ +L + R Y
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPY 173
Query: 728 VAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRP 761
+APE S R + + D++ G+ + E+ TG+ P
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 617
+G+G FG V V G+M A KKL + + + E+E+ L K P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHH 674
+ + LV G L K H L +VI +A+ G+ HLH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDL--KYHIYNVGERGLEME---RVIHYSAQITCGILHLHS 113
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
I++ ++KP N+LLDD N R+SD GLA L D ++ R + GY+APE+
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTN-GYMAPEILK 167
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + D + G I E+V GR P
Sbjct: 168 EEP-YSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 562 VGEGVFG--TVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISL 617
+G+G FG T+Y+ T+ L V K V + E D E+ +L +HPN+I+
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHER---LPSTPPLSWTNRFKVILGTAKGLAHLHH 674
++ L+ +YA G+L K+ + L + W + ++++H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHK 119
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 731
+ I+H ++K NI L ++ DFG++++L ++ M+ ++ +G Y++PE
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMA---ETVVGTPYYMSPE 171
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763
L CQ ++ N K DI+ G ++ EL+T +R +
Sbjct: 172 L-CQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 619
+G+G FG V G+M A KKL I + + E R+L K ++SL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHSF 676
Y T LV G L K H P + + I A+ GL L
Sbjct: 68 AYETKDALCLVLTIMNGGDL--KFHIYNMGNPGF---DEQRAIFYAAELCCGLEDLQ--- 119
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
R I++ +LKP NILLDD + RISD GLA + + + R +GY+APE+ +
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRV-GTVGYMAPEVI-NN 175
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
+ D +G G LI E++ G+ P ++ V
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-11
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 26/191 (13%)
Query: 599 FEREVRVLGKARHPNLISL--EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656
F RE + + HPN+++L G P L V +Y P +L+ E L + L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLR----EVLAADGALPAG 79
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLL--TR 711
+++L LA H I+H +LKP NI++ + ++ DFG+ LL R
Sbjct: 80 ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136
Query: 712 LDKHVMSNRFQSALG---YVAPELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYG 765
R LG Y APE LR V D+Y +G++ LE +TG+R V+ G
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPE----QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ-G 191
Query: 766 EDNVVILSEHV 776
IL + +
Sbjct: 192 ASVAEILYQQL 202
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 619
VG G FG V V G + A+K + S ++ FE E +L + P + L+
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT-------AKGLAHL 672
+ LV +Y P G L LS NR++ A+ + +
Sbjct: 69 AFQDKDNLYLVMEYQPGGDL-------------LSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
H + +H ++KP N+L+D + +++DFG A LT +K V S Y+APE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYIAPEV 174
Query: 733 TCQSLRVNEK------CDIYGFGVLILELVTGRRPVEYGEDNVV 770
++ + K CD + GV+ E++ GR P E
Sbjct: 175 L-TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH--EGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVL----GKARHPNLIS 616
+G G FG VY G+M A+K L I ++ E R++ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTN-RF---KVILGTAKGLAHL 672
+ + TP + D G L H L S RF ++ILG L H+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAEIILG----LEHM 113
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
H+ F +++ +LKP+NILLD++ + RISD GLA ++ H GY+APE+
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH----GYMAPEV 166
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + + D + G ++ +L+ G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 562 VGEGVFGTVYKVSFGTQG-RM-LAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLE 618
+GEG FG V K G RM A+K++ DF E+ VL K HPN+I+L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHER--LPSTPPLSWTNRFKVILGT----------A 666
G L +YAP+G+L L + L + P + N L + A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+G+ +L IH +L NIL+ +NY +I+DFGL+R K M + +
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVR 188
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 785
++A E S+ D++ +GVL+ E+V+ G P Y L E +
Sbjct: 189 WMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLPQGYRLEKP 245
Query: 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 826
L+C +DEV +++ C P RPS A+++
Sbjct: 246 LNC---------DDEVYDLMRQ---CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYY 621
GEG FG VYK GR++A+KK++ + +P RE+++L K +HPN++ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID-- 74
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHERLPS----TP-------PLSWTNRFKVILGTAK--- 667
+ + K + S TP L K+ K
Sbjct: 75 -------MAVERPD------KSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 668 -----GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722
G+ +LH + I+H ++K +NIL+D+ +I+DFGLAR
Sbjct: 122 LQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYD--GPPPNPKGGG 176
Query: 723 SALG-----------YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
Y PEL R DI+G G + E+ T RRP+
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 563 GEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNLI 615
G G +G V+ KV G++ A+K L + I+Q + E E +VL R P L+
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV 68
Query: 616 SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK------VILGTAKG 668
+L Y + KL L+ DY G L L++R F I
Sbjct: 69 TLH-YAFQTDTKLHLILDYVNGGELFTHLYQR----------EHFTESEVRVYIAEIVLA 117
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
L HLH + II+ ++K NILLD + ++DFGL++ ++ + F + Y+
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 729 APELTCQSLRVNEKC-DIYGFGVLILELVTGRRP 761
APE+ ++K D + GVL EL+TG P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-11
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 32 LSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLF 91
L L L+G I + L ++NLS N G++ + G S+ L LDLS+N F
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG----SITSLEVLDLSYNSF 478
Query: 92 SGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCP-HLTTLDLSNN 137
+GSIP+ + L L+ L L GN SG +PA +G H + + ++N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 38/272 (13%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVK-KLVTSDIIQYPED----FEREVRVLGKARHPNLIS 616
+G+G FG V+K GT V K D+ P++ F E R+L + HPN++
Sbjct: 3 LGKGNFGEVFK---GTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVK 56
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
L G Q +V + P G + L ++ L K L A G+A+L
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK- 112
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR--FQSALGYVAPELTC 734
IH +L N L+ +N +ISDFG++R + D + S+ Q + + APE
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPE-AL 166
Query: 735 QSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793
R + + D++ +G+L+ E + G P G N + R +E+G + C
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYP-GMTN-----QQAREQVEKGYRMSCPQKC- 219
Query: 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 825
P+D V K+ C + P +RP +E+
Sbjct: 220 ---PDD----VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGK 608
DP + L+ ++GEG G V + + GR +AVKK+ D+ Q E EV ++
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRD 72
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVIL 663
+HPN++ + Y +V ++ G+L +++E +T V L
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT----------VCL 122
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
K L+ LH +IH ++K +ILL + ++SDFG ++ K V R +S
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC---AQVSKEV--PRRKS 174
Query: 724 ALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+G ++APE+ + E DI+ G++++E+V G P
Sbjct: 175 LVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 617
+G+G FG V + A+K L I+Q +D + E R+L A+HP L +L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T V +Y G L ++ P S +V L L LH R
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA----LMFLH---R 114
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
+I+ +LK NILLD + +++DFG+ + + V + F Y+APE+ Q L
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEIL-QEL 171
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVE 763
D + GVL+ E++ G+ P E
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 45/291 (15%)
Query: 562 VGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLI 615
+GEG FG+V + G+Q + +AVK + DI Y E+F E + HPN++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 616 SLEGYYWT------PQLKLLVSDYAPNGSLQAKL-HERLPSTP---PLSWTNRFKVILGT 665
L G + +++ + +G L + L + RL P PL +F ++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF--MVDI 122
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
A G+ +L S R IH +L N +L ++ ++DFGL++ + D + + +
Sbjct: 123 ALGMEYL--SNRN-FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 726 GYVAPELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLE 781
++A E SL K D++ FGV + E+ T G+ P G +N I L
Sbjct: 180 KWIAIE----SLADRVYTSKSDVWAFGVTMWEIATRGQTPYP-GVENHEIYD-----YLR 229
Query: 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
GN L PED + + L C P RP+ ++ ++L+ I
Sbjct: 230 HGNRL--------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 40/118 (33%), Positives = 52/118 (44%), Gaps = 29/118 (24%)
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239
L N L G +P+ + + L I L GNS+ GNIP L GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL----------------GSIT 466
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG 297
+L +LDLS N+ G IP +G +LR LNL+ N L R+P LG
Sbjct: 467 -------------SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARHP 612
+G G +G V +A+KK+ + F+ RE+++L H
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA--------FDNRIDAKRTLREIKLLRHLDHE 64
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 672
N+I+++ P + Y + LH+ + S+ LS + + +GL ++
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
H + ++H +LKPSN+LL+ N + +I DFGLAR T +K + Y APEL
Sbjct: 125 HSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPEL 179
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
D++ G + EL+ GR+P+ G+D V
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DP +LLE ++GEG G V GR +AV K++ Q E EV ++ +
Sbjct: 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAV-KMMDLRKQQRRELLFNEVVIMRDYQ 76
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 665
H N++ + Y + ++ ++ G+L Q +L+E +T V
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT----------VCESV 126
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+ L +LH +IH ++K +ILL + ++SDFG ++ K V +
Sbjct: 127 LQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGT 180
Query: 726 GY-VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
Y +APE+ ++ E DI+ G++++E+V G P
Sbjct: 181 PYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 619
+G+G FG V V G+ A+K L II E E RVL RHP L SL+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
+ T V +Y G L L ER+ S RF A+ ++ L +
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSED----RTRFY----GAEIVSALDYLHSG 114
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
I++ +LK N++LD + + +I+DFGL + + F Y+APE+ +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVL-EDND 171
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDN 768
D +G GV++ E++ GR P Y +D+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 17/212 (8%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKK-LVTSDIIQYPEDFEREVRVLGKARHPNLI 615
EK ++GEG +G VYK G+++A+KK + D P RE+ +L I
Sbjct: 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 616 -------SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAK 667
+E P L L+ + + R P P P F L K
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LK 121
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALG 726
G+AH H + ++H +LKP N+L+D +I+D GL R + K L
Sbjct: 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLW 176
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTG 758
Y APE+ S + DI+ G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISL-EG 619
VG+G +G V V T G+ +KKL + + + + E+E ++L + +HPN+++ E
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
+ L +V + G L KL E+ LP + W + A L +LH
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYLHEK 121
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
I+H +LK N+ L ++ D G+AR+L ++ M++ Y++PEL
Sbjct: 122 H---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSN 176
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795
N K D++ G + E+ T + + N ++ R++ EG + P M
Sbjct: 177 K-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY----RII--EGKL-----PPM-- 222
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P+D + +L P RPS+ +++
Sbjct: 223 -PKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 561 EVGEGVFGTVYKVS----FGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
E+GEG FG V+ Q +ML K + +DF+RE +L +H +++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-----------PLSWTNRFKVILGT 665
G + L+V +Y +G L L P L+ +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 666 AKG---LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722
A G LA LH +H +L N L+ +I DFG++R + D + + R
Sbjct: 132 ASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 723 SALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
+ ++ PE + + + DI+ FGV++ E+ T G++P
Sbjct: 186 LPIRWMPPE-SILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 562 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNL 614
+G G +G V+ KV+ G++ A+K L + ++Q + E E VL R P L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 615 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
++L Y + + KL L+ DY G + L++R + ++IL L HLH
Sbjct: 68 VTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLH 122
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR-LLTRLDKHVMSNRFQSALGYVAPEL 732
+ I++ ++K NILLD + ++DFGL++ L+ + S F + Y+APE+
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYMAPEI 177
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEY-GEDN 768
+ D + G+LI EL+TG P GE N
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 49/223 (21%)
Query: 562 VGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDIIQYPEDFER---------EVRVLGKA-R 610
+G G FG VYKV G +LA+K++ + + ER EV ++ + R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 611 HPNLIS-----LEGYYWTPQLKLLVSDYAPNG----SLQAKLH----ERLPSTPPLSWTN 657
HPN++ LE + L+ + AP G SL+ K ER+ W
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLI--EGAPLGEHFNSLKEKKQRFTEERI-------WNI 118
Query: 658 RFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717
+++L L +LH R I+H +L P+NI+L ++ I+DFGLA+ K
Sbjct: 119 FVQMVLA----LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--- 169
Query: 718 SNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
S +G Y PE+ ++ EK D++ FG ++ ++ T
Sbjct: 170 ---LTSVVGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 18/223 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 619
+G+G FG V V GR A+K L I+ E E RVL +RHP L +L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
+ T V +YA G L L ER+ S + V L +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV-----SALDYLHS--EK 115
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+++ +LK N++LD + + +I+DFGL + + D M F Y+APE+ +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYLAPEVL-EDND 172
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDN----VVILSEHVR 777
D +G GV++ E++ GR P Y +D+ +IL E +R
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 619
+G+G FG V V GR A+K L II E E RVL RHP L +L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGT--AKGLAHLHHSF 676
+ T V +YA G L L ER+ +T G L +LH
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEYLHSR- 114
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
+++ ++K N++LD + + +I+DFGL + + F Y+APE+
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV---- 166
Query: 737 LRVNE---KCDIYGFGVLILELVTGRRPVEYGEDN----VVILSEHVR 777
L N+ D +G GV++ E++ GR P Y +D+ +IL E +R
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 615
EK + EG +G VY+ G ++A+KKL + + +P RE+ +L K +HPN++
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 616 SLEGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
+++ L +V +Y + L++ L E + P + ++L G+AHLH
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVEH-DLKS-LMETMK--QPFLQSEVKCLMLQLLSGVAHLH 123
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL----LTRLDKHVMSNRFQSALGYVA 729
++ I+H +LK SN+LL++ +I DFGLAR L + V++ L Y A
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT------LWYRA 174
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGR 759
PEL + + D++ G + EL+T +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLE 618
+GEG FG V + G + A+K L DF E+ VL K HPN+I+L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPP-----------LSWTNRFKVILGTA 666
G + +YAP G+L L + R+ T P L+ + A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
G+ +L IH +L N+L+ +N +I+DFGL+R K M + +
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG---RLPVR 183
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
++A E S+ K D++ FGVL+ E+V+
Sbjct: 184 WMAIESLNYSVYTT-KSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-10
Identities = 31/89 (34%), Positives = 49/89 (55%)
Query: 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 143
L L + G IP ++ L +L+ + L GN G +P +G L LDLS N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 144 PVSLRLLNSMIFISVSNNTLTGDIPHWIG 172
P SL L S+ ++++ N+L+G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 18/222 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKAR-HPNLISL 617
+G+G FG V GR+ AVK L D+I +D E E R+L AR HP L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVL-KKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ TP V ++ G L + + + ++ L LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SALMFLHDK-- 115
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
II+ +LK N+LLD + +++DFG+ + + ++ F Y+APE+ Q +
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEIL-QEM 171
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEY-GEDNV--VILSEHV 776
D + GVL+ E++ G P E ED++ IL++ V
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK- 608
DP + E VG G +G VYK G++ A+K + VT D E+ + E+ +L K
Sbjct: 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKY 69
Query: 609 ARHPNLISLEGYYW--TP-----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-K 660
+ H N+ + G + +P QL LV ++ GS+ + + W +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQL-WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 661 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSN 719
IL +GLAHLH +IH ++K N+LL +N ++ DFG++ +LD+ V N
Sbjct: 129 EIL---RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRN 179
Query: 720 RFQSALGYVAPE-LTCQS---LRVNEKCDIYGFGVLILELVTGRRPV 762
F ++APE + C + + DI+ G+ +E+ G P+
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKA-RHPNLISL 617
+G+G FG V +G AVK L D++ +D E E RVL A +P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL-KKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT------AKGLAH 671
+ T + V ++ G L + ++ RF + T GL
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDK----------GRFDLYRATFYAAEIVCGLQF 111
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 728
LH II+ +LK N++LD + + +I+DFG+ + + NR + G Y+
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYI 163
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
APE+ Q L+ D + FGVL+ E++ G+ P +G+D
Sbjct: 164 APEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 67/254 (26%), Positives = 113/254 (44%), Gaps = 41/254 (16%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNL 614
LE E+G G G VYK+ F G ++AVK++ + + + ++ V+ K+ P +
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQA----KLHERLPSTPPLSWTNRFKVILG-----T 665
+ GY+ T SD L + KL +R+ P + ILG
Sbjct: 77 VKCYGYFITD------SDVFICMELMSTCLDKLLKRIQGPIP-------EDILGKMTVAI 123
Query: 666 AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
K L +L H +IH ++KPSNILLD + N ++ DFG++ L R
Sbjct: 124 VKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAG 176
Query: 724 ALGYVAPE-LTCQSLRVNE--KCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780
Y+APE + + D++ G+ ++EL TG+ P + + +L+ ++L
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT---KILQ 233
Query: 781 EEGNVLDCVDPSMG 794
EE + P+ G
Sbjct: 234 EE---PPSLPPNEG 244
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 72/260 (27%), Positives = 114/260 (43%), Gaps = 37/260 (14%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKAR---HP 612
E AE+G G +GTVYK G +A+K + V ++ P REV +L + HP
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 613 NLISLEGYYWTP----QLKLLVSDYAPNGSLQAKLHERLPSTPPL-SWTNRFKVILGTAK 667
N++ L T + K+ + + L+ L + P P + + + L +
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL---R 119
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVMSNRFQSA 724
GL LH + I+H +LKP NIL+ +++DFGLAR+ + L V++
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT------ 170
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784
L Y APE+ QS D++ G + E+ R+P+ G L G
Sbjct: 171 LWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFR-RKPLFCGNSEADQL----------GK 218
Query: 785 VLDCVD-PSMGDYPEDEVLP 803
+ D + P D+P D LP
Sbjct: 219 IFDLIGLPPEDDWPRDVTLP 238
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 561 EVGEGVFGTVY--KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
E+G G FG V +V+ G + VK+L S +Q F E + +H NL+
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPS---TPPLSWTNRFKVILGTAKGLAHLH-H 674
G LLV ++ P G L+ L + TP + R + A GL HLH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHKN 119
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
+F IH +L N LL + +I D+GL+ + D +V ++ L ++APEL
Sbjct: 120 NF----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 735 Q---SLRV---NEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 771
+ +L V ++ +++ GV I EL G +P + D V+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 619
+G+G FG V +V R+ A+K + + I+ E E VL + P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ +P+ LV + G L L + + TA+ L L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALENLHKFN 113
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARL-LTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+I+ +LKP NILLD + + DFGL +L + DK +N F Y+APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPELLL-GHG 169
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782
+ D + GVL+ E++TG P Y E+ ++E R +L+E
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPF-YDEN----VNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRM-LAVKKLVT--SDIIQYPEDFEREVRVLGKARHPNLISLE 618
VG G +G+V ++ T+ R +AVKKL +I + RE+R+L +H N+I L
Sbjct: 23 VGSGAYGSVCS-AYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLL 80
Query: 619 GYYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
+ TP + Y + A L+ + LS + +I +GL ++H +
Sbjct: 81 DVF-TPATSIENFNEVYLVTNLMGADLNN-IVKCQKLSDEHVQFLIYQLLRGLKYIHSA- 137
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
IIH +LKPSN+ ++++ RI DFGLAR ++ R+ Y APE+
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW-----YRAPEIMLNW 190
Query: 737 LRVNEKCDIYGFGVLILELVTGR 759
+ N+ DI+ G ++ EL+ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 65/280 (23%), Positives = 123/280 (43%), Gaps = 48/280 (17%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKARHPN 613
E+G G FGTV K + +M +K V I++ + RE V+ + +P
Sbjct: 2 ELGSGNFGTVKKGMY----KMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPY 57
Query: 614 LISL----EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
++ + E W +LV + A G L ++ L ++ N +++ + G+
Sbjct: 58 IVRMIGICEAESW-----MLVMELAELGPL----NKFLQKNKHVTEKNITELVHQVSMGM 108
Query: 670 AHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF-QSALGY 727
+L +F +H +L N+LL + +ISDFGL++ L + + + + + +
Sbjct: 109 KYLEETNF----VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 728 VAPELTCQS-LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 785
APE C + + + K D++ FGVL+ E + G++P + + N V ++E G
Sbjct: 165 YAPE--CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT------QMIESGER 216
Query: 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 825
++C P+ + L +C + RP A V
Sbjct: 217 MEC--------PQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARHP 612
+GEG +G V + G +A+KK+ FE RE+++L + +H
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKI---------SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 672
N+I + P + Y ++ L+ +L T LS + + +GL ++
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLY-KLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSNRFQSALGYVAPE 731
H + ++H +LKPSN+LL+ N + +I DFGLAR+ H + + Y APE
Sbjct: 123 HSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGR 759
+ S + DI+ G ++ E+++ R
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
+K ++GEG + TVYK G+++A+K++ P RE +L +H N+++
Sbjct: 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHS 675
L T + LV +Y L L + + + ++ L +GLA+ H
Sbjct: 68 LHDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---ALGYVAPEL 732
++H +LKP N+L+ + +++DFGLAR K V S + + L Y P++
Sbjct: 123 R---VLHRDLKPQNLLISERGELKLADFGLARA-----KSVPSKTYSNEVVTLWYRPPDV 174
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGR 759
S + D++G G + E+ TGR
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 59/194 (30%), Positives = 85/194 (43%), Gaps = 6/194 (3%)
Query: 251 FQTLRILDLSSNNLVG--DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 308
L LDL S + + D + L L+L+ N LRS I L +L LDL
Sbjct: 66 LSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLD 124
Query: 309 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI 368
NN + P +L L L N + +P +RN +L L LS N LS +PK +
Sbjct: 125 NNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLL 182
Query: 369 SNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQG 428
SNL+ L L L N++S ++P E+ L++L +++S N +I L L L
Sbjct: 183 SNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSN 241
Query: 429 NLGICSPLLKGPCK 442
N P G
Sbjct: 242 NKLEDLPESIGNLS 255
|
Length = 394 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 619
+G G FG V V ++ A+K L ++++ E F E VL + + +L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 620 YYWTPQLKLLVSDYAPNG---SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
+ LV DY G +L +K +RLP + + + + + LH+
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS---VHQLHY-- 123
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
+H ++KP NIL+D N + R++DFG L D V S+ Y++PE+ Q+
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEIL-QA 177
Query: 737 L-----RVNEKCDIYGFGVLILELVTGRRP 761
+ + +CD + GV + E++ G P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 561 EVGEGVFGTV-----YKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+GEG FG V Y +S T+ +ML K + + +DF+RE +L +H +++
Sbjct: 12 ELGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVIL 663
G ++V +Y +G L L P + L + +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
A G+ +L +H +L N L+ N +I DFG++R + D + +
Sbjct: 131 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 724 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
+ ++ PE + + + D++ FGV++ E+ T G++P
Sbjct: 188 PIRWMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPNLI 615
+G+G FG VY GR LAVK++ + PE E E+++L H ++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 616 SLEGYYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
G P + L ++ P GS++ ++L S L+ K +G+++LH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALG---YVA 729
+ I+H ++K +NIL D N ++ DFG ++ RL +S +S G +++
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSGTGMKSVTGTPYWMS 177
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
PE+ K DI+ G ++E++T + P
Sbjct: 178 PEVISGE-GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 66/287 (22%), Positives = 125/287 (43%), Gaps = 40/287 (13%)
Query: 561 EVGEGVFGTVYK------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL 614
E+G+G FG VY+ V + R +A+K + + ++ +F E V+ + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLH------ERLPSTPPLSWTNRFKVILGTAKG 668
+ L G Q L++ + G L++ L E P P S ++ A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
+A+L+ + +H +L N ++ +++ +I DFG+ R + D + + + ++
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 729 APELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785
+PE SL+ D++ FGV++ E+ T G N E V + EG +
Sbjct: 189 SPE----SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFVMEGGL 239
Query: 786 LDCVD--PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
LD D P M + +L +C + P RPS E++ ++
Sbjct: 240 LDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
LEK +GEG + TVYK G+++A+K + P RE +L +H N++
Sbjct: 10 LEK---LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP-LSWTNRFKVILGTAKGLAHLHH 674
L T + V +Y + L + + P L N + +GLA++H
Sbjct: 67 LLHDIIHTKETLTFVFEY-----MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---ALGYVAPE 731
I+H +LKP N+L+ +++DFGLAR K + S + S L Y P+
Sbjct: 122 QH---ILHRDLKPQNLLISYLGELKLADFGLAR-----AKSIPSQTYSSEVVTLWYRPPD 173
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
+ + + DI+G G + +E++ G +P G +V
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G G GTVYK R+LAVK + ++ + E+ +L K P +I G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 681
+ + +++ GSL ++ ++P L ++ + KGL +L + I+
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPE-HVLG-----RIAVAVVKGLTYL---WSLKIL 117
Query: 682 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE 741
H ++KPSN+L++ ++ DFG++ L + ++ + Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGE-QYGI 172
Query: 742 KCDIYGFGVLILELVTGRRP 761
D++ G+ +EL GR P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLE 618
+GEG FG V K G + A+K++ DF E+ VL K HPN+I+L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPP-----------LSWTNRFKVILGTA 666
G L +YAP+G+L L + R+ T P LS A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+G+ +L IH +L NIL+ +NY +I+DFGL+R K M + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVR 176
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
++A E S+ D++ +GVL+ E+V+
Sbjct: 177 WMAIESLNYSVYTT-NSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 619
+G G FG V V R+ A+K L ++++ E F E VL + +L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 620 YYWTPQLKLLVSDYAPNG---SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
+ LV DY G +L +K +RLP RF + A+ + +H
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYI----AEMVLAIHSIH 119
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
+ +H ++KP N+LLD N + R++DFG + L D V S+ Y++PE+ Q+
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEIL-QA 177
Query: 737 L-----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
+ + +CD + GV + E++ G P Y E V
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL---VTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
VG G +G+V G +A+KKL S+I + + RE+ +L +H N+I L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI--FAKRAYRELTLLKHMQHENVIGLL 80
Query: 619 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
+ T + LV Y +Q L + + PLS ++ GL +
Sbjct: 81 DVF-TSAVSGDEFQDFYLVMPY-----MQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKY 132
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+H + IIH +LKP N+ ++++ +I DFGLAR + R+ Y APE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 184
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGR 759
+ + N+ DI+ G ++ E++TG+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 67/280 (23%), Positives = 127/280 (45%), Gaps = 27/280 (9%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 611
P ++ ++G G FG V+ + + +AVK L + + F E ++ +H
Sbjct: 4 PRESIKLVKKLGAGQFGEVW-MGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQH 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
L+ L + ++++Y GSL L L F + A+G+A+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAY 118
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+ R IH +L+ +N+L+ ++ +I+DFGLAR++ +++ + + + APE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE 174
Query: 732 -LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
+ S + K D++ FG+L+ E+VT G+ P G N ++S L+ G +
Sbjct: 175 AINFGSFTI--KSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMSA-----LQRGYRM--- 223
Query: 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
P M + P DE+ ++K C RP+ + +L
Sbjct: 224 -PRMENCP-DELYDIMKT---CWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 561 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G+G FG VY+ + G +AVK + S ++ +F E V+ +++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLH------ERLPSTPPLSWTNRFKVILGTAKGL 669
L G Q L+V + +G L++ L E P PP + ++ A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
A+L+ +H +L N ++ ++ +I DFG+ R + D + + + ++A
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 730 PELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
PE SL+ D++ FGV++ E+ + G N E V + +G L
Sbjct: 190 PE----SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVMDGGYL 240
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
D P++ V L +C P RP+ E+V +L+
Sbjct: 241 --------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+E E+G+G +G+VYKV G +A+K++ E+ +L KA P ++
Sbjct: 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
G ++ + +Y GSL KL+ +T + ++ KGL L
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLA-RLLTRLDK-------HVMSNRFQSALGY 727
IIH ++KP+N+L++ N ++ DFG++ L+ L K ++ R +S
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
P T QS D++ G+ ILE+ GR P
Sbjct: 180 QNPTYTVQS-------DVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 18/225 (8%)
Query: 561 EVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
E+GEG FG V+ Q ++L K + +DF RE +L +H +++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST-------PP--LSWTNRFKVILGTAK 667
G ++V +Y +G L L P P L+ + + A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
G+ +L +H +L N L+ +N +I DFG++R + D + + + +
Sbjct: 132 GMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 771
+ PE + + + D++ GV++ E+ T G++P +N VI
Sbjct: 189 MPPE-SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 21/271 (7%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 618
++G G F VY+ + G +A+KK+ D++ + D +E+ +L + HPN+I
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
+ +V + A G L + + +K + L H+H S R
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRR- 126
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
++H ++KP+N+ + ++ D GL R + K ++ Y++PE ++
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHEN-G 182
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 798
N K DI+ G L+ E+ + P + N+ L + + C P + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------QCDYPPL---PS 230
Query: 799 DEVLPVL-KLALVCTCHIPSSRPSMAEVVQI 828
D L +L +C P RP + V +
Sbjct: 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 555 LLEKAAEVGEGVFGTV----YKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
L++ ++GEG FG V Y G +AVK L + D ++E+ +L
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 611 HPNLISLEGYY---WTPQLKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTA 666
H N++ +G +KL++ ++ P+GSL+ E LP + ++ + K +
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIM-EFLPSGSLK----EYLPRNKNKINLKQQLKYAVQIC 119
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDKHVMSNRFQSAL 725
KG+ +L +H +L N+L++ + +I DFGL + + T + + + + S +
Sbjct: 120 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
+ APE QS + D++ FGV + EL+T
Sbjct: 177 FWYAPECLIQS-KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 55/176 (31%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 617
+G+G FG V G+ AVK L I++ E ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLH-ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
+ T V DY G L L ER P RF A L +LH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP----RARFYAA-EIASALGYLHSL- 115
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
II+ +LKP NILLD + ++DFGL + ++ ++ F Y+APE+
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 28/281 (9%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 611
P L+ ++G G FG V+ ++ + +AVK + + E F E V+ +H
Sbjct: 4 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM--SVEAFLAEANVMKTLQH 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
L+ L T + +++++ GSL L S PL F + A+G+A
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAF 117
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+ + IH +L+ +NIL+ + +I+DFGLAR++ +++ + + + APE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE 173
Query: 732 -LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
+ S + K D++ FG+L++E+VT GR P + VI + LE G +
Sbjct: 174 AINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA------LERGYRM--- 222
Query: 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
P + PE+ + + + C + P RP+ + +L
Sbjct: 223 -PRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 617
+G+G FG V + G AVK L I++ E ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLH-ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
+ T + V DY G L L ER P RF A + +LH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP----RARFYAA-EVASAIGYLHSL- 115
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
II+ +LKP NILLD + ++DFGL + ++ ++ F Y+APE+ +
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVL-RK 170
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ D + G ++ E++ G P Y D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPF-YSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 29/277 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+GEG FG VY+ + + +AVK E F +E ++ + HP+++ L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
G T +V + AP G L++ L S S + LA+L S R
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLI---LYSYQLSTALAYLE-SKR- 127
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+H ++ N+L+ ++ DFGL+R L + + +++ + + ++APE + R
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPE-SINFRR 184
Query: 739 VNEKCDIYGFGVLILE-LVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 797
D++ FGV + E L+ G +P + ++N VI +E G L P
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR------IENGERLPM--------P 230
Query: 798 EDEVLPVL-KLALVCTCHIPSSRPSMAEVVQILQVIK 833
+ P L L C + PS RP E+ L I
Sbjct: 231 PN-CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 615
EK ++GEG +GTV+K ++A+K++ + D P RE+ +L + +H N++
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L + + LV +Y + L+ K + F L KGLA H
Sbjct: 63 RLYDVLHSDKKLTLVFEYC-DQDLK-KYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHSH 118
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA----LGYVAPE 731
++H +LKP N+L++ N +++DFGLAR + R SA L Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFG------IPVRCYSAEVVTLWYRPPD 169
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ + + D++ G + EL RP+ G D
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 27/79 (34%), Positives = 47/79 (59%)
Query: 117 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 176
G +P DI HL +++LS N G +P SL + S+ + +S N+ G IP +G +++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 177 LEFLDFSNNHLTGSLPSSL 195
L L+ + N L+G +P++L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLV----TSDIIQYPEDFEREVRVLGKARHPNLISL 617
+G G FG VY GR LAVK++ + + + E E+++L RH ++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 618 EGYYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KVILGTAKGLAHLHH 674
G P+ K L +Y P GS++ +L T + T R+ + IL +G+++LH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV--TRRYTRQIL---QGVSYLHS 124
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALG---YVAP 730
+ I+H ++K +NIL D N ++ DFG ++ R+ MS +S G +++P
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSGTGIKSVTGTPYWMSP 178
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
E+ K D++ ++E++T + P
Sbjct: 179 EVI-SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DP L+ ++GEG G V + G+ +AVKK+ Q E EV ++
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYH 77
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 665
H N++ + Y +V ++ G+L +++E +T V L
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT----------VCLSV 127
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+ L++LH+ +IH ++K +ILL + ++SDFG ++ K V +
Sbjct: 128 LRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFC---AQVSKEVPKRKSLVGT 181
Query: 726 GY-VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
Y +APE+ + L + DI+ G++++E++ G P
Sbjct: 182 PYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 53/214 (24%), Positives = 103/214 (48%), Gaps = 13/214 (6%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED---FEREVRVLGKARHPNLISLE 618
+G+G +G V G +A+KK+ +D+ ++ D RE+++L RHP+++ ++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
P + Y +++ LH+ + + L+ + + + L ++H +
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA--- 122
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARL-LTRLDKHVMSNRFQSALGYVAPELTCQSL 737
+ H +LKP NIL + + +I DFGLAR+ + + + Y APEL C S
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL-CGSF 181
Query: 738 --RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
+ DI+ G + E++TG +P+ G++ V
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 73/299 (24%), Positives = 130/299 (43%), Gaps = 33/299 (11%)
Query: 554 TLLEKAAEVGEGVFGTVYKV-SFG------TQGRMLAVKKLVTSDIIQYPEDFEREVRVL 606
T L +GEG FG V + G + +AVK L + D E+ ++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMM 71
Query: 607 GK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSW--------TN 657
+H N+I+L G ++ +YA G+L+ L R P S+
Sbjct: 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 658 RFKVILGTAKGLAH-LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
FK ++ A +A + + IH +L N+L+ ++ +I+DFGLAR + +D +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 775
+ + + ++APE + ++ D++ FGVL+ E+ T G P I E
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPYPG------IPVEE 244
Query: 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
+ LL+EG+ + D P + + + C +PS RP+ ++V+ L + T
Sbjct: 245 LFKLLKEGHRM--------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF----EREVRVLGKARHPNLISL 617
+G G FG V V G++ A+K L ++++ E ER+V V G R I+
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR---WITN 65
Query: 618 EGYYWTPQLKL-LVSDYAPNG---SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
Y + + L LV DY G +L +K +RLP RF + A+ + +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYL----AEMVLAID 116
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
+ +H ++KP N+LLD N + R++DFG + L D V SN Y++PE+
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 734 CQSL-----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
Q++ R +CD + GV + E++ G P Y E V
Sbjct: 176 -QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 41/236 (17%)
Query: 552 PETLLEKAAEVGEGVFGTVY-----------KVSF-----GTQGRMLAVKKLVTSDIIQY 595
P L ++GEG FG V+ F G Q ++AVK L
Sbjct: 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA 62
Query: 596 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP--- 652
DF +E++++ + + PN+I L T ++++Y NG L L P
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 653 ----LSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707
+S++ + A G+ +L +F +H +L N L+ NY +I+DFG++R
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNF----VHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 708 LLTRLD------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
L D + V+ R+ S + + T S D++ FGV + E++T
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS-------DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 617
+G+G FG V + A+K ++ D++ +D E E RVL + + P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T V +Y G L + + P + ++ + GL LH R
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEI----SVGLFFLH---R 119
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
II+ +LK N++LD + +I+DFG+ + + V + F Y+APE+
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQ- 176
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ D + +GVL+ E++ G+ P + GED
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD-GED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 562 VGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKARHPNLI 615
+G+G +G V++V T G++ A+K L + I++ +D + E +L +HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHL 672
L + T L+ +Y G L L ER + T F ++ L L HL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-ER--EGIFMEDTACFYLSEISLA----LEHL 116
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
H II+ +LKP NILLD + +++DFGL + + + +++ F + Y+APE+
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+S + D + G L+ +++TG P
Sbjct: 172 LMRSGH-GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 49/213 (23%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 608
DP+ + ++G+G GTVY G+ +A++++ ++ Q P E E+ V+ +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
++PN+++ Y +V +Y GSL + E ++ R +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQA 128
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
L LH + +IH ++K NILL + + +++DFG +T + + ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWM 183
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
APE+ + K DI+ G++ +E++ G P
Sbjct: 184 APEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 75/298 (25%), Positives = 132/298 (44%), Gaps = 51/298 (17%)
Query: 562 VGEGVFGTVYKV-SFGTQGRM------LAVKKLVT-------SDIIQYPEDFEREVRVLG 607
+GEG FG V + G +AVK L + SD+I E ++++G
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME----MMKMIG 81
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP---------STPP---LSW 655
K H N+I+L G ++ +YA G+L+ L R P + P LS+
Sbjct: 82 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 656 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715
+ A+G+ +L IH +L N+L+ ++ +I+DFGLAR + +D +
Sbjct: 140 KDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSE 774
+ + + ++APE + ++ D++ FGVL+ E+ T G P + E
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSPYPG------VPVE 249
Query: 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+ LL+EG+ + D P + + + C +PS RP+ ++V+ L I
Sbjct: 250 ELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLV----TSDIIQYPEDFEREVRVLGKARHPNLISL 617
+G+G FG VY GR LA K++ + + + E E+++L +H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 618 EGYYWTPQLKLLV--SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
G K L +Y P GS++ ++L + L+ + K +G+++LH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALG---YVAPE 731
I+H ++K +NIL D N ++ DFG ++ RL MS +S G +++PE
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRP-VEY 764
+ K D++ G ++E++T + P EY
Sbjct: 180 VISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 40/277 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G+G FG V + +G +AVK + Q F E V+ + RH NL+ L G
Sbjct: 14 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVI 68
Query: 622 WTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPP 679
+ L +V++Y GSL L R S L K L + + +L ++F
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEANNF--- 123
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYVAPELTCQSL 737
+H +L N+L+ ++ ++SDFGL K S + L + APE +
Sbjct: 124 -VHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPE-ALREK 174
Query: 738 RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV-RVLLEEGNVLDCVDPSMGD 795
+ + K D++ FG+L+ E+ + GR P + L + V RV E+G +D D
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPR-----IPLKDVVPRV--EKGYKMDAPDGC--- 224
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
P V + C ++RPS ++ + L+ I
Sbjct: 225 -PP----VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 558 KAAEVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+ +VG G +G VYK G + A+K++ + I RE+ +L + +HPN+I
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISM---SACREIALLRELKHPNVI 61
Query: 616 SLEGYYWTPQLK--LLVSDYAPNGSLQ-AKLHE-----RLPSTPPLSWTNRFKVILGTAK 667
+L+ + + + L+ DYA + K H + P P S ++
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK--SLLYQILD 119
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARL-------LTRLDKHV 716
G+ +LH ++ ++H +LKP+NIL+ + +I+D G ARL L LD V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
++ Y APEL + + DI+ G + EL+T
Sbjct: 177 VT------FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 619
+G G FG V V + ++ A+K L ++I+ + F E ++ A ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 676
+ + +V +Y P G L + P W RF +V+L L +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWA-RFYTAEVVLA----LDAIHSM- 161
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 733
IH ++KP N+LLD + + +++DFG ++D + M R +A+G Y++PE+
Sbjct: 162 --GFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMDANGMV-RCDTAVGTPDYISPEVL 215
Query: 734 CQSLRVN----EKCDIYGFGVLILELVTGRRP 761
+S + +CD + GV + E++ G P
Sbjct: 216 -KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 32/248 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLE 618
+GEG FG+V + +L AVK + + + EDF E + + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 619 GY---------YWTPQLKLLVSDYAPNGSLQA-KLHERLPSTPPLSWTNRF-KVILGTAK 667
G Y +P +++ + +G L + L+ RL P T K + A
Sbjct: 67 GVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
G+ +L IH +L N +L++N N ++DFGL++ + D + + + +
Sbjct: 124 GMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
+A E + K D++ FGV + E+ T G+ P G +N I L +GN L
Sbjct: 181 IAIESLADRVYTT-KSDVWSFGVTMWEIATRGQTPYP-GVENSEIYD-----YLRQGNRL 233
Query: 787 ----DCVD 790
DC+D
Sbjct: 234 KQPPDCLD 241
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 608
DP+ + ++G+G GTVY G+ +A+K++ ++ Q P E E+ V+ +
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRE 72
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
++PN+++ Y +V +Y GSL + E ++ R +
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQA 127
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
L LH + +IH ++K NILL + + +++DFG +T + + ++
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWM 182
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
APE+ + K DI+ G++ +E+V G P
Sbjct: 183 APEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 63/286 (22%), Positives = 123/286 (43%), Gaps = 31/286 (10%)
Query: 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHP 612
+EK ++G G F VY+ + + +A+KK+ +++ + +D +E+ +L + HP
Sbjct: 5 QIEK--KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 613 NLIS-LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
N+I L+ + +L + V + A G L + + +K + + H
Sbjct: 63 NVIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+H S R ++H ++KP+N+ + ++ D GL R + K ++ Y++PE
Sbjct: 122 MH-SRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPE 176
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
++ N K DI+ G L+ E+ + P + N+ L + + C
Sbjct: 177 RIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE---------QC--- 223
Query: 792 SMGDYP----EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
DYP E + +L +C P RP + V QI + +
Sbjct: 224 ---DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 58/236 (24%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS-------------DIIQYPEDFERE 602
LE E+G G +G V K+ G ++AVK++ + DI D
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 603 VRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTN 657
V G + EG W + + V D SL + L
Sbjct: 63 VTFYGA------LFREGDVW---ICMEVMD----TSLDKFYKKVYDKGLTIPEDILG--- 106
Query: 658 RFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA-RLLTRLDKHV 716
K+ + K L +LH +IH ++KPSN+L++ N ++ DFG++ L+ + K +
Sbjct: 107 --KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI 162
Query: 717 MSNRFQSALGYVAPELTCQSLRVNE---------KCDIYGFGVLILELVTGRRPVE 763
+ Y+APE R+N K D++ G+ ++EL TGR P +
Sbjct: 163 DA----GCKPYMAPE------RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 617
+G+G FG V + A+K ++ D++ +D E E RVL + P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK---VILGTAK---GLAH 671
+ T V +Y G L ++ + RFK + A+ GL
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFF 116
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
LH II+ +LK N++LD + +I+DFG+ + + V + F Y+APE
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ + D + FGVL+ E++ G+ P E GED
Sbjct: 172 IIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFE-GED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 558 KAAEVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+ +VG G +G VYK G R A+K++ + I RE+ +L + +HPN+I
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM---SACREIALLRELKHPNVI 61
Query: 616 SLEGYYWTPQLK--LLVSDYAPNGSLQ-AKLHE-----RLPSTPPLSWTNRFKVILGTAK 667
SL+ + + + L+ DYA + K H + P P ++
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK--SLLYQILD 119
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARL-------LTRLDKHV 716
G+ +LH ++ ++H +LKP+NIL+ + +I+D G ARL L LD V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
++ Y APEL + + DI+ G + EL+T
Sbjct: 177 VT------FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 562 VGEGVFGTVYKVSFGTQ---GRMLAVKKL-----VTSDIIQYPEDFEREVRVLGKARHPN 613
+G+G FG+V + ++ + +AVK L +SDI E+F RE + + HPN
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDI----EEFLREAACMKEFDHPN 62
Query: 614 LISLEGYYWTPQLK------LLVSDYAPNGSLQA-KLHERL---PSTPPLSWTNRFKVIL 663
+I L G + K +++ + +G L L R+ P T PL RF ++
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF--MI 120
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
A G+ +L IH +L N +L++N ++DFGL++ + D + +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 724 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEE 782
+ ++A E ++ D++ FGV + E++T G+ P G +N I + L +
Sbjct: 178 PVKWLALESLADNVYTTHS-DVWAFGVTMWEIMTRGQTPYA-GVENSEIYN-----YLIK 230
Query: 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
GN L P D + V +L C P RPS + L++I
Sbjct: 231 GNRL--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 617
+G+G FG V + A+K L IIQ +D E E RVL + P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT------AKGLAH 671
+ T V +Y G L + + +FK A GL
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ----------VGKFKEPHAVFYAAEIAIGLFF 116
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR----FQSALGY 727
LH II+ +LK N++LD + +I+DFG+ + +++ + F Y
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFGGKTTRTFCGTPDY 167
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+APE+ + D + FGVL+ E++ G+ P + GED
Sbjct: 168 IAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFD-GED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 63/258 (24%), Positives = 114/258 (44%), Gaps = 33/258 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 619
+G G FG V V + ++ A+K L ++I+ + F E ++ A P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + +V +Y P G L + P W + TA+ + L
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFY-----TAEVVLALDAIHSMG 162
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE-LTCQ 735
+IH ++KP N+LLD + + +++DFG ++D+ M R +A+G Y++PE L Q
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMV-RCDTAVGTPDYISPEVLKSQ 218
Query: 736 SLR--VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793
+CD + GV + E++ G P Y + V S+ +++ N L
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF-YADSLVGTYSK----IMDHKNSL------- 266
Query: 794 GDYPEDEVLPVLKLALVC 811
++PED + L+C
Sbjct: 267 -NFPEDVEISKHAKNLIC 283
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 47/213 (22%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 608
DP+ + ++G+G GTV+ G+ +A+K++ ++ + P E E+ V+ +
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKE 72
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
++PN+++ + +V +Y GSL + E ++ R +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQA 127
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
L LH + +IH ++K N+LL + + +++DFG +T + + ++
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWM 182
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
APE+ + K DI+ G++ +E+V G P
Sbjct: 183 APEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPN 613
E +G G FG V G A+K L +I++ + +E +L + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRF---KVILGTAKG 668
++++ + + ++ G L L + R P+ +F +++L
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLA---- 130
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 726
+LH II+ +LKP N+LLD+ + +++DFG A+ + +R + G
Sbjct: 131 FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--------DRTFTLCGTP 179
Query: 727 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
Y+APE+ QS + D + GVL+ E + G P
Sbjct: 180 EYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 5/139 (3%)
Query: 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPS 688
LV DYA G L+ ++ R + + L + L +HH +IH ++K +
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFR---EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 689 NILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 748
NILL N ++ DFG +++ + F YVAPE+ + ++K D++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI-WRRKPYSKKADMFSL 231
Query: 749 GVLILELVTGRRPVEYGED 767
GVL+ EL+T +RP + GE+
Sbjct: 232 GVLLYELLTLKRPFD-GEN 249
|
Length = 496 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 15/216 (6%)
Query: 552 PETLLEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 606
P + L++ +G G FG V+ + ++ VK L + +F RE+ +
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMF 62
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ-----AKLHERLPSTPPLSWTNRFKV 661
K H N++ L G + ++ +Y G L+ K + PPLS + +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 662 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 721
A G+ HL ++ +H +L N L+ ++S L++ + + + + N
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
L ++APE Q + K D++ FGVL+ E+ T
Sbjct: 180 -IPLRWLAPE-AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 608
DP+ + ++G+G GTVY G+ +A+K++ ++ Q P E E+ V+ +
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRE 72
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
+HPN+++ Y +V +Y GSL + E ++ R +
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQA 127
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 726
L LH + +IH ++K NILL + + +++DFG +T ++ + +G
Sbjct: 128 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTP 179
Query: 727 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ + K DI+ G++ +E+V G P
Sbjct: 180 YWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKA-RHPNLISL 617
+G G + V V R+ A+K +V +++ ED + E V +A HP L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMK-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
+ T V +Y G L + +LP ++ + L +LH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER 115
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
II+ +LK N+LLD + +++D+G+ + R ++ F Y+APE+
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEI--- 167
Query: 736 SLRVNE---KCDIYGFGVLILELVTGRRPVE 763
LR + D + GVL+ E++ GR P +
Sbjct: 168 -LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 16/257 (6%)
Query: 146 SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIR 205
+L L + + ++ N L +I + ++ L LD NN++T P L +
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD 146
Query: 206 LRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 264
L N + ++P L +L L+ +DLS N S + L LDLS N +
Sbjct: 147 LSDNKI-ESLPSPLRNLPNLKNLDLSFN-------DLSDLPKLLSNLSNLNNLDLSGNKI 198
Query: 265 VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESR 324
D+P E+ L + L L+LS+N + + L +L L+L NN L +P+ +
Sbjct: 199 -SDLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKL-EDLPESIGNLS 255
Query: 325 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384
+L L L N ++ + + T+L L LS N LS + I+ L L L L
Sbjct: 256 NLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLT 312
Query: 385 SGEIPQELGKLASLLAV 401
+ +L + +
Sbjct: 313 LKALELKLNSILLNNNI 329
|
Length = 394 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 54/233 (23%), Positives = 108/233 (46%), Gaps = 20/233 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
E+G G FG V K + + + + A+K L + ++ RE ++ + +P ++ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
G L +LV + A G L L + +N +++ + G+ +L
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITV---SNVVELMHQVSMGMKYLEGK--- 114
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF-QSALGYVAPELTCQSL 737
+H +L N+LL + + +ISDFGL++ L D + + + L + APE C +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE--CINF 172
Query: 738 R-VNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
R + + D++ +G+ + E + G++P + + V+ +E+G LDC
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM------SFIEQGKRLDC 219
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-07
Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 11/87 (12%)
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-YVA------PEL 732
+IH +LKPSNILL+ + +++DFGLAR L+ L+ N L YVA PE+
Sbjct: 128 VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE----ENPENPVLTDYVATRWYRAPEI 183
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGR 759
S R + D++ G ++ E++ G+
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 43/232 (18%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 619
+G G FG V+ V G++ A+K L SD+I+ + E +L A P ++ L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 620 YYWTPQLKL-LVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
Y + + L LV +Y P G L L + P RF A+ + L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETA-RFY----IAELVLALDSVH 118
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLA------------------------RLLTRL 712
+ IH ++KP NIL+D + + +++DFGL L+ R
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 713 DKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
D R S +G Y+APE+ +CD + GV++ E++ G P
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 51/220 (23%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKL------VTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G G G V G+ +A+KKL VT Y RE+ ++ H N+I
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-----RELVLMKLVNHKNII 78
Query: 616 SLEGYYWTPQLKL-------LVSDYAPNGSL----QAKL-HERLPSTPPLSWTNRFKVIL 663
L + TPQ L LV + + +L Q L HER+ S+ ++
Sbjct: 79 GLLNVF-TPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERM------SY-----LLY 125
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS----N 719
G+ HLH + IIH +LKPSNI++ + +I DFGLAR T +M+
Sbjct: 126 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 180
Query: 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
R+ Y APE+ + E DI+ G ++ E++ G
Sbjct: 181 RY-----YRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKA-RHPNLISL 617
+G G + V V R+ A+K ++ +++ ED + E V A HP L+ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMK-VIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRF---KVILGTAKGLAHL 672
+ T V ++ G L + +LP RF ++ L L L
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA-----RFYSAEISLA----LNFL 112
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
H II+ +LK N+LLD + +++D+G+ + + ++ F Y+APE+
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEI 167
Query: 733 TCQSLRVNE---KCDIYGFGVLILELVTGRRP 761
LR + D + GVL+ E++ GR P
Sbjct: 168 ----LRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 25/155 (16%)
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
IH +L NILL +N +I DFGLAR + + +V + L ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV-YT 253
Query: 741 EKCDIYGFGVLILELVT-GRRP---VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG-- 794
+ D++ FGVL+ E+ + G P V+ E+ L E R M
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---------------MRAP 298
Query: 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
+Y E+ ++ L C + P RP+ +E+V+IL
Sbjct: 299 EYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 617
+G+G FG V + + AVK L I++ E+ ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T V DY G L L P + RF A L +LH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA---RFYAA-EIASALGYLHSL-- 115
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
I++ +LKP NILLD + ++DFGL + ++ + ++ F Y+APE+ +
Sbjct: 116 -NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQ- 171
Query: 738 RVNEKCDIYGFGVLILELVTGRRP 761
+ D + G ++ E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 227 IDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 286
+ L G G IP S + L+ ++LS N++ G+IP +G +L L+LS N
Sbjct: 423 LGLDNQGLRGFIPNDISK------LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476
Query: 287 HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320
IP LG SL L+L N+L G +P +
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 65/239 (27%), Positives = 111/239 (46%), Gaps = 39/239 (16%)
Query: 561 EVGEGVFGTVYKVSF--GTQGRMLAVKKL--VTSDIIQYPEDFEREVRVLGKAR-HPNLI 615
E+G+G +G V ++ +A+KK+ V S I RE+++L R H N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNIT 65
Query: 616 SLEGYYWTPQLKLLVSDYAPNGS------LQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
L Y +V N ++A LH+ + S PL+ + I GL
Sbjct: 66 CL---YDMD----IVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA---LG 726
++H + ++H +LKP N+L++ + +I DFGLAR + N ++A
Sbjct: 119 KYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS-------ENPGENAGFMTE 168
Query: 727 YV------APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
YV APE+ + D++ G ++ EL+ GR+PV G+D V L++ ++VL
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVL 226
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 619
+G G FG V V + ++ A+K L ++I+ + F E ++ A P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + +V +Y P G L + P W RF TA+ + L
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWA-RFY----TAEVVLALDAIHSMG 162
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE-LTCQ 735
IH ++KP N+LLD + + +++DFG +++K M R +A+G Y++PE L Q
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMV-RCDTAVGTPDYISPEVLKSQ 218
Query: 736 SLR--VNEKCDIYGFGVLILELVTGRRP 761
+CD + GV + E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 27/232 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKAR-HPNLISL 617
+G G + V V ++ A+K +V +++ ED + E V +A +P L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMK-VVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
+ T LV +Y G L + +LP + + L LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER 115
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
II+ +LK N+LLD + + +++D+G+ + L ++ F Y+APE+
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEI--- 167
Query: 736 SLRVNE---KCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH--VRVLLEE 782
LR E D + GVL+ E++ GR P + DN + +E +V+LE+
Sbjct: 168 -LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 59/275 (21%), Positives = 89/275 (32%), Gaps = 56/275 (20%)
Query: 43 IGKIFNYCSSLNTLNLSNNHFSGDLDF--ASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA 100
+ SL L LS N + G+ L+ LDLS N +
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 101 ALH---YLKELLLQGNQFSGPLPADIGFC------PHLTTLDLSNNLFTGQLPVSLRLLN 151
+L L+EL L N G + P L L L N G
Sbjct: 103 SLLRSSSLQELKLNNNGL-GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA--------- 152
Query: 152 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-----NCKKLSVIRL 206
S L + L+ L+ +NN + + +L NC L V+ L
Sbjct: 153 -------SCEALAKALRA----NRDLKELNLANNGIGDAGIRALAEGLKANC-NLEVLDL 200
Query: 207 RGNSLNGNIPEGLFDLG--------LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILD 258
N L EG L LE ++L +N + + +S+ + +L L
Sbjct: 201 NNNGLT---DEGASALAETLASLKSLEVLNLGDNN-LTDAGAAALASALLSPNISLLTLS 256
Query: 259 LSSNNLVGDIPAEMGL-----FANLRYLNLSSNHL 288
LS N++ D A+ +L L+L N
Sbjct: 257 LSCNDI-TDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 39/254 (15%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGT--------------QGR--MLAVKKLVTSDIIQY 595
P L ++GEG FG V+ +GR ++AVK L
Sbjct: 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA 62
Query: 596 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERL-------- 647
DF +EV++L + + PN+I L G ++++Y NG L L
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 648 -PSTPP------LSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPR 699
+ PP +S+++ V L A G+ +L +F +H +L N L+ +N +
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF----VHRDLATRNCLVGENLTIK 178
Query: 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
I+DFG++R L D + + R + ++A E + D++ FGV + E++
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLC 237
Query: 760 RPVEYGE--DNVVI 771
+ YGE D VI
Sbjct: 238 KEQPYGELTDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 11/209 (5%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGY 620
VGEG +G V K ++A+KK S+ + E RE+++L + N++ L+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ LV +Y L+ L E +P+ P + L A +H + I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA-----IHWCHKNDI 121
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
+H ++KP N+L+ N ++ DFG AR L+ + + + Y +PEL +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLLGA-PYG 179
Query: 741 EKCDIYGFGVLILELVTGRRPVEYGEDNV 769
+ D++ G ++ EL G +P+ GE +
Sbjct: 180 KAVDMWSVGCILGELSDG-QPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 62/209 (29%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGY 620
+G G G V G +AVKKL Q + + RE+ +L H N+ISL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 621 YWTPQ--LKLLVSDYAPNGSLQAKL---------HERLPSTPPLSWTNRFKVILGTAKGL 669
+ TPQ L+ Y + A L HER+ ++ G+
Sbjct: 89 F-TPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-----------LLYQMLCGI 136
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
HLH + IIH +LKPSNI++ + +I DFGLAR + M + Y A
Sbjct: 137 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRA 190
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTG 758
PE+ + E DI+ G ++ ELV G
Sbjct: 191 PEVIL-GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 29/118 (24%)
Query: 156 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 215
+ + N L G IP+ I + L+ ++ S N + G++P SL + L V+ L NS NG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 216 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 273
PE L L +LRIL+L+ N+L G +PA +G
Sbjct: 483 PESLGQL-----------------------------TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 617
+G+G FG V G+ AVK L ++ E ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T + V D+ G L L P + RF A L +LH S
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA---RF-YAAEIASALGYLH-SIN 116
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
I++ +LKP NILLD + ++DFGL + + + + F Y+APE+ +
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVI-RKQ 171
Query: 738 RVNEKCDIYGFGVLILELVTGRRP 761
+ D + G ++ E++ G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 20/174 (11%)
Query: 597 EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPST 650
+ E E++ L + N++ + G+ + + D P SL + L E L
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFI------IDIVDDLPRLSLILEYCTRGYLREVLDKE 116
Query: 651 PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710
LS+ + + + KGL +L+ P + NL + L+ +NY +I GL ++L+
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 711 RLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVE 763
+ + + Y + ++ K DIY GV++ E+ TG+ P E
Sbjct: 175 -----SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-06
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 56 LNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF 115
L L N G + I L+ L++++LS N G+IP + ++ L+ L L N F
Sbjct: 423 LGLDNQGLRGFI----PNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 116 SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL--RLLNSMIFISVSNNTLTGDIP 168
+G +P +G L L+L+ N +G++P +L RLL+ F N L G IP
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IP 532
|
Length = 623 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 21/153 (13%)
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
IH +L NILL +N +I DFGLAR + + +V + L ++APE +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 741 EKCDIYGFGVLILELVT-GRRP---VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796
+ D++ FGVL+ E+ + G P V+ E+ L + R+
Sbjct: 256 QS-DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM----------------RA 298
Query: 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
PE+ + ++ L C P RP+ + +V+IL
Sbjct: 299 PENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/112 (24%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 648 PSTPPLSWTNRFKVILGT--AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705
+ P + + + V + A G+++LH + +IH ++ N ++D+ +I+D L
Sbjct: 107 EANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNAL 163
Query: 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
+R L +D H + + + ++A E + + + D++ FGVL+ EL+T
Sbjct: 164 SRDLFPMDYHCLGDNENRPVKWMALE-SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 27/239 (11%)
Query: 530 NLAAGKVILFDSRSSSLDCSIDPETLL---EKAAEVGEGVFGTVYK-VSFGTQGRMLAVK 585
+++ G + D S+S D + L+ +KA EV + TV K ++ G++GR+
Sbjct: 27 DISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT 86
Query: 586 K-----LVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 640
K V I Q E +L HP++I ++ + + +V + + L
Sbjct: 87 KPGQPDPVVLKIGQKGTTL-IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLY 144
Query: 641 AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 700
L +R + PL + +GL +LH IIH ++K NI ++D I
Sbjct: 145 TYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCI 198
Query: 701 SDFGLARLLTRLDKHVMSNRFQSALGYV---APELTCQSLRVNEKCDIYGFGVLILELV 756
D G A+ V++ F G V APE+ + + N K DI+ G+++ E++
Sbjct: 199 GDLGAAQF------PVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 62/245 (25%), Positives = 104/245 (42%), Gaps = 60/245 (24%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFERE----VR----VLGKARHPN 613
+G G FG V V G + A+KKL S+++ E+E VR +L +A +P
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML------EKEQVAHVRAERDILAEADNPW 62
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
++ L + L+ +Y P G + L ++ T + RF I T + +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---RF-YIAETILAIDSIH 118
Query: 674 -HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA--------RLLTRLDKHVMSNRFQ-- 722
+ IH ++KP N+LLD + ++SDFGL R+ H + + F
Sbjct: 119 KLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 723 -----------------------SALG---YVAPELTCQSLRVNEKCDIYGFGVLILELV 756
S +G Y+APE+ Q+ N++CD + GV++ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEML 233
Query: 757 TGRRP 761
G P
Sbjct: 234 VGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
IH +L NILL +N +I DFGLAR + + +V + L ++APE +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 741 EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799
+ D++ FGVL+ E+ + G P V I E R L+EG + DY
Sbjct: 261 QS-DVWSFGVLLWEIFSLGASPYP----GVKIDEEFCR-RLKEGTRM-----RAPDYTTP 309
Query: 800 EVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
E+ + L C PS RP+ +E+V+ L
Sbjct: 310 EMYQTM---LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 62/247 (25%), Positives = 97/247 (39%), Gaps = 59/247 (23%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE----DFEREVRVLGKARH 611
+K +G+G G V+ V G++ A+K L ++I+ + E+E+ L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDH 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL----HERLPSTPPLSWTNRF---KVILG 664
P L +L + T LV DY P G L L + L RF +V+L
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA-----RFYAAEVLL- 114
Query: 665 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM------- 717
L +LH I++ +LKP NILL ++ + +SDF L++ V
Sbjct: 115 ---ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 718 --------------------SNRFQSALGYVAPELTC---QSLRVNEKCDIYGFGVLILE 754
SN F Y+APE+ V D + G+L+ E
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYE 224
Query: 755 LVTGRRP 761
++ G P
Sbjct: 225 MLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 42/280 (15%)
Query: 562 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+G G FG + + + +A+ L + F E LG+ H N++ LE
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
G ++V++Y NG+L + L HE L ++ G A G+ +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM- 126
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-----YVAPE 731
+H L +L++ + +IS F RL + + + G + APE
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVT-GRRPV-EYGEDNVVILSEHVRVLLEEGNVLDCV 789
Q + D++ FG+++ E+++ G RP + +V+ +E+G L
Sbjct: 179 -AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------KAVEDGFRL--- 227
Query: 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
P+ + P + +L L C RP +++ IL
Sbjct: 228 -PAPRNCPN----LLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 49/244 (20%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPN 613
E +G G FG V V G + A+K L +D+++ + E +L +A
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 614 LISLEGYYWTPQLKL---LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
++ + +++ Q KL L+ ++ P G + L ++ T +F I T +
Sbjct: 63 VVKM---FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE---ETQF-YIAETVLAID 115
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK--------HVM----- 717
+H + IH ++KP N+LLD + ++SDFGL L + + H +
Sbjct: 116 SIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 718 --------------SNRFQSALG------YVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
NR Q A Y+APE+ Q+ N+ CD + GV++ E++
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLI 231
Query: 758 GRRP 761
G P
Sbjct: 232 GYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGY 620
+G G G V R +A+KKL Q + + RE+ ++ H N+ISL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 621 YWTPQ----------LKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGL 669
+ TPQ L + + D +Q +L HER+ ++ G+
Sbjct: 85 F-TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----------LLYQMLCGI 132
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
HLH + IIH +LKPSNI++ + +I DFGLAR M + Y A
Sbjct: 133 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 186
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELV 756
PE+ + E DI+ G ++ E+V
Sbjct: 187 PEVIL-GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 55/247 (22%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E +G G FG V V G + A+K L +D++ E+E +A L+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML------EKEQVAHIRAERDILV 56
Query: 616 SLEG-----YYWTPQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+G +++ Q K L+ ++ P G + L ++ LS I T
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVL 112
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA------------RLLT----- 710
+ +H + IH ++KP N+LLD + ++SDFGL R LT
Sbjct: 113 AIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 711 ----------RLDKHVMSNRFQ---SALG---YVAPELTCQSLRVNEKCDIYGFGVLILE 754
R + NR Q S +G Y+APE+ Q+ N+ CD + GV++ E
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228
Query: 755 LVTGRRP 761
++ G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 562 VGEGVFGTVYKVS--FGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISL 617
+G+G FGTVY V L V K + + E + +E ++L K HP ++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHE------RLPSTPPLSWTNRFKVILGTAKGLAH 671
+ ++++Y L KL E L W +++LG H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF--IQLLLGV-----H 120
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
H R I+H +LK NI L +N +I DFG++RLL + ++ F Y++PE
Sbjct: 121 YMHQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPE 175
Query: 732 -LTCQSLRVNEKCDIYGFGVLILEL 755
L Q + K DI+ G ++ E+
Sbjct: 176 ALKHQGY--DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 29/250 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL---- 617
+G G G V+ + +AVKK+V +D RE++++ + H N++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVYEVL 71
Query: 618 --EGYYWTPQLKLLV---SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 672
G T + L S Y ++ L + PLS + + +GL ++
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDL-ANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 673 HHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQS----ALGY 727
H + ++H +LKP+N+ ++ ++ +I DFGLAR++ D H + S Y
Sbjct: 131 HSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKWY 184
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG----EDNVVILSEHVRVLLEEG 783
+P L + D++ G + E++TG +P+ G E +IL E V V+ EE
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLIL-ESVPVVREED 242
Query: 784 -NVLDCVDPS 792
N L V PS
Sbjct: 243 RNELLNVIPS 252
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 28/212 (13%)
Query: 562 VGEGVFGTVYK------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G+G F ++K +G + + K++ Y E F ++ + H +L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH-LHH 674
G ++V +Y GSL L + + +SW L AK LA LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAKQLAWALHF 115
Query: 675 SFRPPIIHYNLKPSNILL-----DDNYNP---RISDFGLARLLTRLDKHVMSNRFQSALG 726
+ H N+ N+LL NP ++SD G++ +T L K ++ R +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLER----IP 169
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTG 758
+V PE ++ D + FG + E+ +G
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
RHPN+++ + T ++S + GS + L P +S ++ G +GL
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGL 114
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG-LARLLTRLDKHVMSNRF----QSA 724
+LH + IH N+K S+IL+ + +S L L+ K + F S
Sbjct: 115 NYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV 171
Query: 725 LGYVAPELTCQSLR-VNEKCDIYGFGVLILELVTGRRP 761
L +++PEL Q L N K DIY G+ EL TGR P
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEG 619
+ G FG VY ++ AVK + +D+I + E L ++ P ++ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-- 69
Query: 620 YYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
YY LV +Y G +++ LH ++ K I A L +LH R
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLH---R 122
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717
IIH +LKP N+L+ + + +++DFGL+++ + ++M
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-05
Identities = 21/64 (32%), Positives = 28/64 (43%), Gaps = 4/64 (6%)
Query: 28 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 87
+L+ L L+ N L F +L L+LS N+ L S L LR+LDLS
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNN----LTSISPEAFSGLPSLRSLDLS 56
Query: 88 HNLF 91
N
Sbjct: 57 GNNL 60
|
Length = 60 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 4/134 (2%)
Query: 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 687
LL+ +Y G L ++ +RL P ++V L + + L ++H +LK
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 688 SNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYG 747
+NI L ++ DFG ++ + +++ F Y+APEL + R ++K D++
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL-WERKRYSKKADMWS 256
Query: 748 FGVLILELVTGRRP 761
GV++ EL+T RP
Sbjct: 257 LGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 31/210 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGY 620
+G G G V R +A+KKL Q + + RE+ ++ H N+I L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 621 YWTPQ--LKLLVSDYAPNGSLQAKL---------HERLPSTPPLSWTNRFKVILGTAKGL 669
+ TPQ L+ Y + A L HER+ ++ G+
Sbjct: 92 F-TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----------LLYQMLCGI 139
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
HLH + IIH +LKPSNI++ + +I DFGLAR M + Y A
Sbjct: 140 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 193
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGR 759
PE+ + E DI+ G ++ E++ G
Sbjct: 194 PEVIL-GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 562 VGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLE 618
+G G FG V ++ + +A+K+ S II+ + E ++L HP ++L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
G + LV ++ G L ++R P+ + + +I + L
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN------ 151
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 733
I++ +LKP N+LLD + +++DFG A+ V+ R + G Y+APE+
Sbjct: 152 ---IVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYTLCGTPEYIAPEIL 200
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRP 761
++ + D + G+ I E++ G P
Sbjct: 201 L-NVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 61/251 (24%), Positives = 92/251 (36%), Gaps = 50/251 (19%)
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMI-------FISVSNNTLTGDIPHWIGNI---ST 176
P L L LS N TG++P L+ L + + +S+N L D + ++ S+
Sbjct: 51 PSLKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSS 109
Query: 177 LEFLDFSNN--------HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG----- 223
L+ L +NN L L L + L N L G L
Sbjct: 110 LQELKLNNNGLGDRGLRLLAKGLKD---LPPALEKLVLGRNRLEG---ASCEALAKALRA 163
Query: 224 ---LEEIDLSENGFMGS-IPPGSSSSSSSTLFQTLRILDLSSNNL--VGDIPAEMGL--F 275
L+E++L+ NG + I + + L +LDL++N L G L
Sbjct: 164 NRDLKELNLANNGIGDAGIR---ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220
Query: 276 ANLRYLNLSSNHLRSRIPPEL-----GYFHSLIHLDLRNNALYGSIPQEVCE----SRSL 326
+L LNL N+L L SL+ L L N + +++ E SL
Sbjct: 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL 280
Query: 327 GILQLDGNSLT 337
L L GN
Sbjct: 281 LELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 65/252 (25%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR----VLGKARHPNLISL 617
+G+G FG V V G++ A+K L+ S++ + +D V+ VL ++ P ++SL
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHH 674
+ Q L+ ++ P G L L + + ++ RF + +L + +H
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMAECVLA----IEAVH- 118
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLA-------------RLLT------RLDKH 715
+ IH ++KP NIL+D + ++SDFGL+ +LL R+D
Sbjct: 119 --KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 716 ----------VMSNRFQ-------------SALG---YVAPELTCQSLRVNEKCDIYGFG 749
MS++ Q S +G Y+APE+ Q E CD + G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLG 235
Query: 750 VLILELVTGRRP 761
++ E + G P
Sbjct: 236 AIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 598 DFEREVRVLGKARHPNLISL-EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656
RE+ +L H +I+L Y W + +++ Y + L + + PL
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY------KCDLFTYVDRSGPLPLE 185
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
+ + LA+LH IIH ++K NI LD+ N + DFG A +LD H
Sbjct: 186 QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHP 239
Query: 717 MSNRFQSALGYV---APELTCQSLRVNEKC---DIYGFGVLILELVTGRRP 761
+ + G + +PEL L ++ C DI+ G+++ E+
Sbjct: 240 DTPQCYGWSGTLETNSPEL----LALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 325 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384
+L L L N LT + +L +L LS N+L+ P++ S L L+ L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 19/245 (7%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ N+K LDLS N LS N ++L L L+GN + + S+L L+LSN
Sbjct: 162 LPNLKNLDLSFNDLSDLPKLLS--NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N L + +LK L L+LS+N +P+ + L L+ L L NQ S
Sbjct: 219 NSIIELLS-----SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS 272
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLP--VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
+G +L LDLS N + LP L LL ++ + ++++
Sbjct: 273 --LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALE------LKLNSIL 324
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238
+ ++ S P +L + L+ + N+L+ + I + +
Sbjct: 325 LNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLDLVKKHV 384
Query: 239 PPGSS 243
Sbjct: 385 NQLLE 389
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+K LDLSNN L+ +P F+ +L+ L L+GN L + F+ SL +L+LS N+
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 63 F 63
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 69/260 (26%)
Query: 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARH 611
++ K +G G FG V V + A+K L +D++ + + E +L +A +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 612 PNLISLEGYYWTPQLK---LLVSDYAPNGSLQAKL------HERLPSTPPLSWTNRFKVI 662
++ L Y++ Q K V DY P G + + L E L RF I
Sbjct: 61 EWVVKL---YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---------RF-YI 107
Query: 663 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL------------- 709
+ +H + IH ++KP NIL+D + + +++DFGL
Sbjct: 108 AELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 710 -TRLDKHVMSNRF------------------------QSALG---YVAPELTCQSLRVNE 741
R D S + S +G Y+APE+ ++ +
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQ 223
Query: 742 KCDIYGFGVLILELVTGRRP 761
CD + GV++ E++ G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 46/227 (20%), Positives = 87/227 (38%), Gaps = 52/227 (22%)
Query: 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARH 611
+L + VG+G +G V+ G ++A+K++ S + + E E +L +
Sbjct: 4 QILTQ---VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
L+ L + + L +Y P G + L G+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---------------------NNLGVLS 99
Query: 672 LHHS--------------FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717
H+ IH +LKP N L+D + + +++DFGL+ K ++
Sbjct: 100 EDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS-------KGIV 152
Query: 718 SNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ S +G Y+APE+ + + D + G ++ E + G P
Sbjct: 153 T-YANSVVGSPDYMAPEVL-RGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGL 669
PN++ L Y + LV +A G L + + + +P W V L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG-LARLLTRLDKHVMSNRFQSALGYV 728
LH R I+ +L P+NILLDD + +++ F + + D + N Y
Sbjct: 101 --LH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763
APE+ S E CD + G ++ EL+TG+ VE
Sbjct: 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 128 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHL 187
+L +LDLSNN T + + L ++ + +S N LT P + +L LD S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 46/203 (22%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD 694
+ S +K E + PL + + A+G+ L IH ++ N+LL D
Sbjct: 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTD 247
Query: 695 NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGF 748
+I DFGLAR + +V+ + + ++APE T QS D++ +
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSY 300
Query: 749 GVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKL 807
G+L+ E+ + G+ P +++ S+ + +++ G + P D+ E+ ++K+
Sbjct: 301 GILLWEIFSLGKSPYP----GILVNSKFYK-MVKRGYQMSR--P---DFAPPEIYSIMKM 350
Query: 808 ALVCTCHIPSSRPSMAEVVQILQ 830
C P+ RP+ +++ Q++Q
Sbjct: 351 ---CWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 29/62 (46%), Positives = 34/62 (54%), Gaps = 6/62 (9%)
Query: 254 LRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNN 310
L+ LDLS+N L IP GL NL+ L+LS N+L S I PE SL LDL N
Sbjct: 2 LKSLDLSNNRL-TVIPDGAFKGL-PNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGN 58
Query: 311 AL 312
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 349 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
+L L LS+N L+ + L LK+L L N L+ P+ L SL ++++S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 30/151 (19%), Positives = 48/151 (31%), Gaps = 18/151 (11%)
Query: 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
+ G+ VY + + +K + + D EREV +L L +
Sbjct: 4 KLLKGGLTNRVYLLGTKDED--YVLKINPSR---EKGADREREVAILQLLARKGLPVPKV 58
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT--AKGLAHLHHSFR 677
+ L E + + K + A+ LA LH
Sbjct: 59 LA-----------SGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARL 708
+ H +L P NIL+DD I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 19/97 (19%)
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH----VMSNRFQ 722
K L H+H + I H ++KP NIL+ D+ +++DFG R K +S R+
Sbjct: 111 KSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRW- 163
Query: 723 SALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVT 757
Y APE LT K DI+ G + E+++
Sbjct: 164 ----YRAPECLLTDG--YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 552 PETLLEKAAEVGEGVFGTVYK-VSFG---TQGRM-LAVKKLVTSDIIQYPEDFEREVRVL 606
P L +G G FG V + ++G + M +AVK L + E E++++
Sbjct: 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM 92
Query: 607 GK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
H N+++L G L++++Y G L L + S L+ +
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQV 150
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
AKG+A L IH +L N+LL +I DFGLAR + +V+ + +
Sbjct: 151 AKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757
++APE + E D++ +G+L+ E+ +
Sbjct: 208 KWMAPESIFNCVYTFES-DVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---QYPEDF-EREVRVLGKARHPNLISL 617
+ G +G VY V + A+KK+ ++I Q + F ER++ L A +P ++S+
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVSM 66
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T + +V +Y G A L L + L T L +LH+
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDC-ATL---LKNIGALPVDMARMYFAETVLALEYLHNY-- 120
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLAR-----LLTRLDKHVMSNRFQSALG------ 726
I+H +LKP N+L+ + +++DFGL++ L T L + + + L
Sbjct: 121 -GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 727 --YVAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRPVEYGE 766
Y+APE+ LR + D + G+++ E + G P +G+
Sbjct: 180 PEYIAPEVI---LRQGYGKPVDWWAMGIILYEFLVGCVPF-FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.004
Identities = 61/244 (25%), Positives = 115/244 (47%), Gaps = 45/244 (18%)
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEE---IDLSENGFMGSIPPGSSSSSS-----S 248
N +L + L ++ IPE + L L+ L EN G+I ++S+ +
Sbjct: 179 NKTELRLKILGLTTIPACIPEQITTLILDNNELKSLPEN-LQGNIKTLYANSNQLTSIPA 237
Query: 249 TLFQTLRILDLSSNNLVGDIPAEMG-------LFAN------------LRYLNLSSNHLR 289
TL T++ ++LS N + ++P + LF N LRYL++ N +R
Sbjct: 238 TLPDTIQEMELSINRIT-ELPERLPSALQSLDLFHNKISCLPENLPEELRYLSVYDNSIR 296
Query: 290 SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTS 349
+ +P L + HL++++N+L ++P+ + L L+ N+LT +P +
Sbjct: 297 T-LPAHLP--SGITHLNVQSNSL-TALPETL--PPGLKTLEAGENALTS-LPASLP--PE 347
Query: 350 LYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409
L +L +S N ++ +P+++ + L + N L+ +P+ L A+L + S N L+
Sbjct: 348 LQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV 401
Query: 410 GRLP 413
RLP
Sbjct: 402 -RLP 404
|
Length = 754 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 843 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.3 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.26 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.21 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.2 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.19 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.01 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.0 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.68 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.63 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.62 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-94 Score=888.47 Aligned_cols=768 Identities=32% Similarity=0.507 Sum_probs=574.1
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
|++|++|+|++|.+.+.+|. .|.++++|++|+|++|.+.+..+..|..+++|++|+|++|++++.. +..+..+++
T Consensus 163 l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~ 237 (968)
T PLN00113 163 FSSLKVLDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI----PYEIGGLTS 237 (968)
T ss_pred CCCCCEEECccCcccccCCh-hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcC----ChhHhcCCC
Confidence 46889999999998867775 4788999999999999988777778888899999999998887532 235677888
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
|++|+|++|.+.+..|..|..+++|++|+|++|.+++..|..+.++++|++|+|++|.+.+..|..+..+++|+.|++++
T Consensus 238 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~ 317 (968)
T PLN00113 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317 (968)
T ss_pred CCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCC
Confidence 88888888888878888888888888888888888877888888888888888888888888888888888888888888
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIP 239 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p 239 (843)
|.+.+..|..++.+++|+.|+|++|.+++.+|..+..+++|+.|++++|.+++.+|..+... +++.|++++|.+.+.+|
T Consensus 318 n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p 397 (968)
T PLN00113 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397 (968)
T ss_pred CccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCC
Confidence 88888888888888888888888888887788888888888888888888877777766554 46666666666665554
Q ss_pred CCCCC------------------CCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCcccccc
Q 003156 240 PGSSS------------------SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301 (843)
Q Consensus 240 ~~~~~------------------~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 301 (843)
..... +..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|.+.+..|..+ ...+
T Consensus 398 ~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~ 476 (968)
T PLN00113 398 KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKR 476 (968)
T ss_pred HHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-cccc
Confidence 42211 0012234555555555555555555555556666666666666655555444 3467
Q ss_pred ceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccC
Q 003156 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF 381 (843)
Q Consensus 302 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 381 (843)
|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+.++++|+.|+|++|.+++.+|..|.++++|+.|+|++
T Consensus 477 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 556 (968)
T PLN00113 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556 (968)
T ss_pred ceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCC
Confidence 88888888899888899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCCCCCC---CCCCCCCCCCcCCCCCCCC
Q 003156 382 NELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKG---PCKMNVPKPLVLDPDAYNS 458 (843)
Q Consensus 382 N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~---~c~~~~~~~~~~~~~~~~~ 458 (843)
|++++.+|..+..+++|+.|++++|+++|.+|..+.+.++...++.||+++|+++... +|..
T Consensus 557 N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~--------------- 621 (968)
T PLN00113 557 NQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR--------------- 621 (968)
T ss_pred CcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc---------------
Confidence 9999999999999999999999999999999999999999999999999999854211 1110
Q ss_pred CCCCCCccCCCCCCCccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccCCCCccccccCCceeE
Q 003156 459 NQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVIL 538 (843)
Q Consensus 459 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (843)
. .....+ ++.+++ +++++++ ++++++++ +++++|++.+..+ .+..... .....
T Consensus 622 ----------~-~~~~~~-~~~~~~--~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~---------~~~~~ 674 (968)
T PLN00113 622 ----------V-RKTPSW-WFYITC--TLGAFLV-LALVAFGF-VFIRGRNNLELKR--VENEDGT---------WELQF 674 (968)
T ss_pred ----------c-ccccee-eeehhH--HHHHHHH-HHHHHHHH-HHHHhhhcccccc--ccccccc---------ccccc
Confidence 0 000111 111111 1112222 22222211 1112222111111 0100000 00011
Q ss_pred eccCCCccccccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCcccee
Q 003156 539 FDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618 (843)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 618 (843)
++..........+....+.....||+|+||.||+|++..+++.||||++..... ....|++.+++++|||||+++
T Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~ 749 (968)
T PLN00113 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLI 749 (968)
T ss_pred cccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEE
Confidence 111000000000111223445689999999999999987899999999854331 123568899999999999999
Q ss_pred eEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 619 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
|+|.+++..++||||+++|+|.++++. ++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+
T Consensus 750 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~ 822 (968)
T PLN00113 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822 (968)
T ss_pred EEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce
Confidence 999999999999999999999999963 7899999999999999999997777799999999999999999988
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~ 778 (843)
++. ||....... .....++..|+|||++ .+..++.++|||||||++|||+||+.||...........+|++.
T Consensus 823 ~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 894 (968)
T PLN00113 823 HLR-LSLPGLLCT------DTKCFISSAYVAPETR-ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY 894 (968)
T ss_pred EEE-ecccccccc------CCCccccccccCcccc-cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHH
Confidence 876 665543221 1223678899999988 56679999999999999999999999996554444556667665
Q ss_pred HHhhCCcccccCCCCCC---CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 779 LLEEGNVLDCVDPSMGD---YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~---~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
..........+|+.+.. .+.++..++.+++.+||+.+|++||||+||+++|+++....
T Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred hcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 55544445556666533 34566778899999999999999999999999999986643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=440.98 Aligned_cols=284 Identities=42% Similarity=0.708 Sum_probs=242.8
Q ss_pred CccccccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc
Q 003156 544 SSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT 623 (843)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 623 (843)
+..++..++.+|-... .||+|+||.||+|... +|+.||||++....... ..+|.+|++++.+++|||+|+++|||.+
T Consensus 66 s~~el~~AT~~Fs~~~-~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 66 SYDELRKATNNFSESN-LIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred eHHHHHHHHhCCchhc-ceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 5566666676665544 9999999999999997 66999999886554332 5669999999999999999999999999
Q ss_pred CC-eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEee
Q 003156 624 PQ-LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 624 ~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 702 (843)
.+ ..+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|+++++||+|
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 98 599999999999999999986433 789999999999999999999999999999999999999999999999999
Q ss_pred ccCcccccccccceecccc-ccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC-CchhhHHHHHHHHH
Q 003156 703 FGLARLLTRLDKHVMSNRF-QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE-DNVVILSEHVRVLL 780 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~-~~~~~l~~~~~~~~ 780 (843)
||+|+..+...... ... .||.+|+|||++ ..+..+.|+|||||||++.|++||+.|.+... .....+..|+...+
T Consensus 221 FGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~-~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSV--STTVMGTFGYLAPEYA-STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCcccCCccccce--eeecCCCCccCChhhh-ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99997655311111 122 899999999998 55789999999999999999999999987643 33445889999999
Q ss_pred hhCCcccccCCCCC-C-CCh-hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 781 EEGNVLDCVDPSMG-D-YPE-DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 781 ~~~~~~~~~d~~l~-~-~~~-~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
..+...+++|+.+. + ++. ++..++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999986 3 443 6888899999999999999999999999999776543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=492.09 Aligned_cols=429 Identities=34% Similarity=0.537 Sum_probs=337.8
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
++|++|+|++|.+++.+|.. |.++++|++|+|++|.+.+..+..|.++++|++|+|++|.+.+.. +..+..+++|
T Consensus 140 ~~L~~L~Ls~n~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L 214 (968)
T PLN00113 140 PNLETLDLSNNMLSGEIPND-IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI----PRELGQMKSL 214 (968)
T ss_pred CCCCEEECcCCcccccCChH-HhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcC----ChHHcCcCCc
Confidence 45566666666665455533 566777777777777766655666667777777777777665432 2346667777
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
++|+|++|++.+.+|..+..+++|++|+|++|.+++..|..++++++|++|+|++|.+++..|..+..+++|+.|++++|
T Consensus 215 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 294 (968)
T PLN00113 215 KWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294 (968)
T ss_pred cEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCC
Confidence 77777777777777777777777888888877777777777777888888888888877777777778888888888888
Q ss_pred cccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPP 240 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~ 240 (843)
++.+.+|..+.++++|++|++++|.+++..|..+..+++|+.|++++|.+.+.+|..+... +|+.|++++|.+.+.+|.
T Consensus 295 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~ 374 (968)
T PLN00113 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374 (968)
T ss_pred eeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCCh
Confidence 8877778778888888888888888887778888888888888888888887888777665 688889998888887776
Q ss_pred CCCCC------------------CcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccc
Q 003156 241 GSSSS------------------SSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302 (843)
Q Consensus 241 ~~~~~------------------~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 302 (843)
..... .....+++|+.|++++|++++.+|..+..+++|+.|++++|.+.+..+..+..+++|
T Consensus 375 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 454 (968)
T PLN00113 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454 (968)
T ss_pred hHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC
Confidence 43321 112345677788888888877777778888888888888888887777777778888
Q ss_pred eEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCC
Q 003156 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382 (843)
Q Consensus 303 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 382 (843)
+.|+|++|++.+.+|..+ ..++|+.|++++|++++..|..|.++++|+.|+|++|++++.+|..+.++++|++|+|++|
T Consensus 455 ~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 533 (968)
T PLN00113 455 QMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533 (968)
T ss_pred cEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCC
Confidence 888888888887777655 4578999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcchhcccccceEeeccccceecCCCC-CCCCCCCCCCcCCCCCCCCCC
Q 003156 383 ELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG-GVFPTLDQSSLQGNLGICSPL 436 (843)
Q Consensus 383 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~ 436 (843)
++++.+|..+..+++|+.|+|++|+++|.+|.. ..+..+....+.+|+..+.-|
T Consensus 534 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred cccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 999999999999999999999999999999953 446678888899998766444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=405.81 Aligned_cols=260 Identities=32% Similarity=0.472 Sum_probs=221.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..+.++..+.||+|-||+||.|.|. ....||+|.++... ...++|.+|+++|++++|++||+++|+|..++..+|||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 4456677789999999999999996 44589999997654 34578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|||+.|+|.++|+.. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+||...+
T Consensus 281 E~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999999999999984 456788999999999999999999999 999999999999999999999999999995443
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
+.+.......-++.|.|||.+ ....++.|||||||||+||||+| |+.||..+... .+-..++.|..+.+
T Consensus 356 -~~Y~~~~~~kfPIkWtAPEa~-~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~~~le~GyRlp~-- 425 (468)
T KOG0197|consen 356 -DEYTASEGGKFPIKWTAPEAL-NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVLELLERGYRLPR-- 425 (468)
T ss_pred -CceeecCCCCCCceecCHHHH-hhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHHHHHhccCcCCC--
Confidence 444444555667889999998 66789999999999999999999 88888765332 12223455555433
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
|..|+..++++|..||+.+|++|||++.+...++.+...
T Consensus 426 ------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 ------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 778999999999999999999999999999999887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=384.66 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=216.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC-eeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-LKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e 632 (843)
..++....||+|..|+||++.++.+++.+|+|.+.........+++.+|++++++.+||+||+++|.|..+. ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 445667799999999999999999999999999955544455678999999999999999999999999988 5999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
||++|+|++++... ..+++....+|+.+|++||.|||+.. +||||||||+|||++..|+|||||||.++.+...
T Consensus 159 YMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999875 56899999999999999999999632 9999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.+.++.||..|||||.+ .+..|+.++||||||++++|+.+|+.||.........+.+.+.. +++..
T Consensus 233 ----~a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~---------Iv~~p 298 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA---------IVDEP 298 (364)
T ss_pred ----hcccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH---------HhcCC
Confidence 44778999999999999 67789999999999999999999999997753322222222222 12222
Q ss_pred CCCCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~-~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
-+..|.+ +..++..++..|+++||.+|||++|+++|
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2334554 77889999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=402.98 Aligned_cols=257 Identities=32% Similarity=0.480 Sum_probs=212.9
Q ss_pred hhcCeeccccceEEEEEEECCCCeE-EEEEEeecCCccc-ChHHHHHHHHHHHhccCCCccceeeEEEcCC-eeEEEEEe
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRM-LAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQ-LKLLVSDY 633 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~ 633 (843)
+..+.+|+|+||+||+|.|+ |+. ||||++....... ..+.|.+|+.++.+++|||||+++|+|.++. ..++||||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34446999999999999995 666 9999996543221 1568999999999999999999999999987 78999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC-eeecCCCCCCEEEcCCC-CcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP-IIHYNLKPSNILLDDNY-NPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~ 711 (843)
|++|+|.++++.. ....+++..++.||.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999984 356799999999999999999999998 6 99999999999999997 999999999987653
Q ss_pred cccceeccccccccccCCcccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.. .......||..|||||++.. ...|+.|+|||||||++|||+||+.||..... . .....+ .. .
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-~~~~~v---~~--------~ 261 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-QVASAV---VV--------G 261 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-HHHHHH---Hh--------c
Confidence 21 22244789999999999943 46799999999999999999999999986544 1 111111 11 1
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+..+..+...+..+|.+||..||+.||++.|++..|+.+...
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 222334556788899999999999999999999999999987664
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=419.81 Aligned_cols=267 Identities=28% Similarity=0.433 Sum_probs=231.1
Q ss_pred hhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
...+..+.||+|+||+||+|+.. .+...||||.+++....+..++|++|+++++.++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 33445568999999999999984 2456799999988776667889999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCC----------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 629 LVSDYAPNGSLQAKLHERLPS----------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
+|+|||..|||.++|+.+.+. ..+++..+.+.||.|||.||+||-++ .+|||||.++|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999999876542 23488999999999999999999999 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~ 777 (843)
||+|||++|.+-..|++.......-+++||+||.+ ..++||++||||||||+|||+++ |+.||.....++ |-
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI-ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------VI 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI-LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------VI 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHh-hcCcccchhhhhhhhhhhhhhhccccCcccccchHH------HH
Confidence 99999999998877877766566778999999998 67799999999999999999998 999998654432 22
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
..++.+.... .|+.++.++++||..||+..|.+||+++||-..|+......+.
T Consensus 716 e~i~~g~lL~--------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 716 ECIRAGQLLS--------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHcCCccc--------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 3345555544 4889999999999999999999999999999999988766554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=400.60 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=220.8
Q ss_pred hhhcCeeccccceEEEEEEECCCC---eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
..+.++||.|.||+||+|+++..| ..||||.++....++...+|+.|+.+|.++.||||+++.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 445678999999999999997666 46999999887777778899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
||++|+|+.+|+.+. .++++.+...+.++||.||.||-+. ++|||||.++|||++.+..+||+|||++|.+.++
T Consensus 711 yMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999973 5699999999999999999999999 9999999999999999999999999999987654
Q ss_pred c-cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 713 D-KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 713 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
. ....+..-.-+++|.|||.+ ..++++.+||||||||+|||.++ |..||-.+...+ +-..++++...
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd------VIkaIe~gyRL---- 853 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEQGYRL---- 853 (996)
T ss_pred CCccccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHH------HHHHHHhccCC----
Confidence 4 22222333446889999988 77899999999999999999886 999997654322 22334444433
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..|.+|+..+.+||..||++|-.+||++.|++..|+++
T Consensus 854 ----PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 854 ----PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ----CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 23889999999999999999999999999999999876
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=373.18 Aligned_cols=263 Identities=23% Similarity=0.297 Sum_probs=211.4
Q ss_pred ccccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc------ChHHHHHHHHHHHhccCCCccceeeE
Q 003156 547 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ------YPEDFEREVRVLGKARHPNLISLEGY 620 (843)
Q Consensus 547 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~ 620 (843)
.........|...+.+|+|+||.|-+|..+.+|+.||||.+.+..... ......+|+++|++++|||||+++++
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 334445667788889999999999999999999999999997654332 12235799999999999999999999
Q ss_pred EEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC---CC
Q 003156 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN---YN 697 (843)
Q Consensus 621 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~ 697 (843)
+..++..|+||||++||+|.+++-.. ..+.+..-..++.|++.|+.|||+. ||+||||||+|||+..+ ..
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence 99999999999999999999999875 4566677788999999999999999 99999999999999755 77
Q ss_pred cEEeeccCcccccccccceeccccccccccCCcccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHH
Q 003156 698 PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775 (843)
Q Consensus 698 ~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~ 775 (843)
+||+|||+|+...+.. ...+.+||+.|.|||++...+ .+..++|+||+||++|-+++|..||.....+.. +.+.
T Consensus 318 lKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~eQ 393 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LKEQ 393 (475)
T ss_pred EEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HHHH
Confidence 9999999999876322 236789999999999885433 234589999999999999999999976433321 2221
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+..|+... -+....+..++...+|.+++..||++|||+.|++++=
T Consensus 394 ----I~~G~y~f-----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 394 ----ILKGRYAF-----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred ----HhcCcccc-----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 22222211 1123456667889999999999999999999998863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=363.44 Aligned_cols=200 Identities=29% Similarity=0.463 Sum_probs=179.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|+..+.||+|+||+||+|+++.++..||||.+.... ..+..+....|+.+|+.++|||||.++++++.++..++||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 4556667999999999999999999999999997664 334456778999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC------CCcEEeeccCcc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN------YNPRISDFGLAR 707 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfgl~~ 707 (843)
|+||+|.++|+.+ ..+++.....++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+|+
T Consensus 91 C~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 91 CNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999986 4789999999999999999999999 99999999999999854 458999999999
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCC
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 765 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~ 765 (843)
.+.+.. .....+|++.|||||++ ...+|+.|+|+||+|+++|++++|+.||...
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~-~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVI-MSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHH-HhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 887533 33678999999999998 6778999999999999999999999999753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=351.10 Aligned_cols=264 Identities=24% Similarity=0.383 Sum_probs=217.0
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEE-EcCC-ee
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYY-WTPQ-LK 627 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~-~~ 627 (843)
.+...|++.++||+|.||+||++....+|..||.|.+.-.... +...+...|+.+|++++|||||+++++. .++. ..
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 4556788889999999999999999999999999998643322 2345678999999999999999999943 3443 47
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCC-CeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP-PIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
+||||||..|+|..+++.....+..+++..+++++.|++.||.++|...+. -|+||||||.||+++.+|.||++|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 899999999999999998777788999999999999999999999985332 3999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
+.+.... ..+....||+.||+||.+ .+..|+.+|||||+||++|||+.-+.||... +...+.+ .+..+..
T Consensus 176 r~l~s~~--tfA~S~VGTPyYMSPE~i-~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~----KI~qgd~- 245 (375)
T KOG0591|consen 176 RFLSSKT--TFAHSLVGTPYYMSPERI-HESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCK----KIEQGDY- 245 (375)
T ss_pred hHhcchh--HHHHhhcCCCcccCHHHH-hcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHH----HHHcCCC-
Confidence 9886533 234678999999999998 7778999999999999999999999999754 3333333 2333322
Q ss_pred cccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 787 DCVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 787 ~~~d~~l~~~~-~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
+..| .-...++.+||..|+..||+.||+.-.+++.+..
T Consensus 246 -------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2223 5566789999999999999999997666666554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=377.98 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=214.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..|++.+.||+|||+.||+++...+|+.||+|++.+.... ...+...+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999999889999999999765332 34567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|+|++|+|..+++.+ .++++.++..++.||+.||.|||+. +|+|||||-.|++++++++|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999854 6799999999999999999999999 999999999999999999999999999998875
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.+. ...+.+||+.|+|||++. ....+..+||||+||+||-|++|++||+..... +.........
T Consensus 171 ~~E--rk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-----ety~~Ik~~~-------- 234 (592)
T KOG0575|consen 171 DGE--RKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-----ETYNKIKLNE-------- 234 (592)
T ss_pred ccc--ccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-----HHHHHHHhcC--------
Confidence 332 236789999999999984 556899999999999999999999999753211 1111111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+|.....+..+||..+++.+|.+|||+++|+.+=
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 123556667788999999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=412.22 Aligned_cols=269 Identities=29% Similarity=0.415 Sum_probs=226.8
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCC-C----eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQ-G----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT 623 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 623 (843)
..-.....+..+.||+|+||.||+|..... | ..||||.+.+....+...+|.+|+.+|++++|||||+++|+|.+
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 334455566777899999999999999542 2 24999999887777778899999999999999999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcCC---CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEE
Q 003156 624 PQLKLLVSDYAPNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 700 (843)
Q Consensus 624 ~~~~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 700 (843)
....+|++|||++|+|..+|++.++ ....++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....|||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 9999999999999999999998643 245688899999999999999999999 9999999999999999999999
Q ss_pred eeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHH
Q 003156 701 SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 701 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~ 779 (843)
+|||+|+.+.+.+++.......-++.|||||.+ ..+.++.|+|||||||++||++| |..||...... ..+.. .
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl-~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~----~ 917 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL-KDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLD----V 917 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHH-hhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHH----H
Confidence 999999977766666554444556889999998 56789999999999999999999 88998754332 22221 2
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.+.+ ..+.|..|+.+++++|..||+.+|++||++..+++++..+.+.
T Consensus 918 ~~gg---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 918 LEGG---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HhCC---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2223 1235889999999999999999999999999999999887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=341.61 Aligned_cols=264 Identities=25% Similarity=0.311 Sum_probs=207.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccCh-HHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+...++|+|+||.||+++.+.+|+.||||++..+...... +-..+|+.+|++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3467777999999999999999999999999999877654433 456899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc-c
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-R 711 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-~ 711 (843)
||+. ++.+-|... ...++...+.++++|+++|+.|+|++ ++|||||||+|||++.++.+|+||||+|+.+. +
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9976 555555554 34478888999999999999999999 99999999999999999999999999999887 3
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH----------Hh
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL----------LE 781 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~----------~~ 781 (843)
++.+ +....|.+|+|||.+.+..+|+..+||||+||++.||++|..-|.. ..+.+++....+.. +.
T Consensus 155 gd~Y---TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG-~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNY---TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG-RSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchh---hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC-cchHHHHHHHHHHHcccCHHHHHHhc
Confidence 3322 4456788999999998889999999999999999999999877754 44444443322221 11
Q ss_pred -hCCcccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 782 -EGNVLDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 782 -~~~~~~~~d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+.-+.-|.... -......-+++++..|++.||++|++-+|++.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111111111 011223357899999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=373.67 Aligned_cols=267 Identities=27% Similarity=0.421 Sum_probs=215.1
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
...+-+.......||+|.||+||+|.|- | .||||.+...... +..+.|+.|+.++++-||.||+-+.|||..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 3344555667779999999999999995 3 5999999655432 345789999999999999999999999999887
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
.||+.+|+|.+|+.++|.. ...++..+.+.||.|||+||.|||.+ +|||||||+.||++.+++.|||+|||++.
T Consensus 463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999986 46789999999999999999999999 99999999999999999999999999997
Q ss_pred cccccccceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
.-.............|.+.|||||++.. ...|++++||||||+|+|||+||..||. ....+.++. .+..|.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIif-----mVGrG~- 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIF-----MVGRGY- 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEE-----Eecccc-
Confidence 5433222222234456788999998743 3568999999999999999999999998 332221111 011121
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
..+.+.....+++.++.+|+..||..++++||.+.+++..|+.+...
T Consensus 610 ---l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 ---LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ---cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11223334677888999999999999999999999999998887664
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=363.02 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=215.8
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCC-eeE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ-LKL 628 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~ 628 (843)
...++|...++||.|.||.||+|+-..+|..||||++++.-.....-.-.+|+..|++++ |||||++..++.+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346788999999999999999999999999999999976543322223468999999998 999999999999988 899
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|||||+ .+|.+.++++ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.
T Consensus 87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 9999995 4899999987 57899999999999999999999999 999999999999999999999999999997
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC-----
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG----- 783 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~----- 783 (843)
+.....+ +....|.+|+|||++.....|+.+.||||+|||++|+.+-+.-|... .+.+++.+....+-..+
T Consensus 160 v~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~-sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 160 VRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA-SEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC-cHHHHHHHHHHHhCCCccccch
Confidence 7543332 45677899999999999999999999999999999999988777654 33333333222211110
Q ss_pred -----------CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 -----------NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 -----------~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+-.+....+...-.....+.+++|.+|+++||++||||.|++++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000111111222223467788999999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=325.84 Aligned_cols=265 Identities=26% Similarity=0.346 Sum_probs=218.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|...+.+|+|.||.||+|++..+|+.||||+++.....+ ......+|++.|+.++|+||+.+++++...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4667779999999999999999999999999997765433 335678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
|+. +|...+++. ...++..++..++.++.+|++|+|.+ .|+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 83 m~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 965 899999986 46788999999999999999999999 89999999999999999999999999999887544
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
... ....-|.+|+|||.+.+...|+...||||.||++.||+-| .||-.+..+-+++....+..-.. .+-..|.+
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~LGTP---~~~~WP~~ 229 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRALGTP---TPDQWPEM 229 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHHcCCC---CcccCccc
Confidence 332 2236688999999988889999999999999999999974 67777777777777666543221 11111211
Q ss_pred C-----------------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 794 G-----------------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 794 ~-----------------~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
. ..-..+..++.+++..++..||.+|+|+.|++++=.--
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 1 12234455679999999999999999999999985443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=352.70 Aligned_cols=265 Identities=26% Similarity=0.348 Sum_probs=213.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKL 628 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 628 (843)
..+.|+..++||+|.||.||+|++..+|+.||+|++.-.. ..+...-..+||.+|+++.||||+++.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4466788889999999999999999999999999996554 345566678999999999999999999999876 6899
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+|||+. ||.-++... +..++..++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|++
T Consensus 195 lVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 99999976 788777763 46799999999999999999999999 999999999999999999999999999998
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
+........ +...-|++|+|||++.+...|+.+.|+||.||||.||++|+..|. +..+..++....+-.-... +-
T Consensus 268 y~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~-G~tEveQl~kIfklcGSP~---e~ 342 (560)
T KOG0600|consen 268 YTPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ-GRTEVEQLHKIFKLCGSPT---ED 342 (560)
T ss_pred ccCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC-CccHHHHHHHHHHHhCCCC---hh
Confidence 865443322 455678999999999999999999999999999999999988775 4445555544443221110 00
Q ss_pred cCC--CCCC---------CC-------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDP--SMGD---------YP-------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~--~l~~---------~~-------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+ .++. +. .......++|+..++..||++|.|+.++++.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 1110 11 1223456789999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=351.60 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=207.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC--eeEEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ--LKLLVSD 632 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e 632 (843)
.+...+.||+|+||+||.+....+|...|||......... .+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 3567789999999999999998789999999986553332 567899999999999999999999865544 5889999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-CCCcEEeeccCcccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTR 711 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~ 711 (843)
|+++|+|.+++.... + .+++..+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999863 2 699999999999999999999998 9999999999999999 79999999999987653
Q ss_pred -cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 -LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 -~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
...........||+.|||||++..+.....++||||+||++.||+||+.||....... ... ...+ ..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~----~~ig-----~~ 238 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EAL----LLIG-----RE 238 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHH----HHHh-----cc
Confidence 1111223457899999999999543334469999999999999999999997531111 111 1111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
...+.++...+.+..+++.+|+..+|++||||+|++++--.
T Consensus 239 ~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 239 DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 12234566677788899999999999999999999998544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=366.17 Aligned_cols=263 Identities=27% Similarity=0.379 Sum_probs=225.5
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 625 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 625 (843)
+..+....+.++||+|+||+||+|.|-..|+ +||+|++......+...++.+|+..|.+++|||+++++|+|..+.
T Consensus 692 I~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 692 ILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred echhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 3444556667799999999999999966654 689999987777777789999999999999999999999998776
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..||++||+.|+|.++++.+ +..+.....+.|..|||+||.|||++ ++|||||.++|||+.+-..+||+|||+
T Consensus 772 -~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgl 844 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGL 844 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecch
Confidence 78999999999999999986 46688899999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
++.....+.........-++.|||-|.+ ....++.++|||||||++||++| |..||+....+ -+...++.+.
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------eI~dlle~ge 917 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------EIPDLLEKGE 917 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------HhhHHHhccc
Confidence 9998877766665666677889999988 66789999999999999999998 99999765332 2233344433
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
. ...|.-+..+++.+|.+||..|++.||+|+++...+.++..
T Consensus 918 R--------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 R--------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred c--------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 3 24588899999999999999999999999999999887643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=342.91 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=214.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..|+..++||.|..++||+|+....++.||||++.-++.....+.+.+|+..++.++||||++++..|..+...++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 44677779999999999999999999999999997776666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
|.+|++.+.++...+.+ +++..+..|.+++++||.|||++ |.||||||+.|||++++|.|||+|||.+..+....
T Consensus 106 Ma~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999986554 89999999999999999999999 99999999999999999999999999887664432
Q ss_pred -cceec-cccccccccCCccc-ccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 714 -KHVMS-NRFQSALGYVAPEL-TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 714 -~~~~~-~~~~g~~~y~aPE~-~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
..... ..+.||+.|||||+ ..+...|+.|+||||||++..|+.+|..||.....- ..+...+ .. .-...+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-kvLl~tL----qn--~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-KVLLLTL----QN--DPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-HHHHHHh----cC--CCCCcc
Confidence 22222 56789999999999 444556999999999999999999999999754321 1111111 11 111111
Q ss_pred CCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+ ........+.+++..|++.||++|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111 122333468899999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=357.73 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=206.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
+...+-+|+|+.|.||+|++ .++.||||++..- -..+|+-|++++||||+.+.|+|.....++||||||+
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 34445899999999999999 5889999987432 1357888999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
.|-|...|+.. .++.......|..+||.||.|||.+ .|||||||+-||||+.+..|||+|||-++...+.
T Consensus 196 ~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--- 265 (904)
T KOG4721|consen 196 QGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--- 265 (904)
T ss_pred cccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence 99999999975 4677788899999999999999999 9999999999999999999999999999876543
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC--
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM-- 793 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-- 793 (843)
.+...+.||+.|||||++ ....+++|+||||||||+|||+||..||........+ -.+-.+.
T Consensus 266 STkMSFaGTVaWMAPEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------------wGVGsNsL~ 329 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------------WGVGSNSLH 329 (904)
T ss_pred hhhhhhhhhHhhhCHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------------EeccCCccc
Confidence 223568999999999999 6678999999999999999999999999754221111 1111111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...|..+++.+.=|+.+||+..|..||+|++++.+|+-..+.
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 125788899999999999999999999999999999876654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=350.84 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=222.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.......++||+|-||+|..+... .+..||||.++.........+|.+|+++|.+++|||||+++|+|..++..++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3444556678999999999999995 469999999987776666789999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|||++|+|.+++..+.+. ...-.....|+.|||.||+||.+. ++||||+.++|+|+|.++++||+|||+++.+-.
T Consensus 615 EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999987432 245566778999999999999998 999999999999999999999999999998877
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt--g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.+.+...+...-+++|||||.+. -++++.+||||+|||++||+++ ...||....++ +..+......+.+....
T Consensus 690 g~yy~vqgr~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~-- 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQV-- 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCcce--
Confidence 77777777788889999999884 4589999999999999999865 78898765332 22233332222221111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
....|.-++..++++|.+||+.+-++|||++++...|+..
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1225777888999999999999999999999999998764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=365.42 Aligned_cols=266 Identities=26% Similarity=0.380 Sum_probs=208.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.+.|+..+.||+|+||.||+|.+. .+++.||||++.........+.+.+|+.+++++ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3456778889999999999999852 245689999986544333346789999999999 8999999999987654
Q ss_pred -eeEEEEEeCCCCCHHHHHhhcCCC-------------------------------------------------------
Q 003156 626 -LKLLVSDYAPNGSLQAKLHERLPS------------------------------------------------------- 649 (843)
Q Consensus 626 -~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 649 (843)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999999753210
Q ss_pred ---CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccc
Q 003156 650 ---TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726 (843)
Q Consensus 650 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~ 726 (843)
...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13578889999999999999999998 999999999999999999999999999987644333223334456788
Q ss_pred cCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHH
Q 003156 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVL 805 (843)
Q Consensus 727 y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 805 (843)
|+|||++ .+..++.++|||||||++|||++ |..||........ +. .....+.. ...+......+.
T Consensus 242 y~aPE~~-~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~----~~~~~~~~--------~~~~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC----QRLKDGTR--------MRAPENATPEIY 307 (338)
T ss_pred ccCcHHh-hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH----HHHhcCCC--------CCCCCCCCHHHH
Confidence 9999988 55678999999999999999997 9999975433221 11 11111111 112334556788
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 806 KLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 806 ~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
+++.+||+.||++|||+.|+++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.01 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=209.6
Q ss_pred hhcCeeccccceEEEEEEECCCCe---E-EEEEEeecC--CcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGR---M-LAVKKLVTS--DIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~---~-vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
+..++||+|+||.||+|++...+. . ||||....+ ......++|.+|++++++++|||||+++|++......++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 344789999999999999965422 3 899988642 2233457899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
||+|+||+|.++|++.. ..++..+++.++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++...
T Consensus 240 mEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999862 3689999999999999999999999 99999999999999999999999999987543
Q ss_pred ccccceecc-ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHH-hhCCccc
Q 003156 711 RLDKHVMSN-RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL-EEGNVLD 787 (843)
Q Consensus 711 ~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~-~~~~~~~ 787 (843)
...... ...-++.|+|||.+ ....|++++|||||||++||+++ |..||...... .++..+ ..+....
T Consensus 314 ---~~~~~~~~~klPirWLAPEtl-~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 314 ---QYVMKKFLKKLPIRWLAPETL-NTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRMP 383 (474)
T ss_pred ---ceeeccccccCcceecChhhh-ccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccCC
Confidence 122212 23467889999998 55589999999999999999998 88899765332 222222 3333322
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
.+...+..+..++.+||..+|++||||.++.+.++.+....
T Consensus 384 --------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 384 --------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 34566778889999999999999999999999998886553
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=339.21 Aligned_cols=250 Identities=25% Similarity=0.339 Sum_probs=205.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
-+.++..+.||+|+||+||.++.+.+++.+|+|++.+....+ ..+....|..++.+++||.||++.-.+++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 455677889999999999999999899999999997765443 356788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
+||+.||.|...|+.. ..+++..+.-++..|+.||.|||+. +|||||+||+|||+|.+|.++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999874 5689999999999999999999999 99999999999999999999999999998543
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... ..+..++||+.|||||++ ....|+..+|.||+||++|||++|.+||..... .++.+.... ++
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil-~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~-~k------ 241 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEIL-LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILK-GK------ 241 (357)
T ss_pred cCC--CccccccCCccccChHHH-hcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhc-Cc------
Confidence 322 223568999999999998 455899999999999999999999999975432 122222211 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCC----CHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRP----SMAEVV 826 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP----s~~evl 826 (843)
+...+.-...+..+++...+..||++|. .+.++.
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 1122333445677899999999999995 455543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=349.06 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=210.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
..|.-++.||+|+|++||+|+...++++||||++.+.-..+ -.+....|-.+|.++ .||.|++++-.|.++...|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 34556779999999999999999999999999985543322 224567888999999 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
+||+++|+|.++|++. ..+++.....+|.+|+.|++|||++ |||||||||+|||+|++|++||+|||-|+.+.
T Consensus 153 Le~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999986 5689999999999999999999999 99999999999999999999999999999886
Q ss_pred ccccc---------ee--ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH
Q 003156 711 RLDKH---------VM--SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 711 ~~~~~---------~~--~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 779 (843)
+.... .. ...+.||-.|++||++ .....+..+|+|+|||++|+|+.|++||....+- ..+ +..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liF----qkI 299 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIF----QKI 299 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHH----HHH
Confidence 43211 11 1458899999999998 6778999999999999999999999999765431 111 111
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+. +|- ++++..+..+.+|+.+.+..||.+|+|..|+.+|-
T Consensus 300 ~~-------l~y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 300 QA-------LDY---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH-------hcc---cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 111 24555556788999999999999999999998763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=354.33 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=216.4
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
..++...|+..++||+|+.|.||.|....+++.||||++..... ...+-+.+|+.+|+..+|+|||++++.|...+..+
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 45678889999999999999999999999999999999965543 23456789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|||||++|+|.+.+... .+++.++..|++++++||+|||.+ +|+|||||++|||++.+|.+||+|||++..
T Consensus 347 VVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred EEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 999999999999999875 489999999999999999999999 999999999999999999999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
+..... ......||+.|||||+. ....|+++.||||||++++||+-|++||-....-... . .+....
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-----y-LIa~ng---- 485 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----Y-LIATNG---- 485 (550)
T ss_pred cccccC--ccccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-----H-HHhhcC----
Confidence 765332 33677899999999998 6668999999999999999999999999753221111 0 111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
-|.+ ..++.....+.+++.+|++.||++||++.|++++
T Consensus 486 -~P~l-k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 -TPKL-KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCCc-CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1111 1356666788999999999999999999999987
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=350.19 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=216.5
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
....+||-|.||.||.|.|+.-.-.||||.++.... ..++|..|+.+|+.++|||+|+++|+|..+...|||+|||..
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 344589999999999999988888999999965543 468999999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+||++.. +..++....+.+|.||+.||+||..+ ++|||||.++|+|+.++..|||+|||+++++..+.+ .
T Consensus 348 GNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-T 421 (1157)
T KOG4278|consen 348 GNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-T 421 (1157)
T ss_pred ccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCce-e
Confidence 99999999863 45567777889999999999999998 999999999999999999999999999999875433 3
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
......-++.|.|||-+ ....++.|+|||+|||++||+.| |..||...+- ..+-.+.+.+..++
T Consensus 422 AHAGAKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqVY~LLEkgyRM~-------- 486 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYGLLEKGYRMD-------- 486 (1157)
T ss_pred cccCccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHHHHHHhcccccc--------
Confidence 33344456789999987 67789999999999999999998 8888864321 22334445555443
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.|+.|+..+++||+.||+++|.+||+++|+-+.++.+-.
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 388899999999999999999999999999999887643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.27 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=201.5
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc--cCCCccceeeEEEcCC----eeEEEE
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA--RHPNLISLEGYYWTPQ----LKLLVS 631 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~~----~~~lV~ 631 (843)
..+.||+|+||.||+|.+ +++.||||++...+ .+.|..|-++++.. +|+||++++++-.... +++||+
T Consensus 214 l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hHHHhhcCccceeehhhc--cCceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345789999999999999 57999999986443 56787777776554 8999999999876554 789999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC------CCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF------RPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
||.+.|+|.+||+.+ .++|....+|+..+|+||+|||+.. +|+|+|||||++|||+..|+.+.|+|||+
T Consensus 288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999975 6999999999999999999999763 78999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCC-----CchhHHHHHHHHHHHHhCCCCCcCCCCchhh---------
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN-----EKCDIYGFGVLILELVTGRRPVEYGEDNVVI--------- 771 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-----~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~--------- 771 (843)
|..+.........-...||.+|||||++-+...+. .+.||||+|.|+|||+++...+..+.....+
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99887655544445578999999999985443343 4789999999999999965544322111111
Q ss_pred ---HHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 772 ---LSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 772 ---l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
+.+.-..++++ + -.|.+++ .....+.-+.+.+..||..||+.|.|+.=|-+++..+....
T Consensus 443 hPt~e~mq~~VV~k-K----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRK-K----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhh-c----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111111111 1 1122222 11244556789999999999999999999988887775544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=357.80 Aligned_cols=393 Identities=22% Similarity=0.230 Sum_probs=315.9
Q ss_pred ccEEecCCCcCcccCChhhhhc--CCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 4 MKFLDLSNNLLSGPVPYQLFEN--CASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~--l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
-..||++++++. .+......+ .+..+.|++++|.|+.+....|.++++|++++|.+|.++.+|.. .+...+|
T Consensus 54 ~~lldcs~~~le-a~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f-----~~~sghl 127 (873)
T KOG4194|consen 54 TRLLDCSDRELE-AIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRF-----GHESGHL 127 (873)
T ss_pred ceeeecCccccc-cccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccc-----cccccce
Confidence 356899999987 542222222 24556799999999999999999999999999999999976652 2234669
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
+.|+|.+|.|+++....++.++.|+.|||+.|.|+.+.-..|..-.++++|+|++|+|+.+.-+.|..+.+|..|.|++|
T Consensus 128 ~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrN 207 (873)
T KOG4194|consen 128 EKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRN 207 (873)
T ss_pred eEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccC
Confidence 99999999999888899999999999999999999777777888889999999999999888999999999999999999
Q ss_pred cccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPP 240 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~ 240 (843)
+++...+..|.++++|+.|+|..|+|.-.--..|.++++|+.|.|..|.|+..-...|+.+ +++.|+|+.|++...-
T Consensus 208 rittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn-- 285 (873)
T KOG4194|consen 208 RITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN-- 285 (873)
T ss_pred cccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh--
Confidence 9997777889999999999999999985546788999999999999999984433444444 6888888888876332
Q ss_pred CCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccc
Q 003156 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320 (843)
Q Consensus 241 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 320 (843)
....-.++.|+.|+|++|.|..+-++.....++|+.|+|++|+|+...+..|..+.+|++|+|++|+++..-...|
T Consensus 286 ----~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af 361 (873)
T KOG4194|consen 286 ----EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAF 361 (873)
T ss_pred ----cccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHH
Confidence 2223447788888888888887777777777888888888888888777888888888888888888886666777
Q ss_pred cccCCCcEEEcCCCCCCCCch---hhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccc
Q 003156 321 CESRSLGILQLDGNSLTGPIP---QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLAS 397 (843)
Q Consensus 321 ~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 397 (843)
..+++|+.|||++|.|+..+. ..|.+|++|+.|.|.+|+|..+.-.+|.+++.|+.|||.+|.|....|.+|..+ .
T Consensus 362 ~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~ 440 (873)
T KOG4194|consen 362 VGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-E 440 (873)
T ss_pred HHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-h
Confidence 888888888888888876543 346778888888888888885555678888888888888888887778888887 7
Q ss_pred cceEeeccccce
Q 003156 398 LLAVNVSYNRLI 409 (843)
Q Consensus 398 L~~l~ls~N~l~ 409 (843)
|++|-++.-.+.
T Consensus 441 Lk~Lv~nSssfl 452 (873)
T KOG4194|consen 441 LKELVMNSSSFL 452 (873)
T ss_pred hhhhhhcccceE
Confidence 777777554443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=321.46 Aligned_cols=270 Identities=25% Similarity=0.351 Sum_probs=215.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 629 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 629 (843)
-+.|+....|++|.||.||+|+++.+++.||+|+++... ..+.+-.-.+|+.+|.+++|||||.+-.+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345777779999999999999999999999999996543 234455678999999999999999998887643 56899
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|||||+. +|.+.+... ..++...++..++.|+++|++|||+. .|+|||+|++|+|++..|.+||+|||+||.+
T Consensus 155 VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 899999886 36789999999999999999999999 8999999999999999999999999999988
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
...-.. -....-|.+|+|||++.+...|+++.|+||+|||+.|++++++-|. +..+.+++...++.. |...+.+
T Consensus 228 gsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~-G~sE~dQl~~If~ll---GtPte~i 301 (419)
T KOG0663|consen 228 GSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP-GKSEIDQLDKIFKLL---GTPSEAI 301 (419)
T ss_pred cCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC-CCchHHHHHHHHHHh---CCCcccc
Confidence 754322 2456779999999999899999999999999999999999877665 444455555444432 3223333
Q ss_pred CCCCCCCC--------------------hh-hHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 790 DPSMGDYP--------------------ED-EVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 790 d~~l~~~~--------------------~~-~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.|.....+ .. ..+.-.+++...+..||.+|.|++|.+++=.--..|
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 33322211 11 234567899999999999999999999885443333
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.33 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=205.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECC----------------CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccc
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT----------------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 616 (843)
.+.|+..+.||+|+||.||+|.+.. .+..||+|.+...........|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456677799999999999998632 234799999865433333467899999999999999999
Q ss_pred eeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCC---------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCee
Q 003156 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP---------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 681 (843)
Q Consensus 617 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 681 (843)
+++++.+.+..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999876321 123578899999999999999999998 999
Q ss_pred ecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh--CC
Q 003156 682 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GR 759 (843)
Q Consensus 682 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt--g~ 759 (843)
||||||+||++++++.+||+|||+++.+...+.........++..|+|||++ ....++.++|||||||++|||++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI-LMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH-hcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999876544333333445567889999987 45578999999999999999987 45
Q ss_pred CCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 760 RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 760 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.||..... ......+.......... . ....+..++..+.+++.+||+.+|++|||+.||.+.|+
T Consensus 240 ~p~~~~~~--~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTD--EQVIENAGEFFRDQGRQ-V----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCH--HHHHHHHHHHhhhcccc-c----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66654322 22222222222211100 0 01123345567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=357.31 Aligned_cols=364 Identities=27% Similarity=0.292 Sum_probs=330.5
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCC-CCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCS-SLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~-~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
.+.|||++|.++ .+....|.++++|+++++..|.+..|+. |.+.+ +|+.|+|.+|.|+. +.+..+..++.|+
T Consensus 80 t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt~IP~--f~~~sghl~~L~L~~N~I~s----v~se~L~~l~alr 152 (873)
T KOG4194|consen 80 TQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELTRIPR--FGHESGHLEKLDLRHNLISS----VTSEELSALPALR 152 (873)
T ss_pred eeeeeccccccc-cCcHHHHhcCCcceeeeeccchhhhccc--ccccccceeEEeeecccccc----ccHHHHHhHhhhh
Confidence 467999999999 8888889999999999999999998887 55554 59999999999984 4556788899999
Q ss_pred EEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 162 (843)
.||||.|.|+.+....|..-.++++|+|++|+|+....+.|..+.+|.+|.|++|+|+..++..|++|++|+.|+|..|+
T Consensus 153 slDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ 232 (873)
T KOG4194|consen 153 SLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR 232 (873)
T ss_pred hhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccc
Confidence 99999999997777789888999999999999999999999999999999999999998888999999999999999999
Q ss_pred ccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCC
Q 003156 163 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPG 241 (843)
Q Consensus 163 l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~ 241 (843)
|.-..--.|.++++|+.|.|..|.|.......|..|.++++|+|..|++...-..+++.+ .|+.|++|+|.|....++.
T Consensus 233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence 985556689999999999999999998888899999999999999999997777788887 7999999999998655443
Q ss_pred CCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc---
Q 003156 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ--- 318 (843)
Q Consensus 242 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--- 318 (843)
+...++|++|+|++|+|+...+..|..+..|++|+|++|.|..+....|..+.+|++|||++|.|+..+.+
T Consensus 313 ------WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~ 386 (873)
T KOG4194|consen 313 ------WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAV 386 (873)
T ss_pred ------hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchh
Confidence 33468999999999999999999999999999999999999988888999999999999999999876654
Q ss_pred cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccC
Q 003156 319 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF 381 (843)
Q Consensus 319 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 381 (843)
.|.++++|+.|+|.||+|+.+...+|.++.+|+.|||.+|-|..+-|++|..| .|+.|-+..
T Consensus 387 ~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 387 AFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred hhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 57889999999999999998888899999999999999999998999999999 999887653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=341.77 Aligned_cols=253 Identities=27% Similarity=0.381 Sum_probs=214.0
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
++...|...+.||+|.||.||+|.+..+++.||+|.+.-.......+++++|+.++.+++++||.+++|.+..+...+++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34445566679999999999999999999999999997666666678899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
||||.+|++.+.++.. ..+++..+..|+.++..|+.|||.+ +.+|||||+.||++..+|.||++|||.+-.+.
T Consensus 90 Mey~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence 9999999999999864 3447777888999999999999999 99999999999999999999999999998776
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .....+.||+.|||||++. ...|+.|+||||+|++.+||++|.+|+..... .+....+.
T Consensus 163 ~~~--~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------------mrvlflIp 224 (467)
T KOG0201|consen 163 NTV--KRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------------MRVLFLIP 224 (467)
T ss_pred chh--hccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCc---------------ceEEEecc
Confidence 433 2337789999999999994 66799999999999999999999999976432 11122222
Q ss_pred CCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..-+ .........+.+++..|+.++|+.||||.+++++
T Consensus 225 k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2222 2344666779999999999999999999999886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.94 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=207.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----cChHHHHHHHHHHHhcc-CCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 627 (843)
...|+..+.||+|+||.|+.|.+..+++.||+|.+...... ...+.+.+|+.+++.++ ||||++++.++..+...
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34577788999999999999999989999999966443111 23456678999999999 99999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeeccCc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLA 706 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~ 706 (843)
++||||+.+|+|.+++... .++.+..+..++.|++.|++|+|++ +|+||||||+||++|.+ +++||+|||++
T Consensus 96 ~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999984 4688899999999999999999999 99999999999999999 99999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+... .........+||+.|+|||++.... .-+.++||||+||++|.|++|+.||..... ..+.. . +..+.
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~~---k-i~~~~- 239 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLYR---K-IRKGE- 239 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHHH---H-HhcCC-
Confidence 9774 1223346789999999999996555 445899999999999999999999976321 11111 1 12111
Q ss_pred ccccCCCCCCCChhh-HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDE-VLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~-~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..++... ..++..++.+|+..+|.+|+|+.|++.+=
T Consensus 240 --------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 240 --------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred --------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 1233333 66788999999999999999999999653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.32 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=207.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.+.++..+.||+|+||.||+|.+ ..++..||||++.........+.+.+|+.+++.+ +||||++++++|.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 455678888999999999999975 2346689999986544334456788999999999 8999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC---------------------------------------------------------
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP--------------------------------------------------------- 648 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 648 (843)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999975321
Q ss_pred --------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 649 --------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 649 --------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
....++|..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 112578999999999999999999998 999999999999999999999999999986654332
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
........++..|+|||.+ ....++.++|||||||++|||++ |..||........ ..+. +..+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~----~~~~~~~------- 336 (375)
T cd05104 270 YVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKM----IKEGYRM------- 336 (375)
T ss_pred ccccCCCCCCcceeChhHh-cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHH----HHhCccC-------
Confidence 2222334456779999988 55678999999999999999998 8888865432221 1111 1211110
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..+...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus 337 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 -LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11223345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=339.33 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=200.6
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEc----CCeeEEEEEe
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKLLVSDY 633 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~ 633 (843)
..||+|++|.||+|.+ +|+.||||++....... ..+.|.+|+.++++++||||++++|++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 4799999999999999 68999999986543211 13678899999999999999999999976 3467899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.++++.. ..++|.....++.|++.|+.|||+.. +++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999999864 46889999999999999999999742 78899999999999999999999999998654321
Q ss_pred cceeccccccccccCCcccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
....++..|+|||++.. ...++.++|||||||++|||++|+.||...... . ........+..
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~---~~~~i~~~~~~------- 240 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--E---IYDLIINKNNS------- 240 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--H---HHHHHHhcCCC-------
Confidence 23457788999998843 257899999999999999999999999754321 1 11111111111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+..++..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 241 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 -LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11233456678999999999999999999999999998754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.15 Aligned_cols=259 Identities=26% Similarity=0.375 Sum_probs=219.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECC--CC--eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT--QG--RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
.+.++..+.||+|-||.||+|.+.. .| -.||||..+........+.|..|+.++++++|||||+++|+|.+. ..+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 3556677789999999999999942 22 358999987766666788999999999999999999999999875 568
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
||||.++-|.|..|++.+ ...++......++.|++.+|+|||+. .+|||||.++|||+...-.||++|||++|.
T Consensus 467 ivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999986 45688888999999999999999999 999999999999999999999999999999
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
+.+.+.+.. +...-++.|||||.+ ..++++.+||||-|||+|||++. |..||......+... .++.|
T Consensus 541 ~ed~~yYka-S~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------~iEnG---- 608 (974)
T KOG4257|consen 541 LEDDAYYKA-SRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------HIENG---- 608 (974)
T ss_pred ccccchhhc-cccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE------EecCC----
Confidence 887665554 455567889999988 77789999999999999999986 999998754433221 12222
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.....|+.|+..++.||.+||..+|.+||++.|+...|..+..
T Consensus 609 ----eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ----ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2334688999999999999999999999999999988866543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=341.43 Aligned_cols=251 Identities=35% Similarity=0.567 Sum_probs=197.5
Q ss_pred cCeeccccceEEEEEEEC----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 559 AAEVGEGVFGTVYKVSFG----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.+.||+|+||.||+|.+. ..+..|+||.+.........+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 457999999999999997 3467899999955433334678999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++... ....+++..+..|+.|+|+||+|||+. +++|+||+++||++++++.+||+|||+++.......
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999986 345689999999999999999999998 999999999999999999999999999987643333
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
............|+|||.+ ....++.++||||||+++|||++ |+.||.... ... ..... ..+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~-~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~---~~~~~-~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVL-KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEE---IIEKL-KQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHH-HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHH---HHHHH-HTTEE--------
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccccccccccccc--ccc---ccccc-ccccc--------
Confidence 3333445667889999987 45568999999999999999999 678886542 111 11221 22222
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
...+..++.++.+++.+||..+|++||||.++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 123445667789999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.14 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=205.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc--cCCCccceeeEEEcCC----eeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA--RHPNLISLEGYYWTPQ----LKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~~----~~~l 629 (843)
....+.||+|.||+||+|.|+ |+.||||.+...+ .+.+.+|.++++.. ||+||+.+++.-..+. ..+|
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred eEEEEEecCccccceeecccc--CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 345568999999999999995 8999999996544 45678888887765 9999999998765443 4689
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc-----CCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS-----FRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
|++|.+.|||.|||... .++....++++..+|.||+|||.. .+|.|.|||||+.|||+..++.+.|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999874 688999999999999999999965 48999999999999999999999999999
Q ss_pred Cccccccccc--ceeccccccccccCCcccccCcCC-----CCCchhHHHHHHHHHHHHh----------CCCCCcCCCC
Q 003156 705 LARLLTRLDK--HVMSNRFQSALGYVAPELTCQSLR-----VNEKCDIYGFGVLILELVT----------GRRPVEYGED 767 (843)
Q Consensus 705 l~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~-----~~~~~Dv~S~Gvil~ellt----------g~~p~~~~~~ 767 (843)
+|-....... ........||.+|||||++..... .-..+||||||.|+||++- -+.||.....
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9976654322 223356789999999999844332 2257899999999999986 2577766544
Q ss_pred chhhHHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 768 NVVILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 768 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.+...++..+. + -.+.+.|.++. ...++...+.++|+.||..+|..|-|+-.+.+.|.++.+
T Consensus 442 ~DPs~eeMrkV-V----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMRKV-V----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHhcc-e----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 43333322111 1 11122233333 345667778999999999999999999999999988864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.85 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=211.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|.+.+.||+|.||.||||+.+.+.+.||+|.+.+... .+..+.+.+|++++++++|||||.++++|....+.++|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 35556689999999999999999999999999865432 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+.| +|..+|... ..++++.+..|+.|+..||.|||+. +|.|||+||.||+++..+.+|+||||+|+-+..
T Consensus 83 a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 83 AVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 976 999999874 5689999999999999999999999 999999999999999999999999999998765
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
...+...+.||+-|||||+. .+..|+..+|.||+||++||+++|++||... ...+.++....+ +
T Consensus 153 ~t~vltsikGtPlYmAPElv-~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d--------~-- 216 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELV-EEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD--------P-- 216 (808)
T ss_pred CceeeeeccCcccccCHHHH-cCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC--------C--
Confidence 33445778999999999988 6889999999999999999999999999642 122333332221 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+|......+..++...+.+||..|.|..+++.+
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 12355667778899999999999999999998875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=352.53 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=207.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.+.|+..+.||+|+||.||+|.+.. ++..||+|++.........+.+.+|+++++.+ +||||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 45567788899999999999998643 33579999986544333345788999999999 8999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC---------------------------------------------------------
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP--------------------------------------------------------- 648 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 648 (843)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999865311
Q ss_pred ---------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 649 ---------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 649 ---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
...++++..+++++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 113578889999999999999999998 99999999999999999999999999998654332222223
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCCh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 798 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 798 (843)
...++..|+|||++ ....++.++|||||||++|||++ |+.||........ ... ....+. .+ ..+.
T Consensus 273 ~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~----~~~~~~-----~~---~~~~ 338 (374)
T cd05106 273 NARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYK----MVKRGY-----QM---SRPD 338 (374)
T ss_pred CCCCccceeCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHH----HHHccc-----Cc---cCCC
Confidence 33456789999988 55678999999999999999997 9999975433221 111 111111 01 1122
Q ss_pred hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 799 DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 799 ~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..+.++.+++.+||+.||++|||+.++++.|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=308.65 Aligned_cols=268 Identities=23% Similarity=0.274 Sum_probs=215.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC-----e
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----L 626 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~ 626 (843)
.+++|...+.+|+|||+.||.++...+++.+|+|++.... .+..+..++|++..++++||||+++++++..+. +
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3466777889999999999999988899999999997655 345677899999999999999999999885443 4
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.|+++.|...|||.+.+......+..+++.+.++|+.++++||.+||+. .|+++||||||.||++.+++.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999998877777899999999999999999999998 557999999999999999999999999998
Q ss_pred ccccccccce-------eccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH
Q 003156 707 RLLTRLDKHV-------MSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 707 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~ 777 (843)
+...-..... .......|..|+|||.+. .....++++|||||||++|+|+.|..||+.....++.++-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA-- 254 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA-- 254 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe--
Confidence 7653211100 001234678899999873 23457899999999999999999999997654433333221
Q ss_pred HHHhhCCcccccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 778 VLLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
+..+.+.- ......+.+.+++..|++.||.+||++.+++.+++.+.
T Consensus 255 ----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 ----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11211111 12236678999999999999999999999999988753
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.03 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=204.2
Q ss_pred hhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
..++..+.||+|+||.||+|.+. ..+..||+|.+.........+.|.+|+.++++++||||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 34566778999999999999874 346789999986554333446789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999864 24689999999999999999999998 99999999999999999999999999876532
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
... ........++..|+|||.+ ....++.++|||||||++||+++ |+.||...... ...+ .+..+..
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~----~~~~~~~---- 226 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIK----AVEDGFR---- 226 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHH-hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH----HHHCCCC----
Confidence 211 1111223446789999987 55678999999999999999875 99999654221 1111 1122111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+..++..+.+++.+||+.+|++|||+.|+++.|.++
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112445566789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.99 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=209.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCC-----eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQG-----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+.++..+.||+|+||.||+|.....+ ..||+|.+...........|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 34566778999999999999986444 6799999865443334467899999999999999999999999988899
Q ss_pred EEEEeCCCCCHHHHHhhcCCC------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 629 LVSDYAPNGSLQAKLHERLPS------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
++|||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999864321 14588899999999999999999998 999999999999999999
Q ss_pred CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHH
Q 003156 697 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 775 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~ 775 (843)
.+||+|||+++.....+.........++..|+|||.+ ....++.++|||||||++|||++ |..||...... ....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHh-ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-
Confidence 9999999999865443332333444567889999987 44578999999999999999998 99998653221 1111
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
.+..+. ....+..++.++.+++.+||+.+|++||++.|++++|+.
T Consensus 238 ---~i~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIRSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 112345667789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.90 Aligned_cols=252 Identities=27% Similarity=0.334 Sum_probs=202.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
+..+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.++++++|++|+++++++.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3456899999999999999889999999998654322 22346788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 83 NGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred CCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998887542 34589999999999999999999998 999999999999999999999999999986543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
.....|+..|+|||++ .+..++.++|||||||++|||++|+.||........ ...+...+... ..
T Consensus 158 ---~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~---------~~ 222 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKED---------QE 222 (285)
T ss_pred ---ecCCCCCCCccCHhhh-cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhcc---------cc
Confidence 1345689999999988 556789999999999999999999999975433211 11111111110 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
.++......+.+++.+||+.||++||+ ++|++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 233344567889999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=323.86 Aligned_cols=267 Identities=25% Similarity=0.357 Sum_probs=209.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC-----eeEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLLV 630 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV 630 (843)
++..+.+|+|+||.||+|....+++.||||+...... .-.+|+++|+++.|||||++.-+|.... ...+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4456689999999999999998899999999754432 2347999999999999999998886432 23489
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCcccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLL 709 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~ 709 (843)
||||+. ||.+.++..-..+..++...+.-+..|+.+||+|||+. +|+||||||.|+|+| +.|.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 89999986433456678888889999999999999997 999999999999999 4599999999999988
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC------
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG------ 783 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~------ 783 (843)
..++.. .....|..|+|||.+.+...|+.+.||||.|||+.||+-|++-|.. +....++...++..-...
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhh
Confidence 765543 3345677899999998889999999999999999999999888764 555666666655432211
Q ss_pred ---CcccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCC
Q 003156 784 ---NVLDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 835 (843)
Q Consensus 784 ---~~~~~~d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~ 835 (843)
...+.-.+.+.. +......+..+++.+++..+|.+|.++.|++.+ .+.++++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 111111222221 334556778999999999999999999999876 4555444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=310.35 Aligned_cols=238 Identities=28% Similarity=0.368 Sum_probs=200.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.++..+.||.|+||.|..++.+.+|..+|+|++.+.+... ..+...+|..+|+.+.||.++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34566778999999999999999999999999996654332 3456778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||++||-|.++++.. .++++..+.-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999985 5699999999999999999999999 999999999999999999999999999997764
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
. +-+.+||+.|+|||++ +...++.++|.|||||++|||+.|..||..... ...+.+.+. +..
T Consensus 197 r-----T~TlCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~-----~~v------ 258 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILE-----GKV------ 258 (355)
T ss_pred c-----EEEecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHh-----Ccc------
Confidence 2 2567999999999998 666899999999999999999999999976543 222222221 111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSR 819 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~R 819 (843)
.+|.-...++..|+...++.|-.+|
T Consensus 259 ---~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ---KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2455555567778888888887777
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=316.34 Aligned_cols=273 Identities=23% Similarity=0.269 Sum_probs=211.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCC-ccceeeEEEcCC-----
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPN-LISLEGYYWTPQ----- 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~----- 625 (843)
-..|+..++||+|+||+||+|+...+|+.||+|++..... ++.+....+|+.++++++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3446666789999999999999999999999999976644 455677889999999999999 999999999877
Q ss_pred -eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 626 -LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 626 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
..++|+||++ -+|..++....+....++...+..+++|+++||+|+|++ +|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 489999988643323466678999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC-
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG- 783 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~- 783 (843)
+|+...-.... -....+|.+|+|||++.+...|+...||||+||+++||++++.-|... .+..++....+..-..+
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~-se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD-SEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC-cHHHHHHHHHHHcCCCCc
Confidence 99865422211 245678899999999988888999999999999999999987777544 33344443333221111
Q ss_pred --Cc--ccccCCC--CCCC--C-------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhc
Q 003156 784 --NV--LDCVDPS--MGDY--P-------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVI 832 (843)
Q Consensus 784 --~~--~~~~d~~--l~~~--~-------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~ 832 (843)
+- ....+-. .... + .....+..+++..|++.+|.+|.|++.++++ +..+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00 0000100 0010 0 1111367899999999999999999999998 5554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=340.34 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=213.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.-|+.++.||.|+.|.|-.|++..+|+.+|||.+.... .......+.+|+-+|+.+.||||+++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34667888999999999999999999999999996552 1223456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|-|.+++-.+ +++++.++.+++.||..|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999999875 5688999999999999999999998 999999999999999999999999999986543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
+ ....+-+|++.|.|||++.+..+-+.++||||+|||+|.|+||+.||+++ +...+...+ ..|.
T Consensus 165 g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLlKV----~~G~------- 228 (786)
T KOG0588|consen 165 G---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLLKV----QRGV------- 228 (786)
T ss_pred C---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHHHHHHH----HcCc-------
Confidence 2 22356689999999999966666789999999999999999999999743 222222222 2222
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
-++|.....++.+|+.+|+..||++|.|++||++|-
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 135667777899999999999999999999999984
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=338.11 Aligned_cols=266 Identities=24% Similarity=0.297 Sum_probs=202.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|....+++.||+|.+...........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 34667779999999999999998889999999986544334445678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 85 VH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 95 6888888764 24578889999999999999999998 99999999999999999999999999987543211
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC--C-----cc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--N-----VL 786 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~-----~~ 786 (843)
. ......++..|+|||++.....++.++||||+||++|||++|+.||....+....+........... . ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 1 1133467889999998755566889999999999999999999999764332222222111100000 0 00
Q ss_pred cccCCC-CCC-CC---------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPS-MGD-YP---------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~-l~~-~~---------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...++. ... .+ ......+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 000 00 0112457789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.53 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=209.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 625 (843)
+.+.++..+.||+|+||.||+|.+.. .+..||||++.........+.+.+|+++++++. ||||++++|++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 34567777899999999999998742 235799999865544444567899999999996 999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC---------------------------------------------------------
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP--------------------------------------------------------- 648 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 648 (843)
..++||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999875311
Q ss_pred -----------------------------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc
Q 003156 649 -----------------------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 649 -----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 693 (843)
....+++..+..++.|+++||+|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 013478889999999999999999998 999999999999999
Q ss_pred CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhH
Q 003156 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVIL 772 (843)
Q Consensus 694 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l 772 (843)
+++.+||+|||+++...............++..|+|||.+ .+..++.++|||||||++|||++ |..||.....+....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999866433322222334567789999988 45578999999999999999997 999987543222111
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
. ....+.. ...+...+.++.+++.+||+.+|++|||+.++.+.|+.+.+
T Consensus 351 -~----~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 -N----KIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -H----HHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 1111111 11233455678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.53 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=206.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
...|+..+.||+|+||.||+|.+..++. .||+|.+.........+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3446777899999999999999865554 48999986544334456789999999999999999999999765 567
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999999875 24588999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
+.............++..|+|||.+ ....++.++|||||||++|||++ |+.||...... .+. .....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~- 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EIS----SILEKGERL- 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHhCCCCC-
Confidence 6543333222333446789999988 55678999999999999999998 99998643211 111 111211111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
..+..+..++.+++.+||+.+|++|||+.+++..+..+..
T Consensus 231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1133445678899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.77 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=205.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||++++..+|..||+|.+.........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 45667779999999999999999889999999986543333346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999864 35888999999999999999999852 69999999999999999999999999997654321
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC---cc----
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN---VL---- 786 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~---~~---- 786 (843)
.....|+..|+|||++ .+..++.++|||||||++|||++|+.||...... .+...+......+. ..
T Consensus 159 ----~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 159 ----ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ----cccCCCCcCcCCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCc
Confidence 1345688999999988 5567899999999999999999999999643221 11111110000000 00
Q ss_pred ---------------------------cccCCCCCCC-ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 787 ---------------------------DCVDPSMGDY-PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 787 ---------------------------~~~d~~l~~~-~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.+.....+.. ......++.+++.+||+.||++|||+.|++++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000000 1123457899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.65 Aligned_cols=264 Identities=23% Similarity=0.278 Sum_probs=202.6
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|+||.||+|....+++.||+|.+...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 36667799999999999999988899999999865544444567889999999999999999999999998999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 86 D-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred C-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 7 5899988764 34578899999999999999999998 999999999999999999999999999975432221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH-------h----hC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL-------E----EG 783 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~-------~----~~ 783 (843)
......++..|+|||++.+...++.++||||+||++|||+||+.||...... ..+....+..- . ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhccccch
Confidence 1133467889999998866667899999999999999999999999654221 11111111100 0 00
Q ss_pred CcccccCCCCC-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPSMG-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~l~-----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.......+... ........+..+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000111100 0112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=330.31 Aligned_cols=262 Identities=26% Similarity=0.356 Sum_probs=204.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..++..+.||+|+||+||+|.+..+++ .+|+|.+..........++..|+..+++++||||++++|++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 345566789999999999999976665 4677776433222334567788889999999999999998854 45678
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|+||+++|+|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999864 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.............++..|+|||.+ ....++.++|||||||++||+++ |+.||..... ....+ .+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~~- 231 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESI-LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPD----LLEKGERLA- 231 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHCCCcCC-
Confidence 543332223345567889999988 45578999999999999999998 9999865321 11111 222222111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
.+..+..++.+++.+||..+|++|||+.|+++.|..+....|
T Consensus 232 -------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 232 -------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 122344567889999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=339.52 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=214.8
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCC-C--eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQ-G--RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
..+++.+...++||+|.||.|++|.|... | ..||||.+..........+|.+|+.+|.+++|||+++++|+..+ ..
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34667777788999999999999999643 3 35899999766555567899999999999999999999999988 56
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
..+|+|.++.|+|.+.|++. ....+-......++.|||.||.||..+ ++||||+.++|+++-....|||+|||+.
T Consensus 185 ~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred hhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccce
Confidence 78999999999999999983 345677888899999999999999999 9999999999999999999999999999
Q ss_pred ccccccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 707 RLLTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 707 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
+-+...+..+ +.....-++.|+|||.+ ....++.++|||+|||++|||+| |..||..... ..+.+ . +.
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~---~-iD--- 329 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILK---N-ID--- 329 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHH---h-cc---
Confidence 9887765544 44445567789999998 77789999999999999999998 8889865422 11111 1 11
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.++..-+..|.++++++|.+||..+|++||||..+.+.
T Consensus 330 -----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 -----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 122233588999999999999999999999999999854
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.53 Aligned_cols=244 Identities=25% Similarity=0.303 Sum_probs=199.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
+.||+|+||.||+|....+|+.||+|.+..... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999988999999999865422 122356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 999999764 4689999999999999999999998 99999999999999999999999999987532211 11
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 797 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 797 (843)
.....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .. .... ..+. ..++
T Consensus 152 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~---~~~~-~~~~---------~~~p 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KL---FELI-LMEE---------IRFP 215 (323)
T ss_pred ccceecCccccChhhh-cCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HH---HHHH-HcCC---------CCCC
Confidence 2345689999999988 5567899999999999999999999999653211 11 1111 1111 1233
Q ss_pred hhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 798 EDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 798 ~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
.....++.+++.+|++.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 44556788999999999999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=351.40 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=208.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceee-EEEc------CCee
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEG-YYWT------PQLK 627 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g-~~~~------~~~~ 627 (843)
.++.+.|.+|||+.||.|.+...|..||+|++... .+...+...+|+++|++++ |+|||.+++ .... ..++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 45567899999999999999877799999999766 3455678899999999996 999999999 3322 2367
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
+|.||||.+|.|.+++..+... .|++.++++|+.|+++|+++||.. +|+|||||||-+|||++.++..||||||.|.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 8999999999999999987533 399999999999999999999975 8899999999999999999999999999986
Q ss_pred cccccc-cc-e-----eccccccccccCCcccc--cCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH
Q 003156 708 LLTRLD-KH-V-----MSNRFQSALGYVAPELT--CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 708 ~~~~~~-~~-~-----~~~~~~g~~~y~aPE~~--~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~ 778 (843)
-..... .. . ..-....|+.|+|||++ ..+...++|+|||++||++|-||....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 432211 10 0 00123578999999976 2456789999999999999999999999975421
Q ss_pred HHhhCCcccccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 779 LLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
..+++.+..- -.......+..||+.|++++|++||++.+|++++..+...-
T Consensus 264 -------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1222222211 12467788999999999999999999999999998886543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=330.84 Aligned_cols=261 Identities=21% Similarity=0.353 Sum_probs=205.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.|+..+.||+|+||.||+|.+.. .+..||+|++..........++.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 4557778899999999999998742 35679999885443333345788999999999999999999999998899
Q ss_pred EEEEEeCCCCCHHHHHhhcCCC------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEe
Q 003156 628 LLVSDYAPNGSLQAKLHERLPS------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 701 (843)
++||||+++|+|.++++..... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999764221 23468889999999999999999998 99999999999999999999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHH
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
|||+++...............++..|+|||++ ....++.++|||||||++|||++ |..||..... . +..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~----~~~~~~- 234 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-E----QVLRFV- 234 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHh-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-H----HHHHHH-
Confidence 99999865443332222233456789999988 55678999999999999999999 6888864321 1 111111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+. ....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 112234455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=339.04 Aligned_cols=266 Identities=27% Similarity=0.395 Sum_probs=207.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC-
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP- 624 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~- 624 (843)
+.+.|+..+.||+|+||.||+|.+.. +++.||+|++.........+.+.+|+.+++++ +||||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45678888999999999999997532 35789999986543333345678899999999 899999999988754
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCC-------------------------------------------------------
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPS------------------------------------------------------- 649 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 649 (843)
...++|+||+++|+|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 4678999999999999998653210
Q ss_pred --CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecccccccccc
Q 003156 650 --TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727 (843)
Q Consensus 650 --~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y 727 (843)
...++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999998 9999999999999999999999999999876543333333344566789
Q ss_pred CCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHH
Q 003156 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLK 806 (843)
Q Consensus 728 ~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 806 (843)
+|||++ .+..++.++|||||||++|||++ |..||........ +. ..+..+... ..+.....++.+
T Consensus 242 ~aPE~~-~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~----~~~~~~~~~--------~~~~~~~~~~~~ 307 (337)
T cd05054 242 MAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC----RRLKEGTRM--------RAPEYATPEIYS 307 (337)
T ss_pred cCcHHh-cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH----HHHhccCCC--------CCCccCCHHHHH
Confidence 999987 55678999999999999999998 9999965332221 11 111221111 112334457899
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 807 LALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 807 l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
++.+||+.+|++||++.|++++|+.+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.27 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=199.4
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHH
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 640 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 640 (843)
.||+|+||.||+|.+..+++.||+|.+...........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 68999999999999988899999998754433333467899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccc
Q 003156 641 AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720 (843)
Q Consensus 641 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 720 (843)
+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++.............
T Consensus 82 ~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 82 TFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999764 34588999999999999999999998 999999999999999999999999999876543211111111
Q ss_pred cccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 721 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 721 ~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...+..|+|||.+ ....++.++|||||||++|||++ |..||...... . .......... ...+..
T Consensus 156 ~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~----~~~~~~~~~~--------~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEAL-NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q----TREAIEQGVR--------LPCPEL 220 (252)
T ss_pred CCCceeecCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H----HHHHHHcCCC--------CCCccc
Confidence 2234569999988 55568999999999999999998 88888643221 1 1111111110 112334
Q ss_pred hHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 800 EVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
.+..+.+++.+|++.+|++|||+.|+.+.|+.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 45678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.35 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=211.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.++.++.||+|-||.||.|+.+.++-.||+|++.+++.. +...++.+|+++-+.++||||+++++++.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4567888999999999999999999999999999776543 34567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||.++|++...|++.. ...+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||-+-.-+
T Consensus 102 Eya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999652 45688888999999999999999988 99999999999999999999999999886433
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.......+||+.|.+||+. .+...+...|+|++|++.||++.|..||.....+ ..+.+ ++. .+..
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkr-I~k-------~~~~-- 240 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKR-IRK-------VDLK-- 240 (281)
T ss_pred ---CCCceeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHH-HHH-------cccc--
Confidence 2233667899999999988 6778899999999999999999999999765421 11111 111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+|......+.++|.+|+..+|.+|.+..|++++=
T Consensus 241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ----CCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 2455566788999999999999999999999874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.59 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=206.7
Q ss_pred hhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.|+..+.||+|+||.||+|.+... ...||+|.+...........|.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 455677999999999999998643 45799998865443444567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ...+++..++.++.|++.|++|||+. +|+||||||+||++++++.++++|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 85 EYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999874 23689999999999999999999998 999999999999999999999999999987753
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
...........++..|+|||.+ ....++.++||||||+++|||++ |..||...... .... .+..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~---- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIK----AVEDGYRL---- 227 (266)
T ss_pred cccceeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHH----HHHcCCCC----
Confidence 2222222233456789999987 55678999999999999999998 99998543221 1111 11111111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12344566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.31 Aligned_cols=261 Identities=21% Similarity=0.358 Sum_probs=209.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|+...+++.||+|.+..... ......+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 5567789999999999999988899999998754322 22235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++.........+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999876433345688899999999999999999998 99999999999999999999999999988664322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. ......++..|+|||.+ .+..++.++||||||+++|||++|+.||.........+...+ .... .+..
T Consensus 161 ~--~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~-----~~~~ 228 (267)
T cd08228 161 T--AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCD-----YPPL 228 (267)
T ss_pred H--HHhcCCCCccccChhhh-ccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcCC-----CCCC
Confidence 1 11234677889999987 455688999999999999999999999965433222222111 1111 1111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
........+.+++.+||..+|++||++.||++.+++++
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 12344567899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.59 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=201.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|....+++.||+|.+..... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 4556789999999999999988899999999864332 12345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 83 VPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 9999999999864 4588899999999999999999998 99999999999999999999999999998654311
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
....|++.|+|||++ .+..++.++|||||||++|||++|+.||...... ...+.... +.
T Consensus 156 -----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~-~~--------- 214 (291)
T cd05612 156 -----WTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILA-GK--------- 214 (291)
T ss_pred -----ccccCChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-CC---------
Confidence 234688999999988 5556899999999999999999999999653221 11111111 11
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 829 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~L 829 (843)
..++......+.+++.+|++.||.+||+ +.|++++-
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1123333556889999999999999995 89988763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.04 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=203.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+..++..+|+|.+.........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 35577788999999999999999888999999988654333334678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999864 35788899999999999999999742 7999999999999999999999999999765332
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc-----
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD----- 787 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~----- 787 (843)
. .....|+..|+|||.+ .+..++.++|||||||++|||++|+.||....... +...............
T Consensus 158 ~----~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M----ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c----cccCCCCccccCHHHh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCcc
Confidence 1 1345688899999988 55678999999999999999999999997542211 1110000000000000
Q ss_pred ---------------------------ccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 ---------------------------CVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ---------------------------~~d~~l~~~~-~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
......+..+ .....++.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000 1123568899999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=314.64 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=218.6
Q ss_pred cccccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC
Q 003156 546 LDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 625 (843)
Q Consensus 546 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 625 (843)
..+...+++.+.+..++|+|+||.||+|.++.+|..||+|++.-. ....++.+|+.+++++..|+||+++|.|....
T Consensus 25 ~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 25 SALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred hhhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 345567889999999999999999999999999999999987433 35678999999999999999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++|||||..|++.+.++-+ +.++++.++..++.+.++||+|||.. .-+|||||+.|||++.+|.+|++|||.
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccc
Confidence 999999999999999999987 57899999999999999999999998 889999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
|-.+.+ .........||+.|||||++ ..-.|+.++||||+|++..||..|++||.+...- +.
T Consensus 176 AGQLTD--TMAKRNTVIGTPFWMAPEVI-~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------------RA 237 (502)
T KOG0574|consen 176 AGQLTD--TMAKRNTVIGTPFWMAPEVI-EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------------RA 237 (502)
T ss_pred cchhhh--hHHhhCccccCcccccHHHH-HHhccchhhhHhhhcchhhhhhcCCCCccccccc---------------ce
Confidence 976542 22233667899999999998 6667999999999999999999999999764221 11
Q ss_pred ccccCCCCC---CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 LDCVDPSMG---DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~---~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..++..+-+ .-|+....++-++++.|+-+.|++|-|+.+++++
T Consensus 238 IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 238 IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 112222211 1356667789999999999999999999999887
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.01 Aligned_cols=269 Identities=23% Similarity=0.338 Sum_probs=207.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecC-CcccChHHHHHHHHHHHhccCCCccceeeEEEc-----CCeeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS-DIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-----PQLKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~l 629 (843)
|...+.||+|+||.|+.+.+..+|+.||+|++... +..-..++..+|+.+++.++|+||+.+.+++.. -...|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 33356899999999999999999999999998633 222345678899999999999999999999865 246799
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|+|+| ..+|...++.. ..++......++.|+++||.|+|+. +|+|||+||+|++++.+...||+|||+|+..
T Consensus 104 V~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 99999 55888888864 4589999999999999999999999 9999999999999999999999999999987
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHH---------------
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE--------------- 774 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~--------------- 774 (843)
........-+....|.+|+|||++.....|+.+.||||.||++.||++|+.-|.+.. ...++..
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d-~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD-YVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc-hHHHHHHHHHhcCCCCHHHHHH
Confidence 643222222455678999999999888999999999999999999999998886432 2222111
Q ss_pred ----HHHHHHhhCCcccccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCCC
Q 003156 775 ----HVRVLLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTPL 836 (843)
Q Consensus 775 ----~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~~ 836 (843)
.++..++.-..... ..... ++ ......++|+.+|+..||.+|+|++|++++ +....++.
T Consensus 255 i~s~~ar~yi~slp~~p~--~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPK--QPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred hccHHHHHHHHhCCCCCC--CCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 11111111111000 00001 22 344567899999999999999999999997 66666553
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=354.91 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=204.9
Q ss_pred hhhcCeeccccceEEEEEEECCC-CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQ-GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|...+.||+|+||.||+|....+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 66677899999999999998766 7788888764332 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.++++.......++++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999876544456789999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
........||++|+|||++ ....++.++|||||||++|||++|+.||...... ........ +.. .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~-~~~--------~ 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLY-GKY--------D 289 (478)
T ss_pred cccccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-CCC--------C
Confidence 2223456789999999988 5567899999999999999999999999643211 11111111 111 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.....++.+++.+||..+|++|||+++++++
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1233445678899999999999999999998753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=315.80 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=212.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
...+|+..+.+|+|.||.|-+|.....|+.||||.+.+..... ..-.+.+|+++|+.++||||+.++.+|...+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3456888889999999999999998899999999997665432 23457899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||..+|.|.+|+.++ ..+++.+...+++||..|+.|.|.+ ++||||+|.+|||+|.++++||+|||++..+
T Consensus 131 vMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999986 5799999999999999999999998 9999999999999999999999999999877
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.+. ....+++|++-|.+||++.+..+-++.+|-||+||++|-++.|..||+.... . ..++ .+..|...+.
T Consensus 204 ~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k---~lvr-QIs~GaYrEP- 273 (668)
T KOG0611|consen 204 ADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--K---RLVR-QISRGAYREP- 273 (668)
T ss_pred ccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--H---HHHH-HhhcccccCC-
Confidence 642 2336789999999999996666678999999999999999999999975321 1 1222 2333333221
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+.+..-||++|+..+|++|.|+.+|..+-
T Consensus 274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1222456799999999999999999998775
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=340.70 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=202.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..|+..+.||+|+||.||+|++..+++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 345667789999999999999988899999999865422 223457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999864 4578888999999999999999998 999999999999999999999999999986543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. ....||+.|+|||++ .+..++.++|||||||++|||++|+.||..... . +..+. +..+.
T Consensus 171 ~~-----~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~---~~~~~-i~~~~------- 231 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--F---RIYEK-ILAGR------- 231 (329)
T ss_pred Cc-----ceecCChhhcCHHHH-cCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--H---HHHHH-HhcCC-------
Confidence 21 234688999999988 555689999999999999999999999964321 1 11111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
..++.....++.+++.+||+.||++||+ +++++.+
T Consensus 232 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 --LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1123334456889999999999999997 6888765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=342.04 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=199.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
...++..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 34566777999999999999999888999999998654433345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+. ....+..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999998542 2345677889999999999999998 9999999999999999999999999999865432
Q ss_pred ccceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.. ......|+..|+|||++.. +...+.++|||||||++|||++|+.||....... +......... .
T Consensus 222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~-~----- 291 (353)
T PLN00034 222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICM-S----- 291 (353)
T ss_pred cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhc-c-----
Confidence 21 1134568899999998732 2234568999999999999999999997432211 1111111100 0
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.....+.....++.+++.+||+.||++|||+.|++++-
T Consensus 292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 01112334556789999999999999999999999973
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.56 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=207.8
Q ss_pred hhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
..|...+.||+|+||.||+|.+.. +++.||+|.+......+..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346667789999999999998742 357899999865543334568999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCC----------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 629 LVSDYAPNGSLQAKLHERLP----------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
+||||+++|+|.++++.... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999986532 234578999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~ 777 (843)
||+|||+++...............++..|+|||++ ....++.++|||||||++|||++ |..||....... ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIEC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhh-ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH--
Confidence 99999999865433322222344456789999988 55678999999999999999998 999986543211 1111
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
+..+. ....+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 237 --~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 --ITQGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111 111233455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.11 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=200.7
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
||+|+||+||++.+..+++.||+|.+...... ...+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999889999999998654322 1235678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 998876444456789999999999999999999998 9999999999999999999999999999765432221 23
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...|++.|+|||.+ .+..++.++|||||||++|||++|+.||........ ......... .. ...++..
T Consensus 156 ~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~---------~~-~~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELL-QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRIL---------ND-SVTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhc---------cc-CCCCccc
Confidence 45688999999988 556789999999999999999999999975432111 111111100 00 0123445
Q ss_pred hHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
.+..+.+++.+|++.||++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 566788999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=337.29 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=198.2
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
+.||+|+||.||++....+|+.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 369999999999999988999999999865421 123356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 999888764 4689999999999999999999998 999999999999999999999999999875322111 1
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 797 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 797 (843)
.....||..|+|||++ .+..++.++|||||||++|||++|+.||....... ........ . ..++
T Consensus 152 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~~~~~-~---------~~~p 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILME-E---------IRFP 215 (323)
T ss_pred cccccCCcCcCCcccc-cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcC-C---------CCCC
Confidence 1345689999999988 55678999999999999999999999996542211 11111111 0 1123
Q ss_pred hhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 798 EDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 798 ~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 44556788999999999999998 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.44 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=200.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 5567789999999999999988899999999865432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 98877654432 24588999999999999999999998 999999999999999999999999999987643222
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHH-----------HHHHHhhC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH-----------VRVLLEEG 783 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~-----------~~~~~~~~ 783 (843)
. ......|+..|+|||++ .+..++.++|||||||++|||++|+.||....... .+... .+......
T Consensus 156 ~-~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 156 A-NYTEYVATRWYRSPELL-LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred c-cccccccccccCCcHHH-cCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccc
Confidence 1 11345688999999988 45568999999999999999999999997543211 11111 00000000
Q ss_pred CcccccCCCCCC-------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPSMGD-------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~l~~-------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.......+.... ........+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 111234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.35 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=199.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
++..+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred cEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 455678999999999999986 56789999875433 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999998642 3588999999999999999999998 9999999999999999999999999999865432221
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||.+ ....++.++||||||+++|||++ |+.||..... . +.+... ..+...
T Consensus 157 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~---~~~~~i-~~~~~~-------- 220 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--Y---EVVEMI-SRGFRL-------- 220 (256)
T ss_pred -ccCCCCCchhhCChhhc-ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--H---HHHHHH-HCCCCC--------
Confidence 11233456689999988 45578899999999999999999 8999864322 1 111111 111110
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+......+.+++.+||+.+|++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11222345688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=321.95 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=205.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
++..+.||+|+||.||+|.+...++.||+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 445568999999999999998889999999985432 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 86 ~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999997642 34589999999999999999999998 9999999999999999999999999999876532221
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||.+ .+..++.++|||||||++|||++ |..||..... . +..+. ...+. . .
T Consensus 161 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~---~~~~~-~~~~~-----~---~ 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S---QVYEL-LEKGY-----R---M 224 (263)
T ss_pred -ccCCCCCccccCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H---HHHHH-HHCCC-----C---C
Confidence 11223345679999987 56678999999999999999998 8899864321 1 11111 11111 0 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12344556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.95 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=206.7
Q ss_pred hhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 626 (843)
.+.+...+.||+|+||.||+|++. ..++.||+|++.........+.+.+|+.++.++. ||||++++|++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345666789999999999999974 2456899999965543333457889999999997 9999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCC----------------------------------------------------------
Q 003156 627 KLLVSDYAPNGSLQAKLHERLP---------------------------------------------------------- 648 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 648 (843)
.++|+||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred ------------------------------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 649 ------------------------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 649 ------------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 113478888999999999999999988 99999999999999
Q ss_pred cCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhh
Q 003156 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 771 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~ 771 (843)
++++.+||+|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |+.||........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh-cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999865432222222334567889999988 45568999999999999999998 8899865432211
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 772 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
.. ..+..+.. ...+.....++.+++.+||..+|++||+++|+++.|+.+
T Consensus 351 ~~----~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 FY----NAIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH----HHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 11111111 112334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=328.87 Aligned_cols=264 Identities=23% Similarity=0.399 Sum_probs=209.4
Q ss_pred hhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
+...+.||+|+||.||+|.+. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 455668999999999999863 245678999875433 22345788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 631 SDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
|||+++++|.+++....+ ....++|..++.++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999976432 124589999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~ 777 (843)
+|+|||+++...............++..|+|||.+ ....++.++|||||||++|||+| |+.||....... . .+
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~---~~ 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V---IE 236 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H---HH
Confidence 99999999866543332223344567889999987 55678999999999999999999 999986532211 1 11
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
....+... ..+...+..+.+++.+||+.+|++|||+.+|++.|+++.++.|.
T Consensus 237 -~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 237 -CITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred -HHhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 11222111 12233456788999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.99 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=215.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCe-eEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL-KLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~ 631 (843)
+.|+..+.+|+|+||.++.++++.+++.+|+|.+.-.... .......+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 3577788999999999999999999999999998654432 233467899999999999999999999999888 89999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
+|++||++.+.|.+.. +.-+++..++.++.|++.|+.|||++ .|+|||||+.||+++.+..|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999999874 56789999999999999999999988 999999999999999999999999999998876
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.+ .......||+.||.||++ .+..|+.|+||||+||++|||++-+++|...+... .+....+ .
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----Li~ki~~---------~ 221 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----LILKINR---------G 221 (426)
T ss_pred ch--hhhheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHH-----HHHHHhh---------c
Confidence 44 234678999999999988 78899999999999999999999999997643322 1111111 1
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.....+.....++..++..|++.+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1223466777789999999999999999999999886
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=335.64 Aligned_cols=242 Identities=26% Similarity=0.343 Sum_probs=196.6
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
||+|+||.||+|....+++.||+|.+..... ......+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999988899999999865321 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 9999764 4589999999999999999999998 999999999999999999999999999975432221 123
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...||..|+|||++ .+..++.++||||+||++|||++|+.||..... .+..+...... ..++..
T Consensus 152 ~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~----------~~~~~~ 215 (312)
T cd05585 152 TFCGTPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP----------LRFPDG 215 (312)
T ss_pred cccCCcccCCHHHH-cCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC----------CCCCCc
Confidence 45689999999988 556789999999999999999999999965321 11222211110 112344
Q ss_pred hHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRPS---MAEVVQI 828 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RPs---~~evl~~ 828 (843)
...++.+++.+||+.||++||+ +.|++.+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 4567889999999999999975 6676654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.74 Aligned_cols=244 Identities=25% Similarity=0.317 Sum_probs=198.8
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
+.||+|+||.||++....+|+.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999999988999999999865422 123456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 999988764 4689999999999999999999998 99999999999999999999999999987532211 11
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 797 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 797 (843)
.....||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ........ . + ..++
T Consensus 152 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~-~------~---~~~p 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILM-E------D---IKFP 215 (328)
T ss_pred cccccCCcCccChhhh-cCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhcc-C------C---ccCC
Confidence 2345689999999988 5557899999999999999999999999653221 11111110 0 0 1223
Q ss_pred hhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 798 EDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 798 ~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
.....++.+++.+|++.||++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 44556788999999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.37 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=208.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 626 (843)
.+.|+..+.||+|+||.||+|.+.. ....+|+|.+......+....+.+|+++++++ +||||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3456667789999999999999853 23689999886543333345688999999999 79999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcC------------CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC
Q 003156 627 KLLVSDYAPNGSLQAKLHERL------------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD 694 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~ 694 (843)
.++||||+++|+|.++++... .....+++..++.++.|++.|++|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999997642 2345689999999999999999999998 9999999999999999
Q ss_pred CCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHH
Q 003156 695 NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILS 773 (843)
Q Consensus 695 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~ 773 (843)
++.+|++|||+++.+.............++..|+|||.. ....++.++|||||||++||+++ |..||...... ...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--ELF 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HHH
Confidence 999999999999876543322222333456789999987 55678999999999999999998 99998643221 111
Q ss_pred HHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 774 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 774 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
. ....+. ....+.....++.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 245 ~----~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 K----LLKEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----HHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 111111 11223445667899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.85 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=206.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCC------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 625 (843)
...|+..+.||+|+||+||+|.+..+|+.||||.+...... .....+.+|+..+..++|+|++++.+.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 34677788999999999999999889999999998654322 23356788999999999999999988775432
Q ss_pred --eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeec
Q 003156 626 --LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703 (843)
Q Consensus 626 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 703 (843)
..++||||+++|+|.++++.+......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence 35799999999999999987654556789999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
|+++.+.............||+.|+|||++ ....++.++|||||||++|||++|+.||..... ...+..... +
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~~~-~ 260 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIW-RRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKTLA-G 260 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc-C
Confidence 999876533222223456789999999998 556789999999999999999999999964321 112221111 1
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ....+.....++.+++.+||+.+|++||++.+++.+
T Consensus 261 ~--------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 R--------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 112334455678899999999999999999999875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=338.42 Aligned_cols=270 Identities=17% Similarity=0.199 Sum_probs=203.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..|+..+.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 34777889999999999999999899999999642 23567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+. ++|..++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 7888888764 4588999999999999999999998 99999999999999999999999999997543221
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC------chhhHHHHHHHHHh------
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED------NVVILSEHVRVLLE------ 781 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~------~~~~l~~~~~~~~~------ 781 (843)
.. ......||+.|+|||++ ....++.++|||||||++|||++|+.||..... ....+...++....
T Consensus 237 ~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 237 AN-KYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cc-ccccccCccCCCChhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11 12345789999999988 455789999999999999999999988754211 11111111110000
Q ss_pred ------------hCCcccccCCC-CCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCCCCCCC
Q 003156 782 ------------EGNVLDCVDPS-MGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTPLPQRM 840 (843)
Q Consensus 782 ------------~~~~~~~~d~~-l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~~~~~~ 840 (843)
.........+. ... .....+.++.+++.+|++.||++|||++|++++ ++.+..+.+.++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~~ 390 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNPM 390 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCCC
Confidence 00000000000 000 011234568899999999999999999999976 555555555544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=321.45 Aligned_cols=262 Identities=25% Similarity=0.314 Sum_probs=203.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-------------ChHHHHHHHHHHHhccCCCcccee
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------------YPEDFEREVRVLGKARHPNLISLE 618 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~ 618 (843)
+-+.|+..+.||+|.||.|-+|+...+++.||||.+.+..... ..+...+|+.++++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4566888889999999999999999999999999995443211 125788999999999999999999
Q ss_pred eEEEcCC--eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 619 GYYWTPQ--LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 619 g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
.+..++. ..|+|+|||..|.+... ....+.++..++++++.++..||+|||.+ +||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9998764 68999999998875322 22334499999999999999999999999 999999999999999999
Q ss_pred CcEEeeccCcccccccc---cceeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh
Q 003156 697 NPRISDFGLARLLTRLD---KHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV 770 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~ 770 (843)
+|||+|||.+....... .........||+.|+|||....+ ...+.+.||||+||++|.|+.|+.||..... .
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~ 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--L 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--H
Confidence 99999999987663221 11112347899999999987552 2356789999999999999999999964321 1
Q ss_pred hHHHHHHHHHhhCCcccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 771 ILSEHVRVLLEEGNVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.+. .. ++...+. ....+..+++..||.+++++||+.|.+..+|..+....+.
T Consensus 326 ~l~---~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 ELF---DK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHH---HH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 111 11 1111111 1122456678899999999999999999999988765443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.61 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=205.0
Q ss_pred hhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
.++..+.||+|+||.||+|.+.. .++.||+|++.........+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35666789999999999998743 3578999998654332334668899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC
Q 003156 630 VSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN 697 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 697 (843)
++||+++++|.+++....+ ....+++..++.++.|++.||+|+|+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999999964321 123588889999999999999999998 9999999999999999999
Q ss_pred cEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHH
Q 003156 698 PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV 776 (843)
Q Consensus 698 ~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~ 776 (843)
+||+|||+++...............+++.|+|||.+ ....++.++|||||||++|||++ |..||...... ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence 999999999866543332222344567789999987 44568999999999999999998 77887543221 111
Q ss_pred HHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 777 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
.. +..+. ....+.+++..+.+++..||+.+|++||++.|+++.|+.
T Consensus 237 ~~-i~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM-IRNRQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHcCC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11111 112345566778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.09 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=200.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.++..+.||+|+||+||.|+-+.+|..+|+|+++++... ...+....|=.+|....+|.||+++-.|.+.+..||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 4466777999999999999999999999999999876543 34567888999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||++||++..+|... ..+++..+..++.+++.|++-+|+. |+|||||||+|+|||..|++||+|||+++-+..
T Consensus 221 EylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999875 5788999999999999999999999 999999999999999999999999999854321
Q ss_pred c----------------------ccc----e-------------------eccccccccccCCcccccCcCCCCCchhHH
Q 003156 712 L----------------------DKH----V-------------------MSNRFQSALGYVAPELTCQSLRVNEKCDIY 746 (843)
Q Consensus 712 ~----------------------~~~----~-------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~ 746 (843)
. +.. . ......||+.|||||++.+ ..|+..+|.|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHH
Confidence 0 000 0 0123468999999999944 4599999999
Q ss_pred HHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC---HH
Q 003156 747 GFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS---MA 823 (843)
Q Consensus 747 S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs---~~ 823 (843)
|+|||||||+.|.+||....... .+.+.+ ........ | -......+..+||.+|+. ||+.|.- +.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~-T~rkI~----nwr~~l~f--P----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQE-TYRKIV----NWRETLKF--P----EEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHH-HHHHHH----HHhhhccC--C----CcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 99999999999999997643221 111111 11100100 0 012233678899999998 9999964 66
Q ss_pred HHHH
Q 003156 824 EVVQ 827 (843)
Q Consensus 824 evl~ 827 (843)
||.+
T Consensus 441 EIK~ 444 (550)
T KOG0605|consen 441 EIKK 444 (550)
T ss_pred HHhc
Confidence 6655
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.52 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=202.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 45667899999999999999888999999998654321 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999764 4588899999999999999999998 999999999999999999999999999976543
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||....... ....+. ....... .+..
T Consensus 154 ---~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~---~~~~~~~--~~~~ 222 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVL-RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLK---YWKETLQ--RPVY 222 (333)
T ss_pred ---ccCCcccCccccChhHh-cCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHH---hcccccc--CCCC
Confidence 22445788999999988 45578999999999999999999999996532211 111111 1000000 1111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.........++.+++.+|+..+|++||++.|++++
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11112345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=326.83 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=207.9
Q ss_pred hhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
..+...+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 34556678999999999999862 245678999885432 223457899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCC---------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcE
Q 003156 629 LVSDYAPNGSLQAKLHERLP---------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 699 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 699 (843)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999986432 223589999999999999999999998 999999999999999999999
Q ss_pred EeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHH
Q 003156 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~ 778 (843)
|+|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||...... .. ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~----~~- 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EV----IE- 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HH----HH-
Confidence 9999999866543332233344457789999988 55678999999999999999998 88888644321 11 11
Q ss_pred HHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.+..+... ..+......+.+++.+||+.+|.+|||+.|+++.|+.+.+.
T Consensus 234 ~i~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11112111 11223445689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=346.43 Aligned_cols=268 Identities=22% Similarity=0.305 Sum_probs=200.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-------- 624 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------- 624 (843)
...|+..+.||+|+||.||+|....+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345777889999999999999998889999999885432 2345799999999999999999987432
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeec
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDF 703 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df 703 (843)
...++||||++ +++.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 13568999997 478887765433456789999999999999999999998 99999999999999965 47999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh-
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE- 782 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~- 782 (843)
|+++.+..... .....||..|+|||++.+...++.++|||||||++|||++|..||..... ...+...++.....
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Confidence 99986643222 13346788999999875666789999999999999999999999965322 22222222111000
Q ss_pred --------CCcccccCCCC-----C-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhcc
Q 003156 783 --------GNVLDCVDPSM-----G-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 833 (843)
Q Consensus 783 --------~~~~~~~d~~l-----~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~ 833 (843)
....+..-+.. . .++...+.++.+++.+||+.||.+|||+.|++++ ++.+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00000000000 0 1233445678999999999999999999999976 44443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.98 Aligned_cols=269 Identities=24% Similarity=0.333 Sum_probs=203.4
Q ss_pred hhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 629 (843)
++..+.||+|+||+||.+.+ ..+++.||+|.+.........+.|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36677899999999988654 3467889999986544333456788999999999999999999998654 35789
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... .+++..++.++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999763 489999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
....... ......++..|+|||.. ....++.++||||||+++|||+||..||........................+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECL-KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHh-cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 5432211 11223455679999987 455789999999999999999999999864322111110000000000001111
Q ss_pred cCCCC-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 789 VDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 789 ~d~~l-~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
++... ...+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111 1124455678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=325.44 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=203.9
Q ss_pred hhhcCeeccccceEEEEEEEC----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFG----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
++..+.||+|+||.||+|.+. ..+..||+|.+...........+.+|++++++++||||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 455678999999999999862 3567899999865443333467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCC-------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 632 DYAPNGSLQAKLHERLP-------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 99999999999965321 123578899999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~ 777 (843)
||+|||+++...............++..|+|||.+ .+..++.++|||||||++|||++ |..||..... ....+.+
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~- 239 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV- 239 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH-
Confidence 99999999866433322222334456789999988 45568999999999999999998 8889864321 1111111
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..... ...+..++.++.+++.+||+.+|++||++.++.++|+.
T Consensus 240 ---~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ---RKRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 11234455678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=318.91 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=198.2
Q ss_pred eeccccceEEEEEEEC--CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 561 EVGEGVFGTVYKVSFG--TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.||+|+||.||+|.+. ..+..||+|.+.........+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999875 34567999998655433345678999999999999999999998854 46789999999999
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee-
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM- 717 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~- 717 (843)
|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999764 34689999999999999999999998 999999999999999999999999999986543322211
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
.....++..|+|||.+ ....++.++|||||||++||+++ |..||....... . ...+..+.. ...
T Consensus 155 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~--------~~~ 219 (257)
T cd05115 155 RSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--V----MSFIEQGKR--------LDC 219 (257)
T ss_pred cCCCCCCcccCCHHHH-ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--H----HHHHHCCCC--------CCC
Confidence 1122335689999987 45568899999999999999996 999996543211 1 111222211 123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
+..+..++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 445567888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.13 Aligned_cols=247 Identities=20% Similarity=0.278 Sum_probs=200.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCC-eEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|.+...+ ..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 34666779999999999999875444 6899999865322 22345788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999864 4588999999999999999999998 99999999999999999999999999998654
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... ....||+.|+|||++ .+..++.++|||||||++|||++|+.||..... ... .+.. ..+.
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~---~~~i-~~~~------ 244 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEIL-LNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LLI---YQKI-LEGI------ 244 (340)
T ss_pred CCc-----ceecCChhhcCHHHH-hCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HHH---HHHH-hcCC------
Confidence 311 345688999999988 555688999999999999999999999975322 111 1111 1111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++......+.+++.+|++.+|++|+ |++|++++
T Consensus 245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112333445678999999999999995 89998876
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.50 Aligned_cols=261 Identities=21% Similarity=0.368 Sum_probs=209.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|....+++.+|||.+...... ...+++.+|+.+++.++||||+++++++.+++..++||||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 55667899999999999999889999999988653322 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.........+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||+++......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999986444456789999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.. .....++..|+|||.. .+..++.++||||||+++|||++|..||.....+.....+.+. ....+..
T Consensus 161 ~~--~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~ 228 (267)
T cd08229 161 TA--AHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------QCDYPPL 228 (267)
T ss_pred cc--cccccCCcCccCHHHh-cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh---------cCCCCCC
Confidence 11 1234678889999988 5556889999999999999999999999654332222211111 0111111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
........+.+++.+||..+|++||||.+|++.++++.
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 12335567889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=324.70 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=204.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.++..+.||+|+||.||+|.+.. .+..||+|.+...........|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3456677799999999999999975 56789999875443333345789999999999999999999999998889
Q ss_pred EEEEEeCCCCCHHHHHhhcCC---CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC---CcEEe
Q 003156 628 LLVSDYAPNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY---NPRIS 701 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~ 701 (843)
++||||+++|+|.+++..... ....++|..++.++.|++.|++|||+. +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999987532 123589999999999999999999998 999999999999998654 59999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHH
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
|||+++.+..............+..|+|||++ .+..++.++|||||||++|||++ |..||...... . ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~---~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAF-LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--E---VMEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHH-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--H---HHHHHH
Confidence 99999876432222111223335679999988 55578999999999999999997 99998643221 1 111111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.... ...+...+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 236 ~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 1123445567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.10 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=207.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC-----CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.++..+.||+|+||.||+|.+... +..||+|.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 34566777999999999999998533 3789999985444333345788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCC------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEe
Q 003156 628 LLVSDYAPNGSLQAKLHERLPS------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 701 (843)
++||||+++|+|.+++...... ...++|..++.++.|++.|+.|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999999764322 23578999999999999999999998 99999999999999999999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHH
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
|||+++.+...+.........++..|+|||.+ ....++.++|||||||++||++| |..||..... ....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHH-hcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHH----
Confidence 99999876543332222344567889999987 45568999999999999999998 8889864321 1111111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+. ....+...+.++.+++.+||+.+|++|||+.|+++.|+.
T Consensus 235 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGG--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 112344456788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=320.20 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=205.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 345677789999999999999975 67789999875433 235688999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.++++.. ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999764 234688899999999999999999998 9999999999999999999999999999876432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||+. ....++.++|||||||++|||+| |+.||...... ..... +..+...
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----~~~~~~~----- 223 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA----LQRGYRM----- 223 (261)
T ss_pred cee-ccCCCccceecCCHHHh-ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcCCCC-----
Confidence 211 11233456789999987 45568899999999999999998 99998643221 11111 1111110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
......+.++.+++.+||..+|++||+++++.+.|+.+
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=322.50 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=204.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..++..+.||+|+||+||+|.+..+|+ .||+|.+.........+.+.+|+.+++.+.||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 445667789999999999999866665 48999886544434456788999999999999999999999764 4679
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
++||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999864 24689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.............++..|+|||.. ....++.++|||||||++|||++ |..||..... .....+ +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESI-LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDL----LEKGERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCcC--
Confidence 533222222233446789999987 55578999999999999999998 8899864322 112221 1211111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
..+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1123445678899999999999999999999999988744
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=327.03 Aligned_cols=267 Identities=26% Similarity=0.384 Sum_probs=209.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-------CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFG-------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT 623 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 623 (843)
....|+..+.||+|+||.||+|++. .++..||+|.+.........+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3455677789999999999999852 234579999886443333456788999999999 89999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEE
Q 003156 624 PQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 691 (843)
Q Consensus 624 ~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 691 (843)
....++||||+++|+|.+++....+ ....+++..+..++.|++.||+|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999987532 124578899999999999999999998 9999999999999
Q ss_pred EcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchh
Q 003156 692 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 770 (843)
Q Consensus 692 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~ 770 (843)
+++++.+||+|||+++.+.............++..|+|||++ .+..++.++||||||+++|||++ |..||....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 999999999999999876543333222333456789999988 55678999999999999999998 777775321
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 771 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
..+.... +..+.. ...+..+...+.+++.+||+.+|++|||+.|+++.|+++..-.
T Consensus 245 -~~~~~~~-~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 245 -VEELFKL-LKEGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred -HHHHHHH-HHcCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1122221 111111 1123455667899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=325.63 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=204.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECC----------------CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccc
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT----------------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 616 (843)
.+.|+..+.||+|+||.||++.+.. ++..||+|.+...........+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4557778899999999999986432 345689999865433334567899999999999999999
Q ss_pred eeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCC-------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCC
Q 003156 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS-------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689 (843)
Q Consensus 617 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 689 (843)
+++++...+..++||||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999999875321 23478889999999999999999998 99999999999
Q ss_pred EEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCcCCCC
Q 003156 690 ILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGED 767 (843)
Q Consensus 690 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt--g~~p~~~~~~ 767 (843)
|++++++.++++|||+++.+.............++..|+|||.. ....++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-hcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999866433322222333446789999977 44568999999999999999998 6788754322
Q ss_pred chhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 768 NVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 768 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
. ... ............ .... ..+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 240 ~-~~~-~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 E-QVI-ENTGEFFRDQGR-QVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-HHH-HHHHHHHhhccc-cccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 111 111111111110 0000 1123345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.65 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=206.4
Q ss_pred hhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 626 (843)
.+.++..+.||+|+||.||+|.+ ...+..||+|.+.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45567778999999999999985 2245689999886544333446789999999999 79999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.++++... ...+++.++..++.|++.|++|||+. +|+|+||||+||++++++.++++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999998642 23489999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+...............++..|+|||.+ ....++.++||||+||++|||++ |..||........ ... ....+..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYK----LIKEGYR 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhh-ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHH----HHHcCCc
Confidence 865433222222334456789999987 45568999999999999999998 9999865433211 111 1111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
. ..+.....++.+++.+||..+|++|||+.|+++.|++.
T Consensus 263 ~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 M--------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 11223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=325.38 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=203.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC--------------CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCcccee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQ--------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 618 (843)
...|+..+.||+|+||.||++..... ...||+|.+...........|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 45577778999999999999887432 2358999986543333345789999999999999999999
Q ss_pred eEEEcCCeeEEEEEeCCCCCHHHHHhhcCC--------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCE
Q 003156 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLP--------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNI 690 (843)
Q Consensus 619 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 690 (843)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999975321 113478899999999999999999998 999999999999
Q ss_pred EEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCcCCCCc
Q 003156 691 LLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGEDN 768 (843)
Q Consensus 691 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt--g~~p~~~~~~~ 768 (843)
++++++.+||+|||+++...............++..|+|||.. ....++.++|||||||++|||++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh-ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 9999999999999999865433322222334456789999987 45568999999999999999998 5567654322
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 769 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 769 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
.... .............. ....+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 239 ~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVI-ENTGEFFRNQGRQI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHH-HHHHHhhhhccccc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111 11111111110000 001122345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=332.57 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=205.5
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHH
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 640 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 640 (843)
++|+|.||+||.|++..+...+|||.+...+. +..+-+.+|+...++++|.|||+++|.+.+.+..-|.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 79999999999999998888899999865543 34556789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCC--ChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCccccccccccee
Q 003156 641 AKLHERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 641 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
+.++... +++ .+.++-.+..||++||.|||+. .|||||||.+|||++ -.|.+||+|||-++.+.... ..
T Consensus 661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~ 732 (1226)
T KOG4279|consen 661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PC 732 (1226)
T ss_pred HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--cc
Confidence 9999863 344 6677778899999999999999 999999999999997 68999999999998765322 23
Q ss_pred ccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
+.++.||+.|||||++-++ ..|+.++|||||||++.||.||++||.-.......+. +-| +-..-+..
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-------kVG-----myKvHP~i 800 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-------KVG-----MYKVHPPI 800 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-------hhc-----ceecCCCC
Confidence 4678899999999998655 3589999999999999999999999965432221111 001 01112346
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
|++...+...+|.+|+.+||.+||++.++++.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 88888999999999999999999999999874
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=332.81 Aligned_cols=266 Identities=26% Similarity=0.352 Sum_probs=205.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC-
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP- 624 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~- 624 (843)
+.+.|+..+.||+|+||.||+|.+. .+++.||||++...........+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3456888889999999999999852 357889999986543333345688999999999 689999999988765
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCC--------------------------------------------------------
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLP-------------------------------------------------------- 648 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 648 (843)
...++||||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999999975321
Q ss_pred -------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecccc
Q 003156 649 -------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 721 (843)
Q Consensus 649 -------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 721 (843)
....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012478889999999999999999998 9999999999999999999999999999865432222222334
Q ss_pred ccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhh
Q 003156 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 800 (843)
Q Consensus 722 ~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 800 (843)
.++..|+|||.+ ....++.++||||||+++|||++ |..||........ . ......+... ..+...
T Consensus 242 ~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~----~~~~~~~~~~--------~~~~~~ 307 (343)
T cd05103 242 RLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F----CRRLKEGTRM--------RAPDYT 307 (343)
T ss_pred CCCcceECcHHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-H----HHHHhccCCC--------CCCCCC
Confidence 456779999987 45578999999999999999997 8999865432211 1 1111111111 112223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 801 VLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 801 ~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
..++.+++..||+.+|++|||+.|++++|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.13 Aligned_cols=261 Identities=27% Similarity=0.366 Sum_probs=204.5
Q ss_pred hhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
++..+.||+|+||.||+|.... ....+|+|.+.........+.+.+|+.+++.++||||+++++.+...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 3456689999999999998742 23578888876443333346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCC--------------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCE
Q 003156 631 SDYAPNGSLQAKLHERLP--------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNI 690 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 690 (843)
+||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 999999999999875321 123588999999999999999999998 999999999999
Q ss_pred EEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCch
Q 003156 691 LLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNV 769 (843)
Q Consensus 691 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~ 769 (843)
++++++.+||+|||+++...............++..|+|||.. .+..++.++||||||+++|||++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999865433322222334456789999987 55678999999999999999998 9999864321
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 770 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
..+.+ ....... ...+.....++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 ~~~~~----~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFN----LLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHH----HHhCCCC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 1111110 01234455678899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=320.79 Aligned_cols=257 Identities=26% Similarity=0.349 Sum_probs=196.1
Q ss_pred eeccccceEEEEEEECC--CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 561 EVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.||+|+||.||+|.+.. .+..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 68999999999998742 3467999988654433334578899999999999999999999999888999999999999
Q ss_pred HHHHHhhcCC-CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 639 LQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 639 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
|.++++.... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999986432 234567788889999999999999998 999999999999999999999999999976543332222
Q ss_pred ccccccccccCCcccccCc------CCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 718 SNRFQSALGYVAPELTCQS------LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~------~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.....++..|+|||++... ..++.++|||||||++|||++ |+.||........ ... ... +......+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~----~~~-~~~~~~~~ 232 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTY----TVR-EQQLKLPK 232 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHH----Hhh-cccCCCCC
Confidence 2345567889999987322 235789999999999999996 9999965432221 111 111 11111112
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
+.. .......+.+++..|| .+|++|||++||++.|+
T Consensus 233 ~~~---~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRL---KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred Ccc---CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 221 2233446778999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=300.38 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=204.6
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcc---c----ChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---Q----YPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
.+.+|.|..++|-++.++.+|..+|+|++...... + ..++-.+|+.+++++ .||+|+++.++|..+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 45799999999999999999999999998543221 1 123456899999999 699999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
+|.|+.|.|.+++... ..+++....+|+.|+..|++|||.+ .|||||+||+|||+|++.++||+|||+++.+.
T Consensus 102 Fdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999875 6799999999999999999999999 99999999999999999999999999999888
Q ss_pred ccccceeccccccccccCCcccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQ-----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
++..- ...+||++|.|||.+.- ...|+...|+||+||+||.++.|..||..... .. .+ ..+.+|..
T Consensus 175 ~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-ml----ML-R~ImeGky 245 (411)
T KOG0599|consen 175 PGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-ML----ML-RMIMEGKY 245 (411)
T ss_pred CchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-HH----HH-HHHHhccc
Confidence 76543 56799999999998632 34578899999999999999999999954211 11 11 12233322
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.-. ....+....+.+||.+|++.||.+|.|++|++++
T Consensus 246 -qF~s----peWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 246 -QFRS----PEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -ccCC----cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111 1234555678899999999999999999999986
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.02 Aligned_cols=261 Identities=22% Similarity=0.366 Sum_probs=210.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|....+|+.||+|.+..... ....+.+.+|++++++++|++++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 5566789999999999999988899999998864322 22356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++.........+++..++.++.|+++|++|||+. +|+||||+|+||+++.++.++++|||+++......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999976544456689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.. .....++..|+|||.+ .+..++.++|||||||++|||++|+.||.........+ ... ...+. .
T Consensus 161 ~~--~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~-~~~~~--------~ 225 (267)
T cd08224 161 TA--AHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKK-IEKCD--------Y 225 (267)
T ss_pred cc--cceecCCccccCHHHh-ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---Hhh-hhcCC--------C
Confidence 11 1234577889999987 45678899999999999999999999996543221111 111 11111 1
Q ss_pred CCCCh-hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 794 GDYPE-DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 794 ~~~~~-~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+. .....+.+++.+||..+|++|||+.++++.|+.+++
T Consensus 226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 11122 445678899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=321.60 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=202.4
Q ss_pred hhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCe------
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------ 626 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 626 (843)
+..+.||+|+||.||+|.+..+ +..||+|++...... ...+.+.+|++.++.++||||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 3456899999999999998643 378999998654322 223578899999999999999999999876554
Q ss_pred eEEEEEeCCCCCHHHHHhhcCC--CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLP--STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
.++|+||+++|+|..++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 6899999999999999866421 234689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
+++.+..............+..|+|||.+ ....++.++|||||||++|||++ |..||...... +..... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~~~~-~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIYDYL-RHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH-HcC
Confidence 99876543332222223446789999987 55678999999999999999999 88888543221 111111 111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
. ....+..+..++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 232 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1123445566899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=335.32 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=202.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.+...++||+|.||+|+.+..+.+++.+|||.+++....+ ..+..+.|..++... +||.++.+++.+.+.++.|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 33556678999999999999999999999999998776533 456778888888777 599999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+.||++..+.+ ...+++.++.-+|+.|+.||.|||++ +||+||||-+|||+|.+|.+||+|||+++..-
T Consensus 448 mey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999544443 24699999999999999999999999 99999999999999999999999999998543
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
- ....+++++||+.|||||++ .+..|+.++|.|||||+||||+.|+.||....+++ ... ....+ |
T Consensus 520 ~--~g~~TsTfCGTpey~aPEil-~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~Fd----sI~~d-------~ 584 (694)
T KOG0694|consen 520 G--QGDRTSTFCGTPEFLAPEVL-TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFD----SIVND-------E 584 (694)
T ss_pred C--CCCccccccCChhhcChhhh-ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH----HHhcC-------C
Confidence 1 22245789999999999998 77789999999999999999999999997543322 111 11111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM 822 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~ 822 (843)
..+|.....+.+.+|++.+..+|++|.-+
T Consensus 585 ---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12577778889999999999999999866
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=332.64 Aligned_cols=250 Identities=21% Similarity=0.294 Sum_probs=197.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|....+++.||+|.+..... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 369999999999999988899999999875422 22334577888888877 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 9999888764 4589999999999999999999998 999999999999999999999999999875322111
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc---hhhHHHHHHHHHhhCCcccccCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN---VVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||...... ......++...+....
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------- 221 (329)
T ss_pred ccccccCCccccCHHHH-cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------
Confidence 12345789999999988 5567899999999999999999999999632111 1111112211111111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPS------MAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs------~~evl~~ 828 (843)
...+.....++.+++.+|++.||++||+ +.+++++
T Consensus 222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1234445567889999999999999998 5677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.95 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=208.2
Q ss_pred hhhhhcCeeccccceEEEEEEECC----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc-CCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 628 (843)
+.|+..+.||+|+||.||+|.+.. .+..||+|++.........+.+.+|+.++++++||||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 345566789999999999999864 2678999988644333345678899999999999999999999876 46788
Q ss_pred EEEEeCCCCCHHHHHhhcCCC----CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 629 LVSDYAPNGSLQAKLHERLPS----TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
+++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999999765322 25689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
+++.+...+.........++..|+|||++ ....++.++|||||||++||+++ |+.||.... ...+..++ ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~----~~~ 235 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESL-VNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYL----KDG 235 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHH-hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHH----HcC
Confidence 99876543333222334567789999988 55568999999999999999999 999996432 22222221 111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
... ..+..++..+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 236 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 YRL--------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCC--------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 1123345678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.32 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=193.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|.+..+++.||+|.+..... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999988899999999865321 22334556677777654 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 9999999764 3588899999999999999999998 99999999999999999999999999997543222 1
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||...... . ..... ... ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~---~~~~i-~~~---------~~~~ 215 (316)
T cd05592 152 KASTFCGTPDYIAPEIL-KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--E---LFDSI-LND---------RPHF 215 (316)
T ss_pred ccccccCCccccCHHHH-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--H---HHHHH-HcC---------CCCC
Confidence 22445689999999988 5557899999999999999999999999753221 1 11111 111 1122
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 827 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~-evl~ 827 (843)
+.....++.+++.+||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 344456678999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.88 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=207.1
Q ss_pred hhhhhcCeeccccceEEEEEEECC-------CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.|...+.||+|+||.||+|.+.. ++..+|+|.+...........+.+|+.+++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 557788899999999999998742 23569999986543333345688899999999 7999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 693 (843)
..++||||+++|+|.+++....+ ....++|.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999987532 123589999999999999999999998 999999999999999
Q ss_pred CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhH
Q 003156 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVIL 772 (843)
Q Consensus 694 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l 772 (843)
+++.+||+|||.++...............++..|+|||.+ .+..++.++|||||||++|||++ |..||.... ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--~~-- 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VE-- 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHh-ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC--HH--
Confidence 9999999999999765432222111222344679999987 45568999999999999999998 888885322 11
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
+..+ ....+.. ...+.....++.+++.+||+.+|++|||+.|+++.|+.+.+.
T Consensus 250 -~~~~-~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 -ELFK-LLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -HHHH-HHHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111 1111111 122344556788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=318.20 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=200.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|+||.||.|.+. ++..+|+|.+.... ...+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3455678999999999999886 45579999886433 23467999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++... ...+++..++.++.|++.|++|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999864 23689999999999999999999998 999999999999999999999999999986543222
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.......++..|+|||.. ....++.++|||||||++|||++ |..||....... .... +..+..
T Consensus 156 -~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~----~~~~~~-------- 219 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEK----VSQGLR-------- 219 (256)
T ss_pred -eecCCCccChhhCCHHHH-hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH----HhcCCC--------
Confidence 111233456789999988 44568899999999999999998 999986543211 1111 111111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
...+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112233567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.30 Aligned_cols=253 Identities=27% Similarity=0.336 Sum_probs=202.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||+||++.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 44566899999999999999888999999998653322 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988754 234589999999999999999999998 99999999999999999999999999997654322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. .....|+..|+|||++ ....++.++||||+||++|||++|+.||....... .. +.+...+... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~-~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~-~~~~~~~~~~---------~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KR-EEVERRVKED---------Q 221 (285)
T ss_pred c---cccccCCCCccCcHHh-cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HH-HHHHHHhhhc---------c
Confidence 1 1334678999999988 45678999999999999999999999997543211 11 1111111111 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++......+.+++.+||+.||++|| ++++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 122344556788999999999999999 88899775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.11 Aligned_cols=266 Identities=25% Similarity=0.357 Sum_probs=206.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCC----------------CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQ----------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 617 (843)
+.|+..+.||+|+||.||+|..... +..||+|.+.........+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4466778999999999999887532 356899998655433445678999999999999999999
Q ss_pred eeEEEcCCeeEEEEEeCCCCCHHHHHhhcCC-------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCE
Q 003156 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLP-------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNI 690 (843)
Q Consensus 618 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni 690 (843)
++++...+..++|+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999998999999999999999999987531 123689999999999999999999998 999999999999
Q ss_pred EEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh--CCCCCcCCCCc
Q 003156 691 LLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGEDN 768 (843)
Q Consensus 691 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt--g~~p~~~~~~~ 768 (843)
+++.++.++|+|||+++.....+.........++..|+|||.+ ....++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV-LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh-hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999865443333333445567789999987 44568999999999999999998 6777754322
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 769 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 769 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
...+ ............... ...+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVI-ENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHH-HHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111 111111111111000 1123334567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.23 Aligned_cols=244 Identities=25% Similarity=0.303 Sum_probs=197.5
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
+.||+|+||.||++....+|+.||+|.+..... ......+..|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999988999999999865422 123356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
+|..++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 999988764 468999999999999999999997 6 899999999999999999999999999875432111
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||...... ...... .... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i-~~~~---------~~~ 215 (325)
T cd05594 152 TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELI-LMEE---------IRF 215 (325)
T ss_pred ccccccCCcccCCHHHH-ccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHH-hcCC---------CCC
Confidence 11345689999999988 5567899999999999999999999999653221 111111 1110 112
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
+.....++.+++.+|++.||++|+ ++.+++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 334456788999999999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.62 Aligned_cols=266 Identities=23% Similarity=0.368 Sum_probs=207.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.|+..+.||+|+||.||+|..+. .+..||+|.+...........+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3556777899999999999997642 35589999875443333345688999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCC------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEe
Q 003156 628 LLVSDYAPNGSLQAKLHERLP------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 701 (843)
++||||+++|+|.++++.... .....++..+..++.|++.||.|||+. +|+||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999986421 124567788899999999999999998 99999999999999999999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHH
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||...... +......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~ 235 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFVM 235 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHh-ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH
Confidence 99999865443322222233456779999987 45578999999999999999998 78888543211 1111111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
. + .....+..+...+.+++.+|++.+|++|||+.++++.|+....+.
T Consensus 236 ~-~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 236 D-G--------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred c-C--------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 1 1 111223344567999999999999999999999999998865544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.50 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=198.9
Q ss_pred hcCeeccccceEEEEEEECCCCe--EEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC------CeeE
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QLKL 628 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 628 (843)
..+.||+|+||.||+|.+...+. .||+|.+..... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 35689999999999999976554 689998754321 22346788999999999999999999988532 2458
Q ss_pred EEEEeCCCCCHHHHHhhcC--CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 629 LVSDYAPNGSLQAKLHERL--PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
+|+||+++|+|.+++.... .....+++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999885432 1234589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+.+.............++..|+|||.. ....++.++|||||||++|||++ |+.||..... . ...+ .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~-~~~~----~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-S-EIYD----YLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-H-HHHH----HHHcCCC
Confidence 876543322222233456789999988 55678999999999999999999 7888864321 1 1111 1122211
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 --------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112334556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=324.84 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=205.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.|+..+.||+|+||.||+|.+.. ++..||+|.+.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3456677799999999999998742 57889999986544333456789999999999999999999999998899
Q ss_pred EEEEEeCCCCCHHHHHhhcCC------------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCC
Q 003156 628 LLVSDYAPNGSLQAKLHERLP------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 689 (843)
++|+||+++|+|.+++....+ ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999986421 123578899999999999999999998 99999999999
Q ss_pred EEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCc
Q 003156 690 ILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDN 768 (843)
Q Consensus 690 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~ 768 (843)
|++++++.++|+|||+++.+..............+..|+|||.. ....++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH-hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998765433222222233446679999987 55578999999999999999998 88888543221
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 769 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 769 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
+.... +..+.. ...+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 -----~~~~~-~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYY-VRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHH-HhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 122221 11233455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.61 Aligned_cols=248 Identities=25% Similarity=0.303 Sum_probs=195.0
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
||+|+||.||++....+|+.||+|.+...... .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999888999999998643322 1233456799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 99887642 34588999999999999999999998 999999999999999999999999999976543221 13
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...|+..|+|||++ ....++.++||||+||++|||++|+.||........ .....+.... . ........
T Consensus 153 ~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~--------~~~~~~~~ 221 (277)
T cd05607 153 QRAGTNGYMAPEIL-KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-D--------EVKFEHQN 221 (277)
T ss_pred ccCCCCCccCHHHH-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-c--------cccccccc
Confidence 34688899999988 445589999999999999999999999965432111 1111111111 0 11111123
Q ss_pred hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...++.+++.+||+.||++||+++|+++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 34568899999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=327.53 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=202.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|+||.||+|+...+++.||+|.+...........+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 35667789999999999999988899999999875544444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 87 DK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 75 888888764 34578899999999999999999998 999999999999999999999999999975432221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH-----------HhhC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-----------LEEG 783 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~-----------~~~~ 783 (843)
......++..|+|||.+.....++.++||||+||++|||+||+.||...... ..+....+.. ....
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1123456889999998866667899999999999999999999999654321 1111111100 0000
Q ss_pred CcccccCCCCC-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPSMG-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~l~-----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.....-.+... ........++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 0112234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.69 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=196.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|....+++.||+|.+..... ....+.+..|..+++.. +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999988899999999865321 22345677888888877 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 9999998764 4588999999999999999999998 99999999999999999999999999987542211 1
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ...+... .+. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~-~~~---------~~~ 215 (320)
T cd05590 152 TTSTFCGTPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAIL-NDE---------VVY 215 (320)
T ss_pred cccccccCccccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHh-cCC---------CCC
Confidence 12345789999999988 5567899999999999999999999999754221 1111111 111 012
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSM------AEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~------~evl~~ 828 (843)
+.....++.+++.+|++.||++||++ ++++++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 33345578899999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=330.10 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=198.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999889999999999754321 2235678899999998 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 9999988764 4689999999999999999999998 99999999999999999999999999987432111 1
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc---hhhHHHHHHHHHhhCCcccccCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN---VVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||...... ......+....+....
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------- 221 (329)
T ss_pred ccccccCCccccCHHHH-cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------
Confidence 12345789999999988 5567899999999999999999999999642111 1111122222222111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPS------MAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs------~~evl~~ 828 (843)
...+.....++.+++.+|++.||.+||| +++++++
T Consensus 222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1123344567889999999999999997 6787764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=334.34 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=196.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC-----eeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 629 (843)
|+..+.||+|+||.||+|....+|+.||+|++..... ......+.+|++++++++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 4556789999999999999988999999999864321 223456889999999999999999999886432 4799
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||++ ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 6899988764 4589999999999999999999998 9999999999999999999999999999864
Q ss_pred ccccc-ceeccccccccccCCcccccC-cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH--------
Q 003156 710 TRLDK-HVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------- 779 (843)
Q Consensus 710 ~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~-------- 779 (843)
..... ........|+..|+|||++.. ...++.++|||||||++|||+||+.||...... ..+. .+...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~-~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLD-LITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHH-HHHHHhCCCCHHH
Confidence 32211 111134568899999998743 256889999999999999999999999653221 1100 00000
Q ss_pred ---HhhCC---cccccCCC----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 ---LEEGN---VLDCVDPS----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ---~~~~~---~~~~~d~~----l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.... ....+... ...........+.+++.+||+.+|++|||++|++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 00000000 000011234467899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.84 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=203.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.++..+.||+|+||.||+|.+. +++.||+|.+.... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 34566779999999999999986 56789999986443 2356799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999998752 34689999999999999999999998 99999999999999999999999999998765322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. .......+..|+|||+. ....++.++||||||+++|||+| |+.||..... ..... .+......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~------ 223 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQ----QVDQGYRM------ 223 (261)
T ss_pred cc-ccCCCcCceeccCcccc-ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHH----HHHcCCCC------
Confidence 11 11122234579999987 55678999999999999999999 9999864321 11111 11111110
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+......+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1233445678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.69 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=208.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+...|+..+.||+|+||.||+|.+.. ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 45667888899999999999999985 8899999986543 223567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 82 ELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999998752 35689999999999999999999998 999999999999999999999999999976643
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... . .....++..|+|||.. ....++.++||||||+++|+|++ |+.||...... . .... .. .+..
T Consensus 157 ~~~-~-~~~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~-~~~~---~~-~~~~----- 222 (261)
T cd05148 157 DVY-L-SSDKKIPYKWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-E-VYDQ---IT-AGYR----- 222 (261)
T ss_pred ccc-c-ccCCCCceEecCHHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-H-HHHH---HH-hCCc-----
Confidence 211 1 1233456789999987 45578899999999999999998 89999653311 1 1111 11 1111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 112344556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.32 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=194.3
Q ss_pred eeccccceEEEEEEECC--CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 561 EVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.||+|+||.||+|.... ....+|+|.+...........|.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 68999999999997632 3457888887544333344678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCC-CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 639 LQAKLHERLPS-TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 639 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
|.+++...... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999875322 23456788899999999999999998 999999999999999999999999999875443222222
Q ss_pred ccccccccccCCcccccC------cCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 718 SNRFQSALGYVAPELTCQ------SLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~------~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.....++..|+|||+... ...++.++|||||||++|||++ |..||..... ...+.. ...... ....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~----~~~~~~-~~~~~ 232 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQ----VVREQD-IKLPK 232 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHH----HhhccC-ccCCC
Confidence 233445678999998632 2356889999999999999999 7788864322 111111 111111 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
+ ..+......+.+++..|| .||++|||++||++.|.
T Consensus 233 ~---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 P---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred C---cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 123345566778999999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.12 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=205.0
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..+...|+..+.||+|+||.||+|....+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3456678888899999999999999988899999999864432 234567899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.++++.. ..+++..+..++.|++.|+.|||+. +|+|||+||+||++++++.+||+|||+++.+
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceee
Confidence 99999999999998754 4578999999999999999999998 9999999999999999999999999999865
Q ss_pred cccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
..... ......++..|+|||.+. ....++.++|||||||++|||++|+.||.......... . .....
T Consensus 157 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~-----~~~~~--- 225 (267)
T cd06646 157 TATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-L-----MSKSN--- 225 (267)
T ss_pred ccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-e-----eecCC---
Confidence 42211 113346788899999863 23447889999999999999999999986432211100 0 00000
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
...+... ........+.+++.+||..+|++|||++++++++
T Consensus 226 ~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0011111 1223446788999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=328.73 Aligned_cols=243 Identities=26% Similarity=0.352 Sum_probs=194.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|.+..+++.||+|.+..... ....+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999988899999999865421 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 9999999764 4588999999999999999999998 999999999999999999999999999875322111
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||..... ..+.+.+ .... + .+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i----~~~~------~---~~ 215 (316)
T cd05619 152 KTCTFCGTPDYIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSI----RMDN------P---CY 215 (316)
T ss_pred ceeeecCCccccCHHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCC------C---CC
Confidence 11345688999999988 556789999999999999999999999965322 1111111 1111 1 12
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 827 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~-evl~ 827 (843)
+.....++.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 233445678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.04 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=207.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-------CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFG-------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT 623 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 623 (843)
+.+.+...+.||+|+||.||+|... ..+..||+|.+...........+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4456777889999999999999863 234578999886543333345788999999999 69999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEE
Q 003156 624 PQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 691 (843)
Q Consensus 624 ~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 691 (843)
.+..++||||+++|+|.+++....+ ....++|.++..++.|++.||.|||++ +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 8889999999999999999987432 124589999999999999999999998 9999999999999
Q ss_pred EcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchh
Q 003156 692 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 770 (843)
Q Consensus 692 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~ 770 (843)
+++++.+||+|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHH-ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999876543222211222344679999987 45678999999999999999999 88888543211
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 771 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.... ....+.. ...+..+..++.+++.+||..+|++|||+.|+++.|+++...
T Consensus 244 ~~~~----~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFK----LLREGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHH----HHHcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1111 1111111 112344556788999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=324.59 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=194.9
Q ss_pred hhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCCcc-cChHHHHHHHHHHHhc---cCCCccceeeEEEc-----CC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWT-----PQ 625 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~ 625 (843)
|+..+.||+|+||.||+|++.. +++.||+|.+...... .....+.+|+.+++.+ +||||++++++|.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 5566789999999999999853 4688999998654322 2334567788877766 69999999999852 34
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 5789999996 68999997642 34588999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh---h
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE---E 782 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~---~ 782 (843)
++..... .......|+..|+|||.+ ....++.++|||||||++|||++|+.||...... ..+...+..... .
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC---cccccccccccccChHHH-hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence 9765432 122445688999999988 4557899999999999999999999999754322 222222211000 0
Q ss_pred CCc------ccccCCCCC----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNV------LDCVDPSMG----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~------~~~~d~~l~----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ...+.+... ....+....+.+++.+|++.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 000100000 0112344567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.60 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=193.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|.+..+|+.||+|.+..... ....+.+..|..++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 369999999999999998999999999865421 12345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 9999998764 4588899999999999999999998 999999999999999999999999999874322111
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++ .+..++.++||||+||++|||++|+.||..... ..+ .+. +... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~---~~~-~~~~---------~~~~ 215 (316)
T cd05620 152 RASTFCGTPDYIAPEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DEL---FES-IRVD---------TPHY 215 (316)
T ss_pred ceeccCCCcCccCHHHH-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHH---HHH-HHhC---------CCCC
Confidence 12345689999999988 556789999999999999999999999964322 111 111 1111 1112
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 827 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~-evl~ 827 (843)
+.....++.+++.+|++.||++||++. ++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 333455788999999999999999985 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.58 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=200.4
Q ss_pred CeeccccceEEEEEEECCCC---eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
++||+|+||.||+|.+...+ ..+|+|.+.........+.+.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999885444 7899999865544334567899999999999999999999876 4467899999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999875 3689999999999999999999998 99999999999999999999999999998765433221
Q ss_pred e-ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 717 M-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 717 ~-~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
. .....++..|+|||.. ....++.++|||||||++|||++ |+.||..... ......+ ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGERL-------- 217 (257)
T ss_pred ccccCccccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCcC--------
Confidence 1 1122335679999988 55578999999999999999998 9999865422 1222221 111111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
..+...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 123345567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=330.90 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=199.4
Q ss_pred hhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 628 (843)
|+..+.||+|+||.||+++.. .+++.||+|.+..... ....+.+..|+.+++.+ +||+|+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 445678999999999998873 3678999999865321 22345678899999999 5899999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++..+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999764 4588999999999999999999998 999999999999999999999999999986
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
........ .....||..|+|||++.....++.++|||||||++|||+||+.||........ ..........
T Consensus 155 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------- 225 (332)
T cd05614 155 FLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------- 225 (332)
T ss_pred ccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-------
Confidence 54322221 23456899999999885445578899999999999999999999964322111 1111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
.++ ..+......+.+++.+|++.||++|| ++++++++
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 12334455688999999999999999 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=330.43 Aligned_cols=244 Identities=24% Similarity=0.326 Sum_probs=196.6
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|++..+++.||+|.+..... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999999988899999999865322 22335677889988876 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 9999998764 4588999999999999999999998 99999999999999999999999999987543211 1
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++ ....++.++|||||||++|||++|+.||...... . ....... +. ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~---~~~~i~~-~~---------~~~ 215 (321)
T cd05591 152 TTTTFCGTPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--D---LFESILH-DD---------VLY 215 (321)
T ss_pred cccccccCccccCHHHH-cCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--H---HHHHHHc-CC---------CCC
Confidence 12345689999999988 5567899999999999999999999999754321 1 1111111 11 012
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRP-------SMAEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RP-------s~~evl~~ 828 (843)
+.....++.+++.+|++.||++|| ++.+++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 233445788999999999999999 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=329.18 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=195.7
Q ss_pred CeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 560 AEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.||+|+||.||++... .+++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 47999999999999873 3678999999865322 12234677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999999764 4577888899999999999999998 99999999999999999999999999987543211
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. ......|++.|+|||++ ....++.++|||||||++|||++|+.||...... ........ +.
T Consensus 155 ~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~-~~--------- 216 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILK-GK--------- 216 (323)
T ss_pred C--cccccCCCccccChhhc-cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc-CC---------
Confidence 1 12345689999999988 4556889999999999999999999999653221 11111111 11
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
...+......+.+++.+|++.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 112334456788999999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.75 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=211.0
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccCh--HHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
..+|+..|...+.||.|+||.||-|++..+.+.||||++.-+...... .++.+|+.+|++++|||+|.+-|+|.....
T Consensus 21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence 457889999999999999999999999989999999999655432222 468899999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.+|||||| -|+-.+.+.-. ..++-+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|
T Consensus 101 aWLVMEYC-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred HHHHHHHH-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 99999999 56777777765 35688889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
..+.+ ...+.||+.|||||++. ..+.|+-++||||+|++..|+.-+++|+..++. ...+....+ .
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQ---N--- 240 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ---N--- 240 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHh---c---
Confidence 87654 25678999999999863 457899999999999999999999999865432 111111111 1
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
-.|.+. ..+....+..++..|+++-|.+|||.++++.+-
T Consensus 241 ----esPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 241 ----ESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ----CCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 112222 334456688999999999999999999998874
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.93 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=206.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..++..+.||+|+||.||+|.+..+|+ .||+|.............+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456667799999999999999865554 5899987655433344678899999999999999999999987 67889
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|+||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999874 24589999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.............++..|+|||.. ....++.++||||||+++||+++ |+.||..... ..+.. .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~~~--- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPD----LLEKGER--- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHH----HHhCCCC---
Confidence 543332222223345689999987 55678899999999999999998 9999865422 11111 1111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+..+..++.+++.+||..+|++|||+.++++.|+.+.+
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11233345578899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.57 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=205.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
++++|+..+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+++++.++|||++++++++..++..++|+
T Consensus 3 ~~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 3 PEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 5778888889999999999999998889999999885433 233567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|..++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 82 EFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccc
Confidence 999999999988753 24689999999999999999999998 999999999999999999999999999876533
Q ss_pred cccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
... ......++..|+|||++. ....++.++|||||||++|||++|+.||....... ..... .. ..
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~----~~-~~--- 224 (282)
T cd06643 156 TIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKI----AK-SE--- 224 (282)
T ss_pred ccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHH----hh-cC---
Confidence 211 123446788999999873 23457789999999999999999999986532211 11111 11 10
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.+.. ..+.....++.+++.+||+.+|++|||+.+++++-
T Consensus 225 --~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 225 --PPTL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0111 12233456788999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.39 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=198.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC-----eeEEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLLV 630 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV 630 (843)
+..+.||+|+||.||+|....+|+.||+|++..... ....+.+.+|+++++.++||||+++++++..++ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 456689999999999999988899999999854321 123457889999999999999999999998776 78999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
+||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 83 TELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 99996 5788877653 4689999999999999999999998 99999999999999999999999999998654
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHH--------------
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV-------------- 776 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~-------------- 776 (843)
..... ......++..|+|||++.+...++.++||||+||++|||++|+.||...... ..+....
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHh
Confidence 32221 1133457888999998855566899999999999999999999999653221 1111110
Q ss_pred ----HHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 777 ----RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 777 ----~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+......................++.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000001222335678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.25 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=205.6
Q ss_pred hhhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--Cee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 627 (843)
.+|+..+.||+|+||.||.+.+ ..++..||+|.+.........+.+.+|++++++++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4567888999999999999985 3357889999986554344456899999999999999999999999875 567
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||+++++|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999999764 23589999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC----------chhhHHHHH
Q 003156 708 LLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED----------NVVILSEHV 776 (843)
Q Consensus 708 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~----------~~~~l~~~~ 776 (843)
........ .......++..|+|||.. .+..++.++|||||||++|||+|++.|...... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECL-IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHh-ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 76432221 112344567789999987 455688999999999999999998776532210 011111111
Q ss_pred HHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 777 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
.. ...+.. ...+...+.++.+++.+||+.+|++|||+.++++.++.+
T Consensus 237 ~~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RV-LEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 111111 112334566899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=336.99 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=196.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||+||+|+...+++.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 45667899999999999999989999999999654322 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999764 3578888999999999999999998 99999999999999999999999999976431100
Q ss_pred c---------------------------------------------ceeccccccccccCCcccccCcCCCCCchhHHHH
Q 003156 714 K---------------------------------------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 748 (843)
Q Consensus 714 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~ 748 (843)
. ........||+.|+|||++ ....++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSl 234 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-LRKGYTQLCDWWSV 234 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH-cCCCCCCccceeeh
Confidence 0 0001234689999999988 45568999999999
Q ss_pred HHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHH--ccCCCCCCCCCHHHHH
Q 003156 749 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALV--CTCHIPSSRPSMAEVV 826 (843)
Q Consensus 749 Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~--c~~~~P~~RPs~~evl 826 (843)
||++|||++|+.||.......... ......... ..+. ......++.+++.+ |+..+|..||+++|++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~-----~i~~~~~~~-----~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQL-----KVINWENTL-----HIPP-QVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHH-----HHHcccccc-----CCCC-CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999997543221111 111100000 0111 11233456677766 5666777799999998
Q ss_pred HH
Q 003156 827 QI 828 (843)
Q Consensus 827 ~~ 828 (843)
.+
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.18 Aligned_cols=260 Identities=27% Similarity=0.357 Sum_probs=201.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe--EEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.++..+.||+|+||.||+|.+..++. .+|+|.+.........+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 345666789999999999999876665 45777765433333345788999999999 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 631 SDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
+||+++|+|.++++.... ....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999986421 124688999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~ 777 (843)
||+|||+++...... ......++..|+|||.+ ....++.++|||||||++|||+| |..||...... .. .+
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~---~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL---YE 234 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HH---HH
Confidence 999999986432111 11122345679999987 55568899999999999999998 99998643221 11 11
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
. ...+.. ...+......+.+++.+||+.+|++||++.++++.++.+..
T Consensus 235 ~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 K-LPQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred H-HhcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111110 01122344568899999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.07 Aligned_cols=244 Identities=24% Similarity=0.306 Sum_probs=197.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|.+..+++.||+|.+..... ....+.+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999988899999999875421 22345677899998888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 9999988764 3689999999999999999999998 999999999999999999999999999875322111
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......|+..|+|||++ .+..++.++|||||||++|||++|+.||..... .. ..... .... ..+
T Consensus 152 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~---~~~~i-~~~~---------~~~ 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DE---LFQSI-LEDE---------VRY 215 (318)
T ss_pred cccceecCccccCHHHh-cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HH---HHHHH-HcCC---------CCC
Confidence 11334688999999988 556789999999999999999999999964321 11 11111 1111 012
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~-----~evl~~ 828 (843)
+......+.+++.+||+.||++|||+ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 33445678899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.27 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=203.3
Q ss_pred hhhhcCeeccccceEEEEEEECCCCe---EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.++..+.||+|+||.||+|....+++ .+|+|.+.........+.+..|++++++++|||++++.+++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 45566789999999999999865443 799998855433333567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++.....
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 86 EYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999764 24689999999999999999999998 999999999999999999999999999976643
Q ss_pred ccccee-ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
...... ......+..|+|||++ ....++.++|||||||++|||++ |+.||...... +..+.. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i-~~~~----- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAI-NDGF----- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHh-hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHH-hcCC-----
Confidence 222111 1112234579999988 45578999999999999999997 99999643221 111111 1111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
....+.+.+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=329.75 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=194.8
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHH---HhccCCCccceeeEEEcCCeeEEEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVL---GKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+..+.||+|+||.||+|.+..+++.||||.+..... ....+.+.+|+.++ +.++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 345689999999999999988899999999865431 12234566676655 4567999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|..+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988864 3589999999999999999999998 999999999999999999999999999875332
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .......|+..|+|||.+ .+..++.++|||||||++|||++|+.||...... ........ +.
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~-~~------- 217 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVN-DE------- 217 (324)
T ss_pred CC--CcccccccCccccCHhHh-cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-CC-------
Confidence 11 112345688999999988 5567899999999999999999999999653221 11111111 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++......+.+++.+|++.||++|| ++.+++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112334456788999999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.14 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=197.9
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHH
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 640 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 640 (843)
.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 6899999999999975 788999998865433333457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccc
Q 003156 641 AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720 (843)
Q Consensus 641 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 720 (843)
+++... ...+++..+..++.|++.|+.|+|+. +++||||||+||++++++.+|++|||++........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 998764 24578999999999999999999988 999999999999999999999999999875432211 11122
Q ss_pred cccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 721 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 721 ~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
..++..|+|||+. ....++.++||||||+++||+++ |..||...... ... ..+..+... ..+..
T Consensus 154 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~----~~~~~~~~~--------~~~~~ 218 (250)
T cd05085 154 KQIPIKWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAR----EQVEKGYRM--------SCPQK 218 (250)
T ss_pred CCCcccccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHH----HHHHcCCCC--------CCCCC
Confidence 2345679999988 55678999999999999999998 99998654221 111 111111111 12334
Q ss_pred hHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.+.++.+++.+||..+|++|||+.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=327.88 Aligned_cols=264 Identities=26% Similarity=0.379 Sum_probs=207.0
Q ss_pred hhhhhcCeeccccceEEEEEEECC-------CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
..|+..+.||+|+||.||+|.+.. .+..||+|.+.........+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 346778899999999999998632 22368999876443333456789999999999 7999999999999998
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 693 (843)
..++|+||+++|+|.+++....+ ....++|.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999986432 234588999999999999999999998 999999999999999
Q ss_pred CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhH
Q 003156 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVIL 772 (843)
Q Consensus 694 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l 772 (843)
+++.+||+|||+++...............++..|+|||++ ....++.++|||||||++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHh-ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999866543322222223345679999988 55678899999999999999998 8888854321
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.+.... +..+.. ...+.....++.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 243 ~~~~~~-~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 EELFKL-LKEGHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHH-HHcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111111 111111 112334556788999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=349.95 Aligned_cols=264 Identities=19% Similarity=0.217 Sum_probs=203.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.|+..+.||+|+||.||+|.+..+|+.||+|++..... ....+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 35667799999999999999988899999999864322 1234578999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCC-------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 633 YAPNGSLQAKLHERLP-------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
|+++|+|.+++..... .....++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999975311 123467788899999999999999998 999999999999999999999999999
Q ss_pred ccccccccc----------------ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch
Q 003156 706 ARLLTRLDK----------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769 (843)
Q Consensus 706 ~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~ 769 (843)
++....... ........||+.|+|||.+ .+..++.++|||||||++|||+||+.||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh-cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 986621110 0011234689999999988 55678999999999999999999999996532211
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhccC
Q 003156 770 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-SMAEVVQILQVIKT 834 (843)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-s~~evl~~L~~~~~ 834 (843)
.... .. ..++.-.....+.+..+.+++.+|++.||++|| +++++.+.|+....
T Consensus 239 i~~~---------~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR---------DV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh---------hh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 00 001100001123445688999999999999995 66777777877644
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.71 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=205.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|++++++++||||+++++++......++||
T Consensus 2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 45667777889999999999999987899999998864443334467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||+++....
T Consensus 82 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 82 EYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999999998864 3578999999999999999999998 999999999999999999999999999976543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||.+ .+..++.++|||||||++|||++|+.|+........ .. .+..+
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~----~~~~~-------- 216 (277)
T cd06642 154 TQI--KRNTFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF----LIPKN-------- 216 (277)
T ss_pred cch--hhhcccCcccccCHHHh-CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh----hhhcC--------
Confidence 221 11234577889999988 555788999999999999999999999864322111 00 01111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
............+.+++.+||+.+|++|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112234455678899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.07 Aligned_cols=256 Identities=23% Similarity=0.427 Sum_probs=202.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCe---EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
++..+.||+|+||.||+|.+..+++ .||+|.+.........++|..|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 4566789999999999999976554 6999998654333345689999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 86 FMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred cCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999864 24689999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccee-ccccc--cccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 713 DKHVM-SNRFQ--SALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 713 ~~~~~-~~~~~--g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
..... ..... .+..|+|||.+ ....++.++|||||||++||+++ |..||...... ....++ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i----~~~~~--- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI----EQDYR--- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH----HcCCc---
Confidence 22111 11111 24579999988 55678999999999999999886 99998643221 111111 11110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
. ..+.+++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 230 ----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ----L-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----C-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 11334456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.25 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=199.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
++..+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 556678999999999999986 56789999875433 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||+++...+....
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999998642 3689999999999999999999998 9999999999999999999999999999865432211
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||.+ ....++.++||||||+++||+++ |+.||...... . .... ...+. ..
T Consensus 157 -~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~-~~~~----~~~~~-----~~--- 220 (256)
T cd05059 157 -SSQGTKFPVKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-E-VVES----VSAGY-----RL--- 220 (256)
T ss_pred -ccCCCCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-H-HHHH----HHcCC-----cC---
Confidence 11222344679999988 45578999999999999999999 88998643221 1 1111 11111 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12334566799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.37 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=203.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
+..+.||+|+||.||+|....+++.||+|.+..... ....+.+.+|++++++++|||++++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 345689999999999999988899999999864322 2345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+++|.++++.. ....+++..++.++.|++.|+.|||+. +++||||||+||++++++.++++|||+++........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 83 NGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999999875 235689999999999999999999998 9999999999999999999999999999866543221
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
.....++..|+|||+. ....++.++|||||||++|||++|+.||..... .. ..+.. ..+. ...
T Consensus 158 --~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~-~~~~--------~~~ 220 (256)
T cd08529 158 --ANTIVGTPYYLSPELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GA---LILKI-IRGV--------FPP 220 (256)
T ss_pred --hhccccCccccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHH-HcCC--------CCC
Confidence 1334577889999988 455688999999999999999999999965431 11 11111 1111 112
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+.....++.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 233455678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.04 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=202.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|....+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 4556789999999999999998999999999875432 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999875 24689999999999999999999998 99999999999999999999999999998765322
Q ss_pred cceeccccccccccCCcccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQ-----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.. ......||+.|+|||++.. ...++.++|||||||++|||++|+.||...... ...............
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~~ 230 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRFLKF 230 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCccCC
Confidence 22 2234568899999998742 445789999999999999999999999654221 111111111111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+ ........+.+++..|++ +|++|||+.+++++
T Consensus 231 -----~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 231 -----P-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----C-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 112234567889999997 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.93 Aligned_cols=253 Identities=29% Similarity=0.412 Sum_probs=206.7
Q ss_pred CeeccccceEEEEEEECCC---CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|..... +..||+|.+.........+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3689999999999999755 8899999986554333357889999999999999999999999998899999999999
Q ss_pred CCHHHHHhhcCCC-----CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 637 GSLQAKLHERLPS-----TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 637 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|+|.+++...... ...+++..++.++.|+++|++|||+. +++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875322 36789999999999999999999998 999999999999999999999999999987765
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
...........++..|+|||.+ ....++.++||||+||++|||++ |..||..... ..+ .+. ...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~---~~~-~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESL-KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEV---LEY-LRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHh-ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHH---HHH-HHcCC------
Confidence 4322233445677889999988 44478999999999999999999 6999875421 111 111 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
....+...+.++.+++.+||+.+|++|||+.|++++|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11234444667899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.24 Aligned_cols=259 Identities=27% Similarity=0.345 Sum_probs=201.3
Q ss_pred hhhhcCeeccccceEEEEEEECCCCe--EEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.|+..+.||+|+||.||+|....++. .+|+|.+.........+.+.+|+++++++ +||||+++++++...+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35566789999999999999876654 46888875433233346788999999999 7999999999999988899999
Q ss_pred EeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcE
Q 003156 632 DYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 699 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 699 (843)
||+++|+|.++++.... ....+++..++.++.|++.|++|||+. +|+||||||+||++++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEE
Confidence 99999999999976421 123588999999999999999999998 999999999999999999999
Q ss_pred EeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHH
Q 003156 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~ 778 (843)
|+|||++...... ........+..|+|||+. ....++.++|||||||++|||++ |..||...... .....
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~~ 230 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYEK 230 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH
Confidence 9999998643211 111112234579999987 55568999999999999999997 99999654221 11111
Q ss_pred HHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+. ....+......+.+++.+||+.+|.+|||++++++.|+.+..
T Consensus 231 -~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 -LPQGY--------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -HhcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 011233455678899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.85 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=197.2
Q ss_pred eeccccceEEEEEEE--CCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 561 EVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
+||+|+||.||+|.+ ..++..+|+|++...... ...+.+.+|+.+++.++||||++++|++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999976 346788999988544322 23457889999999999999999999885 45678999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999764 3588999999999999999999998 999999999999999999999999999987654332211
Q ss_pred -ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 718 -SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 718 -~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
.....++..|+|||.+ ....++.++|||||||++|||++ |+.||..... ....+. +..+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----i~~~~~--------~~ 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQM----IESGER--------ME 218 (257)
T ss_pred ecCCCCCCccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHCCCC--------CC
Confidence 1222345789999987 55578899999999999999998 9999965422 111111 222211 11
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
.+...+.++.+++.+||+.||++||++.+|++.|+..
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2344566788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=314.54 Aligned_cols=252 Identities=27% Similarity=0.373 Sum_probs=193.3
Q ss_pred eeccccceEEEEEEECC---CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc-CCeeEEEEEeCCC
Q 003156 561 EVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKLLVSDYAPN 636 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~~ 636 (843)
.||+|+||.||+|.+.. .+..||+|++.........+.+.+|+.+++.++||||+++++++.. ++..++|+||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 68999999999998742 3467999987543333345678899999999999999999998764 4457899999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ....++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++.+.......
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 82 GDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999864 23467788899999999999999998 99999999999999999999999999997654322111
Q ss_pred --eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCC-CCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 717 --MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR-PVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 717 --~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
......++..|+|||.+ ....++.++|||||||++|||++|+. ||... . ...+.. .. ..+. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~-~~~~~~---~~-~~~~--------~ 220 (262)
T cd05058 156 VHNHTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-D-SFDITV---YL-LQGR--------R 220 (262)
T ss_pred ecccccCcCCccccChhHh-ccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-C-HHHHHH---HH-hcCC--------C
Confidence 11233456789999987 45578999999999999999999654 45432 1 111111 11 1111 0
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1112334557889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=297.63 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=205.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
++.|+..+.||+|+|+.||++....+|+.+|+|.+...... ...+++.+|+.+-+.++||||+++...+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45577777899999999999999999999999987544322 24567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~ 708 (843)
|+|.||+|..-|-.+ ...++..+-..+.||+.+|.|.|.+ +|||||+||+|+++.. ..-+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766554 4578888889999999999999999 9999999999999963 34599999999998
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
+.. ........||++|||||++ ...+|+..+|||+.||++|-++.|+.||..... ...+.... .+.. +
T Consensus 163 l~~---g~~~~G~~GtP~fmaPEvv-rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~-----~g~y-d- 230 (355)
T KOG0033|consen 163 VND---GEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIK-----AGAY-D- 230 (355)
T ss_pred eCC---ccccccccCCCcccCHHHh-hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHh-----cccc-C-
Confidence 772 2233677899999999998 556799999999999999999999999975322 22222211 1111 1
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+++ .......++...|+++|+..||.+|.|+.|++.+-
T Consensus 231 ~~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 231 YPS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred CCC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 111 12334455678899999999999999999998763
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=313.91 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=202.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
|+..+.||+|++|.||+|....+++.||+|.+...... ...+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 55677999999999999999888999999998644321 12356888999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999864 3578899999999999999999998 999999999999999999999999999976543
Q ss_pred ccccee-ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
...... .....++..|+|||.. .+..++.++||||+|+++|||++|+.||......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~-------- 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-----FKIATQ-------- 222 (263)
T ss_pred cccccccccCCCcCccccCccee-ccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-----HHHhcc--------
Confidence 221111 0234567889999988 4556899999999999999999999998654221111 111010
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
......+......+.+++.+||..+|++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112344556678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.84 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=203.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
+.++..+.||+|+||.||+|.+..+|. .||+|.+...........+.+|+.+++.++||||++++|++..+ ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 445666789999999999999866665 47888875443333344788999999999999999999999765 4679
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999864 24588999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.............++..|+|||.+ .+..++.++|||||||++||+++ |+.||..... ..... ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPD----LLEKGERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHCCCCC--
Confidence 533322222233456789999987 55678999999999999999997 8999864321 11112 12211111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
..+..+..++.+++.+||..+|++||+++++++.|+.+...
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11233456788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=313.59 Aligned_cols=257 Identities=20% Similarity=0.297 Sum_probs=192.6
Q ss_pred eeccccceEEEEEEECCC--CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 561 EVGEGVFGTVYKVSFGTQ--GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.||+|+||.||+|....+ ...+++|.+.........+.|.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999986432 235667776544433445789999999999999999999999999989999999999999
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceec
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 718 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 718 (843)
|.++++.........++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999987543344567777889999999999999998 9999999999999999999999999998643222211122
Q ss_pred cccccccccCCcccccC------cCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 719 NRFQSALGYVAPELTCQ------SLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 719 ~~~~g~~~y~aPE~~~~------~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
....++..|+|||+... ...++.++|||||||++|||++ |..||..... ...+ ...... ......++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~----~~~~~~-~~~~~~~~ 232 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVL----NHVIKD-QQVKLFKP 232 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHhh-cccccCCC
Confidence 34567788999998632 1245789999999999999997 5667754322 1111 111221 11222333
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.+ .......+.+++..|| .+|++||+++|+++.|.
T Consensus 233 ~~---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QL---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cc---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 32 2234456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.04 Aligned_cols=252 Identities=29% Similarity=0.393 Sum_probs=197.4
Q ss_pred eeccccceEEEEEEECCCCe--EEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 561 EVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.||+|+||.||+|.+..++. .+|+|.+.........+.+.+|+++++++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999976665 46888875433333446788999999999 7999999999999998999999999999
Q ss_pred CHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 638 SLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 638 sL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
+|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 99999986421 123578999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
++..... ........+..|+|||++ ....++.++|||||||++|||++ |+.||...... ...+. +..+.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~-~~~~~ 228 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEK-LPQGY 228 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHH-HhCCC
Confidence 8632211 111122335679999987 55678999999999999999997 99999643211 11111 11111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
.. ..+.....++.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 229 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL--------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC--------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11 122334457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.33 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=201.5
Q ss_pred hhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
+...++||+|+||.||+|... .++..+|+|.+.... ....+.+.+|+++++.++|+||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 445668999999999999752 246688999875432 23346789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCC-----------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcE
Q 003156 631 SDYAPNGSLQAKLHERLPS-----------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 699 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 699 (843)
|||+++|+|.+++....+. ...+++..++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence 9999999999999865321 13588999999999999999999998 999999999999999999999
Q ss_pred EeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHH
Q 003156 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~ 778 (843)
|+|||+++.+.............+++.|+|||.+ ....++.++|||||||++|||++ |..||....... ....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~ 236 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-----AIEC 236 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----HHHH
Confidence 9999999765433222222333456789999987 55578999999999999999998 899985432211 1111
Q ss_pred HHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
...+... ..+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus 237 -~~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 -ITQGREL--------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HHcCccC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111110 1123445678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.34 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=203.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|+||.||++.+..+++.+|+|.+.........+.+.+|+.++++++||||+++++.+.+.+..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 34567899999999999999888999999998654444455778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++.... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++++|||.++.......
T Consensus 82 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 82 GGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999987642 34578899999999999999999998 999999999999999999999999999976543221
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
......++..|+|||++ ....++.++||||||+++|+|++|..||...... ..... +..+.. ..
T Consensus 156 -~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~--------~~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILK-VCQGSY--------KP 219 (255)
T ss_pred -ccccccCCccccCHHHH-ccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHH-HhcCCC--------CC
Confidence 11345678889999988 5556899999999999999999999999643211 11111 111111 11
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+......+.+++.+||+.||++|||+.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 233344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.94 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=196.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccC-CCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e 632 (843)
|+..+.||+|+||.||+|....+++.||+|.+..... ....+.+..|.++++.++| ++|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 3456689999999999999988889999999865321 2234567889999999976 568889999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999764 4588999999999999999999998 9999999999999999999999999998743211
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......||..|+|||++ .+..++.++||||+||++|||+||+.||...... . ...... ...
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~---~~~~i~-~~~-------- 217 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--E---LFQSIM-EHN-------- 217 (324)
T ss_pred CC--ceeeecCCccccChhhh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--H---HHHHHH-cCC--------
Confidence 11 12345689999999988 5557899999999999999999999999754221 1 111111 111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~-----~evl~~ 828 (843)
..++.....++.+++.+|+..+|.+|++. .++.++
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12233445678899999999999999986 566553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.41 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=203.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCC---eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.|+..+.||+|+||.||+|.+..++ ..+|+|.+.........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4556779999999999999985433 4799998854433333467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||+++.+..
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 85 EYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999864 24589999999999999999999998 999999999999999999999999999987654
Q ss_pred ccccee-ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
...... .....++..|+|||.+ ....++.++|||||||++||+++ |..||....... .... +..+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~----~~~~~~---- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKA----IEEGYR---- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHh-ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHH----HhCCCc----
Confidence 322211 1122235679999988 55578999999999999999886 999986432211 1111 111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+...+..+.+++.+||+.+|++||+|.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011233456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=312.91 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=202.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..++||+|+||.||+|.+. ++..||+|++.... ...+.+.+|++++++++||||+++++++.+ ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec-CCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 455778889999999999999986 44569999986433 234678999999999999999999998754 55789999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++.+...
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999998642 34578999999999999999999998 9999999999999999999999999999866543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||+. ....++.++|||||||++|||+| |..||....... .. . .+..+..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~----~-~~~~~~~------ 221 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VL----D-QVERGYR------ 221 (262)
T ss_pred ccc-cccCCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HH----H-HHhcCCC------
Confidence 321 11234456789999987 55578999999999999999999 888886432211 11 1 1111110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 222 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 012334556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=312.69 Aligned_cols=254 Identities=29% Similarity=0.434 Sum_probs=202.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||+++++++++. ....++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 345777889999999999999886 677899999865432 3567999999999999999999999875 456789999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++++|.++++... ...+++.+++.++.|++.|++|||+. +++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999998642 34589999999999999999999998 9999999999999999999999999999866432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.... .....++..|+|||.. ....++.++||||||+++|||++ |..||..... . ..... +..+..
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~-~~~~~----~~~~~~------ 221 (260)
T cd05070 156 EYTA-RQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-R-EVLEQ----VERGYR------ 221 (260)
T ss_pred cccc-ccCCCCCccccChHHH-hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-H-HHHHH----HHcCCC------
Confidence 2211 1223456679999987 55678999999999999999999 8888864321 1 11111 111110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
...+...+..+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11234455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.67 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=200.1
Q ss_pred eeccccceEEEEEEECCCC------eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 561 EVGEGVFGTVYKVSFGTQG------RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.||+|+||.||+|.+.... +.+|+|.+...........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6899999999999985322 6799998865433344567899999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhcCC---CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-----CcEEeeccCc
Q 003156 635 PNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-----NPRISDFGLA 706 (843)
Q Consensus 635 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfgl~ 706 (843)
++|+|.+++..... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999986422 224578999999999999999999988 999999999999999877 8999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+.....+.........++..|+|||.+ ....++.++|||||||++|||+| |+.||..... ......+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~----~~~~- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV----TAGG- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHH-ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH----hcCC-
Confidence 866433322222333456789999988 55678999999999999999998 9999864321 1111111 1111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
....+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111233455678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=316.65 Aligned_cols=262 Identities=22% Similarity=0.361 Sum_probs=209.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||+||+|.+..+|+.||+|.+.........+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677789999999999999998889999999986554444567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.+++.|+.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999998764 35899999999999999999999742 89999999999999999999999999987543211
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch------hhHHHHHHHHHhhCCccc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV------VILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~------~~l~~~~~~~~~~~~~~~ 787 (843)
.....|+..|+|||++ ....++.++|||||||++||+++|+.||....... ..............
T Consensus 159 ----~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERI-QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred ----cCccccCcccCCHHHH-ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 1345688899999987 44578899999999999999999999997543211 11112222211111
Q ss_pred ccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 788 CVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 788 ~~d~~l~~~~-~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
....+ ...+..+.+++.+||+.||++|||+.|++++..-++..
T Consensus 230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 11111 22456788999999999999999999999986555443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=316.65 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=197.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
++..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45566899999999999999888999999998654333334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99986542 367788899999999999999998 99999999999999999999999999997654321
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhh--HHHHHHHHHhhCCcccccCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI--LSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.....++..|+|||++ .+..++.++|||||||++|||++|+.||......... .....+..... ..+.+
T Consensus 150 --~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERI-SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE------DPPVL 220 (279)
T ss_pred --ccCCCCChhhcCceee-cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc------CCCCC
Confidence 1345688899999988 4557899999999999999999999999653221111 11111111100 01111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
. ......++.+++.+||+.+|++||+++|++++-
T Consensus 221 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 221 P--VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred C--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1 122345688999999999999999999998873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.17 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=200.4
Q ss_pred hhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKL 628 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 628 (843)
.++..+.||+|+||.||+|.. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 455667899999999999985 3468899999985443 22346788999999999999999999987543 4578
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999764 24589999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch----------hhHHHHHH
Q 003156 709 LTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV----------VILSEHVR 777 (843)
Q Consensus 709 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~----------~~l~~~~~ 777 (843)
........ ......++..|+|||.. .+..++.++|||||||++|||++|..|+....... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHh-ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65432211 11122334569999988 55578999999999999999999887764321100 00000011
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...... .....+...+.++.+++.+||..+|++|||+.|+++.|+.++
T Consensus 237 ~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 237 ELLKNN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHhcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 111111 011123445567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.34 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=202.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||+||+|....+|+.||+|++..... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 4566789999999999999988899999999865432 12345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999875 4688999999999999999999998 99999999999999999999999999998664332
Q ss_pred ---------------------------cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC
Q 003156 714 ---------------------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 766 (843)
Q Consensus 714 ---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~ 766 (843)
.........||..|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHH-cCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00112345688999999988 45578999999999999999999999997543
Q ss_pred CchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 003156 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-MAEVVQI 828 (843)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-~~evl~~ 828 (843)
... ........... . ..+. ......++.+++.+|+. +|++||+ ++|++++
T Consensus 235 ~~~-----~~~~i~~~~~~--~---~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE-----TYNKIINWKES--L---RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH-----HHHHHhccCCc--c---cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 11111110000 0 0111 11135678899999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.80 Aligned_cols=264 Identities=23% Similarity=0.281 Sum_probs=202.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 35667789999999999999988899999999865544444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 87 D-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 7 6899988764 34578899999999999999999998 999999999999999999999999999975432211
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH-----------HHhhC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV-----------LLEEG 783 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~-----------~~~~~ 783 (843)
......++..|+|||.+.....++.++|||||||++|||+||+.||...... ..+....+. .....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhccc
Confidence 1123356788999998755566889999999999999999999999754221 111111100 00000
Q ss_pred CcccccCCCC-----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPSM-----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~l-----~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.....-.+.. ..........+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000 00112334567899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=314.51 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=202.5
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC-----
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP----- 624 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----- 624 (843)
++.+.|+..+.||+|+||.||+|....+++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 46677888889999999999999998889999999986443 3346788999999998 699999999998753
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeec
Q 003156 625 -QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703 (843)
Q Consensus 625 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 703 (843)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 35789999999999999998642 34688999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 779 (843)
|+++....... ......|+..|+|||++.. ...++.++|||||||++|||++|+.||......... . .
T Consensus 156 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~----~--~ 227 (272)
T cd06637 156 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----F--L 227 (272)
T ss_pred CCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----H--H
Confidence 99976543211 1234568889999998742 335788999999999999999999999643221111 0 0
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..... .+.. .....+..+.+++.+||..+|.+|||+.|++++
T Consensus 228 ~~~~~-----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 IPRNP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HhcCC-----CCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11110 0111 122344568899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.56 Aligned_cols=255 Identities=19% Similarity=0.264 Sum_probs=201.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|+...+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 456667799999999999999988899999999864321 123345788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 123 EYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred cCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998763 367788888999999999999998 999999999999999999999999999986543
Q ss_pred cccceeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
... .......||+.|+|||++... ..++.++|||||||++|||++|+.||...... .............
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~~~-- 266 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKNSL-- 266 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCcC--
Confidence 221 122345789999999987432 34789999999999999999999999753221 1111111111000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~--RPs~~evl~~ 828 (843)
..+. .......+.+++.+|+..+|++ |||+.|++++
T Consensus 267 ---~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 ---TFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111 1134567889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=314.55 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=207.4
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.++.|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.++++++||||+++++++.+....++||
T Consensus 2 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred hHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45667788899999999999999987899999999865443344567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 82 EYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999998652 478889999999999999999998 999999999999999999999999999976543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||++ .+..++.++|||||||++|||++|..||........ .. .....
T Consensus 154 ~~~--~~~~~~~~~~y~apE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~-~~~~~-------- 216 (277)
T cd06640 154 TQI--KRNTFVGTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LF-LIPKN-------- 216 (277)
T ss_pred Ccc--ccccccCcccccCHhHh-ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hh-hhhcC--------
Confidence 221 11334577889999987 455689999999999999999999999865422110 00 01100
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.....+...+..+.+++.+||+.+|++||++.+++++-
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 01123455677899999999999999999999998874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.49 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=193.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||+||+|....+++.||+|.+..... ......+.+|+.++.+++||+|+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 4566789999999999999988899999999865322 12235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999864 4689999999999999999999998 99999999999999999999999999997653211
Q ss_pred cc---------------------------------eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCC
Q 003156 714 KH---------------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR 760 (843)
Q Consensus 714 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~ 760 (843)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH-cCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 001234689999999988 45578999999999999999999999
Q ss_pred CCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHcc--CCCCCCCCCHHHHHHH
Q 003156 761 PVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCT--CHIPSSRPSMAEVVQI 828 (843)
Q Consensus 761 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~--~~~P~~RPs~~evl~~ 828 (843)
||....... .......... ....+.. .....++.+++.+++ ..++..||+++|++++
T Consensus 235 Pf~~~~~~~-----~~~~i~~~~~--~~~~p~~----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQE-----TYKKVMNWKE--TLIFPPE----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHH-----HHHHHHcCcC--cccCCCc----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 996532211 1111111000 0101110 112234555665533 2344567999999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.37 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=189.6
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHH-HHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVR-VLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||+||+|.+..+|+.||+|.+...... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999999889999999998654221 22234555544 56778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 9999998764 4688899999999999999999998 99999999999999999999999999987532211 1
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... +........ . ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~-~---------~~~ 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVL-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNK-P---------LRL 215 (323)
T ss_pred ccccccCChhhcChhhh-cCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcC-C---------CCC
Confidence 22345689999999988 5567899999999999999999999999653211 111111111 0 011
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMA 823 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~ 823 (843)
+......+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 223355688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.40 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=196.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999888999999999754321 2235678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 9999988764 4589999999999999999999998 999999999999999999999999999875322111
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh-hHHHHHHHHHhhCCcccccCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV-ILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||........ .........+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~ 221 (327)
T cd05617 152 TTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------IR 221 (327)
T ss_pred ceecccCCcccCCHHHH-CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------CC
Confidence 12345689999999988 556789999999999999999999999964322111 11111111111111 11
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSM------AEVVQI 828 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~------~evl~~ 828 (843)
.+......+.+++.+|++.||++|+++ .+++++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 233445567899999999999999984 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.78 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=202.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 455677789999999999999975 67889999986443 23578999999999999999999999874 456899999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999987642 34689999999999999999999988 9999999999999999999999999999765432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||++ ....++.++||||||+++||+++ |+.||..... ...... ...+...
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~----~~~~~~~----- 222 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQN----LERGYRM----- 222 (260)
T ss_pred Ccc-cccCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHH----HHcCCCC-----
Confidence 211 11233456789999987 55568899999999999999999 9999964322 111111 1111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+...+.++.+++.+||..+|++|||+++++..|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1223345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.36 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=198.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|+...+|+.||||++..... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 4566789999999999999988899999999965422 12335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 83 LPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999864 3589999999999999999999998 99999999999999999999999999987543211
Q ss_pred cce------------------------------------eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh
Q 003156 714 KHV------------------------------------MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 757 (843)
Q Consensus 714 ~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt 757 (843)
... ......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-cCCCCCCeeeeecchhHHHHhhc
Confidence 000 00124589999999988 55678999999999999999999
Q ss_pred CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003156 758 GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS---MAEVVQI 828 (843)
Q Consensus 758 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs---~~evl~~ 828 (843)
|+.||...... ............... + . .......+.+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~-----~~~~~i~~~~~~~~~--~---~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQ-----ETYRKIINWKETLQF--P---D-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHH-----HHHHHHHcCCCccCC--C---C-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999654221 111111111100000 0 0 11234567788999986 9999998 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.31 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=196.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 632 (843)
|+..+.||+|+||.||+|....+++.||+|.+..... ....+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 3445689999999999999988899999999865432 12234567788888777 58999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998764 3588999999999999999999998 9999999999999999999999999999754321
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. .......||+.|+|||++ ....++.++|||||||++|||+||+.||...... .+ ...... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~---~~~i~~-~~-------- 217 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL---FQSIME-HN-------- 217 (323)
T ss_pred C--CccccCCCChhhcCHHHh-cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HH---HHHHHh-CC--------
Confidence 1 122345689999999988 5567899999999999999999999999754221 11 111111 11
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~-----~evl~~ 828 (843)
..++.....++.+++.+|++.+|++|++. .++.++
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11234455678899999999999999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=331.55 Aligned_cols=259 Identities=20% Similarity=0.191 Sum_probs=196.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|...+.||+|+||.||+|.+...++.||||... ...+.+|++++++++|||||++++++...+..++|||++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 3566678999999999999998889999999632 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
. |+|.+++... ...++|..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 4 7898888764 24689999999999999999999998 999999999999999999999999999986543222
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc--hhhHHHHHHHHHhhCCcc-cccCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--VVILSEHVRVLLEEGNVL-DCVDP 791 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--~~~l~~~~~~~~~~~~~~-~~~d~ 791 (843)
........||..|+|||++ .+..++.++|||||||++|||++|..|+...... .......+...+...... .-+.+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~-~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHH-cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2222345689999999988 5567899999999999999999988776433211 111111111111111100 00000
Q ss_pred -----------------CCCCCC-------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 -----------------SMGDYP-------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 -----------------~l~~~~-------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+. ......+.+++.+|++.||++|||+.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 0122357789999999999999999999986
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.25 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=200.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.++..+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 44667778999999999999986 44579999875433 23467899999999999999999999875 4567899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.++++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999998642 34588999999999999999999998 99999999999999999999999999997664322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......++..|+|||.. ....++.++|||||||++|||+| |..||...... . ...+ +..+...
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~-~~~~----~~~~~~~------ 222 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-E-VLEQ----VERGYRM------ 222 (260)
T ss_pred cc-ccCCCccchhhCCHHHh-ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-H-HHHH----HHcCCCC------
Confidence 11 11233456789999987 55678999999999999999999 89998653221 1 1111 1111110
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1233445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.21 Aligned_cols=252 Identities=27% Similarity=0.340 Sum_probs=200.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
+..+.||+|+||.||+|.+..+++.||+|.+....... ..+.+.+|+.++++++|++++++++.+.+.+..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34568999999999999999899999999986543222 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 83 NGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999987542 24588999999999999999999988 999999999999999999999999999876543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
. ....|+..|+|||++ ....++.++|||||||++|||++|+.||........ ........... ..
T Consensus 158 ~---~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~~---------~~ 222 (285)
T cd05630 158 I---KGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV---------QE 222 (285)
T ss_pred c---cCCCCCccccChHHH-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhhh---------hh
Confidence 1 234688999999998 555789999999999999999999999975432110 01111110000 00
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
.++.....++.+++.+||+.||++||| ++|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 123334456889999999999999999 8898874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=311.74 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=204.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
++.|+..+.||+|+||.||+|.+..+++.||+|.+..... .+.+.+|++++++++||||+++++++.+....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3456777789999999999999987789999999854432 5789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999999764 35689999999999999999999998 9999999999999999999999999999876532
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......++..|+|||++ .+..++.++|||||||++|||++|+.||.......... . ... . ...
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~-~~~-----~-~~~ 217 (256)
T cd06612 153 MA--KRNTVIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----M-IPN-----K-PPP 217 (256)
T ss_pred cc--ccccccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----h-hcc-----C-CCC
Confidence 21 11334577889999987 55578999999999999999999999997532211100 0 000 0 000
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+......+.+++.+||+.+|++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 111233344578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=317.94 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=203.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
...|+..+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3456667789999999999999988899999999865443 234678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.++++.. .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999998653 478899999999999999999998 9999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
... .....++..|+|||.+ ....++.++|||||||++|||++|+.||....... .+.. ...... +.
T Consensus 170 ~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~----~~~~~~------~~ 235 (296)
T cd06654 170 QSK--RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYL----IATNGT------PE 235 (296)
T ss_pred ccc--cCcccCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHH----HhcCCC------CC
Confidence 211 1334678899999987 45568899999999999999999999996543211 1111 011000 00
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ..+......+.+++.+||..+|++|||+.|++++
T Consensus 236 ~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred C-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 1233445568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.38 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=188.8
Q ss_pred eeccccceEEEEEEECCC------------CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 561 EVGEGVFGTVYKVSFGTQ------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
.||+|+||.||+|.+..+ ...||+|.+.... ......|.+|+.+++.++||||+++++++......+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 689999999999986422 2358888874432 233457889999999999999999999999988999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC-------cEEe
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN-------PRIS 701 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~ 701 (843)
+||||+++|+|..+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988764 24589999999999999999999998 9999999999999986664 8999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHH-hCCCCCcCCCCchhhHHHHHHHHH
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELV-TGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ell-tg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
|||++...... ....++..|+|||.+.....++.++|||||||++|||+ +|+.||....... . ....
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~-~~~~ 222 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----K-ERFY 222 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----H-HHHH
Confidence 99998754321 23456788999998855667899999999999999998 5888875432111 0 0111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
. +.. ........++.+++.+||+.||++||++.++++++
T Consensus 223 ~-~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 E-GQC---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred h-cCc---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 110 01122345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.59 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=200.7
Q ss_pred CeeccccceEEEEEEECC-CC--eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGT-QG--RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|++|.||+|.+.. .+ ..||+|.+.........+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999854 33 36899998665443445688999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++..... ..++|..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987532 4689999999999999999999998 99999999999999999999999999998775432221
Q ss_pred -eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 717 -MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 717 -~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||.+ ....++.++|||||||++|||++ |..||...... ...+ ....... ..
T Consensus 155 ~~~~~~~~~~~y~~pE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~---~~~~~~~--------~~ 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILK---KIDKEGE--------RL 220 (257)
T ss_pred ecccCCCCCceecCHHHh-cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHhcCC--------cC
Confidence 11234567889999987 55678999999999999999998 99998643221 1111 1111111 01
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123344567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.66 Aligned_cols=241 Identities=20% Similarity=0.283 Sum_probs=188.1
Q ss_pred eeccccceEEEEEEECCC------------------------CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccc
Q 003156 561 EVGEGVFGTVYKVSFGTQ------------------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 616 (843)
.||+|+||.||+|.+..+ ...||+|.+.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 699999999999986321 2358888875432 223457888999999999999999
Q ss_pred eeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 617 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
+++++.+....++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999998763 34688999999999999999999998 999999999999997543
Q ss_pred -------CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHH-hCCCCCcCCCCc
Q 003156 697 -------NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELV-TGRRPVEYGEDN 768 (843)
Q Consensus 697 -------~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ell-tg~~p~~~~~~~ 768 (843)
.+|++|||.+...... ....++..|+|||.+.....++.++|||||||++||++ +|+.||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3799999988643221 22346678999998855567899999999999999995 689998653221
Q ss_pred hhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 769 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 769 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
. .... ..... ..+.....++.+++.+||+.+|++|||+.++++.|.
T Consensus 229 ~--~~~~----~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 E--KERF----YEKKH----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--HHHH----HHhcc----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1111 11110 112222346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.07 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=198.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEE-cCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW-TPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~ 633 (843)
.++..+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|+|++++++++. ..+..++|+||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 455667899999999999987 47889999875332 3567899999999999999999999865 44568999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999998752 34588999999999999999999998 99999999999999999999999999987543221
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
....++..|+|||++ ....++.++|||||||++|||++ |+.||..... ...... +..+...
T Consensus 157 -----~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~-~~~~~~~------ 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR-VEKGYKM------ 218 (256)
T ss_pred -----CCCccceeecCHHHH-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH-HhcCCCC------
Confidence 223445679999987 55678999999999999999998 9999864321 111111 1111111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12334556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=319.72 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=201.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|+||.||+|.+..++..+|+|.+...........+.+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 45667899999999999999888999999988654333334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.++++.. ..+++..+..++.|+++||+|||+.+ +++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 83 GGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999864 45788999999999999999999732 89999999999999999999999999987553221
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc---------
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL--------- 786 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~--------- 786 (843)
.....++..|+|||.+ .+..++.++|||||||++|||++|+.||..... .................
T Consensus 155 --~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 --ANSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred --cccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCC
Confidence 1345678899999987 556688999999999999999999999864321 11111110000000000
Q ss_pred ---------------cccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 787 ---------------DCVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 787 ---------------~~~d~~l~~~~-~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
..+....+..+ .....++.+++.+||..+|++|||+.|++++-.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000000001 113456889999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.00 Aligned_cols=240 Identities=25% Similarity=0.371 Sum_probs=192.6
Q ss_pred CeeccccceEEEEEEE---CCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 560 AEVGEGVFGTVYKVSF---GTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
+.||+|+||.||++.. ..+|+.||+|++...... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4799999999999876 346889999998654321 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999999764 4589999999999999999999998 999999999999999999999999999976543211
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
......|+..|+|||.+ ....++.++|||||||++|||++|+.||..... . ........ .. ..
T Consensus 154 -~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~----~~~~~i~~-~~---------~~ 216 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-K----ETMTMILK-AK---------LG 216 (318)
T ss_pred -ceecccCChhhcCHHHH-cCCCCCCccceeccceEeeeeccCCCCCCCCCH-H----HHHHHHHc-CC---------CC
Confidence 12345688999999988 455678999999999999999999999965321 1 11111111 11 11
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAE 824 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~e 824 (843)
.+......+.+++.+||+.||++|||+.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23344567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.48 Aligned_cols=262 Identities=28% Similarity=0.413 Sum_probs=204.4
Q ss_pred hhhhcCeeccccceEEEEEEECC----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKL 628 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 628 (843)
.++..+.||+|+||.||+|.+.. +++.||+|.+.........+.|.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 34556789999999999999743 3789999998655432235689999999999999999999999877 55789
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999875 23589999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh----------hHHHHHH
Q 003156 709 LTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV----------ILSEHVR 777 (843)
Q Consensus 709 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~----------~l~~~~~ 777 (843)
....... .......++..|+|||.. ....++.++||||||+++|||+||+.|+........ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECL-RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL- 236 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHH-ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-
Confidence 6532221 111223445679999987 455788999999999999999999999865322110 011111
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
.....+.. ...+..++.++.+++.+||+.+|++||||.|++++|+.+
T Consensus 237 ~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111 011234456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.75 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=213.4
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhcc-CCCccceeeEEEcCCee
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLK 627 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 627 (843)
+....|+..+.||+|.||.||+++.+.+|+.+|+|.+.+..... ..+...+|+.+|+++. |||||.+.+.+.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34456777789999999999999999889999999997665433 3468899999999998 99999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC----CCcEEeec
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN----YNPRISDF 703 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Df 703 (843)
++|||++.||.|.+.+... .+++.++..++.|++.++.|+|+. +|+|||+||+|+|+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999876 289999999999999999999998 99999999999999733 57999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
|++..... ........||+.|+|||+. ....|+..+||||+||++|.|++|..||.......... .+..+
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl-~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~ 253 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVL-GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG 253 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhh-cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC
Confidence 99998765 2233677999999999998 55689999999999999999999999997654332222 12222
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.. +.. .+........+.+++..|+..||.+|+|+.++++|-
T Consensus 254 ~~-~f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 254 DF-DFT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred CC-CCC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 22 111 123344566788999999999999999999999973
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.23 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=203.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.++..+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3456677899999999999998 488999999865432 456889999999999999999999999988899999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999998752 23689999999999999999999998 99999999999999999999999999998663211
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.....+..|+|||.+ ....++.++||||||+++||+++ |+.||..... ..+...+ ..+..
T Consensus 157 -----~~~~~~~~~~ape~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~----~~~~~------- 217 (256)
T cd05039 157 -----DSGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHV----EKGYR------- 217 (256)
T ss_pred -----ccCCCcccccCchhh-cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----hcCCC-------
Confidence 122345679999987 45578899999999999999997 9999864321 1111111 11111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+...+..+.+++.+||..+|++|||++|++++|+.+
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 012334456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=316.11 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=199.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|++|.||+|....+++.||+|.+..... ....+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 3455689999999999999988899999999854432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+ ++|.+++.... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 7 68988887642 235689999999999999999999998 999999999999999999999999999875432211
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh-----------C
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE-----------G 783 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~-----------~ 783 (843)
......++..|+|||.+.....++.++|||||||++|||+||+.||....... ......+..... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence 11233567889999987555567899999999999999999999996432211 111111000000 0
Q ss_pred Ccc----cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVL----DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~----~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ................++.+++.+||..||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 000000001112244567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.77 Aligned_cols=262 Identities=25% Similarity=0.265 Sum_probs=196.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 625 (843)
.+.|+..+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 3556777899999999999999988899999999864322 223456789999999999999999999986543
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||+++ ++.+.++. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999965 56666643 378888999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHH----------
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH---------- 775 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~---------- 775 (843)
++...... ......+|..|+|||.+ .+..++.++||||+||++|||++|+.||...... ..+...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAE 244 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHH
Confidence 97543211 12345678899999988 5567899999999999999999999999754221 111111
Q ss_pred --------HHHHHhhCCccc------c----cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 776 --------VRVLLEEGNVLD------C----VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 776 --------~~~~~~~~~~~~------~----~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+........... . ..+............+.+++.+|++.||++|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 111111000000 0 00000001112235678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.74 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=196.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 4556789999999999999988999999999865321 12235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999764 4578888999999999999999998 99999999999999999999999999996432110
Q ss_pred cc---------------------------------------------eeccccccccccCCcccccCcCCCCCchhHHHH
Q 003156 714 KH---------------------------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 748 (843)
Q Consensus 714 ~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~ 748 (843)
.. .......||+.|+|||++ ....++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSl 234 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-LQQGYGQECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-ccCCCCCceeeEec
Confidence 00 000124689999999988 55678999999999
Q ss_pred HHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCC---CCHHHH
Q 003156 749 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR---PSMAEV 825 (843)
Q Consensus 749 Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~R---Ps~~ev 825 (843)
||++|||++|+.||...... .. ............ .+. ......++.+++.+|+. +|.+| +|+.|+
T Consensus 235 Gvil~elltG~~Pf~~~~~~-~~----~~~i~~~~~~~~-----~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH-ET----YRKIINWRETLY-----FPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH-HH----HHHHHccCCccC-----CCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999999653221 11 111111110000 011 11234567889999997 66665 699999
Q ss_pred HHH
Q 003156 826 VQI 828 (843)
Q Consensus 826 l~~ 828 (843)
+++
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=327.01 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=197.4
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhccCCCccceeeEEEcCCe--eEEEEEe
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL--KLLVSDY 633 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV~e~ 633 (843)
..+||+|+|-+||+|.+..+|..||--.+...+. .+..+.|..|+.+|+.++|||||+++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 3479999999999999988898887654433332 2334689999999999999999999999987654 6799999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~ 712 (843)
|..|+|..|.++. ..++...+..|++||++||.|||++ .|+|+|||||.+||+|+ ..|.|||+|.|+|+.+...
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999986 4577788999999999999999997 88999999999999998 6799999999999976542
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. ...+.||+.|||||+. . ..|++.+||||||++|+||+|+..||.-...... ..+.+-.-++...+..+-|
T Consensus 200 ~----aksvIGTPEFMAPEmY-E-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-IYKKV~SGiKP~sl~kV~d-- 270 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMY-E-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-IYKKVTSGIKPAALSKVKD-- 270 (632)
T ss_pred c----cceeccCccccChHHH-h-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-HHHHHHcCCCHHHhhccCC--
Confidence 2 1447899999999987 3 5799999999999999999999999975433221 1122211111111222222
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.++.++|.+|+.. ..+|||+.|++++
T Consensus 271 ---------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 ---------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2578999999999 9999999999875
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.78 Aligned_cols=241 Identities=21% Similarity=0.319 Sum_probs=190.3
Q ss_pred eeccccceEEEEEEECCCCe-------EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 561 EVGEGVFGTVYKVSFGTQGR-------MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.||+|+||.||+|.....+. .||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 68999999999999854433 48888774332 23346788999999999999999999999998899999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC--------cEEeeccC
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN--------PRISDFGL 705 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfgl 705 (843)
+++|+|.++++.. ...+++..++.++.|++.|++|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999875 23689999999999999999999998 9999999999999987765 59999998
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCC-CCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR-RPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~-~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
+...... ....++..|+|||++.....++.++|||||||++|||++|. .|+..... .. ... .....
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~----~~~-~~~~~- 221 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QK----KLQ-FYEDR- 221 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HH----HHH-HHHcc-
Confidence 8654321 23456788999999855566899999999999999999985 55433211 11 111 11110
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1123334457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.63 Aligned_cols=200 Identities=27% Similarity=0.382 Sum_probs=162.8
Q ss_pred cCeeccccceEEEEEEEC--CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeEEEEEeC
Q 003156 559 AAEVGEGVFGTVYKVSFG--TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLVSDYA 634 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~ 634 (843)
+++||+|+||+||+|... .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 458999999999999975 356889999885432 23567899999999999999999998864 34678999998
Q ss_pred CCCCHHHHHhhcCC-----CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE----cCCCCcEEeeccC
Q 003156 635 PNGSLQAKLHERLP-----STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGL 705 (843)
Q Consensus 635 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl 705 (843)
+ ++|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 588888764321 123588899999999999999999998 99999999999999 4667899999999
Q ss_pred cccccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCC
Q 003156 706 ARLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 765 (843)
Q Consensus 706 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~ 765 (843)
++........ .......+|..|+|||++.....++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876432211 11234577899999998866567899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=289.33 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=203.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
++....+|.|..|.|++++++.+|...|||.+.+....+..+++...+.++.+-. +|.||+.+|||......++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 4445589999999999999998999999999988776666678888888877764 899999999999999999999998
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
.- .....++.. ..++++.-.-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||||++-++.+...
T Consensus 174 s~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 ST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 43 444555543 355888888899999999999999886 999999999999999999999999999976654322
Q ss_pred ceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.....|-..|||||.+.- ...|+.++||||||++++|+.||+.||...+.+-..+.+.+.. ..|.
T Consensus 248 ---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~----------ePP~ 314 (391)
T KOG0983|consen 248 ---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE----------EPPL 314 (391)
T ss_pred ---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc----------CCCC
Confidence 245567788999998732 3468889999999999999999999998766555555443321 1122
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
++. .......+.+++..|+.+|+.+||...+++++
T Consensus 315 L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222 22245678899999999999999999999876
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.11 Aligned_cols=254 Identities=30% Similarity=0.488 Sum_probs=201.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccCh-HHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||+||++....+++.||+|.+......... ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 34567899999999999999989999999999766433222 23356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N 151 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence 999999999843 4689999999999999999999998 999999999999999999999999999976421 1
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC--chhhHHHHHHHHHhhCCcccccCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED--NVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
........++..|+|||.+.....++.++||||+|+++|+|++|..||..... ..................
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 224 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------- 224 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-------
Confidence 22234567788999999984367899999999999999999999999975411 111111111101110000
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........+.+++.+|++.||++|||+.+++++
T Consensus 225 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011123679999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.33 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=199.7
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
+.||+|+||.||+|.+.. ++.||+|.+.........+.+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999999975 9999999886544333456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999764 23578899999999999999999998 99999999999999999999999999997654222111112
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCCh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 798 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 798 (843)
....+..|+|||.+ .+..++.++|||||||++|||+| |..||...... ..... +..... ...+.
T Consensus 154 ~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~----~~~~~~--------~~~~~ 218 (251)
T cd05041 154 LKQIPIKWTAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER----IESGYR--------MPAPQ 218 (251)
T ss_pred cCcceeccCChHhh-ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH----HhcCCC--------CCCCc
Confidence 22335679999987 55578999999999999999999 88888644221 11111 111110 01233
Q ss_pred hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 799 DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 799 ~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 445678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.82 Aligned_cols=252 Identities=26% Similarity=0.311 Sum_probs=200.1
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
+..+.||+|+||+||+|.+..+++.||+|.+...... ...+.+.+|++++++++|++|+++.+++...+..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 3456899999999999999889999999998554322 12345788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 83 NGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred cCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999887642 34689999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
.....|+..|+|||++ .+..++.++|||||||++|||++|+.||....... .... +........ .
T Consensus 158 ---~~~~~g~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-~~~~~~~~~---------~ 222 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-VDRRVLETE---------E 222 (285)
T ss_pred ---ccCCCCCcCccChHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhhccc---------c
Confidence 1334688999999988 45678999999999999999999999997542211 1111 111111110 0
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
.++......+.+++..|++.+|++||+ +.+++.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 123334456789999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=325.06 Aligned_cols=239 Identities=23% Similarity=0.297 Sum_probs=189.2
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHH-HHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVR-VLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|+...+++.||+|.+...... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999888999999998653221 12334555554 57888999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 9999888753 4578888899999999999999998 99999999999999999999999999987532211 1
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||+.|+|||.+ ....++.++|||||||++|||++|+.||..... .. ....... .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~---~~~~i~~-~~---------~~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVL-RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQ---MYDNILH-KP---------LQL 215 (321)
T ss_pred ccccccCCcccCCHHHh-cCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HH---HHHHHhc-CC---------CCC
Confidence 22345688999999988 556789999999999999999999999965321 11 1111111 10 112
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMA 823 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~ 823 (843)
+......+.+++.+|++.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 334456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=344.95 Aligned_cols=263 Identities=19% Similarity=0.301 Sum_probs=202.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 631 (843)
.|+..+.||+|+||+||+|.+..++..||+|.+...... .....|..|+.++++++|||||++++++.. ....++||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 466778999999999999999988999999998644322 234578899999999999999999998854 35688999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCC----CCeeecCCCCCCEEEcC-------------
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR----PPIIHYNLKPSNILLDD------------- 694 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~dlk~~Nill~~------------- 694 (843)
||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 9999999999998754444579999999999999999999998521 25999999999999964
Q ss_pred ----CCCcEEeeccCcccccccccceeccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch
Q 003156 695 ----NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769 (843)
Q Consensus 695 ----~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~ 769 (843)
...+||+|||+++.+.... ......||+.|+|||++... ..++.++|||||||++|||+||+.||.......
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred ccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 2348999999998654322 12345789999999987432 457899999999999999999999996543211
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccC
Q 003156 770 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 834 (843)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~ 834 (843)
..+.. +.... .++ ......++.++|..||..+|++|||+.|++++ +..+..
T Consensus 251 ----qli~~-lk~~p-------~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 251 ----QLISE-LKRGP-------DLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred ----HHHHH-HhcCC-------CCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 11111 11111 110 11234568899999999999999999999853 544433
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=327.28 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=198.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 446677789999999999999988899999999864321 122356789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 123 EYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred cCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999753 478888999999999999999998 999999999999999999999999999987643
Q ss_pred cccceeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
... .......||+.|+|||++... ..++.++||||+||++|||++|+.||..... . ..............
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~----~~~~~i~~~~~~~~- 267 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-V----GTYSKIMDHKNSLN- 267 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-H----HHHHHHHhCCcccC-
Confidence 221 122456789999999987432 2378899999999999999999999965322 1 11111111111010
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~--RPs~~evl~~ 828 (843)
.+. .......+.+++..|+..++.+ |||+.|++++
T Consensus 268 ----~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ----FPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----CCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011 1123455778888888755543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.21 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=196.0
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHH
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 640 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 640 (843)
.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 7999999999999998888999999885443 223467889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCC--ChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-CCCcEEeeccCccccccccccee
Q 003156 641 AKLHERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 641 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
+++.... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+........ .
T Consensus 94 ~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~ 165 (268)
T cd06624 94 ALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--C 165 (268)
T ss_pred HHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--c
Confidence 9998642 234 7788889999999999999998 9999999999999985 67999999999876543221 1
Q ss_pred ccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
.....++..|+|||++... ..++.++|||||||++|||++|+.||........... ... .....+..
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--~~~----------~~~~~~~~ 233 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--KVG----------MFKIHPEI 233 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh--hhh----------hhccCCCC
Confidence 1234578899999987433 3478899999999999999999999964322111110 000 00111123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.....++.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 44455678899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.96 Aligned_cols=264 Identities=17% Similarity=0.263 Sum_probs=195.9
Q ss_pred cCeeccc--cceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 559 AAEVGEG--VFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 559 ~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
.++||+| +||+||++....+|+.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3478999 7899999999989999999998654322 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999997642 23589999999999999999999998 9999999999999999999999999865433211110
Q ss_pred e-----eccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh--------
Q 003156 716 V-----MSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE-------- 781 (843)
Q Consensus 716 ~-----~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~-------- 781 (843)
. ......++..|+|||++... ..++.++|||||||++|||++|+.||............ ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccch
Confidence 0 11223456779999988543 45889999999999999999999999754322111111 000000
Q ss_pred -hCC-----cccccCCCC------------------CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 782 -EGN-----VLDCVDPSM------------------GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 782 -~~~-----~~~~~d~~l------------------~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... .....+... ..........+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 000000000 00112234568899999999999999999999885
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.61 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=196.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|+...+++.||+|.+..... ....+.+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 5667799999999999999988899999999854322 12345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 83 ~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999764 3578888899999999999999998 99999999999999999999999999975321000
Q ss_pred -----------------------------------------cceeccccccccccCCcccccCcCCCCCchhHHHHHHHH
Q 003156 714 -----------------------------------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLI 752 (843)
Q Consensus 714 -----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil 752 (843)
.........||+.|+|||++ ....++.++|||||||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeecccee
Confidence 00001234689999999988 556789999999999999
Q ss_pred HHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 003156 753 LELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP---SMAEVVQI 828 (843)
Q Consensus 753 ~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP---s~~evl~~ 828 (843)
|||++|+.||........ ............ .+ .......++.+++.+|+ .+|.+|+ |+.|++++
T Consensus 235 yell~G~~Pf~~~~~~~~-----~~~i~~~~~~~~--~~----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPAET-----QLKVINWETTLH--IP----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHHHH-----HHHHhccCcccc--CC----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999975432211 111111000000 00 11223445667777766 5999999 89999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.62 Aligned_cols=242 Identities=22% Similarity=0.272 Sum_probs=190.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHH-HHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREV-RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|++..+++.||+|.+...... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999999888999999998653221 1223444444 456778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 9999999764 3577888889999999999999998 99999999999999999999999999997543211 1
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++ .+..++.++||||+||++|||++|+.||...... ......... . ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~-~---------~~~ 215 (325)
T cd05602 152 TTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILNK-P---------LQL 215 (325)
T ss_pred CcccccCCccccCHHHH-cCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHhC-C---------cCC
Confidence 22345689999999988 5567899999999999999999999999643221 111111111 0 011
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVV 826 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl 826 (843)
+......+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 233455688999999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.31 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=202.5
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEE-----cC
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYW-----TP 624 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~ 624 (843)
+..+.|+..+.||+|+||.||+|....+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 44566777889999999999999998889999999875322 2245788899999999 6999999999884 33
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
+..++||||+++|+|.++++........+++..+..++.|++.|+.|||+. +++||||||+||++++++.+|++|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCC
Confidence 467999999999999999876444456789999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
+++.+..... ......|+..|+|||++.. ...++.++||||+||++|||++|+.||........ +.. .
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~----~- 241 (286)
T cd06638 170 VSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK----I- 241 (286)
T ss_pred ceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh----c-
Confidence 9986543221 1133468889999998732 23478899999999999999999999965422111 100 0
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.... .+.. ..+.....++.+++.+||+.+|++|||+.|++++.
T Consensus 242 ~~~~-----~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRNP-----PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccC-----CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 0000 11222345688999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=332.42 Aligned_cols=253 Identities=19% Similarity=0.262 Sum_probs=193.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|+...+++.||+|.+..... ....+.+.+|+.++++++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 4566789999999999999988999999999865432 12345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 83 IPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999764 3578888899999999999999998 99999999999999999999999999975321100
Q ss_pred c---------------------------------------------ceeccccccccccCCcccccCcCCCCCchhHHHH
Q 003156 714 K---------------------------------------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 748 (843)
Q Consensus 714 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~ 748 (843)
. ........||+.|+|||++ .+..++.++||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSl 234 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSV 234 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-cCCCCCCeeeEEec
Confidence 0 0001234689999999988 45578999999999
Q ss_pred HHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC---HHHH
Q 003156 749 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS---MAEV 825 (843)
Q Consensus 749 Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs---~~ev 825 (843)
||++|||++|+.||........ . ......... . ..+. ......++.+++.+++ .+|++|++ +.|+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~-~----~~i~~~~~~--~---~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLET-Q----MKVINWQTS--L---HIPP-QAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHH-H----HHHHccCCC--c---CCCC-cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999999975432111 1 111110000 0 0000 1122344566666654 59999997 8888
Q ss_pred HHH
Q 003156 826 VQI 828 (843)
Q Consensus 826 l~~ 828 (843)
+++
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.25 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=205.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+++.|+..+.||+|+||.||+|....+++.||+|...........+.+.+|+.++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HHHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 46778888899999999999999987899999998765443344567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 82 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999999864 3578999999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||.. ....++.++|||||||++|||++|..||...... ..... .....
T Consensus 154 ~~~--~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~------- 217 (277)
T cd06641 154 TQI--KRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKNN------- 217 (277)
T ss_pred chh--hhccccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcCC-------
Confidence 221 11234577889999987 4557889999999999999999999998643211 11111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111233455678899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.40 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=202.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+..+.||+|+||.||+|....+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 34567778899999999999999988899999999865432 23356788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++.+++.++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999999998764 4588999999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.. .......|+..|+|||++. ....++.++||||+||++|||++|+.||......... .. ...... .
T Consensus 159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~-----~~~~~~---~ 227 (267)
T cd06645 159 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FL-----MTKSNF---Q 227 (267)
T ss_pred cc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hh-----hhccCC---C
Confidence 21 1123456888999999863 2345788999999999999999999998654321111 00 001110 0
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+.... .......+.+++.+|++.+|++|||+++++++
T Consensus 228 ~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111111 11234567899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.03 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=203.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
..++..+.||+|+||.||+|.+... ...||+|...........+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 3355667899999999999997533 346899987554433445678999999999999999999999875 456899
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999764 23589999999999999999999998 99999999999999999999999999998664
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
...... .....++..|+|||.+ ....++.++|||||||++||+++ |..||....... .. .. +..+...
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~-~~----~~~~~~~--- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VI-GR----IENGERL--- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhh-ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HH-HH----HHcCCcC---
Confidence 432211 1223345679999987 55578999999999999999986 999996543211 11 11 1111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
..+...+..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 12344556789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.43 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=204.1
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
.+.+.|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 45577888889999999999999998889999999986443 23356788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++++|..++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 88 IEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred EecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999888654 24589999999999999999999998 99999999999999999999999999987543
Q ss_pred ccccceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
... .......++..|+|||++.. ...++.++|||||||++|||++|..||...... ........ ..
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~-- 231 (292)
T cd06644 162 KTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAK-SE-- 231 (292)
T ss_pred ccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHHhc-CC--
Confidence 211 11133457788999998742 344678999999999999999999998643221 11111111 10
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+.. ..+.....++.+++.+||+.+|++||++.|++++
T Consensus 232 ---~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 ---PPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---CccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111 1233445568899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.36 Aligned_cols=256 Identities=27% Similarity=0.368 Sum_probs=203.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|....+++.+|+|.+...... ..+.+.+|++++++++||||+++++++......++||||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4456677899999999999999878899999998654332 457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999998764 24688999999999999999999998 99999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
. ......++..|+|||.+... ..++.++|||||||++|||++|+.||.......... . ..... ..+
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-----~-~~~~~----~~~ 223 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-----L-ISKSN----FPP 223 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-----H-HHhcc----CCC
Confidence 1 11334677889999987332 267889999999999999999999996543211111 0 11110 011
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...........++.+++.+||..+|++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111233445678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.24 Aligned_cols=251 Identities=21% Similarity=0.299 Sum_probs=203.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..|+..+.||.|+||.||+|....+++.||+|.+..... ...+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 345667789999999999999988999999999865432 3356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|..++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999998753 489999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.. .....++..|+|||.+ ....++.++|||||||++|+|++|+.||........ .. .. ...... .
T Consensus 170 ~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~----~~-~~~~~~------~ 234 (296)
T cd06655 170 SK--RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LI-ATNGTP------E 234 (296)
T ss_pred cc--CCCcCCCccccCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HH-HhcCCc------c
Confidence 21 1334678899999987 556688999999999999999999999965432211 11 11 111100 0
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+......+.+++.+||..+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11233445578899999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=321.69 Aligned_cols=240 Identities=24% Similarity=0.332 Sum_probs=192.1
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
..+.||+|+||.||+|....+|+.||+|.+..... ....+.+..|..+++.+. |++|+++++++.+.+..++||||+
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~ 83 (323)
T cd05615 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYV 83 (323)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCC
Confidence 45689999999999999988999999999865321 123356778999988885 577888999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 84 NGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 999999998764 4589999999999999999999998 99999999999999999999999999987543211
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
.......||..|+|||++ .+..++.++||||+||++|||++|+.||...... ...+..... . .
T Consensus 156 -~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~~~-~---------~ 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQSIMEH-N---------V 218 (323)
T ss_pred -ccccCccCCccccCHHHH-cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhC-C---------C
Confidence 112345689999999988 5557899999999999999999999999754221 111111111 1 0
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSM 822 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~ 822 (843)
.++.....++.+++.+|++.+|++|++.
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1233445578899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.13 Aligned_cols=240 Identities=23% Similarity=0.289 Sum_probs=189.6
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHH-HHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVR-VLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|....+|+.||+|.+..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999999988999999999865421 122344555554 46778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 9999888764 4688999999999999999999998 999999999999999999999999999875322111
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++ .+..++.++|||||||++|||++|+.||...... +..+..... .. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~~-~~---------~~ 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILHK-PL---------VL 215 (325)
T ss_pred CcccccCChhhCCHHHH-cCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHcC-Cc---------cC
Confidence 12345689999999988 5567899999999999999999999999754221 111111111 10 11
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAE 824 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~e 824 (843)
+......+.+++.+|++.+|++||++++
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2234456789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.49 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=204.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.|.+|++++++++||||+++++++..+...++||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 4566888889999999999999998789999999986443 223467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 82 EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 999999999999864 24689999999999999999999998 999999999999999999999999999875432
Q ss_pred cccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
... ......++..|+|||.+. ....++.++|||||||++|||++|+.||....... .+ ... ..+..
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~----~~~-~~~~~-- 225 (280)
T cd06611 156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VL----LKI-LKSEP-- 225 (280)
T ss_pred ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HH----HHH-hcCCC--
Confidence 211 113346788899999863 23456789999999999999999999996532211 11 111 11110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.+ ..+......+.+++.+||+.+|++||++.+++++
T Consensus 226 ---~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111 1123345578899999999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.93 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=203.0
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|+||.||+|.+..+++.||+|.+...........+.+|++++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 35667789999999999999988899999998864332223457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|..++.... ....+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 9999999887642 2346899999999999999999999632 899999999999999999999999999976532211
Q ss_pred ceeccccccccccCCcccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 715 HVMSNRFQSALGYVAPELTCQS-----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
....++..|+|||.+... ..++.++|||||||++|||++|+.||....... ........ .
T Consensus 159 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~---------~ 223 (286)
T cd06622 159 ----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAI---------V 223 (286)
T ss_pred ----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHH---------h
Confidence 234567889999987332 235789999999999999999999996532211 11111111 1
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+......+.....++.+++.+||+.+|++||++.+++.+-
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 1111223444666788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.71 Aligned_cols=262 Identities=24% Similarity=0.283 Sum_probs=194.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhc---cCCCccceeeEEEcC-----Ce
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWTP-----QL 626 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~-----~~ 626 (843)
|+..+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+++++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 45567899999999999999989999999998643222 2234566777777666 699999999988642 34
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 789999997 58999887652 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh---hC
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE---EG 783 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~---~~ 783 (843)
+....... .....++..|+|||++ .+..++.++||||+||++|||++|+.||..... ...+.+....... ..
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQMA---LTPVVVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCccc---CCCccccccccCchHh-hCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHHHHHHHhCCCChhh
Confidence 86543211 1334678899999988 455689999999999999999999999864322 2222222111100 00
Q ss_pred Cc------ccccCCCC----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NV------LDCVDPSM----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~------~~~~d~~l----~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+. .....+.. ..........+.+++.+|++.||++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000000 01112345567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.99 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=203.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45666779999999999999986 66889999986443 2357899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+|++|||.++......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999998752 34689999999999999999999998 99999999999999999999999999998665322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. .......+..|+|||.. .+..++.++||||+||++||+++ |+.||..... ...+.. . ..+..
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~----~-~~~~~------- 222 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQ----V-ERGYR------- 222 (261)
T ss_pred hh-hhhccCCCccccCHHHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH----H-HcCCC-------
Confidence 11 11222345679999988 45578999999999999999999 9999864322 111111 1 11100
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
...+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01123335678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.68 Aligned_cols=265 Identities=23% Similarity=0.266 Sum_probs=199.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|...+.||+|+||.||+|....+|+.||+|.+...........+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 45567789999999999999988899999999865544444457789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
. +++.+++... ...+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 86 H-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred c-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 5 6787777653 23477888899999999999999998 999999999999999999999999999875432211
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH-----------hhC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL-----------EEG 783 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~-----------~~~ 783 (843)
. .....++..|+|||.+.....++.++|||||||++|||++|+.||.........+.+.+.... ...
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 T--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred C--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 1 123346788999998755456788999999999999999999999754332222222111000 000
Q ss_pred Ccc-c----ccCCCCCCC--ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVL-D----CVDPSMGDY--PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~-~----~~d~~l~~~--~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... . +........ .......+.+++.+|+..||++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 0 000000000 01124567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.10 Aligned_cols=253 Identities=28% Similarity=0.386 Sum_probs=205.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|++++++++||||+++++++......++|+||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 44556899999999999999888999999998765444445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999998752 568889999999999999999998 7 999999999999999999999999999876532211
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
....++..|+|||.. .+..++.++||||||+++|+|++|+.||.............++...... ..
T Consensus 157 ----~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~ 222 (265)
T cd06605 157 ----KTFVGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---------PP 222 (265)
T ss_pred ----hcccCChhccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC---------CC
Confidence 125677889999988 5557899999999999999999999999754322222222222221111 11
Q ss_pred CCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~-~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.. ...++.+++.+||..+|++|||+.|++.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11222 55678899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.27 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=200.0
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--------ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
.....||+|+||.||+|....+++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 34568999999999999998788999999885433211 1246789999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++.
T Consensus 83 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999764 4578899999999999999999998 999999999999999999999999999987
Q ss_pred ccccccc----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 709 LTRLDKH----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 709 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
....... .......++..|+|||.+ ....++.++||||+||++|||++|+.||........ +... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~-~~-- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----IFKI-GE-- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHh-ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----HHHH-hc--
Confidence 6521111 111234577889999987 455688999999999999999999999975422111 1110 00
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+..+......+.+++.+||+.+|++||++.|++++
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11112344556678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.01 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=189.8
Q ss_pred cCeeccccceEEEEEEECC--CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeEEEEEeC
Q 003156 559 AAEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLVSDYA 634 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~ 634 (843)
+.+||+|+||.||+|.... ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3479999999999999753 45789999885432 23567899999999999999999999854 45678999998
Q ss_pred CCCCHHHHHhhcCC-----CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE----cCCCCcEEeeccC
Q 003156 635 PNGSLQAKLHERLP-----STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGL 705 (843)
Q Consensus 635 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl 705 (843)
+ ++|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 6 478887754211 223588999999999999999999998 99999999999999 5667899999999
Q ss_pred cccccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh----hHHHHHHHHH
Q 003156 706 ARLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVRVLL 780 (843)
Q Consensus 706 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~----~l~~~~~~~~ 780 (843)
++........ .......+|..|+|||++.....++.++|||||||++|||+||+.||.....+.. ..........
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9876432211 1123456788999999885556689999999999999999999999965322110 0000010000
Q ss_pred hh-C--------------Cc---cc-----cc-CCC----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 EE-G--------------NV---LD-----CV-DPS----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 ~~-~--------------~~---~~-----~~-d~~----l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. + .. .. .. ... ...........+.+++.+|++.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0 00 00 00 000 000111223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.90 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=203.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||.|+||.||+|.+..+++.||+|.+...........+.+|++++++++|||++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 35566789999999999999988899999999865543444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.......
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999763 689999999999999999999998 999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||++ .+..++.++|||||||++|||+||+.||....... .... +.... .+.
T Consensus 154 --~~~~~~~~~~y~~PE~~-~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~-~~~~~-----~~~-- 217 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVI-KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFL-IPKNN-----PPS-- 217 (274)
T ss_pred --ccccccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHH-hhhcC-----CCC--
Confidence 11344677889999988 44558999999999999999999999996533111 1111 11111 111
Q ss_pred CCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~-~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+.. ...++.+++.+||..+|++|||+++++++
T Consensus 218 -~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 -LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 45568899999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.72 Aligned_cols=263 Identities=24% Similarity=0.303 Sum_probs=199.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|++++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 44566899999999999999889999999998654322 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+ ++|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 6 5888887654 24589999999999999999999998 999999999999999999999999999976543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC------cccc
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN------VLDC 788 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 788 (843)
. .....++..|+|||.+.....++.++|||||||++|||+||+.|+.........+....+.. .... ....
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPTEESWPGVSKL 231 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHh-CCCChHHhHHhhhc
Confidence 1 12345678899999875555678999999999999999999999765433322222111110 0000 0000
Q ss_pred cC----CCCC------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VD----PSMG------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d----~~l~------~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+ +... ........++.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0000 0112234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.08 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=201.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.++++++|||++++++++..+...++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 55667899999999999999888999999998654322 23456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+++++..++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 998888776543 3589999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH----------HhhCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL----------LEEGN 784 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~----------~~~~~ 784 (843)
. .....++..|+|||.+.....++.++|||||||++|||++|+.||....... ......... .....
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 D--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhccccc
Confidence 1 1234567889999987555668899999999999999999999997543221 111111100 00000
Q ss_pred c-ccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 V-LDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~-~~~~d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. .....+.... ........+.+++.+||+.+|++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 0000000000 011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.26 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=203.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
....|+..+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 44567777899999999999999988899999999865432 23467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 96 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999998753 478889999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.... .....++..|+|||.. .+..++.++|||||||++|++++|+.||........... ....+ .+
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~~ 233 (297)
T cd06656 168 EQSK--RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------TP 233 (297)
T ss_pred CccC--cCcccCCccccCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------CC
Confidence 2211 1334677889999987 556788999999999999999999999965322111000 00000 00
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+......+.+++.+||+.+|++||++++++++
T Consensus 234 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 -ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233445567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.57 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=204.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||.++...+++.+++|.+.... .......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 455678999999999999998889999999986443 2234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.++.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999998652 35689999999999999999999998 999999999999999999999999999986643221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||.. .+..++.++||||||+++|||++|+.||...... +....... +.. .
T Consensus 157 --~~~~~~~~~~y~ape~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~--------~ 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELC-QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQ-GNY--------T 219 (256)
T ss_pred --cccccCCCccccCHhhc-CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc-CCC--------C
Confidence 12345678899999987 4556889999999999999999999998643221 11211111 111 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+.....++.+++.+||+.+|++||++.|+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 12234456788999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.64 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=202.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc---CCCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR---HPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e 632 (843)
|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 5566789999999999999988899999999865443444567889999999997 9999999999999889999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++++|.++++.. .+++...+.++.|++.|+.|||+. +|+||||+|+||++++++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998653 588999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
... .....|+..|+|||.+..+..++.++|||||||++|+|++|+.||....... ... ..... ..+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~~~~-----~~~- 220 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LIPKS-----KPP- 220 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-ccccC-----CCC-
Confidence 321 1334678889999988555667899999999999999999999996432211 110 00000 011
Q ss_pred CCCCCh-hhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPE-DEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~-~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+. ....++.+++.+||+.||++||++.|++.+
T Consensus 221 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 --RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111 245678899999999999999999999886
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.01 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=201.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC-----C
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP-----Q 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~ 625 (843)
+.+.|+..+.||+|+||.||+|....+++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++... +
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 4455777779999999999999998889999999985432 2346778899999999 799999999998754 3
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++|+||+++|+|.++++........+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 57899999999999999876443456789999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcC----CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSL----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
++........ .....++..|+|||.+.... .++.++|||||||++|||++|+.||...... ..+.. . .
T Consensus 175 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~----~-~ 246 (291)
T cd06639 175 SAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFK----I-P 246 (291)
T ss_pred chhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHH----H-h
Confidence 8865432211 12345788899999874332 3688999999999999999999999654221 11111 1 1
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....... ..+......+.+++.+||+.+|++||++.|++++
T Consensus 247 ~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 RNPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cCCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 1123344568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=339.92 Aligned_cols=259 Identities=27% Similarity=0.369 Sum_probs=213.2
Q ss_pred hhcCeeccccceEEEEEEECC-------CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 628 (843)
+..+.+|+|+||.|++|.... ....||||.++........+.+..|+++++.+ +||||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 555689999999999998631 14579999998766656678899999999999 6999999999999988999
Q ss_pred EEEEeCCCCCHHHHHhhcC----------CCC--CCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 629 LVSDYAPNGSLQAKLHERL----------PST--PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~----------~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
+|+||++.|+|.++++..+ ... ..++..+.+.++.|||.||+||++. ++||||+.++|||++++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999999865 001 2388899999999999999999999 999999999999999999
Q ss_pred CcEEeeccCcccccccccceecccc-ccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHH
Q 003156 697 NPRISDFGLARLLTRLDKHVMSNRF-QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSE 774 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~ 774 (843)
.+||+|||+|+.....+.+...... .-+..|||||.+ ....|+.++|||||||++|||+| |..||......... .+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl-~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~ 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL-FDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LE 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHh-ccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HH
Confidence 9999999999977655544422211 135679999998 55789999999999999999998 88998653212211 11
Q ss_pred HHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 775 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
.++.|... +.|..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus 534 ----~l~~G~r~--------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 ----FLKEGNRM--------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----HHhcCCCC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 34445443 24777788999999999999999999999999998874
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.34 Aligned_cols=256 Identities=22% Similarity=0.266 Sum_probs=197.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||++....+++.||+|.+..... ....+.+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 5566789999999999999988899999999864321 12345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999763 34588899999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.. ......||+.|+|||++.. ...++.++|||||||++|||++|+.||...... +.............
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~-- 228 (331)
T cd05597 157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKEHFQ-- 228 (331)
T ss_pred Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCCccc--
Confidence 21 1123468999999998742 245788999999999999999999999643211 11111111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCH--IPSSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~--~P~~RPs~~evl~~ 828 (843)
+..........+.+++.+|+.. ++..||++.+++++
T Consensus 229 ---~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ---FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111222445677788886654 34448899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.27 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=214.7
Q ss_pred eeccccceEEEEEEECCC-----CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC-CeeEEEEEeC
Q 003156 561 EVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-QLKLLVSDYA 634 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~ 634 (843)
.+-+|.||.||+|.|+.. .+.|-||.++.....-....+..|..++..+.|||+..+.+++.+. ...+++|.++
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 478999999999988643 3456777775554443456788999999999999999999999765 4578999999
Q ss_pred CCCCHHHHHhhcCC----CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 635 PNGSLQAKLHERLP----STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 635 ~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
..|+|..++...+. ....++-.+...++.|++.|++|||.+ +|||.||.++|+++|+..+||++|=.++|.+.
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLF 447 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccC
Confidence 99999999984322 234577788899999999999999999 99999999999999999999999999999999
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
+.+++........++.||+||.+ ....|+.++|||||||++|||+| |+.||... +...+... +.+|...
T Consensus 448 P~DYhcLGDnEnRPvkWMslEal-~n~~yssasDvWsfGVllWELmtlg~~PyaeI--DPfEm~~y----lkdGyRl--- 517 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMSLEAL-QNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--DPFEMEHY----LKDGYRL--- 517 (563)
T ss_pred cccccccCCCCCCcccccCHHHH-hhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--CHHHHHHH----Hhcccee---
Confidence 99998887888889999999988 66789999999999999999998 99998643 33333333 3333332
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
..|-+|++++..+|.-||..+|++||+++|++..|..+...
T Consensus 518 -----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 518 -----AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 35888999999999999999999999999999999887544
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.27 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=201.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.++..+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345667779999999999999875 56779999875432 234678999999999999999999999887 67899999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999998742 34688999999999999999999998 9999999999999999999999999999765432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||++ ....++.++|||||||++||++| |..||...... .... .+..+...
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~~~~~----- 222 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYRM----- 222 (260)
T ss_pred Ccc-cccCCcccccccCHhHh-ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhCCCCC-----
Confidence 221 11223456779999988 45568999999999999999999 89998643221 1111 11111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1123345578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.96 Aligned_cols=261 Identities=23% Similarity=0.251 Sum_probs=196.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCC------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 625 (843)
.+.|+..+.||+|+||.||+|.....++.||+|++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 34567778999999999999999888999999998643322 23456788999999999999999999886432
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999965 67666653 378889999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH--------
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR-------- 777 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~-------- 777 (843)
++...... ......+|..|+|||++ .+..++.++|||||||++|||++|+.||..... ...+...+.
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHH
Confidence 98653221 12345688999999988 556789999999999999999999999965321 111111111
Q ss_pred ----------HHHhhCC-cccccCCC-----C----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 778 ----------VLLEEGN-VLDCVDPS-----M----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 778 ----------~~~~~~~-~~~~~d~~-----l----~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....... ......+. . .........++.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0110000 00000000 0 00112234567899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=324.03 Aligned_cols=256 Identities=20% Similarity=0.264 Sum_probs=199.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 556777899999999999999998999999999864321 122345788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 123 EYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred cCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999753 377888889999999999999998 999999999999999999999999999986643
Q ss_pred cccceeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
... .......||+.|+|||++... ..++.++|||||||++|||++|+.||...... ...............
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~~~~~~~~ 268 (371)
T cd05622 195 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMNHKNSLTF 268 (371)
T ss_pred CCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCCCcccC
Confidence 221 122355789999999987432 23789999999999999999999999753221 111111111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQIL 829 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~--RPs~~evl~~L 829 (843)
+ ........+.+++..|+...+.+ ||++.|++++.
T Consensus 269 -----~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 -----P-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----C-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1 11234556788999999744433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=313.26 Aligned_cols=264 Identities=26% Similarity=0.319 Sum_probs=199.0
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|++|.||+|....+++.||+|.+...........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 35566789999999999999988899999999865443333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+ ++|.+++... ...+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 86 D-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred C-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 7 5999988764 23688999999999999999999998 999999999999999999999999999875432111
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC---C-------
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG---N------- 784 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~---~------- 784 (843)
. .....++..|+|||++.+...++.++||||+||++|||++|+.||.........+....+. .... .
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV-LGTPTEETWPGVSSN 235 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHh-cCCCChhhhhhhhhc
Confidence 1 1223457789999987555568899999999999999999999996543222222111110 0000 0
Q ss_pred --cccc----c-CCCCCCC--ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 --VLDC----V-DPSMGDY--PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 --~~~~----~-d~~l~~~--~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.... . ...+... .......+.+++.+|++.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0 0000000 01112567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.95 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=198.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
++..+.||+|+||.||+|.+. +++.+|+|.+.... .....|.+|++++++++||+++++++++......++|+||++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred eEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 445668999999999999986 57789999875433 234679999999999999999999999999889999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999999764 24578999999999999999999998 999999999999999999999999999876543211
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
.......++.+|+|||.. .+..++.++||||||+++|||++ |+.||...... ..... ...+. ....
T Consensus 156 ~~~~~~~~~~~~~aPe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~-~~~~~--~~~~---- 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVF-SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVET-INAGF--RLYK---- 222 (256)
T ss_pred cccCCCccchhhcCHhHh-ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHH-HhCCC--CCCC----
Confidence 111223346789999988 45678899999999999999998 99998643211 11111 11111 1111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
+...+..+.+++.+||+.+|++|||+.|++++|.
T Consensus 223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2223467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=309.50 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=202.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~ 633 (843)
++..+.||.|++|.||+|....+++.+|+|.+...........+.+|++++++++||||+++++++.+. ...++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 344568999999999999998889999999986554334456789999999999999999999998654 367999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999998876443456688999999999999999999998 99999999999999999999999999987543211
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. ....++..|+|||.+ .+..++.++||||+||++|||++|+.||...........+..... ..... ..+....
T Consensus 160 ~----~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~ 232 (287)
T cd06621 160 A----GTFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI-VNMPN-PELKDEP 232 (287)
T ss_pred c----ccccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH-hcCCc-hhhccCC
Confidence 1 234567889999987 556789999999999999999999999976532111111111111 11110 0111110
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.........+.+++.+||+.+|++|||+.|++++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0112335678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.30 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=194.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----cChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 629 (843)
|+..+.||+|+||.||+|....+++.||+|++...... +..+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 45567899999999999999888999999988543211 2234688899999999999999999998753 56789
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|+||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 84 ~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999764 3478899999999999999999988 9999999999999999999999999999765
Q ss_pred cccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... .......++..|+|||.+ .+..++.++|||||||++|||++|+.||...... ..+..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~~-----~~ 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIAT-----QP 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHh-CCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHhc-----CC
Confidence 432111 111234578899999988 5567899999999999999999999999643221 11111111 01
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. +..+......+..++ +||..+|++||+++|++++
T Consensus 226 ~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11 122333444566666 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.63 Aligned_cols=258 Identities=25% Similarity=0.355 Sum_probs=206.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|+||+||+|....++..+|+|++.........+.+.+|+++++.++|+|++++++.+..++..++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 55677899999999999999888999999998655444456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+++|.++++...+ ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++..+......
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999987532 24589999999999999999999998 9999999999999999999999999999776543322
Q ss_pred e--eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 716 V--MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 716 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. ......++..|+|||++.....++.++|||||||++|||++|+.||...... ..+... .... .+..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~----~~~~------~~~~ 227 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLT----LQND------PPSL 227 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHH----hcCC------CCCc
Confidence 1 2234467889999998855447899999999999999999999999654221 111111 1110 1111
Q ss_pred CC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ........+.+++.+||+.+|++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 112445678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=306.37 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=213.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
..|...+.||+|.|+.|-.|++.-+|.+||||++.+.+... ....+.+|+..|+.++|||||+++.+...+...|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44666778999999999999998899999999996554433 34578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCcccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTR 711 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~ 711 (843)
.=++|+|.+||-++ ...+.+....+++.||..|+.|.|+. .+||||+||+||.+- .-|-||++|||++..+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999886 35589999999999999999999998 899999999999876 678899999999988776
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
+... ...+|++.|-|||++.+..+..+++||||+|||+|.+++|+.||.-.++.+ .+.. ++|.
T Consensus 172 G~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-TLTm-------------ImDC 234 (864)
T KOG4717|consen 172 GKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-TLTM-------------IMDC 234 (864)
T ss_pred cchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-hhhh-------------hhcc
Confidence 5543 567899999999999888777899999999999999999999998665432 1111 1121
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ..|.-...+..+||..|+..||++|.|.+||+..
T Consensus 235 KY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 11 2366677788899999999999999999999875
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=306.95 Aligned_cols=251 Identities=23% Similarity=0.382 Sum_probs=203.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||++....+|+.||+|++..... ....+++.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 4556789999999999999988899999999864322 223457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++.... ...+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999997642 23578899999999999999999998 999999999999999999999999999976543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
. .....++..|+|||+. .+..++.++|||||||++|||++|+.||...... ..+..... +. ..
T Consensus 157 ~--~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~-~~--------~~ 219 (256)
T cd08218 157 L--ARTCIGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIR-GS--------YP 219 (256)
T ss_pred h--hhhccCCccccCHHHh-CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhc-CC--------CC
Confidence 1 1234578889999987 5567889999999999999999999998653221 11111111 11 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.....++.+++.+||+.+|++||++.||+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2234456678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.50 Aligned_cols=256 Identities=19% Similarity=0.216 Sum_probs=191.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|+||.||+|....+++.||+|..... ....|+.++++++||||+++++++......++|+||+
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 467778999999999999999888899999974322 2356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
. |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 140 ~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 140 S-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred C-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 4 6888888764 35689999999999999999999998 99999999999999999999999999997533211
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC-CchhhH----HHHHHHHHhhCCcc-cc
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE-DNVVIL----SEHVRVLLEEGNVL-DC 788 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~-~~~~~l----~~~~~~~~~~~~~~-~~ 788 (843)
......||..|+|||++ .+..++.++|||||||++|||+++..|+.... ...... ...+...+...... ..
T Consensus 212 --~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred --ccccccccccccCCeec-CCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 11345688999999988 45578999999999999999999766653321 111110 01111111100000 00
Q ss_pred cC--CC------------CC--CC-------ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VD--PS------------MG--DY-------PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d--~~------------l~--~~-------~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+. +. .. .+ ......++..++.+||+.||++|||+.|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 00 00 00 01123345679999999999999999999876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=289.81 Aligned_cols=283 Identities=23% Similarity=0.309 Sum_probs=214.0
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCC----CeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEc-C
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQ----GRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWT-P 624 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~ 624 (843)
+....|+....||+|.||.||+|....+ .+.+|+|+++.... .+......+|+..++.++||||+.+..++.+ +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3445677788899999999999966432 23689999865432 2344567899999999999999999999877 6
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCC-CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC----CCcE
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN----YNPR 699 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~k 699 (843)
...++++||.+. +|...|+-+.. ....++...+..|+.||+.|+.|||++ =|+|||+||.|||+..+ |+||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 788999999976 88888876432 335788889999999999999999999 69999999999999877 9999
Q ss_pred EeeccCcccccccc-cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch----hhHHH
Q 003156 700 ISDFGLARLLTRLD-KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV----VILSE 774 (843)
Q Consensus 700 l~Dfgl~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~----~~l~~ 774 (843)
|+|||+++.+...- ..........|++|+|||.+.+...||.+.||||.||++.||+|-.+-|...+... .+...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999875432 22234566789999999999899999999999999999999999887775432111 11122
Q ss_pred HHHHHHh-hCCcccccCCCCCCCChh--------------------------hHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003156 775 HVRVLLE-EGNVLDCVDPSMGDYPED--------------------------EVLPVLKLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 775 ~~~~~~~-~~~~~~~~d~~l~~~~~~--------------------------~~~~l~~l~~~c~~~~P~~RPs~~evl~ 827 (843)
.+...++ -|...+...|.+..+|+- -....++|+..++..||.+|.|++++++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 2222222 222223333333332211 0112678999999999999999999999
Q ss_pred HHHhccCCCC
Q 003156 828 ILQVIKTPLP 837 (843)
Q Consensus 828 ~L~~~~~~~~ 837 (843)
+.--..+++|
T Consensus 337 h~yF~~d~lp 346 (438)
T KOG0666|consen 337 HPYFTEDPLP 346 (438)
T ss_pred ccccccCCCC
Confidence 9877777665
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=323.32 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=190.6
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhc---cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA---RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
||+|+||+||+|+...+++.||+|++...... .....+..|..++... +||+|+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999888999999998643221 1223455677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 9999998764 4588999999999999999999998 999999999999999999999999999875432221
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......||..|+|||++.....++.++||||+||++|||++|+.||...... +..+. +..+.. .++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~-i~~~~~------~~~-- 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRN-IAFGKV------RFP-- 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHH-HHcCCC------CCC--
Confidence 1234568999999998855556899999999999999999999999653221 11111 111111 111
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRP----SMAEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RP----s~~evl~~ 828 (843)
......++.+++.+|++.||++|| ++.|++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 112344677899999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=305.31 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=200.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC-CeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP-QLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~ 633 (843)
|+..+.||+|++|.||++....+++.||+|++..... ....+.+.+|++++++++|||++++++.+... ...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 4556789999999999999988899999999865432 22345688999999999999999999987644 457899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998742 34589999999999999999999998 99999999999999999999999999998664322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. ......++..|+|||+. ....++.++||||+|+++|||++|+.||...... ....... .+. +
T Consensus 157 ~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~-~~~--------~ 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELF-SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRII-EGK--------L 219 (257)
T ss_pred C--ccccccCCcCccChhHh-cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH-hcC--------C
Confidence 1 12345678899999987 5557889999999999999999999998643211 1111111 111 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+......+.+++.+||+.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12233455678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=308.05 Aligned_cols=257 Identities=26% Similarity=0.363 Sum_probs=200.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--c-------ChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--Q-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
|...+.||+|+||.||+|....+|+.||+|.+...... . ..+.+.+|+.++++++|||++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 34566899999999999999878999999987532111 0 12467889999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.++++.. ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999875 4688899999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+...............++..|+|||.+.... .++.++||||||+++||+++|..||....... ... .... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~-~~~~-~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMF-KLGN-KRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHH-Hhhc-ccc
Confidence 7654322222223456788999999874443 47899999999999999999999996432211 111 1111 111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...++. .........+.+++.+||..+|++|||+.+++++
T Consensus 230 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 1222345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.85 Aligned_cols=260 Identities=22% Similarity=0.252 Sum_probs=195.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC------Ce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 626 (843)
+.|+..+.||+|+||.||+|.....++.||||++..... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 456777899999999999999988899999999864322 22345678999999999999999999987543 34
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 6899999965 67777753 378889999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH---------
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR--------- 777 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~--------- 777 (843)
+...... ......+|..|+|||++ .+..++.++|||||||++|||++|+.||..... ...+...+.
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHH-hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHH
Confidence 8654321 12345688999999988 556789999999999999999999999965322 111111111
Q ss_pred ---------HHHhhCCcccc-----cCCC-----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 778 ---------VLLEEGNVLDC-----VDPS-----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 778 ---------~~~~~~~~~~~-----~d~~-----l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........... ..+. ..........++.+++.+|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 0000 000111223467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.95 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=196.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHH-HHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV-LGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|.+..+|+.||+|++...........+..|+.. ++..+||||+++++++..++..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 44556899999999999999888999999998654333333456666665 55668999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+ |+|.+++.........+++..++.++.|++.|++|||+++ +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 6 7898888765444467899999999999999999999753 89999999999999999999999999998654211
Q ss_pred ceeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
......++..|+|||.+... ..++.++|||||||++|||++|+.||.........+.. .... ..+
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~ 226 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----VVEE------PSP 226 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----HHhc------CCC
Confidence 11234577889999987332 34688999999999999999999999643322221111 1111 011
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ....+.++.+++.+||..+|++||++.+++++
T Consensus 227 ~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 QLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 12234578899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.08 Aligned_cols=256 Identities=21% Similarity=0.254 Sum_probs=197.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||++++..+++.||+|.+..... ......+.+|+.++..++|++|+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 4556789999999999999988899999999854321 12234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999864 24588999999999999999999998 99999999999999999999999999987653322
Q ss_pred cceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
. .......||+.|+|||++.. ...++.++|||||||++|||++|+.||..... .+...........
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~---- 226 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKER---- 226 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCcc----
Confidence 2 12234578999999998742 34578999999999999999999999965321 1111111111110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIP--SSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P--~~RPs~~evl~~ 828 (843)
...+.........+.+++.+|+..++ ..|++++|++++
T Consensus 227 -~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 -FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01111223345567788888775544 447899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=295.60 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=206.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..++..+.||+|.-|+||.+....++..+|+|++.+..... ...+...|-++|+.+.||.+..+++.+..+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34667779999999999999999888999999996554332 2345677999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|||+||+|....+.+ .+..+++..+..+|..++.||+|||.. |||.|||||+||||.++|.+.++||.++.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999999886 456799999999999999999999999 999999999999999999999999998754311
Q ss_pred cc---------------------------------c---------------------ceeccccccccccCCcccccCcC
Q 003156 712 LD---------------------------------K---------------------HVMSNRFQSALGYVAPELTCQSL 737 (843)
Q Consensus 712 ~~---------------------------------~---------------------~~~~~~~~g~~~y~aPE~~~~~~ 737 (843)
.. . ......+.||-.|.|||++ .+.
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI-~G~ 310 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI-RGE 310 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee-ecC
Confidence 00 0 0112345688899999999 555
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCC
Q 003156 738 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPS 817 (843)
Q Consensus 738 ~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~ 817 (843)
.-+.++|.|+|||++|||+.|..||...... ..+...+ .. +...++.+ .....+.+||++.+.+||.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv----~~-------~l~Fp~~~-~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIV----GQ-------PLKFPEEP-EVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHh----cC-------CCcCCCCC-cchhHHHHHHHHHhccChh
Confidence 6789999999999999999999999765432 2222221 11 12222222 4556788999999999999
Q ss_pred CCCC----HHHHHHH
Q 003156 818 SRPS----MAEVVQI 828 (843)
Q Consensus 818 ~RPs----~~evl~~ 828 (843)
+|.- +.||.+|
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 8888775
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.41 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=200.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 45567899999999999999878999999997554322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+++++..+.... ..++|..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 83 DHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999988876643 3489999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH----------HHHhhCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR----------VLLEEGN 784 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~----------~~~~~~~ 784 (843)
. .....++..|+|||+......++.++|||||||++|||++|+.||..... ...+..... .......
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 V--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 12345778899999885555678899999999999999999998864321 111111110 0000000
Q ss_pred c-ccccCCCCC------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 V-LDCVDPSMG------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~-~~~~d~~l~------~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. .....+... .........+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 000000000 0112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=311.09 Aligned_cols=264 Identities=22% Similarity=0.269 Sum_probs=199.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|++|.||+|....+|+.||+|++..... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 3456689999999999999988899999998864332 223357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
. ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++.......
T Consensus 82 ~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 5 68999887642 35689999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh------------
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE------------ 782 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~------------ 782 (843)
. .....++..|+|||.+.+...++.++|||||||++|||+||+.||...... ....+..+..-..
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 123346788999998755555788999999999999999999999654321 1111111110000
Q ss_pred ---CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 ---GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ---~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.....................+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000111233457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.36 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=198.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
|+..+.||+|+||+||+|... +++.+|+|.+...... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 455678999999999999875 7889999988543211 1234688899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
+||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999764 3578899999999999999999998 99999999999999999999999999987653
Q ss_pred cccc----ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 711 RLDK----HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 711 ~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
.... ........++..|+|||++ .+..++.++|||||||++|||++|+.||.......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~-- 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRG-- 225 (265)
T ss_pred hccccccccccccccCCCccccChhhh-cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccC--
Confidence 2111 1111234578899999988 55568899999999999999999999996532211110 0000000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+..+.....++.+++.+||+.+|++||++.|++++
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0112234455678899999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=304.15 Aligned_cols=240 Identities=22% Similarity=0.331 Sum_probs=190.0
Q ss_pred CeeccccceEEEEEEECCCC----------eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 560 AEVGEGVFGTVYKVSFGTQG----------RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
+.||+|+||.||+|.+...+ ..|++|.+...... ...|.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 36899999999999997555 35788876543322 5788999999999999999999999988 77899
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-------CcEEee
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-------NPRISD 702 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~D 702 (843)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999998752 2688999999999999999999998 999999999999999887 799999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHH
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
||+++.... .....++..|+|||++... ..++.++|||||||++|||++ |..||...... .+.. .+
T Consensus 152 fg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~~~-~~ 219 (259)
T cd05037 152 PGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EKER-FY 219 (259)
T ss_pred CCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hHHH-HH
Confidence 999986543 1223456779999987444 368899999999999999999 57777543211 1111 11
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
..... .+......+.+++.+||..+|++|||+.|+++.|+
T Consensus 220 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQHR----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcCCC----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11110 11111267889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=324.54 Aligned_cols=261 Identities=20% Similarity=0.209 Sum_probs=198.6
Q ss_pred hhhhhcCeeccccceEEEEEEECC--CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..|+..+.||+|+||.||++.... .++.||+|.+... +...+|++++++++||||+++++++......++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 346777899999999999998642 4578999987432 23568999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|++. ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9995 688888843 35689999999999999999999998 999999999999999999999999999986654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc--hhhHHHHHHHHHhhCCc----
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--VVILSEHVRVLLEEGNV---- 785 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--~~~l~~~~~~~~~~~~~---- 785 (843)
...........||..|+|||++ ....++.++|||||||++|||++|+.||...... ...+...++.. .....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~-~~~~~~~~~ 315 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQ 315 (392)
T ss_pred ccccccccccccccCccCHhHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh-ccCccccCC
Confidence 3333233456789999999988 5567899999999999999999999999654221 12222221111 00000
Q ss_pred -------------ccccCCC--CCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 786 -------------LDCVDPS--MGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 786 -------------~~~~d~~--l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.....+. .+. .......++.+++.+|+..||++|||+.|++.+=.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 0000000 000 00122346778999999999999999999998743
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=309.34 Aligned_cols=264 Identities=25% Similarity=0.336 Sum_probs=203.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 4556789999999999999988899999999876543 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+++|.+++.... ..+++.+++.++.|+++||+|||+. +++|+||||+||++++++.++++|||++........
T Consensus 82 -~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999998642 5689999999999999999999998 999999999999999999999999999986654321
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC-----------
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG----------- 783 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~----------- 783 (843)
.......++..|+|||.+.....++.++||||+||++|||++|+.||... .+...+.......-...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE-NDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC-CHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 11133467889999998855556789999999999999999997777543 22222222111100000
Q ss_pred CcccccCCC-----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPS-----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~-----l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.......+. +.+...+....+.+++.+|++.+|++|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 001112344678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=304.89 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=203.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e 632 (843)
|+..+.||.|+||.||+|....+++.||+|.+...... ...+.+..|++++++++||||+++++++.. ....++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 34556899999999999999888999999998654322 234568889999999999999999998864 345789999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC--CCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF--RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|+++++|.+++.........+++..++.++.|++.|++|||..+ ..+++|+||+|+||++++++.+|++|||+++...
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999999875444567999999999999999999999322 2399999999999999999999999999998765
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
..... .....++..|+|||.+ ....++.++||||||+++|+|++|+.||.... ...+.+ .+..+.
T Consensus 162 ~~~~~--~~~~~~~~~~~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~----~~~~~~------ 226 (265)
T cd08217 162 HDSSF--AKTYVGTPYYMSPEQL-NHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLAS----KIKEGK------ 226 (265)
T ss_pred CCccc--ccccccCCCccChhhh-cCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHH----HHhcCC------
Confidence 43321 1334678899999988 45568899999999999999999999997543 111111 111111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+.....++.+++.+|++.+|++|||+.+|+++
T Consensus 227 --~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 --FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 122344556678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.51 Aligned_cols=259 Identities=23% Similarity=0.357 Sum_probs=211.1
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
...+.+++++...||.|+||.||+|..+..+-..|.|.+... ..+..++|.-|+++|..+.||+||++++.|+..+..+
T Consensus 27 dlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 27 DLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred cCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 356888999999999999999999999855555667776433 3445688999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+..|||.||-++..+-+- +..+.+.++..+++|++.||.|||++ .|||||+|+.|||++-+|.++++|||.+..
T Consensus 106 iliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred EEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999988775 46799999999999999999999999 999999999999999999999999998864
Q ss_pred ccccccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
... .......+.||+.|||||+.. ....|+.++||||||+++.||..+.+|-..... ...+ ++..
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRVl---lKia----- 248 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVL---LKIA----- 248 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHHH---HHHh-----
Confidence 322 122236788999999999763 356789999999999999999999999754321 1111 1111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.-+|...-.|......+.+++.+|+.++|+.||++++++++
T Consensus 249 ---KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 249 ---KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11222222466667778899999999999999999999986
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.15 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=202.8
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
.+.+.+.....||+|+||.||++....++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++|
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 45566776778999999999999998889999999885432 23346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 98 MEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999999998854 2478999999999999999999998 99999999999999999999999999987553
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.... ......++..|+|||.. ....++.++|||||||++|||++|+.||....... . ... +.. .+.
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~----~~~-~~~-----~~~ 235 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-A----MRR-IRD-----NLP 235 (292)
T ss_pred cccc--cCceeecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H----HHH-HHh-----cCC
Confidence 2211 11334578899999987 55578899999999999999999999996532211 1 111 111 111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.... .......+..++.+||..+|.+|||++|++++
T Consensus 236 ~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 236 PRVKD-SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred Ccccc-ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111 12234467889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=306.90 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=201.8
Q ss_pred hhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+.++..+.||+|+||.||+|+... +.+.||+|.+.........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 445667789999999999999753 346789998754432223467899999999999999999999999988899
Q ss_pred EEEEeCCCCCHHHHHhhcCCC-----CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeec
Q 003156 629 LVSDYAPNGSLQAKLHERLPS-----TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 703 (843)
+||||+++|+|.++++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999865321 12689999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
|+++........ ......++..|+|||.+ ....++.++||||||+++|||++ |..||...... . .... ...
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~-~~~~----~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAV-QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-E-VLNR----LQA 233 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-H-HHHH----HHc
Confidence 998754322211 11333556789999987 44567899999999999999999 78888543221 1 1111 111
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 783 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
+.... ..+...+..+.+++.+||+.+|++|||+.|++++|+
T Consensus 234 ~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 112344567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.59 Aligned_cols=259 Identities=24% Similarity=0.300 Sum_probs=195.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcC------Ce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 626 (843)
+.|+..+.||+|+||.||+|....+++.||||++...... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 4577778999999999999999888999999998543221 2335677899999999999999999987543 34
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 68999988 7899888764 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH-------
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------- 779 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~------- 779 (843)
+..... .....||..|+|||++.....++.++||||+||++|||++|+.||..... ...+.......
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 865431 13346788999999885556789999999999999999999999964321 11111111100
Q ss_pred ---HhhCCcccccCCCCCCCC--------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 ---LEEGNVLDCVDPSMGDYP--------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ---~~~~~~~~~~d~~l~~~~--------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+........ ...+...+ ......+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKY-IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHH-hhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00000111 1123347799999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=305.89 Aligned_cols=256 Identities=21% Similarity=0.313 Sum_probs=200.4
Q ss_pred hhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCCc---------ccChHHHHHHHHHHHh-ccCCCccceeeEEEcC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDI---------IQYPEDFEREVRVLGK-ARHPNLISLEGYYWTP 624 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~ 624 (843)
|+..+.||+|+||.||+|.+.. .++.+|+|.+..... .....++.+|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4456689999999999999976 578899998753221 1123456778888875 6999999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
+..++||||+++++|.+++.........+++..++.++.|++.|+.|||+.. +++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEeccc
Confidence 9999999999999999998764334567899999999999999999999631 89999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
.+....... ......++..|+|||.+ ....++.++||||||+++|||++|+.||..... .. ..... ..+.
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~-~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--~~---~~~~~-~~~~ 229 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LS---LATKI-VEAV 229 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhh-cCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--HH---HHHHH-hhcc
Confidence 998655432 22345678889999988 455689999999999999999999999864321 11 11111 1111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.... ........+.+++.+||+.||++||++.|+..+++
T Consensus 230 ~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPL-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcC-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1100 11133457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.91 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=200.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|....+++.+|+|.+..... ....+.+.+|++++++++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 4456689999999999999988899999999865432 223467889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeeccCcccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRLD 713 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~~ 713 (843)
++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++++ +.+|++|||.++......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998752 34589999999999999999999998 99999999999999854 468999999998664322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. .....++..|+|||.. ....++.++||||||+++|+|++|+.||...... ........ .. .
T Consensus 157 ~---~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~-~~--------~ 218 (256)
T cd08220 157 K---AYTVVGTPCYISPELC-EGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMS-GT--------F 218 (256)
T ss_pred c---ccccccCCcccCchhc-cCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHh-cC--------C
Confidence 1 1234678899999988 4556889999999999999999999998653221 11111111 11 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+.....++.+++.+||+.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11233445678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=303.50 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=201.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
|+..+.||+|+||.||+|....+++.||+|.+...... +..+.+.+|+++++.++||||+++++++......++|+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 34556899999999999999878999999998654321 23457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999764 3588999999999999999999998 999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. ......++..|+|||.+.....++.++|+|||||++|+|++|+.||...... ... .......
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~----~~~~~~~-------- 218 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAV----FKIGRSK-------- 218 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHH----HHHHhcc--------
Confidence 22 1234567888999998744334889999999999999999999999654311 111 1111100
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.....+......+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1112233445678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.14 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=198.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+++...+++.||+|.+..... ......+.+|..++..++|++|+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 5566789999999999999988899999999864321 12234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999864 24588899999999999999999998 99999999999999999999999999997664322
Q ss_pred cceeccccccccccCCcccccCc----CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQS----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.. ......|++.|+|||++... ..++.++|||||||++|||++|+.||...... +............
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~--- 227 (331)
T cd05624 157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHEERF--- 227 (331)
T ss_pred ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHHHcCCCcc---
Confidence 21 12345689999999987431 45788999999999999999999999653221 1111111111100
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~--RPs~~evl~~ 828 (843)
..+....+...++.+++.+|+...+++ |+++++++++
T Consensus 228 --~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 --QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111112234567888999988865544 5689988775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.66 Aligned_cols=247 Identities=27% Similarity=0.396 Sum_probs=197.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.. .++.||+|...... ..+.+.+|+.++++++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4567778999999999999976 68889999885432 346789999999999999999999998664 46899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++.... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999999998652 34588999999999999999999998 99999999999999999999999999987543211
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.....+..|+|||.+ ....++.++|||||||++|||++ |+.||...... .. ...+..+...
T Consensus 155 -----~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~----~~~~~~~~~~------ 216 (254)
T cd05083 155 -----DNSKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EV----KECVEKGYRM------ 216 (254)
T ss_pred -----CCCCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HH----HHHHhCCCCC------
Confidence 122335679999987 55578999999999999999998 99998643221 11 1112221111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 --EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1123445678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.21 Aligned_cols=251 Identities=31% Similarity=0.445 Sum_probs=201.6
Q ss_pred hcCeeccccceEEEEEEECCCC----eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQG----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..+.||+|+||.||++.+...+ ..||+|.+.........+.+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 3468999999999999997655 889999986554333567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999998752 11289999999999999999999998 99999999999999999999999999998765442
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.... ....++..|+|||.. ....++.++||||+|+++|||++ |+.||.... ...+.+. ...+..
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~----~~~~~~------- 222 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEY----LKKGYR------- 222 (258)
T ss_pred cccc-ccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH----HhcCCC-------
Confidence 2221 123367889999987 56678999999999999999998 778875421 1111111 111111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
...+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112333566789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.91 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=200.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
|+..+.||+|+||.||+|....+++.||+|.+...... .....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 34456899999999999999888999999998654432 12345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+ +|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 999999997642 3689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh--------C
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE--------G 783 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~--------~ 783 (843)
.... .....++..|+|||.+.....++.++|||||||++|||++|..||... .....+....+..... .
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD-SDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC-ccHHHHHHHHHHcCCCchhhhhhcc
Confidence 3211 123345678999998755566889999999999999999997766533 2222222211110000 0
Q ss_pred Cccccc------CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCV------DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~------d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...... ..............+.+++.+||+.+|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 000001112335678899999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.49 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=195.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|....+++.||+|.+..... ......+.+|+.++..++||+|+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 4556789999999999999988899999999864321 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999764 4588999999999999999999998 99999999999999999999999999987543211
Q ss_pred cc---------------------------------eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCC
Q 003156 714 KH---------------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR 760 (843)
Q Consensus 714 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~ 760 (843)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-cCCCCCCcceeccccceeeecccCCC
Confidence 00 001234689999999988 55678999999999999999999999
Q ss_pred CCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003156 761 PVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS---MAEVVQI 828 (843)
Q Consensus 761 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs---~~evl~~ 828 (843)
||....... ............ .+.+ ......++.+++.+|+ .+|.+|++ +.|++++
T Consensus 235 Pf~~~~~~~-----~~~~i~~~~~~~-~~p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQE-----TYRKVMNWKETL-VFPP-----EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHH-----HHHHHHcCCCce-ecCC-----CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 996542211 111111100000 0111 0112345667777765 49999985 6777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=308.25 Aligned_cols=259 Identities=21% Similarity=0.251 Sum_probs=196.5
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcC--CeeEEEEEe
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTP--QLKLLVSDY 633 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~ 633 (843)
+..+.||+|+||.||+|....+++.||+|++.............+|+.++.++. |||++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 345689999999999999988899999999865432222334567899999885 99999999999987 788999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
++ |++.+++... ...++|.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++......
T Consensus 82 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 82 MD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred CC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 96 5888888764 24689999999999999999999998 9999999999999999 999999999998664322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH-----------HHhh
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV-----------LLEE 782 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~-----------~~~~ 782 (843)
.. ....++..|+|||.+.....++.++||||+||++|||++|..||....... .. ..... ....
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QI-AKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HH-HHHHHHcCCCCHHHHHhhcc
Confidence 21 234567889999976555667899999999999999999999996532211 11 11111 0000
Q ss_pred CCcccccCCC-----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNVLDCVDPS-----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~~~~~d~~-----l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........+. +.......+..+.+++.+||+.+|++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 001122446789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.99 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=202.3
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.++....||+|+||.||+|....+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 34445579999999999999988899999999854432 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 101 QGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999998764 3478999999999999999999998 999999999999999999999999999875543221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||++ .+..++.++|||||||++|||++|+.||....... . ...+ ..... + ..
T Consensus 173 --~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~-~~~~----~~~~~-----~-~~ 237 (297)
T cd06659 173 --KRKSLVGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-A-MKRL----RDSPP-----P-KL 237 (297)
T ss_pred --cccceecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H-HHHH----hccCC-----C-Cc
Confidence 11335678899999988 45568999999999999999999999996432211 1 1111 11100 0 00
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.........+.+++.+||+.+|++||++.|++++---.+.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 1122334568899999999999999999999996433333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.88 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=203.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC-----
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ----- 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~----- 625 (843)
+.+.|+..+.||+|+||.||+|....+++.+|+|.+..... ..+.+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45677888899999999999999988889999999865432 346789999999999 6999999999997644
Q ss_pred -eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 626 -LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 626 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
..++||||+++++|.+++.........+++..+..++.|++.||+|||+. +++||||+|+||++++++.+|++|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 47999999999999999876533346789999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
++........ ......++..|+|||++.. ...++.++|||||||++|||++|+.||...... ..... .
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~- 230 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK----I- 230 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH----h-
Confidence 9876543221 1234467888999998632 234678999999999999999999999643221 11111 1
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+. .+.. ..+......+.+++.+||..||++|||+.|++++
T Consensus 231 ~~~~-----~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNP-----PPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccC-----CCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 1111 1123345678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.75 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=195.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----cChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 629 (843)
|+..+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|+.++++++||||+++++++.++ ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 45567899999999999999888999999987533211 1235678899999999999999999988764 45779
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999999764 3478888999999999999999998 9999999999999999999999999999765
Q ss_pred cccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
....... ......++..|+|||.+ ....++.++|||||||++|||++|+.||....... . ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~-~~~~~~------- 223 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----A-IFKIAT------- 223 (265)
T ss_pred ccccccccccccCCCCccccChhhh-cCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----H-HHHHhc-------
Confidence 3221111 11234578899999988 45668999999999999999999999996432111 1 111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+.....+......+..++.+|+. +|++||+++|++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 -QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111112344555677889999994 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.37 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=197.2
Q ss_pred hcCeeccccceEEEEEEECC---CCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC------ee
Q 003156 558 KAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------LK 627 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 627 (843)
..+.||+|+||.||+|.+.. +++.||+|.+..... ....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 45689999999999998743 468899999854322 223457889999999999999999999886542 23
Q ss_pred EEEEEeCCCCCHHHHHhhcC--CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 628 LLVSDYAPNGSLQAKLHERL--PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
++++||+++|+|.+++.... .....+++...+.++.|++.|++|||+. +|+||||||+||++++++.+|++|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 78999999999998876432 1223578899999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
++...............++..|++||.. ....++.++|||||||++|||++ |+.||..... .....+ +..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~----~~~~~ 232 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNY----LIKGN 232 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHH----HHcCC
Confidence 9866433222222233456779999987 45567899999999999999999 8888864322 111111 11111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
. ...+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 233 ~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R--------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 011233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.81 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=192.0
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHh---ccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGK---ARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~---l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
.||+|+||.||++....+++.+|+|.+....... ....+.+|..+++. .+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999998889999999986543221 12334455544443 369999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++........
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 99999998764 4589999999999999999999998 999999999999999999999999999875432211
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
....|+..|+|||....+..++.++||||+||++|||++|..||......... ....... ..+. .
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~------~~~~---~ 217 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL------TVNV---E 217 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh------cCCc---C
Confidence 23468899999998754556889999999999999999999999654322111 1111100 0111 1
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
.+.....++.+++.+|++.||++|| |++|++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2344556788999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.05 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=201.6
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
++...|+..+.||+|+||.||+|....+++.||+|.+...... +..+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 3455677888999999999999999888999999998643322 22356889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+||++ |++.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++..
T Consensus 92 lv~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 92 LVMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9999996 6777777643 24589999999999999999999998 999999999999999999999999999876
Q ss_pred ccccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
.... ....++..|+|||++. ....++.++||||||+++|||+||+.||........ ... .....
T Consensus 165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~----~~~~~-- 230 (307)
T cd06607 165 VSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH----IAQND-- 230 (307)
T ss_pred cCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHH----HhcCC--
Confidence 5422 2345678899999873 235688999999999999999999999864322111 000 01000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
.+.. ........+.+++.+||+.+|++||++.+++.+..-
T Consensus 231 ---~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 231 ---SPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred ---CCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0111 122345678999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.91 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=200.1
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
+..+.||+|++|.||+|.+..+|+.||+|++...... ...+.+.+|++++++++|||++++++++.+.+..++||||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 3456899999999999999889999999998654322 234678899999999999999999999999999999999995
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||+++........
T Consensus 82 -~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 82 -LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred -cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 68999987652 24689999999999999999999998 9999999999999999999999999999765322111
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC-----------C
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG-----------N 784 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-----------~ 784 (843)
. ....++..|+|||++.....++.++||||||+++|||++|+.||...... ..+....+...... .
T Consensus 156 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 Y--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 22345788999998755556789999999999999999999999654321 11111111100000 0
Q ss_pred ----cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 ----VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ----~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...................+.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000011111123334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=322.14 Aligned_cols=408 Identities=28% Similarity=0.397 Sum_probs=236.1
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCE
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~ 83 (843)
+..|+++.|.+. ++|+++ +.+..|+.|+..+|+|++.+++ +..+..|..|++.+|++...++. .-+++.|++
T Consensus 116 l~~l~~s~n~~~-el~~~i-~~~~~l~dl~~~~N~i~slp~~-~~~~~~l~~l~~~~n~l~~l~~~-----~i~m~~L~~ 187 (565)
T KOG0472|consen 116 LVKLDCSSNELK-ELPDSI-GRLLDLEDLDATNNQISSLPED-MVNLSKLSKLDLEGNKLKALPEN-----HIAMKRLKH 187 (565)
T ss_pred hhhhhcccccee-ecCchH-HHHhhhhhhhccccccccCchH-HHHHHHHHHhhccccchhhCCHH-----HHHHHHHHh
Confidence 445555555555 555443 3345555555555555555544 33455555666666665543331 223666777
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcc
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 163 (843)
||..+|-+. .+|..++++.+|+-|||.+|+|. ..| .|.++..|.+|+++.|.|........+++.++..|+|.+|++
T Consensus 188 ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNkl 264 (565)
T KOG0472|consen 188 LDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKL 264 (565)
T ss_pred cccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccc
Confidence 777777665 56666777777777777777776 455 577777777777777777633333344777777777777777
Q ss_pred cccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccC----cceee--ccCCcce--
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG----LEEID--LSENGFM-- 235 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~----L~~L~--l~~n~l~-- 235 (843)
+ ..|+.++-+.+|++||+++|.|+ .+|.+++++ .|+.|-+.||++. ++-..+.... |++|. +.+-++.
T Consensus 265 k-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~s 340 (565)
T KOG0472|consen 265 K-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQS 340 (565)
T ss_pred c-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCC
Confidence 6 66777777777777777777777 466677777 7777777777775 2222222110 11111 0000110
Q ss_pred --ecC--CC-CCCCCCcccccCccCEEeCCCCccceeCCccccCCCC---CcEEEcCCCcccCCCCCCccccccce-EEE
Q 003156 236 --GSI--PP-GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN---LRYLNLSSNHLRSRIPPELGYFHSLI-HLD 306 (843)
Q Consensus 236 --~~~--p~-~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~ 306 (843)
|.. +. ............+.++|+++.-+++ .+|++...-.. .+..+++.|++. .+|..+..+..+. .+.
T Consensus 341 e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 341 EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLV 418 (565)
T ss_pred cccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHH
Confidence 000 00 0001111233446677777777777 45554433323 667777777775 3455544444332 344
Q ss_pred ccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccc
Q 003156 307 LRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSG 386 (843)
Q Consensus 307 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 386 (843)
+++|.+. .+|..++.+++|+.|+|++|.+. .+|..++.+..|+.||+|+|+|. .+|..+..+..|+.+-.++|++..
T Consensus 419 lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 419 LSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred hhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence 4555554 56666666666666666666666 56666666666666666666666 566666666666666666666664
Q ss_pred cCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCC
Q 003156 387 EIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLG 431 (843)
Q Consensus 387 ~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~ 431 (843)
..|..+.++.+|..|||.+|.+...+|..|.+.++...-+.|||.
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred cChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 445556666666666666666666666666666666666666654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.27 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=202.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|++|.||+|+...+|+.||+|.+.........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 44567899999999999999888999999998765444445677889999999999999999999999999999999998
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++.......
T Consensus 82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 4 8988887643 234689999999999999999999998 999999999999999999999999999975533211
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh-------CCcccc
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE-------GNVLDC 788 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~-------~~~~~~ 788 (843)
......++..|+|||.+.....++.++|||||||++|||++|+.||..... ........+..... ......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-EDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112335678899999875555678999999999999999999999975432 21111111110000 000000
Q ss_pred cCCCCCC--------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGD--------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~--------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....... ........+.+++.+|++.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011100 112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.77 Aligned_cols=269 Identities=23% Similarity=0.279 Sum_probs=199.5
Q ss_pred hhhcCeeccccceEEEEEEECC--CCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 629 (843)
|+..+.||+|+||.||+|.... +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 3445689999999999999987 78999999986532 122346678899999999999999999999988 78999
Q ss_pred EEEeCCCCCHHHHHhhcCCC-CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC----CCCcEEeecc
Q 003156 630 VSDYAPNGSLQAKLHERLPS-TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD----NYNPRISDFG 704 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg 704 (843)
||||+++ ++.+.+...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 677777654322 23688999999999999999999998 9999999999999999 9999999999
Q ss_pred Cccccccccc-ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch--------hhHHHH
Q 003156 705 LARLLTRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV--------VILSEH 775 (843)
Q Consensus 705 l~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~--------~~l~~~ 775 (843)
+++....... ........++..|+|||.+.....++.++|||||||++|||++|+.||....... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643222 1122344678889999987555668899999999999999999999997543321 011111
Q ss_pred HHHHH-----------hhCCccccc-CCCCCCCC-----------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 776 VRVLL-----------EEGNVLDCV-DPSMGDYP-----------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 776 ~~~~~-----------~~~~~~~~~-d~~l~~~~-----------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+...- ......... ......++ .....++.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11000 000000000 00000011 1334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.43 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=199.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc------C
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT------P 624 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~ 624 (843)
+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++++ +||||+++++++.. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 4566778889999999999999998889999999875432 2345688899999999 69999999999853 3
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCc
Confidence 56799999999999999998642 34578888899999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
+++....... ......++..|+|||.+.. ...++.++|||||||++|||++|+.||......... ...
T Consensus 167 ~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----~~~- 238 (282)
T cd06636 167 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----FLI- 238 (282)
T ss_pred chhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----hhH-
Confidence 9875532111 1134567889999998742 345788999999999999999999999643221110 000
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ..+.. ........+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~-----~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 PRN-----PPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhC-----CCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 01111 123345678999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.04 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=201.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 44567899999999999999888999999998655432 24567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999864 3578899999999999999999998 999999999999999999999999999987654322
Q ss_pred cee--ccccccccccCCcccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 715 HVM--SNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 715 ~~~--~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .....++..|+|||++.... .++.++||||||+++||+++|+.||....... ...... ..+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~----~~~-----~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHV----GAG-----HK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHH----hcC-----CC
Confidence 211 12345778899999874332 27899999999999999999999996543211 111111 101 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.++. .......+.+++.+||+.+|++|||+.|++.+
T Consensus 225 ~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111 11235567899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.36 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=197.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.++..+.||+|+||.||++.+..+++.||+|.+...........+.+|+.++.++. ||||+++++++..+...++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 34455689999999999999988899999999865443334567889999999996 99999999999998889999999
Q ss_pred CCCCCHHHHHhhc-CCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 634 APNGSLQAKLHER-LPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 634 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
+. +++.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 4555543221 112356899999999999999999999742 8999999999999999999999999999765432
Q ss_pred ccceeccccccccccCCcccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.. .....++..|+|||.+... ..++.++|||||||++|||++|+.||..... ....+..... ...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~------~~~ 228 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK------GDP 228 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcC------CCC
Confidence 21 1234578889999988444 3688999999999999999999999965431 1111111111 011
Q ss_pred CCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.+. ........++.+++.+||+.+|++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 1223456678999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.91 Aligned_cols=264 Identities=24% Similarity=0.320 Sum_probs=201.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 631 (843)
.|+..+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 466677999999999999999888999999998654322 2334677899999999999999999999877 7899999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9997 59999887642 3689999999999999999999998 999999999999999999999999999986654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH-----------
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL----------- 780 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~----------- 780 (843)
... ......++..|+|||.+.....++.++||||+|+++|||++|..||..... ............
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchHHHHHhh
Confidence 221 112345678899999885555578999999999999999999999965322 111111111000
Q ss_pred -----hhCCcccccCCCCCC-CChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 -----EEGNVLDCVDPSMGD-YPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 -----~~~~~~~~~d~~l~~-~~~~-~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
............+.. ++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000111111 2222 35668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.60 Aligned_cols=263 Identities=26% Similarity=0.339 Sum_probs=200.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 4566789999999999999988899999998865332 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+++.+..+.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 987776655442 4488999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh------------h
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE------------E 782 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~------------~ 782 (843)
. ......++..|+|||++.....++.++||||||+++|||++|+.||...... ..+.. ...... .
T Consensus 156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYL-IQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCCHHHhhhcccC
Confidence 1 1133456788999999855447889999999999999999999998643221 11111 000000 0
Q ss_pred CCcc--cccCCCCC-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNVL--DCVDPSMG-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~~--~~~d~~l~-----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.... ...+.... .++.....++.+++.+||..+|++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 00000000 0222336778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=290.52 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=199.0
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..+....||.|+||+|++-.++..|+..|||++.........+++..|.+...+- ++||||+++|.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3445558999999999999999999999999997766555667888898887666 699999999999999999999999
Q ss_pred CCCCCHHHHHhh-cCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 634 APNGSLQAKLHE-RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 634 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+ -|++.+.+. ..-....+++.-.-+|......||.||.+.. .|||||+||+|||+|..|.+|+||||++-.+.+
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~- 220 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD- 220 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence 94 466554332 1113456888888889999999999999876 899999999999999999999999999865432
Q ss_pred ccceeccccccccccCCcccccCcCC-CCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLR-VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
....+...|-..|||||.+..... |+.+|||||+|+++||+.||..||..... ..+++...... |+
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~g-------dp 287 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIG-------DP 287 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcC-------CC
Confidence 122234456677999998855554 88999999999999999999999965432 12222222221 22
Q ss_pred CCCCCCh---hhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPE---DEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~---~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....++. .....+..++..|+.+|-..||+..++.++
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2212222 345678899999999999999999998764
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=300.54 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=205.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|++|.||+|....+++.||+|++.........+.+.+|+.++++++|||++++++++..++..++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 44567899999999999999888999999998665433345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
+++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999864 468999999999999999999999 8 999999999999999999999999999986643222
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
.. ....++..|+|||.. ....++.++||||||+++|||+||+.||...... ...+..+.... . ...
T Consensus 156 ~~--~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~-~--------~~~ 221 (264)
T cd06623 156 QC--NTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICD-G--------PPP 221 (264)
T ss_pred cc--cceeecccccCHhhh-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhc-C--------CCC
Confidence 11 234577889999987 5557889999999999999999999999765321 11111111111 1 111
Q ss_pred CCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~-~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.. .+..+.+++.+||..+|++|||+.|++++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22333 55688999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=326.14 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=190.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCC------CccceeeEEEcC-C
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHP------NLISLEGYYWTP-Q 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~g~~~~~-~ 625 (843)
...|+..+.||+|+||+||+|.+...++.||||++.... .....+..|+++++.++|. +++++++++... .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 355777789999999999999998889999999985432 2334567788888887654 588888888765 4
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC---------
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY--------- 696 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--------- 696 (843)
..++|||++ +++|.+++... ..+++..+..|+.|++.||+|||+++ +||||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence 678999988 77899988764 46899999999999999999999732 899999999999998665
Q ss_pred -------CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch
Q 003156 697 -------NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769 (843)
Q Consensus 697 -------~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~ 769 (843)
.+||+|||.+..... ......||..|+|||++ .+..++.++|||||||++|||++|+.||..... .
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~ 351 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVV-LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-L 351 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHh-hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-H
Confidence 499999998764221 12346789999999998 556789999999999999999999999965432 1
Q ss_pred hhHHHHHHH-------------------HHh-hCCcccccCCCC-----C-C-C-ChhhHHHHHHHHHHccCCCCCCCCC
Q 003156 770 VILSEHVRV-------------------LLE-EGNVLDCVDPSM-----G-D-Y-PEDEVLPVLKLALVCTCHIPSSRPS 821 (843)
Q Consensus 770 ~~l~~~~~~-------------------~~~-~~~~~~~~d~~l-----~-~-~-~~~~~~~l~~l~~~c~~~~P~~RPs 821 (843)
..+....+. .+. .+....+.++.- . . . .......+.+|+.+|++.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111111000 000 000001111100 0 0 0 0011235679999999999999999
Q ss_pred HHHHHHH
Q 003156 822 MAEVVQI 828 (843)
Q Consensus 822 ~~evl~~ 828 (843)
++|+++|
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.60 Aligned_cols=271 Identities=22% Similarity=0.337 Sum_probs=201.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC-----eeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 628 (843)
+.|+..+.||+|+||.||+|.+..+|+.||+|.+...........+.+|+.++++++||||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 346677799999999999999988999999999864333344567889999999999999999999876543 478
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+||++ +++.+.+.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 85 IVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 9999996 488777754 3589999999999999999999998 999999999999999999999999999976
Q ss_pred ccccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC---
Q 003156 709 LTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN--- 784 (843)
Q Consensus 709 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~--- 784 (843)
........ ......++..|+|||.+.....++.++||||+||++|||++|+.||..... ...+.. +........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~-~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNL-ILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH-HHHHcCCCCHHH
Confidence 54322211 112346788899999875556689999999999999999999999964321 111111 110000000
Q ss_pred ccccc-------------CCCCC--CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCC
Q 003156 785 VLDCV-------------DPSMG--DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 835 (843)
Q Consensus 785 ~~~~~-------------d~~l~--~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~ 835 (843)
...+. .+... ........++.+++.+||+.+|++|||+.|++++ ++...++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000 00000 0011234568899999999999999999999998 6655443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.51 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=200.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|....+|..||+|.+...... ...+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 34556899999999999999988999999998654221 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCcccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLD 713 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~ 713 (843)
++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999997642 34579999999999999999999998 999999999999999775 46999999997664322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.. .....|+..|+|||.. ....++.++|||||||++|||++|+.||..... .+.+..... +. .
T Consensus 157 ~~--~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~~--------~ 219 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQ-GY--------F 219 (257)
T ss_pred cc--ccccCCCccccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc-cc--------C
Confidence 11 1234578889999987 455688999999999999999999999864321 122222111 11 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.........++.+++.+||..+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122334578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.15 Aligned_cols=255 Identities=20% Similarity=0.264 Sum_probs=196.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||++....+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 4456689999999999999998899999999865432 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 83 ~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999764 3588999999999999999999998 99999999999999999999999999986421100
Q ss_pred -------------cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 714 -------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 714 -------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
.........++..|+|||.+ ....++.++|||||||++||+++|+.||..... . +......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~----~~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI-LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-E----ELFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHHH
Confidence 00011123567889999987 445689999999999999999999999964321 1 1111111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.. . ...+. .....+.++.+++.+||+.+|++||++.++.+.|+
T Consensus 230 ~~-~---~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 230 SD-D---IEWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred hc-c---cCCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11 1 01111 11134556889999999999999999654444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=305.23 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=203.6
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+++..|+..+.||+|+||.||+|.+..++..||+|.+...... .....+.+|++++++++|||++++++++.++...
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 34566677888999999999999999888999999998644322 2235688999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||++ |++.+.+... ...++|..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++.
T Consensus 101 ~lv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred EEEEeCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcc
Confidence 99999996 5788877653 34589999999999999999999998 99999999999999999999999999987
Q ss_pred cccccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
..... ....++..|+|||.+. ....++.++|||||||++|||++|+.||...... ..... ......
T Consensus 174 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~----~~~~~~- 241 (317)
T cd06635 174 IASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYH----IAQNES- 241 (317)
T ss_pred ccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHH----HHhccC-
Confidence 54321 2345778899999863 2346889999999999999999999998653211 11111 111110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
+ ..........+.+++.+||+.+|.+||++.+++++....
T Consensus 242 -----~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 -----P--TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -----C--CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0 011223445688999999999999999999999976544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.85 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=201.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 45667778999999999999987788999999985432 22346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999999753 478899999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.. .....++..|+|||.+ ....++.++|||||||++||+++|+.||........... ....+. +..
T Consensus 170 ~~--~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----~~~~~~------~~~ 235 (293)
T cd06647 170 SK--RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGT------PEL 235 (293)
T ss_pred cc--cccccCChhhcCchhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----hhcCCC------CCC
Confidence 21 1334678889999987 455688999999999999999999999965432111100 000000 000
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+......+.+++.+||..+|++||++.+++.+
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123344568899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.75 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=200.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||++.+..+++.||+|.+..... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 4556789999999999999988899999999865432 12346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999875 4688999999999999999999998 9999999999999999999999999999876432
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.....++..|+|||.+ .....+.++||||||+++|+|++|+.||..... .. ..+... .+.
T Consensus 155 ----~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~~-~~~--------- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEII-LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQ---IYEKIL-EGK--------- 214 (290)
T ss_pred ----CCCCCCCccccChhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHHh-cCC---------
Confidence 1344678899999988 445688999999999999999999999965431 11 111111 111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
...+......+.+++.+||..+|++|| +++|++++
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 012333456788999999999999999 77887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=298.53 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=198.8
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
||+|+||.||+|....+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999878999999998654322 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||+++...... ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 9999874 3488899999999999999999998 99999999999999999999999999998765432 112
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...++..|+|||.+ ....++.++|+||+|+++|||++|..||.....+.. +..+..... .....++..
T Consensus 151 ~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~--------~~~~~~~~~ 218 (262)
T cd05572 151 TFCGTPEYVAPEII-LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDILKG--------NGKLEFPNY 218 (262)
T ss_pred cccCCcCccChhHh-cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHHhcc--------CCCCCCCcc
Confidence 34577889999987 455689999999999999999999999976543221 111111110 011122333
Q ss_pred hHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
....+.+++.+||+.+|++||+ ++|++++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 4567899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=321.38 Aligned_cols=415 Identities=26% Similarity=0.340 Sum_probs=344.4
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
.-+++|+++.|++. .+|+. .+.+..++.|+.++|+++.++.. ...+.+|+.|+.+.|.+...++ .+..+-.|
T Consensus 68 ~~l~vl~~~~n~l~-~lp~a-ig~l~~l~~l~vs~n~ls~lp~~-i~s~~~l~~l~~s~n~~~el~~-----~i~~~~~l 139 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAA-IGELEALKSLNVSHNKLSELPEQ-IGSLISLVKLDCSSNELKELPD-----SIGRLLDL 139 (565)
T ss_pred cceeEEEeccchhh-hCCHH-HHHHHHHHHhhcccchHhhccHH-HhhhhhhhhhhccccceeecCc-----hHHHHhhh
Confidence 34789999999999 88876 47799999999999999987766 4667899999999999987665 46678889
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
..|+..+|+++ ..|..+..+.+|..|++.+|.++...|..+. ++.|++||...|-++ .+|..++.+.+|..|+|..|
T Consensus 140 ~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~N 216 (565)
T KOG0472|consen 140 EDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRN 216 (565)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhc
Confidence 99999999998 6788889999999999999999966666555 999999999999888 78889999999999999999
Q ss_pred cccccCCCCccCCCCccEEEcccCCcCCCCCCC-CCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS-LFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIP 239 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p 239 (843)
+|. ..| .|.+++.|.+|+++.|+|+ .+|.. ..++.+|..|||+.|+++ +.|+.++.+ +|+.||+|+|.|++. |
T Consensus 217 ki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p 291 (565)
T KOG0472|consen 217 KIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-P 291 (565)
T ss_pred ccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccC-C
Confidence 998 677 7999999999999999999 45554 459999999999999998 889988887 699999999999853 3
Q ss_pred CCCCCCCcccccCccCEEeCCCCccce-------------------------------------e-CCcc---ccCCCCC
Q 003156 240 PGSSSSSSSTLFQTLRILDLSSNNLVG-------------------------------------D-IPAE---MGLFANL 278 (843)
Q Consensus 240 ~~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------------------------~-~p~~---~~~l~~L 278 (843)
.. .+++ .|+.|.+.+|.+.. . .+.. .....+.
T Consensus 292 ~s------Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~t 364 (565)
T KOG0472|consen 292 YS------LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITT 364 (565)
T ss_pred cc------cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhh
Confidence 32 3345 78888999997741 0 1111 1123468
Q ss_pred cEEEcCCCcccCCCCCCccc--cccceEEEccCCcccccCCccccccCCCcE-EEcCCCCCCCCchhhhcccCCCcEEec
Q 003156 279 RYLNLSSNHLRSRIPPELGY--FHSLIHLDLRNNALYGSIPQEVCESRSLGI-LQLDGNSLTGPIPQVIRNCTSLYLLSL 355 (843)
Q Consensus 279 ~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L 355 (843)
++|+++.-+++.++.+.|.. -.-....+++.|++. .+|..+..+..+.+ +++++|.++ -+|..+..+++|..|+|
T Consensus 365 kiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L 442 (565)
T KOG0472|consen 365 KILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDL 442 (565)
T ss_pred hhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeec
Confidence 99999999998644344432 224889999999999 78998888887765 566666665 89999999999999999
Q ss_pred ccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCCC-CCCCCCCCCCCcCCCCCCCC
Q 003156 356 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV-GGVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 356 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~ 434 (843)
++|-+. .+|..++.+..|+.|++++|++. .+|..+..+..|+.+-.++|++....|. .+.+.++....+.+|...-.
T Consensus 443 ~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~I 520 (565)
T KOG0472|consen 443 SNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQI 520 (565)
T ss_pred ccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhC
Confidence 999998 89999999999999999999999 8999999998888888888998777665 35577889999999999888
Q ss_pred CCCCCCCCC
Q 003156 435 PLLKGPCKM 443 (843)
Q Consensus 435 ~~~~~~c~~ 443 (843)
||.-++|..
T Consensus 521 Pp~Lgnmtn 529 (565)
T KOG0472|consen 521 PPILGNMTN 529 (565)
T ss_pred Chhhccccc
Confidence 888888853
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.12 Aligned_cols=262 Identities=25% Similarity=0.344 Sum_probs=199.7
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEEEEEe
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVSDY 633 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~ 633 (843)
+..+.||+|+||.||+|....+++.+|+|++.... .......+.+|++++++++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 34568999999999999998889999999997653 233456788999999999999999999999988 789999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++ +|.+++... ...+++..++.++.|+++|++|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 82 MDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 974 888888764 24689999999999999999999998 99999999999999999999999999998665432
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC---Ccc---c
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG---NVL---D 787 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~---~~~---~ 787 (843)
.. ......++..|+|||.+.....++.++||||||+++|||++|+.||..... ...+....+ ..... ... +
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFE-LCGSPTDENWPGVSK 231 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCCCchhhcccccc
Confidence 11 112334567899999775555688999999999999999999999965432 111111111 10000 000 0
Q ss_pred -----cc------CCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 -----CV------DPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 -----~~------d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ...+.+ +...+...+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 000000 111125678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.29 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=197.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhcc-CCCccceeeEEEcCCe-----eE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQL-----KL 628 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~-----~~ 628 (843)
|+..+.||+|+||.||+|.+..+++.||+|........ .....+.+|+.+++.++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 45567899999999999999888999999987544322 23457888999999995 6999999999987665 79
Q ss_pred EEEEeCCCCCHHHHHhhcCCC-CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-CCCcEEeeccCc
Q 003156 629 LVSDYAPNGSLQAKLHERLPS-TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLA 706 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~ 706 (843)
+||||+++ +|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 898888764322 35689999999999999999999998 9999999999999998 899999999998
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC--
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN-- 784 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~-- 784 (843)
+.+...... .....+++.|+|||.+.....++.++||||||+++|||++|..||..... ...+....+. .....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-LQQLLHIFKL-LGTPTEQ 234 (295)
T ss_pred eecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHH-hCCCChh
Confidence 765321111 12234577899999875555678999999999999999999999965322 1111111110 00000
Q ss_pred cc-ccc-------CCC-----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VL-DCV-------DPS-----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~-~~~-------d~~-----l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ... -+. +.........++.+++.+|+..+|++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 000 000 000112345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=299.16 Aligned_cols=255 Identities=22% Similarity=0.375 Sum_probs=200.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
|+..+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34567899999999999999888999999998643211 1235788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCcccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLL 709 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~ 709 (843)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++ .+||+|||.+..+
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 82 VEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999764 3578999999999999999999998 999999999999998765 5999999999776
Q ss_pred cccccc--eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 710 TRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 710 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
...... .......++..|+|||.+ ....++.++||||+|+++|+|++|..||....... . ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~-~~~~~~~~~~----- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-H-LALIFKIASA----- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHh-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-h-HHHHHHHhcc-----
Confidence 532111 111234678899999987 45578899999999999999999999996432211 1 1111110000
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
......+.....++.+++.+|+..+|++|||+.|++++
T Consensus 227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00112344455678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.08 Aligned_cols=254 Identities=26% Similarity=0.324 Sum_probs=201.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|....+++.||+|.+....... ..+.+..|+++++.++||||+++++.+......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 455678999999999999998789999999987654332 345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 83 CPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred cCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999998754 235689999999999999999999998 99999999999999999999999999987553221
Q ss_pred cce---------------------------eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC
Q 003156 714 KHV---------------------------MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 766 (843)
Q Consensus 714 ~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~ 766 (843)
... ......|+..|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH-cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 11133578889999988 45568999999999999999999999996543
Q ss_pred CchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 003156 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS----MAEVVQI 828 (843)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs----~~evl~~ 828 (843)
... .+.. ..... ..... .......+.+++.+||+.+|++||| ++|++.+
T Consensus 237 ~~~-~~~~----~~~~~-------~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDE-TFSN----ILKKE-------VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHH-HHHH----HhcCC-------ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 221 1111 11100 00011 1114567899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.77 Aligned_cols=370 Identities=28% Similarity=0.379 Sum_probs=288.2
Q ss_pred CCccEEecCCCcCcc-cCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 2 MNMKFLDLSNNLLSG-PVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~-~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
+=++-.|+++|.++| ..|.+ ...++++++|.|...++..++.. ++.|.+|++|.+++|++..... .+..|+.
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~-v~qMt~~~WLkLnrt~L~~vPeE-L~~lqkLEHLs~~HN~L~~vhG-----ELs~Lp~ 79 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHD-VEQMTQMTWLKLNRTKLEQVPEE-LSRLQKLEHLSMAHNQLISVHG-----ELSDLPR 79 (1255)
T ss_pred ceeecccccCCcCCCCcCchh-HHHhhheeEEEechhhhhhChHH-HHHHhhhhhhhhhhhhhHhhhh-----hhccchh
Confidence 345678999999994 67765 58899999999999999877654 7899999999999999985433 4668999
Q ss_pred CCEEecCCccCcc-cCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEee
Q 003156 81 LRTLDLSHNLFSG-SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159 (843)
Q Consensus 81 L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 159 (843)
|+.+++.+|++.. -+|..+..+..|..|+|++|+++ ..|..+.+-+++-.|+||+|+|..++..-|.+|+.|-+|+||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccc
Confidence 9999999999963 37778889999999999999998 788999999999999999999997666778899999999999
Q ss_pred cCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCC-CCCCchhhccCcceeeccCCcceecC
Q 003156 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN-GNIPEGLFDLGLEEIDLSENGFMGSI 238 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~~~L~~L~l~~n~l~~~~ 238 (843)
+|++. .+|..+..+..|++|.|++|.+....-..+..+++|+.|.+++.+-+ ..+|..+.+
T Consensus 159 ~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~----------------- 220 (1255)
T KOG0444|consen 159 NNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD----------------- 220 (1255)
T ss_pred cchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh-----------------
Confidence 99998 78888999999999999999987655566777889999999887654 234444433
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 318 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 318 (843)
+.+|+.+|||.|.+. ..|+.+-.+.+|+.|+||+|+|+. +.-..+...+|+.|+||.|+++ .+|.
T Consensus 221 ------------l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~ 285 (1255)
T KOG0444|consen 221 ------------LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPD 285 (1255)
T ss_pred ------------hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchH
Confidence 456666666666666 667777777777777777777763 2233344456777777777777 6777
Q ss_pred cccccCCCcEEEcCCCCCCC-CchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccc
Q 003156 319 EVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLAS 397 (843)
Q Consensus 319 ~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 397 (843)
.++.++.|+.|++.+|+++- -+|+.++.|.+|+.+..++|++. .+|..+..+..|+.|.|+.|++- .+|+++--|+.
T Consensus 286 avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~ 363 (1255)
T KOG0444|consen 286 AVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPD 363 (1255)
T ss_pred HHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCC
Confidence 77777777777777776642 36777777777777777777776 67777777777777777777776 67777777777
Q ss_pred cceEeeccccceecCCC
Q 003156 398 LLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 398 L~~l~ls~N~l~~~~p~ 414 (843)
|+.|||..|+=.--+|.
T Consensus 364 l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 364 LKVLDLRENPNLVMPPK 380 (1255)
T ss_pred cceeeccCCcCccCCCC
Confidence 77777777765544453
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.17 Aligned_cols=249 Identities=26% Similarity=0.303 Sum_probs=201.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+...++||+|+||.||.++.+.+|+.+|.|++.+.... +.......|-.++++++.+.||.+--.|.+++..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 3345567899999999999999999999999998544322 23345678999999999999999988899999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
..|+||+|.-+|.... .+.+++.+++.+|.+|+.||++||.. +||.||+||+|||+|+.|+|+|+|.|+|..+.+
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998864 36799999999999999999999999 999999999999999999999999999998876
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.... ....||.+|||||++ ....|+...|.||+||++|||+.|+.||........ ..+ +...+. .
T Consensus 340 g~~~---~~rvGT~GYMAPEvl-~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-~eE-vdrr~~---------~ 404 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVL-QNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-REE-VDRRTL---------E 404 (591)
T ss_pred CCcc---ccccCcccccCHHHH-cCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-HHH-HHHHHh---------c
Confidence 5443 344899999999999 555699999999999999999999999975432110 001 111000 0
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSM 822 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~ 822 (843)
.-..+++...++...+.+..+.+||.+|.-.
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 0112456666778888889999999998643
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=300.74 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=200.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..+...+.||+|++|.||+|....+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 34555668999999999999998889999999885432 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 98 LEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999999876 2478899999999999999999998 99999999999999999999999999887554321
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. ......|+..|+|||.. .+..++.++|||||||++|||++|+.||..... . ...+.. .... .+..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~---~~~~~~-~~~~-----~~~~ 235 (285)
T cd06648 170 P--RRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--L---QAMKRI-RDNL-----PPKL 235 (285)
T ss_pred c--ccccccCCccccCHHHh-cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--H---HHHHHH-HhcC-----CCCC
Confidence 1 11234578899999987 455688999999999999999999999864321 1 111111 1111 0111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+......+.+++.+||+.+|++|||+.+++++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1122245678999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.55 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=201.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 44566899999999999999888999999998654322 3456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999764 4688999999999999999999998 99999999999999999999999999987654322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
......++..|+|||.+ ....++.++||||+|+++|+|++|+.||....... .......... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~---------~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAKQET---------AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHH-cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHHhcc---------cc
Confidence 11345677889999988 44568999999999999999999999997653321 1111111110 11
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSM--AEVVQ 827 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~--~evl~ 827 (843)
...+...+..+.+++.+||+.||++||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 12344455778899999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.74 Aligned_cols=247 Identities=28% Similarity=0.331 Sum_probs=195.7
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
||+|+||+||+|....+|+.||+|.+..... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999999988899999999865332 12344667899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 99998753 24689999999999999999999998 99999999999999999999999999987654311 113
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...++..|+|||.+ .+..++.++||||+||++|+|++|+.||........ ...... ... ......+..
T Consensus 153 ~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----~~~-----~~~~~~~~~ 220 (277)
T cd05577 153 GRAGTPGYMAPEVL-QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKR-----RTL-----EMAVEYPDK 220 (277)
T ss_pred cccCCCCcCCHHHh-cCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHh-----ccc-----cccccCCcc
Confidence 34567889999987 444588999999999999999999999965432111 111110 000 011112334
Q ss_pred hHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
....+.+++.+||+.+|++|| ++.+++.+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 456788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=301.32 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=205.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+....||+|+||.||+|.+..+++.||+|.+..... ..+.+.+|++++++++|+|++++++++...+..++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 44556677789999999999999988899999999865432 3567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999998752 4789999999999999999999998 999999999999999999999999999875543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||.+ .+..++.++|||||||++|+|++|+.||....... ... .. .......
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~----~~-~~~~~~~---- 235 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALF----LI-TTKGIPP---- 235 (286)
T ss_pred chh--hhccccCCcccCCHhHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHH----HH-HhcCCCC----
Confidence 221 11234567889999987 45568999999999999999999999986432211 111 11 1111100
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
. ..+......+.+++.+||+.+|.+|||+.+++++-
T Consensus 236 -~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 236 -L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred -C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0 01222456788999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.46 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=205.3
Q ss_pred cccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 548 CSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 548 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+..-....|++.+.||+||.+.||++... +.+.||+|++.... ..+....|..|+..|.++ .|.+||.+++|-..++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 33344566888999999999999999885 66788888875433 233456799999999999 4999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..|+||||= ..+|..+|+.+. ....+| .+..+..|++.++.+.|++ ||||.||||.|+|+- .|.+||+|||+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGI 505 (677)
T ss_pred eEEEEeecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeech
Confidence 999999985 559999999863 333455 5677889999999999999 999999999999986 47899999999
Q ss_pred cccccccccceeccccccccccCCcccccCc----------CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHH
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQS----------LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~ 775 (843)
|.-+.............||+.||+||.+... -+.++++||||+|||+|+|+.|+.||..... .|
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~ 579 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QI 579 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HH
Confidence 9999887777777889999999999976321 1356899999999999999999999964211 11
Q ss_pred HHHHHhhCCcccccCCCC----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 776 VRVLLEEGNVLDCVDPSM----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l----~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ++..+.||.- ++.+.. .+++++|..|+..||++|||..|++++
T Consensus 580 a-------Kl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 A-------KLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H-------HHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1 1223344432 222222 238999999999999999999999986
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.45 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=201.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-C-----CCccceeeEEEcCCeeE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-H-----PNLISLEGYYWTPQLKL 628 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~ 628 (843)
.|++.+.||+|+||.|.+|.+..+++.||||+++... ....+-..|+.+|..++ | -|+|++++++...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 5778889999999999999999999999999996543 23455677999999997 4 48999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC--CCCcEEeeccCc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD--NYNPRISDFGLA 706 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~ 706 (843)
||+|.++ -+|.++++.... ..++...+..|+.||+.||.+||+. +|||+||||+|||+.+ ...+||+|||.+
T Consensus 265 iVfELL~-~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999994 589999998754 3488899999999999999999998 9999999999999974 346999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh-----
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE----- 781 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~----- 781 (843)
....+.-. ...-+..|+|||++ -+.+|+.+.||||||||+.||++|.+-| .+..+.+++...++..-.
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVI-LGlpY~~~IDmWSLGCIlAEL~tG~PLf-pG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVI-LGLPYDTAIDMWSLGCILAELFTGEPLF-PGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccCCcce-----eeeeccccccchhh-ccCCCCCccceeehhhhHHhHhcCcccc-CCCCHHHHHHHHHHHhCCCCHHH
Confidence 87654332 23345679999999 5668999999999999999999995444 555555555443322100
Q ss_pred --hC-CcccccCC---------------------------------CCC----C----CChhhHHHHHHHHHHccCCCCC
Q 003156 782 --EG-NVLDCVDP---------------------------------SMG----D----YPEDEVLPVLKLALVCTCHIPS 817 (843)
Q Consensus 782 --~~-~~~~~~d~---------------------------------~l~----~----~~~~~~~~l~~l~~~c~~~~P~ 817 (843)
.+ +....++. ..+ + ........+++++.+|+.+||+
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00 00000000 001 0 1124455689999999999999
Q ss_pred CCCCHHHHHHH
Q 003156 818 SRPSMAEVVQI 828 (843)
Q Consensus 818 ~RPs~~evl~~ 828 (843)
+|+|+.|+++|
T Consensus 492 ~R~tp~qal~H 502 (586)
T KOG0667|consen 492 ERITPAQALNH 502 (586)
T ss_pred hcCCHHHHhcC
Confidence 99999999987
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.11 Aligned_cols=273 Identities=27% Similarity=0.341 Sum_probs=203.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 630 (843)
+.|+..+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.++++++|+||+++++++... +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 3466677899999999999999888999999998654322 2234567899999999999999999998765 467999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||++ ++|.+++... ...+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||.++...
T Consensus 87 ~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 87 MEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 99996 5888888764 25689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC--Cc---
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--NV--- 785 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~~--- 785 (843)
...... ....++..|+|||.+.+...++.++||||+||++|||++|+.||..... ...+.... ...... ..
T Consensus 160 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~-~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLII-QLLGTPNESIWPG 235 (309)
T ss_pred CccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH-HhcCCCChhhchh
Confidence 322111 2234567899999875556688999999999999999999999965322 11111111 110000 00
Q ss_pred ------cccc--CCC-CCC---CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 786 ------LDCV--DPS-MGD---YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 786 ------~~~~--d~~-l~~---~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
...+ ... ... ........+.+++.+|++.||++|||+.|++.+-.-...++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 0000 000 000 001124567889999999999999999999988555444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.87 Aligned_cols=273 Identities=23% Similarity=0.343 Sum_probs=203.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhc-cCCCccceeeEEEcC--CeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP--QLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~ 628 (843)
.+.|+..+.||+|+||.||+|.+..+++.+|+|++.... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456777889999999999999998789999999885432 122335677899999999 999999999998654 3579
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||++ ++|..++... .++|..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 5998888753 578899999999999999999998 999999999999999999999999999987
Q ss_pred ccccccc---eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH------
Q 003156 709 LTRLDKH---VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------ 779 (843)
Q Consensus 709 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~------ 779 (843)
....... .......++..|+|||.+.....++.++||||||+++|||++|+.||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHH
Confidence 6443221 11233467889999998756566889999999999999999999999643221 1111100000
Q ss_pred ----Hhh---CCcccccC----CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCC
Q 003156 780 ----LEE---GNVLDCVD----PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 835 (843)
Q Consensus 780 ----~~~---~~~~~~~d----~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~ 835 (843)
... ....+.+. ............++.+++.+||+.+|++|||+.+++++ ++.+..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 000 00000000 00111112245678999999999999999999999987 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=312.75 Aligned_cols=269 Identities=24% Similarity=0.328 Sum_probs=203.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC------eeEEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------LKLLV 630 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV 630 (843)
+..+.||+||||.||+|+.+.+|+.||||.+.........+...+|++++++++|||||+++++-.+.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 344579999999999999999999999999987665666788999999999999999999999865543 45899
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc--CCC--CcEEeeccCc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNY--NPRISDFGLA 706 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfgl~ 706 (843)
||||.+|||...+..-. ....+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| .-||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999998742 345699999999999999999999998 999999999999984 333 4899999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC-Cc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG-NV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-~~ 785 (843)
+.++++. ......||..|.+||++-....|+..+|.|||||++||++||..||.+...........+....+.. ..
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9887644 3367899999999998843578999999999999999999999999765332211111111111111 11
Q ss_pred ccccCCCCC----------C---CChhhHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHhc
Q 003156 786 LDCVDPSMG----------D---YPEDEVLPVLKLALVCTCHIPSSRP--SMAEVVQILQVI 832 (843)
Q Consensus 786 ~~~~d~~l~----------~---~~~~~~~~l~~l~~~c~~~~P~~RP--s~~evl~~L~~~ 832 (843)
.-..++... . .......++-+....++..+|++|. .+.+....+..|
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 111111111 0 1122333455667777788899998 766666666554
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=307.26 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=193.8
Q ss_pred eeccc--cceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 561 EVGEG--VFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 561 ~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.||+| +||+||+|.+..+|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++..++..++|+||+++|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999999889999999998644322 23467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce-
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV- 716 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 716 (843)
++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999998753 23588899999999999999999988 99999999999999999999999998654332211100
Q ss_pred ----eccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH-------------
Q 003156 717 ----MSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV------------- 778 (843)
Q Consensus 717 ----~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~------------- 778 (843)
......++..|+|||++... ..++.++|||||||++|||++|+.||.......... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL-QKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH-HHhcCCCCCCccccccch
Confidence 01112345679999988443 347899999999999999999999996543221111 10000
Q ss_pred ---H-------H---------hhCCcccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 779 ---L-------L---------EEGNVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 779 ---~-------~---------~~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. . .........+..+. .........+.+++++||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0 00000000000000 1123455678999999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=328.23 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=193.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC---------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--------- 624 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------- 624 (843)
..++..+.||+||||.||+++.+-||+.||||++...........+.+|+..+++++|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 34566668999999999999999999999999997665444456788999999999999999997633100
Q ss_pred --------------------------------------------------------------------------------
Q 003156 625 -------------------------------------------------------------------------------- 624 (843)
Q Consensus 625 -------------------------------------------------------------------------------- 624 (843)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh
Q 003156 625 ------------------------------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674 (843)
Q Consensus 625 ------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~ 674 (843)
...||=||||+..++.++++...... .....++++.+|+.||+|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHh
Confidence 01267899999888888887753111 356788999999999999999
Q ss_pred cCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc----cc------------ccceeccccccccccCCcccccCcC-
Q 003156 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT----RL------------DKHVMSNRFQSALGYVAPELTCQSL- 737 (843)
Q Consensus 675 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~----~~------------~~~~~~~~~~g~~~y~aPE~~~~~~- 737 (843)
. +||||||||.||++|++..|||+|||+|+... .. ......+...||--|+|||++....
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998722 00 0111234567888999999986555
Q ss_pred -CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCC
Q 003156 738 -RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIP 816 (843)
Q Consensus 738 -~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P 816 (843)
.|+.|+|+||+|||++||+ .||....++...+.. .+.+.+- .-.++..+....-.++|+++++.||
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~-----LR~g~iP-----~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTN-----LRKGSIP-----EPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHh-----cccCCCC-----CCcccccccchHHHHHHHHHhcCCC
Confidence 6999999999999999997 467654333222211 1122111 1122344445556789999999999
Q ss_pred CCCCCHHHHHH
Q 003156 817 SSRPSMAEVVQ 827 (843)
Q Consensus 817 ~~RPs~~evl~ 827 (843)
.+||||.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.61 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=206.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||++.+..+++.||+|++...... ...+.+.+|++++++++|||++++.+.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 34456899999999999999888999999998654332 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++.........+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99999999988644456799999999999999999999998 99999999999999999999999999997654432
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
.......++..|+|||.. ....++.++||||+|+++|+|++|+.||..... ......... ....
T Consensus 158 -~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~---------~~~~ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELC-QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILK---------GQYP 221 (258)
T ss_pred -ceecceeeeecccChhHh-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhc---------CCCC
Confidence 122345678889999987 555688999999999999999999999865431 111111111 1112
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+......+.+++.+||..+|++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2334556678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=302.22 Aligned_cols=262 Identities=25% Similarity=0.320 Sum_probs=199.1
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeCC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
+..+.||+|+||+||+|....+++.||+|++.............+|+..+++++ |||++++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 345689999999999999987889999999865432222334567999999998 999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||+++........
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889999888752 34689999999999999999999998 9999999999999999999999999999865432221
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHH------------HHHHHHhhC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE------------HVRVLLEEG 783 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~------------~~~~~~~~~ 783 (843)
....++..|+|||.+.....++.++||||||+++|||++|+.||....... ...+ |........
T Consensus 156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhhhhHhhhhc
Confidence 234577889999987566668999999999999999999999986542211 1111 000000000
Q ss_pred CcccccC----CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVD----PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d----~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.....+. ..+.........++.+++.+||+.+|++|||++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00011111224678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=296.70 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=205.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||++....+++.+|+|.+...... .....+.+|++++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 34556899999999999999888999999998654322 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++.........+++..++.++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++.....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999987544456789999999999999999999998 9999999999999999999999999999876543
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......++..|+|||.. .+..++.++|+||+|+++|||++|+.||...... .+.. ....+. ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~----~~~~~~--------~~ 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRY----KVQRGK--------YP 219 (256)
T ss_pred --CcccccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHhcCC--------CC
Confidence 11234577889999988 5567889999999999999999999999654221 1111 111111 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.....++.+++.+|+..+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2233455678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=302.59 Aligned_cols=262 Identities=22% Similarity=0.262 Sum_probs=196.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|++|.||+|.+..+|+.||+|.+...... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 55667899999999999999888999999998544322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-CCCcEEeeccCcccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~ 713 (843)
+ +++.+++.... ....++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||+++......
T Consensus 84 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 58888876542 23467888889999999999999998 9999999999999984 5679999999997653221
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc-----
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC----- 788 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~----- 788 (843)
.. .....++..|+|||.+.....++.++||||+||++|+|+||+.||...... ....+.... .... ....
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~-~~~~-~~~~~~~~~ 232 (294)
T PLN00009 158 RT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRI-LGTP-NEETWPGVT 232 (294)
T ss_pred cc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-hCCC-Chhhccccc
Confidence 11 123356788999998755556889999999999999999999999754221 111111110 0000 0000
Q ss_pred --c----------CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 --V----------DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 --~----------d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. .............++.+++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000112334567899999999999999999999875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.06 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=202.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|++|.||+|....+++.+++|++..... ...+.+.+|++++++++||+++++++++......++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3455689999999999999988899999999865443 345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999998752 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
.....++..|+|||.+ ....++.++||||||+++|+|++|+.||......... ... ....... . .
T Consensus 154 --~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~-~~~~~~~-----~-~ 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVI-NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-----FKI-ATNGPPG-----L-R 218 (253)
T ss_pred --ccceecCCcccCHHHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHH-HhcCCCC-----c-C
Confidence 2345678889999988 4456889999999999999999999998654221111 000 1010000 0 0
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112224578899999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.98 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=197.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+..+++.||||.+...........+.+|+.++.+.. ||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 446667799999999999999987799999999875543334456777887777775 9999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|++ +++.+.+... ...+++..+..++.|+++|++|||+.. +|+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 5777776653 236899999999999999999999732 8999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
... ....++..|+|||.+... ..++.++||||||+++|||++|+.||.........+.. ......
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~----- 236 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK----ILQEEP----- 236 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH----HhcCCC-----
Confidence 211 233567889999987433 24788999999999999999999999653322211111 111110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+... .......++.+++.+||..+|++||++.+++++-
T Consensus 237 -~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 -PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1111 1123456789999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.42 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=190.4
Q ss_pred cceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHh
Q 003156 566 VFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH 644 (843)
Q Consensus 566 ~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 644 (843)
++|.||.++...+++.||+|++.... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44555555555589999999986542 23345678999999999999999999999999999999999999999999998
Q ss_pred hcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc-----ceecc
Q 003156 645 ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK-----HVMSN 719 (843)
Q Consensus 645 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~-----~~~~~ 719 (843)
... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+........ .....
T Consensus 92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 753 23578889999999999999999998 999999999999999999999999998875533221 11112
Q ss_pred ccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh----h-------CCccc
Q 003156 720 RFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE----E-------GNVLD 787 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~----~-------~~~~~ 787 (843)
...++..|+|||++... ..++.++|||||||++|||++|+.||........... ....... . .....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE-KVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccCccccccCchhhhcCCcCc
Confidence 34567789999987443 3578999999999999999999999975432221111 1110000 0 00000
Q ss_pred ----ccCCCCC-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 ----CVDPSMG-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ----~~d~~l~-----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..++... ........++.+++.+||+.+|++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 0122334568899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.33 Aligned_cols=245 Identities=23% Similarity=0.307 Sum_probs=191.4
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHH---HHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRV---LGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~---l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
.||+|+||.||+|....+++.||+|.+...... .....+..|..+ ++...||+|+++.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999999878999999998654322 112234445444 444579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|..++... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988753 4689999999999999999999998 999999999999999999999999999875532211
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
....|+..|+|||.+..+..++.++||||+||++|||++|+.||......... . ...... ..++ .
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~-~~~~~~------~~~~---~ 217 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E-IDRMTL------TMAV---E 217 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--H-HHHHhh------ccCC---C
Confidence 23468889999999855556889999999999999999999999754221111 0 010000 0111 1
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
.+.....++.+++.+|+..+|.+|| ++.+++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 2333456788999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.34 Aligned_cols=260 Identities=15% Similarity=0.136 Sum_probs=184.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcccChH----------HHHHHHHHHHhccCCCccceeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPE----------DFEREVRVLGKARHPNLISLEGY 620 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~h~niv~l~g~ 620 (843)
..|+..+.||+|+||.||+|.+..+ +..+|+|...........+ ....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4577788999999999999999766 5567777543222111011 11233344556689999999997
Q ss_pred EEcCC----eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 621 YWTPQ----LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 621 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
+.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 76543 3467888764 3566666543 2356788899999999999999998 999999999999999999
Q ss_pred CcEEeeccCcccccccccc-----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhh
Q 003156 697 NPRISDFGLARLLTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 771 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~ 771 (843)
.++|+|||+++.+...... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 9999999999876432211 111234689999999988 5667899999999999999999999999765332221
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 772 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
........+..- ..... ....++..+.+++..||..+|++||++.++++.+
T Consensus 243 ~~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRL-----HEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHh-----hhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111111100 00000 1223356788999999999999999999999876
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.92 Aligned_cols=266 Identities=22% Similarity=0.292 Sum_probs=196.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCC-------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------- 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 625 (843)
+.|+..+.||+|+||.||+|....+++.||+|.+...... .....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 3466778999999999999999888999999998644322 23345678999999999999999999987654
Q ss_pred -eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 626 -LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 626 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
..++||||+. +++.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 3489999996 5888888654 24689999999999999999999998 99999999999999999999999999
Q ss_pred Ccccccccccc--eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 705 LARLLTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 705 l~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
++......... .......++..|+|||.+.....++.++||||||+++|||++|+.||...... .. ...+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~-~~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQ-LTLISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HH-HHHHHHHhCC
Confidence 99866432221 11123356788999998755555789999999999999999999998653221 11 1111111100
Q ss_pred --------CCcccccCC-CCCC----------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 --------GNVLDCVDP-SMGD----------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 --------~~~~~~~d~-~l~~----------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+..+. .... .+......+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000 0000 000122356789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=335.91 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=204.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
++....||.|.||.||.|....+|...|+|.+..... ........+|+.++..++|||+|+++|+-...+..+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 4456679999999999999998999999998854432 233456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+.+... ...++.....+-.|++.|++|||++ |||||||||.||+++.+|.+|.+|||.|..+.....
T Consensus 1317 ~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1317 EGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred ccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999864 3455666667889999999999999 999999999999999999999999999988765321
Q ss_pred c--eeccccccccccCCcccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 715 H--VMSNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 715 ~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
. .......||+.|||||++.+.. ....++||||+|||+.||+||+.||...+.+-..+ .+|. .
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM-y~V~----~-------- 1456 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM-YHVA----A-------- 1456 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH-hHHh----c--------
Confidence 1 1124567999999999985443 24568999999999999999999998654432222 1111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+.+|+....+-.+++.+|+..||++|+++.|++++
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12234566677777899999999999999999999886
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.59 Aligned_cols=265 Identities=25% Similarity=0.311 Sum_probs=199.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC-------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------- 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 625 (843)
+.|+..+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 456677799999999999999988899999999865432 233456788999999999999999999987654
Q ss_pred ---eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEee
Q 003156 626 ---LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 626 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 702 (843)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 68899999976 777777653 34689999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
||+++........ ......++..|+|||.+.....++.++|||||||++|||++|+.||..... ...+....+ ....
T Consensus 160 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~-~~~~ 236 (302)
T cd07864 160 FGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISR-LCGS 236 (302)
T ss_pred ccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCC
Confidence 9999876543221 112234567899999875555678999999999999999999999965322 222211111 1100
Q ss_pred CC---cccc--------cCC------CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GN---VLDC--------VDP------SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~---~~~~--------~d~------~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ..+. .+. .........+..+.+++.+||+.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000 000 0000112235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.64 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=202.3
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.++...|+..+.||+|+||.||+|+...+++.+|+|.+..... .....++.+|+++++.++|+|++++.+++......
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence 3456668778899999999999999988899999999854321 12235678899999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||+. |++.+.+... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 91 ~lv~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred EEEEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccce
Confidence 99999996 6888877653 24588999999999999999999998 99999999999999999999999999987
Q ss_pred cccccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
..... ....++..|+|||.+. ....++.++|||||||++|||++|+.||....... .... ...+..
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~-----~~~~~~ 231 (308)
T cd06634 164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYH-----IAQNES 231 (308)
T ss_pred eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHH-----HhhcCC
Confidence 65431 2345778899999863 23457889999999999999999999986532211 1111 111110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
+.. ........+.+++.+||+.+|++||++.+++++-...
T Consensus 232 -----~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 232 -----PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred -----CCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 100 1223445688999999999999999999999875443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=292.74 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=204.6
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEEEEEe
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVSDY 633 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~ 633 (843)
...+.||+|++|.||+|....+++.|++|.+..... ....+.+.+|++++++++||||+++++.+... ...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 445689999999999999988899999999865432 12356788999999999999999999999988 889999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 83 VSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999875 2789999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.........++..|+|||.. ....++.++||||||+++|+|++|+.||........... .... ....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~-----~~~~ 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-------KIGS-----SGEP 222 (260)
T ss_pred ccccccCCCCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-------hccc-----cCCC
Confidence 21112345677889999987 555689999999999999999999999976441111110 0000 0111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+......+.+++.+|+..+|++||++.|++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22344456789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.70 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=199.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
...++....||+|+||.||+|....+++.||+|++.... ....+.+.+|+.+++.++|+|++++++++...+..++|||
T Consensus 19 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 19 RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred HHHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 344555568999999999999998899999999874332 2334568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 98 FLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 99999999987542 478999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......++..|+|||.. ....++.++||||+||++|||++|..||...... ....... .. ..+.
T Consensus 170 ~~--~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~----~~-----~~~~ 235 (292)
T cd06657 170 VP--RRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIR----DN-----LPPK 235 (292)
T ss_pred cc--cccccccCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH----hh-----CCcc
Confidence 21 11334578889999987 4556889999999999999999999998643221 1111111 10 1111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... .......+.+++.+||+.+|.+||++.+++++
T Consensus 236 ~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 LKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111 12234467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.40 Aligned_cols=269 Identities=21% Similarity=0.273 Sum_probs=202.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcC-----CeeE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QLKL 628 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 628 (843)
.|+..+.||+|+||.||+|....+++.||+|.+.... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 4566778999999999999998889999999986432 222345677899999999999999999988654 2479
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 86 IVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 9999995 6898888753 4589999999999999999999998 999999999999999999999999999986
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh------
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE------ 782 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~------ 782 (843)
...... ......++..|+|||.+.....++.++|||||||++|+|++|+.||...... ........ ....
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~-~~~~~~~~~~ 233 (337)
T cd07858 158 TSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITE-LLGSPSEEDL 233 (337)
T ss_pred cCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHH-HhCCCChHHh
Confidence 643221 1133456788999998755456889999999999999999999999643211 11110000 0000
Q ss_pred -----CC-------cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCC
Q 003156 783 -----GN-------VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 835 (843)
Q Consensus 783 -----~~-------~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~ 835 (843)
.. .....++...........++.+++.+||+.+|++|||++|++++ ++.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00 00000111111123455678899999999999999999999998 6665444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.68 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=199.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEc----CCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 628 (843)
..|+..+.||+|+||.||+|....+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 456667789999999999999988899999999865432 2334667889999999999999999998753 34678
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+||+. |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 6898888653 3489999999999999999999998 999999999999999999999999999976
Q ss_pred ccccccc--eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH-------
Q 003156 709 LTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------- 779 (843)
Q Consensus 709 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~------- 779 (843)
....... .......++..|+|||.+.....++.++|||||||++|||++|+.||...... ..+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEV 235 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHh
Confidence 5432211 11123467888999998755556899999999999999999999999653221 1111100000
Q ss_pred ---HhhCCcccccC--CCCCC-----CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 780 ---LEEGNVLDCVD--PSMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 780 ---~~~~~~~~~~d--~~l~~-----~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..........+ +.... .......++.+++.+|++.+|++|||+++++.+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000000 00000 1123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=292.35 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=196.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC----cccChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD----IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 629 (843)
|+..+.||+|+||.||+|....+++.||+|.+.... ..+....+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456778999999999999998889999999875321 112335788999999999999999999998764 45789
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|+||+++++|.+++... ..+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 99999999999999764 3478889999999999999999998 9999999999999999999999999999865
Q ss_pred cccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... .......++..|+|||.. .+..++.++|||||||++||+++|+.||...... .. +......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~------ 224 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVI-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AA-IFKIATQ------ 224 (264)
T ss_pred ccccccCccccccCCcccccCHhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HH-HHHHHcC------
Confidence 321111 111234578899999988 4456889999999999999999999999643211 11 1111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.....+......+.+++.+||. +|..|||+.+++.+
T Consensus 225 --~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 225 --PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11122345556678899999998 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.99 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=200.7
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
+..+.||+|++|.||+|....+++.+|+|++...... .....+.+|++++++++||||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 3456899999999999999888999999998654322 234678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+ ++.+++... ...+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.++|+|||.+........
T Consensus 82 ~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 82 T-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred C-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 5 888888764 24689999999999999999999998 999999999999999999999999999977654321
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC------Ccc---
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG------NVL--- 786 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~------~~~--- 786 (843)
......++..|+|||.......++.++||||+|+++|+|+||+.||..... ...+...... .... ...
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRT-LGTPDPEVWPKFTSLA 230 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH-cCCCchHhcccchhhh
Confidence 112345677899999885544789999999999999999999999965432 1111111111 0000 000
Q ss_pred --------cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 --------DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 --------~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+............++.+++.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000011123345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.50 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=199.8
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+..+++...+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|+++++.++|||++++++++.+....
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 35566777777899999999999999888999999998644322 2234678899999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||+. |++.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 97 ~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99999995 6788877654 34589999999999999999999998 99999999999999999999999999986
Q ss_pred cccccccceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
.... .....++..|+|||++.. ...++.++|||||||++|||++|..||........ .........
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~- 237 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNDS- 237 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCC-
Confidence 4321 123467888999998732 35678899999999999999999999865422111 111111100
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.. ........+.+++.+||+.+|.+||++.+++.+
T Consensus 238 -----~~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -----PTL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 112223457889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.59 Aligned_cols=264 Identities=23% Similarity=0.277 Sum_probs=198.7
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-------------ChHHHHHHHHHHHhccCCCccceeeEEEcC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------------YPEDFEREVRVLGKARHPNLISLEGYYWTP 624 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 624 (843)
..+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+++++.++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4567999999999999998889999999986543221 112477899999999999999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
+..++||||++ |+|.+++... ..+++.....++.|++.||+|||+. +++||||+|+||+++.++.++++|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence 99999999996 6899988753 4588999999999999999999998 99999999999999999999999999
Q ss_pred Cccccccccc------------ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhH
Q 003156 705 LARLLTRLDK------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772 (843)
Q Consensus 705 l~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l 772 (843)
.++....... ........++..|+|||.+.....++.++||||+||++|||++|+.||..... ...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-~~~~ 243 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE-IDQL 243 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHH
Confidence 9976541110 00112234577899999885555678999999999999999999999975432 2222
Q ss_pred HHHHHHHHhhCC---cc------------cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 773 SEHVRVLLEEGN---VL------------DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 773 ~~~~~~~~~~~~---~~------------~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
..... ...... .. ....+...........++.+++.+|++.+|++|||++|++.+-.-
T Consensus 244 ~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 244 GRIFE-LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHHHH-HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 11111 110000 00 000000011112335568899999999999999999999987543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=289.19 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=202.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|++|.||+|....+++.||+|.+...... ...+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 34566899999999999999888999999998655432 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999764 4689999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
. .....++..|+|||.. ....++.++||||+|+++|+|++|+.||....... .. ... . .. ...
T Consensus 155 ~--~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-~~---~~~-~-~~--------~~~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVI-EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-AL---FRI-V-QD--------DHP 217 (254)
T ss_pred c--ccccccchhhcCHhhh-cCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-HH---HHH-h-cc--------CCC
Confidence 1 1344678889999987 44458899999999999999999999986543211 11 111 0 01 011
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+......+.+++.+|+..+|++|||+.+++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1233445678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.91 Aligned_cols=261 Identities=21% Similarity=0.257 Sum_probs=196.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcC------C
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------Q 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 625 (843)
...|+..+.||+|+||.||+|....+|+.||+|.+.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 345667778999999999999998899999999985432 122345677899999999999999999988643 2
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999995 5888887642 78888999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH--------
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR-------- 777 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~-------- 777 (843)
++....... .....++..|+|||.+ .+..++.++|||||||++|+|++|+.||..... ...+.....
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHH-hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhcCCCCHH
Confidence 986543211 1334578889999988 556789999999999999999999999965421 111111100
Q ss_pred ----------HHHhhCCc------ccccCCCC----CC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 778 ----------VLLEEGNV------LDCVDPSM----GD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 778 ----------~~~~~~~~------~~~~d~~l----~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........ ...+.... .. .+......+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00000000 00 012345568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.55 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=197.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc----ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI----IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
|...+.||+|+||.||++.+...+..+++|.++.... ......+..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4456689999999999999976666666666543221 122345778999999999999999999999888999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++.........+++..++.++.|++.|+.|||+. +++|+||+|+||++++ +.++++|||.++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999999986544456799999999999999999999998 9999999999999975 5699999999876643
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......++..|+|||.. ....++.++||||||+++|+|++|..||..... ........ .+
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~-~~-------- 220 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIV-EG-------- 220 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHH-cC--------
Confidence 222 12345678889999987 555678899999999999999999999854211 11111111 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+..+.....++.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1112344555678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=293.90 Aligned_cols=261 Identities=26% Similarity=0.309 Sum_probs=195.1
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhc---cCCCccceeeEEEcCCe-----e
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWTPQL-----K 627 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 627 (843)
+..+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++++ +|||++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 3456899999999999999878999999998644322 2234567788877766 59999999999988776 8
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
+++|||++ ++|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||+++
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 99999997 58999887642 23589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc--
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV-- 785 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 785 (843)
....... .....++..|+|||.+ ....++.++|||||||++|||++|..||.... ....+.............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~-~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVL-LQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHh-ccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhc
Confidence 7643221 1233567889999988 45568899999999999999999988886432 222222222111000000
Q ss_pred -------ccccCCCC----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 -------LDCVDPSM----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 -------~~~~d~~l----~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........ .....+....+.+++.+||+.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 01112334567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=290.42 Aligned_cols=236 Identities=22% Similarity=0.301 Sum_probs=186.7
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCCCCHH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 640 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 640 (843)
+|+|+||.||++....+++.+|+|......... .|+.....+ +||||+++++++...+..++||||+++|+|.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 599999999999998889999999986443211 122222222 7999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCcccccccccceecc
Q 003156 641 AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 641 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
+++... ..+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++|+|||+++..... .
T Consensus 98 ~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~ 164 (267)
T PHA03390 98 DLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------S 164 (267)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------c
Confidence 999875 3689999999999999999999998 999999999999999888 9999999998765421 2
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...++..|+|||++ ....++.++|||||||++|||++|+.||............+.... . . ....+..
T Consensus 165 ~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~--------~~~~~~~ 232 (267)
T PHA03390 165 CYDGTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q--K--------KLPFIKN 232 (267)
T ss_pred cCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c--c--------cCCcccc
Confidence 34578899999988 455688999999999999999999999975433332222222211 0 0 0012234
Q ss_pred hHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRPS-MAEVVQI 828 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RPs-~~evl~~ 828 (843)
....+.+++.+|++.+|.+||+ ++|++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 5567889999999999999996 6988864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.70 Aligned_cols=245 Identities=24% Similarity=0.390 Sum_probs=194.6
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
||+|+||.||++.+..+|+.||+|.+...... ...+.+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999878999999998544321 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc-----
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK----- 714 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~----- 714 (843)
.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999874 3689999999999999999999998 999999999999999999999999999875433211
Q ss_pred -ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 715 -HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 715 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
........++..|+|||.. .....+.++||||||+++||+++|..||...... ........ +..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~-------- 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVI-LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILN-GKI-------- 218 (265)
T ss_pred ccccccCcccCccccCHHHh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhc-CCc--------
Confidence 0111334567789999988 4445889999999999999999999999654321 11111111 110
Q ss_pred CCCChh--hHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 794 GDYPED--EVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 794 ~~~~~~--~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+.. ....+.+++.+||+.+|++|||+.++.+.|
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11122 256788999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=303.09 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=196.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC------ee
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------LK 627 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 627 (843)
.|+..+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 35556789999999999999987899999999864322 223456889999999999999999999986542 45
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++
T Consensus 96 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 96 YLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 899999964 6766542 2488999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH--------
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------- 779 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~-------- 779 (843)
...... ....++..|+|||.+.....++.++|||||||++|||++|+.||..... ...+.......
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 643211 2345678899999875555688999999999999999999999975321 11111111100
Q ss_pred --HhhC---Cccc----ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCC
Q 003156 780 --LEEG---NVLD----CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 835 (843)
Q Consensus 780 --~~~~---~~~~----~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~ 835 (843)
.... .... .....+.........++.+++.+||+.||++||++.|++.+ ++..++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000 0000 00000000011234567899999999999999999999976 7776554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=290.95 Aligned_cols=243 Identities=22% Similarity=0.332 Sum_probs=187.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHH-HhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVL-GKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|....+|+.||+|.+...... .....+..|..++ ...+|||++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 3689999999999999888999999998543321 1122344554444 444899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999764 3578899999999999999999998 999999999999999999999999999875432
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
.....++..|+|||.. .+..++.++||||||+++|||++|..||...... .. .... ..+... ... ..
T Consensus 150 -~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~----~~~~-~~~~~~--~~~---~~ 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETI-LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AV----FDNI-LSRRIN--WPE---EV 216 (260)
T ss_pred -cccCCCCcCccChhhh-cCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HH----HHHH-HhcccC--CCC---cc
Confidence 1334577889999987 4445899999999999999999999999654321 11 1111 111110 000 11
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~ 827 (843)
.......+.+++.+||+.+|++|||+.++.+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 2234567889999999999999997754443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=298.77 Aligned_cols=250 Identities=24% Similarity=0.285 Sum_probs=205.7
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|.....||+|.|+.|..|++..++..||+|.+.+..... ....+.+|+++++.++|||||+++++...+...|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 4556678999999999999999999999999886654332 234588999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+.+|.+.+++... .......+..++.|+.++++|+|++ .|||||||++||+++.++++||+|||++..+....
T Consensus 137 a~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 137 ASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred ccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999999986 3345577888999999999999999 99999999999999999999999999999876432
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.....+|++.|.|||++.+....++++|+||+|+++|-|+.|..||+...- ..+... ++-.+
T Consensus 210 ---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--k~Lr~r------------vl~gk- 271 (596)
T KOG0586|consen 210 ---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--KELRPR------------VLRGK- 271 (596)
T ss_pred ---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--ccccch------------heeee-
Confidence 336788999999999997777778999999999999999999999975311 000000 00000
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
-..+.....+..+++++++..+|.+|++++++.++-
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 012333444567899999999999999999998764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=297.70 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=195.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCC-------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------- 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 625 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+++++.++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 4466677899999999999999888999999998654322 22356788999999999999999999875443
Q ss_pred -eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 626 -LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 626 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
..++|+||+++ ++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999964 677777653 34689999999999999999999998 99999999999999999999999999
Q ss_pred Cccccccccccee---------ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHH
Q 003156 705 LARLLTRLDKHVM---------SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775 (843)
Q Consensus 705 l~~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~ 775 (843)
+++.......... .....++..|+|||.+.+...++.++|||||||++|||++|+.||..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 9976543221111 11234577899999875555688999999999999999999999864322 1111111
Q ss_pred HHHHHhhC--------Cccc--------ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 776 VRVLLEEG--------NVLD--------CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 776 ~~~~~~~~--------~~~~--------~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........ .... ...+............+.+++.+|+..+|++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000000 0000 00000000011222567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=317.11 Aligned_cols=269 Identities=15% Similarity=0.181 Sum_probs=185.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCC-eEEEEEEe--------------ecC--CcccChHHHHHHHHHHHhccCCCccc
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQG-RMLAVKKL--------------VTS--DIIQYPEDFEREVRVLGKARHPNLIS 616 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~--------------~~~--~~~~~~~~~~~E~~~l~~l~h~niv~ 616 (843)
+.|+..+.||+|+||+||++.++... ..++.|.+ .+. ........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 45777889999999999998874322 12222211 000 01112346789999999999999999
Q ss_pred eeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCC-CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC
Q 003156 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN 695 (843)
Q Consensus 617 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 695 (843)
+++++...+..++|+|++. +++.+++..... ............++.|++.||+|||+. +||||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 9999999999999999984 577777765321 122234566778999999999999998 99999999999999999
Q ss_pred CCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCC-CcCCCCc-hhhHH
Q 003156 696 YNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP-VEYGEDN-VVILS 773 (843)
Q Consensus 696 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p-~~~~~~~-~~~l~ 773 (843)
+.+||+|||+++.+...... ......||..|+|||++ .+..++.++|||||||++|||++|..+ +...... ...+.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEIL-AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCccccc-ccccccCCcCCCCchhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999876532221 22345789999999988 556789999999999999999998754 4332211 11222
Q ss_pred HHHHHHHh-hCCc-------cccc-----C---CCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 774 EHVRVLLE-EGNV-------LDCV-----D---PSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 774 ~~~~~~~~-~~~~-------~~~~-----d---~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.+..... .... .+.+ + ..+.. .......++.+++.+|++.||++|||+.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 21111000 0000 0000 0 00000 001123356778999999999999999999875
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=300.47 Aligned_cols=270 Identities=24% Similarity=0.326 Sum_probs=205.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC-----eeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 629 (843)
|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 4556789999999999999987899999999865432 234567889999999999999999999998775 7899
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||++ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999997 5888888754 3789999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh------
Q 003156 710 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE------ 782 (843)
Q Consensus 710 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~------ 782 (843)
...... .......++..|+|||.+.....++.++||||+|+++|+|++|+.||...... ..... +......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~-i~~~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNL-IVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHH-HHHhcCCCChhHh
Confidence 543210 11133456788999999855447899999999999999999999999654321 11111 0000000
Q ss_pred -----CCcccccC-------CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCC
Q 003156 783 -----GNVLDCVD-------PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 835 (843)
Q Consensus 783 -----~~~~~~~d-------~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~ 835 (843)
......+. ..+..........+.+++.+||+.+|++|||+.+++++ ++.+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00000000 00001112245668899999999999999999999996 6666655
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=275.42 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=198.8
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC----CeeEEEEEeC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP----QLKLLVSDYA 634 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~~lV~e~~ 634 (843)
++||-|-.|.|..+..+.+++++|+|.+.+.. ..++|++..-.. .|||||.++++|... ....+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 47999999999999999999999999986543 345777765544 699999999998643 3567999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc---CCCCcEEeeccCcccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLLTR 711 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~~~ 711 (843)
+||.|.+.++++. ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|.. .+..+|++|||+|+.-.+
T Consensus 142 eGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999999999973 56799999999999999999999999 999999999999997 456799999999986443
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.....+.+-|+.|.|||++ +..+|+..+|+||+||+||-|++|.+||..... ..++-..+..++.+... .-++
T Consensus 217 ---~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~gqy~-FP~p 289 (400)
T KOG0604|consen 217 ---PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQYE-FPEP 289 (400)
T ss_pred ---CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhccCcc-CCCh
Confidence 2222455678999999998 777899999999999999999999999976433 22223333333333321 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
......+...++|+..++.+|.+|.|+.|++.+=.-.
T Consensus 290 ----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 290 ----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred ----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 1234456678899999999999999999998875433
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=293.30 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=196.9
Q ss_pred hhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 628 (843)
|+..+.||+|+||.||+|... .+|+.||+|++..... ....+.+.+|+++++++ +|+||+++++++......+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 345668999999999999874 3688999999865322 12346678899999999 5899999999999888899
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999864 3578889999999999999999998 999999999999999999999999999976
Q ss_pred ccccccceeccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... ......|+..|+|||..... ..++.++||||||+++|+|++|+.||..... ........+.....
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~----- 227 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKS----- 227 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhcc-----
Confidence 5432211 11234578899999987432 3467899999999999999999999964321 11112222211111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
...++......+.+++.+||+.+|++|| ++.+++.+
T Consensus 228 -----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1112344556788999999999999997 77777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=293.10 Aligned_cols=261 Identities=26% Similarity=0.348 Sum_probs=199.1
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
..+.||+|+||.||+|....+++.||+|.+.... .....+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3457999999999999998889999999986543 22345678899999999999999999999999999999999997
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++........
T Consensus 82 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 82 MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 58999998752 4689999999999999999999998 9999999999999999999999999999865432211
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH-------HhhCCccccc
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------LEEGNVLDCV 789 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~-------~~~~~~~~~~ 789 (843)
.....++..|+|||.+.....++.++|||||||++||+++|+.||..... ...+....... +.........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12334567799999885555789999999999999999999999865321 11111111100 0000000000
Q ss_pred CCCCCCC--------ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 790 DPSMGDY--------PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~--------~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+...+.+ .......+.+++.+||..+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 1111110 11224578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.61 Aligned_cols=268 Identities=20% Similarity=0.271 Sum_probs=196.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC---------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--------- 624 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------- 624 (843)
..|+..+.||+|+||.||+|....+|+.||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 456677799999999999999988899999999865543 3456788999999999999999999876543
Q ss_pred -----CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCc
Q 003156 625 -----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNP 698 (843)
Q Consensus 625 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~ 698 (843)
...++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999997 588888764 2488999999999999999999998 999999999999998 55678
Q ss_pred EEeeccCcccccccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~ 777 (843)
|++|||.++......... ......++..|+|||.+.....++.++|||||||++|||++|+.||........ ......
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 999999997654321111 112235678899999875556788999999999999999999999965432111 111100
Q ss_pred HH--------------HhhCCcccccCCC--CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhc
Q 003156 778 VL--------------LEEGNVLDCVDPS--MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVI 832 (843)
Q Consensus 778 ~~--------------~~~~~~~~~~d~~--l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~ 832 (843)
.. ...........+. ..........++.+++.+|++.||++|||+.|++.+ ++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 0000000000000 000112234567899999999999999999999975 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=257.44 Aligned_cols=212 Identities=22% Similarity=0.304 Sum_probs=175.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..+....||+|++|.|-+.++..+|+..|+|++...-..+..+...+|+.+..+. .+|.+|.++|.+......++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3444558999999999999999999999999996655455567788899887666 699999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
|. -||..+-++....+..+++.-.-+||..+.+||.|||++. .++|||+||+|||++.+|+|||||||++-.+.+.
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS- 202 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS- 202 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh-
Confidence 94 5888887776666788999999999999999999999986 8999999999999999999999999998765431
Q ss_pred cceeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhH
Q 003156 714 KHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l 772 (843)
...+...|-..|||||.+... ..|+.+|||||+|+++.||.+++.||+.....-.++
T Consensus 203 --iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 203 --IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred --hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 111223455679999987332 368899999999999999999999998765443333
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.16 Aligned_cols=270 Identities=24% Similarity=0.326 Sum_probs=202.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEc-CCeeEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKLLV 630 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV 630 (843)
.+.|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|++++++++||||+++.+++.. ....++|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 4557778899999999999999988999999998854322 2234678899999999999999999999876 4567899
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
+||+ +++|.++++.. .+++.....++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.++...
T Consensus 89 ~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 89 TELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred eehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 9998 56898888642 478888889999999999999998 99999999999999999999999999987543
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHH-----------HHHH
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH-----------VRVL 779 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~-----------~~~~ 779 (843)
... ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ...... .+..
T Consensus 160 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 160 PQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhc
Confidence 211 23456788999998755467899999999999999999999999653211 111110 0000
Q ss_pred HhhCCcccccCC-CC-C-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCCCCC
Q 003156 780 LEEGNVLDCVDP-SM-G-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTPLPQ 838 (843)
Q Consensus 780 ~~~~~~~~~~d~-~l-~-----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~~~~ 838 (843)
.. ....+.+.. .. . .........+.+++.+|++.+|++|||+.+++.+ ++..+.+..+
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 234 CS-ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred cc-hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 00 000000000 00 0 0112234678899999999999999999999987 5555555433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.64 Aligned_cols=256 Identities=26% Similarity=0.340 Sum_probs=197.5
Q ss_pred hhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 629 (843)
+..+.||+|+||.||++... .+++.||||.+..... ....+.+.+|++++.++ +||||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 44568999999999999864 3568899999864322 22345688999999999 59999999999998889999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 83 ILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998764 3588899999999999999999998 9999999999999999999999999998765
Q ss_pred cccccceeccccccccccCCcccccCcC-CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... ......++..|+|||...... ..+.++||||||+++|||++|..||...... .......+......
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~----- 228 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSK----- 228 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHccC-----
Confidence 432221 112345788999999873332 3688999999999999999999999643211 11112222211110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
...+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 229 -----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 -----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11233344568899999999999999998888766644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=292.53 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=200.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 632 (843)
|+..+.||+|+||.||+|....+|+.||+|.+...... ...+.+.+|++++++++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 45566899999999999999888999999998653221 22356889999999998 9999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999875 3699999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccc------------------eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHH
Q 003156 713 DKH------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774 (843)
Q Consensus 713 ~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~ 774 (843)
... .......++..|+|||.. ....++.++||||+|+++|++++|+.||.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 211 112334567889999987 45568899999999999999999999997543111
Q ss_pred HHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 003156 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM----AEVVQI 828 (843)
Q Consensus 775 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~----~evl~~ 828 (843)
..+..... ....+......+.+++.+||+.+|++|||+ ++++++
T Consensus 230 ~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 TFQKILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11111110 011233445678899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.41 Aligned_cols=370 Identities=27% Similarity=0.394 Sum_probs=274.5
Q ss_pred CCCcEEEccCccccc-cccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCC
Q 003156 27 ASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYL 105 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~-~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 105 (843)
+-++-.|+++|.+++ --+.....++.++.|-|...++...++ .+..+.+|++|.++||++. .+-+.++.|+.|
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPe-----EL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L 80 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPE-----ELSRLQKLEHLSMAHNQLI-SVHGELSDLPRL 80 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChH-----HHHHHhhhhhhhhhhhhhH-hhhhhhccchhh
Confidence 344556666776663 222334556666666666666654433 3556666666666666665 344556666666
Q ss_pred CEEEcCCCcccc-cCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEccc
Q 003156 106 KELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN 184 (843)
Q Consensus 106 ~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 184 (843)
+.+.+..|++.. -+|..+..+..|+.||||+|++. ..|..+..-+++..|+||+|+|..+....|.+++.|-.||||+
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence 666666666642 24555666666666666666666 5566666666666666666666644444555666666666666
Q ss_pred CCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCcc
Q 003156 185 NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 264 (843)
Q Consensus 185 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l 264 (843)
|++. .+|..+..+..|++|.|++|++.. ++ | ..+| .+++|+.|.+++.+-
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~h------fQ--L-----------rQLP----------smtsL~vLhms~TqR 209 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNH------FQ--L-----------RQLP----------SMTSLSVLHMSNTQR 209 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhH------HH--H-----------hcCc----------cchhhhhhhcccccc
Confidence 6666 455566666666666666666541 10 1 1112 267888899988764
Q ss_pred c-eeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhh
Q 003156 265 V-GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQV 343 (843)
Q Consensus 265 ~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 343 (843)
+ ..+|.++..+.||..+|+|.|.+. +.|+.+-++.+|+.|+||+|+|+ .+........+|++|+||.|+++ .+|..
T Consensus 210 Tl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~a 286 (1255)
T KOG0444|consen 210 TLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDA 286 (1255)
T ss_pred hhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHH
Confidence 4 357999999999999999999997 68999999999999999999999 66777788899999999999999 89999
Q ss_pred hcccCCCcEEecccccccc-cCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCCCCCCCCCCC
Q 003156 344 IRNCTSLYLLSLSHNHLSG-SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLD 422 (843)
Q Consensus 344 ~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~ 422 (843)
+..|++|+.|++.+|+++- -+|..++.|.+|+.+..++|.+. .+|+.++.+..|+.|+|+.|+|...+-....++.+.
T Consensus 287 vcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~ 365 (1255)
T KOG0444|consen 287 VCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLK 365 (1255)
T ss_pred HhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcc
Confidence 9999999999999999873 38999999999999999999998 999999999999999999999986544455678899
Q ss_pred CCCcCCCCCCCCCCC
Q 003156 423 QSSLQGNLGICSPLL 437 (843)
Q Consensus 423 ~~~~~~n~~~c~~~~ 437 (843)
...+..||.+--||-
T Consensus 366 vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 366 VLDLRENPNLVMPPK 380 (1255)
T ss_pred eeeccCCcCccCCCC
Confidence 999999999877664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=269.75 Aligned_cols=275 Identities=25% Similarity=0.370 Sum_probs=209.1
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEee-cCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC------
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLV-TSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------ 624 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 624 (843)
....|+...+||+|.||+||+|+.+.+|++||+|+.. .....+......+|+.+++.++|+|++.++..|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3455777779999999999999999899999998753 344456677889999999999999999999988532
Q ss_pred --CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEee
Q 003156 625 --QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 625 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 702 (843)
...++|+++|+. +|.-.+..+ ...++..++.+++.++..||.|+|.. .|+|||+||.|+|++.++.+||+|
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 346899999976 788888775 36788999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccccccceec--cccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 703 FGLARLLTRLDKHVMS--NRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
||+++.+...+..... .....|++|++||.+.+...|+++.|||+.||++.||+||.+-+... .+...+. .+....
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn-teqqql~-~Is~Lc 245 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN-TEQQQLH-LISQLC 245 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC-hHHHHHH-HHHHHh
Confidence 9999866543332221 12345889999999989999999999999999999999987776543 2222221 111111
Q ss_pred hhCCcccccCCCCCCC-----------C-------hhhH------HHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 781 EEGNVLDCVDPSMGDY-----------P-------EDEV------LPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~-----------~-------~~~~------~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
|.+..-+.|..... + .+.. .+..+|+..++..||++|+++.+++.+-.-.+++.
T Consensus 246 --Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 246 --GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred --ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 11111111211110 0 0111 14668899999999999999999999877766666
Q ss_pred C
Q 003156 837 P 837 (843)
Q Consensus 837 ~ 837 (843)
|
T Consensus 324 p 324 (376)
T KOG0669|consen 324 P 324 (376)
T ss_pred c
Confidence 5
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.60 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=198.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC------e
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------L 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 626 (843)
+.|+..+.||+|+||.||+|....+|+.||||++..... ....+.+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 346677789999999999999988999999999854321 223456789999999999999999999987543 3
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 58999999 7799888764 3588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH---------
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR--------- 777 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~--------- 777 (843)
+...... ....++..|+|||.+.....++.++||||+||++|++++|+.||...... ........
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHH
Confidence 7654211 23456788999998755456889999999999999999999999754221 11111110
Q ss_pred --HHHhhC--Cccc---cc-CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhc
Q 003156 778 --VLLEEG--NVLD---CV-DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVI 832 (843)
Q Consensus 778 --~~~~~~--~~~~---~~-d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~ 832 (843)
...... .... .+ ...+..........+.+++.+|++.||++|||+.+++++ ++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 0000 00 000011122344568899999999999999999999965 4444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=282.64 Aligned_cols=238 Identities=29% Similarity=0.372 Sum_probs=194.0
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
||+|+||.||++....+++.+|+|.+....... ..+.+..|+.++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999998789999999986554322 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecc
Q 003156 640 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719 (843)
Q Consensus 640 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 719 (843)
.+++... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 9999864 3589999999999999999999998 999999999999999999999999999976543221 123
Q ss_pred ccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChh
Q 003156 720 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799 (843)
Q Consensus 720 ~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 799 (843)
...++..|+|||.. .+...+.++|+||||+++||+++|+.||..... . ...+.... . ...++..
T Consensus 152 ~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~---~~~~~~~~-~---------~~~~~~~ 215 (250)
T cd05123 152 TFCGTPEYLAPEVL-LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--K---EIYEKILK-D---------PLRFPEF 215 (250)
T ss_pred CCcCCccccChHHh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--H---HHHHHHhc-C---------CCCCCCC
Confidence 45678889999987 455678999999999999999999999964322 1 11111111 0 0112333
Q ss_pred hHHHHHHHHHHccCCCCCCCCCHHH
Q 003156 800 EVLPVLKLALVCTCHIPSSRPSMAE 824 (843)
Q Consensus 800 ~~~~l~~l~~~c~~~~P~~RPs~~e 824 (843)
....+.+++.+||..||++|||+++
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 4567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=245.99 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=202.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|...++||+|.||+||+|+...+++.||+|+..-.+ .++.+....+|+-+++.++|.|||+++++...+....+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 445568999999999999999899999999986543 3456678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
.. +|..+.... ...++.+....++.|+.+|+.|.|++ ++.|||+||.|.+++.+|+.|++|||+++-++-.-.
T Consensus 84 dq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 DQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 54 777777664 35688899999999999999999999 999999999999999999999999999986643221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh--CC---ccccc
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE--GN---VLDCV 789 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~--~~---~~~~~ 789 (843)
. -+....|.+|++|.++.+..-|++..|+||.||++.|+.....|..++.+-.+++....+..-.. +. ....-
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 1 13345689999999987777899999999999999999986677666655555555444432111 11 01111
Q ss_pred CCCC-CCCCh---------hhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 790 DPSM-GDYPE---------DEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l-~~~~~---------~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
|... +.++. .....=.++.+..+.-+|..|.++++++++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 11111 111112356666777789999999998875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=271.16 Aligned_cols=252 Identities=26% Similarity=0.300 Sum_probs=203.7
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
+-+.++..+.+|+|.||.|..++.+.+|+.+|+|.+++..... ....-..|-.+++..+||.+..+--.+...+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3455666778999999999999999999999999997654332 23455779999999999999999888899999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+.||.|.-.|... ..+++.....+...|..||.|||++ +||.||+|.+|.|+|.+|.+||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999888764 4688888888999999999999998 9999999999999999999999999999843
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
- ........++||+.|.|||++ ....|+.+.|.|.+||+||||++|+.||.....+. +-+.+ --+
T Consensus 319 I--~~g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLI----l~e------ 383 (516)
T KOG0690|consen 319 I--KYGDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELI----LME------ 383 (516)
T ss_pred c--cccceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHH----Hhh------
Confidence 2 233334778999999999998 78899999999999999999999999997543221 11111 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
| ..+|.....+...|+.-.+.+||.+|. .++||.++
T Consensus 384 d---~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 D---LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred h---ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 0 124555566777888899999999995 35555543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.67 Aligned_cols=261 Identities=24% Similarity=0.285 Sum_probs=194.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC------Ce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 626 (843)
+.|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 446667789999999999999988899999999864321 22245678899999999999999999988643 23
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.+++++++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccc
Confidence 57888877 78998887642 489999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh-----
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE----- 781 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~----- 781 (843)
+..... .....++..|+|||.......++.++|||||||++|||++|+.||...... ..+....+....
T Consensus 168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 168 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAEL 241 (345)
T ss_pred cccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 754321 133467788999998755456889999999999999999999999643221 111111110000
Q ss_pred -----hC---Ccc----cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 782 -----EG---NVL----DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 782 -----~~---~~~----~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.. ... .................+.+++.+|++.||++|||+.+++.+=
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00 000 0000000011112345678999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=294.09 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=193.6
Q ss_pred hhhcCeeccccceEEEEEEECCC--CeEEEEEEeecCCc-ccChHHHHHHHHHHHhc-cCCCccceeeEEEcC----Cee
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQ--GRMLAVKKLVTSDI-IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP----QLK 627 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~ 627 (843)
|+..+.||+|+||.||+|..... +..||+|++..... ....+.+.+|+++++++ .||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 34456899999999999999877 88999999854321 12245678899999999 599999999876432 346
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++++||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78899885 6898888653 4689999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc--eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH-------
Q 003156 708 LLTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV------- 778 (843)
Q Consensus 708 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~------- 778 (843)
........ .......|+..|+|||.......++.++||||+||++|+|++|+.||..... ...+...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEE 232 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHH
Confidence 65432211 1112346788999999875556689999999999999999999999865321 1111111110
Q ss_pred ----HHhhC------CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 779 ----LLEEG------NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 779 ----~~~~~------~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..... .....-...+..........+.+++.+|++.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 000000000011112234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=271.12 Aligned_cols=260 Identities=21% Similarity=0.291 Sum_probs=199.9
Q ss_pred hhhhhhh-cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEE
Q 003156 552 PETLLEK-AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 552 ~~~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 629 (843)
..+.|+. .+.+|+|+|+.|--+....+|..+|||++.+. .........+|++++.+. .|+||+.++.++.++...||
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 3444543 24799999999999998889999999998543 233456788999999999 59999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC---cEEeeccCc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFGLA 706 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~ 706 (843)
|||-|.||.|.+.|+++ ..+++.++.++..+||.||.|||.+ +|.|||+||+|||..+... ||||||.++
T Consensus 154 VfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 99999999999999986 5689999999999999999999999 9999999999999975544 899999988
Q ss_pred ccccccccce-----eccccccccccCCcccc----cCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh-------
Q 003156 707 RLLTRLDKHV-----MSNRFQSALGYVAPELT----CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV------- 770 (843)
Q Consensus 707 ~~~~~~~~~~-----~~~~~~g~~~y~aPE~~----~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~------- 770 (843)
.-+.....-. ...+..|+..|||||+. .....|+.++|.||+|||+|-|++|..||...-..+-
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 6543221111 11234677789999975 2234688999999999999999999999976321110
Q ss_pred --hHHHHHHHHHhhCCcccccCCCCCCCChhh----HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 771 --ILSEHVRVLLEEGNVLDCVDPSMGDYPEDE----VLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 771 --~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.-.+.+-..+.+|.. ++|+.+ ..+..+++...+..|+..|.++.+++.+
T Consensus 307 Cr~CQ~~LFesIQEGkY---------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKY---------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred cHHHHHHHHHHHhccCC---------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 111122222333332 234333 3445678888899999999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.91 Aligned_cols=260 Identities=24% Similarity=0.321 Sum_probs=196.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCe------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------ 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 626 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 346667799999999999999988899999998854321 2233567789999999999999999998866554
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 95 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 79999998 6799988875 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH-------
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------- 779 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~------- 779 (843)
...... .....++..|+|||.......++.++||||+||++||+++|+.||..... ...+.......
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHH
Confidence 865432 13345678899999875545678999999999999999999999964322 11111111100
Q ss_pred ---HhhC---CcccccC----CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 ---LEEG---NVLDCVD----PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ---~~~~---~~~~~~d----~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+... .....+. +...........++.+++.+|++.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 0000000 00000111235678899999999999999999999885
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=279.36 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=202.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc------cChHHHHHHHHHHHhccCCCccceeeEEE-cCC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII------QYPEDFEREVRVLGKARHPNLISLEGYYW-TPQ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~ 625 (843)
.++|-....||+|||++||+|.+....+.||||.-.-...+ ...+...+|..+.+.+.||.||++++|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34566666899999999999999888899999986433322 22345678999999999999999999996 455
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc---CCCCcEEee
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISD 702 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~D 702 (843)
..+-|+|||+|.+|+-||+.. ..+++.++..|+.||+.||.||.+. +|+|||-|+||.|||+- .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 678999999999999999875 5688999999999999999999987 88999999999999995 557899999
Q ss_pred ccCcccccccccc-----eeccccccccccCCcccccCc---CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHH
Q 003156 703 FGLARLLTRLDKH-----VMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774 (843)
Q Consensus 703 fgl~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~ 774 (843)
||+++.++...+. ..+....||.+|.+||.+.-+ .+.+.++||||.||++|.++.|+.||.........+.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999998764433 223566799999999987433 45788999999999999999999999765443333322
Q ss_pred HHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003156 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 775 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~ 827 (843)
..+...-.-..+. -.....+...+|++|+...-++|....++..
T Consensus 697 --------NTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 --------NTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --------hchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1121111111111 1223345678999999998888887766643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=276.29 Aligned_cols=221 Identities=23% Similarity=0.255 Sum_probs=177.7
Q ss_pred ccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHh
Q 003156 565 GVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH 644 (843)
Q Consensus 565 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 644 (843)
|.+|.||++.+..+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999899999999985432 23445555556679999999999999999999999999999999997
Q ss_pred hcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccc
Q 003156 645 ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724 (843)
Q Consensus 645 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~ 724 (843)
.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~ 145 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE 145 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence 64 3489999999999999999999998 99999999999999999999999999886554321 223446
Q ss_pred cccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHH
Q 003156 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPV 804 (843)
Q Consensus 725 ~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 804 (843)
..|+|||.. ....++.++||||+|+++|||++|+.|+....... . .... ...+......+
T Consensus 146 ~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~-----~~~~---~~~~~~~~~~~ 205 (237)
T cd05576 146 NMYCAPEVG-GISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------N-----THTT---LNIPEWVSEEA 205 (237)
T ss_pred ccccCCccc-CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------c-----cccc---cCCcccCCHHH
Confidence 679999987 55567899999999999999999998875321100 0 0000 01233345578
Q ss_pred HHHHHHccCCCCCCCCCHH
Q 003156 805 LKLALVCTCHIPSSRPSMA 823 (843)
Q Consensus 805 ~~l~~~c~~~~P~~RPs~~ 823 (843)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=310.66 Aligned_cols=146 Identities=26% Similarity=0.374 Sum_probs=130.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.|+..+.||+|+||.||+|.+..+++.||+|++...... .....+..|+.+++.++||||+++++++......++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 355667899999999999999888999999998654322 223568889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
|+++|+|.+++... ..+++..++.++.|++.||+|||.. +||||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999764 3578889999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=306.03 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=204.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|++.+.||+|+||.|..++.+.+++.||+|++.+.... ....-|..|-++|..-..+=|+.++-.|.+..+.|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 4577788999999999999999999999999998663322 23456888999998888999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|||+||+|...+... .++++..+..++..|..||.-+|+. |+|||||||+|||+|..|++|++|||.+-.+..
T Consensus 155 dY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999986 2678888888999999999999999 999999999999999999999999998877764
Q ss_pred cccceeccccccccccCCcccccC---c-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQ---S-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~---~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
+....+....|||.|++||++.. + +.|++.+|.||+||++|||+.|..||+.. .+.............
T Consensus 228 -dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk~~-- 299 (1317)
T KOG0612|consen 228 -DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHKES-- 299 (1317)
T ss_pred -CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchhhh--
Confidence 34455577899999999998732 2 56899999999999999999999999743 122211111111111
Q ss_pred ccCCCCCCCC--hhhHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 003156 788 CVDPSMGDYP--EDEVLPVLKLALVCTCHIPSSRPS---MAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~--~~~~~~l~~l~~~c~~~~P~~RPs---~~evl~~ 828 (843)
-.|| .+.+.....||++-+ -+|+.|.. +.++..|
T Consensus 300 ------l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 300 ------LSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ------cCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 1223 345667778888866 46888887 8888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=289.79 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=195.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+....+|.|+|+.|-.+....+++..+||++.+.. .+-.+|+.++... .||||+++.+.+.+..+.++|||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 34555567999999999999999999999999986552 2344577666666 69999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE-cCCCCcEEeeccCcccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL-DDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfgl~~~~~~ 711 (843)
.+.+|-+.+.+... +... ..+..|+++++.++.|||++ ||||||+||+|||+ ++.+.++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999888877764 2223 67778999999999999998 99999999999999 5999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
. ....+-|..|.|||+. ....|++++|+||+|+++|+|++|+.||.....+.. +. ..+..+
T Consensus 469 ~-----~~tp~~t~~y~APEvl-~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i~----~~i~~~-------- 529 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVL-AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-IH----TRIQMP-------- 529 (612)
T ss_pred h-----hcccchhhcccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-HH----HhhcCC--------
Confidence 3 1233557889999998 577899999999999999999999999987654411 11 111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
.+.........+|+..|++.||.+||+|.++..+=..
T Consensus 530 ---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 ---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1224455678899999999999999999999887444
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=293.17 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=211.2
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc----
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT---- 623 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~---- 623 (843)
..++...++..+.||.|.+|.||+++...+|+.+|+|++..... ..++...|.++++.. .|||++.++|++..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 44566667777799999999999999999999999998855432 346778899999888 69999999999963
Q ss_pred -CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEee
Q 003156 624 -PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 624 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 702 (843)
++..+||||||.+||..++++... +..+.|..+..|++.++.|+.|||.. .++|||||-.|||++.++.||++|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 567899999999999999999875 67799999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCc----CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~ 778 (843)
||.+..+.. .-.......||+.|||||++... ..|+.++|+||+|++..||.-|.+|+.++..-. .
T Consensus 167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------a 236 (953)
T KOG0587|consen 167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------A 236 (953)
T ss_pred eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------h
Confidence 999987653 22234677899999999987432 346789999999999999999999997653211 1
Q ss_pred HHhhCCcccccCCCCC---CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 779 LLEEGNVLDCVDPSMG---DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~---~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+-.+.++-+ ..+..-..++.++|..|+.+|.++||++.+++++
T Consensus 237 -------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 -------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111111111 1367778889999999999999999999998875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=281.02 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=196.4
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.+.+|+|.||+||-|+++.+|+.||||.+.+.... +....++.|+.+|++++||.||.+.-.|..++..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 45899999999999999999999999999655433 23467889999999999999999999999999999999999 55
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC---CCcEEeeccCccccccccc
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN---YNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~~~~~~~~ 714 (843)
+..++|-.. ...++++.....+..||+.||.|||.+ +|||+|+||+|||+.+. -.+||||||+|+.+++..
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 666666543 345688888888999999999999999 99999999999999743 469999999999987532
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......||+.|.|||++ ....|+..-|+||.||++|--++|..||.-+++-.++ + ....+ +..+.
T Consensus 722 --FRrsVVGTPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ----I----QNAaF--MyPp~-- 786 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ----I----QNAAF--MYPPN-- 786 (888)
T ss_pred --hhhhhcCCccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCccchhHH----h----hcccc--ccCCC--
Confidence 23567899999999998 5557899999999999999999999999654332211 1 11111 11111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+.....+++|...++..=++|-|..+.+.+
T Consensus 787 -PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 -PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 123444567788999898888899888876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=266.04 Aligned_cols=240 Identities=28% Similarity=0.376 Sum_probs=193.8
Q ss_pred cceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHhh
Q 003156 566 VFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE 645 (843)
Q Consensus 566 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 645 (843)
+||.||+|.+..+|+.+|+|++.........+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998789999999986554333267899999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceecccccccc
Q 003156 646 RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725 (843)
Q Consensus 646 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~ 725 (843)
.. .+++..++.++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 42 288999999999999999999998 99999999999999999999999999998765432 123456778
Q ss_pred ccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHH
Q 003156 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVL 805 (843)
Q Consensus 726 ~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~ 805 (843)
.|++||.. ....++.++||||||+++|++++|..||....... ...+.. ..+... ..........++.
T Consensus 151 ~~~~pE~~-~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~----~~~~~~------~~~~~~~~~~~~~ 218 (244)
T smart00220 151 EYMAPEVL-LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKI----GKPKPP------FPPPEWKISPEAK 218 (244)
T ss_pred CCCCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHH----hccCCC------CccccccCCHHHH
Confidence 89999987 45567889999999999999999999996532211 111111 111100 0000111456789
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 003156 806 KLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 806 ~l~~~c~~~~P~~RPs~~evl~ 827 (843)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=267.20 Aligned_cols=237 Identities=26% Similarity=0.349 Sum_probs=190.9
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccC--hHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
..+||+|+||.|..|..+.+.+.+|||++++....+. .+--..|-.+|+.- +.|.++.++.++...+..|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 3479999999999999998889999999976544332 23345566777655 57899999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
||+|--.|+.. ..+.+..+..+|..||-||-+||++ +|+.||+|.+|||+|.+|.+||+|||+++.-- -..
T Consensus 434 GGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~ 504 (683)
T KOG0696|consen 434 GGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDG 504 (683)
T ss_pred CchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc--cCC
Confidence 99998888775 4577788889999999999999999 99999999999999999999999999997422 223
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
.++.+++||+.|+|||++ ....|+.++|.|||||++|||+.|+.||+...+++ +-+.+ .+.+ -.
T Consensus 505 ~TTkTFCGTPdYiAPEIi-~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~aI----~ehn---------vs 568 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQAI----MEHN---------VS 568 (683)
T ss_pred cceeeecCCCcccccceE-EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH----HHcc---------Cc
Confidence 344678999999999988 77789999999999999999999999997643322 21111 1111 12
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCC
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRP 820 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RP 820 (843)
+|.....+...+...-+.+.|.+|.
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCcccc
Confidence 4566666778888888888888884
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=306.67 Aligned_cols=404 Identities=31% Similarity=0.364 Sum_probs=272.7
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
+|+.|||++|++. ..|.. ...+++|+.|+++.|.|...+ ....++.+|++|+|.+|.+...+. .+..+++|+
T Consensus 46 ~L~~l~lsnn~~~-~fp~~-it~l~~L~~ln~s~n~i~~vp-~s~~~~~~l~~lnL~~n~l~~lP~-----~~~~lknl~ 117 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQ-ITLLSHLRQLNLSRNYIRSVP-SSCSNMRNLQYLNLKNNRLQSLPA-----SISELKNLQ 117 (1081)
T ss_pred eeEEeeccccccc-cCCch-hhhHHHHhhcccchhhHhhCc-hhhhhhhcchhheeccchhhcCch-----hHHhhhccc
Confidence 4889999999998 77765 477899999999999998877 446778999999999998885554 577889999
Q ss_pred EEecCCccCcccCchhhhcCCCC-------------------CEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccC
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYL-------------------KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 143 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L-------------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 143 (843)
+||++.|++. ..|..+..++.+ +.++|..|.+.+.++..+.++.. .|||.+|++.
T Consensus 118 ~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~--- 191 (1081)
T KOG0618|consen 118 YLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME--- 191 (1081)
T ss_pred ccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---
Confidence 9999999987 556555554444 44455555555555555655555 6888888876
Q ss_pred CchhhcccCCcEEEeecCcccccCCCC------------------ccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEE
Q 003156 144 PVSLRLLNSMIFISVSNNTLTGDIPHW------------------IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIR 205 (843)
Q Consensus 144 ~~~~~~l~~L~~L~L~~N~l~~~~p~~------------------~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 205 (843)
-..+..+.+|+.|....|++....-.. -.--.+|++++++.|+++ .+|+++..+.+|+.|+
T Consensus 192 ~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~ 270 (1081)
T KOG0618|consen 192 VLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALN 270 (1081)
T ss_pred hhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccceEec
Confidence 224455556666666666554211100 001134555555555555 3445555555555555
Q ss_pred ecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCC-CcEEEc
Q 003156 206 LRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN-LRYLNL 283 (843)
Q Consensus 206 L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~L~L 283 (843)
..+|.+. .+|..++.. +|+.|++..|.+. .+|+. ...++.|++|+|..|+|....+..+..... |..|+.
T Consensus 271 ~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~------le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~ 342 (1081)
T KOG0618|consen 271 ANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPF------LEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNV 342 (1081)
T ss_pred ccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCc------ccccceeeeeeehhccccccchHHHhhhhHHHHHHhh
Confidence 5555553 444443332 4555555555553 22221 123455666666666665222222222222 455555
Q ss_pred CCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccccccc
Q 003156 284 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS 363 (843)
Q Consensus 284 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 363 (843)
+.|++....-..=.....|+.|++.+|.++...-.-+.+...|++|+|++|+|.......+.++..|+.|+||+|+|+ .
T Consensus 343 s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~ 421 (1081)
T KOG0618|consen 343 SSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-T 421 (1081)
T ss_pred hhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-h
Confidence 555554322111123457899999999999887778888999999999999998555567888999999999999999 8
Q ss_pred CCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccce-ecCCCCCCCCCCCCCCcCCCCCC
Q 003156 364 IPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI-GRLPVGGVFPTLDQSSLQGNLGI 432 (843)
Q Consensus 364 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~-~~~p~~~~~~~~~~~~~~~n~~~ 432 (843)
+|..+.+++.|++|...+|+|. ..| .+.+++.|+.+|+|.|+|+ +.+|..-..++++..++.||.++
T Consensus 422 Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 422 LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9999999999999999999998 777 8899999999999999997 44454433478899999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=263.65 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=200.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-C-C----CccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-H-P----NLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~g~~~~~~~ 626 (843)
.+.|++...+|+|.||.|-++.+...+..||||+++... ...++..-|+++++++. + | -+|.+.+|+.-.++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 456778889999999999999998889999999985433 44566778999999993 2 3 36777888888899
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC------------
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD------------ 694 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~------------ 694 (843)
.+||+|.+ |-|+.+++... .-.+++...+..|+.|++++++|||+. +++|-|+||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999998 66999999986 345688899999999999999999999 9999999999999831
Q ss_pred --------CCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC
Q 003156 695 --------NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 766 (843)
Q Consensus 695 --------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~ 766 (843)
...+||.|||.|+.-.+.. .....|..|+|||++ -+..++.++||||+|||++|++||..-|..-+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEVi-LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVI-LGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchhe-eccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 2358999999998754433 455678899999999 56679999999999999999999999987654
Q ss_pred CchhhHHH-----------H-----HHHHHhhCCcc-----------cccCCCCC-----CCChhhHHHHHHHHHHccCC
Q 003156 767 DNVVILSE-----------H-----VRVLLEEGNVL-----------DCVDPSMG-----DYPEDEVLPVLKLALVCTCH 814 (843)
Q Consensus 767 ~~~~~l~~-----------~-----~~~~~~~~~~~-----------~~~d~~l~-----~~~~~~~~~l~~l~~~c~~~ 814 (843)
+ ...++- . .+.....+.+. ...++-.+ .....+..++.+|+++++..
T Consensus 314 n-~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 314 N-LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred c-HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 2 222210 0 11111111100 00000000 02345566799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003156 815 IPSSRPSMAEVVQI 828 (843)
Q Consensus 815 ~P~~RPs~~evl~~ 828 (843)
||.+|+|+.|++++
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=294.13 Aligned_cols=260 Identities=18% Similarity=0.183 Sum_probs=168.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCC----CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeE------EEc
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQ----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY------YWT 623 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~ 623 (843)
+.|+..+.||+|+||.||+|.+..+ +..||+|++.... ..+.+..| .+....+.++..+... +..
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4466778999999999999999877 8999999875322 11222211 1112222333322221 234
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcCC----------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCC
Q 003156 624 PQLKLLVSDYAPNGSLQAKLHERLP----------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 687 (843)
Q Consensus 624 ~~~~~lV~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 687 (843)
....++||||+++++|.+++..... ......+..+..++.|++.||+|||+. +|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 5678999999999999999875421 011112334567999999999999998 999999999
Q ss_pred CCEEEcC-CCCcEEeeccCcccccccccceeccccccccccCCcccccCcC---------------------CCCCchhH
Q 003156 688 SNILLDD-NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL---------------------RVNEKCDI 745 (843)
Q Consensus 688 ~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---------------------~~~~~~Dv 745 (843)
+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+.... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999995 689999999999865433222 224567889999999542211 23456799
Q ss_pred HHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC----cccccCCC----CC---CCChhhHHHHHHHHHHccCC
Q 003156 746 YGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN----VLDCVDPS----MG---DYPEDEVLPVLKLALVCTCH 814 (843)
Q Consensus 746 ~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~----~~~~~d~~----l~---~~~~~~~~~l~~l~~~c~~~ 814 (843)
|||||++|||+++..|+... ...+...+. ..+. ....+.+. .. +..........+|+.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~---~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN---LIQFNRQLK---RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH---HHHHHHHHH---hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999976664321 111111110 0000 00000110 00 00111222456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 003156 815 IPSSRPSMAEVVQI 828 (843)
Q Consensus 815 ~P~~RPs~~evl~~ 828 (843)
||++|||++|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=292.16 Aligned_cols=245 Identities=27% Similarity=0.350 Sum_probs=186.8
Q ss_pred cCeeccccceE-EEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 559 AAEVGEGVFGT-VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 559 ~~~ig~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
.+.+|.|+.|+ ||+|.+ +|+.||||++.... .+-..+|+..++.- +|||||++++.-.+++..||+.|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 34688998876 899999 69999999985432 34567999999888 69999999999899999999999994
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---C--CCcEEeeccCcccccc
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---N--YNPRISDFGLARLLTR 711 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfgl~~~~~~ 711 (843)
.+|.+++...........-...+.+..|+++||+|||+. +||||||||.||||+. + .+++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 599999987421222222245678899999999999997 9999999999999975 2 5799999999998865
Q ss_pred cccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhC-CCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTG-RRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
+... .......||-||+|||.+ .....+.++||||+||++|+.++| .+||.....++... .........+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L-~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~~~L~~L 735 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQL-REDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGNYTLVHL 735 (903)
T ss_pred CcchhhcccCCCCcccccCHHHH-hccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCccceeee
Confidence 4332 234567899999999998 444567799999999999999985 99997643222111 1111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. . ..++ ...+||.+|+.++|..||++.+|+.|
T Consensus 736 ~----~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 E----P-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred c----c-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 1 1111 67899999999999999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=241.67 Aligned_cols=259 Identities=21% Similarity=0.255 Sum_probs=207.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCC--eeEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ--LKLL 629 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~l 629 (843)
.+.|+..+++|+|.+++||.|....+.++++||.++... .+.+.+|+.+++.++ ||||++++++..++. ...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 456888889999999999999988889999999996554 467899999999997 999999999998765 4579
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARL 708 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~ 708 (843)
|+||+++.+...... .++..++...+.++++||.|.|+. ||.|||+||.|+|+| +....+++|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 999998877655443 377788899999999999999999 999999999999999 556799999999998
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC-----
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG----- 783 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~----- 783 (843)
+.+...... ...+..|.-||.+.....|+.+-|+|||||++..|+..+.||..+.++.+++.+.++.+-...
T Consensus 183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 876554422 234456889999878888999999999999999999999999999888888877665432211
Q ss_pred -CcccccCCCCCC----CC-------------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 -NVLDCVDPSMGD----YP-------------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 -~~~~~~d~~l~~----~~-------------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...-.+||...+ .. .-...++++++.+.+..|-.+|||++|++.+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 011113333211 00 1112457789999999999999999999876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=254.34 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=192.0
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC-----eeEEEEE
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLLVSD 632 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e 632 (843)
.+.||-|+||.||.+++..+|+.||.|++..... -...+.+.+|++++..++|.|++..+++...+. +.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 4579999999999999999999999999854321 123467889999999999999999998876543 4578888
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
.|. .+|...|- +...++...+..+..||++||.|||+. +|.||||||.|.+++.+...||||||+++..+..
T Consensus 138 LmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 873 34444443 456788888999999999999999999 9999999999999999999999999999976554
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHH------------------H
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS------------------E 774 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~------------------~ 774 (843)
+...+ .....|-.|+|||++.+...|+.+.||||.||++.|++.++.-|.....- .++. +
T Consensus 210 ~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-HHHHHHHHHhCCCcHHHHHHHhh
Confidence 43222 33455778999999989999999999999999999999888887543211 1110 1
Q ss_pred HHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 775 HVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 775 ~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
..+..+-.+.....--+.+.. .+.....+...+...++..||++|.+.++.+.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111111111100011111 11223334567778889999999999999988753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=278.51 Aligned_cols=262 Identities=18% Similarity=0.173 Sum_probs=179.5
Q ss_pred hhhhhcCeeccccceEEEEEEEC----------------CCCeEEEEEEeecCCcc-------------cChHHHHHHHH
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG----------------TQGRMLAVKKLVTSDII-------------QYPEDFEREVR 604 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~ 604 (843)
+.|+..++||+|+||.||+|.+. ..++.||||++...... ...+.+..|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 44667779999999999999752 24568999998543211 11123445777
Q ss_pred HHHhccCCCc-----cceeeEEEc--------CCeeEEEEEeCCCCCHHHHHhhcCC--------------------CCC
Q 003156 605 VLGKARHPNL-----ISLEGYYWT--------PQLKLLVSDYAPNGSLQAKLHERLP--------------------STP 651 (843)
Q Consensus 605 ~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~ 651 (843)
++.+++|.++ ++++++|.. .+..++||||+++|+|.++++.... ...
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 8888876654 678888753 3467999999999999999975321 112
Q ss_pred CCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcc
Q 003156 652 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731 (843)
Q Consensus 652 ~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE 731 (843)
.++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+...... ......+++.|+|||
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE 380 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence 357788999999999999999998 9999999999999999999999999999765432211 112223468899999
Q ss_pred cccCcCC---------------------CCCchhHHHHHHHHHHHHhCCC-CCcCCCCchhhH-------HHHHHHHHhh
Q 003156 732 LTCQSLR---------------------VNEKCDIYGFGVLILELVTGRR-PVEYGEDNVVIL-------SEHVRVLLEE 782 (843)
Q Consensus 732 ~~~~~~~---------------------~~~~~Dv~S~Gvil~elltg~~-p~~~~~~~~~~l-------~~~~~~~~~~ 782 (843)
.+..... ...+.||||+||++|||++|.. |+.........+ ..|. . +..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-~-~~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-M-YKG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-h-hcc
Confidence 8743211 1234799999999999999875 664321111111 1111 0 011
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 003156 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIP---SSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P---~~RPs~~evl~~ 828 (843)
.. .+ .. ..........+++.+++..+| .+|+|++|+++|
T Consensus 459 ~~----~~--~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QK----YD--FS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cC----CC--cc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 10 01 11 122234567788889998765 789999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=267.04 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=204.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+++...+|-|+||.|-.+........+|+|.+++.... ...+....|-.+|...+.|.||+++..|.+....|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 44555799999999999998755555899988665432 2346678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
|-||.+-..++++ ..++......++..+.+|++|||.+ +||.||+||+|.++|.+|-+|+.|||+|+.+..+.
T Consensus 502 ClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 502 CLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999986 5688888889999999999999999 99999999999999999999999999999887655
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.. -+++||+.|.|||++... ..+.++|.||+|+++||+++|.+||..... ...+...++. +| .
T Consensus 575 KT---wTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkG----------id--~ 637 (732)
T KOG0614|consen 575 KT---WTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKG----------ID--K 637 (732)
T ss_pred ce---eeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhh----------hh--h
Confidence 43 568999999999998554 468899999999999999999999975422 2222212111 11 0
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 829 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~L 829 (843)
-.+|........++|++..+.+|.+|.- +.++.+|-
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 1356666777888999999999999976 66676654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=242.80 Aligned_cols=242 Identities=21% Similarity=0.296 Sum_probs=190.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+...++||+|+|+.|..+++..+.+.+|+|++++.-.. +...=.+.|-.+..+. +||.+|.+..++..+...++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 45567899999999999999989999999998654221 1222244566666555 79999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|++||+|--.++.. ..++++.+..+-..|..||.|||++ ||+.||+|.+|||+|..|.+|++|+|.++.--.
T Consensus 332 yv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~- 403 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG- 403 (593)
T ss_pred EecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence 99999997777654 4688899999999999999999999 999999999999999999999999999985322
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC------CchhhHHHHHHHHHhhCCcc
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE------DNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~------~~~~~l~~~~~~~~~~~~~~ 786 (843)
....+++++||+.|+|||++ .+..|....|.|++||+|+||+.|+.||+... ..++++.+. ..+...
T Consensus 404 -~gd~tstfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv---ilekqi-- 476 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV---ILEKQI-- 476 (593)
T ss_pred -CCcccccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH---Hhhhcc--
Confidence 22234778999999999988 67789999999999999999999999997521 112222221 111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 820 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP 820 (843)
..|.....+...++..-+.+||.+|.
T Consensus 477 --------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 --------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 12444455666788888999999985
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=287.11 Aligned_cols=385 Identities=26% Similarity=0.295 Sum_probs=247.8
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCC-CccccC-----------
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH-FSGDLD----------- 68 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~-i~~~~~----------- 68 (843)
|++|++|.|.+|.+. .+|.. |..+.+|+.|+++.|++..++.- +..++.+++++.++|. +.....
T Consensus 90 ~~~l~~lnL~~n~l~-~lP~~-~~~lknl~~LdlS~N~f~~~Pl~-i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n 166 (1081)
T KOG0618|consen 90 MRNLQYLNLKNNRLQ-SLPAS-ISELKNLQYLDLSFNHFGPIPLV-IEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLN 166 (1081)
T ss_pred hhcchhheeccchhh-cCchh-HHhhhcccccccchhccCCCchh-HHhhhHHHHHhhhcchhhhhhccccchhhhhhhh
Confidence 455666666666666 55654 46666666666666666544432 2334444444444441 100000
Q ss_pred CCcCccccCCccCCE-EecCCccCcccCchhhhcCCCCCEEEcCCCcc--------------------cccCCCCCCCCC
Q 003156 69 FASGYGIWSLKRLRT-LDLSHNLFSGSIPQGVAALHYLKELLLQGNQF--------------------SGPLPADIGFCP 127 (843)
Q Consensus 69 ~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l--------------------~~~~~~~~~~l~ 127 (843)
.+...-......|+. |||++|.+.. -.+..+.+|+.|....|++ +...+. ....
T Consensus 167 ~l~~~~~~~i~~l~~~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~--p~p~ 241 (1081)
T KOG0618|consen 167 VLGGSFLIDIYNLTHQLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH--PVPL 241 (1081)
T ss_pred hcccchhcchhhhheeeecccchhhh---hhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccc--cccc
Confidence 000000111223444 7888887761 1234444555555555544 422111 1235
Q ss_pred CCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEec
Q 003156 128 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 207 (843)
Q Consensus 128 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 207 (843)
+|+++|++.|+++. +|..+..+.+|+.|....|++. .+|..+...++|+.|.+.+|.++ .+|.....++.|++|+|.
T Consensus 242 nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 67777777777773 4477777777777777777775 66667777777777777777777 566677777788888888
Q ss_pred CCcCCCCCCchhhcc---CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcC
Q 003156 208 GNSLNGNIPEGLFDL---GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 284 (843)
Q Consensus 208 ~N~l~~~~p~~~~~~---~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 284 (843)
.|.|. .+|+.++.. .++.|+.+.|.+... | ......++.|+.|.+.+|.+++..-..+.++++|+.|+|+
T Consensus 319 ~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~l-p-----~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLs 391 (1081)
T KOG0618|consen 319 SNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTL-P-----SYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLS 391 (1081)
T ss_pred hcccc-ccchHHHhhhhHHHHHHhhhhcccccc-c-----cccchhhHHHHHHHHhcCcccccchhhhccccceeeeeec
Confidence 88876 666655443 366666666666422 2 1112345678888888888887766677788888888888
Q ss_pred CCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccC
Q 003156 285 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 364 (843)
Q Consensus 285 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 364 (843)
+|+|.......+.++..|++|+||+|+++ .+|..+..+..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...
T Consensus 392 yNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~ 468 (1081)
T KOG0618|consen 392 YNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVT 468 (1081)
T ss_pred ccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhh
Confidence 88887766667788888888888888888 67788888888888888888887 677 7888888888888888887433
Q ss_pred CccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccc
Q 003156 365 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 406 (843)
Q Consensus 365 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N 406 (843)
-..-..-++|++|||++|.-....-..|..+.++..++++-|
T Consensus 469 l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 469 LPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 222222378888888888754455666777777777777766
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=260.82 Aligned_cols=197 Identities=20% Similarity=0.352 Sum_probs=170.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cCh-----HHHHHHHHHHHhcc---CCCccceeeEEEcCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYP-----EDFEREVRVLGKAR---HPNLISLEGYYWTPQ 625 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~-----~~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 625 (843)
|...+.+|+|+||.|+.|.++.+...|+||.+.+++.- .+. ...-.|+++|..++ |+||+++++++.+++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 66777899999999999999988889999998765431 111 13457999999997 999999999999999
Q ss_pred eeEEEEEeC-CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 626 LKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 626 ~~~lV~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
.+||+||-. ++-+|.++|... +.+++.++..|++||+-|+++||+. +|||||||-+||.++.+|-+|++|||
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 999999976 455999999874 6789999999999999999999999 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCc
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~ 763 (843)
.+.....+.. ..+.||++|.|||++.+..+.+..-|||++|+++|.++....||.
T Consensus 716 saa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9976543322 567899999999999666666788999999999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=257.91 Aligned_cols=202 Identities=23% Similarity=0.379 Sum_probs=169.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.+.+.||-|+||+|..+.-..+...+|.|.+.+.+.. ......+.|-++|..-..+=||+++-.|.+.+..|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 44566899999999999988767778999998766532 2334567899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc----
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---- 709 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~---- 709 (843)
++||++-++|-.. ..+.+..+..++..++.|+++.|.. |+|||||||+|||||.+|.+||+|||+++-+
T Consensus 711 IPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999988875 4678888888899999999999998 9999999999999999999999999998532
Q ss_pred -----ccccc-------------------------------ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHH
Q 003156 710 -----TRLDK-------------------------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLIL 753 (843)
Q Consensus 710 -----~~~~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ 753 (843)
.+++. ........||..|+|||++ ....++..+|.||.|||+|
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-ARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-cccCccccchhhHhhHHHH
Confidence 11110 0011234689999999998 4456899999999999999
Q ss_pred HHHhCCCCCcCC
Q 003156 754 ELVTGRRPVEYG 765 (843)
Q Consensus 754 elltg~~p~~~~ 765 (843)
||+.|+.||...
T Consensus 863 em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 863 EMLVGQPPFLAD 874 (1034)
T ss_pred HHhhCCCCccCC
Confidence 999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=237.67 Aligned_cols=213 Identities=35% Similarity=0.524 Sum_probs=183.4
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHHH
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQA 641 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 641 (843)
||+|++|.||++....+++.+++|.+.........+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999777999999998655432234679999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-CCCcEEeeccCcccccccccceeccc
Q 003156 642 KLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVMSNR 720 (843)
Q Consensus 642 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~ 720 (843)
++.... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 998642 4588999999999999999999998 9999999999999998 89999999999986644321 1133
Q ss_pred cccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhh
Q 003156 721 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 800 (843)
Q Consensus 721 ~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 800 (843)
..+...|++||........+.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 45667899999874433778999999999999999
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 801 VLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 801 ~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.+++..|++.+|++||++.+++++
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 247789999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=238.03 Aligned_cols=257 Identities=24% Similarity=0.274 Sum_probs=192.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-cccChHHHHHHHHHHHhccCCCccceeeEEEcC------CeeE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QLKL 628 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 628 (843)
|...+.+|.|+- .|..|.+.-.++.||+|++.... .....+...+|...+..+.|+||++++.++.-. .+.|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 444556888888 78888887789999999985442 223446778999999999999999999998643 3468
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|||+| .++|...+... ++-.++..|..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|+.
T Consensus 98 ~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 98 LVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 999999 56888888843 67788899999999999999999 999999999999999999999999999986
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHH--------------
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE-------------- 774 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~-------------- 774 (843)
.... .+.+....|..|.|||++.+.+ +.+.+||||.||++.||++|+.-|.. ++.-+++-+
T Consensus 168 e~~~---~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g-~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 168 EDTD---FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPG-KDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cCcc---cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecC-chHHHHHHHHHHHhcCCCHHHHH
Confidence 4432 2335567788899999986655 99999999999999999999988863 222222211
Q ss_pred ----HHHHHHhhCCccc--ccCCCCCC--------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 775 ----HVRVLLEEGNVLD--CVDPSMGD--------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 775 ----~~~~~~~~~~~~~--~~d~~l~~--------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.++...+...... .+...+++ .+.-....+..++.+|+..+|++|.++++++.|
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111110000 00111111 122334456789999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=230.86 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=188.9
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeE-EEcCCee
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGY-YWTPQLK 627 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~ 627 (843)
++..+.|.+.+.+|+|.||.+-.++++.+.+.+++|.+..... ..++|.+|..---.+ .|.||+.-+++ +...+.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3456778889999999999999999999999999999866543 357899998765455 48999987765 4566788
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc--CCCCcEEeeccC
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGL 705 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl 705 (843)
++++||++.|+|.+-+... .+.+....+++.|+++|+.|||++ ++||||||.+|||+- +..+||+||||.
T Consensus 98 vF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 8999999999999888764 367778889999999999999999 999999999999994 556899999999
Q ss_pred cccccccccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
++..+..- .....+..|.|||... ......+.+|||.||+++|.++||..||......+..+.+|.+- .
T Consensus 170 t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w--~ 242 (378)
T KOG1345|consen 170 TRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW--L 242 (378)
T ss_pred ccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH--h
Confidence 97654211 2233456699999642 22346788999999999999999999998543333333333321 1
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHH
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAE 824 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~e 824 (843)
.+ ..+.++..-......++++.++-+..+|++|=...+
T Consensus 243 ~r-----k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 243 KR-----KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred cc-----cCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 11 112333322233445778888899999999933333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=261.59 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=204.9
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
.++...|+....+|.|.||.||++++..+++..|+|.++-.... ..+...+|+-+++..+|||||.++|-|...+..++
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 36777888889999999999999999999999999998654322 34556789999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
+||||.+|+|++.-+.. .++++.++..+.+...+|++|||+. +-+|||||-.||++++.|.+|++|||.+..+
T Consensus 90 cMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 99999999999988764 5788999999999999999999998 8899999999999999999999999998766
Q ss_pred cccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
.. .-.....+.||+.|||||+.. ..+.|...+|||+.|++..|+---+.|...... ..+-.+... .
T Consensus 163 ta--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTk----S 230 (829)
T KOG0576|consen 163 TA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTK----S 230 (829)
T ss_pred hh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhc----c
Confidence 43 222235678999999999763 234588999999999999999877777543211 011111111 1
Q ss_pred ccC-CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003156 788 CVD-PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 788 ~~d-~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~ 827 (843)
.++ +.+.+ ...-..-+.++++.|+-++|++|||++.+++
T Consensus 231 ~~qpp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 122 22222 3334455788999999999999999998765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=239.68 Aligned_cols=132 Identities=23% Similarity=0.277 Sum_probs=113.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-----C---CCccceeeEEEc--
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----H---PNLISLEGYYWT-- 623 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~-- 623 (843)
.+|.+.++||-|.|++||.+.+....+.||+|+.+... ...+....||++|++++ | .+||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 45777889999999999999999999999999986443 44567789999999994 2 479999999964
Q ss_pred --CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 624 --PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 624 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
+.++++|+|+. |.+|..+|.... ...++...+.+|+.||+.||.|||.+| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 778999998763 345788899999999999999999998 99999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=240.96 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=203.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 628 (843)
.+.|....+||+|.|++||++.+.. ..+.||+|.+.... .+.....|++++..+ .+.||+++.+++...+...
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3456677799999999999999976 67899999985543 457789999999999 4999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCcc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLAR 707 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~ 707 (843)
+|+||++..+-.++... ++...+..+++.+.+||+|+|.. |||||||||.|++.+ ..+.-.|.|||+|.
T Consensus 112 ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 99999999988888876 56788899999999999999999 999999999999998 66788999999997
Q ss_pred cccccc------c---------------------------ce---------eccccccccccCCcccccCcCCCCCchhH
Q 003156 708 LLTRLD------K---------------------------HV---------MSNRFQSALGYVAPELTCQSLRVNEKCDI 745 (843)
Q Consensus 708 ~~~~~~------~---------------------------~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv 745 (843)
..+... . +. ......||+||+|||++.....-+++.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321110 0 00 00123589999999999788888999999
Q ss_pred HHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH---------HhhCC--ccc---------------ccC-----C---
Q 003156 746 YGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL---------LEEGN--VLD---------------CVD-----P--- 791 (843)
Q Consensus 746 ~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~---------~~~~~--~~~---------------~~d-----~--- 791 (843)
||.||++.-+++++.||....++...+.+.+... ...+. +.+ -++ +
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999988766665554433211 11111 000 000 0
Q ss_pred ---CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 ---SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ---~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
......+..+..++++..+|+..||.+|.|++|++++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0001112223367899999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=232.36 Aligned_cols=200 Identities=33% Similarity=0.478 Sum_probs=170.2
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
..+.||+|++|.||+|....+++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 34579999999999999987789999999865433224578899999999999999999999999988999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
+|.+++.... ..+++..+..++.+++.++.|||+. +++|+|++|.||+++.++.++|+|||.+......... .
T Consensus 83 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 83 DLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 9999998752 1278999999999999999999998 9999999999999999999999999999876543210 1
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEY 764 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~ 764 (843)
.....++..|++||.......++.++||||||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 13345667899999874445677899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-29 Score=251.18 Aligned_cols=293 Identities=19% Similarity=0.180 Sum_probs=169.1
Q ss_pred EEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEe
Q 003156 6 FLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD 85 (843)
Q Consensus 6 ~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~ 85 (843)
..|.++-+++ +||..+ -+...+++|..|+|+.|++.+|+.+.+|+.||||+|.|+ .+.+.+|.+|.+|..|-
T Consensus 50 ~VdCr~~GL~-eVP~~L---P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is----~I~p~AF~GL~~l~~Lv 121 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANL---PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS----FIAPDAFKGLASLLSLV 121 (498)
T ss_pred eEEccCCCcc-cCcccC---CCcceEEEeccCCcccCChhhccchhhhceecccccchh----hcChHhhhhhHhhhHHH
Confidence 3455666676 677553 356677777788887787777877777777777777777 34455677777777766
Q ss_pred cCC-ccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc
Q 003156 86 LSH-NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 86 L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
+.+ |+|+....+.|.+|..|+.|.++-|++.-...+.|..+++|..|.+-+|.+..+.-.+|..+..++.+.++.|.+.
T Consensus 122 lyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i 201 (498)
T KOG4237|consen 122 LYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI 201 (498)
T ss_pred hhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc
Confidence 555 7777666677777777777777777777677777777777777777777777554557777777777777777632
Q ss_pred ------------ccCCCCccCCCCccEEEcccCCcCCCCCCCCCCC-CCCcEEEecCCcCCCCCCchhhc-c-Ccceeec
Q 003156 165 ------------GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFD-L-GLEEIDL 229 (843)
Q Consensus 165 ------------~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~-~-~L~~L~l 229 (843)
...|..++.+.-..-..+.++++..+-+..|... ..+..=-.+.+...+..|..-|. + +|++|+|
T Consensus 202 cdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnl 281 (498)
T KOG4237|consen 202 CDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNL 281 (498)
T ss_pred cccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEecc
Confidence 1223333333333333344444443322222211 11111011111122233333222 1 3444444
Q ss_pred cCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccC
Q 003156 230 SENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRN 309 (843)
Q Consensus 230 ~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 309 (843)
++|.+++.-+.++ ..+..+++|.|..|+|..+-...|.++..|++|+|.+|+|+...|.+|..+.+|.+|+|-.
T Consensus 282 snN~i~~i~~~aF------e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~ 355 (498)
T KOG4237|consen 282 SNNKITRIEDGAF------EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLS 355 (498)
T ss_pred CCCccchhhhhhh------cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehcc
Confidence 4444443322221 2234555666666666555555556666666666666666655566666666666666555
Q ss_pred Ccc
Q 003156 310 NAL 312 (843)
Q Consensus 310 n~l 312 (843)
|.+
T Consensus 356 Np~ 358 (498)
T KOG4237|consen 356 NPF 358 (498)
T ss_pred Ccc
Confidence 543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-27 Score=243.41 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=198.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc------CCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR------HPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~~~ 626 (843)
...|.+....|+|-|++|.+|.+...|..||||++...... .+.=+.|+++|+++. -.|+++++..|...++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34566667789999999999999888999999999765432 345578999999995 3589999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeeccC
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGL 705 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 705 (843)
.++|+|-+ .-+|.+.|+... ....+....+..++.|+.-||..|... +|+|.||||+|||+++. ...||||||.
T Consensus 509 LClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcc
Confidence 99999987 458999998864 345688889999999999999999987 99999999999999954 5689999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH-------H
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR-------V 778 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~-------~ 778 (843)
|....+.+. .....+..|.|||++ -+..|+...|+||.||++||+.||+.-|.....+. .+..++. .
T Consensus 584 A~~~~enei----tPYLVSRFYRaPEIi-LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 584 ASFASENEI----TPYLVSRFYRAPEII-LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-MLRLFMELKGKFPNK 657 (752)
T ss_pred ccccccccc----cHHHHHHhccCccee-ecCcccCCccceeeceeeEEeeccceecCCCCcHH-HHHHHHHhcCCCcHH
Confidence 987665332 223344569999998 56689999999999999999999999997643322 1111110 0
Q ss_pred HHhhCC---------------------------cccccCCC------CC---CCCh---hhHHHHHHHHHHccCCCCCCC
Q 003156 779 LLEEGN---------------------------VLDCVDPS------MG---DYPE---DEVLPVLKLALVCTCHIPSSR 819 (843)
Q Consensus 779 ~~~~~~---------------------------~~~~~d~~------l~---~~~~---~~~~~l~~l~~~c~~~~P~~R 819 (843)
+++.+. .+..+.|. +. .++. .....+..|+..|+..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 111111 11111121 00 0222 334457789999999999999
Q ss_pred CCHHHHHHH
Q 003156 820 PSMAEVVQI 828 (843)
Q Consensus 820 Ps~~evl~~ 828 (843)
.|..+++++
T Consensus 738 it~nqAL~H 746 (752)
T KOG0670|consen 738 ITVNQALKH 746 (752)
T ss_pred CCHHHHhcC
Confidence 999999876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=269.45 Aligned_cols=348 Identities=22% Similarity=0.273 Sum_probs=188.4
Q ss_pred CChhhhhcCCCCcEEEccCcccc------ccccccccCC-CCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCcc
Q 003156 18 VPYQLFENCASLRYLSLAGNILQ------GPIGKIFNYC-SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNL 90 (843)
Q Consensus 18 ~~~~~f~~l~~L~~L~L~~n~i~------~~~~~~f~~l-~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~ 90 (843)
+...+|.++++|+.|.+..+... ...+..|..+ .+|+.|++.+|.+...+.. | ...+|+.|++++|+
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~-----f-~~~~L~~L~L~~s~ 622 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSN-----F-RPENLVKLQMQGSK 622 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCc-----C-CccCCcEEECcCcc
Confidence 55666777777777777555321 1112224444 3577777777766654432 2 34667777777777
Q ss_pred CcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCC
Q 003156 91 FSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW 170 (843)
Q Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 170 (843)
+. .++..+..+++|+.|+|++|.....+|. +..+++|++|+|++|.....+|..+..+++|+.|++++|...+.+|..
T Consensus 623 l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 623 LE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG 700 (1153)
T ss_pred cc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc
Confidence 66 4556666677777777776653334443 666677777777776555566666677777777777766444455554
Q ss_pred ccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccc
Q 003156 171 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 250 (843)
Q Consensus 171 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~ 250 (843)
+ ++++|+.|+|++|.....+|.. .++|+.|++++|.+. .+|..+...+|..|++.++.... +.
T Consensus 701 i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~-l~----------- 763 (1153)
T PLN03210 701 I-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEK-LW----------- 763 (1153)
T ss_pred C-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhh-cc-----------
Confidence 4 5666777777666543344432 345666666666665 45544322244444444322110 00
Q ss_pred cCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEE
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 330 (843)
+.+....+..+...++|+.|++++|.....+|..++++++|+.|++++|...+.+|..+ .+++|+.|+
T Consensus 764 -----------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~ 831 (1153)
T PLN03210 764 -----------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLD 831 (1153)
T ss_pred -----------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEE
Confidence 00000111112223455555555555444455555555555555555544333445443 455666666
Q ss_pred cCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCC-cccccCCcchhcccccceEeecccc
Q 003156 331 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN-ELSGEIPQELGKLASLLAVNVSYNR 407 (843)
Q Consensus 331 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~l~ls~N~ 407 (843)
|++|.....+|.. .++|+.|+|++|.++ .+|.++..+++|++|+|++| ++. .+|..+..++.|+.+++++|.
T Consensus 832 Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 832 LSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 6655433333332 245666666666665 45666666666666666653 333 455555566666666666553
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-27 Score=240.58 Aligned_cols=386 Identities=20% Similarity=0.168 Sum_probs=260.0
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEEC-CCCCCccccCCCcCccccCCccC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNL-SNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~L-s~N~i~~~~~~~~~~~~~~l~~L 81 (843)
....++|..|+|+ .||+.+|+.+++|++|||++|+|+.|.+++|.++.+|.+|-+ ++|+|+.++ ..+|.+|..|
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~----k~~F~gL~sl 142 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP----KGAFGGLSSL 142 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh----hhHhhhHHHH
Confidence 3578999999999 999999999999999999999999999999999999998855 559999544 4579999999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCc------------ccccCCchhhc
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL------------FTGQLPVSLRL 149 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~------------l~~~~~~~~~~ 149 (843)
+.|.+.-|++.-+..+.|..+++|..|.+.+|.+..+.-..|..+..++++.+..|. +....|..++.
T Consensus 143 qrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsg 222 (498)
T KOG4237|consen 143 QRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSG 222 (498)
T ss_pred HHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccc
Confidence 999999999998888999999999999999999996666689999999999999998 22233444444
Q ss_pred ccCCcEEEeecCcccccCCCCccCC-CCc-cEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-Ccce
Q 003156 150 LNSMIFISVSNNTLTGDIPHWIGNI-STL-EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEE 226 (843)
Q Consensus 150 l~~L~~L~L~~N~l~~~~p~~~~~l-~~L-~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~ 226 (843)
..-..-..+.++++....+..|... ..+ ..+....+....-....|..+++|+.|+|++|+|+.+-+.+|.+. .+++
T Consensus 223 arc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~e 302 (498)
T KOG4237|consen 223 ARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQE 302 (498)
T ss_pred ceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhh
Confidence 4444333344444432222222111 011 011111111111111234444455555555555543333333333 3444
Q ss_pred eeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccC-----CCC--------
Q 003156 227 IDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS-----RIP-------- 293 (843)
Q Consensus 227 L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~~-------- 293 (843)
|.|..|++.. .....+..+..|+.|+|.+|+|+..-|..|..+..|.+|+|-.|.+.- |..
T Consensus 303 L~L~~N~l~~------v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~ 376 (498)
T KOG4237|consen 303 LYLTRNKLEF------VSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSV 376 (498)
T ss_pred hhcCcchHHH------HHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCC
Confidence 5555554431 111223446778888999999988888888888888998888877531 110
Q ss_pred ---CCccccccceEEEccCCccccc---CCcccc---------ccCCCcEE-EcCCCCCCCCchhhhcccCCCcEEeccc
Q 003156 294 ---PELGYFHSLIHLDLRNNALYGS---IPQEVC---------ESRSLGIL-QLDGNSLTGPIPQVIRNCTSLYLLSLSH 357 (843)
Q Consensus 294 ---~~~~~l~~L~~L~L~~n~l~~~---~~~~~~---------~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 357 (843)
..+..-..++.+.++.+.+... .|+..+ ..+-+.+. ..|++.++ .+|..+- ..-.+|++.+
T Consensus 377 ~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~g 453 (498)
T KOG4237|consen 377 VGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDG 453 (498)
T ss_pred CCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhccc
Confidence 1122333677777777665411 222221 12334433 34444454 6665443 3567899999
Q ss_pred ccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccc
Q 003156 358 NHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 406 (843)
Q Consensus 358 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N 406 (843)
|.++ .+|.. .+.+| .+||++|+|+..--..|.+++.|.+|-+|||
T Consensus 454 n~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 454 NAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred chhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 9999 78887 67888 9999999999777888999999999999987
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=266.17 Aligned_cols=339 Identities=19% Similarity=0.202 Sum_probs=218.3
Q ss_pred cccCCccCCEEecCCcc------CcccCchhhhcCC-CCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCch
Q 003156 74 GIWSLKRLRTLDLSHNL------FSGSIPQGVAALH-YLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS 146 (843)
Q Consensus 74 ~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 146 (843)
+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.++.++ .+|..| .+.+|+.|+|++|++. .++..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 34455555555554332 1122344444442 4666666665554 344444 3455666666666555 34444
Q ss_pred hhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcce
Q 003156 147 LRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEE 226 (843)
Q Consensus 147 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~ 226 (843)
+..+++|+.|+|++|.....+|+ ++.+++|++|+|++|.....+|..+.++++|+.|++++|.....+|......+|+.
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~ 708 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYR 708 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCE
Confidence 55566666666655543334443 55566666666666544445566666666666666666543335555443335666
Q ss_pred eeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCccc-------CCCCCCcccc
Q 003156 227 IDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR-------SRIPPELGYF 299 (843)
Q Consensus 227 L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~l 299 (843)
|++++|...+.+|.. .++|+.|+|++|.+. .+|..+ .+++|++|++.++... ...+..+...
T Consensus 709 L~Lsgc~~L~~~p~~---------~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 709 LNLSGCSRLKSFPDI---------STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred EeCCCCCCccccccc---------cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcc
Confidence 666666554444431 356788888888876 566554 5678888888774422 1122223345
Q ss_pred ccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEc
Q 003156 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 379 (843)
Q Consensus 300 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 379 (843)
++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 689999999998888899999999999999999986555788776 7999999999998665566653 468999999
Q ss_pred cCCcccccCCcchhcccccceEeecc-ccceecCCCCCCCCCCCCCCcCCCCCC
Q 003156 380 EFNELSGEIPQELGKLASLLAVNVSY-NRLIGRLPVGGVFPTLDQSSLQGNLGI 432 (843)
Q Consensus 380 ~~N~l~~~~p~~~~~l~~L~~l~ls~-N~l~~~~p~~~~~~~~~~~~~~~n~~~ 432 (843)
++|.|+ .+|..+..+++|+.|++++ |+|++..+....+..+....+.+...+
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L 906 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGAL 906 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCccc
Confidence 999998 7899999999999999999 556554444455666766666655433
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=215.64 Aligned_cols=249 Identities=22% Similarity=0.376 Sum_probs=188.4
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.+|.+...|+.|+|+|. |..+++|.+.-.+. ....++|..|.-.++-+.||||+.++|.|..+....++..||+.|+
T Consensus 196 tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 36889999999999994 66677787744332 2334689999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceec
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 718 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 718 (843)
|...+++. .....+-.++.++|.++|+|++|||+. .|-|.---+.+..|++|++..++|+ .+-+++.. ..
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf------qe 343 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF------QE 343 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee------ec
Confidence 99999986 456678889999999999999999987 5555556799999999999998885 12122111 01
Q ss_pred cccccccccCCcccccCcCC--CCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 719 NRFQSALGYVAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 719 ~~~~g~~~y~aPE~~~~~~~--~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
......+.||+||.+..... --.++|+|||++++||+.|+..||.....-+ -..+... +.+.+ ..
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme----cgmkial------eglrv---~i 410 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME----CGMKIAL------EGLRV---HI 410 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----hhhhhhh------ccccc---cC
Confidence 22233577999998844322 2357999999999999999999997642211 1111111 11111 23
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
|......+.++|.-|+..||.+||.+..++-.|+++.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 4555567788999999999999999999999998864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=211.87 Aligned_cols=168 Identities=23% Similarity=0.272 Sum_probs=127.3
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.++++.+ +..++|.+++.++.|+++||+|||+. + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence 7899999864 34699999999999999999999988 4 999999999999999 9999865431
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
...|++.|||||++ .+..++.++|||||||++|||+||+.||.........+....... .. .++.....
T Consensus 63 ---~~~g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~ 131 (176)
T smart00750 63 ---QSRVDPYFMAPEVI-QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM----PA---DDPRDRSN 131 (176)
T ss_pred ---cCCCcccccChHHh-cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh----cc---CCcccccc
Confidence 12578999999998 556789999999999999999999999965432222222221111 10 11110111
Q ss_pred ChhhHH--HHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 797 PEDEVL--PVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 797 ~~~~~~--~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
+..... ++.+++.+||..+|++|||+.|+++++..+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 222222 5899999999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=265.78 Aligned_cols=196 Identities=20% Similarity=0.198 Sum_probs=137.9
Q ss_pred ccC-CCccceeeEE-------EcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCe
Q 003156 609 ARH-PNLISLEGYY-------WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680 (843)
Q Consensus 609 l~h-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 680 (843)
++| +||+++++++ ......+.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 455 5788888877 2234567888987 66999999753 34589999999999999999999998 99
Q ss_pred eecCCCCCCEEEcC-------------------CCCcEEeeccCccccccccc--------c------eecccccccccc
Q 003156 681 IHYNLKPSNILLDD-------------------NYNPRISDFGLARLLTRLDK--------H------VMSNRFQSALGY 727 (843)
Q Consensus 681 vH~dlk~~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~~--------~------~~~~~~~g~~~y 727 (843)
+||||||+|||++. ++.+|++|||+++....... . .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776654221000 0 000123578889
Q ss_pred CCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHH
Q 003156 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKL 807 (843)
Q Consensus 728 ~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 807 (843)
||||++ .+..++.++|||||||++|||++|..|+..... .+..... . ...+. ......+...+
T Consensus 182 ~APE~~-~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~-----~----~~~~~----~~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEED-NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRH-----R----VLPPQ----ILLNWPKEASF 244 (793)
T ss_pred EChhhh-ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHH-----h----hcChh----hhhcCHHHHHH
Confidence 999988 455789999999999999999998887642111 1111100 0 01111 11112345678
Q ss_pred HHHccCCCCCCCCCHHHHHHH
Q 003156 808 ALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 808 ~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.+||+++|.+||||.|++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 899999999999999999876
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=241.95 Aligned_cols=266 Identities=27% Similarity=0.295 Sum_probs=139.8
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCE
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~ 83 (843)
-+.|+|++|+|+ .+|+.+. ++|+.|++++|+|+.++. .+++|++|+|++|+|+.++. ..++|+.
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~LtsLP~--------lp~sL~~ 266 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV--------LPPGLLE 266 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCcccC--------cccccce
Confidence 345666666666 5665432 356666666666665543 23556666666666554322 1245555
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcc
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 163 (843)
|+|++|.+. .+|.. +.+|+.|+|++|+|+. +|. .+++|+.|+|++|++++
T Consensus 267 L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~---------------------- 316 (788)
T PRK15387 267 LSIFSNPLT-HLPAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS---------------------- 316 (788)
T ss_pred eeccCCchh-hhhhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc----------------------
Confidence 566555555 23322 2345555555555552 222 12445555555555543
Q ss_pred cccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCC
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSS 243 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~ 243 (843)
+|... .+|+.|++++|++++ +|.. ..+|+.|+|++|+|+ .+|..
T Consensus 317 ---Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l------------------------- 360 (788)
T PRK15387 317 ---LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL------------------------- 360 (788)
T ss_pred ---CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccC-CCCCC-------------------------
Confidence 22211 234555555555552 3321 134555555555555 23321
Q ss_pred CCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCcccccc
Q 003156 244 SSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES 323 (843)
Q Consensus 244 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 323 (843)
..+|+.|++++|+|. .+|.. ..+|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|.. .
T Consensus 361 -------p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l---~ 421 (788)
T PRK15387 361 -------PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPML---P 421 (788)
T ss_pred -------Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcc---h
Confidence 122334444444444 23322 1345555555555553 2221 235666777777766 34543 2
Q ss_pred CCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCC
Q 003156 324 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL 371 (843)
Q Consensus 324 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 371 (843)
.+|+.|++++|+|+ .+|..|.++++|+.|+|++|+|++..|..+..+
T Consensus 422 ~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 422 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 35677788888887 677778888888888888888887777666433
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=243.32 Aligned_cols=260 Identities=31% Similarity=0.363 Sum_probs=144.5
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
-..|+|++|.++ .+|..+. .+|+.|++.+|+|+. +|. .+++|++|+|++|+|+.+ |.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccccceeeccC
Confidence 456677777666 4554443 356677777776663 333 245666666666666633 321 34566666666
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~ 240 (843)
|++. .+|..+ ++|+.|+|++|+++ .+|.. .++|+.|+|++|++++ +|..
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---------------------- 320 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---------------------- 320 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC----------------------
Confidence 6665 333322 34556666666666 33432 2456666666666652 3321
Q ss_pred CCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccc
Q 003156 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320 (843)
Q Consensus 241 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 320 (843)
..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+++ |.. ..+|+.|++++|+|+ .+|..
T Consensus 321 ----------p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~-~LP~l- 380 (788)
T PRK15387 321 ----------PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLT-SLPAL- 380 (788)
T ss_pred ----------cccccccccccCccc-ccccc---ccccceEecCCCccCCC-CCC---Ccccceehhhccccc-cCccc-
Confidence 123445555555554 23321 13555666666666542 221 134555666666666 34432
Q ss_pred cccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccce
Q 003156 321 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLA 400 (843)
Q Consensus 321 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 400 (843)
..+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.
T Consensus 381 --~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~ 449 (788)
T PRK15387 381 --PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETT 449 (788)
T ss_pred --ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCe
Confidence 2456666666666663 4432 245666777777766 355432 35666777777776 56666777777777
Q ss_pred EeeccccceecCC
Q 003156 401 VNVSYNRLIGRLP 413 (843)
Q Consensus 401 l~ls~N~l~~~~p 413 (843)
|+|++|+|+|.+|
T Consensus 450 LdLs~N~Ls~~~~ 462 (788)
T PRK15387 450 VNLEGNPLSERTL 462 (788)
T ss_pred EECCCCCCCchHH
Confidence 7777777776655
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=215.91 Aligned_cols=163 Identities=21% Similarity=0.209 Sum_probs=124.9
Q ss_pred hhhhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCC----cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSD----IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
..|+..+.||+|+||+||+|.+.. +++.||||++.... .....+.|.+|++++++++|+|+++.+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 446677899999999999999875 67888999875321 11124568999999999999999863322 24579
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCC-CCCCEEEcCCCCcEEeeccCcc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNL-KPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~ 707 (843)
+||||+++++|.. +... . ...++.|++++|+|||+. +|+|||| ||+|||++.++.+||+|||+++
T Consensus 95 LVmE~~~G~~L~~-~~~~---~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 95 LVRGWTEGVPLHL-ARPH---G-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEccCCCCHHH-hCcc---c-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 9999999999962 2110 1 146788999999999998 9999999 9999999999999999999998
Q ss_pred ccccccccee------ccccccccccCCcccc
Q 003156 708 LLTRLDKHVM------SNRFQSALGYVAPELT 733 (843)
Q Consensus 708 ~~~~~~~~~~------~~~~~g~~~y~aPE~~ 733 (843)
.+........ -....+++.|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 7654321111 1245677889999987
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-20 Score=202.95 Aligned_cols=263 Identities=19% Similarity=0.211 Sum_probs=194.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCC-eEEEEEEeecCCcccChHHHHHHHHHHHhccC----CCccceeeEE-EcCCeeE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDIIQYPEDFEREVRVLGKARH----PNLISLEGYY-WTPQLKL 628 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~ 628 (843)
.|+..+.||+|+||.||.|....++ ..+|+|........... .+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 5677889999999999999987553 57888887554333222 67889999988863 6888888888 4777889
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-----CCcEEeec
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-----YNPRISDF 703 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Df 703 (843)
+||+.. |.+|.+...... ...++..+...|+.|++.+|+++|+. |++||||||.|+++... ..+++.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 779999776553 46799999999999999999999999 99999999999999854 46999999
Q ss_pred cCcc--ccccccc----cee--ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHH
Q 003156 704 GLAR--LLTRLDK----HVM--SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775 (843)
Q Consensus 704 gl~~--~~~~~~~----~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~ 775 (843)
|+++ .+..... ... .....||..|+++... .+...+.+.|+||++.++.|+..|..||........ ...
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~ 248 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSK 248 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHh-CCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHH
Confidence 9998 3321111 111 1345699999999988 666789999999999999999999999966543222 111
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
+........ ... .....+..+.+++..+-..+..++|....+...++....+
T Consensus 249 ~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 FEKDPRKLL----TDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHhhhhc----ccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 111111100 000 1222334556666666668999999999999988765443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-22 Score=227.63 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=122.2
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCE
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~ 83 (843)
.+.|+|++++++ .+|..+ .++|+.|+|++|+|..++...+ ++|++|+|++|++++++.. + ..+|+.
T Consensus 180 ~~~L~L~~~~Lt-sLP~~I---p~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~LtsLP~~-----l--~~~L~~ 245 (754)
T PRK15370 180 KTELRLKILGLT-TIPACI---PEQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTSIPAT-----L--PDTIQE 245 (754)
T ss_pred ceEEEeCCCCcC-cCCccc---ccCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccccCChh-----h--hccccE
Confidence 455555555555 455432 2345555555555555544332 3455555555555533221 1 124555
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcc
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 163 (843)
|+|++|++. .+|..+. .+|+.|+|++|+|+ .+|..+ . .+|+.|++++|++
T Consensus 246 L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l------------------------~--~sL~~L~Ls~N~L 295 (754)
T PRK15370 246 MELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENL------------------------P--EELRYLSVYDNSI 295 (754)
T ss_pred EECcCCccC-cCChhHh--CCCCEEECcCCccC-cccccc------------------------C--CCCcEEECCCCcc
Confidence 555555554 3333332 24455555555444 233322 2 2455555555555
Q ss_pred cccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCC
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSS 243 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~ 243 (843)
+ .+|..+. ++|+.|+|++|.++. +|..+. ++|+.|++++|.+++ +|..+
T Consensus 296 t-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l------------------------ 344 (754)
T PRK15370 296 R-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASL------------------------ 344 (754)
T ss_pred c-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhh------------------------
Confidence 4 2333222 356666777776663 444332 467777777776662 33221
Q ss_pred CCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccc---
Q 003156 244 SSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV--- 320 (843)
Q Consensus 244 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~--- 320 (843)
.++|+.|++++|+|+ .+|..+. ++|+.|++++|.|+.+ |..+. ..|+.|++++|+|+ .+|..+
T Consensus 345 -------~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~ 410 (754)
T PRK15370 345 -------PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNL-PENLP--AALQIMQASRNNLV-RLPESLPHF 410 (754)
T ss_pred -------cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCcc-cCchhHHHH
Confidence 134666666666665 3454332 4566666666666543 32222 24666666666665 334322
Q ss_pred -cccCCCcEEEcCCCCCC
Q 003156 321 -CESRSLGILQLDGNSLT 337 (843)
Q Consensus 321 -~~l~~L~~L~Ls~N~l~ 337 (843)
..++++..|+|.+|.++
T Consensus 411 ~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 411 RGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred hhcCCCccEEEeeCCCcc
Confidence 22355556666666555
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=229.58 Aligned_cols=257 Identities=16% Similarity=0.170 Sum_probs=189.7
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeec----CCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVT----SDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
..+.+|.|++|.|+.+......+..+.|.... ... ......+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 34579999999888888766666666665431 111 1111225567777788899999988888777666666699
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
||++ +|...+... ..+...++..++.|+..|+.|+|+. ||.|||+|++|++++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999999874 3577788899999999999999999 9999999999999999999999999998765443
Q ss_pred ccc--eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 713 DKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 713 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......|+-.|+|||+......-....||||.|+++..|.+|+.||............. ...++.. +.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~~~~--~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSDQRN--IF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----ccccccc--cc
Confidence 332 344677888999999998555444567899999999999999999998764443322000 0000000 00
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..........+.+...+|.++++.+|.+|.|+++|++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00111234455567789999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-20 Score=198.82 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=197.0
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCC-CccceeeEEEcCCeeEEEEEe
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHP-NLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~ 633 (843)
+..+.||.|+||.||++.+. ..+|+|.+....... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred eeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 44568999999999999986 788999986655443 367899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRL 712 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 712 (843)
+.++++.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777664211 3688889999999999999999998 899999999999999888 7999999999865443
Q ss_pred ccce----eccccccccccCCcccccCc--CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc--hhhHHHHHHHHHhhCC
Q 003156 713 DKHV----MSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--VVILSEHVRVLLEEGN 784 (843)
Q Consensus 713 ~~~~----~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--~~~l~~~~~~~~~~~~ 784 (843)
.... ......|+..|+|||..... ..++...|+||+|++++++++|..||...... .......+ ....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH----HhcC
Confidence 3221 23567889999999988443 57889999999999999999999997554321 11111111 1111
Q ss_pred cccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ....... .........+.+++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000000 0012223567889999999999999999987765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=225.20 Aligned_cols=266 Identities=24% Similarity=0.433 Sum_probs=154.8
Q ss_pred ccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEe
Q 003156 79 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 158 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 158 (843)
.+...|+++++.++ .+|..+. ++|+.|+|++|.|+. +|..+. ++|++|++++|+++. +|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence 34566777777776 3454332 467777777777773 444332 467777777777763 444432 36777777
Q ss_pred ecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecC
Q 003156 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238 (843)
Q Consensus 159 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~ 238 (843)
++|++. .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|.++ .+|..+. .+|+.|++++|.+
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp-~sL~~L~Ls~N~L---- 316 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP-SGITHLNVQSNSL---- 316 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch-hhHHHHHhcCCcc----
Confidence 777776 4555443 46888888888887 4566554 47888888888877 3443321 1344444444444
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 318 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 318 (843)
+ .+|..+ .++|++|++++|.+++ +|..+. ++|+.|++++|+|+ .+|.
T Consensus 317 --------------------------t-~LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~ 363 (754)
T PRK15370 317 --------------------------T-ALPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPE 363 (754)
T ss_pred --------------------------c-cCCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCCh
Confidence 3 222222 1345555555555543 232221 45666666666665 3454
Q ss_pred cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccc----cCCCCCCEEEccCCcccccCCcchhc
Q 003156 319 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI----SNLNKLKILKLEFNELSGEIPQELGK 394 (843)
Q Consensus 319 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~ 394 (843)
.+ .++|+.|+|++|.|+ .+|..+. ..|+.|++++|+|+ .+|..+ +.++++..|+|.+|.|+. ..
T Consensus 364 ~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~t 431 (754)
T PRK15370 364 TL--PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RT 431 (754)
T ss_pred hh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HH
Confidence 44 246777777777777 4455443 35777777777777 455543 344777888888888762 23
Q ss_pred ccccceEeeccccceec
Q 003156 395 LASLLAVNVSYNRLIGR 411 (843)
Q Consensus 395 l~~L~~l~ls~N~l~~~ 411 (843)
+.+|+.+ ++.|.+.|.
T Consensus 432 l~~L~~L-l~s~~~~gp 447 (754)
T PRK15370 432 IQNMQRL-MSSVGYQGP 447 (754)
T ss_pred HHHHHHh-hhcccccCC
Confidence 3444444 344444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=207.35 Aligned_cols=218 Identities=28% Similarity=0.376 Sum_probs=165.7
Q ss_pred HhccCCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCe-eecCC
Q 003156 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI-IHYNL 685 (843)
Q Consensus 607 ~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vH~dl 685 (843)
+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...++|.....+.+++++||+|+|.. +| .|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 5678999999999999999999999999999999999884 56799999999999999999999987 55 99999
Q ss_pred CCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCc--CC----CCCchhHHHHHHHHHHHHhCC
Q 003156 686 KPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS--LR----VNEKCDIYGFGVLILELVTGR 759 (843)
Q Consensus 686 k~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~----~~~~~Dv~S~Gvil~elltg~ 759 (843)
+++|+++|....+|++|||+....................-|.|||.+... .. .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998876531111111222234569999987442 11 467899999999999999999
Q ss_pred CCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 760 RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 760 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.||......... .+.+.. ++. .....+-|.+.... +....+..++.+||..+|++||++++|-..++.+..
T Consensus 156 ~~~~~~~~~~~~-~eii~~-~~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-DEIILR-VKK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCCh-HHHHHH-HHh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999875333221 122221 111 11122233332211 334468899999999999999999999988877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=174.54 Aligned_cols=261 Identities=15% Similarity=0.178 Sum_probs=189.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC-CCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e 632 (843)
..|...++||+|+||.+|.|....+|+.||+|.-.... ..-.+..|..+.+.+++ ..|..+.-|..+.....+|||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34667789999999999999999999999999853322 12357789999999975 677777777778888899999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc---CCCCcEEeeccCcccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLL 709 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~ 709 (843)
.. |-+|.+...-. ...++..+++..|-|+..-++|+|.+ ++|||||||+|+|.. ....+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 77999888765 34588899999999999999999999 999999999999997 3345899999999987
Q ss_pred cccccc-----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 710 TRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 710 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
-+.... .......||.+|.+--.. -+..-+.+.|+-|+|.++...--|..||......... +..+. +.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh-~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~--QKyEk-I~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAH-LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK--QKYEK-ISEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhh-hhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH--HHHHH-HHHhh
Confidence 543321 122345688889876654 2334578899999999999999999999875433211 11111 11111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
.. ..+.......+.++.-.+.-|-..--++-|...-+-+.++.+
T Consensus 241 ~s----~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 241 MS----TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred cC----CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 11 111112233344566777888888888888877766655443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-21 Score=215.85 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=176.8
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHH--HHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV--LGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
..+.+|++.|=+|.+|++. .|. |+||++.+.+..-..+.|.++++- ...++|||++++.-+-......|+|-+|..
T Consensus 27 ~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 3457999999999999996 565 999999776644344555444333 444589999999877777777788888874
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc--cccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL--TRLD 713 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~--~~~~ 713 (843)
+ +|.|.+..+ +-+...+...||+|++.|+...|.. +|+|||||.+|||++...-+.|+||.--+-. +++.
T Consensus 105 h-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 105 H-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 4 777777654 6788888999999999999999998 9999999999999999999999999866532 2221
Q ss_pred ccee---ccccccccccCCcccccCcC----------CCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHH
Q 003156 714 KHVM---SNRFQSALGYVAPELTCQSL----------RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 714 ~~~~---~~~~~g~~~y~aPE~~~~~~----------~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~ 779 (843)
.... -.+-..-.+|.|||.+.... ..+++.||||.||++.|+++ |++||... ++..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~a----- 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLA----- 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHh-----
Confidence 1111 11112224699999875422 15678999999999999988 67777421 1110
Q ss_pred HhhCCcccccCCC--CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 780 LEEGNVLDCVDPS--MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 780 ~~~~~~~~~~d~~--l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
++.+. ..|+. +...+. ..+..++..|++.||++|.++++.++.-+++.
T Consensus 247 Yr~~~---~~~~e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 247 YRSGN---ADDPEQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HhccC---ccCHHHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11110 00000 000011 14778999999999999999999999865543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=177.39 Aligned_cols=261 Identities=13% Similarity=0.106 Sum_probs=192.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|.++++||+|.||+++.|+..-+++.||||.-.... ..-++..|....+.+. .++|...+-+-.++-+-.+|+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3677889999999999999998899999999754332 2345778888888884 68998888777777778899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-----CCcEEeeccCccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-----YNPRISDFGLARL 708 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfgl~~~ 708 (843)
. |-+|.|...-. +..++..++..+|.|+..-++|+|++ .+|.|||||+|+||... ..+.|.|||+|+.
T Consensus 106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 77999988765 46799999999999999999999999 99999999999999743 4589999999998
Q ss_pred cccccc-----ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 709 LTRLDK-----HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 709 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
+-+... +.......||.+||+--.. -+..-+.+-|.-|+|-+++..+-|..||...+.+.. .+..+ .+.+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTH-lGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--K~kYe-KIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--KEKYE-KIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecc-ccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--HHHHH-Hhccc
Confidence 754332 1123456799999998877 445678899999999999999999999987543211 01111 11111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
.....+ ....+..+.++..-+.-.-+.+-++-|..+-+..-+..+.
T Consensus 255 Kr~T~i----~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 255 KRSTPI----EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred cccCCH----HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 111111 1122334445556666666677788888877666555443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=179.80 Aligned_cols=139 Identities=19% Similarity=0.192 Sum_probs=108.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccc-C-------hHH-----------------HHHHHHHHHhccCCCc
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-Y-------PED-----------------FEREVRVLGKARHPNL 614 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~-------~~~-----------------~~~E~~~l~~l~h~ni 614 (843)
..||+|+||.||+|... +|+.||||++....... . ... ...|++.+.++.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 47999999999999997 89999999986542110 1 011 2349999999988877
Q ss_pred cceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhh-hhcCCCCeeecCCCCCCEEEc
Q 003156 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 615 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~Nill~ 693 (843)
.....+... ..++||||++++++....... ..+++.....++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 544333222 238999999988776543222 3578899999999999999999 676 999999999999998
Q ss_pred CCCCcEEeeccCcccc
Q 003156 694 DNYNPRISDFGLARLL 709 (843)
Q Consensus 694 ~~~~~kl~Dfgl~~~~ 709 (843)
++.++++|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.5e-19 Score=172.78 Aligned_cols=139 Identities=24% Similarity=0.248 Sum_probs=110.6
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccc--------------------C-----hHHHHHHHHHHHhccCCCc
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--------------------Y-----PEDFEREVRVLGKARHPNL 614 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~E~~~l~~l~h~ni 614 (843)
+.||+|+||.||+|... +|+.||||.+....... . ...+..|.+.+.++.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 47999999999999987 89999999986542110 0 1123578999999999988
Q ss_pred cceeeEEEcCCeeEEEEEeCCCCCHHHH-HhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCEEE
Q 003156 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAK-LHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 615 v~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill 692 (843)
.....+.... .++||||++++++... +.. ..++..+...++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 6555444332 4899999998865443 332 346778889999999999999999 7 99999999999999
Q ss_pred cCCCCcEEeeccCccccc
Q 003156 693 DDNYNPRISDFGLARLLT 710 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~ 710 (843)
+ ++.++|+|||+++...
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=183.15 Aligned_cols=235 Identities=21% Similarity=0.259 Sum_probs=150.8
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhcc----------CCCccceeeEEEcC
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKAR----------HPNLISLEGYYWTP 624 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~----------h~niv~l~g~~~~~ 624 (843)
.+.+.||.|+++.||.+++..+|+++|||.+...... ...+++.+|.-....+. |-.++..++....+
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3456899999999999999999999999998655422 23456777776655532 22233333332211
Q ss_pred ------------C-----eeEEEEEeCCCCCHHHHHhh---cCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecC
Q 003156 625 ------------Q-----LKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYN 684 (843)
Q Consensus 625 ------------~-----~~~lV~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d 684 (843)
. ..+++|+-+ .+||.+++.. .......+....++.+..|+.+.+++||+. |+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 1 125678777 5688877553 321222344556677779999999999999 999999
Q ss_pred CCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCc-------CCCCCchhHHHHHHHHHHHHh
Q 003156 685 LKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS-------LRVNEKCDIYGFGVLILELVT 757 (843)
Q Consensus 685 lk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~Dv~S~Gvil~ellt 757 (843)
|+|+|++++.+|.++++||+.....+... . . ...+..|.+||..... ..++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE---E-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee---e-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999998776544311 1 1 3344779999965332 347889999999999999999
Q ss_pred CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCC
Q 003156 758 GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR 819 (843)
Q Consensus 758 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~R 819 (843)
|+.||.......... ....... +.++.+..||..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999997542211100 0122223 677889999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=178.44 Aligned_cols=171 Identities=14% Similarity=0.122 Sum_probs=128.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHH------HHHHHHHHHhccCCCccceeeEEEcC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPED------FEREVRVLGKARHPNLISLEGYYWTP 624 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~niv~l~g~~~~~ 624 (843)
...|...+.+|.|+||.||.+.. ++..+|+|.+....... ..+. +.+|+..+.+++||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 34466677899999999999765 46789999986543221 1112 67899999999999999999886643
Q ss_pred --------CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 625 --------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 625 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
...++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 24789999999999987732 222 2456899999999999 999999999999999888
Q ss_pred CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHH
Q 003156 697 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELV 756 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ell 756 (843)
++++|||..+....... . +.+.....+..++|+||||+++.-..
T Consensus 173 -i~liDfg~~~~~~e~~a-~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA-K--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhh-H--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999998875432110 0 11112334667999999999987553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=169.20 Aligned_cols=187 Identities=17% Similarity=0.140 Sum_probs=137.9
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccC---hHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY---PEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
...|++|+||+||.+.. .+.+++.+.+........ ...|.+|+++++++. |+++.+++++ +..+++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 34799999999997665 677888777754432111 125789999999995 5889999886 3468999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCC-CCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNL-KPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+|.+|...+.. ....++.|++.++.++|+. +|+|||| ||.||+++.++.++|+|||++....+..
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998654321 1135778999999999999 9999999 7999999999999999999998554322
Q ss_pred cc----e-------eccccccccccCCcccccCcCCCC-CchhHHHHHHHHHHHHhCCCCCcCC
Q 003156 714 KH----V-------MSNRFQSALGYVAPELTCQSLRVN-EKCDIYGFGVLILELVTGRRPVEYG 765 (843)
Q Consensus 714 ~~----~-------~~~~~~g~~~y~aPE~~~~~~~~~-~~~Dv~S~Gvil~elltg~~p~~~~ 765 (843)
.. . .......++.|++|+...--...+ ...+.++-|.-+|.++|++.+....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0 011223566788887542222333 5678899999999999999887543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-21 Score=171.08 Aligned_cols=176 Identities=27% Similarity=0.399 Sum_probs=155.9
Q ss_pred cCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEE
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 330 (843)
++.++.|.|++|+++ .+|..+..+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|.+|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 567888999999998 77888999999999999999998 57889999999999999999998 8999999999999999
Q ss_pred cCCCCCCC-CchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccce
Q 003156 331 LDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 331 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 409 (843)
|.+|++.. .+|..|..++.|+.|+|++|.+. .+|..+++|++|+.|.+..|.+- .+|.+++.|..|++|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 99999864 68999999999999999999998 89999999999999999999998 89999999999999999999999
Q ss_pred ecCCCCCCCCCC---CCCCcCCCCC
Q 003156 410 GRLPVGGVFPTL---DQSSLQGNLG 431 (843)
Q Consensus 410 ~~~p~~~~~~~~---~~~~~~~n~~ 431 (843)
-.+|+.+.+... .....+.|||
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPw 211 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPW 211 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCC
Confidence 988876554332 2333455655
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.2e-19 Score=176.92 Aligned_cols=197 Identities=21% Similarity=0.287 Sum_probs=138.1
Q ss_pred cCCCccceeeEEEcC---------------------------CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHH
Q 003156 610 RHPNLISLEGYYWTP---------------------------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 662 (843)
Q Consensus 610 ~h~niv~l~g~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 662 (843)
+|||||+++++|.+. ...|+||...+ .+|..++..+ ..+......|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence 599999999877532 34589998874 4888888765 24556677789
Q ss_pred HHHHHHHHhhhhcCCCCeeecCCCCCCEEEc--CCCC--cEEeeccCcccccc----cccceeccccccccccCCccccc
Q 003156 663 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYN--PRISDFGLARLLTR----LDKHVMSNRFQSALGYVAPELTC 734 (843)
Q Consensus 663 ~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~--~kl~Dfgl~~~~~~----~~~~~~~~~~~g~~~y~aPE~~~ 734 (843)
.|+++|+.|||.+ +|.|||+|++|||+. +|+. ..|+|||++---.. ...........|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999994 5544 56789998732111 01111112334566789999873
Q ss_pred CcCC-----CCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHH
Q 003156 735 QSLR-----VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLAL 809 (843)
Q Consensus 735 ~~~~-----~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~ 809 (843)
.... -..|+|.|+.|.+.||+++...||+...+ ..+.. +. +. ...++..++.++..+.+++.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~--r~-Yq--------e~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDT--RT-YQ--------ESQLPALPSRVPPVARQLVF 491 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heech--hh-hh--------hhhCCCCcccCChHHHHHHH
Confidence 3211 13589999999999999999999975211 00100 00 11 12244567777888899999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 003156 810 VCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 810 ~c~~~~P~~RPs~~evl~~ 828 (843)
..++.||.+|++..=....
T Consensus 492 ~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHhcCCccccCCccHHHhH
Confidence 9999999999997654433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-20 Score=202.69 Aligned_cols=109 Identities=27% Similarity=0.332 Sum_probs=66.7
Q ss_pred ccceEEEccCCccccc----CCccccccCCCcEEEcCCCCCCCCchhhhcc-----cCCCcEEeccccccc----ccCCc
Q 003156 300 HSLIHLDLRNNALYGS----IPQEVCESRSLGILQLDGNSLTGPIPQVIRN-----CTSLYLLSLSHNHLS----GSIPK 366 (843)
Q Consensus 300 ~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~----~~~p~ 366 (843)
++|+.|++++|.+++. +...+..+++|+.|++++|.+++.....+.. .+.|+.|++++|.++ ..+..
T Consensus 193 ~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~ 272 (319)
T cd00116 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAE 272 (319)
T ss_pred CCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHH
Confidence 3455555555544322 2334455677777777777777533333332 367888888888776 22344
Q ss_pred cccCCCCCCEEEccCCccccc----CCcchhcc-cccceEeeccccc
Q 003156 367 SISNLNKLKILKLEFNELSGE----IPQELGKL-ASLLAVNVSYNRL 408 (843)
Q Consensus 367 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~l~ls~N~l 408 (843)
.+..+++|++|++++|.++.. +...+... +.|+++++.+|++
T Consensus 273 ~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 273 VLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 556667888888888888744 33344444 5778888877754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-19 Score=192.57 Aligned_cols=226 Identities=23% Similarity=0.286 Sum_probs=177.4
Q ss_pred eccccceEEEEEEE---CCCCeEEEEEEeecCCccc-ChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 562 VGEGVFGTVYKVSF---GTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 562 ig~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+|+|+||.|+.++- ...|..+|+|..++..... .......|-.++...+ ||.+|++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999986543 2246778888876543322 1124556888888886 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|++...+... ..++..........+|-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-+...
T Consensus 82 g~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 82 GDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred chhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9998888764 4567777778888999999999999 999999999999999999999999999986543222
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
.+||..|||||++. ....++|.||||++++||+||..||.. + ..+.+... -..+
T Consensus 153 ----~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-----~----~~~~Il~~----------~~~~ 206 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-----D----TMKRILKA----------ELEM 206 (612)
T ss_pred ----cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-----H----HHHHHhhh----------ccCC
Confidence 28899999999984 357889999999999999999999965 1 11111110 1134
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSM 822 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~ 822 (843)
|.+....+..++..+...+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 66666777788888888888888655
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-20 Score=197.71 Aligned_cols=208 Identities=28% Similarity=0.287 Sum_probs=130.5
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCcccccc----ccccccCCCCCCEEECCCCCCccccC--CCcCccccCC
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGP----IGKIFNYCSSLNTLNLSNNHFSGDLD--FASGYGIWSL 78 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~----~~~~f~~l~~L~~L~Ls~N~i~~~~~--~~~~~~~~~l 78 (843)
+.|+|.++++++.--...|..+.+|+.|++++|.+... ....+...++|++|+++++.+.+... ...+..+..+
T Consensus 1 ~~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 1 LQLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred CccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 36889999998544456788899999999999998532 23345677889999999988763111 0111245567
Q ss_pred ccCCEEecCCccCcccCchhhhcCCC---CCEEEcCCCcccc----cCCCCCCCC-CCCcEEEccCCccccc----CCch
Q 003156 79 KRLRTLDLSHNLFSGSIPQGVAALHY---LKELLLQGNQFSG----PLPADIGFC-PHLTTLDLSNNLFTGQ----LPVS 146 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~ 146 (843)
++|+.|++++|.+....+..+..+.+ |++|++++|.+++ .+...+..+ ++|+.|++++|.+++. .+..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 78888888888887555666655555 8888888887762 222334455 7778888888877732 2234
Q ss_pred hhcccCCcEEEeecCccccc----CCCCccCCCCccEEEcccCCcCCC----CCCCCCCCCCCcEEEecCCcCC
Q 003156 147 LRLLNSMIFISVSNNTLTGD----IPHWIGNISTLEFLDFSNNHLTGS----LPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 147 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+..+++|+.|++++|.+++. ++..+..+++|++|+|++|.+++. +...+..+++|++|++++|.++
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 45555666677766666531 222333445666666666665432 2233444555666666655554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=162.73 Aligned_cols=135 Identities=17% Similarity=0.184 Sum_probs=105.4
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-----cCCCccceeeEEEcCC---eeE-E
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-----RHPNLISLEGYYWTPQ---LKL-L 629 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~~~-l 629 (843)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++. ..+ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 45899999999995 6545554 799886543 23456799999999999 5799999999998863 333 7
Q ss_pred EEEe--CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHH-HhhhhcCCCCeeecCCCCCCEEEcC----CCCcEEee
Q 003156 630 VSDY--APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL-AHLHHSFRPPIIHYNLKPSNILLDD----NYNPRISD 702 (843)
Q Consensus 630 V~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~D 702 (843)
|+|| +++|+|.+++... .+++. ..++.+++.++ +|||++ +||||||||+||+++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5589999999653 24444 35677888787 999999 9999999999999973 34799999
Q ss_pred ccCcc
Q 003156 703 FGLAR 707 (843)
Q Consensus 703 fgl~~ 707 (843)
|+-++
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 54443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=190.47 Aligned_cols=194 Identities=20% Similarity=0.295 Sum_probs=154.3
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc---CCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR---HPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~ 631 (843)
.+.+.+.||+|+||+||+|... +|+.||+|+-+....++. .-=.+++.+++ -+.|+.+...+.-.+..++|+
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~-~~~~~alK~e~P~~~WEf----YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHS-NGKLVALKVEKPPNPWEF----YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eEEEEeeeccccceEEEEeecC-CCcEEEEEeecCCCceee----eehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 3455668999999999999998 499999999876665532 22233344444 345666666666677789999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-------CCCCcEEeecc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-------DNYNPRISDFG 704 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~Dfg 704 (843)
||.+.|||.+++.. ...++|.-.+.+..|+++.+++||.. +|||+||||+|+|+. +...++|+|||
T Consensus 774 ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 774 EYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999984 36789999999999999999999998 999999999999994 33458999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p 761 (843)
.+-.+.-..+...-...++|-++-.+|+. .+..++.+.|.|.++.+++-|+.|+.-
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99766433333223456778889999987 788899999999999999999998653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9e-20 Score=163.06 Aligned_cols=157 Identities=31% Similarity=0.503 Sum_probs=108.8
Q ss_pred cCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCccc-ccCCccccccCCCcEE
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY-GSIPQEVCESRSLGIL 329 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L 329 (843)
+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. +.|..|+.++.|+.|||.+|.+. ..+|..|..++.|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 445555555555555 55556666666666666666664 45666666666666666666665 3467777778888888
Q ss_pred EcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccc---cceEeeccc
Q 003156 330 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLAS---LLAVNVSYN 406 (843)
Q Consensus 330 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~l~ls~N 406 (843)
+|+.|.++ .+|..++++++|+.|.+..|.+- .+|..++.|..|+.|.+++|+++ .+|.+++++.- -+.+.+..|
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~N 209 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEEN 209 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhC
Confidence 88888887 77777888888888888888877 67888888888888888888887 67777766542 245566777
Q ss_pred cceecC
Q 003156 407 RLIGRL 412 (843)
Q Consensus 407 ~l~~~~ 412 (843)
++...|
T Consensus 210 Pwv~pI 215 (264)
T KOG0617|consen 210 PWVNPI 215 (264)
T ss_pred CCCChH
Confidence 765443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=162.11 Aligned_cols=144 Identities=19% Similarity=0.179 Sum_probs=110.0
Q ss_pred hhhhcCeeccccceEEEEEE-ECCCCeEEEEEEeecCCccc-----------------------ChHHHHHHHHHHHhcc
Q 003156 555 LLEKAAEVGEGVFGTVYKVS-FGTQGRMLAVKKLVTSDIIQ-----------------------YPEDFEREVRVLGKAR 610 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 610 (843)
.|+..+.||+|+||.||+|. ...+|+.||+|.+....... ....+.+|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35667789999999999998 55689999999986542100 0123568999999997
Q ss_pred CCC--ccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC-eeecCCCC
Q 003156 611 HPN--LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP-IIHYNLKP 687 (843)
Q Consensus 611 h~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~ 687 (843)
+.. +.+++++ ...++||||++++++....... ......+...++.|++.++.|||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 3344432 2348999999998887654322 2345566788999999999999998 8 99999999
Q ss_pred CCEEEcCCCCcEEeeccCccccc
Q 003156 688 SNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 688 ~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
+||+++ ++.++++|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-16 Score=158.21 Aligned_cols=135 Identities=22% Similarity=0.349 Sum_probs=113.8
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccc-------ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.||+|++|.||+|.+ .|..|++|+........ ....+.+|+.++..++|+++.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 4689999999999998 67789999865332111 12357789999999999999888888777778899999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
|++|++|.+++... .+ .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998753 11 7789999999999999998 999999999999999 78899999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=156.73 Aligned_cols=131 Identities=24% Similarity=0.345 Sum_probs=107.7
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccc-------ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.||+|+||.||+|.+ +|..|++|......... ..+.+.+|++++..++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999996 57889999865432111 124567899999999988776666666666777899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
++|++|.+.+.... ..++.+++.+|.++|+. +++|||++|.||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998876531 07899999999999998 999999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-17 Score=175.37 Aligned_cols=177 Identities=24% Similarity=0.361 Sum_probs=130.3
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++.|++|.-++|.+||..+. .....+|.....++.|++.|+.| + +.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999998653 34557888999999999999999 5 899999999999999999999999999
Q ss_pred cccccccc----cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 706 ARLLTRLD----KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 706 ~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
........ .........||..||+||.+ .+..|+.++||||+|++++|+++ +|.........+. -++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~-----d~r 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLT-----DIR 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhh-----hhh
Confidence 98776544 12223566899999999998 67789999999999999999986 2222111111111 111
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHH
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 826 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl 826 (843)
.+. +++. +..+.+ .-+.++.+++.+.|.+||++.++.
T Consensus 474 ~g~----ip~~---~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 474 DGI----IPPE---FLQDYP-EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred cCC----CChH---HhhcCc-HHHHHHHHhcCCCcccCchHHHHh
Confidence 111 1111 111111 224688899999999999666554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.5e-16 Score=176.78 Aligned_cols=134 Identities=24% Similarity=0.319 Sum_probs=109.5
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-------cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-------QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
...+.||+|+||.||+|.+. +..+++|+....... ...+.+.+|+++++.++|++++....++..+...++
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred CccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34568999999999999985 444555543222111 112467899999999999999988888877777899
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ +++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998886 2467899999999999998 99999999999999 678999999999975
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.7e-16 Score=152.45 Aligned_cols=137 Identities=18% Similarity=0.075 Sum_probs=106.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc---------------------cChHHHHHHHHHHHhccCCC-
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---------------------QYPEDFEREVRVLGKARHPN- 613 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~n- 613 (843)
+...+.||+|+||.||+|... +|+.||||++...... .....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 455678999999999999885 7999999987543210 01123567899999998874
Q ss_pred -ccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 614 -LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 614 -iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
+.+.++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444443 2345899999999998765321 23467889999999999998 99999999999999
Q ss_pred cCCCCcEEeeccCccccc
Q 003156 693 DDNYNPRISDFGLARLLT 710 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~ 710 (843)
++++.++|+|||.+....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-15 Score=172.19 Aligned_cols=209 Identities=20% Similarity=0.288 Sum_probs=139.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
..++..+.|..|+||.||.++++...+.+|+| +.+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee------------------
Confidence 44556778999999999999998788889984 32221 11111 22222333333
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
|+=.+.++.. +.++.. .+.+++|+|+. +|||||+||+|.+|+.-|.+|++|||+++.....-
T Consensus 136 ---gDc~tllk~~----g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4434444432 122222 27789999998 99999999999999999999999999987542110
Q ss_pred -------------cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 714 -------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 714 -------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
........+||+.|+|||++ ....|...+|.|++|+++||.+.|..||.....+ +.+..++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi-lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-----elfg~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI-LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhh-hhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-----HHHhhhh
Confidence 01112345899999999998 4456899999999999999999999999754221 1111222
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 820 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP 820 (843)
.+. + ...+-.+....++..++.+.++.+|.+|-
T Consensus 272 sd~----i---~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 SDD----I---EWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhh----c---cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111 0 01111333345677888999999999994
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4e-14 Score=144.05 Aligned_cols=145 Identities=22% Similarity=0.205 Sum_probs=110.6
Q ss_pred cChhhhhhhcCeec-cccceEEEEEEECCCCeEEEEEEeecCCc------------ccChHHHHHHHHHHHhccCCCc--
Q 003156 550 IDPETLLEKAAEVG-EGVFGTVYKVSFGTQGRMLAVKKLVTSDI------------IQYPEDFEREVRVLGKARHPNL-- 614 (843)
Q Consensus 550 ~~~~~~~~~~~~ig-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni-- 614 (843)
.++.........|| .|+.|+||.+.. .+..++||++..... ......+.+|++++.+++|+++
T Consensus 27 ~~~~~~~~~~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~v 104 (239)
T PRK01723 27 FDPDFWQQQARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPV 104 (239)
T ss_pred cCHHHHhhcCceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCC
Confidence 34444445566798 999999999988 477899998854221 0123467889999999998775
Q ss_pred cceeeEEEcCC----eeEEEEEeCCC-CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCC
Q 003156 615 ISLEGYYWTPQ----LKLLVSDYAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689 (843)
Q Consensus 615 v~l~g~~~~~~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 689 (843)
++.+++..... ..++|+||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||.|
T Consensus 105 P~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~N 172 (239)
T PRK01723 105 PRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHN 172 (239)
T ss_pred ceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchh
Confidence 67777654322 22599999997 6998888642 23333 357899999999999 99999999999
Q ss_pred EEEcCCCCcEEeeccCccc
Q 003156 690 ILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 690 ill~~~~~~kl~Dfgl~~~ 708 (843)
||++.++.++|+|||.++.
T Consensus 173 ILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 173 ILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEEcCCCCEEEEECCCccc
Confidence 9999888999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.9e-16 Score=177.80 Aligned_cols=259 Identities=21% Similarity=0.220 Sum_probs=192.3
Q ss_pred hhhhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCC-cccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV 630 (843)
..|...+.||+|+|+.|-...... ....+|+|.+.... .....+....|..+-+.+. |+|++.+++....++..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 335556679999999998877742 34457777765443 2223344556777777776 99999999999999999999
Q ss_pred EEeCCCCCHHHHH-hhcCCCCCCCChhHHHHHHHHHHHHHHhhh-hcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCcc
Q 003156 631 SDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLAR 707 (843)
Q Consensus 631 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~ 707 (843)
.||..+|++.+.+ +.. ....+......++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999998888 432 223455566788999999999999 76 999999999999999999 99999999998
Q ss_pred cccc-cccceecccccc-ccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 708 LLTR-LDKHVMSNRFQS-ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 708 ~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
.+.. ...........| ++.|+|||...+.....+..|+||.|+++.-+++|..|+............|....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~------ 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK------ 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc------
Confidence 8766 444444455667 89999999885545677899999999999999999999987644433322222110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+..-............++...++..+|..|.+.+++...
T Consensus 248 ----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 248 ----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ----cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 000011223334456778888888999999999887553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-14 Score=135.52 Aligned_cols=133 Identities=22% Similarity=0.178 Sum_probs=112.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC--CCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH--PNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| .++.+++++...++..++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 47999999999999984 47899998754432 4678999999999976 58999998888778899999999887
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
.+... +......++.+++++++++|....++++|+|++|+||+++..+.+++.|||.++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66433 4566778899999999999986445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-14 Score=140.23 Aligned_cols=136 Identities=21% Similarity=0.213 Sum_probs=97.7
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccc-ChHH----------------------HHHHHHHHHhccCCC--c
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPED----------------------FEREVRVLGKARHPN--L 614 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~h~n--i 614 (843)
+.||+|+||.||+|... +|+.||||++....... .... ...|...+.++.+.. +
T Consensus 3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 47999999999999986 79999999986532111 0011 135666666665433 4
Q ss_pred cceeeEEEcCCeeEEEEEeCCCCCHHH-HHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCEEE
Q 003156 615 ISLEGYYWTPQLKLLVSDYAPNGSLQA-KLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 615 v~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill 692 (843)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 23589999999965431 222210 01 5577899999999999998 6 99999999999999
Q ss_pred cCCCCcEEeeccCccccc
Q 003156 693 DDNYNPRISDFGLARLLT 710 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~ 710 (843)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.9e-15 Score=169.90 Aligned_cols=117 Identities=33% Similarity=0.560 Sum_probs=100.7
Q ss_pred CCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeec
Q 003156 325 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404 (843)
Q Consensus 325 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls 404 (843)
.++.|+|++|.+++.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccceecCCCC--CCCCCCCCCCcCCCCCCCCCCCCCCC
Q 003156 405 YNRLIGRLPVG--GVFPTLDQSSLQGNLGICSPLLKGPC 441 (843)
Q Consensus 405 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~c 441 (843)
+|+++|.+|.. ..+..+...++.+|+++|+.|....|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 99999999953 22234456778999999987654556
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.8e-14 Score=140.38 Aligned_cols=208 Identities=21% Similarity=0.252 Sum_probs=142.2
Q ss_pred HHHHHhccCCCccceeeEEEcCC-----eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCC
Q 003156 603 VRVLGKARHPNLISLEGYYWTPQ-----LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677 (843)
Q Consensus 603 ~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 677 (843)
..-+-++.|.|+|+++.|+.+.. ...+++|||+.|++..+|++.......+......+|.-||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455567999999999986543 4679999999999999999866556677778888999999999999997 59
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEeeccCccc--ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHH
Q 003156 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARL--LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILEL 755 (843)
Q Consensus 678 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~--~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~el 755 (843)
|+|+|+++..+-|++..++-+|++----... ..............+-++|.|||+- .....+.++|||+||+...||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHH
Confidence 9999999999999999999888852111000 0000001111234456889999975 344567899999999999999
Q ss_pred HhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 756 VTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 756 ltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+..--....... ......... ....... .=..++..|+...|..||+|++++.+.
T Consensus 276 ailEiq~tnseS~~-~~ee~ia~~------i~~len~----------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKV-EVEENIANV------IIGLENG----------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCccee-ehhhhhhhh------eeeccCc----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 88765422111110 111111100 0000000 012467889999999999999987653
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.3e-15 Score=155.41 Aligned_cols=134 Identities=32% Similarity=0.517 Sum_probs=81.0
Q ss_pred CccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEc
Q 003156 252 QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL 331 (843)
Q Consensus 252 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 331 (843)
..|..|+|+.|++. ..|..++.++ |+.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|.+
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 33444445555544 4455555443 555555555554 34555555556666666666666 55666666666666666
Q ss_pred CCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchh
Q 003156 332 DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELG 393 (843)
Q Consensus 332 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 393 (843)
..|++. .+|.++. .-.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|+ ..|..++
T Consensus 197 rRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 197 RRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 666666 4555555 345666777777776 66666777777777777777776 5666554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-14 Score=154.25 Aligned_cols=195 Identities=36% Similarity=0.457 Sum_probs=154.7
Q ss_pred EEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEc
Q 003156 55 TLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDL 134 (843)
Q Consensus 55 ~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 134 (843)
+|.|++-++...+.... . ..|.--...||+.|++. .+|..+..+..|+.|.|+.|.+. .+|..+.++..|+.|||
T Consensus 54 ~l~Ls~rrlk~fpr~a~--~-~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~l 128 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAA--S-YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDL 128 (722)
T ss_pred ccccccchhhcCCCccc--c-ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhh
Confidence 45666666654333211 2 45666778899999998 78888899999999999999998 77888999999999999
Q ss_pred cCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCC
Q 003156 135 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 214 (843)
Q Consensus 135 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (843)
+.|+++ .+|..++.++ |+.|-+++|+++ .+|+.++.+.+|..||.+.|.+. .+|..++++.+|+.|.++.|++. .
T Consensus 129 s~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~ 203 (722)
T KOG0532|consen 129 SSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-D 203 (722)
T ss_pred ccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-h
Confidence 999998 6788787765 899999999998 88889999999999999999998 68889999999999999999998 6
Q ss_pred CCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccC
Q 003156 215 IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 290 (843)
Q Consensus 215 ~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 290 (843)
+|+.+..+.|. .||++.|++. .+|-.|..|..|++|-|.+|.+.+
T Consensus 204 lp~El~~LpLi------------------------------~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 204 LPEELCSLPLI------------------------------RLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred CCHHHhCCcee------------------------------eeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 77766665444 4455555554 566667777777777777776653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.1e-13 Score=149.20 Aligned_cols=155 Identities=35% Similarity=0.526 Sum_probs=106.0
Q ss_pred ccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcC
Q 003156 253 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 332 (843)
Q Consensus 253 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 332 (843)
+|+.|++++|++. .+|..++.+++|+.|++++|++.. +|......+.|+.|++++|++. .+|.....+..|+.|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 5666666666665 455556666777777777777664 3333335667777777777777 556555556667777777
Q ss_pred CCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecC
Q 003156 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 333 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
+|.+. ..+..+.++.++..|.+++|++. .++..++.+++|++|++++|+++ .++. ++.+.+++.|++++|.++..+
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccc
Confidence 77544 45666777777777777777776 44677777777888888888887 4444 777778888888888877776
Q ss_pred CC
Q 003156 413 PV 414 (843)
Q Consensus 413 p~ 414 (843)
|.
T Consensus 294 ~~ 295 (394)
T COG4886 294 PL 295 (394)
T ss_pred hh
Confidence 64
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.9e-13 Score=146.12 Aligned_cols=177 Identities=36% Similarity=0.556 Sum_probs=72.3
Q ss_pred cCCcEEEeecCcccccCCCCccCCC-CccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchh-hccCcceee
Q 003156 151 NSMIFISVSNNTLTGDIPHWIGNIS-TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGL-FDLGLEEID 228 (843)
Q Consensus 151 ~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~~~L~~L~ 228 (843)
+.++.|++.+|+++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|++. .+|... ....|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44444444444444 3333333332 4555555555554 33344455555555555555554 233222 111222222
Q ss_pred ccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEcc
Q 003156 229 LSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 308 (843)
Q Consensus 229 l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 308 (843)
+++|++. .+|... .....|++|.+++|.+. ..+..+..+.++..|.+.+|++.. .+..++.+.++++|+++
T Consensus 193 ls~N~i~-~l~~~~------~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s 263 (394)
T COG4886 193 LSGNKIS-DLPPEI------ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLS 263 (394)
T ss_pred ccCCccc-cCchhh------hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceeccc
Confidence 2222222 011100 01122444444444322 233344444444444444444432 13334444444445555
Q ss_pred CCcccccCCccccccCCCcEEEcCCCCCCCCch
Q 003156 309 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIP 341 (843)
Q Consensus 309 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 341 (843)
+|+++ .++. ++.+.+|+.|++++|.+....|
T Consensus 264 ~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 264 NNQIS-SISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred ccccc-cccc-ccccCccCEEeccCccccccch
Confidence 55444 2222 4444555555555555543333
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.8e-12 Score=141.01 Aligned_cols=142 Identities=18% Similarity=0.218 Sum_probs=101.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccC---------------------------------------hHHHH
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY---------------------------------------PEDFE 600 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~ 600 (843)
+.||.|++|.||+|++. +|+.||||+.+..-.... .-+|.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46999999999999996 899999999854311000 01245
Q ss_pred HHHHHHHhcc----CCCccceeeEEEc-CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHH-HHHhhhh
Q 003156 601 REVRVLGKAR----HPNLISLEGYYWT-PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK-GLAHLHH 674 (843)
Q Consensus 601 ~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~ 674 (843)
+|+..+.+++ |.+-+.+-.++.+ ....++||||++|++|.++..... ... .+..++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 5666666653 3333343334432 345789999999999988775421 112 24556666666 4678888
Q ss_pred cCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 675 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
. +++|+|+||.||++++++.++++|||++..+.+
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.2e-11 Score=130.95 Aligned_cols=170 Identities=19% Similarity=0.222 Sum_probs=131.2
Q ss_pred EEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCC
Q 003156 572 KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 651 (843)
Q Consensus 572 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~ 651 (843)
.|..+.++.+|.|........ ...+...+.++.++.+|||||++++..+...+..|+|+|.+. -|..++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----
Confidence 466667889999988866554 344567788999999999999999999999999999999974 467777764
Q ss_pred CCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcc
Q 003156 652 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731 (843)
Q Consensus 652 ~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE 731 (843)
........+.||+.||.|||+.| +++|++|.-..|+++..|+.||++|.++........ ......--..|..|+
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPE 175 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChh
Confidence 24566778899999999999776 899999999999999999999999998865443221 111111122367777
Q ss_pred cccCcCCCCCchhHHHHHHHHHHHHhC
Q 003156 732 LTCQSLRVNEKCDIYGFGVLILELVTG 758 (843)
Q Consensus 732 ~~~~~~~~~~~~Dv~S~Gvil~elltg 758 (843)
.+... .-..|.|-||+++||++.|
T Consensus 176 ~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCcc---ccchhhhhHHHHHHHHhCc
Confidence 55111 1346999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4e-12 Score=137.99 Aligned_cols=248 Identities=22% Similarity=0.237 Sum_probs=179.4
Q ss_pred hhcCeecc--ccceEEEEEEE--CCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 557 EKAAEVGE--GVFGTVYKVSF--GTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 557 ~~~~~ig~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
.....+|. |.+|.||.+.. ..++..+|+|+-+.... ......-.+|+...+++ .|++.++.+..+...+..++-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 34457899 99999999999 77899999998433221 12223345677777777 499999988889999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHH----HHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeeccC
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK----GLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGL 705 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl 705 (843)
+|++. .++.++-+... ..++....+.+..+..+ |+.++|.. +++|-|+||.||+...+ ..++++|||+
T Consensus 197 tE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 197 TELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 99984 68888777642 23555667777778888 99999998 99999999999999988 8999999999
Q ss_pred ccccccccccee---ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 706 ARLLTRLDKHVM---SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 706 ~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
...+........ .....|...|++||.. ...++..+|+||+|.++.+..++.++...+.... |.+ .+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~--~r~ 340 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ--LRQ 340 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc--ccc
Confidence 988866442211 1222566679999986 3357899999999999999999888776543221 100 000
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003156 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 783 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~ 827 (843)
+. .+ .++......++...+..+++.+|..|++++.+..
T Consensus 341 ~~-----ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 GY-----IP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc-----Cc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 00 0122222334555888999999999999886644
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.4e-13 Score=137.39 Aligned_cols=207 Identities=22% Similarity=0.213 Sum_probs=112.3
Q ss_pred CCccEEecCCCcCcccCC-hhhhhcCCCCcEEEccCcccccc--ccccccCCCCCCEEECCCCCCccccCCCcCccccCC
Q 003156 2 MNMKFLDLSNNLLSGPVP-YQLFENCASLRYLSLAGNILQGP--IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL 78 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~-~~~f~~l~~L~~L~L~~n~i~~~--~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l 78 (843)
++|+...|.++... ..+ ....+.|++++.|||++|-+... ...+...|++|+.|+|+.|++..-.... .-..+
T Consensus 121 kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~---~~~~l 196 (505)
T KOG3207|consen 121 KKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN---TTLLL 196 (505)
T ss_pred HhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc---chhhh
Confidence 34666667777665 222 13456677777777777776542 3344566777777777777765322211 12245
Q ss_pred ccCCEEecCCccCccc-CchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCC-chhhcccCCcEE
Q 003156 79 KRLRTLDLSHNLFSGS-IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP-VSLRLLNSMIFI 156 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L 156 (843)
++|+.|.|+.|.++.. +-.....+++|+.|+|..|..-.........+..|++|||++|++-...- ...+.++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 6677777777776632 22334556677777777764222333334445666777777766653221 234556666666
Q ss_pred EeecCccccc-CCCC-----ccCCCCccEEEcccCCcCCC-CCCCCCCCCCCcEEEecCCcCC
Q 003156 157 SVSNNTLTGD-IPHW-----IGNISTLEFLDFSNNHLTGS-LPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 157 ~L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+++.+.+..+ .|+. ...+++|+.|+++.|+|... .-..+..+.+|+.|.+..|.++
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 6666665532 2332 33455666666666666421 1112233445555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1e-12 Score=128.52 Aligned_cols=132 Identities=24% Similarity=0.294 Sum_probs=67.5
Q ss_pred CCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEe
Q 003156 275 FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 354 (843)
Q Consensus 275 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 354 (843)
+..|++||||+|.|+. +.++..-.+.++.|++|+|.|... ..+..+++|+.||||+|.++ .+..+-..+-+.++|.
T Consensus 283 Wq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 3344444444444432 223334444455555555555422 22455555555555555555 3444444555566666
Q ss_pred cccccccccCCccccCCCCCCEEEccCCcccccC-CcchhcccccceEeeccccceecC
Q 003156 355 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI-PQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 355 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
|+.|.|. . -..++.|-+|..||+++|+|.... -..+++|+-|+.+-|.+|++.+.+
T Consensus 359 La~N~iE-~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 359 LAQNKIE-T-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhhHh-h-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 6666554 1 123555556666666666665221 234566666666666666665543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.5e-12 Score=120.19 Aligned_cols=120 Identities=33% Similarity=0.453 Sum_probs=34.4
Q ss_pred cCCCcCcccCChhhhhcCCCCcEEEccCcccccccccccc-CCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecC
Q 003156 9 LSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFN-YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 87 (843)
Q Consensus 9 L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~-~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~ 87 (843)
|..+-|. .++. +.+...+++|+|++|.|+.|.. ++ .+.+|++|||++|.|+... .+..+++|+.|+++
T Consensus 4 lt~~~i~-~~~~--~~n~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~l~------~l~~L~~L~~L~L~ 72 (175)
T PF14580_consen 4 LTANMIE-QIAQ--YNNPVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITKLE------GLPGLPRLKTLDLS 72 (175)
T ss_dssp -----------------------------------S----TT-TT--EEE-TTS--S--T------T----TT--EEE--
T ss_pred ccccccc-cccc--cccccccccccccccccccccc--hhhhhcCCCEEECCCCCCcccc------CccChhhhhhcccC
Confidence 4555565 5553 4566678888888888887653 33 5678888888888877532 35567888888888
Q ss_pred CccCcccCchhh-hcCCCCCEEEcCCCcccccCC-CCCCCCCCCcEEEccCCccc
Q 003156 88 HNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLP-ADIGFCPHLTTLDLSNNLFT 140 (843)
Q Consensus 88 ~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 140 (843)
+|+|+. +...+ ..+++|++|+|++|+|..... ..++.+++|+.|+|.+|.++
T Consensus 73 ~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 73 NNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 888874 33333 467788888888888764211 23445677777777777766
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.5e-12 Score=144.79 Aligned_cols=113 Identities=38% Similarity=0.563 Sum_probs=106.0
Q ss_pred cceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEcc
Q 003156 301 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLE 380 (843)
Q Consensus 301 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 380 (843)
.++.|+|++|.+.|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCcchhcc-cccceEeeccccceecCC
Q 003156 381 FNELSGEIPQELGKL-ASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 381 ~N~l~~~~p~~~~~l-~~L~~l~ls~N~l~~~~p 413 (843)
+|+++|.+|..+..+ .++..+++++|...+..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999998874 467899999998766555
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.5e-11 Score=115.87 Aligned_cols=129 Identities=20% Similarity=0.210 Sum_probs=95.4
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCcc-ceeeEEEcCCeeEEEEEeCCCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI-SLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
+.++.|.++.||+++. .++.|++|....... ....+..|+.+++.+.+.+++ +++++. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEE--CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 3689999999999997 478899998754321 123567899999998765554 444433 334579999999987
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC--CCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF--RPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
+.+. . .....++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7543 0 011345678999999999872 22369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.2e-11 Score=134.80 Aligned_cols=143 Identities=15% Similarity=0.204 Sum_probs=94.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc---------------------------------cChH------HHH
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---------------------------------QYPE------DFE 600 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------------------~~~~------~~~ 600 (843)
+.||+|++|.||+|++..+|+.||||+..+.-.. +..+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 4799999999999999856999999998643100 0011 244
Q ss_pred HHHHHHHhcc----CCCccceeeEEEc-CCeeEEEEEeCCCCCHHHHH--hhcCCCCCCCChhHHHHHHHHHHHHHHhhh
Q 003156 601 REVRVLGKAR----HPNLISLEGYYWT-PQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLH 673 (843)
Q Consensus 601 ~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH 673 (843)
+|+..+.+++ +...+.+-.++++ ....++||||++|+.+.+.- .........+.......++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 5555555553 4444554444543 34578999999999998742 2221011122222223333333 3
Q ss_pred hcCCCCeeecCCCCCCEEEcCCC----CcEEeeccCccccccc
Q 003156 674 HSFRPPIIHYNLKPSNILLDDNY----NPRISDFGLARLLTRL 712 (843)
Q Consensus 674 ~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfgl~~~~~~~ 712 (843)
.. |++|+|+||.||+++.++ .+++.|||++..+.+.
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 34 999999999999999888 9999999999877653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-12 Score=126.16 Aligned_cols=204 Identities=26% Similarity=0.277 Sum_probs=143.9
Q ss_pred CCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCccee-----eccCCcceecCCCC
Q 003156 167 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEI-----DLSENGFMGSIPPG 241 (843)
Q Consensus 167 ~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L-----~l~~n~l~~~~p~~ 241 (843)
+|-.+.-+.+|..+.++.+.-.. +.+....-+.|..+...+..+. ..|.-+....+... +...-.....
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~-~~~~l~pe~~~~D~~~~E~~t~~G~~~~~---- 279 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQ-DVPSLLPETILADPSGSEPSTSNGSALVS---- 279 (490)
T ss_pred cccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeeccccc-ccccccchhhhcCccCCCCCccCCceEEe----
Confidence 34444556677777777665432 2222233356777777766654 22221111111110 1111111111
Q ss_pred CCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCcccc
Q 003156 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 321 (843)
Q Consensus 242 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 321 (843)
...++.|+++||++|.|+ .+..++.-.+.++.|++|+|.|+.+ ..+..+++|+.||||+|.++ .+..+-.
T Consensus 280 ------~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 280 ------ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred ------cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHh
Confidence 223568999999999998 7788888999999999999999854 45888999999999999998 5666777
Q ss_pred ccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccccccc-CCccccCCCCCCEEEccCCcccccC
Q 003156 322 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS-IPKSISNLNKLKILKLEFNELSGEI 388 (843)
Q Consensus 322 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~ 388 (843)
.+-++++|.|++|.|.. -+.++.+-+|..||+++|+|... --..+++||-|+.|.|.+|.|++.+
T Consensus 350 KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 88999999999999973 35688999999999999999732 2357899999999999999999544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-12 Score=134.30 Aligned_cols=216 Identities=22% Similarity=0.222 Sum_probs=130.5
Q ss_pred cCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCccc--CchhhhcCCCCCEEEcCCCcccccCCCCC-C
Q 003156 48 NYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS--IPQGVAALHYLKELLLQGNQFSGPLPADI-G 124 (843)
Q Consensus 48 ~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~ 124 (843)
+++..|++..|.+..+...... .....+++++.||||+|-+... .......|++|+.|+|+.|++........ .
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~---~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~ 194 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIE---EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL 194 (505)
T ss_pred hhHHhhhheeecCccccccchh---hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh
Confidence 4566677777777665522211 2344567777777777766532 23455677777777777777653222211 2
Q ss_pred CCCCCcEEEccCCccccc-CCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCC--CCCCCCCCC
Q 003156 125 FCPHLTTLDLSNNLFTGQ-LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP--SSLFNCKKL 201 (843)
Q Consensus 125 ~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L 201 (843)
.+++|+.|.|+.|.++.- .-.....+++|+.|+|..|............+..|++|||++|++-. .+ .....++.|
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccch
Confidence 456777777777777621 12233556777777777775333334445556778888888877663 23 345667777
Q ss_pred cEEEecCCcCCCCC-CchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeC-CccccCCCCCc
Q 003156 202 SVIRLRGNSLNGNI-PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI-PAEMGLFANLR 279 (843)
Q Consensus 202 ~~L~L~~N~l~~~~-p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~ 279 (843)
+.|+++.+.+...- |+. ..+ .-...+++|++|++..|+|.+.. -..+..+++|+
T Consensus 274 ~~Lnls~tgi~si~~~d~------~s~------------------~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk 329 (505)
T KOG3207|consen 274 NQLNLSSTGIASIAEPDV------ESL------------------DKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLK 329 (505)
T ss_pred hhhhccccCcchhcCCCc------cch------------------hhhcccccceeeecccCccccccccchhhccchhh
Confidence 77877777775211 110 000 11234678888888888886321 23455677888
Q ss_pred EEEcCCCcccCC
Q 003156 280 YLNLSSNHLRSR 291 (843)
Q Consensus 280 ~L~L~~N~l~~~ 291 (843)
.|.+..|.+...
T Consensus 330 ~l~~~~n~ln~e 341 (505)
T KOG3207|consen 330 HLRITLNYLNKE 341 (505)
T ss_pred hhhccccccccc
Confidence 888889988754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-11 Score=115.77 Aligned_cols=123 Identities=31% Similarity=0.370 Sum_probs=44.0
Q ss_pred CCCcEEEcCCCcccCCCCCCcc-ccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhh-cccCCCcEE
Q 003156 276 ANLRYLNLSSNHLRSRIPPELG-YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI-RNCTSLYLL 353 (843)
Q Consensus 276 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 353 (843)
.++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+. + +.+..++.|++|++++|+|+. +.+.+ ..+++|+.|
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence 3566666666666543 2343 45667777777777773 3 356677788888888888874 33334 467888888
Q ss_pred ecccccccccC-CccccCCCCCCEEEccCCcccccC---CcchhcccccceEee
Q 003156 354 SLSHNHLSGSI-PKSISNLNKLKILKLEFNELSGEI---PQELGKLASLLAVNV 403 (843)
Q Consensus 354 ~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~l~l 403 (843)
+|++|+|...- -..+..+++|+.|+|.+|.++... ...+..+|+|+.||-
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 88888886321 134567788888888888887432 123566777777764
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.1e-12 Score=139.28 Aligned_cols=246 Identities=27% Similarity=0.265 Sum_probs=140.2
Q ss_pred hcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCC
Q 003156 24 ENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH 103 (843)
Q Consensus 24 ~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 103 (843)
..+..++.+++..|.|..+ .+.+..+++|+.|++.+|+|.+.... +..+++|++|+|++|+|+... .+..++
T Consensus 69 ~~l~~l~~l~l~~n~i~~~-~~~l~~~~~l~~l~l~~n~i~~i~~~-----l~~~~~L~~L~ls~N~I~~i~--~l~~l~ 140 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKI-LNHLSKLKSLEALDLYDNKIEKIENL-----LSSLVNLQVLDLSFNKITKLE--GLSTLT 140 (414)
T ss_pred HHhHhHHhhccchhhhhhh-hcccccccceeeeeccccchhhcccc-----hhhhhcchheecccccccccc--chhhcc
Confidence 3456666666777766642 22355566777777777776644321 445667777777777776332 345566
Q ss_pred CCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCC-chhhcccCCcEEEeecCcccccCCCCccCCCCccEEEc
Q 003156 104 YLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP-VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182 (843)
Q Consensus 104 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 182 (843)
.|+.|++.+|.|+.. ..+..+++|+.+++++|.+....+ . ...+.+++.+.+.+|.+.. ...+..+..+..+++
T Consensus 141 ~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l 215 (414)
T KOG0531|consen 141 LLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSL 215 (414)
T ss_pred chhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhc
Confidence 677777777777632 335556777777777777664433 2 4566666777777776652 222444445555566
Q ss_pred ccCCcCCCCCCCCCCCCC--CcEEEecCCcCCCCCCchhhc-cCcceeeccCCcceecCCCCCCCCCcccccCccCEEeC
Q 003156 183 SNNHLTGSLPSSLFNCKK--LSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 259 (843)
Q Consensus 183 ~~N~i~~~~~~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~-~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L 259 (843)
..|.++..- .+..+.. |+.+++++|.+. ..+..+.. ..+..+++.+|++...- .......+..+.+
T Consensus 216 ~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--------~~~~~~~~~~~~~ 284 (414)
T KOG0531|consen 216 LDNKISKLE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--------GLERLPKLSELWL 284 (414)
T ss_pred ccccceecc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--------cccccchHHHhcc
Confidence 666666321 2222222 667777777766 23222222 25666777776665321 1123445666666
Q ss_pred CCCcccee---CCcc-ccCCCCCcEEEcCCCcccCCCC
Q 003156 260 SSNNLVGD---IPAE-MGLFANLRYLNLSSNHLRSRIP 293 (843)
Q Consensus 260 ~~n~l~~~---~p~~-~~~l~~L~~L~L~~N~l~~~~~ 293 (843)
..|.+... .... .+....++.+.+..|.+....+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 285 NDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred CcchhcchhhhhccccccccccccccccccCccccccc
Confidence 66665521 1221 4556778888888888876443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.8e-11 Score=127.28 Aligned_cols=248 Identities=20% Similarity=0.258 Sum_probs=172.5
Q ss_pred hhcCeeccccceEEEEEEEC-CCCeEEEEEEeecCCcccChHHH-HHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEe
Q 003156 557 EKAAEVGEGVFGTVYKVSFG-TQGRMLAVKKLVTSDIIQYPEDF-EREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~-~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.....||.|.|+.|+....+ .++..|++|.....-.....+.| ..|+.+...+ .|.++++++..+..-...++=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34458999999999998876 57788999987554322212222 4566666666 488888887777766677799999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeeccCccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRL 712 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~~~ 712 (843)
++++++...+.- ...++...++.+..|++.++.++|+. .++|+|+||+||++..+ +..+++|||+++.+.-
T Consensus 348 ~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 348 CEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred hcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce-
Confidence 999988776633 24477788899999999999999988 99999999999999875 8899999999974221
Q ss_pred ccceeccccccccccC-CcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYV-APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~-aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
........-+++ ..|++.....+..+.|+||||..+.|.+++..--..+.. |. .+.. .
T Consensus 420 ----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~-------~i~~---~ 478 (524)
T KOG0601|consen 420 ----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SL-------TIRS---G 478 (524)
T ss_pred ----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------ce-------eeec---c
Confidence 011122233444 355555666788999999999999999987543221111 00 0000 0
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.....+..- ..+..+...+...++..||.+.+...+.+..++
T Consensus 479 ~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 479 DTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred cccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 011112222 556778888899999999999998877655443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.7e-12 Score=128.02 Aligned_cols=132 Identities=20% Similarity=0.257 Sum_probs=77.3
Q ss_pred CCcEEEcCCCcccCCCC----CCccccccceEEEccCCcccc----cCCccccccCCCcEEEcCCCCCCCC----chhhh
Q 003156 277 NLRYLNLSSNHLRSRIP----PELGYFHSLIHLDLRNNALYG----SIPQEVCESRSLGILQLDGNSLTGP----IPQVI 344 (843)
Q Consensus 277 ~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~ 344 (843)
+|+.+..++|++..... ..|...+.|+.+.++.|.|.. .+...+..++.|+.|||..|.++.. +...+
T Consensus 158 ~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL 237 (382)
T KOG1909|consen 158 KLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL 237 (382)
T ss_pred ceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHh
Confidence 44444444444432211 223334455555555555531 1223456667777777777766532 33445
Q ss_pred cccCCCcEEecccccccccCCccc-----cCCCCCCEEEccCCcccc----cCCcchhcccccceEeeccccc
Q 003156 345 RNCTSLYLLSLSHNHLSGSIPKSI-----SNLNKLKILKLEFNELSG----EIPQELGKLASLLAVNVSYNRL 408 (843)
Q Consensus 345 ~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~l~ls~N~l 408 (843)
..++.|+.|++++|.++..-..+| ...++|+.|.|.+|.|+- .+...+...+.|..|+|++|++
T Consensus 238 ~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 238 SSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 567777777777777764433332 235788888888888862 2334455678888888888887
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-11 Score=137.91 Aligned_cols=218 Identities=28% Similarity=0.359 Sum_probs=105.4
Q ss_pred CCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEE
Q 003156 125 FCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 204 (843)
Q Consensus 125 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 204 (843)
.+..++.+++..|.+.. .-..+..+.+|..|++.+|+|.. +...+..+++|++|+|++|.|+.+ ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 34555555555555552 22334445555555555555542 222244455555555555555532 223444445555
Q ss_pred EecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCcc-ccCCCCCcEEEc
Q 003156 205 RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAE-MGLFANLRYLNL 283 (843)
Q Consensus 205 ~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L 283 (843)
++++|.|+. +.. ...++.|+.+++++|++...-+ . ...+.+++.+.+
T Consensus 146 ~l~~N~i~~-~~~------------------------------~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l 193 (414)
T KOG0531|consen 146 NLSGNLISD-ISG------------------------------LESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDL 193 (414)
T ss_pred eeccCcchh-ccC------------------------------CccchhhhcccCCcchhhhhhh-hhhhhccchHHHhc
Confidence 555555441 110 1114566666666666663322 1 345566666666
Q ss_pred CCCcccCCCCCCccccccceEEEccCCcccccCCccccccCC--CcEEEcCCCCCCCCchhhhcccCCCcEEeccccccc
Q 003156 284 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRS--LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361 (843)
Q Consensus 284 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 361 (843)
.+|.+..+ ..+..+..+..+++..|.++..- .+..+.. |+.+++++|.+. ..+..+..+.++..|++++|+++
T Consensus 194 ~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 194 GGNSIREI--EGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred cCCchhcc--cchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 66666432 33344444455566666665321 1222222 556666666665 33344555555666666666554
Q ss_pred ccCCccccCCCCCCEEEccCCccc
Q 003156 362 GSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 362 ~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
.. ..+...+.+..+.+..|++.
T Consensus 269 ~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 269 NL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cc--ccccccchHHHhccCcchhc
Confidence 21 11333445555555555544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-09 Score=105.22 Aligned_cols=137 Identities=14% Similarity=0.108 Sum_probs=96.9
Q ss_pred CeeccccceEEEEEEECC------CCeEEEEEEeecCCc------------c---------cChHHHH----HHHHHHHh
Q 003156 560 AEVGEGVFGTVYKVSFGT------QGRMLAVKKLVTSDI------------I---------QYPEDFE----REVRVLGK 608 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~------------~---------~~~~~~~----~E~~~l~~ 608 (843)
..||.|--+.||.|.... ++..+|||..+.... . ...+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 378999999999998642 257899998743211 0 0012233 79999999
Q ss_pred ccC--CCccceeeEEEcCCeeEEEEEeCCCCCHH-HHHhhcCCCCCCCChhHHHHHHHHHHHHHHhh-hhcCCCCeeecC
Q 003156 609 ARH--PNLISLEGYYWTPQLKLLVSDYAPNGSLQ-AKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYN 684 (843)
Q Consensus 609 l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~d 684 (843)
+.. -++.+.+++ ...++||||+.++.+. ..+++. .++..+...+..+++.+|.++ |.. ++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 853 455556654 4568999999765442 223321 234455667889999999999 766 999999
Q ss_pred CCCCCEEEcCCCCcEEeeccCcccc
Q 003156 685 LKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 685 lk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
+++.||+++ ++.+.++|||-+-..
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 467999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.2e-09 Score=98.70 Aligned_cols=131 Identities=27% Similarity=0.371 Sum_probs=99.8
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcc--c-----ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--Q-----YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.+++|+-+.+|.+.+. |..+++|.-..+.-. + ..+...+|+.++.+++--.|--..=+..+++...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5789999999999884 555666654322111 1 113456899999999766665555566778888999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
++|-.|.+.+... ...++..+-.-+.-||.. +|||+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888764 145666677778889998 999999999999998765 99999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.6e-09 Score=96.93 Aligned_cols=141 Identities=20% Similarity=0.254 Sum_probs=104.7
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccc-------ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
..+-+|+-+.|+++.+ .|+...||.-....... ..+...+|+..+.+++--.|.-..=++.+...-.|+||
T Consensus 13 ~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3788999999999999 68888888643322111 12456789999999875555444445666677789999
Q ss_pred eCCC-CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC---cEEeeccCcc
Q 003156 633 YAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFGLAR 707 (843)
Q Consensus 633 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~ 707 (843)
|+++ .++.+++...... .........++..|-+.+.-||.. .|+|+||..+||++.+++. +.+.|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 9976 4888888875322 222233367888999999999999 9999999999999975543 5899999985
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.8e-09 Score=109.81 Aligned_cols=143 Identities=24% Similarity=0.311 Sum_probs=107.4
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC--CCccceeeEEEcCC---eeEEEEEeC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH--PNLISLEGYYWTPQ---LKLLVSDYA 634 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lV~e~~ 634 (843)
+.+|.|.++.||++... +|+.+++|.............+..|+++++.+++ ..+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 36899999999999885 4688999987544322234578899999999976 34567777766542 568999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC--------------------------------------
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF-------------------------------------- 676 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 676 (843)
+++++.+.+.. ..++..++..++.++++++.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99887665431 23566667777888888888887421
Q ss_pred ---------------CCCeeecCCCCCCEEEcC--CCCcEEeeccCccc
Q 003156 677 ---------------RPPIIHYNLKPSNILLDD--NYNPRISDFGLARL 708 (843)
Q Consensus 677 ---------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~ 708 (843)
...++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-10 Score=135.21 Aligned_cols=126 Identities=28% Similarity=0.264 Sum_probs=64.0
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCcc--ccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNI--LQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~--i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
+.+.+.+|++. .++.. ..+++|++|-+..|. +..+....|..++.|++|||++|.=.+. -|..++.|-+|+
T Consensus 526 rr~s~~~~~~~-~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~----LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 526 RRMSLMNNKIE-HIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSK----LPSSIGELVHLR 598 (889)
T ss_pred eEEEEeccchh-hccCC--CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCc----CChHHhhhhhhh
Confidence 44555555554 44432 234455555555554 4455555555555666666655432111 112344555555
Q ss_pred EEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCc
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 138 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 138 (843)
+|+|++..+. .+|..+..|++|.+|++..+.-....|.....+++|++|.+..-.
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 5555555555 455555555555555555554433344444445555555555443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.9e-10 Score=89.73 Aligned_cols=61 Identities=38% Similarity=0.481 Sum_probs=53.1
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF 63 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i 63 (843)
++|++|+|++|+|+ .+|..+|.++++|++|++++|.|+.++++.|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57888999999888 88888888899999999998988888888888888888888888875
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-11 Score=121.55 Aligned_cols=190 Identities=22% Similarity=0.313 Sum_probs=120.9
Q ss_pred hhcCCCCcEEEccCccccccc----cccccCCCCCCEEECCCCCCccccCCC---------cCccccCCccCCEEecCCc
Q 003156 23 FENCASLRYLSLAGNILQGPI----GKIFNYCSSLNTLNLSNNHFSGDLDFA---------SGYGIWSLKRLRTLDLSHN 89 (843)
Q Consensus 23 f~~l~~L~~L~L~~n~i~~~~----~~~f~~l~~L~~L~Ls~N~i~~~~~~~---------~~~~~~~l~~L~~L~L~~n 89 (843)
..+++.|+.|+||.|-+.--. ...++.++.|++|.|.+|.+...-... .......-++|+++...+|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 345566677777766664211 122355666777777776665211100 0112334467888888888
Q ss_pred cCccc----CchhhhcCCCCCEEEcCCCcccc----cCCCCCCCCCCCcEEEccCCcccccC----CchhhcccCCcEEE
Q 003156 90 LFSGS----IPQGVAALHYLKELLLQGNQFSG----PLPADIGFCPHLTTLDLSNNLFTGQL----PVSLRLLNSMIFIS 157 (843)
Q Consensus 90 ~l~~~----~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~ 157 (843)
++..- +...|+..+.|+++.++.|.|.. .....|..+++|+.|||.+|-++... ...++.+++|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 87632 23456677788888888887752 12234667888888888888877432 34567778888888
Q ss_pred eecCcccccCCCCcc-----CCCCccEEEcccCCcCC----CCCCCCCCCCCCcEEEecCCcCC
Q 003156 158 VSNNTLTGDIPHWIG-----NISTLEFLDFSNNHLTG----SLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 158 L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+++|.+......+|. ..++|+.|.|.+|.|+. .+...+...+.|+.|+|++|.+.
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 888887644333222 36788999999998874 23344556788999999999884
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.1e-09 Score=83.81 Aligned_cols=59 Identities=36% Similarity=0.456 Sum_probs=29.1
Q ss_pred CCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeecccc
Q 003156 349 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR 407 (843)
Q Consensus 349 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~ 407 (843)
+|+.|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34445555555543333444555555555555555554444455555555555555554
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.1e-08 Score=99.74 Aligned_cols=141 Identities=13% Similarity=0.078 Sum_probs=100.3
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccc---------C-hHHHHHHHHHHHhccCCC--ccceeeEEEc-----
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ---------Y-PEDFEREVRVLGKARHPN--LISLEGYYWT----- 623 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~-~~~~~~E~~~l~~l~h~n--iv~l~g~~~~----- 623 (843)
.+-+.....|+++.+ +|+.|.||+.......+ . ...+.+|...+.++...+ +...+++...
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 344344445777776 68899999874332111 1 114778999988885333 3445555543
Q ss_pred CCeeEEEEEeCCCC-CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-------C
Q 003156 624 PQLKLLVSDYAPNG-SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-------N 695 (843)
Q Consensus 624 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~ 695 (843)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||+. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999876 8999886431 12345566778999999999999999 9999999999999975 4
Q ss_pred CCcEEeeccCccc
Q 003156 696 YNPRISDFGLARL 708 (843)
Q Consensus 696 ~~~kl~Dfgl~~~ 708 (843)
+.+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998853
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-09 Score=125.80 Aligned_cols=104 Identities=30% Similarity=0.386 Sum_probs=52.9
Q ss_pred cCCEEecCCcc--CcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEE
Q 003156 80 RLRTLDLSHNL--FSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 157 (843)
Q Consensus 80 ~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 157 (843)
+|++|-+..|. +.....+.|..++.|+.|||++|.=-+.+|..++.+-+|++|+|++..+. .+|..+.+|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 34444444443 33233334555555555555555433455555555555555555555555 4555555555555555
Q ss_pred eecCcccccCCCCccCCCCccEEEccc
Q 003156 158 VSNNTLTGDIPHWIGNISTLEFLDFSN 184 (843)
Q Consensus 158 L~~N~l~~~~p~~~~~l~~L~~L~L~~ 184 (843)
+..+.-...+|.....+++|++|.+..
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred cccccccccccchhhhcccccEEEeec
Confidence 555543333444444455555555544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.5e-07 Score=100.25 Aligned_cols=171 Identities=22% Similarity=0.259 Sum_probs=130.3
Q ss_pred cceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEE----cCCeeEEEEEeCCC-CCHH
Q 003156 566 VFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW----TPQLKLLVSDYAPN-GSLQ 640 (843)
Q Consensus 566 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~ 640 (843)
...+.|++....+|..|++|+++-. ..+....-..-+++++++.|+|+|++..++. .+...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~-r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGD-RDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccc-cccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4467899999999999999999432 2233333445688999999999999998886 34467899999886 4777
Q ss_pred HHHhhcCC-----------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 641 AKLHERLP-----------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 641 ~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
+.--...+ .+...++...|.++.|++.||.++|+. |+.-+-+.+++|+++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 65433211 234567889999999999999999999 9999999999999999999999988887655
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCC
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR 760 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~ 760 (843)
..... |.+ . --.+-|.=.||.+++.+.||..
T Consensus 444 ~~d~~----------------~~l-e---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT----------------EPL-E---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC----------------cch-h---HHhhhhHHHHHHHHHHHhhccc
Confidence 43220 111 1 1235688899999999999854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.3e-07 Score=98.02 Aligned_cols=264 Identities=17% Similarity=0.177 Sum_probs=159.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEE----E--c-CCee
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYY----W--T-PQLK 627 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~----~--~-~~~~ 627 (843)
+...+.+|+|+-+.+|-.-.- +. -+.|+....... .-.+.+.+|.+. .||-+-.-+.|= + + +...
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchh--hc-hhheeecCCCch----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 344668999999999965432 21 234666544321 112223334333 465443312111 1 1 1224
Q ss_pred EEEEEeCCCCC-HHHHHhh--cCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 628 LLVSDYAPNGS-LQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 628 ~lV~e~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
-+.|..+++-- ...++.. ++.+-+..+|...+++++.+|.+.+.||.. |.+-+|+.++|+|+.+++.|.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 56777766542 2222221 223456789999999999999999999999 99999999999999999999998754
Q ss_pred CcccccccccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhC-CCCCcCCC---CchhhHHHHH
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTG-RRPVEYGE---DNVVILSEHV 776 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg-~~p~~~~~---~~~~~l~~~~ 776 (843)
.-.....+. ......|...|.+||.-. .+..-+...|-|.+||++++++.| ++||.... +...-++..
T Consensus 163 sfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~- 238 (637)
T COG4248 163 SFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD- 238 (637)
T ss_pred ceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh-
Confidence 333221111 112345677899999642 122346788999999999999886 99997632 111112111
Q ss_pred HHHHhhCCcccccCCCC------CCCC-hhhHHHHHHHHHHccCCC--CCCCCCHHHHHHHHHhccCCC
Q 003156 777 RVLLEEGNVLDCVDPSM------GDYP-EDEVLPVLKLALVCTCHI--PSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 777 ~~~~~~~~~~~~~d~~l------~~~~-~~~~~~l~~l~~~c~~~~--P~~RPs~~evl~~L~~~~~~~ 836 (843)
+..+.+...-|... ...| +-.+..+..+..+|+... +.-|||++-.+..|..+.+.+
T Consensus 239 ---Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 ---IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ---hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11222222222111 1111 122345777888998653 678999999999888776653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.6e-09 Score=123.83 Aligned_cols=246 Identities=22% Similarity=0.231 Sum_probs=164.2
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
..+-+-+|.+|.++-+.-...|...+.|......... ..+....+-.+.-..++|-++...--+......++|++|..
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~ 887 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLN 887 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhc
Confidence 3447889999999988876666555555543222111 12222333333323355666655544444556789999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc---
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL--- 712 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--- 712 (843)
++++...++... ..+..........+..+.+|||.. .+.|||++|.|.+...++..+++|||......-.
T Consensus 888 ~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 888 GGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred cCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999998752 344444555666778899999987 7999999999999999999999999843322110
Q ss_pred --------------------------ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC
Q 003156 713 --------------------------DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 766 (843)
Q Consensus 713 --------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~ 766 (843)
+.........+|..|.|||.. .+......+|.|+.|++++|.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~-lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL-LGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCccc-ccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 000112345688999999987 55567888999999999999999999997643
Q ss_pred CchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHH
Q 003156 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 823 (843)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~ 823 (843)
... .++.. . --+...+.-+.........++.+-+..+|.+|-.|.
T Consensus 1040 pq~-----~f~ni------~-~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQ-----IFENI------L-NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhh-----hhhcc------c-cCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 321 11110 0 011222233455555677788888889999997776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1e-07 Score=92.29 Aligned_cols=125 Identities=26% Similarity=0.294 Sum_probs=80.1
Q ss_pred EEEEEEECCCCeEEEEEEeecCCc------------cc---------C----hHHHHHHHHHHHhccCC--CccceeeEE
Q 003156 569 TVYKVSFGTQGRMLAVKKLVTSDI------------IQ---------Y----PEDFEREVRVLGKARHP--NLISLEGYY 621 (843)
Q Consensus 569 ~Vy~~~~~~~~~~vavK~~~~~~~------------~~---------~----~~~~~~E~~~l~~l~h~--niv~l~g~~ 621 (843)
.||.|... +|..+|||....... .. . .....+|++.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999885 789999998743211 00 0 12356799999999765 455555442
Q ss_pred EcCCeeEEEEEeCC--CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhh-hhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 622 WTPQLKLLVSDYAP--NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 622 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
..++||||++ |..+.. +... .++......++.+++..+..+ |.. +|||+|+.+.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 3479999998 444433 3332 122345567788888866665 566 99999999999999988 99
Q ss_pred EEeeccCccc
Q 003156 699 RISDFGLARL 708 (843)
Q Consensus 699 kl~Dfgl~~~ 708 (843)
.++|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.1e-10 Score=122.85 Aligned_cols=125 Identities=30% Similarity=0.367 Sum_probs=56.0
Q ss_pred CcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchh-hhcccCCCcEEecc
Q 003156 278 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ-VIRNCTSLYLLSLS 356 (843)
Q Consensus 278 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls 356 (843)
|.+.+.++|.+.. ...++.-++.|+.|+|++|+++.. +.+..++.|++|||++|.++ .+|. ...++. |+.|+|+
T Consensus 166 L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 4444444444431 223344444444444444444422 14444445555555555554 2222 112222 5555555
Q ss_pred cccccccCCccccCCCCCCEEEccCCcccccC-CcchhcccccceEeeccccce
Q 003156 357 HNHLSGSIPKSISNLNKLKILKLEFNELSGEI-PQELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 357 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~ 409 (843)
+|.++ .+- .+.+|.+|+.|||++|-|++.- -..++.|..|..|+|.+|++.
T Consensus 241 nN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 55554 221 2445555555555555554322 122445555555666666553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.2e-09 Score=95.05 Aligned_cols=131 Identities=24% Similarity=0.283 Sum_probs=87.3
Q ss_pred CcEEEcCCCcccCCCCC---CccccccceEEEccCCcccccCCccccc-cCCCcEEEcCCCCCCCCchhhhcccCCCcEE
Q 003156 278 LRYLNLSSNHLRSRIPP---ELGYFHSLIHLDLRNNALYGSIPQEVCE-SRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 353 (843)
Q Consensus 278 L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 353 (843)
+..++|++++|.. +++ .+.....|+..+|++|.+. .+|+.|.. .+.+++|+|++|.|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4555666665532 222 2334456777788888887 55655554 357888888888888 677778888888888
Q ss_pred ecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCC
Q 003156 354 SLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 354 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 413 (843)
++++|.|. ..|..+..|.+|..|+..+|.+. .+|..+-.-+.....++.++++.+.-|
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 88888888 67777777888888888888887 555443222233334445555555544
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.9e-09 Score=105.92 Aligned_cols=62 Identities=23% Similarity=0.290 Sum_probs=30.3
Q ss_pred CccCEEeCCCCccceeC-CccccCCCCCcEEEcCCCcccCCCC-CCccccccceEEEccCCccc
Q 003156 252 QTLRILDLSSNNLVGDI-PAEMGLFANLRYLNLSSNHLRSRIP-PELGYFHSLIHLDLRNNALY 313 (843)
Q Consensus 252 ~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 313 (843)
+++..+-+..|.++..- -+.+..++.+..|+|+.|+|.+|.. +.+.++++|..|.+++|.+.
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 34444444444443211 1223344455556666666655533 34555556666666666555
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.5e-10 Score=120.48 Aligned_cols=179 Identities=25% Similarity=0.273 Sum_probs=127.9
Q ss_pred ccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCc------cc---CCCCCCccccccceEEEccCCcccccCCc
Q 003156 248 STLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH------LR---SRIPPELGYFHSLIHLDLRNNALYGSIPQ 318 (843)
Q Consensus 248 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~------l~---~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 318 (843)
+..|.+|+.|.|.++.|.. .-....--..|+.|...+.- +. +.+-..+.| ..|...+.++|++. .+..
T Consensus 105 ifpF~sLr~LElrg~~L~~-~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~W-n~L~~a~fsyN~L~-~mD~ 181 (1096)
T KOG1859|consen 105 IFPFRSLRVLELRGCDLST-AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVW-NKLATASFSYNRLV-LMDE 181 (1096)
T ss_pred eccccceeeEEecCcchhh-hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhh-hhHhhhhcchhhHH-hHHH
Confidence 3457788888888888863 22222222345555443321 00 111112222 36889999999998 7778
Q ss_pred cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCc-cccCCCCCCEEEccCCcccccCCcchhcccc
Q 003156 319 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK-SISNLNKLKILKLEFNELSGEIPQELGKLAS 397 (843)
Q Consensus 319 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 397 (843)
.+.-++.|+.|+|++|++.... .+..|+.|+.|||+.|+|. .+|. ....+. |+.|.|++|.++.. ..+.+|.+
T Consensus 182 SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lks 255 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKS 255 (1096)
T ss_pred HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhhh
Confidence 8888999999999999998543 8899999999999999999 5664 233444 99999999999833 35789999
Q ss_pred cceEeeccccceecCC--CCCCCCCCCCCCcCCCCCCCCC
Q 003156 398 LLAVNVSYNRLIGRLP--VGGVFPTLDQSSLQGNLGICSP 435 (843)
Q Consensus 398 L~~l~ls~N~l~~~~p--~~~~~~~~~~~~~~~n~~~c~~ 435 (843)
|+.|||++|-|.+--- ....+..+....++|||.-|.+
T Consensus 256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 9999999999876432 1234456677789999988873
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.7e-06 Score=83.97 Aligned_cols=139 Identities=17% Similarity=0.089 Sum_probs=102.8
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecC--Cc---ccChHHHHHHHHHHHhccC--CCccceeeEEE-c--C--CeeEE
Q 003156 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DI---IQYPEDFEREVRVLGKARH--PNLISLEGYYW-T--P--QLKLL 629 (843)
Q Consensus 562 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~---~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~-~--~--~~~~l 629 (843)
-|+||.+-|++..+ +|..+-+|+-... .. +-....|.+|...+.++.. -.+.+.. ++. . + ..-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 47899999999887 4667899986311 11 1234679999999999953 2244444 332 1 1 23579
Q ss_pred EEEeCCC-CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC--cEEeeccCc
Q 003156 630 VSDYAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN--PRISDFGLA 706 (843)
Q Consensus 630 V~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~ 706 (843)
|+|-+++ -+|.+++.... ..+.+...+..+..++++.++-||+. ++.|+|+.+.||+++.++. |+++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9998764 48988886642 23456777889999999999999999 9999999999999986666 999999876
Q ss_pred cc
Q 003156 707 RL 708 (843)
Q Consensus 707 ~~ 708 (843)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 53
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-09 Score=106.14 Aligned_cols=178 Identities=28% Similarity=0.317 Sum_probs=108.4
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
.|++||||+-.|+.+--....+.|.+|+-|.|.++++..-....+..-.+|+.|+|+.+. |.......-.+.+++.|.
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~s--G~t~n~~~ll~~scs~L~ 263 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCS--GFTENALQLLLSSCSRLD 263 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeecccccc--ccchhHHHHHHHhhhhHh
Confidence 478888888888744445567788888888888888887666677777888888888753 221122223456678888
Q ss_pred EEecCCccCcccCchh-hhc-CCCCCEEEcCCCccc---ccCCCCCCCCCCCcEEEccCCccc-ccCCchhhcccCCcEE
Q 003156 83 TLDLSHNLFSGSIPQG-VAA-LHYLKELLLQGNQFS---GPLPADIGFCPHLTTLDLSNNLFT-GQLPVSLRLLNSMIFI 156 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~-~~~-l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L 156 (843)
.|+|++|.+....-.. +.. -.+|+.|+|+++.=. .-+..-...+++|.+||||+|..- ...-..|..++.|++|
T Consensus 264 ~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~l 343 (419)
T KOG2120|consen 264 ELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHL 343 (419)
T ss_pred hcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheee
Confidence 8888888776332221 111 246778888776421 011112245778888888876532 2112344556666666
Q ss_pred EeecCcccccCCCC---ccCCCCccEEEccc
Q 003156 157 SVSNNTLTGDIPHW---IGNISTLEFLDFSN 184 (843)
Q Consensus 157 ~L~~N~l~~~~p~~---~~~l~~L~~L~L~~ 184 (843)
+++.|.. ++|.. +...++|.+|++.+
T Consensus 344 SlsRCY~--i~p~~~~~l~s~psl~yLdv~g 372 (419)
T KOG2120|consen 344 SLSRCYD--IIPETLLELNSKPSLVYLDVFG 372 (419)
T ss_pred ehhhhcC--CChHHeeeeccCcceEEEEecc
Confidence 6666643 34432 33445555555443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.2e-08 Score=107.05 Aligned_cols=152 Identities=18% Similarity=0.279 Sum_probs=103.8
Q ss_pred HHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce-------eccccccccccCCcccccC
Q 003156 663 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-------MSNRFQSALGYVAPELTCQ 735 (843)
Q Consensus 663 ~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~ 735 (843)
.+++.|+.|+|.. +++||++|.|++|.++..+.+||+.|+.+........+. ...-......|.|||++ .
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~-~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL-L 182 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh-c
Confidence 3455899999975 589999999999999999999999999876554321111 01111223569999998 4
Q ss_pred cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCC
Q 003156 736 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHI 815 (843)
Q Consensus 736 ~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~ 815 (843)
....+.++|+||+||++|-+..|..+.........+... . ....+.....+....+.++.+=+.+.+..+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~---------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-S---------RNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-h---------hcccccccccccccCcHHHHHHHHHHhcCC
Confidence 467889999999999999998655554333222211111 0 001122222344566677888888999999
Q ss_pred CCCCCCHHHHHH
Q 003156 816 PSSRPSMAEVVQ 827 (843)
Q Consensus 816 P~~RPs~~evl~ 827 (843)
+..||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999998777643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.4e-06 Score=86.43 Aligned_cols=135 Identities=19% Similarity=0.146 Sum_probs=92.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-----------------cc----ChHHHHHHHHHHHhccCC--
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-----------------IQ----YPEDFEREVRVLGKARHP-- 612 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------------~~----~~~~~~~E~~~l~~l~h~-- 612 (843)
...+..||.|--+.||.|... +|.++|||.-..... .. ......+|.++|+++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 344568999999999999986 799999996422110 00 112456899999998644
Q ss_pred CccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 613 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
.|.+.+++ +.-.+||||++|--|... +++....-.++..|.+-+.-.-.. ||||+|+++-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 56666554 345799999988544221 112233334444455544444445 99999999999999
Q ss_pred cCCCCcEEeeccCcc
Q 003156 693 DDNYNPRISDFGLAR 707 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~ 707 (843)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.8e-06 Score=84.69 Aligned_cols=106 Identities=25% Similarity=0.289 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHhccC--CCccceeeEEEcCC----eeEEEEEeCCCC-CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHH
Q 003156 597 EDFEREVRVLGKARH--PNLISLEGYYWTPQ----LKLLVSDYAPNG-SLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669 (843)
Q Consensus 597 ~~~~~E~~~l~~l~h--~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l 669 (843)
....+|...+..+.. =.+.+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 457788888888753 33556667665432 348999999874 8999988742 255566788999999999
Q ss_pred HhhhhcCCCCeeecCCCCCCEEEcCCC---CcEEeeccCcccc
Q 003156 670 AHLHHSFRPPIIHYNLKPSNILLDDNY---NPRISDFGLARLL 709 (843)
Q Consensus 670 ~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~ 709 (843)
+-||+. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999776 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 843 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-35 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-24 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-05 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-128
Identities = 135/480 (28%), Positives = 219/480 (45%), Gaps = 32/480 (6%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGK-IFNYCSSLNTLNLS 59
++ L LS+N SG +P L+ L L+ N G + + + N +SL TL+LS
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
+N+FSG + L+ L L +N F+G IP ++ L L L N SG +
Sbjct: 377 SNNFSGPIL--PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 120 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
P+ +G L L L N+ G++P L + ++ + + N LTG+IP + N + L +
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSI 238
+ SNN LTG +P + + L++++L NS +GNIP L D L +DL+ N F G+I
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI 554
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN--HLRSRIPPEL 296
P S +++N + G + + + + N + +L
Sbjct: 555 PAAMFKQS----------GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604
Query: 297 GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 356
+ ++ + G + S+ L + N L+G IP+ I + L++L+L
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
Query: 357 HNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGG 416
HN +SGSIP + +L L IL L N+L G IPQ + L L +++S N L G +P G
Sbjct: 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724
Query: 417 VFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHH 476
F T + N G+C L C + + DG+ H +HHH
Sbjct: 725 QFETFPPAKFLNNPGLCGYPLP-RC---------------DPSNADGYAHHQRSHHHHHH 768
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-122
Identities = 151/417 (36%), Positives = 222/417 (53%), Gaps = 19/417 (4%)
Query: 3 NMKFLDLSNNLLSGPVP--YQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+++ LDLS N +SG + L + C L++L+++GN + G + + C +L L++S+
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSR-CVNLEFLDVSS 209
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N+FS + F + L+ LD+S N SG + ++ LK L + NQF GP+P
Sbjct: 210 NNFSTGIPF-----LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLR-LLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
L L L+ N FTG++P L +++ + +S N G +P + G+ S LE
Sbjct: 265 PLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 180 LDFSNNHLTGSLP-SSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMG 236
L S+N+ +G LP +L + L V+ L N +G +PE L +L L +DLS N F G
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 296
I P + +TL + L L +N G IP + + L L+LS N+L IP L
Sbjct: 383 PILPNLCQNPKNTL----QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 297 GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 356
G L L L N L G IPQE+ ++L L LD N LTG IP + NCT+L +SLS
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 357 HNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413
+N L+G IPK I L L ILKL N SG IP ELG SL+ ++++ N G +P
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-112
Identities = 133/418 (31%), Positives = 201/418 (48%), Gaps = 18/418 (4%)
Query: 3 NMKFLDLSNNLLSGPVPYQL-FENCASLRYLSLAGNILQGPI-GKIFNYCSSLNTLNLSN 60
++ LDLS N LSGPV +C+ L++L+++ N L P +SL L+LS
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N SG L+ L +S N SG + V+ L+ L + N FS +P
Sbjct: 161 NSISGAN-VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+G C L LD+S N +G ++ + +++S+N G IP + +L++L
Sbjct: 218 F-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYL 274
Query: 181 DFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSI 238
+ N TG +P L C L+ + L GN G +P LE + LS N F G +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG-LFANLRYLNLSSNHLRSRIPPELG 297
P + L++LDLS N G++P + L A+L L+LSSN+ I P L
Sbjct: 335 PMDTLLKMRG-----LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389
Query: 298 --YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 355
++L L L+NN G IP + L L L N L+G IP + + + L L L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 356 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413
N L G IP+ + + L+ L L+FN+L+GEIP L +L +++S NRL G +P
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-109
Identities = 147/422 (34%), Positives = 210/422 (49%), Gaps = 27/422 (6%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPI--GKIFNYCSSLNTLNLSN 60
++ L LSN+ ++G V F+ ASL L L+ N L GP+ CS L LN+S+
Sbjct: 78 GLESLFLSNSHINGSVS--GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSS 135
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA---LHYLKELLLQGNQFSG 117
N + G L L LDLS N SG+ G LK L + GN+ SG
Sbjct: 136 NTLDFPGKVSGGL---KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 118 PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTL 177
+ + C +L LD+S+N F+ +P L +++ + +S N L+GD I + L
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 178 EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFM 235
+ L+ S+N G +P K L + L N G IP+ L L +DLS N F
Sbjct: 250 KLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307
Query: 236 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM-GLFANLRYLNLSSNHLRSRIPP 294
G++PP S S L L LSSNN G++P + L+ L+LS N +P
Sbjct: 308 GAVPPFFGSCSL------LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
Query: 295 ELGYFH-SLIHLDLRNNALYGSIPQEVCES--RSLGILQLDGNSLTGPIPQVIRNCTSLY 351
L SL+ LDL +N G I +C++ +L L L N TG IP + NC+ L
Sbjct: 362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV 421
Query: 352 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGR 411
L LS N+LSG+IP S+ +L+KL+ LKL N L GEIPQEL + +L + + +N L G
Sbjct: 422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGE 481
Query: 412 LP 413
+P
Sbjct: 482 IP 483
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-106
Identities = 129/418 (30%), Positives = 195/418 (46%), Gaps = 24/418 (5%)
Query: 7 LDLSNNLLS---GPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF 63
+DLS+ L+ V L + L L L+ + + G + +SL +L+LS N
Sbjct: 55 IDLSSKPLNVGFSAVSSSLL-SLTGLESLFLSNSHINGSVSGFKC-SASLTSLDLSRNSL 112
Query: 64 SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP-QGVAALHYLKELLLQGNQFSGPLPAD 122
SG + + + S L+ L++S N G L+ L+ L L N SG
Sbjct: 113 SGPVT--TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 123 I---GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
C L L +S N +G + VS ++ F+ VS+N + IP ++G+ S L+
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP-FLGDCSALQH 227
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239
LD S N L+G ++ C +L ++ + N G IP L+ + L+EN F G IP
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK-SLQYLSLAENKFTGEIP 286
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGY 298
S + + L LDLS N+ G +P G + L L LSSN+ +P + L
Sbjct: 287 DFLSGACDT-----LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
Query: 299 FHSLIHLDLRNNALYGSIPQEVCE-SRSLGILQLDGNSLTGPIPQVIRNC--TSLYLLSL 355
L LDL N G +P+ + S SL L L N+ +GPI + +L L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 356 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413
+N +G IP ++SN ++L L L FN LSG IP LG L+ L + + N L G +P
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = 3e-94
Identities = 116/401 (28%), Positives = 185/401 (46%), Gaps = 31/401 (7%)
Query: 28 SLRYLSLAGNILQGPIGKI---FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84
+ + L+ L + + L +L LSN+H +G + G L +L
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-----GFKCSASLTSL 105
Query: 85 DLSHNLFSGSIP--QGVAALHYLKELLLQGNQFSGPLPADIGF-CPHLTTLDLSNNLFTG 141
DLS N SG + + + LK L + N P G L LDLS N +G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 142 QLPVSLRLLNSM---IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC 198
V L + +++S N ++GD+ + LEFLD S+N+ + +P L +C
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDC 222
Query: 199 KKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 257
L + + GN L+G+ + L+ +++S N F+G IPP S L+ L
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--------LQYL 274
Query: 258 DLSSNNLVGDIPAEM-GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 316
L+ N G+IP + G L L+LS NH +PP G L L L +N G +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 317 PQEV-CESRSLGILQLDGNSLTGPIPQVIRNCT-SLYLLSLSHNHLSGSIPKSISN--LN 372
P + + R L +L L N +G +P+ + N + SL L LS N+ SG I ++ N
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
Query: 373 KLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413
L+ L L+ N +G+IP L + L+++++S+N L G +P
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-50
Identities = 73/273 (26%), Positives = 120/273 (43%), Gaps = 21/273 (7%)
Query: 169 HWIG---NISTLEFLDFSNNHLT---GSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 222
+ G + +D S+ L ++ SSL + L + L + +NG++
Sbjct: 41 TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSA 100
Query: 223 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL-FANLRYL 281
L +DLS N G + +S S S L+ L++SSN L GL +L L
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCS----GLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156
Query: 282 NLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 338
+LS+N + L HL + N + G + V +L L + N+ +
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFST 214
Query: 339 PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 398
IP + +C++L L +S N LSG ++IS +LK+L + N+ G IP L SL
Sbjct: 215 GIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSL 271
Query: 399 LAVNVSYNRLIGRLP--VGGVFPTLDQSSLQGN 429
++++ N+ G +P + G TL L GN
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-100
Identities = 108/274 (39%), Positives = 167/274 (60%), Gaps = 11/274 (4%)
Query: 562 VGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
+G G FG VYK G G ++AVK+L F+ EV ++ A H NL+ L G
Sbjct: 38 LGRGGFGKVYK---GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ TP +LLV Y NGS+ + L ER S PPL W R ++ LG+A+GLA+LH P
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
IIH ++K +NILLD+ + + DFGLA+L+ D HV + + +G++APE + +
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPE-YLSTGKS 212
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYG---EDNVVILSEHVRVLLEEGNVLDCVDPSM-GD 795
+EK D++G+GV++LEL+TG+R + D+ V+L + V+ LL+E + VD + G+
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 272
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829
Y ++EV ++++AL+CT P RP M+EVV++L
Sbjct: 273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 7e-90
Identities = 99/292 (33%), Positives = 147/292 (50%), Gaps = 25/292 (8%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDII---QYPEDFEREVRVL 606
D + ++GEG FG VYK G +AVKKL I + + F++E++V+
Sbjct: 28 DERPISVGGNKMGEGGFGVVYK---GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
K +H NL+ L G+ LV Y PNGSL +L TPPLSW R K+ G A
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAA 143
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
G+ LH IH ++K +NILLD+ + +ISDFGLAR + + VM++R
Sbjct: 144 NGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 727 YVAPE-----LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL- 780
Y+APE +T K DIY FGV++LE++TG V+ + ++L + +
Sbjct: 201 YMAPEALRGEIT-------PKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-DIKEEIED 252
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
EE + D +D M D V + +A C + RP + +V Q+LQ +
Sbjct: 253 EEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-79
Identities = 92/275 (33%), Positives = 143/275 (52%), Gaps = 16/275 (5%)
Query: 562 VGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
+G GVFG VYK G G +A+K+ T + Q E+FE E+ L RHP+L+SL G
Sbjct: 47 IGHGVFGKVYK---GVLRDGAKVALKRR-TPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ +L+ Y NG+L+ L+ T +SW R ++ +G A+GL +LH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RA 159
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK-HVMSNRFQSALGYVAPE-LTCQSL 737
IIH ++K NILLD+N+ P+I+DFG+++ T LD+ H+ S + LGY+ PE L
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL-STVVKGTLGYIDPEYFIKGRL 218
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYG-EDNVVILSEHVRVLLEEGNVLDCVDPSM-GD 795
EK D+Y FGV++ E++ R + +V L+E G + VDP++
Sbjct: 219 --TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ + A+ C RPSM +V+ L+
Sbjct: 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-78
Identities = 80/331 (24%), Positives = 128/331 (38%), Gaps = 40/331 (12%)
Query: 119 LPADIGFCPHL----TTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG--DIPHWIG 172
+ D+G L T D N + G L + + + +S L IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 173 NISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSE 231
N+ L FL N+L G +P ++ +L + + +++G IP+ L +
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI--------- 124
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291
+TL LD S N L G +P + NL + N +
Sbjct: 125 --------------------KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 292 IPPELGYFHSLI-HLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 350
IP G F L + + N L G IP + +L + L N L G + + +
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 351 YLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410
+ L+ N L+ + + L L L N + G +PQ L +L L ++NVS+N L G
Sbjct: 224 QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 411 RLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 441
+P GG D S+ N +C L C
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-63
Identities = 76/285 (26%), Positives = 114/285 (40%), Gaps = 19/285 (6%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG--PIGKIFNYCSSLNTLNLSN-NHF 63
D N G + + L L+G L PI LN L + N+
Sbjct: 31 TDCCNRTWLGVLCDTDT-QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 64 SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI 123
G + I L +L L ++H SG+IP ++ + L L N SG LP I
Sbjct: 90 VGPI----PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 124 GFCPHLTTLDLSNNLFTGQLPVSL-RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
P+L + N +G +P S +++S N LTG IP N++ L F+D
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDL 204
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPG 241
S N L G + K I L NSL ++ + + L +DL N G++P G
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 286
+ + L L++S NNL G+IP G ++N
Sbjct: 264 LTQ------LKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-53
Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 9/242 (3%)
Query: 3 NMKFLDLSN-NLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNN 61
+ FL + N L GP+P + L YL + + G I + +L TL+ S N
Sbjct: 77 YLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELL-LQGNQFSGPLP 120
SG L + I SL L + N SG+IP + L + + N+ +G +P
Sbjct: 136 ALSGTLPPS----ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+L +DLS N+ G V + I ++ N+L D+ +G L L
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGL 249
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240
D NN + G+LP L K L + + N+L G IP+G + + N + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
Query: 241 GS 242
+
Sbjct: 310 PA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 40/122 (32%), Positives = 57/122 (46%), Gaps = 9/122 (7%)
Query: 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNN 61
+N+ F+DLS N+L G + + + + LA N L +GK+ +LN L+L NN
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLGKVGL-SKNLNGLDLRNN 254
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF--SGPL 119
G L G+ LK L +L++S N G IPQG L N+ PL
Sbjct: 255 RIYGTLPQ----GLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
Query: 120 PA 121
PA
Sbjct: 310 PA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 19/96 (19%), Positives = 38/96 (39%), Gaps = 7/96 (7%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
N + + L+ N L+ + +L L L N + G + + L++LN+S
Sbjct: 220 DKNTQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 96
N+ G++ +L+R ++N P
Sbjct: 278 NNLCGEIP-----QGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-70
Identities = 89/441 (20%), Positives = 156/441 (35%), Gaps = 23/441 (5%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ LD+ N +S + +L + L+ L+L N L K F +C++L L+L +N
Sbjct: 50 QLTSLDVGFNTISK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+ K L TLDLSHN S + L L+ELLL N+ +
Sbjct: 109 IQKIKNNP----FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164
Query: 123 IGFC--PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIG---NISTL 177
+ L L+LS+N P + + + ++N L + + +++
Sbjct: 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224
Query: 178 EFLDFSNNHLTGSLPSSLFNCK--KLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGF 234
L SN+ L+ + ++ K L+++ L N+LN + L LE L N
Sbjct: 225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
Query: 235 MGSIPP---GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291
G + L ++ +S +L L +LN+ N +
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344
Query: 292 IPPELGYFHSLIHLDLRNNAL-YGSIPQEVCES---RSLGILQLDGNSLTGPIPQVIRNC 347
+L +L L N+ ++ E S L IL L N ++
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404
Query: 348 TSLYLLSLSHNHLSGSIPKS-ISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 406
L +L L N + + L + + L +N+ + SL + +
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 407 RLIGRLPVGGVFPTLDQSSLQ 427
L F L +L
Sbjct: 465 ALKNVDSSPSPFQPL--RNLT 483
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-69
Identities = 98/424 (23%), Positives = 156/424 (36%), Gaps = 23/424 (5%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+K L+L +N LS + + F C +L L L N +Q F +L TL+LS+N
Sbjct: 74 MLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH--YLKELLLQGNQFSGPLP 120
S L+ L+ L LS+N + + LK+L L NQ P
Sbjct: 133 LSSTKLGT----QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRL---LNSMIFISVSNNTLTGDIPHWIGN--IS 175
L L L+N L L L S+ +S+SN+ L+ +
Sbjct: 189 GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
Query: 176 TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGF 234
L LD S N+L S +L L N++ L L + ++L +
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308
Query: 235 MGSIPPGSSSSSSSTLFQ---TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291
SI S FQ L L++ N++ G NL+YL+LS++ R
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 292 IPPELGYFH----SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP-QVIRN 346
+ L L+L N + L +L L N + + Q R
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
Query: 347 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSG--EIPQELGKLASLLAVNVS 404
+++ + LS+N S + + L+ L L L P L +L +++S
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488
Query: 405 YNRL 408
N +
Sbjct: 489 NNNI 492
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-66
Identities = 87/438 (19%), Positives = 162/438 (36%), Gaps = 40/438 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCA--SLRYLSLAGNILQGPIGKIFNYC--SSLNTLNL 58
+ L L+N L + +L A S+R LSL+ + L F ++L L+L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 59 SNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP 118
S N+ + + + L +L L +N + L ++ L L+ +
Sbjct: 256 SYNNLNVVGNDS----FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 119 L---------PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPH 169
+ + L L++ +N G L ++ ++S+SN+ +
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 170 ----WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LG 223
S L L+ + N ++ + L V+ L N + + +
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL--VGDIPAEMGLFANLRYL 281
+ EI LS N ++ +S L +L+ L L L V P+ NL L
Sbjct: 432 IFEIYLSYNKYLQLTR------NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTIL 485
Query: 282 NLSSNHLRSRIPPELGYFHSLIHLDLRNN--------ALYGSIPQEVCESRSLGILQLDG 333
+LS+N++ + L L LDL++N A G + L IL L+
Sbjct: 486 DLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 334 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELG 393
N +V ++ L ++ L N+L+ +N LK L L+ N ++ + G
Sbjct: 546 NGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFG 605
Query: 394 K-LASLLAVNVSYNRLIG 410
+L +++ +N
Sbjct: 606 PAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-64
Identities = 84/430 (19%), Positives = 138/430 (32%), Gaps = 48/430 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+ L+L++N L +P F + L L + N + ++ L LNL +N
Sbjct: 26 NITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
S D L L L N L L L N S
Sbjct: 85 LSQLSDKT----FAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT 140
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+L L LSNN L + + S+L+ L+
Sbjct: 141 QVQLENLQELLLSNNKIQALKSEELDIFAN----------------------SSLKKLEL 178
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD----LGLEEIDLSENGFMGSI 238
S+N + P +L + L L ++ E L + + LS +
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-T 237
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 298
+ T L +LDLS NNL L Y L N+++ L
Sbjct: 238 SNTTFLGLKWT---NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294
Query: 299 FHSLIHLDLRNNALYGSIPQEVCES---------RSLGILQLDGNSLTGPIPQVIRNCTS 349
++ +L+L+ + SI + L L ++ N + G + +
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN 354
Query: 350 LYLLSLSHNHLSGSIPKSIS----NLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSY 405
L LSLS++ S + + + L IL L N++S L L +++
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414
Query: 406 NRLIGRLPVG 415
N + L
Sbjct: 415 NEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 4e-59
Identities = 73/396 (18%), Positives = 133/396 (33%), Gaps = 36/396 (9%)
Query: 52 SLNTLNLSNNHFS---GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 108
S + S+ + DL + L+L+HN L L
Sbjct: 5 SHEVADCSHLKLTQVPDDL----------PTNITVLNLTHNQLRRLPAANFTRYSQLTSL 54
Query: 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 168
+ N S P P L L+L +N + + ++ + + +N++
Sbjct: 55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 169 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG---LE 225
+ L LD S+N L+ + + + L + L N + E L L+
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 226 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN---LRYLN 282
+++LS N PG + L L L++ L + ++ L +R L+
Sbjct: 175 KLELSSNQIKE-FSPGCFHAIGR-----LFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 283 LSSNHLRSRIPPELGYFH--SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI 340
LS++ L + +L LDL N L L L+ N++
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 341 PQVIRNCTSLYLLSLSHN---------HLSGSIPKSISNLNKLKILKLEFNELSGEIPQE 391
+ ++ L+L + L S L L+ L +E N++ G
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
Query: 392 LGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 427
L +L +++S + R F +L S L
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-41
Identities = 64/327 (19%), Positives = 117/327 (35%), Gaps = 27/327 (8%)
Query: 1 MMNMKFLDLSNNLLS-GPVPYQLFENCA--SLRYLSLAGNILQGPIGKIFNYCSSLNTLN 57
++N+K+L LSN+ S + + F + A L L+L N + F++ L L+
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411
Query: 58 LSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG 117
L N +L L+ + + LS+N + A + L+ L+L+
Sbjct: 412 LGLNEIGQELTGQE---WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 118 --PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT--------GDI 167
P+ +LT LDLSNN L L + + + +N L G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 168 PHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEE 226
+++ +S L L+ +N + +L +I L N+LN + L+
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 227 IDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 286
++L +N F+ L LD+ N + + + +
Sbjct: 589 LNLQKNLITSVEK-----KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIP 643
Query: 287 HLRSRI----PPELGYFHSLIHLDLRN 309
L S PP + + D +
Sbjct: 644 ELSSHYLCNTPPHY-HGFPVRLFDTSS 669
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 9e-70
Identities = 71/454 (15%), Positives = 132/454 (29%), Gaps = 65/454 (14%)
Query: 7 LDLSNNLLSGPVPYQL-FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSG 65
E+ + L + + Q I K + +N+ +
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 66 DLDFASGYGIWSLKRLRTLDLSHNLFSG-------------------SIPQGVAALHYLK 106
+ L +LR + ++ F + L L
Sbjct: 198 VSK-----AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLT 252
Query: 107 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT--------GQLPVSLRLLNSMIFISV 158
++ + LP + P + ++++ N Q + + I +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 159 SNNTL-TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 217
N L T + + + L L+ N L G LP + + KL+ + L N + IP
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPA 370
Query: 218 GLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG-------DI 268
+E + + N IP + S + +D S N + +
Sbjct: 371 NFCGFTEQVENLSFAHNKL-KYIPNIFDAKS----VSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 269 PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL-------YGSIPQEVC 321
N+ +NLS+N + L ++L N L +
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 322 ESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLE 380
+ L + L N LT L + LS+N S P N + LK +
Sbjct: 486 NTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR 544
Query: 381 ------FNELSGEIPQELGKLASLLAVNVSYNRL 408
N E P+ + SL + + N +
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 3e-69
Identities = 72/443 (16%), Positives = 140/443 (31%), Gaps = 63/443 (14%)
Query: 3 NMKFLDLSNNLLSGPVPYQL------------------FENCASLRYLSLAGNILQGPIG 44
++ + N+ + ++N L + + +
Sbjct: 207 KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266
Query: 45 KIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS----LKRLRTLDLSHN-LFSGSIPQGV 99
+ +N++ N + + ++++ + + +N L + + +
Sbjct: 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
Query: 100 AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159
+ L L NQ G LPA G L +L+L+ N T + +S +
Sbjct: 327 QKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFA 385
Query: 160 NNTLTGDIPHW--IGNISTLEFLDFSNNHLTG-------SLPSSLFNCKKLSVIRLRGNS 210
+N L IP+ ++S + +DFS N + L + F +S I L N
Sbjct: 386 HNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ 444
Query: 211 LNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQ--TLRILDLSSNNLVGD 267
++ E L I+L N IP S + L +DL N L
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK- 502
Query: 268 IPAEMGL--FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRS 325
+ + L ++LS N S+ P + +L +RN
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ--------------- 546
Query: 326 LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385
GN P+ I C SL L + N + + + I + +L ++ N
Sbjct: 547 ---RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNI 600
Query: 386 GEIPQELGKLASLLAVNVSYNRL 408
+ + Y++
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 5e-69
Identities = 65/436 (14%), Positives = 130/436 (29%), Gaps = 47/436 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGP----IGKIFNYCSSLNTLNL 58
+ L L SG VP + L L+L + + K + S
Sbjct: 82 RVTGLSLEGFGASGRVPDAIG-QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQK 140
Query: 59 SNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP 118
H+ F L ++ + SI + ++ N +
Sbjct: 141 MRMHYQK--TFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF- 197
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
+ + L + N+ F + + N+ L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLT 252
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL--------NGNIPEGLFDLG-LEEIDL 229
++ N LP+ L ++ +I + N + ++ I +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 230 SENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR 289
N S L +L+ N L G +P G L LNL+ N +
Sbjct: 313 GYNNLKTFPVETSLQKMKK-----LGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI- 365
Query: 290 SRIPPEL-GYFHSLIHLDLRNNALYGSIPQ--EVCESRSLGILQLDGNSLTG-------P 339
+ IP G+ + +L +N L IP + + + N + P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 340 IPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSG-------EIPQEL 392
+ ++ ++LS+N +S + S + L + L N L+ + +
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 393 GKLASLLAVNVSYNRL 408
L ++++ +N+L
Sbjct: 485 KNTYLLTSIDLRFNKL 500
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 2e-63
Identities = 61/408 (14%), Positives = 129/408 (31%), Gaps = 45/408 (11%)
Query: 41 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG----SIP 96
G N + L+L SG + A I L L L L + P
Sbjct: 71 AQPGVSLNSNGRVTGLSLEGFGASGRVPDA----IGQLTELEVLALGSHGEKVNERLFGP 126
Query: 97 QGVAALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLNSMI 154
+G++A ++ + L ++++ + S R+
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 155 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG-------------------SLPSSL 195
I +N +T + + ++ L N+ +
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245
Query: 196 FNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMG--SIPPGSSSSSSSTLFQ 252
N K L+ + + +P L L ++ I+++ N + + + + + + +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 253 TLRILDLSSNNL-VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 311
++I+ + NNL + + L L N L P G L L+L N
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQ 364
Query: 312 LYGSIPQEVCE-SRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSG------- 362
+ IP C + + L N L P ++ + + + S+N +
Sbjct: 365 I-TEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 363 SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410
+ + + + L N++S + + L ++N+ N L
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-60
Identities = 71/376 (18%), Positives = 131/376 (34%), Gaps = 41/376 (10%)
Query: 3 NMKFLDLS-NNLLSGPVPYQLFE------NCASLRYLSLAGN-ILQGPIGKIFNYCSSLN 54
M+ ++++ N +SG ++ ++ + + N + P+ L
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333
Query: 55 TLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQ 114
L N G L S +L +L+L++N + ++ L N+
Sbjct: 334 MLECLYNQLEGKLP-----AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK 388
Query: 115 FSG-PLPADIGFCPHLTTLDLSNNLFTG-------QLPVSLRLLNSMIFISVSNNTLTGD 166
P D ++ +D S N L + ++ I++SNN ++
Sbjct: 389 LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448
Query: 167 IPHWIGNISTLEFLDFSNNHLTG-------SLPSSLFNCKKLSVIRLRGNSLNGNIPEGL 219
S L ++ N LT + N L+ I LR N L + +
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDF 507
Query: 220 FDLG---LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
L IDLS N F P +SS+ F D N + + P + L
Sbjct: 508 RATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
+L L + SN + ++ ++ ++ LD+++N VC G+ L +
Sbjct: 567 SLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK- 622
Query: 337 TGPIPQVIRNCTSLYL 352
Q IR C +L +
Sbjct: 623 ----TQDIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-52
Identities = 51/359 (14%), Positives = 124/359 (34%), Gaps = 34/359 (9%)
Query: 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 142
+ +++ + + + L L+G SG +P IG L L L ++
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 143 ----LPVSLRLLNSMIFISVSNNTLTGDIPHWIG--NISTLEFLDFSNNHLTGSLPSSLF 196
P + S + + S L +++ S+ S
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTL----- 250
K + I N++ + + + L L + + + F+ + + +S
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239
Query: 251 --------FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS--------RIPP 294
+ L +++ + + +P + ++ +N++ N S +
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 295 ELGYFHSLIHLDLRNNAL-YGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 353
+ + + + N L + + + + LG+L+ N L G +P + L L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASL 358
Query: 354 SLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQ--ELGKLASLLAVNVSYNRLIG 410
+L++N ++ +++ L N+L IP + ++ + A++ SYN +
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-41
Identities = 41/299 (13%), Positives = 97/299 (32%), Gaps = 28/299 (9%)
Query: 131 TLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG- 189
+ +++ Q VSL + +S+ +G +P IG ++ LE L ++
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 190 ---SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD---LGLEEIDLSENGFMGSIPPGSS 243
P + + + L + ++ + SI S
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 244 SSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLI 303
+ + SNN+ + + LR + ++ + E
Sbjct: 181 ITLK------DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA-----WE 228
Query: 304 HLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL--- 360
+ + Y + + + L +++ +P ++ + L++++ N
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 361 -----SGSIPKSISNLNKLKILKLEFNEL-SGEIPQELGKLASLLAVNVSYNRLIGRLP 413
K++I+ + +N L + + L K+ L + YN+L G+LP
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-34
Identities = 31/266 (11%), Positives = 75/266 (28%), Gaps = 39/266 (14%)
Query: 170 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN----IPEGLFDL-GL 224
+ + + L +G +P ++ +L V+ L + N P+G+
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 225 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 284
E+ + + S L + ++S+ I + +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIK----DCINSDPQQKSIKKSSRITLKDTQIGQL 191
Query: 285 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 344
SN++ + + L + N+
Sbjct: 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI--------------------------- 223
Query: 345 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404
C + + + + NL L +++ ++P L L + +NV+
Sbjct: 224 --CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 405 YNRLIGRLPVGGVFPTLDQSSLQGNL 430
NR I + + L + + +
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKI 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 41/201 (20%), Positives = 74/201 (36%), Gaps = 21/201 (10%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-------PIGKIFNYCSSL 53
+N+ ++LSNN +S P +LF + L ++L GN+L + F L
Sbjct: 432 GINVSSINLSNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 54 NTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL----- 108
+++L N + + + +L L +DLS+N FS P LK
Sbjct: 491 TSIDLRFNKLTK---LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 109 -LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDI 167
QGN+ P I CP LT L + +N + + ++ + + +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK--ITPNISVLDIKDNPNISID 603
Query: 168 PHWIGNISTLEFLDFSNNHLT 188
++ +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-63
Identities = 91/442 (20%), Positives = 168/442 (38%), Gaps = 44/442 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
++ LDLS + +++ + L L L GN +Q F+ SSL L +
Sbjct: 53 ELQVLDLSRCEIQTIED-GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLF-SGSIPQGVAALHYLKELLLQGNQFSGPLPA 121
+ +F I LK L+ L+++HNL S +P+ + L L+ L L N+
Sbjct: 112 LASLENFP----IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 122 DIGFCPHLT----TLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP-HWIGNIST 176
D+ + +LDLS N P + + + + +++ NN + ++ I ++
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAG 226
Query: 177 LEFLD------FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN---GNIPEGLFDL-GLEE 226
LE + +L S+L L++ R L+ +I + L +
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 227 IDLSENGFMGSIPPGSSSSSSSTL--------------FQTLRILDLSSNNLVGDIPAEM 272
L + S + L ++L+ L +SN +E+
Sbjct: 287 FSLVSVTI-ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-AFSEV 344
Query: 273 GLFANLRYLNLSSNHLRSR--IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330
L +L +L+LS N L + SL +LDL N + + L L
Sbjct: 345 DL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 402
Query: 331 LDGNSLTGPIPQ-VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI- 388
++L V + +L L +SH H + + L+ L++LK+ N
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 389 PQELGKLASLLAVNVSYNRLIG 410
P +L +L +++S +L
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQ 484
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-63
Identities = 90/449 (20%), Positives = 152/449 (33%), Gaps = 53/449 (11%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSL----NTL 56
+ +K L++++NL+ + F N +L +L L+ N +Q + +L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 57 NLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQF 115
+LS N + G + RL L L +N S ++ + L L+ L +F
Sbjct: 183 DLSLNPMNFIQP-----GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 116 SG---PLPADIGFCPHLTTLDLSNN------LFTGQLPVSLRLLNSMIFISVSNNTLTGD 166
D L L + + + L ++ S+ + T+
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 167 IPHWIGNISTLEFLDFSNNHLT-------------------GSLPSSLFNCKKLSVIRLR 207
+ L+ N G S + L + L
Sbjct: 298 KD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLS 355
Query: 208 GNSLN--GNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 264
N L+ G + F L+ +DLS NG + + L LD +NL
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQ------LEHLDFQHSNL 408
Query: 265 VGDIPAEM-GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV-CE 322
+ NL YL++S H R SL L + N+ + ++ E
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 323 SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382
R+L L L L P + +SL +L++SHN+ LN L++L N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 383 ELSGEIPQELGKLASLLAV-NVSYNRLIG 410
+ QEL S LA N++ N
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-60
Identities = 78/425 (18%), Positives = 140/425 (32%), Gaps = 30/425 (7%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLS 59
+ +++ L L+ + +L+ L++A N++Q + + F+ ++L L+LS
Sbjct: 99 LSSLQKLVAVETNLASLEN-FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
+N +LDLS N + P + L +L L+ N S +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNV 216
Query: 120 PAD-IGFCPHLTTLDLSNNLFTGQ---LPVSLRLLNSMIFISVSNNTLT------GDIPH 169
I L L F + L + +++ L DI
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 170 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDL 229
++ + + + S + L L L+ +
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKL--KSLKRLTF 332
Query: 230 SENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL--VGDIPAEMGLFANLRYLNLSSNH 287
+ N + S L LDLS N L G +L+YL+LS N
Sbjct: 333 TSNKGGNAFSEVDLPS--------LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 288 LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV-CESRSLGILQLDGNSLTGPIPQVIRN 346
+ + L HLD +++ L V R+L L + +
Sbjct: 385 V-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 347 CTSLYLLSLSHNHLSGSI-PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSY 405
+SL +L ++ N + P + L L L L +L P L+SL +N+S+
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 406 NRLIG 410
N
Sbjct: 504 NNFFS 508
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-58
Identities = 91/429 (21%), Positives = 146/429 (34%), Gaps = 37/429 (8%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ K LDLS N L + F + L+ L L+ +Q + S L+TL L+ N
Sbjct: 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF-SGPLPA 121
A L L+ L + + L LKEL + N S LP
Sbjct: 88 IQSLALGA----FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM----IFISVSNNTLTGDIPHWIGNISTL 177
+L LDLS+N LR+L+ M + + +S N + P I L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-L 202
Query: 178 EFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIP---------EGLFDLGLEEI 227
L NN + ++ + L V RL EGL +L +EE
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 287
L+ + + ++ + L S + ++L L +
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTN-----VSSFSLVSVTIERVKD--FSYNFGWQHLELVNCK 315
Query: 288 LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT--GPIPQVIR 345
+ P SL L +N + + SL L L N L+ G Q
Sbjct: 316 F-GQFPT--LKLKSLKRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 346 NCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVS 404
TSL L LS N + + + L +L+ L + + L L +L+ +++S
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 405 YNRLIGRLP 413
+
Sbjct: 430 HTHTRVAFN 438
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-58
Identities = 73/400 (18%), Positives = 128/400 (32%), Gaps = 47/400 (11%)
Query: 51 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 110
S L+LS N ++ +S L+ LDLS +L +L L+L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYS----FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 111 QGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG-DIPH 169
GN L L + L ++ ++V++N + +P
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 170 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV----IRLRGNSLNGNIPEGLFDLGLE 225
+ N++ LE LD S+N + + L ++ + + L N +N P ++ L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 226 EIDLSENGFMGSIPPGSSSSSSST----------------------LFQTLRILDLSSNN 263
++ L N ++ + + L L +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 264 L------VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317
L + DI N+ +L S + + Y HL+L N
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF----- 316
Query: 318 QEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS--GSIPKSISNLNKLK 375
+ + + +L S G + SL L LS N LS G +S LK
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 376 ILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 415
L L FN + + L L ++ ++ L
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-55
Identities = 73/417 (17%), Positives = 144/417 (34%), Gaps = 30/417 (7%)
Query: 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPI---GKIFNYCSSLNTLNL 58
+ + L L NN S V + A L L + + L L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 59 SNNHFSGDLDFASGYGIWS---LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF 115
+ LD+ I L + + L + + L L +F
Sbjct: 260 EEFRLAY-LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316
Query: 116 SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT--GDIPHWIGN 173
L L ++N S L S+ F+ +S N L+ G
Sbjct: 317 GQFPT---LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 174 ISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSE 231
++L++LD S N + + S+ ++L + + ++L +F L +D+S
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAE-MGLFANLRYLNLSSNHLRS 290
+ + SS L +L ++ N+ + + NL +L+LS L
Sbjct: 431 THTRVAFNGIFNGLSS------LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 291 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC-TS 349
P SL L++ +N + SL +L N + Q +++ +S
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
Query: 350 LYLLSLSHNHLSGSIPKS--ISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404
L L+L+ N + + + + + L +E + P + + +L++N++
Sbjct: 545 LAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-46
Identities = 62/386 (16%), Positives = 109/386 (28%), Gaps = 46/386 (11%)
Query: 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 140
+ LDLS N + L+ L L + HL+TL L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG-SLPSSLFNCK 199
+ L+S+ + L IG++ TL+ L+ ++N + LP N
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 200 KLSVIRLRGNSLNGNIPEGLFDLG----------------------------LEEIDLSE 231
L + L N + L L L ++ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS- 290
N ++ + L + + + + L L + L
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK--SALEGLCNLTIEEFRLAYL 267
Query: 291 -----RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR 345
I ++ L + + L+L ++
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLK 325
Query: 346 NCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS--GEIPQELGKLASLLAVNV 403
+ L L+ G S +L L+ L L N LS G Q SL +++
Sbjct: 326 S-----LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 404 SYNRLIGRLPVGGVFPTLDQSSLQGN 429
S+N +I L+ Q +
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 43/190 (22%), Positives = 70/190 (36%), Gaps = 14/190 (7%)
Query: 226 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSS 285
E F IP L + + LDLS N L F L+ L+LS
Sbjct: 11 TYQCMELNFY-KIPDN--------LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 286 NHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR 345
+++ L L L N + SL L +L I
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 346 NCTSLYLLSLSHNHL-SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL----LA 400
+ +L L+++HN + S +P+ SNL L+ L L N++ +L L + L+
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 401 VNVSYNRLIG 410
+++S N +
Sbjct: 182 LDLSLNPMNF 191
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 4e-63
Identities = 66/320 (20%), Positives = 119/320 (37%), Gaps = 36/320 (11%)
Query: 540 DSRSSSLDCSID----PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY 595
SS +D + L+ G FG V+K +AVK D +
Sbjct: 6 HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSW 63
Query: 596 PEDFEREVRVLGKARHPNLISLEGY----YWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 651
E EV L +H N++ G L++ + GSL L
Sbjct: 64 --QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----- 116
Query: 652 PLSWTNRFKVILGTAKGLAHLHH-------SFRPPIIHYNLKPSNILLDDNYNPRISDFG 704
+SW + A+GLA+LH +P I H ++K N+LL +N I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN----EKCDIYGFGVLILELVTGRR 760
LA ++ Y+APE+ ++ + D+Y G+++ EL +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 761 PVEY-GEDNVVILSEHVRVLLEEGNVLDCV-----DPSMGD-YPEDEVLPVL-KLALVCT 812
+ ++ ++ E + ++ + V P + D + + + +L + C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 813 CHIPSSRPSMAEVVQILQVI 832
H +R S V + + +
Sbjct: 297 DHDAEARLSAGCVGERITQM 316
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-61
Identities = 86/417 (20%), Positives = 156/417 (37%), Gaps = 24/417 (5%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ + L+ S N+L + F +L +L L + F L+TL L+ N
Sbjct: 34 STECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+ A + K L+ L S + L+ L L N S
Sbjct: 93 LIFMAETA----LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNS--MIFISVSNNTLTGDIPHWIGNISTLEFL 180
L LD NN + L + ++++ N + G I + + + L
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSL 207
Query: 181 DFSNNHLTGSLPSSLFNCK--KLSVIRLRGNSLNG---NIPEGLFDLGLEEIDLSENGFM 235
+F + L N L + + EGL ++ +E I+L ++ F
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF- 266
Query: 236 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE 295
+I + S L+ LDL++ +L ++P+ + + L+ L LS+N +
Sbjct: 267 FNISSNTFHCFSG-----LQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 296 LGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLT--GPIPQVIRNCTSLYL 352
F SL HL ++ N + E+ +L L L + + +RN + L
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380
Query: 353 LSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRL 408
L+LS+N ++ +L++L L F L + Q L L +N+S++ L
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-61
Identities = 79/439 (17%), Positives = 148/439 (33%), Gaps = 38/439 (8%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+K L +S + + N +L L L N + L L+ N
Sbjct: 104 PKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162
Query: 61 NHFSG---------------DLDFAS------GYGIWSLKRLRTLDLSHNLFSGSIPQGV 99
N L+ G + ++L+ I +G+
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
Query: 100 A--ALHYLKELLLQGNQFSGPLPADIGFCP--HLTTLDLSNNLFTGQLPVSLRLLNSMIF 155
+ L + PA + +++L + F + + +
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE 282
Query: 156 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 215
+ ++ L+ ++P + +STL+ L S N S N L+ + ++GN+ +
Sbjct: 283 LDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 216 PEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 273
G + L E+DLS + S + S L+ L+LS N +
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS----HLQSLNLSYNEPLSLKTEAFK 397
Query: 274 LFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 332
L L+L+ L+ + H L L+L ++ L S Q +L L L
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 333 GNSLTGPIPQ---VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIP 389
GN Q ++ L +L LS LS + ++L + + L N L+
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
Query: 390 QELGKLASLLAVNVSYNRL 408
+ L L + +N++ N +
Sbjct: 518 EALSHL-KGIYLNLASNHI 535
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-59
Identities = 86/442 (19%), Positives = 145/442 (32%), Gaps = 47/442 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ L L+ N L + +L++L + + +L +L L +NH
Sbjct: 82 RLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSG-------------------------SIPQ 97
S + + ++L+ LD +N I
Sbjct: 141 ISS-IKLPK---GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP 196
Query: 98 GVAALHYLKELLLQGNQFSGPLPADIGFC--PHLTTLDLSNNLFTGQLPVSLRLL--NSM 153
G + L G Q + + L + P L S+
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 154 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 213
I++ + + S L+ LD + HL+ LPS L L + L N
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315
Query: 214 NIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL--VGDIPA 270
+ L + + N + G + + LR LDLS +++
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN-----LRELDLSHDDIETSDCCNL 370
Query: 271 EMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGIL 329
++ ++L+ LNLS N S L LDL L Q ++ L +L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 330 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI---PKSISNLNKLKILKLEFNELSG 386
L + L Q+ +L L+L NH S+ L +L+IL L F +LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 387 EIPQELGKLASLLAVNVSYNRL 408
L + V++S+NRL
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRL 512
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 6e-52
Identities = 67/374 (17%), Positives = 129/374 (34%), Gaps = 23/374 (6%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQL-FENCASLRYLSLAGNILQGPIGKIFNYCSSLN--TLN 57
+ L+ + L SL + + +F ++ ++N
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 58 LSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG 117
L ++F L+ LDL+ S +P G+ L LK+L+L N+F
Sbjct: 261 LQKHYFFNISSNT----FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315
Query: 118 PLPADIGFCPHLTTLDLS-NNLFTGQLPVSLRLLNSMIFISVSNNTLT--GDIPHWIGNI 174
P LT L + N L L ++ + +S++ + + N+
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 175 STLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSEN 232
S L+ L+ S N + C +L ++ L L + F L+ ++LS +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 233 GFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN---LRYLNLSSNHLR 289
+ + L+ L+L N+ + L L LS L
Sbjct: 436 -LLDISSEQLFDGLPA-----LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 290 SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTS 349
S + H+DL +N L S + + + + L L N ++ +P ++ +
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548
Query: 350 LYLLSLSHNHLSGS 363
++L N L +
Sbjct: 549 QRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-51
Identities = 81/390 (20%), Positives = 142/390 (36%), Gaps = 20/390 (5%)
Query: 6 FLDLSNNLLSGPVPYQLFENCASLRYLSLAGN--ILQGPIGKIFNYCSSLNTLNLSNNHF 63
L+L+ N ++G + F + A + L+ G +L G + SL +
Sbjct: 183 SLNLNGNDIAG-IEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 64 SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI 123
D+ A G+ + + +++L + F L+EL L S LP+ +
Sbjct: 241 E-DISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGL 297
Query: 124 GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDI-PHWIGNISTLEFLDF 182
L L LS N F +S S+ +S+ NT ++ + N+ L LD
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 183 SNNHLTGS--LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIP 239
S++ + S L N L + L N E + LE +DL+
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
+ L++L+LS + L L++LNL NH +
Sbjct: 418 QSPFQNLHL-----LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 300 H---SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 356
L L L L + + + L N LT + + + +YL +L+
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLA 531
Query: 357 HNHLSGSIPKSISNLNKLKILKLEFNELSG 386
NH+S +P + L++ + + L N L
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-46
Identities = 70/392 (17%), Positives = 126/392 (32%), Gaps = 34/392 (8%)
Query: 49 YCSSLN-TLNLSNNHFS---GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHY 104
+N T N N + G L L+ S N+ + L
Sbjct: 9 IEKEVNKTYNCENLGLNEIPGTL----------PNSTECLEFSFNVLPTIQNTTFSRLIN 58
Query: 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164
L L L Q L TL L+ N +L ++ + ++
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--- 221
+ N TLE L +NH++ F +KL V+ + N+++ + +
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQ 177
Query: 222 -LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL--FANL 278
++L+ N + I PG+ S+ + L+ + I + +L
Sbjct: 178 QATNLSLNLNGN-DIAGIEPGAFDSAV------FQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 279 RYLNLSSNHLR--SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
S E S+ ++L+ + + L L L L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI-PQELGKL 395
+ +P + ++L L LS N S SN L L ++ N E+ L L
Sbjct: 291 SE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349
Query: 396 ASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 427
+L +++S++ + L S LQ
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNL--SHLQ 379
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-37
Identities = 60/315 (19%), Positives = 109/315 (34%), Gaps = 18/315 (5%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGK-IFNYCSSLNTLNLSNN 61
+K L LS N + N SL +LS+ GN + +G +L L+LS++
Sbjct: 302 TLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLP 120
D + + +L L++L+LS+N + L+ L L +
Sbjct: 361 DIET-SDCCNL-QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDI---PHWIGNISTL 177
+ L L+LS++L L ++ +++ N + + + L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478
Query: 178 EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGS 237
E L S L+ + + K ++ + L N L + E L L ++L+ N +
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN-HISI 537
Query: 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG 297
I P S R ++L N L L + + L
Sbjct: 538 ILPSLLPILSQ-----QRTINLRQNPLDCTC----SNIYFLEWYKENMQKLEDTEDTLCE 588
Query: 298 YFHSLIHLDLRNNAL 312
L + L + L
Sbjct: 589 NPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 39/207 (18%), Positives = 67/207 (32%), Gaps = 11/207 (5%)
Query: 225 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 284
+ + G IP L + L+ S N L NL +L+L+
Sbjct: 15 KTYNCENLGL-NEIPGT--------LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLT 65
Query: 285 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 344
+ H L L L N L + ++L L ++ +
Sbjct: 66 RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 345 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL--LAVN 402
N +L L L NH+S KLK+L + N + +++ L L++N
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 403 VSYNRLIGRLPVGGVFPTLDQSSLQGN 429
++ N + G P + G
Sbjct: 186 LNGNDIAGIEPGAFDSAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 31/167 (18%), Positives = 51/167 (30%), Gaps = 3/167 (1%)
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
+SS + + + + L +IP L + L S N L + +
Sbjct: 2 TSSDQKCIEKEVNKTYNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLIN 58
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361
L LDL +Y L L L N L + +L L +S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 362 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
+ N L+ L L N +S + L ++ N +
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 6e-60
Identities = 56/432 (12%), Positives = 123/432 (28%), Gaps = 49/432 (11%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 66
L L+ G VP + L+ LS + + + + +
Sbjct: 328 LSLAGFGAKGRVPDAIG-QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMH 386
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFS-----GSIPQGVAALHYLKELLLQGNQFSGPLPA 121
+ +RL DL + + I + ++ N+ + +
Sbjct: 387 Y---KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISK 442
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
I L + +N+ FT +++ + + + N+ L ++
Sbjct: 443 AIQRLTKLQIIYFANSPFTY-DNIAVDWED----ANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG---------NIPEGLFDLG-LEEIDLSE 231
N LP L++ +L + + N + + ++ +
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291
N S L +LD N + + G L L L N +
Sbjct: 558 NNLEEFPASASLQKMVK-----LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE- 609
Query: 292 IPPELGYF-HSLIHLDLRNNALYGSIPQ--EVCESRSLGILQLDGNSLTG-----PIPQV 343
IP + F + L +N L IP +G + N +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 344 IRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS-------GEIPQELGKLA 396
+ ++LS+N + + + + + + L N ++
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 397 SLLAVNVSYNRL 408
L +++ +N+L
Sbjct: 729 LLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-57
Identities = 62/441 (14%), Positives = 133/441 (30%), Gaps = 61/441 (13%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
++ + +N+ + + ++ L + L N
Sbjct: 449 KLQIIYFANSPFTYDNI------AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSG---------SIPQGVAALHYLKELLLQGN 113
L ++ L L++L+++ N + ++ + N
Sbjct: 503 NMTQLPDF----LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 114 QFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIG 172
P A + L LD +N L + + + + N + IP
Sbjct: 559 NLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDFC 615
Query: 173 NIST-LEFLDFSNNHLTGSLPSSLF--NCKKLSVIRLRGNSLNGNIPEGLFDLG------ 223
+ +E L FS+N L +P+ + + + N + +
Sbjct: 616 AFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL-------VGDIPAEMGLFA 276
+ LS N P ++ S + + LS+N + +
Sbjct: 675 ASTVTLSYNEIQK-FPTELFATGSP-----ISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 277 NLRYLNLSSNHLRSRIPPEL--GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL--- 331
L ++L N L + + + L ++D+ N S P + S L +
Sbjct: 729 LLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQ 786
Query: 332 ---DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL-SGE 387
+GN + P I C SL L + N + + + + +L IL + N S +
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISID 843
Query: 388 IPQELGKLASLLAVNVSYNRL 408
+ + + Y++
Sbjct: 844 VTSVCPYI-EAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 9e-56
Identities = 66/469 (14%), Positives = 134/469 (28%), Gaps = 67/469 (14%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+K L + + E I +Y LN +L +
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 63 FSGDLDFAS------------------------GYGIWSLKRLRTLDLSHNLFSGSIPQG 98
+ + + I L +L+ + +++ F+
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 99 VAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 158
++ + LT ++L N QLP L L + +++
Sbjct: 468 -----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522
Query: 159 SNNTLTG---------DIPHWIGNISTLEFLDFSNNHLTGSLPS-SLFNCKKLSVIRLRG 208
+ N + ++ N+L S SL KL ++
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582
Query: 209 NSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI 268
N + ++ ++ L ++ L N IP + + + L S N L I
Sbjct: 583 NKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQ-----VEGLGFSHNKLKY-I 634
Query: 269 PAEMGL--FANLRYLNLSSNHLRSRIPPELG------YFHSLIHLDLRNNALYGSIPQEV 320
P + ++ S N + S + + + L N + +
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 321 CESRSLGILQLDGNSLT-------GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI--SNL 371
+ + L N +T P +N L + L N L+ S+ + L
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTL 752
Query: 372 NKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPT 420
L + + +N S P + + L A + + R + +PT
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-50
Identities = 68/376 (18%), Positives = 124/376 (32%), Gaps = 43/376 (11%)
Query: 3 NMKFLDLSNNLLSGPVPY--------QLFENCASLRYLSLAGNILQG-PIGKIFNYCSSL 53
++ L+++ N + ++ + N L+ P L
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKL 575
Query: 54 NTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQG 112
L+ +N L+ + +L L L +N IP+ A ++ L
Sbjct: 576 GLLDCVHNKVR-HLEA-----FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH 628
Query: 113 NQFSG-PLPADIGFCPHLTTLDLSNNLFTG---QLPVSLRLLN--SMIFISVSNNTLTGD 166
N+ P + + ++D S N + S+ + +++S N +
Sbjct: 629 NKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKF 688
Query: 167 IPHWIGNISTLEFLDFSNNHLT-------GSLPSSLFNCKKLSVIRLRGNSLNGNIPEGL 219
S + + SNN +T + N L+ I LR N L + +
Sbjct: 689 PTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDF 747
Query: 220 FDLG---LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
L +D+S N F S P +SS F D N ++ P +
Sbjct: 748 RATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCP 806
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
+L L + SN + ++ +L L LD+ +N VC G+ L +
Sbjct: 807 SLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
Query: 337 TGPIPQVIRNCTSLYL 352
Q IR C +L +
Sbjct: 864 -----QDIRGCDALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-48
Identities = 56/385 (14%), Positives = 123/385 (31%), Gaps = 39/385 (10%)
Query: 47 FNYCSSLNTLNLSNNHFSGDLDF---ASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH 103
+ + NT++ N +F+ +LD G + + R+ L L+ G +P + L
Sbjct: 288 YYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347
Query: 104 YLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL-PVSLRLLNSMIFISVSNNT 162
LK L + + + + + L + + +
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 163 LT-----GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 217
+ I + N +T + ++ KL +I + +
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIA 466
Query: 218 GLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 277
+ E+ + + S+ L ++L + + +P +
Sbjct: 467 ----VDWEDANSDYAKQYENEELSWSNLKD------LTDVELYNCPNMTQLPDFLYDLPE 516
Query: 278 LRYLNLSSNHLRS---------RIPPELGYFHSLIHLDLRNNALYGSIPQEV--CESRSL 326
L+ LN++ N S R+ + + + N L P + L
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKL 575
Query: 327 GILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELS 385
G+L N + + L L L +N + IP+ + ++++ L N+L
Sbjct: 576 GLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632
Query: 386 GEIPQ--ELGKLASLLAVNVSYNRL 408
IP + + +V+ SYN++
Sbjct: 633 -YIPNIFNAKSVYVMGSVDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-38
Identities = 45/348 (12%), Positives = 104/348 (29%), Gaps = 36/348 (10%)
Query: 92 SGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLN 151
+ I A + L + ++ + + +++ Q V L
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTI-NNTIHSLNWNFNKELDMWGDQPGVDLDNNG 323
Query: 152 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 211
+ +S++ G +P IG ++ L+ L F + T S + R + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 212 NGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP 269
+ + D L DL ++ + S + +I +L N + I
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL--TNRITFIS 441
Query: 270 AEMGLFANLRYLNLSSNHLRS-------------------RIPPELGYFHSLIHLDLRNN 310
+ L+ + +++ L ++L N
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 311 ALYGSIPQEVCESRSLGILQLDGNSLTGP---------IPQVIRNCTSLYLLSLSHNHLS 361
+P + + L L + N + + + + +N+L
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
Query: 362 G-SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
S+ + KL +L N++ + G L + + YN++
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQI 607
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-28
Identities = 35/291 (12%), Positives = 79/291 (27%), Gaps = 32/291 (10%)
Query: 132 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSL 191
LD N + + + F + + + N + L + G +
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 192 PSSLFNCKKLSVIRLRGNSLNGNIPE-GLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 250
P ++ +L V+ +S + G +L + + ++
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
Query: 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 310
L ++ N + I + + + +N + I + L + N+
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANS 458
Query: 311 ALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISN 370
+ + + S SN
Sbjct: 459 PFTYDNI-----------------------------AVDWEDANSDYAKQYENEELSWSN 489
Query: 371 LNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTL 421
L L ++L ++P L L L ++N++ NR I + + L
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 22/173 (12%), Positives = 48/173 (27%), Gaps = 1/173 (0%)
Query: 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 316
+ + I L A L+ + S + + + + +
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQP 315
Query: 317 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 376
++ + + L L G G +P I T L +LS + + S +
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 377 LKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 429
+ + + + L ++ I R P + SL+
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-57
Identities = 71/437 (16%), Positives = 127/437 (29%), Gaps = 39/437 (8%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
++ L L+ N + F SL L L +L LN+++N
Sbjct: 81 HLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELL----LQGNQFSGP 118
+L L +DLS+N + L ++ + N
Sbjct: 140 IHS---CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF- 195
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLP-------VSLRLLNSMIFISVSNNTLTGDIPHWI 171
+ L L L N + + L + ++ L P +
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 172 GNISTL--EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDL 229
+ + + + + +S + L G S+ + + + + +
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSI 314
Query: 230 SENGFMGSIPPGS--------------SSSSSSTLFQTLRILDLSSNNL--VGDIPAEMG 273
P S S +L LDLS N L G
Sbjct: 315 IRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 274 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV-CESRSLGILQLD 332
+LR+L+LS N + L HLD +++ L L L +
Sbjct: 374 GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQE 391
+ + TSL L ++ N + ++ +N L L L +L
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 392 LGKLASLLAVNVSYNRL 408
L L +N+S+N L
Sbjct: 493 FDTLHRLQLLNMSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 7e-53
Identities = 82/452 (18%), Positives = 141/452 (31%), Gaps = 65/452 (14%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIF----NYCSSLNTL 56
++ +K L++++N + F N +L ++ L+ N +Q +L
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 57 NLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP----QGVAALHYLK------ 106
++S N + +L L L N S +I Q +A LH +
Sbjct: 187 DMSLNPIDF-----IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241
Query: 107 -----------------------ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 143
E L +++ + L+
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-- 299
Query: 144 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 203
+ +S+ L P ++ L+ L + N S+ LS
Sbjct: 300 LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSY 354
Query: 204 IRLRGNSLNGNIPEGLFDLG---LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
+ L N+L+ + DLG L +DLS NG I + L+ LD
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA--IIMSANFMGLEE-----LQHLDFQ 407
Query: 261 SNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317
+ L F L YL++S + + SL L + N+ +
Sbjct: 408 HSTLKRVTEF--SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 318 QEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 376
V + +L L L L V L LL++SHN+L + L L
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525
Query: 377 LKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
L FN + SL N++ N +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-50
Identities = 88/426 (20%), Positives = 137/426 (32%), Gaps = 42/426 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ K +DLS N L + F N + L++L L+ ++ K ++ L+ L L+ N
Sbjct: 33 STKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLPA 121
+ L L L + + L LK+L + N LPA
Sbjct: 92 IQSFSPGS----FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
+L +DLS N L+ L LD
Sbjct: 148 YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ--------------------VNLSLD 187
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIP 239
S N + + F KL + LRGN + NI + GL L F
Sbjct: 188 MSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246
Query: 240 PGSSSSSSSTLFQTLRI--LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG 297
S + I L+ N D + AN+ ++L+ ++ ++
Sbjct: 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVP 304
Query: 298 YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSH 357
L + L P L L L N + SL L LS
Sbjct: 305 KHFKWQSLSIIRCQL-KQFPTLDL--PFLKSLTLTMNKGSISFK--KVALPSLSYLDLSR 359
Query: 358 NHLSGSIPKSISNLN--KLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 415
N LS S S S+L L+ L L FN + L L ++ ++ + R+
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHST-LKRVTEF 417
Query: 416 GVFPTL 421
F +L
Sbjct: 418 SAFLSL 423
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-46
Identities = 71/388 (18%), Positives = 118/388 (30%), Gaps = 24/388 (6%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGK-IFNYCSSLNTLNLSNNHFSG 65
LD+S N + + Q F+ L L+L GN I K + L+ L F
Sbjct: 186 LDMSLNPIDF-IQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
Query: 66 --DLDFASGYGIWSLKRLRT--LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPA 121
+L+ + L + L++ L + + L G
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--E 301
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
D+ +L + + L L S ++++ N + I + +L +LD
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPTLDLPFLKS---LTLTMNKGS--ISFKKVALPSLSYLD 356
Query: 182 FSNNHLTGSLPSSLFN--CKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSI 238
S N L+ S S + L + L N + L L+ +D +
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVT 415
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LG 297
+ S L LD+S N D +L L ++ N +
Sbjct: 416 EFSAFLSLEK-----LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 298 YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSH 357
+L LDL L L +L + N+L SL L S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 358 NHLSGSIPKSISNLNKLKILKLEFNELS 385
N + S L L N ++
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-38
Identities = 58/358 (16%), Positives = 100/358 (27%), Gaps = 23/358 (6%)
Query: 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 142
T S +P + K + L N L LDLS
Sbjct: 15 TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 143 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 202
+ L+ + + ++ N + P +++LE L L + L
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 203 VIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
+ + N ++ F L +DLS N +I Q LD+S
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRE-NPQVNLSLDMS 189
Query: 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY-FHSLIHLDLRNNALYGSIPQE 319
N + I + L L L N S I L L E
Sbjct: 190 LNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 320 VCESRSLG--------ILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL 371
+ E + +L + ++ +SL+ + + +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKH 306
Query: 372 NKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 429
K + L + +L +L L SL ++ N+ P+L L N
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPFLKSL---TLTMNKGSISFKKVA-LPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-37
Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 26/294 (8%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+ + L+ + + LS+ L+ L +L L+ N
Sbjct: 286 NVSAMSLAGVSIKYLED---VPKHFKWQSLSIIRCQLKQFP---TLDLPFLKSLTLTMNK 339
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHY--LKELLLQGNQFSGPLP 120
S +L L LDLS N S S + L L+ L L N +
Sbjct: 340 GSISFKK------VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MS 392
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
A+ L LD ++ S L ++++ +S D +++L
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452
Query: 180 LDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMG 236
L + N + S++F N L+ + L L I G+FD L+ +++S N +
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLL- 510
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 290
+ + S L LD S N + +L + NL++N +
Sbjct: 511 FLDSSHYNQLYS-----LSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-23
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 6/170 (3%)
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
PGS + + L +P + ++ + ++LS N L+ F
Sbjct: 1 PGSLNPCIEVVPNI--TYQCMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNF 55
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359
L LDL + + L L L GN + P TSL L
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 360 LSGSIPKSISNLNKLKILKLEFNELSG-EIPQELGKLASLLAVNVSYNRL 408
L+ I L LK L + N + ++P L +L+ V++SYN +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-56
Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 34/296 (11%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
ID + +E VG G FG V K + + + +A+K++ + + F E+R L +
Sbjct: 5 IDYK-EIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESER---KAFIVELRQLSRV 58
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
HPN++ L G P LV +YA GSL LH P P + + L ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGV 115
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYN-PRISDFGLARLLTRLDKHVMSNRFQSALG-- 726
A+LH +IH +LKP N+LL +I DFG A + + G
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--------DIQTHMTNNKGSA 167
Query: 727 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785
++APE+ + +EKCD++ +G+++ E++T R+P + D + + + + G
Sbjct: 168 AWMAPEV-FEGSNYSEKCDVFSWGIILWEVITRRKP--F--DEIGGPAFRIMWAVHNGTR 222
Query: 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRME 841
P + + P+ P+ L C PS RPSM E+V+I+ + P E
Sbjct: 223 P----PLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-55
Identities = 88/327 (26%), Positives = 140/327 (42%), Gaps = 39/327 (11%)
Query: 524 SSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRML 582
++ + + F D I L K ++G G FGTV++ G +
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE-KIGAGSFGTVHR---AEWHGSDV 63
Query: 583 AVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQA 641
AVK L+ D +F REV ++ + RHPN++ G P +V++Y GSL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 642 KLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701
LH+ L R + AKG+ +LH + PPI+H NLK N+L+D Y ++
Sbjct: 124 LLHKSGAR-EQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 702 DFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTG 758
DFGL+RL S G ++APE+ + NEK D+Y FGV++ EL T
Sbjct: 182 DFGLSRLKASTFLSSKSAA-----GTPEWMAPEVL-RDEPSNEKSDVYSFGVILWELATL 235
Query: 759 RRP---VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHI 815
++P + + + + R + P + V + C +
Sbjct: 236 QQPWGNLNPAQVVAAVGFKCKR-------------LEI---PRNLNPQVAAIIEGCWTNE 279
Query: 816 PSSRPSMAEVVQILQVIKT---PLPQR 839
P RPS A ++ +L+ + P P R
Sbjct: 280 PWKRPSFATIMDLLRPLIKSAVPPPNR 306
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-55
Identities = 70/309 (22%), Positives = 137/309 (44%), Gaps = 35/309 (11%)
Query: 536 VILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--- 592
+ S ++ + + ++G+G FG V+K ++A+K L+ D
Sbjct: 2 AMGGSEFPKSRLPTLADNEIEYEK-QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 593 ---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS 649
I+ ++F+REV ++ HPN++ L G P +V ++ P G L +L ++
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDK--- 115
Query: 650 TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-----DNYNPRISDFG 704
P+ W+ + +++L A G+ ++ + PPI+H +L+ NI L +++DFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 705 LARLLTRLDKHVMSNRFQSALGYVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763
L++ H +S + ++APE + + EK D Y F +++ ++TG P
Sbjct: 175 LSQQSV----HSVSGLLGN-FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-- 227
Query: 764 YGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 823
+ E + + + EEG PED + + +C P RP +
Sbjct: 228 FDEYSYGKIKFINMI-REEGLRPTI--------PEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 824 EVVQILQVI 832
+V+ L +
Sbjct: 279 YIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 71/293 (24%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDII-QYPEDFEREVRVLG 607
ID + L ++ E G ++K G QG + VK L D + DF E L
Sbjct: 7 IDFKQLNFLT-KLNENHSGELWK---GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 608 KARHPNLISLEGYYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
HPN++ + G +P ++ + P GSL LHE + + + K L
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDM 120
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
A+G+A LH + P I + L ++++D++ RIS + M
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--SPGRMYA-----P 172
Query: 726 GYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRP---VEYGEDNVVILSEHVRVLL 780
+VAPE D++ F VL+ ELVT P + E + + E +R +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
G + P + KL +C P+ RP +V IL+ ++
Sbjct: 233 PPG-----ISPHVS-----------KLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-50
Identities = 66/306 (21%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 608
P L + +G+G FG KV+ G ++ +K+L+ D F +EV+V+
Sbjct: 7 FRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRC 63
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
HPN++ G + + +++Y G+L+ + W+ R A G
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASG 120
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---------TRLDKHVMSN 719
+A+LH IIH +L N L+ +N N ++DFGLARL+ R K
Sbjct: 121 MAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 720 RFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 776
+ + +G ++APE+ +EK D++ FG+++ E++ +
Sbjct: 178 KRYTVVGNPYWMAPEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD----F 232
Query: 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836
+ + C P + + + C P RPS ++ L+ ++ L
Sbjct: 233 GLNVRGFLDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 837 PQRMEV 842
+ +
Sbjct: 285 AGHLPL 290
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 8e-50
Identities = 70/338 (20%), Positives = 128/338 (37%), Gaps = 54/338 (15%)
Query: 544 SSLDCSIDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER 601
++ + S+D + LLE +G G +G VYK S R +AVK ++ ++F
Sbjct: 4 AASEPSLDLDNLKLLEL---IGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFIN 54
Query: 602 EVRV--LGKARHPNLISLEGY------YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPL 653
E + + H N+ + LLV +Y PNGSL L
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLH-----TS 108
Query: 654 SWTNRFKVILGTAKGLAHLH------HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707
W + ++ +GLA+LH ++P I H +L N+L+ ++ ISDFGL+
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 708 LLTR------LDKHVMSNRFQSALGYVAPEL------TCQSLRVNEKCDIYGFGVLILEL 755
LT ++ + + Y+APE+ ++ D+Y G++ E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 756 V---TGRRPVEYGEDNVVILSEHV--RVLLEEGNVLDCVD---PSMGD-YPEDEVLP--V 804
T P E + + V E+ VL + P + + E+ + +
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 805 LKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEV 842
+ C +R + + + + + V
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 8e-50
Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 23/295 (7%)
Query: 541 SRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDF 599
SR ++ D I + +G G FGTVYK G +AVK L + + F
Sbjct: 12 SRDAADDWEIPDGQITVGQ-RIGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAF 67
Query: 600 EREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF 659
+ EV VL K RH N++ GY PQL +V+ + SL LH
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHAS---ETKFEMKKLI 123
Query: 660 KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719
+ TA+G+ +LH IIH +LK +NI L ++ +I DFGLA +R
Sbjct: 124 DIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 720 RFQSALGYVAPEL--TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
+ ++ ++APE+ S + + D+Y FG+++ EL+TG+ P +N + +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNR----DQII 235
Query: 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
++ G++ P + + + +L C RPS ++ ++ +
Sbjct: 236 EMVGRGSLS----PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 8e-50
Identities = 82/438 (18%), Positives = 147/438 (33%), Gaps = 40/438 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
++ L L+ N + + F +SL+ L L + +L LN+++N
Sbjct: 77 HLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK----ELLLQGNQFSGP 118
F +L L LDLS N + LH + L L N +
Sbjct: 136 IQ---SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF- 191
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLP-------VSLRLLNSMIFISVSNNTLTGDIPHWI 171
+ L L L NN + + L + ++ + L +
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 172 GNISTLEFLDFSNNHLTGS---LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEID 228
+ L +F +L + +S L ++ + + ++ G + ++
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLE 310
Query: 229 LSENGFMGSIPPGS--------------SSSSSSTLFQTLRILDLSSNNL--VGDIPAEM 272
L F P ++ S +L LDLS N L G
Sbjct: 311 LVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 273 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV-CESRSLGILQL 331
+L+YL+LS N + + + L HLD +++ L V R+L L +
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 332 DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQ 390
+ +SL +L ++ N + I + L L L L +L P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 391 ELGKLASLLAVNVSYNRL 408
L+SL +N++ N+L
Sbjct: 489 AFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 84/443 (18%), Positives = 156/443 (35%), Gaps = 46/443 (10%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ-GPIGKIFNYCSSLNTLNLS 59
+ +++ L L+ + + +L+ L++A N++Q + + F+ ++L L+LS
Sbjct: 99 LSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
+N +LDLS N + I G L +L L+ N S +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNV 216
Query: 120 PAD-IGFCPHLTTLDLSNNLFTGQ---LPVSLRLLNSMIFISVSNNTLTG------DIPH 169
I L L F + L + +++ L DI
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 170 WIGNISTLEFLDFSNNHLTGSLPSSLF-------------------NCKKLSVIRLRGNS 210
++ + + + S K L + N
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK 336
Query: 211 LNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPA 270
N + LE +DLS NG + S S +T +L+ LDLS N ++ + +
Sbjct: 337 GG-NAFSEVDLPSLEFLDLSRNG-LSFKGCCSQSDFGTT---SLKYLDLSFNGVI-TMSS 390
Query: 271 EMGLFANLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCES-RSL 326
L +L+ ++L+ E F +LI+LD+ + + SL
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQ--MSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL 447
Query: 327 GILQLDGNSLTGPIPQ-VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385
+L++ GNS + +L L LS L P + ++L+ L++L + N+L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 386 GEIPQELGKLASLLAVNVSYNRL 408
+L SL + + N
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-41
Identities = 98/427 (22%), Positives = 149/427 (34%), Gaps = 43/427 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ K LDLS N L + F + L+ L L+ +Q + S L+TL L+ N
Sbjct: 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF-SGPLPA 121
+ + L L+ L + + L LKEL + N S LP
Sbjct: 88 ----IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
+L LDLS+N LR+L+ M +++S LD
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS--------------------LD 183
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIP 239
S N + + F +L + LR N + N+ + GLE L F
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF---ANLRYLNLSSNHLRSRIPPEL 296
S+ L I + L + + LF N+ +L S + +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDF 300
Query: 297 GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 356
Y HL+L N P +SL L N +V + SL L LS
Sbjct: 301 SYNFGWQHLELVNCKFG-QFPTLKL--KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLS 355
Query: 357 HNHLS--GSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 414
N LS G +S LK L L FN + + L L ++ ++ L ++
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 413
Query: 415 GGVFPTL 421
VF +L
Sbjct: 414 FSVFLSL 420
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 72/371 (19%), Positives = 119/371 (32%), Gaps = 29/371 (7%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPI-GKIFNYCSSLNTLNLSNNHFSG 65
LDLS N ++ + F+ L L+L N + + L L F
Sbjct: 182 LDLSLNPMNF-IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 66 DLDFASGYGIWSLKRLRTLDLSHN------LFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
+ + + +L+ L L + + I L + L
Sbjct: 240 EGNLEK-FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 120 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
+ L+L N F + L+ L ++ ++N ++ +LEF
Sbjct: 299 DFS--YNFGWQHLELVNCKFGQFPTLKLKSLKR---LTFTSNKGGNAFS--EVDLPSLEF 351
Query: 180 LDFSNNHLT--GSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMG 236
LD S N L+ G S F L + L N + + L LE +D +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK- 409
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE- 295
+ S S L LD+S + ++L L ++ N + P+
Sbjct: 410 QMSEFSVFLSLRNL----IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
Query: 296 LGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 354
+L LDL L + S SL +L + N L + TSL +
Sbjct: 466 FTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524
Query: 355 LSHNHLSGSIP 365
L N S P
Sbjct: 525 LHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 69/358 (19%), Positives = 121/358 (33%), Gaps = 64/358 (17%)
Query: 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-------------------- 41
+ + L L NN S V + A L L +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 42 -------------PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSH 88
I +FN +++++ +L + + + L ++
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER---VKDFSYNFGWQHLELVNCKF 316
Query: 89 NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT--GQLPVS 146
F L LK L N+ +++ P L LDLS N + G S
Sbjct: 317 GQFPTL------KLKSLKRLTFTSNKGGN-AFSEVD-LPSLEFLDLSRNGLSFKGCCSQS 368
Query: 147 LRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIR 205
S+ ++ +S N + + + LE LDF +++L S+F + + L +
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 206 LRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNN 263
+ G+F+ LE + ++ N F + P + + L LDLS
Sbjct: 428 ISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN-----LTFLDLSQCQ 481
Query: 264 LVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSIP 317
L + F +L+ LN++SN L+S +P SL + L N S P
Sbjct: 482 LEQ-LSP--TAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 66/360 (18%), Positives = 109/360 (30%), Gaps = 26/360 (7%)
Query: 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 142
T F IP + K L L N P L LDLS
Sbjct: 11 TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 143 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 202
+ + L+ + + ++ N + +S+L+ L +L + + K L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 203 VIRLRGNSLN-GNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
+ + N + +PE +L LE +DLS N SI L LDLS
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS-LDLS 185
Query: 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYG----- 314
N + I L L L +N + + L L
Sbjct: 186 LNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 315 SIPQEVCES-RSLGILQLDGNSLTG---PIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-S 369
+ E +L I + L I + T++ SL + S
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 370 NLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 429
L+++ +F + + L +L + N+ G P+L+ L N
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRL------TFTSNK-GGNAFSEVDLPSLEFLDLSRN 357
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 14/223 (6%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ--GPIGKIFNYCSSLNTLNLSN 60
++K L ++N + SL +L L+ N L G + +SL L+LS
Sbjct: 326 SLKRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPL 119
N L++L LD H+ V +L L L +
Sbjct: 383 NGVI-----TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 120 PADIGFCPHLTTLDLSNNLFTGQL-PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
L L ++ N F P L ++ F+ +S L P ++S+L+
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 179 FLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLF 220
L+ ++N L S+P +F L I L N + + P +
Sbjct: 498 VLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 6/97 (6%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ +++ L ++ N +F +L +L L+ L+ FN SSL LN+++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 61 NHFSG-DLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 96
N L L+ + L N + S P
Sbjct: 504 NQLKSVPDGIFDR-----LTSLQKIWLHTNPWDCSCP 535
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 9e-50
Identities = 81/295 (27%), Positives = 122/295 (41%), Gaps = 39/295 (13%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKL---VTSDIIQYPEDFEREVRV 605
ID L + +G G FG VY+ G +AVK DI Q E+ +E ++
Sbjct: 4 IDFAELTLEE-IIGIGGFGKVYR---AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+HPN+I+L G LV ++A G L L + + +
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQI 114
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR--------ISDFGLARLLTRLDKHVM 717
A+G+ +LH PIIH +LK SNIL+ I+DFGLAR R K M
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--M 172
Query: 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
S ++APE+ ++ ++ D++ +GVL+ EL+TG P + + + ++ V
Sbjct: 173 SAAGA--YAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGV- 226
Query: 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
L P P KL C P SRPS ++ L I
Sbjct: 227 --AMNKLALPI--------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-48
Identities = 77/323 (23%), Positives = 131/323 (40%), Gaps = 39/323 (12%)
Query: 540 DSRSSSLDCSIDPETL---LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP 596
S S S + T+ ++ ++G+G +G V+ + +G +AVK T++ +
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASW- 76
Query: 597 EDFEREVRVLGKARHPNLI-----SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 651
E E+ RH N++ ++G QL L++DY NGSL L
Sbjct: 77 -FRETEIYQTVLMRHENILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKST----- 129
Query: 652 PLSWTNRFKVILGTAKGLAHLH-----HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706
L + K+ + GL HLH +P I H +LK NIL+ N I+D GLA
Sbjct: 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 707 RLLTRLDKHVMSNRFQSALG---YVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTG 758
D + + + +G Y+ PE+ + D+Y FG+++ E+
Sbjct: 190 VKFIS-DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
Query: 759 RRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD-----PSMGD-YPEDEVLPVL-KLALVC 811
E+ + + V ++ + V PS + + DE L + KL C
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308
Query: 812 TCHIPSSRPSMAEVVQILQVIKT 834
H P+SR + V + L +
Sbjct: 309 WAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 34/301 (11%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+ VG+G +G V++ S+ QG +AVK + D + E E+ RH N++
Sbjct: 10 ITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSW--FRETELYNTVMLRHENIL 65
Query: 616 SLEGYYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
T + L++ Y GSL L L + +++L A GLAH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAH 120
Query: 672 LH-----HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
LH +P I H +LK NIL+ N I+D GLA + ++ + +G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ-LDVGNNPRVG 179
Query: 727 ---YVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV-- 776
Y+APE+ ++ DI+ FG+++ E+ ED + V
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 777 RVLLEEGNVLDCVD---PSM-GDYPEDEVLPVL-KLALVCTCHIPSSRPSMAEVVQILQV 831
E+ + CVD P++ + D L L KL C PS+R + + + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 832 I 832
I
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 75/323 (23%), Positives = 124/323 (38%), Gaps = 39/323 (12%)
Query: 540 DSRSSSLDCSIDPETL---LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP 596
S S S + T+ + +G+G FG V++ + +G +AVK + + +
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW- 81
Query: 597 EDFEREVRVLGKARHPNLISLEGY-----YWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 651
E E+ RH N++ QL LVSDY +GSL L+
Sbjct: 82 -FREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY----- 134
Query: 652 PLSWTNRFKVILGTAKGLAHLH-----HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706
++ K+ L TA GLAHLH +P I H +LK NIL+ N I+D GLA
Sbjct: 135 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
Query: 707 RLLTRLDKHVMSNRFQSALG---YVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTG 758
+ +G Y+APE+ + ++ DIY G++ E+
Sbjct: 195 VRHDS-ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
Query: 759 RRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD-----PSM-GDYPEDEVLPVL-KLALVC 811
ED + + V + V P++ + E L V+ K+ C
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313
Query: 812 TCHIPSSRPSMAEVVQILQVIKT 834
++R + + + L +
Sbjct: 314 WYANGAARLTALRIKKTLSQLSQ 336
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-46
Identities = 92/435 (21%), Positives = 170/435 (39%), Gaps = 43/435 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ L ++ V + + L ++ G Y ++L +N SN
Sbjct: 23 LAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSN 77
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + +L +L + +++N + P +A L L L L NQ + P
Sbjct: 78 NQLTDITPLK------NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+ +L L+LS+N + +L L S+ +S N +T P + N++TLE L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERL 182
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240
D S+N ++ S L L + N ++ P G+ L+E+ L+ N I
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQL-KDIGT 238
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH 300
+S L LDL++N + ++ GL L L L +N + + L
Sbjct: 239 LAS-------LTNLTDLDLANNQIS-NLAPLSGL-TKLTELKLGANQISN--ISPLAGLT 287
Query: 301 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL 360
+L +L+L N L P + ++L L L N+++ P + + T L L +N +
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 361 SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPT 420
S S++NL + L N++S P L L + + ++ +
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399
Query: 421 LDQSSLQGNLGICSP 435
+ + + +P
Sbjct: 400 IPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-44
Identities = 89/407 (21%), Positives = 158/407 (38%), Gaps = 43/407 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+ ++ SNN L+ P +N L + + N + ++L L L NN
Sbjct: 69 NLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQ 123
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+ D+D + +L L L+LS N S ++ L L++L GNQ + P
Sbjct: 124 IT-DIDP-----LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP-- 172
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+ L LD+S+N + L L ++ + +NN ++ P +G ++ L+ L
Sbjct: 173 LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPG 241
+ N L +L + L+ + L N ++ P L L L E+ L N
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI------- 277
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
S+ S L L+L+ N L P + NL YL L N++ P +
Sbjct: 278 -SNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361
L L NN + S + ++ L N ++ P + N T + L L+ +
Sbjct: 333 LQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 362 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
+ +N++ +K L P + S ++++N
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLP 433
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-39
Identities = 78/391 (19%), Positives = 139/391 (35%), Gaps = 40/391 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+ L L NN ++ P +N +L L L+ N + + +SL L+ N
Sbjct: 113 NLTGLTLFNNQITDIDP---LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQV 167
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+ +L L LD+S N S +A L L+ L+ NQ S P
Sbjct: 168 TDLK-------PLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP-- 216
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+G +L L L+ N +L L ++ + ++NN ++ P + ++ L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPG 241
N ++ S L L+ + L N L + +L L + L N P
Sbjct: 273 GANQISNI--SPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS 328
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
S + L+ L +N + D+ + L N+ +L+ N + L
Sbjct: 329 SLTK--------LQRLFFYNNKV-SDVSSLANL-TNINWLSAGHNQISD--LTPLANLTR 376
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361
+ L L + A + P + S+ + P I + S ++ N S
Sbjct: 377 ITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGALIA-PATISDGGSYTEPDITWNLPS 434
Query: 362 GSIPKSISNLNKLKILKLEFNELSGEIPQEL 392
+ ++ + SG + Q L
Sbjct: 435 -YTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-37
Identities = 80/379 (21%), Positives = 139/379 (36%), Gaps = 40/379 (10%)
Query: 52 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQ 111
L + ++ + + +L L + ++ Q L + L
Sbjct: 2 PLGSATITQDTPINQIF-----TDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQAD 54
Query: 112 GNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 171
+ + +LT ++ SNN T P L+ L ++ I ++NN + P +
Sbjct: 55 RLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L 108
Query: 172 GNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLS 230
N++ L L NN +T L N L+ + L N+++ L L L+++
Sbjct: 109 ANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG 164
Query: 231 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 290
+ TL LD+SSN + + + NL L ++N + S
Sbjct: 165 NQ---------VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI-S 212
Query: 291 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 350
I P LG +L L L N L + +L L L N ++ P + T L
Sbjct: 213 DITP-LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKL 267
Query: 351 YLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410
L L N +S P ++ L L L+L N+L P + L +L + + +N +
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 411 RLPVGGVFPTLDQSSLQGN 429
PV L + N
Sbjct: 324 ISPVSS-LTKLQRLFFYNN 341
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 56/301 (18%), Positives = 116/301 (38%), Gaps = 40/301 (13%)
Query: 547 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYP-EDFEREVR 604
+ I E L +G+G FG VY G G +A++ + + + F+REV
Sbjct: 27 EWDIPFEQLEIGE-LIGKGRFGQVYH---GRWHGE-VAIRLIDIERDNEDQLKAFKREVM 81
Query: 605 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 664
+ RH N++ G +P +++ +L + + + L ++
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQE 138
Query: 665 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724
KG+ +LH I+H +LK N+ D+ I+DFGL + L ++ +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 725 LG---YVAPEL--------TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
G ++APE+ L ++ D++ G + EL P + + I+
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII- 252
Query: 774 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLK-LALVCTCHIPSSRPSMAEVVQILQVI 832
+ + P++ + + + + L C RP+ +++ +L+ +
Sbjct: 253 ---------WQMGTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
Query: 833 K 833
Sbjct: 301 P 301
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-44
Identities = 61/348 (17%), Positives = 113/348 (32%), Gaps = 41/348 (11%)
Query: 49 YCSSLNTLNLSN-NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKE 107
+ S L D + +R D + + + +
Sbjct: 10 HSSGRENLYFQGSTALRPYHD-----VLSQWQRHYNADRNRWHSAWRQAN----SNNPQI 60
Query: 108 LLLQGNQFSGPLPADIGFC--PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 165
G + P L+L + Q P L+ + +++ L
Sbjct: 61 ETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 166 DIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLE 225
++P + + LE L + N L +LP+S+ + +L + +R +PE L
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST--- 173
Query: 226 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSS 285
+S L+ L L + +PA + NL+ L + +
Sbjct: 174 -----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215
Query: 286 NHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL-DGNSLTGPIPQVI 344
+ L + + P + + L LDLR + P L L L D ++L +P I
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDI 273
Query: 345 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 392
T L L L +P I+ L I+ + + L ++ Q
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 52/301 (17%), Positives = 97/301 (32%), Gaps = 30/301 (9%)
Query: 126 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 185
L + L + N + + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66
Query: 186 HLTGSLPSSLFNCK--KLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGS 242
L + L + + LR L P+ F L L+ + + G M +P
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD-- 121
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG----- 297
+ F L L L+ N L +PA + LR L++ + + +P L
Sbjct: 122 ----TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 298 ----YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 353
+L L L + S+P + ++L L++ + L+ + I + L L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234
Query: 354 SLSHNHLSGSIPKSISNLNKLKILKL-EFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 412
L + P LK L L + + L +P ++ +L L +++ + RL
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 413 P 413
P
Sbjct: 294 P 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 43/255 (16%), Positives = 84/255 (32%), Gaps = 22/255 (8%)
Query: 168 PHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEI 227
H + S E L F + L ++ +I
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQI 60
Query: 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 287
+ + + ++ L+L S L P + ++L+++ + +
Sbjct: 61 ETRTGRALKATADLLEDATQ----PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 288 LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC 347
L +P + F L L L N L ++P + L L + +P+ + +
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 348 ---------TSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 398
+L L L + S+P SI+NL LK LK+ + LS + + L L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 399 LAVNVSYNRLIGRLP 413
+++ + P
Sbjct: 232 EELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 47/299 (15%), Positives = 98/299 (32%), Gaps = 27/299 (9%)
Query: 9 LSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCS-SLNTLNLSNNHFSGDL 67
N + N + + + G L+ + + L L +
Sbjct: 38 HYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFP 97
Query: 68 DFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCP 127
D + L L+ + + +P + L+ L L N LPA I
Sbjct: 98 D-----QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLN 150
Query: 128 HLTTLDLSNN---------LFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
L L + L + + L ++ + + + +P I N+ L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGS 237
L N+ L+ +L ++ + KL + LRG + N P L+ + L + + +
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 296
+P + L LDL + +P+ + + + HL++++
Sbjct: 269 LPLDIHRLTQ------LEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 50/243 (20%), Positives = 88/243 (36%), Gaps = 22/243 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
L+L + L P Q F + L+++++ L + + L TL L+
Sbjct: 80 QPGRVALELRSVPLPQ-FPDQAF-RLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHN---------LFSGSIPQGVAALHYLKELLLQ 111
N I SL RLR L + L S L L+ L L+
Sbjct: 137 NPLRALPA-----SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 112 GNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 171
LPA I +L +L + N+ + L ++ L + + + T + P
Sbjct: 192 WTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
Query: 172 GNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDL 229
G + L+ L + ++L +LP + +L + LRG +P + L I +
Sbjct: 250 GGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 230 SEN 232
+
Sbjct: 309 PPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 45/233 (19%), Positives = 80/233 (34%), Gaps = 16/233 (6%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-P--IGKIFNYCSSLNTLN 57
+ +++ + + L +P + + A L L+LA N L+ P I + L L+
Sbjct: 103 LSHLQHMTIDAAGLME-LPDTM-QQFAGLETLTLARNPLRALPASIAS----LNRLRELS 156
Query: 58 LSNNHFSGDL-----DFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQG 112
+ +L + L L++L L S+P +A L LK L ++
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215
Query: 113 NQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIG 172
+ S L I P L LDL P + + + + + +P I
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274
Query: 173 NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLE 225
++ LE LD LPS + +I + + E
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-43
Identities = 86/426 (20%), Positives = 154/426 (36%), Gaps = 29/426 (6%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
MK LDLS N ++ + + CA+L+ L L + + G F SL L+LS+NH
Sbjct: 27 AMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH 85
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQG-NQFSGPLP 120
L S L L+ L+L N + + L L+ L + FS
Sbjct: 86 ----LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
D L L++ SL+ + + +++ + + + +S++ +L
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201
Query: 181 DFSNNHLTG---SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGF--- 234
+ + +L S + + RG+ L L L ++LSE F
Sbjct: 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC 261
Query: 235 ----MGSIPPGSSSSSSSTLFQ---TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 287
+G P S S T+R L + L D+ L ++ + + ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 288 LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ---LDGNSLT--GPIPQ 342
+ + SL LDL N + + + LQ L N L +
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 343 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVN 402
++ +L L +S N +P S K++ L L + + + +L ++
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLD 437
Query: 403 VSYNRL 408
VS N L
Sbjct: 438 VSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-39
Identities = 75/433 (17%), Positives = 152/433 (35%), Gaps = 43/433 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG-NILQGPIGKIFNYCSSLNTLNLS 59
+ ++K+L+L N LF N +L+ L + F +SLN L +
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
+ S++ + L L + + + L ++ L L+ +
Sbjct: 157 ALSLRN----YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212
Query: 120 PADIGFCPHLTTLDLSNNLFT-------GQLPVSLRLLNSMIFISVSNNTLTG--DIPHW 170
+ + + + + +L LR + + + + TL G D
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272
Query: 171 IGNI---------STLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD 221
++ T+ L +L L + +K+ I + + + +P
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQ 331
Query: 222 L--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA--- 276
LE +DLSEN + +S+ + +L+ L LS N+L + +
Sbjct: 332 HLKSLEFLDLSENLMVEEYLK---NSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLK 387
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
NL L++S N +P + + L+L + + + + ++L +L + N+L
Sbjct: 388 NLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNL 443
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
L L +S N L ++P S L ++K+ N+L +L
Sbjct: 444 D----SFSLFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLT 497
Query: 397 SLLAVNVSYNRLI 409
SL + + N
Sbjct: 498 SLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 66/399 (16%), Positives = 132/399 (33%), Gaps = 43/399 (10%)
Query: 50 CSSLNTLNLSNNHFSG------------DLDF-----ASGYGIWSLKRLRTLDLSHNLFS 92
C + + + F+ DL F + + L+ L L + +
Sbjct: 4 CDASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 93 GSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG-QLPVSLRLL 150
+I +L L+ L L N S + G L L+L N + + L
Sbjct: 64 -TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 151 NSMIFISVSNNTLTGDIP-HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 209
++ + + N +I +++L L+ L SL + + + + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 210 SLNGNIPEGLFD-------LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 262
+ E D L L + +L+ F SS F+ + D S N
Sbjct: 183 ESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 263 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH--------SLIHLDLRNNALYG 314
L+ + + L + + + + N L P E ++ L + L+
Sbjct: 242 ELLKLLRYILELS-EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 315 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKS---ISNL 371
+ + + ++ + + ++ SL L LS N + K+
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 372 NKLKILKLEFNELS--GEIPQELGKLASLLAVNVSYNRL 408
L+ L L N L + + L L +L ++++S N
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 4/119 (3%)
Query: 305 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 364
D R+ + SIP + + ++ L L N +T +R C +L +L L + ++
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 365 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQ 423
+ +L L+ L L N LS G L+SL +N+ N L V +FP L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 67/380 (17%), Positives = 134/380 (35%), Gaps = 39/380 (10%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 66
L ++ P + A L + + S+ L ++ +
Sbjct: 5 LATLPAPINQIFP---DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 126
+ GI L L L+L+ N + P ++ L L L + N+ + +
Sbjct: 59 IQ-----GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNL 109
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186
+L L L+ + + + L L M +++ N D+ + N++ L +L + +
Sbjct: 110 TNLRELYLNEDNISD-IS-PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESK 166
Query: 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSS 245
+ + + N L + L N + L L L N P + +
Sbjct: 167 VKDV--TPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITPVANMTR 222
Query: 246 SSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 305
L L + +N + D+ L + L +L + +N + + L L
Sbjct: 223 --------LNSLKIGNNKIT-DLSPLANL-SQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 306 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 365
++ +N + S + L L L+ N L +VI T+L L LS NH++ P
Sbjct: 271 NVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 366 KSISNLNKLKILKLEFNELS 385
+++L+K+ +
Sbjct: 329 --LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 76/375 (20%), Positives = 139/375 (37%), Gaps = 38/375 (10%)
Query: 37 NILQGPIGKIFN--YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS 94
L PI +IF + L + + L+ + L ++ + S
Sbjct: 6 ATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQEE------LESITKLVVAGEKVA-S 58
Query: 95 IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI 154
I G+ L L+ L L GNQ + P + LT L + N T +L+ L ++
Sbjct: 59 IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLR 113
Query: 155 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 214
+ ++ + ++ P + N++ + L+ NH S S L N L+ + + + +
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDV 170
Query: 215 IP-EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 273
P L DL + L+ N P S +S L N + DI
Sbjct: 171 TPIANLTDL--YSLSLNYNQIEDISPLASLTS--------LHYFTAYVNQIT-DITPVAN 219
Query: 274 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 333
+ L L + +N + L L L++ N + S V + L +L +
Sbjct: 220 M-TRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGS 274
Query: 334 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELG 393
N ++ + N + L L L++N L + I L L L L N ++ P L
Sbjct: 275 NQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330
Query: 394 KLASLLAVNVSYNRL 408
L+ + + + + +
Sbjct: 331 SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 55/301 (18%), Positives = 106/301 (35%), Gaps = 46/301 (15%)
Query: 129 LTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 188
TL P L I + ++T + + ++ L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 189 -----GSLP---------------SSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEI 227
L S L N KL+ + + N + L +L L E+
Sbjct: 58 SIQGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLREL 115
Query: 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 287
L+E+ P + + L+L +N+ + D+ + L YL ++ +
Sbjct: 116 YLNEDNISDISPLAN--------LTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK 166
Query: 288 LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC 347
++ + L L L N + P + SL N +T P + N
Sbjct: 167 VKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220
Query: 348 TSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR 407
T L L + +N ++ P ++NL++L L++ N++S + L L +NV N+
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQ 276
Query: 408 L 408
+
Sbjct: 277 I 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 43/211 (20%), Positives = 81/211 (38%), Gaps = 19/211 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
M + +L ++ + + P N L LSL N ++ +SL+
Sbjct: 154 MTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV 208
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + D+ + ++ RL +L + +N + P +A L L L + NQ S
Sbjct: 209 NQIT-DIT-----PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA 260
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+ L L++ +N + L L+ + + ++NN L + IG ++ L L
Sbjct: 261 --VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 211
S NH+T L + K+ +
Sbjct: 317 FLSQNHITDI--RPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 33/176 (18%), Positives = 61/176 (34%), Gaps = 12/176 (6%)
Query: 254 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 313
L + I + L A L + S+ L + +
Sbjct: 2 AATLATLPAPI-NQIFPDADL-AEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV- 56
Query: 314 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 373
SI + +L L L+GN +T P + N L L + N ++ ++ NL
Sbjct: 57 ASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 374 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 429
L+ L L + +S P L L + ++N+ N + L L+ ++ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTES 165
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-41
Identities = 64/406 (15%), Positives = 118/406 (29%), Gaps = 36/406 (8%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
K ++++ L L ++ +++ L L+GN L + L LNLS+N
Sbjct: 11 RYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
LD SL LRTLDL++N + ++ L N S +
Sbjct: 70 LYETLDLE------SLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISR-VSCS 117
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG-DIPHWIGNISTLEFLD 181
G + L+NN T + + + ++ + N + + + TLE L+
Sbjct: 118 RG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPP 240
N + + + KL + L N L + + I L N + I
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH 300
S + L DL N N R ++ ++
Sbjct: 232 ALRFSQN------LEHFDLRGNGFHCGTL-RDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 301 SLIHLDLRNNALYGSIPQEVCE------SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 354
+P + + +L G+ + N +
Sbjct: 285 VPTLGHYGAYCC-EDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREID 342
Query: 355 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLA 400
I + L+ + L ++ A L
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 63/393 (16%), Positives = 132/393 (33%), Gaps = 29/393 (7%)
Query: 22 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81
+ +N + + + L+ + + ++ L+LS N S + A + +L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAAD---LAPFTKL 60
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
L+LS N+ ++ + +L L+ L L N ++ P + TL +NN +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 142 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKK 200
VS I ++NN +T G S +++LD N + + L +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 201 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
L + L+ N + ++ + L+ +DLS N + P S++ + + L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAG------VTWISLR 222
Query: 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320
+N LV I + NL + +L N + + + + + Q
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNE 280
Query: 321 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS----IPKSISNLNKLKI 376
E + +L + GS + N + +
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 377 LKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409
+ + I Q + + + + L
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-37
Identities = 63/353 (17%), Positives = 135/353 (38%), Gaps = 23/353 (6%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+ R + ++ + ++ + +KEL L GN S AD+ L L+LS+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 196
N+ + L L+++ + ++NN + + ++E L +NN+++ + S
Sbjct: 68 NVLY-ETL-DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 254
+ I L N + + + ++ +DL N ++ ++SS TL
Sbjct: 120 --QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS----DTL 171
Query: 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 314
L+L N + D+ ++ A L+ L+LSSN L + + PE + + LRNN L
Sbjct: 172 EHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL-V 227
Query: 315 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 374
I + + S++L L GN + + + + +++ + ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 375 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 427
+ +L +L + G +Q+ +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 56/308 (18%), Positives = 114/308 (37%), Gaps = 22/308 (7%)
Query: 94 SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 153
+I + + K + + L + ++ LDLS N + L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 154 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 213
+++S+N L + + ++STL LD +NN++ L + + N+++
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 214 NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG-DIPAEM 272
+ G + I L+ N + S ++ LDL N + +
Sbjct: 113 RVSCSRGQ-GKKNIYLANNKI-TMLRDLDEGCRSR-----VQYLDLKLNEIDTVNFAELA 165
Query: 273 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 332
L +LNL N + + ++ F L LDL +N L + E + + + L
Sbjct: 166 ASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLR 222
Query: 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLS-GSIPKSISNLNKLKILKLE-FNELSGEIPQ 390
N L I + +R +L L N G++ S +++ + + +L+G+ +
Sbjct: 223 NNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 391 ELGKLASL 398
E
Sbjct: 282 ECTVPTLG 289
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-33
Identities = 63/432 (14%), Positives = 130/432 (30%), Gaps = 43/432 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+K LDLS N LS + L L+L+ N+L + S+L TL+L+NN+
Sbjct: 35 NVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY 91
Query: 63 FSG--------DLDFA----SGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 110
L A S + + + L++N + ++ L L
Sbjct: 92 VQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 111 QGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPH 169
+ N+ L L+L N + + + + + +S+N L +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP 208
Query: 170 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDL 229
+ + + ++ NN L + +L + L LRGN + F +
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
Query: 230 SENGFMGSIPPGSS---------------SSSSSTLFQTLRILDLSSN-------NLVGD 267
++ + L L + +
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER 327
Query: 268 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLG 327
+ E A R ++ R+ I + I L+ + AL + L
Sbjct: 328 LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
Query: 328 ILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 387
L ++ + + + N ++ + ++ + +
Sbjct: 388 GTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-Q 446
Query: 388 IPQELGKLASLL 399
+ +E +L L
Sbjct: 447 LAEENARLKKLN 458
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 51/383 (13%), Positives = 110/383 (28%), Gaps = 26/383 (6%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLS 59
K + L+NN ++ + + ++YL L N + ++ +L LNL
Sbjct: 119 GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
N D+ G +L+TLDLS N + + + + + L+ N+ +
Sbjct: 178 YNFIY-DVK-----GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-I 229
Query: 120 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
+ F +L DL N F N + +V+ T+ +
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV-QTVAKQTVKKLTGQNEEECTVPTL 288
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN----IPEGLFDLG-LEEIDLSENGF 234
+ L S G+ + + EID + +
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 235 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR--SRI 292
++ + + L+ L + A L +
Sbjct: 349 R-TVIDQVTLRKQA-----KITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHA 402
Query: 293 PPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYL 352
E L + R + Q+ ++ ++ + + T + R
Sbjct: 403 TEEQSPLQLLRAIVKRYE--EMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGE 460
Query: 353 LSLSHNHLSGSIPKSISNLNKLK 375
L+ + ++ + + L
Sbjct: 461 ADLALASANATLQELVVREQNLA 483
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 20/94 (21%), Positives = 43/94 (45%), Gaps = 2/94 (2%)
Query: 315 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 374
+I + I ++ +SL + + ++ ++ L LS N LS ++ KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 375 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
++L L N L +L L++L ++++ N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 16/77 (20%), Positives = 31/77 (40%)
Query: 340 IPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLL 399
I ++ +N + ++ + L ++ + +K L L N LS +L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 400 AVNVSYNRLIGRLPVGG 416
+N+S N L L +
Sbjct: 62 LLNLSSNVLYETLDLES 78
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-41
Identities = 66/366 (18%), Positives = 132/366 (36%), Gaps = 40/366 (10%)
Query: 48 NYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLK 106
++ + + + G D +L + + ++ +P + + ++
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDI-------TLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 107 ELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 165
L L Q + + + L + N P + + + + + N L+
Sbjct: 73 LLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 166 DIPHWI-GNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDLG 223
+P I N L L SNN+L + F L ++L N L ++ L
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP-S 187
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNL 283
L ++S N + ++ + + LD S N++ + + L L L
Sbjct: 188 LFHANVSYN-LLSTLAIPIA----------VEELDASHNSIN-VVRG--PVNVELTILKL 233
Query: 284 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQ 342
N+L L + L+ +DL N L I + L L + N L +
Sbjct: 234 QHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLVA-LNL 289
Query: 343 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVN 402
+ +L +L LSHNHL + ++ ++L+ L L+ N + + L +L +
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLT 345
Query: 403 VSYNRL 408
+S+N
Sbjct: 346 LSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-38
Identities = 79/362 (21%), Positives = 135/362 (37%), Gaps = 39/362 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N K + N+ + +P L ++ + L+L ++ F Y ++ L + N
Sbjct: 46 NQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 121
L + L L L N S S+P+G+ L L + N +
Sbjct: 105 IR-YLPPHVFQN---VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IED 158
Query: 122 DI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
D L L LS+N T V L L+ S+ +VS N L+ + +E L
Sbjct: 159 DTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLST-----LAIPIAVEEL 210
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240
D S+N + + + +L++++L+ N+L + L GL E+DLS N I
Sbjct: 211 DASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMY 265
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH 300
L L +S+N LV + L+ L+LS NHL + F
Sbjct: 266 HPFVKMQR-----LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFD 318
Query: 301 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL 360
L +L L +N++ ++ +L L L N N +++ +
Sbjct: 319 RLENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWDC-------NSLRALFRNVARPAV 368
Query: 361 SG 362
Sbjct: 369 DD 370
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 62/323 (19%), Positives = 123/323 (38%), Gaps = 25/323 (7%)
Query: 89 NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 148
I + ++ + + + + N+ L
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 149 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLR 207
+ +++++ + + T++ L N + LP +F N L+V+ L
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 125
Query: 208 GNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV 265
N L+ ++P G+F L + +S N I + +++S L+ L LSSN L
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTS-----LQNLQLSSNRLT 178
Query: 266 GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRS 325
+ L +L + N+S N L + L ++ LD +N++ + V
Sbjct: 179 -HVDL--SLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSI-NVVRGPVN--VE 227
Query: 326 LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385
L IL+L N+LT + N L + LS+N L + + +L+ L + N L
Sbjct: 228 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 386 GEIPQELGKLASLLAVNVSYNRL 408
+ + +L +++S+N L
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 69/296 (23%), Positives = 114/296 (38%), Gaps = 32/296 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ L L N LS +P +F N L LS++ N L+ F +SL L LS+N
Sbjct: 118 LLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+ +D + + L ++S+NL S +A ++EL N + +
Sbjct: 177 LT-HVDLS------LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGP 223
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+ LT L L +N T L ++ + +S N L + H + LE L
Sbjct: 224 V--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPG 241
SNN L +L L V+ L N L ++ LE + L N + ++
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS 336
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG 297
+ TL+ L LS N+ + + LF N+ + +I +L
Sbjct: 337 T--------HHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 35/200 (17%), Positives = 69/200 (34%), Gaps = 16/200 (8%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ ++ LD S+N ++ V + L L L N L L ++LS
Sbjct: 204 PIAVEELDASHNSINV-VRGPVNVE---LTILKLQHNNLTDT--AWLLNYPGLVEVDLSY 257
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + + ++RL L +S+N ++ + LK L L N +
Sbjct: 258 NELE-KIMYHPFVK---MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VE 311
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD-IPHWIGNISTLEF 179
+ L L L +N + L +++ +++S+N + + N++
Sbjct: 312 RNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAV 368
Query: 180 LDFSNNHLTGSLPSSLFNCK 199
D + CK
Sbjct: 369 DDADQHCKIDYQLEHGLCCK 388
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 5e-41
Identities = 80/433 (18%), Positives = 151/433 (34%), Gaps = 45/433 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
++ L+L + + + F N +LR L L + + F L L L
Sbjct: 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG 108
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 121
S + +LK L LDLS N L+ LK + NQ
Sbjct: 109 LSDAV--LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166
Query: 122 DIGF--CPHLTTLDLSNNLFTGQLP------------VSLRLLN------SMIFISVSNN 161
++ L+ L+ N ++ + L +L+ ++ +N
Sbjct: 167 ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
Query: 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV--IRLRGNSLNGNIPEGL 219
++ + + F +++ ++ + SV + L + ++ +
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRV 285
Query: 220 FDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 277
F+ L+ ++L+ N + I + L++L+LS N L +
Sbjct: 286 FETLKDLKVLNLAYN-KINKIADEAFYG-----LDNLQVLNLSYNLLGELYSSNFYGLPK 339
Query: 278 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 337
+ Y++L NH+ + L LDLR+NAL + S+ + L GN L
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV 394
Query: 338 GPIPQVIRNCTSLYLLSLSHNHLSG-SIPKSISNLNKLKILKLEFNELSGEIPQEL-GKL 395
+ + + L+ LS N L I + + L+IL L N S + +
Sbjct: 395 ----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450
Query: 396 ASLLAVNVSYNRL 408
SL + + N L
Sbjct: 451 PSLEQLFLGENML 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-40
Identities = 82/462 (17%), Positives = 154/462 (33%), Gaps = 54/462 (11%)
Query: 1 MMNMKFLDLSNNLLS-GPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNL 58
+ ++ L L LS + F N +L L L+ N ++ + F +SL +++
Sbjct: 96 LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF 155
Query: 59 SNNHFSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH------YLKELLL 110
S+N + + K L L+ N + L+ L +
Sbjct: 156 SSNQIFLVCEHELEP----LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211
Query: 111 QGNQFSGPLPA------------DIGFCPHLTTLDLSNNLFTGQLPVSLRLL--NSMIFI 156
GN ++ + + H+ + + L +S+ +
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271
Query: 157 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 216
+S+ + + L+ L+ + N + + + L V+ L N L +
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELY 330
Query: 217 EGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 274
F + IDL +N I + L+ LDL N L +
Sbjct: 331 SSNFYGLPKVAYIDLQKNHI-AIIQDQTFKFLEK-----LQTLDLRDNALT-----TIHF 379
Query: 275 FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG-SIPQEVCESRSLGILQLDG 333
++ + LS N L + +P + + L N L I + L IL L+
Sbjct: 380 IPSIPDIFLSGNKLVT-LPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435
Query: 334 NSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-----SNLNKLKILKLEFNELSGE 387
N + Q SL L L N L + + L+ L++L L N L+
Sbjct: 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSL 495
Query: 388 IPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 429
P L +L ++++ NR + L + L+ + N
Sbjct: 496 PPGVFSHLTALRGLSLNSNR-LTVLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-37
Identities = 98/460 (21%), Positives = 154/460 (33%), Gaps = 56/460 (12%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGK-IFNYCSSLNTLNLSNN 61
+ L LS N + V F L+ L L I K F +L L+L ++
Sbjct: 25 TTERLLLSFNYIRT-VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 62 HFSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSI--PQGVAALHYLKELLLQGNQFSG 117
F L L L L S ++ L L L L NQ
Sbjct: 84 KIYFLHPDAFQ------GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137
Query: 118 -PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLL--NSMIFISVSNNTLTGDIPHWIGNI 174
L G L ++D S+N L L ++ F S++ N+L + G
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 175 S------TLEFLDFSNNHLTGSLPSSLFNC------------KKLSVIRLRGN---SLNG 213
LE LD S N T + + N + + +
Sbjct: 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257
Query: 214 NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 273
N GL + +DLS F+ S+ + L++L+L+ N +
Sbjct: 258 NTFAGLARSSVRHLDLSHG-FVFSLNSRVFETLKD-----LKVLNLAYNKINKIADEAFY 311
Query: 274 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLD 332
NL+ LNLS N L + ++DL+ N + I + + L L L
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLR 370
Query: 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 392
N+LT I S+ + LS N L ++PK N + + + L I L
Sbjct: 371 DNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENLD--ILYFL 422
Query: 393 GKLASLLAVNVSYNRLIGRLPVGGVF---PTLDQSSLQGN 429
++ L + ++ NR P+L+Q L N
Sbjct: 423 LRVPHLQILILNQNR-FSSCSGDQTPSENPSLEQLFLGEN 461
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-37
Identities = 86/457 (18%), Positives = 156/457 (34%), Gaps = 70/457 (15%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFN--YCSSLNTLNLSN 60
+ LDLS N + + F SL+ + + N + +L+ +L+
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 61 NHFSG--DLDFASGYGIWSLKRLRTLDLSH------------NLFSGSIPQGVAALHYLK 106
N +D+ + L LD+S N S S + H++
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 107 ELLLQGNQFSGP--------------------------LPADIGFCPHLTTLDLSNNLFT 140
+ P L L+L+ N
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 200
+ L+++ +++S N L + + ++D NH+ + +K
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363
Query: 201 LSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 259
L + LR N+L + + + +I LS N + + T ++ L
Sbjct: 364 LQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL----------VTLPKINLTANLIHL 408
Query: 260 SSNNLVG-DIPAEMGLFANLRYLNLSSNHLRSRIPPEL-GYFHSLIHLDLRNNALYGSIP 317
S N L DI + +L+ L L+ N S + SL L L N L +
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468
Query: 318 QEVCES-----RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN 372
E+C L +L L+ N L P V + T+L LSL+ N L+ + +
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHN-DLPA 526
Query: 373 KLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409
L+IL + N+L P L+ +++++N+ I
Sbjct: 527 NLEILDISRNQLLAPNPDVFVSLSV---LDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-36
Identities = 86/426 (20%), Positives = 151/426 (35%), Gaps = 59/426 (13%)
Query: 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 64
+ L+ Q+ + + L L+ N ++ F + L L L + +
Sbjct: 7 RIAFYRFCNLT-----QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADI 123
+D + +L LR LDL + + L +L EL L S + D
Sbjct: 62 LTIDKEA---FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDG 117
Query: 124 GFC--PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
F LT LDLS N + + G +++L+ +D
Sbjct: 118 YFRNLKALTRLDLSKNQIR-----------------------SLYLHPSFGKLNSLKSID 154
Query: 182 FSNNHLTGSLPSSL--FNCKKLSVIRLRGNSLNGNIPEGLF-------DLGLEEIDLSEN 232
FS+N + L K LS L NSL + ++ LE +D+S N
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 233 GFMGSIPPGSSSSSSSTLFQT------LRILDLSSNNLVGDIPAEM--GLFA-NLRYLNL 283
G+ I S++ S + + + +N+ D GL ++R+L+L
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDL 273
Query: 284 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQV 343
S + S L L+L N + + +L +L L N L
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 344 IRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNV 403
+ + L NH++ ++ L KL+ L L N L+ + + S+ + +
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFL 388
Query: 404 SYNRLI 409
S N+L+
Sbjct: 389 SGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-22
Identities = 58/278 (20%), Positives = 96/278 (34%), Gaps = 29/278 (10%)
Query: 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 218
LT +P ++T E L S N++ SS ++L ++ L I +
Sbjct: 12 RFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 219 LFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
F L +DL + + P + L L L L D + G F
Sbjct: 68 AFRNLPNLRILDLGSSKIY-FLHPDAFQGLFH-----LFELRLYFCGL-SDAVLKDGYFR 120
Query: 277 ---NLRYLNLSSNHLRS-RIPPELGYFHSLIHLDLRNNALYGSIPQ--EVCESRSLGILQ 330
L L+LS N +RS + P G +SL +D +N ++ E + ++L
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180
Query: 331 LDGNSLTGPIPQVIRNCT-SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIP 389
L NSL + C + L +SG N + I N +S
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQA 233
Query: 390 QELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 427
L ++ ++ I F L +SS++
Sbjct: 234 FSLILAHHIMGAGFGFHN-IKDPDQ-NTFAGLARSSVR 269
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-38
Identities = 82/440 (18%), Positives = 150/440 (34%), Gaps = 64/440 (14%)
Query: 18 VPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 77
+ L +C + + G ++ + N+ L A + S
Sbjct: 19 IDSNLQYDC-VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL---LDS 73
Query: 78 LKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLS 135
+++ L+L+ I A H +++L + N LP + P LT L L
Sbjct: 74 FRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLE 131
Query: 136 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 195
N + S+ N L L SNN+L +
Sbjct: 132 RNDLS----------------SLPRGIF--------HNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 196 F-NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 254
F L ++L N L ++ L L ++S N + ++ + +
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVDLSLIP-SLFHANVSYN-LLSTLAIPIA----------V 213
Query: 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 314
LD S N++ + + L L L N+L L + L+ +DL N L
Sbjct: 214 EELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-E 267
Query: 315 SIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 373
I + L L + N L + + +L +L LSHNHL + ++ ++
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325
Query: 374 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN---L 430
L+ L L+ N + + L +L + +S+N + +F + + ++
Sbjct: 326 LENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDDADQHC 381
Query: 431 GICSPLLKGPCKMNVPKPLV 450
I L G C KP +
Sbjct: 382 KIDYQLEHGLCCKESDKPYL 401
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 9e-36
Identities = 79/363 (21%), Positives = 136/363 (37%), Gaps = 41/363 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N K + N+ + +P L ++ + L+L ++ F Y ++ L + N
Sbjct: 52 NQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 121
L + L L L N S S+P+G+ L L + N +
Sbjct: 111 IR-YLPPHVFQN---VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IED 164
Query: 122 DI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
D L L LS+N T V L L+ S+ +VS N L+ + +E L
Sbjct: 165 DTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEEL 216
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIP 239
D S+N + + + +L++++L+ N+L + L + GL E+DLS N I
Sbjct: 217 DASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIM 270
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
L L +S+N LV + L+ L+LS NHL + F
Sbjct: 271 YHPFVKMQR-----LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQF 323
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359
L +L L +N++ ++ +L L L N N +++
Sbjct: 324 DRLENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWDC-------NSLRALFRNVARPA 373
Query: 360 LSG 362
+
Sbjct: 374 VDD 376
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-32
Identities = 73/385 (18%), Positives = 137/385 (35%), Gaps = 44/385 (11%)
Query: 94 SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 153
I + ++ + + + + N+ L +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 154 IFISVSNNTLTGDIPHWI-GNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSL 211
+++++ + +I + T++ L N + LP +F N L+V+ L N L
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 212 NGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP 269
+ ++P G+F L + +S N I + +++S L+ L LSSN L +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTS-----LQNLQLSSNRLT-HVD 187
Query: 270 AEMGLFANLRYLNLSSNHLRS------------------RIPPELGYFHSLIHLDLRNNA 311
L +L + N+S N L + + + L L L++N
Sbjct: 188 L--SLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNN 243
Query: 312 LYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL 371
L + + L + L N L + L L +S+N L ++ +
Sbjct: 244 L--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300
Query: 372 NKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLG 431
LK+L L N L + + + L + + +N I L + TL +L N
Sbjct: 301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLKL-STHHTLKNLTLSHNDW 357
Query: 432 ICSPLLKGPCKMNVPKPLVLDPDAY 456
C+ L NV +P V D D +
Sbjct: 358 DCNSLRALF--RNVARPAVDDADQH 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 79/420 (18%), Positives = 139/420 (33%), Gaps = 76/420 (18%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI-FNYCSSLNTLNLS 59
+ L +SNN L + F+ SL+ L L+ N + + + SL N+S
Sbjct: 146 TPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSN----RLTHVDLSLIPSLFHANVS 200
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 119
N S + + LD SHN + + L L LQ N +
Sbjct: 201 YNLLS---------TLAIPIAVEELDASHNSIN-VVRGP--VNVELTILKLQHNNLT-DT 247
Query: 120 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
+ P L +DLS N + + + + +SNN L + + I TL+
Sbjct: 248 AW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239
LD S+NHL + + +L + L NS+ ++
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV------------------------TLK 340
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
+ TL+ L LS N+ + + LF N+ + +I +L
Sbjct: 341 LST--------HHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLE-- 388
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359
H L + + + S+ + + C++ ++ +
Sbjct: 389 HGLCCKESDK------------PYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSL 436
Query: 360 LSGSIPKSISNLNKLKILKLEFNELSGEIPQ------ELGKLASLLAVNVSYNRLIGRLP 413
+ L + L+ E NEL E+ Q + +L L + N RLP
Sbjct: 437 SHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLP 496
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 59/290 (20%), Positives = 116/290 (40%), Gaps = 43/290 (14%)
Query: 126 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 185
P +D + V + + ++ + TL + + F N+
Sbjct: 13 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLN-----------NQKIVTFKNS 61
Query: 186 HLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGS 242
+ LP++L + +++ ++ L + I F ++++ + N + +PP
Sbjct: 62 TMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN-AIRYLPPHV 118
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN---LRYLNLSSNHLRSRIPPE-LGY 298
+ L +L L N+L +P G+F N L L++S+N+L I +
Sbjct: 119 FQNVPL-----LTVLVLERNDLS-SLPR--GIFHNTPKLTTLSMSNNNLER-IEDDTFQA 169
Query: 299 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
SL +L L +N L + + SL + N L+ + ++ L SHN
Sbjct: 170 TTSLQNLQLSSNRL-THVDLSLI--PSLFHANVSYNLLS-----TLAIPIAVEELDASHN 221
Query: 359 HLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
++ + + +L ILKL+ N L+ + L L+ V++SYN L
Sbjct: 222 SIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNEL 266
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 3e-17
Identities = 60/401 (14%), Positives = 124/401 (30%), Gaps = 48/401 (11%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ ++ LD S+N ++ V + L L L N L L ++LS
Sbjct: 210 PIAVEELDASHNSINV-VRGPVNVE---LTILKLQHNNLTDT--AWLLNYPGLVEVDLSY 263
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + + ++RL L +S+N ++ + LK L L N +
Sbjct: 264 NELE-KIMYHP---FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VE 317
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD-IPHWIGNISTLEF 179
+ L L L +N + L +++ +++S+N + + N++
Sbjct: 318 RNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAV 374
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239
D + CK+ + D L+ I L+
Sbjct: 375 DDADQHCKIDYQLEHGLCCKES--------------DKPYLDRLLQYIALTSVVEKVQRA 420
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
G S++ + ++ V L N LR+ +
Sbjct: 421 QGRCSATDTINSVQSLSHYITQQGGV--------PLQGNEQLEAEVNELRAEV------- 465
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG-NSLTGPIPQVIRNCTSLYLLSLSHN 358
L + ++ L + E+ + L DG + + +V + L
Sbjct: 466 QQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRET 525
Query: 359 HLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLL 399
++ + + + L+ E L ++ + K A L
Sbjct: 526 QA--RRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELR 564
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 57/328 (17%), Positives = 114/328 (34%), Gaps = 45/328 (13%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+ R + ++ + ++ + +KEL L GN S AD+ L L+LS+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 196
N+ + + ++STL LD +NN++ L
Sbjct: 68 NVLY-------------------------ETLD-LESLSTLRTLDLNNNYVQ-----ELL 96
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
+ + N+++ + G + I L+ N + ++
Sbjct: 97 VGPSIETLHAANNNIS-RVSCSRGQ-GKKNIYLANNKI-TMLRDLDEGC-----RSRVQY 148
Query: 257 LDLSSNNLVG-DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS 315
LDL N + + L +LNL N + + ++ F L LDL +N L
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL-AF 205
Query: 316 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS-GSIPKSISNLNKL 374
+ E + + + L N L I + +R +L L N G++ S ++
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 375 KILKLEFNELSGEIPQELGKLASLLAVN 402
+ + + + +E + +L
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 65/365 (17%), Positives = 128/365 (35%), Gaps = 54/365 (14%)
Query: 22 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81
+ +N + + + L+ + + ++ L+LS N S + A + +L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAAD---LAPFTKL 60
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
L+LS N+ ++ + +L L+ L L N ++ P + TL +NN +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 142 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG-SLPSSLFNCKK 200
VS I ++NN +T G S +++LD N + + +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 201 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
L + L+ N + ++ + F L+ LDLS
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV------------------------------FAKLKTLDLS 199
Query: 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320
SN L + E A + +++L +N L I L + +L H DLR N +
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CGTLRD 256
Query: 321 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLE 380
S++ + + ++ Q CT L + + +++ L
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC-----EDLPAPFADRLIALG 311
Query: 381 FNELS 385
+
Sbjct: 312 HHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 58/336 (17%), Positives = 109/336 (32%), Gaps = 33/336 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
K ++++ L L ++ +++ L L+GN L + L LNLS+N
Sbjct: 11 RYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
LD SL LRTLDL++N + ++ L N S +
Sbjct: 70 LYETLDLE------SLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISR-VSCS 117
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG-DIPHWIGNISTLEFLD 181
G + L+NN T + + + ++ + N + + + TLE L+
Sbjct: 118 RG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPP 240
N + + + KL + L N L + + I L N + I
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH 300
S + L DL N N R ++ ++ + +
Sbjct: 232 ALRFSQN------LEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEEC 283
Query: 301 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
++ L +P + ++ L +
Sbjct: 284 TVPTLGHYGAYCCEDLP----APFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 50/263 (19%), Positives = 100/263 (38%), Gaps = 22/263 (8%)
Query: 148 RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 207
+ N V++++L + + ++ LD S N L+ + L KL ++ L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 208 GNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 266
N L + L L L +DL+ N ++ + G S + L ++NN+
Sbjct: 67 SNVLY-ETLD-LESLSTLRTLDLNNN-YVQELLVGPS----------IETLHAANNNI-S 112
Query: 267 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG-SIPQEVCESRS 325
+ + + L++N + + G + +LDL+ N + + + S +
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 326 LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385
L L L N + + + L L LS N L+ + + + + L N+L
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 386 GEIPQELGKLASLLAVNVSYNRL 408
I + L +L ++ N
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/277 (18%), Positives = 102/277 (36%), Gaps = 37/277 (13%)
Query: 190 SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSS 247
++ N + + ++ +SL L ++E+DLS N I + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPL-SQISAADLAPFT 58
Query: 248 STLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS----------------- 290
L +L+LSSN L ++ + LR L+L++N+++
Sbjct: 59 K-----LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111
Query: 291 -RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCT 348
R+ ++ L NN + + + L L N + ++ +
Sbjct: 112 SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 349 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
+L L+L +N + + + KLK L L N+L+ + E A + +++ N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 409 IGRLPVG-GVFPTLDQSSLQGNLGICSPLLKGPCKMN 444
+ + L+ L+GN C L K
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-36
Identities = 81/358 (22%), Positives = 126/358 (35%), Gaps = 54/358 (15%)
Query: 49 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 108
+ LN+ + + L + TL + N + S+P A L+ L
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLP------AHITTLVIPDNNLT-SLP---ALPPELRTL 86
Query: 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 168
+ GNQ + LP L+ LP L L + N LT +P
Sbjct: 87 EVSGNQLTS-LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLW------IFGNQLT-SLP 137
Query: 169 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEID 228
L+ L S+N L SLP+ KL N L ++P GL+E+
Sbjct: 138 VLPPG---LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPS--GLQELS 187
Query: 229 LSENGFMGSIPPGSSS-----------SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 277
+S+N S+P S +S L L+ L +S N L +P
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRL-TSLPVLPS---E 242
Query: 278 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 337
L+ L +S N L S +P L+ L + N L +P+ + S + L+GN L+
Sbjct: 243 LKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLS 297
Query: 338 GPIPQVIRNCTSLYLLS---LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 392
Q +R TS S + + S P+ L+ L P +
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-36
Identities = 87/411 (21%), Positives = 141/411 (34%), Gaps = 53/411 (12%)
Query: 75 IWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDL 134
L++ + + ++P + A + L++ N + LPA L TL++
Sbjct: 36 ACLNNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLTS-LPALPP---ELRTLEV 88
Query: 135 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 194
S N T LPV L + S L S L L N LT SLP
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVL 139
Query: 195 LFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 254
++LS + N L ++P + L ++ N S+P L L
Sbjct: 140 PPGLQELS---VSDNQLA-SLPALPSE--LCKLWAYNNQL-TSLPM---------LPSGL 183
Query: 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 314
+ L +S N L +P L L +N L S +P L L + N L
Sbjct: 184 QELSVSDNQLA-SLPTLPS---ELYKLWAYNNRLTS-LPALPS---GLKELIVSGNRL-T 234
Query: 315 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 374
S+P L L + GN LT +P + SL + N L+ +P+S+ +L+
Sbjct: 235 SLPVLPS---ELKELMVSGNRLTS-LPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSE 286
Query: 375 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICS 434
+ LE N LS Q L ++ S +I G P ++
Sbjct: 287 TTVNLEGNPLSERTLQALREITSA---PGYSGPIIRFDMAGASAPRETRALHLAAADWLV 343
Query: 435 PLLKG-PCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAI 484
P +G P + + +A + + +S+
Sbjct: 344 PAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSW 394
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 77/351 (21%), Positives = 121/351 (34%), Gaps = 53/351 (15%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
++ L + +N L+ L LR L ++GN L + + L+ + H
Sbjct: 62 HITTLVIPDNNLT-----SLPALPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTH 115
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
L L + N + S+P L+EL + NQ + LPA
Sbjct: 116 LPA-----------LPSGLCKLWIFGNQLT-SLP---VLPPGLQELSVSDNQLAS-LPAL 159
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
L L NN T LP+ L +SVS+N L +P L L
Sbjct: 160 PS---ELCKLWAYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSE---LYKLWA 208
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 242
NN LT SLP+ K+L + GN L ++P +L +E+ +S N + S+P
Sbjct: 209 YNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPSEL--KELMVSGN-RLTSLPM-- 258
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302
L L L + N L +P + ++ +NL N L R L S
Sbjct: 259 -------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 353
+ E+R+L + L ++
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRAL--HLAAADWLVPAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 18/90 (20%), Positives = 36/90 (40%), Gaps = 8/90 (8%)
Query: 319 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 378
C + +L + + LT +P + + L + N+L+ S+P L+ L+
Sbjct: 35 RACLNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTLE 87
Query: 379 LEFNELSGEIPQELGKLASLLAVNVSYNRL 408
+ N+L+ +P L L + L
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHL 116
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 85/418 (20%), Positives = 155/418 (37%), Gaps = 68/418 (16%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+++ L S N L+ +P +L ++ SL + + + L L +SNN
Sbjct: 92 HLESLVASCNSLT-ELP-ELPQSLKSLLVDNNNLK-------ALSDLPPLLEYLGVSNNQ 142
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
L + + L+ +D+ +N +P L+ + NQ LP +
Sbjct: 143 LE-KLP-----ELQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEE-LP-E 190
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+ P LT + NN +LP L S I NN L ++P + N+ L +
Sbjct: 191 LQNLPFLTAIYADNNSLK-KLPDLPLSLES---IVAGNNILE-ELPE-LQNLPFLTTIYA 244
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 242
NN L +LP + + L+V L L +D+SEN F +
Sbjct: 245 DNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQ------SLTFLDVSENIFS-GLSELP 296
Query: 243 SS-----------SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291
+ S L +L L++S+N L+ ++PA L L S NHL
Sbjct: 297 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE- 351
Query: 292 IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLY 351
+P +L L + N L P S+ L+++ + +P++ +N L+
Sbjct: 352 VPELPQ---NLKQLHVEYNPLR-EFPDIPE---SVEDLRMNSHLAE--VPELPQNLKQLH 402
Query: 352 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409
+ N L P ++ + L++ + + + + L +V +
Sbjct: 403 V---ETNPLR-EFPDIPESV---EDLRMNSERVV-DPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 81/383 (21%), Positives = 145/383 (37%), Gaps = 61/383 (15%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+++L +SNN L +P +N + L+ + + N + K+ + SL + NN
Sbjct: 132 LLEYLGVSNNQLEK-LP--ELQNSSFLKIIDVDNN----SLKKLPDLPPSLEFIAAGNNQ 184
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+L + +L L + +N +P L+ ++ N +
Sbjct: 185 LE-ELPE-----LQNLPFLTAIYADNNSLK-KLPDL---PLSLESIVAGNNILE--ELPE 232
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+ P LTT+ NNL LP L + ++V +N LT D+P + L FLD
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNVRDNYLT-DLPELPQS---LTFLDV 284
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 242
S N + L N L+ SL P LEE+++S N + +P
Sbjct: 285 SENIFS-GLSELPPNLYYLNASSNEIRSLCDLPP------SLEELNVSNNKLI-ELPA-- 334
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302
L L L S N+L ++P NL+ L++ N LR P S+
Sbjct: 335 -------LPPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPDIPE---SV 379
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG 362
L + ++ +P+ ++L L ++ N L P + + L + + +
Sbjct: 380 EDLRMNSH--LAEVPELP---QNLKQLHVETNPLRE-FPDIPESVEDLRM---NSERVVD 430
Query: 363 SIPKSISNLNKLKILKLEFNELS 385
+ +KL+ E +
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-34
Identities = 89/413 (21%), Positives = 143/413 (34%), Gaps = 74/413 (17%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFEN------------CASLRYLSLAGNILQGPIGKIFNYC 50
+ + + P E L L L +
Sbjct: 35 SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS----SLPELP 90
Query: 51 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 110
L +L S N + +L SLK L + + S P L+ L +
Sbjct: 91 PHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKALSDLPPL-------LEYLGV 138
Query: 111 QGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW 170
NQ LP ++ L +D+ NN +LP L I+ NN L ++P
Sbjct: 139 SNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IAAGNNQLE-ELPE- 190
Query: 171 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDL 229
+ N+ L + NN L LP + + + N L +PE L +L L I
Sbjct: 191 LQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE-ELPE-LQNLPFLTTIYA 244
Query: 230 SENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR 289
N + ++P S L L++ N L D+P +L +L++S N
Sbjct: 245 DNN-LLKTLPDLPPS---------LEALNVRDNYLT-DLPELPQ---SLTFLDVSENIF- 289
Query: 290 SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTS 349
S + +L +L+ +N + S+ SL L + N L +P +
Sbjct: 290 SGLSELPP---NLYYLNASSNEI-RSLCDLP---PSLEELNVSNNKLIE-LPALPPRLER 341
Query: 350 LYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVN 402
L S NHL+ +P+ N LK L +E+N L E P + L +
Sbjct: 342 LIA---SFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNS 386
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-34
Identities = 65/325 (20%), Positives = 114/325 (35%), Gaps = 50/325 (15%)
Query: 102 LHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF------ 155
+L+E L + + +P + T + + + P M
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 156 -------ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG 208
+ ++N L+ +P + LE L S N LT LP + K L V
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 209 NSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI 268
+L+ P LE + +S N + +P +SS L+I+D+ +N+L +
Sbjct: 124 KALSDLPP------LLEYLGVSNN-QLEKLPELQNSSF-------LKIIDVDNNSLK-KL 168
Query: 269 PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 328
P +L ++ +N L PEL L + NN+L +P SL
Sbjct: 169 PDLPP---SLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSL-KKLPDLPL---SLES 219
Query: 329 LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI 388
+ N L ++N L + +N L ++P +L L + +L
Sbjct: 220 IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL---- 272
Query: 389 PQELGKLASLLAVNVSYNRLIGRLP 413
P+ L L ++ L P
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-33
Identities = 80/347 (23%), Positives = 123/347 (35%), Gaps = 60/347 (17%)
Query: 75 IWSLKRLRTLDLSHNLFSGSIPQGVAALHY-------------LKELLLQGNQFSGPLPA 121
++K + + + + P G EL L S LP
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
HL +L S N T +LP + L S++ + + L+ LE+L
Sbjct: 89 LPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-------DLPPLLEYLG 137
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241
SNN L LP L N L +I + NSL +P+ LE I N + +P
Sbjct: 138 VSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS--LEFIAAGNN-QLEELPEL 191
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
+ L + +N+L +P +L + +N L PEL
Sbjct: 192 QNLPF-------LTAIYADNNSLK-KLPDLPL---SLESIVAGNNILEE--LPELQNLPF 238
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361
L + NN L ++P SL L + N LT +P++ ++ T L + + LS
Sbjct: 239 LTTIYADNNLL-KTLPDLPP---SLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS 293
Query: 362 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
P L L NE+ + L L NVS N+L
Sbjct: 294 ELPP-------NLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 71/353 (20%), Positives = 120/353 (33%), Gaps = 69/353 (19%)
Query: 75 IWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDL 134
S L+ + + +P + E +++ P G + L
Sbjct: 7 NVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65
Query: 135 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 194
+ L L ++N L+ +P + LE L S N LT LP
Sbjct: 66 RDCLDR-----QAHELE------LNNLGLS-SLPELPPH---LESLVASCNSLT-ELPEL 109
Query: 195 LFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 254
+ K L V +L+ P LE + +S N + +P +SS L
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNN-QLEKLPELQNSSF-------L 155
Query: 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 314
+I+D+ +N+L +P +L ++ +N L PEL L + NN+L
Sbjct: 156 KIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSL-K 208
Query: 315 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG------------ 362
+P SL + N L ++N L + +N L
Sbjct: 209 KLPDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALN 263
Query: 363 -------SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
+P+ +L L + + F+ LS E+P L L N S N +
Sbjct: 264 VRDNYLTDLPELPQSLTFLDVSENIFSGLS-ELPPNLYYL------NASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-24
Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 42/271 (15%)
Query: 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 218
++ LT ++P N+ + + + + P ++++V RLR
Sbjct: 19 HSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR------ 71
Query: 219 LFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL 278
E++L+ G S+P L L L S N+L ++P +L
Sbjct: 72 ----QAHELELNNLGL-SSLPE---------LPPHLESLVASCNSLT-ELPELPQSLKSL 116
Query: 279 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 338
N + L S +PP L +L + NN L +P E+ S L I+ +D NSL
Sbjct: 117 LVDNNNLKAL-SDLPP------LLEYLGVSNNQL-EKLP-ELQNSSFLKIIDVDNNSLKK 167
Query: 339 PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 398
+P + SL ++ +N L +P + NL L + + N L ++P L S+
Sbjct: 168 -LPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI 220
Query: 399 LAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 429
N L LP P L N
Sbjct: 221 ---VAGNNIL-EELPELQNLPFLTTIYADNN 247
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 58/310 (18%), Positives = 92/310 (29%), Gaps = 95/310 (30%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ + + NNLL L + SL L++ N L + SL L++S
Sbjct: 236 LPFLTTIYADNNLLK-----TLPDLPPSLEALNVRDNYLT----DLPELPQSLTFLDVSE 286
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N FSG + L L+ S N S+
Sbjct: 287 NIFSGLSEL--------PPNLYYLNASSNEIR-SLC------------------------ 313
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
P L L++SNN ++P LE L
Sbjct: 314 ---DLPPSLEELNVSNNKLI-------------------------ELPALPPR---LERL 342
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240
S NHL +P N K+L + N L P+ + DL N + +P
Sbjct: 343 IASFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIPESVE----DLRMNSHLAEVP- 392
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH 300
L Q L+ L + +N L + P ++ L ++S +
Sbjct: 393 --------ELPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTD 440
Query: 301 SLIHLDLRNN 310
L ++
Sbjct: 441 KLEDDVFEHH 450
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-35
Identities = 68/340 (20%), Positives = 118/340 (34%), Gaps = 33/340 (9%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS-- 64
+ VP + R L L N ++ F L L L+ N S
Sbjct: 16 VLCHRKRFVA-VPEGIPTE---TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADI 123
F +L LRTL L N IP GV L L +L + N+ L
Sbjct: 72 EPGAFN------NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 124 GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
+L +L++ +N + LNS+ +++ LT + ++ L L
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLR 184
Query: 184 NNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGFMGSIPPG 241
+ ++ ++ F +L V+ + + L L + ++ ++P
Sbjct: 185 HLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LG 297
+ LR L+LS N + I + L+ + L L + P
Sbjct: 243 AVRHLVY-----LRFLNLSYNPIS-TIEG--SMLHELLRLQEIQLVGGQLAV-VEPYAFR 293
Query: 298 YFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSL 336
+ L L++ N L ++ + V S +L L LD N L
Sbjct: 294 GLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 67/358 (18%), Positives = 129/358 (36%), Gaps = 51/358 (14%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
R + F ++P+G+ + L L N+ + PHL L+L+ N+ +
Sbjct: 14 RAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 142 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKK 200
+V + L L +N L +P +F
Sbjct: 70 ---------------AVEPGAFNN--------LFNLRTLGLRSNRLK-LIPLGVFTGLSN 105
Query: 201 LSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILD 258
L+ + + N + + + +F L+ +++ +N + I + S +S L L
Sbjct: 106 LTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS-----LEQLT 158
Query: 259 LSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS 315
L NL IP + L L L ++ + + L L++ + +
Sbjct: 159 LEKCNLT-SIPT--EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215
Query: 316 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLK 375
+ +L L + +LT +R+ L L+LS+N +S + L +L+
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275
Query: 376 ILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRLIGRLPVGGVF---PTLDQSSLQGN 429
++L +L+ + L L +NVS N+ + L VF L+ L N
Sbjct: 276 EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ-LTTLE-ESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-31
Identities = 65/298 (21%), Positives = 116/298 (38%), Gaps = 28/298 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+++ L+L+ N++S V F N +LR L L N L+ +F S+L L++S
Sbjct: 55 FPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISE 113
Query: 61 NHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSG 117
N D F L L++L++ N I + L+ L++L L+ +
Sbjct: 114 NKIVILLDYMFQ------DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS 166
Query: 118 PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTL 177
+ L L L + S + L + + +S+ + L
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 178 EFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGF 234
L ++ +LT ++P + L + L N ++ I + L L+EI L
Sbjct: 227 TSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ- 283
Query: 235 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLR 289
+ + P + + LR+L++S N L + +F NL L L SN L
Sbjct: 284 LAVVEPYAFRGLNY-----LRVLNVSGNQLT-TLEE--SVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 68/315 (21%), Positives = 127/315 (40%), Gaps = 23/315 (7%)
Query: 80 RLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSN 136
R LDL N ++ Q A+ +L+EL L N S + F +L TL L +
Sbjct: 33 ETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGA-FNNLFNLRTLGLRS 89
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 196
N L+++ + +S N + + + ++ L+ L+ +N L + F
Sbjct: 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 197 -NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 253
L + L +L +IP GL + L +I S
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYR----- 201
Query: 254 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNAL 312
L++L++S + + NL L+++ +L + +P + + L L+L N +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPI 260
Query: 313 YGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SN 370
+I + L +QL G L P R L +L++S N L+ ++ +S+ +
Sbjct: 261 -STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
Query: 371 LNKLKILKLEFNELS 385
+ L+ L L+ N L+
Sbjct: 319 VGNLETLILDSNPLA 333
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 66/336 (19%), Positives = 126/336 (37%), Gaps = 53/336 (15%)
Query: 523 SSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML 582
SS R G +++ D++ ++GEG F V V G
Sbjct: 10 HSSGRENLYFQGHMVIIDNKH------------YLFIQKLGEGGFSYVDLVEGLHDGHFY 57
Query: 583 AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK----LLVSDYAPNGS 638
A+K+++ + E+ +RE + HPN++ L Y + L+ + G+
Sbjct: 58 ALKRILCHEQQDR-EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116
Query: 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698
L ++ L+ ++LG +GL +H H +LKP+NILL D P
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQP 173
Query: 699 RISDFGLARLLTR-LDKHVMSNRFQSALG------YVAPEL-TCQS-LRVNEKCDIYGFG 749
+ D G ++ + Q Y APEL + QS ++E+ D++ G
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 750 VLILELVTGRRPVEY----GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVL 805
++ ++ G P + G+ + + + + P + L
Sbjct: 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI------------PQSPRHSSA-----L 276
Query: 806 KLALVCTC--HIPSSRPSMAEVVQILQVIKTPLPQR 839
L+ + P RP + ++ L+ ++ P P +
Sbjct: 277 W-QLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 48/297 (16%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
E+ A +G+G FG V K R A+KK+ ++ EV +L H ++
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVVR 66
Query: 617 LEGYYWTPQLKL-------------LVSDYAPNGSLQAKLHER-LPSTPPLSWTNRFKVI 662
+ + + + +Y NG+L +H L W F+ I
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQI 125
Query: 663 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR---------LD 713
L + L+++H IIH +LKP NI +D++ N +I DFGLA+ + R +
Sbjct: 126 L---EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 714 KHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV 770
S+ SA+G YVA E+ + NEK D+Y G++ E++ P G + V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236
Query: 771 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
IL + L ++ + + + E K+ + H P+ RP ++
Sbjct: 237 ILKK-----LRSVSI-EFPPDFDDNKMKVEK----KIIRLLIDHDPNKRPGARTLLN 283
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 89/454 (19%), Positives = 161/454 (35%), Gaps = 71/454 (15%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 61
++ L +S+N + + +F+ L YL L+ N L +L L+LS N
Sbjct: 46 KLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNKLVKISCHPT----VNLKHLDLSFN 100
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGN-------- 113
F ++ +L+ L LS S +A L+ K LL+ G
Sbjct: 101 AFD---ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP 157
Query: 114 -------------------QFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI 154
+F L + +L ++ L + L +L +
Sbjct: 158 EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQ 217
Query: 155 F------ISVSNNTLTGDIPHWIGNI---STLEFLDFSNNHLTGSLPSSLFNCKKLSVIR 205
++++N T + I + +T+ + SN L G L F+ S+
Sbjct: 218 TNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277
Query: 206 LRGNSLNGNI----PEGLFD----LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 257
L + + ++ +++ + ++ +S + S S L
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM---VHMLCPSKISP-----FLHL 329
Query: 258 DLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYG 314
D S+N L + G L L L N L+ + SL LD+ N++
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 315 SIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 373
+ C +SL L + N LT I + + + +L L N + SIPK + L
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEA 445
Query: 374 LKILKLEFNELSGEIPQE-LGKLASLLAVNVSYN 406
L+ L + N+L +P +L SL + + N
Sbjct: 446 LQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 90/445 (20%), Positives = 145/445 (32%), Gaps = 57/445 (12%)
Query: 6 FLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSG 65
+D S N L VP L L+++ N + S L L +S+N
Sbjct: 4 LVDRSKNGLIH-VPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 66 DLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF-SGPLPADIG 124
LD + + L LDLSHN I LK L L N F + P+ + G
Sbjct: 59 YLDISV---FKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFG 112
Query: 125 FCPHLTTLDLSNNLFTGQLPVSLRLLN---------------------------SMIFIS 157
L L LS + + LN S+ +
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172
Query: 158 VSNNTLTGDIPHWIGNISTLEFLDFSNN------HLTGSLPSSLFNCKKLSVIRLRGNSL 211
+N + + ++ LE + S+ + L KLS + L
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 212 NGN----IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD 267
N I + ++ + +S G + S ++L + L I + S+
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL-KALSIHQVVSDVFGFP 291
Query: 268 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSL 326
+F+N+ N + + R +HLD NN L E C L
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL-TDTVFENCGHLTEL 350
Query: 327 GILQLDGNSLT--GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNE 383
L L N L I ++ SL L +S N +S K S L L + N
Sbjct: 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 384 LSGEIPQELGKLASLLAVNVSYNRL 408
L+ I + L + +++ N++
Sbjct: 411 LTDTIFRCL--PPRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 55/419 (13%), Positives = 122/419 (29%), Gaps = 67/419 (15%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
L++S N +S + + + LR L ++ N +Q +F + L L+LS+N
Sbjct: 22 KTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+ L+ LDLS N F + P+ +
Sbjct: 81 LVK-ISC------HPTVNLKHLDLSFNAFD-----------------------ALPICKE 110
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
G L L LS + + LN + V T +
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESL 168
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 242
T + + +V L +++ + + L
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI-------------LAK 215
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302
++ TL ++ + N+ + + + + + + + F
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIR-------ILQLVWHTTVWYFSISNVKLQGQLDFRDF 268
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG 362
D +L ++L I Q+ + P + +++ + + + +
Sbjct: 269 ---DYSGTSL-----------KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 363 SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTL 421
S ++ L N L+ + + G L L + + N+L + + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 40/217 (18%), Positives = 82/217 (37%), Gaps = 23/217 (10%)
Query: 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 64
+ +++ P ++E +++ + + + + S L+ SNN +
Sbjct: 279 SIHQVVSDVFGFP-QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELL---LQGNQFSGPLPA 121
+ G L L TL L N + + +K L + N S
Sbjct: 338 DTVFENCG----HLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 122 DI-GFCPHLTTLDLSNNLFT----GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 176
+ L +L++S+N+ T LP +++L+ + +N + IP + +
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLD------LHSNKIK-SIPKQVVKLEA 445
Query: 177 LEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLN 212
L+ L+ ++N L S+P +F L I L N +
Sbjct: 446 LQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 40/160 (25%), Positives = 56/160 (35%), Gaps = 23/160 (14%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ--GPIGKIFNYCSSLNTLNL 58
+ LD SNNLL+ ++ + L L L N L+ I ++ SL L++
Sbjct: 323 ISPFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDI 381
Query: 59 SNNHFSGDLDFASGYGIWSLKRL-------------------RTLDLSHNLFSGSIPQGV 99
S N S D SL L + LDL N SIP+ V
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQV 440
Query: 100 AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 139
L L+EL + NQ L + L N +
Sbjct: 441 VKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 53/278 (19%), Positives = 95/278 (34%), Gaps = 44/278 (15%)
Query: 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 218
S N L +P + L+ S N+++ S + + KL ++ + N + +
Sbjct: 8 SKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDIS 63
Query: 219 LFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF- 275
+F LE +DLS N S L+ LDLS N +P F
Sbjct: 64 VFKFNQELEYLDLSHNKL---------VKISCHPTVNLKHLDLSFNAF-DALP-ICKEFG 112
Query: 276 --ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES----RSLGIL 329
+ L++L LS+ HL + HL++ L E +
Sbjct: 113 NMSQLKFLGLSTTHLEK------SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166
Query: 330 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG-----------SIPKSISNLNKLKILK 378
L T I + + + +L +++ SI + KL L
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226
Query: 379 LEFNELSGEIPQELGKLA---SLLAVNVSYNRLIGRLP 413
L E + + +L ++ ++S +L G+L
Sbjct: 227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 26/117 (22%), Positives = 51/117 (43%), Gaps = 7/117 (5%)
Query: 305 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 364
+D N L +P+++ S+ IL + N ++ I + + L +L +SHN +
Sbjct: 5 VDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 365 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTL 421
+L+ L L N+L +I +L +++S+N LP+ F +
Sbjct: 62 ISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAF-DALPICKEFGNM 114
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 81/404 (20%), Positives = 130/404 (32%), Gaps = 73/404 (18%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ +++FL + + F +SL L L N L
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL----------------QLET 96
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHN-LFSGSIPQGV-AALHYLKELLLQGNQFSGP 118
F+G L L L L+ L + L L+ L+L+ N
Sbjct: 97 GAFNG------------LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI 144
Query: 119 LPADIGFC--PHLTTLDLSNN--------LFTGQLPVSLRLLN--SMIFISVSNNTLTGD 166
PA F LDL+ N LL S+ ++ L +
Sbjct: 145 QPASF-FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWE 203
Query: 167 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEE 226
+++ LD S N S+ F+ + I+ S + N+ +
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK- 262
Query: 227 IDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNL 283
D F G G ++ DLS + + + +F+ +L L L
Sbjct: 263 -DPDNFTFKGLEASG------------VKTCDLSKSKI-FALLK--SVFSHFTDLEQLTL 306
Query: 284 SSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGP 339
+ N + I F L+ L+L N L GSI + E+ L +L L N +
Sbjct: 307 AQNEINK-IDD--NAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRAL 362
Query: 340 IPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
Q +L L+L N L S+P I L L+ + L N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 77/417 (18%), Positives = 139/417 (33%), Gaps = 75/417 (17%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGK-IFNYCSSLNTLNLSNN 61
++ ++DLS N ++ + F L++L + I F SSL L L N
Sbjct: 31 HVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 62 HFS----GDLDFASGYGIWSLKRLRTLDLSHN-LFSGSIPQGV-AALHYLKELLLQGNQF 115
F G + L L L L+ L + L L+ L+L+ N
Sbjct: 90 QFLQLETGAFN--------GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 116 SGPLPADIGFC--PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGN 173
PA F LDL+ N ++ + ++ T +
Sbjct: 142 KKIQPASF-FLNMRRFHVLDLTFN--------KVKSICEEDLLNFQGKHFT------LLR 186
Query: 174 ISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENG 233
+S++ D + L + F ++ + L GN ++ + FD + +
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA-IAGTKIQSLI 245
Query: 234 FMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIP 293
S GSS ++ D + G + ++ +LS + + + +
Sbjct: 246 LSNSYNMGSSFGHTN-------FKDPDNFTFKGLEAS------GVKTCDLSKSKIFA-LL 291
Query: 294 PELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 353
F L+ L L N + T L L
Sbjct: 292 K--SVFSHFTDLE---------------------QLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 354 SLSHNHLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYNRL 408
+LS N L SI + NL+KL++L L +N + + + L +L + + N+L
Sbjct: 329 NLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL 383
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 73/332 (21%), Positives = 120/332 (36%), Gaps = 48/332 (14%)
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI-GNISTLEFLDFSNN 185
H+ +DLS N S L + F+ V T I + +S+L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 186 HLTGSLPSSLF-NCKKLSVIRLRGNSLNG-NIPEGLFD--LGLEEIDLSENGFMGSIPPG 241
L + F L V+ L +L+G + F LE + L +N + I P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN-IKKIQPA 147
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL-----RYLNLSSNHLRSRIPPEL 296
S + +LDL+ N + I N L LSS L+ L
Sbjct: 148 SFFLNMR----RFHVLDLTFNKVK-SICE--EDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 297 GYF--------HSLIHLDLRNNALYGSIPQEVCESRSLGILQ-------------LDGNS 335
G+ S+ LDL N S+ + ++ + +Q +
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 336 LTGPIPQVIRN--CTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQE- 391
P + + + LS + + ++ KS+ S+ L+ L L NE++ +I
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNA 318
Query: 392 LGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQ 423
L LL +N+S N L G + +F LD+
Sbjct: 319 FWGLTHLLKLNLSQNFL-GSID-SRMFENLDK 348
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 54/294 (18%), Positives = 98/294 (33%), Gaps = 53/294 (18%)
Query: 175 STLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSE 231
+ + ++D S N + L + F + L +++ + I F L + L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL-VGDIPAEMGLFA---NLRYLNLSSNH 287
N F + G+ + ++ L +L L+ NL + F +L L L N+
Sbjct: 89 NQF-LQLETGAFNGLAN-----LEVLTLTQCNLDGAVLSG--NFFKPLTSLEMLVLRDNN 140
Query: 288 LRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEV---CESRSLGILQLDGNSLT---- 337
++ I P +F LDL N + SI +E + + +L+L +L
Sbjct: 141 IKK-IQPA-SFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197
Query: 338 ----GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL-------------NKLKILKLE 380
TS+ L LS N S+ K + +
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 381 FNELSGEIPQELGKL--ASLLAVNVSYNRLIGRLPVGGVF---PTLDQSSLQGN 429
L + + ++S ++ I L VF L+Q +L N
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSK-IFALLK-SVFSHFTDLEQLTLAQN 309
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 28/118 (23%), Positives = 47/118 (39%), Gaps = 15/118 (12%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+++ L L+ N ++ + F L L+L+ N L ++F L L+LS NH
Sbjct: 300 DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358
Query: 63 FS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQF 115
L L+ L L N S+P G+ L L+++ L N +
Sbjct: 359 IRALGDQSFL--------GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEG 619
+G G +G K+ + G++L K+L + + + EV +L + +HPN++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 620 YYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH--HS 675
L V +Y G L + + + L +V+ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 732
++H +LKP+N+ LD N ++ DFGLAR+L ++ +G Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-----KTFVGTPYYMSPEQ 187
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ NEK DI+ G L+ EL P
Sbjct: 188 -MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 64/341 (18%), Positives = 119/341 (34%), Gaps = 57/341 (16%)
Query: 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 140
LR + S +P+ + L LQ N+ + D +L TL L NN +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 200
+S + LE L S N L LP + K
Sbjct: 90 ----------------KISPGAFAP--------LVKLERLYLSKNQLK-ELPEKMP--KT 122
Query: 201 LSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGF-MGSIPPGSSSSSSSTLFQTLRIL 257
L +R+ N + + + +F+ + ++L N I G+ L +
Sbjct: 123 LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK-----LSYI 176
Query: 258 DLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSI 316
++ N+ IP GL +L L+L N + + L ++L L L N++ ++
Sbjct: 177 RIADTNIT-TIPQ--GLPPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSI-SAV 231
Query: 317 PQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKS-------I 368
+ L L L+ N L +P + + + ++ L +N++S +I +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN 289
Query: 369 SNLNKLKILKLEFNELS-GEIPQEL-GKLASLLAVNVSYNR 407
+ + L N + EI + AV + +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 61/297 (20%), Positives = 105/297 (35%), Gaps = 33/297 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ LDL NN ++ + F+N +L L L N + F L L LS N
Sbjct: 53 DTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQF-SGPLP 120
+ K L+ L + N + + + V L+ + + L N S +
Sbjct: 112 LK---ELPEK----MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIE 163
Query: 121 ADIGF--CPHLTTLDLSNNLFTG---QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIS 175
F L+ + +++ T LP SL L+ + N +T + ++
Sbjct: 164 NGA-FQGMKKLSYIRIADTNITTIPQGLPPSLTELH------LDGNKITKVDAASLKGLN 216
Query: 176 TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGF 234
L L S N ++ SL N L + L N L +P GL D ++ + L N
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN-N 274
Query: 235 MGSIPPGS-SSSSSSTLFQTLRILDLSSNNL-VGDIPAEMGLFA---NLRYLNLSSN 286
+ +I +T + + L SN + +I F + L +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP--STFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 64/322 (19%), Positives = 110/322 (34%), Gaps = 57/322 (17%)
Query: 117 GPLPADIGFCP-----HLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIP 168
+ CP HL + S+ LP LL+ + NN +T
Sbjct: 16 PEIEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLD------LQNNKITEIKD 69
Query: 169 HWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEI 227
N+ L L NN ++ + F KL + L N L +PE + L+E+
Sbjct: 70 GDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK-TLQEL 126
Query: 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLS 284
+ EN + + + + +++L +N L E G F L Y+ ++
Sbjct: 127 RVHENEI-TKVRKSVFNGLNQ-----MIVVELGTNPL-KSSGIENGAFQGMKKLSYIRIA 179
Query: 285 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 344
++ + IP L SL L L N + + +
Sbjct: 180 DTNITT-IPQGL--PPSLTELHLDGNKI-TKVD-----------------------AASL 212
Query: 345 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404
+ +L L LS N +S S++N L+ L L N+L ++P L + V +
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271
Query: 405 YNRLIGRLPVGGVFPTLDQSSL 426
N I + P +
Sbjct: 272 NNN-ISAIGSNDFCPPGYNTKK 292
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 39/215 (18%), Positives = 74/215 (34%), Gaps = 35/215 (16%)
Query: 1 MMNMKFLDLSNNLL-SGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 59
+ M ++L N L S + F+ L Y+ +A + + SL L+L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLD 200
Query: 60 NNHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFS 116
N + L L L LS N S ++ G A +L+EL L N+
Sbjct: 201 GNKITKVDAASLK------GLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253
Query: 117 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 176
+P + ++ + L NN + ++ +N P + ++
Sbjct: 254 K-VPGGLADHKYIQVVYLHNNNIS----------------AIGSNDFCP--PGYNTKKAS 294
Query: 177 LEFLDFSNNHLT-GSLPSSLFNC-KKLSVIRLRGN 209
+ +N + + S F C + ++L
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 72/408 (17%), Positives = 134/408 (32%), Gaps = 77/408 (18%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 61
+ LD N+ ++ E L L N + + + ++L L +N
Sbjct: 43 TLTSLDCHNSSITDMTG---IEKLTGLTKLICTSNNITTLDLSQ----NTNLTYLACDSN 95
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPA 121
+ +LD L +L L+ N + + V+ L L N +
Sbjct: 96 KLT-NLDVT------PLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EI 142
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
D+ LT LD N +L V+ + + S N +T ++ + L L+
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLN 197
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241
N++T L L +L+ + N L EID++
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNK-------------LTEIDVTPL--------- 232
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
L D S N L ++ + + L L+ L I L +
Sbjct: 233 ----------TQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQ 276
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361
LI+ + +V + L +L +T + + L L L++ L+
Sbjct: 277 LIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
Query: 362 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409
+ +S+ KLK L + + +GK+ +L + + I
Sbjct: 332 -ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 65/412 (15%), Positives = 131/412 (31%), Gaps = 54/412 (13%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 61
+ L ++N ++ + +L YL+ N L + + L LN N
Sbjct: 65 GLTKLICTSNNITT-LD---LSQNTNLTYLACDSNKLTNLDVTP----LTKLTYLNCDTN 116
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPA 121
+ LD + L L+ + N + I V+ L EL N+ L
Sbjct: 117 KLT-KLDVSQ------NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKL-- 164
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
D+ LTTLD S N T + + + ++ N +T + + L FLD
Sbjct: 165 DVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLD 218
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241
S+N LT + + +L+ N L + L + + + I
Sbjct: 219 CSSNKLT-EIDVT--PLTQLTYFDCSVNPLT-ELDVSTLS-KLTTLHCIQTDLL-EIDLT 272
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
++ L + ++ ++ L L+ + + +L
Sbjct: 273 HNTQ--------LIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITE---LDLSQNPK 319
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361
L++L L N L + V + L L + + +L +
Sbjct: 320 LVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI 374
Query: 362 GSIPKSISNLNKLKILKLEFNELSG---EIPQELGKLASLLAVNVSYNRLIG 410
++++N + + + + G I G + +++ L
Sbjct: 375 TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 63/380 (16%), Positives = 129/380 (33%), Gaps = 69/380 (18%)
Query: 29 LRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSH 88
A +Q ++L +L+ N+ + D+ GI L L L +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-----GIEKLTGLTKLICTS 73
Query: 89 NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 148
N + ++ ++ L L N+ + D+ LT L+ N T + +
Sbjct: 74 NNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLDVS 124
Query: 149 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG 208
+ +++ + NTLT +I + + + L LD N L + +L+ +
Sbjct: 125 QNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 209 NSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI 268
N + E+D+S+N + L L+ +NN+ +
Sbjct: 180 NKI-------------TELDVSQN-------------------KLLNRLNCDTNNIT-KL 206
Query: 269 PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 328
+ L +L+ SSN L ++ L + D N L + L
Sbjct: 207 D--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPL-TELDVSTLSK--LTT 258
Query: 329 LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI 388
L L I + + T L + +++ +L +L + ++ E+
Sbjct: 259 LHCIQTDLLE-ID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-EL 312
Query: 389 PQELGKLASLLAVNVSYNRL 408
L + L+ + ++ L
Sbjct: 313 D--LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-21
Identities = 58/312 (18%), Positives = 103/312 (33%), Gaps = 36/312 (11%)
Query: 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164
+ + LT+LD N+ T + L + + ++N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEK--LTGLTKLICTSNNIT 77
Query: 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGL 224
+ + + L +L +N LT +L + KL+ + N L + L L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPL-L 129
Query: 225 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 284
++ + N + + L LD N + + + L L+ S
Sbjct: 130 TYLNCARNTL---------TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCS 178
Query: 285 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 344
N + ++ L L+ N + + + ++ L L N LT I +
Sbjct: 179 FNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-ID--V 229
Query: 345 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404
T L S N L+ + +S L+KL L +L EI L L+
Sbjct: 230 TPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAE 283
Query: 405 YNRLIGRLPVGG 416
R I L V
Sbjct: 284 GCRKIKELDVTH 295
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 24/133 (18%), Positives = 56/133 (42%), Gaps = 11/133 (8%)
Query: 276 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 335
N ++ +++ +L LD N+++ + + + L L N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTSNN 75
Query: 336 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 395
+T + + T+L L+ N L+ ++ ++ L KL L + N+L+ ++ + +
Sbjct: 76 ITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQN 126
Query: 396 ASLLAVNVSYNRL 408
L +N + N L
Sbjct: 127 PLLTYLNCARNTL 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 6e-30
Identities = 61/319 (19%), Positives = 115/319 (36%), Gaps = 39/319 (12%)
Query: 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF--SGPLPADIGFCPHLTTLDLSNNLFT 140
+ + +N SG+ +A ++ L G + L + + L L+ +
Sbjct: 14 SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI-NQFSELQLNRLNLS 72
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 200
LP + L + + ++ N L +P + LE+LD +N L+ +LP + K
Sbjct: 73 -SLPDN--LPPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKH 124
Query: 201 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
L + N L +PE LE I+ N +P L +L +L +
Sbjct: 125 L---DVDNNQLT-MLPELP--ALLEYINADNNQL-TMLPE---------LPTSLEVLSVR 168
Query: 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL----IHLDLRNNALYGSI 316
+N L +P +L L++S+N L S +P H I R N + I
Sbjct: 169 NNQL-TFLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THI 222
Query: 317 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 376
P+ + + L+ N L+ I + + T+ + S S + N +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ--QNTLHRPL 280
Query: 377 LKLEFNELSGEIPQELGKL 395
++ ++
Sbjct: 281 ADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-26
Identities = 63/316 (19%), Positives = 110/316 (34%), Gaps = 43/316 (13%)
Query: 126 CPHLTTLDLSNNLFTGQLPV-------SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
P LS N F + + + N + I+
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFS 62
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238
L + +L+ SLP +L +++V+ + N+L ++PE L E +D +N ++
Sbjct: 63 ELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASL--EYLDACDNRLS-TL 115
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 298
P L +L+ LD+ +N L +P L Y+N +N L +P
Sbjct: 116 PE---------LPASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLTM-LPELPT- 160
Query: 299 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL----YLLS 354
SL L +RNN L +P+ SL L + N L +P V
Sbjct: 161 --SLEVLSVRNNQL-TFLPELP---ESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 355 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 414
N ++ IP++I +L+ + LE N LS I + L + + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 415 GGVFPTLDQSSLQGNL 430
++
Sbjct: 273 QNTLHRPLADAVTAWF 288
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 65/325 (20%), Positives = 101/325 (31%), Gaps = 31/325 (9%)
Query: 37 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 96
N + G F+ L + + + + + L L+ S S+P
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK---ECLINQFSELQLNRLNLS-SLP 75
Query: 97 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 156
+ + L + N LP L LD +N + LP L +
Sbjct: 76 DNLPPQ--ITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHL--- 125
Query: 157 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 216
V NN LT +P LE+++ NN LT LP + L V+ +R N L +P
Sbjct: 126 DVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LP 176
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 276
E LE +D+S N + S+P + +T N + IP +
Sbjct: 177 ELPE--SLEALDVSTN-LLESLPAVPVRNHH--SEETEIFFRCRENRIT-HIPENILSLD 230
Query: 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336
+ L N L SRI L + S Q+ R L
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT--AWF 288
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLS 361
+ + N S
Sbjct: 289 PENKQSDVSQIWHAFEHEEHANTFS 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 1e-17
Identities = 58/353 (16%), Positives = 103/353 (29%), Gaps = 71/353 (20%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ L+++ N L SL +SL L+ +N
Sbjct: 81 QITVLEITQNALI-----------------SLPELP------------ASLEYLDACDNR 111
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
S + L+ LD+ +N + +P+ A L+ + NQ + LP
Sbjct: 112 LSTLPE--------LPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLTM-LPEL 158
Query: 123 IGFCPHLTTLDLSNNLFTG--QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE-- 178
L L + NN T +LP SL L+ VS N L +P E
Sbjct: 159 PT---SLEVLSVRNNQLTFLPELPESLEALD------VSTNLLE-SLPAVPVRNHHSEET 208
Query: 179 --FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMG 236
F N +T +P ++ + I L N L+ I E L + +
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSN-------NLVGDIPAEMGLFANLRYLNLSSNH-- 287
++ + + A L L+ + +
Sbjct: 268 MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARN 327
Query: 288 ---LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 337
R ++ L + L ++ A+ + + +L L L
Sbjct: 328 TSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 41/293 (13%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLG 607
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILG 664
+P++ L G T + L++ P G L + E + L+W +
Sbjct: 73 SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 665 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
AKG+ +L +H +L N+L+ + +I+DFGLA+LL +K + +
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 724 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 779
+ ++A E S+ + D++ +GV + EL+T G +P Y I + + +
Sbjct: 182 PIKWMALE----SILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDG----IPASEISSI 231
Query: 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
LE+G L P + V + C SRP E++ +
Sbjct: 232 LEKGERLPQ--------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 53/308 (17%), Positives = 100/308 (32%), Gaps = 55/308 (17%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
E +G G FG V++ A+K++ + E REV+ L K HP ++
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 617 LEGYYWTPQLKL------------LVSDYAPNGSLQAKLHERLPSTPP-----LSWTNRF 659
+ + +L+ ++ R L F
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI---F 124
Query: 660 KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719
I + + LH ++H +LKPSNI + ++ DFGL + + ++
Sbjct: 125 LQIA---EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 720 RFQSALG----------YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769
A Y++PE + K DI+ G+++ EL+ P + V
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234
Query: 770 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ-- 827
L++ + P E + P RP +++
Sbjct: 235 RTLTD-----VRNLK----FPPLFTQKYPCEY----VMVQDMLSPSPMERPEAINIIENA 281
Query: 828 ILQVIKTP 835
+ + + P
Sbjct: 282 VFEDLDFP 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 61/297 (20%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNL 614
++G G F VY+ + G +A+KK+ D++ D +E+ +L + HPN+
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
I + +V + A G L + + +K + L H+H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH- 153
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 731
++H ++KP+N+ + ++ D GL R + S +G Y++PE
Sbjct: 154 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-----HSLVGTPYYMSPE 206
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
N K DI+ G L+ E+ + P + N+ L + +
Sbjct: 207 R-IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------------- 251
Query: 792 SMGDYPEDEVLPVLKL-----ALVCTC--HIPSSRPSMAEVVQILQVIKTPLPQRME 841
DYP LP LV C P RP + V + + + +E
Sbjct: 252 -QCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 67/311 (21%)
Query: 549 SIDPETLL--EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRV 605
++D + ++ +G G FG V+K G+ +K+ ++Y E EREV+
Sbjct: 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR------VKYNNEKAEREVKA 57
Query: 606 LGKARHPNLISLEGYYWTPQLKL----------------LVSDYAPNGSLQAKLHERLPS 649
L K H N++ G + + ++ G+L+ + +R
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 650 TPP----LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705
L F+ I KG+ ++H +I+ +LKPSNI L D +I DFGL
Sbjct: 118 KLDKVLALEL---FEQIT---KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 706 ARLLTRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
L K + G Y++PE S ++ D+Y G+++ EL+
Sbjct: 169 VTSLKNDGKR------TRSKGTLRYMSPEQ-ISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 763 EYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM 822
++ D + + + + E L P RP+
Sbjct: 222 FETSKFFT-------------DLRDGIISDI--FDKKEK----TLLQKLLSKKPEDRPNT 262
Query: 823 AEVVQILQVIK 833
+E+++ L V K
Sbjct: 263 SEILRTLTVWK 273
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 27/287 (9%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 608
++ E L L + ++G G FG V+ ++AVK + F +E R+L +
Sbjct: 111 LNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQ 168
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
HPN++ L G Q +V + G L L +++ A G
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAG 225
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
+ +L IH +L N L+ + +ISDFG++R Q + +
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEEGNVL 786
APE R + + D++ FG+L+ E + G P Y N + R +E+G L
Sbjct: 283 APE-ALNYGRYSSESDVWSFGILLWETFSLGASP--YPNLSN-----QQTREFVEKGGRL 334
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
C PE V +L C + P RPS + + Q LQ I+
Sbjct: 335 PC--------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 69/293 (23%), Positives = 125/293 (42%), Gaps = 41/293 (13%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLG 607
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILG 664
+P++ L G T + L++ P G L + E + L+W +
Sbjct: 73 SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQ 125
Query: 665 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
AKG+ +L +H +L N+L+ + +I+DFGLA+LL +K + +
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 724 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 779
+ ++A E S+ + D++ +GV + EL+T G +P Y I + + +
Sbjct: 182 PIKWMALE----SILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDG----IPASEISSI 231
Query: 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
LE+G L P + V + + C SRP E++ +
Sbjct: 232 LEKGERLPQ--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 549 SIDPETLLEKAAE-VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVL 606
+ + K +G G F TVYK +A +L + + + F+ E +L
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 79
Query: 607 GKARHPNLISLEGYYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPL--SWTNRFK 660
+HPN++ + + +LV++ +G+L+ L + SW +
Sbjct: 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC---R 136
Query: 661 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLDKHVMSN 719
IL KGL LH + PPIIH +LK NI + + +I D GLA L +
Sbjct: 137 QIL---KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-------S 185
Query: 720 RFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++ +G ++APE+ + +E D+Y FG+ +LE+ T P
Sbjct: 186 FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYP 228
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 71/308 (23%), Positives = 120/308 (38%), Gaps = 48/308 (15%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGY 620
+ EG F VY+ GR A+K+L++++ + +EV + K HPN++
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 621 YW-------TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
T Q + L+ G L L + P LS K+ T + + H+H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMH 153
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------- 726
+PPIIH +LK N+LL + ++ DFG A ++ + S + ++ +
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 727 ---YVAPEL--TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781
Y PE+ + + EK DI+ G ++ L + P E + I++ +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-DGAKLRIVNGKYSI--- 268
Query: 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI--------K 833
P L P R S+AEVV LQ I K
Sbjct: 269 ---------PPHDTQYTV----FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
Query: 834 TPLPQRME 841
+P+ + +E
Sbjct: 316 SPITELLE 323
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEG 619
++GEG FG V GR +K++ S + E+ REV VL +HPN++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP----LSWTNRFKVILGTAKGLAHLHHS 675
+ +V DY G L +++ + L W F I L H+H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---FVQIC---LALKHVH-- 142
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 732
I+H ++K NI L + ++ DFG+AR+L + ++ +G Y++PE+
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-----RACIGTPYYLSPEI 196
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRP 761
C++ N K DI+ G ++ EL T +
Sbjct: 197 -CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 26/217 (11%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G+G V++ G + A+K ++ + RE VL K H N++ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 621 YW--TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
T + K+L+ ++ P GSL L E + L + V+ G+ HL +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 679 PIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 731
I+H N+KP NI+ D +++DFG AR L +F S G Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPD 185
Query: 732 L-------TCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + D++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 94/475 (19%), Positives = 169/475 (35%), Gaps = 58/475 (12%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 61
K L LS N +S + + LR L L+ N ++ +F + L L++S+N
Sbjct: 53 RTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRSLDFH-VFLFNQDLEYLDVSHN 110
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA--ALHYLKELLLQGNQF-SGP 118
+ + LR LDLS N F +P L L L L +F
Sbjct: 111 RLQN-ISCC------PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
L LDL + G SL++ N+ + + + + + +++ L
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV-LHLVFHPNSLFSVQVNMSVNALG 221
Query: 179 FLDFSNNHLTGSLPSSLFN-----CKKLSVIRLRGNSLNGN------IPEGLFDLGLEEI 227
L SN L L + +++ + + + + + +E +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 287
++ I + S + L ++L I + + + A +FA + LS +
Sbjct: 282 NIYNLTITERIDREEFTYSETAL-KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 288 LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLT--GPIPQVI 344
S L+ N + C + + L L L N L + +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399
Query: 345 RNCTSLYLLSLSHNHLSG-------SIPKSISNLN----------------KLKILKLEF 381
+N +SL L +S N L+ + +SI LN K+K+L L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHN 459
Query: 382 NELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG--GVFPTLDQSSLQGNLGICS 434
N + IP+++ L +L +NV+ N+L +P G +L L N C+
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHDNPWDCT 512
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 77/316 (24%), Positives = 126/316 (39%), Gaps = 47/316 (14%)
Query: 552 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
E L+ +++G+G FG+V G ++AVK+L DF+RE+++L
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILK 79
Query: 608 KARHPNLISLEGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVI 662
++ G + P + LV +Y P+G L+ L L ++
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS------ 133
Query: 663 LGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNR 720
KG+ +L +H +L NIL++ + +I+DFGLA+LL + V+
Sbjct: 134 SQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 721 FQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRP--------VEYGEDN 768
QS + + APE SL N + D++ FGV++ EL T + G +
Sbjct: 190 GQSPIFWYAPE----SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 769 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828
V + LLEEG L P V +L +C P RPS + +
Sbjct: 246 DVPALSRLLELLEEGQRLPA--------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297
Query: 829 LQ-VIKTPLPQRMEVF 843
L + F
Sbjct: 298 LDMLWSGSRGCETHAF 313
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGY 620
G+G FG VY +LA+K L + + + REV + RHPN++ L GY
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 621 YWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
+ L+ +YAP G++ +L + I A L++ H
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATY-ITELANALSYCH---SK 128
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQ 735
+IH ++KP N+LL +I+DFG + H S+R G Y+ PE+ +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEM-IE 180
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRP 761
+EK D++ GVL E + G+ P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 41/293 (13%)
Query: 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLG 607
ET L K +G GVFGTV+K + +G + +K + Q + + +G
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILG 664
H +++ L G L LV+ Y P GSL + + + P L+W +
Sbjct: 71 SLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQ 123
Query: 665 TAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
AKG+ +L H +H NL N+LL +++DFG+A LL DK ++ + ++
Sbjct: 124 IAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 724 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 779
+ ++A E S+ + + D++ +GV + EL+T G P Y + V L
Sbjct: 180 PIKWMALE----SIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YAG----LRLAEVPDL 229
Query: 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
LE+G L P+ + V + + C + RP+ E+ +
Sbjct: 230 LEKGERLAQ--------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 42/234 (17%), Positives = 92/234 (39%), Gaps = 36/234 (15%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY----------------PEDFEREVRVL 606
+G F + + A+KK S + + +DF+ E++++
Sbjct: 40 NQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRF--KVI 662
++ ++ EG ++ +Y N S+ L + +I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 663 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722
+++H+ I H ++KPSNIL+D N ++SDFG + ++++ + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES-------EYMVDKKIK 208
Query: 723 SALG---YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
+ G ++ PE + +S K DI+ G+ + + P + ++V L
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-LKISLVEL 261
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/322 (19%), Positives = 130/322 (40%), Gaps = 45/322 (13%)
Query: 534 GKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVT 589
G ++ ++ +D + + L++ ++GEG FG V G +AVK L
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 590 SDIIQYPEDFEREVRVLGKARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLH--- 644
+ D ++E+ +L H N++ +G L+ ++ P+GSL+ L
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 645 ERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDF 703
++ L + + KG+ +L + +H +L N+L++ + +I DF
Sbjct: 121 NKINLKQQLKYA------VQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDF 170
Query: 704 GLARLLTR-LDKHVMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-G 758
GL + + + + + + S + + APE L ++ D++ FGV + EL+T
Sbjct: 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPE----CLMQSKFYIASDVWSFGVTLHELLTYC 226
Query: 759 RRPVEYGEDNVVILS--------EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALV 810
+ ++ + L+EG L C P + V +L
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC--------PPNCPDEVYQLMRK 278
Query: 811 CTCHIPSSRPSMAEVVQILQVI 832
C PS+R S +++ + +
Sbjct: 279 CWEFQPSNRTSFQNLIEGFEAL 300
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-27
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 29/288 (10%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 608
++ + ++ ++G G +G VY+ + +AVK L + E+F +E V+ +
Sbjct: 217 MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKE 272
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
+HPNL+ L G +++++ G+L L E +
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQISSA 330
Query: 669 LAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
+ +L +F IH NL N L+ +N+ +++DFGL+RL+T D + + + +
Sbjct: 331 MEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKW 385
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
APE + + + K D++ FGVL+ E+ T G P G D V LLE+ +
Sbjct: 386 TAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYP-GIDL-----SQVYELLEKDYRM 438
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
+ PE V +L C PS RPS AE+ Q + +
Sbjct: 439 ER--------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 39/302 (12%)
Query: 552 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
+ L+K ++GEG FG V + G M+AVK L Q+ +++E+ +L
Sbjct: 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILR 88
Query: 608 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
H ++I +G LV +Y P GSL+ L L
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQI 143
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRFQSA 724
+G+A+L H+ IH +L N+LLD++ +I DFGLA+ + + + + S
Sbjct: 144 CEGMAYL-HAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 725 LGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILS------- 773
+ + APE L+ + D++ FGV + EL+T + ++
Sbjct: 201 VFWYAPE----CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 774 -EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+ LLE G L P+ V L C S RP+ ++ IL+ +
Sbjct: 257 VLRLTELLERGERLPR--------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 833 KT 834
Sbjct: 309 HE 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/295 (19%), Positives = 118/295 (40%), Gaps = 37/295 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNL--ISLE 618
+G G V++V + ++ A+K + + + + E+ L K + + I L
Sbjct: 36 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
Y T Q +V + N L + L ++ P + +K +L + + +H
Sbjct: 95 DYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER-KSYWKNML---EAVHTIHQH--- 146
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL------ 732
I+H +LKP+N L+ D ++ DFG+A + V+ + + Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 733 ----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
+++ K D++ G ++ + G+ P + + + L +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------PN 256
Query: 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ--ILQVIKTPLPQRME 841
+ D PE ++ VLK C P R S+ E++ +Q+ P+ Q +
Sbjct: 257 HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 39/335 (11%), Positives = 79/335 (23%), Gaps = 45/335 (13%)
Query: 524 SSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLA 583
+ V V ++ ++ E L+ + G V+ V + A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 584 VKKLVTSDIIQYP--EDFEREVRVLGKARHPN---------------LISLEGYYWTPQL 626
+K E + + ++++ QL
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 627 KLLVSDYAPN-------------GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
DYA L + L + + A+L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 732
++H + P N+ + + + D + + Y E L
Sbjct: 212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFL 263
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792
+ + + G+ I + P +G I R L S
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321
Query: 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P+ V ++ L R E ++
Sbjct: 322 CTPLPD-FVKTLIGRFLNFD---RRRRLLPLEAME 352
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 63/263 (23%), Positives = 97/263 (36%), Gaps = 29/263 (11%)
Query: 515 ETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLL----EKAAEVGEGVFGTV 570
+SM R V+ S PE+ ++ + +G G +G V
Sbjct: 17 NLYFQSMHQLQPRRVSFRGEASETLQSPGYD---PSRPESFFQQSFQRLSRLGHGSYGEV 73
Query: 571 YKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGK-ARHPNLISLEGYYWTPQLKL 628
+KV GR+ AVK+ ++ + EV K +HP + LE + +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133
Query: 629 LVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 687
L ++ SLQ S P W + T LAHLH ++H ++KP
Sbjct: 134 LQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQG---LVHLDVKP 185
Query: 688 SNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCD 744
+NI L ++ DFGL L + G Y+APEL Q D
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAG------EVQEGDPRYMAPEL-LQG-SYGTAAD 237
Query: 745 IYGFGVLILELVTGRRPVEYGED 767
++ G+ ILE+ GE
Sbjct: 238 VFSLGLTILEVACNMELPHGGEG 260
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 18/220 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
++G G FG V+ V + G +K + E E E+ VL HPN+I +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHLHHSFR 677
+ +V + G L ++ LS K ++ LA+ H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---ALAYFHSQ-- 143
Query: 678 PPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
++H +LKP NIL + +I DFGLA L +N +A Y+APE+
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTA-LYMAPEVFK 199
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
+ + KCDI+ GV++ L+TG P G + +
Sbjct: 200 RDV--TFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQK 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G+G V++ G + A+K ++ + RE VL K H N++ L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 622 --WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
T + K+L+ ++ P GSL L E + L + V+ G+ HL +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 680 IIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 732
I+H N+KP NI+ D +++DFG AR L +F S G Y+ P++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPDM 186
Query: 733 -------TCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ D++ GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 70/318 (22%), Positives = 116/318 (36%), Gaps = 38/318 (11%)
Query: 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 140
LR + S ++P+ ++ L LQ N S D HL L L NN +
Sbjct: 35 LRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCK 199
+ L + + +S N L +IP S+L L +N + +P +F +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIP--PNLPSSLVELRIHDNRIR-KVPKGVFSGLR 147
Query: 200 KLSVIRLRGNSL-NGNIPEGLFD-LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 257
++ I + GN L N G FD L L + +SE + IP L +TL L
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA-KLTGIPKD--------LPETLNEL 198
Query: 258 DLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALY 313
L N + I L L L N +R I L + +L L L NN L
Sbjct: 199 HLDHNKIQ-AIEL--EDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS 254
Query: 314 GSIPQEVCESRSLGILQLDGNSLTGPIP-------QVIRNCTSLYLLSLSHNHLS-GSIP 365
+P + + + L ++ L N++T + +SL +N + +
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
Query: 366 KSI-SNLNKLKILKLEFN 382
+ + ++
Sbjct: 313 PATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 70/327 (21%), Positives = 114/327 (34%), Gaps = 60/327 (18%)
Query: 120 PADIGFCP-----HLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 171
P CP HL + S+ ++ LL+ + NN ++
Sbjct: 21 PTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLD------LQNNDISELRKDDF 74
Query: 172 GNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSE 231
+ L L NN ++ + +KL + + N L IP L L E+ + +
Sbjct: 75 KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS-SLVELRIHD 132
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA--NLRYLNLSSNHLR 289
N +P G S + + +++ N L + E G F L YL +S L
Sbjct: 133 NRI-RKVPKGVFSGLRN-----MNCIEMGGNPL-ENSGFEPGAFDGLKLNYLRISEAKLT 185
Query: 290 SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTS 349
IP +L +L L L +N + +I + + +
Sbjct: 186 G-IPKDL--PETLNELHLDHNKI-QAIE-----------------------LEDLLRYSK 218
Query: 350 LYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL- 408
LY L L HN + S+S L L+ L L+ N+LS +P L L L V + N +
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
Query: 409 ------IGRLPVGGVFPTLDQSSLQGN 429
+ G + SL N
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 43/215 (20%), Positives = 69/215 (32%), Gaps = 36/215 (16%)
Query: 1 MMNMKFLDLSNNLL-SGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 59
+ NM +++ N L + F+ L YL ++ L G + +LN L+L
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP---ETLNELHLD 201
Query: 60 NNHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFS 116
+N D +L L L HN I G + L L+EL L N+ S
Sbjct: 202 HNKIQAIELEDLL------RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254
Query: 117 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 176
+PA + L + L N T V N + +
Sbjct: 255 R-VPAGLPDLKLLQVVYLHTNNIT----------------KVGVNDFCP--VGFGVKRAY 295
Query: 177 LEFLDFSNNHLT-GSLPSSLFNC-KKLSVIRLRGN 209
+ NN + + + F C I+
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 36/278 (12%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 619
+G G GT+ R +AVK+++ +REV++L + HPN+I
Sbjct: 31 VLGHGAEGTIVYRGMFD-NRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFC 85
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
Q + + + +LQ + ++ + L ++ T GLAHLH
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSLN--- 138
Query: 680 IIHYNLKPSNILL-----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSA--LGYVAPEL 732
I+H +LKP NIL+ ISDFGL + L +H S R G++APE+
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHSFSRRSGVPGTEGWIAPEM 197
Query: 733 TCQSL--RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
+ DI+ G + +++ G P +G+ +LL + LDC+
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSL----QRQANILLGACS-LDCL 250
Query: 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P + L + K P RPS V++
Sbjct: 251 HPEKHEDVIAREL-IEK----MIAMDPQKRPSAKHVLK 283
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/301 (21%), Positives = 130/301 (43%), Gaps = 36/301 (11%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLG 607
+ + LL E+G G FG+V + + + + + A+K L E+ RE +++
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 65
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+ +P ++ L G L +LV + A G L L + + +N +++ +
Sbjct: 66 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSM 121
Query: 668 GLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQSAL 725
G+ +L +F +H +L N+LL + + +ISDFGL++ L D + + + L
Sbjct: 122 GMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 726 GYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGE-DNVVILSEHVRVLL 780
+ APE + + + D++ +GV + E ++ G++P Y + V +
Sbjct: 178 KWYAPE----CINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKG-----PEVMAFI 226
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 840
E+G ++C P + + L C + RP V Q ++ L ++
Sbjct: 227 EQGKRMEC--------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
Query: 841 E 841
E
Sbjct: 279 E 279
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/266 (20%), Positives = 100/266 (37%), Gaps = 26/266 (9%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
+ + + S+P G+ L L+ N+ LT L LS+N +
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 142 Q--LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 198
+ S S+ ++ +S N + + + LE LDF +++L S+F +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 199 KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
+ L + + G+F+ LE + ++ N F + P + + L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN-----LTF 179
Query: 257 LDLSSNNLVGDIPAEMGLFAN---LRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNAL 312
LDLS L + F + L+ LN+S N+ S + +SL LD N +
Sbjct: 180 LDLSQCQLE-QLSP--TAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHI 235
Query: 313 YGSIPQEVCES--RSLGILQLDGNSL 336
+ ++ + SL L L N
Sbjct: 236 -MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/292 (20%), Positives = 109/292 (37%), Gaps = 47/292 (16%)
Query: 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 64
+ ++ L+ VP + +S L L N LQ +F+ + L L+LS+N S
Sbjct: 10 TEIRCNSKGLTS-VPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIG 124
+ L+ LDLS N ++ L L+ L Q + +
Sbjct: 66 --FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSV 121
Query: 125 F--CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
F +L LD+S+ R+ + IF +S+ LE L
Sbjct: 122 FLSLRNLIYLDISHT--------HTRVAFNGIFNGLSS----------------LEVLKM 157
Query: 183 SNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIP 239
+ N + +F + L+ + L L + F+ L+ +++S N F S+
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLD 215
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLR 289
+S L++LD S N+++ + ++L +LNL+ N
Sbjct: 216 TFPYKCLNS-----LQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 11/215 (5%)
Query: 3 NMKFLDLSNNLLS-GPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNN 61
+ L LS+N LS Q SL+YL L+ N + + F L L+ ++
Sbjct: 53 QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 111
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLP 120
+ +F+ SL+ L LD+SH G+ L L+ L + GN F
Sbjct: 112 NLKQMSEFSV---FLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 121 ADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
DI +LT LDLS P + L+S+ +++S+N +++L+
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 180 LDFSNNHLTGSLPSSLFN--CKKLSVIRLRGNSLN 212
LD+S NH+ + L+ + L N
Sbjct: 228 LDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 26/261 (9%)
Query: 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLN-GNIP 216
++ LT +P I S+ L+ +N L SLP +F +L+ + L N L+
Sbjct: 15 NSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70
Query: 217 EGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 274
L+ +DLS NG + ++ L LD +NL + E +
Sbjct: 71 SQSDFGTTSLKYLDLSFNG-VITMSSNFLGLEQ------LEHLDFQHSNLK-QMS-EFSV 121
Query: 275 FA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGIL 329
F NL YL++S H R SL L + N+ + ++ R+L L
Sbjct: 122 FLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 330 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIP 389
L L P + +SL +L++SHN+ LN L++L N +
Sbjct: 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK 239
Query: 390 QEL--GKLASLLAVNVSYNRL 408
++ +SL +N++ N
Sbjct: 240 KQELQHFPSSLAFLNLTQNDF 260
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGY 620
G+G FG VY ++A+K L S + + RE+ + RHPN++ + Y
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 621 YWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
+ + L+ ++AP G L +L H R + + A L + H
Sbjct: 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRSATF-MEELADALHYCH---ER 133
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQ 735
+IH ++KP N+L+ +I+DFG + H S R ++ G Y+ PE+ +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMI-E 185
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRP 761
+EK D++ GVL E + G P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 78/310 (25%), Positives = 128/310 (41%), Gaps = 39/310 (12%)
Query: 540 DSRSSSLDCSIDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQY 595
+ + I P +L + +G G FG VY + + AVK L I
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 596 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL-VSDYAPNGSLQAKLHERLPSTPPLS 654
F E ++ HPN++SL G + L V Y +G L+ + T +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPT 126
Query: 655 WTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713
+ L AKG+ +L F +H +L N +LD+ + +++DFGLAR + +
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 714 KHVMSNRFQSAL--GYVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GE 766
+ + N+ + L ++A E SL + K D++ FGVL+ EL+T G P Y
Sbjct: 183 YYSVHNKTGAKLPVKWMALE----SLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDV 236
Query: 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 826
+ + V L +G L PE P+ ++ L C RPS +E+V
Sbjct: 237 NT-----FDITVYLLQGRRLLQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 283
Query: 827 QILQVIKTPL 836
+ I +
Sbjct: 284 SRISAIFSTF 293
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 32/276 (11%)
Query: 51 SSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYL 105
++ +L+LSNN + DL L+ L L+ N + +I + ++L L
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQ--------RCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 106 KELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLFTGQLPVSL-RLLNSMIFISVSNNT 162
+ L L N S L + F LT L+L N + SL L + + V N
Sbjct: 103 EHLDLSYNYLSN-LSSSW-FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160
Query: 163 LTGDIPH-WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD 221
I ++ LE L+ + L P SL + + +S + L + E D
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD 219
Query: 222 L--GLEEIDLSENGF----MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 275
+ +E ++L + + G ++S T R + ++ +L + +
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF--TFRNVKITDESLFQVMKLLNQI- 276
Query: 276 ANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNN 310
+ L L S N L+S +P SL + L N
Sbjct: 277 SGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 55/275 (20%), Positives = 102/275 (37%), Gaps = 28/275 (10%)
Query: 124 GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
G + +LDLSNN T L+ ++ + +++N + ++ +LE LD S
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108
Query: 184 NNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPP 240
N+L+ +L SS F L+ + L GN LF L+ + + I
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPEL- 296
+ + L L++ +++L N+ +L L +
Sbjct: 168 KDFAGLTF-----LEELEIDASDLQ-SYEP--KSLKSIQNVSHLILHMKQHIL-LLEIFV 218
Query: 297 GYFHSLIHLDLRNNALYGSIPQEVCE--------SRSLGILQLDGNSLTGPIPQVIRNCT 348
S+ L+LR+ L E+ + +++ SL + +++ +
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 349 SLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
L L S N L S+P I L L+ + L N
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 33/271 (12%)
Query: 155 FISVSNNTLTGDIPHWIGNIST-LEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLN 212
S+ +L IP ++ ++ LD SNN +T + +S C L + L N +N
Sbjct: 35 ICKGSSGSLN-SIPS---GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN 89
Query: 213 GNIPEGLFD-LG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPA 270
I E F LG LE +DLS N ++ ++ SS L L+L N +
Sbjct: 90 -TIEEDSFSSLGSLEHLDLSYN-YLSNLSSSWFKPLSS-----LTFLNLLGNPYK-TLG- 140
Query: 271 EMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSIPQEVCES-RS 325
E LF+ L+ L + + ++I + L L++ + L S + +S ++
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQN 199
Query: 326 LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS--------NLNKLKIL 377
+ L L + + +S+ L L L +S + +
Sbjct: 200 VSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259
Query: 378 KLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
K+ L ++ + L +++ LL + S N+L
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 52/264 (19%), Positives = 99/264 (37%), Gaps = 32/264 (12%)
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPP 240
S+ L S+PS L + + + L N + I + L+ + L+ NG + +I
Sbjct: 39 SSGSLN-SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNG-INTIEE 93
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-- 295
S SS S L LDLS N L ++ + F +L +LNL N ++ +
Sbjct: 94 DSFSSLGS-----LEHLDLSYNYLS-NLSS--SWFKPLSSLTFLNLLGNPYKT-LGETSL 144
Query: 296 LGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 354
+ L L + N + I ++ L L++D + L P+ +++ ++ L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 355 LSHNHLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQEL--------GKLASLLAVNVSY 405
L + + + ++ L+L +L EL K + V ++
Sbjct: 205 LHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 406 NRLIGRLPVGGVFPTLDQSSLQGN 429
L + + L + N
Sbjct: 264 ESLFQVMKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 22/169 (13%), Positives = 46/169 (27%), Gaps = 13/169 (7%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ ++ L + N + + F L L + + LQ K +++ L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG----SIPQGVAA----LHYLKELLLQG 112
L+ + + L+L + G + + +
Sbjct: 208 KQHILLLEIF----VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 113 NQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161
+ + L L+ S N L S+ I + N
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 66/321 (20%), Positives = 100/321 (31%), Gaps = 48/321 (14%)
Query: 33 SLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS 92
S A N L +++ SL L + + F I L+ L +
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTD---IIKSLSLKRLTVRAARIP 81
Query: 93 GSIPQGVAALH---YLKELLLQGNQFSGPLPADIGFCPH--LTTLDLSNNLFTGQLPVSL 147
I G + L+EL L+ + +G P + L L+L N + +
Sbjct: 82 SRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA 141
Query: 148 RLLN----SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC----K 199
L + +S++ + L LD S+N G C
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 200 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 259
L V+ LR + + S+ + L+ LDL
Sbjct: 202 TLQVLALRNAGME------------------------TPSG--VCSALAAARVQLQGLDL 235
Query: 260 SSNNLVGDIPAEMGLF-ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 318
S N+L A + + L LNLS L+ +P L L LDL N L P
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRL-DRNPS 291
Query: 319 EVCESRSLGILQLDGNSLTGP 339
E +G L L GN
Sbjct: 292 P-DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 55/295 (18%), Positives = 88/295 (29%), Gaps = 62/295 (21%)
Query: 2 MNMKFLDLSNNLLSGPVPYQLFE--NCASLRYLSLAGNILQG--PIGKIFNYCSSLNTLN 57
+++K L + + + + + L+ L+L + G P + LN LN
Sbjct: 68 LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127
Query: 58 LSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG 117
L N ++ + + W L+ L ++ + V L L L N G
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 118 PLPADIGFC----PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGN 173
C P L L L N T +G
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAA 226
Query: 174 ISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENG 233
L+ LD S+N L + + + L ++LS G
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQ----------------------LNSLNLSFTG 264
Query: 234 FMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHL 288
+P G L L +LDLS N L P+ L + L+L N
Sbjct: 265 L-KQVPKG--------LPAKLSVLDLSYNRL-DRNPSPDEL-PQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 51/298 (17%), Positives = 91/298 (30%), Gaps = 21/298 (7%)
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186
P N L + + + + + I +L+ L
Sbjct: 20 PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAAR 79
Query: 187 LTGSLPSS---LFNCKKLSVIRLRGNSLNGNIPEGLFDL---GLEEIDLSENGFMGSIPP 240
+ + + L + L + G P L + L ++L + +
Sbjct: 80 IPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW--ATRD 137
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE----L 296
+ L L++L ++ + + ++ +F L L+LS N
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197
Query: 297 GYFHSLIHLDLRNN---ALYGSIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYL 352
F +L L LRN G L L L NSL + L
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 353 LSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410
L+LS L +PK + KL +L L +N L P L + +++ N +
Sbjct: 258 LNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 32/145 (22%), Positives = 48/145 (33%), Gaps = 14/145 (9%)
Query: 3 NMKFLDLSNNLLSGPVP---YQLFENCASLRYLSLAGN---ILQGPIGKIFNYCSSLNTL 56
+ LDLS+N G +L+ L+L G + L L
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 57 NLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS 116
+LS+N S +L +L+LS +P+G+ L L L N+
Sbjct: 234 DLSHNSLRDAAGAPSCDW---PSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD 287
Query: 117 GPLPADIGFCPHLTTLDLSNNLFTG 141
P P + L L N F
Sbjct: 288 R-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 30/119 (25%), Positives = 43/119 (36%), Gaps = 12/119 (10%)
Query: 3 NMKFLDLSNNLLS--GPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLS 59
++ L L N + V L L+ L L+ N L+ ++ S LN+LNLS
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP 118
+L LDLS+N P L + L L+GN F
Sbjct: 262 FTGLKQVPK-------GLPAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 21/94 (22%), Positives = 36/94 (38%), Gaps = 9/94 (9%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ ++ LDLS+N L + + L L+L+ L+ + + L+ L+LS
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSY 283
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS 94
N L ++ L L N F S
Sbjct: 284 NRLD------RNPSPDELPQVGNLSLKGNPFLDS 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 58/295 (19%), Positives = 118/295 (40%), Gaps = 37/295 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNL--ISLE 618
+G G V++V + ++ A+K + + + + E+ L K + + I L
Sbjct: 17 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
Y T Q +V + N L + L ++ P + +K +L + + +H
Sbjct: 76 DYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER-KSYWKNML---EAVHTIHQH--- 127
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL------ 732
I+H +LKP+N L+ D ++ DFG+A + V+ + + Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 733 ----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
+++ K D++ G ++ + G+ P + + + L +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------PN 237
Query: 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ--ILQVIKTPLPQRME 841
+ D PE ++ VLK L P R S+ E++ +Q+ P+ Q +
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLK---RDPKQRISIPELLAHPYVQIQTHPVNQMAK 289
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 31/288 (10%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 608
I E+L LE ++G+G FG V+ ++ R +A+K L + PE F +E +V+ K
Sbjct: 181 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKK 235
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
RH L+ L + + +V++Y GSL L L A G
Sbjct: 236 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASG 292
Query: 669 LAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
+A++ ++ +H +L+ +NIL+ +N +++DFGLARL+ +++ + + +
Sbjct: 293 MAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 347
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
APE R K D++ FG+L+ EL T GR P G N V +E G +
Sbjct: 348 TAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYP-GMVN-----REVLDQVERGYRM 400
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
C P + + L C P RP+ + L+ T
Sbjct: 401 PC--------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 33/235 (14%), Positives = 74/235 (31%), Gaps = 24/235 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+GEG F VY+ + G + +K ++ ++ + + L + +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF-YIGTQLMERLKPSMQHMFM 130
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
+ +LV + G+L ++ + + + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH- 189
Query: 675 SFRPPIIHYNLKPSNILLDDNYNP-----------RISDFGLARLLTRLDKHVMSNRFQS 723
IIH ++KP N +L + + + D G + + K +
Sbjct: 190 --DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 724 ALGYVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
G+ E L+ + N + D +G + ++ G E R
Sbjct: 248 TSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G G F V K + G A K + S E+ EREV +L + H N+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 672
+L Y +L+ + G +L + L LS T+ K IL G+ +L
Sbjct: 79 TLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQILD---GVNYL 131
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNP----RISDFGLARLLTRLDKHVMSNRFQSALGYV 728
H I H++LKP NI+L D P ++ DFGLA + D N F + +V
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTP-EFV 185
Query: 729 APE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
APE + + + + D++ GV+ L++G P G+ L+
Sbjct: 186 APEIVNYEP--LGLEADMWSIGVITYILLSGASPF-LGDTKQETLA 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 37/232 (15%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK--------KLVTSDIIQYPEDFEREVRVLGK-ARH 611
+G GV V + + AVK ++ + E +EV +L K + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGT 665
PN+I L+ Y T LV D G L + L E+ + +L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-------KIMRALL-- 134
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+ + LH I+H +LKP NILLDD+ N +++DFG + L + +
Sbjct: 135 -EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP- 187
Query: 726 GYVAPE-LTCQSLRV----NEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
Y+APE + C ++ D++ GV++ L+ G P + +++L
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLML 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 64/286 (22%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 561 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G+G FG VY+ V +A+K + + ++ +F E V+ + +++
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------PPLSWTNRFKVILGTAKGL 669
L G Q L++ + G L++ L P+ P S + ++ A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 670 AHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
A+L+ + F +H +L N ++ +++ +I DFG+ R + D + + + ++
Sbjct: 152 AYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 729 APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784
+PE SL+ D++ FGV++ E+ T +P G N E V + EG
Sbjct: 208 SPE----SLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSN-----EQVLRFVMEGG 257
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+LD P++ + +L +C + P RPS E++ ++
Sbjct: 258 LLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 56/258 (21%), Positives = 98/258 (37%), Gaps = 51/258 (19%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP----EDFEREVRVLGKARHPNLIS 616
+G+G +G V + A+K + + I Q E + EVR++ K HPN+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK--------- 667
L Y Q LV + G L KL+ + + + K +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 668 ---------------------------GLAHLHHSFRPPIIHYNLKPSNILL--DDNYNP 698
L +LH+ I H ++KP N L + ++
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 699 RISDFGLARLLTRL---DKHVMSNRFQSALGYVAPE-LTCQSLRVNEKCDIYGFGVLILE 754
++ DFGL++ +L + + M+ + + +VAPE L + KCD + GVL+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTP-YFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 755 LVTGRRPVEYGEDNVVIL 772
L+ G P G ++ +
Sbjct: 269 LLMGAVPF-PGVNDADTI 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 71/319 (22%), Positives = 127/319 (39%), Gaps = 56/319 (17%)
Query: 541 SRSSSL-DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF 599
SR +++ + + L+ +G G GTV GR +AVK+++ I + +
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRML----IDFCDIA 55
Query: 600 EREVRVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR 658
E+++L + HPN+I T + + + N +LQ + + S L
Sbjct: 56 LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKE 114
Query: 659 F---KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-------------DNYNPRISD 702
+ ++ A G+AHLH IIH +LKP NIL+ +N ISD
Sbjct: 115 YNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 703 FGLARLLTRLDKHVMSNRFQSALG---YVAPEL------TCQSLRVNEKCDIYGFGVLIL 753
FGL + L + + G + APEL R+ DI+ G +
Sbjct: 172 FGLCKKLDS-GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 754 ELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLA--LV 810
+++ G+ P +G+ E N++ + S+ + ++ A L+
Sbjct: 231 YILSKGKHP--FGDKY-----------SRESNIIRGI-FSLDEMKCLHDRSLIAEATDLI 276
Query: 811 --CTCHIPSSRPSMAEVVQ 827
H P RP+ +V++
Sbjct: 277 SQMIDHDPLKRPTAMKVLR 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G G F V K G+ A K +L +S E+ EREV +L + RHPN+I
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLA 670
+L + +L+ + G L L E+ S T K IL G+
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK------ESLTEDEATQFLKQILD---GVH 122
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNP----RISDFGLARLLTRLDKHVMSNRFQSALG 726
+LH I H++LKP NI+L D P ++ DFG+A + + N F +
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFKNIFGTP-E 176
Query: 727 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
+VAPE + + + + D++ GV+ L++G P GE L+
Sbjct: 177 FVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPF-LGETKQETLT 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 72/306 (23%), Positives = 123/306 (40%), Gaps = 43/306 (14%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVR 604
ID L L K +GEG FG+V + +AVK + + + + E+F E
Sbjct: 31 IDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA 88
Query: 605 VLGKARHPNLISLEG-----YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR- 658
+ HPN+I L G +++ + G L L T P +
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 659 -FKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
K ++ A G+ +L + +F +H +L N +L D+ ++DFGL++ + D +
Sbjct: 149 LLKFMVDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 717 MSNRFQSALGYVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVI 771
+ + ++A E SL K D++ FGV + E+ T G P Y G N
Sbjct: 205 QGRIAKMPVKWIAIE----SLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQN--- 255
Query: 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831
+ L G+ L PED + + ++ C P RP+ + + L+
Sbjct: 256 --HEMYDYLLHGHRLKQ--------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
Query: 832 IKTPLP 837
+ LP
Sbjct: 306 LLESLP 311
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-25
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G G F V K + G A K + S E+ EREV +L + HPN+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 672
+L Y +L+ + G +L + L LS T+ K IL G+ +L
Sbjct: 79 TLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQILD---GVNYL 131
Query: 673 HHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
H I H++LKP NI+L + ++ DFGLA + D N F + +V
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTP-EFV 185
Query: 729 APE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
APE + + + + D++ GV+ L++G P G+ L+
Sbjct: 186 APEIVNYEP--LGLEADMWSIGVITYILLSGASPF-LGDTKQETLA 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 36/293 (12%)
Query: 547 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML--AVKKL-VTSDIIQYPEDFEREV 603
+ +D + L + E+G G FGTV K + + + AVK L ++ ++ E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 604 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 663
V+ + +P ++ + G +LV + A G L L + + N +++
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVH 124
Query: 664 GTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRF 721
+ G+ +L +F +H +L N+LL + +ISDFGL++ L + +
Sbjct: 125 QVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 722 QSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777
+ + + APE + + K D++ FGVL+ E + G++P Y + SE V
Sbjct: 181 KWPVKWYAPE----CINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRG---MKGSE-VT 230
Query: 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+LE+G + C P + L +C + +RP A V L+
Sbjct: 231 AMLEKGERMGC--------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 71/307 (23%), Positives = 131/307 (42%), Gaps = 47/307 (15%)
Query: 552 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
E L+ ++G+G FG+V G ++AVKKL ++ DFERE+ +L
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILK 66
Query: 608 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVI 662
+H N++ +G Y + L+ +Y P GSL+ L + R+ L +T
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------ 120
Query: 663 LGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNR 720
KG+ +L + IH +L NIL+++ +I DFGL ++L + + +
Sbjct: 121 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 721 FQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVIL---- 772
+S + + APE SL ++ D++ FGV++ EL T + + + ++
Sbjct: 177 GESPIFWYAPE----SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 773 -----SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
H+ LL+ L P+ + + C + + RPS ++
Sbjct: 233 QGQMIVFHLIELLKNNGRLPR--------PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
Query: 828 ILQVIKT 834
+ I+
Sbjct: 285 RVDQIRD 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 81/347 (23%), Positives = 135/347 (38%), Gaps = 44/347 (12%)
Query: 510 RLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSID------PETLLEKAAEVG 563
+ + T+L S + A I + + L ++ ++ +G
Sbjct: 39 SIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIG 98
Query: 564 EGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
G FG VY + + AVK L I F E ++ HPN++SL G
Sbjct: 99 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158
Query: 621 YWTPQLKLL-VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRP 678
+ L V Y +G L+ + T + + L AKG+ L F
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKF-- 213
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYVAPELTCQS 736
+H +L N +LD+ + +++DFGLAR + + + N+ + L ++A E S
Sbjct: 214 --VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE----S 267
Query: 737 L---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEEGNVLDCVDP 791
L + K D++ FGVL+ EL+T G P Y + + V L +G L
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNT-----FDITVYLLQGRRLLQ--- 317
Query: 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838
PE P+ ++ L C RPS +E+V + I +
Sbjct: 318 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G G F V K + G A K + +S ED EREV +L + +HPN+I
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 672
+L Y +L+ + G +L + L L+ T K IL G+ +L
Sbjct: 78 TLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN---GVYYL 130
Query: 673 HHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
H I H++LKP NI+L +I DFGLA + + N F + +V
Sbjct: 131 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTP-EFV 184
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
APE+ + + D++ GV+ L++G P G+ L+
Sbjct: 185 APEIVNYE-PLGLEADMWSIGVITYILLSGASPF-LGDTKQETLAN 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 70/307 (22%), Positives = 129/307 (42%), Gaps = 47/307 (15%)
Query: 552 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
E L+ ++G+G FG+V G ++AVKKL ++ DFERE+ +L
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILK 97
Query: 608 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVI 662
+H N++ +G Y + L+ +Y P GSL+ L + L +T
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------ 151
Query: 663 LGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNR 720
KG+ +L + IH +L NIL+++ +I DFGL ++L + + + +
Sbjct: 152 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 721 FQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVTGRRPVEYGEDNVV------- 770
+S + + APE SL ++ D++ FGV++ EL T + +
Sbjct: 208 GESPIFWYAPE----SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 771 ---ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
++ H+ LL+ L P+ + + C + + RPS ++
Sbjct: 264 QGQMIVFHLIELLKNNGRLPR--------PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
Query: 828 ILQVIKT 834
+ I+
Sbjct: 316 RVDQIRD 322
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 70/301 (23%), Positives = 116/301 (38%), Gaps = 45/301 (14%)
Query: 561 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G G FG VY+ + +AVK L Q DF E ++ K H N++
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---PPLSWTNRFKVILGTAKGLAHL 672
G + ++ + G L++ L E P L+ + V A G +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 673 -HHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
+ F IH ++ N LL +I DFG+AR + R + + ++
Sbjct: 157 EENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 729 APELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784
PE + K D + FGVL+ E+ + G P + N + V + G
Sbjct: 213 PPE----AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSN-----QEVLEFVTSGG 262
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ-------VIKTPLP 837
+D P++ PV ++ C H P RP+ A +++ ++ VI T LP
Sbjct: 263 RMDP--------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 314
Query: 838 Q 838
Sbjct: 315 I 315
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 38/295 (12%)
Query: 556 LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHP 612
+G+G FG VY + A+K L +Q E F RE ++ HP
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 613 NLISLEGYYWTPQ-LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
N+++L G P+ L ++ Y +G L + + + L A+G+ +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEY 139
Query: 672 L-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYV 728
L F +H +L N +LD+++ +++DFGLAR + + + + + L +
Sbjct: 140 LAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 729 APELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEEG 783
A E SL R K D++ FGVL+ EL+T G P Y D + L +G
Sbjct: 196 ALE----SLQTYRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDP-----FDLTHFLAQG 244
Query: 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838
L PE + ++ C P+ RP+ +V ++ I + L
Sbjct: 245 RRLPQ--------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 31/288 (10%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 608
I E+L LE ++G+G FG V+ ++ R +A+K L + PE F +E +V+ K
Sbjct: 264 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKK 318
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
RH L+ L + + +V++Y GSL L L A G
Sbjct: 319 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASG 375
Query: 669 LAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
+A++ ++ +H +L+ +NIL+ +N +++DFGLARL+ +++ + + +
Sbjct: 376 MAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 430
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
APE R K D++ FG+L+ EL T GR P G N V +E G +
Sbjct: 431 TAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYP-GMVN-----REVLDQVERGYRM 483
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
C P + + L C P RP+ + L+ T
Sbjct: 484 PC--------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (272), Expect = 1e-24
Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 28/229 (12%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL----- 617
G G FG V + G +A+K+ + E + E++++ K HPN++S
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 618 -EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
L LL +Y G L+ L E I L +LH
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS---SALRYLHE 139
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPR---ISDFGLARLLTRLDKHVMSNRFQSALG---YV 728
+ IIH +LKP NI+L I D G A+ L + +G Y+
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ------GELCTEFVGTLQYL 190
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
APEL + + D + FG L E +TG RP V VR
Sbjct: 191 APELL-EQKKYTVTVDYWSFGTLAFECITGFRPF-LPNWQPVQWHGKVR 237
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-24
Identities = 89/466 (19%), Positives = 145/466 (31%), Gaps = 81/466 (17%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ----GPIGKIFNYCSSLNTLNL 58
+++ LD+ LS +L + + L L I +L LNL
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 59 SNNHF--SGDLDFASGYGIWSLKRLRTLDLSHNLFS----GSIPQGVAALHYLKELLLQG 112
+N G G S K ++ L L + + G + + L L+EL L
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCK-IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 113 NQFSGPLPADIGF----------CPHLTTLDLSNNLFTGQ----LPVSLRLLNSMIFISV 158
N D G L L L + L LR ++V
Sbjct: 123 NLLG-----DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 159 SNNTLTGDIPHWIG-----NISTLEFLDFSNNHLT----GSLPSSLFNCKKLSVIRLRGN 209
SNN + + + LE L + +T L + + L + L N
Sbjct: 178 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN 237
Query: 210 SLNGNIPEGLFDLG---------LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
L G+ +L L + + E G + ++L+ L L+
Sbjct: 238 KLGD---VGMAELCPGLLHPSSRLRTLWIWECGI--TAKGCGDLCRVLRAKESLKELSLA 292
Query: 261 SNNLVGD----IPAEMGLFAN--LRYLNLSSNHLRSR----IPPELGYFHSLIHLDLRNN 310
N L GD + E L L L + S + L L+ L + NN
Sbjct: 293 GNEL-GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351
Query: 311 ALYGSIPQEVCES-----RSLGILQLDGNSLT----GPIPQVIRNCTSLYLLSLSHNHLS 361
L + +E+C+ L +L L ++ + + SL L LS+N L
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
Query: 362 GSIPKSIS-----NLNKLKILKLEFNELSGEIPQELGKLASLLAVN 402
+ + L+ L L S E+ L +L
Sbjct: 412 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR---LQALEKDK 454
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-20
Identities = 74/373 (19%), Positives = 131/373 (35%), Gaps = 69/373 (18%)
Query: 81 LRTLDLSHNLFS-GSIPQGVAALHYLKELLLQGNQFS----GPLPADIGFCPHLTTLDLS 135
+++LD+ S + + L + + L + + + + P L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 136 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT----GSL 191
+N V + + + + + ++ L N LT G L
Sbjct: 65 SNELG---DVGVHCVLQGL---QTPSC-------------KIQKLSLQNCCLTGAGCGVL 105
Query: 192 PSSLFNCKKLSVIRLRGNSLNG----NIPEGLFDLG--LEEIDLSENGFMGSIPPGSSSS 245
S+L L + L N L + EGL D LE++ L S+ S
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC----SLSAASCEP 161
Query: 246 SSSTLF--QTLRILDLSSNNLVGDIPAEM---GLFAN---LRYLNLSSNHLRSR----IP 293
+S L + L +S+N++ + + GL + L L L S + S +
Sbjct: 162 LASVLRAKPDFKELTVSNNDI-NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220
Query: 294 PELGYFHSLIHLDLRNNALYGSIPQEVCE-----SRSLGILQLDGNSLTGP----IPQVI 344
+ SL L L +N L E+C S L L + +T + +V+
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280
Query: 345 RNCTSLYLLSLSHNHLSGSIPKSISNL-----NKLKILKLEFNELSGE----IPQELGKL 395
R SL LSL+ N L + + +L+ L ++ + L +
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 396 ASLLAVNVSYNRL 408
LL + +S NRL
Sbjct: 341 RFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 53/302 (17%), Positives = 99/302 (32%), Gaps = 76/302 (25%)
Query: 175 STLEFLDFSNNHLTGS-----------------------------LPSSLFNCKKLSVIR 205
++ LD L+ + + S+L L+ +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 206 LRGNSLNGNIPEGLFDLG---------LEEIDLSENGFMGSIPPGSSSSSSSTLF--QTL 254
LR N L G+ + ++++ L + SSTL TL
Sbjct: 63 LRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNC----CLTGAGCGVLSSTLRTLPTL 115
Query: 255 RILDLSSNNLVGDIPA----EMGLFAN--LRYLNLSSNHLRSR----IPPELGYFHSLIH 304
+ L LS N L GD E L L L L L + + L
Sbjct: 116 QELHLSDNLL-GDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174
Query: 305 LDLRNNALYGSIPQEVCES-----RSLGILQLDGNSLT----GPIPQVIRNCTSLYLLSL 355
L + NN + + + +C+ L L+L+ +T + ++ + SL L+L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELAL 234
Query: 356 SHNHLSGSIPKSISN-----LNKLKILKLEFNELSGE----IPQELGKLASLLAVNVSYN 406
N L + ++L+ L + ++ + + + L SL ++++ N
Sbjct: 235 GSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294
Query: 407 RL 408
L
Sbjct: 295 EL 296
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G+G F V + G+ AVK K +S + ED +RE + +HP+++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS-TEDLKREASICHMLKHPHIV 89
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 672
L Y + + +V ++ L ++ +R + S ++ + IL + L +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYC 146
Query: 673 HHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
H + IIH ++KP +LL +++ ++ FG+A L V R + ++A
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTP-HFMA 201
Query: 730 PE-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
PE + + + D++G GV++ L++G P
Sbjct: 202 PEVVKREPY--GKPVDVWGCGVILFILLSGCLP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 82/302 (27%), Positives = 125/302 (41%), Gaps = 45/302 (14%)
Query: 544 SSLDCSIDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRML---AVK--KLVTSDIIQYPE 597
SL C I + L L + ++G+G FG V + + AVK K + +
Sbjct: 9 QSLTCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 598 DFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LS 654
DF REV + H NLI L G TP + +V++ AP GSL +L +
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 655 WTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713
+ + A+G+ +L F IH +L N+LL +I DFGL R L + D
Sbjct: 126 YA------VQVAEGMGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 714 KH-VMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDN 768
H VM + + APE SL+ D + FGV + E+ T G+ P +
Sbjct: 176 DHYVMQEHRKVPFAWCAPE----SLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIG-- 227
Query: 769 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828
+ S+ + + +EG L PED + + + C H P RP+ +
Sbjct: 228 -LNGSQILHKIDKEGERLPR--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278
Query: 829 LQ 830
L
Sbjct: 279 LL 280
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 77/371 (20%), Positives = 133/371 (35%), Gaps = 63/371 (16%)
Query: 508 RRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAA------- 560
+ T E++ + L + + L R+S++ +P
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 561 -----------EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR 604
+G G FG VY+ + +AVK L Q DF E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 605 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---PPLSWTNRFKV 661
++ K H N++ G + ++ + G L++ L E P L+ + V
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 662 ILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLLTRLDKHVM 717
A G +L + F IH ++ N LL +I DFG+AR + R +
Sbjct: 187 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 718 SNRFQSALGYVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILS 773
+ ++ PE + K D + FGVL+ E+ + G P + N
Sbjct: 243 GGCAMLPVKWMPPE----AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSN----- 292
Query: 774 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ--- 830
+ V + G +D P++ PV ++ C H P RP+ A +++ ++
Sbjct: 293 QEVLEFVTSGGRMDP--------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
Query: 831 ----VIKTPLP 837
VI T LP
Sbjct: 345 QDPDVINTALP 355
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 39/308 (12%), Positives = 82/308 (26%), Gaps = 58/308 (18%)
Query: 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREV---RVLGKA 609
L + +G+ + + G V ++ + + EV R+L
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 610 RHPNLISLEGYYWTPQLKLLVSD--------------------------YAPNGSLQAKL 643
++ + + P + + + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 644 HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703
+ L R ++ L + LA LHH ++H L+P +I+LD ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGR 759
R + A + + D + G+ I +
Sbjct: 256 EHLVRDGA-SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 760 RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR 819
P +D + SE + C + V +L+ L R
Sbjct: 315 LP--NTDDAALGGSEWI--------FRSCKNIP------QPVRALLEGFLRYP---KEDR 355
Query: 820 PSMAEVVQ 827
+ ++
Sbjct: 356 LLPLQAME 363
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 36/231 (15%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-------KLVTSDIIQYPEDFEREVRVLGK-ARHP 612
+G GV V + G AVK +L + + E RE +L + A HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTA 666
++I+L Y + LV D G L + L E+ + + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-------SIMRSLL--- 210
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+ ++ LH + I+H +LKP NILLDDN R+SDFG + L + + G
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCGTP-G 264
Query: 727 YVAPE-LTCQSLRV----NEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
Y+APE L C ++ D++ GV++ L+ G P + +++L
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF-WHRRQILML 314
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 43/296 (14%)
Query: 561 EVGEGVFGTVYK---VSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLIS 616
+G+G FG+V + +AVK L E+F RE + + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 617 LEG------YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR--FKVILGTAKG 668
L G + +++ + +G L A L P + + + ++ A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 669 LAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+ +L + IH +L N +L ++ ++DFGL+R + D + + +
Sbjct: 150 MEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 727 YVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLE 781
++A E SL D++ FGV + E++T G+ P Y G +N + L
Sbjct: 205 WLALE----SLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIEN-----AEIYNYLI 253
Query: 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837
GN L P + + V L C P RPS + L+ I L
Sbjct: 254 GGNRLKQ--------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
++G G +G V A+K + TS EV VL HPN++
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN----SKLLEEVAVLKLLDHPNIM 99
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L ++ + LV + G L + + + + +I G+ +LH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELF----DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 676 FRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
I+H +LKP N+LL + + +I DFGL+ + ++ M R +A Y+APE+
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTA-YYIAPEV 209
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
+ +EKCD++ GV++ L+ G P G+ + IL +
Sbjct: 210 LRKK--YDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRK 248
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 38/227 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G+G F V + T G A K KL D + ERE R+ K +HPN++
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF----QKLEREARICRKLQHPNIV 68
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
L LV D G L + E S + + IL + +
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL---ESI 118
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNP---RISDFGLARLLTRLDKHVMSNRFQSALG 726
A+ H + I+H NLKP N+LL +++DFGLA + D + G
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-G 172
Query: 727 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
Y++PE L ++ DI+ GV++ L+ G P + ED +
Sbjct: 173 YLSPEVLKKDPY--SKPVDIWACGVILYILLVGYPPF-WDEDQHRLY 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 59/295 (20%), Positives = 119/295 (40%), Gaps = 37/295 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNL--ISLE 618
+G G V++V + ++ A+K + + + + E+ L K + + I L
Sbjct: 64 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
Y T Q +V + N L + L ++ P + +K +L + + +H
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER-KSYWKNML---EAVHTIHQH--- 174
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL------ 732
I+H +LKP+N L+ D ++ DFG+A + V+ + A+ Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 733 ----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
+++ K D++ G ++ + G+ P + + + L +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------PN 284
Query: 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ--ILQVIKTPLPQRME 841
+ D PE ++ VLK L P R S+ E++ +Q+ P+ Q +
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLK---RDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 47/217 (21%), Positives = 80/217 (36%), Gaps = 22/217 (10%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
+ + VG G FG V+++ G AVKK ++ E+
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLS 108
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKG 668
P ++ L G + + GSL + + LP L + L +G
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL---GQAL---EG 162
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALG- 726
L +LH I+H ++K N+LL + + + DFG A L G
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 727 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ + K DI+ ++L ++ G P
Sbjct: 220 ETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 18/219 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLE 618
+G+G FG V G+ AVK + + Q E REV++L + HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
++ LV + G L + + S S + ++I G+ ++H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELF----DEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 679 PIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
I+H +LKP N+LL + N RI DFGL+ M ++ +A Y+APE+
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTA-YYIAPEVLHG 202
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
+ +EKCD++ GV++ L++G P G + IL +
Sbjct: 203 T--YDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKK 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G+G FG V K + AVK D REV +L K HPN++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT----STILREVELLKKLDHPNIM 84
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
L +V + G L + + E + K + G+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFS---GI 134
Query: 670 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
++H I+H +LKP NILL + + + +I DFGL+ M +R +A
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTA-Y 188
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
Y+APE+ + +EKCD++ GV++ L++G P YG++ IL
Sbjct: 189 YIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKR 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 65/292 (22%), Positives = 128/292 (43%), Gaps = 34/292 (11%)
Query: 547 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVR 604
+ + LL E+G G FG+V + + + + + A+K L E+ RE +
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 605 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 664
++ + +P ++ L G L +LV + A G L L + + +N +++
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 444
Query: 665 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQ 722
+ G+ +L +F +H NL N+LL + + +ISDFGL++ L D + + +
Sbjct: 445 VSMGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 723 SALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 778
L + APE + + + D++ +GV + E ++ G++P Y + + E V
Sbjct: 501 WPLKWYAPE----CINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKK---MKGPE-VMA 550
Query: 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+E+G ++C P + + L C + RP V Q ++
Sbjct: 551 FIEQGKRMEC--------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 53/296 (17%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 606
++ + ++ ++G G +G VY+ + +AVK K T + E+F +E V+
Sbjct: 10 MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 63
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
+ +HPNL+ L G +++++ G+L L E +
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQIS 121
Query: 667 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+ +L +F IH +L N L+ +N+ +++DFGL+RL+T + + +
Sbjct: 122 SAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHA 170
Query: 726 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 774
G + APE SL N+ K D++ FGVL+ E+ T G P Y G D
Sbjct: 171 GAKFPIKWTAPE----SLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDL-----S 219
Query: 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
V LLE+ ++ PE V +L C PS RPS AE+ Q +
Sbjct: 220 QVYELLEKDYRMER--------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 60/311 (19%), Positives = 106/311 (34%), Gaps = 64/311 (20%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK------VSFGTQGRML-AVKKLVTSDIIQYPEDFER 601
I E L + +G+G F ++K +G +K L Y E F
Sbjct: 5 IRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSESFFE 61
Query: 602 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV 661
++ K H +L+ G +LV ++ GSL L + ++ + +V
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEV 118
Query: 662 ILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPR--------ISDFGLARLLTRL 712
A + L ++ IH N+ NILL + + +SD G++ +
Sbjct: 119 AKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 713 DKHVMSNRFQSALGY------VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEY- 764
D V PE +N D + FG + E+ + G +P
Sbjct: 175 D------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LS 220
Query: 765 GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAE 824
D+ + E+ + L P+ + L C + P RPS
Sbjct: 221 ALDS-----QRKLQFYEDRHQLPA--------PKAA--ELANLINNCMDYEPDHRPSFRA 265
Query: 825 VVQILQVIKTP 835
+++ L + TP
Sbjct: 266 IIRDLNSLFTP 276
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 33/226 (14%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARH-PNL 614
E+G G F V + + G+ A K + + E+ VL A+ P +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR----AEILHEIAVLELAKSCPRV 91
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGL 669
I+L Y +L+ +YA G ++ + K IL G+
Sbjct: 92 INLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILE---GV 144
Query: 670 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+LH + I+H +LKP NILL + +I DFG++R + + +
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACELREIMGTP-E 198
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
Y+APE+ + D++ G++ L+T P GEDN
Sbjct: 199 YLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETY 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 608
I E+L LEK ++G G FG V+ ++ + +AVK + + E F E V+
Sbjct: 185 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV--EAFLAEANVMKT 239
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
+H L+ L T + +++++ GSL L S PL F A+G
Sbjct: 240 LQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEG 296
Query: 669 LAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
+A + ++ IH +L+ +NIL+ + +I+DFGLAR++ +++ + + +
Sbjct: 297 MAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKW 351
Query: 728 VAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEE 782
APE ++ K D++ FG+L++E+VT GR P Y G N V LE
Sbjct: 352 TAPE----AINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSN-----PEVIRALER 400
Query: 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
G + PE+ + + + C + P RP+ + +L T
Sbjct: 401 GYRMPR--------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 45/223 (20%), Positives = 83/223 (37%), Gaps = 29/223 (13%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G +G V A KK+ + + F++E+ ++ HPN+I L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 621 YWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
+ LV + G L + E + K +L +A+ H
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVL---SAVAYCHK 124
Query: 675 SFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+ H +LKP N L + ++ DFGLA +M + + YV+P+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTP-YYVSPQ 178
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
+ +CD + GV++ L+ G P + ++ +
Sbjct: 179 VLEGLY--GPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLK 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 28/229 (12%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYP-------EDFEREVRVLGK 608
++G G +G V A+K + E+ E+ +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
HPN+I L + + LV+++ G L E++ + + ++ G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF----EQIINRHKFDECDAANIMKQILSG 158
Query: 669 LAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+ +LH I+H ++KP NILL + N +I DFGL+ + + + +R +A
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTA- 212
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
Y+APE+ + NEKCD++ GV++ L+ G P G+++ I+ +
Sbjct: 213 YYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKK 258
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 55/215 (25%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
PE + + ++GEG +G+VYK G+++A+K++ + ++ +E+ ++ +
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCD 82
Query: 611 HPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
P+++ G Y+ L +V +Y GS+ + R L+ ++ T KGL
Sbjct: 83 SPHVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGL 138
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 726
+LH IH ++K NILL+ + +++DFG+A LT M+ R + +G
Sbjct: 139 EYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT----DTMAKR-NTVIGTPF 190
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ + N DI+ G+ +E+ G+ P
Sbjct: 191 WMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPP 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G+G FG V K + AVK D REV +L K HPN++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT----STILREVELLKKLDHPNIM 84
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L +V + G L + + S + ++I G+ ++H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELF----DEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 676 FRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
I+H +LKP NILL + + + +I DFGL+ M +R +A Y+APE+
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTA-YYIAPEV 194
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
+ +EKCD++ GV++ L++G P YG++ IL
Sbjct: 195 LRGT--YDEKCDVWSAGVILYILLSGTPPF-YGKNEYDIL 231
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 69/307 (22%), Positives = 125/307 (40%), Gaps = 41/307 (13%)
Query: 543 SSSLDCSIDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPED 598
SS+ D I E + L + +GEG FG V++ +S +A+K E
Sbjct: 5 SSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 62
Query: 599 FEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR 658
F +E + + HP+++ L G T ++ + G L++ L R S L +
Sbjct: 63 FLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASL 118
Query: 659 FKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717
+ LA+L F +H ++ N+L+ N ++ DFGL+R + +
Sbjct: 119 ILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYK 173
Query: 718 SNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVIL 772
+++ + + ++APE S+ D++ FGV + E++ G +P + G N
Sbjct: 174 ASKGKLPIKWMAPE----SINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKN---- 223
Query: 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL-QV 831
V +E G L P + + L C + PS RP E+ L +
Sbjct: 224 -NDVIGRIENGERLPM--------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
Query: 832 IKTPLPQ 838
++ Q
Sbjct: 275 LEEEKAQ 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 606
IDP L + E+G G FG V+ + + + +A+K + EDF E V+
Sbjct: 5 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMS----EEDFIEEAEVM 57
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
K HP L+ L G LV+++ +G L L + + + L
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVC 114
Query: 667 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+G+A+L IH +L N L+ +N ++SDFG+ R V+ +++ S+
Sbjct: 115 EGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSST 163
Query: 726 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 774
G + +PE + K D++ FGVL+ E+ + G+ P Y N
Sbjct: 164 GTKFPVKWASPE----VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSN-----S 212
Query: 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ-VIK 833
V + G L P V ++ C P RP+ + +++ L + +
Sbjct: 213 EVVEDISTGFRLYK--------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
Query: 834 TPL 836
+ L
Sbjct: 265 SGL 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 63/297 (21%), Positives = 122/297 (41%), Gaps = 44/297 (14%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV 605
I E + L + +GEG FG VY+ + + +AVK + E F E +
Sbjct: 9 IAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI 66
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVIL 663
+ HP+++ L G + ++ + P G L L ++ L L
Sbjct: 67 MKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSL 120
Query: 664 GTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722
K +A+L + +H ++ NIL+ ++ DFGL+R + + + ++ +
Sbjct: 121 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTR 175
Query: 723 SALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVR 777
+ +++PE S+ D++ F V + E+++ G++P + +N + V
Sbjct: 176 LPIKWMSPE----SINFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLEN-----KDVI 224
Query: 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
+LE+G+ L P+ + L C + PS RP E+V L +
Sbjct: 225 GVLEKGDRLPK--------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 39/233 (16%)
Query: 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPN 613
VG G G VY+ + R++A+K + D +RE R G+ + P+
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 614 LISL------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
++ + +G + + L A L + P PP + ++
Sbjct: 96 VVPIHDFGEIDGQLY------VDMRLINGVDLAAMLRRQGPLAPPRA----VAIVRQIGS 145
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 726
L H H ++KP NIL+ + + DFG+A T D+ + + +G
Sbjct: 146 ALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQL--GNTVGT 198
Query: 727 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
Y+APE + DIY ++ E +TG P Y D + ++ H+
Sbjct: 199 LYYMAPER-FSESHATYRADIYALTCVLYECLTGSPP--YQGDQLSVMGAHIN 248
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 39/292 (13%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRV 605
I+ + +EK +G G G V G+ +A+K L + DF E +
Sbjct: 46 IEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+G+ HPN+I LEG +L ++V++Y NGSL L + ++ G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGV 160
Query: 666 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQS 723
G+ +L + +H +L N+L+D N ++SDFGL+R+L D + +
Sbjct: 161 GAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 724 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRV 778
+ + APE ++ D++ FGV++ E++ G RP Y N V
Sbjct: 217 PIRWTAPE----AIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTN-----RDVIS 265
Query: 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+EEG L P + +L L C + RP +++V +L
Sbjct: 266 SVEEGYRLPA--------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 58/265 (21%), Positives = 95/265 (35%), Gaps = 25/265 (9%)
Query: 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 139
+ + + S +PQG+ + L L N HL L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 140 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 198
+ L S+ + + +N LT +S L L NN + S+PS F
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170
Query: 199 KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
L + L I EG F+ L+ ++L +P + L
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVG-------LEE 222
Query: 257 LDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNAL 312
L++S N+ +I G F +L+ L + ++ + I SL+ L+L +N L
Sbjct: 223 LEMSGNHFP-EIRP--GSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNL 278
Query: 313 YGSIPQEVCES-RSLGILQLDGNSL 336
S+P ++ R L L L N
Sbjct: 279 -SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-22
Identities = 60/289 (20%), Positives = 99/289 (34%), Gaps = 51/289 (17%)
Query: 127 PHLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
+ + + + +P + R LN + N + ++ LE L
Sbjct: 54 NQFSKVVCTRRGLSEVPQGIPSNTRYLN------LMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 184 NNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPP 240
N + + F L+ + L N L IP G F+ L E+ L N SIP
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPS 164
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPELGY 298
+ + S L LDL + I GL NL+YLNL +++ +
Sbjct: 165 YAFNRVPS-----LMRLDLGELKKLEYISEGAFEGL-FNLKYLNLGMCNIKD-----MPN 213
Query: 299 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
L L L++ GN P +SL L + ++
Sbjct: 214 LTPL---------------------VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 359 HLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYN 406
+S + L L L L N LS +P + L L+ +++ +N
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 62/269 (23%), Positives = 99/269 (36%), Gaps = 26/269 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ + LS VP + N RYL+L N +Q F + L L L N
Sbjct: 55 QFSKVVCTRRGLSE-VPQGIPSN---TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 121
A L L TL+L N + IP G L L+EL L+ N +P+
Sbjct: 111 IRQIEVGA----FNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPS 164
Query: 122 DI-GFCPHLTTLDLSNNLFTGQLPV-SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
P L LDL + + L ++ ++++ + D+P+ + LE
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGLEE 222
Query: 180 LDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMG 236
L+ S NH + F L + + + ++ I FD L E++L+ N +
Sbjct: 223 LEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHN-NLS 279
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLV 265
S+P + L L L N
Sbjct: 280 SLPHDLFTPLRY-----LVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 51/216 (23%), Positives = 82/216 (37%), Gaps = 23/216 (10%)
Query: 200 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 259
+ S + L+ +P+G+ ++L EN I + L +L L
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPS-NTRYLNLMENNIQ-MIQADTFRHLHH-----LEVLQL 106
Query: 260 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGS 315
N++ I G F +L L L N L IP Y L L LRNN + S
Sbjct: 107 GRNSI-RQIEV--GAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPI-ES 161
Query: 316 IPQEVCES-RSLGILQL-DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 373
IP SL L L + L +L L+L ++ +P +++ L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVG 219
Query: 374 LKILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRL 408
L+ L++ N EI L+SL + V +++
Sbjct: 220 LEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 9/116 (7%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ N+K+L+L + +P L L ++GN F+ SSL L + N
Sbjct: 195 LFNLKYLNLGMCNIKD-MPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQF 115
+ + L L L+L+HN S S+P + L YL EL L N +
Sbjct: 252 SQ----VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 72/370 (19%), Positives = 138/370 (37%), Gaps = 46/370 (12%)
Query: 482 SAIVAIIAAILIAGGVLVISLLNVST----RRRLTFVETTLESMCSSSSRSVNLAAGKVI 537
S +A A LI G +++ S ++ ++ + ++ + V V
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 538 LFDSRSSSLDCSIDPETLLEKAAEV-----------GEGVFGTVYK---VSFGTQGRMLA 583
D + +D + E+ GEG FG V++ +S +A
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 584 VKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL 643
+K E F +E + + HP+++ L G + ++ + G L++ L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL 481
Query: 644 HERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISD 702
R L + + LA+L F +H ++ N+L+ N ++ D
Sbjct: 482 QVR---KFSLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGD 534
Query: 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 761
FGL+R + + +++ + + ++APE + R D++ FGV + E++ G +P
Sbjct: 535 FGLSRYMED-STYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP 592
Query: 762 VEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 820
+ G N V +E G L P + + L C + PS RP
Sbjct: 593 --FQGVKN-----NDVIGRIENGERLPM--------PPNCPPTLYSLMTKCWAYDPSRRP 637
Query: 821 SMAEVVQILQ 830
E+ L
Sbjct: 638 RFTELKAQLS 647
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G F V+ V G++ A+K + S + E E+ VL K +H N+++LE
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLEDI 74
Query: 621 YWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
Y + LV G L + E+ S + +L + +LH
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLS---AVKYLHE 124
Query: 675 SFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+ I+H +LKP N+L ++N I+DFGL+++ +MS + GYVAPE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTP-GYVAPE 177
Query: 732 -LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
L + ++ D + GV+ L+ G P Y E + +
Sbjct: 178 VLAQKPY--SKAVDCWSIGVITYILLCGYPPF-YEETESKLFEK 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 49/295 (16%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
++ + L L + +G+G FG V G +G +AVK + + F E V+
Sbjct: 18 LNMKELKLLQ--TIGKGEFGDVML---GDYRGNKVAVKCIKNDAT---AQAFLAEASVMT 69
Query: 608 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+ RH NL+ L G L +V++Y GSL L R S +F L
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDV 126
Query: 666 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724
+ + +L ++F +H +L N+L+ ++ ++SDFGL + + + +
Sbjct: 127 CEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 177
Query: 725 LGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVL 779
+ + APE +LR + K D++ FG+L+ E+ + GR P Y + V
Sbjct: 178 VKWTAPE----ALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPL-----KDVVPR 226
Query: 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
+E+G +D P+ V ++ C + RPS ++ + L+ IKT
Sbjct: 227 VEKGYKMDA--------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 58/316 (18%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 603
I + L++ E+GEG FG V+ +S ++AVK L + +DF+RE
Sbjct: 12 IKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREA 68
Query: 604 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------P 651
+L +H +++ G ++V +Y +G L L P
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 652 PLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710
L + + A G+ +L F +H +L N L+ N +I DFG++R +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 711 RLDKHVMSNRFQSALGYV-----APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRP 761
D + + + PE S+ + D++ FGV++ E+ T G++P
Sbjct: 185 STDYYRVGGH-----TMLPIRWMPPE----SIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 762 VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS 821
+ N V + +G VL+ P V + L C P R +
Sbjct: 236 W-FQLSN-----TEVIECITQGRVLER--------PRVCPKEVYDVMLGCWQREPQQRLN 281
Query: 822 MAEVVQILQVIKTPLP 837
+ E+ +IL + P
Sbjct: 282 IKEIYKILHALGKATP 297
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK---KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
E+G G FG V++V+ G A K SD E +E++ + RHP L++L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVLRHPTLVNL 219
Query: 618 EGYYWTPQLKLLVSDYAPNGSL-------QAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
+ +++ ++ G L K+ E + + KGL
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-------EAVEYMRQVC---KGLC 269
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYV 728
H+H + +H +LKP NI+ + + DFGL L K + +A +
Sbjct: 270 HMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTA-EFA 323
Query: 729 APE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
APE + V D++ GVL L++G P GE++ L
Sbjct: 324 APEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLR 366
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGY 620
G+G F VY+ G +A+K + + + + + EV++ + +HP+++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAHLHH 674
+ LV + NG + L R F + G+ +LH
Sbjct: 80 FEDSNYVYLVLEMCHNGEMNRYLKNR---------VKPFSENEARHFMHQIITGMLYLH- 129
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 731
S I+H +L SN+LL N N +I+DFGLA L + + G Y++PE
Sbjct: 130 SHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-----EKHYTLCGTPNYISPE 182
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ +S + D++ G + L+ GR P
Sbjct: 183 IATRSAH-GLESDVWSLGCMFYTLLIGRPP 211
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 43/216 (19%), Positives = 87/216 (40%), Gaps = 17/216 (7%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
++G G FG V++ + + K + Q ++E+ +L ARH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNILHLHES 69
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ + + +++ ++ + +++ + + + L LH I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFLHSH---NI 123
Query: 681 IHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-LTCQSL 737
H++++P NI+ + +I +FG AR L F + Y APE
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAP-EYYAPEVHQHDV- 179
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
V+ D++ G L+ L++G P E N I+
Sbjct: 180 -VSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIE 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DPE L K ++G+G FG V+K +++A+K + + ED ++E+ VL +
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 611 HPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
P + G Y +L ++ +Y GS L ++ ++ KGL
Sbjct: 79 SPYVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGL 132
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 726
+LH IH ++K +N+LL ++ +++DFG+A LT R + +G
Sbjct: 133 DYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKR-NTFVGTPF 184
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ QS + K DI+ G+ +EL G P
Sbjct: 185 WMAPEVIKQS-AYDSKADIWSLGITAIELARGEPP 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 41/234 (17%), Positives = 85/234 (36%), Gaps = 36/234 (15%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK-ARHPNL 614
+ ++G G FG+V+K G + A+K+ ++ REV +H ++
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 615 ISLEGYY--WTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
+ Y+ W + + ++Y GSL + E ++L +GL +
Sbjct: 74 VR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNP-------------------RISDFGLARLLTRL 712
+H ++H ++KPSNI + P +I D G ++
Sbjct: 131 IHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 766
+R ++A E+ ++ K DI+ + ++ G+
Sbjct: 188 QVEEGDSR------FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 14/215 (6%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
E+G G FG V++ GR+ K + T + + E+ ++ + HP LI+L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDA 116
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ +L+ ++ G L ++ N + GL H+H I
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH---SI 170
Query: 681 IHYNLKPSNILL--DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+H ++KP NI+ + +I DFGLA L ++ +A + APE+ +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATA-EFAAPEIVDRE-P 226
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
V D++ GVL L++G P GED++ L
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQ 260
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 70/295 (23%), Positives = 128/295 (43%), Gaps = 49/295 (16%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
++ + L L + +G+G FG V G +G +AVK + + F E V+
Sbjct: 190 LNMKELKLLQ--TIGKGEFGDVML---GDYRGNKVAVKCIKNDAT---AQAFLAEASVMT 241
Query: 608 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+ RH NL+ L G L +V++Y GSL L R S +F L
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDV 298
Query: 666 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724
+ + +L ++F +H +L N+L+ ++ ++SDFGL + + + +
Sbjct: 299 CEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--P 349
Query: 725 LGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVL 779
+ + APE +LR + K D++ FG+L+ E+ + GR P Y + V
Sbjct: 350 VKWTAPE----ALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPL-----KDVVPR 398
Query: 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
+E+G +D P+ V + C ++RP+ ++ + L+ I+T
Sbjct: 399 VEKGYKMDA--------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 74/310 (23%), Positives = 122/310 (39%), Gaps = 59/310 (19%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 603
I + + E+GE FG VYK + G Q + +A+K L E+F E
Sbjct: 6 ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 604 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------P 651
+ + +HPN++ L G Q ++ Y +G L L R P +
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 652 PLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710
L + ++ A G+ +L H +H +L N+L+ D N +ISD GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 711 RLDKHVMSNRFQSALGYV-----APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRP 761
D + + + APE ++ DI+ +GV++ E+ + G +P
Sbjct: 180 AADYYKLLGN-----SLLPIRWMAPE----AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 762 VEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 820
Y G N + V ++ VL C P+D V L + C PS RP
Sbjct: 231 --YCGYSN-----QDVVEMIRNRQVLPC--------PDDCPAWVYALMIECWNEFPSRRP 275
Query: 821 SMAEVVQILQ 830
++ L+
Sbjct: 276 RFKDIHSRLR 285
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 26/227 (11%)
Query: 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPN 613
++G G TVY +A+K + E FEREV + H N
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFI----PPREKEETLKRFEREVHNSSQLSHQN 72
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
++S+ LV +Y +L + PLS G+ H H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH 128
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAP 730
I+H ++KP NIL+D N +I DFG+A+ L+ + + LG Y +P
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQT--NHVLGTVQYFSP 181
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
E + +E DIY G+++ E++ G P GE V I +H++
Sbjct: 182 EQA-KGEATDECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAIKHIQ 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 39/226 (17%)
Query: 549 SIDPETLLEK---AAEVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQY--PED 598
S+ P+ L ++ + +G G G V + +A+K K + +
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 599 FEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPP 652
E E+ +L K HP +I ++ ++ +V + G L +L E
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK--- 117
Query: 653 LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLL 709
F +L + +LH + IIH +LKP N+LL +++ +I+DFG +++L
Sbjct: 118 ----LYFYQMLL---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRV--NEKCDIYGFGVLIL 753
+ +M + Y+APE+ N D + GV IL
Sbjct: 168 G--ETSLMRTLCGTP-TYLAPEVLVSVGTAGYNRAVDCWSLGV-IL 209
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G+G +G VY + +A+K+ + +Y + E+ + +H N++ G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 622 WTPQLKLLVSDYAPNGSLQAKL---HERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSF 676
+ + P GSL A L L +T K IL +GL +LH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT---KQIL---EGLKYLHDN- 141
Query: 677 RPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
I+H ++K N+L++ + +ISDFG ++ L ++ + F L Y+APE+ +
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 736 SLR-VNEKCDIYGFGVLILELVTGRRP 761
R + DI+ G I+E+ TG+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREV-------RVLGKARHPNL 614
+GEG F TV R A+K L II+ E +V V+ + HP
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTRERDVMSRLDHPFF 92
Query: 615 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKL-HERLPSTPPLSWTNRF---KVILGTAKGL 669
+ L + + KL YA NG L + RF +++ L
Sbjct: 93 VKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSA----L 143
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 726
+LH IIH +LKP NILL+++ + +I+DFG A++L+ K +N F +G
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF---VGTAQ 197
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
YV+PEL + D++ G +I +LV G P
Sbjct: 198 YVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 33/289 (11%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRV 605
+D + ++K VG G FG V + +A+K L + DF E +
Sbjct: 42 LDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+G+ HPN+I LEG + ++V++Y NGSL + L + + ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGI 156
Query: 666 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQS 723
A G+ +L + +H +L NIL++ N ++SDFGL R+L + + +
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 724 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLE 781
+ + +PE + D++ +G+++ E+++ G RP Y N + V ++
Sbjct: 213 PIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSN-----QDVIKAVD 264
Query: 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
EG L P D + +L L C ++RP ++V IL
Sbjct: 265 EGYRLPP--------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 37/229 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G+G F V + G+ A KL D + ERE R+ +HPN++
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH----QKLEREARICRLLKHPNIV 73
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
L L+ D G L + E S + + IL +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILE---AV 123
Query: 670 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
H H ++H NLKP N+LL +++DFGLA + ++ + G
Sbjct: 124 LHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTP-G 178
Query: 727 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
Y++PE L + D++ GV++ L+ G P + ED + +
Sbjct: 179 YLSPEVLRKDPY--GKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQ 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 38/229 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
E+G+G F V + T G A K KL D + ERE R+ K +HPN++
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF----QKLEREARICRKLQHPNIV 91
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
L LV D G L + E S + + IL + +
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL---ESI 141
Query: 670 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
A+ H + I+H NLKP N+LL +++DFGLA + D + G
Sbjct: 142 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-G 195
Query: 727 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
Y++PE L ++ DI+ GV++ L+ G P + ED + ++
Sbjct: 196 YLSPEVLKKDPY--SKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQ 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 69/305 (22%), Positives = 119/305 (39%), Gaps = 48/305 (15%)
Query: 561 EVGEGVFGTVYK-----VSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNL 614
E+GEG FG V+ + ++AVK L S+ +DF+RE +L +H ++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQHI 105
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST-----------PPLSWTNRFKVIL 663
+ G + L+V +Y +G L L P PL V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 664 GTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722
A G+ +L F +H +L N L+ +I DFG++R + D + + R
Sbjct: 166 QVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 723 SALGYVAPELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVR 777
+ ++ PE S+ + D++ FGV++ E+ T G++P + N
Sbjct: 222 LPIRWMPPE----SILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSN-----TEAI 270
Query: 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837
+ +G L+ P V + C P R S+ +V LQ + P
Sbjct: 271 DCITQGRELER--------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322
Query: 838 QRMEV 842
++V
Sbjct: 323 VYLDV 327
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 55/255 (21%), Positives = 107/255 (41%), Gaps = 39/255 (15%)
Query: 528 SVNLAAGKVILFDSRSSSLDCSIDPETLLEK---AAEVGEGVFGTVYKVSFGTQGRMLAV 584
+++L+ KV +F + D S+ P+ L ++ + +G G G V + +A+
Sbjct: 107 ALSLSRNKVFVFFDLTVD-DQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165
Query: 585 K-----KLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637
+ K + + E E+ +L K HP +I ++ ++ +V + G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG 224
Query: 638 SL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 691
L +L E F +L + +LH + IIH +LKP N+L
Sbjct: 225 ELFDKVVGNKRLKEATCK-------LYFYQML---LAVQYLHEN---GIIHRDLKPENVL 271
Query: 692 L---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV--NEKCDIY 746
L +++ +I+DFG +++L + +M + Y+APE+ N D +
Sbjct: 272 LSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP-TYLAPEVLVSVGTAGYNRAVDCW 328
Query: 747 GFGVLILELVTGRRP 761
GV++ ++G P
Sbjct: 329 SLGVILFICLSGYPP 343
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 48/350 (13%), Positives = 93/350 (26%), Gaps = 70/350 (20%)
Query: 466 HSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSS 525
H H SS +++F V V+ + T E + S
Sbjct: 3 HHHHHSSGRENLYFQGPGDV-----------VIEELFNRIPQANVRTTSEYMQSAADSLV 51
Query: 526 SRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK 585
S S+ G+ +S L + +G+ + + G V
Sbjct: 52 STSL-WNTGQPFRVESELGE------RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 104
Query: 586 ---------------------------KLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+ + F ++ + +I +
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 619 GYYWTPQLKLLVSDY----APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
+ Y + + L + L R ++ L + LA LHH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
++H L+P +I+LD ++ F + G+ PEL
Sbjct: 225 Y---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVSRGFEPPELEA 275
Query: 735 QS----------LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 774
+ + D + G++I + P +D + SE
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--ITKDAALGGSE 323
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 23/232 (9%)
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPP 240
L ++P + I L GN ++ ++P F L + L N I
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDA 73
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-L 296
+ + + L LDLS N + + F L L+L L+ + P
Sbjct: 74 AAFTGLAL-----LEQLDLSDNAQLRSVDP--ATFHGLGRLHTLHLDRCGLQE-LGPGLF 125
Query: 297 GYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 355
+L +L L++NAL ++P + +L L L GN ++ + R SL L L
Sbjct: 126 RGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 356 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYN 406
N ++ P + +L +L L L N LS +P E L L +L + ++ N
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 56/235 (23%), Positives = 86/235 (36%), Gaps = 37/235 (15%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ + L N +S VP F C +L L L N+L F + L L+LS+N
Sbjct: 33 ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 121
+D A+ L RL TL L + G+ L L+ L LQ N LP
Sbjct: 92 QLRSVDPAT---FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPD 146
Query: 122 DI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
D +LT L L N + SV G + +L+ L
Sbjct: 147 DTFRDLGNLTHLFLHGNRIS----------------SVPERAFRG--------LHSLDRL 182
Query: 181 DFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSEN 232
N + + F + +L + L N+L+ +P L+ + L++N
Sbjct: 183 LLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 58/268 (21%), Positives = 96/268 (35%), Gaps = 47/268 (17%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+ T ++P G+ A + + L GN+ S A C +LT L L +
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 196
N+ + TG ++ LE LD S+N S+ + F
Sbjct: 66 NVLA----------------RIDAAAFTG--------LALLEQLDLSDNAQLRSVDPATF 101
Query: 197 -NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 253
+L + L L + GLF L+ + L +N + ++P + +
Sbjct: 102 HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGN----- 154
Query: 254 LRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRN 309
L L L N + +P F +L L L N + + P L+ L L
Sbjct: 155 LTHLFLHGNRIS-SVPE--RAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 310 NALYGSIPQEVCES-RSLGILQLDGNSL 336
N L ++P E R+L L+L+ N
Sbjct: 211 NNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 54/262 (20%), Positives = 84/262 (32%), Gaps = 49/262 (18%)
Query: 10 SNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDF 69
L + VP + A+ + + L GN + F C +L L L +N +
Sbjct: 20 QQGLQA--VPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA----R 70
Query: 70 ASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--C 126
L L LDLS N S+ L L L L L + F
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGL-FRGL 128
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186
L L L +N +L+ L F + N L L N
Sbjct: 129 AALQYLYLQDN--------ALQALPDDTFRDLGN----------------LTHLFLHGNR 164
Query: 187 LTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSS 243
++ S+P F L + L N + ++ F L + L N ++P +
Sbjct: 165 IS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEAL 221
Query: 244 SSSSSTLFQTLRILDLSSNNLV 265
+ + L+ L L+ N V
Sbjct: 222 APLRA-----LQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 50/249 (20%), Positives = 84/249 (33%), Gaps = 52/249 (20%)
Query: 51 SSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKE 107
++ + L N S F + + L L L N+ + I L L++
Sbjct: 32 AASQRIFLHGNRISHVPAASF------RACRNLTILWLHSNVLA-RIDAAAFTGLALLEQ 84
Query: 108 LLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 166
L L N + L TL L + G
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ----------------ELGPGLFRG- 127
Query: 167 IPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LG 223
++ L++L +N L +LP F + L+ + L GN ++ ++PE F
Sbjct: 128 -------LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS 178
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRY 280
L+ + L +N + + P + L L L +NNL +P A L+Y
Sbjct: 179 LDRLLLHQNR-VAHVHPHAFRDLGR-----LMTLYLFANNLS-ALPT--EALAPLRALQY 229
Query: 281 LNLSSNHLR 289
L L+ N
Sbjct: 230 LRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 32/116 (27%), Positives = 50/116 (43%), Gaps = 7/116 (6%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ +++L L +N L +P F + +L +L L GN + + F SL+ L L
Sbjct: 128 LAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQF 115
N + + L RL TL L N S ++P A L L+ L L N +
Sbjct: 187 NR----VAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 59/301 (19%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGT-QGRML-AVK--KLVTSDIIQYPEDFEREVR 604
+ E + L K E+G G FG V G +G+ AVK K + ++F +E +
Sbjct: 5 LKREEITLLK--ELGSGQFGVVKL---GKWKGQYDVAVKMIKEGSMS----EDEFFQEAQ 55
Query: 605 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 664
+ K HP L+ G +V++Y NG L L L + ++
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYD 112
Query: 665 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
+G+A L H F IH +L N L+D + ++SDFG+ R V+ +++ S
Sbjct: 113 VCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVS 161
Query: 724 ALG------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVIL 772
++G + APE + K D++ FG+L+ E+ + G+ P Y N
Sbjct: 162 SVGTKFPVKWSAPE----VFHYFKYSSKSDVWAFGILMWEVFSLGKMP--YDLYTN---- 211
Query: 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
V + + +G+ L P + ++ C +P RP+ +++ ++ +
Sbjct: 212 -SEVVLKVSQGHRLYR--------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
Query: 833 K 833
+
Sbjct: 263 R 263
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 24/207 (11%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
G+G F +++S + A K L+ E E+ + H +++
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR---EKMSMEISIHRSLAHQHVVGF 80
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
G++ +V + SL R T P + + G +LH R
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQYLH---R 133
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTC 734
+IH +LK N+ L+++ +I DFGLA + R + G Y+APE+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLCGTPNYIAPEVLS 188
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + + D++ G ++ L+ G+ P
Sbjct: 189 KKGH-SFEVDVWSIGCIMYTLLVGKPP 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 540 DSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKK--LVTSDIIQYPE 597
+ +DP + E E+G+G FG VYK G + A K + + + E
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---E 61
Query: 598 DFEREVRVLGKARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656
D+ E+ +L HP ++ L G YY +L ++ ++ P G++ A + E L+
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKL-WIMIEFCPGGAVDAIMLEL---DRGLTEP 117
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
V + L LH IIH +LK N+L+ + R++DFG++
Sbjct: 118 QIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL----KT 170
Query: 717 MSNRFQSALG---YVAPEL-TCQSLRV---NEKCDIYGFGVLILELVTGRRP 761
+ R S +G ++APE+ C++++ + K DI+ G+ ++E+ P
Sbjct: 171 LQKR-DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 24/207 (11%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
G+G F +++S + A K L+ E E+ + H +++
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR---EKMSMEISIHRSLAHQHVVGF 106
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
G++ +V + SL R T P + + G +LH R
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQYLH---R 159
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTC 734
+IH +LK N+ L+++ +I DFGLA + R + G Y+APE+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLCGTPNYIAPEVLS 214
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + + D++ G ++ L+ G+ P
Sbjct: 215 KKGH-SFEVDVWSIGCIMYTLLVGKPP 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+ K +G G FG V+K G LA K + T + E+ + E+ V+ + H NLI
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLI 149
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L + + +LV +Y G L ++ + + L K I G+ H+H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQM 206
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
I+H +LKP NIL + +I DFGLAR + + F + ++APE+
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKLKVNFGTP-EFLAPEVV 260
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773
V+ D++ GV+ L++G P G+++ L+
Sbjct: 261 NYD-FVSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLN 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 16/273 (5%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
+ EK +E+G G G V+KVS G ++A K + RE++VL +
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQA--KLHERLPSTPPLSWTNRFKVILGTAKG 668
P ++ G +++ + ++ GSL K R+P L KV + KG
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG-----KVSIAVIKG 143
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
L +L + I+H ++KPSNIL++ ++ DFG++ L M+N F Y+
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 197
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP-VEYGEDNVVILSEHVRVLLEEGNVLD 787
+PE Q + + DI+ G+ ++E+ GR P + ++
Sbjct: 198 SPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 820
P +I + P
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 28/231 (12%)
Query: 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPN 613
+G G V+ R +AVK L D F RE + HP
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLARDPSFYLRFRREAQNAAALNHPA 73
Query: 614 LISL----EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
++++ E L +V +Y +L+ +H P++ +VI + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQAL 129
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 726
H + IIH ++KP+NI++ ++ DFG+AR + V + +G
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQ 184
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
Y++PE + V+ + D+Y G ++ E++TG P G+ V + +HVR
Sbjct: 185 YLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVR 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 608
DP LL+ ++GEG G V GR +AVK + D+ + E EV ++
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRD 98
Query: 609 ARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+H N++ + Y +L ++ ++ G+L + + L+ V +
Sbjct: 99 YQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQ 152
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 726
LA+LH +IH ++K +ILL + ++SDFG ++ + R +S +G
Sbjct: 153 ALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS----KDVPKR-KSLVGT 204
Query: 727 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ +S + DI+ G++++E+V G P
Sbjct: 205 PYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 55/296 (18%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 606
+ ETL L + +G G FG V+ + + +AVK K + P+ F E ++
Sbjct: 10 VPRETLKLVE--RLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS----PDAFLAEANLM 62
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
+ +H L+ L T + ++++Y NGSL L ++ A
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM--AAQIA 119
Query: 667 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+G+A + ++ IH +L+ +NIL+ D + +I+DFGLARL + N + +
Sbjct: 120 EGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTARE 168
Query: 726 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 774
G + APE ++ K D++ FG+L+ E+VT GR P Y G N
Sbjct: 169 GAKFPIKWTAPE----AINYGTFTIKSDVWSFGILLTEIVTHGRIP--YPGMTN-----P 217
Query: 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
V LE G + P++ + +L +C P RP+ + +L+
Sbjct: 218 EVIQNLERGYRMVR--------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 29/238 (12%)
Query: 540 DSRSSSLDCSIDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL----VTSDII 593
SS+L SI+ + L E +G G V + +A+K++ + +
Sbjct: 2 SEDSSALPWSINRDDYELQEV---IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM- 57
Query: 594 QYPEDFEREVRVLGKARHPNLISLEGYY--WTPQLKL-LVSDYAPNGSLQAKLHERLPST 650
++ +E++ + + HPN++S YY + + +L LV GS+ + +
Sbjct: 58 ---DELLKEIQAMSQCHHPNIVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG 111
Query: 651 PPLSWTNRFKVI----LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706
S I +GL +LH + IH ++K NILL ++ + +I+DFG++
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168
Query: 707 RLLTRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
L + ++ +G ++APE+ Q + K DI+ FG+ +EL TG P
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 55/296 (18%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 606
IDP+ L K E+G G FG V + Q +A+K K + ++F E +V+
Sbjct: 21 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS----EDEFIEEAKVM 73
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
H L+ L G + ++++Y NG L L E ++
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVC 130
Query: 667 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+ + +L F +H +L N L++D ++SDFGL+R V+ + + S++
Sbjct: 131 EAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSV 179
Query: 726 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 774
G + PE L ++ K DI+ FGVL+ E+ + G+ P Y N
Sbjct: 180 GSKFPVRWSPPE----VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTN-----S 228
Query: 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ +G L P V + C RP+ ++ +
Sbjct: 229 ETAEHIAQGLRLYR--------PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 75/293 (25%), Positives = 133/293 (45%), Gaps = 40/293 (13%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR 604
I P + +K +G G FG VYK S G + +A+K L + DF E
Sbjct: 41 IHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 605 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 664
++G+ H N+I LEG + +++++Y NG+L L E+ S ++ G
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRG 155
Query: 665 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQ 722
A G+ +L + ++ +H +L NIL++ N ++SDFGL+R+L + ++ +
Sbjct: 156 IAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 723 SALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVR 777
+ + APE ++ + D++ FG+++ E++T G RP Y N V
Sbjct: 212 IPIRWTAPE----AISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSN-----HEVM 260
Query: 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ +G L P D + +L + C + RP A++V IL
Sbjct: 261 KAINDGFRLPT--------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 608
DP+ + ++G+G GTVY G+ +A++++ ++ Q P E E+ V+ +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 609 ARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
++PN+++ Y +L +V +Y GSL + E + V +
Sbjct: 74 NKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQ 127
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 726
L LH + +IH ++K NILL + + +++DFG +T S R + +G
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKR-STMVGT 179
Query: 727 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
++APE+ + K DI+ G++ +E++ G P
Sbjct: 180 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 1e-21
Identities = 45/237 (18%), Positives = 89/237 (37%), Gaps = 22/237 (9%)
Query: 538 LFDSRSSSLDCSIDPETLLEKAAEVGEGV--FGTVYKVSFGTQGRMLAVKKL-VTSDIIQ 594
+ + + + E +G+G TV + G + V+++ + + +
Sbjct: 9 MENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE 68
Query: 595 YPEDFEREVRVLGKARHPNLISLEGYY--WTPQLKL-LVSDYAPNGSLQAKLHERLPSTP 651
+ E+ V HPN++ Y + +L +V+ + GS + +
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVP---YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 652 PLSWTNRFKVIL-GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710
IL G K L ++HH +H ++K S+IL+ + +S +
Sbjct: 126 NELAI---AYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 711 -----RLDKHVMSNRFQSALGYVAPELTCQSLR-VNEKCDIYGFGVLILELVTGRRP 761
+ H L +++PE+ Q+L+ + K DIY G+ EL G P
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 545 SLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREV 603
L DP + E VG G +G VYK G++ A+K + VT D E+ ++E+
Sbjct: 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEI 71
Query: 604 RVLGKA-RHPNLISLEGYY-----WTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWT 656
+L K H N+ + G + +L LV ++ GS+ + +T W
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131
Query: 657 NRFKVIL-GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715
I +GL+HLH +IH ++K N+LL +N ++ DFG++ L R
Sbjct: 132 ---AYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR---- 181
Query: 716 VMSNRFQSALG---YVAPE-LTCQSLRV---NEKCDIYGFGVLILELVTGRRP 761
R + +G ++APE + C + K D++ G+ +E+ G P
Sbjct: 182 -TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 33/219 (15%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEG 619
+GEG F K + AVK + + ++E+ L HPN++ L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRME----ANTQKEITALKLCEGHPNIVKLHE 73
Query: 620 YYWTPQLKLLVSDYAPNGSL----QAKLH--ERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
+ LV + G L + K H E S ++ ++H+H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSAVSHMH 123
Query: 674 HSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
++H +LKP N+L +DN +I DFG ARL D + + Y AP
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTL-HYAAP 178
Query: 731 E-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 768
E L +E CD++ GV++ +++G+ P D
Sbjct: 179 ELLNQNGY--DESCDLWSLGVILYTMLSGQVPF-QSHDR 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 77/304 (25%), Positives = 120/304 (39%), Gaps = 52/304 (17%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK--VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 606
+D + + +GEG FG V K + A+K++ DF E+ VL
Sbjct: 22 LDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 79
Query: 607 GK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPL 653
K HPN+I+L G L +YAP+G+L L + L
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 654 SWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712
S A+G+ +L F IH +L NIL+ +NY +I+DFGL+R
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR----- 190
Query: 713 DKHVMSNRFQSAL--GYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGE 766
+ V + L ++A E SL + D++ +GVL+ E+V+ G P Y
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIE----SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCG 244
Query: 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 826
+ + L +G L+ P + V L C P RPS A+++
Sbjct: 245 ----MTCAELYEKLPQGYRLEK--------PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292
Query: 827 QILQ 830
L
Sbjct: 293 VSLN 296
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 28/231 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
+G+G FG V G+M A KKL I + + E ++L K ++SL
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 675
Y T LV G L+ ++ + P + F ++ G L LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-VFYAAEICCG----LEDLHRE 305
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL----GYVAPE 731
I++ +LKP NILLDD+ + RISD GLA HV + GY+APE
Sbjct: 306 R---IVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYMAPE 355
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782
+ ++ R D + G L+ E++ G+ P + E R++ E
Sbjct: 356 V-VKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEV 404
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 64/288 (22%), Positives = 100/288 (34%), Gaps = 49/288 (17%)
Query: 127 PHLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
+ + + + RLLN + N + + ++ LE L S
Sbjct: 43 NQFSKVICVRKNLREVPDGISTNTRLLN------LHENQIQIIKVNSFKHLRHLEILQLS 96
Query: 184 NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPG 241
NH+ + L+ + L N L IP G F L+E+ L N SIP
Sbjct: 97 RNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSY 154
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPELGYF 299
+ + S LR LDL + I GL +NLRYLNL+ +LR +
Sbjct: 155 AFNRIPS-----LRRLDLGELKRLSYISEGAFEGL-SNLRYLNLAMCNLRE-----IPNL 203
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359
L L L L GN L+ P + L L + +
Sbjct: 204 TPL---------------------IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 360 LSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYN 406
+ + NL L + L N L+ +P + L L +++ +N
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 23/239 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N + L+L N + + F++ L L L+ N ++ FN ++LNTL L +N
Sbjct: 65 NTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 63 FSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQG-NQFSGP 118
+ + F L +L+ L L +N SIP + L+ L L + S
Sbjct: 124 LTTIPNGAFV------YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSY- 175
Query: 119 LPADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 176
+ F +L L+L+ ++P +L L + + +S N L+ P +
Sbjct: 176 ISEGA-FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232
Query: 177 LEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSEN 232
L+ L + + + + F N + L I L N+L +P LF LE I L N
Sbjct: 233 LQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 55/212 (25%), Positives = 81/212 (38%), Gaps = 10/212 (4%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+++ L LS N + + F A+L L L N L F Y S L L L NN
Sbjct: 89 HLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP 147
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 121
Y + LR LDL I +G L L+ L L +P
Sbjct: 148 IE----SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN 202
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
+ L LDLS N + P S + L + + + + + + N+ +L ++
Sbjct: 203 -LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 182 FSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLN 212
++N+LT LP LF L I L N N
Sbjct: 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 70/315 (22%), Positives = 111/315 (35%), Gaps = 72/315 (22%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ L VP + N R L+L N +Q F + L L LS NH
Sbjct: 44 QFSKVICVRKNLRE-VPDGISTN---TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 121
+ L L TL+L N + +IP G L LKEL L+ N +P+
Sbjct: 100 ----IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPS 153
Query: 122 DI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
P L LDL L ++ F +SN L +L
Sbjct: 154 YAFNRIPSLRRLDLGEL-------KRLSYISEGAFEGLSN----------------LRYL 190
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSI 238
+ + +L +P+ L KL + L GN L+ I G F + L+++ + ++ + I
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQ-IQVI 246
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LG 297
+ F L+ +L +NL+ N+L +P +
Sbjct: 247 ERNA--------FDNLQ---------------------SLVEINLAHNNLTL-LPHDLFT 276
Query: 298 YFHSLIHLDLRNNAL 312
H L + L +N
Sbjct: 277 PLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 58/215 (26%), Positives = 85/215 (39%), Gaps = 21/215 (9%)
Query: 200 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 259
+ S + +L +P+G+ ++L EN I S L IL L
Sbjct: 44 QFSKVICVRKNLR-EVPDGIST-NTRLLNLHENQIQ-IIKVNSFKHLRH-----LEILQL 95
Query: 260 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGS 315
S N++ I G F NL L L N L + IP Y L L LRNN + S
Sbjct: 96 SRNHI-RTIEI--GAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPI-ES 150
Query: 316 IPQEVCES-RSLGILQL-DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 373
IP SL L L + L+ ++L L+L+ +L IP +++ L K
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIK 208
Query: 374 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
L L L N LS P L L + + +++
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF----EREVRVLGK---ARHPNL 614
+G G FG VY G+M A+K L I + ER +L P +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER--IMLSLVSTGDCPFI 254
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 671
+ + + TP + D G L L + + RF ++ILG L H
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM---RFYAAEIILG----LEH 307
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 728
+H+ F +++ +LKP+NILLD++ + RISD GLA + +++G Y+
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYM 357
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
APE+ + + + D + G ++ +L+ G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
E+G G VY+ + A+K L + + E+ VL + HPN+I L+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK---KIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 621 YWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
+ TP LV + G L + ER + + K IL +A+LH
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------DAVKQILE---AVAYLHE 166
Query: 675 SFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
+ I+H +LKP N+L + +I+DFGL++++ + +M + GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTP-GYCAPE 220
Query: 732 -LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 768
L + + D++ G++ L+ G P Y E
Sbjct: 221 ILRGCAY--GPEVDMWSVGIITYILLCGFEPF-YDERG 255
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 6e-21
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 19/228 (8%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 618
+G G FG V+ G++ A KKL + + + ++ E ++L K ++SL
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS-WTNRF---KVILGTAKGLAHLHH 674
+ T LV G ++ ++ P F +++ G L HLH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ 307
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
II+ +LKP N+LLDD+ N RISD GLA L + + G++APEL
Sbjct: 308 RN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELL- 361
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782
+ D + GV + E++ R P V E + +LE+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRVLEQ 408
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-21
Identities = 39/256 (15%), Positives = 76/256 (29%), Gaps = 45/256 (17%)
Query: 589 TSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP 648
+ ++R + N + + +L+ ++ R
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 649 STPP-----LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703
L F I + + LH ++H +LKPSNI + ++ DF
Sbjct: 158 LEDREHGVCLHI---FIQIA---EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 208
Query: 704 GLARLL-------TRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLIL 753
GL + T L +G Y++PE + K DI+ G+++
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYSHKVDIFSLGLILF 267
Query: 754 ELVTGRRPVEYGEDNVVILSEHVRVL--LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVC 811
EL+ E VR++ + E +
Sbjct: 268 ELLYSFSTQ----------MERVRIITDVRNLK----FPLLFTQKYPQEH----MMVQDM 309
Query: 812 TCHIPSSRPSMAEVVQ 827
P+ RP ++++
Sbjct: 310 LSPSPTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 16/67 (23%), Positives = 27/67 (40%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
E +G G FG V++ A+K++ + E REV+ L K HP ++
Sbjct: 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68
Query: 617 LEGYYWT 623
+
Sbjct: 69 YFNAWLE 75
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 54/296 (18%), Positives = 99/296 (33%), Gaps = 63/296 (21%)
Query: 560 AEVGEGVFGTVYKVSFGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+ G G +Y GR + +K LV S + E + L + HP+++
Sbjct: 86 GCIAHGGLGWIYL---ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 616 SL-----EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
+ + +V +Y SL+ ++LP ++ +L L+
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YLLEILPALS 196
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---Y 727
+LH +++ +LKP NI+L + ++ D G + F G +
Sbjct: 197 YLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN---------SFGYLYGTPGF 243
Query: 728 VAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
APE DIY G + L +V L E+
Sbjct: 244 QAPE---IVRTGPTVATDIYTVGRTLAALTLDLPTRN---------GRYVDGLPED---- 287
Query: 787 DCVDPSMGDYPE-DEVLPVLKLALVCTCHIPSSRPSMAEVV--QILQVIKTPLPQR 839
DP + Y + + + P R + AE + Q+ V++ + Q
Sbjct: 288 ---DPVLKTYDSYGRL--LRR----AIDPDPRQRFTTAEEMSAQLTGVLREVVAQD 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 76/307 (24%), Positives = 127/307 (41%), Gaps = 66/307 (21%)
Query: 561 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
++GEG FG V++ + M+AVK L DF+RE ++ + +PN++
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST--------------------PPLSW 655
L G + L+ +Y G L L P T PPLS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 656 TNRFKVILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713
+ + A G+A+L +H +L N L+ +N +I+DFGL+R + D
Sbjct: 174 AEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 714 KHVMSNRFQSALGYV-----APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEY 764
+ + PE S+ N + D++ +GV++ E+ + G +P Y
Sbjct: 229 YYKADGN-----DAIPIRWMPPE----SIFYNRYTTESDVWAYGVVLWEIFSYGLQP--Y 277
Query: 765 -GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 823
G + E V + +GN+L C PE+ L + L +C +P+ RPS
Sbjct: 278 YGMAH-----EEVIYYVRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 824 EVVQILQ 830
+ +ILQ
Sbjct: 325 SIHRILQ 331
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 36/207 (17%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 619
++G G + + AVK + S D E+ +L + +HPN+I+L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKS-----KRDPTEEIEILLRYGQHPNIITLKD 83
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAHLH 673
Y + +V++ G L K+ + F V+ K + +LH
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQ----------KFFSEREASAVLFTITKTVEYLH 133
Query: 674 HSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
++H +LKPSNIL + + RI DFG A+ L R + ++ +A +VA
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTA-NFVA 188
Query: 730 PE-LTCQSLRVNEKCDIYGFGVL--IL 753
PE L Q + CDI+ GVL +
Sbjct: 189 PEVLERQGY--DAACDIWSLGVLLYTM 213
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 66/232 (28%), Positives = 93/232 (40%), Gaps = 29/232 (12%)
Query: 540 DSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKK--LVTSDIIQYPE 597
D + L DPE L E+G G FG VY ++A+KK + +
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 99
Query: 598 DFEREVRVLGKARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656
D +EVR L K RHPN I G Y LV +Y GS L PL
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTA-WLVMEYCL-GSASDLLEVH---KKPLQEV 154
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
V G +GLA+LH +IH ++K NILL + ++ DFG A ++ + V
Sbjct: 155 EIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211
Query: 717 -----MSNRFQSALGYVAPELTCQSLRV--NEKCDIYGFGVLILELVTGRRP 761
M APE+ + K D++ G+ +EL + P
Sbjct: 212 GTPYWM-----------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 68/311 (21%), Positives = 116/311 (37%), Gaps = 57/311 (18%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 603
L K +G G FG V + + +AVK L S + E E+
Sbjct: 20 FPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 604 RVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 662
+VL H N+++L G L++++Y G L L + S +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 663 LGT--------------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706
AKG+A L + IH +L NILL +I DFGLA
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLA 192
Query: 707 RLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GR 759
R + +V+ + + ++APE T +S D++ +G+ + EL + G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIFLWELFSLGS 245
Query: 760 RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR 819
P Y + + +++EG + PE + + C P R
Sbjct: 246 SP--YPG---MPVDSKFYKMIKEGFRMLS--------PEHAPAEMYDIMKTCWDADPLKR 292
Query: 820 PSMAEVVQILQ 830
P+ ++VQ+++
Sbjct: 293 PTFKQIVQLIE 303
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 622
GEG +G V +AVK + + PE+ ++E+ + H N++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 623 TPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLHHSFRP 678
++ L +Y G L ++ +P + F ++ G+ +LH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE-----PDAQRFFHQLMA---GVVYLHGIG-- 125
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
I H ++KP N+LLD+ N +ISDFGLA + ++ + N+ L YVAPEL +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
E D++ G+++ ++ G P + D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 49/222 (22%), Positives = 94/222 (42%), Gaps = 15/222 (6%)
Query: 545 SLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR 604
S++ D LE E+G G +G V K+ G+++AVK++ + Q + ++
Sbjct: 1 SMEVKAD---DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD 57
Query: 605 VLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 663
+ + P ++ G + + + + SL + + + K+ +
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRFQ 722
K L HLH +IH ++KPSN+L++ ++ DFG++ L + K +
Sbjct: 117 SIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDA 170
Query: 723 SALGYVAPE---LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
Y+APE + K DI+ G+ ++EL R P
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 34/232 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G G FG VY+ G ++A+KK ++Q RE++++ K H N++ L ++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 622 WTPQLKL------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 674
++ K LV DY P ++ + L K+ + + LA++ H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYI-H 173
Query: 675 SFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALGYV----- 728
SF I H ++KP N+LLD + ++ DFG A+ L R + +V Y+
Sbjct: 174 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---------SYICSRYY 222
Query: 729 -APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
APEL + D++ G ++ EL+ G +P+ G+ V L E ++VL
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVL 273
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 61/307 (19%)
Query: 561 EVGEGVFGTVYK-------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHP 612
+GEG FG V + +AVK L + D E+ ++ +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPLSWTNRFK 660
N+I+L G ++ +YA G+L+ L R P +++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 661 VILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 718
A+G+ +L IH +L N+L+ +N +I+DFGLAR + +D + +
Sbjct: 208 CTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 719 NRFQSALGYV-----APELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDN 768
G + APE +L + D++ FGVL+ E+ T G P Y G
Sbjct: 263 TN-----GRLPVKWMAPE----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPV 311
Query: 769 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828
E + LL+EG+ +D P + + + C +PS RP+ ++V+
Sbjct: 312 -----EELFKLLKEGHRMDK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 829 LQVIKTP 835
L I T
Sbjct: 359 LDRILTL 365
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 79/317 (24%), Positives = 128/317 (40%), Gaps = 65/317 (20%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 603
+ L L K +GEG FG V K + +AVK L + D E
Sbjct: 20 FPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF 77
Query: 604 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 663
VL + HP++I L G LL+ +YA GSL+ L E P + +
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 664 GT--------------------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRIS 701
++G+ +L ++H +L NIL+ + +IS
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKIS 192
Query: 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILEL 755
DFGL+R + D +V ++ + + ++A E T QS D++ FGVL+ E+
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEI 245
Query: 756 VT-GRRPVEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTC 813
VT G P Y G E + LL+ G+ ++ P++ + +L L C
Sbjct: 246 VTLGGNP--YPGIPP-----ERLFNLLKTGHRMER--------PDNCSEEMYRLMLQCWK 290
Query: 814 HIPSSRPSMAEVVQILQ 830
P RP A++ + L+
Sbjct: 291 QEPDKRPVFADISKDLE 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 51/302 (16%)
Query: 561 EVGEGVFGTVYK-------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHP 612
+GEG FG V + +AVK L + D E+ ++ +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPLSWTNRFK 660
N+I+L G ++ +YA G+L+ L R P +++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 661 VILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 718
A+G+ +L IH +L N+L+ +N +I+DFGLAR + +D + +
Sbjct: 162 CTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 719 NRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILS 773
+ + ++APE +L + D++ FGVL+ E+ T G P Y G
Sbjct: 217 TNGRLPVKWMAPE----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPV----- 265
Query: 774 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833
E + LL+EG+ +D P + + + C +PS RP+ ++V+ L I
Sbjct: 266 EELFKLLKEGHRMDK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317
Query: 834 TP 835
T
Sbjct: 318 TL 319
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 34/244 (13%), Positives = 84/244 (34%), Gaps = 44/244 (18%)
Query: 51 SSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKE 107
S TL L H F++ L + + +S ++ + L +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSN------LPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84
Query: 108 LLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 166
+ ++ + + D P L L + N L++ + + ++
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNT--------GLKMFPDLTKVYSTDI----- 131
Query: 167 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFN--CKKLSVIRLRGNSLNGNIPEGLFD-LG 223
L+ ++N S+P + F C + ++L N ++ F+
Sbjct: 132 ----------FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNL 283
L+ + L++N ++ I + ++ +LD+S ++ +P+ +L+ L
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGG----VYSGPSLLDVSQTSVT-ALPS--KGLEHLKELIA 233
Query: 284 SSNH 287
+
Sbjct: 234 RNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 42/232 (18%), Positives = 77/232 (33%), Gaps = 23/232 (9%)
Query: 156 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGN 214
V+ + IP + + L HL ++PS F N +S I + +
Sbjct: 16 FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 215 IPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 272
+ F + I++ + I P + L+ L + + L P
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPL-----LKFLGIFNTGLK-MFPDLT 124
Query: 273 GLF--ANLRYLNLSSNHLRSRIPPEL--GYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 328
++ L ++ N + IP G + + L L NN S+ L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDA 183
Query: 329 LQLDGN-SLTGPIPQVIRNCTS-LYLLSLSHNHLSGSIPKSI-SNLNKLKIL 377
+ L+ N LT S LL +S ++ ++P +L +L
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 24/180 (13%), Positives = 50/180 (27%), Gaps = 36/180 (20%)
Query: 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGS 315
++ ++ IP L + + L L HLR+ IP ++ + + +
Sbjct: 16 FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 316 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKL 374
+ N + + + + + I L L
Sbjct: 71 LE-----------------------SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107
Query: 375 KILKLEFNELSGEIPQE--LGKLASLLAVNVSYNRLIGRLPVG---GVFPTLDQSSLQGN 429
K L + L P + + ++ N + +PV G+ L N
Sbjct: 108 KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 42/216 (19%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEGYY 621
G GV G V + G+ A+K ++ +EV + + P+++ + Y
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALK------LLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 622 ----WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLAHL 672
+ L++ + G L +++ ER ++T R + I + L
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIG---TAIQFL 144
Query: 673 HHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 726
H I H ++KP N+L + + +++DFG A K N Q+
Sbjct: 145 HSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-------KETTQNALQTPCYTPY 194
Query: 727 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
YVAPE L + ++ CD++ GV++ L+ G P
Sbjct: 195 YVAPEVLGPEKY--DKSCDMWSLGVIMYILLCGFPP 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYY 621
GEG V + AVK + REV +L + + H N++ L ++
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 622 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAHLHHS 675
LV + GS+ + +H+R F V+ A L LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKR----------RHFNELEASVVVQDVASALDFLH-- 128
Query: 676 FRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLT--RLDKHVMSNRFQSALG---Y 727
I H +LKP NIL + +I DF L + + + + G Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 728 VAPE-LTCQSLRV---NEKCDIYGFGVLILELVTGRRP 761
+APE + S +++CD++ GV++ L++G P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNL 614
L+ E+G G +G+V K+ G+++AVK++ ++ + + ++ V+ ++ P +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKG 668
+ G + + + + S + K+ L T K
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD-----DVIPEEILGKITLATVKA 137
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 726
L HL + + IIH ++KPSNILLD + N ++ DFG++ L ++ G
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRD--AGCR 189
Query: 727 -YVAPELTCQSLRV---NEKCDIYGFGVLILELVTGRRP 761
Y+APE S + + D++ G+ + EL TGR P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 622
GEG +G V +AVK + + PE+ ++E+ + H N++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 623 TPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLHHSFRP 678
++ L +Y G L ++ +P + F ++ G+ +LH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE-----PDAQRFFHQLMA---GVVYLHGIG-- 125
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
I H ++KP N+LLD+ N +ISDFGLA + ++ + N+ L YVAPEL +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
E D++ G+++ ++ G P + D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 57/234 (24%), Positives = 82/234 (35%), Gaps = 44/234 (18%)
Query: 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 140
++ + ++P + L L N A + LT L+L T
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCK 199
+L V L + + +S+N L +P + L LD S N LT SLP
Sbjct: 69 -KLQVDGTLPV-LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 200 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 259
+L + L+GN L +P GL + L L L
Sbjct: 125 ELQELYLKGNELK-TLPPGLLT------PTPK----------------------LEKLSL 155
Query: 260 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 310
++NNL ++PA GL NL L L N L + IP H L L N
Sbjct: 156 ANNNLT-ELPA--GLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 53/211 (25%), Positives = 80/211 (37%), Gaps = 17/211 (8%)
Query: 198 CKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 257
L V +L +P L + LSEN + + + L L
Sbjct: 10 ASHLEV-NCDKRNL-TALPPDLPK-DTTILHLSENLL-YTFSLATLMPYTR-----LTQL 60
Query: 258 DLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317
+L L + + L L L+LS N L+S +P +L LD+ N L S+P
Sbjct: 61 NLDRAEL-TKLQVDGTL-PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRL-TSLP 116
Query: 318 QEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLK 375
L L L GN L P ++ L LSL++N+L+ +P + + L L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 376 ILKLEFNELSGEIPQELGKLASLLAVNVSYN 406
L L+ N L IP+ L + N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 56/230 (24%), Positives = 77/230 (33%), Gaps = 43/230 (18%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 66
++ L+ +P L L L+ N+L + L LNL +
Sbjct: 15 VNCDKRNLTA-LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 126
+L L TLDLSHN S+P L L L + N+ + LP
Sbjct: 71 QVD------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGA-LR 121
Query: 127 --PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN 184
L L L N LP + LE L +N
Sbjct: 122 GLGELQELYLKGNELK-TLPPG-------LLTPTPK----------------LEKLSLAN 157
Query: 185 NHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSEN 232
N+LT LP+ L + L + L+ NSL IP+G F L L N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 50/216 (23%), Positives = 80/216 (37%), Gaps = 24/216 (11%)
Query: 173 NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLS 230
+++ ++ +LT +LP L K +++ L N L L +++L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLL-YTFSLATLMPYTRLTQLNLD 63
Query: 231 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 290
+ + + L LDLS N L +P L L++S N L S
Sbjct: 64 RAE-LTKLQVDGTLPV-------LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS 114
Query: 291 RIPPELGYFHSLI---HLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRN 346
+P G L L L+ N L ++P + L L L N+LT ++
Sbjct: 115 -LPL--GALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 347 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382
+L L L N L +IPK + L L N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 20/196 (10%)
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 298
P S +S ++ NL +P L + L+LS N L + L
Sbjct: 2 PICEVSKVAS-----HLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMP 53
Query: 299 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
+ L L+L L + + LG L L N L +P + + +L +L +S N
Sbjct: 54 YTRLTQLNLDRAEL-TKLQVDG-TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFN 110
Query: 359 HLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYNRLIGRLPVGG 416
L+ S+P L +L+ L L+ NEL +P L L ++++ N L LP G
Sbjct: 111 RLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL-TELPA-G 166
Query: 417 VF---PTLDQSSLQGN 429
+ LD LQ N
Sbjct: 167 LLNGLENLDTLLLQEN 182
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 62/308 (20%), Positives = 119/308 (38%), Gaps = 55/308 (17%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 603
L K +G G FG V + + +AVK L ++ E E+
Sbjct: 43 FPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSEL 100
Query: 604 RVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 662
+++ +H N+++L G L++++Y G L L +
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 663 LGT----------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710
T A+G+A L + IH ++ N+LL + + +I DFGLAR +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 711 RLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 763
+++ + + ++APE T QS D++ +G+L+ E+ + G P
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFSLGLNP-- 266
Query: 764 Y-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM 822
Y G ++++ L+++G + P + + C P+ RP+
Sbjct: 267 YPG----ILVNSKFYKLVKDGYQMAQ--------PAFAPKNIYSIMQACWALEPTHRPTF 314
Query: 823 AEVVQILQ 830
++ LQ
Sbjct: 315 QQICSFLQ 322
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNL 614
LE E+G G G V+K+ F G ++AVK++ S + + ++ V+ K+ P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLH 673
+ G + T + + + + K + P L K+ + K L +L
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLK 141
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-- 731
+IH ++KPSNILLD+ ++ DFG++ RL +R Y+APE
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196
Query: 732 --LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + D++ G+ ++EL TG+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
+G+G FG V V +M A+K + ++ + +E++++ HP L++L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 619 GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK--------GL 669
+ + + +V D G L + H L FK T K L
Sbjct: 82 YSFQDEE-DMFMVVDLLLGGDL--RYH--------LQQNVHFK--EETVKLFICELVMAL 128
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL---- 725
+L + IIH ++KP NILLD++ + I+DF +A + + +
Sbjct: 129 DYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIA-------AMLPRETQITTMAGTK 178
Query: 726 GYVAPELTCQSLRV--NEKCDIYGFGVLILELVTGRRP 761
Y+APE+ + D + GV EL+ GRRP
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 74/310 (23%), Positives = 121/310 (39%), Gaps = 56/310 (18%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 603
+ L L K +G G FG V + + R +AVK L E+
Sbjct: 24 FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 81
Query: 604 RVLGK-ARHPNLISLEG---YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR- 658
++L H N+++L G P + ++ ++ G+L L + P
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 659 -FKVILGT----------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705
+K L AKG+ L IH +L NILL + +I DFGL
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGL 194
Query: 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRP 761
AR + + +V + L ++APE ++ + D++ FGVL+ E+ + G P
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPE----TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 762 VEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 820
Y G V + E L+EG + P+ + + L C PS RP
Sbjct: 251 --YPG----VKIDEEFCRRLKEGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRP 296
Query: 821 SMAEVVQILQ 830
+ +E+V+ L
Sbjct: 297 TFSELVEHLG 306
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR---VLGKARHPNLISLE 618
G+G FGTV + G +A+KK +IQ P RE++ L HPN++ L+
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKK-----VIQDPRFRNRELQIMQDLAVLHHPNIVQLQ 85
Query: 619 GYYWTPQLK-------LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 670
Y++T + +V +Y P+ +L KV L + +
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFLFQLIRSIG 143
Query: 671 HLH-HSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
LH S + H ++KP N+L++ + ++ DFG A+ L+ + +V Y+
Sbjct: 144 CLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---------AYI 192
Query: 729 ------APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
APEL + DI+ G + E++ G P+ G+++ L E VRVL
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSAGQLHEIVRVL 248
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 62/316 (19%), Positives = 107/316 (33%), Gaps = 62/316 (19%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 603
E L K +G G FG V +S +AVK L E E+
Sbjct: 42 FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 604 RVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 662
+++ + H N+++L G L+ +Y G L L + +
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 663 LGT-------------------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRIS 701
L AKG+ L +H +L N+L+ +I
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKIC 214
Query: 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILEL 755
DFGLAR + +V+ + + ++APE T +S D++ +G+L+ E+
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS-------DVWSYGILLWEI 267
Query: 756 VT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCH 814
+ G P Y + + + L++ G +D P + + C
Sbjct: 268 FSLGVNP--YPG---IPVDANFYKLIQNGFKMDQ--------PFYATEEIYIIMQSCWAF 314
Query: 815 IPSSRPSMAEVVQILQ 830
RPS + L
Sbjct: 315 DSRKRPSFPNLTSFLG 330
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 74/309 (23%), Positives = 131/309 (42%), Gaps = 54/309 (17%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-------VSFGTQGRMLAVKKLVTSDIIQYPEDFER 601
+ + L L K +GEG FG V + +AVK L + + D
Sbjct: 66 LPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 123
Query: 602 EVRVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-- 658
E+ ++ +H N+I+L G ++ +YA G+L+ L R P S+
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 659 ------FKVILG----TAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706
K ++ A+G+ +L IH +L N+L+ ++ +I+DFGLA
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPV 762
R + +D + + + + ++APE +L + D++ FGVL+ E+ T G P
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPE----ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP- 293
Query: 763 EY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS 821
Y G E + LL+EG+ +D P + + + C +PS RP+
Sbjct: 294 -YPGVPV-----EELFKLLKEGHRMDK--------PSNCTNELYMMMRDCWHAVPSQRPT 339
Query: 822 MAEVVQILQ 830
++V+ L
Sbjct: 340 FKQLVEDLD 348
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 619
+G G FG V V + ++ A+K L ++I+ + F E ++ A P ++ L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 620 YYWTPQLKLLVSDYAPNG---SLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
+ + +V +Y P G +L + +P RF +V+L L +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEK-----WARFYTAEVVLA----LDAIH 185
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 732
IH ++KP N+LLD + + +++DFG + + + V + Y++PE L
Sbjct: 186 SM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVL 241
Query: 733 TCQSLRV--NEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 771
Q +CD + GV + E++ G P Y + V
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGT 281
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 41/218 (18%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 619
+G G+ G V ++ A+K ++Q REV + + ++ P+++ +
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELHWRASQCPHIVRIVD 122
Query: 620 YYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLA 670
Y L+V + G L +++ +R ++T R K I + +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIG---EAIQ 175
Query: 671 HLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 726
+LH I H ++KP N+L N +++DFG A+ T N +
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS------HNSLTTPCYT 226
Query: 727 --YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
YVAPE L + ++ CD++ GV++ L+ G P
Sbjct: 227 PYYVAPEVLGPEKY--DKSCDMWSLGVIMYILLCGYPP 262
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-18
Identities = 58/231 (25%), Positives = 94/231 (40%), Gaps = 26/231 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 619
+G G FG V V ++ A+K L ++++ E F E VL + +L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 620 YYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 675
+ L LV DY G L L + P RF ++++ + +H
Sbjct: 142 AFQDDN-NLYLVMDYYVGGDLLTLL-SKFEDRLPEEMA-RFYLAEMVIA----IDSVHQL 194
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
+H ++KP NIL+D N + R++DFG L D V S+ Y++PE+
Sbjct: 195 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQA 250
Query: 736 SLRVNEK----CDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVRV 778
+ CD + GV + E++ G P Y E V I++ R
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERF 300
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 58/243 (23%), Positives = 88/243 (36%), Gaps = 50/243 (20%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 61
+ K LDLS N L + F + L+ L L+ +Q G + S L+TL L+ N
Sbjct: 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDG-AYQSLSHLSTLILTGN 86
Query: 62 H--------FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA-LHYLKELLLQG 112
FSG L L+ L + S+ L LKEL +
Sbjct: 87 PIQSLALGAFSG------------LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAH 133
Query: 113 NQF-SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 171
N S LP +L LDLS+N ++ + + +
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSN--------KIQSIYCTDLRVLHQ--MPLLNLS-- 181
Query: 172 GNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDL 229
LD S N + + F +L + L N L ++P+G+FD L++I L
Sbjct: 182 --------LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 231
Query: 230 SEN 232
N
Sbjct: 232 HTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 54/242 (22%), Positives = 88/242 (36%), Gaps = 45/242 (18%)
Query: 175 STLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSE 231
+ + LD S N L L S F + +L V+ L + I +G + L + L+
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHL 288
N + S+ G+ S SS L+ L NL + L+ LN++ N +
Sbjct: 86 NP-IQSLALGAFSGLSS-----LQKLVAVETNLA-SLEN--FPIGHLKTLKELNVAHNLI 136
Query: 289 RSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCT 348
+S P YF +L +L+ L L N + +R
Sbjct: 137 QSFKLP--EYFSNLTNLE---------------------HLDLSSNKIQSIYCTDLRVLH 173
Query: 349 SL----YLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404
+ L LS N ++ I +LK L L+ N+L +L SL + +
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232
Query: 405 YN 406
N
Sbjct: 233 TN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 33/229 (14%)
Query: 143 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKL 201
LP S + L+ +S N L + + L+ LD S + ++ + + L
Sbjct: 26 LPFSTKNLD------LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 202 SVIRLRGNSLNGNIPEGLFD-LG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 259
S + L GN + ++ G F L L+++ E S+ +TL+ L++
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH-----LKTLKELNV 131
Query: 260 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSL-------IHLDLRN 309
+ N + F+ NL +L+LSSN ++S I L + LDL
Sbjct: 132 AHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQS-IYC--TDLRVLHQMPLLNLSLDLSL 186
Query: 310 NALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
N + I + L L LD N L + TSL + L N
Sbjct: 187 NPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 29/207 (14%)
Query: 215 IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 274
IP+ L + +DLS N + S S L++LDLS + I G
Sbjct: 22 IPDNLPF-STKNLDLSFNPL-RHLGSYSFFSFPE-----LQVLDLSRCEI-QTIED--GA 71
Query: 275 FA---NLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCES-RSLG 327
+ +L L L+ N ++S + G F SL L L S+ ++L
Sbjct: 72 YQSLSHLSTLILTGNPIQS-LAL--GAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLK 127
Query: 328 ILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLE----F 381
L + N + +P+ N T+L L LS N + SI + L+++ +L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 382 NELSGEIPQELGKLASLLAVNVSYNRL 408
N ++ I K L + + N+L
Sbjct: 187 NPMN-FIQPGAFKEIRLKELALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 41/170 (24%), Positives = 65/170 (38%), Gaps = 16/170 (9%)
Query: 260 SSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL---DLRNNALYGSI 316
N IP L + + L+LS N LR + F S L DL + +I
Sbjct: 15 MELNFY-KIPD--NLPFSTKNLDLSFNPLRH-LGS--YSFFSFPELQVLDLSRCEI-QTI 67
Query: 317 PQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKL 374
+S L L L GN + +SL L +L+ S+ +L L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTL 126
Query: 375 KILKLEFNEL-SGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQ 423
K L + N + S ++P+ L +L +++S N+ I + L Q
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIYC-TDLRVLHQ 174
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 562 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLI 615
+G+G +G V+ KV+ G++ A+K L + I++ +D E +L + +HP ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 616 SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 671
L + T KL L+ +Y G L +L + F ++ + L H
Sbjct: 85 DLIYAFQTGG-KLYLILEYLSGGELFMQLEREGIFMEDTA---CFYLAEISMA----LGH 136
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 728
LH II+ +LKP NI+L+ + +++DFGL + + +++ F G Y+
Sbjct: 137 LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTF---CGTIEYM 188
Query: 729 APELTCQSLRVNEK-----CDIYGFGVLILELVTGRRPVEYGED 767
APE+ + D + G L+ +++TG P GE+
Sbjct: 189 APEI------LMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGEN 225
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 618
+G+G FG V V GR A+K L I+ ++ E RVL +RHP L +L+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTENRVLQNSRHPFLTALK 214
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLH-ERLPSTPPLSWTNRF---KVILGTAKGLAHLHH 674
+ T V +YA G L L ER+ S RF +++ L +LH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAEIVSA----LDYLHS 266
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
+++ +LK N++LD + + +I+DFGL + + F Y+APE+
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVL- 321
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ D +G GV++ E++ GR P Y +D
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQD 353
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 57/232 (24%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G G FG V++ + + +A+KK ++Q RE++++ +HPN++ L+ ++
Sbjct: 48 IGNGSFGVVFQ-AKLVESDEVAIKK-----VLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 622 WTPQLKL------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 674
++ K LV +Y P ++ + K+ + + LA++H
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIH- 158
Query: 675 SFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALGYV----- 728
S I H ++KP N+LLD ++ DFG A++L + +V Y+
Sbjct: 159 SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---------SYICSRYY 207
Query: 729 -APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
APEL + DI+ G ++ EL+ G +P+ GE + L E ++VL
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFPGESGIDQLVEIIKVL 258
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 1e-17
Identities = 58/283 (20%), Positives = 86/283 (30%), Gaps = 53/283 (18%)
Query: 105 LKELLLQGNQFS--GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162
+ E + P A +L T V+ LNS+ I +N+
Sbjct: 1 MGETITVSTPIKQIFPDDA----FAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD 54
Query: 163 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 222
+ + I + + L + N LT + L N K L + L N + ++ L DL
Sbjct: 55 IK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDL 108
Query: 223 -GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYL 281
L+ + L NG I L L L +N + DI L L L
Sbjct: 109 KKLKSLSLEHNGIS-DINGLVH-------LPQLESLYLGNNKIT-DITVLSRL-TKLDTL 158
Query: 282 NLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP 341
+L N + I P L L +L L N I L
Sbjct: 159 SLEDNQISD-IVP-LAGLTKLQNLYLSKN----------------HISDLRA-------- 192
Query: 342 QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384
+ +L +L L SNL +K L
Sbjct: 193 --LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 52/261 (19%), Positives = 98/261 (37%), Gaps = 30/261 (11%)
Query: 34 LAGNILQG-PIGKIFN--YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNL 90
+ I PI +IF + NL + + L + + +++
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNE------LNSIDQIIANNSD 54
Query: 91 FSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLL 150
S+ QG+ L + +L L GN+ + P + +L L L N L SL+ L
Sbjct: 55 IK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDL 108
Query: 151 NSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNS 210
+ +S+ +N ++ DI + ++ LE L NN +T + L KL + L N
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 164
Query: 211 LNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP 269
++ +I L L L+ + LS+N + + + L +L+L S +
Sbjct: 165 IS-DI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKN-------LDVLELFSQECLNKPI 214
Query: 270 AEMGLFANLRYLNLSSNHLRS 290
+ + L +
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVT 235
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 3e-15
Identities = 42/214 (19%), Positives = 81/214 (37%), Gaps = 23/214 (10%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFN--YCSSLNTLNL 58
+ ++ + +N+ + + ++ L L GN + I +L L L
Sbjct: 42 LNSIDQIIANNSDIKSVQG---IQYLPNVTKLFLNGN----KLTDIKPLTNLKNLGWLFL 94
Query: 59 SNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP 118
N DL + LK+L++L L HN S I G+ L L+ L L N+ +
Sbjct: 95 DENKIK-DLS-----SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI 146
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
+ L TL L +N + + L L + + +S N ++ D+ + + L+
Sbjct: 147 TV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLD 200
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212
L+ + + N + ++ SL
Sbjct: 201 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 31/147 (21%), Positives = 43/147 (29%), Gaps = 17/147 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSN 60
++ L L NN ++ L LSL N I I + L L LS
Sbjct: 132 QLESLYLGNNKITDITV---LSRLTKLDTLSLEDN----QISDIVPLAGLTKLQNLYLSK 184
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
NH S DL + LK L L+L + L + P
Sbjct: 185 NHIS-DLR-----ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSL 147
I ++ +L VS
Sbjct: 239 --ISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 28/215 (13%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 609
+ ++GEG +G VYK +A+K+ I+ + E REV +L +
Sbjct: 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKR------IRLEHEEEGVPGTAIREVSLLKEL 90
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
+H N+I L+ L+ +Y + L + + P +S + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPR-----ISDFGLARLLTRLDKHVMSNRFQSA 724
H +H +LKP N+LL + I DFGLAR + ++
Sbjct: 146 NFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEII-T 200
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
L Y PE+ S + DI+ + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 609
EK ++GEG +GTV+K ++A+K+ ++ +D E RE+ +L +
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKEL 58
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKG 668
+H N++ L + + LV ++ L + S K L KG
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
L H ++H +LKP N+L++ N ++++FGLAR + S L Y
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEV-VTLWYR 168
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
P++ + + D++ G + EL RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 22/217 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 619
+G G F V V G++ A+K + D+++ E F E VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 676
+ LV +Y G L L + P RF ++++ + +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMA-RFYLAEIVMA----IDSVH--- 179
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-LTCQ 735
R +H ++KP NILLD + R++DFG L R D V S Y++PE L
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 736 SLRVNEK-----CDIYGFGVLILELVTGRRPVEYGED 767
CD + GV E+ G+ P Y +
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADS 274
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKARHPNLISL-E 618
GEG +G V +V AVK L + + P ++E+++L + RH N+I L +
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 619 GYYW-TPQLKLLVSDYAPNGS--LQAKL-HERLPSTPPLSWTNR--FKVILGTAKGLAHL 672
Y Q +V +Y G + + +R P F ++ GL +L
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV-----CQAHGYFCQLID---GLEYL 125
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE- 731
H S I+H ++KP N+LL +IS G+A L Q + + PE
Sbjct: 126 H-SQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
K DI+ GV + + TG P E DN+ L
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE--GDNIYKL 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
G G FG V G +AVK K+ + D++ +RE++ L RHP++I L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVV---GKIKREIQNLKLFRHPHIIKL 76
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
TP +V +Y G L + H R+ F+ IL + + H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILS---AVDYCH-- 128
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 732
R ++H +LKP N+LLD + N +I+DFGL+ +++ +++ G Y APE+
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD------GEFLRTSCGSPNYAAPEV 181
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
L + DI+ GV++ L+ G P + +++V L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD--DEHVPTL 219
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISL 617
+GEG +G V + G ++A+KK+ + P RE+++L +H N+I++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 618 EGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAH 671
+ ++ + +Q LH R+ ST LS + + + T + +
Sbjct: 75 FNIQRPDSFENFNEVYIIQEL-----MQTDLH-RVISTQMLS-DDHIQYFIYQTLRAVKV 127
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYV- 728
LH S +IH +LKPSN+L++ N + ++ DFGLAR++ Q + +V
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 729 -----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
APE+ S + + D++ G ++ EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 50/284 (17%), Positives = 105/284 (36%), Gaps = 49/284 (17%)
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186
+ + + T V+ L+ + +S +T I + ++ L L+ +N
Sbjct: 19 ANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSS 245
+T + L N K++ + L GN L N+ + L ++ +DL+ + + P +
Sbjct: 75 ITD--LAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQ-ITDVTPLAG-- 127
Query: 246 SSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 305
L++L L N + +I GL NL+YL++ + + + P L L L
Sbjct: 128 -----LSNLQVLYLDLNQIT-NISPLAGL-TNLQYLSIGNAQVSD-LTP-LANLSKLTTL 178
Query: 306 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 365
+N + + ++ + + +L + L +N +S P
Sbjct: 179 KADDNKI---------------------SDISP-----LASLPNLIEVHLKNNQISDVSP 212
Query: 366 KSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409
++N + L I+ L ++ + L V I
Sbjct: 213 --LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 54/299 (18%), Positives = 109/299 (36%), Gaps = 38/299 (12%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSN 60
N + + ++ V + + LS G + I Y ++L L L +
Sbjct: 20 NAIKIAAGKSNVTDTVT---QADLDGITTLSAFGT----GVTTIEGVQYLNNLIGLELKD 72
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + DL + +L ++ L+LS N ++ +A L +K L L Q + P
Sbjct: 73 NQIT-DLA-----PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP 124
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+ +L L L N T P L L ++ ++S+ N ++ D+ + N+S L L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTL 178
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIP 239
+N ++ S L + L + L+ N ++ L + L + L+
Sbjct: 179 KADDNKISDI--SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQ------- 227
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 298
+ ++ L + ++ I + N Y + + + + Y
Sbjct: 228 --TITNQPVFYNNNLVVPNVVKGPSGAPIAPA-TISDNGTYASPNLTWNLTSFINNVSY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 32/297 (10%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+L + + + ++ Q A L + L G + + + + +L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKD 72
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 196
N T P L+ L + + +S N L ++ I + +++ LD ++ +T + L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPLA 126
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 255
L V+ L N + NI L L L+ + + + P ++ S L
Sbjct: 127 GLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DLTPLANLSK-------LT 176
Query: 256 ILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS 315
L N + DI L NL ++L +N + + P L +L + L N +
Sbjct: 177 TLKADDNKIS-DISPLASL-PNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTNQTITN- 231
Query: 316 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN 372
Q V + +L + N + GP I T + + +L+ ++ I+N++
Sbjct: 232 --QPVFYNNNLVVP----NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 18/113 (15%), Positives = 44/113 (38%), Gaps = 8/113 (7%)
Query: 296 LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 355
+ I + + + ++ Q + + L G +T ++ +L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLD--GITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 356 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408
N ++ + + NL K+ L+L N L + L S+ ++++ ++
Sbjct: 71 KDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI 119
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 62/263 (23%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G FG V +V G+ A+KK ++Q P RE+ ++ H N+I L Y
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKK-----VLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------------------KVI 662
++T + P+ + + S KV+
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 663 LGTAK-------------------GLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISD 702
+ + +H S I H ++KP N+L++ N ++ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 703 FGLARLLTRLDKHVMSNRFQSALGYV------APELTCQSLRVNEKCDIYGFGVLILELV 756
FG A+ L + V Y+ APEL + D++ G + EL+
Sbjct: 186 FGSAKKLIPSEPSV---------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 757 TGRRPVEYGEDNVVILSEHVRVL 779
G +P+ GE ++ L ++++
Sbjct: 237 LG-KPLFSGETSIDQLVRIIQIM 258
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 51/228 (22%), Positives = 98/228 (42%), Gaps = 46/228 (20%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 609
EK A++G+G FG V+K G+ +A+KK + + E RE+++L
Sbjct: 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKILQLL 73
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH----------ERLPSTPPLSWTNR- 658
+H N+++L + + +P + ++ L S + +T
Sbjct: 74 KHENVVNLIE--------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 659 ----FKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---TR 711
+++L GL ++H + I+H ++K +N+L+ + +++DFGLAR
Sbjct: 126 IKRVMQMLL---NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
+ +NR L Y PEL D++G G ++ E+ T
Sbjct: 180 SQPNRYTNRV-VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 47/232 (20%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
G+G F V GR +A+K +L + + + REVR++ HPN++ L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK----LFREVRIMKILNHPNIVKL 79
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLH 673
T + L+ +YA G + L H R+ R F+ I+ + + H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EARSKFRQIV---SAVQYCH 131
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---------A 724
+ I+H +LK N+LLD + N +I+DFG SN F A
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGF------------SNEFTVGGKLDAFCGA 176
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 776
Y APEL + D++ GV++ LV+G P + N+ L E V
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD--GQNLKELRERV 226
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 47/270 (17%), Positives = 86/270 (31%), Gaps = 53/270 (19%)
Query: 51 SSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKE 107
+ L F+ L +++S N I V + L L E
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSG------FGDLEKIEISQNDVLEVIEADVFSNLPKLHE 83
Query: 108 L-LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 166
+ + + N P P+L L +SN ++ L + I
Sbjct: 84 IRIEKANNLLYINPEAFQNLPNLQYLLISNT--------GIKHLPDVHKIHSLQ------ 129
Query: 167 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFN--CKKLSVIRLRGNSLNGNIPEGLFD-LG 223
LD +N ++ + F + ++ L N + I F+
Sbjct: 130 ----------KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ 178
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTL---RILDLSSNNLVGDIPAEMGLFANLRY 280
L+E++LS+N + +P F ILD+S + +P+ NL+
Sbjct: 179 LDELNLSDNNNLEELPNDV--------FHGASGPVILDISRTRIH-SLPS--YGLENLKK 227
Query: 281 LNLSSNHLRSRIPPELGYFHSLIHLDLRNN 310
L S + ++P L +L+ L
Sbjct: 228 LRARSTYNLKKLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 51/263 (19%), Positives = 91/263 (34%), Gaps = 25/263 (9%)
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGS 237
+ +T +PS L + +R L I +G F LE+I++S+N +
Sbjct: 14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPP 294
I S+ L + + N + I F NL+YL +S+ ++ +P
Sbjct: 70 IEADVFSNLPK-----LHEIRIEKANNLLYINP--EAFQNLPNLQYLLISNTGIKH-LPD 121
Query: 295 ELGYF-HSLIHLDLRNNALYGSIPQEVCE--SRSLGILQLDGNSLTGPIPQVIRNCTSLY 351
+ LD+++N +I + S IL L+ N +
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDE 181
Query: 352 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRLIG 410
L +N+L + IL + + +P L L L A + +
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK--- 237
Query: 411 RLPVGGVFPTLDQSSLQGNLGIC 433
+LP L ++SL C
Sbjct: 238 KLPTLEKLVALMEASLTYPSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 42/237 (17%), Positives = 81/237 (34%), Gaps = 23/237 (9%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
R + + IP + EL + L +++S N
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 142 QLPVS-LRLLNSMIFISVSN-NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 198
+ L + I + N L P N+ L++L SN + LP +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 199 KKLSVIRLRGNSLNGNIPEGLFD---LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 255
+ ++ ++ N I F + L++NG I + + + L
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ------LD 180
Query: 256 ILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 310
L+LS NN + ++P ++ G + L++S + S +P +L L R+
Sbjct: 181 ELNLSDNNNLEELPNDVFHGA-SGPVILDISRTRIHS-LPSYG--LENLKKLRARST 233
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 39/234 (16%), Positives = 71/234 (30%), Gaps = 16/234 (6%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNN 61
N L L + F L + ++ N +L+ +F+ L+ + +
Sbjct: 31 NAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLP 120
+ +L + + +L L+ L +S+ +P L +Q N +
Sbjct: 90 N---NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 121 ADI--GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
+ G L L+ N + NN L S
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLS 230
LD S + SLPS ++ +LR S + + L E L+
Sbjct: 206 ILDISRTRIH-SLPSYGLE----NLKKLRARSTYNLKKLPTLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 24/139 (17%), Positives = 38/139 (27%), Gaps = 11/139 (7%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCAS-LRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 59
+ LD+ +N+ + F + L L N +Q FN
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD 186
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGP 118
NN+ L+ LD+S S+P L L+ +
Sbjct: 187 NNN----LEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK--- 238
Query: 119 LPADIGFCPHLTTLDLSNN 137
LP L L+
Sbjct: 239 LPTLEKL-VALMEASLTYP 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 7e-17
Identities = 74/403 (18%), Positives = 121/403 (30%), Gaps = 102/403 (25%)
Query: 28 SLRYLSLAGNILQG----PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83
S+ SL + + + + S+ + LS N + I S K L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 143
+ S + AL L + LL+ CP L T+ LS+N F
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLK--------------CPKLHTVRLSDNAFG--- 107
Query: 144 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT-------------GS 190
P + L + S +T LE L NN L +
Sbjct: 108 PTAQEPLIDFL----SKHT-------------PLEHLYLHNNGLGPQAGAKIARALQELA 150
Query: 191 LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG--------LEEIDLSENGFMGSIPPGS 242
+ N L I N L + + L + + +NG P G
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLE---NGSMKEWAKTFQSHRLLHTVKMVQNGI---RPEGI 204
Query: 243 SSSSSSTL--FQTLRILDLSSNNLVGDIPAE-----MGLFANLRYLNLSSNHLRSRIPPE 295
L Q L++LDL N + + + + NLR L L+ L +R
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263
Query: 296 LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI-----RNCTSL 350
+ +A E+ L L+L N + + + L
Sbjct: 264 VV------------DAF------SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 351 YLLSLSHNHLS------GSIPKSISNLNKLKILKLEFNELSGE 387
L L+ N S I + S + ++ +L+ E +
Sbjct: 306 LFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 39/256 (15%), Positives = 77/256 (30%), Gaps = 48/256 (18%)
Query: 3 NMKFLDLSNNLLSGPVPYQL---------FENCASLRYLSLAGNILQG----PIGKIFNY 49
+++ + S+ C L + L+ N P+ +
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 50 CSSLNTLNLSNNHFSGD---------LDFASGYGIWSLKRLRTLDLSHNLFSG----SIP 96
+ L L L NN + A + LR++ N
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180
Query: 97 QGVAALHYLKELLLQGNQF-----SGPLPADIGFCPHLTTLDLSNNLFTGQ----LPVSL 147
+ + L + + N L + +C L LDL +N FT L ++L
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240
Query: 148 RLLNSMIFISVSNNTLT-------GDIPHWIGNISTLEFLDFSNNHLTG----SLPSSLF 196
+ ++ + +++ L+ D + N L+ L N + +L + +
Sbjct: 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN-IGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 197 -NCKKLSVIRLRGNSL 211
L + L GN
Sbjct: 300 EKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 25/160 (15%)
Query: 3 NMKFLDLSNNLL-SGPVPY--QLFENCASLRYLSLAGNIL-----QGPIGKIFNYCSSLN 54
++ + N L +G + + F++ L + + N + + + + YC L
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 55 TLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL---------HYL 105
L+L +N F+ A + S LR L L+ L S +G AA+ L
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS---ARGAAAVVDAFSKLENIGL 276
Query: 106 KELLLQGNQFSGPLPADIG-----FCPHLTTLDLSNNLFT 140
+ L LQ N+ + P L L+L+ N F+
Sbjct: 277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLISLEG 619
+G G FG V V G A+K L +++ E E R+L P L+ LE
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 676
+ +V +Y G + + L + P + RF +++L +LH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIVLT----FEYLHSL- 160
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 733
+I+ +LKP N+L+D +++DFG A K V R + G +APE+
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFA-------KRV-KGRTWTLCGTPEALAPEII 210
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVR 777
S N+ D + GVLI E+ G P + + + I+S VR
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVR 256
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REVRVLGKARHP 612
E VGEG +G V K GR++A+KK + SD + + RE+++L + RH
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHE 84
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKGLAH 671
NL++L + LV ++ + + + L P L + K + G+
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
H IIH ++KP NIL+ + ++ DFG AR L V + + Y APE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEV-ATRWYRAPE 194
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGR 759
L ++ + D++ G L+ E+ G
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--------REVRVLGK 608
K ++GEG + TVYK ++A+K++ + E REV +L
Sbjct: 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL--------EHEEGAPCTAIREVSLLKD 56
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAK 667
+H N+++L T + LV +Y L L + L ++ N + +
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
GLA+ H ++H +LKP N+L+++ +++DFGLAR + + N L Y
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWY 166
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
P++ S + + D++G G + E+ TGR
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REVRVLGKARHP 612
EK ++GEG +G V+K G+++A+KK + S + + RE+R+L + +HP
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLKQLKHP 62
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKGLAH 671
NL++L + + LV +Y + L + + T + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
H IH ++KP NIL+ + ++ DFG ARLLT + + Y +PE
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEV-ATRWYRSPE 172
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGR 759
L + D++ G + EL++G
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 42/215 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
VG G +G+V G +A+KKL S Q + RE+ +L +H N+I L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 619 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 670
+ TP L LV + +Q L + + S + + ++ KGL
Sbjct: 90 DVF-TPASSLRNFYDFYLVMPF-----MQTDLQKIMGL--KFS-EEKIQYLVYQMLKGLK 140
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 728
++H + ++H +LKP N+ ++++ +I DFGLAR M+ GYV
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMT-------GYVVT 186
Query: 729 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
APE+ + N+ DI+ G ++ E++TG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 52/246 (21%), Positives = 98/246 (39%), Gaps = 51/246 (20%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQY-------------------- 595
E+G+G +G V A+K KL+
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 596 PEDFEREVRVLGKARHPNLISL-EGYYWTPQLKL-LVSDYAPNGSLQAKL-HERLPSTPP 652
E +E+ +L K HPN++ L E + L +V + G + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 653 LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712
+ F+ ++ KG+ +LH + IIH ++KPSN+L+ ++ + +I+DFG++
Sbjct: 140 RFY---FQDLI---KGIEYLH-YQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 713 DKHVMSNRFQSALG---YVAPELTCQSLRVN---EKCDIYGFGVLILELVTGRRPVEYGE 766
D + +G ++APE R + D++ GV + V G+ P +
Sbjct: 191 DAL-----LSNTVGTPAFMAPES-LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM--D 242
Query: 767 DNVVIL 772
+ ++ L
Sbjct: 243 ERIMCL 248
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 618
+G+G FG V V GR A+K L II ++ E RVL RHP L +L+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 619 GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK----------VILGTAK 667
+ T +L V +YA G L H LS F ++
Sbjct: 72 YAFQTHD-RLCFVMEYANGGELF--FH--------LSRERVFTEERARFYGAEIVSA--- 117
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
L +LH +++ ++K N++LD + + +I+DFGL + + F Y
Sbjct: 118 -LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEY 171
Query: 728 VAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+APE L D +G GV++ E++ GR P Y +D
Sbjct: 172 LAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPF-YNQD 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 609
+K +VGEG +G VYK + +QGR++A+K+ I+ + E RE+ +L +
Sbjct: 24 QKLEKVGEGTYGVVYK-AKDSQGRIVALKR------IRLDAEDEGIPSTAIREISLLKEL 76
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKG 668
HPN++SL + + LV ++ ++ L + L L + + +G
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
+AH H I+H +LKP N+L++ + +++DFGLAR + ++ L Y
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYR 186
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
AP++ S + + DI+ G + E++TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 42/222 (18%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FE---------REVRVLGKAR 610
+ G +G V ++G +A+K++ + + RE+R+L
Sbjct: 29 FISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 611 HPNLISLEGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPST-PPLSWTNRFKVIL- 663
HPN++ L + + LV++ ++ L + + +S + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVIS-PQHIQYFMY 141
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 723
GL LH + ++H +L P NILL DN + I DF LAR T +
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANKT----- 191
Query: 724 ALGYV------APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
YV APEL Q + D++ G ++ E+ +
Sbjct: 192 --HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 609
++GEG +G VYK G A+KK I+ ++ E RE+ +L +
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNY-GETFALKK------IRLEKEDEGIPSTTIREISILKEL 57
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKG 668
+H N++ L T + +LV ++ L L + L + K L G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
+A+ H ++H +LKP N+L++ +I+DFGLAR + ++ L Y
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYR 167
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
AP++ S + + DI+ G + E+V G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 562 VGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
VG G +G VYK G + A+K++ + I RE+ +L + +HPN+ISL+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQK 85
Query: 620 YYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV---------ILGTAKG 668
+ + + L+ DYA + L + + ++ + IL G
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DL-WHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---DG 140
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPR----ISDFGLARL-------LTRLDKHVM 717
+ +LH ++ ++H +LKP+NIL+ R I+D G ARL L LD V+
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
Y APEL + + DI+ G + EL+T
Sbjct: 198 ------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 1e-15
Identities = 51/272 (18%), Positives = 95/272 (34%), Gaps = 24/272 (8%)
Query: 144 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 203
P + L + W G+ S E + + ++L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRP--ECWCRDSATDEQLFR 353
Query: 204 IRLRGNSLNGNIPEGLFDLGLEEID-------LSENGFMGSIPPGSSSSSSSTLFQTLRI 256
L E L+E++ L+ M ++ P + F TL+
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 257 LD--------LSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 308
+D + + + +A++R L+L+ L L + HLDL
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLS 471
Query: 309 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG-SIPKS 367
+N L ++P + R L +LQ N+L + + N L L L +N L + +
Sbjct: 472 HNRL-RALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQSAAIQP 528
Query: 368 ISNLNKLKILKLEFNELSGEIPQELGKLASLL 399
+ + +L +L L+ N L + +LA +L
Sbjct: 529 LVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 3e-13
Identities = 55/316 (17%), Positives = 98/316 (31%), Gaps = 21/316 (6%)
Query: 28 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 87
++S L + S + TL L + +++ + G + DL
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 88 HNLFSGSIPQGVAALHYL-----KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 142
+ +PQ + + KE +L ++ D L +LS T
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRCELSVEKST-V 363
Query: 143 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 202
L L + + N I + + L + + + + ++ +
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL--KAVDPMRAAY 421
Query: 203 VIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 262
+ LR L N + + + L+ + + LDLS N
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQ-------LLLVTHLDLSHN 473
Query: 263 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG-SIPQEVC 321
L +P + L L S N L + + L L L NN L + Q +
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALEN--VDGVANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 322 ESRSLGILQLDGNSLT 337
L +L L GNSL
Sbjct: 531 SCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 73/399 (18%), Positives = 125/399 (31%), Gaps = 35/399 (8%)
Query: 47 FNYCSSLNTLNLSNN-----------HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 95
+ SL T N SN D + L+ L+L N F +
Sbjct: 164 LAFTDSLITRNFSNYSSWHYRSCLLPQLHPQPDSGPQGRLPENVLLKELELVQNAFF-TD 222
Query: 96 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 155
P +A Y + LL + + ++ S L G +L L+
Sbjct: 223 PNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAP 282
Query: 156 ISVSNNTLTGD---IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212
+SV T G W+ ++ D H + + + K+ +++ R
Sbjct: 283 LSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC 342
Query: 213 GNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 272
+ D L +LS S S Q L + + + +
Sbjct: 343 RDSAT---DEQLFRCELSVE----KSTVLQSELESCKELQELEPENKWCLLTIILLMRAL 395
Query: 273 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 332
+ + L++ P Y L L N E + +L L
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHLA 449
Query: 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 392
LT + + L LSHN L ++P +++ L L++L+ N L + +
Sbjct: 450 HKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV 504
Query: 393 GKLASLLAVNVSYNRL--IGRLPVGGVFPTLDQSSLQGN 429
L L + + NRL + P L +LQGN
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 7e-07
Identities = 25/87 (28%), Positives = 33/87 (37%), Gaps = 7/87 (8%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ LDLS+N L +P L L L + N L+ G L L L NN
Sbjct: 464 LVTHLDLSHNRLRA-LPPAL-AALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNR 519
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHN 89
A+ + S RL L+L N
Sbjct: 520 LQ---QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 38/231 (16%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 618
+G G FG V+ + GR A+K L +++ + E E +L HP +I +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 619 GYYWTPQLKL-LVSDYAPNGSLQAKL-HERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
G + Q ++ ++ DY G L + L + P +F +V L L +LH
Sbjct: 73 GTFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYAAEVCLA----LEYLH 123
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAP 730
II+ +LKP NILLD N + +I+DFG A K+V + + G Y+AP
Sbjct: 124 SK---DIIYRDLKPENILLDKNGHIKITDFGFA-------KYV-PDVTYTLCGTPDYIAP 172
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVR 777
E+ + N+ D + FG+LI E++ G P Y + + IL+ +R
Sbjct: 173 EVV-STKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELR 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 41/215 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
VG G +G V G G +A+KKL Q + RE+R+L RH N+I L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 619 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 670
+ TP L LV + + L +L L +R + ++ KGL
Sbjct: 91 DVF-TPDETLDDFTDFYLVMPF-----MGTDLG-KLMKHEKLG-EDRIQFLVYQMLKGLR 142
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 728
++H + IIH +LKP N+ ++++ +I DFGLAR M+ GYV
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT-------GYVVT 188
Query: 729 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
APE+ +R + DI+ G ++ E++TG+
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 41/215 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
VG G +G+V G +AVKKL S Q + RE+R+L +H N+I L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 619 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 670
+ TP L LV+ + A L+ + L+ + + ++ +GL
Sbjct: 95 DVF-TPARSLEEFNDVYLVTHL-----MGADLN-NIVKCQKLT-DDHVQFLIYQILRGLK 146
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 728
++H + IIH +LKPSN+ ++++ +I DFGLAR M+ GYV
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMT-------GYVAT 192
Query: 729 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
APE+ + N+ DI+ G ++ EL+TGR
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 41/215 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
+G G G V R +A+KKL S Q + RE+ ++ H N+I L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 619 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 670
+ TPQ L +V + + A L + + L R +L G+
Sbjct: 91 NVF-TPQKSLEEFQDVYIVMEL-----MDANLCQVIQM--ELD-HERMSYLLYQMLCGIK 141
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 728
HLH + IIH +LKPSNI++ + +I DFGLAR +M+ YV
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT-------PYVVT 189
Query: 729 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
APE+ + E DI+ G ++ E++ G
Sbjct: 190 RYYRAPEV-ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
G G FG V G +AVK K+ + D++ RE++ L RHP++I L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVV---GKIRREIQNLKLFRHPHIIKL 81
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
TP +V +Y G L + + RL F+ IL G+ + H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR---RLFQQILS---GVDYCH-- 133
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 732
R ++H +LKP N+LLD + N +I+DFGL+ +++ +++ G Y APE+
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD------GEFLRTSCGSPNYAAPEV 186
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
L + DI+ GV++ L+ G P + +D+V L
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD--DDHVPTL 224
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 562 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPED---FEREVRVLGKARHPNLI 615
+G+G FG V+ K+S ++ A+K L + + ER +L + HP ++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER--DILVEVNHPFIV 89
Query: 616 SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 671
L + T KL L+ D+ G L +L + + T +F ++ L L H
Sbjct: 90 KLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDV---KFYLAELALA----LDH 141
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
LH II+ +LKP NILLD+ + +++DFGL++ +D + F + Y+APE
Sbjct: 142 LHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPE 196
Query: 732 LTCQSLRVNEK-----CDIYGFGVLILELVTGRRPVEYGEDN 768
+ VN + D + FGVL+ E++TG P G+D
Sbjct: 197 V------VNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDR 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 42/215 (19%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G G G V+ + +A+KK+V +D RE++++ + H N++ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEIL 77
Query: 622 WTPQLKLLVSDYAPNGS---------LQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAH 671
+L + ++ L + PL ++ + +GL +
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLL-EEHARLFMYQLLRGLKY 135
Query: 672 LHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 728
+H + ++H +LKP+N+ ++ ++ +I DFGLAR+ +D H S +
Sbjct: 136 IHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARI---MDPHYSHKGHLS--EGLVT 187
Query: 729 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
+P L + D++ G + E++TG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 52/241 (21%), Positives = 90/241 (37%), Gaps = 40/241 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISL 617
+G G +G VY + +A+KK+ + + + D + RE+ +L + + +I L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 618 EGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKGLAH 671
L +V + + L + + L+ K IL G
Sbjct: 91 YDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-EEHIKTILYNLLLGENF 144
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL------ 725
+H S IIH +LKP+N LL+ + + ++ DFGLAR + + N +
Sbjct: 145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 726 --------GYV------APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 771
+V APEL + DI+ G + EL+ + N
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 772 L 772
L
Sbjct: 262 L 262
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REVRVLGKARHP 612
EK +GEG F TVYK +++A+KK+ + + RE+++L + HP
Sbjct: 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPL--SWTNRFKVILGTAKGL 669
N+I L + LV D+ L+ + L TP ++ +L T +GL
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY------MLMTLQGL 125
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
+LH + I+H +LKP+N+LLD+N +++DFGLA+ +++ Y A
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYRA 180
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGR 759
PEL + D++ G ++ EL+
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 562 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNL 614
+G G +G V+ K+S G++ A+K L + I+Q + E E +VL R P L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 615 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLA 670
++L + T KL L+ DY G L L +R T + +++L L
Sbjct: 122 VTLHYAFQTET-KLHLILDYINGGELFTHLSQRERFTEHEV---QIYVGEIVL----ALE 173
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA---LG- 726
HLH II+ ++K NILLD N + ++DFGL+ K +++ + A G
Sbjct: 174 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS-------KEFVADETERAYDFCGT 223
Query: 727 --YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
Y+AP+ + ++ D + GVL+ EL+TG P +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDG 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 47/216 (21%), Positives = 86/216 (39%), Gaps = 36/216 (16%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPED--FEREVRVLGKARHPNLI 615
G G FG V+ + + + VK K++ I+ P+ E+ +L + H N+I
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 616 SLEGYYWTPQLKLLVSDYAPNG-------SLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
+ + LV + +G +L E L S F+ ++
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS-------YIFRQLVS---A 142
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 726
+ +L IIH ++K NI++ +++ ++ DFG A L R F + G
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER------GKLFYTFCGTI 193
Query: 727 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
Y APE+ + + +++ GV + LV P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL---------VTSDIIQYPEDFEREVRVLG 607
++ ++G G + TVYK T G +A+K++ T+ I RE+ ++
Sbjct: 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--I-------REISLMK 58
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGT 665
+ +H N++ L T LV ++ N L+ + + L
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
+GLA H + I+H +LKP N+L++ ++ DFGLAR + + S+ L
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TL 172
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
Y AP++ S + DI+ G ++ E++TG+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
GEG FG V + + +A+K L SD+ ERE+ L RHP++I L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM---HMRVEREISYLKLLRHPHIIKL 74
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
TP ++V +YA G L + +R+ F+ I+ + + H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGR---RFFQQIIC---AIEYCH-- 125
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 732
R I+H +LKP N+LLDDN N +I+DFGL+ ++T N +++ G Y APE+
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD------GNFLKTSCGSPNYAAPEV 178
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772
L + D++ G+++ ++ GR P + ++ + L
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD--DEFIPNL 216
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 47/222 (21%), Positives = 81/222 (36%), Gaps = 25/222 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSN 60
+L ++ V S+ + + I + Y ++ L L+
Sbjct: 25 ETIKDNLKKKSVTDAVT---QNELNSIDQIIANNS----DIKSVQGIQYLPNVTKLFLNG 77
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + D+ + +LK L L L N + + L LK L L+ N S
Sbjct: 78 NKLT-DIK-----PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING 129
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+ P L +L L NN T L L + +S+ +N ++ DI + ++ L+ L
Sbjct: 130 --LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 222
S NH++ L +L K L V+ L +L
Sbjct: 184 YLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNL 223
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 46/238 (19%), Positives = 91/238 (38%), Gaps = 23/238 (9%)
Query: 173 NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSE 231
+ + +T + + I + + ++ +G+ L + ++ L+
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291
N + I P ++ + L L L N + D+ + L L+ L+L N +
Sbjct: 78 NK-LTDIKPLAN-------LKNLGWLFLDENKVK-DLSSLKDL-KKLKSLSLEHNGISD- 126
Query: 292 IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLY 351
I L + L L L NN + + + L L L+ N ++ +P + T L
Sbjct: 127 ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 352 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409
L LS NH+S + ++++ L L +L+L E + L V + L+
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 42/213 (19%), Positives = 83/213 (38%), Gaps = 27/213 (12%)
Query: 24 ENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83
+ A +L + + N +S++ + +N+ + GI L +
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-----GIQYLPNVTK 72
Query: 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGF---CPHLTTLDLSNNLFT 140
L L+ N + I +A L L L L N+ D+ L +L L +N +
Sbjct: 73 LFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGIS 125
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 200
+ L L + + + NN +T DI + ++ L+ L +N ++ + L K
Sbjct: 126 -DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTK 179
Query: 201 LSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSEN 232
L + L N ++ ++ L L L+ ++L
Sbjct: 180 LQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/185 (21%), Positives = 66/185 (35%), Gaps = 21/185 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSN 60
N+ +L L N + ++ L+ LSL N I I + L +L L N
Sbjct: 91 NLGWLFLDENKVKDLSS---LKDLKKLKSLSLEHN----GISDINGLVHLPQLESLYLGN 143
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + D+ + L +L TL L N S I +A L L+ L L N S
Sbjct: 144 NKIT-DIT-----VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDLRA 195
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+ +L L+L + + L + ++ +L P I + E
Sbjct: 196 --LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKP 251
Query: 181 DFSNN 185
+ +
Sbjct: 252 NVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 40/188 (21%), Positives = 73/188 (38%), Gaps = 21/188 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSN 60
N+ L L+ N L+ P N +L +L L N + + L +L+L +
Sbjct: 69 NVTKLFLNGNKLTDIKP---LANLKNLGWLFLDEN----KVKDLSSLKDLKKLKSLSLEH 121
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N S D++ G+ L +L +L L +N + ++ L L L L+ NQ S +P
Sbjct: 122 NGIS-DIN-----GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP 173
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
+ L L LS N + L L ++ + + + + N+ +
Sbjct: 174 --LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 181 DFSNNHLT 188
++ L
Sbjct: 230 KNTDGSLV 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 32/289 (11%), Positives = 72/289 (24%), Gaps = 61/289 (21%)
Query: 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISL 617
G ++ R +A+ + ++ ++ L + P + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 618 ------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
+V+++ GSLQ P + + + A
Sbjct: 97 LDVVHTRAGGL------VVAEWIRGGSLQEVADTSPS--PVGA----IRAMQSLAAAADA 144
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
H R + PS + + + + ++ +
Sbjct: 145 AH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD- 178
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
N + DI G G + L+ R P+ L+ R + +D
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLP-EAGVRSGLAPAERDTAGQPIEPADIDR 230
Query: 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 840
D P + +A R + + + Q +
Sbjct: 231 ---DIPFQ----ISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEV 272
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 7e-15
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G+G FG V + AVK L +IQ +D E E RVL + P L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQL 407
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHH 674
+ T V +Y G L + + P + F ++ +G L L
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA---VFYAAEIAIG----LFFLQS 460
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-LT 733
II+ +LK N++LD + +I+DFG+ + + V + F Y+APE +
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
Q + D + FGVL+ E++ G+ P GED
Sbjct: 516 YQPY--GKSVDWWAFGVLLYEMLAGQAPF-EGED 546
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARHP 612
+GEG +G V +A+KK+ FE RE+++L + RH
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKI---------SPFEHQTYCQRTLREIKILLRFRHE 85
Query: 613 NLISLEGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTA 666
N+I + P ++ +V D ++ L+ +L T LS + L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDL-----METDLY-KLLKTQHLS-NDHICYFLYQIL 138
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+GL ++H + ++H +LKPSN+LL+ + +I DFGLAR+ D F +
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLT--E 190
Query: 727 YV------APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
YV APE+ S + DI+ G ++ E+++ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 27/225 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKAR-HPNLISL 617
+G G + V++ T + VK L P + RE+++L R PN+I+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITL 96
Query: 618 EGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
P + LV ++ N + + IL K L + H S
Sbjct: 97 ADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYDIRFYMYEIL---KALDYCH-S 148
Query: 676 FRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
I+H ++KP N+++D ++ R+ D+GLA + R S + PEL
Sbjct: 149 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVRVAS-RYFKGPELLV 203
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
+ D++ G ++ ++ + P +G DN L +VL
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 618
+G G G V R +A+KKL S Q + RE+ ++ H N+ISL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 619 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 670
+ TPQ L LV + + A L + + L R +L G+
Sbjct: 128 NVF-TPQKTLEEFQDVYLVMEL-----MDANLCQVIQM--ELD-HERMSYLLYQMLCGIK 178
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 728
HLH + IIH +LKPSNI++ + +I DFGLAR +M+ YV
Sbjct: 179 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT-------PYVVT 226
Query: 729 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
APE+ + E DI+ G ++ E+V +
Sbjct: 227 RYYRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 49/178 (27%), Positives = 73/178 (41%), Gaps = 24/178 (13%)
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL--FANLRYLNLSSNHLRSRIPP 294
++P L +LDLS NNL + AE NL L LS NHL I
Sbjct: 32 NVPQS--------LPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF-ISS 81
Query: 295 ELGYFH---SLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSL 350
F +L +LDL +N L ++ + + ++L +L L N + + L
Sbjct: 82 --EAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL 138
Query: 351 YLLSLSHNHLSGSIP----KSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404
L LS N +S P K + L KL +L L N+L +L KL + + +
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 51/228 (22%), Positives = 77/228 (33%), Gaps = 33/228 (14%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
LDLS+N LS +L L L+ N L + F +L L+LS+NH
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 63 F----SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSG 117
L+ L L L +N + + + L++L L NQ S
Sbjct: 100 LHTLDEFLFS--------DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR 150
Query: 118 PLPADI----GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS--NNTLTGD----- 166
P ++ P L LDLS+N L+ L + + + NN L D
Sbjct: 151 -FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQ 209
Query: 167 -IPHWIG-NISTLEFLD-----FSNNHLTGSLPSSLFNCKKLSVIRLR 207
HW +S++ + L FNC +
Sbjct: 210 LFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWE 257
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 49/196 (25%), Positives = 73/196 (37%), Gaps = 25/196 (12%)
Query: 198 CKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 257
C + L N+P+ L +DLS N + + + + L L
Sbjct: 18 CASNIL-SCSKQQLP-NVPQSL-PSYTALLDLSHN-NLSRLRAEWTPTR----LTNLHSL 69
Query: 258 DLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNNA 311
LS N+L I + F NLRYL+LSSNHL + + F L L L NN
Sbjct: 70 LLSHNHL-NFISS--EAFVPVPNLRYLDLSSNHLHT-LDE--FLFSDLQALEVLLLYNNH 123
Query: 312 LYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNC---TSLYLLSLSHNHLSGSIPKS 367
+ + + E L L L N ++ ++I++ L LL LS N L
Sbjct: 124 I-VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 368 ISNLNKLKILKLEFNE 383
+ L L +
Sbjct: 183 LQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 60/274 (21%), Positives = 95/274 (34%), Gaps = 47/274 (17%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC--PHLTTLDLSNNLF 139
L S ++PQ + + Y L L N S L A+ +L +L LS+N
Sbjct: 21 NILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHN-- 74
Query: 140 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 198
L ++S F+ V N L +LD S+NHL +L LF +
Sbjct: 75 ------HLNFISSEAFVPVPN----------------LRYLDLSSNHLH-TLDEFLFSDL 111
Query: 199 KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
+ L V+ L N + + F+ L+++ LS+N P + L +
Sbjct: 112 QALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK--LPKLML 167
Query: 257 LDLSSNNLVGDIPAEMGLFANL-----RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 311
LDLSSN L +P L L L +N L F + L +
Sbjct: 168 LDLSSNKL-KKLPLTD--LQKLPAWVKNGLYLHNNPLEC-DCKLYQLFSHWQYRQLSSVM 223
Query: 312 LYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR 345
+ + + I LD + +
Sbjct: 224 DFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWE 257
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 43/215 (20%)
Query: 175 STLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD-LG-LEEIDLSE 231
+ + LD +N L+ SLPS F KL ++ L N L +P G+F L LE + +++
Sbjct: 37 ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHL 288
N ++P G + L L L N L +P +F L YL+L N L
Sbjct: 95 NKLQ-ALPIGVFDQLVN-----LAELRLDRNQLK-SLPP--RVFDSLTKLTYLSLGYNEL 145
Query: 289 RSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCT 348
+S +P G F L L L+L N L T
Sbjct: 146 QS-LPK--GVFDKLTSLK---------------------ELRLYNNQLKRVPEGAFDKLT 181
Query: 349 SLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
L L L +N L +P+ +L KLK+L+L+ N
Sbjct: 182 ELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 64/218 (29%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
N K SV L IP + +++DL N S+P + + LR+
Sbjct: 15 NNNKNSV-DCSSKKLTA-IPSNIPA-DTKKLDLQSNKL-SSLPSKAFHRLTK-----LRL 65
Query: 257 LDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNN 310
L L+ N L +PA G+F NL L ++ N L++ +P G F L+ L L N
Sbjct: 66 LYLNDNKLQ-TLPA--GIFKELKNLETLWVTDNKLQA-LPI--GVFDQLVNLAELRLDRN 119
Query: 311 ALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI- 368
L S+P V +S L L L N L V TSL L L +N L +P+
Sbjct: 120 QL-KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAF 177
Query: 369 SNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 406
L +LK LKL+ N+L L L + + N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 55/197 (27%), Positives = 80/197 (40%), Gaps = 32/197 (16%)
Query: 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH--------FSGDLDFASGYGIWSL 78
A + L L N L K F+ + L L L++N F L
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE------------L 84
Query: 79 KRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLS 135
K L TL ++ N ++P GV L L EL L NQ LP + F LT L L
Sbjct: 85 KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRV-FDSLTKLTYLSLG 141
Query: 136 NNLFTGQLPVSL-RLLNSMIFISVSNNTLTGDIPHWI-GNISTLEFLDFSNNHLTGSLPS 193
N LP + L S+ + + NN L +P ++ L+ L NN L +P
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK-RVPE 198
Query: 194 SLF-NCKKLSVIRLRGN 209
F + +KL +++L+ N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 41/117 (35%), Positives = 55/117 (47%), Gaps = 17/117 (14%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 61
N+ L L N L +P ++F++ L YLSL N LQ P G +F+ +SL L L NN
Sbjct: 110 NLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKG-VFDKLTSLKELRLYNN 167
Query: 62 HFS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGN 113
G D L L+TL L +N +P+G +L LK L LQ N
Sbjct: 168 QLKRVPEGAFD--------KLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 54/214 (25%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 619
+G G+ G V ++ A+K ++Q REV + + ++ P+++ +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 620 YYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLA 670
Y L+V + G +L R+ ++T R K I + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGG----ELFSRIQDRGDQAFTEREASEIMKSIG---EAIQ 131
Query: 671 HLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
+LH I H ++KP N+L N +++DFG
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
A E T + ++ CD++ GV++ L+ G P
Sbjct: 167 -AKETTGEKY--DKSCDMWSLGVIMYILLCGYPP 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 30/213 (14%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARH--PNLI 615
G G FG+VY + +A+K ++ + EV +L K +I
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 616 SLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNR--FKVILGTAKGLAHL 672
L ++ P +L+ + P L + ER L+ R F +L + + H
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---RSFFWQVL---EAVRHC 165
Query: 673 HHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 728
H ++H ++K NIL+D N ++ DFG LL + G Y
Sbjct: 166 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-------TVYTDFDGTRVYS 215
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
PE ++ G+L+ ++V G P
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 34/162 (20%), Positives = 70/162 (43%), Gaps = 32/162 (19%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARH 611
+G G +G V + + R++A+KK+ FE RE+ +L + H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI--------LRVFEDLIDCKRILREIAILNRLNH 111
Query: 612 PNLISLEGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GT 665
+++ + ++ +V + + + + L+ K +L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT-ELHIKTLLYNL 165
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707
G+ ++H S I+H +LKP+N L++ + + ++ DFGLAR
Sbjct: 166 LVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 38/224 (16%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKAR-HPNLISL 617
+G+G +G V+K G ++AVKK+ D Q D + RE+ +L + H N+++L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 618 EGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 674
+ LV DY ++ LH + L + ++ K + +LH
Sbjct: 75 LNVLRADNDRDVYLVFDY-----METDLH-AVIRANILE-PVHKQYVVYQLIKVIKYLHS 127
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--------- 725
++H ++KPSNILL+ + +++DFGL+R + + +
Sbjct: 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 726 ----GYV------APELTCQSLRVNEKCDIYGFGVLILELVTGR 759
YV APE+ S + + D++ G ++ E++ G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 38/222 (17%)
Query: 557 EKAAEVGEGVFGTVYK-VSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REV---RV 605
E AE+GEG +G V+K GR +A+K+ ++ E REV R
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKR------VRVQTGEEGMPLSTIREVAVLRH 67
Query: 606 LGKARHPNLISLE----GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK 660
L HPN++ L + KL LV ++ L +++P P +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DL-TTYLDKVPE-PGVPTETIKD 124
Query: 661 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVM 717
++ +GL LH ++H +LKP NIL+ + +++DFGLAR+ + L V+
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
L Y APE+ QS D++ G + E+ +
Sbjct: 182 ------TLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G+G FG V+ F + A+K L ++ +D E E RVL A HP L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 618 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
+ T + L V +Y G L + + F ++ILG L LH
Sbjct: 84 FCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRA---TFYAAEIILG----LQFLH 135
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
I++ +LK NILLD + + +I+DFG+ + + +N F Y+APE+
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPDYIAPEIL 190
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ N D + FGVL+ E++ G+ P +G+D
Sbjct: 191 -LGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQD 222
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 622
G G FG + ++AVK + I E+ +RE+ RHPN++ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAID--ENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 623 TPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLHHSFRP 678
TP ++ +YA G L ++ R R F+ +L G+++ H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQLLS---GVSYCHSMQ-- 136
Query: 679 PIIHYNLKPSNILLDDNYNPR--ISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 733
I H +LK N LLD + PR I DFG ++ V+ ++ +S +G Y+APE+
Sbjct: 137 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 189
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRP 761
+ + D++ GV + ++ G P
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G+G FG V + AVK L +IQ +D E E RVL + P L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQL 86
Query: 618 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
+ T +L V +Y G L + + P + F ++ +G L L
Sbjct: 87 HSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHA---VFYAAEIAIG----LFFLQ 138
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 732
II+ +LK N++LD + +I+DFG+ + + V + F Y+APE +
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEII 193
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
Q + D + FGVL+ E++ G+ P GED
Sbjct: 194 AYQPY--GKSVDWWAFGVLLYEMLAGQAPF-EGED 225
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 29/169 (17%), Positives = 61/169 (36%), Gaps = 15/169 (8%)
Query: 23 FENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80
SL Y++LA + + Y ++ L ++N H + + + I L
Sbjct: 40 EAQMNSLTYITLANI----NVTDLTGIEYAHNIKDLTINNIHAT-NYN-----PISGLSN 89
Query: 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 140
L L + + ++ L L L + + + I P + ++DLS N
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG 189
+ L+ L + +++ + + D I + L L + + G
Sbjct: 150 TDIM-PLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 33/149 (22%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 261 SNNLVGDI-PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQE 319
+ +I A+M +L Y+ L++ ++ + + Y H++ L + N +
Sbjct: 31 GQSSTANITEAQM---NSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHA--TNYNP 83
Query: 320 VCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 379
+ +L L++ G +T + TSL LL +SH+ SI I+ L K+ + L
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 380 EFNELSGEIPQELGKLASLLAVNVSYNRL 408
+N +I L L L ++N+ ++ +
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 30/139 (21%), Positives = 54/139 (38%), Gaps = 10/139 (7%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+K L ++N + P ++L L + G + + +SL L++S++
Sbjct: 67 NIKDLTINNIHATNYNP---ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
D I +L ++ ++DLS+N I + L LK L +Q +
Sbjct: 124 HD-DSILT---KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG-- 176
Query: 123 IGFCPHLTTLDLSNNLFTG 141
I P L L + G
Sbjct: 177 IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 32/193 (16%), Positives = 69/193 (35%), Gaps = 18/193 (9%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+ K L + + A ++ L + L + I + ++ L ++N
Sbjct: 21 TFKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 196
T P + L+++ + + +T D + +++L LD S++ S+ + +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 255
K++ I L N +I L L L+ +++ +G F L
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV-HDYRGIED-------FPKLN 184
Query: 256 ILDLSSNNLVGDI 268
L S +G
Sbjct: 185 QLYAFSQT-IGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 24/216 (11%), Positives = 63/216 (29%), Gaps = 41/216 (18%)
Query: 173 NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSE 231
+ + + L+ I L ++ ++ G+ ++++ ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291
++ + S L L L + ++ D + +L L++S +
Sbjct: 76 IHA-------TNYNPISGLSN-LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 292 IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLY 351
I ++ + +DL N I ++ L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDI-------------------------MPLKTLPELK 162
Query: 352 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 387
L++ + + I + KL L + G+
Sbjct: 163 SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REV---RVLGKA 609
E AE+G G +GTVYK G +A+K + + REV R L
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 610 RHPNLISLE----GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 664
HPN++ L ++K+ LV ++ L ++ P P L ++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DL-RTYLDKAP-PPGLPAETIKDLMRQ 128
Query: 665 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVMSNRF 721
+GL LH + I+H +LKP NIL+ +++DFGLAR+ + L V+
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV---- 181
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
L Y APE+ QS D++ G + E+ +
Sbjct: 182 --TLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRK 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 45/216 (20%), Positives = 79/216 (36%), Gaps = 34/216 (15%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKAR----HPN 613
G+G FGTV+ T +A+K +++ + EV +L K HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 614 LISLEGYYWTPQLKLLVSDYAPNG-------SLQAKLHERLPSTPPLSWTNRFKVILGTA 666
+I L ++ T + +LV + + + L E F ++
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-------CFFGQVV--- 149
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSAL 725
+ H H ++H ++K NIL+D ++ DFG LL F
Sbjct: 150 AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTR 202
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761
Y PE + ++ G+L+ ++V G P
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G+G FG V G + AVK L I+Q +D E E R+L A HP L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQL 89
Query: 618 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
+ TP +L V ++ G L + + + RF ++I L LH
Sbjct: 90 FCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARA---RFYAAEIISA----LMFLH 141
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 732
II+ +LK N+LLD + +++DFG+ + + V + F Y+APE L
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYIAPEIL 196
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
D + GVL+ E++ G P E+
Sbjct: 197 QEMLY--GPAVDWWAMGVLLYEMLCGHAPF-EAEN 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 25/229 (10%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G G + V V R+ A+K + + ED + E V +A HP L+ L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 618 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
+ T +L V +Y G L + + + RF ++ L L +LH
Sbjct: 76 HSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA----LNYLH 127
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 732
II+ +LK N+LLD + +++D+G+ + L ++ F Y+APE L
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEIL 182
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781
+ D + GVL+ E++ GR P + + L +
Sbjct: 183 RGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 37/237 (15%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G G + V V R+ A++ + + ED + E V +A HP L+ L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 618 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
+ T +L V +Y G L + + + RF ++ L L +LH
Sbjct: 119 HSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA----LNYLH 170
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 732
II+ +LK N+LLD + +++D+G+ + L ++ F Y+APE L
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEIL 225
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRP--------VEYGEDNV----VILSEHVR 777
+ D + GVL+ E++ GR P VIL + +R
Sbjct: 226 RGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 66/331 (19%), Positives = 112/331 (33%), Gaps = 75/331 (22%)
Query: 126 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 185
+T+LDLS N +S L +++ L+ S N
Sbjct: 21 PHGVTSLDLSLNNLY---SISTVELIQAF----------------ANTPASVTSLNLSGN 61
Query: 186 HLT----GSLPSSL-FNCKKLSVIRLRGNSLNGNIPEGLFDLG---------LEEIDLSE 231
L L L ++ + L GN L+ + +L + +DL
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLS---YKSSDELVKTLAAIPFTITVLDLGW 118
Query: 232 NGFMGSIPPGSSSSSS-----STLFQTLRILDLSSNNLVGDIPAE------MGLFANLRY 280
N F S SSS S L ++ L+L N+L G ++ + AN+
Sbjct: 119 NDF------SSKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDELIQILAAIPANVNS 171
Query: 281 LNLSSNHLRSRIPPELGYF-----HSLIHLDLRNNALYGSIPQEVCE-----SRSLGILQ 330
LNL N+L S+ EL F S+ LDL N L E+ + L
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLN 231
Query: 331 LDGNSLTGP----IPQVIRNCTSLYLLSLSHNHLSG-------SIPKSISNLNKLKILKL 379
L N L GP + + + L + L ++ + ++ + N+ K+ ++
Sbjct: 232 LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDK 291
Query: 380 EFNELSGEIPQELGKLASLLAVNVSYNRLIG 410
E+ + L L+ L+
Sbjct: 292 NGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 58/394 (14%), Positives = 118/394 (29%), Gaps = 103/394 (26%)
Query: 43 IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL--------KRLRTLDLSHNLFSGS 94
+ + + + +L+LS N+ L + +L+LS N
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSI-------STVELIQAFANTPASVTSLNLSGNSLG-- 64
Query: 95 IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI 154
+ L ++L ++T+L+LS N + + S L +
Sbjct: 65 -FKNSDEL---VQILAAIPA-------------NVTSLNLSGNFLSYK---SSDELVKTL 104
Query: 155 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGS----LPSSLFNC-KKLSVIRLRGN 209
+ T+ LD N + + N ++ + LRGN
Sbjct: 105 ---AAIPF-------------TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGN 148
Query: 210 SLNGNIPEGLFDLG---------LEEIDLSENGFMGSIPPGSS--SSSSSTLFQTLRILD 258
L + +L + ++L N + + +++ ++ LD
Sbjct: 149 DLG---IKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASIPASVTSLD 202
Query: 259 LSSNNLVGDIPAEM---GLFAN---LRYLNLSSNHLRSRIPPELGYF----HSLIHLDLR 308
LS+N L G + + LNL N L L L + L
Sbjct: 203 LSANLL-GLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 309 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI 368
+ + ++ +E C++ + N + L+ + + S I
Sbjct: 262 YDIV-KNMSKEQCKA----------------LGAAFPNIQKIILVDKNGKEIHPSHSIPI 304
Query: 369 SNLNKLKILKLEFNELSGEIPQELGKLASLLAVN 402
SNL + K + L + K + +
Sbjct: 305 SNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDL 338
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 61/356 (17%), Positives = 102/356 (28%), Gaps = 94/356 (26%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFE----NCASLRYLSLAGNILQGPIGKIF-----NYCSSL 53
+ LDLS N L +L + AS+ L+L+GN L +++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 54 NTLNLSNNHFSGDLDFASGYGIWSL--------KRLRTLDLSHNLFSGSIPQGVAAL--- 102
+LNLS N S L + LDL N FS + +
Sbjct: 83 TSLNLSGNFLSYK-------SSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEFKQA 132
Query: 103 -----HYLKELLLQGNQFSGPLPADIG----------FCPHLTTLDLSNNLFT------- 140
+ L L+GN ++ +L+L N
Sbjct: 133 FSNLPASITSLNLRGNDLG-----IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAEL 187
Query: 141 ----GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIG-----NISTLEFLDFSNNHLTGS- 190
+P S+ L+ +S N L + + + L+ N L G
Sbjct: 188 AKFLASIPASVTSLD------LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241
Query: 191 ---LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG--------LEEIDLSENGFMGSIP 239
L + K L + L + + E LG + +D + P
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI---HP 298
Query: 240 PGSS--SSSSSTLFQTLRILDLSSNNL-----VGDIPAEMGLFANLRYLNLSSNHL 288
S S+ L + L + L ++ + LR + L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 617
+G+G FG V + AVK L I++ ++ + E VL K +HP L+ L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 618 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 673
+ T KL V DY G L L P + RF ++ L +LH
Sbjct: 105 HFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPRA---RFYAAEIASA----LGYLH 156
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
I++ +LKP NILLD + ++DFGL + ++ + ++ F Y+APE+
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAPEVL 211
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767
+ D + G ++ E++ G P Y +
Sbjct: 212 -HKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRN 243
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 59/419 (14%), Positives = 126/419 (30%), Gaps = 41/419 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFE-NCASLRYLSLAG--NILQGPIGKIFNYCSSLNTLNLS 59
+K + ++S +L + L L L + I +C + TL +
Sbjct: 113 QLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLME 172
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL----HYLKELLLQGNQF 115
+ FS L L+ F+ P+ + + L + + +
Sbjct: 173 ESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI 232
Query: 116 SGP--LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGN 173
L+ ++ + ++L + + +S +P
Sbjct: 233 LELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPF 291
Query: 174 ISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-----LEEI 227
+ + LD T + + C L V+ R + GL L L+ +
Sbjct: 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD----RGLEVLAQYCKQLKRL 347
Query: 228 DLSENGFMGSIPPGSSSSSSSTL------FQTLRILDLSSNNL----VGDIPAEMGLFAN 277
+ + S L Q L + + +++ + I + +
Sbjct: 348 RIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD 407
Query: 278 LRYLNLSSNHLRSRIPPELGYFHSLIHL-DLRNNALYG--------SIPQEVCESRSLGI 328
R + L + +P + G LI LR A Y + S ++
Sbjct: 408 FRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRW 467
Query: 329 LQLDGNSLTGP-IPQVIRNCTSLYLLSLSHNHLS-GSIPKSISNLNKLKILKLEFNELS 385
+ L + + + R C +L L + S +I +++ L L+ L ++ S
Sbjct: 468 MLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 49/394 (12%), Positives = 107/394 (27%), Gaps = 90/394 (22%)
Query: 9 LSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLD 68
++ L P +L +LR L L G NL ++ G +
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKG-------------KPRAAMFNLIPENWGGYVT 101
Query: 69 FASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPH 128
+L++L+++ + S L L +
Sbjct: 102 PWVTEISNNLRQLKSVHFRRMIVSDL------DLDRLAK----------------ARADD 139
Query: 129 LTTLDLSN--NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186
L TL L T L + + + + ++ + W+ ++
Sbjct: 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ---------- 189
Query: 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-----LEEIDLSENGFMGSIPPG 241
+ L V+ P+ L + L + + + + +
Sbjct: 190 ----------HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFF 239
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 301
++++ + L+ + + + + L L LS +P +
Sbjct: 240 KAAAN----LEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQ 294
Query: 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361
+ LDL L T +I+ C +L +L +
Sbjct: 295 IRKLDLLYALL-----------------------ETEDHCTLIQKCPNLEVLETRNVIGD 331
Query: 362 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 395
+ +LK L++E + E G +
Sbjct: 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLV 365
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 77/355 (21%), Positives = 121/355 (34%), Gaps = 96/355 (27%)
Query: 550 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFERE- 602
+ L L K +G G FG V + + R +AVK L E
Sbjct: 19 FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 76
Query: 603 ------------VRVLG---KARHPNLI--------SLEGYYWT-----PQLKLLVSDYA 634
V +LG K P ++ +L Y + K + +
Sbjct: 77 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136
Query: 635 PN----GSLQAKLHERLPSTPP--------------LSWTNRFKVILGT----------- 665
G++ L RL S LS +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 666 ------AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 719
AKG+ L + R IH +L NILL + +I DFGLAR + + +V
Sbjct: 197 CYSFQVAKGMEFL--ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 720 RFQSALGYVAPELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 775
+ L ++APE ++ + D++ FGVL+ E+ + G P Y V + E
Sbjct: 254 DARLPLKWMAPE----TIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPG---VKIDEE 304
Query: 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
L+EG + P+ + + L C PS RP+ +E+V+ L
Sbjct: 305 FCRRLKEGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 65/440 (14%), Positives = 133/440 (30%), Gaps = 47/440 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG--NILQGPIGKIFNYCSSLNTLNLSN 60
++ + L +++ + ++ + + L L+ + I C +L L+L
Sbjct: 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRE 165
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLS--HNLFS-GSIPQGVAALHYLKELLLQGNQFSG 117
+ + + L +L++S + S ++ + V LK L L
Sbjct: 166 SDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225
Query: 118 PLPADIGFCPHLTTLDLS------NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 171
L + P L L L V+L + +S + + +P
Sbjct: 226 KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVY 285
Query: 172 GNISTLEFLDFSNNHLTG-SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-----LE 225
S L L+ S + L L C KL + + + GL L L
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIED----AGLEVLASTCKDLR 341
Query: 226 EIDLSE-NGFMGSIPPGSSSSSSSTLFQTLRILD--LSSNNLVGDIPAEMGLFA------ 276
E+ + F+ + ++ L+ L + + L
Sbjct: 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTN----AALITIARNRP 397
Query: 277 NLRYLNLSSNHLRSRIPPELG-----------YFHSLIHLDLRNNALYGSIPQEVCESRS 325
N+ L ++ L + L L L ++
Sbjct: 398 NMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKK 457
Query: 326 LGILQLDGNSLTGP-IPQVIRNCTSLYLLSLSH-NHLSGSIPKSISNLNKLKILKLEFNE 383
+ +L + + + V+ C SL L + ++ + S L ++ L +
Sbjct: 458 MEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517
Query: 384 LSGEIPQELGKLASLLAVNV 403
+S + LG+ L V V
Sbjct: 518 VSFGACKLLGQKMPKLNVEV 537
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 57/358 (15%), Positives = 104/358 (29%), Gaps = 43/358 (12%)
Query: 22 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYG--IWSLK 79
L C +L+ L L + + + L L D SG + K
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCK 265
Query: 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP-LPADIGFCPHLTTLDLSNNL 138
LR L + +P + L L L L + CP L L + + +
Sbjct: 266 ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI 325
Query: 139 -------FTGQLP--VSLRLLNSMIFISVSNNTLTGDIPHWIG-NISTLEFLDFSNNHLT 188
LR+ S F+ N LT + LE + + +T
Sbjct: 326 EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT 385
Query: 189 G-SLPSSLFNCKKLSVIRLRGNSLNG--NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSS 245
+L + N ++ RL + D+G I
Sbjct: 386 NAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAI------------------ 427
Query: 246 SSSTLFQTLRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSR-IPPELGYFHSL 302
+ LR L LS L+ D E + L+++ + L SL
Sbjct: 428 --VEHCKDLRRLSLS--GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSL 483
Query: 303 IHLDLRNNALYG-SIPQEVCESRSLGILQLDGNSLTGP-IPQVIRNCTSLYLLSLSHN 358
L++R+ ++ + ++ L + S++ + + L + +
Sbjct: 484 RKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER 541
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 59/465 (12%), Positives = 127/465 (27%), Gaps = 78/465 (16%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAG---------------NILQGPIGKIFNYCS 51
+ P + +R + L G + I + + +
Sbjct: 46 RKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYT 105
Query: 52 SLNTLNLSNNHFSGD--------------LDFASGYGI---------WSLKRLRTLDLSH 88
L + L + D L +S G + + L+ LDL
Sbjct: 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRE 165
Query: 89 NLFSGSIPQGVAAL----HYLKELLLQGNQFS---GPLPADIGFCPHLTTLDLSNNLFTG 141
+ ++ L L + L + CP+L +L L+ +
Sbjct: 166 SDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225
Query: 142 QLPV------SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 195
+L L L + + + + + + L L + + LP+
Sbjct: 226 KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVY 285
Query: 196 FNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 253
C +L+ + L ++ L L+ + + + + +S+ +
Sbjct: 286 SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGL---EVLASTCKDLRE 342
Query: 254 LRILDLSSNNLVGDIP-AEMGLFA------NLRYLNLSSNHLRSRIPPELG-YFHSLIHL 305
LR+ + ++ E GL + L + + + + ++
Sbjct: 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRF 402
Query: 306 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 365
L C L L ++ +C L LSLS
Sbjct: 403 RL-------------CIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFE 449
Query: 366 KSISNLNKLKILKLEFNELSGE-IPQELGKLASLLAVNVSYNRLI 409
+ K+++L + F S + L SL + +
Sbjct: 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 46/192 (23%), Positives = 73/192 (38%), Gaps = 27/192 (14%)
Query: 24 ENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81
A+ +L + + S + N N++ L G+ L
Sbjct: 16 PGLANAVKQNLGKQ----SVTDLVSQKELSGVQNFNGDNSNIQ-SLA-----GMQFFTNL 65
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLF 139
+ L LSHN S + + L L+EL + N+ ++ L+ L L NN
Sbjct: 66 KELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNEL 118
Query: 140 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCK 199
SL L ++ +S+ NN L I +G +S LE LD N +T + L K
Sbjct: 119 RD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT-GGLTRLK 172
Query: 200 KLSVIRLRGNSL 211
K++ I L G
Sbjct: 173 KVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 41/254 (16%), Positives = 80/254 (31%), Gaps = 47/254 (18%)
Query: 157 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 216
S+ T + ++ + +T S + +++ ++
Sbjct: 2 SIQRPTPINQVFP-DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL- 56
Query: 217 EGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 275
G+ L+E+ LS N + + P L L ++ N L ++
Sbjct: 57 AGMQFFTNLKELHLSHNQ-ISDLSPLKD-------LTKLEELSVNRNRLK-NLNGIPSA- 106
Query: 276 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 335
L L L +N LR L + +L L +RNN L S
Sbjct: 107 -CLSRLFLDNNELRD-TDS-LIHLKNLEILSIRNNKL---------------------KS 142
Query: 336 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 395
+ + + L +L L N ++ + ++ L K+ + L + E + +L
Sbjct: 143 IVM-----LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPEL 195
Query: 396 ASLLAVNVSYNRLI 409
V R I
Sbjct: 196 YITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 38/187 (20%), Positives = 65/187 (34%), Gaps = 20/187 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFN-YCSSLNTLNLSNN 61
N+K L LS+N +S P ++ L LS+ N + + + L+ L L NN
Sbjct: 64 NLKELHLSHNQISDLSP---LKDLTKLEELSVNRN----RLKNLNGIPSACLSRLFLDNN 116
Query: 62 HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPA 121
D D + LK L L + +N SI + L L+ L L GN+ +
Sbjct: 117 ELR-DTD-----SLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG- 167
Query: 122 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181
+ + +DL+ + L + + P++I N +
Sbjct: 168 -LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGC 224
Query: 182 FSNNHLT 188
Sbjct: 225 VLWELPV 231
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 24/154 (15%)
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIP 293
IP L +T+ + L N + IP G F+ LR ++LS+N + +
Sbjct: 25 EIPTN--------LPETITEIRLEQNTIK-VIPP--GAFSPYKKLRRIDLSNNQISE-LA 72
Query: 294 PELGYFHSLIHL---DLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTS 349
P F L L L N + +P+ + E SL +L L+ N + ++ +
Sbjct: 73 P--DAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 350 LYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
L LLSL N L +I K S L ++ + L N
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 35/168 (20%), Positives = 59/168 (35%), Gaps = 45/168 (26%)
Query: 175 STLEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENG 233
T+ + N + +P F+ KKL I L N ++ + F GL
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQ-GLRS------- 81
Query: 234 FMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRS 290
L L L N + ++P LF +L+ L L++N +
Sbjct: 82 --------------------LNSLVLYGNKIT-ELPK--SLFEGLFSLQLLLLNANKINC 118
Query: 291 RIPPELGYF---HSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGN 334
+ F H+L L L +N L +I + R++ + L N
Sbjct: 119 -LRV--DAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 30/143 (20%), Positives = 47/143 (32%), Gaps = 17/143 (11%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 61
+ + L N + +P F LR + L+ N + F SLN+L L N
Sbjct: 33 TITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPD-AFQGLRSLNSLVLYGN 90
Query: 62 HF----SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFS 116
+ L L+ L L+ N + + LH L L L N+
Sbjct: 91 KITELPKSLFE--------GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 117 GPLPADIGFCPHLTTLDLSNNLF 139
+ T+ L+ N F
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 30/142 (21%), Positives = 55/142 (38%), Gaps = 18/142 (12%)
Query: 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLR 82
++ + L N ++ F+ L ++LSNN S L+ L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ--------GLRSLN 83
Query: 83 TLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFC--PHLTTLDLSNNLF 139
+L L N + +P+ + L L+ LLL N+ + L D F +L L L +N
Sbjct: 84 SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDA-FQDLHNLNLLSLYDNKL 140
Query: 140 TGQLPVSLRLLNSMIFISVSNN 161
+ L ++ + ++ N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 31/164 (18%), Positives = 52/164 (31%), Gaps = 46/164 (28%)
Query: 55 TLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELL 109
+ L N G K+LR +DLS+N S + L L L+
Sbjct: 36 EIRLEQNTIKVIPPGAFS--------PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV 86
Query: 110 LQGNQFSGPLPADIGFC--PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDI 167
L GN+ + LP + F L L L+ N ++ +
Sbjct: 87 LYGNKITE-LPKSL-FEGLFSLQLLLLNAN----KI---------------------NCL 119
Query: 168 PHWI-GNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGN 209
++ L L +N L ++ F + + + L N
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 36/171 (21%), Positives = 63/171 (36%), Gaps = 33/171 (19%)
Query: 268 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLG 327
IP L + + L N ++ IPP G F + L
Sbjct: 26 IPT--NLPETITEIRLEQNTIKV-IPP--GAFSPY---------------------KKLR 59
Query: 328 ILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELSG 386
+ L N ++ P + SL L L N ++ +PKS+ L L++L L N+++
Sbjct: 60 RIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN- 117
Query: 387 EIPQEL-GKLASLLAVNVSYNRLIGRLPVGGV--FPTLDQSSLQGNLGICS 434
+ + L +L +++ N+L + G + L N IC
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQNPFICD 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 35/195 (17%), Positives = 63/195 (32%), Gaps = 65/195 (33%)
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
LP I T + L N +++++ F L
Sbjct: 30 LPETI------TEIRLEQN--------TIKVIPPGAFSPYKK----------------LR 59
Query: 179 FLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFM 235
+D SNN ++ L F + L+ + L GN + +P+ LF+ L+ + L+ N +
Sbjct: 60 RIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK-I 116
Query: 236 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE 295
+ + FQ L NL L+L N L++
Sbjct: 117 NCLRVDA--------FQDLH---------------------NLNLLSLYDNKLQTIAKGT 147
Query: 296 LGYFHSLIHLDLRNN 310
++ + L N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 6e-11
Identities = 33/200 (16%), Positives = 58/200 (29%), Gaps = 45/200 (22%)
Query: 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-------VTSDIIQYPEDFER 601
P L++ ++GEGVFG V++ +A+K + V + E+
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 602 EVRVL---------GKARHPNLISLEGYY----WTPQLKLLVSDY--APNGSLQAKLHER 646
E+ + R I L + P L L D+ + GS +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 647 LPSTPPL-------------------SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 687
+ S ++ LA S R H +L
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 688 SNILLDDNYNPRISDFGLAR 707
N+LL ++ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 40/146 (27%), Positives = 58/146 (39%), Gaps = 29/146 (19%)
Query: 3 NMKFLDLSNNLLS---GPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 59
K L LS N + +LR LSL N+++ I + +L L +S
Sbjct: 49 ACKHLALSTNNIEKISS------LSGMENLRILSLGRNLIKK-IENLDAVADTLEELWIS 101
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS--GSIPQGVAALHYLKELLLQGNQFSG 117
N + L GI L LR L +S+N + G I +AAL L++LLL GN
Sbjct: 102 YNQIA-SLS-----GIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYN 154
Query: 118 PLPAD----------IGFCPHLTTLD 133
+ + P+L LD
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 20/150 (13%)
Query: 43 IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL 102
+ + + L LS N+ + + ++ LR L L NL I A
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KIS-----SLSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 103 HYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNN 161
L+EL + NQ + + I +L L +SNN T + L L+ + + ++ N
Sbjct: 93 DTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
Query: 162 TLTGDIPHW----------IGNISTLEFLD 181
L D + + L+ LD
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 30/139 (21%), Positives = 49/139 (35%), Gaps = 15/139 (10%)
Query: 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI---GFCPHLTTLDLSNNLFT 140
L + ++ L K L L N I +L L L NL
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK 83
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT--GSLPSSLFNC 198
++ + +++ + +S N + + I + L L SNN +T G + L
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAAL 139
Query: 199 KKLSVIRLRGNSLNGNIPE 217
KL + L GN L + E
Sbjct: 140 DKLEDLLLAGNPLYNDYKE 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 40/179 (22%), Positives = 68/179 (37%), Gaps = 41/179 (22%)
Query: 217 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL-- 274
+ + E+++L G IPP ++ + + + L LS+NN I L
Sbjct: 18 KSVVATEAEKVELH-----GMIPPIEKMDATLSTLKACKHLALSTNN----IEKISSLSG 68
Query: 275 FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGN 334
NLR L+L N + +I +L L + N I L G
Sbjct: 69 MENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQ----------------IASLSG- 110
Query: 335 SLTGPIPQVIRNCTSLYLLSLSHNHLS--GSIPKSISNLNKLKILKLEFNELSGEIPQE 391
I +L +L +S+N ++ G I ++ L+KL+ L L N L + +
Sbjct: 111 ---------IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 32/134 (23%), Positives = 49/134 (36%), Gaps = 20/134 (14%)
Query: 107 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT-----GQLPVSLRLLNSMIFISVSNN 161
EL + A + L LS N + +LR+L+ + N
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLSGME-NLRILS------LGRN 80
Query: 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE--GL 219
+ I + TLE L S N + SL S + L V+ + N + N E L
Sbjct: 81 LIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKL 136
Query: 220 FDL-GLEEIDLSEN 232
L LE++ L+ N
Sbjct: 137 AALDKLEDLLLAGN 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 31/144 (21%), Positives = 53/144 (36%), Gaps = 18/144 (12%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
L L+NN + +F+ LR ++ + N + F S +N + L++N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 63 F----SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSG 117
L+ L+TL L N + + L ++ L L NQ +
Sbjct: 93 LENVQHKMFK--------GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT- 142
Query: 118 PLPADIGF--CPHLTTLDLSNNLF 139
+ F L+TL+L N F
Sbjct: 143 TVAPGA-FDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 16/140 (11%)
Query: 268 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCES- 323
IP + L L++N + + G F L ++ NN + I + E
Sbjct: 26 IPE--HIPQYTAELRLNNNEF-TVLEAT-GIFKKLPQLRKINFSNNKI-TDIEEGAFEGA 80
Query: 324 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
+ + L N L ++ + SL L L N ++ + L+ +++L L N
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 383 ELSGEIPQE----LGKLASL 398
+++ + L L++L
Sbjct: 140 QIT-TVAPGAFDTLHSLSTL 158
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 40/181 (22%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 66
+ L+ L+ Y N R L L G + I + + ++ S+N
Sbjct: 2 VKLTAELIEQAAQY---TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 126
LD G L+RL+TL +++N + + E L Q
Sbjct: 57 LD-----GFPLLRRLKTLLVNNN-----------RICRIGEGLDQA-------------L 87
Query: 127 PHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNNTLTGDIPHW----IGNISTLEFLD 181
P LT L L+NN + L L S+ ++ + N +T + H+ I + + LD
Sbjct: 88 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146
Query: 182 F 182
F
Sbjct: 147 F 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 18/87 (20%), Positives = 29/87 (33%), Gaps = 6/87 (6%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+D S+N + F L+ L + N + + L L L+NN
Sbjct: 43 QFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHN 89
+ + SLK L L + N
Sbjct: 100 LV---ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 24/134 (17%), Positives = 46/134 (34%), Gaps = 15/134 (11%)
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGS 237
+ + + + + N + + LRG + + E L + ID S+N
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDN----- 52
Query: 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS-RIPPEL 296
L + L+ L +++N + +L L L++N L L
Sbjct: 53 ---EIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 109
Query: 297 GYFHSLIHLDLRNN 310
SL +L + N
Sbjct: 110 ASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 22/128 (17%), Positives = 39/128 (30%), Gaps = 8/128 (6%)
Query: 281 LNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI 340
+ L++ + + LDLR + I + N + +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 341 PQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS--GEIPQELGKLASL 398
L L +++N + L L L L N L G++ L L SL
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSL 115
Query: 399 LAVNVSYN 406
+ + N
Sbjct: 116 TYLCILRN 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 28/115 (24%), Positives = 43/115 (37%), Gaps = 8/115 (6%)
Query: 25 NCASLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83
A++R L L G I + +L L+L N + + L +L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-----NLPKLPKLKK 75
Query: 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD-IGFCPHLTTLDLSNN 137
L+LS N G + L L L L GN+ + + L +LDL N
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 34/141 (24%), Positives = 47/141 (33%), Gaps = 14/141 (9%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSN 60
++ L L N + L +L +LSL L + L L LS
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI----SVSNLPKLPKLKKLELSE 80
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG-SIPQGVAALHYLKELLLQGN---QFS 116
N G LD + L L L+LS N S + + L LK L L +
Sbjct: 81 NRIFGGLDMLAE----KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136
Query: 117 GPLPADIGFCPHLTTLDLSNN 137
+ P LT LD +
Sbjct: 137 DYRESVFKLLPQLTYLDGYDR 157
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 29/142 (20%), Positives = 52/142 (36%), Gaps = 11/142 (7%)
Query: 49 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 108
+++ L L N + L L L + S+ + L LK+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTA---EFVNLEFLSLINVGLI-SV-SNLPKLPKLKKL 76
Query: 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNNTLTGDI 167
L N+ G L P+LT L+LS N + L+ L + + + N +T ++
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NL 135
Query: 168 PHW----IGNISTLEFLDFSNN 185
+ + L +LD +
Sbjct: 136 NDYRESVFKLLPQLTYLDGYDR 157
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 23/86 (26%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIG-KIFNYCSSLNTLNLS 59
+ +K L+LS N + G L E +L +L+L+GN L+ + L +L+L
Sbjct: 70 LPKLKKLELSENRIFG-GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLF 128
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLD 85
N + D+ L +L LD
Sbjct: 129 NCEVTNLNDYRE-SVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 26/132 (19%), Positives = 43/132 (32%), Gaps = 32/132 (24%)
Query: 251 FQTLRILDLSSNNL--VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 308
F L L L + L V ++P L+ L LS N + + +L HL+L
Sbjct: 48 FVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 309 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN---HLSGSIP 365
N L + + L + ++ L L L + +L+
Sbjct: 104 GNKL-----------KDISTL------------EPLKKLECLKSLDLFNCEVTNLNDYRE 140
Query: 366 KSISNLNKLKIL 377
L +L L
Sbjct: 141 SVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 11/110 (10%)
Query: 129 LTTLDLSNNLFT-GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST---LEFLDFSN 184
+ L L N G++ ++ F+S+ N L + N+ L+ L+ S
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-----VSNLPKLPKLKKLELSE 80
Query: 185 NHLTGSLPSSLFNCKKLSVIRLRGNSLNG-NIPEGLFDL-GLEEIDLSEN 232
N + G L L+ + L GN L + E L L L+ +DL
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 24/87 (27%), Positives = 37/87 (42%), Gaps = 6/87 (6%)
Query: 254 LRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNN 310
L L + + + + GL LR L + + LR + P+ + L L+L N
Sbjct: 33 LTELYIENQQHLQHLELRDLRGL-GELRNLTIVKSGLRF-VAPDAFHFTPRLSRLNLSFN 90
Query: 311 ALYGSIPQEVCESRSLGILQLDGNSLT 337
AL S+ + + SL L L GN L
Sbjct: 91 AL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 21/120 (17%), Positives = 32/120 (26%), Gaps = 26/120 (21%)
Query: 94 SIPQGVAALHYLKELLLQGNQFSGPLPA-DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNS 152
+ L EL ++ Q L D+ L L + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------ 69
Query: 153 MIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212
V+ + L L+ S N L SL L + L GN L+
Sbjct: 70 ----FVAPDAFHF--------TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 7/116 (6%)
Query: 50 CSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKEL 108
+ L + + L + + L L + + + L L+ L
Sbjct: 7 PHGSSGLRCTRDGALDSLH-----HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164
+ + P F P L+ L+LS N L S+ + +S N L
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 12/118 (10%)
Query: 198 CKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
S +R + + L L E+ + + + LR
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGE-----LRN 60
Query: 257 LDLSSNNLVGDIPAE--MGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 312
L + + L + + L LNLS N L S + + SL L L N L
Sbjct: 61 LTIVKSGLR-FVAPDAFHFT-PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 18/92 (19%), Positives = 25/92 (27%), Gaps = 6/92 (6%)
Query: 47 FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYL 105
+L L + N L+ + L LR L + + + L
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRD---LRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 137
L L N L L L LS N
Sbjct: 83 SRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 20/95 (21%), Positives = 28/95 (29%), Gaps = 2/95 (2%)
Query: 291 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTS 349
L +L L + N + L L + + L P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 350 LYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384
L L+LS N L S+ L+ L L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 21/113 (18%), Positives = 36/113 (31%), Gaps = 29/113 (25%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+ L + N + + LR L++ + L+ ++ +
Sbjct: 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR----------------FVAPDA 75
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF 115
F RL L+LS N S+ L+EL+L GN
Sbjct: 76 FHF------------TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 1e-04
Identities = 18/112 (16%), Positives = 37/112 (33%), Gaps = 6/112 (5%)
Query: 126 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW-IGNISTLEFLDFSN 184
+ L + + L ++ + + N + + + L L
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 185 NHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGF 234
+ L + F +LS + L N+L ++ L L+E+ LS N
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 56/356 (15%), Positives = 98/356 (27%), Gaps = 93/356 (26%)
Query: 78 LKRLRTLDLSHNLFSGSIPQGVAAL--------HYLKELLLQGNQFSGPLPADIGFCP-- 127
L LR L+L+ + P + H L E+ L Q G
Sbjct: 71 LSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLD-----PAGLRTLL 122
Query: 128 ----HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183
L L N + + + L ++ + + + L S
Sbjct: 123 PVFLRARKLGLQLNSLGPE---ACKDLRDLL----------------LHDQCQITTLRLS 163
Query: 184 NNHLTGS----LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239
NN LT + L L ++ + L L D GLE +
Sbjct: 164 NNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG--------DEGLELL------------ 203
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM---GLFAN--LRYLNLSSNHLRSR--- 291
++ + L+ L+++ N GD A + L L+L N L S
Sbjct: 204 --AAQLDRNR---QLQELNVAYNGA-GDTAALALARAAREHPSLELLHLYFNELSSEGRQ 257
Query: 292 -IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 350
+ G + + G+ E S L +Q + NS ++ L
Sbjct: 258 VLRDLGGAAEGGARVVVSL--TEGTAVSEYW-SVILSEVQRNLNSWD---RARVQRHLEL 311
Query: 351 YLLSLSHNHLSGSIPKSISNL----NKLKILKLEFNELSGEIPQELGKLASLLAVN 402
L L + + P + L +++ L +
Sbjct: 312 LLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG---SPSGSWSHPQFEKG 364
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 44/282 (15%), Positives = 77/282 (27%), Gaps = 54/282 (19%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIF-----NYCSSLNTLN 57
+ ++L++ L L R L L N L K + + TL
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLR 161
Query: 58 LSNNHF--SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL-------HYLKEL 108
LSNN +G G+ + L L H +G+ L L+EL
Sbjct: 162 LSNNPLTAAGVAVLME--GLAGNTSVTHLSLLHTGLG---DEGLELLAAQLDRNRQLQEL 216
Query: 109 LLQGNQFSGP----LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164
+ N L P L L L N + ++L + +
Sbjct: 217 NVAYNGAGDTAALALARAAREHPSLELLHLYFNELS---SEGRQVLRDLGGAAEGG---- 269
Query: 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGL 224
+ + ++ + LS ++ NS + L L
Sbjct: 270 ----------ARVVVSLTEGTAVS------EYWSVILSEVQRNLNSWDRA--RVQRHLEL 311
Query: 225 EEIDLSENGFMGSIPPGSSSSSSSTLF--QTLRILDLSSNNL 264
DL ++ + + L +R L +
Sbjct: 312 LLRDLEDS----RGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 48/329 (14%), Positives = 86/329 (26%), Gaps = 92/329 (27%)
Query: 51 SSLNTLNLSNNHFSGDLDFASGYGIWSL--------KRLRTLDLSHNLFSGSIPQGVAAL 102
SSL LNL+ + + L ++L+ P G+ L
Sbjct: 72 SSLRQLNLAGVRMTPV-------KCTVVAAVLGSGRHALDEVNLASCQLD---PAGLRTL 121
Query: 103 ----HYLKELLLQGNQFSGPLPADIGF----------CPHLTTLDLSNNLFTGQLPVSLR 148
++L LQ N +TTL LSNN T +
Sbjct: 122 LPVFLRARKLGLQLNSLG-----PEACKDLRDLLLHDQCQITTLRLSNNPLT---AAGVA 173
Query: 149 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT----GSLPSSLFNCKKLSVI 204
+L + + NT ++ L + L L + L ++L +
Sbjct: 174 VLMEGL----AGNT-------------SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQEL 216
Query: 205 RLRGNSLNGNIPEGLFDLG--------LEEIDLSENGF----MGSIPPGSSSSSSSTLFQ 252
+ N L LE + L N + ++
Sbjct: 217 NVAYNGAG---DTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVV 273
Query: 253 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 312
L+ V + + + ++ S + R + EL DL ++
Sbjct: 274 VS----LTEGTAVSE--YWSVILSEVQRNLNSWDRARVQRHLELL------LRDLEDSRG 321
Query: 313 YGSIPQEVCES----RSLGILQLDGNSLT 337
P + + L S
Sbjct: 322 ATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER----EVRVLGKARHPNLISL 617
+G+G FG V K + +A+K +++ + F R E+R+L H
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK------MVRNEKRFHRQAAEEIRIL---EHLRKQDK 155
Query: 618 EGYYWTPQLK---------LLVSDYAPNGSLQAKLHERLPSTP----PLSWTNRF-KVIL 663
+ + + + L L+E + L +F IL
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 664 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRF 721
+ L LH + IIH +LKP NILL ++ DFG + + + +RF
Sbjct: 211 ---QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
Y APE+ R D++ G ++ EL+TG P+ GED L+ + +L
Sbjct: 265 -----YRAPEVILG-ARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIELL 315
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 34/137 (24%), Positives = 48/137 (35%), Gaps = 14/137 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSN 60
++K L L N+ + L + L +LS L I + L L LS+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT----SIANLPKLNKLKKLELSD 73
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG-SIPQGVAALHYLKELLLQGN---QFS 116
N SG L+ + L L+LS N S + + L LK L L +
Sbjct: 74 NRVSGGLEVLAE----KCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129
Query: 117 GPLPADIGFCPHLTTLD 133
P LT LD
Sbjct: 130 DYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 32/141 (22%), Positives = 57/141 (40%), Gaps = 11/141 (7%)
Query: 46 IFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYL 105
S + L L N+ + + + L L + + SI + L+ L
Sbjct: 12 RNRTPSDVKELVLDNSRSN---EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKL 66
Query: 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNNTLT 164
K+L L N+ SG L CP+LT L+LS N + L+ L ++ + + N +T
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
Query: 165 GDIPHW----IGNISTLEFLD 181
++ + + L +LD
Sbjct: 127 -NLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 29/131 (22%)
Query: 105 LKELLLQGNQFS-GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 163
+KEL+L ++ + G L L L N T S++N
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT----------------SIAN--- 59
Query: 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG-NIPEGLFDL 222
+ ++ L+ L+ S+N ++G L C L+ + L GN + + E L L
Sbjct: 60 -------LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL 112
Query: 223 -GLEEIDLSEN 232
L+ +DL
Sbjct: 113 ENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 24/86 (27%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIG-KIFNYCSSLNTLNLS 59
+ +K L+LS+N +SG + L E C +L +L+L+GN ++ + +L +L+L
Sbjct: 63 LNKLKKLELSDNRVSGGLE-VLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121
Query: 60 NNHFSGDLDFASGYGIWSLKRLRTLD 85
N + D+ L +L LD
Sbjct: 122 NCEVTNLNDYRE-NVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 20/90 (22%), Positives = 36/90 (40%), Gaps = 7/90 (7%)
Query: 251 FQTLRILDLSSNNL--VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 308
F+ L L + L + ++P L+ L LS N + + +L HL+L
Sbjct: 41 FEELEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96
Query: 309 NNALYG-SIPQEVCESRSLGILQLDGNSLT 337
N + S + + + +L L L +T
Sbjct: 97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 27/104 (25%), Positives = 44/104 (42%), Gaps = 5/104 (4%)
Query: 329 LQLDGNSLT-GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 387
L LD + G + + L LS + L+ SI ++ LNKLK L+L N +SG
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGG 79
Query: 388 IPQELGKLASLLAVNVSYNRL--IGRLPVGGVFPTLDQSSLQGN 429
+ K +L +N+S N++ + + L L
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 44/223 (19%)
Query: 563 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARH--PNLIS 616
G G F TV+ +A+K I+ Y E E E+++L +
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMK------IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 617 LEGYYWTPQLKLLVSDY----APNGSLQAKLHERL-PSTPPLSWTNRFKVI-LGTAK--- 667
G +L D+ PNG + E L + L + I L K
Sbjct: 82 SMGANHILKLL----DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 668 -----GLAHLHHSFRPPIIHYNLKPSNILLDDNYNP------RISDFGLARLLTRLDKHV 716
GL ++H IIH ++KP N+L++ +P +I+D G A +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 759
+ R Y +PE+ DI+ LI EL+TG
Sbjct: 196 IQTRE-----YRSPEVLLG-APWGCGADIWSTACLIFELITGD 232
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 43/232 (18%)
Query: 94 SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 153
P A + L+ + + + +N+ + L N +
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVTD-AVTQNEL-NSIDQIIANNSDIKS-VQGIQYLPN-V 65
Query: 154 IFISVSNNTLTGDIPHWIG---NISTLEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGN 209
++++ N L I ++ L +L + N L SLP+ +F+ L + L N
Sbjct: 66 RYLALGGNKLHD-----ISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 210 SLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL---RILDLSSNNL 264
L ++P+G+FD L ++L+ N + S+P G +F L LDLS N L
Sbjct: 120 QLQ-SLPDGVFDKLTNLTYLNLAHNQ-LQSLPKG--------VFDKLTNLTELDLSYNQL 169
Query: 265 VGDIPAEMGLF---ANLRYLNLSSNHLRSRIPPELGYF---HSLIHLDLRNN 310
+P G+F L+ L L N L+S +P G F SL ++ L +N
Sbjct: 170 -QSLPE--GVFDKLTQLKDLRLYQNQLKS-VPD--GVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 44/143 (30%), Positives = 58/143 (40%), Gaps = 23/143 (16%)
Query: 3 NMKFLDLSNN-LLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNN 61
N+++L L N L + +L YL L GN LQ +F+ ++L L L N
Sbjct: 64 NVRYLALGGNKLHDISA----LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
Query: 62 HF----SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFS 116
G D L L L+L+HN S+P+GV L L EL L NQ
Sbjct: 120 QLQSLPDGVFD--------KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170
Query: 117 GPLPADIGF--CPHLTTLDLSNN 137
LP + F L L L N
Sbjct: 171 S-LPEGV-FDKLTQLKDLRLYQN 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 45/133 (33%), Positives = 54/133 (40%), Gaps = 10/133 (7%)
Query: 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNNALY 313
LDL S L A L +LNL N L++ + G F L L L NN L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSA--GVFDDLTELGTLGLANNQL- 95
Query: 314 GSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNL 371
S+P V + L L L GN L V T L L L+ N L SIP L
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 372 NKLKILKLEFNEL 384
L+ L L N+L
Sbjct: 155 TNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 51/167 (30%), Positives = 71/167 (42%), Gaps = 24/167 (14%)
Query: 225 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF---ANLRYL 281
E++DL G ++ + + L L+L N L + A G+F L L
Sbjct: 38 EKLDLQSTGLA-TLSDATFRGLTK-----LTWLNLDYNQLQT-LSA--GVFDDLTELGTL 88
Query: 282 NLSSNHLRSRIPPELGYFHSLI---HLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLT 337
L++N L S +P G F L L L N L S+P V + L L+L+ N L
Sbjct: 89 GLANNQLAS-LPL--GVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 338 GPIPQ-VIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
IP T+L LSLS N L S+P L KL+ + L N
Sbjct: 145 S-IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 50/163 (30%), Positives = 67/163 (41%), Gaps = 21/163 (12%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHF-- 63
LDL + L+ + F L +L+L N LQ G +F+ + L TL L+NN
Sbjct: 40 LDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAG-VFDDLTELGTLGLANNQLAS 97
Query: 64 --SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLP 120
G D L +L L L N S+P GV L LKEL L NQ +P
Sbjct: 98 LPLGVFD--------HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IP 147
Query: 121 ADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161
A F +L TL LS N + L + I++ N
Sbjct: 148 AGA-FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 53/209 (25%), Positives = 75/209 (35%), Gaps = 61/209 (29%)
Query: 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 165
++L LQ + A LT L+L N L +F + LT
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAG-------VF-----DDLT- 83
Query: 166 DIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFDLGL 224
L L +NN L SLP +F+ +L + L GN L +P G+FD L
Sbjct: 84 ----------ELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFD-RL 130
Query: 225 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF---ANLRYL 281
+ L+ L L++N L IPA G F NL+ L
Sbjct: 131 TK---------------------------LKELRLNTNQL-QSIPA--GAFDKLTNLQTL 160
Query: 282 NLSSNHLRSRIPPELGYFHSLIHLDLRNN 310
+LS+N L+S L + L N
Sbjct: 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 11/157 (7%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCP-HLTTLDLSNNLFT 140
LDL + L L L L NQ L A + L TL L+NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 141 GQLPVSL-RLLNSMIFISVSNNTLTGDIPHWI-GNISTLEFLDFSNNHLTGSLPSSLFNC 198
LP+ + L + + + N L +P + ++ L+ L + N L S+P+ F+
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 199 -KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSEN 232
L + L N L ++P G FD L+ I L N
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 54/191 (28%), Positives = 67/191 (35%), Gaps = 44/191 (23%)
Query: 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLR 82
A L L L F + L LNL N G D L L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD--------DLTELG 86
Query: 83 TLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLF 139
TL L++N + S+P GV L L +L L GNQ LP+ + F L L L+ N
Sbjct: 87 TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGV-FDRLTKLKELRLNTNQL 143
Query: 140 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 198
+P F + LT L+ L S N L S+P F
Sbjct: 144 Q-SIPAG-------AF-----DKLTN-----------LQTLSLSTNQLQ-SVPHGAFDRL 178
Query: 199 KKLSVIRLRGN 209
KL I L GN
Sbjct: 179 GKLQTITLFGN 189
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 10/209 (4%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
++ +DLSN+++ + + C+ L+ LSL G L PI S+L LNLS
Sbjct: 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLS--HNLFSGSIPQGVA-ALHYLKELLLQGNQFS--- 116
+ + S RL L+LS + + VA + +L L G + +
Sbjct: 154 GFSEFALQ--TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 211
Query: 117 GPLPADIGFCPHLTTLDLSN-NLFTGQLPVSLRLLNSMIFISVSNNT-LTGDIPHWIGNI 174
L + CP+L LDLS+ + LN + +S+S + + +G I
Sbjct: 212 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 271
Query: 175 STLEFLDFSNNHLTGSLPSSLFNCKKLSV 203
TL+ L G+L L +
Sbjct: 272 PTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 56/282 (19%), Positives = 88/282 (31%), Gaps = 75/282 (26%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G G F TV+ + +A+K V Y E E+R+L R+ + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNSD-PNDPNRE 101
Query: 622 WTPQLKLLVSDYAPNGS----LQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAH 671
QL NG+ + L L S K+I +GL +
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 672 LHHSFRPPIIHYNLKPSNILL--------------------------------------- 692
LH R IIH ++KP NILL
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 693 ----------DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEK 742
+ +I+D G A + KH + Q+ Y + E+ S N
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNAC---WVHKH-FTEDIQT-RQYRSLEVLIGS-GYNTP 273
Query: 743 CDIYGFGVLILELVTGR-----RPVEYGEDNVVILSEHVRVL 779
DI+ + EL TG E + ++ + +L
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 38/139 (27%), Positives = 59/139 (42%), Gaps = 22/139 (15%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHF-- 63
L L +N ++ + +F++ +L+ L L N L P+G +F+ + L L+L N
Sbjct: 45 LYLHDNQITK-LEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLTVLDLGTNQLTV 102
Query: 64 --SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF-SGPLP 120
S D L L+ L + N + +P+G+ L +L L L NQ S P
Sbjct: 103 LPSAVFD--------RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153
Query: 121 ADIGF--CPHLTTLDLSNN 137
A F LT L N
Sbjct: 154 A---FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 47/151 (31%), Positives = 63/151 (41%), Gaps = 19/151 (12%)
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 296
S+P G +++ +IL L N + P NL+ L L SN L + +P
Sbjct: 33 SVPAGIPTNA--------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPV-- 81
Query: 297 GYFHSLI---HLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYL 352
G F SL LDL N L +P V + L L + N LT +P+ I T L
Sbjct: 82 GVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTH 139
Query: 353 LSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
L+L N L SIP L+ L L N
Sbjct: 140 LALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 40/121 (33%), Positives = 56/121 (46%), Gaps = 11/121 (9%)
Query: 268 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNNALYGSIPQEVCES- 323
+PA G+ N + L L N + + P G F SLI L L +N L G++P V +S
Sbjct: 34 VPA--GIPTNAQILYLHDNQITK-LEP--GVFDSLINLKELYLGSNQL-GALPVGVFDSL 87
Query: 324 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNE 383
L +L L N LT V L L + N L+ +P+ I L L L L+ N+
Sbjct: 88 TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146
Query: 384 L 384
L
Sbjct: 147 L 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 34/116 (29%), Positives = 48/116 (41%), Gaps = 15/116 (12%)
Query: 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF----SGDLDFASGYGIWSLKRLR 82
+ + L L N + +F+ +L L L +N G D SL +L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD--------SLTQLT 91
Query: 83 TLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 137
LDL N + +P V L +LKEL + N+ + LP I HLT L L N
Sbjct: 92 VLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQN 145
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRFQSA 724
L L IIH +LKP NILL + +I DFG + L + + +RF
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
Y +PE+ + + D++ G +++E+ TG P+ G + V +++ V VL
Sbjct: 224 --YRSPEV-LLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGANEVDQMNKIVEVL 274
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 2e-07
Identities = 26/176 (14%), Positives = 59/176 (33%), Gaps = 25/176 (14%)
Query: 38 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 97
I Q + + + LN L + +L L++L++ S+ +
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGT---NNLSIGK----KPRPNLKSLEIISGGLPDSVVE 211
Query: 98 GVAA--LHYLKELLL---QGNQFSGPLPADI------GFCPHLTTLDLSNNLFTGQLPVS 146
+ L L++L+L + P+L L + + +
Sbjct: 212 DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271
Query: 147 L---RLLNSMIFISVSNNTLTGD----IPHWIGNISTLEFLDFSNNHLTGSLPSSL 195
+L + + +S LT + + + I L+F++ N+L+ + L
Sbjct: 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 6e-06
Identities = 25/167 (14%), Positives = 56/167 (33%), Gaps = 23/167 (13%)
Query: 258 DLSSNNLVGDIPAEMGLF--ANLRYLNLSSNHLRSRIPPELG--YFHSLIHLDL---RNN 310
L++ + G +G NL+ L + S L + ++ +L L L +
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232
Query: 311 ALYGSIPQEVCES------RSLGILQLDGNSLTGPIPQVI---RNCTSLYLLSLSHNHLS 361
+ +L L + + ++ L + +S L+
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 362 GS----IPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404
+ + + LK + +++N LS E+ +E L L + +
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE---LQKSLPMKID 336
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 5e-05
Identities = 18/136 (13%), Positives = 43/136 (31%), Gaps = 14/136 (10%)
Query: 27 ASLRYLSLAGNIL--QGPIGKIFNYCSSLNTLNLS--NNHFSGDLDFASGYGIWS---LK 79
+L+ L + L + + +L L L + D D ++S
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252
Query: 80 RLRTLDLSHNLFSGSIPQGVAA---LHYLKELLLQGNQFSG----PLPADIGFCPHLTTL 132
L+ L + + + L L+ + + + L + HL +
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI 312
Query: 133 DLSNNLFTGQLPVSLR 148
++ N + ++ L+
Sbjct: 313 NMKYNYLSDEMKKELQ 328
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 26/119 (21%)
Query: 203 VIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQ---TLRIL 257
+ L N L +GLF L +++L N + I P F+ ++ L
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ-LTGIEPN--------AFEGASHIQEL 83
Query: 258 DLSSNNLVGDIPAEMGLF---ANLRYLNLSSNHLRSRIPPELGYF---HSLIHLDLRNN 310
L N + +I +F L+ LNL N + + P G F +SL L+L +N
Sbjct: 84 QLGENKI-KEISN--KMFLGLHQLKTLNLYDNQISC-VMP--GSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 31/115 (26%), Positives = 39/115 (33%), Gaps = 16/115 (13%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFS- 64
L L++N L LF L L L N L G F S + L L N
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN-AFEGASHIQELQLGENKIKE 92
Query: 65 ---GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQF 115
L +L+TL+L N S + G L+ L L L N F
Sbjct: 93 ISNKMFL--------GLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 14/88 (15%)
Query: 254 LRILDLSSNNLVGDIPAEMGLF---ANLRYLNLSSNHLRSRIPPELGYF---HSLIHLDL 307
L L+L N L I F ++++ L L N ++ I F H L L+L
Sbjct: 56 LVKLELKRNQLT-GIEP--NAFEGASHIQELQLGENKIKE-ISN--KMFLGLHQLKTLNL 109
Query: 308 RNNALYGSIPQEVCES-RSLGILQLDGN 334
+N + + E SL L L N
Sbjct: 110 YDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 31/147 (21%), Positives = 54/147 (36%), Gaps = 40/147 (27%)
Query: 94 SIPQGVAALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLN 151
IP+ + + ELLL N+ + +D F PHL L+L N L +
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGR-ISSDGLFGRLPHLVKLELKRN--------QLTGIE 70
Query: 152 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 211
F S+ ++ L N + + + +F L +L+ +L
Sbjct: 71 PNAFEGASH----------------IQELQLGENKIK-EISNKMFL--GLH--QLKTLNL 109
Query: 212 NGN----IPEGLFD-LG-LEEIDLSEN 232
N + G F+ L L ++L+ N
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 75/520 (14%), Positives = 151/520 (29%), Gaps = 172/520 (33%)
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS-------IPQGVAALHYLKELLL-QGNQ 114
F + D D+ ++ S V+ L LL + +
Sbjct: 29 FVDNFDCKD-----------VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE 77
Query: 115 -----FSGPLPADIGFC----------PHLTT---LDLSNNLFTG-----QLPVS----- 146
L + F P + T ++ + L+ + VS
Sbjct: 78 MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 147 ------LRLLNSMIFISV----------------SNNTLTGDIP---HWI--GNISTLE- 178
L L + + + + + W+ N ++ E
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI---------PEGLFDLGLEEIDL 229
L+ L P+ S I+LR +S+ + L L L +
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNV-- 253
Query: 230 SENGFMGSIPPGSSSSSSSTLFQTL----RILDLSSNNLVGDIPAEMGLFANLRYLNLSS 285
++ + +IL + V D + ++S
Sbjct: 254 ----------------QNAKAWNAFNLSCKILLTTRFKQVTDF------LSAATTTHISL 291
Query: 286 NHLRSRIPPE--LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQV 343
+H + P+ + +P+EV + + S+ I +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRP------QDLPREVLTTNPRRL------SI---IAES 336
Query: 344 IRN--CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS-----GEIPQELGKLA 396
IR+ T ++ + L+ I S++ L + K+ F+ LS IP L
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM-FDRLSVFPPSAHIPT---ILL 392
Query: 397 SLLAVNVSY-------NRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPL 449
SL+ +V N+L +++ + + I S L+ K+ L
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYS-------LVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 450 ---VLD----PDAYNSN-----QMDGHIHSHSFSSNHHHM 477
++D P ++S+ +D + +SH HH+
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH-IG---HHL 481
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 64/425 (15%), Positives = 122/425 (28%), Gaps = 147/425 (34%)
Query: 1 MMNMKFLDLSNNLLSGPVPY--------QLFENC-ASLRYLSLAGNI-LQGP--IGKIFN 48
MM +++ + L + + Q + +L L A N+ + G GK
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK--- 163
Query: 49 YCSSLNTLNLSNNHFSGDLDFASGYGI-W-SLKRLRT--------LDLSHNL-------- 90
+ + L++ ++ + + I W +LK + L + +
Sbjct: 164 --TWV-ALDVCLSY---KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 91 -FSGSIPQGVAALHYLKELLLQGNQFSGPL-------------PADIGFCPHL-TTLDLS 135
S +I + ++ LL+ + L ++ C L TT
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS-CKILLTTRFKQ 276
Query: 136 N---------------------------NLF-------TGQLPVSLR----LLNSMIFIS 157
+L LP + S+I S
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 158 VSNNTLTGDIPHW--IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 215
+ + T D +W + ++ S N L + +F +LSV + +I
Sbjct: 337 IRDGLATWD--NWKHVNCDKLTTIIESSLNVLEPAEYRKMF--DRLSVFPP-----SAHI 387
Query: 216 PEGLF-----DLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQ-----TLRILDLSSNNLV 265
P L D+ ++ + N S + + T+ I + L
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLH----------KYSLVEKQPKESTISIPSIYLE-LK 436
Query: 266 GDIPAEMGLFANL--RYLNLSSNHLRSRIPPEL-GYF------H-------------SLI 303
+ E L ++ Y + IPP L YF H ++
Sbjct: 437 VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV 496
Query: 304 HLDLR 308
LD R
Sbjct: 497 FLDFR 501
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 68/536 (12%), Positives = 144/536 (26%), Gaps = 185/536 (34%)
Query: 327 GILQLDGNSLTGPIPQVIRNCTSLYLLSLS-HNHLSGS----IPKSISNLNKLKILKLEF 381
+L+++ L PI R + + + + + L ++S L L+
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 382 NELSGEIPQEL---------GKLASLLAVNVSYNRLIGRLPVGGVF-------------- 418
EL P + GK + +A++V + + +F
Sbjct: 145 LELR---PAKNVLIDGVLGSGK--TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 419 -------PTLDQSSLQGNLGICSP-------------LLKGP------------------ 440
+D + + + LLK
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 441 ------CKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAIL-- 492
CK+ L+ ++ + +H S +HH M + + +++ L
Sbjct: 260 NAFNLSCKI-----LLTTRFKQVTDFLSAATTTH-ISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 493 ---------IAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRS 543
+ +S++ S R L + C + +
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII-------------E 360
Query: 544 SSLDCSIDPE---------TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ 594
SSL+ ++P ++ +A + + ++ M+ V KL +++
Sbjct: 361 SSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV-IKSDVMVVVNKLHKYSLVE 418
Query: 595 YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERL------- 647
+ P E P + L + + LH +
Sbjct: 419 ---------------KQPK----ESTISIPSIYL---ELKVKLENEYALHRSIVDHYNIP 456
Query: 648 -----PSTPPLSWTNRFKVILG---TAKGLAHLHHSFRP----------PIIH----YNL 685
P F +G FR I H +N
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 686 KPS--NILLD-DNYNPRISD---------FGLARLLTRLDKHVMSNRF----QSAL 725
S N L Y P I D + L +++++++ +++ + AL
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 63/438 (14%), Positives = 122/438 (27%), Gaps = 140/438 (31%)
Query: 466 HSHSFSSNHHHMFFSVS---------------AIV-------------AIIAA-----IL 492
H H HHHM F A V +I++ I+
Sbjct: 1 HHH-----HHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHII 55
Query: 493 IAGGV------LVISLLNVSTRRRLTFVETTLES----MCSSSSRSVNLAAGKVILFDSR 542
++ L +LL+ FVE L + S + ++ +
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 543 SSSLD-----------CSIDPETLLEKA---AEVGEGVFGTVY-KVSFGTQGRMLAVKKL 587
L + P L +A + V + + G +A+
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV--LIDGVLGSGKT--WVALDVC 171
Query: 588 VTSDIIQYPEDFEREVRV----LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL 643
++ + + ++ L P + LE L+ L+ PN + ++
Sbjct: 172 LSYKVQCKMDF-----KIFWLNLKNCNSPETV-LE------MLQKLLYQIDPNWTSRSDH 219
Query: 644 HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD- 702
+ S + +L + ++L + N + +
Sbjct: 220 SSNIKL-RIHSIQAELRRLL-----------------KSKPYENCLLVLLNVQNAKAWNA 261
Query: 703 FGL-ARLL--TRLDKHVM-----SNRFQSALGYVAPELT---------------CQSLRV 739
F L ++L TR K V + +L + + LT Q L
Sbjct: 262 FNLSCKILLTTR-FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP- 319
Query: 740 NEKCDIYGFGV-LILELVTGR--RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP----- 791
E + +I E + + N L+ + L NVL+ +
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFD 376
Query: 792 SMGDYPEDEVLP--VLKL 807
+ +P +P +L L
Sbjct: 377 RLSVFPPSAHIPTILLSL 394
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 44/152 (28%), Positives = 61/152 (40%), Gaps = 20/152 (13%)
Query: 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 296
S+P G + + LDL +N+L +L L L N L+S +P
Sbjct: 21 SVPTGIPAQT--------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPN-- 69
Query: 297 GYFHSLIHLD---LRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQ-VIRNCTSLY 351
G F+ L L L N L S+P V + L L L+ N L +P V T L
Sbjct: 70 GVFNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLK 127
Query: 352 LLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 382
L L N L S+P + L L+ + L N
Sbjct: 128 DLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 8/116 (6%)
Query: 130 TTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGN-ISTLEFLDFSNNHLT 188
T LDL N L S+ + + N L +P+ + N +++L +L+ S N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 189 GSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFD-LG-LEEIDLSENGFMGSIPPG 241
SLP+ +F+ +L + L N L ++P+G+FD L L+++ L +N + S+P G
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ-LKSVPDG 142
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 321 CESRSL-----GI------LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS 369
C ++ L GI L LDGN T +P+ + N L L+ LS+N +S +S S
Sbjct: 17 CSNKGLKVLPKGIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFS 75
Query: 370 NLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYNRL 408
N+ +L L L +N L IP L SL +++ N +
Sbjct: 76 NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 27/131 (20%)
Query: 253 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 312
+ L L N +P E+ + +L ++LS+N + + + F ++ L
Sbjct: 32 DVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIST-LSN--QSFSNMTQLL------ 81
Query: 313 YGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNL 371
L L N L P+ SL LLSL N +S +P+ ++L
Sbjct: 82 ---------------TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125
Query: 372 NKLKILKLEFN 382
+ L L + N
Sbjct: 126 SALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 30/130 (23%)
Query: 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 165
EL L GNQF+ +P ++ HLT +DLSNN + L++ F +++
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNN--------RISTLSNQSFSNMTQ----- 79
Query: 166 DIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN-CKKLSVIRLRGNSLNGNIPEGLFD-LG 223
L L S N L +P F+ K L ++ L GN ++ +PEG F+ L
Sbjct: 80 -----------LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLS 126
Query: 224 -LEEIDLSEN 232
L + + N
Sbjct: 127 ALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 305 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 364
L L N +P+E+ + L ++ L N ++ Q N T L L LS+N L I
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 365 PKSI-SNLNKLKILKLEFNELS 385
P L L++L L N++S
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS 115
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 31/137 (22%), Positives = 49/137 (35%), Gaps = 39/137 (28%)
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-------------------RISDFGLAR 707
L LH + + H +LKP NIL ++ R++DFG A
Sbjct: 134 HALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 708 LLTRLDKHVM---SNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
T +H + R Y PE L L + CD++ G ++ E G +
Sbjct: 190 --TFDHEHHTTIVATRH-----YRPPEVIL---ELGWAQPCDVWSIGCILFEYYRG-FTL 238
Query: 763 EYGEDNVVILSEHVRVL 779
+N L ++L
Sbjct: 239 FQTHENREHLVMMEKIL 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 34/143 (23%), Positives = 56/143 (39%), Gaps = 45/143 (31%)
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-------------------------RIS 701
K L +L + H +LKP NILLDD Y ++
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 702 DFGLARLLTRLDKH---VMSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELV 756
DFG A T + +++ R Y APE L +L + D++ FG ++ EL
Sbjct: 205 DFGCA---TFKSDYHGSIINTRQ-----YRAPEVIL---NLGWDVSSDMWSFGCVLAELY 253
Query: 757 TGRRPVEYGEDNVVILSEHVRVL 779
TG + +++ L+ ++
Sbjct: 254 TG-SLLFRTHEHMEHLAMMESII 275
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 46/165 (27%)
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-------------------RISDFGLAR 707
K + LH + H +LKP NIL + ++ DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 708 LLTRLDKH---VMSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762
T D+H ++S R Y APE L +L ++ CD++ G +++E G V
Sbjct: 185 --TYDDEHHSTLVSTRH-----YRAPEVIL---ALGWSQPCDVWSIGCILIEYYLG-FTV 233
Query: 763 EYGEDNVVILSEHVRVL-------LEEGNVLDCVDPSMGDYPEDE 800
D+ L+ R+L +++ D+ E
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 843 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.72 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.71 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.57 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.27 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.15 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.75 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.58 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.57 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.55 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.4 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.07 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.93 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.9 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.62 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.43 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.31 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.02 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.75 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.58 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.67 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.88 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.58 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 86.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.0 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.52 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.56 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.9 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=545.80 Aligned_cols=430 Identities=38% Similarity=0.559 Sum_probs=315.2
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccc-cccccccCCCCCCEEECCCCCCccccCCCcCccccCCc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 79 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~-~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~ 79 (843)
+++|++|+|++|++++.+|.. .+++|++|+|++|.+.+ ++...+..+++|++|+|++|++++.. +..|..++
T Consensus 246 l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~----p~~~~~l~ 318 (768)
T 3rgz_A 246 CTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV----PPFFGSCS 318 (768)
T ss_dssp CSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECC----CGGGGGCT
T ss_pred CCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCcc----chHHhcCC
Confidence 456777777777776555542 56677777777777663 33333333467777777777666432 23456666
Q ss_pred cCCEEecCCccCcccCchh-hhcCCCCCEEEcCCCcccccCCCCCCCCC-CCcEEEccCCcccccCCchhhc--ccCCcE
Q 003156 80 RLRTLDLSHNLFSGSIPQG-VAALHYLKELLLQGNQFSGPLPADIGFCP-HLTTLDLSNNLFTGQLPVSLRL--LNSMIF 155 (843)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~--l~~L~~ 155 (843)
+|++|+|++|++.+.+|.. |..+++|++|+|++|.+++..|..+..++ +|++|++++|.+++..|..+.. +++|++
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~ 398 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence 7777777777766555543 66677777777777776666666666665 6666666666666666655554 566666
Q ss_pred EEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcc
Q 003156 156 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGF 234 (843)
Q Consensus 156 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l 234 (843)
|++++|++++.+|..|+++++|++|+|++|++++.+|..+..+++|+.|++++|.+.+.+|..+... +|+.|++++|++
T Consensus 399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 6666666666666666666666666666666666666666666666666666666666666666554 566666666666
Q ss_pred eecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccc
Q 003156 235 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 314 (843)
Q Consensus 235 ~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 314 (843)
.+.+|.. +..+++|++|+|++|++++.+|..++.+++|++|++++|++.+.+|..+..+++|+.|++++|+++|
T Consensus 479 ~~~~p~~------l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 552 (768)
T 3rgz_A 479 TGEIPSG------LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552 (768)
T ss_dssp CSCCCGG------GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEES
T ss_pred cCcCCHH------HhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCC
Confidence 6555543 2345666666666666666666666666666666666666666666666666666666666666665
Q ss_pred cCCc----------------------------------------------------------------------cccccC
Q 003156 315 SIPQ----------------------------------------------------------------------EVCESR 324 (843)
Q Consensus 315 ~~~~----------------------------------------------------------------------~~~~l~ 324 (843)
.+|. .+..++
T Consensus 553 ~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~ 632 (768)
T 3rgz_A 553 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632 (768)
T ss_dssp BCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSB
T ss_pred cCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccc
Confidence 5554 445567
Q ss_pred CCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeec
Q 003156 325 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 404 (843)
Q Consensus 325 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls 404 (843)
+|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|++|++|+.|||++|+++|.+|..++++++|+.||++
T Consensus 633 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp CCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred cccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCCCCCCCCCCCcCCCCCCCCCCCCCCCCCC
Q 003156 405 YNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMN 444 (843)
Q Consensus 405 ~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c~~~ 444 (843)
+|+|+|.||..++|.++...+|.||+++||+|+. +|...
T Consensus 713 ~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 713 NNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp SSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred CCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 9999999999999999999999999999999986 88643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=455.12 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=216.7
Q ss_pred hhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
++..++||+|+||+||+|.+. .+++.||||++.........++|.+|+.++++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 344568999999999999974 256899999997655555668899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCC------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 631 SDYAPNGSLQAKLHERLPS------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
||||++|+|.++|+.+.+. ...++|.+++.|+.|||+||+|||++ +||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 9999999999999765321 24689999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~ 777 (843)
||+|||+++.+...+.........||+.|||||++ .+..++.++|||||||++|||+| |+.||..... ..+..
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~--- 258 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVE--- 258 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHH---
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHH-hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHH---
Confidence 99999999987655544444667899999999988 56689999999999999999999 8999975432 11211
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
.+..+.. ...+.+++.++.++|.+||+.||++||||+||+++|+++.
T Consensus 259 -~i~~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 259 -MIRNRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HHHcCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2222222 2345677788999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=451.68 Aligned_cols=265 Identities=26% Similarity=0.440 Sum_probs=211.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.++..++||+|+||+||+|++. + .||||.++.... .+..+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~--~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWH--G-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESS--S-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HeEEeeEEeeCCCcEEEEEEEC--C-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 3456678999999999999974 2 599999864432 2334679999999999999999999999865 567999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
|++|+|.++|+.. ...++|.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999865 35699999999999999999999998 99999999999999999999999999998766544
Q ss_pred cceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.........||+.|||||++.. ...|+.++|||||||++|||+||+.||....... .+ ...+..+ ...|
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~----~~~~~~~----~~~p 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QI----IFMVGRG----YASP 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HH----HHHHHTT----CCCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HH----HHHHhcC----CCCC
Confidence 3333456789999999998743 3458999999999999999999999997543321 11 1122222 2234
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
.+...+.+++..+.++|.+||+.||++||||.||+++|+.++.++|+
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 44455667778899999999999999999999999999999988875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=454.38 Aligned_cols=269 Identities=22% Similarity=0.351 Sum_probs=221.0
Q ss_pred hhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+.+...+.||+|+||+||+|++. .+++.||||++.... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45666779999999999999984 257899999996543 334578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcC---------CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcE
Q 003156 629 LVSDYAPNGSLQAKLHERL---------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 699 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 699 (843)
+|||||++|+|.++|+... .....++|.+++.|+.|+|+||+|||++ +||||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999998642 1245799999999999999999999998 999999999999999999999
Q ss_pred EeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHH
Q 003156 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~ 778 (843)
|+|||+|+.....+.........||+.|||||++ .+..++.++|||||||++|||+| |+.||..... ..+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~---- 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIE---- 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH----
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----
Confidence 9999999987665555454556799999999998 56689999999999999999999 8999975432 11111
Q ss_pred HHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 003156 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRME 841 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~~~~ 841 (843)
.+..+.. ...|..++.++.++|.+||+.||++||||+||++.|+.+.+..|.-.+
T Consensus 242 ~i~~~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ld 296 (299)
T 4asz_A 242 CITQGRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLD 296 (299)
T ss_dssp HHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSC
T ss_pred HHHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCcccc
Confidence 2222222 223566777899999999999999999999999999998776665443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=455.08 Aligned_cols=267 Identities=24% Similarity=0.350 Sum_probs=209.7
Q ss_pred hhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+.+...++||+|+||+||+|++. .+++.||||++.... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34455678999999999999975 257899999996443 334578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCC-----------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC
Q 003156 629 LVSDYAPNGSLQAKLHERLP-----------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN 697 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~ 697 (843)
+|||||++|+|.++++.... ...+++|.+++.|+.|+|+||+|||+. +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999987532 134699999999999999999999998 9999999999999999999
Q ss_pred cEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHH
Q 003156 698 PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV 776 (843)
Q Consensus 698 ~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~ 776 (843)
+||+|||+++.+...+.........||+.|||||++ .+..++.++|||||||++|||+| |+.||...... .+ +
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~---~ 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EA---I 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HH---H
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhh-cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HH---H
Confidence 999999999977655444444567899999999988 66689999999999999999999 89999754321 11 1
Q ss_pred HHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 003156 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 839 (843)
Q Consensus 777 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~~ 839 (843)
. .+..+.. ...|..++.++.++|.+||+.||++||||+||+++|+.+.+..|..
T Consensus 271 ~-~i~~g~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~ 324 (329)
T 4aoj_A 271 D-CITQGRE--------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVY 324 (329)
T ss_dssp H-HHHHTCC--------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC--
T ss_pred H-HHHcCCC--------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCccc
Confidence 1 1222221 1235566778999999999999999999999999999997765543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=499.52 Aligned_cols=423 Identities=37% Similarity=0.562 Sum_probs=331.8
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCC----------
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFA---------- 70 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~---------- 70 (843)
+++|++|+|++|++++.+|. |.++++|++|+|++|.+.+..+..|..+++|++|+|++|++.+..+..
T Consensus 199 l~~L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L 276 (768)
T 3rgz_A 199 CVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSL 276 (768)
T ss_dssp CTTCCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEEC
T ss_pred CCcCCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEEC
Confidence 46788888888888765654 778888888888888888777777888888888888888776533211
Q ss_pred --------cCccccC-CccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCC-CCCCCCCcEEEccCCccc
Q 003156 71 --------SGYGIWS-LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD-IGFCPHLTTLDLSNNLFT 140 (843)
Q Consensus 71 --------~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~ 140 (843)
.+..+.. +++|++|+|++|++.+..|..|..+++|++|+|++|.+++.+|.. +..+++|++|+|++|.++
T Consensus 277 ~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~ 356 (768)
T 3rgz_A 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356 (768)
T ss_dssp CSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEE
T ss_pred cCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccC
Confidence 1112222 255666666666665556666666666666666666665555543 566666666666666666
Q ss_pred ccCCchhhccc-CCcEEEeecCcccccCCCCccC--CCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCc
Q 003156 141 GQLPVSLRLLN-SMIFISVSNNTLTGDIPHWIGN--ISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 217 (843)
Q Consensus 141 ~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 217 (843)
+..|..+..++ +|+.|++++|++++.+|..+.. +++|++|+|++|.+++.+|..+.++++|+.|++++|.+++.+|.
T Consensus 357 ~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 436 (768)
T 3rgz_A 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436 (768)
T ss_dssp ECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCG
T ss_pred ccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccH
Confidence 66666666665 6666666666666666665555 66777777777777777788888888888888888888877887
Q ss_pred hhhcc-CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCc
Q 003156 218 GLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 296 (843)
Q Consensus 218 ~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 296 (843)
.+..+ +|+.|++++|.+.+.+|.. +..+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..+
T Consensus 437 ~l~~l~~L~~L~L~~n~l~~~~p~~------~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 510 (768)
T 3rgz_A 437 SLGSLSKLRDLKLWLNMLEGEIPQE------LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGG------GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred HHhcCCCCCEEECCCCcccCcCCHH------HcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHH
Confidence 77765 6888888888887766653 3457899999999999999999999999999999999999999999999
Q ss_pred cccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhc-------------------------------
Q 003156 297 GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR------------------------------- 345 (843)
Q Consensus 297 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------------------------- 345 (843)
+.+++|++|+|++|++++.+|..++.+++|+.|++++|.++|.+|..+.
T Consensus 511 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (768)
T 3rgz_A 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGA 590 (768)
T ss_dssp GGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSS
T ss_pred hcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999999887776543
Q ss_pred ---------------------------------------ccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccc
Q 003156 346 ---------------------------------------NCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSG 386 (843)
Q Consensus 346 ---------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 386 (843)
++++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|
T Consensus 591 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g 670 (768)
T 3rgz_A 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG 670 (768)
T ss_dssp EEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred ccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCC
Confidence 35779999999999999999999999999999999999999
Q ss_pred cCCcchhcccccceEeeccccceecCCCC-CCCCCCCCCCcCCCCC
Q 003156 387 EIPQELGKLASLLAVNVSYNRLIGRLPVG-GVFPTLDQSSLQGNLG 431 (843)
Q Consensus 387 ~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 431 (843)
.+|..++++++|+.|||++|+++|.+|.. +.+..+...++.+|+.
T Consensus 671 ~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred CCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 99999999999999999999999999953 5567788888888864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=446.67 Aligned_cols=266 Identities=25% Similarity=0.330 Sum_probs=219.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC-----CeEEEEEEeecCCcccChHHHHHHHHHHHhccC-CCccceeeEEEcC-C
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNLISLEGYYWTP-Q 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~-~ 625 (843)
.+.|+..+.||+|+||+||+|.+... ++.||||++.........+.|.+|++++++++| ||||+++|+|.++ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 45677888999999999999998543 468999999765544445679999999999965 8999999999765 4
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 693 (843)
..++|||||++|+|.++|+.... ....++|.+++.++.|||+||+|||++ +||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence 68999999999999999986421 134589999999999999999999999 999999999999999
Q ss_pred CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhH
Q 003156 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVIL 772 (843)
Q Consensus 694 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l 772 (843)
+++.+||+|||+|+.+.............||+.|||||++ .+..|+.++|||||||++|||+| |+.||........ +
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-~ 297 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F 297 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-H
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH-hcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-H
Confidence 9999999999999987665555555667899999999998 56689999999999999999998 9999976543322 1
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+..+... ..|..++.++.++|.+||+.||++||||.|++++|+.+.+.
T Consensus 298 ----~~~i~~g~~~--------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 298 ----CRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ----HHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHcCCCC--------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1222333221 23455667899999999999999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=437.05 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=205.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4578888999999999999999989999999999755432 234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
||++|+|.++|.... ...+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999998652 34578899999999999999999999 9999999999999999999999999999876532
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......||+.|||||++ .+..|+.++||||+||++|||+||+.||..... . +....... +.
T Consensus 179 ~~--~~~~~~GT~~YmAPE~l-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~----~~~~~i~~-~~-------- 241 (350)
T 4b9d_A 179 VE--LARACIGTPYYLSPEIC-ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-K----NLVLKIIS-GS-------- 241 (350)
T ss_dssp HH--HHHHHHSCCTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-H----HHHHHHHH-TC--------
T ss_pred cc--cccccCCCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-H----HHHHHHHc-CC--------
Confidence 21 22456799999999998 566799999999999999999999999965321 1 11222222 11
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+..+...+.++.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112234455678899999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=430.86 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=211.4
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+..++||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..||||
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4456777889999999999999999899999999996543 234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|||++|+|.+++... .+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 151 Ey~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 151 EFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 999999999999763 489999999999999999999999 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......||+.|||||++ ....|+.++||||+||++|||++|+.||..... ... ... +..+ ..+
T Consensus 223 ~~~--~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~---~~~-i~~~-----~~~ 288 (346)
T 4fih_A 223 EVP--RRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKA---MKM-IRDN-----LPP 288 (346)
T ss_dssp SSC--CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHH-HHHS-----SCC
T ss_pred CCC--cccccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHH---HHH-HHcC-----CCC
Confidence 322 22567899999999988 566799999999999999999999999964321 111 111 1111 111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ..+.....++.+++.+||+.||++|||++|++++
T Consensus 289 ~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1234556678899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=432.26 Aligned_cols=264 Identities=26% Similarity=0.358 Sum_probs=202.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHH--HHHHHHHHhccCCCccceeeEEEcCC----eeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF--EREVRVLGKARHPNLISLEGYYWTPQ----LKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~--~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 629 (843)
+...+.||+|+||+||+|++ +|+.||||++.... .+.+ ..|+..+.+++|||||+++|+|.+++ ..+|
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 44567899999999999998 58999999985432 2333 34566667889999999999998654 5789
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc-----CCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS-----FRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
|||||++|+|.++++.. .++|..+.+++.|+|+||+|||++ ..++||||||||+|||+++++++||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 99999999999999864 589999999999999999999976 25689999999999999999999999999
Q ss_pred Ccccccccccce--eccccccccccCCcccccCc-----CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc---------
Q 003156 705 LARLLTRLDKHV--MSNRFQSALGYVAPELTCQS-----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--------- 768 (843)
Q Consensus 705 l~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--------- 768 (843)
+|+......... ......||+.|||||++... ..++.++|||||||++|||+||+.||......
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 998775433322 22345799999999988432 14678999999999999999998876432211
Q ss_pred -hhhHHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 769 -VVILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 769 -~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...... +...+.. ...+|.++. ...++...+.++|.+||+.||++||||.||++.|+++.+.
T Consensus 234 ~~~~~~~-~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 234 SDPSVEE-MRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHH-HHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchHHH-HHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111111 1111111 223344433 2335667889999999999999999999999999988643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=421.21 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=200.1
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc----CCeeEEEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKLLVS 631 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 631 (843)
+..++||+|+||+||+|.+..+++.||+|++...... ...+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4455799999999999999989999999999755432 234678999999999999999999999865 34578999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLT 710 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~ 710 (843)
|||++|+|.++++.. ..+++..+..++.||+.||+|||++ .++||||||||+|||++ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999875 4689999999999999999999987 22499999999999998 47999999999998543
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.. ......||+.|||||++. + .|+.++|||||||++|||+||+.||....... .+.. .+..+...
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~-~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~----~i~~~~~~---- 248 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYR----RVTSGVKP---- 248 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHH----HHTTTCCC----
T ss_pred CC----ccCCcccCccccCHHHcC-C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHH----HHHcCCCC----
Confidence 21 224568999999999873 3 58999999999999999999999996543221 1111 11111110
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..++.....++.+++.+||+.||++|||++|++++
T Consensus 249 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01223334568899999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=427.48 Aligned_cols=253 Identities=20% Similarity=0.222 Sum_probs=206.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..++||+|+||+||+|++..+|+.||||++..... +.+|+.++++++|||||++++++.+++..||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 345667789999999999999998999999999965432 24799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRL 712 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~ 712 (843)
|++|+|.++++.. ..+++..+..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999875 4699999999999999999999998 999999999999999887 6999999999877543
Q ss_pred ccc---eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 713 DKH---VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 713 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
... .......||+.|||||++ .+..|+.++||||+||++|||+||+.||....... .+.... ...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~----~~~------ 272 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVV-MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIA----SEP------ 272 (336)
T ss_dssp ---------CCCCCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHH----HSC------
T ss_pred CcccceecCCccccCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHH----cCC------
Confidence 221 122446799999999998 55679999999999999999999999997543222 121111 111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
+.....+...+..+.+++.+||+.||++|||+.|++++|...
T Consensus 273 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 273 -PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111123455667789999999999999999999999988654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=461.14 Aligned_cols=426 Identities=20% Similarity=0.191 Sum_probs=286.0
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
+++++|+|++|+|+ .+++..|.++++|++|+|++|+|.++.+..|.++++|++|+|++|++++..+ ..|..+++|
T Consensus 33 ~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L 107 (606)
T 3t6q_A 33 NSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAE----TALSGPKAL 107 (606)
T ss_dssp TTCCEEECTTCCCS-EECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECT----TTTSSCTTC
T ss_pred CcCcEEEccCCccC-cCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccCh----hhhcccccc
Confidence 35889999999998 6666778999999999999999998888889999999999999998886433 357788899
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCc--EEEee
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI--FISVS 159 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~ 159 (843)
++|+|++|++++..+..|..+++|++|+|++|.+++.....+..+++|++|++++|.+++..+..|..+++|+ .|+++
T Consensus 108 ~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~ 187 (606)
T 3t6q_A 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187 (606)
T ss_dssp CEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECT
T ss_pred cEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecC
Confidence 9999999998876677788888999999999988865544555688888888888888877777777777766 66666
Q ss_pred cCcccccC------------------------------------------------------------------------
Q 003156 160 NNTLTGDI------------------------------------------------------------------------ 167 (843)
Q Consensus 160 ~N~l~~~~------------------------------------------------------------------------ 167 (843)
+|++.+..
T Consensus 188 ~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~ 267 (606)
T 3t6q_A 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267 (606)
T ss_dssp TCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCS
T ss_pred CCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccC
Confidence 66555433
Q ss_pred ---CCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCCCC
Q 003156 168 ---PHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSS 243 (843)
Q Consensus 168 ---p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~ 243 (843)
+..|+++++|++|+|++|+++ .+|..+..+++|++|++++|.+.+..|..+... +|+.|++++|.+.+.+|....
T Consensus 268 ~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 346 (606)
T 3t6q_A 268 NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346 (606)
T ss_dssp SCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTT
T ss_pred ccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhh
Confidence 334666777888888888777 567777778888888888888776556555554 577777777776655554321
Q ss_pred C---------------------CCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCC-Ccccccc
Q 003156 244 S---------------------SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPP-ELGYFHS 301 (843)
Q Consensus 244 ~---------------------~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~ 301 (843)
. ...+..+++|++|++++|++.+..|..+..+++|++|++++|.+++..+. .+..+++
T Consensus 347 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 426 (606)
T 3t6q_A 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426 (606)
T ss_dssp TTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTT
T ss_pred hccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCccc
Confidence 1 01122344555555555555555555555555555555555555544332 2555555
Q ss_pred ceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCC---chhhhcccCCCcEEecccccccccCCccccCCCCCCEEE
Q 003156 302 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGP---IPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 378 (843)
Q Consensus 302 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 378 (843)
|++|++++|.+++..|..+..+++|+.|++++|.+++. .+..+..+++|+.|+|++|++++..|..|+++++|+.|+
T Consensus 427 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 506 (606)
T 3t6q_A 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506 (606)
T ss_dssp CCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEE
Confidence 55555555555555555555556666666666655541 223455566666666666666655566666666666666
Q ss_pred ccCCcccccCCcchhcccccceEeeccccceecCCCC-CCCCCCCCCCcCCCCCCCC
Q 003156 379 LEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG-GVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 379 L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~ 434 (843)
|++|++++..|..+.+++.| .|++++|++++.+|.. +.++.+....+.||++.|.
T Consensus 507 Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp CCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred CCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 66666666666666666666 6666666666555531 3344556666667766653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=422.03 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=211.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||+||+|++..+|+.||||.+.+.. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34778889999999999999999999999999996542 1234578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999875 4689999999999999999999999 999999999999999999999999999998765
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
...........||+.|||||++ .+..|+.++||||+||++|||+||+.||.... ...+ ...... +..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~---~~~i~~-~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLI---FAKIIK-LEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHH-HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH---HHHHHH-TCC------
T ss_pred CCCcccccCcccCcccCCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHH---HHHHHc-CCC------
Confidence 4444444667899999999998 56678999999999999999999999996532 1111 111111 111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~ 827 (843)
.++.....++.+++.+|++.||++|||++|++.
T Consensus 252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 234445567889999999999999999998643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=432.24 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=212.4
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
++.+.|+..++||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|||
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 45667888889999999999999999999999999996543 33456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
||||++|+|.++++.. .+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.
T Consensus 227 mEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 9999999999999763 489999999999999999999999 99999999999999999999999999998765
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.... ......||+.|||||++ .+..|+.++||||+||++|||++|+.||..... ... ... +..+. .
T Consensus 299 ~~~~--~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~---~~~-i~~~~-----~ 364 (423)
T 4fie_A 299 KEVP--RRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKA---MKM-IRDNL-----P 364 (423)
T ss_dssp SSCC--CBCCCEECTTTCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH---HHH-HHHSC-----C
T ss_pred CCCc--cccccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHH---HHH-HHcCC-----C
Confidence 4222 22567899999999988 566799999999999999999999999964321 111 111 11111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.+ ........++.+++.+||..||++|||+.|++++
T Consensus 365 ~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 1233445678899999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=410.33 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=194.6
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.|+..+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 46778899999999999999998999999999965432 2345679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+ +|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+...+.
T Consensus 94 y~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 94 YA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp CC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99 68999999875 4699999999999999999999999 9999999999999999999999999999876542
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. ......||+.|||||++.+...++.++||||+||++|||+||+.||.... ...+ .+.. ..+..
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~---~~~i-~~~~~------- 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVL---FKNI-SNGVY------- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH---HHHH-HHTCC-------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHH---HHHH-HcCCC-------
Confidence 2 22456899999999998555455789999999999999999999996432 1111 1211 11111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.++.....++.+++.+|++.||++|||++|++++
T Consensus 230 --~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 --TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1234455678899999999999999999999986
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=474.83 Aligned_cols=418 Identities=24% Similarity=0.213 Sum_probs=282.0
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCcc-ccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNI-LQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~-i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
+++++|||++|.|+ .+++..|.++++|++|+|++|. +..+.+..|.++++|++|+|++|.|++.. +..|..+++
T Consensus 24 ~~l~~LdLs~N~i~-~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~----p~~~~~l~~ 98 (844)
T 3j0a_A 24 NTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLH----PDAFQGLFH 98 (844)
T ss_dssp TTCCEEEEESCCCC-EECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEEC----TTSSCSCSS
T ss_pred CCcCEEECCCCcCC-ccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccC----HhHccCCcc
Confidence 57889999999988 5555668889999999998884 45566788888999999999999888543 346788888
Q ss_pred CCEEecCCccCcccCchh--hhcCCCCCEEEcCCCcccccCC-CCCCCCCCCcEEEccCCcccccCCchhhcc--cCCcE
Q 003156 81 LRTLDLSHNLFSGSIPQG--VAALHYLKELLLQGNQFSGPLP-ADIGFCPHLTTLDLSNNLFTGQLPVSLRLL--NSMIF 155 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~ 155 (843)
|++|+|++|.+.+..+.. |..+++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+ ++|+.
T Consensus 99 L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~ 178 (844)
T 3j0a_A 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178 (844)
T ss_dssp CCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCC
T ss_pred cCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccce
Confidence 999999999888655554 8888899999999998886654 468888999999999998888778877776 66777
Q ss_pred EEeecCcccccCCCCccCCCC------ccEEEcccC--------------------------------------------
Q 003156 156 ISVSNNTLTGDIPHWIGNIST------LEFLDFSNN-------------------------------------------- 185 (843)
Q Consensus 156 L~L~~N~l~~~~p~~~~~l~~------L~~L~L~~N-------------------------------------------- 185 (843)
|++++|.+.+..|..++.+++ |+.|+|++|
T Consensus 179 L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~ 258 (844)
T 3j0a_A 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258 (844)
T ss_dssp CEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGT
T ss_pred EECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChh
Confidence 777777666555544444333 445555444
Q ss_pred ------------------CcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCCCCCCC
Q 003156 186 ------------------HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSS 246 (843)
Q Consensus 186 ------------------~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~ 246 (843)
.+++..+..|..+++|+.|+|++|.+++..|..+..+ +|+.|++++|.+.+..|..
T Consensus 259 ~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----- 333 (844)
T 3j0a_A 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN----- 333 (844)
T ss_dssp TTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCS-----
T ss_pred hhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHH-----
Confidence 4444444445555555555555555554444444333 4555555555554332222
Q ss_pred cccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCC------------------C--------------
Q 003156 247 SSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIP------------------P-------------- 294 (843)
Q Consensus 247 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~------------------~-------------- 294 (843)
+..+++|+.|+|++|.+.+..+..|..+++|++|++++|.++++.. .
T Consensus 334 -~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~ 412 (844)
T 3j0a_A 334 -FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENR 412 (844)
T ss_dssp -CSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCC
T ss_pred -hcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCc
Confidence 1234555555555555554444455555555555555555543210 0
Q ss_pred --------CccccccceEEEccCCcccccCCc-cccccCCCcEEEcCCCCCC-----CCchhhhcccCCCcEEecccccc
Q 003156 295 --------ELGYFHSLIHLDLRNNALYGSIPQ-EVCESRSLGILQLDGNSLT-----GPIPQVIRNCTSLYLLSLSHNHL 360 (843)
Q Consensus 295 --------~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l 360 (843)
.+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|
T Consensus 413 l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 492 (844)
T 3j0a_A 413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492 (844)
T ss_dssp CCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH
T ss_pred cccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc
Confidence 011233444444444444422211 2333455555555555554 33345678889999999999999
Q ss_pred cccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCC
Q 003156 361 SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 361 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 434 (843)
++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|. .+..+....+.||++.|.
T Consensus 493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICE 562 (844)
T ss_dssp TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCS
T ss_pred cccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcccc
Confidence 988888899999999999999999987777776 7899999999999999884 577888889999999984
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=447.64 Aligned_cols=425 Identities=21% Similarity=0.176 Sum_probs=316.9
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
+++++|+|++|+++ .++...|.++++|++|+|++|.|.++.+..|.++++|++|+|++|.+++.. +..|.++++|
T Consensus 32 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~----p~~~~~l~~L 106 (606)
T 3vq2_A 32 SSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS----PGSFSGLTSL 106 (606)
T ss_dssp TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCC----TTSSTTCTTC
T ss_pred CCcCEEECCCCCcC-EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccC----hhhcCCcccC
Confidence 46889999999998 677777889999999999999999888888999999999999999888543 3467888999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccc-cCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCc----EE
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI----FI 156 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L 156 (843)
++|+|++|++.+..+..|+.+++|++|+|++|.+++ .+|..|+++++|++|++++|++++..+..|..+.+|+ .|
T Consensus 107 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L 186 (606)
T 3vq2_A 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186 (606)
T ss_dssp CEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEE
T ss_pred CEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhcccccccee
Confidence 999999999887777788899999999999998875 4588888899999999999988887777776666554 56
Q ss_pred EeecCcccccCCCCcc----------------------------------------------------------------
Q 003156 157 SVSNNTLTGDIPHWIG---------------------------------------------------------------- 172 (843)
Q Consensus 157 ~L~~N~l~~~~p~~~~---------------------------------------------------------------- 172 (843)
++++|++++..+..+.
T Consensus 187 ~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l 266 (606)
T 3vq2_A 187 DMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266 (606)
T ss_dssp ECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEE
T ss_pred eccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhhe
Confidence 6666666544333332
Q ss_pred ----------------CCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCccee
Q 003156 173 ----------------NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMG 236 (843)
Q Consensus 173 ----------------~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~ 236 (843)
.+++|+.|++++|.++ .+| .+..+++|+.|++++|.+ +.+|.. ...+|+.|++++|...+
T Consensus 267 ~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~~-~l~~L~~L~l~~n~~~~ 342 (606)
T 3vq2_A 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPTL-DLPFLKSLTLTMNKGSI 342 (606)
T ss_dssp EECCCTTCCGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCCC-CCSSCCEEEEESCSSCE
T ss_pred eccccccccccccccccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccccC-CCCccceeeccCCcCcc
Confidence 3344444444444443 233 566666777777777776 355532 21234444444443322
Q ss_pred cCCCCCC------------------CCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCC-CCcc
Q 003156 237 SIPPGSS------------------SSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIP-PELG 297 (843)
Q Consensus 237 ~~p~~~~------------------~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~ 297 (843)
.++.... .......+++|++|++++|.+++ +|..+..+++|++|++++|++.+..+ ..+.
T Consensus 343 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 421 (606)
T 3vq2_A 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421 (606)
T ss_dssp ECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTT
T ss_pred chhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhh
Confidence 2211000 00112345677777777777763 55777888888888888888887766 6788
Q ss_pred ccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCC-CchhhhcccCCCcEEecccccccccCCccccCCCCCCE
Q 003156 298 YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 376 (843)
Q Consensus 298 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 376 (843)
.+++|++|++++|++++..|..+..+++|++|++++|.+++ .+|..|+++++|+.|+|++|++++..|..|.++++|++
T Consensus 422 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 501 (606)
T 3vq2_A 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501 (606)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE
Confidence 88888899999888888888888888999999999998887 47888888999999999999998888888899999999
Q ss_pred EEccCCcccccCCcchhcccccceEeeccccceecCCCCCCCC-CCCCCCcCCCCCCCCCC
Q 003156 377 LKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFP-TLDQSSLQGNLGICSPL 436 (843)
Q Consensus 377 L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~~ 436 (843)
|+|++|++++.+|..+.++++|+.|++++|+++...+....++ .+....+.+|++.|.-+
T Consensus 502 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp EECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred EECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999998888899999999999999999885444334454 47778888999888644
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=411.13 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=198.5
Q ss_pred hhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
+.|+..+.||+|+||+||+|+.. .+++.||||.+...... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45788889999999999999884 35789999998654321 223468899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|||||++|+|.+++... ..+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999875 4689999999999999999999999 9999999999999999999999999999865
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
..... ......||+.|||||++ .+..++.++||||+||++|||+||+.||..... .. ....... +.
T Consensus 177 ~~~~~--~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~----~~~~i~~-~~----- 242 (304)
T 3ubd_A 177 IDHEK--KAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KE----TMTMILK-AK----- 242 (304)
T ss_dssp ----C--CCCSCCCCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH----HHHHHHH-CC-----
T ss_pred cCCCc--cccccccCcccCCHHHh-ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-HH----HHHHHHc-CC-----
Confidence 43222 22457899999999998 556789999999999999999999999965321 11 1111111 11
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
..++...+.++.+++.+||+.||++||| ++|++++
T Consensus 243 ----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 243 ----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1234455667889999999999999998 4677764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=411.11 Aligned_cols=253 Identities=18% Similarity=0.270 Sum_probs=190.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC---------
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ--------- 625 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------- 625 (843)
.|+..+.||+|+||+||+|++..+|+.||||++.........+.+.+|++++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 46677899999999999999998999999999976554444567899999999999999999999987544
Q ss_pred ---eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEee
Q 003156 626 ---LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 626 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 702 (843)
..|+|||||++|+|.+++..... ....++..++.++.|+++||+|||++ +||||||||+|||++.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999987532 23356677889999999999999999 999999999999999999999999
Q ss_pred ccCcccccccccce----------eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhH
Q 003156 703 FGLARLLTRLDKHV----------MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772 (843)
Q Consensus 703 fgl~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l 772 (843)
||+|+.+....... ......||+.|||||++ .+..|+.++|||||||++|||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~- 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY---PFSTQM---ER- 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HH-
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHH-cCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HH-
Confidence 99998775432211 12345799999999998 56679999999999999999996 774311 11
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+.. +... ..+.........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~-~~~~--------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VRTLTD-VRNL--------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHH-HHTT--------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHH-HhcC--------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 1111 1111122333456789999999999999999999985
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=446.60 Aligned_cols=185 Identities=23% Similarity=0.261 Sum_probs=124.7
Q ss_pred ccCccCEEeCCCCccceeCC-ccccCCCCCcEEEcCCCcccC--------------------------CCCCCccccccc
Q 003156 250 LFQTLRILDLSSNNLVGDIP-AEMGLFANLRYLNLSSNHLRS--------------------------RIPPELGYFHSL 302 (843)
Q Consensus 250 ~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~--------------------------~~~~~~~~l~~L 302 (843)
.+++|+.|+|++|.+.+.+| ..+..+++|++|++++|++.+ ..|..|..+++|
T Consensus 403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L 482 (680)
T 1ziw_A 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482 (680)
T ss_dssp TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence 34566666666666655443 445555555555555555543 345556666677
Q ss_pred eEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCch--------hhhcccCCCcEEecccccccccCCccccCCCCC
Q 003156 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP--------QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 374 (843)
Q Consensus 303 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 374 (843)
+.|++++|++++..+..|..+++|+.|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.++++|
T Consensus 483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 562 (680)
T 1ziw_A 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence 777777777776656667777777777777777764321 236677777777777777774444467788888
Q ss_pred CEEEccCCcccccCCcchhcccccceEeeccccceecCCCC-C-CCCCCCCCCcCCCCCCCC
Q 003156 375 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG-G-VFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 375 ~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~-~~~~~~~~~~~~n~~~c~ 434 (843)
+.|+|++|+|++..+..|..+++|+.|++++|++++.+|.. + .++++....+.||++.|.
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 88888888888666666778888888888888888766632 1 466778888899999886
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=437.05 Aligned_cols=405 Identities=22% Similarity=0.207 Sum_probs=277.9
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCC-----------
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDF----------- 69 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~----------- 69 (843)
+++|++|+|++|+++ .+++.+|.++++|++|+|++|.+.++.+..|.++++|++|+|++|++++..+.
T Consensus 56 l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L 134 (606)
T 3t6q_A 56 LINLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134 (606)
T ss_dssp CTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEE
T ss_pred CccceEEECCCCccc-eeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEE
Confidence 356666777776666 44445566666666666666666666666666666666666666666542110
Q ss_pred ---------CcCccccCCccCCEEecCCccCcccCchhhhcCCCCC--EEEcCCCcccccCCCC----------------
Q 003156 70 ---------ASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK--ELLLQGNQFSGPLPAD---------------- 122 (843)
Q Consensus 70 ---------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~~~~~~~---------------- 122 (843)
.....+..+++|++|++++|.+++..+..|..+++|+ +|++++|.+++..|..
T Consensus 135 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~ 214 (606)
T 3t6q_A 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214 (606)
T ss_dssp ECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSC
T ss_pred ECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchh
Confidence 0111233356666666666666655556666666666 5666666555444333
Q ss_pred -----------------------------------------------------------CCCCCCCcEEEccCCcccccC
Q 003156 123 -----------------------------------------------------------IGFCPHLTTLDLSNNLFTGQL 143 (843)
Q Consensus 123 -----------------------------------------------------------~~~l~~L~~L~L~~N~l~~~~ 143 (843)
|..+++|++|++++|.++ .+
T Consensus 215 ~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~l 293 (606)
T 3t6q_A 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293 (606)
T ss_dssp HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CC
T ss_pred HHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CC
Confidence 333344444444444444 33
Q ss_pred CchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCC-CCCCCCCCcEEEecCCcCCCCC--Cchhh
Q 003156 144 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPS-SLFNCKKLSVIRLRGNSLNGNI--PEGLF 220 (843)
Q Consensus 144 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~ 220 (843)
|..+..+++|++|++++|++.+..|..+.++++|++|++++|.+.+.++. .+..+++|+.|++++|.+.+.. +..+.
T Consensus 294 p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 373 (606)
T 3t6q_A 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373 (606)
T ss_dssp CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTT
T ss_pred ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcc
Confidence 33444444444444444444444444444444444444444444432222 2455555555555555554332 33333
Q ss_pred cc-CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCcc-ccCCCCCcEEEcCCCcccCCCCCCccc
Q 003156 221 DL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAE-MGLFANLRYLNLSSNHLRSRIPPELGY 298 (843)
Q Consensus 221 ~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~ 298 (843)
.. +|+.|++++|++.+..|.. +..+++|+.|++++|++.+..+.. +..+++|++|++++|.+.+..|..+..
T Consensus 374 ~l~~L~~L~l~~n~l~~~~~~~------~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 447 (606)
T 3t6q_A 374 NLSHLQSLNLSYNEPLSLKTEA------FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447 (606)
T ss_dssp TCTTCCEEECCSCSCEEECTTT------TTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTT
T ss_pred cCCCCCEEECCCCcCCcCCHHH------hcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhC
Confidence 33 4666666666666544433 345789999999999999776554 899999999999999999999999999
Q ss_pred cccceEEEccCCccccc---CCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCC
Q 003156 299 FHSLIHLDLRNNALYGS---IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLK 375 (843)
Q Consensus 299 l~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 375 (843)
+++|++|++++|++++. .+..+..+++|+.|++++|.+++..|..|.++++|+.|+|++|++++..|..+.++++|
T Consensus 448 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L- 526 (606)
T 3t6q_A 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI- 526 (606)
T ss_dssp CTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-
T ss_pred CCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-
Confidence 99999999999999863 33678999999999999999999889999999999999999999999999999999999
Q ss_pred EEEccCCcccccCCcchhcccccceEeeccccceecCCC
Q 003156 376 ILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 376 ~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 414 (843)
+|+|++|++++.+|..+..+++|+.|++++|++++..+.
T Consensus 527 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 999999999999999999999999999999999987773
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=440.09 Aligned_cols=417 Identities=23% Similarity=0.214 Sum_probs=337.4
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
+++++|+|++|+++ .++...|.++++|++|+|++|.|.++++..|.++++|++|+|++|++++.++ ..|..+++|
T Consensus 28 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L 102 (570)
T 2z63_A 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL----GAFSGLSSL 102 (570)
T ss_dssp SSCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECT----TTTTTCTTC
T ss_pred ccccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCH----hhhcCcccc
Confidence 36899999999998 6777788999999999999999999988899999999999999999886543 367889999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCccccc-CCCCCCCCCCCcEEEccCCcccccCCchhhcccCC----cEE
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP-LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM----IFI 156 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L 156 (843)
++|++++|+++...+..|+.+++|++|+|++|.+++. .|..|+++++|++|++++|.+++..+..|..+++| +.|
T Consensus 103 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L 182 (570)
T 2z63_A 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182 (570)
T ss_dssp CEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEE
T ss_pred ccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhc
Confidence 9999999999866665789999999999999999863 58889999999999999999998888888888888 788
Q ss_pred EeecCcccccCCCCccCCCCccEEEcccC---------------------------------------------------
Q 003156 157 SVSNNTLTGDIPHWIGNISTLEFLDFSNN--------------------------------------------------- 185 (843)
Q Consensus 157 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N--------------------------------------------------- 185 (843)
++++|.+.+..|..|..+ +|++|++++|
T Consensus 183 ~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~ 261 (570)
T 2z63_A 183 DLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261 (570)
T ss_dssp ECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEE
T ss_pred ccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhh
Confidence 888888776655555443 4444444443
Q ss_pred -------CcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccC---------------------cceeeccCCcceec
Q 003156 186 -------HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG---------------------LEEIDLSENGFMGS 237 (843)
Q Consensus 186 -------~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~---------------------L~~L~l~~n~l~~~ 237 (843)
.+.+..+..+..+++|+.|++++|.+. .+|..+...+ |+.|++++|.+.+.
T Consensus 262 l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~ 340 (570)
T 2z63_A 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA 340 (570)
T ss_dssp EEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCB
T ss_pred hhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccc
Confidence 222233344444455555555555554 3444333334 45555555554433
Q ss_pred CCCCCCCCCcccccCccCEEeCCCCccceeC--CccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCccccc
Q 003156 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDI--PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS 315 (843)
Q Consensus 238 ~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 315 (843)
++. ..+++|++|++++|++++.. |..+..+++|++|++++|.+.+..+. +..+++|++|++++|.+.+.
T Consensus 341 ~~~--------~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~ 411 (570)
T 2z63_A 341 FSE--------VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQM 411 (570)
T ss_dssp CCC--------CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESC
T ss_pred ccc--------ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccc
Confidence 322 45789999999999998654 77888999999999999999876554 89999999999999999977
Q ss_pred CC-ccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccccc-ccCCccccCCCCCCEEEccCCcccccCCcchh
Q 003156 316 IP-QEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS-GSIPKSISNLNKLKILKLEFNELSGEIPQELG 393 (843)
Q Consensus 316 ~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 393 (843)
.+ ..+..+++|++|++++|.+++..|..|.++++|+.|+|++|+++ +.+|..+..+++|++|+|++|++++..|..+.
T Consensus 412 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 491 (570)
T 2z63_A 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491 (570)
T ss_dssp TTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh
Confidence 66 57889999999999999999999999999999999999999998 67999999999999999999999999899999
Q ss_pred cccccceEeeccccceecCCC-CCCCCCCCCCCcCCCCCCCC
Q 003156 394 KLASLLAVNVSYNRLIGRLPV-GGVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 394 ~l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~ 434 (843)
.+++|+.|++++|++++.+|. ...++.+....+.+|+..|.
T Consensus 492 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 999999999999999998875 35678888889999998875
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=436.76 Aligned_cols=404 Identities=22% Similarity=0.191 Sum_probs=264.4
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
+++++|+|++|+|+ .++...|.++++|++|+|++|.+.++.+..|.++++|++|+|++|++++.++ ..|..+++|
T Consensus 25 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~----~~~~~l~~L 99 (680)
T 1ziw_A 25 TNITVLNLTHNQLR-RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD----KTFAFCTNL 99 (680)
T ss_dssp TTCSEEECCSSCCC-CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCT----TTTTTCTTC
T ss_pred CCCcEEECCCCCCC-CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccCh----hhhccCCCC
Confidence 46899999999998 6787889999999999999999999988999999999999999999885443 357889999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhh--cccCCcEEEee
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR--LLNSMIFISVS 159 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~ 159 (843)
++|+|++|++.+..+..|..+++|++|+|++|.+++..|..+.++++|++|++++|.+++..+..+. .+++|+.|+++
T Consensus 100 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~ 179 (680)
T 1ziw_A 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179 (680)
T ss_dssp SEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECT
T ss_pred CEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECC
Confidence 9999999999877778899999999999999999988888889999999999999999877776665 34788888888
Q ss_pred cCcccccCCCCccCC---------------------------CCccEEEcccCCcCCCCCCCCCCCCC--CcEEEecCCc
Q 003156 160 NNTLTGDIPHWIGNI---------------------------STLEFLDFSNNHLTGSLPSSLFNCKK--LSVIRLRGNS 210 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l---------------------------~~L~~L~L~~N~i~~~~~~~~~~l~~--L~~L~L~~N~ 210 (843)
+|++++..|..|..+ ++|+.|++++|.+++..|..|.+++. |+.|++++|.
T Consensus 180 ~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~ 259 (680)
T 1ziw_A 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259 (680)
T ss_dssp TCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSC
T ss_pred CCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCC
Confidence 888877666655543 33455555555555555555555533 6666666666
Q ss_pred CCCCCCchhhcc-CcceeeccCCcceecCCCCCCC---------------------------CCcccccCccCEEeCCCC
Q 003156 211 LNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSS---------------------------SSSSTLFQTLRILDLSSN 262 (843)
Q Consensus 211 l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~---------------------------~~~~~~l~~L~~L~L~~n 262 (843)
+++..|..+... +|+.|++++|.+.+..|..... ...+..+++|++|++++|
T Consensus 260 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n 339 (680)
T 1ziw_A 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339 (680)
T ss_dssp CCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSC
T ss_pred cCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCC
Confidence 655444444443 4666666666665544432211 012345677888888888
Q ss_pred ccceeCCccccCCCCCcEEEcCCCcccC--CCCCCcccc--ccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCC
Q 003156 263 NLVGDIPAEMGLFANLRYLNLSSNHLRS--RIPPELGYF--HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 338 (843)
Q Consensus 263 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 338 (843)
.+.+..+..|..+++|++|++++|.+.. .....|..+ .+|+.|++++|++++..|..|..+++|+.|++++|.+++
T Consensus 340 ~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 419 (680)
T 1ziw_A 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419 (680)
T ss_dssp CBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEE
T ss_pred ccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcc
Confidence 8887777777777777777776665321 111222222 244455555555554444555555555555555555544
Q ss_pred Cch-hhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc--ccCCcchhcccccceEeecccccee
Q 003156 339 PIP-QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS--GEIPQELGKLASLLAVNVSYNRLIG 410 (843)
Q Consensus 339 ~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~ls~N~l~~ 410 (843)
.+| ..|.++++|+.|++++|++++..+..|..+++|+.|++++|.++ +.+|..+..+++|+.|++++|++++
T Consensus 420 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~ 494 (680)
T 1ziw_A 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494 (680)
T ss_dssp ECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCC
T ss_pred ccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCc
Confidence 333 34455555555555555544444444444444444444444433 2334444444444444444444443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=440.96 Aligned_cols=413 Identities=21% Similarity=0.255 Sum_probs=313.6
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccc-----------------------------------
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIF----------------------------------- 47 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f----------------------------------- 47 (843)
+++.|+|++|+++|.+|+ .|+++++|+.|+|++|.+.... ..|
T Consensus 82 ~V~~L~L~~~~l~g~lp~-~l~~L~~L~~L~Ls~N~~~~~~-~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNE-RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159 (636)
T ss_dssp CEEEEECTTSCCEEEECG-GGGGCTTCCEEESCCGGGGGTC-CSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred CEEEEEecCcccCCcCCh-HHhcCccceEEECcCCccccCC-ccccccccccCchHHHHHHHHhhHHHhhhccCchhhHH
Confidence 688999999999999996 5789999999999999762100 000
Q ss_pred ------------------cCCCCCCEEECC--CCCCccccCCCcCccccCCccCCEEecCCccCccc-------------
Q 003156 48 ------------------NYCSSLNTLNLS--NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS------------- 94 (843)
Q Consensus 48 ------------------~~l~~L~~L~Ls--~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~------------- 94 (843)
.....++.+.+. .|++++++. .|..+++|++|+|++|.+++.
T Consensus 160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~ip~-----~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~ 234 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSK-----AVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234 (636)
T ss_dssp HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECG-----GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHH
T ss_pred HHHHHHhhcCccccccccccccchhhhhhccccCCCccCCH-----HHhcccCCCEEECcCCccccccccccccccccch
Confidence 011122223232 466665322 477788888888888888864
Q ss_pred ----Cchhhh--cCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCc-ccc-cCCchhhcc------cCCcEEEeec
Q 003156 95 ----IPQGVA--ALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL-FTG-QLPVSLRLL------NSMIFISVSN 160 (843)
Q Consensus 95 ----~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~L~~ 160 (843)
+|..+. .+++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+..+ ++|++|+|++
T Consensus 235 ~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~ 314 (636)
T 4eco_A 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314 (636)
T ss_dssp HHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCS
T ss_pred hcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCC
Confidence 777777 88888888888888888888888888888888888887 777 677777776 8888888888
Q ss_pred CcccccCCC--CccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-C-cceeeccCCccee
Q 003156 161 NTLTGDIPH--WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-G-LEEIDLSENGFMG 236 (843)
Q Consensus 161 N~l~~~~p~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~-L~~L~l~~n~l~~ 236 (843)
|+++ .+|. .|+++++|++|+|++|++++.+| .+..+++|+.|++++|.++ .+|..+... + |+.|++++|.+.
T Consensus 315 n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~- 390 (636)
T 4eco_A 315 NNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK- 390 (636)
T ss_dssp SCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-
T ss_pred CcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-
Confidence 8888 7777 78888888888888888887777 7888888888888888887 777776665 5 888888888887
Q ss_pred cCCCCCCCCCcccccCccCEEeCCCCccceeCCcccc-------CCCCCcEEEcCCCcccCCCCCCccccccceEEEccC
Q 003156 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG-------LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRN 309 (843)
Q Consensus 237 ~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 309 (843)
.+|..... ..+++|+.|++++|.+.+.+|..+. .+++|++|++++|.++++.+..+..+++|++|+|++
T Consensus 391 ~lp~~~~~----~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 391 YIPNIFDA----KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp SCCSCCCT----TCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred ccchhhhh----cccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 56653321 1234788888888888888887777 777888888888888865444556678888888888
Q ss_pred CcccccCCccccc-c-------CCCcEEEcCCCCCCCCchhhhc--ccCCCcEEecccccccccCCccccCCCCCCEEEc
Q 003156 310 NALYGSIPQEVCE-S-------RSLGILQLDGNSLTGPIPQVIR--NCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 379 (843)
Q Consensus 310 n~l~~~~~~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 379 (843)
|+++ .+|..+.. . ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|
T Consensus 467 N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 467 NMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp SCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 8888 55544333 2 28888888888888 6777776 88888888888888886 7888888888888888
Q ss_pred ------cCCcccccCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCC
Q 003156 380 ------EFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSP 435 (843)
Q Consensus 380 ------~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~ 435 (843)
++|++.+.+|..+.++++|+.|++++|++ +.+|.. .++++....+.+|+..|..
T Consensus 544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEE
T ss_pred CCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcccc
Confidence 55777888888888888888888888888 677753 3367777788888877753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=429.86 Aligned_cols=398 Identities=20% Similarity=0.210 Sum_probs=320.9
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
+++|++|+|++|+|+ .+++.+|.++++|++|+|++|.|.++.+..|.++++|++|+|++|.+++.++ ..|..+++
T Consensus 55 l~~L~~L~Ls~n~l~-~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~ 129 (606)
T 3vq2_A 55 FSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLES----FPIGQLIT 129 (606)
T ss_dssp CTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSS----SCCTTCTT
T ss_pred CccCcEEeCCCCccc-ccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccc----cccCCCCC
Confidence 578999999999999 6777789999999999999999999989999999999999999999986543 35888999
Q ss_pred CCEEecCCccCcc-cCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCc----EEEccCCcccccCCch---------
Q 003156 81 LRTLDLSHNLFSG-SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLT----TLDLSNNLFTGQLPVS--------- 146 (843)
Q Consensus 81 L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~--------- 146 (843)
|++|+|++|.+.+ .+|..|..+++|++|+|++|++++..+..|+.+++|+ +|++++|.+++..+..
T Consensus 130 L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L 209 (606)
T 3vq2_A 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHEL 209 (606)
T ss_dssp CCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred CCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeee
Confidence 9999999999986 4688999999999999999999887777665544433 5555555555333322
Q ss_pred -----------------------------------------------------------------------hhcccCCcE
Q 003156 147 -----------------------------------------------------------------------LRLLNSMIF 155 (843)
Q Consensus 147 -----------------------------------------------------------------------~~~l~~L~~ 155 (843)
+..+++|+.
T Consensus 210 ~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~ 289 (606)
T 3vq2_A 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289 (606)
T ss_dssp EEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSE
T ss_pred eccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCE
Confidence 223344444
Q ss_pred EEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCC--------------------CCCCCCCCcEEEecCCcCCCC-
Q 003156 156 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPS--------------------SLFNCKKLSVIRLRGNSLNGN- 214 (843)
Q Consensus 156 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~--------------------~~~~l~~L~~L~L~~N~l~~~- 214 (843)
|++++|.+. .+| .+..+++|++|++++|.+. .+|. .+..+++|+.|++++|.+++.
T Consensus 290 L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~ 366 (606)
T 3vq2_A 290 MSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG 366 (606)
T ss_dssp EEEESCCCC-CCC-CCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEE
T ss_pred EEecCccch-hhh-hccccccCCEEEcccccCc-ccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCc
Confidence 444444443 233 5556666666666666653 3442 344556666666666666644
Q ss_pred -CCchhhcc-CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCC-ccccCCCCCcEEEcCCCcccCC
Q 003156 215 -IPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP-AEMGLFANLRYLNLSSNHLRSR 291 (843)
Q Consensus 215 -~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ 291 (843)
+|..+... +|+.|++++|.+.+ +|. .+..+++|+.|++++|++.+..| ..+..+++|++|++++|.+.+.
T Consensus 367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 439 (606)
T 3vq2_A 367 CCSYSDLGTNSLRHLDLSFNGAII-MSA------NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439 (606)
T ss_dssp ECCHHHHCCSCCCEEECCSCSEEE-ECC------CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEEC
T ss_pred chhhhhccCCcccEeECCCCcccc-chh------hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCcc
Confidence 25555554 68888888888765 332 23457899999999999998877 6899999999999999999999
Q ss_pred CCCCccccccceEEEccCCcccc-cCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccC
Q 003156 292 IPPELGYFHSLIHLDLRNNALYG-SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISN 370 (843)
Q Consensus 292 ~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 370 (843)
.|..+..+++|++|++++|++++ .+|..+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..|.+
T Consensus 440 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 519 (606)
T 3vq2_A 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519 (606)
T ss_dssp CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTT
T ss_pred chhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccC
Confidence 99999999999999999999997 47899999999999999999999999999999999999999999999988999999
Q ss_pred CCCCCEEEccCCcccccCCcchhccc-ccceEeeccccceecCCC
Q 003156 371 LNKLKILKLEFNELSGEIPQELGKLA-SLLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 371 l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~ls~N~l~~~~p~ 414 (843)
+++|++|+|++|+|+ .+|..+..++ +|+.|++++|++.+..+.
T Consensus 520 l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 520 LYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999999999 6777799997 599999999999988775
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=439.16 Aligned_cols=393 Identities=20% Similarity=0.233 Sum_probs=304.5
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEc-cCcccccc---------------------------------------
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSL-AGNILQGP--------------------------------------- 42 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L-~~n~i~~~--------------------------------------- 42 (843)
+++.|+|++|++.|.+|+. |.+|++|+.|+| ++|.+.+.
T Consensus 324 ~V~~L~Ls~~~L~G~ip~~-l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 324 RVTGLSLAGFGAKGRVPDA-IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp CEEEEECTTTCCEEEECGG-GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CEEEEECccCCCCCcCchH-HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 6889999999999999965 799999999999 77755332
Q ss_pred -------------------------------------ccccccCCCCCCEEECCCCCCcc------------------cc
Q 003156 43 -------------------------------------IGKIFNYCSSLNTLNLSNNHFSG------------------DL 67 (843)
Q Consensus 43 -------------------------------------~~~~f~~l~~L~~L~Ls~N~i~~------------------~~ 67 (843)
.+..|.++++|++|+|++|++++ ++
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 33457888888888888888887 32
Q ss_pred CCCcCcccc--CCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCc-ccc-cCCCCC-------CCCCCCcEEEccC
Q 003156 68 DFASGYGIW--SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQ-FSG-PLPADI-------GFCPHLTTLDLSN 136 (843)
Q Consensus 68 ~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~-------~~l~~L~~L~L~~ 136 (843)
+ .+. .+++|++|+|++|++.+.+|..|..+++|++|+|++|+ +++ .+|..+ ..+++|++|+|++
T Consensus 483 ~-----~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~ 557 (876)
T 4ecn_A 483 E-----ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557 (876)
T ss_dssp S-----CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCS
T ss_pred h-----hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeC
Confidence 2 333 78888888888888887888888888888888888887 776 556533 4455888888888
Q ss_pred CcccccCCc--hhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCC-CcEEEecCCcCCC
Q 003156 137 NLFTGQLPV--SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK-LSVIRLRGNSLNG 213 (843)
Q Consensus 137 N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~ 213 (843)
|.++ .+|. .|..+++|+.|+|++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.++
T Consensus 558 N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~- 632 (876)
T 4ecn_A 558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK- 632 (876)
T ss_dssp SCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-
T ss_pred CcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-
Confidence 8888 6676 8888888888888888888 677 7888888888888888888 77888888888 888888888888
Q ss_pred CCCchhhcc---CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccc-cCCCCCcEEEcCCCccc
Q 003156 214 NIPEGLFDL---GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM-GLFANLRYLNLSSNHLR 289 (843)
Q Consensus 214 ~~p~~~~~~---~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~L~~N~l~ 289 (843)
.+|..+... +|+.|++++|++.+.+|..... ......++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+
T Consensus 633 ~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~-l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~ 710 (876)
T 4ecn_A 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS-MDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT 710 (876)
T ss_dssp SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSC-TTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS
T ss_pred cCchhhhccccCCCCEEECcCCcCCCccccchhh-hccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC
Confidence 677666554 3888888888888766543211 11112347888888888888 455544 47788888888888888
Q ss_pred CCCCCCccc-------cccceEEEccCCcccccCCcccc--ccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccc---
Q 003156 290 SRIPPELGY-------FHSLIHLDLRNNALYGSIPQEVC--ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSH--- 357 (843)
Q Consensus 290 ~~~~~~~~~-------l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~--- 357 (843)
.+.+..+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|.|++ +|..+.++++|+.|+|++
T Consensus 711 ~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ 788 (876)
T 4ecn_A 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788 (876)
T ss_dssp CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBC
T ss_pred ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCC
Confidence 544444432 338888888888888 6777776 88888888888888886 687888888888888866
Q ss_pred ---ccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCC
Q 003156 358 ---NHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 358 ---N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 413 (843)
|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|+|++|++....+
T Consensus 789 ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred cccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccCh
Confidence 777788888888888888888888888 57887765 588888888888765544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=439.53 Aligned_cols=413 Identities=23% Similarity=0.202 Sum_probs=329.1
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
+..|.++++++ .+|. -.++|++|+|++|.|+++.+..|.++++|++|+|++|.+.+. +.+..|.++++|++|
T Consensus 7 ~~~dcs~~~L~-~vP~----lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~---i~~~~f~~L~~L~~L 78 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT---IDKEAFRNLPNLRIL 78 (844)
T ss_dssp EEEEESCCCSS-CCCS----SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCE---ECTTTTSSCTTCCEE
T ss_pred eEEEccCCCCC-CCCC----CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccc---cCHHHhcCCCCCCEE
Confidence 46889999999 8996 368999999999999999999999999999999999965432 334578999999999
Q ss_pred ecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCC--CCCCCCCcEEEccCCcccccCC-chhhcccCCcEEEeecC
Q 003156 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD--IGFCPHLTTLDLSNNLFTGQLP-VSLRLLNSMIFISVSNN 161 (843)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N 161 (843)
+|++|.+.+..|..|.++++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..+ ..|+.+++|++|+|++|
T Consensus 79 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N 158 (844)
T 3j0a_A 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158 (844)
T ss_dssp ECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESS
T ss_pred ECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCC
Confidence 99999999889999999999999999999999766554 8999999999999999997765 68999999999999999
Q ss_pred cccccCCCCccCC--CCccEEEcccCCcCCCCCCCCCCCCC------CcEEEecCCcCCCCCCchhhc------------
Q 003156 162 TLTGDIPHWIGNI--STLEFLDFSNNHLTGSLPSSLFNCKK------LSVIRLRGNSLNGNIPEGLFD------------ 221 (843)
Q Consensus 162 ~l~~~~p~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~------------ 221 (843)
++++..+..|..+ ++|+.|+|++|.+.+..|..+..+.+ |+.|++++|.+++..+..+..
T Consensus 159 ~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l 238 (844)
T 3j0a_A 159 QIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238 (844)
T ss_dssp CCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEEC
T ss_pred cCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceec
Confidence 9999999999888 89999999999999888887777665 999999999887666554432
Q ss_pred ---------------------------cCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccC
Q 003156 222 ---------------------------LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 274 (843)
Q Consensus 222 ---------------------------~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 274 (843)
.+++.|++++|.+.+..|... ..+++|+.|+|++|++++..|..|..
T Consensus 239 ~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~------~~l~~L~~L~L~~n~i~~~~~~~~~~ 312 (844)
T 3j0a_A 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF------ETLKDLKVLNLAYNKINKIADEAFYG 312 (844)
T ss_dssp CSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCS------SSCCCCCEEEEESCCCCEECTTTTTT
T ss_pred ccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhh------hcCCCCCEEECCCCcCCCCChHHhcC
Confidence 257888888888876654432 34677888888888888777777788
Q ss_pred CCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCc--------------
Q 003156 275 FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI-------------- 340 (843)
Q Consensus 275 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------------- 340 (843)
+++|++|++++|.+++..|..|..+++|+.|++++|++.+..+..|..+++|+.|+|++|.+++..
T Consensus 313 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~ 392 (844)
T 3j0a_A 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNK 392 (844)
T ss_dssp CSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCC
T ss_pred CCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCC
Confidence 888888888888887777777777888888888888877666666777777777777777665321
Q ss_pred --------------------------hhhhcccCCCcEEecccccccc------------------------------cC
Q 003156 341 --------------------------PQVIRNCTSLYLLSLSHNHLSG------------------------------SI 364 (843)
Q Consensus 341 --------------------------p~~~~~l~~L~~L~Ls~N~l~~------------------------------~~ 364 (843)
+..+.++++|+.|+|++|++++ ..
T Consensus 393 l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~ 472 (844)
T 3j0a_A 393 LVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC 472 (844)
T ss_dssp CCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCC
T ss_pred cccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccc
Confidence 1123356666666666666653 22
Q ss_pred CccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCC
Q 003156 365 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGI 432 (843)
Q Consensus 365 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 432 (843)
|..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++.+|..-. +.+....+.+|...
T Consensus 473 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~ 539 (844)
T 3j0a_A 473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLL 539 (844)
T ss_dssp SSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCC
T ss_pred hhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCC
Confidence 34567788888888888888888888888888888999999988876664322 55666666666543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=425.58 Aligned_cols=403 Identities=22% Similarity=0.261 Sum_probs=326.5
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
+++|++|+|++|+++ .+++.+|.++++|++|+|++|.+..+++..|.++++|++|+|++|++++.+. ..|..+++
T Consensus 51 l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~----~~~~~l~~ 125 (570)
T 2z63_A 51 FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN----FPIGHLKT 125 (570)
T ss_dssp CSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTT----CSCTTCTT
T ss_pred CCCceEEECCCCcCC-ccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCC----cccccccc
Confidence 578999999999999 7888889999999999999999999999999999999999999999986543 24788999
Q ss_pred CCEEecCCccCcc-cCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCC----cEEEccCCcccccCCchhhcccCCcE
Q 003156 81 LRTLDLSHNLFSG-SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHL----TTLDLSNNLFTGQLPVSLRLLNSMIF 155 (843)
Q Consensus 81 L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~ 155 (843)
|++|+|++|.+.+ .+|..|.++++|++|++++|.+++..+..++.+++| +.|++++|.+++..+..|... +|+.
T Consensus 126 L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~ 204 (570)
T 2z63_A 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHK 204 (570)
T ss_dssp CCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEE
T ss_pred ccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-ccee
Confidence 9999999999986 368999999999999999999998877778777777 788888888776666555433 3444
Q ss_pred EEeecC----------------------------------------------------------cccccCCCCccCCCCc
Q 003156 156 ISVSNN----------------------------------------------------------TLTGDIPHWIGNISTL 177 (843)
Q Consensus 156 L~L~~N----------------------------------------------------------~l~~~~p~~~~~l~~L 177 (843)
|++++| .+.+..|..|..+++|
T Consensus 205 L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L 284 (570)
T 2z63_A 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284 (570)
T ss_dssp EEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTC
T ss_pred EecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcc
Confidence 444443 2222334444445555
Q ss_pred cEEEcccCCcCCCCCCCCCC--------------------CCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceec
Q 003156 178 EFLDFSNNHLTGSLPSSLFN--------------------CKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGS 237 (843)
Q Consensus 178 ~~L~L~~N~i~~~~~~~~~~--------------------l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~ 237 (843)
++|++++|.++ .+|..+.. +++|+.|++++|.+.+..+. ....+|+.|++++|.+.+.
T Consensus 285 ~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~-~~~~~L~~L~l~~n~l~~~ 362 (570)
T 2z63_A 285 SSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE-VDLPSLEFLDLSRNGLSFK 362 (570)
T ss_dssp SEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC-CBCTTCCEEECCSSCCBEE
T ss_pred cEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccc-ccCCCCCEEeCcCCccCcc
Confidence 55555555544 34444444 45555555555555444333 2223799999999998754
Q ss_pred CCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCC-CCccccccceEEEccCCcccccC
Q 003156 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIP-PELGYFHSLIHLDLRNNALYGSI 316 (843)
Q Consensus 238 ~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~ 316 (843)
... ......+++|++|++++|.+.+..+. +..+++|++|++++|.+.+..+ ..+..+++|++|++++|++.+..
T Consensus 363 ~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 437 (570)
T 2z63_A 363 GCC----SQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437 (570)
T ss_dssp EEE----EHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECC
T ss_pred ccc----cccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccc
Confidence 210 01234578999999999999965555 9999999999999999998766 57899999999999999999999
Q ss_pred CccccccCCCcEEEcCCCCCC-CCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcc
Q 003156 317 PQEVCESRSLGILQLDGNSLT-GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 395 (843)
Q Consensus 317 ~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 395 (843)
|..+..+++|+.|++++|.++ +.+|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+.++
T Consensus 438 ~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 517 (570)
T 2z63_A 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517 (570)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred hhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcc
Confidence 999999999999999999997 5789999999999999999999998889999999999999999999999888899999
Q ss_pred cccceEeeccccceecCCCCC
Q 003156 396 ASLLAVNVSYNRLIGRLPVGG 416 (843)
Q Consensus 396 ~~L~~l~ls~N~l~~~~p~~~ 416 (843)
++|+.|++++|++++.+|...
T Consensus 518 ~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 518 TSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp TTCCEEECCSSCBCCCTTTTH
T ss_pred cCCcEEEecCCcccCCCcchH
Confidence 999999999999999998643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=404.66 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=204.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC------Ce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 626 (843)
+.|+..+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|++++++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 457788899999999999999998999999999964432 22345688999999999999999999997643 56
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.|+|||||+ |+|.+++... ..+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 799999996 6899999764 5699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccc--cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 707 RLLTRLD--KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 707 ~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
+.+.... .........||+.|||||++.+...++.++||||+||++|||++|+.||... .....+............
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCCh
Confidence 8764322 1222356789999999998866667899999999999999999999999643 222222222221100000
Q ss_pred -ccc------------ccCCCCCC----CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 -VLD------------CVDPSMGD----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 -~~~------------~~d~~l~~----~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... .+.+..+. .......++.+|+.+|+..||++|||++|+++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000 011234567899999999999999999999987
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=428.43 Aligned_cols=391 Identities=21% Similarity=0.264 Sum_probs=332.5
Q ss_pred CCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcC-----------------------------ccc--
Q 003156 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASG-----------------------------YGI-- 75 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~-----------------------------~~~-- 75 (843)
..++.|+|++|.+++..+..|.++++|++|+|++|.+......... ..+
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 4799999999999988888999999999999999976211100000 000
Q ss_pred -----------------cCCccCCEEecC--CccCcccCchhhhcCCCCCEEEcCCCccccc-----------------C
Q 003156 76 -----------------WSLKRLRTLDLS--HNLFSGSIPQGVAALHYLKELLLQGNQFSGP-----------------L 119 (843)
Q Consensus 76 -----------------~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------------~ 119 (843)
.....++.+.+. +|++++ +|..|+.+++|++|+|++|.+++. +
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i 239 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence 011122233332 688987 899999999999999999999985 8
Q ss_pred CCCCC--CCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc-ccc-cCCCCccCC------CCccEEEcccCCcCC
Q 003156 120 PADIG--FCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT-LTG-DIPHWIGNI------STLEFLDFSNNHLTG 189 (843)
Q Consensus 120 ~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~i~~ 189 (843)
|..++ ++++|++|+|++|.+.+.+|..|..+++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~- 318 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK- 318 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-
T ss_pred chhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-
Confidence 99999 99999999999999999999999999999999999998 988 789888876 99999999999999
Q ss_pred CCCC--CCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCCCCCCCcccccCc-cCEEeCCCCccc
Q 003156 190 SLPS--SLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQT-LRILDLSSNNLV 265 (843)
Q Consensus 190 ~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~-L~~L~L~~n~l~ 265 (843)
.+|. .+.++++|+.|++++|.++|.+| .+..+ +|+.|++++|++. .+|.. +..+++ |++|++++|.++
T Consensus 319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~------l~~l~~~L~~L~Ls~N~l~ 390 (636)
T 4eco_A 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPAN------FCGFTEQVENLSFAHNKLK 390 (636)
T ss_dssp SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTT------SEEECTTCCEEECCSSCCS
T ss_pred ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHh------hhhhcccCcEEEccCCcCc
Confidence 7888 99999999999999999998999 55554 7999999999998 66654 345788 999999999999
Q ss_pred eeCCccccCCC--CCcEEEcCCCcccCCCCCCcc-------ccccceEEEccCCcccccCCccccccCCCcEEEcCCCCC
Q 003156 266 GDIPAEMGLFA--NLRYLNLSSNHLRSRIPPELG-------YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336 (843)
Q Consensus 266 ~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 336 (843)
.+|..+..+. +|++|++++|.+.+..|..+. .+.+|++|+|++|++++..+..+..+++|+.|+|++|++
T Consensus 391 -~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l 469 (636)
T 4eco_A 391 -YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469 (636)
T ss_dssp -SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCC
T ss_pred -ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCC
Confidence 7888887765 899999999999999998888 788999999999999944334456699999999999999
Q ss_pred CCCchhh-hccc-------CCCcEEecccccccccCCcccc--CCCCCCEEEccCCcccccCCcchhcccccceEee---
Q 003156 337 TGPIPQV-IRNC-------TSLYLLSLSHNHLSGSIPKSIS--NLNKLKILKLEFNELSGEIPQELGKLASLLAVNV--- 403 (843)
Q Consensus 337 ~~~~p~~-~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l--- 403 (843)
+ .+|.. +..+ ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|
T Consensus 470 ~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N 546 (636)
T 4eco_A 470 T-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546 (636)
T ss_dssp S-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred C-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence 9 55554 4333 39999999999999 7888887 99999999999999997 9999999999999999
Q ss_pred ---ccccceecCCC-CCCCCCCCCCCcCCCCC
Q 003156 404 ---SYNRLIGRLPV-GGVFPTLDQSSLQGNLG 431 (843)
Q Consensus 404 ---s~N~l~~~~p~-~~~~~~~~~~~~~~n~~ 431 (843)
++|++.+.+|. .+.++++....+.+|..
T Consensus 547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred cccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence 56889999994 35678888889999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=394.29 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=203.5
Q ss_pred hhhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 628 (843)
.+.|+..+.||+|+||+||+|+.+ .+++.||+|++.... ....+.+|+++++.+ +|||||++++++.+.+..+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 356788889999999999999874 357899999985543 456788999999998 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeeccCcc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLAR 707 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~ 707 (843)
+||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999984 278999999999999999999999 99999999999999876 799999999998
Q ss_pred cccccccc--------------------------eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCC
Q 003156 708 LLTRLDKH--------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761 (843)
Q Consensus 708 ~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p 761 (843)
........ .......||+.|||||++.+...++.++||||+||++|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432110 0112346999999999886666789999999999999999999999
Q ss_pred CcCCCCchhhHHHHHHHHHh---------hC---------------------CcccccCCCC----------CCCChhhH
Q 003156 762 VEYGEDNVVILSEHVRVLLE---------EG---------------------NVLDCVDPSM----------GDYPEDEV 801 (843)
Q Consensus 762 ~~~~~~~~~~l~~~~~~~~~---------~~---------------------~~~~~~d~~l----------~~~~~~~~ 801 (843)
|..+.++...+.......-. .. ...+...+.. ........
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 98766655444333221100 00 0000000000 00112334
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 802 LPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 802 ~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.++.+|+.+|++.||++|||++|+++|
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 567899999999999999999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=418.11 Aligned_cols=409 Identities=22% Similarity=0.196 Sum_probs=302.3
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
++||+++|+++ .+|..++ ++|++|+|++|.|.++++..|.++++|++|+|++|+|++.. +..|..+++|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L 74 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD----ISVFKFNQELEYL 74 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC---TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEE----GGGGTTCTTCCEE
T ss_pred ceEecCCCCcc-ccccccc---ccccEEECCCCcccccChhhccccccccEEecCCCccCCcC----hHHhhcccCCCEE
Confidence 56777777777 6776543 67777777777777777777777777777777777777542 2356677777777
Q ss_pred ecCCccCcccCchhhhcCCCCCEEEcCCCcccc-cCCCCCCCCCCCcEEEccCCcccccCCchhhcccCC--cEEEeecC
Q 003156 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM--IFISVSNN 161 (843)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N 161 (843)
+|++|+|+. +|.. .+++|++|+|++|.+++ ..|..|+++++|++|++++|.+++ ..+..+++| +.|++++|
T Consensus 75 ~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n 148 (520)
T 2z7x_B 75 DLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLG 148 (520)
T ss_dssp ECCSSCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEEC
T ss_pred ecCCCceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecc
Confidence 777777773 4443 67777777777777775 356677777777777777777764 456666666 77777777
Q ss_pred cc--cccCCCCccC--------------------------CCCccEEEcccCC-------cCCCCCCCCCCCCCCcEEEe
Q 003156 162 TL--TGDIPHWIGN--------------------------ISTLEFLDFSNNH-------LTGSLPSSLFNCKKLSVIRL 206 (843)
Q Consensus 162 ~l--~~~~p~~~~~--------------------------l~~L~~L~L~~N~-------i~~~~~~~~~~l~~L~~L~L 206 (843)
++ .+..|..|.. +++|+.|++++|. +.+.++ .+..+++|+.|++
T Consensus 149 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l 227 (520)
T 2z7x_B 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTL 227 (520)
T ss_dssp TTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEE
T ss_pred cccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccc
Confidence 77 5555555544 5566666666665 443333 5666677777777
Q ss_pred cCCcCCCCCCchhh----ccCcceeeccCCcceecCCCCCCCCCccccc--------------------------CccCE
Q 003156 207 RGNSLNGNIPEGLF----DLGLEEIDLSENGFMGSIPPGSSSSSSSTLF--------------------------QTLRI 256 (843)
Q Consensus 207 ~~N~l~~~~p~~~~----~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l--------------------------~~L~~ 256 (843)
++|.+++..+..+. ..+|+.|++++|.+.|.+|....... ...+ .+|+.
T Consensus 228 ~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~-~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~ 306 (520)
T 2z7x_B 228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS-GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306 (520)
T ss_dssp EEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCC-SCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSE
T ss_pred cccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcc-cccCceeEeccccccceecchhhhhcccccCceeE
Confidence 76666543322222 22688888888888877776542110 0122 34666
Q ss_pred EeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccc--cCCccccccCCCcEEEcCCC
Q 003156 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG--SIPQEVCESRSLGILQLDGN 334 (843)
Q Consensus 257 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N 334 (843)
|++++|.+.... .+..+++|++|++++|++++..|..+..+++|++|++++|++++ .+|..+..+++|++|++++|
T Consensus 307 L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N 384 (520)
T 2z7x_B 307 FTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384 (520)
T ss_dssp EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSS
T ss_pred EEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCC
Confidence 666666655221 12678999999999999999889999999999999999999996 55678999999999999999
Q ss_pred CCCCCchh-hhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCC
Q 003156 335 SLTGPIPQ-VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 335 ~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 413 (843)
.+++.+|. .|..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++..+
T Consensus 385 ~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~ 461 (520)
T 2z7x_B 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD 461 (520)
T ss_dssp CCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCT
T ss_pred cCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCH
Confidence 99985665 488899999999999999988888775 79999999999999 889988899999999999999995433
Q ss_pred C-CCCCCCCCCCCcCCCCCCCC
Q 003156 414 V-GGVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 414 ~-~~~~~~~~~~~~~~n~~~c~ 434 (843)
. ...++.+....+.+|+..|.
T Consensus 462 ~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 462 GIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp TTTTTCTTCCEEECCSSCBCCC
T ss_pred HHhccCCcccEEECcCCCCccc
Confidence 3 45567788889999998775
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=415.56 Aligned_cols=410 Identities=24% Similarity=0.271 Sum_probs=224.0
Q ss_pred EecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEec
Q 003156 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 86 (843)
Q Consensus 7 L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L 86 (843)
.|+++|+++ .+|..++ ++|++|+|++|.|+++.+..|.++++|++|+|++|++++.++ ..|..+++|++|+|
T Consensus 10 c~~~~~~l~-~ip~~~~---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~----~~~~~l~~L~~L~L 81 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG----DAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSCCS-SCCSCCC---TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT----TTTTTCTTCCEEEC
T ss_pred EECCCCccc-cccccCC---CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh----hhccccccCCEEEC
Confidence 344555555 4554332 445555555555555544455555555555555555543221 23445555555555
Q ss_pred CCccCcccCchhhhcCCCCCEEEcCCCccccc-CCCCCCCCCCCcEEEccCCc-ccccCCchhhcccCCcEEEeecCccc
Q 003156 87 SHNLFSGSIPQGVAALHYLKELLLQGNQFSGP-LPADIGFCPHLTTLDLSNNL-FTGQLPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 87 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
++|++++..+..|.++++|++|+|++|.+++. .|..++++++|++|++++|. +....+..|..+++|++|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 55555544444455555555555555555432 23445555555555555554 23222344555555555555555555
Q ss_pred ccCCCCccCC------------------------CCccEEEcccCCcCCCC--C-CCCCCCCCCcEEEecCCcCCCCCCc
Q 003156 165 GDIPHWIGNI------------------------STLEFLDFSNNHLTGSL--P-SSLFNCKKLSVIRLRGNSLNGNIPE 217 (843)
Q Consensus 165 ~~~p~~~~~l------------------------~~L~~L~L~~N~i~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~p~ 217 (843)
+..|..++.+ ++|++|++++|++++.. + .....+++|+.|++++|.+++..+.
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 241 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH
T ss_pred ccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH
Confidence 5455555544 44555555555544321 1 1112234444444444444322222
Q ss_pred hhhc-----cCcceeeccCCcceecCCCCC---------C----------------------------------------
Q 003156 218 GLFD-----LGLEEIDLSENGFMGSIPPGS---------S---------------------------------------- 243 (843)
Q Consensus 218 ~~~~-----~~L~~L~l~~n~l~~~~p~~~---------~---------------------------------------- 243 (843)
.+.. .+++.+++++|.+.+...... .
T Consensus 242 ~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~ 321 (549)
T 2z81_A 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321 (549)
T ss_dssp HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSC
T ss_pred HHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCc
Confidence 1111 134455555554443110000 0
Q ss_pred ---CC-CcccccCccCEEeCCCCccceeCC---ccccCCCCCcEEEcCCCcccCCCC--CCccccccceEEEccCCcccc
Q 003156 244 ---SS-SSSTLFQTLRILDLSSNNLVGDIP---AEMGLFANLRYLNLSSNHLRSRIP--PELGYFHSLIHLDLRNNALYG 314 (843)
Q Consensus 244 ---~~-~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~n~l~~ 314 (843)
.+ .....+++|++|+|++|++.+.+| ..++.+++|++|++++|++++..+ ..+..+++|++|++++|+++
T Consensus 322 l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~- 400 (549)
T 2z81_A 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH- 400 (549)
T ss_dssp CCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-
T ss_pred cccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-
Confidence 00 000235566666666666665442 235556666666666666654322 33556666666666666666
Q ss_pred cCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhc
Q 003156 315 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGK 394 (843)
Q Consensus 315 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 394 (843)
.+|..+..+++|++|++++|.+++ +|..+ .++|+.|+|++|+|++. +..+++|++|+|++|+|+ .+|. ...
T Consensus 401 ~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~ 471 (549)
T 2z81_A 401 PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASL 471 (549)
T ss_dssp CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGG
T ss_pred cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhh----cccCChhcEEECCCCccC-cCCC-ccc
Confidence 456666666666666666666652 33322 24666777777766643 247889999999999998 6776 567
Q ss_pred ccccceEeeccccceecCCC-CCCCCCCCCCCcCCCCCCCC
Q 003156 395 LASLLAVNVSYNRLIGRLPV-GGVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 395 l~~L~~l~ls~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~ 434 (843)
+++|+.|+|++|++++.+|. .+.++.+....+.+|++.|.
T Consensus 472 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred CccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 89999999999999998885 35678888889999998775
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=398.06 Aligned_cols=385 Identities=20% Similarity=0.163 Sum_probs=325.4
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
+.++.++++++ .+|. + .++|++|+|++|.|.++.+..|.++++|++|+|++|.+.+. +.+..|..+++|++|
T Consensus 13 ~~~~c~~~~l~-~lp~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~---i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 13 YNAICINRGLH-QVPE--L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV---IRNNTFRGLSSLIIL 84 (455)
T ss_dssp TEEECCSSCCS-SCCC--C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE---ECTTTTTTCTTCCEE
T ss_pred cccCcCCCCcc-cCCC--C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce---ECcccccccccCCEE
Confidence 56889999998 8886 2 38999999999999999899999999999999999998643 223468899999999
Q ss_pred ecCCccCcccCchhhhcCCCCCEEEcCCCcccccCC--CCCCCCCCCcEEEccCCcccccCCch-hhcccCCcEEEeecC
Q 003156 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP--ADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNN 161 (843)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N 161 (843)
+|++|++.+..|..|.++++|++|+|++|.+++..+ ..|..+++|++|+|++|.+++..|.. |..+++|++|++++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 999999998889999999999999999999987444 34899999999999999999887876 899999999999999
Q ss_pred cccccCCCCccCC--CCccEEEcccCCcCCCCCCC--------CCCCCCCcEEEecCCcCCCCCCchhhc----cCccee
Q 003156 162 TLTGDIPHWIGNI--STLEFLDFSNNHLTGSLPSS--------LFNCKKLSVIRLRGNSLNGNIPEGLFD----LGLEEI 227 (843)
Q Consensus 162 ~l~~~~p~~~~~l--~~L~~L~L~~N~i~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~p~~~~~----~~L~~L 227 (843)
++.+..+..+..+ .+|+.|++++|.+.+..+.. +..+++|+.|++++|.+++..|..+.. .+++.|
T Consensus 165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence 9999889888877 78999999999999655443 346789999999999999877777665 357888
Q ss_pred eccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccC--CCCCcEEEcCCCcccCCCCCCccccccceEE
Q 003156 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL--FANLRYLNLSSNHLRSRIPPELGYFHSLIHL 305 (843)
Q Consensus 228 ~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 305 (843)
++++|.+.+.. +..+.+.+..+..+.. .++|++|++++|.+.+..|..|..+++|++|
T Consensus 245 ~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 304 (455)
T 3v47_A 245 ILSNSYNMGSS--------------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQL 304 (455)
T ss_dssp ECTTCTTTSCC--------------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred eeccccccccc--------------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEE
Confidence 88887765321 1122222222233332 3688999999999988888888889999999
Q ss_pred EccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 306 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 306 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
+|++|++++..|..|..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..|.++++|++|+|++|+|+
T Consensus 305 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 384 (455)
T 3v47_A 305 TLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK 384 (455)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccc
Confidence 99999999888888999999999999999998888889999999999999999999888999999999999999999999
Q ss_pred ccCCcchhcccccceEeeccccceecCCCCCC
Q 003156 386 GEIPQELGKLASLLAVNVSYNRLIGRLPVGGV 417 (843)
Q Consensus 386 ~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~ 417 (843)
+..+..+..+++|+.|++++|++++.+|...+
T Consensus 385 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 416 (455)
T 3v47_A 385 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 416 (455)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred cCCHhHhccCCcccEEEccCCCcccCCCcchH
Confidence 77777889999999999999999999885443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=407.05 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=204.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHH---HHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFERE---VRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+.|+..+.||+|+||+||+|+...+|+.||||++.+... ......+.+| +.+++.++|||||++++++.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 457778899999999999999999999999999965422 1222334444 56667778999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|||||+||+|.++|... ..+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999875 4699999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
+.... .....||+.|||||++..+..|+.++||||+||++|||++|+.||........ ....+.... ..
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~-~~---- 410 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT-MA---- 410 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHH-CC----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcC-CC----
Confidence 65422 24568999999999985566799999999999999999999999975322211 111111111 11
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
..++.....++.+++.+|++.||++|++ ++||++|
T Consensus 411 -----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1234455667889999999999999998 7888765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=409.85 Aligned_cols=387 Identities=22% Similarity=0.274 Sum_probs=325.4
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
++|++|+|++|+|+ .+++..|.++++|++|+|++|+|.++.+..|.++++|++|+|++|+|++.+.. .+++|
T Consensus 21 ~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~-------~l~~L 92 (520)
T 2z7x_B 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH-------PTVNL 92 (520)
T ss_dssp TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC-------CCCCC
T ss_pred ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc-------ccCCc
Confidence 47999999999999 67777899999999999999999999999999999999999999999965442 68999
Q ss_pred CEEecCCccCcc-cCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCC--cEEEccCCcc--cccCCchhhc-------
Q 003156 82 RTLDLSHNLFSG-SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHL--TTLDLSNNLF--TGQLPVSLRL------- 149 (843)
Q Consensus 82 ~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~------- 149 (843)
++|+|++|++++ ..|..|+.+++|++|+|++|.+++ ..+..+++| ++|++++|.+ .+..|..+..
T Consensus 93 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~ 169 (520)
T 2z7x_B 93 KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169 (520)
T ss_dssp SEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEE
T ss_pred cEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEE
Confidence 999999999986 468899999999999999999985 356777778 9999999998 5556655544
Q ss_pred -------------------ccCCcEEEeecCc-------ccccCCCCccC---------------------------CCC
Q 003156 150 -------------------LNSMIFISVSNNT-------LTGDIPHWIGN---------------------------IST 176 (843)
Q Consensus 150 -------------------l~~L~~L~L~~N~-------l~~~~p~~~~~---------------------------l~~ 176 (843)
+++|+.|++++|. +.+.+| .++. +++
T Consensus 170 l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~ 248 (520)
T 2z7x_B 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248 (520)
T ss_dssp EECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSS
T ss_pred EEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCc
Confidence 4556666666664 222222 2222 237
Q ss_pred ccEEEcccCCcCCCCCCCC-----CCCCCCcEEEecCCcCCCCCC-chhhc----cCcceeeccCCcceecCCCCCCCCC
Q 003156 177 LEFLDFSNNHLTGSLPSSL-----FNCKKLSVIRLRGNSLNGNIP-EGLFD----LGLEEIDLSENGFMGSIPPGSSSSS 246 (843)
Q Consensus 177 L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~----~~L~~L~l~~n~l~~~~p~~~~~~~ 246 (843)
|++|++++|++++.+|..+ ..+++|+.+++++|.+ .+| ..+.. .+++.|++++|.+.+...
T Consensus 249 L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~------- 319 (520)
T 2z7x_B 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC------- 319 (520)
T ss_dssp CSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCC-------
T ss_pred ccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccc-------
Confidence 8888888888888888888 8899999999999998 566 34433 369999999998864211
Q ss_pred cccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccC--CCCCCccccccceEEEccCCcccccCCc-ccccc
Q 003156 247 SSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS--RIPPELGYFHSLIHLDLRNNALYGSIPQ-EVCES 323 (843)
Q Consensus 247 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l 323 (843)
...+++|++|++++|++++..|..++.+++|++|++++|++++ ..|..+..+++|++|++++|++++.+|. .+..+
T Consensus 320 -~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l 398 (520)
T 2z7x_B 320 -PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398 (520)
T ss_dssp -CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCC
T ss_pred -hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccC
Confidence 1357899999999999998899999999999999999999986 3456789999999999999999975665 48889
Q ss_pred CCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcc-hhcccccceEe
Q 003156 324 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVN 402 (843)
Q Consensus 324 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~l~ 402 (843)
++|+.|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|+.|+
T Consensus 399 ~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~ 474 (520)
T 2z7x_B 399 KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIW 474 (520)
T ss_dssp TTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEE
Confidence 9999999999999988887665 79999999999999 88988889999999999999999 56554 99999999999
Q ss_pred eccccceecCCC
Q 003156 403 VSYNRLIGRLPV 414 (843)
Q Consensus 403 ls~N~l~~~~p~ 414 (843)
+++|++++..+.
T Consensus 475 l~~N~~~c~c~~ 486 (520)
T 2z7x_B 475 LHTNPWDCSCPR 486 (520)
T ss_dssp CCSSCBCCCHHH
T ss_pred CcCCCCcccCCc
Confidence 999999987763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=384.65 Aligned_cols=277 Identities=38% Similarity=0.671 Sum_probs=231.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+. +|+.||||++...........+.+|++++++++||||+++++++.+++..++|||
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 345677789999999999999875 7899999998765544444579999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.++++........++|..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 99999999999987666677999999999999999999999987789999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcC---CCCchhhHHHHHHHHHhhCCccccc
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEY---GEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~---~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.. ..........++.............
T Consensus 188 ~~~~-~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 3uim_A 188 DTHV-TTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265 (326)
T ss_dssp SSCE-ECCCCSCGGGCCHHHH-HHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred cccc-cccccCCcCccCHHHh-ccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence 3322 2455689999999988 555689999999999999999999999963 2233334555655555555555666
Q ss_pred CCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 790 DPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 790 d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
+..... .+......+.+++.+||+.||++|||++|++++|+..
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 665544 6778889999999999999999999999999999874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=420.41 Aligned_cols=393 Identities=21% Similarity=0.247 Sum_probs=338.2
Q ss_pred CCCcEEEccCccccccccccccCCCCCCEEEC-CCCCCccccCCC-----------------------------------
Q 003156 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNL-SNNHFSGDLDFA----------------------------------- 70 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~L-s~N~i~~~~~~~----------------------------------- 70 (843)
..++.|+|++|++.+..+..|.+|++|++|+| ++|.+++.....
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999888888999999999999 888765431100
Q ss_pred -------------------------------------cCccccCCccCCEEecCCccCcc-----------------cCc
Q 003156 71 -------------------------------------SGYGIWSLKRLRTLDLSHNLFSG-----------------SIP 96 (843)
Q Consensus 71 -------------------------------------~~~~~~~l~~L~~L~L~~n~l~~-----------------~~~ 96 (843)
.+..|..+++|++|+|++|++++ .+|
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 23468889999999999999997 378
Q ss_pred hhhh--cCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCc-ccc-cCCchhhccc-------CCcEEEeecCcccc
Q 003156 97 QGVA--ALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL-FTG-QLPVSLRLLN-------SMIFISVSNNTLTG 165 (843)
Q Consensus 97 ~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~ 165 (843)
..+. .+++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+..++ +|+.|+|++|+++
T Consensus 483 ~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~- 561 (876)
T 4ecn_A 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE- 561 (876)
T ss_dssp SCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-
T ss_pred hhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-
Confidence 8876 99999999999999999999999999999999999998 987 7888888776 9999999999999
Q ss_pred cCCC--CccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-C-cceeeccCCcceecCCCC
Q 003156 166 DIPH--WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-G-LEEIDLSENGFMGSIPPG 241 (843)
Q Consensus 166 ~~p~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~-L~~L~l~~n~l~~~~p~~ 241 (843)
.+|. .|+++++|++|+|++|+++ .+| .|..+++|+.|+|++|.++ .+|..+... + |+.|++++|.+. .+|..
T Consensus 562 ~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~ 637 (876)
T 4ecn_A 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637 (876)
T ss_dssp BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSC
T ss_pred ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchh
Confidence 8888 8999999999999999999 778 8999999999999999999 888888776 6 999999999998 66654
Q ss_pred CCCCCcccccCccCEEeCCCCccceeCCccc---c--CCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccC
Q 003156 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEM---G--LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 316 (843)
Q Consensus 242 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 316 (843)
... ...++|+.|+|++|++.+.+|... . .+++|+.|+|++|.++.+.+..+..+++|+.|+|++|+|+ .+
T Consensus 638 ~~~----~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~i 712 (876)
T 4ecn_A 638 FNA----KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SI 712 (876)
T ss_dssp CCT----TCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CC
T ss_pred hhc----cccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-cc
Confidence 321 123459999999999998766433 2 3358999999999999654445568899999999999999 66
Q ss_pred Ccccccc--------CCCcEEEcCCCCCCCCchhhhc--ccCCCcEEecccccccccCCccccCCCCCCEEEccC-----
Q 003156 317 PQEVCES--------RSLGILQLDGNSLTGPIPQVIR--NCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF----- 381 (843)
Q Consensus 317 ~~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~----- 381 (843)
|..+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|++
T Consensus 713 p~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls 790 (876)
T 4ecn_A 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAE 790 (876)
T ss_dssp CTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTT
T ss_pred ChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcc
Confidence 6655443 39999999999999 7888887 99999999999999996 899999999999999976
Q ss_pred -CcccccCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCC
Q 003156 382 -NELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGIC 433 (843)
Q Consensus 382 -N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c 433 (843)
|++.+.+|..+.++++|+.|+|++|++ +.+|.. .++.+....+.+|+...
T Consensus 791 ~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 791 GNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNIS 841 (876)
T ss_dssp CCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCE
T ss_pred cccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCc
Confidence 889999999999999999999999999 888864 44678888888997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=378.09 Aligned_cols=276 Identities=33% Similarity=0.543 Sum_probs=231.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 345677889999999999999975 78999999885543 2345788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++.........++|..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987644455799999999999999999999998 9999999999999999999999999999875543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC-chhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED-NVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
..........||..|+|||++ .+..++.++|||||||++|||++|+.||..... .......|.......+.....+++
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHH-HHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHh-cCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 333333455689999999987 455789999999999999999999999975432 223344455555555666666776
Q ss_pred CCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 792 SMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 792 ~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.... .+.+....+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 6544 677888899999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=404.66 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=207.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+.+|+.++|||||++++++.++...++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 457788899999999999999999999999999865432 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC--CCcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN--YNPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfgl~~~~~~ 711 (843)
|++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999754 34689999999999999999999999 99999999999999854 8999999999998764
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.... ....||+.|||||++ .+..|+.++||||+||++|||++|+.||..... ... .... .....
T Consensus 310 ~~~~---~~~~GT~~y~APEv~-~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-~~~----~~~i-~~~~~------ 373 (573)
T 3uto_A 310 KQSV---KVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DET----LRNV-KSCDW------ 373 (573)
T ss_dssp TSEE---EEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHH----HHHH-HTTCC------
T ss_pred CCce---eeeEECccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHH----HHHH-HhCCC------
Confidence 3322 345799999999998 556789999999999999999999999975422 111 1111 11111
Q ss_pred CCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.... .......++.+|+.+||+.||++|||+.|+++|
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 122345568899999999999999999999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=400.32 Aligned_cols=383 Identities=22% Similarity=0.249 Sum_probs=227.3
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCE
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~ 83 (843)
.+++++++|+++ .+|...+ ++|++|+|++|.|.++++..|.++++|++|+|++|+|++..+ ..|..+++|++
T Consensus 33 ~~~l~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~ 104 (562)
T 3a79_B 33 ESMVDYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDF----HVFLFNQDLEY 104 (562)
T ss_dssp CCEEECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECT----TTTTTCTTCCE
T ss_pred CcEEEcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCH----HHhCCCCCCCE
Confidence 367888888887 6776543 678888888888888777778888888888888888775432 35777788888
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCccccc-CCCCCCCCCCCcEEEccCCcccccCCchhhcccCC--cEEEeec
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP-LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM--IFISVSN 160 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~ 160 (843)
|+|++|+|+. +|.. .+++|++|+|++|++++. .|..|+++++|++|++++|.++.. .+..+++| +.|++++
T Consensus 105 L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~ 178 (562)
T 3a79_B 105 LDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDL 178 (562)
T ss_dssp EECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEE
T ss_pred EECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeec
Confidence 8888888874 4444 778888888888888753 356777888888888888887742 44455555 8888888
Q ss_pred Ccc--cccCCCCccCCC--------------------------CccEEEcccCCc-------------------------
Q 003156 161 NTL--TGDIPHWIGNIS--------------------------TLEFLDFSNNHL------------------------- 187 (843)
Q Consensus 161 N~l--~~~~p~~~~~l~--------------------------~L~~L~L~~N~i------------------------- 187 (843)
|++ ++..|..|..+. +|+.|++++|+.
T Consensus 179 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~ 258 (562)
T 3a79_B 179 VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258 (562)
T ss_dssp SSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEE
T ss_pred ccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecC
Confidence 877 656665555432 333333333320
Q ss_pred ---CC----CCCCCCCCCCCCcEEEecCCcCCCCCCchhhc--------------------------------cCcceee
Q 003156 188 ---TG----SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--------------------------------LGLEEID 228 (843)
Q Consensus 188 ---~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------------------------------~~L~~L~ 228 (843)
.+ ..+.. ...++|++|++++|.+++.+|..++. .+++.|+
T Consensus 259 ~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~ 337 (562)
T 3a79_B 259 IETTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337 (562)
T ss_dssp EEECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEE
T ss_pred CcCcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEE
Confidence 00 00000 01124555555555555555544421 2355555
Q ss_pred ccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCC--CCCccccccceEEE
Q 003156 229 LSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRI--PPELGYFHSLIHLD 306 (843)
Q Consensus 229 l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~ 306 (843)
+++|.+..... ...+++|++|++++|++++..|..++.+++|++|++++|+++++. |..+..+++|++|+
T Consensus 338 l~~n~~~~~~~--------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~ 409 (562)
T 3a79_B 338 ISDTPFIHMVC--------PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409 (562)
T ss_dssp EESSCCCCCCC--------CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEE
T ss_pred ccCCCcccccC--------ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEE
Confidence 55555432110 023455666666666666555555666666666666666665432 23455556666666
Q ss_pred ccCCcccccCCc-cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 307 LRNNALYGSIPQ-EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 307 L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
+++|++++.+|. .+..+++|+.|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+
T Consensus 410 l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp CTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC
T ss_pred CCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC
Confidence 666666553332 355556666666666666554444332 45666666666665 45555556666666666666666
Q ss_pred ccCCcc-hhcccccceEeeccccceecCC
Q 003156 386 GEIPQE-LGKLASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 386 ~~~p~~-~~~l~~L~~l~ls~N~l~~~~p 413 (843)
.+|.. +..+++|+.|++++|++.+..|
T Consensus 487 -~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 487 -SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp -CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred -CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 33333 5556666666666666655544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=403.49 Aligned_cols=394 Identities=23% Similarity=0.255 Sum_probs=297.6
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
++|++|+|++|+|+ .+++..|.++++|++|+|++|.|.++++..|.++++|++|+|++|++++.++ ..|..+++|
T Consensus 26 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~~L 100 (549)
T 2z81_A 26 AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS----SWFGPLSSL 100 (549)
T ss_dssp TTCCEEECCSSCCC-EECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH----HHHTTCTTC
T ss_pred CCccEEECcCCccC-ccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH----HHhccCCCC
Confidence 36788888888887 4555567888888888888888887777778888888888888888775432 346677888
Q ss_pred CEEecCCccCccc-CchhhhcCCCCCEEEcCCCc-ccccCCCCCCCCCCCcEEEccCCcccccCCchhh-----------
Q 003156 82 RTLDLSHNLFSGS-IPQGVAALHYLKELLLQGNQ-FSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR----------- 148 (843)
Q Consensus 82 ~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----------- 148 (843)
++|+|++|.+++. .|..|..+++|++|++++|. +....+..|..+++|++|++++|.+++..|..+.
T Consensus 101 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 180 (549)
T 2z81_A 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180 (549)
T ss_dssp CEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEE
T ss_pred cEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecc
Confidence 8888888877652 45667777788888888777 4444445677777777777777777766665554
Q ss_pred -------------cccCCcEEEeecCcccccC--C-CCccCCCCccEEE----------------------------ccc
Q 003156 149 -------------LLNSMIFISVSNNTLTGDI--P-HWIGNISTLEFLD----------------------------FSN 184 (843)
Q Consensus 149 -------------~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~L~~L~----------------------------L~~ 184 (843)
.+++|++|++++|++++.. | .....+++|+.|+ +++
T Consensus 181 ~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~ 260 (549)
T 2z81_A 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260 (549)
T ss_dssp CSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEES
T ss_pred cCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccc
Confidence 3677888888888887532 1 1122334444444 444
Q ss_pred CCcCCCCC---------CC--------------------------CCCCCCCcEEEecCCcCCCCCCchhh-c-cCccee
Q 003156 185 NHLTGSLP---------SS--------------------------LFNCKKLSVIRLRGNSLNGNIPEGLF-D-LGLEEI 227 (843)
Q Consensus 185 N~i~~~~~---------~~--------------------------~~~l~~L~~L~L~~N~l~~~~p~~~~-~-~~L~~L 227 (843)
|.+.+... .. +....+|+.|++++|.+. .+|..++ . .+|+.|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L 339 (549)
T 2z81_A 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFL 339 (549)
T ss_dssp CEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEE
T ss_pred ccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEE
Confidence 44332100 00 111356888888888887 7887775 3 379999
Q ss_pred eccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCC--ccccCCCCCcEEEcCCCcccCCCCCCccccccceEE
Q 003156 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP--AEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 305 (843)
Q Consensus 228 ~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 305 (843)
++++|++.+.+|... .....+++|++|+|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|
T Consensus 340 ~Ls~N~l~~~~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L 415 (549)
T 2z81_A 340 DLSENLMVEEYLKNS---ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415 (549)
T ss_dssp ECCSSCCCHHHHHHH---TCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEE
T ss_pred EccCCccccccccch---hhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEE
Confidence 999999987654321 112457899999999999986533 56889999999999999998 467889999999999
Q ss_pred EccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 306 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 306 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
++++|+++ .+|..+ .++|++|+|++|++++.. .++++|+.|+|++|+|+ .+|. ...+++|++|+|++|+|+
T Consensus 416 ~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~ 486 (549)
T 2z81_A 416 NLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLK 486 (549)
T ss_dssp ECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCC
T ss_pred ECCCCCcc-cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccC
Confidence 99999998 455444 368999999999999643 58999999999999999 6776 578999999999999999
Q ss_pred ccCCcchhcccccceEeeccccceecCCC
Q 003156 386 GEIPQELGKLASLLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 386 ~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 414 (843)
+.+|..+..+++|+.|++++|++++.+|.
T Consensus 487 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 487 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99999999999999999999999998884
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=401.95 Aligned_cols=420 Identities=23% Similarity=0.194 Sum_probs=322.2
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
+++++|||++|+|+ .+|+..|.++++|++|+|++|+|+++++++|.++++|++|+|++|+|++.++ ..|.++++|
T Consensus 52 ~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~----~~f~~L~~L 126 (635)
T 4g8a_A 52 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL----GAFSGLSSL 126 (635)
T ss_dssp TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECG----GGGTTCTTC
T ss_pred cCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCH----HHhcCCCCC
Confidence 36899999999998 7888889999999999999999999999999999999999999999886543 468889999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCccccc-CCCCCCCCCCCcEEEccCCcccccCCchhhcccCCc----EE
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP-LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI----FI 156 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L 156 (843)
++|+|++|++++..+..|+++++|++|+|++|.++.. .|..++.+++|++|+|++|++++..+..|..+.+++ .+
T Consensus 127 ~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~ 206 (635)
T 4g8a_A 127 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 206 (635)
T ss_dssp CEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEE
T ss_pred CEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhh
Confidence 9999999999977777899999999999999998754 567788899999999999999988888877666543 56
Q ss_pred EeecCcccccCCCCccCCCCccEEEcc-----------------------------------------------------
Q 003156 157 SVSNNTLTGDIPHWIGNISTLEFLDFS----------------------------------------------------- 183 (843)
Q Consensus 157 ~L~~N~l~~~~p~~~~~l~~L~~L~L~----------------------------------------------------- 183 (843)
+++.|.+....+..+.. ..++.+++.
T Consensus 207 ~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~ 285 (635)
T 4g8a_A 207 DLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 285 (635)
T ss_dssp ECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEE
T ss_pred hcccCcccccCcccccc-hhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhh
Confidence 66666665333322211 122222222
Q ss_pred -----------------------------cCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchh---------------
Q 003156 184 -----------------------------NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGL--------------- 219 (843)
Q Consensus 184 -----------------------------~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~--------------- 219 (843)
+|.+... ..+.....|+.|++.+|.+....+..+
T Consensus 286 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~ 363 (635)
T 4g8a_A 286 FRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 363 (635)
T ss_dssp EEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCC
T ss_pred hhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCC
Confidence 2222211 123344566667776666653322211
Q ss_pred -----hccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCC-
Q 003156 220 -----FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIP- 293 (843)
Q Consensus 220 -----~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~- 293 (843)
...+|+.+++++|.+....+. ......+.+|+.+++..|.+. ..+..+..+++|+.+++++|......+
T Consensus 364 ~~~~~~l~~L~~L~ls~n~l~~~~~~----~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~ 438 (635)
T 4g8a_A 364 AFSEVDLPSLEFLDLSRNGLSFKGCC----SQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 438 (635)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEEC----CHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSS
T ss_pred Ccccccccccccchhhcccccccccc----ccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccc
Confidence 112456666666665422111 011123456777777777776 455667788899999998888766544
Q ss_pred CCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCC-CCCchhhhcccCCCcEEecccccccccCCccccCCC
Q 003156 294 PELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL-TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN 372 (843)
Q Consensus 294 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 372 (843)
..|..+.+++.+++++|.+.+..+..+..++.|+.|++++|.+ .+..|..|..+++|+.|+|++|+|++..|..|.+++
T Consensus 439 ~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~ 518 (635)
T 4g8a_A 439 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 518 (635)
T ss_dssp CTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCC
Confidence 5678899999999999999999899999999999999999974 446788999999999999999999999999999999
Q ss_pred CCCEEEccCCcccccCCcchhcccccceEeeccccceecCCCC-CCC-CCCCCCCcCCCCCCCC
Q 003156 373 KLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG-GVF-PTLDQSSLQGNLGICS 434 (843)
Q Consensus 373 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~-~~~~~~~~~~n~~~c~ 434 (843)
+|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|.. ..+ .++....+.+||+.|.
T Consensus 519 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 519 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9999999999999999999999999999999999999998853 233 4678888999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=378.50 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=216.0
Q ss_pred hhhhhhcCeeccccceEEEEEEEC-------CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFG-------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP 624 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 624 (843)
.+.|+..+.||+|+||.||+|.+. .++..||||.+.........+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 456777889999999999999873 245689999996654444456789999999999 899999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999987532 124589999999999999999999998 99999999999999
Q ss_pred cCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhh
Q 003156 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 771 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~ 771 (843)
+.++.+||+|||+++...............+|+.|+|||++ .+..++.++|||||||++|||+| |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999876554433333445678899999988 45678999999999999999999 99999754322 1
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 772 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
+.. .+..+. ....+..+..++.+++.+||+.||++|||+.|++++|+.+..
T Consensus 314 ~~~----~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 LFK----LLKEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHH----HHHTTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HHhcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 112221 112345566789999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=384.38 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=213.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||.+.........+.|.+|++++++++||||++++|++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 34567778999999999999999888999999998654332333568899999999999999999999999899999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.++++.. ...+++..++.++.|+|.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999875 34589999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
..........+++.|+|||.+ ....++.++|||||||++|||+| |..||...... . +...+..+...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~----~~~~~~~~~~~----- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEAL-NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--Q----TREFVEKGGRL----- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--H----HHHHHHTTCCC-----
T ss_pred ceeecCCCCCCCcCcCCHhHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHcCCCC-----
Confidence 222222233457889999988 45578999999999999999998 99999654321 1 11222222211
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
..+..++..+.++|.+||+.||++|||++++++.|+.+.+
T Consensus 335 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 ---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 2344556778999999999999999999999999998754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=388.21 Aligned_cols=367 Identities=20% Similarity=0.216 Sum_probs=316.5
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCcccc-ccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ-GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~-~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
++|++|+|++|+|+ .+++..|.++++|++|+|++|.+. .+++..|.++++|++|+|++|++++.. +..|..+++
T Consensus 30 ~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~ 104 (455)
T 3v47_A 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLE----TGAFNGLAN 104 (455)
T ss_dssp TTCCEEECCSSCCC-EECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEEC----TTTTTTCTT
T ss_pred CccCEEEecCCccC-cCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccC----hhhccCccc
Confidence 57999999999999 566677999999999999999997 577888999999999999999998653 346889999
Q ss_pred CCEEecCCccCcccCchh--hhcCCCCCEEEcCCCcccccCCCC-CCCCCCCcEEEccCCcccccCCchhhcc--cCCcE
Q 003156 81 LRTLDLSHNLFSGSIPQG--VAALHYLKELLLQGNQFSGPLPAD-IGFCPHLTTLDLSNNLFTGQLPVSLRLL--NSMIF 155 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~ 155 (843)
|++|+|++|++++..+.. |..+++|++|+|++|.+++..|.. +..+++|++|++++|.+++..+..+..+ .+|+.
T Consensus 105 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~ 184 (455)
T 3v47_A 105 LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTL 184 (455)
T ss_dssp CCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEE
T ss_pred CCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccc
Confidence 999999999998755544 999999999999999999887776 8899999999999999999999988877 78999
Q ss_pred EEeecCcccccCCCCc--------cCCCCccEEEcccCCcCCCCCCCCCCC---CCCcEEEecCCcCCCCCCchhhccCc
Q 003156 156 ISVSNNTLTGDIPHWI--------GNISTLEFLDFSNNHLTGSLPSSLFNC---KKLSVIRLRGNSLNGNIPEGLFDLGL 224 (843)
Q Consensus 156 L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~~~L 224 (843)
|++++|.+.+..+..+ ..+++|++|+|++|++++..|..+..+ ++|+.|++++|.+.+...
T Consensus 185 L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~-------- 256 (455)
T 3v47_A 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF-------- 256 (455)
T ss_dssp EECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------
T ss_pred cccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc--------
Confidence 9999999987655443 367899999999999998777766544 899999999998764321
Q ss_pred ceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceE
Q 003156 225 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIH 304 (843)
Q Consensus 225 ~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 304 (843)
..+.+.+..+.. ......++|+.|++++|.+.+..|..++.+++|++|++++|.+++..|..|..+++|++
T Consensus 257 -----~~~~~~~~~~~~----~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 327 (455)
T 3v47_A 257 -----GHTNFKDPDNFT----FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK 327 (455)
T ss_dssp -----TCCSSCCCCTTT----TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred -----chhhhccCcccc----cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCE
Confidence 111111111000 01112468999999999999999999999999999999999999999999999999999
Q ss_pred EEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcc
Q 003156 305 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384 (843)
Q Consensus 305 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 384 (843)
|+|++|++++..|..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|++
T Consensus 328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 407 (455)
T 3v47_A 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407 (455)
T ss_dssp EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc
Confidence 99999999988889999999999999999999988899999999999999999999977777889999999999999999
Q ss_pred cccCCc
Q 003156 385 SGEIPQ 390 (843)
Q Consensus 385 ~~~~p~ 390 (843)
++..|.
T Consensus 408 ~~~~~~ 413 (455)
T 3v47_A 408 DCSCPR 413 (455)
T ss_dssp CCCTTT
T ss_pred ccCCCc
Confidence 988873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=370.68 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=211.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 44667779999999999999998899999999885432 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999874 35689999999999999999999999 99999999999999999999999999998764432
Q ss_pred cce------------eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 714 KHV------------MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 714 ~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
... ......||+.|+|||++ .+..++.++|||||||++|||++|..|+...................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 01145789999999988 56678999999999999999999999986542221111111111111
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.. .+..++..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 242 ~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 242 RY------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HT------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cc------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 1233344688999999999999999999999999988654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.53 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=210.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+...|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4456778889999999999999998899999999986543 234677899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999999999874 489999999999999999999999 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... . ..........
T Consensus 169 ~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~----~~~~~~~~~~------ 234 (297)
T 3fxz_A 169 EQS--KRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-A----LYLIATNGTP------ 234 (297)
T ss_dssp TTC--CBCCCCSCGGGCCHHHH-HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-H----HHHHHHHCSC------
T ss_pred ccc--ccCCccCCcCccChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H----HHHHHhCCCC------
Confidence 322 22456789999999988 55578999999999999999999999996542211 1 1111111110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ...+......+.+++.+||+.||++|||++|++++
T Consensus 235 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 E-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp C-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 11245556678999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.44 Aligned_cols=270 Identities=35% Similarity=0.559 Sum_probs=220.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+...+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44557899999999999997 688999999865321 2234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 111 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 111 YMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp CCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 999999999998642 235689999999999999999999998 9999999999999999999999999999876554
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh-CCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE-GNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~ 791 (843)
..........||..|+|||.+. + .++.++||||||+++|||++|+.||....... .+..+.+..... ....+.+++
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~-~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALR-G-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHT-T-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCS
T ss_pred cccccccccCCCcCcCChHHhc-C-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHHHHHHhhhhhhhhhhhccc
Confidence 4333345567899999999873 3 47899999999999999999999997653322 122222222221 223344566
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.+...+......+.+++.+||+.||++|||++|++++|+.+..
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 6666778888899999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.85 Aligned_cols=263 Identities=30% Similarity=0.457 Sum_probs=203.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
+...|+..+.||+|+||.||+|++ +|+.||||.+...... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 345677788999999999999988 5889999998654322 2235788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC--eeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP--IIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 99999999999998642 112489999999999999999999998 7 99999999999999999999999999976
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
..... .......||..|+|||++ .+..++.++|||||||++|||++|+.||....... . ........
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~---~~~~~~~~----- 255 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVL-RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--V---VAAVGFKC----- 255 (309)
T ss_dssp ---------------CCTTSCHHHH-TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--H---HHHHHHSC-----
T ss_pred ccccc--cccccCCCCccccChhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHHHhcC-----
Confidence 44321 122456789999999988 55678999999999999999999999997543211 1 11111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
.....+.....++.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 256 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 ---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111234555667899999999999999999999999999886643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=372.48 Aligned_cols=269 Identities=26% Similarity=0.420 Sum_probs=215.3
Q ss_pred hhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.|+..+.||+|+||.||+|.+. .+++.||+|.+.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 355677789999999999999996 345899999997554434456789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCC--------------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCC
Q 003156 628 LLVSDYAPNGSLQAKLHERLPS--------------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 687 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 687 (843)
++||||+++|+|.+++...... ...+++.+++.++.|+++||+|||+. +|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence 9999999999999999875321 25799999999999999999999999 999999999
Q ss_pred CCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCC
Q 003156 688 SNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGE 766 (843)
Q Consensus 688 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~ 766 (843)
+||+++.++.+||+|||+++...............+|+.|+|||.+ ....++.++|||||||++|||+| |+.||....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh-ccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999876544433333456778899999987 45578999999999999999999 999996542
Q ss_pred CchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 003156 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 839 (843)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~~ 839 (843)
.. . .. ..+..+.. ...+..++.++.+++.+||+.||++|||+.|++++|+.+.......
T Consensus 282 ~~--~---~~-~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 282 HE--E---VI-YYVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp HH--H---HH-HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred hH--H---HH-HHHhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 21 1 11 11222211 1234455678999999999999999999999999999988766544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.83 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=207.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3467778999999999999999889999999999654322 234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 95 YASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999875 4589999999999999999999998 9999999999999999999999999999866543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. .....||+.|+|||++......+.++||||+||++|||++|+.||..... . ...... ..+..
T Consensus 168 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~---~~~~~i-~~~~~------- 231 (328)
T 3fe3_A 168 GK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--K---ELRERV-LRGKY------- 231 (328)
T ss_dssp CG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHH-HHCCC-------
T ss_pred Cc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--H---HHHHHH-HhCCC-------
Confidence 22 24567999999999985554456899999999999999999999965321 1 111111 11211
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.....++.+++.+||..||++|||++|++++
T Consensus 232 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 --RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1233455678899999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=375.41 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=214.8
Q ss_pred cChhhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP 624 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 624 (843)
....+.|+..+.||+|+||.||+|.+. .+++.||||++...........+.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344566778889999999999999953 467789999986544444456788999999999999999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCC---CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC---Cc
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY---NP 698 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~ 698 (843)
...++||||+++|+|.+++..... ....+++.+++.++.|+++||+|||+. +|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999987542 234689999999999999999999999 999999999999999554 59
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~ 777 (843)
||+|||+++.+.............+|+.|+|||++ .+..++.++|||||||++|||++ |..||...... . ...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~---~~~ 297 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--E---VLE 297 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H---HHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H---HHH
Confidence 99999999876543333333455678999999988 45678999999999999999998 99999654221 1 111
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
. +..+.. ...+..++..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 298 ~-i~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 F-VTSGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp H-HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHcCCC--------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 1 121111 12244556678999999999999999999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=375.88 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=215.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.+.|+..+.||+|+||.||+|.+ ..+++.||||++.........+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 345677788999999999999994 4467899999997654444456799999999999 7999999999998765
Q ss_pred e-eEEEEEeCCCCCHHHHHhhcCCC-------------------------------------------------------
Q 003156 626 L-KLLVSDYAPNGSLQAKLHERLPS------------------------------------------------------- 649 (843)
Q Consensus 626 ~-~~lV~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 649 (843)
. .++||||+++|+|.++++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4 89999999999999999875321
Q ss_pred -------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccc
Q 003156 650 -------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 722 (843)
Q Consensus 650 -------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~ 722 (843)
...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...............
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 12289999999999999999999999 99999999999999999999999999998765544444445667
Q ss_pred cccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhH
Q 003156 723 SALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEV 801 (843)
Q Consensus 723 g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 801 (843)
||..|+|||++ .+..++.++|||||||++|||+| |+.||.......... . .+..+.. ...+....
T Consensus 257 ~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-~----~~~~~~~--------~~~~~~~~ 322 (359)
T 3vhe_A 257 LPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-R----RLKEGTR--------MRAPDYTT 322 (359)
T ss_dssp ECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-H----HHHHTCC--------CCCCTTCC
T ss_pred CCceeEChhhh-cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-H----HHHcCCC--------CCCCCCCC
Confidence 88999999988 45678999999999999999998 999997654332211 1 1122211 11234455
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 802 LPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 802 ~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.++.+++.+||+.||++|||+.|++++|+.+.++
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999987543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=367.94 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=208.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+..+++.||||.+.........+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 45677789999999999999998899999999986555444456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999988754 4589999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.........||+.|+|||++.....++.++|||||||++|||++|+.||............+. .....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~-------- 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTY-------- 227 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTCTT--------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----ccccc--------
Confidence 333335567899999999985554457899999999999999999999976544333222221 11100
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..........+.+++.+||+.||++|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 011234456788999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.89 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=211.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCC---eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
...|+..+.||+|+||.||+|.+..++ ..||||.+.........+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 455777889999999999999997444 46999999755444445679999999999999999999999999889999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999764 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred ccccc-ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 710 TRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 710 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
..... ........+|+.|+|||++ .+..++.++|||||||++|||++ |+.||...... .. ... +..+..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~---~~~-~~~~~~-- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DV---ISS-VEEGYR-- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HH---HHH-HHTTCC--
T ss_pred ccCccceeeccCCCCcccccCHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HH---HHH-HHcCCC--
Confidence 54322 1222334567789999988 55678999999999999999999 99999654221 11 111 111111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+..++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 273 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 ------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 123445667889999999999999999999999999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=366.45 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=205.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeE----EEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRM----LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
..+.|+..+.||+|+||.||+|.+..+++. ||+|.+.........+.+.+|+.++++++||||+++++++.+.. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 345577788999999999999998766654 58888765554456678999999999999999999999998765 6
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 7999999999999999875 35689999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
...............+|..|+|||.+ .+..++.++|||||||++|||+| |+.||...... .+... +..+..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~----~~~~~~- 237 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI----LEKGER- 237 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCC-
T ss_pred EccCCcccccccCCCccccccChHHh-ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHH----HHcCCC-
Confidence 77654443333445678899999988 55678999999999999999999 99999754322 12221 121111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+..+..++.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 238 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 12344566689999999999999999999999999988754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=366.87 Aligned_cols=271 Identities=22% Similarity=0.292 Sum_probs=214.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.+.|+..+.||+|+||.||+|.+ ..+++.||+|.+.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 446677888999999999999997 2356789999997554444567899999999999 8999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCC-------------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPS-------------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLK 686 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 686 (843)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999875321 13489999999999999999999998 99999999
Q ss_pred CCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCC
Q 003156 687 PSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYG 765 (843)
Q Consensus 687 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~ 765 (843)
|+||+++.++.+||+|||+++...............+|+.|+|||.+ .+..++.++|||||||++|||+| |..||...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh-ccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999877654444444556778899999987 45678999999999999999998 99999765
Q ss_pred CCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 003156 766 EDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 839 (843)
Q Consensus 766 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~~ 839 (843)
..... .. .....+.. ...+.....++.+++.+||+.||++|||+.|++++|+.+....+..
T Consensus 279 ~~~~~-~~----~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 279 PVDAN-FY----KLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp CCSHH-HH----HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred CcHHH-HH----HHHhcCCC--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 43322 11 11222111 1123445667899999999999999999999999999987765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=367.34 Aligned_cols=267 Identities=23% Similarity=0.295 Sum_probs=207.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC----eeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ----LKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 629 (843)
..|+..+.||+|+||.||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 44667779999999999999984 8999999985433 22345667899999999999999999998754 3689
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc-------CCCCeeecCCCCCCEEEcCCCCcEEee
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS-------FRPPIIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------~~~~ivH~dlk~~Nill~~~~~~kl~D 702 (843)
||||+++|+|.++++.. .++|..++.++.|++.||+|||+. +.++|+||||||+||+++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999999874 489999999999999999999975 134899999999999999999999999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCc----CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh--------
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV-------- 770 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~-------- 770 (843)
||+++...............||+.|+|||++... ..++.++|||||||++|||+||+.||........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999877654433333456789999999988442 3456788999999999999999999975422111
Q ss_pred ---hHHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 771 ---ILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 771 ---~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....... ..... ...+.+.. ....+..++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 255 ~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQE-VVVHK----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHH-HHTTS----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhh-hhhcc----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11111 11222222 123456679999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=357.03 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=209.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
.+.|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 34577788999999999999999889999999998654322 2235788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999875 4689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
..... ......||+.|+|||.+ .+..++.++||||+||++|||+||+.||........ ........ . .
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~-~----~ 230 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQDS-V----P 230 (294)
T ss_dssp -------------CCSSCCHHHH-HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSSC-C----C
T ss_pred ccccc-ccCccccCccccCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhcc-C----C
Confidence 42221 22445689999999988 555789999999999999999999999975432111 11111110 0 0
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhccCCCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRP-SMAEVVQILQVIKTPLP 837 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-s~~evl~~L~~~~~~~~ 837 (843)
........+.+..+.+++.+|++.||++|| +++++.+.|+.+.....
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 000112344556789999999999999998 99999999998865543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=356.23 Aligned_cols=273 Identities=20% Similarity=0.249 Sum_probs=217.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC--eeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ--LKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+++.||||++.........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 456777899999999999999998899999999976555556678899999999999999999999998765 679999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE----cCCCCcEEeeccCcc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLAR 707 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~ 707 (843)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999999998752 223489999999999999999999999 99999999999999 778889999999998
Q ss_pred cccccccceeccccccccccCCcccccC-------cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQ-------SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
........ ....||..|+|||++.. ...++.++|||||||++|||++|+.||.......... ..+....
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII 240 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHHh
Confidence 76543322 34568999999998732 4578999999999999999999999997543322222 2222222
Q ss_pred hhCC---cccc-------c--C---CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 781 EEGN---VLDC-------V--D---PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 781 ~~~~---~~~~-------~--d---~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.... .... + . +............+.+++.+|++.||++|||++|++++.....-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 2111 0000 0 0 11112456777889999999999999999999999999877543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=370.14 Aligned_cols=266 Identities=27% Similarity=0.374 Sum_probs=217.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-------CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT 623 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 623 (843)
..+.|+..+.||+|+||.||+|++.. .+..||||++.........+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34567778899999999999999742 34689999997654444456789999999999 89999999999999
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcCCC------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEE
Q 003156 624 PQLKLLVSDYAPNGSLQAKLHERLPS------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 691 (843)
Q Consensus 624 ~~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 691 (843)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 99999999999999999999876421 24589999999999999999999998 9999999999999
Q ss_pred EcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchh
Q 003156 692 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 770 (843)
Q Consensus 692 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~ 770 (843)
++.++.+||+|||+++...............+|..|+|||++ .+..++.++|||||||++|||++ |+.||..... .
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~ 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 999999999999999877654433333455678899999988 45678999999999999999999 9999965422 1
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 771 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
+..+ .+..+.. ...+..+..++.+++.+||+.||++|||++|++++|+++...
T Consensus 301 ---~~~~-~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 301 ---ELFK-LLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ---HHHH-HHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHH-HHHcCCC--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 1222211 122445566789999999999999999999999999988543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=350.34 Aligned_cols=258 Identities=22% Similarity=0.377 Sum_probs=211.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+. ++..||+|.+.... ...+++.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 345677789999999999999987 67889999986543 235779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999875 34589999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .......+|..|+|||.+ ....++.++||||+|+++|||++ |+.||....... .... ...+..
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~-~~~~~~------ 223 (268)
T 3sxs_A 158 QY-VSSVGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLK-VSQGHR------ 223 (268)
T ss_dssp CE-EECCSCCCCGGGCCHHHH-HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHH-HHTTCC------
T ss_pred hh-hcccCCCcCcccCCHHHH-hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHH-HHcCCC------
Confidence 22 222445567789999988 55568999999999999999999 999996543211 1111 111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+...+..+.+++.+||+.||++|||+.|++++|+.+++.
T Consensus 224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 --LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 112333455788999999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=361.33 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=207.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 44677789999999999999998899999999986432 1223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+ +|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 89 E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 78999998875 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... .....||+.|+|||++......+.++||||+||++|||++|+.||....... ....+..
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~~ 222 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVNS 222 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCCS
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHc
Confidence 332 2445789999999998554445789999999999999999999997532211 1111222
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.....+......+.+++.+||+.||++|||++|++++-
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 22234555667789999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.02 Aligned_cols=269 Identities=24% Similarity=0.384 Sum_probs=207.7
Q ss_pred hhhhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--Ce
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 626 (843)
...|+..+.||+|+||.||+|++ ..+++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 45577788999999999999994 4578999999986433 23346789999999999999999999999654 45
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 79999999999999999875 24589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc----------hhhHHHH
Q 003156 707 RLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN----------VVILSEH 775 (843)
Q Consensus 707 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~----------~~~l~~~ 775 (843)
+........ .......++..|+|||.+ .+..++.++||||||+++|||+||..|+...... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHh-cCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 876543321 222344577889999988 5567899999999999999999999998642110 0111111
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
.......+. ....+..++.++.+++.+||+.||++|||+.|+++.|+.+.+..+
T Consensus 241 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 241 LIELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 111122111 112345666789999999999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.93 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=210.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 44667779999999999999997 68889999986543 2357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999764 34689999999999999999999998 99999999999999999999999999998765422
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. .......+|..|+|||.+ ....++.++||||+|+++|||++ |+.||...... ...... ..+.
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~-~~~~-------- 224 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI-STGF-------- 224 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHH-HTTC--------
T ss_pred c-ccccCcccccccCCHHHh-cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHH-hcCc--------
Confidence 2 122345567889999988 55678999999999999999999 99999653221 111111 1111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+......+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111233445678899999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=370.56 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=198.9
Q ss_pred hhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
..|+..+.||+|+||.||+|++. .++..||||.+.........+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 45677789999999999999986 357789999986554333456799999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999864 35689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 711 RLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 711 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... ......+++.|+|||++ ....++.++|||||||++|||++ |+.||...... .... .+..+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~----~i~~~~~--- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIK----AVDEGYR--- 268 (373)
T ss_dssp ---------------CTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHH----HHHTTEE---
T ss_pred cCCccceeccCCCcCCCccChhhh-ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC---
Confidence 432211 11223456789999988 55678999999999999999998 99999654221 1111 1122111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...+..++..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1123455677999999999999999999999999998874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=361.11 Aligned_cols=264 Identities=27% Similarity=0.358 Sum_probs=215.4
Q ss_pred hhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
...|+..+.||+|+||.||+|.+ ..+++.||+|.+.........+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45577788999999999999998 2356899999987554434456789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCC--------------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCC
Q 003156 628 LLVSDYAPNGSLQAKLHERLP--------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 687 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 687 (843)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999987532 123489999999999999999999998 999999999
Q ss_pred CCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCC
Q 003156 688 SNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGE 766 (843)
Q Consensus 688 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~ 766 (843)
+||+++.++.+||+|||+++...............+++.|+|||.+ .+..++.++|||||||++|||++ |+.||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh-cCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999877554443333455678889999988 45578999999999999999999 999997543
Q ss_pred CchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
... +... +..+. ....+.....++.+++.+||+.||++|||+.|++++|+++..
T Consensus 258 ~~~--~~~~----~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PER--LFNL----LKTGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGG--HHHH----HHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--HHHH----hhcCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221 1111 11111 112344556778999999999999999999999999998754
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=379.52 Aligned_cols=391 Identities=20% Similarity=0.170 Sum_probs=316.1
Q ss_pred cCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCC
Q 003156 25 NCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHY 104 (843)
Q Consensus 25 ~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 104 (843)
.+...+++++++|+++.++...+ ++|++|+|++|.|++.+ +..|..+++|++|+|++|+|++..|+.|.++++
T Consensus 29 ~~~~~~~l~ls~~~L~~ip~~~~---~~L~~L~Ls~N~i~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 101 (562)
T 3a79_B 29 SNELESMVDYSNRNLTHVPKDLP---PRTKALSLSQNSISELR----MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD 101 (562)
T ss_dssp ----CCEEECTTSCCCSCCTTSC---TTCCEEECCSSCCCCCC----GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTT
T ss_pred ccCCCcEEEcCCCCCccCCCCCC---CCcCEEECCCCCccccC----hhhhccCCCccEEECCCCCCCcCCHHHhCCCCC
Confidence 45566899999999999887654 79999999999998654 346889999999999999999888999999999
Q ss_pred CCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccC-CchhhcccCCcEEEeecCcccccCCCCccCCCCc--cEEE
Q 003156 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL-PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTL--EFLD 181 (843)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~ 181 (843)
|++|+|++|+|+ .+|.. .+++|++|+|++|++++.. |..|..+++|++|++++|++.+ ..+..+++| ++|+
T Consensus 102 L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~ 175 (562)
T 3a79_B 102 LEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCIL 175 (562)
T ss_dssp CCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEE
T ss_pred CCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEE
Confidence 999999999999 45554 8999999999999999743 6899999999999999999985 345666666 9999
Q ss_pred cccCCc--CCCCCCCCCCC--------------------------CCCcEEEecCCc-----------------------
Q 003156 182 FSNNHL--TGSLPSSLFNC--------------------------KKLSVIRLRGNS----------------------- 210 (843)
Q Consensus 182 L~~N~i--~~~~~~~~~~l--------------------------~~L~~L~L~~N~----------------------- 210 (843)
+++|.+ ++..|..+..+ ++|+.|++++|.
T Consensus 176 L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~ 255 (562)
T 3a79_B 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255 (562)
T ss_dssp EEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEE
T ss_pred eecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEE
Confidence 999999 77777766653 356666666653
Q ss_pred -----CCC----CCCchhhccCcceeeccCCcceecCCCCCCCCCccccc--------------------------CccC
Q 003156 211 -----LNG----NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF--------------------------QTLR 255 (843)
Q Consensus 211 -----l~~----~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l--------------------------~~L~ 255 (843)
+.+ .++......+|+.|++++|.+.|.+|....... ...+ .+|+
T Consensus 256 L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~-~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~ 334 (562)
T 3a79_B 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS-ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334 (562)
T ss_dssp EEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCC-SCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCS
T ss_pred ecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcc-cccchheehhhcccceeecChhhhhhhhccCcce
Confidence 110 011111222789999999999988887652110 0011 3478
Q ss_pred EEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCccccc--CCccccccCCCcEEEcCC
Q 003156 256 ILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS--IPQEVCESRSLGILQLDG 333 (843)
Q Consensus 256 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~Ls~ 333 (843)
.|++++|.+.... ....+++|++|++++|.+++..|..+..+++|++|+|++|++++. +|..+..+++|+.|++++
T Consensus 335 ~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~ 412 (562)
T 3a79_B 335 MLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412 (562)
T ss_dssp EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTT
T ss_pred EEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCC
Confidence 8888888875321 126789999999999999998999999999999999999999963 346789999999999999
Q ss_pred CCCCCCchh-hhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecC
Q 003156 334 NSLTGPIPQ-VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 334 N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
|.+++.+|. .+..+++|+.|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|++++|++++..
T Consensus 413 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~ 489 (562)
T 3a79_B 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVP 489 (562)
T ss_dssp SCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCC
T ss_pred CcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCC
Confidence 999984554 588999999999999999988887665 79999999999999 78888889999999999999999544
Q ss_pred CC-CCCCCCCCCCCcCCCCCCCC
Q 003156 413 PV-GGVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 413 p~-~~~~~~~~~~~~~~n~~~c~ 434 (843)
+. ...++.+....+.+|++.|.
T Consensus 490 ~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 490 DGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp TTSTTTCTTCCCEECCSCCBCCC
T ss_pred HHHHhcCCCCCEEEecCCCcCCC
Confidence 43 45677888899999998875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.50 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=207.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-----ChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-----YPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
..+.|+..+.||+|+||.||+|....+|+.||+|.+....... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3456778889999999999999999899999999997654322 34679999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC----CcEEee
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY----NPRISD 702 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 702 (843)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999999764 4689999999999999999999998 999999999999998776 799999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
||+++....... .....||+.|+|||++ ....++.++||||+||++|||++|..||..... .. ..... ..
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-~~----~~~~i-~~ 232 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QE----TLANI-TA 232 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HH----HHHHH-HT
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HH----HHHHH-Hh
Confidence 999987654322 2445799999999988 556789999999999999999999999965322 11 11111 11
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+... +++ .........+.+++.+|+..||++|||+.|++++
T Consensus 233 ~~~~--~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 233 VSYD--FDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TCCC--CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCC--CCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1100 000 0112334568899999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.96 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=207.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|+...+|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 34667789999999999999999899999999996542 2234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999875 4689999999999999999999998 999999999999999999999999999986432
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... .. ....... +.
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~---~~~~i~~-~~------- 221 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ER---LFELILM-EE------- 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHH-CC-------
T ss_pred CC--CcccccccChhhCChhhh-cCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HH---HHHHHHc-CC-------
Confidence 22 122456789999999998 556789999999999999999999999965321 11 1111111 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++.....++.+++.+||+.||++|| +++|++++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 113444566788999999999999999 99999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.41 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=207.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeE----EEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRM----LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
.+.|+..+.||+|+||.||+|.+..+++. ||+|.+.........+.+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 34567778999999999999999777664 78887755444444567789999999999999999999986 45678
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999864 34689999999999999999999999 999999999999999999999999999998
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
+.............++..|+|||.+ ....++.++|||||||++|||+| |+.||....... ... .+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~- 236 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESI-HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPD----LLEKGERL- 236 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHH----HHHTTCBC-
T ss_pred cCcccccccccCCCCcccccChHHh-ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHH----HHHcCCCC-
Confidence 7654444444556778899999988 55678999999999999999999 999997543221 111 11222111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
..+..+..++.+++.+||+.||++|||+.|++++|+.+..
T Consensus 237 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1233344467889999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=377.37 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=213.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.++..+.||+|+||.||+|.+. ++..||||++.... ...+.|.+|+.++++++||||+++++++. .+..++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 3455677789999999999999996 67889999986543 34688999999999999999999999986 56789999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.++++... ...+++..++.++.|+|.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 262 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred eecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999998641 23578899999999999999999998 999999999999999999999999999987653
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......+++.|+|||++ ....++.++|||||||++|||+| |+.||...... .... .+..+...
T Consensus 337 ~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~----~i~~~~~~---- 404 (454)
T 1qcf_A 337 NEY-TAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYRM---- 404 (454)
T ss_dssp HHH-HTTCSSSSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH----HHHHTCCC----
T ss_pred Cce-eccCCCcccccccCHHHh-ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCCC----
Confidence 221 112334567889999988 55678999999999999999999 99999754221 1111 12222111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
..+..++.++.++|.+||+.||++|||++++++.|+.+......
T Consensus 405 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 405 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 12445667899999999999999999999999999998776544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=354.07 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=209.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
...++..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 344555668999999999999998889999999986543 3446778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 123 ~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 123 FLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp CCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred cCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence 99999999998753 589999999999999999999998 9999999999999999999999999999876542
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......||..|+|||++ .+..++.++|||||||++|||++|+.||..... .. ..... .... .+.
T Consensus 195 ~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~---~~~~~-~~~~-----~~~ 260 (321)
T 2c30_A 195 VP--KRKSLVGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQ---AMKRL-RDSP-----PPK 260 (321)
T ss_dssp SC--CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH---HHHHH-HHSS-----CCC
T ss_pred cc--ccccccCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHH-hcCC-----CCC
Confidence 22 12456789999999988 556789999999999999999999999965321 11 11111 1111 111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
. .........+.+++.+||+.||++|||+.|++++-.-...
T Consensus 261 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 261 L-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp C-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred c-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 1 1123445678899999999999999999999987544333
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=380.40 Aligned_cols=260 Identities=27% Similarity=0.356 Sum_probs=215.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
...|+..+.||+|+||.||+|.+..++..||||.+.... ...+.|.+|+.++++++||||++++++|...+..++|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 344667779999999999999998779999999986543 346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999998752 35689999999999999999999998 9999999999999999999999999999876532
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
. ........++..|+|||++ ....++.++|||||||++|||+| |+.||...... ..... +..+..
T Consensus 372 ~-~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~----~~~~~~------ 437 (495)
T 1opk_A 372 T-YTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL----LEKDYR------ 437 (495)
T ss_dssp C-EECCTTCCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH----HHTTCC------
T ss_pred c-eeecCCCcCCcceeCHhHH-hcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCCC------
Confidence 2 2222344567889999988 55678999999999999999999 99999754322 11111 222211
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+..++..+.++|.+||+.||++|||+.|+++.|+.+...
T Consensus 438 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred --CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 123455667899999999999999999999999999987554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.35 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=218.1
Q ss_pred hhhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.+.|+..+.||+|+||.||+|.+ ..+++.||+|.+.........+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 345677788999999999999986 3467899999997554434457789999999999 9999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCC--------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEE
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPS--------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 691 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 691 (843)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 999999999999999999875321 23589999999999999999999998 9999999999999
Q ss_pred EcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchh
Q 003156 692 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 770 (843)
Q Consensus 692 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~ 770 (843)
++.++.+||+|||+++...............+|..|+|||.+ .+..++.++|||||||++|||+| |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999877654444444556678899999987 45678999999999999999999 9999976543322
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 771 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
. .. ....+.. ...+...+..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 257 ~-~~----~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 F-YK----MIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp H-HH----HHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H-HH----HhccCCC--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 11 1121111 0123345567899999999999999999999999999875543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.25 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=210.6
Q ss_pred hhhhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--Ce
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~ 626 (843)
...|+..+.||+|+||.||+|++ ..+++.||+|++.........+.+.+|++++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45577788999999999999994 5578999999997665555668899999999999999999999999876 56
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 79999999999999999765 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC---------CchhhHHHHH
Q 003156 707 RLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE---------DNVVILSEHV 776 (843)
Q Consensus 707 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~---------~~~~~l~~~~ 776 (843)
+........ .......+|..|+|||.+ .+..++.++||||+|+++|||++|+.|+.... .........+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECL-MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeee-cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 876543322 223455678889999987 55578899999999999999999999874321 0011111111
Q ss_pred HHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 777 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
......+.. ...+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 253 ~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKR--------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCC--------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCC--------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 112222111 1234556678999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=351.31 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=207.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||+||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 566779999999999999999899999999997554332 2467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 84 DQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred CC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 75 666666553 35689999999999999999999999 999999999999999999999999999987643221
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC--c---ccc-
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN--V---LDC- 788 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~--~---~~~- 788 (843)
......||..|+|||++.....++.++||||+||++|||++|..||.........+....+....... . ...
T Consensus 157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 22445788999999988555558999999999999999999999976654444333333222111000 0 000
Q ss_pred ---------cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 ---------VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ---------~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...............+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0001111233456678899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=348.36 Aligned_cols=256 Identities=25% Similarity=0.481 Sum_probs=207.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccC------hHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY------PEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
.+.|+..+.||+|+||.||+|.+..+++.||+|++........ .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4557777899999999999999988999999999865443222 267899999999999999999999987655
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC--eeecCCCCCCEEEcCCCC-----cE
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP--IIHYNLKPSNILLDDNYN-----PR 699 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~k 699 (843)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 6999999999999998764 35699999999999999999999998 7 999999999999987776 99
Q ss_pred EeeccCcccccccccceeccccccccccCCccccc-CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH
Q 003156 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC-QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~ 778 (843)
|+|||+++..... .....||..|+|||.+. ....++.++||||+||++|||++|+.||..............
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-- 242 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-- 242 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH--
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH--
Confidence 9999999754321 23457899999999873 234578899999999999999999999976543332221111
Q ss_pred HHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+ . ....+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 243 -~~~~-~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 -REEG-L-------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HHSC-C-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -hccC-C-------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 1 1123455567899999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.48 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=208.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----cChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
..+.|+..+.||+|+||.||+|....+|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 456788888999999999999999889999999998654322 135779999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC----CcEEee
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY----NPRISD 702 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 702 (843)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 99999999999999999764 4689999999999999999999998 999999999999999877 899999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
||+++....... .....||+.|+|||++ ....++.++|||||||++|||++|+.||..... ... .......
T Consensus 162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~----~~~~~~~ 232 (326)
T 2y0a_A 162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QET----LANVSAV 232 (326)
T ss_dssp CTTCEECCTTSC---CCCCCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHH----HHHHHHT
T ss_pred CCCCeECCCCCc---cccccCCcCcCCceee-cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-HHH----HHHHHhc
Confidence 999987653322 1345789999999988 556789999999999999999999999965322 111 1111111
Q ss_pred CCcccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~~~~~d~~l~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. .... .........+.+++.+||+.||++|||+.|++++
T Consensus 233 -~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 -N------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -C------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -C------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 0000 0112334568899999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.61 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=208.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC----cccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD----IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
..+.|+..+.||+|+||.||+|.+..+|+.||||.+.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567888889999999999999998899999999985432 112457899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC---cEEeecc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFG 704 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 704 (843)
++||||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999998876543445689999999999999999999998 9999999999999986554 9999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
+++....... ......||+.|+|||++ ....++.++||||+||++|||++|+.||.... . ........ +.
T Consensus 179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~----~~~~~i~~-~~ 248 (351)
T 3c0i_A 179 VAIQLGESGL--VAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--E----RLFEGIIK-GK 248 (351)
T ss_dssp TCEECCTTSC--BCCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--H----HHHHHHHH-TC
T ss_pred ceeEecCCCe--eecCCcCCcCccCHHHH-cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--H----HHHHHHHc-CC
Confidence 9987654222 22455789999999988 55578999999999999999999999997531 1 11111111 11
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. .++ .........+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~--~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 YK--MNP---RQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CC--CCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC--CCc---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 10 000 0012334578899999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.69 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=203.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHh--ccCCCccceeeEEEcC----Ce
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK--ARHPNLISLEGYYWTP----QL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~ 626 (843)
.+.|+..+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 45567778999999999999998 6899999998543 24566777777777 7899999999997543 45
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhh--------hcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH--------HSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
.++||||+++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 7899999999999999964 35899999999999999999999 66 99999999999999999999
Q ss_pred EEeeccCcccccccccce--eccccccccccCCcccccCcC-----CCCCchhHHHHHHHHHHHHhC----------CCC
Q 003156 699 RISDFGLARLLTRLDKHV--MSNRFQSALGYVAPELTCQSL-----RVNEKCDIYGFGVLILELVTG----------RRP 761 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Dv~S~Gvil~elltg----------~~p 761 (843)
||+|||+++......... ......||+.|+|||++.... .++.++|||||||++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999998765433221 123457899999999884432 344799999999999999999 888
Q ss_pred CcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 762 VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 762 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
|................ .... ...+..+. ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 f~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKV-VCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHH-HTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHH-Hhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 86543332222222221 1111 11122211 2345677899999999999999999999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.65 Aligned_cols=268 Identities=22% Similarity=0.274 Sum_probs=197.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+..+|+.||+|++.........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 34677789999999999999998889999999997655445567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC--CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERL--PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
++ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 69999987642 1234589999999999999999999998 999999999999999999999999999987643
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC-Cc-----
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG-NV----- 785 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-~~----- 785 (843)
... ......+|..|+|||++.....++.++|||||||++|||++|+.||..... ...+........... ..
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 161 PVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCTTTCGGGG
T ss_pred Ccc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhHhhhhh
Confidence 221 123456889999999885556789999999999999999999999975432 222222221110000 00
Q ss_pred -ccccCCCCCC-------------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 -LDCVDPSMGD-------------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 -~~~~d~~l~~-------------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.....+.... .......++.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000111110 111344578899999999999999999999886
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=371.75 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=207.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC-eeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-LKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+. |+.||||.+.... ..+.|.+|+.++++++||||+++++++...+ ..++|||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 44666779999999999999984 8899999986543 4578999999999999999999999988765 6899999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.++++... ...+++..++.++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999998762 33478999999999999999999999 9999999999999999999999999999854321
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
. ....++..|+|||.+ ....++.++|||||||++|||+| |+.||....... ... .+..+..
T Consensus 343 ~-----~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~~~------ 404 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGYK------ 404 (450)
T ss_dssp ---------CCCTTTSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH----HHHTTCC------
T ss_pred c-----cCCCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCCC------
Confidence 1 223567889999988 55678999999999999999998 999997643322 111 1122211
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+..++..+.++|.+||+.||++|||+.|+++.|+.+...
T Consensus 405 --~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 --MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 123456677899999999999999999999999999988653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=358.11 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=212.9
Q ss_pred hhhhhhcCeeccccceEEEEEEEC-------CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFG-------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP 624 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 624 (843)
.+.|+..+.||+|+||.||+|.+. .+++.||+|++.........+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 456777889999999999999985 356789999986554434456789999999999 899999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCC------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPS------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999875321 23489999999999999999999998 99999999999999
Q ss_pred cCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhh
Q 003156 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 771 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~ 771 (843)
+.++.+||+|||+++...............+++.|+|||++ .+..++.++|||||||++|||++ |+.||..... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHh-cCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HH
Confidence 99999999999999876654433333445677889999987 45568999999999999999999 9999965422 11
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 772 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
+ ... +..+.. ...+..+..++.+++.+||+.||++|||+.|++++|+.+..
T Consensus 268 ~---~~~-~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 L---FKL-LKEGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp H---HHH-HHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HHH-HhcCCC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 111 122211 12244556678999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.71 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=198.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
..+.|+..+.||+|+||.||+|.+.. .+..||+|.+.........+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34567778899999999999999854 356799999865443344567899999999999999999999984 45678
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999875 34689999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... ......+++.|+|||.+ ....++.++|||||||++|||++ |..||....... .... +..+.
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~----i~~~~--- 234 (281)
T 1mp8_A 166 MEDSTYY-KASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR----IENGE--- 234 (281)
T ss_dssp --------------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTC---
T ss_pred cCccccc-ccccCCCcccccChhhc-ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH----HHcCC---
Confidence 6543221 22344567889999988 55678999999999999999997 999997543321 1111 11111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
....+...+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 235 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11234455677899999999999999999999999998874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=348.87 Aligned_cols=258 Identities=25% Similarity=0.297 Sum_probs=205.4
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
...+.|+..+.||+|+||.||+|....+++.||+|++.........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 34567788889999999999999998899999999997765555668899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE---cCCCCcEEeeccCcc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLAR 707 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~ 707 (843)
|||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999976433346799999999999999999999998 99999999999999 456889999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... .....||..|+|||.+. ..++.++|||||||++|||++|+.||...... .. ...... ..
T Consensus 176 ~~~~~~~---~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~---~~~~~~-~~--- 241 (285)
T 3is5_A 176 LFKSDEH---STNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EV---QQKATY-KE--- 241 (285)
T ss_dssp C-------------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHHHH-CC---
T ss_pred ecCCccc---CcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HH---Hhhhcc-CC---
Confidence 6654222 24456899999999873 35889999999999999999999999754221 11 111111 11
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+...........++.+++.+||+.||++|||+.|++++
T Consensus 242 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 ---PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ---CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ---cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112234568899999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.75 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=193.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..+.|+..+.||+|+||.||+|.+..+++.||||.+.... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4456788889999999999999998889999999986543 3456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~ 708 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999999764 4589999999999999999999998 9999999999999975 88999999999986
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.........+. .... ... ..
T Consensus 201 ~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~i~~-~~~-~~ 270 (349)
T 2w4o_A 201 VEHQV---LMKTVCGTPGYCAPEIL-RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR----RILN-CEY-YF 270 (349)
T ss_dssp ---------------CGGGSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH----HHHT-TCC-CC
T ss_pred cCccc---ccccccCCCCccCHHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH----HHHh-CCC-cc
Confidence 54322 12345789999999988 556789999999999999999999999975443322211 1111 111 01
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..........++.+++.+||+.||++|||+.|++++
T Consensus 271 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233455678899999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.54 Aligned_cols=253 Identities=19% Similarity=0.284 Sum_probs=206.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 45677789999999999999999899999999986432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC--CCCcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD--NYNPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~ 711 (843)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999764 34689999999999999999999998 9999999999999996 78999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.... ....||+.|+|||++ .+..++.++||||+||++|||++|..||..... . ............. +
T Consensus 157 ~~~~---~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~----~~~~~i~~~~~~~---~- 223 (321)
T 1tki_A 157 GDNF---RLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-Q----QIIENIMNAEYTF---D- 223 (321)
T ss_dssp TCEE---EEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-H----HHHHHHHHTCCCC---C-
T ss_pred CCcc---ccccCChhhcCcHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-H----HHHHHHHcCCCCC---C-
Confidence 3321 345689999999988 555689999999999999999999999965322 1 1112111111100 0
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.......+.++.+++.+|+..||++|||+.|++++-
T Consensus 224 --~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 224 --EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp --HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred --hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 000123355788999999999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=359.66 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=207.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|....+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45677889999999999999999899999999986542 2234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 95 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999864 4689999999999999999999999 999999999999999999999999999987653
Q ss_pred cccceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.. ......||+.|+|||++.. +..++.++|||||||++|||++|+.||....... .......... .
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~-~------ 235 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFET-T------ 235 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHH-C------
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhh-c------
Confidence 22 2245679999999998843 3458899999999999999999999997543221 1111111111 1
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-MAEVVQ 827 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-~~evl~ 827 (843)
...++......+.+++.+||+.||++||+ ++++++
T Consensus 236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11234455667899999999999999998 777765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=373.06 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=207.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+..+.||+|+||.||+|.+. .+..||||.+.... ...+.|.+|++++++++||||+++++++.+ +..++||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 3455677789999999999999997 56789999986543 345789999999999999999999999876 6689999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 9999999999998631 24589999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......++..|+|||.+ ....++.++|||||||++|||+| |+.||...... +... .+..+..
T Consensus 333 ~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~-~i~~~~~----- 399 (452)
T 1fmk_A 333 NEY-TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD-QVERGYR----- 399 (452)
T ss_dssp -----------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHH-HHHTTCC-----
T ss_pred Cce-ecccCCcccccccCHhHH-hcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH-HHHcCCC-----
Confidence 222 122344567889999988 45678999999999999999999 99999654221 1111 1222211
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
...+..++..+.++|.+||+.||++|||++++++.|+.+.....+
T Consensus 400 ---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 123455667899999999999999999999999999998765543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.39 Aligned_cols=267 Identities=21% Similarity=0.344 Sum_probs=216.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
..+.|+..+.||+|+||.||+|.+. .+++.||+|.+...........+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 3456778889999999999999875 24788999998755443445578999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcC------CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEE
Q 003156 627 KLLVSDYAPNGSLQAKLHERL------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 700 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 700 (843)
.++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence 999999999999999998632 1224578999999999999999999999 9999999999999999999999
Q ss_pred eeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHH
Q 003156 701 SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 701 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~ 779 (843)
+|||+++...............+|+.|+|||.+ .+..++.++|||||||++|||++ |+.||..... . .....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~---~~~~~- 252 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--E---QVLRF- 252 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--H---HHHHH-
T ss_pred CcCccccccccccccccccCCCCCCCccChhhh-ccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--H---HHHHH-
Confidence 999999876554433333445678899999987 55678999999999999999999 8899865322 1 11111
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
+..+. ....+...+..+.+++.+||+.||++|||+.|++++|+.+..+.
T Consensus 253 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 253 VMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp HHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 11111 12234455667899999999999999999999999999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=348.58 Aligned_cols=263 Identities=12% Similarity=0.114 Sum_probs=211.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||.+.... ..+.+.+|+.+++.+ +|++++++++++.+....++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 44677789999999999999998899999999986543 234688899999999 79999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC-----cEEeeccCcc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN-----PRISDFGLAR 707 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~ 707 (843)
|+ +|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999875 34589999999999999999999998 9999999999999987776 9999999998
Q ss_pred cccccccc-----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc-hhhHHHHHHHHHh
Q 003156 708 LLTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-VVILSEHVRVLLE 781 (843)
Q Consensus 708 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~-~~~l~~~~~~~~~ 781 (843)
........ .......||..|+|||.+ .+..++.++|||||||++|||++|+.||...... .......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 76543221 122456789999999988 5567899999999999999999999999764322 2111111111111
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
..... ......+.++.+++.+||+.||++|||++++++.|+.+...
T Consensus 239 ~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 239 STPLR--------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HSCHH--------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CccHH--------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 11110 11223456789999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=352.63 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=202.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||+||+|.+. +|+.||+|++...... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 44677789999999999999996 6999999998654322 224678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 997 5888888764 34589999999999999999999998 9999999999999999999999999999876432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc-------
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV------- 785 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~------- 785 (843)
... .....+|..|+|||++.....++.++||||+||++|||++|+.||....... .+...... ......
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSI-LGTPNPREWPQVQ 248 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHH-HCCCCTTTSGGGT
T ss_pred ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH-HCCCChHHhhhhh
Confidence 221 2345678999999988555678999999999999999999999997543322 22222221 111000
Q ss_pred ---------ccccCCCC-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 ---------LDCVDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ---------~~~~d~~l-~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+... .........++.+++.+|++.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000 00112334578899999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=361.34 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=205.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 4567778999999999999999989999999999754322 2335688899999887 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999875 4589999999999999999999999 99999999999999999999999999998533
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch---hhHHHHHHHHHhhCCccc
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV---VILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~ 787 (843)
... .......||+.|+|||++ .+..++.++||||+||++|||++|+.||....... ......+...+....
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l-~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred cCC--CccccccCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 221 223556899999999998 55678999999999999999999999996432111 011111111122111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM------AEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~------~evl~~ 828 (843)
..++.....++.+++.+||+.||++||++ +|++++
T Consensus 279 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 ------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 12344556678899999999999999995 677664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.45 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=204.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeE----EEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRM----LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
.+.|+..+.||+|+||.||+|.+..+++. ||+|.+.........+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 35577788999999999999999777664 57777765555556788999999999999999999999998765 78
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999875 35689999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
..............+|..|+|||.+ .+..++.++|||||||++|||++ |+.||....... +... +..+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~----~~~~~--- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSI----LEKGE--- 236 (327)
T ss_dssp -------------CCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTC---
T ss_pred ccCccccccccCCCccccccCHHHH-cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHcCC---
Confidence 7544433333445667889999988 56678999999999999999999 999997543321 1111 11111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+.....++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 112344556678999999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.91 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=195.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCe---EEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
+.+.|+..+.||+|+||.||+|.+..++. .||||.+..... ....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34567778899999999999999876554 899999865432 22356789999999999999999999999877655
Q ss_pred ------EEEEEeCCCCCHHHHHhhcC--CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcE
Q 003156 628 ------LLVSDYAPNGSLQAKLHERL--PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 699 (843)
Q Consensus 628 ------~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 699 (843)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 89999999999999997642 1223689999999999999999999999 999999999999999999999
Q ss_pred EeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHH
Q 003156 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~ 778 (843)
|+|||+++...............++..|+|||.+ .+..++.++|||||||++|||++ |+.||....... .. . .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~-~---~ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-IY-N---Y 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HH-H---H
T ss_pred EeeccccccccccccccccccccCcccccCchhh-cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-HH-H---H
Confidence 9999999876554433333445667889999988 55678999999999999999999 999997543321 11 1 1
Q ss_pred HHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 779 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
... +. ....+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 252 ~~~-~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 252 LIG-GN--------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHT-TC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhc-CC--------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 11 112344556678999999999999999999999999988744
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=379.73 Aligned_cols=399 Identities=24% Similarity=0.258 Sum_probs=317.9
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
|++|++|+|++|+|+ .+++.+|.++++|++|+|++|+|+++++..|.++++|++|+|++|+|++.++ ..|.++++
T Consensus 75 l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~----~~~~~L~~ 149 (635)
T 4g8a_A 75 FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN----FPIGHLKT 149 (635)
T ss_dssp CTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTT----CCCTTCTT
T ss_pred CCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCCh----hhhhcCcc
Confidence 578999999999999 7898999999999999999999999999999999999999999999986543 46889999
Q ss_pred CCEEecCCccCccc-CchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCC----cEEEccCCcccccCCchhhc------
Q 003156 81 LRTLDLSHNLFSGS-IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHL----TTLDLSNNLFTGQLPVSLRL------ 149 (843)
Q Consensus 81 L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~------ 149 (843)
|++|+|++|.++.. .|..+..+++|++|+|++|++++..+..|..+.++ ..++++.|.++...+..+..
T Consensus 150 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l 229 (635)
T 4g8a_A 150 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 229 (635)
T ss_dssp CCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred cCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhh
Confidence 99999999999754 57889999999999999999988777766544333 35666666655333222211
Q ss_pred ---------------------------------------------------------------------------ccCCc
Q 003156 150 ---------------------------------------------------------------------------LNSMI 154 (843)
Q Consensus 150 ---------------------------------------------------------------------------l~~L~ 154 (843)
+.+++
T Consensus 230 ~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~ 309 (635)
T 4g8a_A 230 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVS 309 (635)
T ss_dssp EEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCS
T ss_pred hhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccc
Confidence 11222
Q ss_pred EEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCC-------------------CCCCCCCCCcEEEecCCcCCC--
Q 003156 155 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP-------------------SSLFNCKKLSVIRLRGNSLNG-- 213 (843)
Q Consensus 155 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-------------------~~~~~l~~L~~L~L~~N~l~~-- 213 (843)
.+.+.+|.+.... .+.....|+.|++.+|.+....+ .....+++|+.|++++|.+..
T Consensus 310 ~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~ 387 (635)
T 4g8a_A 310 SFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 387 (635)
T ss_dssp EEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEE
T ss_pred ccccccccccccc--ccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccccccc
Confidence 2222222222111 12333455555555555443222 233467899999999998863
Q ss_pred CCCchhhcc-CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCC-ccccCCCCCcEEEcCCCcccCC
Q 003156 214 NIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP-AEMGLFANLRYLNLSSNHLRSR 291 (843)
Q Consensus 214 ~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ 291 (843)
..+...... +++.++++.|.+....+. ...+++|+.++++.|......+ ..+..+.+++.++++.|.+...
T Consensus 388 ~~~~~~~~~~~L~~L~~~~~~~~~~~~~-------~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~ 460 (635)
T 4g8a_A 388 CCSQSDFGTISLKYLDLSFNGVITMSSN-------FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 460 (635)
T ss_dssp ECCHHHHSCSCCCEEECCSCSEEEECSC-------CTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEEC
T ss_pred ccccchhhhhhhhhhhcccccccccccc-------ccccccccchhhhhccccccccccccccccccccccccccccccc
Confidence 234444443 799999999998754332 2347899999999998876544 5578899999999999999999
Q ss_pred CCCCccccccceEEEccCCccc-ccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccC
Q 003156 292 IPPELGYFHSLIHLDLRNNALY-GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISN 370 (843)
Q Consensus 292 ~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 370 (843)
.+..+..+++|+.|+|++|.+. +..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.+
T Consensus 461 ~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 540 (635)
T 4g8a_A 461 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 540 (635)
T ss_dssp CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTT
T ss_pred cccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhC
Confidence 9999999999999999999854 467889999999999999999999999999999999999999999999888999999
Q ss_pred CCCCCEEEccCCcccccCCcchhcc-cccceEeeccccceecCC
Q 003156 371 LNKLKILKLEFNELSGEIPQELGKL-ASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 371 l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~l~ls~N~l~~~~p 413 (843)
+++|++|+|++|+|++..|..+..+ ++|+.|+|++|++++...
T Consensus 541 l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 541 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999999998 689999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.51 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=207.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+. ++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 345677789999999999999997 78889999986543 235789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999874 24589999999999999999999998 9999999999999999999999999999876542
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .......+|+.|+|||.+ ....++.++||||+|+++|||+| |+.||...... ..... +..+.
T Consensus 174 ~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~-~~~~~------- 238 (283)
T 3gen_A 174 EY-TSSVGSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEH-IAQGL------- 238 (283)
T ss_dssp HH-HSTTSTTSCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH-HHTTC-------
T ss_pred cc-ccccCCccCcccCCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHH-Hhccc-------
Confidence 22 122344567889999988 45578999999999999999998 99999754321 11111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+......+.+++.+||+.+|++|||++|++++|+.+.+
T Consensus 239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 011233445678899999999999999999999999988743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.56 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=210.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45677789999999999999998889999999997655444557889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988753 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
.........|+..|+|||.+.....++.++||||||+++|||++|+.||............+.. ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~-------- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTY-------- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----TCTT--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----cccc--------
Confidence 3222345678999999999854444578999999999999999999999765443332222211 1100
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..........+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01123445678899999999999999999999886
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=353.40 Aligned_cols=260 Identities=12% Similarity=0.105 Sum_probs=208.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 632 (843)
..|+..+.||+|+||.||+|....+|+.||||.+..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 446677799999999999999988999999999865432 34688999999999 99999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC-----cEEeeccCcc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN-----PRISDFGLAR 707 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfgl~~ 707 (843)
|+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999874 35699999999999999999999998 9999999999999998887 9999999998
Q ss_pred cccccccce-----eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch-hhHHHHHHHHHh
Q 003156 708 LLTRLDKHV-----MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV-VILSEHVRVLLE 781 (843)
Q Consensus 708 ~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~-~~l~~~~~~~~~ 781 (843)
.+....... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTH-LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHH-cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 765432211 12456789999999988 55678999999999999999999999997643221 111111111111
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
.... +. .....+ ++.+++..||+.||++||++.++++.|+.+.
T Consensus 238 ~~~~-~~-------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 238 ATPI-EV-------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HSCH-HH-------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCH-HH-------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0000 00 011233 7899999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.62 Aligned_cols=271 Identities=21% Similarity=0.295 Sum_probs=211.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc----CCeeE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKL 628 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 628 (843)
.+.|+..+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 455777889999999999999998899999999986543 2335678999999999999999999999973 34678
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999987544456799999999999999999999999 999999999999999999999999999876
Q ss_pred ccccccce-------eccccccccccCCcccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH
Q 003156 709 LTRLDKHV-------MSNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 709 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 779 (843)
........ ......||..|+|||.+.... .++.++|||||||++|||++|+.||..............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---
Confidence 53211100 012335689999999874322 368999999999999999999999964211111111111
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCCC
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 839 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~~ 839 (843)
.... . ..........+.+++.+||+.||++|||+.|++++|+.+.++.|..
T Consensus 261 -~~~~-------~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 261 -QNQL-------S-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp -HCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred -hccC-------C-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 1100 0 0112344567899999999999999999999999999998887653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=349.86 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=198.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.+.|+..+.||+|+||.||+|++. ..||+|.+..... ....+.|.+|+.++++++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 455777889999999999999874 3599999865432 22346789999999999999999999965 455678999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999764 35689999999999999999999998 999999999999999999999999999986654
Q ss_pred cccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
...........||..|+|||.+. ....++.++||||||+++|||++|+.||........ +. .....+..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~----~~~~~~~~---- 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II----EMVGRGSL---- 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HH----HHHHHTSC----
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HH----HHhccccc----
Confidence 33322334567899999999874 245678899999999999999999999976543221 11 12222221
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.+........++..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 222333445666789999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=354.11 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=214.5
Q ss_pred hhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC-
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ- 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~- 625 (843)
.+.|+..+.||+|+||.||+|.+ ..+++.||||.+.........+.+.+|+.+++++ +||||+++++++..++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 45677788999999999999985 3467899999997654433456789999999999 7999999999998765
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCC------------CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPS------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 693 (843)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence 489999999999999999875321 22388999999999999999999998 999999999999999
Q ss_pred CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhH
Q 003156 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVIL 772 (843)
Q Consensus 694 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l 772 (843)
.++.+||+|||+++...............+|+.|+|||++ .+..++.++|||||||++|||+| |+.||..........
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhh-ccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 9999999999999876554444444556778899999988 55678999999999999999998 999997654332221
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
. .+..+.. ...+.....++.+++.+||+.||++|||+.|++++|+.+.++
T Consensus 262 -~----~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 262 -R----RLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp -H----HHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -H----HhccCcc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1 1122211 112334456789999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=348.85 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=196.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-------------------------cChHHHHHHHHHHHh
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-------------------------QYPEDFEREVRVLGK 608 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~ 608 (843)
+.|+..+.||+|+||.||+|....+++.||||.+...... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 3466777999999999999999889999999998654321 113568899999999
Q ss_pred ccCCCccceeeEEEc--CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCC
Q 003156 609 ARHPNLISLEGYYWT--PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLK 686 (843)
Q Consensus 609 l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 686 (843)
++||||+++++++.+ .+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 999999999999987 567899999999999877543 24689999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCC--CCCchhHHHHHHHHHHHHhCCCCCcC
Q 003156 687 PSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRPVEY 764 (843)
Q Consensus 687 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~Dv~S~Gvil~elltg~~p~~~ 764 (843)
|+||+++.++.+||+|||+++....... ......||+.|+|||.+..... ++.++|||||||++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 1244578999999998844332 47889999999999999999999965
Q ss_pred CCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 765 GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 765 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ..+ .. .+....... + .......++.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~--~~~---~~-~~~~~~~~~---~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERI--MCL---HS-KIKSQALEF---P----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSH--HHH---HH-HHHHCCCCC---C----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccH--HHH---HH-HHhcccCCC---C----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 321 111 11 111111110 1 122345578899999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=364.78 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=206.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.+.|+..+.||+|+||.||+|....+|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45677888999999999999999989999999998655432 23456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc---CCCCcEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~ 708 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++.
T Consensus 90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999875 4589999999999999999999999 999999999999998 568899999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... ......||+.|+|||++ ....++.++||||+||++|+|++|+.||..... . .+ ... +..+.. ..
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~-~~---~~~-i~~~~~-~~ 232 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-H-RL---YQQ-IKAGAY-DF 232 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-H-HH---HHH-HHHTCC-CC
T ss_pred ecCCCc--eeecccCCcccCCHHHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-H-HH---HHH-HHhCCC-CC
Confidence 654322 12346789999999988 556789999999999999999999999965322 1 11 111 122211 11
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+ .......++.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 122345678899999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=358.43 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=196.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|+...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 355777889999999999999999899999999996543 234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC--cEEeeccCccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN--PRISDFGLARLLT 710 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~~ 710 (843)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999875 3589999999999999999999998 9999999999999987665 9999999997543
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... ......||+.|+|||++......+.++||||+||++|||++|+.||....... .....++.......
T Consensus 170 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~------ 239 (361)
T 3uc3_A 170 LHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRILSVKY------ 239 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHHHTTCC------
T ss_pred ccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhcCCC------
Confidence 221 12445789999999988544333455999999999999999999997643322 22222222222111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+ ........+.+++.+||+.||++|||+.|++++-
T Consensus 240 -~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 240 -SIP-DDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp -CCC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred -CCC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 000 1112345688999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.97 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=214.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCC-----eEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQG-----RMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 626 (843)
.+.|+..+.||+|+||.||+|.+..++ ..||+|.+.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 345677789999999999999986554 379999986554334456789999999999 89999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCC----------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 627 KLLVSDYAPNGSLQAKLHERLP----------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999986421 134589999999999999999999998 999999999999999999
Q ss_pred CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHH
Q 003156 697 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 775 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~ 775 (843)
.+||+|||+++...............+|..|+|||.+ .+..++.++|||||||++|||+| |..||........ ...
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~- 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYK- 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHH-
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHh-ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHH-
Confidence 9999999999876554443344556678899999987 45678999999999999999999 9999976433321 111
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+.. ...+...+..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 279 ---~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 279 ---LVKDGYQ--------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp ---HHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHhcCCC--------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1222111 11233445678899999999999999999999999988643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=357.02 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=207.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
..+.|+..+.||+|+||.||+|.+..+|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 345678888999999999999999889999999999755432 2235688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC---CCcEEeeccCcc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN---YNPRISDFGLAR 707 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~ 707 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++
T Consensus 107 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999764 4689999999999999999999999 99999999999999864 459999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..... ..+ ... +..+...
T Consensus 180 ~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~---~~~-i~~~~~~- 248 (362)
T 2bdw_A 180 EVNDSEA---WHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRL---YAQ-IKAGAYD- 248 (362)
T ss_dssp CCTTCCS---CCCSCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHH-HHHTCCC-
T ss_pred EecCCcc---cccCCCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH---HHH-HHhCCCC-
Confidence 7653222 2346789999999988 555789999999999999999999999965322 111 111 1111110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. .........++.+++.+||+.||++|||+.|++++
T Consensus 249 ~~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YP----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 01123345678899999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=349.34 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=199.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+ .++.||+|++... ...+.|.+|+.++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 4466777999999999999998 4789999998533 235679999999999999999999998864 47899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC-cEEeeccCccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN-PRISDFGLARLLTRL 712 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~~~ 712 (843)
+++|+|.+++.... ....+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999998652 2235788999999999999999999942238999999999999998887 799999999765432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. ....||..|+|||++ .+..++.++|||||||++|||++|+.||............ . ...+.
T Consensus 160 ~-----~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~-~~~~~-------- 221 (307)
T 2eva_A 160 M-----TNNKGSAAWMAPEVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW---A-VHNGT-------- 221 (307)
T ss_dssp ----------CCTTSSCHHHH-TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH---H-HHTTC--------
T ss_pred c-----ccCCCCCceEChhhh-CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH---H-HhcCC--------
Confidence 1 234689999999988 5567899999999999999999999999754332211111 1 11111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
....+...+..+.+++.+||+.||++|||++|++++|+.+....
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11223445567889999999999999999999999999886644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=344.55 Aligned_cols=253 Identities=30% Similarity=0.406 Sum_probs=193.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.|+..+.||+|+||.||+|.+ .++.||||.+..... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred heeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 456677999999999999998 488999999865432 233567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC--------CCCcEEeec
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD--------NYNPRISDF 703 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Df 703 (843)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+....+|+||||||+||+++. ++.+||+||
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999864 35899999999999999999999982222999999999999986 778999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
|+++....... ....||..|+|||.+ .+..++.++||||||+++|||++|+.||........ .... ...
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~-~~~ 229 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----AYGV-AMN 229 (271)
T ss_dssp CC-----------------CCGGGSCHHHH-HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHHH-HTS
T ss_pred Ccccccccccc----cCCCCccceeCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHhh-hcC
Confidence 99986553222 345688999999988 556789999999999999999999999975432111 1111 111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
.. ....+...+..+.+++.+||+.||++|||+.|++++|+.+
T Consensus 230 ~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KL-------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CC-------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 1123455567799999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=358.49 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=201.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.|+..+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|..+++.+ +||||+++++++.+.+..++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 4667779999999999999999899999999996542 123456788999999988 6999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 104 EFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999875 4589999999999999999999999 999999999999999999999999999985432
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... .. ....... +.
T Consensus 177 ~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~----~~~~i~~-~~------- 240 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DD----LFEAILN-DE------- 240 (353)
T ss_dssp -----------CCGGGCCHHHH-HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH----HHHHHHH-CC-------
T ss_pred CC--ccccccCCCcCeEChhhc-CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-HH----HHHHHHc-CC-------
Confidence 21 222456799999999988 555789999999999999999999999975422 11 1111111 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSM------AEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~------~evl~~ 828 (843)
..++......+.+++.+|++.||++||++ .|++++
T Consensus 241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11344455678899999999999999998 777764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=362.32 Aligned_cols=260 Identities=26% Similarity=0.349 Sum_probs=197.1
Q ss_pred hhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC-CeeEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-QLKLLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~ 631 (843)
|+..+.||+|+||.||+|.+..+ +..||+|.+.........+.|.+|+.++++++||||+++++++... +..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 45567899999999999998432 2468999986544444457899999999999999999999998654 5778999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 171 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999864 35688999999999999999999998 999999999999999999999999999987643
Q ss_pred cccce--eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 712 LDKHV--MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 712 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
..... ......+|..|+|||.+ ....++.++|||||||++|||+| |..||....... .... +..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~----~~~~~~--- 314 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY----LLQGRR--- 314 (373)
T ss_dssp -------------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHH----HHTTCC---
T ss_pred cccccccccCCCCCcccccChHHh-cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHH----HHcCCC---
Confidence 32211 12334567889999988 56678999999999999999999 666775443221 1111 111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
...+..++..+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 315 -----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 315 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1124455667899999999999999999999999999986554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=348.70 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=207.9
Q ss_pred hhhcCeeccccceEEEEEEECCCC---eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee-EEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK-LLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV~ 631 (843)
++..+.||+|+||.||+|.+..++ ..||+|.+.........+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 344568999999999999975443 379999986544434456789999999999999999999999876655 8999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 103 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999874 35689999999999999999999999 999999999999999999999999999986644
Q ss_pred ccc--ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 712 LDK--HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
... ........++..|+|||.+ .+..++.++||||||+++|||++|..|+........ ....+ ..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~----~~~~----- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFL----AQGR----- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHH-TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHH----HTTC-----
T ss_pred CcccccccCcCCCCCccccChhhh-ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHh----hcCC-----
Confidence 321 1222345678899999988 566789999999999999999997666544333222 22111 1111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
....+...+..+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 246 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 ---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 11123445567899999999999999999999999999886654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.29 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=206.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|+...+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 346677899999999999999988999999999965421 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999874 4589999999999999999999998 999999999999999999999999999986543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
. .....||+.|+|||++ .+..++.++||||+||++|||++|+.||..... . ......... .
T Consensus 159 ~-----~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~----~~~~~i~~~-~------- 219 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-M----KTYEKILNA-E------- 219 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-H----HHHHHHHHC-C-------
T ss_pred c-----cccccCCccccCHhHh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-H----HHHHHHHhC-C-------
Confidence 2 2345789999999988 556789999999999999999999999965322 1 111122211 1
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++.....++.+++.+|+..||++|| +++|++++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112344556788999999999999999 89999865
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=354.38 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=205.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4466778999999999999999989999999999765322 2235678899999988 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999875 3589999999999999999999998 99999999999999999999999999998643
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh---hHHHHHHHHHhhCCccc
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV---ILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~---~l~~~~~~~~~~~~~~~ 787 (843)
... .......||+.|+|||++ .+..++.++||||+||++|||++|+.||........ .....+...+....
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 235 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 235 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred CCC--CcccccCCCccccCcccc-CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence 222 122456799999999988 556789999999999999999999999965311110 00111111111111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM------AEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~------~evl~~ 828 (843)
..++.....++.+++.+||+.||++||++ .|++++
T Consensus 236 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 ------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11344556678899999999999999995 677764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=355.33 Aligned_cols=269 Identities=23% Similarity=0.325 Sum_probs=209.6
Q ss_pred cccChhhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEE
Q 003156 548 CSIDPETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 622 (843)
Q Consensus 548 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 622 (843)
+.....+.|+..+.||+|+||.||+|.+ ..+++.||||.+...........+.+|+.++++++||||+++++++.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3334566788888999999999999994 44678999999865444444567899999999999999999999999
Q ss_pred cCCeeEEEEEeCCCCCHHHHHhhcCCC---CCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CC
Q 003156 623 TPQLKLLVSDYAPNGSLQAKLHERLPS---TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NY 696 (843)
Q Consensus 623 ~~~~~~lV~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~ 696 (843)
.....++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+++. +.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999999875321 24589999999999999999999998 9999999999999994 45
Q ss_pred CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHH
Q 003156 697 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 775 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~ 775 (843)
.+||+|||+++...............+++.|+|||.+ ....++.++||||||+++|||+| |+.||..... .. .
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~---~ 254 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QE---V 254 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH---H
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HH---H
Confidence 6999999999866543333333455678899999987 45578999999999999999998 9999865322 11 1
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.. .+..+.. ...+......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 255 ~~-~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 255 LE-FVTSGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HH-HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-HHhcCCC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11 1121111 12234455678999999999999999999999999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=350.77 Aligned_cols=269 Identities=20% Similarity=0.323 Sum_probs=204.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
....|+..+.||+|+||.||+|....+|+.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 34567788899999999999999988999999999865332 2234578899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++.........+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999986433456789999999999999999999998 9999999999999999999999999999866
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
..... ......|+..|+|||.+ ....++.++||||||+++|||++|+.||.........+... +.......
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~-- 257 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDYPP-- 257 (310)
T ss_dssp --------------CCSSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH----HHTTCSCC--
T ss_pred cCCCc--cccccCCCeeEeChHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH----hhcccCCC--
Confidence 43221 12345688999999988 55678999999999999999999999997543332222221 12111110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
. .......++.+++.+||+.||++|||+.|+++.|+.+++...
T Consensus 258 ---~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 258 ---L--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---C--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---C--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0 123445678899999999999999999999999999866543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.37 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=205.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCC-------eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQG-------RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 625 (843)
.+.|+..+.||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 455777789999999999999987655 579999985433 334578999999999999999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC--------
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN-------- 697 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------- 697 (843)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999875 23489999999999999999999999 9999999999999998887
Q ss_pred cEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH
Q 003156 698 PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777 (843)
Q Consensus 698 ~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~ 777 (843)
+||+|||+++..... ....++..|+|||.+.....++.++|||||||++|||++|..|+.......... .
T Consensus 160 ~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~----~ 229 (289)
T 4fvq_A 160 IKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL----Q 229 (289)
T ss_dssp EEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----H
T ss_pred eeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH----H
Confidence 999999999755331 234578889999988554678999999999999999999665554332221111 1
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
...... ..+.....++.+++.+||+.||++|||+.|++++|+.+..+.
T Consensus 230 -~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 230 -FYEDRH----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -HHHTTC----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -HhhccC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 111111 112222345788999999999999999999999999997764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.89 Aligned_cols=254 Identities=18% Similarity=0.268 Sum_probs=200.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC--------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-------- 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 625 (843)
+.|+..+.||+|+||.||+|++..+|+.||||++.........+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 456777899999999999999988999999999976554445678999999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEEeCCCCCHHHHHhhcCCCCCCCChh
Q 003156 626 -------------------------------------------------LKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 656 (843)
Q Consensus 626 -------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~ 656 (843)
..++||||+++|+|.+++.... .....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 2789999999999999998753 23445777
Q ss_pred HHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc----------eeccccccccc
Q 003156 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH----------VMSNRFQSALG 726 (843)
Q Consensus 657 ~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~----------~~~~~~~g~~~ 726 (843)
.++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999998 9999999999999999999999999999876543211 12234568999
Q ss_pred cCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHH
Q 003156 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLK 806 (843)
Q Consensus 727 y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 806 (843)
|+|||++ .+..++.++|||||||++|||++|..|+... ...... .... ..+........++.+
T Consensus 242 y~aPE~~-~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~-~~~~--------~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQI-HGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITD-VRNL--------KFPLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHH-HCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHH-HHTT--------CCCHHHHHHCHHHHH
T ss_pred ccChHHh-cCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHH-hhcc--------CCCcccccCChhHHH
Confidence 9999988 4557899999999999999999987765211 011111 1111 111112334456789
Q ss_pred HHHHccCCCCCCCCCHHHHHHH
Q 003156 807 LALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 807 l~~~c~~~~P~~RPs~~evl~~ 828 (843)
++.+||+.||++|||++|++++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 9999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=346.41 Aligned_cols=261 Identities=24% Similarity=0.312 Sum_probs=201.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
|+..+.||+|+||.||+|.. .+|+.||+|++..... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred chhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 55677899999999999999 4799999999865432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 83 DQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp SE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred CC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 75 999998764 34689999999999999999999998 999999999999999999999999999986543211
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC--------cc
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN--------VL 786 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~--------~~ 786 (843)
......+|..|+|||++.....++.++||||+||++|||++|+.||..... ...+....+. ..... ..
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRI-LGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHH-HCCCCTTTSTTGGGS
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH-HCCCChhhchhhhcc
Confidence 113446789999999885556789999999999999999999999975422 2222222211 11000 00
Q ss_pred cccCCCCC--------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMG--------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~--------~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...++... ........++.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01111111 1123355678899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=381.10 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=203.0
Q ss_pred eeccccceEEEEEEEC--CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 561 EVGEGVFGTVYKVSFG--TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.||+|+||.||+|.+. .++..||||++.........+.|.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999885 34667999999765545567889999999999999999999999976 56899999999999
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce-e
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-M 717 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~-~ 717 (843)
|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999764 35689999999999999999999998 99999999999999999999999999998765433221 1
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
.....+++.|+|||++ ....++.++|||||||++|||+| |+.||....... .. ..+..+.. ...
T Consensus 496 ~~~~~~~~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~----~~i~~~~~--------~~~ 560 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGKR--------MEC 560 (613)
T ss_dssp ------CCTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH----HHHHTTCC--------CCC
T ss_pred ccCCCCccceeCHhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCC--------CCC
Confidence 1233456889999988 55679999999999999999998 999997653321 11 12222221 123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
+..++.++.++|.+||+.+|++|||+.++++.|+.+.
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 4566778999999999999999999999999998863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=357.14 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=204.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|++..+|+.||+|++..... ....+.+..|..+++.+ +||||+++++++.+.+..++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 346677799999999999999998999999999965421 23456788899999887 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 97 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999875 4589999999999999999999998 99999999999999999999999999998643
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ..+ .... ..+.
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~---~~~i-~~~~------ 234 (345)
T 1xjd_A 170 LGDA--KTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EEL---FHSI-RMDN------ 234 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHH-HHCC------
T ss_pred cCCC--cccCCCCCcccCChhhh-cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHH---HHHH-HhCC------
Confidence 2221 22456799999999988 556789999999999999999999999965322 111 1111 1111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 827 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~-evl~ 827 (843)
+ .++.....++.+++.+|++.||++||++. |+++
T Consensus 235 ~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1 12344556788999999999999999998 7754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=362.56 Aligned_cols=358 Identities=24% Similarity=0.321 Sum_probs=278.7
Q ss_pred CCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCcc
Q 003156 11 NNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNL 90 (843)
Q Consensus 11 ~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~ 90 (843)
.+++.+.++. ..+++|++|++++|.+..++. +..+++|++|+|++|.+++.++ +..+++|++|++++|.
T Consensus 33 ~~~~~~~i~~---~~l~~l~~L~l~~~~i~~l~~--~~~l~~L~~L~Ls~n~l~~~~~------~~~l~~L~~L~l~~n~ 101 (466)
T 1o6v_A 33 KTNVTDTVSQ---TDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP------LKNLTKLVDILMNNNQ 101 (466)
T ss_dssp CSSTTSEECH---HHHHTCCEEECCSSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG------GTTCTTCCEEECCSSC
T ss_pred ccccccccCh---hHhccccEEecCCCCCccCcc--hhhhcCCCEEECCCCccCCchh------hhccccCCEEECCCCc
Confidence 3444444443 335677888888888877654 6777888888888888775432 6677888888888888
Q ss_pred CcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCC
Q 003156 91 FSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW 170 (843)
Q Consensus 91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 170 (843)
+.+..+ +..+++|++|+|++|.+++..+ +..+++|++|++++|.+++. + .+..+++|+.|+++ |.+.+..+
T Consensus 102 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~-- 172 (466)
T 1o6v_A 102 IADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP-- 172 (466)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--
T ss_pred cccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--
Confidence 875443 7788888888888888875433 77788888888888887753 2 47778888888886 44443332
Q ss_pred ccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccc
Q 003156 171 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 250 (843)
Q Consensus 171 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~ 250 (843)
+.++++|++|++++|.+++. ..+..+++|+.|++++|.+.+..| .....+|+.|++++|.+.+. .....
T Consensus 173 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--------~~l~~ 241 (466)
T 1o6v_A 173 LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--------GTLAS 241 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--------GGGGG
T ss_pred hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc--------hhhhc
Confidence 77888888888888887743 347778888888888888875444 11223688888888877642 13456
Q ss_pred cCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEE
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 330 (843)
+++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 7899999999999986554 8899999999999999987654 8889999999999999996544 88999999999
Q ss_pred cCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeecccccee
Q 003156 331 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410 (843)
Q Consensus 331 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 410 (843)
+++|.+++..| +..+++|+.|++++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 99999998766 78999999999999999964 468999999999999999998877 8999999999999999997
Q ss_pred c
Q 003156 411 R 411 (843)
Q Consensus 411 ~ 411 (843)
.
T Consensus 390 ~ 390 (466)
T 1o6v_A 390 A 390 (466)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=343.89 Aligned_cols=254 Identities=26% Similarity=0.345 Sum_probs=204.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcC--CeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 630 (843)
+.|+..+.||+|+||.||+|++ +++.||||.+...... ...+.+.+|+.++++++||||+++++++.++ ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 4466777999999999999999 4899999998654322 2345789999999999999999999999887 678999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC--eeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP--IIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
|||+++|+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999875 234689999999999999999999998 6 99999999999999999999999998764
Q ss_pred ccccccceeccccccccccCCcccccCcC--CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
... ....||+.|+|||.+.... .++.++|||||||++|||++|+.||....... ........+.
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~-- 228 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGL-- 228 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSCC--
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcCC--
Confidence 322 3346789999999884432 23348999999999999999999997543211 1111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+...+.++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 ------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 112344556678999999999999999999999999998864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.49 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=206.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|++..+|+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 446677799999999999999988999999999865432 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999875 3589999999999999999999998 999999999999999999999999999986643
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
. .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..... . ........ +..
T Consensus 194 ~-----~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~---~~~~~i~~-~~~------ 255 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--I---QIYEKIVS-GKV------ 255 (350)
T ss_dssp C-----BCCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHHHH-CCC------
T ss_pred C-----cccccCCccccCHHHh-cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--H---HHHHHHHc-CCC------
Confidence 2 1345789999999988 456789999999999999999999999975321 1 11111111 111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
.++......+.+++.+||+.||++||+ ++|++++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 134445667899999999999999998 8998875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.20 Aligned_cols=274 Identities=20% Similarity=0.224 Sum_probs=216.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC--eeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ--LKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~ 631 (843)
..|+..+.||+|+||.||+|.+..+|+.||||++.........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 456777899999999999999998899999999976555556678899999999999999999999998765 679999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE----cCCCCcEEeeccCcc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLAR 707 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfgl~~ 707 (843)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999998752 123489999999999999999999999 99999999999999 777889999999998
Q ss_pred cccccccceeccccccccccCCcccccC-------cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQ-------SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
....... .....||..|+|||++.. ...++.++|||||||++|||++|+.||.......... +.+....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII 240 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHh
Confidence 7654332 134578999999998733 1457789999999999999999999997543222221 2222222
Q ss_pred hhCCcc---cc------------cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 781 EEGNVL---DC------------VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 781 ~~~~~~---~~------------~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...... .. .-+............+.+++.+||+.||++|||+.|+++.++.+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 211100 00 00111124567778899999999999999999999999999887553
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.70 Aligned_cols=259 Identities=26% Similarity=0.359 Sum_probs=213.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
...|+..+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 345677779999999999999998889999999986433 235678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999875 235689999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .......++..|+|||.+ ....++.++||||+|+++|||++ |..||...... .....+ ....
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~----~~~~------- 229 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELL----EKDY------- 229 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH----HTTC-------
T ss_pred cc-ccccCCccccCcCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----hccC-------
Confidence 32 222445667889999988 55578999999999999999999 99998654322 111111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+...+..+.+++.+|++.||++|||+.|+++.|+.+..
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 112244556678999999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=351.73 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=201.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCe--
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL-- 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-- 626 (843)
.+.|+..+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4567778899999999999998854 456899999865432 2234678999999999999999999999987653
Q ss_pred ---eEEEEEeCCCCCHHHHHhhcC--CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEe
Q 003156 627 ---KLLVSDYAPNGSLQAKLHERL--PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701 (843)
Q Consensus 627 ---~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 701 (843)
.++||||+++|+|.+++.... .....+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 489999999999999996532 2345699999999999999999999998 99999999999999999999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHH
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
|||+++...............++..|+|||.+ .+..++.++||||||+++|||++ |..||....... .... .
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~---~- 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDY---L- 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH---H-
T ss_pred ecCcceecccccccCcccccCCCccccCchhh-cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHH---H-
Confidence 99999876544333333445678899999988 55678999999999999999999 888986543221 1111 1
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
..+. ....+...+..+.+++.+||+.||++|||+.+++++|+.+...+|
T Consensus 263 ~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 LHGH--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HTTC--------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HcCC--------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1111 112344556679999999999999999999999999999876554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=363.56 Aligned_cols=258 Identities=21% Similarity=0.236 Sum_probs=207.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|..++..++||||+++++++.+.+..++||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 456777899999999999999998899999999965321 122345889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 154 Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999999874 35689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
... .......||+.|+|||++. ....++.++|||||||++|||++|+.||..... .......+.....
T Consensus 228 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~------ 299 (437)
T 4aw2_A 228 DGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKER------ 299 (437)
T ss_dssp TSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHHHH------
T ss_pred CCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhhcccc------
Confidence 332 2224567999999999884 245689999999999999999999999975322 1122221111100
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~--RPs~~evl~~ 828 (843)
...+........++.+++.+|++.+|++ ||+++|++++
T Consensus 300 ---~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 ---FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0111122334567889999999888888 9999999886
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.54 Aligned_cols=275 Identities=19% Similarity=0.259 Sum_probs=208.7
Q ss_pred hhhhhhhcCeeccc--cceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 552 PETLLEKAAEVGEG--VFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 552 ~~~~~~~~~~ig~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
..+.|+..+.||+| +||.||+|++..+|+.||||++...... ...+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34567788899999 9999999999989999999999754322 23356788999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999998752 34589999999999999999999998 999999999999999999999999999875
Q ss_pred cccccc-----ceeccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 709 LTRLDK-----HVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 709 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
...... ........||..|+|||++... ..++.++|||||||++|||++|+.||.......... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC-------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhcCCCCc
Confidence 532211 1112334688899999988543 568999999999999999999999997643322211 111100000
Q ss_pred ---------C-------------Ccccc----------cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--
Q 003156 783 ---------G-------------NVLDC----------VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI-- 828 (843)
Q Consensus 783 ---------~-------------~~~~~----------~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~-- 828 (843)
. ...+. .+......+......+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 0 00000 0000001233445678899999999999999999999976
Q ss_pred HHhc
Q 003156 829 LQVI 832 (843)
Q Consensus 829 L~~~ 832 (843)
++.+
T Consensus 337 f~~~ 340 (389)
T 3gni_B 337 FKQI 340 (389)
T ss_dssp GGGC
T ss_pred HHHH
Confidence 4444
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.37 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=207.5
Q ss_pred hhcCeeccccceEEEEEEEC--CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 557 EKAAEVGEGVFGTVYKVSFG--TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
...+.||+|+||.||+|.+. .++..||+|.+.........+.+.+|++++++++||||+++++++ ..+..++||||+
T Consensus 13 i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~ 91 (287)
T 1u59_A 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMA 91 (287)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECC
T ss_pred hhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeC
Confidence 33448999999999999864 367889999997654444456789999999999999999999999 455689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 ~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 92 GGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp TTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred CCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999754 35689999999999999999999998 999999999999999999999999999987654332
Q ss_pred ce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 715 HV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 715 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......+|+.|+|||++ ....++.++||||||+++|||++ |+.||....... ... .+..+.
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~i~~~~-------- 230 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA----FIEQGK-------- 230 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHH----HHHTTC--------
T ss_pred eeeccccccccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHH----HHhcCC--------
Confidence 21 22334568899999988 45578999999999999999998 999997543221 111 112221
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
....+...+.++.+++.+||+.||++|||+.|++++|+.+...
T Consensus 231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1123455667899999999999999999999999999987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.94 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=208.1
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
++...|+..+.||+|+||.||+|+...+|+.||||++...... ...+.+.+|++++++++||||+++++++..++..+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 4556677888999999999999999889999999998654322 22356889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||++ |++.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 131 lv~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9999997 6888888764 35689999999999999999999999 999999999999999999999999999986
Q ss_pred ccccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
.... ....||+.|+|||++. ....++.++|||||||++|||++|+.||...... . ..........
T Consensus 204 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~----~~~~~~~~~~-- 270 (348)
T 1u5q_A 204 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-S----ALYHIAQNES-- 270 (348)
T ss_dssp SSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-H----HHHHHHHSCC--
T ss_pred cCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-H----HHHHHHhcCC--
Confidence 5432 3457899999999874 2456899999999999999999999999654221 1 1111111111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
+.. .+......+.+++.+||+.||++|||++|++++..-..
T Consensus 271 ----~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 271 ----PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----CCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 111 12334556889999999999999999999998755443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=366.95 Aligned_cols=328 Identities=19% Similarity=0.148 Sum_probs=198.9
Q ss_pred cCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEee
Q 003156 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159 (843)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 159 (843)
++++|+|++|+|++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+++...+..|..+++|++|+|+
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 34444444444444444444444444444444444444444444444444444444444444434444444445555555
Q ss_pred cCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCC
Q 003156 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p 239 (843)
+|++.+..+..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|.+++..+..+.
T Consensus 113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~------------------- 173 (477)
T 2id5_A 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALS------------------- 173 (477)
T ss_dssp TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHT-------------------
T ss_pred CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhc-------------------
Confidence 5544444445555555555555555555555555555555555555555555422111111
Q ss_pred CCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCcc
Q 003156 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQE 319 (843)
Q Consensus 240 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 319 (843)
.+++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+..+..+....+|++|+|++|++++..+..
T Consensus 174 ----------~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 243 (477)
T 2id5_A 174 ----------HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243 (477)
T ss_dssp ----------TCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHH
T ss_pred ----------ccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHH
Confidence 1344555555555555555555666666666666666655555544444557777777777777444456
Q ss_pred ccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccc
Q 003156 320 VCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLL 399 (843)
Q Consensus 320 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 399 (843)
+..+++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+
T Consensus 244 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 323 (477)
T 2id5_A 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323 (477)
T ss_dssp HTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCC
T ss_pred hcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccC
Confidence 77788888888888888877777788888888888888888877788888888888888888888876677778888888
Q ss_pred eEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCCC
Q 003156 400 AVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPL 436 (843)
Q Consensus 400 ~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 436 (843)
.|++++|++++..+....+.......+.++...|..|
T Consensus 324 ~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 324 TLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp EEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred EEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 8888888887765533223334445677777777655
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.61 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=209.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 34666779999999999999997 788999999865442 357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999875 34689999999999999999999998 99999999999999999999999999998764322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. .......++..|+|||.+ ....++.++||||+|+++|||++ |+.||...... ..... +..+..
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~-i~~~~~------- 223 (267)
T 3t9t_A 159 Y-TSSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVED-ISTGFR------- 223 (267)
T ss_dssp H-HSTTSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH-HHTTCC-------
T ss_pred c-cccccccccccccChhhh-cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHHHH-HhcCCc-------
Confidence 1 122344567889999988 55578999999999999999999 89998653221 11111 111111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+......+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 224 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11233445678899999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=352.48 Aligned_cols=264 Identities=27% Similarity=0.350 Sum_probs=209.4
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEE--EEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCee
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 627 (843)
...+.|+..+.||+|+||.||+|++..++..+ |+|.+.........+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 34456777889999999999999998778755 999987554444556799999999999 899999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcC------------CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC
Q 003156 628 LLVSDYAPNGSLQAKLHERL------------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN 695 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~ 695 (843)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999998753 2235789999999999999999999998 99999999999999999
Q ss_pred CCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHH
Q 003156 696 YNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSE 774 (843)
Q Consensus 696 ~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~ 774 (843)
+.+||+|||+++...... ......++..|+|||.+ ....++.++|||||||++|||+| |+.||...... .
T Consensus 179 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~ 249 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E 249 (327)
T ss_dssp GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H
T ss_pred CeEEEcccCcCccccccc---cccCCCCCccccChhhh-ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----H
Confidence 999999999997433211 12334567889999988 55568999999999999999998 99999654221 1
Q ss_pred HHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 775 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 775 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
... .+..+. ....+.....++.+++.+||+.||++|||+.|++++|+.+...
T Consensus 250 ~~~-~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 250 LYE-KLPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHH-HGGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHH-HhhcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 111111 1123445567789999999999999999999999999887543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.11 Aligned_cols=262 Identities=26% Similarity=0.326 Sum_probs=204.2
Q ss_pred hhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc-CCeeEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKLLV 630 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV 630 (843)
.|+..+.||+|+||.||+|.+..+ +..||+|.+.........+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 356677899999999999997533 346899998654444445678999999999999999999999754 4577899
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999764 35689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccc--eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCC-CCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 711 RLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR-RPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 711 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
..... .......+|..|+|||.+ .+..++.++||||+|+++|||++|. .||.... ........ ..+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~~~~~~~~-----~~~~--- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYL-----LQGR--- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-TTTHHHHH-----HTTC---
T ss_pred ccchhccccccCCCCCccccChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHH-----hcCC---
Confidence 43321 122345677889999988 5567899999999999999999954 4554332 22211111 1111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
....+...+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 250 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111234455678999999999999999999999999999866543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=375.98 Aligned_cols=262 Identities=26% Similarity=0.396 Sum_probs=212.7
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..+.|+..+.||+|+||.||+|.+. .+..||||++.... ...+.|.+|++++++++||||+++++++.+ +..++||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 3455677789999999999999997 56789999986543 345789999999999999999999999876 6689999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 341 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999998631 24589999999999999999999998 999999999999999999999999999987653
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......++..|+|||++ ....++.++|||||||++|||++ |+.||...... +... .+..+...
T Consensus 416 ~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~-~i~~~~~~---- 483 (535)
T 2h8h_A 416 NEY-TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLD-QVERGYRM---- 483 (535)
T ss_dssp HHH-HTTCSTTSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHH-HHHTTCCC----
T ss_pred Cce-ecccCCcCcccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH-HHHcCCCC----
Confidence 221 112334567889999988 45678999999999999999999 99999654221 1111 12222211
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
..+..+...+.++|.+||+.||++|||++++++.|+.+.....+
T Consensus 484 ----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 12445667889999999999999999999999999998766543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.78 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=206.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|....+|+.||+|.+..... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457778899999999999999998999999999865432 2245788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc--CCCCcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~ 711 (843)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999764 34689999999999999999999998 999999999999997 457899999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.... ....||+.|+|||++ ....++.++|||||||++|||++|+.||..... .. ........... .++
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~----~~~~i~~~~~~---~~~ 271 (387)
T 1kob_A 204 DEIV---KVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LE----TLQNVKRCDWE---FDE 271 (387)
T ss_dssp TSCE---EEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HH----HHHHHHHCCCC---CCS
T ss_pred Ccce---eeeccCCCccCchhc-cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-HH----HHHHHHhCCCC---CCc
Confidence 3221 334689999999988 556789999999999999999999999975322 11 11111111110 111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........++.+++.+||+.||++|||+.|++++
T Consensus 272 ---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 ---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1223445678899999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=353.62 Aligned_cols=246 Identities=20% Similarity=0.290 Sum_probs=205.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-------ChHHHHHHHHHHHhccCCCccceeeEEEcC
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKARHPNLISLEGYYWTP 624 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 624 (843)
..+.|+..+.||+|+||.||+|.+..+++.||||.+....... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3456778889999999999999998899999999997653211 234677899999999999999999999999
Q ss_pred CeeEEEEEeCCCC-CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeec
Q 003156 625 QLKLLVSDYAPNG-SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703 (843)
Q Consensus 625 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 703 (843)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 999999864 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
|+++........ ....||+.|+|||++......+.++|||||||++|||++|+.||......
T Consensus 175 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 175 GSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 999876543322 34578999999998855444588999999999999999999999642110
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.... ...+.....++.+++.+||+.||++|||+.|++++
T Consensus 237 -----~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAA-IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----Hhhc-cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 11233345678899999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.08 Aligned_cols=265 Identities=26% Similarity=0.375 Sum_probs=209.8
Q ss_pred hhhhhcCeeccccceEEEEEEEC----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC--Cee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 627 (843)
..|+..+.||+|+||.||++.+. .+++.||||++.........+.+.+|++++++++||||+++++++.+. ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 34577889999999999888763 368899999997654334456789999999999999999999999874 567
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999864 389999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch---------hhHHHHHH
Q 003156 708 LLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV---------VILSEHVR 777 (843)
Q Consensus 708 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~---------~~l~~~~~ 777 (843)
........ .......+|..|+|||.+ .+..++.++||||||+++|||+||+.||....... ..-...+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECL-KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 77543322 222445678889999988 55568899999999999999999999986432110 00011111
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.....+. ....+..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 262 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 262 ELLERGE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhccc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 1122111 1123455667899999999999999999999999999887543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.73 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=202.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCC----CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQ----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..|+..+.||+|+||.||+|.+..+ +..||+|.+...........+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 3455667899999999999998643 346999998655433345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999874 35689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 710 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 710 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
...... .......+|..|+|||.+ ....++.++|||||||++|||++ |+.||...... . ... .+..+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~---~~~-~~~~~~~-- 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E---VMK-AINDGFR-- 268 (333)
T ss_dssp -------------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H---HHH-HHHTTCC--
T ss_pred ccccccccccCCCCccccccCchhc-ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--H---HHH-HHHCCCc--
Confidence 543221 112233457789999988 55578999999999999999999 99999653221 1 111 1122111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+...+..+.+++.+||+.+|++|||+.|++++|+.+..
T Consensus 269 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 ------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11234556678999999999999999999999999988643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.29 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=207.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||.+..... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 346677899999999999999988999999999965422 234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999764 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... .....||+.|+|||++......+.++||||+||++|||++|+.||...... ...... ..+..
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~~i-~~~~~------ 233 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFKKI-CDGIF------ 233 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHHHH-HTTCC------
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHHHH-hcCCc------
Confidence 322 244578999999999855444578999999999999999999999754321 111111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+......+.+++.+||+.||++|||+.|++++
T Consensus 234 ---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1233445578899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.71 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=214.2
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
...+.+.|+..+.||+|+||.||+|....+++.||+|.+.........+.+.+|+.++++++||||+++++++.+....+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 17 KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp EECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 34567778888899999999999999988899999999976655556788999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccccee
Confidence 99999999999999975 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... ......|+..|+|||++ ....++.++||||||+++|||++|+.||...... .... .+.....
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~~~~~--- 236 (303)
T 3a7i_A 169 LTDTQI--KRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLF----LIPKNNP--- 236 (303)
T ss_dssp CBTTBC--CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH----HHHHSCC---
T ss_pred cCcccc--ccCccCCCcCccCHHHH-hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHH----HhhcCCC---
Confidence 654221 22455788999999988 5567899999999999999999999999653221 1111 1111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
...+......+.+++.+||+.||++|||+.|++++..
T Consensus 237 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 237 -----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1123344567889999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.57 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=204.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
.+.|+..+.||+|+||.||+|.+.. ++..||+|.+.........+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 3556777899999999999999743 34569999986654434457789999999999999999999998654 5689
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999875 34589999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... ......++..|+|||.+ ....++.++||||||+++|||++ |+.||....... .... +..+..
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~----~~~~~~--- 232 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGV----LEKGDR--- 232 (281)
T ss_dssp ----------CCCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHH----HHHTCC---
T ss_pred cccccc-ccccCCCCcceeCchhh-ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHH----HhcCCC---
Confidence 543221 22345567889999988 55678999999999999999998 999997543322 1111 111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...+...+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 233 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 233 -----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1123345567889999999999999999999999998864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.13 Aligned_cols=255 Identities=23% Similarity=0.297 Sum_probs=208.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-----ChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-----YPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
..+.|+..+.||+|+||.||+|.+..+|+.||+|.+....... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567888889999999999999998889999999997654322 35779999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC----CcEEee
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY----NPRISD 702 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 702 (843)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999999864 4689999999999999999999998 999999999999999887 799999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
||+++....... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||..... .. .......
T Consensus 163 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~----~~~~i~~- 232 (321)
T 2a2a_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QE----TLANITS- 232 (321)
T ss_dssp CTTCEECCTTCC---CCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HH----HHHHHHT-
T ss_pred CccceecCcccc---ccccCCCCCccCcccc-cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-HH----HHHHHHh-
Confidence 999987654322 2345689999999988 556789999999999999999999999965322 11 1111111
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ..++ .........+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~--~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VSY--DFDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCC--CCCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccc--ccCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110 0000 0112344568899999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.66 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=204.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 446677799999999999999998999999999865321 123356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 149 E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp CCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred eCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999999999764 488999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcC---CCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSL---RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
... .......||+.|+|||++.... .++.++|||||||++|||++|+.||..... ............. ...
T Consensus 221 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~----~~~ 294 (410)
T 3v8s_A 221 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNS----LTF 294 (410)
T ss_dssp TSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHHHH----CCC
T ss_pred CCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhHHHHHHhcccc----ccC
Confidence 322 2234668999999999884432 278899999999999999999999975322 2122221111100 000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~--RPs~~evl~~ 828 (843)
+ .......++.+++.+|+..+|++ ||+++|++++
T Consensus 295 --p----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 --P----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --C----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --C----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1 01234457889999999999988 9999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.04 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=205.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|+...+|+.||+|.+..... ....+.+..|..+++.+ +||+|+++++++.+.+..++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 346677799999999999999988899999999965421 23456788999999988 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 100 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999875 3589999999999999999999998 99999999999999999999999999998543
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||..... . ...+.... +.
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~---~~~~~i~~-~~------ 237 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--D---ELFQSIME-HN------ 237 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHHHH-CC------
T ss_pred cCC--cccccccCCccccChhhh-cCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--H---HHHHHHHh-CC------
Confidence 211 123456799999999988 556789999999999999999999999965321 1 11122221 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
..++.....++.+++.+|++.||++||+ ++|++++
T Consensus 238 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234455667889999999999999995 5788765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.54 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=187.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|....+|+.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 346777899999999999999988899999999865421 233567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999864 35689999999999999999999998 999999999999999999999999999986543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......||..|+|||.+ .+..++.++||||||+++|||++|+.||........ + . .....
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~--------~-----~~~~~ 227 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIA-TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-L--------N-----KVVLA 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS
T ss_pred CCC--cceeccCCCCcCCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-H--------H-----HHhhc
Confidence 221 11345688999999988 555788999999999999999999999975432210 0 0 00000
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ...+.....++.+++.+||+.||++|||++|++++
T Consensus 228 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 D-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 11234455678899999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=358.62 Aligned_cols=269 Identities=15% Similarity=0.170 Sum_probs=203.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCC-----CeEEEEEEeecCCcc----------cChHHHHHHHHHHHhccCCCcccee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDII----------QYPEDFEREVRVLGKARHPNLISLE 618 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~ 618 (843)
+.|+..+.||+|+||.||+|.+..+ ++.||||.+...... .....+..|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4567788999999999999999653 578999998654311 0112234455666777899999999
Q ss_pred eEEEcC----CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-
Q 003156 619 GYYWTP----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD- 693 (843)
Q Consensus 619 g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~- 693 (843)
+++... ...++||||+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 999764 4479999999 99999999874 35699999999999999999999999 999999999999999
Q ss_pred -CCCCcEEeeccCccccccccccee-----ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC
Q 003156 694 -DNYNPRISDFGLARLLTRLDKHVM-----SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767 (843)
Q Consensus 694 -~~~~~kl~Dfgl~~~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~ 767 (843)
.++.+||+|||+++.+........ .....||+.|+|||++ .+..++.++|||||||++|||+||+.||.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH-NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999987654332211 1334589999999988 555689999999999999999999999985433
Q ss_pred chhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 768 NVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 768 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
..... ......... ...+.+++.+. ....+.++.+++..||+.+|++||++.++++.|+.+..
T Consensus 267 ~~~~~-~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 DPKYV-RDSKIRYRE-NIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CHHHH-HHHHHHHHH-CHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHH-HHHHHHhhh-hHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 32222 111111111 11111111110 12335678899999999999999999999999987754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.89 Aligned_cols=271 Identities=15% Similarity=0.162 Sum_probs=203.8
Q ss_pred hhhhhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCcc----------cChHHHHHHHHHHHhccCCCccceeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDII----------QYPEDFEREVRVLGKARHPNLISLEGY 620 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~ 620 (843)
+.|+..+.||+|+||.||+|.+.. ++..||+|........ .....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 456777899999999999999976 6789999998654321 012346788889999999999999999
Q ss_pred EEc----CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 621 YWT----PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 621 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
+.. ....++||||+ +|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 987 67789999999 99999999875 2689999999999999999999998 999999999999999877
Q ss_pred --CcEEeeccCcccccccccce-----eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch
Q 003156 697 --NPRISDFGLARLLTRLDKHV-----MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 769 (843)
Q Consensus 697 --~~kl~Dfgl~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~ 769 (843)
.+||+|||+++.+....... ......||..|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH-KGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 99999999998765432211 11345789999999988 45578999999999999999999999996543333
Q ss_pred hhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 770 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
.............-. ..+.... .....+.++.+++.+||+.||++|||+.++++.|+....+.+
T Consensus 268 ~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 331 (345)
T 2v62_A 268 VAVQTAKTNLLDELP--QSVLKWA--PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG 331 (345)
T ss_dssp HHHHHHHHHHHHTTT--HHHHHHS--CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred HHHHHHHHhhccccc--HHHHhhc--cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence 222222222111100 0000000 011445678999999999999999999999999998765543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.16 Aligned_cols=269 Identities=25% Similarity=0.363 Sum_probs=204.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc--cCCCccceeeEEEcC----C
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA--RHPNLISLEGYYWTP----Q 625 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~----~ 625 (843)
..+.|+..+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++... +||||+++++++... .
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3466788889999999999999984 8999999985432 34556666666655 899999999999877 6
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC-----CCCeeecCCCCCCEEEcCCCCcEE
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF-----RPPIIHYNLKPSNILLDDNYNPRI 700 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl 700 (843)
..++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ +++|+||||||+||+++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999764 5899999999999999999999752 448999999999999999999999
Q ss_pred eeccCcccccccccce--eccccccccccCCcccccCcCCCCC------chhHHHHHHHHHHHHhC----------CCCC
Q 003156 701 SDFGLARLLTRLDKHV--MSNRFQSALGYVAPELTCQSLRVNE------KCDIYGFGVLILELVTG----------RRPV 762 (843)
Q Consensus 701 ~Dfgl~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~~Dv~S~Gvil~elltg----------~~p~ 762 (843)
+|||+++.+....... ......||..|+|||++.. ...+. ++|||||||++|||+|| +.||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999997664432211 1234578999999998843 33344 49999999999999999 6666
Q ss_pred cCCCCchhhHHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 763 EYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 763 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
............. ....... ...+..+. ....+..++.+++.+||+.||++|||+.|++++|+.+.....
T Consensus 263 ~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 263 HDLVPSDPSYEDM-REIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTSCSSCCHHHH-HHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhhcCCCCchhhh-HHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 5432222222221 1111111 11222221 123677889999999999999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.80 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=197.5
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.+.||+|+||.||+|....+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 4579999999999999988999999999865432 335678999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE--cCCCCcEEeeccCcccccccccce
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL--DDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.+......
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~- 245 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL- 245 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-
Confidence 99998764 34589999999999999999999998 99999999999999 56788999999999876543321
Q ss_pred eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
....||+.|+|||++ ....++.++|||||||++|||++|+.||..... ... .......... ..+ ..
T Consensus 246 --~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~----~~~i~~~~~~--~~~----~~ 311 (373)
T 2x4f_A 246 --KVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AET----LNNILACRWD--LED----EE 311 (373)
T ss_dssp --CCCCSSCTTCCHHHH-TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHH----HHHHHHTCCC--SCS----GG
T ss_pred --ccccCCCcEeChhhc-cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHH----HHHHHhccCC--CCh----hh
Confidence 345689999999988 556789999999999999999999999965422 111 1222221110 000 01
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
......++.+++.+|++.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12345678899999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.82 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=196.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
.+.|+..+.||+|+||+||+|.+..+|+.||||++...... .....+..|+..+.++ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 35677788999999999999999889999999997543221 2223455666666665 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+ +|+|.+++... ...++|..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 77999998876 35699999999999999999999998 99999999999999999999999999998664
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.... .....||++|+|||++. + .++.++|||||||++|||++|..|+.... ... . +..+...
T Consensus 209 ~~~~---~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~----~-~~~~~~~---- 270 (311)
T 3p1a_A 209 TAGA---GEVQEGDPRYMAPELLQ-G-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQ----Q-LRQGYLP---- 270 (311)
T ss_dssp ---------CCCCCGGGCCGGGGG-T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHH----H-HTTTCCC----
T ss_pred cCCC---CcccCCCccccCHhHhc-C-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHH----H-HhccCCC----
Confidence 3222 24456899999999874 3 68999999999999999999977764321 111 1 1111110
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..++.....++.+++.+||+.||++|||++|++++
T Consensus 271 ---~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 ---PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 01223345678999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.49 Aligned_cols=264 Identities=24% Similarity=0.315 Sum_probs=201.0
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|+..+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 356677999999999999999888999999998654322 2235678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 84 CDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred CCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999988764 4589999999999999999999999 99999999999999999999999999998765322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH----------HHhhC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV----------LLEEG 783 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~----------~~~~~ 783 (843)
.. .....||..|+|||++.....++.++||||+||++|||++|+.||...... .......+. .....
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 157 DY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-DQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred cc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhcccccccccccccc
Confidence 21 234568899999998866677899999999999999999999999654322 111111110 01111
Q ss_pred Cccccc-CCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCV-DPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~-d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...... .+.... .......++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 110000 000000 012345568899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=353.93 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=197.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|+||.||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 56677999999999999999889999999998654433333345679999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 84 -KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp -EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 5999998875 34689999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC---ccccc---
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN---VLDCV--- 789 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~~~--- 789 (843)
......||..|+|||++.....++.++||||+||++|||++|+.||..... ...+....+ ...... .....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFR-ILGTPTEETWPGILSNE 232 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHH-HHCCCCTTTSTTGGGCH
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH-HhCCCChHhchhhhcch
Confidence 123456789999999886656789999999999999999999999975422 222222211 111100 00000
Q ss_pred ------CCCCC-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 790 ------DPSMG-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 790 ------d~~l~-----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+... ........++.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0112334568899999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.17 Aligned_cols=257 Identities=21% Similarity=0.236 Sum_probs=204.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|+...+|+.||+|++..... ....+.+.+|..++..++||||+++++++.+.+..++||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 456677799999999999999988999999999965321 122345889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... +..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 141 E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999875 24689999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccC------cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQ------SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
... .......||+.|+|||++.. ...++.++|||||||++|||++|+.||..... .......+... ..
T Consensus 215 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~-~~--- 288 (412)
T 2vd5_A 215 DGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-AETYGKIVHYK-EH--- 288 (412)
T ss_dssp TSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHH-HH---
T ss_pred CCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc-cC---
Confidence 322 22245679999999998842 34689999999999999999999999965322 11111111110 00
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR---PSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~R---Ps~~evl~~ 828 (843)
...+..+.....++.+++.+|+. +|++| |+++|++++
T Consensus 289 -----~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 289 -----LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -----CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -----cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00111123445678899999999 99998 699999886
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=345.49 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=208.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 4566778999999999999999889999999999654322 234578899999999999999999998854 5678999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC-----eeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP-----IIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
|||+++|+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999987544456699999999999999999999998 7 99999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
++....... ......|+..|+|||.+ .+..++.++||||||+++|||++|+.||..... ..+. ..+..+..
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~----~~i~~~~~ 233 (279)
T 2w5a_A 163 ARILNHDTS--FAKTFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA----GKIREGKF 233 (279)
T ss_dssp HHHC---CH--HHHHHHSCCTTCCHHHH-HCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHHTCC
T ss_pred heeeccccc--cccccCCCccccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHH----HHHhhccc
Confidence 987643221 11345688999999988 455789999999999999999999999975421 1111 11222221
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...+.....++.+++.+||+.||++|||+.|+++++....
T Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1233455667899999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.20 Aligned_cols=265 Identities=28% Similarity=0.385 Sum_probs=210.2
Q ss_pred hhhhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc--CCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 626 (843)
.+.|+..+.||+|+||.||+|++ ..+++.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 45577788999999999999994 5578999999986543 2234668999999999999999999999874 456
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 88999999999999999874 23589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch----------hhHHHH
Q 003156 707 RLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV----------VILSEH 775 (843)
Q Consensus 707 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~----------~~l~~~ 775 (843)
+........ .......+|..|+|||.+ .+..++.++|||||||++|||++|+.||....... .... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 252 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS-R 252 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH-H
T ss_pred eecccCCccceeeccCCccccccCHHHh-ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH-H
Confidence 876543322 222445678889999988 55568999999999999999999999986432110 0011 1
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
+......+. ....+...+..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 253 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 253 LLELLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111111 112345566789999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.85 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=183.5
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.+.||+|+||.||+|.+..+++.||||.+... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 46799999999999999989999999998543 2467889999999997 999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC---CcEEeeccCccccccccc
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY---NPRISDFGLARLLTRLDK 714 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfgl~~~~~~~~~ 714 (843)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999999874 4689999999999999999999998 999999999999998665 799999999986543222
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch--hhHHHHHHHHHhhCCcccccCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV--VILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
......||..|+|||++ ....++.++||||+||++|||++|+.||....... ....+.... +..+.. .
T Consensus 165 --~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~------~ 234 (325)
T 3kn6_A 165 --PLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF------S 234 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC------C
T ss_pred --cccccCCCcCccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC------C
Confidence 12345679999999988 56678999999999999999999999997542211 111111111 111111 0
Q ss_pred CCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... .......++.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000 112345678899999999999999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=340.01 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=209.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 3456777889999999999999986 67889999986543 346789999999999999999999999864 4578999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999997641 23589999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......++..|+|||.+ ....++.++||||||+++|||++ |+.||...... +.... +..+..
T Consensus 162 ~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~-~~~~~~----- 228 (279)
T 1qpc_A 162 NEY-TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQN-LERGYR----- 228 (279)
T ss_dssp SCE-ECCTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH-HHTTCC-----
T ss_pred ccc-ccccCCCCccCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHHH-HhcccC-----
Confidence 322 222344567889999988 45578999999999999999999 89999653221 11111 111111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+...+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 112344556789999999999999999999999999987544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=346.00 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=196.1
Q ss_pred hhhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
.+.|+..+.||+|+||.||+|+.. .+|+.||+|++..... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 345777889999999999999984 5789999999865432 1234567889999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999875 3588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
+....... ......||+.|+|||++ ....++.++|||||||++|||++|+.||..... . ......... .
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~----~~~~~i~~~-~-- 237 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-K----KTIDKILKC-K-- 237 (327)
T ss_dssp ------------CTTSSCCTTSCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-H----HHHHHHHHT-C--
T ss_pred cccccCCc--cccccCCCcCccCHhhC-cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-H----HHHHHHHhC-C--
Confidence 75432221 22456789999999988 555789999999999999999999999975422 1 111222111 1
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++......+.+++.+||+.||++|| ++.|++++
T Consensus 238 -------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 -------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 112344556788999999999999999 78898875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=337.48 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=207.1
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..+.|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 4567788889999999999999999889999999986543 234678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE---cCCCCcEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 708 (843)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999999999875 4589999999999999999999998 99999999999999 7889999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... .....||..|+|||.+. + .++.++||||||+++|||++|+.||...... .. ... +..+..
T Consensus 159 ~~~~~~---~~~~~~t~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~----~~~-~~~~~~--- 224 (277)
T 3f3z_A 159 FKPGKM---MRTKVGTPYYVSPQVLE-G-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EV----MLK-IREGTF--- 224 (277)
T ss_dssp CCTTSC---BCCCCSCTTTCCHHHHT-T-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHH-HHHCCC---
T ss_pred ccCccc---hhccCCCCCccChHHhc-c-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-HH----HHH-HHhCCC---
Confidence 654322 24457899999999873 3 4899999999999999999999999754321 11 111 111111
Q ss_pred cCCCCCCCCh----hhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPE----DEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~----~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+. .....+.+++.+|++.||++|||+.|++++
T Consensus 225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 ------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 335678899999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=339.82 Aligned_cols=264 Identities=14% Similarity=0.159 Sum_probs=208.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEE-EcCCeeEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY-WTPQLKLLVS 631 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~ 631 (843)
.+.|+..+.||+|+||.||+|++..+|+.||||.+.... ..+.+.+|+.+++.++|++++..++++ ...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 455777889999999999999998899999999986543 235789999999999998877777666 5566789999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE---cCCCCcEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 708 (843)
||+ +|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 99999999864 34689999999999999999999999 99999999999999 4889999999999987
Q ss_pred ccccccce-----eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc--hhhHHHHHHHHHh
Q 003156 709 LTRLDKHV-----MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--VVILSEHVRVLLE 781 (843)
Q Consensus 709 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--~~~l~~~~~~~~~ 781 (843)
........ ......||..|+|||.+ .+..++.++|||||||++|||++|+.||...... ...+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 65433211 12455789999999998 5567899999999999999999999999764221 1122222221111
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
. .. . ......+.++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 237 ~-~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 237 T-PI-E-------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp S-CH-H-------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C-ch-H-------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 1 00 0 011234457889999999999999999999999999875443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.98 Aligned_cols=255 Identities=19% Similarity=0.315 Sum_probs=197.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccC--CCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARH--PNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV 630 (843)
..|+..+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.++++++| |||+++++++.+++..++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 44677789999999999999985 7899999998654322 233678899999999976 9999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|| +.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 4688999999875 4689999999999999999999998 999999999999997 5789999999998775
Q ss_pred ccccceeccccccccccCCcccccC----------cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQ----------SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
............||+.|+|||++.. ...++.++|||||||++|||++|+.||.........+ ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~~~ 234 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAII 234 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----HHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH----HHHh
Confidence 5443333345679999999998732 2568899999999999999999999997543322111 1111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
.... ...++......+.+++.+||+.||++|||+.|++++-.
T Consensus 235 ~~~~--------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 235 DPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp CTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCc--------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1110 11233444557889999999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=366.56 Aligned_cols=255 Identities=27% Similarity=0.325 Sum_probs=208.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|+...+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 446667799999999999999988999999999965422 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 264 Ey~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998752 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ...... ..+....
T Consensus 339 ~~~---~~~~~GT~~Y~APEvl-~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~-~~i~~~~------- 405 (576)
T 2acx_A 339 GQT---IKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVE-RLVKEVP------- 405 (576)
T ss_dssp TCC---EECCCSCGGGCCHHHH-TTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHH-HHHHHCC-------
T ss_pred Ccc---ccccCCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHH-HHhhccc-------
Confidence 322 1345799999999988 55578999999999999999999999997643211 111111 1111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++.....++.+++.+|++.||++|| +++|++++
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 123344556788999999999999999 78999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=338.89 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=205.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.+.|+..+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 34567778999999999999999989999999998654422 23356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC---cEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~ 708 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999998875 4589999999999999999999998 9999999999999986655 99999999976
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... .....||..|+|||.+ .+..++.++||||+|+++|||++|+.||...... ... .. +..+... .
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~---~~-~~~~~~~-~ 226 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLY---AQ-IKAGAYD-Y 226 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HH-HHHTCCC-C
T ss_pred cccCcc---ccCCCCCcCCcCchhh-cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHH---HH-HHhcccc-C
Confidence 653222 1345789999999988 5567899999999999999999999999653221 111 11 1111111 1
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+ ........+.+++.+|++.||++|||+.|++++
T Consensus 227 ~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 PSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011 122345568899999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.44 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=203.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 446777899999999999999998899999999865321 234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999875 4589999999999999999999998 999999999999999999999999999865443
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .....|+..|+|||.+ .+..++.++||||+|+++|||++|+.||...... ...... ....
T Consensus 162 ~~----~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~------- 223 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRI-SRVE------- 223 (279)
T ss_dssp ----------CCCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHH-HHTC-------
T ss_pred cc----ccccCCCCCccCHhHh-ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----HHHHHH-HhCC-------
Confidence 22 1345788999999988 5567899999999999999999999999643211 111111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..++......+.+++.+||+.||++|||++|++++-
T Consensus 224 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 224 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp --CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred --CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 112344556788999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.09 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=209.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHh--ccCCCccceeeEEEcCC----e
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK--ARHPNLISLEGYYWTPQ----L 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~ 626 (843)
.+.|+..+.||+|+||.||+|.+ +|+.||||.+... ....+.+|++++.. ++||||+++++++.... .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 35677788999999999999998 5899999998543 24678889999988 68999999999998876 7
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhh--------hcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH--------HSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
.++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred eEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence 89999999999999999763 4899999999999999999999 66 99999999999999999999
Q ss_pred EEeeccCcccccccccce--eccccccccccCCcccccCcC-----CCCCchhHHHHHHHHHHHHhC----------CCC
Q 003156 699 RISDFGLARLLTRLDKHV--MSNRFQSALGYVAPELTCQSL-----RVNEKCDIYGFGVLILELVTG----------RRP 761 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Dv~S~Gvil~elltg----------~~p 761 (843)
||+|||+++......... ......||..|+|||++.... .++.++|||||||++|||+|| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433221 224557899999999884432 233689999999999999999 778
Q ss_pred CcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 762 VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 762 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
|............+.... ... ...+..+. ...++...+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVV-CEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTSCSSCCHHHHHHHH-TTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCcCcccHHHHHHHH-HHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 865433222222222222 111 12222222 23466778999999999999999999999999999986543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.69 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=203.9
Q ss_pred hhhhhcC-eeccccceEEEEEEE--CCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAA-EVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~-~ig~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..|+..+ .||+|+||.||+|.+ ..+++.||||.+...... ...+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4455555 899999999999965 446789999998654322 2246789999999999999999999999 5567889
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 95 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999874 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred cccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 710 TRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 710 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... ......++..|+|||.+ ....++.++||||||+++|||++ |+.||...... ... ..+..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~~~-- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGER-- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCC--
T ss_pred ccCCCcccccccCCCCceeeChHHh-ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCCC--
Confidence 5433222 12234467889999988 45568899999999999999999 99999754321 111 11222211
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+...+..+.+++.+||+.||++|||+.|+++.|+.+-.
T Consensus 239 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 239 ------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 12344566789999999999999999999999999988643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=339.63 Aligned_cols=264 Identities=14% Similarity=0.159 Sum_probs=205.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEE-EcCCeeEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY-WTPQLKLLV 630 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV 630 (843)
..+.|+..+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.++|++++..++++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 34567788899999999999999988999999998754432 24588899999999998888777766 556778999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE---cCCCCcEEeeccCcc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLAR 707 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~ 707 (843)
|||+ +|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 99999999864 34689999999999999999999999 99999999999999 789999999999998
Q ss_pred cccccccc-----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc--hhhHHHHHHHHH
Q 003156 708 LLTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--VVILSEHVRVLL 780 (843)
Q Consensus 708 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--~~~l~~~~~~~~ 780 (843)
........ .......||..|+|||.+ .+..++.++|||||||++|||++|+.||...... ...+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHh-cCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 76543321 122356789999999988 5557899999999999999999999999764322 112222211111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.. .. . ......+.++.+++.+||+.||++|||++|+++.|+.+...
T Consensus 236 ~~-~~-~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 236 ST-PI-E-------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HS-CH-H-------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cc-hh-h-------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 11 00 0 01122345789999999999999999999999999887543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=364.94 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=210.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|++..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 445666789999999999999988999999999965432 234567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999987654456799999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ......+.... ..
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l-~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~-~~------- 409 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLE-QA------- 409 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHH-CC-------
T ss_pred CCc--ccccccCCccccChhhh-cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhh-cc-------
Confidence 322 12345799999999998 55678999999999999999999999997643211 11122222221 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~-----~evl~~ 828 (843)
..++......+.+++.+|++.||++||++ +|++++
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 12344556678899999999999999975 677653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=353.03 Aligned_cols=263 Identities=20% Similarity=0.278 Sum_probs=198.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCe----
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL---- 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 626 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35577788999999999999999889999999998654322 223568899999999999999999999876543
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.++++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 38999999999999999875 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+.+...... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCC
Confidence 876543222 122345689999999988 45578999999999999999999999996543211 11111111110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH-HHHhccC
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ-ILQVIKT 834 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~-~L~~~~~ 834 (843)
.. .......+.++.+++.+||+.||++||++.+++. .+.+...
T Consensus 238 ~~------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 238 PP------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CH------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred Cc------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 00 0012234567889999999999999997766654 4655543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.10 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=204.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
.+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4567778899999999999999988999999999875432 22346788999999999 999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC----------------
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---------------- 694 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---------------- 694 (843)
|||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999987533335689999999999999999999998 9999999999999984
Q ss_pred ---CCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhh
Q 003156 695 ---NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 771 (843)
Q Consensus 695 ---~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~ 771 (843)
...+||+|||.++..... ....||..|+|||.+.....++.++|||||||++|||++|..|+.... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----H
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----H
Confidence 447999999999866532 233588999999998555567789999999999999999987764321 1
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 772 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... +..+ .....+......+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~-----~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHE-----IRQG--------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH-----HHTT--------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH-----HHcC--------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 1111 1122344556678999999999999999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.13 Aligned_cols=254 Identities=19% Similarity=0.323 Sum_probs=198.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhcc--CCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKAR--HPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV 630 (843)
..|+..+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 34777889999999999999987 599999999865432 223467899999999996 59999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|| +.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 135 ~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 5688999999875 3688899999999999999999998 999999999999996 5899999999998775
Q ss_pred ccccceeccccccccccCCcccccC----------cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQ----------SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
............||+.|+|||++.. ...++.++|||||||++|||++|+.||......... +....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----~~~~~ 281 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHAII 281 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----HHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----HHHHh
Confidence 4433333345679999999998743 236889999999999999999999999754332211 11111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.... . ..++.....++.+++.+||+.||++|||+.|++++-
T Consensus 282 ~~~~-----~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 DPNH-----E---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CTTS-----C---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Cccc-----c---CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1111 0 112333345788999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=367.35 Aligned_cols=251 Identities=25% Similarity=0.290 Sum_probs=198.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
.+.|+..+.||+|+||.||+|....+|+.||||++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 355777889999999999999999899999999986542 223345678899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999875 468999999999999999999998 7 9999999999999999999999999999864
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||..... .. ........ .
T Consensus 300 ~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~---~~~~i~~~-~----- 365 (446)
T 4ejn_A 300 IKDGA--TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EK---LFELILME-E----- 365 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHHC-C-----
T ss_pred cCCCc--ccccccCCccccCHhhc-CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HH---HHHHHHhC-C-----
Confidence 33221 22456799999999988 556789999999999999999999999965322 11 11111111 1
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++.....++.+++.+||+.||++|| |++|++++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 113444556788999999999999999 99999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=344.80 Aligned_cols=263 Identities=24% Similarity=0.288 Sum_probs=202.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc----ccChHHHHHHHHHHHhcc---CCCccceeeEEEcCC-
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI----IQYPEDFEREVRVLGKAR---HPNLISLEGYYWTPQ- 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~- 625 (843)
+.|+..+.||+|+||+||+|++..+++.||+|++..... ......+.+|+.++++++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 456777899999999999999988999999999864321 123457788888888775 999999999998765
Q ss_pred ----eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEe
Q 003156 626 ----LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701 (843)
Q Consensus 626 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 701 (843)
..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 4789999996 69999998753 33489999999999999999999999 99999999999999999999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
|||+++...... ......||..|+|||++ ....++.++|||||||++|||++|+.||..... ...+...... ..
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~-~~ 236 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDL-IG 236 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHH-HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-HHHHHHHHHH-HC
T ss_pred eCccccccCCCc---ccCCccccccccCchHH-cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH-hC
Confidence 999998664322 22456789999999988 455689999999999999999999999965422 2222222221 11
Q ss_pred hCCccc----------ccCCCCC----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 782 EGNVLD----------CVDPSMG----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 782 ~~~~~~----------~~d~~l~----~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...... .+.+... ....+....+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 0000000 0112345678899999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=351.16 Aligned_cols=271 Identities=21% Similarity=0.226 Sum_probs=207.1
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC----cccChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD----IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
...+.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 34566788889999999999999998899999999986542 12334678999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCC------------------------------------CCCCChhHHHHHHHHHHHHHH
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPS------------------------------------TPPLSWTNRFKVILGTAKGLA 670 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~l~ 670 (843)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999999631100 112356778899999999999
Q ss_pred hhhhcCCCCeeecCCCCCCEEEcCCC--CcEEeeccCccccccccc--ceeccccccccccCCcccccC-cCCCCCchhH
Q 003156 671 HLHHSFRPPIIHYNLKPSNILLDDNY--NPRISDFGLARLLTRLDK--HVMSNRFQSALGYVAPELTCQ-SLRVNEKCDI 745 (843)
Q Consensus 671 ~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfgl~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Dv 745 (843)
|||+. +|+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|||++.. ...++.++||
T Consensus 183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999 999999999999998766 899999999987643222 112245678999999998743 2568899999
Q ss_pred HHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHH
Q 003156 746 YGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 825 (843)
Q Consensus 746 ~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~ev 825 (843)
|||||++|||++|+.||...... . ............ .. .........+.+++.+||+.||++|||+.|+
T Consensus 260 wslG~il~el~~g~~pf~~~~~~-~----~~~~~~~~~~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDA-D----TISQVLNKKLCF--EN----PNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHH-H----HHHHHHHCCCCT--TS----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChH-H----HHHHHHhccccc--CC----cccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999999999654322 1 111222211100 00 0112345678899999999999999999999
Q ss_pred HHH--HHhccCC
Q 003156 826 VQI--LQVIKTP 835 (843)
Q Consensus 826 l~~--L~~~~~~ 835 (843)
+++ ++.+...
T Consensus 329 l~hp~~~~~~~~ 340 (345)
T 3hko_A 329 LQHPWISQFSDK 340 (345)
T ss_dssp HHSHHHHTTSSC
T ss_pred hcChhhccChHh
Confidence 986 5554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=354.74 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=191.7
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc----CCeeEEEEEeC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT----PQLKLLVSDYA 634 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~ 634 (843)
+.||+|+||.||+|.+..+|+.||||++.. ...+.+|+.++.+. +||||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 579999999999999998999999999853 24677899887554 89999999999865 45689999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeeccCcccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLARLLTR 711 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~ 711 (843)
++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 142 ~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 142 DGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 9999999998752 34689999999999999999999998 9999999999999997 78999999999986543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh--hHHHHHHHHHhhCCccccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV--ILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~ 789 (843)
.. ......||..|+|||++ ....++.++|||||||++|||++|+.||........ ..... +..+... ..
T Consensus 217 ~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~~-~~ 287 (400)
T 1nxk_A 217 HN---SLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYE-FP 287 (400)
T ss_dssp -------------CTTCCGGGS-CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCCC-CC
T ss_pred CC---ccccCCCCCCccCHhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCccc-CC
Confidence 22 12455789999999998 566789999999999999999999999975432211 11111 1111111 00
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
.+ .......++.+++.+||+.||++|||+.|++++-.-
T Consensus 288 ~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 288 NP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp TT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred Cc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 11 123445678899999999999999999999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.20 Aligned_cols=257 Identities=21% Similarity=0.274 Sum_probs=192.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccCh-HHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+..+|+.||+|++......... +.+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 4567778999999999999999889999999998654322222 234455556788899999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|++ |+|.+++.........+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 997 5898888764334567999999999999999999999853 8999999999999999999999999999876542
Q ss_pred ccceeccccccccccCCcccc---cCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 713 DKHVMSNRFQSALGYVAPELT---CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.. .....||..|+|||.+ .....++.++||||+||++|||++|+.||.........+.. .......
T Consensus 164 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~---- 232 (290)
T 3fme_A 164 VA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEEPSP---- 232 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----HHHSCCC----
T ss_pred cc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----HhccCCC----
Confidence 22 2334688999999986 24556889999999999999999999999754333222222 1221111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ........++.+++.+||+.||++|||+.|++++
T Consensus 233 --~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 233 --Q--LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --C--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --C--cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 0 1123445678899999999999999999999884
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.60 Aligned_cols=359 Identities=28% Similarity=0.344 Sum_probs=206.0
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCC-------------CEEECCCCCCccccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSL-------------NTLNLSNNHFSGDLD 68 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L-------------~~L~Ls~N~i~~~~~ 68 (843)
++|++|++++|++ +.+|.. |+++++|++|++++|.+.+..+..+..+++| ++|++++|.+++.+.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~-i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred ccchhhhcccCch-hhCChh-HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 4689999999999 489975 6889999999999999987777777777754 888888888886543
Q ss_pred CCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhh
Q 003156 69 FASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 148 (843)
Q Consensus 69 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 148 (843)
. .++|++|++++|.+++ +|.. +++|++|++++|++++. +.. .++|++|++++|++++ +| .|.
T Consensus 89 ~--------~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~ 150 (454)
T 1jl5_A 89 L--------PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQ 150 (454)
T ss_dssp C--------CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCT
T ss_pred C--------cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccC
Confidence 1 2678888888888875 5532 36777888888777742 221 2577788888877775 45 477
Q ss_pred cccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceee
Q 003156 149 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEID 228 (843)
Q Consensus 149 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~ 228 (843)
.+++|++|++++|++++ +|..+ .+|++|++++|++++ +| .+.++++|+.|++++|.+++ +|... .+|+.|+
T Consensus 151 ~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ 221 (454)
T 1jl5_A 151 NSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIV 221 (454)
T ss_dssp TCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEE
T ss_pred CCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEE
Confidence 77778888888777774 45433 477777777777775 45 57777777777777777774 44332 2677777
Q ss_pred ccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEcc
Q 003156 229 LSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 308 (843)
Q Consensus 229 l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 308 (843)
+++|.+. .+|. +..+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|+++
T Consensus 222 l~~n~l~-~lp~-------~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls 285 (454)
T 1jl5_A 222 AGNNILE-ELPE-------LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVS 285 (454)
T ss_dssp CCSSCCS-SCCC-------CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred CcCCcCC-cccc-------cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECc
Confidence 7777776 4442 2346677777777777763 4432 3567777777777665 2322 2456666666
Q ss_pred CCcccc--cCCccc-------------ccc-CCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCC
Q 003156 309 NNALYG--SIPQEV-------------CES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN 372 (843)
Q Consensus 309 ~n~l~~--~~~~~~-------------~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 372 (843)
+|++++ .+|..+ ..+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .++
T Consensus 286 ~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~ 357 (454)
T 1jl5_A 286 ENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQ 357 (454)
T ss_dssp SSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCT
T ss_pred CCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhh
Confidence 666654 111111 112 356666666666664 4432 456666666666666 3554 356
Q ss_pred CCCEEEccCCcccc--cCCcchhcc-------------cccceEeecccccee--cCC
Q 003156 373 KLKILKLEFNELSG--EIPQELGKL-------------ASLLAVNVSYNRLIG--RLP 413 (843)
Q Consensus 373 ~L~~L~L~~N~l~~--~~p~~~~~l-------------~~L~~l~ls~N~l~~--~~p 413 (843)
+|++|+|++|++++ .+|..+.+| ++|+.|++++|++++ .+|
T Consensus 358 ~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 358 NLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp TCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------------
T ss_pred hccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccch
Confidence 66666666666666 566666666 566666666666665 444
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.85 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=205.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 34567778999999999999999989999999999765433445678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999875 35899999999999999999999842 7999999999999999999999999999765432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh----------
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE---------- 782 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~---------- 782 (843)
. .....||..|+|||++ .+..++.++|||||||++|||++|+.||......... .........
T Consensus 186 ~----~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 186 M----ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp C--------CCCCTTCCHHHH-TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH--HHHC---------------
T ss_pred c----ccCCCCCCCeECHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcccccccCCCCCCCcc
Confidence 1 2345789999999988 5567899999999999999999999999754322111 000000000
Q ss_pred --CCcc------------------cccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 --GNVL------------------DCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 --~~~~------------------~~~d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+... ......... ........+.+++.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000 000000001 112345578899999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=348.54 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=203.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
..+.|+..+.||+|+||.||+|.+..+|+.||+|.+..... ...+|++++.++ +||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 45667888899999999999999998999999999865432 245788888888 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC----CCcEEeeccCc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN----YNPRISDFGLA 706 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~ 706 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999999864 4689999999999999999999999 99999999999998533 34999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
+....... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||....... ..+.... +..+...
T Consensus 168 ~~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~-i~~~~~~ 241 (342)
T 2qr7_A 168 KQLRAENG--LLMTPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILAR-IGSGKFS 241 (342)
T ss_dssp EECBCTTC--CBCCSSCCSSCCCHHHH-HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHH-HHHCCCC
T ss_pred ccCcCCCC--ceeccCCCccccCHHHh-cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHH-HccCCcc
Confidence 87653222 22455789999999988 44558899999999999999999999997542211 1122222 2222211
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
+ ...........+.+++.+|+..||++|||+.|++++-
T Consensus 242 --~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 242 --L---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp --C---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred --c---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 0 0112344556788999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=341.45 Aligned_cols=262 Identities=18% Similarity=0.221 Sum_probs=201.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 3466777999999999999999888999999998654321 12367889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 114 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp ECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999875 4589999999999999999999998 999999999999999999999999999986654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.... ......|+..|+|||.+ .+..++.++||||||+++|||++|+.||..... . .....+.....
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~----~~~~~~~~~~~------ 252 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQL--S----VMGAHINQAIP------ 252 (309)
T ss_dssp -----------CCGGGCCGGGT-CC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--H----HHHHHHHSCCC------
T ss_pred cccc-cccccCCCcCccCHHHH-cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--H----HHHHHhccCCC------
Confidence 2211 12345688999999988 556789999999999999999999999975321 1 11111111110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhccCCC
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-SMAEVVQILQVIKTPL 836 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-s~~evl~~L~~~~~~~ 836 (843)
.....+...+..+.+++.+||+.||++|| |++++++.|+......
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 01112334455788999999999999999 9999999999876554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=341.05 Aligned_cols=253 Identities=19% Similarity=0.284 Sum_probs=208.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 4566778999999999999999888999999998654322 23457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998875 4689999999999999999999998 999999999999999999999999999987643
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......|+..|+|||.+ .+..++.++||||+|+++|||++|+.||....... ..... ....
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~-~~~~------- 231 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI-KKNE------- 231 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHH-TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH-HTTC-------
T ss_pred Ccc--ccccccCCCCcCCcchh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-hhcc-------
Confidence 222 12345688999999988 55678999999999999999999999996543211 11111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
...+......+.+++.+||+.||++|||++|++++-.-
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 11233445678899999999999999999999987443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.38 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=205.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc---------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--------- 623 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 623 (843)
...|+..+.||+|+||.||+|.+..+++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 455777889999999999999998889999999986543 457789999999999999999998854
Q ss_pred -------CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC
Q 003156 624 -------PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 696 (843)
Q Consensus 624 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~ 696 (843)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 344789999999999999998652 35689999999999999999999998 999999999999999999
Q ss_pred CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHH
Q 003156 697 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 776 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~ 776 (843)
.+||+|||+++....... .....|+..|+|||.+ .+..++.++||||||+++|||++|..|+... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFF 228 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHH-HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHH
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhh-ccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHH
Confidence 999999999987654322 2345688999999988 4557899999999999999999999887421 1111
Q ss_pred HHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 777 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
.. ...+. .+......+.+++.+||+.||++|||+.|++++|+.+++...
T Consensus 229 ~~-~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 TD-LRDGI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH-HHTTC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HH-hhccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 11111 122234567899999999999999999999999999877643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=375.27 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=200.9
Q ss_pred CeeccccceEEEEEEE--CCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.||+|+||.||+|.+ ...++.||||++...... ...+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999966 345688999998654322 235789999999999999999999999965 457899999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc-
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH- 715 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 715 (843)
|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999864 4689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
.......+|+.|+|||++ ....++.++|||||||++|||++ |+.||...... . +...+..+.. .
T Consensus 527 ~~~~~~~~t~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~----~~~~i~~~~~--------~ 591 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--E----VTAMLEKGER--------M 591 (635)
T ss_dssp --------CGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTTCC--------C
T ss_pred ccccCCCCceeeeChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHcCCC--------C
Confidence 222334567889999988 56678999999999999999998 99999754321 1 1112222221 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
..+..++.++.++|..||+.||++|||++++++.|+.+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 234556678999999999999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.99 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=194.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhcc-CCCccceeeEEEcCC--eeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ--LKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~l 629 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++++. ||||+++++++..++ ..++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 456777899999999999999998999999999854321 223456789999999997 999999999997654 6799
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 89 v~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 999997 6899999763 588999999999999999999999 9999999999999999999999999999865
Q ss_pred cccc-------------------cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh
Q 003156 710 TRLD-------------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV 770 (843)
Q Consensus 710 ~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~ 770 (843)
.... .........||+.|+|||++.....++.++||||+||++|||++|+.||.... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~ 238 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS-TMN 238 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HHH
Confidence 3211 01112345789999999988665779999999999999999999999996532 222
Q ss_pred hHHHHHHHHHhhCCccc---------------------ccCCCCCC-------------CChhhHHHHHHHHHHccCCCC
Q 003156 771 ILSEHVRVLLEEGNVLD---------------------CVDPSMGD-------------YPEDEVLPVLKLALVCTCHIP 816 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~---------------------~~d~~l~~-------------~~~~~~~~l~~l~~~c~~~~P 816 (843)
.+...... ........ ........ .......++.+++.+||+.||
T Consensus 239 ~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 239 QLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 22222211 10000000 00000000 011334578899999999999
Q ss_pred CCCCCHHHHHHH--HHhc
Q 003156 817 SSRPSMAEVVQI--LQVI 832 (843)
Q Consensus 817 ~~RPs~~evl~~--L~~~ 832 (843)
++|||++|++++ +..+
T Consensus 318 ~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIF 335 (388)
T ss_dssp GGSCCHHHHTTSTTTTTT
T ss_pred ccCCCHHHHhCCHHHHHh
Confidence 999999999988 4444
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=337.86 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=205.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+.|+..+.||+|+||.||+|.+..+|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4567788999999999999999888999999998654322 23578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC----CcEEeecc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY----NPRISDFG 704 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 704 (843)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999874 4689999999999999999999998 999999999999999877 89999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
+++....... .....++..|+|||.+ ....++.++||||||+++|||++|+.||...... . ..... ....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~~-~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-E----TLTNI-SAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-H----HHHHH-HTTC
T ss_pred cceeccCCCc---ccccCCCcCccCccee-cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-H----HHHHh-Hhcc
Confidence 9987643222 1345688999999988 5567899999999999999999999999653221 1 11111 1111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhcc
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 833 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~ 833 (843)
.. .+ ..........+.+++.+||+.||++|||+.|++++ ++.+.
T Consensus 228 ~~--~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 228 YD--FD---EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CC--CC---HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cC--Cc---chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 00 00 00112334568899999999999999999999985 45543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.29 Aligned_cols=258 Identities=22% Similarity=0.265 Sum_probs=199.1
Q ss_pred hhhhh-cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEK-AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+. .+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 44555 357999999999999998899999999986543 34567899999999995 7999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC---cEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfgl~~~ 708 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999875 4589999999999999999999999 9999999999999997776 99999999976
Q ss_pred ccccccc-----eeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhh--------
Q 003156 709 LTRLDKH-----VMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI-------- 771 (843)
Q Consensus 709 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~-------- 771 (843)
....... .......||..|+|||++.. ...++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 5422111 11123458999999998742 145789999999999999999999999764321100
Q ss_pred -HHHHHHHHHhhCCcccccCCCCCCCC----hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 772 -LSEHVRVLLEEGNVLDCVDPSMGDYP----EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 772 -l~~~~~~~~~~~~~~~~~d~~l~~~~----~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+...+..+.. .++ ......+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00111111222211 111 1234578899999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=346.29 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=206.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEc--CCeeE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWT--PQLKL 628 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~ 628 (843)
..+.|+..+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 345677888999999999999999889999999998533 3578999999999997 9999999999987 55689
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCcc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLAR 707 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~ 707 (843)
+||||+++++|.+++.. +++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++
T Consensus 110 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999998854 78899999999999999999998 999999999999999766 89999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH--------
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------- 779 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~-------- 779 (843)
....... .....++..|+|||++.....++.++||||+||++|||++|+.||.........+.......
T Consensus 180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 7654332 23457888999999985556789999999999999999999999976655444333322211
Q ss_pred HhhCCcccccCCC----------------C-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 LEEGNVLDCVDPS----------------M-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ~~~~~~~~~~d~~----------------l-~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+..... ..++. . .........++.+++.+|++.||++|||++|++++
T Consensus 257 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 257 IDKYNI--ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHTTC--CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhcc--ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 010000 00000 0 01122346678999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=345.50 Aligned_cols=266 Identities=24% Similarity=0.379 Sum_probs=209.6
Q ss_pred hhhhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC--e
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ--L 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~ 626 (843)
...|+..+.||+|+||.||+|++ ..+++.||||++.... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 34567778999999999999995 4578999999986532 233567899999999999999999999987654 6
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 78999999999999999875 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC----------chhhHHHH
Q 003156 707 RLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED----------NVVILSEH 775 (843)
Q Consensus 707 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~----------~~~~l~~~ 775 (843)
+........ .......++..|+|||.+ .+..++.++||||||+++|||+||..|+..... ........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhh-cCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 876543322 122344567789999987 455688999999999999999999999863210 00111111
Q ss_pred HHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 776 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
+......+.. ...+..++.++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 272 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 272 LIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhcCCC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222111 12244556789999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=347.52 Aligned_cols=265 Identities=22% Similarity=0.232 Sum_probs=197.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 34577788999999999999999889999999998654322 23456789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-----CCCCcEEeeccCc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-----DNYNPRISDFGLA 706 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfgl~ 706 (843)
||++ |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9997 5999999875 4589999999999999999999998 999999999999994 4556999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC--
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN-- 784 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~-- 784 (843)
+....... ......+|..|+|||++.....++.++|||||||++|||++|+.||..... ...+............
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTT
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-HHHHHHHHHHhCCCchhh
Confidence 87643222 123456789999999985556689999999999999999999999965422 2222222221100000
Q ss_pred ccc-----ccCCCCCC---------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLD-----CVDPSMGD---------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~-----~~d~~l~~---------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ........ .+.....++.+++.+|++.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 00000000 011244678899999999999999999999875
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=352.92 Aligned_cols=342 Identities=19% Similarity=0.190 Sum_probs=223.2
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
++|++|+|++|+|+ .+| .|..+++|++|+|++|+|++++ |..+++|++|+|++|++++. .+..+++|
T Consensus 42 ~~L~~L~Ls~n~l~-~~~--~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~~-------~~~~l~~L 108 (457)
T 3bz5_A 42 ATLTSLDCHNSSIT-DMT--GIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTNL-------DVTPLTKL 108 (457)
T ss_dssp TTCCEEECCSSCCC-CCT--TGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCC-------CCTTCTTC
T ss_pred CCCCEEEccCCCcc-cCh--hhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCcee-------ecCCCCcC
Confidence 56777777777777 455 3667777777777777777663 66777777777777777653 15567777
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
++|++++|++++ ++ +..+++|++|++++|++++. .++.+++|++|++++|...+.. .+..+++|+.|++++|
T Consensus 109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n 180 (457)
T 3bz5_A 109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN 180 (457)
T ss_dssp CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence 777777777765 33 67777777777777777753 2667777777777777443333 4666777777777777
Q ss_pred cccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPP 240 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~ 240 (843)
++++ +| ++.+++|+.|++++|++++. .+..+++|+.|++++|++++ +| +... +|+.|++++|++.+..+
T Consensus 181 ~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~- 250 (457)
T 3bz5_A 181 KITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV- 250 (457)
T ss_dssp CCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC-
T ss_pred ccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH-
Confidence 7775 34 66777777777777777753 36677777777777777774 44 2222 56677777776664321
Q ss_pred CCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc--
Q 003156 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ-- 318 (843)
Q Consensus 241 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-- 318 (843)
..+++|+.|++++| +|+.|++++|.+.+..| ++.+++|+.|++++|...+.+|.
T Consensus 251 --------~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~ 306 (457)
T 3bz5_A 251 --------STLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA 306 (457)
T ss_dssp --------TTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT
T ss_pred --------HHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC
Confidence 12344444444333 22333444444333222 23445555555555544433332
Q ss_pred ------cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcch
Q 003156 319 ------EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 392 (843)
Q Consensus 319 ------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 392 (843)
.+..+++|+.|++++|++++. + ++++++|+.|++++|+|++ ++.|..|++++|+++|.
T Consensus 307 ~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~----- 370 (457)
T 3bz5_A 307 AGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE----- 370 (457)
T ss_dssp CCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----
T ss_pred CcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----
Confidence 134446788888888888864 3 7888888888888888875 24566677888888876
Q ss_pred hcccccceEeeccccceecCCC
Q 003156 393 GKLASLLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 393 ~~l~~L~~l~ls~N~l~~~~p~ 414 (843)
.++..|..+++++|+++|.+|.
T Consensus 371 ~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 371 GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp EEEEECCCBCCBTTBEEEECCT
T ss_pred ceeeecCccccccCcEEEEcCh
Confidence 3567788899999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=350.14 Aligned_cols=265 Identities=17% Similarity=0.178 Sum_probs=207.8
Q ss_pred hhhhhcCeeccccceEEEEEEECC--------CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccc---------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT--------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS--------- 616 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 616 (843)
+.|+..+.||+|+||.||+|.+.. +++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 457778899999999999999976 4789999998643 36889999999999999988
Q ss_pred ------eeeEEEc-CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCC
Q 003156 617 ------LEGYYWT-PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 689 (843)
Q Consensus 617 ------l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N 689 (843)
+++++.. ....++||||+ +|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 67889999999 999999998741 35699999999999999999999999 99999999999
Q ss_pred EEEcCCC--CcEEeeccCcccccccccce-----eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 003156 690 ILLDDNY--NPRISDFGLARLLTRLDKHV-----MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762 (843)
Q Consensus 690 ill~~~~--~~kl~Dfgl~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~ 762 (843)
|+++.++ .+||+|||+++.+....... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH-KGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999988 99999999998765433211 11344789999999988 5557899999999999999999999999
Q ss_pred cCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 763 EYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 763 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
..................... ....+... ........+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKP--GPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSC--CCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCcCHHHHHHHHHhccCCh--hhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 865433333333332222211 11111110 1123346789999999999999999999999999887543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.60 Aligned_cols=254 Identities=15% Similarity=0.165 Sum_probs=204.9
Q ss_pred hhhhhcCeeccccceEEEEEE-----ECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc---CCCccceeeEEEcCC
Q 003156 554 TLLEKAAEVGEGVFGTVYKVS-----FGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR---HPNLISLEGYYWTPQ 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 625 (843)
+.|+..+.||+|+||.||+|. ...+++.||||++... ...++..|+++++.++ |+||+++++++...+
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 456677899999999999994 4557899999998543 3567888999998887 999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC-CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC----------
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---------- 694 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---------- 694 (843)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +||||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999986322 245699999999999999999999998 9999999999999998
Q ss_pred -CCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHH
Q 003156 695 -NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 773 (843)
Q Consensus 695 -~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~ 773 (843)
++.+||+|||+++.+.............||.+|+|||++ .+..++.++|||||||++|||+||+.||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh-cCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999866543333344566799999999988 555689999999999999999999999964322110
Q ss_pred HHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHhccC
Q 003156 774 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR-PSMAEVVQILQVIKT 834 (843)
Q Consensus 774 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~R-Ps~~evl~~L~~~~~ 834 (843)
.+.......+ ....+.+++..|+..+|.+| |++.++.+.|+.+..
T Consensus 294 --------------~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 --------------KPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp --------------EECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------------eechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 1111122222 24467789999999999999 678888888877543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=336.74 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=198.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 34667779999999999999998889999999986542 2234568899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999875 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... .....++..|+|||.+......+.++||||||+++|||++|+.||..... ... .+. +..+.
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~---~~~-~~~~~------- 227 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTL---FKK-IRGGV------- 227 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHH-HHHCC-------
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHH---HHH-hhcCc-------
Confidence 221 13456889999999985444446899999999999999999999965321 111 111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+......+.+++.+||+.||++|||+.|++++
T Consensus 228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11233445678899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.18 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=206.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|....+++.||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 456777899999999999999988899999999865421 234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999875 3589999999999999999999998 999999999999999999999999999976543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .....|+..|+|||.+ .+..++.++||||||+++|||++|+.||...... ........ . +.
T Consensus 167 ~~----~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~------~~ 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMI-EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIVN-V------DL 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHT-T------CC
T ss_pred cc----cccccCCCCcCCHHHh-ccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHhc-c------cc
Confidence 22 2345788999999988 5567899999999999999999999999754221 11111111 1 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.++......+.+++.+|++.||++|||++|++++
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1234455678899999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.28 Aligned_cols=267 Identities=25% Similarity=0.299 Sum_probs=202.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..|+..+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 4577788999999999999999888999999998643221 123468899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 90 v~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999975 898888764 35688999999999999999999999 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC--Cccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--NVLD 787 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~ 787 (843)
..... ......+|..|+|||++.....++.++|||||||++|||++|..||.... ....+........... ...+
T Consensus 163 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 163 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhh
Confidence 43222 12345789999999988555568999999999999999999999986542 2222222222110000 0000
Q ss_pred -ccCC------CCCCC-----ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 788 -CVDP------SMGDY-----PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 788 -~~d~------~l~~~-----~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
+-.+ ..+.. ......++.+++.+|++.||++|||+.|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0000 00011 1334567899999999999999999999998743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=352.74 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=193.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHH-HHhccCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRV-LGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 4567788999999999999999989999999999765432 223456667766 5678999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999875 4588999999999999999999998 99999999999999999999999999998643
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||..... . ...+..... ..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~----~~~~~i~~~-~~----- 256 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-A----EMYDNILNK-PL----- 256 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-H----HHHHHHHHS-CC-----
T ss_pred cCC--CccccccCCccccCHHHh-CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-H----HHHHHHHhc-cc-----
Confidence 221 223556899999999988 556789999999999999999999999965322 1 111122211 10
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAE 824 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~e 824 (843)
.++......+.+++.+|++.||++||++.+
T Consensus 257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 123344567889999999999999999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=339.00 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=200.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc----CCeeEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKLL 629 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~l 629 (843)
.|+..+.||+|+||.||+|.+..++..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 355666899999999999999989999999998654322 234578899999999999999999999865 345789
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC--eeecCCCCCCEEEc-CCCCcEEeeccCc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP--IIHYNLKPSNILLD-DNYNPRISDFGLA 706 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfgl~ 706 (843)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||+++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999875 4589999999999999999999998 6 99999999999998 8899999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
+...... .....||..|+|||++. ..++.++||||+||++|||++|+.||.......... .. ...+...
T Consensus 180 ~~~~~~~----~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~-~~~~~~~ 248 (290)
T 1t4h_A 180 TLKRASF----AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----RR-VTSGVKP 248 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----HH-HTTTCCC
T ss_pred ccccccc----cccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH----HH-HhccCCc
Confidence 7544322 13456899999999873 358999999999999999999999997543322211 11 1111110
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+.....++.+++.+||+.||++|||++|++++
T Consensus 249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01223334578899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=359.29 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=194.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-------cChHHHHHHHHHHHhccCCCccceeeEEEcCC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-------QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 625 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 45577788999999999999999989999999998654311 112357899999999999999999999854 4
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC---CCcEEee
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN---YNPRISD 702 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~D 702 (843)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 578999999999998888754 4689999999999999999999998 99999999999999754 4599999
Q ss_pred ccCcccccccccceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
||+++...... ......||+.|+|||++.. ...++.++|||||||++|||++|+.||........ +... +
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~----i 357 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQ----I 357 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHH----H
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHH----H
Confidence 99998765322 2245678999999998743 35678899999999999999999999975433221 1111 1
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+... ..+.........+.+++.+||+.||++|||++|++++
T Consensus 358 ~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYN-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCC-----CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111110 0000112345678899999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=347.40 Aligned_cols=252 Identities=19% Similarity=0.296 Sum_probs=207.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
...|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 34567778999999999999999988999999998654322 2346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998875 4689999999999999999999998 99999999999999999999999999998764
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.... ......|+..|+|||++ .+..++.++|||||||++|||++|+.||...... ........ ...
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~----- 258 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKK-NEY----- 258 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHH-HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHH-TCC-----
T ss_pred cCcc--cccccCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHHhc-CCC-----
Confidence 3222 12445789999999988 4556899999999999999999999999654221 11111111 110
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+......+.+++.+||+.||++|||++|++++-
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 12334455788999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=346.24 Aligned_cols=268 Identities=25% Similarity=0.325 Sum_probs=204.8
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..-+.|+..+.||+|+||.||+|.+..+|+.||+|++....... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 34566788889999999999999998889999999986554322 23557899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 102 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 99999999998887653 4589999999999999999999999 9999999999999999999999999999866
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH----------H
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV----------L 779 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~----------~ 779 (843)
..... ......|+..|+|||++.....++.++||||+||++|||++|+.||...... ..+...... .
T Consensus 175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHH
T ss_pred cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhH
Confidence 43222 1234568899999998855557899999999999999999999999754322 112111110 1
Q ss_pred HhhCC-cccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 LEEGN-VLDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ~~~~~-~~~~~d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..... ......+.... ........+.+++.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111 11111111111 112345678999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=346.82 Aligned_cols=272 Identities=23% Similarity=0.279 Sum_probs=200.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHH--HHhccCCCccceeeEEEc-----CCe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV--LGKARHPNLISLEGYYWT-----PQL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~-----~~~ 626 (843)
+.|+..+.||+|+||.||+|++ +++.||||++.... ...+..|.++ +..++||||+++++++.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 4466777999999999999988 68999999986433 3445555555 445799999999986642 225
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC------CCCeeecCCCCCCEEEcCCCCcEE
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF------RPPIIHYNLKPSNILLDDNYNPRI 700 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl 700 (843)
.++||||+++|+|.+++... ..++..++.++.|+++||+|||+.+ .++|+||||||+||+++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 68999999999999999764 3588999999999999999999763 338999999999999999999999
Q ss_pred eeccCccccccccc------ceeccccccccccCCcccccCc------CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc
Q 003156 701 SDFGLARLLTRLDK------HVMSNRFQSALGYVAPELTCQS------LRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 768 (843)
Q Consensus 701 ~Dfgl~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~ 768 (843)
+|||+++.+..... ........||..|+|||++... ..++.++|||||||++|||++|+.||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221 1112345689999999988432 34667899999999999999998887554221
Q ss_pred hhh------------HHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 769 VVI------------LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 769 ~~~------------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
... .................+.... ........++.+++.+||+.||++|||++|+++.|+.+..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 110 0011111111111111111111 123446678999999999999999999999999999987654
Q ss_pred C
Q 003156 837 P 837 (843)
Q Consensus 837 ~ 837 (843)
.
T Consensus 321 ~ 321 (336)
T 3g2f_A 321 E 321 (336)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=349.31 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=205.9
Q ss_pred hhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 626 (843)
+.|+..+.||+|+||.||+|+.. .+++.||||++..... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 55777889999999999999984 4789999999854321 23345677899999999 69999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999875 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+.+...... ......||+.|+|||++... ..++.++|||||||++|||++|+.||....... ......+.....
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS--- 281 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC---
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc---
Confidence 866432222 22446789999999988542 357899999999999999999999997543221 112222222211
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQIL 829 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~L 829 (843)
...++......+.+++.+||..||++|| |++|++++.
T Consensus 282 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1123445556788999999999999999 999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=340.67 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=205.7
Q ss_pred ccChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 549 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
..++.+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..+
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3456778888999999999999999998889999999985443 345678999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 93 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp EEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 999999999999998864 34589999999999999999999998 999999999999999999999999999864
Q ss_pred ccccccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
..... .......|+..|+|||++. ....++.++||||||+++|||++|+.||....... .........
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~- 238 (302)
T 2j7t_A 167 NLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSD- 238 (302)
T ss_dssp HHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSC-
T ss_pred ccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHHHHhccC-
Confidence 33211 1113456889999999873 34568899999999999999999999997542211 111111111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. .....+......+.+++.+||+.||++|||+.|++++
T Consensus 239 ~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 239 P------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp C------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred C------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0111234455678999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=335.71 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=201.3
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 3448999999999999998899999999986543 334577999999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-CCCcEEeeccCcccccccccce
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 105 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-- 178 (295)
T 2clq_A 105 SLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-- 178 (295)
T ss_dssp EHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--
Confidence 9999998752 234567888999999999999999998 9999999999999997 89999999999987643221
Q ss_pred eccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 717 MSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 717 ~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
......|+..|+|||++... ..++.++||||||+++|||++|+.||............ .... . . ...
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~-~-----~---~~~ 246 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMF-K-----V---HPE 246 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---HHHH-C-----C---CCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---hccc-c-----c---ccc
Confidence 12445788999999987433 23789999999999999999999999654322211111 1000 0 1 112
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+.....++.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 344556678899999999999999999999876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.29 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=187.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 34666779999999999999998789999999986554444556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcC----CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 634 APNGSLQAKLHERL----PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 634 ~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 99999999997521 1235689999999999999999999998 9999999999999999999999999999766
Q ss_pred ccccc---ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 710 TRLDK---HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 710 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
..... ........||..|+|||++.....++.++||||||+++|||++|+.||......... . ...... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~----~~~~~~-~~ 245 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-M----LTLQND-PP 245 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-H----HHHTSS-CC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-H----HHhccC-CC
Confidence 43221 111234568899999998754456899999999999999999999999764332211 1 111111 10
Q ss_pred cccC-CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVD-PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d-~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.... ............++.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000 00011233445678899999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.06 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=202.9
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..+.+.|+..+.||+|+||.||+|.+..+|+.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 345566778889999999999999998889999999986543 34678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 102 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 99999999999999754 35689999999999999999999998 9999999999999999999999999999866
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
..... ......|+..|+|||.+ .+..++.++||||||+++|||++|+.||....... .... ......
T Consensus 176 ~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~---- 242 (314)
T 3com_A 176 TDTMA--KRNTVIGTPFWMAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFM-IPTNPP---- 242 (314)
T ss_dssp BTTBS--CBCCCCSCGGGCCHHHH-SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHH-HHHSCC----
T ss_pred hhhcc--ccCccCCCCCccChhhc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHH-HhcCCC----
Confidence 53221 12445688999999988 55578999999999999999999999997542211 1111 111110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+. ...+......+.+++.+||+.||++|||+.|++++
T Consensus 243 -~~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 243 -PT-FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -CC-CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -cc-cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 11234445678999999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=355.09 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=201.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC---------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--------- 624 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------- 624 (843)
..|+..+.||+|+||.||+|.+..+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 456778899999999999999988999999999865432 234799999999999999999998543
Q ss_pred -----------------------------CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc
Q 003156 625 -----------------------------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675 (843)
Q Consensus 625 -----------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~ 675 (843)
...++||||++ |+|.+.+.........+++..+..++.|+++||+|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 23789999998 588888876433456799999999999999999999998
Q ss_pred CCCCeeecCCCCCCEEEc-CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHH
Q 003156 676 FRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILE 754 (843)
Q Consensus 676 ~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~e 754 (843)
+|+||||||+||+++ .++.+||+|||+++........ ....+|..|+|||++.....++.++||||+||++||
T Consensus 161 ---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 161 ---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp ---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred ---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999999999999998 6889999999999876543322 345678999999988566668999999999999999
Q ss_pred HHhCCCCCcCCCCchhhHHHHHHHHH--------hh-CCcccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCC
Q 003156 755 LVTGRRPVEYGEDNVVILSEHVRVLL--------EE-GNVLDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSR 819 (843)
Q Consensus 755 lltg~~p~~~~~~~~~~l~~~~~~~~--------~~-~~~~~~~d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~R 819 (843)
|++|+.||.... ....+...++... .. ....+..-+.... ++...+..+.+++.+||+.||++|
T Consensus 235 ll~g~~pf~~~~-~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 235 LILGKPLFSGET-SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999997532 2223333222110 00 0001110111111 344456678999999999999999
Q ss_pred CCHHHHHHH
Q 003156 820 PSMAEVVQI 828 (843)
Q Consensus 820 Ps~~evl~~ 828 (843)
||+.|++++
T Consensus 314 ~t~~e~l~h 322 (383)
T 3eb0_A 314 INPYEAMAH 322 (383)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=338.07 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=199.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC-CeeEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-QLKLLVS 631 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~ 631 (843)
.+.|+..+.||+|+||.||+|.+ .|+.||||.+.... ..+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34577788999999999999998 58899999986432 457899999999999999999999998655 4689999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999998651 22378899999999999999999998 999999999999999999999999999976543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.. ....++..|+|||.+ .+..++.++||||||+++|||+| |+.||....... .... +..+.
T Consensus 170 ~~-----~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~----~~~~~------ 231 (278)
T 1byg_A 170 TQ-----DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR----VEKGY------ 231 (278)
T ss_dssp -----------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHH----HTTTC------
T ss_pred cc-----cCCCccccccCHHHh-CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HhcCC------
Confidence 21 233567889999987 55678999999999999999998 999997543221 1111 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 112344556778999999999999999999999999998854
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=360.42 Aligned_cols=261 Identities=23% Similarity=0.275 Sum_probs=194.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 625 (843)
.+.|+..+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 3557778899999999999999998999999999965421 223467889999999999999999999997553
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999976 46666653 388999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh---
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE--- 782 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~--- 782 (843)
++...... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||.... ....+...++..-..
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHH-cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHH
Confidence 98765322 22456789999999998 45579999999999999999999999996532 222222222211000
Q ss_pred --CCc----cccc--CCCCCC------CC-----------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 --GNV----LDCV--DPSMGD------YP-----------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 --~~~----~~~~--d~~l~~------~~-----------~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ...+ .+.... ++ .....++.+++.+|++.||++|||++|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000 000000 00 1125578899999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.26 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=202.7
Q ss_pred hhhhhhc-CeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEE
Q 003156 553 ETLLEKA-AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 553 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 629 (843)
.++|... +.||+|+||.||+|....+++.||+|.+..... ......+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3445554 689999999999999998999999999865432 234578899999999994 6999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeeccCc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLA 706 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~ 706 (843)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999998654 235689999999999999999999998 9999999999999997 789999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
+....... .....||+.|+|||++ ....++.++|||||||++|||++|+.||....... .. ... .....
T Consensus 182 ~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~----~~i-~~~~~- 250 (327)
T 3lm5_A 182 RKIGHACE---LREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-TY----LNI-SQVNV- 250 (327)
T ss_dssp EEC------------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHH-HHTCC-
T ss_pred cccCCccc---cccccCCcCccCCeee-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HH----HHH-Hhccc-
Confidence 87653222 2345789999999988 56678999999999999999999999996543211 11 111 11110
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.............+.+++.+||+.||++|||++|++++
T Consensus 251 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 ----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00111233455678899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.28 Aligned_cols=264 Identities=22% Similarity=0.319 Sum_probs=200.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 625 (843)
...|+..+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3457778899999999999999988999999999854322 223457889999999999999999999997653
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999999863 588999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH------
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------ 779 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~------ 779 (843)
++..... .....+|..|+|||++.....++.++||||+||++|||++|+.||.... ....+....+..
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-HLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHH
Confidence 9865431 1345788999999988665679999999999999999999999997532 222222221110
Q ss_pred -------------HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhcc
Q 003156 780 -------------LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 833 (843)
Q Consensus 780 -------------~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~ 833 (843)
...- ..................+.+++.+|++.||++|||++|++++ ++.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGL--PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHS--CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhC--CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0000 0000111112233445678899999999999999999999996 44443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.74 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=205.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..+.|+..+.||+|+||.||+|+...+|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 34567778899999999999999988999999999975432 23457889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE---cCCCCcEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~ 708 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 86 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999999999875 3589999999999999999999998 99999999999999 7889999999999975
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
..... .....|+..|+|||.+ .+..++.++||||+||++|||++|+.||..... .. .... +..+... .
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~---~~~~-i~~~~~~-~ 226 (304)
T 2jam_A 159 EQNGI----MSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SK---LFEK-IKEGYYE-F 226 (304)
T ss_dssp CCCBT----THHHHSCCCBCCTTTB-SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HH---HHHH-HHHCCCC-C
T ss_pred cCCCc----cccccCCCCccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HH---HHHH-HHcCCCC-C
Confidence 43221 1334688999999988 556789999999999999999999999965322 11 1111 1222110 0
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
. ..........+.+++.+|++.||++|||+.|++++-
T Consensus 227 -~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 227 -E---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp -C---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred -C---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 0 112334556788999999999999999999999863
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=357.08 Aligned_cols=320 Identities=20% Similarity=0.143 Sum_probs=191.2
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
+.++.++++++ .+|... .++++.|+|++|+|.++.+..|.++++|++|+|++|.|++.. +..|.++++|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L 85 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE----PGAFNNLFNLRTL 85 (477)
T ss_dssp TEEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEEC----TTTTTTCTTCCEE
T ss_pred CEEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeC----hhhhhCCccCCEE
Confidence 45677777776 667543 246777777777777776667777777777777777766432 2346666777777
Q ss_pred ecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc
Q 003156 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
+|++|+++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|+++
T Consensus 86 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 86 GLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp ECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred ECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 77777776555556666777777777777776666666667777777777777766666666666666666666666666
Q ss_pred ccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCC
Q 003156 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSS 244 (843)
Q Consensus 165 ~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~ 244 (843)
+..+..|.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|...+.
T Consensus 166 ~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~----------------------- 222 (477)
T 2id5_A 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY----------------------- 222 (477)
T ss_dssp SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTT-----------------------
T ss_pred ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCccccc-----------------------
Confidence 555555666666666666666666655556666666666666666554333322211
Q ss_pred CCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccC
Q 003156 245 SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESR 324 (843)
Q Consensus 245 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 324 (843)
..+|+.|+|++|++++..+..+..+++|++|+|++|.|+++.+..|..+++|++|+|++|++++..|..|..++
T Consensus 223 ------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 296 (477)
T 2id5_A 223 ------GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLN 296 (477)
T ss_dssp ------TCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCT
T ss_pred ------CccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcc
Confidence 12455555555555533334455555555555555555554444455555555555555555544444444455
Q ss_pred CCcEEEcCCCCCCCCchhhhcccCCCcEEeccccccc
Q 003156 325 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361 (843)
Q Consensus 325 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 361 (843)
+|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 297 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 297 YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp TCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred cCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 5555555555554444444444444444444444444
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.04 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=201.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-----CCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----HPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~ 627 (843)
.+.|+..+.||+|+||.||+|++..+++.||||++.... ...+.+..|+.+++.++ ||||+++++++...+..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 345777889999999999999998899999999985322 23456788999999996 99999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-------------
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD------------- 694 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~------------- 694 (843)
++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred EEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcc
Confidence 9999999 999999998752 34589999999999999999999998 9999999999999975
Q ss_pred ------------CCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 003156 695 ------------NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762 (843)
Q Consensus 695 ------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~ 762 (843)
++.+||+|||+++...... ....||+.|+|||++ .+..++.++|||||||++|||++|+.||
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVI-LNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHH-cCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 7899999999998644321 345789999999988 5567899999999999999999999999
Q ss_pred cCCCCchhhHHHHHHHHHhh-----------CCcccccCCC-----CCC-----------------CChhhHHHHHHHHH
Q 003156 763 EYGEDNVVILSEHVRVLLEE-----------GNVLDCVDPS-----MGD-----------------YPEDEVLPVLKLAL 809 (843)
Q Consensus 763 ~~~~~~~~~l~~~~~~~~~~-----------~~~~~~~d~~-----l~~-----------------~~~~~~~~l~~l~~ 809 (843)
..... ...+.. +...... ......++.. .+. ........+.+++.
T Consensus 260 ~~~~~-~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 260 RTHEH-MEHLAM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp CCSSH-HHHHHH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCcH-HHHHHH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 75422 111111 1111000 0000000000 000 00011256779999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 003156 810 VCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 810 ~c~~~~P~~RPs~~evl~~ 828 (843)
+||+.||++|||++|++++
T Consensus 338 ~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCChhhCCCHHHHhcC
Confidence 9999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=354.93 Aligned_cols=202 Identities=22% Similarity=0.269 Sum_probs=168.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC-----Ce
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 626 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3557778899999999999999998999999999964322 12346788999999999999999999999766 56
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||++ |+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 6999999764 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccc--------------------eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 003156 707 RLLTRLDKH--------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762 (843)
Q Consensus 707 ~~~~~~~~~--------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~ 762 (843)
+........ .......||..|+|||++.....++.++||||+||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 876543211 11245678999999998656677999999999999999999865554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.70 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=201.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC----C--eeE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP----Q--LKL 628 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----~--~~~ 628 (843)
.|+..+.||+|+||.||+|++..+|+.||||++.... ..+.+|++++++++||||+++++++... + ..+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4667779999999999999998889999999986543 2234799999999999999999998542 2 356
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-CCcEEeeccCcc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLAR 707 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfgl~~ 707 (843)
+||||+++ ++.+.+.........+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 67776654323346799999999999999999999998 99999999999999955 568999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH-------H
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------L 780 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~-------~ 780 (843)
.+..... .....+|..|+|||++.....++.++|||||||++|||++|+.||.... ....+.+.++.. +
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHH
Confidence 7644322 1345789999999988555678999999999999999999999997542 223333333211 0
Q ss_pred h--hCCcccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhcc
Q 003156 781 E--EGNVLDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 833 (843)
Q Consensus 781 ~--~~~~~~~~d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~ 833 (843)
. .....+...+.+.. ++.....++.+|+.+||+.||++|||+.|++++ ++.+.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0 01111111111111 223445678999999999999999999999986 44443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.08 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=206.5
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC-----Cee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 627 (843)
...|+..+.||+|+||.||+|.+..+++.||||++.........+.+.+|++++++++||||+++++++..+ ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 346778889999999999999998899999999986544333446788999999999999999999999765 357
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 5999999763 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC--
Q 003156 708 LLTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN-- 784 (843)
Q Consensus 708 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~-- 784 (843)
......... ......||+.|+|||++.....++.++||||+||++|||++|+.||...... ..+...... .....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~-~~~~~~~ 254 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGI-LGSPSQE 254 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHHHH-HCSCCHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHHH-hCCCCHH
Confidence 765432221 1244578999999998756667899999999999999999999999654322 222221111 00000
Q ss_pred -------------cccccCCCCC---CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 -------------VLDCVDPSMG---DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 -------------~~~~~d~~l~---~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
......+... ........++.+++.+|++.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0112345578899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=359.63 Aligned_cols=266 Identities=18% Similarity=0.212 Sum_probs=187.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC-----Cee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QLK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 627 (843)
+.|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 567788899999999999999988999999999854322 12346788999999999999999999999543 468
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||+ +|+|.+++... ..+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 57899998764 4689999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc-------------------------eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-----
Q 003156 708 LLTRLDKH-------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT----- 757 (843)
Q Consensus 708 ~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt----- 757 (843)
........ .......||+.|+|||++.....++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76432111 112345679999999986566779999999999999999999
Q ss_pred ------CCCCCcCCCCc-------------------hhhHHHHHHHHHhhC------------------CcccccCCCCC
Q 003156 758 ------GRRPVEYGEDN-------------------VVILSEHVRVLLEEG------------------NVLDCVDPSMG 794 (843)
Q Consensus 758 ------g~~p~~~~~~~-------------------~~~l~~~~~~~~~~~------------------~~~~~~d~~l~ 794 (843)
|+.+|...... ...+..... ..... .........+.
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN-ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHH-HHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHH-HcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 45554322100 001111000 00000 00000000011
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........++.+|+.+|+..||++|||++|++++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1122335678899999999999999999999997
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=342.60 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=203.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-------ChHHHHHHHHHHHhc-cCCCccceeeEEEcCC
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 625 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 625 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 44666678999999999999998889999999986543211 134678999999999 7999999999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCc
Confidence 999999999999999999875 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQ-----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
+..+..... .....||+.|+|||++.. ...++.++|||||||++|||++|+.||..... .. .... +
T Consensus 247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~---~~~~-i 317 (365)
T 2y7j_A 247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--IL---MLRM-I 317 (365)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHH-H
T ss_pred ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HH---HHHH-H
Confidence 987654322 244678999999998732 23578999999999999999999999965321 11 1111 1
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+... ...+ ........+.+++.+||+.||++|||+.|++++
T Consensus 318 ~~~~~~-~~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQYQ-FSSP----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTCCC-CCHH----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCC-CCCc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111110 0000 011234568899999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=361.23 Aligned_cols=253 Identities=17% Similarity=0.153 Sum_probs=192.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHH---HHHHhccCCCcccee-------eE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREV---RVLGKARHPNLISLE-------GY 620 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~ 620 (843)
.+.|+..+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4557778899999999999999987899999999975422 22346788999 455555899999998 66
Q ss_pred EEcCCe-----------------eEEEEEeCCCCCHHHHHhhcCC---CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCe
Q 003156 621 YWTPQL-----------------KLLVSDYAPNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680 (843)
Q Consensus 621 ~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 680 (843)
+.+++. .++||||+ +|+|.+++..... ....+++..++.|+.|++.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 6899999986421 112344688889999999999999999 99
Q ss_pred eecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCc----------CCCCCchhHHHHHH
Q 003156 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS----------LRVNEKCDIYGFGV 750 (843)
Q Consensus 681 vH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~Dv~S~Gv 750 (843)
+||||||+|||++.++.+||+|||+++.... ......| ..|+|||++... ..++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985432 1134466 899999988433 26899999999999
Q ss_pred HHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--
Q 003156 751 LILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI-- 828 (843)
Q Consensus 751 il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~-- 828 (843)
++|||++|+.||....... ....+.. .....+.++.+++.+||+.||++|||+.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~---------------~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------------GSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHHSSCCC------C---------------CSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHHCCCCCccccccc---------------chhhhhh----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 9999999999996432111 0000101 112334578899999999999999999999874
Q ss_pred HHhccC
Q 003156 829 LQVIKT 834 (843)
Q Consensus 829 L~~~~~ 834 (843)
++.+..
T Consensus 363 f~~~~~ 368 (377)
T 3byv_A 363 YEQLRT 368 (377)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 444433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=357.18 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=206.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
..+.|+..+.||+|+||+||+|.+..+++.||||++..... ......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 45667888899999999999999988999999999864322 23457889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc---CCCCcEEeeccCcc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLAR 707 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~ 707 (843)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999875 4589999999999999999999999 999999999999995 56679999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... .....||+.|+|||++.. .++.++||||+||++|+|++|+.||..... .. ..... ..+....
T Consensus 173 ~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~----~~~~i-~~~~~~~ 241 (486)
T 3mwu_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YD----ILKRV-ETGKYAF 241 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HH----HHHHH-HHTCCCS
T ss_pred ECCCCCc---cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH----HHHHH-HhCCCCC
Confidence 7654322 234578999999998843 589999999999999999999999965322 11 11111 1111110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. .........+.+++.+||+.||++|||+.|++++
T Consensus 242 ----~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 ----DL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----CS-GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----CC-cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 1123445678899999999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.46 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=199.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-------ccChHHHHHHHHHHHhccCCCccceeeEEEcCC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-------IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 625 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||.+..... ......+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 4567788899999999999999988899999999854321 112245889999999999999999999987665
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC---cEEee
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISD 702 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D 702 (843)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 79999999999999998754 4689999999999999999999998 9999999999999986654 99999
Q ss_pred ccCcccccccccceeccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
||+++....... .....||..|+|||++. ....++.++|||||||++|||++|+.||........ +...+
T Consensus 161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~---- 232 (322)
T 2ycf_A 161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQI---- 232 (322)
T ss_dssp CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHH----
T ss_pred Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHH----
Confidence 999987643221 13456889999999863 345688999999999999999999999975433221 11111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+... ..+.........+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGKYN-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTCCC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCccc-----cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111110 0000112345678899999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=357.66 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=202.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
..+.|+..+.||+|+||.||+|++..++..||+|.+..... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45678888899999999999999998999999999865432 23457789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeeccCcc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLAR 707 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~ 707 (843)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 115 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999998875 4589999999999999999999998 9999999999999975 4559999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||..... . ...... ..+...
T Consensus 188 ~~~~~~~---~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~----~~~~~i-~~~~~~- 255 (494)
T 3lij_A 188 VFENQKK---MKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-Q----EILRKV-EKGKYT- 255 (494)
T ss_dssp ECBTTBC---BCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-H----HHHHHH-HHTCCC-
T ss_pred ECCCCcc---ccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHH-HhCCCC-
Confidence 7654322 24457899999999873 3589999999999999999999999975422 1 111111 111111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+ ........+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 FDSP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000 112344578899999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=341.52 Aligned_cols=272 Identities=22% Similarity=0.295 Sum_probs=206.5
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC-------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------- 624 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 624 (843)
.+.|+..+.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4567788899999999999999988999999999855433 23356788999999999999999999999873
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeec
Q 003156 625 -QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703 (843)
Q Consensus 625 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 703 (843)
+..++||||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 467899999975 788877764 34589999999999999999999998 9999999999999999999999999
Q ss_pred cCccccccccc--ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 704 GLARLLTRLDK--HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 704 gl~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
|+++.+..... ........||+.|+|||++.....++.++|||||||++|||++|+.||..... ...+. .+.....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~-~i~~~~~ 246 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLA-LISQLCG 246 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH-HHHHHHC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHH-HHHHHhC
Confidence 99987653221 11223456799999999885556789999999999999999999999975322 21221 1111111
Q ss_pred hCCcccccCCCC------------CC--CC-hh------hHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 782 EGNVLDCVDPSM------------GD--YP-ED------EVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 782 ~~~~~~~~d~~l------------~~--~~-~~------~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
.......+.. .. .. .+ ....+.+++.+|++.||++|||++|++++-.--..+
T Consensus 247 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 247 --SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp --CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred --CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 1000000000 00 00 00 134578999999999999999999999974433333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=358.44 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=203.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc------------cChHHHHHHHHHHHhccCCCccceee
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII------------QYPEDFEREVRVLGKARHPNLISLEG 619 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~g 619 (843)
..+.|+..+.||+|+||+||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 346678888999999999999999988999999998654321 34567899999999999999999999
Q ss_pred EEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC---
Q 003156 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY--- 696 (843)
Q Consensus 620 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--- 696 (843)
++.+....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999999875 4589999999999999999999998 999999999999998765
Q ss_pred CcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHH
Q 003156 697 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 776 (843)
Q Consensus 697 ~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~ 776 (843)
.+||+|||+++....... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||...... ...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-----DII 256 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHH
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence 699999999987654322 24457899999999873 35899999999999999999999999754221 111
Q ss_pred HHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 777 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. +..+.... + . ......+.++.+++.+|++.||++|||++|++++
T Consensus 257 ~~-i~~~~~~~--~--~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KK-VEKGKYYF--D--F-NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH-HHHCCCCC--C--H-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-HHcCCCCC--C--c-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 12221100 0 0 0012334578899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=359.66 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=208.7
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
..+.|+..+.||+|+||.||+|....+|+.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45678888899999999999999998999999999865432 3356789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE---cCCCCcEEeeccCc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLA 706 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~ 706 (843)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999864 4689999999999999999999999 99999999999999 56789999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
+.+..... .....||+.|+|||++.. .++.++||||+||++|+|++|+.||..... .. .... +..+...
T Consensus 177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~----~~~~-i~~~~~~ 245 (484)
T 3nyv_A 177 THFEASKK---MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANE-YD----ILKK-VEKGKYT 245 (484)
T ss_dssp HHBCCCCS---HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH----HHHH-HHHCCCC
T ss_pred EEcccccc---cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-HH----HHHH-HHcCCCC
Confidence 87654322 234568999999998733 589999999999999999999999975422 11 1111 1222111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... ......+..+.+++.+||+.||++|||+.|++++
T Consensus 246 ----~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 ----FEL-PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----CCS-GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000 1123455678899999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=349.66 Aligned_cols=347 Identities=25% Similarity=0.335 Sum_probs=299.4
Q ss_pred cCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCC
Q 003156 48 NYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCP 127 (843)
Q Consensus 48 ~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 127 (843)
..+++|++|++++|.+...+ .+..+++|++|+|++|.+.+..+ +..+++|++|++++|.+++..+ +.+++
T Consensus 43 ~~l~~l~~L~l~~~~i~~l~------~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~ 112 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKSID------GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112 (466)
T ss_dssp HHHHTCCEEECCSSCCCCCT------TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCT
T ss_pred hHhccccEEecCCCCCccCc------chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCC
Confidence 44678999999999988543 36789999999999999996544 9999999999999999996655 99999
Q ss_pred CCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEec
Q 003156 128 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 207 (843)
Q Consensus 128 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 207 (843)
+|++|++++|.+++..+ +..+++|++|++++|++.+ ++ .++.+++|++|+++ |.+.+. ..+.++++|+.|+++
T Consensus 113 ~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~ 185 (466)
T 1o6v_A 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDIS 185 (466)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECc
Confidence 99999999999997643 8999999999999999985 33 48999999999997 555533 238999999999999
Q ss_pred CCcCCCCCCchhhcc-CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCC
Q 003156 208 GNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 286 (843)
Q Consensus 208 ~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 286 (843)
+|.+++ ++. +..+ +|+.|++++|.+.+..| ...+++|+.|++++|++++. ..+..+++|++|++++|
T Consensus 186 ~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n 253 (466)
T 1o6v_A 186 SNKVSD-ISV-LAKLTNLESLIATNNQISDITP--------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 253 (466)
T ss_dssp SSCCCC-CGG-GGGCTTCSEEECCSSCCCCCGG--------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred CCcCCC-Chh-hccCCCCCEEEecCCccccccc--------ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCC
Confidence 999984 433 4443 79999999999986543 34578999999999999853 46889999999999999
Q ss_pred cccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCc
Q 003156 287 HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK 366 (843)
Q Consensus 287 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 366 (843)
.+++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..|
T Consensus 254 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~- 326 (466)
T 1o6v_A 254 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP- 326 (466)
T ss_dssp CCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-
T ss_pred ccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-
Confidence 9987654 8899999999999999996544 8899999999999999997655 8899999999999999997666
Q ss_pred cccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCC
Q 003156 367 SISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICS 434 (843)
Q Consensus 367 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~ 434 (843)
+..+++|+.|++++|++++. ..+.++++|+.|++++|++++.+| ...++++....+.+|+..+.
T Consensus 327 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 327 -VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp -GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECC
T ss_pred -hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCC
Confidence 78999999999999999965 578999999999999999999998 57788888888999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=350.06 Aligned_cols=260 Identities=13% Similarity=0.180 Sum_probs=206.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC-CCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++| +++..+..++...+..++|||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 457778899999999999999988999999998765432 2458899999999987 556666666677888899999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE---cCCCCcEEeeccCcccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLL 709 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfgl~~~~ 709 (843)
|+ +++|.+++... ...+++..++.|+.|++.||+|||+. +||||||||+|||+ +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 99999999864 34699999999999999999999998 99999999999999 68899999999999876
Q ss_pred cccccc-----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch--hhHHHHHHHHHhh
Q 003156 710 TRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV--VILSEHVRVLLEE 782 (843)
Q Consensus 710 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~--~~l~~~~~~~~~~ 782 (843)
...... .......||..|+|||++ .+..++.++|||||||++|||++|+.||....... ..+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~- 234 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA- 234 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-
T ss_pred cCCccccccccccccccCCCccccCHHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-
Confidence 543321 112356789999999998 55678999999999999999999999997653321 112111111111
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 783 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
..... .....+.++.+++..||+.+|++||++.++++.|+.+.
T Consensus 235 ~~~~~--------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 235 TSIEA--------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp SCHHH--------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHH--------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11100 11233457899999999999999999999999998873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=351.65 Aligned_cols=254 Identities=11% Similarity=-0.013 Sum_probs=183.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhc--cCCCcccee-------eEEEcC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA--RHPNLISLE-------GYYWTP 624 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~~ 624 (843)
|+..+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.+ +||||++++ +++..+
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 66777999999999999999889999999999765431 2345677886555555 599988754 454433
Q ss_pred -----------------CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHH------HHHHHHHHHHHHhhhhcCCCCee
Q 003156 625 -----------------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR------FKVILGTAKGLAHLHHSFRPPII 681 (843)
Q Consensus 625 -----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~iv 681 (843)
...++||||++ |+|.+++... ...+.+..+ ..++.|+++||+|||++ +|+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 23799999998 8999999875 223466666 78889999999999998 999
Q ss_pred ecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccC-cCCCCCchhHHHHHHHHHHHHhCCC
Q 003156 682 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRR 760 (843)
Q Consensus 682 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Dv~S~Gvil~elltg~~ 760 (843)
||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.. ...++.++|||||||++|||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998654311 13456699999998843 1578999999999999999999999
Q ss_pred CCcCCCCchhhHHHHHHHHHhhCCcccccCCCC-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 761 PVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 761 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
||.......... .............. ..........+.+++.+||+.||++|||+.|++++
T Consensus 292 Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 997653221100 00000000000010 01123556788999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.45 Aligned_cols=272 Identities=20% Similarity=0.291 Sum_probs=196.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCe------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------ 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 626 (843)
.+.|+..+.||+|+||.||+|.+..+|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 345677789999999999999998889999999986543 233567788899999999999999999975433
Q ss_pred -eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhh--hcCCCCeeecCCCCCCEEEcC-CCCcEEee
Q 003156 627 -KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH--HSFRPPIIHYNLKPSNILLDD-NYNPRISD 702 (843)
Q Consensus 627 -~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~dlk~~Nill~~-~~~~kl~D 702 (843)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+||+++. ++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999976 566555543334567899999999999999999999 76 9999999999999996 89999999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH--
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL-- 780 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~-- 780 (843)
||+++........ ....||..|+|||++.....++.++|||||||++|||++|+.||..... ...+...++...
T Consensus 176 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 176 FGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRVLGCP 251 (360)
T ss_dssp CTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCC
T ss_pred CCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHHcCCC
Confidence 9999876543322 3456899999999885666689999999999999999999999975432 222222222110
Q ss_pred ---------hhCCcccccCCC-------CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccC
Q 003156 781 ---------EEGNVLDCVDPS-------MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 834 (843)
Q Consensus 781 ---------~~~~~~~~~d~~-------l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~ 834 (843)
......+..+.. ..........++.+++.+||+.||++|||+.|++++ ++.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 000000000000 011223356789999999999999999999999987 555544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.42 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=187.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEE--------cC
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYW--------TP 624 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~~ 624 (843)
..|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35677789999999999999998899999999985543 233467889999999996 999999999994 23
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCC--eeecCCCCCCEEEcCCCCcEEee
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP--IIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~D 702 (843)
...++||||++ |+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 34789999995 79999987632 234699999999999999999999998 7 99999999999999999999999
Q ss_pred ccCcccccccccce----------eccccccccccCCccccc--CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchh
Q 003156 703 FGLARLLTRLDKHV----------MSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV 770 (843)
Q Consensus 703 fgl~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~--~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~ 770 (843)
||+++......... ......||+.|+|||++. ....++.++|||||||++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998765432211 111345889999999873 34567899999999999999999999996432210
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 771 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.. .. .. .. .........+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 261 ----~~----~~-~~----~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ----IV----NG-KY----SI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------C----CC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hh----cC-cc----cC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 00 00 00 0112223347789999999999999999999999988854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.52 Aligned_cols=254 Identities=27% Similarity=0.338 Sum_probs=205.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--------cChHHHHHHHHHHHhcc-CCCccceeeEEEcC
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--------QYPEDFEREVRVLGKAR-HPNLISLEGYYWTP 624 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 624 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||.+...... ...+.+.+|++++++++ ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 4567778999999999999999889999999998654311 12356789999999996 99999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999875 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCccccc-----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTC-----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 779 (843)
+++....... .....++..|+|||++. ....++.++||||||+++|||++|+.||..... . ......
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~---~~~~~~ 241 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--M---LMLRMI 241 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHH
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--H---HHHHHH
Confidence 9987654322 23456889999999873 244678999999999999999999999965322 1 111111
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. +... .. .......+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~-~~~~-~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 242 MS-GNYQ-FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HH-TCCC-CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hc-CCcc-cC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11 1111 00 01123456678999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.11 Aligned_cols=263 Identities=28% Similarity=0.406 Sum_probs=198.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-CC--eEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-QG--RMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.|+..+.||+|+||.||+|++.. ++ ..||+|.+..... ....+.+.+|+.++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4557778899999999999999743 33 3689998865432 223467899999999999999999999998765 7
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999875 24589999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 708 LLTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 708 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
......... ......+|..|+|||.+ ....++.++||||||+++|||++ |+.||...... ............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCCC
Confidence 765433222 22345677889999988 45568899999999999999999 99999654221 111111111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
...+...+.++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 244 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 244 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred --------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 1123455677899999999999999999999999999886543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.18 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=201.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc------cCCCccceeeEEEcCCee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA------RHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~ 627 (843)
..|+..+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++......
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45778889999999999999998889999999985432 2345678899998888 467999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC--cEEeeccC
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN--PRISDFGL 705 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl 705 (843)
++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 69999998752 34589999999999999999999999 9999999999999998887 99999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH------
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------ 779 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~------ 779 (843)
++..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.... ....+...+...
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVI-LGARYGMPIDMWSLGCILAELLTGYPLLPGED-EGDQLACMIELLGMPSQK 321 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHH-HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHH
T ss_pred ceecCCc-----ccccCCCCCccChHHH-hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCCHH
Confidence 9754321 1345788999999988 45578999999999999999999999996542 222222222210
Q ss_pred -HhhC-CcccccCCC---------------------------------CCC----CChhhHHHHHHHHHHccCCCCCCCC
Q 003156 780 -LEEG-NVLDCVDPS---------------------------------MGD----YPEDEVLPVLKLALVCTCHIPSSRP 820 (843)
Q Consensus 780 -~~~~-~~~~~~d~~---------------------------------l~~----~~~~~~~~l~~l~~~c~~~~P~~RP 820 (843)
.... .....++.. ... ........+.+++.+||+.||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0000 000000000 000 1112245688999999999999999
Q ss_pred CHHHHHHH
Q 003156 821 SMAEVVQI 828 (843)
Q Consensus 821 s~~evl~~ 828 (843)
|++|++++
T Consensus 402 ta~e~L~H 409 (429)
T 3kvw_A 402 TPGQALRH 409 (429)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhCC
Confidence 99999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.12 Aligned_cols=270 Identities=22% Similarity=0.307 Sum_probs=204.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC-----Cee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 627 (843)
.+.|+..+.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 345677789999999999999998889999999986544333446788999999999999999999998754 567
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 6899998763 589999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccce--------eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH
Q 003156 708 LLTRLDKHV--------MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 708 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 779 (843)
......... ......||..|+|||++.....++.++|||||||++|||++|+.||...... ..+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~-~~ 238 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-HQLLLIF-GI 238 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH-HH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH-HH
Confidence 765322111 1123468999999998756677899999999999999999999999754321 1111111 11
Q ss_pred HhhCC---cccccC----------------CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhcc
Q 003156 780 LEEGN---VLDCVD----------------PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 833 (843)
Q Consensus 780 ~~~~~---~~~~~d----------------~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~ 833 (843)
..... ...++. ..+.........++.+++.+||+.||++|||++|++++ ++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 11000 000000 00000112445678899999999999999999999986 44443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=334.28 Aligned_cols=254 Identities=24% Similarity=0.281 Sum_probs=202.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc---ccChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLL 629 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 629 (843)
.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 46677899999999999999988999999999865421 2234678999999999999999999999854 457899
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++| +.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 99999877 778777642 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.............|+..|+|||++... ..++.++||||||+++|||++|+.||..... . ..... +..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~---~~~~~-i~~~~~--- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--Y---KLFEN-IGKGSY--- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--H---HHHHH-HHHCCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--H---HHHHH-HhcCCC---
Confidence 543333333456789999999987432 2347799999999999999999999975321 1 11111 111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
..+......+.+++.+||+.||++|||++|++++-
T Consensus 231 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 231 ------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred ------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 12344566788999999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=337.45 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=199.4
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc------
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT------ 623 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------ 623 (843)
...+.|+..+.||+|+||.||+|.+..+|+.||+|.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 35566788889999999999999998899999999986543 2357889999999999 79999999999986
Q ss_pred CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeec
Q 003156 624 PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703 (843)
Q Consensus 624 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 703 (843)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence 457899999999999999998742 34688999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccceeccccccccccCCcccccC----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 779 (843)
|+++....... ......|+..|+|||++.. ...++.++|||||||++|||++|+.||....... . ...
T Consensus 174 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~----~~~- 245 (326)
T 2x7f_A 174 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-A----LFL- 245 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-H----HHH-
T ss_pred cCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-H----HHH-
Confidence 99986543211 1234568899999998742 4568899999999999999999999996532211 1 111
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+..... +.. ........+.+++.+||..||++|||+.|++++
T Consensus 246 ~~~~~~-----~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 246 IPRNPA-----PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSCC-----CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhcCcc-----ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111 111 123344578899999999999999999999885
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=367.92 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=205.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
.+.|+..+.||+|+||.||+|.+.. .+..||+|.+.........+.|.+|+.++++++||||++++|++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 3557778899999999999999854 356799999865443334467899999999999999999999985 456899
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999865 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... ......+|+.|+|||++ ....++.++|||||||++|||++ |..||...... .. ... +..+..
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~---~~~-i~~~~~--- 610 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DV---IGR-IENGER--- 610 (656)
T ss_dssp CC-----------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH---HHH-HHHTCC---
T ss_pred CCCcce-eccCCCCCcceeCHHHh-cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HH---HHH-HHcCCC---
Confidence 543222 22344567899999988 55678999999999999999997 99999654221 11 111 111211
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...+..++..+.+++.+||..||++|||+.|+++.|+.+.
T Consensus 611 -----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1234455678899999999999999999999999998874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.87 Aligned_cols=259 Identities=18% Similarity=0.239 Sum_probs=204.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccC----------------hHHHHHHHHHHHhccCCCccce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY----------------PEDFEREVRVLGKARHPNLISL 617 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~l 617 (843)
+.|+..+.||+|+||.||+|.+ +|+.||+|.+........ .+.+.+|+.++++++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 4577778999999999999999 899999999865432211 1789999999999999999999
Q ss_pred eeEEEcCCeeEEEEEeCCCCCHHHH------HhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCE
Q 003156 618 EGYYWTPQLKLLVSDYAPNGSLQAK------LHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNI 690 (843)
Q Consensus 618 ~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Ni 690 (843)
++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4432 24679999999999999999999998 7 999999999999
Q ss_pred EEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCC-chhHHHHHHHHHHHHhCCCCCcCCCCch
Q 003156 691 LLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE-KCDIYGFGVLILELVTGRRPVEYGEDNV 769 (843)
Q Consensus 691 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~~Dv~S~Gvil~elltg~~p~~~~~~~~ 769 (843)
+++.++.+||+|||.++..... ......|+..|+|||.+.....++. ++|||||||++|||++|+.||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 9999999999999999875432 2245678999999999854435555 9999999999999999999997654322
Q ss_pred hhHHHHHHHHHhhCCcccccC------CCC----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 770 VILSEHVRVLLEEGNVLDCVD------PSM----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 770 ~~l~~~~~~~~~~~~~~~~~d------~~l----~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.... . +..+......+ +.. ..........+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~~----~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELFN----N-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHH----H-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHH----H-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2111 1 11111110000 000 00114455678999999999999999999999885
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.44 Aligned_cols=261 Identities=22% Similarity=0.251 Sum_probs=192.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCC------e
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------L 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 626 (843)
..|+..+.||+|+||.||+|....+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 457778899999999999999988999999999865432 223456889999999999999999999997665 6
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||++ |+|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 799999997 578888863 388999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH---------
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR--------- 777 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~--------- 777 (843)
+...... ......||..|+|||++ .+..++.++||||+||++|||++|+.||..... ...+...++
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------------CTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHC-CCCCCHHH
T ss_pred ccccccc---ccCCceecCCccCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 8654321 12345789999999988 456789999999999999999999999975422 111111110
Q ss_pred ---------HHHhhCCccc----------ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 778 ---------VLLEEGNVLD----------CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 778 ---------~~~~~~~~~~----------~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.......... ..-+............+.+++.+|++.||++|||++|++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0000000000 000000001122356789999999999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=335.20 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=196.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc---------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--------- 623 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 623 (843)
.+.|+..+.||+|+||.||+|+...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 355677789999999999999998899999999985432 234678899999999999999999999865
Q ss_pred ----CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcE
Q 003156 624 ----PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 699 (843)
Q Consensus 624 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 699 (843)
....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 34578999999999999999864 34578889999999999999999999 999999999999999999999
Q ss_pred EeeccCccccccccc------------ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC
Q 003156 700 ISDFGLARLLTRLDK------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~ 767 (843)
|+|||+++....... ........|+..|+|||++.....++.++|||||||++|||++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999986643211 1112345688999999998555578999999999999999998 5542211
Q ss_pred chhhHHHHHHHHHhhCCcccccCCCC-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 768 NVVILSEHVRVLLEEGNVLDCVDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 768 ~~~~l~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ...... +... .... ..++......+.+++.+||+.||++|||+.|++++
T Consensus 234 ~----~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 R----VNILKK-LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H----HHHHHH-HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H----HHHHHh-cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 111111 1111 1111 12445556678899999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.97 Aligned_cols=266 Identities=21% Similarity=0.326 Sum_probs=198.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCe------e
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------K 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 627 (843)
..|+..+.||+|+||.||+|++.. +..||+|++...... ..+|+++++.++||||+++++++..... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~-~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE-SDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT-TEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC-CCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 346778899999999999999974 445999988654321 2379999999999999999999965432 6
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLA 706 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~ 706 (843)
++||||++++ +.+.+.........+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999875 4444433222345789999999999999999999998 999999999999999 8999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH------
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL------ 780 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~------ 780 (843)
+........ ....+|..|+|||++.....++.++||||+||++|||++|+.||.... ....+...++..-
T Consensus 190 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES-GIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHH
T ss_pred ccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHH
Confidence 876443322 345678999999988666679999999999999999999999997542 2222332222110
Q ss_pred -h--hCCcccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhcc
Q 003156 781 -E--EGNVLDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 833 (843)
Q Consensus 781 -~--~~~~~~~~d~~l~~------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~ 833 (843)
. ........-+.... ++.....++.+++.+||+.||++|||+.|++++ ++.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0 00000000011111 233455678999999999999999999999987 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.29 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=185.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC------Ce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 626 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 557778899999999999999988999999999854321 22345788999999999999999999999754 45
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 79999999 7899988865 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC---
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--- 783 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--- 783 (843)
+..... .....||..|+|||++.....++.++||||+||++|||++|+.||.... ....+....+......
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHH
Confidence 865431 1345789999999988665778999999999999999999999996532 2222222221110000
Q ss_pred --Cc--------ccccCCCCCC-----CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 --NV--------LDCVDPSMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 --~~--------~~~~d~~l~~-----~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ...+ +.... ........+.+++.+|++.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTS-CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhcc-CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 0000 00000 112234568899999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=367.83 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=206.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.|+..+.||+|+||.||+|++..+++.||||++.... .....+.+..|..++..+ +||+|+++++++.+.+..++|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 34667779999999999999999899999999996532 123456788999999988 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+++...
T Consensus 421 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999875 3589999999999999999999999 99999999999999999999999999998643
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
... .......||+.|+|||++ ....++.++|||||||++|||++|+.||..... . +..+.... ..
T Consensus 494 ~~~--~~~~~~~GT~~Y~APE~l-~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-~----~~~~~i~~-~~------ 558 (674)
T 3pfq_A 494 WDG--VTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-D----ELFQSIME-HN------ 558 (674)
T ss_dssp CTT--CCBCCCCSCSSSCCHHHH-TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-H----HHHHHHHS-SC------
T ss_pred cCC--cccccccCCCcccCHhhh-cCCCCCccceEechHHHHHHHHcCCCCCCCCCH-H----HHHHHHHh-CC------
Confidence 222 223556899999999988 566789999999999999999999999975322 1 11111111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~-----~evl~~ 828 (843)
..++.....++.+++.+|++.||++||++ +|++++
T Consensus 559 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 12345566788999999999999999997 777664
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=347.31 Aligned_cols=272 Identities=23% Similarity=0.295 Sum_probs=188.6
Q ss_pred hhhhh-cCeeccccceEEEEEEEC--CCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeE
Q 003156 554 TLLEK-AAEVGEGVFGTVYKVSFG--TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKL 628 (843)
Q Consensus 554 ~~~~~-~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 628 (843)
+.|+. +++||+|+||.||+|++. .+++.||+|++.... ....+.+|+.++++++||||+++++++.. ....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34444 457999999999999975 468899999985433 34678899999999999999999999954 66789
Q ss_pred EEEEeCCCCCHHHHHhhcC-----CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE----cCCCCcE
Q 003156 629 LVSDYAPNGSLQAKLHERL-----PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPR 699 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~k 699 (843)
+||||++ |+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 58888876431 1223589999999999999999999999 99999999999999 6789999
Q ss_pred EeeccCccccccccc-ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc--------hh
Q 003156 700 ISDFGLARLLTRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--------VV 770 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~--------~~ 770 (843)
|+|||+++.+..... ........||+.|+|||++.....++.++|||||||++|||++|+.||.....+ ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987653221 122245678999999998865566899999999999999999999999654321 11
Q ss_pred hHHHHHHHHHhhCCcccccCCCCCC---------------------------CChhhHHHHHHHHHHccCCCCCCCCCHH
Q 003156 771 ILSEHVRVLLEEGNVLDCVDPSMGD---------------------------YPEDEVLPVLKLALVCTCHIPSSRPSMA 823 (843)
Q Consensus 771 ~l~~~~~~~~~~~~~~~~~d~~l~~---------------------------~~~~~~~~l~~l~~~c~~~~P~~RPs~~ 823 (843)
.+...+... +.......+.+.. ........+.+|+.+|++.||++|||++
T Consensus 253 ~l~~i~~~~---g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 253 QLDRIFNVM---GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp HHHHHHHHH---CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHhh---CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 222221111 0000000000000 0001134678999999999999999999
Q ss_pred HHHHHHHhccCC
Q 003156 824 EVVQILQVIKTP 835 (843)
Q Consensus 824 evl~~L~~~~~~ 835 (843)
|++++=.-...+
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999985443333
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=342.50 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=197.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCee-----
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK----- 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----- 627 (843)
+.|...+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 4566778999999999999999989999999998654322 2246788999999999999999999999877654
Q ss_pred -EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 628 -LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 628 -~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
++||||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 688877743 389999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC---
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--- 783 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--- 783 (843)
+..... .....||..|+|||++.....++.++|||||||++|||++|+.||..... ...+....+......
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCcHHH
Confidence 865432 13456799999999885557789999999999999999999999975321 122222111100000
Q ss_pred --C---------cccccCCCC---CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 --N---------VLDCVDPSM---GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 --~---------~~~~~d~~l---~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ......... ..........+.+++.+|++.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000000 01123345678999999999999999999999987
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.98 Aligned_cols=334 Identities=18% Similarity=0.175 Sum_probs=246.2
Q ss_pred CccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEE
Q 003156 78 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 157 (843)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 157 (843)
++++++|++++|.+....+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45666666666666655555566666666666666666666666666666666666666666666666666666666777
Q ss_pred eecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhc-cCcceeeccCCccee
Q 003156 158 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGFMG 236 (843)
Q Consensus 158 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~L~l~~n~l~~ 236 (843)
|++|+++...+..|.++++|++|+|++|.+++..+..+..+++|+.|++++|.+++. + +.. .+|+.|++++|.+.+
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~--~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-C--GGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-c--cccccccceeecccccccc
Confidence 766666644444456666777777777776666666666667777777777766632 2 111 256667777776653
Q ss_pred cCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccC
Q 003156 237 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 316 (843)
Q Consensus 237 ~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 316 (843)
. ...++|+.|++++|.+... |.. .+++|++|++++|.+++. ..+..+++|++|++++|.+++..
T Consensus 201 ~-----------~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~ 264 (390)
T 3o6n_A 201 L-----------AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIM 264 (390)
T ss_dssp E-----------ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEE
T ss_pred c-----------CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcC
Confidence 2 1235789999999998854 333 347899999999999864 57888999999999999999888
Q ss_pred CccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhccc
Q 003156 317 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396 (843)
Q Consensus 317 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 396 (843)
|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|++. | +..++
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~ 339 (390)
T 3o6n_A 265 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHH 339 (390)
T ss_dssp SGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTC
T ss_pred hhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhc
Confidence 999999999999999999998 46777788999999999999998 6787888999999999999999854 3 67788
Q ss_pred ccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCCC
Q 003156 397 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPL 436 (843)
Q Consensus 397 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 436 (843)
+|+.|++++|++.+... ...+..+....+.+++..|..+
T Consensus 340 ~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 340 TLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp CCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCCTT
T ss_pred cCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceeccc
Confidence 99999999999987543 2445666777788888888754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.93 Aligned_cols=266 Identities=24% Similarity=0.301 Sum_probs=203.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-CCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhc---cCCCccceeeEEE----
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFG-TQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKA---RHPNLISLEGYYW---- 622 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~---- 622 (843)
..+.|+..+.||+|+||.||+|.+. .+|+.||+|++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3456778889999999999999994 5789999999865432 22234677888887777 8999999999997
Q ss_pred -cCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEe
Q 003156 623 -TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701 (843)
Q Consensus 623 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 701 (843)
.....++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4557899999997 69999998752 34589999999999999999999998 99999999999999999999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
|||+++...... ......||..|+|||++ ....++.++|||||||++|||++|+.||..... ...+...+.....
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHHcCC
Confidence 999998664322 12445788999999988 555789999999999999999999999975432 2222222211100
Q ss_pred h---CCcc------ccc----CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 782 E---GNVL------DCV----DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 782 ~---~~~~------~~~----d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. .+.. ... ..............+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000 000 001111334456678899999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.79 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=193.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccC----------hHHHHHHHHHHHhccCCCccceeeEEEc
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY----------PEDFEREVRVLGKARHPNLISLEGYYWT 623 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~g~~~~ 623 (843)
+.|+..+.||+|+||.||+|... +|+.||||++........ .+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 34666779999999999999986 599999999855332211 2678999999999999999999999854
Q ss_pred C-----CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 624 P-----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 624 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
. ...++||||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCE
Confidence 2 35799999997 6888888754 35689999999999999999999999 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 778 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~ 778 (843)
||+|||+++....... .....+|..|+|||++.....++.++||||+||++|||++|+.||..... ...+...+..
T Consensus 174 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~ 249 (362)
T 3pg1_A 174 TICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-YNQLNKIVEV 249 (362)
T ss_dssp EECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHH
T ss_pred EEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Confidence 9999999975443221 23457889999999885556789999999999999999999999975422 1112111110
Q ss_pred HHhhCCc-----------ccccCCCCCC--------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 779 LLEEGNV-----------LDCVDPSMGD--------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 779 ~~~~~~~-----------~~~~d~~l~~--------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...... .+.+...... ........+.+++.+|++.||++|||+.|++++
T Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 250 -VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000 0000001111 123345568899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.09 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=204.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 630 (843)
..+.|+..+.||+|+||.||+|....+++.||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 34567778899999999999999988899999999865432 33567899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC---CCcEEeeccCcc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN---YNPRISDFGLAR 707 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfgl~~ 707 (843)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998775 3589999999999999999999998 99999999999999754 479999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
....... .....++..|+|||.+. + .++.++||||||+++|+|++|+.||..... .. .... +..+....
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~---~~~~-~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLR-G-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YD---ILKR-VETGKYAF 241 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHT-T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHH-HHHCCCCC
T ss_pred eecCCCc---cccccCcccccChHHhc-C-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HH---HHHH-HHcCCCCC
Confidence 6653322 13345788999999873 3 489999999999999999999999965322 11 1111 12221110
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ......+.++.+++.+||+.||++|||+.|++++
T Consensus 242 ----~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 ----DL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ----CS-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----Cc-hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 0112345578899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.52 Aligned_cols=260 Identities=21% Similarity=0.334 Sum_probs=198.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+.. .||+|.+..... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 446778899999999999999852 499999865432 2234567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 110 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999864 34689999999999999999999998 999999999999998 679999999998765322
Q ss_pred cc---ceeccccccccccCCcccccC--------cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 713 DK---HVMSNRFQSALGYVAPELTCQ--------SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 713 ~~---~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
.. ........|+..|+|||++.. ...++.++|||||||++|||++|+.||....... . ... +.
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~---~~~-~~ 256 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--I---IWQ-MG 256 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--H---HHH-HH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H---HHH-hc
Confidence 11 111234468899999998743 2357889999999999999999999997543211 1 111 11
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
.+.. +... ....+.++.+++.+||..||++|||+.|+++.|+.+....
T Consensus 257 ~~~~-----~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 257 TGMK-----PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TTCC-----CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCC-----CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 1111 1123345889999999999999999999999999987653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.13 Aligned_cols=263 Identities=21% Similarity=0.240 Sum_probs=201.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc--------CCCccceeeEEE--
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR--------HPNLISLEGYYW-- 622 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~-- 622 (843)
.+.|+..+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 356778889999999999999998899999999985432 23467889999999996 788999999987
Q ss_pred --cCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC----
Q 003156 623 --TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY---- 696 (843)
Q Consensus 623 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---- 696 (843)
.....++||||+ +|++.+++... ....+++..+..++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 455789999999 66777776654 2346899999999999999999999864 899999999999999775
Q ss_pred ---------------------------------------------CcEEeeccCcccccccccceeccccccccccCCcc
Q 003156 697 ---------------------------------------------NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731 (843)
Q Consensus 697 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE 731 (843)
.+||+|||+++..... .....||..|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 8999999999866432 13457899999999
Q ss_pred cccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch-----hhHHHHHHHH-------HhhCC-cccccCCC------
Q 003156 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV-----VILSEHVRVL-------LEEGN-VLDCVDPS------ 792 (843)
Q Consensus 732 ~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~-----~~l~~~~~~~-------~~~~~-~~~~~d~~------ 792 (843)
++ .+..++.++|||||||++|||+||+.||....... ..+....+.. +..+. ....+...
T Consensus 264 ~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 264 VL-IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HH-HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hh-cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 88 45568999999999999999999999997543221 1111111100 00000 00000000
Q ss_pred --------------CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 --------------MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 --------------l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
....+......+.+++.+||+.||++|||++|++++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012345667789999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=338.41 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=201.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-----ChHHHHHHHHHHHhcc--CCCccceeeEEEcCC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-----YPEDFEREVRVLGKAR--HPNLISLEGYYWTPQ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~ 625 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||.+....... ..+.+.+|+.++++++ ||||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 345777889999999999999998899999999996553221 2345778999999996 599999999999999
Q ss_pred eeEEEEEeCCC-CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeec
Q 003156 626 LKLLVSDYAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDF 703 (843)
Q Consensus 626 ~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df 703 (843)
..++|+||+.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999976 8999999875 4689999999999999999999998 999999999999999 7899999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
|+++...... .....||..|+|||++......+.++|||||||++|||++|+.||.... . ... +
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~----~~~-~ 258 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E----IIR-G 258 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HHH-C
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------h----hhc-c
Confidence 9998765322 1345689999999988444445788999999999999999999996421 0 011 1
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. .++.....++.+++.+||+.||++|||++|++++
T Consensus 259 ~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 QV---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc---------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 1223345678899999999999999999999885
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.83 Aligned_cols=259 Identities=21% Similarity=0.259 Sum_probs=198.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCe------
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------ 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 626 (843)
..|+..+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 3466677899999999999999889999999998654322 224578899999999999999999999987654
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 688776643 389999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh----
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE---- 782 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~---- 782 (843)
+..... .....+|..|+|||++.....++.++|||||||++|||++|+.||..... ...+....+.....
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-HHHHHHHHHHHCBCCHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence 865421 13456789999999885556789999999999999999999999975432 11222211110000
Q ss_pred -------------CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 -------------GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 -------------~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........+............+.+++.+|++.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000001111222334556788999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.48 Aligned_cols=256 Identities=18% Similarity=0.268 Sum_probs=175.7
Q ss_pred hhhhhhhc-CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc----CCe
Q 003156 552 PETLLEKA-AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT----PQL 626 (843)
Q Consensus 552 ~~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~ 626 (843)
..+.|+.. +.||+|+||.||+|.+..+|+.||||++... .....+....++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 34456663 4699999999999999989999999998542 2222333344566799999999999976 345
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeec
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDF 703 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Df 703 (843)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 789999999999999998752 34699999999999999999999999 9999999999999985 455999999
Q ss_pred cCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC
Q 003156 704 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 783 (843)
Q Consensus 704 gl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 783 (843)
|+++...... .....+|+.|+|||++ ....++.++|||||||++|||++|+.||......... ......+..+
T Consensus 176 g~~~~~~~~~----~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~ 248 (336)
T 3fhr_A 176 GFAKETTQNA----LQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRLG 248 (336)
T ss_dssp TTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccceeccccc----cccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhcc
Confidence 9998654322 1345678999999988 5567889999999999999999999999654322110 0000000000
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 784 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 784 ~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.. ... ..........+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~-~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 249 QY-GFP----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---CCC----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cc-ccC----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 000 011234556788999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.79 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=182.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHH-HHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR-VLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||++...........+..|+. +++.++||||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 446677799999999999999988999999999976543333445666666 6777799999999999999999999999
Q ss_pred eCCCCCHHHHHhhcC-CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 633 YAPNGSLQAKLHERL-PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9975 8888776421 12456899999999999999999999852 799999999999999999999999999987643
Q ss_pred cccceeccccccccccCCccccc---CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTC---QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
... .....||..|+|||++. ....++.++|||||||++|||++|+.||.........+ ......
T Consensus 179 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~ 245 (327)
T 3aln_A 179 SIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----------TQVVKG 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCCCS
T ss_pred ccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----------HHHhcC
Confidence 221 13346889999999873 34468899999999999999999999997532211000 011111
Q ss_pred cCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..+.+.. ........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1111111 223456678999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.44 Aligned_cols=255 Identities=19% Similarity=0.316 Sum_probs=196.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhcc--CCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKAR--HPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV 630 (843)
..|+..+.||+|+||.||+|.+. +++.||||.+...... ...+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 44677789999999999999986 6899999998654322 23467899999999997 59999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|| +.+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+|||+++...
T Consensus 107 ~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred Ee-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 99 5688999999875 4689999999999999999999998 9999999999999975 899999999998765
Q ss_pred ccccceeccccccccccCCcccccC----------cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQ----------SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~ 780 (843)
............|+..|+|||.+.. ...++.++|||||||++|||++|+.||.........+ ....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~----~~~~ 253 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAII 253 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----HHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH----HHHH
Confidence 4433333345578999999998743 1467889999999999999999999997543322111 1111
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~ 830 (843)
..... ..++.....++.+++.+||+.||++|||+.|++++-.
T Consensus 254 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 254 DPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp CTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hcccc--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 11110 1123334567889999999999999999999998743
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=353.53 Aligned_cols=335 Identities=18% Similarity=0.166 Sum_probs=266.3
Q ss_pred CccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEE
Q 003156 78 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 157 (843)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 157 (843)
+.+++.|++++|.+...++..|..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56677777777777766666677777777777777777777777777777777777777777777777777777777777
Q ss_pred eecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceec
Q 003156 158 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGS 237 (843)
Q Consensus 158 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~ 237 (843)
|++|++++..+..|+++++|++|+|++|.+++..|..|..+++|+.|+|++|.+++. +.. ...+|+.|++++|.+.+.
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~-~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLS-LIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-CGG-GCTTCSEEECCSSCCSEE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-Chh-hhhhhhhhhcccCccccc
Confidence 777777765555667777788888877777777777777777788888887777743 211 112577778887777643
Q ss_pred CCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCC
Q 003156 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317 (843)
Q Consensus 238 ~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 317 (843)
. ...+|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|
T Consensus 208 ~-----------~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~ 271 (597)
T 3oja_B 208 A-----------IPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMY 271 (597)
T ss_dssp E-----------CCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEES
T ss_pred c-----------CCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCH
Confidence 1 2357999999999998554432 3689999999999986 4678899999999999999999999
Q ss_pred ccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccc
Q 003156 318 QEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLAS 397 (843)
Q Consensus 318 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 397 (843)
..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|+|++|+|++. | +..+++
T Consensus 272 ~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~ 346 (597)
T 3oja_B 272 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHT 346 (597)
T ss_dssp GGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCC
T ss_pred HHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCC
Confidence 999999999999999999995 6777888999999999999999 6888899999999999999999855 3 667889
Q ss_pred cceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCCC
Q 003156 398 LLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPL 436 (843)
Q Consensus 398 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 436 (843)
|+.|++++|++++..+ ...+..+....+.++...|+.+
T Consensus 347 L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 347 LKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCTT
T ss_pred CCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCCcc
Confidence 9999999999998754 3456777778889999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.77 Aligned_cols=265 Identities=19% Similarity=0.262 Sum_probs=194.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEE----------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW---------- 622 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------- 622 (843)
.+.|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 345677789999999999999998889999999986543 233567889999999999999999999874
Q ss_pred ----cCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCC
Q 003156 623 ----TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYN 697 (843)
Q Consensus 623 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~ 697 (843)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3357799999997 699999865 3588999999999999999999998 999999999999997 6779
Q ss_pred cEEeeccCccccccccc-ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHH
Q 003156 698 PRISDFGLARLLTRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 776 (843)
Q Consensus 698 ~kl~Dfgl~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~ 776 (843)
+||+|||+++....... ........++..|+|||.+.....++.++|||||||++|||++|+.||..... ...+....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~ 238 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLIL 238 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 99999999987643211 11123445688899999875656789999999999999999999999975432 11111111
Q ss_pred HH-----------HHhhCCc---ccccCCCC--CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 777 RV-----------LLEEGNV---LDCVDPSM--GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 777 ~~-----------~~~~~~~---~~~~d~~l--~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ....-.. .....+.. .........++.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 10 0000000 00000000 01123345678999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=332.07 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=204.2
Q ss_pred hhhhhcCeeccccceEEEEEEE-CCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCC------ccceeeEEEcCCe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSF-GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN------LISLEGYYWTPQL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~ 626 (843)
+.|+..+.||+|+||.||+|.+ ..+++.||||.+.... ...+.+.+|+++++.++|++ ++++++++...+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 4577788999999999999998 5578999999985432 23467889999999997654 9999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC------------
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD------------ 694 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~------------ 694 (843)
.++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 899999998752 34688999999999999999999998 9999999999999987
Q ss_pred -------CCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCC
Q 003156 695 -------NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 767 (843)
Q Consensus 695 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~ 767 (843)
++.+||+|||+++..... .....||..|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVI-LALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHh-hCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 678999999999864432 1345789999999988 556789999999999999999999999975422
Q ss_pred chhhHHHHHHHHHhh--------CCccccc---------------------CC--CCCCCChhhHHHHHHHHHHccCCCC
Q 003156 768 NVVILSEHVRVLLEE--------GNVLDCV---------------------DP--SMGDYPEDEVLPVLKLALVCTCHIP 816 (843)
Q Consensus 768 ~~~~l~~~~~~~~~~--------~~~~~~~---------------------d~--~l~~~~~~~~~~l~~l~~~c~~~~P 816 (843)
..... .+...... ....... .+ ...........++.+++.+||+.||
T Consensus 240 -~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 240 -KEHLA-MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp -HHHHH-HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred -HHHHH-HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 11111 11111110 0000000 00 0001234556789999999999999
Q ss_pred CCCCCHHHHHHH--HHhcc
Q 003156 817 SSRPSMAEVVQI--LQVIK 833 (843)
Q Consensus 817 ~~RPs~~evl~~--L~~~~ 833 (843)
++|||++|++++ ++.++
T Consensus 318 ~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 318 AKRITLREALKHPFFDLLK 336 (339)
T ss_dssp TTSCCHHHHTTSGGGGGGG
T ss_pred ccccCHHHHhcCHHHHHHh
Confidence 999999999976 44443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=335.02 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=194.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-----ChHHHHHHHHHHHhc----cCCCccceeeEEEc
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-----YPEDFEREVRVLGKA----RHPNLISLEGYYWT 623 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l----~h~niv~l~g~~~~ 623 (843)
.+.|+..+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+.+++++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 345677889999999999999998899999999986543221 223456799999999 89999999999999
Q ss_pred CCeeEEEEEe-CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEe
Q 003156 624 PQLKLLVSDY-APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRIS 701 (843)
Q Consensus 624 ~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 701 (843)
.+..++|+|| +++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++ .++.+||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 8999999999 7899999999875 3589999999999999999999999 999999999999999 88999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
|||+++....... ....|+..|+|||++......+.++|||||||++|||++|+.||.... . ...
T Consensus 183 dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~----~~~ 247 (312)
T 2iwi_A 183 DFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------E----ILE 247 (312)
T ss_dssp CCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HHH
T ss_pred EcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------H----Hhh
Confidence 9999987654221 345688999999987444444568999999999999999999996321 0 011
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ..++.....++.+++.+||+.||++|||++|++++
T Consensus 248 -~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 -AE---------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -TC---------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hc---------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 11234455678899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=328.98 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=182.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChH-HHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE-DFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||.+.......... .+.++..+++.++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 44667779999999999999998889999999997654332223 34455566788899999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhh-cCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|+ ++.+..+.... ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 45555555443 3468999999999999999999998 5 899999999999999999999999999976543
Q ss_pred cccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 712 LDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
... .....++..|+|||++. ....++.++|||||||++|||++|+.||.........+. .......
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~--- 247 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT----KVLQEEP--- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----HHHHSCC---
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH----HHhccCC---
Confidence 221 23456889999999874 244678999999999999999999999976433322222 1122111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+..+ .......++.+++.+||+.||++|||++|++++
T Consensus 248 ---~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 ---PLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ---CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---CCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 112345578899999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=342.85 Aligned_cols=258 Identities=25% Similarity=0.296 Sum_probs=189.9
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 629 (843)
...+.+...+.||+|+||+||.+... +|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 34455556678999999999865443 79999999986432 45678999999987 89999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCC---CChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCC-----------
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN----------- 695 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----------- 695 (843)
||||++ |+|.+++......... .++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999995 6999999875322221 24456788999999999999998 99999999999999754
Q ss_pred --CCcEEeeccCcccccccccce--eccccccccccCCcccccC------cCCCCCchhHHHHHHHHHHHHh-CCCCCcC
Q 003156 696 --YNPRISDFGLARLLTRLDKHV--MSNRFQSALGYVAPELTCQ------SLRVNEKCDIYGFGVLILELVT-GRRPVEY 764 (843)
Q Consensus 696 --~~~kl~Dfgl~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~ 764 (843)
+.+||+|||+++.+....... ......||+.|+|||++.. ...++.++|||||||++|||+| |+.||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 479999999998765432211 1234578999999998843 2568999999999999999999 9999965
Q ss_pred CCCchhhHHHHHHHHHhhCCcccccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 765 GEDNVVILSEHVRVLLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 765 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...... . ........ +.... .......++.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~---~----i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 243 KYSRES---N----IIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTTHHH---H----HHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhHH---H----HhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 432211 1 11111100 11111 234566789999999999999999999999864
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=330.85 Aligned_cols=346 Identities=30% Similarity=0.352 Sum_probs=248.1
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
++++|++++|+++ .+|.. .++|++|++++|.+++++. .+++|++|++++|++++.+.. .++|+
T Consensus 72 ~l~~L~l~~~~l~-~lp~~----~~~L~~L~l~~n~l~~lp~----~~~~L~~L~l~~n~l~~l~~~--------~~~L~ 134 (454)
T 1jl5_A 72 QAHELELNNLGLS-SLPEL----PPHLESLVASCNSLTELPE----LPQSLKSLLVDNNNLKALSDL--------PPLLE 134 (454)
T ss_dssp TCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCCCSC--------CTTCC
T ss_pred CCCEEEecCCccc-cCCCC----cCCCCEEEccCCcCCcccc----ccCCCcEEECCCCccCcccCC--------CCCCC
Confidence 4688888888888 56642 4788899999998888664 247899999999988854321 26899
Q ss_pred EEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 162 (843)
+|++++|++++ +| .|..+++|++|++++|++++ +|..+ ++|++|++++|++++ +| .|..+++|++|++++|+
T Consensus 135 ~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~ 206 (454)
T 1jl5_A 135 YLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNS 206 (454)
T ss_dssp EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSC
T ss_pred EEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCc
Confidence 99999999985 66 58999999999999999985 45433 589999999999986 45 58899999999999999
Q ss_pred ccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCC
Q 003156 163 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 242 (843)
Q Consensus 163 l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~ 242 (843)
+++ +|... ++|++|++++|.++ .+| .+..+++|+.|++++|.+++ +|... .+|+.|++++|++.+ +|..
T Consensus 207 l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~N~l~~-l~~~- 275 (454)
T 1jl5_A 207 LKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLP--PSLEALNVRDNYLTD-LPEL- 275 (454)
T ss_dssp CSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSCC--TTCCEEECCSSCCSC-CCCC-
T ss_pred CCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccccc--cccCEEECCCCcccc-cCcc-
Confidence 985 55433 58999999999998 567 48899999999999999984 55532 479999999999875 4432
Q ss_pred CCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccc
Q 003156 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCE 322 (843)
Q Consensus 243 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 322 (843)
+++|+.|++++|++++. |.. .++|++|++++|+++++. . ..++|++|++++|++++ +|..
T Consensus 276 --------~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~-~---~~~~L~~L~Ls~N~l~~-lp~~--- 335 (454)
T 1jl5_A 276 --------PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLC-D---LPPSLEELNVSNNKLIE-LPAL--- 335 (454)
T ss_dssp --------CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEEC-C---CCTTCCEEECCSSCCSC-CCCC---
T ss_pred --------cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCccc-C---CcCcCCEEECCCCcccc-cccc---
Confidence 36899999999999863 322 268999999999998632 1 12589999999999996 6654
Q ss_pred cCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccc--cCCccccCC-------------CCCCEEEccCCcccc-
Q 003156 323 SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG--SIPKSISNL-------------NKLKILKLEFNELSG- 386 (843)
Q Consensus 323 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l-------------~~L~~L~L~~N~l~~- 386 (843)
+++|+.|++++|+++ .+|. .+++|+.|++++|++++ .+|.++..| ++|+.|++++|++++
T Consensus 336 ~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~ 411 (454)
T 1jl5_A 336 PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREF 411 (454)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-------------------------
T ss_pred CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCcc
Confidence 589999999999999 4666 57999999999999998 789999888 899999999999997
Q ss_pred -cCCcchhcccccceEeeccccceecCCC
Q 003156 387 -EIPQELGKLASLLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 387 -~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 414 (843)
.+|.. ++.|.+.+|.+.+.+|.
T Consensus 412 ~~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 412 PDIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp -----------------------------
T ss_pred ccchhh------HhheeCcCcccCCcccc
Confidence 66654 55667888888877663
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=336.25 Aligned_cols=200 Identities=23% Similarity=0.285 Sum_probs=169.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CC-----CccceeeEEEcCCee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HP-----NLISLEGYYWTPQLK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~ 627 (843)
+.|+..+.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.++ |+ +|+++++++...+..
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 45777889999999999999998899999999986432 23456778999998885 55 399999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc--CCCCcEEeeccC
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGL 705 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl 705 (843)
++||||++ |+|.+++.... ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999996 59999998752 24589999999999999999999952 23899999999999995 578899999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCC
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 765 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~ 765 (843)
++..... .....||+.|+|||++ .+..++.++|||||||++|||+||+.||...
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc-----cccccCCccccChHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 1345788999999988 5557899999999999999999999999754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=329.54 Aligned_cols=311 Identities=22% Similarity=0.200 Sum_probs=223.5
Q ss_pred CCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCC
Q 003156 26 CASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYL 105 (843)
Q Consensus 26 l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 105 (843)
+++++.|++++|.+..++...|..+++|++|+|++|.+++.++ ..|..+++|++|+|++|.+.+..|..|..+++|
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 119 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDT----YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 119 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECT----TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccCh----hhccCCCCcCEEECCCCCCCcCCHHHhcCCCCC
Confidence 4666777777777776666666667777777777776664322 245566666777777666666666666666666
Q ss_pred CEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccC
Q 003156 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 185 (843)
Q Consensus 106 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 185 (843)
++|+|++|+++...+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++. .+..+++|+.|++++|
T Consensus 120 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 120 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYN 196 (390)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSS
T ss_pred CEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccc
Confidence 6666666666644444456666666666666666665556666666666666666666532 1445556666666666
Q ss_pred CcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccc
Q 003156 186 HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV 265 (843)
Q Consensus 186 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~ 265 (843)
.+++ +...++|+.|++++|.+. .. |. ..+++|+.|++++|.++
T Consensus 197 ~l~~-----~~~~~~L~~L~l~~n~l~-----------------------~~-~~--------~~~~~L~~L~l~~n~l~ 239 (390)
T 3o6n_A 197 LLST-----LAIPIAVEELDASHNSIN-----------------------VV-RG--------PVNVELTILKLQHNNLT 239 (390)
T ss_dssp CCSE-----EECCSSCSEEECCSSCCC-----------------------EE-EC--------CCCSSCCEEECCSSCCC
T ss_pred cccc-----cCCCCcceEEECCCCeee-----------------------ec-cc--------cccccccEEECCCCCCc
Confidence 5552 122234555555555554 22 11 11467999999999998
Q ss_pred eeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhc
Q 003156 266 GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR 345 (843)
Q Consensus 266 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 345 (843)
+. ..+..+++|++|++++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+.
T Consensus 240 ~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~ 315 (390)
T 3o6n_A 240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP 315 (390)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHH
T ss_pred cc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcccc
Confidence 53 578889999999999999998888899999999999999999984 5667788999999999999999 6777899
Q ss_pred ccCCCcEEecccccccccCCccccCCCCCCEEEccCCccccc
Q 003156 346 NCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 387 (843)
Q Consensus 346 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 387 (843)
.+++|+.|+|++|+++. +| +..+++|+.|+|++|+++..
T Consensus 316 ~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 316 QFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp HHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHH
T ss_pred ccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccch
Confidence 99999999999999984 44 77899999999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.94 Aligned_cols=340 Identities=20% Similarity=0.157 Sum_probs=266.2
Q ss_pred hhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhc
Q 003156 22 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA 101 (843)
Q Consensus 22 ~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 101 (843)
.+.++++|++|++++|.|.+++ .|..+++|++|+|++|++++. .+..+++|++|+|++|++++. + +..
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~~--~l~~l~~L~~L~Ls~n~l~~~-------~~~~l~~L~~L~Ls~N~l~~~-~--~~~ 104 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDMT--GIEKLTGLTKLICTSNNITTL-------DLSQNTNLTYLACDSNKLTNL-D--VTP 104 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCCT--TGGGCTTCSEEECCSSCCSCC-------CCTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred ChhHcCCCCEEEccCCCcccCh--hhcccCCCCEEEccCCcCCeE-------ccccCCCCCEEECcCCCCcee-e--cCC
Confidence 4678899999999999999875 488999999999999998864 267889999999999999864 3 889
Q ss_pred CCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEE
Q 003156 102 LHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181 (843)
Q Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 181 (843)
+++|++|+|++|++++. + ++.+++|++|++++|++++. .++.+++|++|++++|+..+.+ .++.+++|++|+
T Consensus 105 l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp CTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 99999999999999864 3 88999999999999999874 3788999999999999655555 478899999999
Q ss_pred cccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCC
Q 003156 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260 (843)
Q Consensus 182 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~ 260 (843)
+++|++++ +| +..+++|+.|++++|.+++. + +... +|+.|++++|++.+ +| ...+++|+.|+++
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l~~l~~L~~L~Ls~N~l~~-ip--------~~~l~~L~~L~l~ 241 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--LNQNIQLTFLDCSSNKLTE-ID--------VTPLTQLTYFDCS 241 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--------CTTCTTCSEEECC
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCee-c--cccCCCCCEEECcCCcccc-cC--------ccccCCCCEEEee
Confidence 99999986 44 88889999999999999853 2 3332 57777777777765 33 2235677777777
Q ss_pred CCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCc
Q 003156 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI 340 (843)
Q Consensus 261 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 340 (843)
+|++++.. ++.+++|+.|++++|. |+.|++++|.+.+.+| +..+++|+.|++++|...+.+
T Consensus 242 ~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l 302 (457)
T 3bz5_A 242 VNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLL 302 (457)
T ss_dssp SSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEE
T ss_pred CCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCccccee
Confidence 77777542 3456667777766653 4567888888877776 567899999999999877766
Q ss_pred hh--------hhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecC
Q 003156 341 PQ--------VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 341 p~--------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
|. .+.++++|+.|+|++|+|++ ++ ++++++|+.|++++|+|++ ++.|..|++++|.++|.
T Consensus 303 ~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~- 370 (457)
T 3bz5_A 303 DCQAAGITELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE- 370 (457)
T ss_dssp ECTTCCCSCCCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-
T ss_pred ccCCCcceEechhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-
Confidence 64 25667889999999999997 33 8889999999999999986 24667778999999887
Q ss_pred CCCCCCCCCCCCCcCCCC
Q 003156 413 PVGGVFPTLDQSSLQGNL 430 (843)
Q Consensus 413 p~~~~~~~~~~~~~~~n~ 430 (843)
| .+..++...+..|.
T Consensus 371 ~---~~~~l~~l~l~~N~ 385 (457)
T 3bz5_A 371 G---QTITMPKETLTNNS 385 (457)
T ss_dssp E---EEEECCCBCCBTTB
T ss_pred c---eeeecCccccccCc
Confidence 2 33445555555554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=336.58 Aligned_cols=262 Identities=19% Similarity=0.235 Sum_probs=199.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-----------CCCccceeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----------HPNLISLEGYYW 622 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~ 622 (843)
..|+..+.||+|+||.||+|.+..+++.||||.+.... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 45777889999999999999998899999999985332 23467889999999886 899999999997
Q ss_pred cCC----eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-----
Q 003156 623 TPQ----LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD----- 693 (843)
Q Consensus 623 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~----- 693 (843)
..+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 644 678999999 899999998752 345899999999999999999999853 899999999999994
Q ss_pred -CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc----
Q 003156 694 -DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN---- 768 (843)
Q Consensus 694 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~---- 768 (843)
..+.+||+|||+++..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHH-HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHH-hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4457999999999866432 1344789999999988 4556899999999999999999999999754221
Q ss_pred -hhhHHHHHHHHH-------hhCC----------cccccCC-----------CCCCCChhhHHHHHHHHHHccCCCCCCC
Q 003156 769 -VVILSEHVRVLL-------EEGN----------VLDCVDP-----------SMGDYPEDEVLPVLKLALVCTCHIPSSR 819 (843)
Q Consensus 769 -~~~l~~~~~~~~-------~~~~----------~~~~~d~-----------~l~~~~~~~~~~l~~l~~~c~~~~P~~R 819 (843)
...+.......- ..+. ....+.. ....++.....++.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111111111100 0000 0000000 0012456777889999999999999999
Q ss_pred CCHHHHHHH
Q 003156 820 PSMAEVVQI 828 (843)
Q Consensus 820 Ps~~evl~~ 828 (843)
||++|++++
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=326.84 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=199.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCC-eEEEEEEeecCCcccChHHHHHHHHHHHhccCCC------ccceeeEEEcCC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN------LISLEGYYWTPQ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~ 625 (843)
.+.|+..+.||+|+||.||+|.+..++ +.||+|.+.... ...+.+.+|+.++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 355777889999999999999997666 789999985432 23467889999999998766 899999999999
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE-------------
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL------------- 692 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill------------- 692 (843)
..++||||+ +|++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 677878777642 34689999999999999999999998 99999999999999
Q ss_pred ------cCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCC
Q 003156 693 ------DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 766 (843)
Q Consensus 693 ------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~ 766 (843)
+.++.+||+|||+++...... ....||..|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVI-LELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeee-ecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 568899999999998643321 345789999999988 55678999999999999999999999997543
Q ss_pred CchhhHHHHHHHHHhh--------CCccccc-C-----C-----------------CCCCCChhhHHHHHHHHHHccCCC
Q 003156 767 DNVVILSEHVRVLLEE--------GNVLDCV-D-----P-----------------SMGDYPEDEVLPVLKLALVCTCHI 815 (843)
Q Consensus 767 ~~~~~l~~~~~~~~~~--------~~~~~~~-d-----~-----------------~l~~~~~~~~~~l~~l~~~c~~~~ 815 (843)
.. ..+. .+...... ....... . + ...........++.+++.+||+.|
T Consensus 244 ~~-~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 244 NR-EHLV-MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp HH-HHHH-HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred HH-HHHH-HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 21 1111 11111100 0000000 0 0 000112344567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 003156 816 PSSRPSMAEVVQI 828 (843)
Q Consensus 816 P~~RPs~~evl~~ 828 (843)
|++|||++|++++
T Consensus 322 P~~Rpt~~e~l~h 334 (355)
T 2eu9_A 322 PAQRITLAEALLH 334 (355)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.91 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=185.6
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|+..+.||+|+||+||.... .+|+.||||++..... ..+.+|+++++++ +|||||++++++.+....++||||
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 355667899999999654333 3789999999854332 3356899999999 799999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-----CCCcEEeeccCccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-----NYNPRISDFGLARL 708 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~~ 708 (843)
++ |+|.+++.... ....+..++.++.|+++||+|||+. +|+||||||+||+++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 69999998752 3355566789999999999999998 9999999999999953 34688999999987
Q ss_pred cccccc-ceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 709 LTRLDK-HVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 709 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
...... ........||+.|+|||++.. ...++.++|||||||++|||++ |..||....... .... ....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------~~~~-~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------ANIL-LGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------HHHH-TTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------HHHH-hccC
Confidence 654321 122245678999999998843 4567889999999999999999 999986432211 1111 1111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.... ..........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 SLDC-----LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCTT-----SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Cccc-----cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111 11233445567899999999999999999999853
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=350.77 Aligned_cols=271 Identities=25% Similarity=0.294 Sum_probs=203.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc------CCee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT------PQLK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 627 (843)
+.|+..+.||+|+||.||+|.+..+|+.||||++.........+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5577888999999999999999888999999998654433445678999999999999999999998765 5667
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC---cEEeecc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFG 704 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 704 (843)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999998753 234689999999999999999999998 9999999999999997665 9999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHH-HHHhhC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR-VLLEEG 783 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~-~~~~~~ 783 (843)
+++....... .....||..|+|||.+ .+..++.++|||||||++|||++|+.||........ +...+. ......
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-WHGKVREKSNEHI 244 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSS-CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-SSTTCC------C
T ss_pred cccccccccc---cccccCCcccCChHHh-ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-hhhhhhcccchhh
Confidence 9987654322 2446789999999988 566789999999999999999999999965321100 000000 000000
Q ss_pred Cccccc------C---CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHHhcc
Q 003156 784 NVLDCV------D---PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAE-----VVQILQVIK 833 (843)
Q Consensus 784 ~~~~~~------d---~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~e-----vl~~L~~~~ 833 (843)
...+.. . +............+.+++.+|+..||++|||++| +.+.++.+.
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 000000 0 1111244567888999999999999999999988 445555543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=317.03 Aligned_cols=307 Identities=21% Similarity=0.315 Sum_probs=216.4
Q ss_pred hhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcC
Q 003156 23 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL 102 (843)
Q Consensus 23 f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 102 (843)
+..+++|++|++++|.+..++. |..+++|++|+|++|++++.+. +..+++|++|++++|.++. + ..|..+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~~~--~~~~~~L~~L~l~~n~i~~~~~------~~~l~~L~~L~L~~n~i~~-~-~~~~~l 109 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASIQG--IEYLTNLEYLNLNGNQITDISP------LSNLVKLTNLYIGTNKITD-I-SALQNL 109 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG------GTTCTTCCEEECCSSCCCC-C-GGGTTC
T ss_pred chhcccccEEEEeCCccccchh--hhhcCCccEEEccCCccccchh------hhcCCcCCEEEccCCcccC-c-hHHcCC
Confidence 5678899999999999988764 8889999999999998885432 7788999999999999985 3 368999
Q ss_pred CCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEc
Q 003156 103 HYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182 (843)
Q Consensus 103 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 182 (843)
++|++|+|++|.+++..+ +..+++|++|++++|..... ...+..+++|++|++++|.+.+..+ +..+++|++|++
T Consensus 110 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l 184 (347)
T 4fmz_A 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEEC
T ss_pred CcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEc
Confidence 999999999999985543 88899999999999966543 3448899999999999999885544 889999999999
Q ss_pred ccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCC
Q 003156 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 262 (843)
Q Consensus 183 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n 262 (843)
++|.+++. +. +..+++|+.|++++|.+.+..+ + ..+++|++|++++|
T Consensus 185 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~-----------------------------~~~~~L~~L~l~~n 231 (347)
T 4fmz_A 185 NYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--V-----------------------------ANMTRLNSLKIGNN 231 (347)
T ss_dssp TTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--G-----------------------------GGCTTCCEEECCSS
T ss_pred cCCccccc-cc-ccCCCccceeecccCCCCCCch--h-----------------------------hcCCcCCEEEccCC
Confidence 99999854 33 7888889999988888873221 1 22456777777777
Q ss_pred ccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchh
Q 003156 263 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ 342 (843)
Q Consensus 263 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 342 (843)
.+++..+ +..+++|++|++++|.+++. ..+..+++|++|++++|++++. ..+..+++|+.|++++|.+++..|.
T Consensus 232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 232 KITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred ccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 7764333 66667777777777766543 3455555555555555555532 2345555555555555555555555
Q ss_pred hhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 343 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 343 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
.|.++++|+.|+|++|++++..| +..+++|++|++++|+|+
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 55555555555555555554333 455555555555555543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.77 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=194.4
Q ss_pred CCcEEEeecCcccc--cCCCCccCCCCccEEEccc-CCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceee
Q 003156 152 SMIFISVSNNTLTG--DIPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEID 228 (843)
Q Consensus 152 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~ 228 (843)
+++.|+|++|++.+ .+|..|+++++|++|+|++ |.+.+.+|..|.++++|++|+|++|.+++.+|..+.
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-------- 122 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-------- 122 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG--------
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHh--------
Confidence 34444444444444 4445555555555555552 555555555555555555555555555544443332
Q ss_pred ccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccc-cceEEEc
Q 003156 229 LSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH-SLIHLDL 307 (843)
Q Consensus 229 l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L 307 (843)
.+++|++|+|++|.+++.+|..+..+++|++|++++|++++..|..+..+. +|++|++
T Consensus 123 ---------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L 181 (313)
T 1ogq_A 123 ---------------------QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181 (313)
T ss_dssp ---------------------GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred ---------------------CCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEEC
Confidence 235566666666666666666677777777777777777766777777776 7888888
Q ss_pred cCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccccc
Q 003156 308 RNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 387 (843)
Q Consensus 308 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 387 (843)
++|++++.+|..+..++ |+.|++++|.+++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.
T Consensus 182 ~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~ 259 (313)
T 1ogq_A 182 SRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp CSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEEC
T ss_pred cCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCc
Confidence 88888888888888887 99999999999888899999999999999999999976665 88899999999999999999
Q ss_pred CCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCCCCCCCC
Q 003156 388 IPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 441 (843)
Q Consensus 388 ~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c 441 (843)
+|..+..+++|+.|++++|+++|.+|..+.++++....+.||+++||.|+. .|
T Consensus 260 ~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 999999999999999999999999999888999999999999999998875 56
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=315.98 Aligned_cols=318 Identities=20% Similarity=0.287 Sum_probs=269.4
Q ss_pred ccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCC
Q 003156 34 LAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGN 113 (843)
Q Consensus 34 L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 113 (843)
+..+.+.++. .+..+++|++|++++|.+...+ .+..+++|++|++++|++++..+ +..+++|++|+|++|
T Consensus 29 ~~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~~------~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n 98 (347)
T 4fmz_A 29 LQKASVTDVV--TQEELESITKLVVAGEKVASIQ------GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTN 98 (347)
T ss_dssp HTCSCTTSEE--CHHHHTTCSEEECCSSCCCCCT------TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred ccccccCCcc--cchhcccccEEEEeCCccccch------hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCC
Confidence 3444444333 3567899999999999988542 37789999999999999985443 999999999999999
Q ss_pred cccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCC
Q 003156 114 QFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPS 193 (843)
Q Consensus 114 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~ 193 (843)
.+++. + .+..+++|++|++++|.+++..+ +..+++|+.|++++|......+ .+..+++|++|++++|.+.+..+
T Consensus 99 ~i~~~-~-~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~- 172 (347)
T 4fmz_A 99 KITDI-S-ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP- 172 (347)
T ss_dssp CCCCC-G-GGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG-
T ss_pred cccCc-h-HHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh-
Confidence 99853 3 59999999999999999996544 8899999999999997664444 48999999999999999985433
Q ss_pred CCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCcccc
Q 003156 194 SLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 273 (843)
Q Consensus 194 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 273 (843)
+..+++|+.|++++|.+.+ ++. ...+++|+.|++++|.+.+..+ +.
T Consensus 173 -~~~l~~L~~L~l~~n~l~~-~~~------------------------------~~~l~~L~~L~l~~n~l~~~~~--~~ 218 (347)
T 4fmz_A 173 -IANLTDLYSLSLNYNQIED-ISP------------------------------LASLTSLHYFTAYVNQITDITP--VA 218 (347)
T ss_dssp -GGGCTTCSEEECTTSCCCC-CGG------------------------------GGGCTTCCEEECCSSCCCCCGG--GG
T ss_pred -hccCCCCCEEEccCCcccc-ccc------------------------------ccCCCccceeecccCCCCCCch--hh
Confidence 8899999999999999873 221 1236789999999999985544 88
Q ss_pred CCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEE
Q 003156 274 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 353 (843)
Q Consensus 274 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 353 (843)
.+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|.+++. ..+..+++|+.|
T Consensus 219 ~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L 292 (347)
T 4fmz_A 219 NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL 292 (347)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEE
Confidence 99999999999999987654 88999999999999999853 5789999999999999999964 458999999999
Q ss_pred ecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccce
Q 003156 354 SLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 354 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 409 (843)
++++|++++..|..++.+++|++|+|++|++++..| +..+++|+.|++++|+++
T Consensus 293 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999998899999999999999999999997666 889999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.73 Aligned_cols=231 Identities=13% Similarity=0.071 Sum_probs=185.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|.+..+++.||||.+...... ...+.+.+|+..+++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 4467778999999999999999888999999999654322 22367899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++++|.++++.. ....++..++.|++.||+|||+. +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999642 35567889999999999999999 99999999999999999999998443
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
|++| ++.++|||||||++|||+||+.||.......... .....+..
T Consensus 175 ---------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------~~~~~~~~ 220 (286)
T 3uqc_A 175 ---------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------PAERDTAG 220 (286)
T ss_dssp ---------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------ECCBCTTS
T ss_pred ---------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------HHHHHhcc
Confidence 3332 5789999999999999999999997643211000 00000000
Q ss_pred CCC---CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 792 SMG---DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 792 ~l~---~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
... ......+.++.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000 1223455678999999999999999 999999999987653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=340.44 Aligned_cols=311 Identities=23% Similarity=0.217 Sum_probs=200.1
Q ss_pred CCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCC
Q 003156 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK 106 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 106 (843)
++++.|++++|.+..+++..|.++++|++|+|++|.|++.++ ..|..+++|++|+|++|.+++..|..|+.+++|+
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 126 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDT----YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 126 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECT----TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCCh----HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCC
Confidence 444555555555555555555555555555555555443221 1344445555555555555444444445555555
Q ss_pred EEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCC
Q 003156 107 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186 (843)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 186 (843)
+|+|++|.+++..+..|.++++|++|+|++|.+++..|..| +++++|++|+|++|.
T Consensus 127 ~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~------------------------~~l~~L~~L~L~~N~ 182 (597)
T 3oja_B 127 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF------------------------QATTSLQNLQLSSNR 182 (597)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT------------------------TTCTTCCEEECTTSC
T ss_pred EEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh------------------------hcCCcCcEEECcCCC
Confidence 55555555544333334445555555555555544444444 444444444444444
Q ss_pred cCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccce
Q 003156 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 266 (843)
Q Consensus 187 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~ 266 (843)
+++. .+..+++|+.|++++|.+++. + ...+|+.|++++|.+....+. ..++|+.|+|++|.+++
T Consensus 183 l~~~---~~~~l~~L~~L~l~~n~l~~l-~---~~~~L~~L~ls~n~l~~~~~~---------~~~~L~~L~L~~n~l~~ 246 (597)
T 3oja_B 183 LTHV---DLSLIPSLFHANVSYNLLSTL-A---IPIAVEELDASHNSINVVRGP---------VNVELTILKLQHNNLTD 246 (597)
T ss_dssp CSBC---CGGGCTTCSEEECCSSCCSEE-E---CCTTCSEEECCSSCCCEEECS---------CCSCCCEEECCSSCCCC
T ss_pred CCCc---ChhhhhhhhhhhcccCccccc-c---CCchhheeeccCCcccccccc---------cCCCCCEEECCCCCCCC
Confidence 4432 133344444555555444421 0 011355555555555432211 13579999999999985
Q ss_pred eCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcc
Q 003156 267 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN 346 (843)
Q Consensus 267 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 346 (843)
+..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..
T Consensus 247 --~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~ 322 (597)
T 3oja_B 247 --TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322 (597)
T ss_dssp --CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred --ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCccccc
Confidence 4778899999999999999999889999999999999999999995 5777788999999999999999 68888999
Q ss_pred cCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccC
Q 003156 347 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI 388 (843)
Q Consensus 347 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 388 (843)
+++|+.|+|++|.|++. | +..+++|+.|+|++|.+++..
T Consensus 323 l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 323 FDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp HTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred CCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChh
Confidence 99999999999999854 4 778899999999999998654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.90 Aligned_cols=223 Identities=20% Similarity=0.322 Sum_probs=178.8
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHH-HhccCCCccceeeEEEc----CCeeEEEEEeC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL-GKARHPNLISLEGYYWT----PQLKLLVSDYA 634 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lV~e~~ 634 (843)
+.||+|+||.||+|....+++.||+|.+.. ...+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 579999999999999988999999999853 24677899888 55589999999999876 56789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeeccCcccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLARLLTR 711 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl~~~~~~ 711 (843)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 98 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 9999999998752 34689999999999999999999998 9999999999999997 7899999999986432
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
+..++.++||||+||++|||++|+.||........ . ......+..
T Consensus 172 ------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~-~~~~~~~~~ 216 (299)
T 3m2w_A 172 ------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------S-PGMKTRIRM 216 (299)
T ss_dssp ------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCT
T ss_pred ------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------h-HHHHHHHhh
Confidence 12467899999999999999999999965322110 0 001111111
Q ss_pred CCCCCC----hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 003156 792 SMGDYP----EDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 829 (843)
Q Consensus 792 ~l~~~~----~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L 829 (843)
.....+ .....++.+++.+||+.||++|||+.|++++-
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 111122 33466789999999999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=348.64 Aligned_cols=240 Identities=19% Similarity=0.217 Sum_probs=190.7
Q ss_pred hhhhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCe-----e
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL-----K 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~ 627 (843)
+.|+..+.||+|+||.||+|.+.. +|+.||||++.........+.+.+|+.++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 457778899999999999999965 6899999998654433445678899999999999999999999987655 6
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||+++++|.+++.. .++|..++.++.|++.||.|||+. +|+||||||+||+++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999887654 589999999999999999999998 99999999999999985 89999999998
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
..... ....||++|+|||++.. .++.++|||||||++|||++|..||.......
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------ 283 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------ 283 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------
T ss_pred hcccC------CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCccccccc------------------
Confidence 65432 34578999999998733 34889999999999999999988875321100
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHhc
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-MAEVVQILQVI 832 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-~~evl~~L~~~ 832 (843)
+.. ..........+.+++.+||+.||++||+ ++++.+.+..+
T Consensus 284 -~~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 -LPE--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -CCT--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -ccc--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000 0001122356889999999999999995 55555555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=328.15 Aligned_cols=244 Identities=16% Similarity=0.083 Sum_probs=181.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccC-CCccce---------eeE---
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARH-PNLISL---------EGY--- 620 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~niv~l---------~g~--- 620 (843)
+...+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++| ++.... ...
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 45567899999999999999889999999998633322 235789999999999987 322111 111
Q ss_pred ---------EEc-----CCeeEEEEEeCCCCCHHHHHhhc---CCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeec
Q 003156 621 ---------YWT-----PQLKLLVSDYAPNGSLQAKLHER---LPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHY 683 (843)
Q Consensus 621 ---------~~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 683 (843)
+.. ....+++|+++ +|+|.+++... ......+++..++.++.|+++||+|||+. +|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 111 12346677765 68999988532 22345688899999999999999999998 99999
Q ss_pred CCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCccccc---------CcCCCCCchhHHHHHHHHHH
Q 003156 684 NLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC---------QSLRVNEKCDIYGFGVLILE 754 (843)
Q Consensus 684 dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---------~~~~~~~~~Dv~S~Gvil~e 754 (843)
||||+|||++.++.+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999865432 234566 8999999873 34457889999999999999
Q ss_pred HHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 755 LVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 755 lltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
|+||+.||....... .....+. . ....+.++.+++.+||+.||++|||+.|++++
T Consensus 310 lltg~~Pf~~~~~~~--------------~~~~~~~-~----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 310 IWCADLPNTDDAALG--------------GSEWIFR-S----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHSSCCCCTTGGGS--------------CSGGGGS-S----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCcchhh--------------hHHHHHh-h----cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999996532211 0001111 0 11234578899999999999999998877543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=303.64 Aligned_cols=130 Identities=18% Similarity=0.188 Sum_probs=65.9
Q ss_pred CCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecc
Q 003156 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 356 (843)
Q Consensus 277 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 356 (843)
+|++|++++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|+
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 272 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence 4444444444444444444444444444444444444444444555555555555555555 444455555555555555
Q ss_pred cccccccCCccccC------CCCCCEEEccCCccc--ccCCcchhcccccceEeecccc
Q 003156 357 HNHLSGSIPKSISN------LNKLKILKLEFNELS--GEIPQELGKLASLLAVNVSYNR 407 (843)
Q Consensus 357 ~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~l~ls~N~ 407 (843)
+|+|++..+..|.. ..+|+.|++++|.+. +..|..+..+++|+.+++++|+
T Consensus 273 ~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 273 TNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 55555444444433 245666666666665 4555666666666666666653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=300.52 Aligned_cols=295 Identities=21% Similarity=0.205 Sum_probs=147.3
Q ss_pred CCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcE
Q 003156 52 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTT 131 (843)
Q Consensus 52 ~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 131 (843)
+|+.++++++.++..+... .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|++
T Consensus 32 ~l~~l~~~~~~l~~lp~~~-------~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (330)
T 1xku_A 32 HLRVVQCSDLGLEKVPKDL-------PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 104 (330)
T ss_dssp ETTEEECTTSCCCSCCCSC-------CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCeEEEecCCCccccCccC-------CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCE
Confidence 4555555555555433211 134555555555555544445555555555555555555555555555555555
Q ss_pred EEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCC--CCCCCCCCCCCCcEEEecCC
Q 003156 132 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG--SLPSSLFNCKKLSVIRLRGN 209 (843)
Q Consensus 132 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N 209 (843)
|+|++|.++. +|..+. ++|++|++++|++.+..+..|.++++|++|++++|.++. ..+..+..+++|+.|++++|
T Consensus 105 L~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n 181 (330)
T 1xku_A 105 LYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181 (330)
T ss_dssp EECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred EECCCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence 5555555552 222221 455555555555554444445555555555555555532 34445555555555555555
Q ss_pred cCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCccc
Q 003156 210 SLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR 289 (843)
Q Consensus 210 ~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 289 (843)
.++ .+|..+ .++|++|++++|++++..|..+..+++|++|++++|.++
T Consensus 182 ~l~-~l~~~~-------------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 229 (330)
T 1xku_A 182 NIT-TIPQGL-------------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229 (330)
T ss_dssp CCC-SCCSSC-------------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred ccc-cCCccc-------------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence 554 122110 134555666666655555555555555555555555555
Q ss_pred CCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCcccc
Q 003156 290 SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS 369 (843)
Q Consensus 290 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 369 (843)
+..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|.|++..+..|.... ...
T Consensus 230 ~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~ 290 (330)
T 1xku_A 230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNT 290 (330)
T ss_dssp EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCT
T ss_pred eeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------ccc
Confidence 544444555555555555555554 4444444455555555555555443333332210 000
Q ss_pred CCCCCCEEEccCCcccc--cCCcchhcccccceEeecccc
Q 003156 370 NLNKLKILKLEFNELSG--EIPQELGKLASLLAVNVSYNR 407 (843)
Q Consensus 370 ~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~l~ls~N~ 407 (843)
..+.|+.|++++|.+.. ..|..+..+.+++.+++++|+
T Consensus 291 ~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 12455556666665542 344555556666666666553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.89 Aligned_cols=288 Identities=21% Similarity=0.210 Sum_probs=183.5
Q ss_pred ccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEe
Q 003156 79 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 158 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 158 (843)
.+++.++++++.++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 45666666666665 3443332 45666666666666555555566666666666666665554555555555555555
Q ss_pred ecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecC
Q 003156 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238 (843)
Q Consensus 159 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~ 238 (843)
++|+++ .+|..+. ++|++|++++|.+++..+..|.+++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~--------------------------------------- 145 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLN--------------------------------------- 145 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCT---------------------------------------
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCc---------------------------------------
Confidence 555554 2332222 3444444444444433333344444
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccc--eeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccC
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLV--GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 316 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 316 (843)
+|+.|++++|.+. +..+..+..+++|++|++++|.++.+ |..+. ++|++|++++|++++..
T Consensus 146 --------------~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~ 208 (330)
T 1xku_A 146 --------------QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDGNKITKVD 208 (330)
T ss_dssp --------------TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-CSSCC--TTCSEEECTTSCCCEEC
T ss_pred --------------cccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC-Ccccc--ccCCEEECCCCcCCccC
Confidence 4444444444443 24455666667777777777777643 33332 67888888888888777
Q ss_pred CccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhc--
Q 003156 317 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGK-- 394 (843)
Q Consensus 317 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-- 394 (843)
+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..
T Consensus 209 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~ 287 (330)
T 1xku_A 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287 (330)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS
T ss_pred HHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc
Confidence 888888889999999999988777778888999999999999998 78888889999999999999999777777654
Q ss_pred ----ccccceEeecccccee-cCCC--CCCCCCCCCCCcCCC
Q 003156 395 ----LASLLAVNVSYNRLIG-RLPV--GGVFPTLDQSSLQGN 429 (843)
Q Consensus 395 ----l~~L~~l~ls~N~l~~-~~p~--~~~~~~~~~~~~~~n 429 (843)
...|+.|++++|++.. .++. ...+..+....+.+|
T Consensus 288 ~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred cccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 3788999999999864 2221 122344455555555
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.45 Aligned_cols=245 Identities=16% Similarity=0.129 Sum_probs=185.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-------ccChHHHHHHHHHHHhcc---------CCCccc
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-------IQYPEDFEREVRVLGKAR---------HPNLIS 616 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~ 616 (843)
.+.|+..+.||+|+||+||+|++ +|+.||||++..... ....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46688888999999999999998 689999999976532 233478899999999996 777777
Q ss_pred eeeEEE-----------------c-------------CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHH
Q 003156 617 LEGYYW-----------------T-------------PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666 (843)
Q Consensus 617 l~g~~~-----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia 666 (843)
+.+++. + .+..++||||+++|++.+.+.. ..+++..+..++.|++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 766643 2 6778999999999977666643 3579999999999999
Q ss_pred HHHHhhh-hcCCCCeeecCCCCCCEEEcCCC--------------------CcEEeeccCcccccccccceecccccccc
Q 003156 667 KGLAHLH-HSFRPPIIHYNLKPSNILLDDNY--------------------NPRISDFGLARLLTRLDKHVMSNRFQSAL 725 (843)
Q Consensus 667 ~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~ 725 (843)
.||+||| +. +|+||||||+|||++.++ .+||+|||+++.... ....||.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 88 999999999999999887 899999999986653 2347899
Q ss_pred ccCCcccccCcCCCCCchhHHHHHHH-HHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHH
Q 003156 726 GYVAPELTCQSLRVNEKCDIYGFGVL-ILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPV 804 (843)
Q Consensus 726 ~y~aPE~~~~~~~~~~~~Dv~S~Gvi-l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l 804 (843)
.|+|||++.+. . +.++||||+|++ .+++++|..||... ................. .............++
T Consensus 242 ~y~aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 242 VSMDEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFK---TKCNTPAMKQIKRKI 312 (336)
T ss_dssp CTTCSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCCS---SCCCSHHHHHHHHHH
T ss_pred cccChhhhcCC-C-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhccC---cccchhhhhhcCHHH
Confidence 99999998433 3 889999998777 77888999998421 00011111111111110 011111234567789
Q ss_pred HHHHHHccCCCCCCCCCHHHHH-HH
Q 003156 805 LKLALVCTCHIPSSRPSMAEVV-QI 828 (843)
Q Consensus 805 ~~l~~~c~~~~P~~RPs~~evl-~~ 828 (843)
.+++.+|++.| |++|++ ++
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHhccC-----CHHHHHhcC
Confidence 99999999976 999998 54
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.11 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=190.7
Q ss_pred CCCcEEEccCCcccc--cCCchhhcccCCcEEEeec-CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcE
Q 003156 127 PHLTTLDLSNNLFTG--QLPVSLRLLNSMIFISVSN-NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 203 (843)
Q Consensus 127 ~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 203 (843)
.+++.|+|++|.+++ .+|..|..+++|++|+|++ |++.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356666666666665 5666666666666666663 6666666666666666666666666666666666666666777
Q ss_pred EEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCC-CCcEEE
Q 003156 204 IRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA-NLRYLN 282 (843)
Q Consensus 204 L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~ 282 (843)
|+|++|.+++.+|..+.. +++|++|+|++|++++.+|..+..++ +|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~-----------------------------l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~ 180 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISS-----------------------------LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180 (313)
T ss_dssp EECCSSEEESCCCGGGGG-----------------------------CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEE
T ss_pred EeCCCCccCCcCChHHhc-----------------------------CCCCCeEECcCCcccCcCCHHHhhhhhcCcEEE
Confidence 776666666555544332 45666666666666666777777766 777777
Q ss_pred cCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccc
Q 003156 283 LSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG 362 (843)
Q Consensus 283 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 362 (843)
+++|++++..|..+..+. |++|++++|++++..|..+..+++|+.|+|++|.+++.+|. +..+++|++|+|++|++++
T Consensus 181 L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~ 258 (313)
T 1ogq_A 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYG 258 (313)
T ss_dssp CCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEE
T ss_pred CcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccC
Confidence 777777777777777776 88888888888888888888888999999999988866665 7888999999999999998
Q ss_pred cCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeecccc-ceec
Q 003156 363 SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR-LIGR 411 (843)
Q Consensus 363 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~-l~~~ 411 (843)
.+|..|..+++|++|+|++|+++|.+|.. ..+++|+.+++++|+ ++|.
T Consensus 259 ~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEEST
T ss_pred cCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccCC
Confidence 99999999999999999999999999887 889999999999998 5553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.61 Aligned_cols=288 Identities=20% Similarity=0.226 Sum_probs=192.9
Q ss_pred CCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcE
Q 003156 52 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTT 131 (843)
Q Consensus 52 ~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 131 (843)
+|+.+++++|.+...+... .++|++|+|++|.+.+..+..|..+++|++|+|++|++++..|..|..+++|++
T Consensus 34 ~l~~l~~~~~~l~~ip~~~-------~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 106 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEI-------SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQK 106 (332)
T ss_dssp ETTEEECCSSCCSSCCSCC-------CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCE
T ss_pred cCCEEECCCCCccccCCCC-------CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCE
Confidence 4555566555555433211 135555555555555544555555555555555555555555555555555555
Q ss_pred EEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCC--CCCCCCCCCCCCcEEEecCC
Q 003156 132 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG--SLPSSLFNCKKLSVIRLRGN 209 (843)
Q Consensus 132 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N 209 (843)
|+|++|.++. +|..+. ++|++|++++|++.+..+..|.++++|++|++++|.++. ..+..+..+ +
T Consensus 107 L~L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~--------- 173 (332)
T 2ft3_A 107 LYISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-K--------- 173 (332)
T ss_dssp EECCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-C---------
T ss_pred EECCCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-c---------
Confidence 5555555552 222222 445555555555554433444555555555555555432 334444444 4
Q ss_pred cCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCccc
Q 003156 210 SLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR 289 (843)
Q Consensus 210 ~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 289 (843)
|+.|++++|++.+ +|.. ..++|++|++++|.+++..+..+..+++|++|++++|.++
T Consensus 174 --------------L~~L~l~~n~l~~-l~~~--------~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~ 230 (332)
T 2ft3_A 174 --------------LNYLRISEAKLTG-IPKD--------LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230 (332)
T ss_dssp --------------CSCCBCCSSBCSS-CCSS--------SCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC
T ss_pred --------------cCEEECcCCCCCc-cCcc--------ccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC
Confidence 4445555554442 2221 1257899999999999888889999999999999999999
Q ss_pred CCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhccc------CCCcEEeccccccc--
Q 003156 290 SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC------TSLYLLSLSHNHLS-- 361 (843)
Q Consensus 290 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~-- 361 (843)
+..+..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|.|++..+..|..+ ..|+.|++++|.+.
T Consensus 231 ~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 231 MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp CCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred cCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 988889999999999999999999 788889999999999999999998777777653 67999999999987
Q ss_pred ccCCccccCCCCCCEEEccCCc
Q 003156 362 GSIPKSISNLNKLKILKLEFNE 383 (843)
Q Consensus 362 ~~~p~~~~~l~~L~~L~L~~N~ 383 (843)
+..|..|..+++|+.|+|++|+
T Consensus 310 ~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 310 EVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp GSCGGGGTTBCCSTTEEC----
T ss_pred ccCcccccccchhhhhhccccc
Confidence 6788889999999999999985
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=347.12 Aligned_cols=381 Identities=19% Similarity=0.121 Sum_probs=264.4
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCcccccc----ccccccCCCCCCEEECCCCCCccccCCCcCccccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGP----IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 77 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~----~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~ 77 (843)
++|++|+|++|++++.....+|..+++|++|+|++|.+... .+..|..+++|++|+|++|.+++.... ..+..
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~---~l~~~ 79 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH---CVLQG 79 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH---HHHHT
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHH---HHHHH
Confidence 57899999999998444455589999999999999999853 245678889999999999998753211 01223
Q ss_pred Cc----cCCEEecCCccCcc----cCchhhhcCCCCCEEEcCCCcccccCCCC-----CCCCCCCcEEEccCCcccccC-
Q 003156 78 LK----RLRTLDLSHNLFSG----SIPQGVAALHYLKELLLQGNQFSGPLPAD-----IGFCPHLTTLDLSNNLFTGQL- 143 (843)
Q Consensus 78 l~----~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-----~~~l~~L~~L~L~~N~l~~~~- 143 (843)
++ +|++|+|++|+++. .++..+..+++|++|+|++|.+++..+.. +...++|++|+|++|++++..
T Consensus 80 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 159 (461)
T 1z7x_W 80 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159 (461)
T ss_dssp TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred HhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHH
Confidence 44 79999999999984 45888999999999999999987543322 233678999999999998644
Q ss_pred ---CchhhcccCCcEEEeecCcccccCCCCcc-----CCCCccEEEcccCCcCCC----CCCCCCCCCCCcEEEecCCcC
Q 003156 144 ---PVSLRLLNSMIFISVSNNTLTGDIPHWIG-----NISTLEFLDFSNNHLTGS----LPSSLFNCKKLSVIRLRGNSL 211 (843)
Q Consensus 144 ---~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l 211 (843)
+..+..+++|++|++++|++....+..+. .+++|++|+|++|.++.. ++..+..+++|+.|++++|.+
T Consensus 160 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 239 (461)
T 1z7x_W 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcC
Confidence 55667789999999999988754444343 256899999999988853 466677788888888888887
Q ss_pred CCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCcccee----CCccccCCCCCcEEEcCCCc
Q 003156 212 NGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD----IPAEMGLFANLRYLNLSSNH 287 (843)
Q Consensus 212 ~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~ 287 (843)
+......+... ....+++|++|++++|.+++. ++..+..+++|++|++++|.
T Consensus 240 ~~~~~~~l~~~------------------------~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 295 (461)
T 1z7x_W 240 GDVGMAELCPG------------------------LLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295 (461)
T ss_dssp HHHHHHHHHHH------------------------HTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCC
T ss_pred ChHHHHHHHHH------------------------HhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCC
Confidence 63221111110 001245677777777777643 45566667778888888877
Q ss_pred ccCCCCCCccc-----cccceEEEccCCccccc----CCccccccCCCcEEEcCCCCCCCCchhhhcc-----cCCCcEE
Q 003156 288 LRSRIPPELGY-----FHSLIHLDLRNNALYGS----IPQEVCESRSLGILQLDGNSLTGPIPQVIRN-----CTSLYLL 353 (843)
Q Consensus 288 l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L 353 (843)
+++..+..+.. .++|++|++++|.+++. ++..+..+++|+.|+|++|.+++..+..+.. .++|+.|
T Consensus 296 i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L 375 (461)
T 1z7x_W 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375 (461)
T ss_dssp CHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred CchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEE
Confidence 76433322322 24777777777777754 3455566677788888887777655555543 5677788
Q ss_pred ecccccccc----cCCccccCCCCCCEEEccCCcccccCCcchh-----cccccceEeeccccce
Q 003156 354 SLSHNHLSG----SIPKSISNLNKLKILKLEFNELSGEIPQELG-----KLASLLAVNVSYNRLI 409 (843)
Q Consensus 354 ~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~l~ls~N~l~ 409 (843)
+|++|++++ .+|..+..+++|++|+|++|++++.-...+. ....|+.|++.+|.+.
T Consensus 376 ~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp ECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred ECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 888887775 5677777777788888888877754222221 1224555665555543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-35 Score=336.19 Aligned_cols=361 Identities=20% Similarity=0.166 Sum_probs=270.0
Q ss_pred CCCCcEEEccCccccccccc-cccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhh-hcCC
Q 003156 26 CASLRYLSLAGNILQGPIGK-IFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALH 103 (843)
Q Consensus 26 l~~L~~L~L~~n~i~~~~~~-~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~ 103 (843)
+++|++|+|++|++...... .|..+++|++|+|++|.++.......+..+..+++|++|+|++|.+.+..+..+ ..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 36789999999999765543 478899999999999998743211122356677999999999999876544433 4465
Q ss_pred ----CCCEEEcCCCcccc----cCCCCCCCCCCCcEEEccCCcccccCCchhhc-----ccCCcEEEeecCcccccC---
Q 003156 104 ----YLKELLLQGNQFSG----PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL-----LNSMIFISVSNNTLTGDI--- 167 (843)
Q Consensus 104 ----~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~--- 167 (843)
+|++|+|++|+++. .++..+..+++|++|+|++|.++...+..+.. .++|++|+|++|++++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 69999999999884 45777888999999999999987654444432 456888888888877532
Q ss_pred -CCCccCCCCccEEEcccCCcCCCCCCCCC-----CCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCC
Q 003156 168 -PHWIGNISTLEFLDFSNNHLTGSLPSSLF-----NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241 (843)
Q Consensus 168 -p~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~ 241 (843)
+..+..+++|++|+|++|.+++..+..+. ..++|+.|++++|.++......+..
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~-------------------- 221 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG-------------------- 221 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH--------------------
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH--------------------
Confidence 44556677888888888877643333332 2457777777777776321111110
Q ss_pred CCCCCcccccCccCEEeCCCCccceeC-----CccccCCCCCcEEEcCCCcccCC----CCCCccccccceEEEccCCcc
Q 003156 242 SSSSSSSTLFQTLRILDLSSNNLVGDI-----PAEMGLFANLRYLNLSSNHLRSR----IPPELGYFHSLIHLDLRNNAL 312 (843)
Q Consensus 242 ~~~~~~~~~l~~L~~L~L~~n~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l 312 (843)
....+++|++|++++|.+.+.. +..+..+++|++|++++|.++.. ++..+..+++|++|++++|.+
T Consensus 222 -----~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 296 (461)
T 1z7x_W 222 -----IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296 (461)
T ss_dssp -----HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCC
T ss_pred -----HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCC
Confidence 0123578999999999887543 33344688999999999999864 455677789999999999999
Q ss_pred cccCCcccccc-----CCCcEEEcCCCCCCCC----chhhhcccCCCcEEecccccccccCCccccC-----CCCCCEEE
Q 003156 313 YGSIPQEVCES-----RSLGILQLDGNSLTGP----IPQVIRNCTSLYLLSLSHNHLSGSIPKSISN-----LNKLKILK 378 (843)
Q Consensus 313 ~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~ 378 (843)
++..+..+... ++|+.|++++|.+++. ++..+..+++|+.|+|++|++++..+..+.. .++|++|+
T Consensus 297 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 376 (461)
T 1z7x_W 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred chHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEE
Confidence 86555555443 6999999999999876 5677888999999999999998766665543 78999999
Q ss_pred ccCCcccc----cCCcchhcccccceEeeccccceec
Q 003156 379 LEFNELSG----EIPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 379 L~~N~l~~----~~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
|++|++++ .+|..+..+++|+.|++++|++++.
T Consensus 377 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 99999997 7899999999999999999998765
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=278.93 Aligned_cols=199 Identities=21% Similarity=0.181 Sum_probs=106.1
Q ss_pred EEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEe
Q 003156 6 FLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD 85 (843)
Q Consensus 6 ~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~ 85 (843)
..++++|+++ .+|...+ ++|++|+|++|+|.+++...|.++++|++|+|++|++++..+ ..|..+++|++|+
T Consensus 35 ~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~ 106 (353)
T 2z80_A 35 ICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE----DSFSSLGSLEHLD 106 (353)
T ss_dssp EEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT----TTTTTCTTCCEEE
T ss_pred EeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH----hhcCCCCCCCEEE
Confidence 3555566665 5554432 355666666666665555555666666666666665554322 2355555666666
Q ss_pred cCCccCcccCchhhhcCCCCCEEEcCCCcccccCC-CCCCCCCCCcEEEccCC-cccccCCchhhcccCCcEEEeecCcc
Q 003156 86 LSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP-ADIGFCPHLTTLDLSNN-LFTGQLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l 163 (843)
|++|++++..+..|..+++|++|+|++|++++..+ ..|..+++|++|++++| .++...+..|..+++|++|++++|++
T Consensus 107 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 107 LSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp CCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence 66666654444445556666666666665553332 24555555666666555 34444445555555555555555555
Q ss_pred cccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCC
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
.+..|..|..+++|++|++++|.++...+..+..+++|+.|++++|.++
T Consensus 187 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp CEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred CccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence 5555555555555555555555554222222223455555555555554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=277.06 Aligned_cols=254 Identities=19% Similarity=0.202 Sum_probs=123.9
Q ss_pred cCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEee
Q 003156 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159 (843)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 159 (843)
+|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 45555555555554444455555555555555555555555555555555555555555554333345555555555555
Q ss_pred cCcccccCC-CCccCCCCccEEEcccC-CcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceec
Q 003156 160 NNTLTGDIP-HWIGNISTLEFLDFSNN-HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGS 237 (843)
Q Consensus 160 ~N~l~~~~p-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~ 237 (843)
+|+++...+ ..|.++++|++|++++| .++...+..|..+++|+.|++++|.++
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~------------------------- 187 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ------------------------- 187 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC-------------------------
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC-------------------------
Confidence 555543222 24445555555555554 233333344444444444444444443
Q ss_pred CCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCC
Q 003156 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317 (843)
Q Consensus 238 ~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 317 (843)
+..|..+..+++|++|++++|.++...+..+..+++|++|++++|++++..+
T Consensus 188 ----------------------------~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~ 239 (353)
T 2z80_A 188 ----------------------------SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239 (353)
T ss_dssp ----------------------------EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCC
T ss_pred ----------------------------ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccc
Confidence 3333333334444444444444332211122233444444444444443222
Q ss_pred ccc---cccCCCcEEEcCCCCCCC----CchhhhcccCCCcEEecccccccccCCcc-ccCCCCCCEEEccCCccccc
Q 003156 318 QEV---CESRSLGILQLDGNSLTG----PIPQVIRNCTSLYLLSLSHNHLSGSIPKS-ISNLNKLKILKLEFNELSGE 387 (843)
Q Consensus 318 ~~~---~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~ 387 (843)
..+ .....++.++|++|.+++ .+|..+.++++|+.|+|++|+++ .+|.. |.++++|++|+|++|++++.
T Consensus 240 ~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 240 SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp C------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 221 123345555555555543 24555666666666666666666 34443 46666666666666666643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=267.85 Aligned_cols=275 Identities=20% Similarity=0.223 Sum_probs=163.4
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCccccc--CCchhhcccCCcEEEee
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ--LPVSLRLLNSMIFISVS 159 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~ 159 (843)
+.++++++.++ .+|..+ .++|++|+|++|+++...+..|..+++|++|+|++|.++.. .+..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 46677777776 344433 24677777777777655445566777777777777766632 13444445555555555
Q ss_pred cCcccccCCCCccCCCCccEEEcccCCcCCCCC-CCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecC
Q 003156 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP-SSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~ 238 (843)
+|.+. .+|..+..+++|++|++++|.+++..+ ..+..+
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l---------------------------------------- 125 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL---------------------------------------- 125 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTC----------------------------------------
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhc----------------------------------------
Confidence 55554 233334444555555555544443222 233333
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccC-CCCCCccccccceEEEccCCcccccCC
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS-RIPPELGYFHSLIHLDLRNNALYGSIP 317 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~ 317 (843)
++|++|++++|.+.+..+..+..+++|++|++++|.+++ ..|..+..+++|++|++++|++++..|
T Consensus 126 -------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 192 (306)
T 2z66_A 126 -------------RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192 (306)
T ss_dssp -------------TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred -------------cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCH
Confidence 445555555555554555555555666666666666654 345566666666666666666666666
Q ss_pred ccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCC-CCCEEEccCCcccccCC--cchhc
Q 003156 318 QEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN-KLKILKLEFNELSGEIP--QELGK 394 (843)
Q Consensus 318 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p--~~~~~ 394 (843)
..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..+ ....-
T Consensus 193 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~ 272 (306)
T 2z66_A 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 272 (306)
T ss_dssp TTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHH
T ss_pred HHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHH
Confidence 6667777777777777777766666677777777777777777777777777774 77777777777775432 11222
Q ss_pred ccccceEeeccccceecCC
Q 003156 395 LASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 395 l~~L~~l~ls~N~l~~~~p 413 (843)
+...+.+.+..|.+.+..|
T Consensus 273 l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 273 IKDQRQLLVEVERMECATP 291 (306)
T ss_dssp HHHTGGGBSCGGGCBEEES
T ss_pred HHhhhhhhccccccccCCc
Confidence 3344455556666666665
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.34 Aligned_cols=281 Identities=20% Similarity=0.181 Sum_probs=207.0
Q ss_pred CCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCccccc--CCCCCCCCCCCc
Q 003156 53 LNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP--LPADIGFCPHLT 130 (843)
Q Consensus 53 L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~ 130 (843)
-+.++++++.++..+... .++|++|+|++|+++...+..|..+++|++|+|++|.++.. .+..+..+++|+
T Consensus 9 ~~~l~c~~~~l~~ip~~~-------~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 81 (306)
T 2z66_A 9 GTEIRCNSKGLTSVPTGI-------PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK 81 (306)
T ss_dssp TTEEECCSSCCSSCCSCC-------CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred CCEEEcCCCCcccCCCCC-------CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccC
Confidence 368999999998765432 26899999999999976666789999999999999999843 255667799999
Q ss_pred EEEccCCcccccCCchhhcccCCcEEEeecCcccccCC-CCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCC
Q 003156 131 TLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP-HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 209 (843)
Q Consensus 131 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 209 (843)
+|+|++|.++ .+|..+..+++|++|++++|++.+..+ ..+..+++|++|++++|.+++..+..+..+++|+.|++++|
T Consensus 82 ~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 9999999998 466679999999999999999996655 68999999999999999999888888888899999998888
Q ss_pred cCCC-CCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcc
Q 003156 210 SLNG-NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHL 288 (843)
Q Consensus 210 ~l~~-~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 288 (843)
.+.+ .+|..+ ..+++|++|+|++|++++..|..+..+++|++|++++|.+
T Consensus 161 ~l~~~~~~~~~-----------------------------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 211 (306)
T 2z66_A 161 SFQENFLPDIF-----------------------------TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211 (306)
T ss_dssp EEGGGEECSCC-----------------------------TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccchhHH-----------------------------hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCcc
Confidence 8763 222211 2356777777777777776677777777777777777777
Q ss_pred cCCCCCCccccccceEEEccCCcccccCCccccccC-CCcEEEcCCCCCCCCch--hhhcccCCCcEEecccccccccCC
Q 003156 289 RSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESR-SLGILQLDGNSLTGPIP--QVIRNCTSLYLLSLSHNHLSGSIP 365 (843)
Q Consensus 289 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p 365 (843)
++..+..+..+++|++|++++|++++..|..+..++ +|+.|+|++|.+++..+ .....+..++.+....+.+....|
T Consensus 212 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 212 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp SBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred CccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 766555666666677777777766666666666663 66666666666654321 112223334444444455554445
Q ss_pred ccccC
Q 003156 366 KSISN 370 (843)
Q Consensus 366 ~~~~~ 370 (843)
..+.+
T Consensus 292 ~~~~g 296 (306)
T 2z66_A 292 SDKQG 296 (306)
T ss_dssp GGGTT
T ss_pred hhhCC
Confidence 44433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=264.78 Aligned_cols=233 Identities=22% Similarity=0.300 Sum_probs=155.5
Q ss_pred CCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEe
Q 003156 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRL 206 (843)
Q Consensus 127 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 206 (843)
++++.|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..|+++++|++|+|++|.++ .+|..+.++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 45566666666665 44555555666666666666666 56666666667777777777666 55666666777777777
Q ss_pred cCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCC
Q 003156 207 RGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 286 (843)
Q Consensus 207 ~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 286 (843)
++|.+.+.+|..+... ..+..+..+++|++|++++|
T Consensus 158 ~~n~~~~~~p~~~~~~--------------------------------------------~~~~~~~~l~~L~~L~L~~n 193 (328)
T 4fcg_A 158 RACPELTELPEPLAST--------------------------------------------DASGEHQGLVNLQSLRLEWT 193 (328)
T ss_dssp EEETTCCCCCSCSEEE--------------------------------------------C-CCCEEESTTCCEEEEEEE
T ss_pred CCCCCccccChhHhhc--------------------------------------------cchhhhccCCCCCEEECcCC
Confidence 7766655555433211 11122444556666666666
Q ss_pred cccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCc
Q 003156 287 HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK 366 (843)
Q Consensus 287 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 366 (843)
.++ .+|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|.+.+.+|..|+++++|+.|+|++|++.+.+|.
T Consensus 194 ~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~ 271 (328)
T 4fcg_A 194 GIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271 (328)
T ss_dssp CCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCT
T ss_pred CcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcch
Confidence 665 44555666666666677777766 3555677777777777777777777777777777777777777777777777
Q ss_pred cccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccc
Q 003156 367 SISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408 (843)
Q Consensus 367 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l 408 (843)
.+.++++|++|+|++|++.+.+|..+++|++|+.+++..|.+
T Consensus 272 ~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp TGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred hhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 777778888888888777777888888888888777776654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-28 Score=273.64 Aligned_cols=246 Identities=22% Similarity=0.225 Sum_probs=132.8
Q ss_pred CEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccC
Q 003156 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 185 (843)
Q Consensus 106 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 185 (843)
..++.+++.++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34444444444 2333221 34555555555555444455555555555555555555444555555555555555555
Q ss_pred CcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCC-Ccc
Q 003156 186 HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSS-NNL 264 (843)
Q Consensus 186 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~-n~l 264 (843)
+++...+..|..+++|++|+|++|.++. +|... +..+++|+.|+|++ |.+
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~----------------------------~~~l~~L~~L~l~~~~~l 184 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYA----------------------------FNRVPSLMRLDLGELKKL 184 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCE-ECTTT----------------------------TTTCTTCCEEECCCCTTC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcce-eCHhH----------------------------HhcCCcccEEeCCCCCCc
Confidence 5554444445555555555555555541 11111 01234555555555 333
Q ss_pred ceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhh
Q 003156 265 VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 344 (843)
Q Consensus 265 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 344 (843)
....+..|..+++|++|++++|.+++. ..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|
T Consensus 185 ~~i~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 262 (452)
T 3zyi_A 185 EYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262 (452)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cccChhhccCCCCCCEEECCCCccccc--ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHh
Confidence 333344566677777777777777643 235555666666666666665555566666666666666666665555556
Q ss_pred cccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 345 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 345 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 263 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred cCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 66666666666666666544455555666666666666554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=272.40 Aligned_cols=247 Identities=23% Similarity=0.242 Sum_probs=139.9
Q ss_pred CCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcc
Q 003156 104 YLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183 (843)
Q Consensus 104 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 183 (843)
..+.++.+++.++ .+|..+. ++++.|+|++|+++...+..|..+++|++|+|++|++.+..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3567777777777 4555443 567777777777777667777777777777777777776666677777777777777
Q ss_pred cCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCC-C
Q 003156 184 NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSS-N 262 (843)
Q Consensus 184 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~-n 262 (843)
+|+++...+..|..+++|+.|+|++|.++...+..+ ..+++|++|+|++ |
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-----------------------------~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF-----------------------------NRIPSLRRLDLGELK 171 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTT-----------------------------TTCTTCCEEECCCCT
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHh-----------------------------hhCcccCEeCCCCCC
Confidence 777775555566677777777777666652111111 1245566666665 3
Q ss_pred ccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchh
Q 003156 263 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ 342 (843)
Q Consensus 263 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 342 (843)
.+....+..|..+++|++|++++|.++.+ | .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.
T Consensus 172 ~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 249 (440)
T 3zyj_A 172 RLSYISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249 (440)
T ss_dssp TCCEECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred CcceeCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChh
Confidence 33333334455555666666666655532 2 244444444444444444444444444444444444444444444444
Q ss_pred hhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcc
Q 003156 343 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384 (843)
Q Consensus 343 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 384 (843)
.|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+
T Consensus 250 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291 (440)
T ss_dssp SSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred hhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence 444444444444444444433333444444444444444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-27 Score=276.13 Aligned_cols=269 Identities=27% Similarity=0.262 Sum_probs=177.1
Q ss_pred CCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCC
Q 003156 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK 106 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 106 (843)
.+++.|++++|+|+.++...+ ++|++|+|++|.|+.++. .+++|++|+|++|+|++ +|. .+++|+
T Consensus 40 ~~l~~L~ls~n~L~~lp~~l~---~~L~~L~L~~N~l~~lp~--------~l~~L~~L~Ls~N~l~~-lp~---~l~~L~ 104 (622)
T 3g06_A 40 NGNAVLNVGESGLTTLPDCLP---AHITTLVIPDNNLTSLPA--------LPPELRTLEVSGNQLTS-LPV---LPPGLL 104 (622)
T ss_dssp HCCCEEECCSSCCSCCCSCCC---TTCSEEEECSCCCSCCCC--------CCTTCCEEEECSCCCSC-CCC---CCTTCC
T ss_pred CCCcEEEecCCCcCccChhhC---CCCcEEEecCCCCCCCCC--------cCCCCCEEEcCCCcCCc-CCC---CCCCCC
Confidence 346666666666666655443 566666666666664332 24666777777776663 333 556677
Q ss_pred EEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCC
Q 003156 107 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186 (843)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 186 (843)
+|+|++|.+++. |. .+++|+.|++++|+++.+ |.. +++|++|+|++|++++ +|. .+++|+.|++++|.
T Consensus 105 ~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~ 172 (622)
T 3g06_A 105 ELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQ 172 (622)
T ss_dssp EEEECSCCCCCC-CC---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred EEECcCCcCCCC-CC---CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCC
Confidence 777777776643 32 456677777777777643 332 3667777777777763 343 24567788888888
Q ss_pred cCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccce
Q 003156 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 266 (843)
Q Consensus 187 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~ 266 (843)
++. +| ..+++|+.|++++|.+++ +|.. +++|+.|++++|.++
T Consensus 173 l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~--------------------------------~~~L~~L~L~~N~l~- 214 (622)
T 3g06_A 173 LTS-LP---MLPSGLQELSVSDNQLAS-LPTL--------------------------------PSELYKLWAYNNRLT- 214 (622)
T ss_dssp CSC-CC---CCCTTCCEEECCSSCCSC-CCCC--------------------------------CTTCCEEECCSSCCS-
T ss_pred CCC-Cc---ccCCCCcEEECCCCCCCC-CCCc--------------------------------cchhhEEECcCCccc-
Confidence 874 44 445777788888777762 3321 245666666666666
Q ss_pred eCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcc
Q 003156 267 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN 346 (843)
Q Consensus 267 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 346 (843)
.+|.. +++|++|++++|.|+++ | ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|.|+ .+|..|.+
T Consensus 215 ~l~~~---~~~L~~L~Ls~N~L~~l-p---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~ 282 (622)
T 3g06_A 215 SLPAL---PSGLKELIVSGNRLTSL-P---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIH 282 (622)
T ss_dssp SCCCC---CTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGG
T ss_pred ccCCC---CCCCCEEEccCCccCcC-C---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhh
Confidence 34432 35677777777777653 3 34467788888888887 4554 5678888888888888 67788888
Q ss_pred cCCCcEEecccccccccCCccccCCC
Q 003156 347 CTSLYLLSLSHNHLSGSIPKSISNLN 372 (843)
Q Consensus 347 l~~L~~L~Ls~N~l~~~~p~~~~~l~ 372 (843)
+++|+.|+|++|.+++..|..+..++
T Consensus 283 l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 283 LSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ccccCEEEecCCCCCCcCHHHHHhcc
Confidence 88888888888888888888776664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-27 Score=270.30 Aligned_cols=248 Identities=21% Similarity=0.157 Sum_probs=197.0
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
...++.+++.++ .+|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456677777776 3444332 4677777777777777777777777777777777777777777777777777777777
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~ 240 (843)
|+++...+..|.++++|++|+|++|+++...+..|.++++|+.|++++|...+.++...
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~--------------------- 191 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGA--------------------- 191 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTT---------------------
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhh---------------------
Confidence 77776666677778888888888888876666677888888888887744332333221
Q ss_pred CCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccc
Q 003156 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320 (843)
Q Consensus 241 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 320 (843)
+..+++|++|+|++|++++ +| .+..+++|++|+|++|.|++..|..|..+++|++|+|++|++++..+..|
T Consensus 192 -------~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 262 (452)
T 3zyi_A 192 -------FEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262 (452)
T ss_dssp -------TTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTT
T ss_pred -------ccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHh
Confidence 1235778888888888874 44 47889999999999999999999999999999999999999999989999
Q ss_pred cccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccccc
Q 003156 321 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361 (843)
Q Consensus 321 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 361 (843)
..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 263 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred cCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 99999999999999999888888999999999999999987
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=274.65 Aligned_cols=267 Identities=21% Similarity=0.223 Sum_probs=205.0
Q ss_pred CCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEccc
Q 003156 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN 184 (843)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 184 (843)
++.++++.+.+.......+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+ |..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4445666666654444445556677777777777776666667777777777777777765443 66667777777777
Q ss_pred CCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCcc
Q 003156 185 NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 264 (843)
Q Consensus 185 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l 264 (843)
|++++.. ..++|+.|++++|.++ +..+. .+++|++|++++|++
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~-----------------------~~~~~---------~~~~L~~L~l~~N~l 132 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNIS-----------------------RVSCS---------RGQGKKNIYLANNKI 132 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCS-----------------------EEEEC---------CCSSCEEEECCSSCC
T ss_pred Ccccccc-----CCCCcCEEECCCCccC-----------------------CcCcc---------ccCCCCEEECCCCCC
Confidence 7666321 2256666666666655 22211 256799999999999
Q ss_pred ceeCCccccCCCCCcEEEcCCCcccCCCCCCc-cccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhh
Q 003156 265 VGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL-GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQV 343 (843)
Q Consensus 265 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 343 (843)
++..+..+..+++|++|++++|.+++..+..+ ..+++|++|+|++|++++. + ....+++|+.|+|++|++++ +|..
T Consensus 133 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~ 209 (317)
T 3o53_A 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPE 209 (317)
T ss_dssp CSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGG
T ss_pred CCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhh
Confidence 98888889999999999999999998777766 4789999999999999965 3 33458999999999999995 5556
Q ss_pred hcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc-ccCCcchhcccccceEeec-cccceecCCC
Q 003156 344 IRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS-GEIPQELGKLASLLAVNVS-YNRLIGRLPV 414 (843)
Q Consensus 344 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~ls-~N~l~~~~p~ 414 (843)
|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..++.|+.++++ .+.++|..|.
T Consensus 210 ~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp GGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred hcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 999999999999999999 67888999999999999999999 8889999999999999999 5557776663
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=257.41 Aligned_cols=123 Identities=20% Similarity=0.237 Sum_probs=54.0
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
+.++.+++.++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 44555555554 233222 234555555555555444444555555555555555554444444444444444444444
Q ss_pred c-ccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEec
Q 003156 162 T-LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 207 (843)
Q Consensus 162 ~-l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 207 (843)
+ +....|..|..+++|++|+|++|.+++..+..|.++++|++|+++
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 137 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECC
Confidence 3 333333334444444444444444433333333333333333333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-27 Score=269.09 Aligned_cols=248 Identities=22% Similarity=0.182 Sum_probs=165.7
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
.+.++.+++.++ .+|..+. ++++.|+|++|+++...+..|.++++|++|+|++|.++...+..|..+++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 445666666665 3444332 4566666666666666666666666666666666666666666666666666666666
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~ 240 (843)
|+++...+..|..+++|++|+|++|+++...+..|.++++|+.|+|++|...+.++...+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~-------------------- 181 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF-------------------- 181 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTT--------------------
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchh--------------------
Confidence 666655555666677777777777777665555666777777777766433223322111
Q ss_pred CCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccc
Q 003156 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 320 (843)
Q Consensus 241 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 320 (843)
..+++|++|+|++|+++ .+| .+..+++|++|+|++|.|+++.|..|..+++|+.|+|++|++++..+..|
T Consensus 182 --------~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 251 (440)
T 3zyj_A 182 --------EGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251 (440)
T ss_dssp --------TTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSS
T ss_pred --------hcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhh
Confidence 22456666666666666 344 35667777777777777777777777777777777777777777777777
Q ss_pred cccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccccc
Q 003156 321 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 361 (843)
Q Consensus 321 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 361 (843)
..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 252 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 78888888888888888777777788888888888888775
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-28 Score=256.04 Aligned_cols=133 Identities=20% Similarity=0.201 Sum_probs=69.3
Q ss_pred ccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCc-ccccCCchhhcccCCcEEE
Q 003156 79 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL-FTGQLPVSLRLLNSMIFIS 157 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~ 157 (843)
++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|++++|. ++...+..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 345555555555554444455555555555555555555445555555555555555554 4444455555555555555
Q ss_pred eecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcC
Q 003156 158 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 211 (843)
Q Consensus 158 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 211 (843)
+++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 165 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence 555555544455555555555555555555543333344444444444444433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=273.06 Aligned_cols=268 Identities=28% Similarity=0.347 Sum_probs=150.3
Q ss_pred CCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcE
Q 003156 52 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTT 131 (843)
Q Consensus 52 ~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 131 (843)
++++|++++|.++.++... . ++|++|+|++|+|+. +|. .+++|++|+|++|+|++ +|. .+++|++
T Consensus 41 ~l~~L~ls~n~L~~lp~~l-----~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~ 105 (622)
T 3g06_A 41 GNAVLNVGESGLTTLPDCL-----P--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLE 105 (622)
T ss_dssp CCCEEECCSSCCSCCCSCC-----C--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCE
T ss_pred CCcEEEecCCCcCccChhh-----C--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCE
Confidence 4666666666666443321 1 456666666666653 333 35566666666666653 332 4556666
Q ss_pred EEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcC
Q 003156 132 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 211 (843)
Q Consensus 132 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 211 (843)
|+|++|.+++..+ .+++|+.|++++|+++. +|.. +++|++|+|++|++++ +|. .+++|+.|++++|.+
T Consensus 106 L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l 173 (622)
T 3g06_A 106 LSIFSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQL 173 (622)
T ss_dssp EEECSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EECcCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCC
Confidence 6666666654322 34455555555555552 3322 2445555555555542 222 123444444444444
Q ss_pred CCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCC
Q 003156 212 NGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 291 (843)
Q Consensus 212 ~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 291 (843)
++ + | ..+++|+.|++++|.+++ +|.. +++|+.|++++|.|+.+
T Consensus 174 ~~-l-----------------------~---------~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l 216 (622)
T 3g06_A 174 TS-L-----------------------P---------MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL 216 (622)
T ss_dssp SC-C-----------------------C---------CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC
T ss_pred CC-C-----------------------c---------ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc
Confidence 41 1 1 114567777777777763 4432 35677777777777643
Q ss_pred CCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCC
Q 003156 292 IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL 371 (843)
Q Consensus 292 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 371 (843)
|. .+++|+.|+|++|+|++ +| ..+++|+.|+|++|.|+ .+|. .+++|+.|+|++|+|+ .+|..|.++
T Consensus 217 -~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l 283 (622)
T 3g06_A 217 -PA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHL 283 (622)
T ss_dssp -CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred -CC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence 22 23566777777777764 44 34466677777777666 3443 4566667777777666 556666666
Q ss_pred CCCCEEEccCCcccccCCcchhccc
Q 003156 372 NKLKILKLEFNELSGEIPQELGKLA 396 (843)
Q Consensus 372 ~~L~~L~L~~N~l~~~~p~~~~~l~ 396 (843)
++|+.|+|++|++++.+|..+..++
T Consensus 284 ~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 284 SSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cccCEEEecCCCCCCcCHHHHHhcc
Confidence 7777777777777666666665554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=257.46 Aligned_cols=232 Identities=19% Similarity=0.265 Sum_probs=103.9
Q ss_pred ccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEe
Q 003156 79 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 158 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 158 (843)
.+++.|+|++|.+. .+|..+..+++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..|..+++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 34445555555554 33444444555555555555544 44444444555555555555444 33444444444444444
Q ss_pred ecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecC
Q 003156 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238 (843)
Q Consensus 159 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~ 238 (843)
++|++.+.+|..+... ..+..|.++++|++|+|++|.++ .+|..+.
T Consensus 158 ~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~------------------ 203 (328)
T 4fcg_A 158 RACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIA------------------ 203 (328)
T ss_dssp EEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGG------------------
T ss_pred CCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhc------------------
Confidence 4444444444333220 00111223555666665555554 3333221
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 318 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 318 (843)
.+++|++|+|++|+++ .+|..+..+++|++|++++|.+.+..|..+..+++|++|+|++|.+.+.+|.
T Consensus 204 -----------~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~ 271 (328)
T 4fcg_A 204 -----------NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271 (328)
T ss_dssp -----------GCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCT
T ss_pred -----------CCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcch
Confidence 1234444444444444 2333444444555555555444444444444444444444444444444444
Q ss_pred cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccc
Q 003156 319 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359 (843)
Q Consensus 319 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 359 (843)
.+..+++|+.|+|++|.+.+.+|..++++++|+.+++..|.
T Consensus 272 ~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp TGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred hhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 44444444444444444444444444444444444444333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-31 Score=309.40 Aligned_cols=377 Identities=14% Similarity=0.038 Sum_probs=239.0
Q ss_pred hcCCCCcEEEccCccccccccccccC-CC-CCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCccc----Cch
Q 003156 24 ENCASLRYLSLAGNILQGPIGKIFNY-CS-SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS----IPQ 97 (843)
Q Consensus 24 ~~l~~L~~L~L~~n~i~~~~~~~f~~-l~-~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~ 97 (843)
..+++|++|+|++|.+.......+.. ++ +|++|+|++|.-.. ..........+++|++|+|++|.+.+. ++.
T Consensus 109 ~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~--~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~ 186 (592)
T 3ogk_B 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT--TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHE 186 (592)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE--HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHH
T ss_pred hhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC--HHHHHHHHhhCCCCCEEECccccccCcchhHHHH
Confidence 36777777777777766544444433 23 37777777765110 000011123567788888888777644 333
Q ss_pred hhhcCCCCCEEEcCCCccc----ccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc---ccCCCC
Q 003156 98 GVAALHYLKELLLQGNQFS----GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT---GDIPHW 170 (843)
Q Consensus 98 ~~~~l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~p~~ 170 (843)
.+..+++|++|+|++|.++ ..++..+.++++|++|++++|.+.+ .+..+..+++|+.|+++.+... ...+..
T Consensus 187 ~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~ 265 (592)
T 3ogk_B 187 LAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMN 265 (592)
T ss_dssp HHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSC
T ss_pred HHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHH
Confidence 4566777888888777775 2233344567778888888877774 5567777778888877754332 233445
Q ss_pred ccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCch-hhcc-CcceeeccCCccee-cCCCCCCCCCc
Q 003156 171 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG-LFDL-GLEEIDLSENGFMG-SIPPGSSSSSS 247 (843)
Q Consensus 171 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~-~L~~L~l~~n~l~~-~~p~~~~~~~~ 247 (843)
+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++..... +... +|+.|+++ +.+.. .++. .
T Consensus 266 l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~------~ 337 (592)
T 3ogk_B 266 LVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEV------L 337 (592)
T ss_dssp CCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHH------H
T ss_pred hhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHH------H
Confidence 667777888877775443 56666777778888888888765333222 2222 67778777 33321 1110 1
Q ss_pred ccccCccCEEeCCC-----------CccceeC-CccccCCCCCcEEEcCCCcccCCCCCCccc-cccceEEEcc----CC
Q 003156 248 STLFQTLRILDLSS-----------NNLVGDI-PAEMGLFANLRYLNLSSNHLRSRIPPELGY-FHSLIHLDLR----NN 310 (843)
Q Consensus 248 ~~~l~~L~~L~L~~-----------n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~n 310 (843)
...+++|++|++++ |.+++.. +..+..+++|++|+++.|.+++..+..+.. +++|+.|+++ .|
T Consensus 338 ~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n 417 (592)
T 3ogk_B 338 AQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREE 417 (592)
T ss_dssp HHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCS
T ss_pred HHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCc
Confidence 12356788888883 5555332 222345778888888878777654444444 6778888885 66
Q ss_pred ccccc-----CCccccccCCCcEEEcCCC--CCCCCchhhhcc-cCCCcEEecccccccc-cCCccccCCCCCCEEEccC
Q 003156 311 ALYGS-----IPQEVCESRSLGILQLDGN--SLTGPIPQVIRN-CTSLYLLSLSHNHLSG-SIPKSISNLNKLKILKLEF 381 (843)
Q Consensus 311 ~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~ 381 (843)
.+++. ++..+..+++|+.|++++| .+++..+..+.. +++|+.|+|++|++++ .++..+..+++|+.|+|++
T Consensus 418 ~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~ 497 (592)
T 3ogk_B 418 RITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497 (592)
T ss_dssp CCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEES
T ss_pred cccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccC
Confidence 77643 2333566788888888754 366655555554 7888888888888875 3455557788888888888
Q ss_pred Cccccc-CCcchhcccccceEeeccccceec
Q 003156 382 NELSGE-IPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 382 N~l~~~-~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
|.+++. ++..+..+++|+.|++++|+++..
T Consensus 498 n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 498 CCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp CCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred CCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 888755 344456788888888888887643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=267.03 Aligned_cols=258 Identities=20% Similarity=0.183 Sum_probs=171.9
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
.++.++++.+.+. ..+...|..+++|++|+|++|+|.++.+..|..+++|++|+|++|++++.++ +..+++|+
T Consensus 11 ~l~i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~------~~~l~~L~ 83 (317)
T 3o53_A 11 RYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD------LESLSTLR 83 (317)
T ss_dssp EEEEESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE------ETTCTTCC
T ss_pred ceeEeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh------hhhcCCCC
Confidence 3667788888887 6777788888899999999999998888888999999999999998876432 67788899
Q ss_pred EEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 162 (843)
+|+|++|++++.. ..++|++|++++|++++..+.. +++|++|++++|++++..+..|..+++|++|+|++|+
T Consensus 84 ~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 155 (317)
T 3o53_A 84 TLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155 (317)
T ss_dssp EEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSC
T ss_pred EEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCC
Confidence 9999998887432 3478888888888887655443 5678888888888877666677777777777777777
Q ss_pred ccccCCCCcc-CCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCC
Q 003156 163 LTGDIPHWIG-NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241 (843)
Q Consensus 163 l~~~~p~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~ 241 (843)
+.+..+..+. .+++|++|+|++|.+++. + ....+++|+.|+|++|.+++ +|..+.
T Consensus 156 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~--------------------- 211 (317)
T 3o53_A 156 IDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQ--------------------- 211 (317)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGG---------------------
T ss_pred CCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhc---------------------
Confidence 7765555543 566777777777766643 2 22235566666666665552 222211
Q ss_pred CCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCccc-CCCCCCccccccceEEEcc
Q 003156 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR-SRIPPELGYFHSLIHLDLR 308 (843)
Q Consensus 242 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~ 308 (843)
.+++|+.|+|++|+++ .+|..+..+++|+.|++++|.+. +..+..+..+++|+.|+++
T Consensus 212 --------~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 212 --------SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp --------GGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred --------ccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 1344555555555555 34444555555555555555554 3334444444455555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=268.00 Aligned_cols=252 Identities=23% Similarity=0.234 Sum_probs=175.1
Q ss_pred CCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc-ccCCCCcc-------CCCCccEEEcccCCcCCCCCCCC-
Q 003156 125 FCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT-GDIPHWIG-------NISTLEFLDFSNNHLTGSLPSSL- 195 (843)
Q Consensus 125 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~-------~l~~L~~L~L~~N~i~~~~~~~~- 195 (843)
..++|+.|++++|.+ ..|..+... |+.|+|++|++. ..+|..+. ++++|++|+|++|++++..|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 344555566666665 344444433 555666666653 23444333 56777777777777777667665
Q ss_pred -CCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccC
Q 003156 196 -FNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 274 (843)
Q Consensus 196 -~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 274 (843)
..+++|++|+|++|.+++. |..+.... . ..+++|++|+|++|++.+..|..|+.
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~----------------~--------~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQ----------------Q--------WLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHH----------------T--------TCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHH----------------H--------hhcCCCcEEEeeCCCCccchHHHhcc
Confidence 6777777777777777754 54443210 0 01256777777777777766677788
Q ss_pred CCCCcEEEcCCCcccCC--CCCC--ccccccceEEEccCCcccc---cCCccccccCCCcEEEcCCCCCCCCch-hhhcc
Q 003156 275 FANLRYLNLSSNHLRSR--IPPE--LGYFHSLIHLDLRNNALYG---SIPQEVCESRSLGILQLDGNSLTGPIP-QVIRN 346 (843)
Q Consensus 275 l~~L~~L~L~~N~l~~~--~~~~--~~~l~~L~~L~L~~n~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~ 346 (843)
+++|++|++++|++.+. .+.. +..+++|++|+|++|++++ .....+..+++|+.|+|++|++++..| ..+..
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 251 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence 88888888888876543 1222 3677888888888888873 122334577889999999999987665 45667
Q ss_pred cCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeecccccee
Q 003156 347 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410 (843)
Q Consensus 347 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 410 (843)
+++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 889999999999998 7787776 8899999999999865 65 8889999999999998875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-30 Score=301.53 Aligned_cols=398 Identities=14% Similarity=0.061 Sum_probs=290.4
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCC-CcEEEccCcc-ccc-cccccccCCCCCCEEECCCCCCccccCCCcCccccC
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCAS-LRYLSLAGNI-LQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 77 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~-L~~L~L~~n~-i~~-~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~ 77 (843)
+++|++|+|++|.+++..+..+...++. |++|+|++|. +.. .......++++|++|+|++|.+++.........+..
T Consensus 111 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~ 190 (592)
T 3ogk_B 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH 190 (592)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHH
T ss_pred CCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhc
Confidence 4689999999999885544433232445 9999999987 321 122334578999999999998764321101113456
Q ss_pred CccCCEEecCCccCc----ccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCccc---ccCCchhhcc
Q 003156 78 LKRLRTLDLSHNLFS----GSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT---GQLPVSLRLL 150 (843)
Q Consensus 78 l~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l 150 (843)
+++|++|+|++|.++ ..++..+..+++|++|+|++|.+.+ .+..+..+++|++|+++.+... ...+..+..+
T Consensus 191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~ 269 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP 269 (592)
T ss_dssp CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCC
T ss_pred CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcc
Confidence 899999999999997 3455567789999999999999985 5677888999999999864433 2334567788
Q ss_pred cCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCC-CCCCCCCCCcEEEecCCcCCCCCCchh-hcc-Cccee
Q 003156 151 NSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP-SSLFNCKKLSVIRLRGNSLNGNIPEGL-FDL-GLEEI 227 (843)
Q Consensus 151 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~~-~L~~L 227 (843)
++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++ +.+.......+ ... +|+.|
T Consensus 270 ~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L 347 (592)
T 3ogk_B 270 RKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRL 347 (592)
T ss_dssp TTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEE
T ss_pred ccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEE
Confidence 99999999987544 677888899999999999999765332 346789999999999 44443222222 222 69999
Q ss_pred eccC-----------CcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccC-CCCCcEEEcC----CCcccCC
Q 003156 228 DLSE-----------NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL-FANLRYLNLS----SNHLRSR 291 (843)
Q Consensus 228 ~l~~-----------n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~ 291 (843)
++++ |.+.+.... .....+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++.
T Consensus 348 ~L~~g~~~~~~~~~~~~~~~~~~~-----~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~ 422 (592)
T 3ogk_B 348 RIERGADEQGMEDEEGLVSQRGLI-----ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL 422 (592)
T ss_dssp EEECCCCSSTTSSTTCCCCHHHHH-----HHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC
T ss_pred EeecCccccccccccCccCHHHHH-----HHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc
Confidence 9993 455422100 01234689999999999998877777765 8999999996 7788753
Q ss_pred C-----CCCccccccceEEEccCCc--ccccCCccccc-cCCCcEEEcCCCCCCC-CchhhhcccCCCcEEecccccccc
Q 003156 292 I-----PPELGYFHSLIHLDLRNNA--LYGSIPQEVCE-SRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSG 362 (843)
Q Consensus 292 ~-----~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~ 362 (843)
. +..+..+++|++|++++|. +++..+..+.. +++|+.|++++|.+++ .++..+.++++|+.|+|++|.+++
T Consensus 423 p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 423 PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred hHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence 2 2236678999999998543 66555555544 8899999999999986 345667889999999999999875
Q ss_pred c-CCccccCCCCCCEEEccCCcccccCCcch-hcccccceEeeccc
Q 003156 363 S-IPKSISNLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYN 406 (843)
Q Consensus 363 ~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~ls~N 406 (843)
. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus 503 ~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 503 RAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 5 44445689999999999999986644434 35666666655554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=282.94 Aligned_cols=188 Identities=14% Similarity=0.050 Sum_probs=132.7
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcc---------cChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---------QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
..+.|++|.+..++....|+.||+|.+...... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456777777776666557889999999654321 1235689999999999 699999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 710 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~ 710 (843)
|||++||+|.++|... .+++.. +|+.||+.||+|+|++ +||||||||+|||+++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999875 345543 5899999999999999 99999999999999999999999999998765
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~ 762 (843)
.... ......||++|||||++. + .+..++|+||+|++++++.++..++
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~-g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFA-E-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred CCCc--cccCceechhhccHHHhC-C-CCCCcccccccccchhhhccccchh
Confidence 3222 224567999999999883 2 4677899999999988876655443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-29 Score=264.46 Aligned_cols=134 Identities=21% Similarity=0.247 Sum_probs=77.0
Q ss_pred cccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCc-ccCchhhh-------cCCCCCEEEcCCCcccc
Q 003156 46 IFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS-GSIPQGVA-------ALHYLKELLLQGNQFSG 117 (843)
Q Consensus 46 ~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~-------~l~~L~~L~L~~n~l~~ 117 (843)
.+...++|++|++++|.+ ..+. .+. ..|+.|+|++|.+. ..+|..+. .+++|++|+|++|.+++
T Consensus 38 ~~~~~~~L~~l~l~~n~l-~~p~-----~~~--~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 109 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE-ADLG-----QFT--DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG 109 (312)
T ss_dssp EEEEEEECTTHHHHCCTT-CCCH-----HHH--HHHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBS
T ss_pred EEccCCCceeEeeccccc-ccHH-----HHH--HHHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccc
Confidence 355556677777777776 3222 111 12666777777763 33444443 56677777777777766
Q ss_pred cCCCCC--CCCCCCcEEEccCCcccccCCchhhcc-----cCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcC
Q 003156 118 PLPADI--GFCPHLTTLDLSNNLFTGQLPVSLRLL-----NSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 188 (843)
Q Consensus 118 ~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~ 188 (843)
..|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++.+..|..|+++++|++|+|++|++.
T Consensus 110 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 186 (312)
T 1wwl_A 110 TAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186 (312)
T ss_dssp CCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTC
T ss_pred hhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcC
Confidence 666654 6667777777777776655 5555555 45555555555555444444555555555555555443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-28 Score=274.93 Aligned_cols=235 Identities=22% Similarity=0.239 Sum_probs=160.3
Q ss_pred CCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEec
Q 003156 128 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 207 (843)
Q Consensus 128 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 207 (843)
+|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |+.+++|++|+|++|.|++.. ..++|+.|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence 44444444444444333444444444444444444443333 455555555555555555321 12455555555
Q ss_pred CCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCc
Q 003156 208 GNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 287 (843)
Q Consensus 208 ~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 287 (843)
+|.+++..+ ..+++|+.|+|++|.+++..|..++.+++|++|+|++|.
T Consensus 108 ~N~l~~~~~--------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 155 (487)
T 3oja_A 108 NNNISRVSC--------------------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155 (487)
T ss_dssp SSCCCCEEE--------------------------------CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSC
T ss_pred CCcCCCCCc--------------------------------cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCC
Confidence 555542111 013567777777777777777777788888888888888
Q ss_pred ccCCCCCCcc-ccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCc
Q 003156 288 LRSRIPPELG-YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK 366 (843)
Q Consensus 288 l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 366 (843)
+++..|..+. .+++|+.|+|++|.|++.. .+..+++|+.|+|++|.|++. |..|..+++|+.|+|++|.|++ +|.
T Consensus 156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~ 231 (487)
T 3oja_A 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEK 231 (487)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECT
T ss_pred CCCcChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cch
Confidence 8877776665 6788888888888888652 344588999999999999964 4458899999999999999994 788
Q ss_pred cccCCCCCCEEEccCCccc-ccCCcchhcccccceEeecc
Q 003156 367 SISNLNKLKILKLEFNELS-GEIPQELGKLASLLAVNVSY 405 (843)
Q Consensus 367 ~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~l~ls~ 405 (843)
.+..+++|+.|+|++|.++ +.+|..+..++.|+.++++.
T Consensus 232 ~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp TCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred hhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence 8999999999999999998 77888888888888888863
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=262.17 Aligned_cols=237 Identities=24% Similarity=0.204 Sum_probs=124.2
Q ss_pred CccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEE
Q 003156 78 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 157 (843)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 157 (843)
.++|++|+|++|.+.+..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.+++..+ .++|+.|+
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~ 105 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH 105 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence 3466666777666666666666677777777777777665444 6666777777777776664321 25566666
Q ss_pred eecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceec
Q 003156 158 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGS 237 (843)
Q Consensus 158 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~ 237 (843)
+++|.+++..+. .+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++..|..+..
T Consensus 106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~---------------- 166 (487)
T 3oja_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA---------------- 166 (487)
T ss_dssp CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGG----------------
T ss_pred CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhh----------------
Confidence 666665544332 2345666666666666555555555555555555555555433332221
Q ss_pred CCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCC
Q 003156 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317 (843)
Q Consensus 238 ~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 317 (843)
.+++|+.|+|++|.+++..+ +..+++|++|+|++|.|++..| .+..+++|+.|+|++|.|++ +|
T Consensus 167 ------------~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp 230 (487)
T 3oja_A 167 ------------SSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IE 230 (487)
T ss_dssp ------------GTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-EC
T ss_pred ------------hCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cc
Confidence 13445555555555543311 1234445555555554443222 24444444444444444442 34
Q ss_pred ccccccCCCcEEEcCCCCCC-CCchhhhcccCCCcEEecc
Q 003156 318 QEVCESRSLGILQLDGNSLT-GPIPQVIRNCTSLYLLSLS 356 (843)
Q Consensus 318 ~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls 356 (843)
..+..+++|+.|++++|.+. +.+|..+..++.|+.|+++
T Consensus 231 ~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp TTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred hhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 44444455555555555544 3344444444455444443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-24 Score=227.66 Aligned_cols=206 Identities=24% Similarity=0.212 Sum_probs=186.1
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
+.+.+++++++++ .+|..+ .++|++|+|++|+|..+++..|.++++|++|+|++|.++..+ +..|..+++|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~----~~~~~~l~~L~ 88 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNI---PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP----AGIFKELKNLE 88 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC----TTTTSSCTTCC
T ss_pred CCCEEEccCCCCC-ccCCCC---CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC----hhhhcCCCCCC
Confidence 5789999999999 788754 368999999999999999989999999999999999998544 34577899999
Q ss_pred EEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 162 (843)
+|+|++|++....+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|+
T Consensus 89 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 168 (270)
T 2o6q_A 89 TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ 168 (270)
T ss_dssp EEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence 99999999998778889999999999999999998888889999999999999999998888889999999999999999
Q ss_pred ccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCC
Q 003156 163 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 216 (843)
Q Consensus 163 l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 216 (843)
+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++....+
T Consensus 169 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 169 LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 998878889999999999999999998777789999999999999999976543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-28 Score=286.69 Aligned_cols=395 Identities=15% Similarity=0.140 Sum_probs=251.6
Q ss_pred CCCccEEecCCCcCcccC---C-----------hhhhhcCCCCcEEEccCcccccccccccc-CCCCCCEEECCCC-CCc
Q 003156 1 MMNMKFLDLSNNLLSGPV---P-----------YQLFENCASLRYLSLAGNILQGPIGKIFN-YCSSLNTLNLSNN-HFS 64 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~---~-----------~~~f~~l~~L~~L~L~~n~i~~~~~~~f~-~l~~L~~L~Ls~N-~i~ 64 (843)
+++|+.|+|++|.....+ | ..++..+++|++|+|++|.+.......+. .+++|++|+|++| .++
T Consensus 65 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~ 144 (594)
T 2p1m_B 65 FPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS 144 (594)
T ss_dssp CTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEE
T ss_pred CCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCC
Confidence 367888999887532121 1 23456788999999999888765544453 6889999999888 444
Q ss_pred cccCCCcCccccCCccCCEEecCCccCcccCchhhh----cCCCCCEEEcCCCc--cccc-CCCCCCCCCCCcEEEccCC
Q 003156 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA----ALHYLKELLLQGNQ--FSGP-LPADIGFCPHLTTLDLSNN 137 (843)
Q Consensus 65 ~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~L~~n~--l~~~-~~~~~~~l~~L~~L~L~~N 137 (843)
... ....+..+++|++|+|++|.+++..+..+. .+++|++|+|++|. ++.. ++..+..+++|++|+|++|
T Consensus 145 ~~~---l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 145 TDG---LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp HHH---HHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred HHH---HHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 210 111233678899999999987755544443 56689999998886 2211 1112234688999999988
Q ss_pred -cccccCCchhhcccCCcEEEeecC-------cccccCCCCccCCCCccEE-EcccCCcCCCCCCCCCCCCCCcEEEecC
Q 003156 138 -LFTGQLPVSLRLLNSMIFISVSNN-------TLTGDIPHWIGNISTLEFL-DFSNNHLTGSLPSSLFNCKKLSVIRLRG 208 (843)
Q Consensus 138 -~l~~~~~~~~~~l~~L~~L~L~~N-------~l~~~~p~~~~~l~~L~~L-~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 208 (843)
.+.+ ++..+..+++|+.|++..+ .+.+ ++..+.++++|+.| .+.+.... .++..+..+++|+.|+|++
T Consensus 222 ~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~L~L~~ 298 (594)
T 2p1m_B 222 VPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTTLNLSY 298 (594)
T ss_dssp SCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCEEECTT
T ss_pred CcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCEEEccC
Confidence 4443 6677788888999885544 3332 33356777788877 34333322 3444444677888888888
Q ss_pred CcCCCCCCchhh-c-cCcceeeccCCcceec-CCCCCCCCCcccccCccCEEeC---------CCCccceeCCcccc-CC
Q 003156 209 NSLNGNIPEGLF-D-LGLEEIDLSENGFMGS-IPPGSSSSSSSTLFQTLRILDL---------SSNNLVGDIPAEMG-LF 275 (843)
Q Consensus 209 N~l~~~~p~~~~-~-~~L~~L~l~~n~l~~~-~p~~~~~~~~~~~l~~L~~L~L---------~~n~l~~~~p~~~~-~l 275 (843)
|.+++.....+. . .+|+.|++++| +... ++. ....+++|++|++ +.+.+++.....+. .+
T Consensus 299 ~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~------l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~ 371 (594)
T 2p1m_B 299 ATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEV------LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGC 371 (594)
T ss_dssp CCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHH------HHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHC
T ss_pred CCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHH------HHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhc
Confidence 876532222211 2 26778888776 3211 100 0123567888877 33455433322332 36
Q ss_pred CCCcEEEcCCCcccCCCCCCcc-ccccceEEEcc--C----Cccccc-----CCccccccCCCcEEEcCCCCCCCCchhh
Q 003156 276 ANLRYLNLSSNHLRSRIPPELG-YFHSLIHLDLR--N----NALYGS-----IPQEVCESRSLGILQLDGNSLTGPIPQV 343 (843)
Q Consensus 276 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 343 (843)
++|++|.++.|.+++.....+. .+++|+.|+++ + |.+++. ++..+..+++|+.|+|++ .+++..+..
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~ 450 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEY 450 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHH
Confidence 7888888888877654433443 46788888888 4 555521 112255678888888877 666666666
Q ss_pred hcc-cCCCcEEecccccccccCCccc-cCCCCCCEEEccCCcccccCCc-chhcccccceEeeccccce
Q 003156 344 IRN-CTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQ-ELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 344 ~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~l~ls~N~l~ 409 (843)
+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|+++
T Consensus 451 l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 665 7888888888888876555555 5678888888888888655443 3445788888888888774
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-25 Score=230.67 Aligned_cols=211 Identities=21% Similarity=0.173 Sum_probs=162.4
Q ss_pred CCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCcc
Q 003156 175 STLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 254 (843)
Q Consensus 175 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L 254 (843)
++|++|+|++|.+++..+..|.++++|++|++++|.+++..+..+ ..+++|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----------------------------~~l~~L 78 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY-----------------------------QSLSHL 78 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTT-----------------------------TTCTTC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHc-----------------------------cCCcCC
Confidence 356667777776665555566666777777777666653222111 225677
Q ss_pred CEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCccccc-CCccccccCCCcEEEcCC
Q 003156 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS-IPQEVCESRSLGILQLDG 333 (843)
Q Consensus 255 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~ 333 (843)
++|+|++|.+++..+..|..+++|++|++++|.+.+..+..+..+++|++|++++|++++. +|..+..+++|+.|++++
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~ 158 (276)
T 2z62_A 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (276)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred CEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCC
Confidence 7777777777777777788888888888888888877777788888888889988888863 588889999999999999
Q ss_pred CCCCCCchhhhcccCCCc----EEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccce
Q 003156 334 NSLTGPIPQVIRNCTSLY----LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 334 N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 409 (843)
|++++..+..|..+++|+ .|++++|++++..+..+ ...+|+.|+|++|++++..+..+..+++|+.|++++|+++
T Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp SCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred CCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 999987778888888777 89999999986555544 4558999999999999777777889999999999999998
Q ss_pred ecCCCC
Q 003156 410 GRLPVG 415 (843)
Q Consensus 410 ~~~p~~ 415 (843)
+..|..
T Consensus 238 c~c~~l 243 (276)
T 2z62_A 238 CSCPRI 243 (276)
T ss_dssp CCTTTT
T ss_pred ccCCch
Confidence 877743
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=233.84 Aligned_cols=221 Identities=19% Similarity=0.178 Sum_probs=173.0
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCE
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~ 83 (843)
+..+++.++.+.+.+. +..+++|++|++++|.+..+.. +..+++|++|+|++|.+++.. .+..+++|++
T Consensus 21 l~~l~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~~~~--l~~l~~L~~L~l~~n~l~~~~------~l~~l~~L~~ 89 (272)
T 3rfs_A 21 TIKANLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHDIS------ALKELTNLTY 89 (272)
T ss_dssp HHHHHHTCSCTTSEEC---HHHHTTCCEEECTTSCCCCCTT--GGGCTTCCEEECTTSCCCCCG------GGTTCTTCCE
T ss_pred HHHHHhcCcccccccc---cccccceeeeeeCCCCcccccc--cccCCCCcEEECCCCCCCCch------hhcCCCCCCE
Confidence 3455677777763333 4567888888888888886654 778888888888888887532 4677888888
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcc
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 163 (843)
|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|++
T Consensus 90 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 169 (272)
T 3rfs_A 90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCc
Confidence 88888888877777788888888888888888877777788888888888888888877777788888888888888888
Q ss_pred cccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCC
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~ 241 (843)
++..+..|+.+++|++|+|++|++++..+..+..+++|+.|++++|++.+..| +++.++++.|.+.|.+|..
T Consensus 170 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 170 QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT------TTHHHHHHHHHTGGGBBCT
T ss_pred CccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc------HHHHHHHHHHhCCCcccCc
Confidence 87777778888888888888888887777778888888888888888875444 3555566666666655544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-25 Score=231.03 Aligned_cols=223 Identities=22% Similarity=0.164 Sum_probs=170.1
Q ss_pred EEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEe
Q 003156 6 FLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD 85 (843)
Q Consensus 6 ~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~ 85 (843)
.++.++.+++ .+|... .++|++|+|++|+|.+++...|.++++|++|+|++|++++.+. ..|..+++|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l---~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~ 82 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED----GAYQSLSHLSTLI 82 (276)
T ss_dssp EEECTTSCCS-SCCSSS---CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECT----TTTTTCTTCCEEE
T ss_pred eEEecCCCcc-ccCCCC---CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCH----HHccCCcCCCEEE
Confidence 5677777777 777653 2568888888888888887778888888888888888875433 3567788888888
Q ss_pred cCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCccccc-CCchhhcccCCcEEEeecCccc
Q 003156 86 LSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ-LPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 86 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
|++|.+++..+..|.++++|++|++++|.+++..+..+..+++|++|++++|.+++. .|..|..+++|++|+|++|+++
T Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence 888888877777888888888888888888877666788888888888888888764 4788888888888888888888
Q ss_pred ccCCCCccCCCCcc----EEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceec
Q 003156 165 GDIPHWIGNISTLE----FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGS 237 (843)
Q Consensus 165 ~~~p~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~ 237 (843)
+..+..|..+.+|+ +|++++|.+++..+..+. ..+|+.|++++|.+++..+..+... +|+.|++++|.+.+.
T Consensus 163 ~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp EECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred cCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 77677777776666 788888888855444444 4478888888888874444334433 688888888888754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=228.41 Aligned_cols=202 Identities=24% Similarity=0.200 Sum_probs=179.9
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
+++++.+++++|+++ .+|..++ ++++.|+|++|.|..+.+..|.++++|++|+|++|.|++.+. ...+++
T Consensus 9 l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~------~~~l~~ 78 (290)
T 1p9a_G 9 VASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV------DGTLPV 78 (290)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC------CSCCTT
T ss_pred cCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC------CCCCCc
Confidence 468899999999999 8887653 689999999999999988899999999999999999987543 257899
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 999999999998 6778889999999999999999988888899999999999999999988888899999999999999
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 214 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (843)
|+++...+..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|++...
T Consensus 158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 9999777777889999999999999999 6788888888999999999998753
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.2e-26 Score=257.61 Aligned_cols=186 Identities=16% Similarity=0.168 Sum_probs=147.4
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCccc-------ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.+.||+|+||.||+|.+ .++.+|+|+........ ..+.+.+|++++++++||||+++..++...+..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 45799999999999965 57889999875432211 1245789999999999999997777777778889999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999975 358999999999999998 9999999999999999 999999999998765
Q ss_pred cccce-----eccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCc
Q 003156 712 LDKHV-----MSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVE 763 (843)
Q Consensus 712 ~~~~~-----~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~ 763 (843)
..... ......||+.|||||++... ..|+..+|+||..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 33221 12456799999999988331 346788899999999999888887773
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=220.14 Aligned_cols=160 Identities=26% Similarity=0.214 Sum_probs=91.0
Q ss_pred CccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEc
Q 003156 252 QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL 331 (843)
Q Consensus 252 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 331 (843)
++|++|+|++|.++...+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 34444444444444333333444555555555555555544445555555555555555555554555556666666666
Q ss_pred CCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceec
Q 003156 332 DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 332 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
++|.+++..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|+.|++++|++.+.
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 66666655445566666666666666666655455566666666666666666655555566666666666666665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=224.24 Aligned_cols=206 Identities=19% Similarity=0.173 Sum_probs=186.6
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
+++|+.|++++|.++ .++. +..+++|++|+|++|.+.+++ .+..+++|++|+|++|.+++.++ ..|..+++
T Consensus 40 l~~L~~L~l~~~~i~-~~~~--l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~ 110 (272)
T 3rfs_A 40 LNSIDQIIANNSDIK-SVQG--IQYLPNVRYLALGGNKLHDIS--ALKELTNLTYLILTGNQLQSLPN----GVFDKLTN 110 (272)
T ss_dssp HTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECTTSCCCCCCT----TTTTTCTT
T ss_pred ccceeeeeeCCCCcc-cccc--cccCCCCcEEECCCCCCCCch--hhcCCCCCCEEECCCCccCccCh----hHhcCCcC
Confidence 467999999999998 6663 788999999999999999864 68999999999999999986543 35788999
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus 111 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 190 (272)
T 3rfs_A 111 LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ 190 (272)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCC
Confidence 99999999999988888899999999999999999988888889999999999999999988888899999999999999
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 222 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 222 (843)
|++++..+..|..+++|++|+|++|.+.+ .+++|+.|+++.|.++|.+|..+...
T Consensus 191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred CcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCccccc
Confidence 99998888889999999999999999874 36689999999999999999887754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8.6e-24 Score=222.56 Aligned_cols=204 Identities=25% Similarity=0.237 Sum_probs=147.1
Q ss_pred ccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccc
Q 003156 171 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 250 (843)
Q Consensus 171 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~ 250 (843)
++++++++++++++|.++ .+|..+. ++++.|+|++|.+++..+..+ ..
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~-----------------------------~~ 53 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATL-----------------------------MP 53 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGG-----------------------------TT
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHh-----------------------------hc
Confidence 456677777777777777 4455443 567777777777663333222 23
Q ss_pred cCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEE
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 330 (843)
+++|+.|+|++|.|++..+. +.+++|++|++++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 54 l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp CTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 56788888888888754432 67778888888888887 4566777778888888888888866667778888888888
Q ss_pred cCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeecccccee
Q 003156 331 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410 (843)
Q Consensus 331 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 410 (843)
|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.++|++|++..
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 8888888776677777888888888888887555556677888888888888887 677777777778888877777654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-26 Score=271.95 Aligned_cols=399 Identities=15% Similarity=0.107 Sum_probs=282.7
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCc-ccccc-ccccccCCCCCCEEECCCCCCccccCCCcCccccCC
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN-ILQGP-IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL 78 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n-~i~~~-~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l 78 (843)
+++|++|+|++|.+++..+..+...+++|++|+|++| .+... ....+.++++|++|+|++|.+++............+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 4689999999999986656555457999999999999 55542 334456899999999999998753322122233467
Q ss_pred ccCCEEecCCcc--Ccc-cCchhhhcCCCCCEEEcCCC-cccccCCCCCCCCCCCcEEEccCC-------cccccCCchh
Q 003156 79 KRLRTLDLSHNL--FSG-SIPQGVAALHYLKELLLQGN-QFSGPLPADIGFCPHLTTLDLSNN-------LFTGQLPVSL 147 (843)
Q Consensus 79 ~~L~~L~L~~n~--l~~-~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N-------~l~~~~~~~~ 147 (843)
++|++|++++|. +.. .+...+..+++|++|+|++| .+.+ ++..+..+++|++|+++.+ .+.+ ++..+
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l 261 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVAL 261 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHH
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHH
Confidence 899999999997 321 12233456799999999999 4543 6667778999999996554 4443 33477
Q ss_pred hcccCCcEEE-eecCcccccCCCCccCCCCccEEEcccCCcCCCC-CCCCCCCCCCcEEEecCCcCCCCCCchhh-c-cC
Q 003156 148 RLLNSMIFIS-VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSL-PSSLFNCKKLSVIRLRGNSLNGNIPEGLF-D-LG 223 (843)
Q Consensus 148 ~~l~~L~~L~-L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~-~~ 223 (843)
.++++|+.|+ +.+... ..++..+..+++|++|+|++|.+++.. ...+..+++|+.|++++| +.......+. . .+
T Consensus 262 ~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~ 339 (594)
T 2p1m_B 262 SGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD 339 (594)
T ss_dssp HTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT
T ss_pred hcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC
Confidence 8899999983 443332 345555667899999999999976432 223568899999999998 4422222222 2 36
Q ss_pred cceeeccC---------CcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCcccc-CCCCCcEEEcC--C----Cc
Q 003156 224 LEEIDLSE---------NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG-LFANLRYLNLS--S----NH 287 (843)
Q Consensus 224 L~~L~l~~---------n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~--~----N~ 287 (843)
|+.|++++ +.+.+.... .....+++|+.|.++.|.+++.....+. .+++|+.|+++ + |.
T Consensus 340 L~~L~L~~~~~~g~~~~~~l~~~~l~-----~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~ 414 (594)
T 2p1m_B 340 LRELRVFPSEPFVMEPNVALTEQGLV-----SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDY 414 (594)
T ss_dssp CCEEEEECSCTTCSSCSSCCCHHHHH-----HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCT
T ss_pred CCEEEEecCcccccccCCCCCHHHHH-----HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccc
Confidence 99998844 333211000 0012368899999999999876665554 58999999999 4 55
Q ss_pred ccCCCC-----CCccccccceEEEccCCcccccCCccccc-cCCCcEEEcCCCCCCCCchhhh-cccCCCcEEecccccc
Q 003156 288 LRSRIP-----PELGYFHSLIHLDLRNNALYGSIPQEVCE-SRSLGILQLDGNSLTGPIPQVI-RNCTSLYLLSLSHNHL 360 (843)
Q Consensus 288 l~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l 360 (843)
++.... ..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|+.|+|++|.+
T Consensus 415 l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 415 LTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp TTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred ccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 653221 1256778999999987 777665566665 8999999999999987666665 7799999999999999
Q ss_pred cccCCc-cccCCCCCCEEEccCCcccccCCcch-hcccccceEeeccccce
Q 003156 361 SGSIPK-SISNLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYNRLI 409 (843)
Q Consensus 361 ~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~l~ls~N~l~ 409 (843)
++..+. .+..+++|++|+|++|+++......+ ..++.|+...+..+.-.
T Consensus 494 ~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 494 GDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp CHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred cHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 755444 44568999999999999965444445 55677776666655433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-25 Score=243.34 Aligned_cols=262 Identities=21% Similarity=0.205 Sum_probs=150.7
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCcccccCC----CCCCCCC-CCcEEEccCCcccccCCchhhcc-----cCC
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP----ADIGFCP-HLTTLDLSNNLFTGQLPVSLRLL-----NSM 153 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L 153 (843)
++|++|.+++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5666677766666655555567777777777765544 4555666 67777777777766555555554 556
Q ss_pred cEEEeecCcccccCCCCcc----CC-CCccEEEcccCCcCCCCCCCCC----C-CCCCcEEEecCCcCCCCCCchhhccC
Q 003156 154 IFISVSNNTLTGDIPHWIG----NI-STLEFLDFSNNHLTGSLPSSLF----N-CKKLSVIRLRGNSLNGNIPEGLFDLG 223 (843)
Q Consensus 154 ~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~i~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~p~~~~~~~ 223 (843)
++|+|++|++++..+..++ .+ ++|++|+|++|++++..+..+. . .++|++|+|++|.++...+..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l---- 158 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL---- 158 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH----
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH----
Confidence 6666666655544333222 22 4555555555555543332221 1 2345555555554442221111
Q ss_pred cceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCC-CCcEEEcCCCcccCCCCCCcc----c
Q 003156 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA-NLRYLNLSSNHLRSRIPPELG----Y 298 (843)
Q Consensus 224 L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~----~ 298 (843)
+..+..++ +|++|+|++|.|++..+..+. .
T Consensus 159 ---------------------------------------------~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 193 (362)
T 3goz_A 159 ---------------------------------------------IQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193 (362)
T ss_dssp ---------------------------------------------HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHT
T ss_pred ---------------------------------------------HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHh
Confidence 11122222 455555555554443332222 2
Q ss_pred c-ccceEEEccCCccccc----CCccccc-cCCCcEEEcCCCCCCCCchh----hhcccCCCcEEeccccccccc-----
Q 003156 299 F-HSLIHLDLRNNALYGS----IPQEVCE-SRSLGILQLDGNSLTGPIPQ----VIRNCTSLYLLSLSHNHLSGS----- 363 (843)
Q Consensus 299 l-~~L~~L~L~~n~l~~~----~~~~~~~-l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----- 363 (843)
+ .+|++|+|++|.|++. ++..+.. .++|+.|+|++|.+++..+. .+..+++|+.|+|++|.+.+.
T Consensus 194 ~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~ 273 (362)
T 3goz_A 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC 273 (362)
T ss_dssp SCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHH
T ss_pred CCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHH
Confidence 2 3566666666666532 3444544 35888888888888876553 346678899999999985432
Q ss_pred --CCccccCCCCCCEEEccCCcccccCCcchhc
Q 003156 364 --IPKSISNLNKLKILKLEFNELSGEIPQELGK 394 (843)
Q Consensus 364 --~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 394 (843)
++..+..+++|+.|||++|++.+..+..+.+
T Consensus 274 ~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~~ 306 (362)
T 3goz_A 274 KALGAAFPNIQKIILVDKNGKEIHPSHSIPISN 306 (362)
T ss_dssp HHHHTTSTTCCEEEEECTTSCBCCGGGCHHHHH
T ss_pred HHHHHHhccCCceEEEecCCCcCCCcchHHHHH
Confidence 3446778888999999999988776665543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-25 Score=246.54 Aligned_cols=290 Identities=21% Similarity=0.226 Sum_probs=184.7
Q ss_pred cCCEEecCCccCcccCchhhhcCCCCCEEEcCCCccccc----CCCCCCCCCCCcEEEccCCccc---ccCCchhhcccC
Q 003156 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP----LPADIGFCPHLTTLDLSNNLFT---GQLPVSLRLLNS 152 (843)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~ 152 (843)
.|+...++...+. .++..+..+++|++|+|++|.++.. ++..+..+++|++|+|++|.+. +..|..+..+
T Consensus 10 ~L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l-- 86 (386)
T 2ca6_A 10 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL-- 86 (386)
T ss_dssp CCEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH--
T ss_pred ccccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHH--
Confidence 3444445555554 5667778888888888888888754 3344677888888888886443 3334433211
Q ss_pred CcEEEeecCcccccCCCCccCCCCccEEEcccCCcCC----CCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceee
Q 003156 153 MIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG----SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEID 228 (843)
Q Consensus 153 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~ 228 (843)
...|..+++|++|+|++|.++. .++..+..+++|++|+|++|.++...+..+... +..
T Consensus 87 ---------------~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~-l~~-- 148 (386)
T 2ca6_A 87 ---------------LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQE-- 148 (386)
T ss_dssp ---------------HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH-HHH--
T ss_pred ---------------HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH-HHH--
Confidence 1234566777777777777765 355566777778888888777753333222211 000
Q ss_pred ccCCcceecCCCCCCCCCcccccCccCEEeCCCCccc-eeCC---ccccCCCCCcEEEcCCCcccC-----CCCCCcccc
Q 003156 229 LSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV-GDIP---AEMGLFANLRYLNLSSNHLRS-----RIPPELGYF 299 (843)
Q Consensus 229 l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l 299 (843)
+..|.+.+. .++|++|+|++|+++ +.++ ..+..+++|++|++++|.|+. ..+..+..+
T Consensus 149 l~~~~~~~~-------------~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~ 215 (386)
T 2ca6_A 149 LAVNKKAKN-------------APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215 (386)
T ss_dssp HHHHHHHHT-------------CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred Hhhhhhccc-------------CCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence 011111110 157888888888876 2333 356677788888888888762 234467777
Q ss_pred ccceEEEccCCccc----ccCCccccccCCCcEEEcCCCCCCCC----chhhhc--ccCCCcEEecccccccc----cCC
Q 003156 300 HSLIHLDLRNNALY----GSIPQEVCESRSLGILQLDGNSLTGP----IPQVIR--NCTSLYLLSLSHNHLSG----SIP 365 (843)
Q Consensus 300 ~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~----~~p 365 (843)
++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. ++..+. .+++|+.|+|++|.+++ .+|
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 78888888888885 56677777888888888888888765 455553 37888888888888876 367
Q ss_pred ccc-cCCCCCCEEEccCCcccccCC--cchh-cccccceEee
Q 003156 366 KSI-SNLNKLKILKLEFNELSGEIP--QELG-KLASLLAVNV 403 (843)
Q Consensus 366 ~~~-~~l~~L~~L~L~~N~l~~~~p--~~~~-~l~~L~~l~l 403 (843)
..+ .++++|++|+|++|++++..+ ..+. .++.++.+++
T Consensus 296 ~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l 337 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGEL 337 (386)
T ss_dssp HHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEE
T ss_pred HHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchh
Confidence 666 567888888888888876653 2222 3444444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=212.96 Aligned_cols=208 Identities=14% Similarity=0.137 Sum_probs=170.0
Q ss_pred CCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCC-CccccCCCcCccccCCccCCEEecCC-
Q 003156 11 NNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH-FSGDLDFASGYGIWSLKRLRTLDLSH- 88 (843)
Q Consensus 11 ~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~-i~~~~~~~~~~~~~~l~~L~~L~L~~- 88 (843)
.++++ .+|. + .++|++|+|++|+|+++++..|.++++|++|+|++|+ ++..++ ..|..+++|++|++++
T Consensus 20 c~~l~-~ip~--~--~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~----~~f~~l~~L~~L~l~~~ 90 (239)
T 2xwt_C 20 CKDIQ-RIPS--L--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES----HSFYNLSKVTHIEIRNT 90 (239)
T ss_dssp ECSCS-SCCC--C--CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECT----TTEESCTTCCEEEEEEE
T ss_pred ccCcc-ccCC--C--CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCH----hHcCCCcCCcEEECCCC
Confidence 34476 7886 3 3589999999999999988889999999999999997 775443 3578889999999998
Q ss_pred ccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCc---EEEccCC-cccccCCchhhcccCCc-EEEeecCcc
Q 003156 89 NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLT---TLDLSNN-LFTGQLPVSLRLLNSMI-FISVSNNTL 163 (843)
Q Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l 163 (843)
|+++...+..|.++++|++|+|++|++++ +|. |..+++|+ +|++++| .++...+..|..+++|+ .|++++|++
T Consensus 91 n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 91 RNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp TTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred CCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 89987777888999999999999999985 555 88888888 9999999 89888888899999999 999999999
Q ss_pred cccCCCCccCCCCccEEEcccCC-cCCCCCCCCCCC-CCCcEEEecCCcCCCCCCchhhccCcceeeccCC
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNH-LTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSEN 232 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n 232 (843)
+...+..|.. ++|++|+|++|+ ++...+..|..+ ++|+.|++++|.++ .+|.. .-.+|+.|+++++
T Consensus 169 ~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~-~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 169 TSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK-GLEHLKELIARNT 236 (239)
T ss_dssp CEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT-TCTTCSEEECTTC
T ss_pred cccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh-HhccCceeeccCc
Confidence 8544555555 889999999995 887777788888 99999999999998 45554 2236888888765
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-25 Score=239.25 Aligned_cols=256 Identities=19% Similarity=0.203 Sum_probs=163.9
Q ss_pred EccCCcccccCCchhhcccCCcEEEeecCcccccCC----CCccCCC-CccEEEcccCCcCCCCCCCCCCC-----CCCc
Q 003156 133 DLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP----HWIGNIS-TLEFLDFSNNHLTGSLPSSLFNC-----KKLS 202 (843)
Q Consensus 133 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l-----~~L~ 202 (843)
+++.|.+++.+|..+...++|++|+|++|++++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 444444444444444433344444444444443333 3444444 55555555555554444444443 5666
Q ss_pred EEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCccccc-CccCEEeCCCCccceeCCcccc----C-CC
Q 003156 203 VIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF-QTLRILDLSSNNLVGDIPAEMG----L-FA 276 (843)
Q Consensus 203 ~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l-~~L~~L~L~~n~l~~~~p~~~~----~-l~ 276 (843)
+|+|++|.+++..+..+... ...+ ++|++|+|++|++++..+..+. . .+
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~-------------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 138 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKT-------------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHH-------------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCT
T ss_pred EEECcCCcCChHHHHHHHHH-------------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCC
Confidence 66666666654443333221 0012 4677777777777655444433 2 25
Q ss_pred CCcEEEcCCCcccCCCCCC----ccccc-cceEEEccCCcccccCCccccc----c-CCCcEEEcCCCCCCCC----chh
Q 003156 277 NLRYLNLSSNHLRSRIPPE----LGYFH-SLIHLDLRNNALYGSIPQEVCE----S-RSLGILQLDGNSLTGP----IPQ 342 (843)
Q Consensus 277 ~L~~L~L~~N~l~~~~~~~----~~~l~-~L~~L~L~~n~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~----~p~ 342 (843)
+|++|+|++|.+++..+.. +..++ +|++|+|++|++++..+..+.. + ++|+.|+|++|.|++. ++.
T Consensus 139 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 7888888888887543322 34444 9999999999999776655554 4 6999999999999863 556
Q ss_pred hhcc-cCCCcEEecccccccccCC----ccccCCCCCCEEEccCCcccccC-------CcchhcccccceEeecccccee
Q 003156 343 VIRN-CTSLYLLSLSHNHLSGSIP----KSISNLNKLKILKLEFNELSGEI-------PQELGKLASLLAVNVSYNRLIG 410 (843)
Q Consensus 343 ~~~~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~-------p~~~~~l~~L~~l~ls~N~l~~ 410 (843)
.+.. .++|+.|+|++|++++..+ ..+..+++|+.|+|++|.+.+.. +..+..+++|+.||+++|++..
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 6666 4599999999999986544 44578899999999999965433 3456788899999999999876
Q ss_pred cCC
Q 003156 411 RLP 413 (843)
Q Consensus 411 ~~p 413 (843)
..|
T Consensus 299 ~~~ 301 (362)
T 3goz_A 299 SHS 301 (362)
T ss_dssp GGC
T ss_pred cch
Confidence 643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-23 Score=217.72 Aligned_cols=191 Identities=23% Similarity=0.303 Sum_probs=90.3
Q ss_pred cCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCC
Q 003156 25 NCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHY 104 (843)
Q Consensus 25 ~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 104 (843)
.+++|++|++++|.+..++ .+..+++|++|+|++|.+++.+. +..+++|++|+|++|++++ ++ .+..+++
T Consensus 39 ~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~------~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~ 108 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP------LKNLTKITELELSGNPLKN-VS-AIAGLQS 108 (308)
T ss_dssp HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG------GTTCCSCCEEECCSCCCSC-CG-GGTTCTT
T ss_pred HcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh------HccCCCCCEEEccCCcCCC-ch-hhcCCCC
Confidence 3445555555555554443 24445555555555555443211 3444555555555555542 21 3455555
Q ss_pred CCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEccc
Q 003156 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN 184 (843)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 184 (843)
|++|+|++|++++. +. +..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|+|++
T Consensus 109 L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~ 182 (308)
T 1h6u_A 109 IKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182 (308)
T ss_dssp CCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCC
Confidence 55555555555432 21 4455555555555555543322 4455555555555555543222 45555555555555
Q ss_pred CCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcce
Q 003156 185 NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFM 235 (843)
Q Consensus 185 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~ 235 (843)
|++++..+ +..+++|+.|++++|.+++.. . +..+ +|+.|++++|.+.
T Consensus 183 n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~-~-l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 183 NKISDISP--LASLPNLIEVHLKNNQISDVS-P-LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp SCCCCCGG--GGGCTTCCEEECTTSCCCBCG-G-GTTCTTCCEEEEEEEEEE
T ss_pred CccCcChh--hcCCCCCCEEEccCCccCccc-c-ccCCCCCCEEEccCCeee
Confidence 55543221 445555555555555554322 1 2222 4555555555554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-25 Score=242.60 Aligned_cols=243 Identities=22% Similarity=0.296 Sum_probs=182.6
Q ss_pred cCCchhhcccCCcEEEeecCccccc----CCCCccCCCCccEEEcccCCc---CCCCCCCC-------CCCCCCcEEEec
Q 003156 142 QLPVSLRLLNSMIFISVSNNTLTGD----IPHWIGNISTLEFLDFSNNHL---TGSLPSSL-------FNCKKLSVIRLR 207 (843)
Q Consensus 142 ~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~i---~~~~~~~~-------~~l~~L~~L~L~ 207 (843)
.++..+..+++|+.|+|++|++... ++..|..+++|++|+|++|.+ ++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 3445555666666666666666543 233466777788888777533 33444444 678899999999
Q ss_pred CCcCCCC----CCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccC----C----
Q 003156 208 GNSLNGN----IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL----F---- 275 (843)
Q Consensus 208 ~N~l~~~----~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~----l---- 275 (843)
+|.++.. +|..+. .+++|++|+|++|.+++..+..+.. +
T Consensus 103 ~n~l~~~~~~~l~~~l~-----------------------------~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~ 153 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLS-----------------------------KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153 (386)
T ss_dssp SCCCCTTTHHHHHHHHH-----------------------------HCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHH-----------------------------hCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhh
Confidence 9988752 232222 3567888888888886544444433 3
Q ss_pred -----CCCcEEEcCCCcccC-CCC---CCccccccceEEEccCCcccc-----cCCccccccCCCcEEEcCCCCCC----
Q 003156 276 -----ANLRYLNLSSNHLRS-RIP---PELGYFHSLIHLDLRNNALYG-----SIPQEVCESRSLGILQLDGNSLT---- 337 (843)
Q Consensus 276 -----~~L~~L~L~~N~l~~-~~~---~~~~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~---- 337 (843)
++|++|++++|+++. ..+ ..+..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++
T Consensus 154 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~ 233 (386)
T 2ca6_A 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233 (386)
T ss_dssp HHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH
T ss_pred hcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHH
Confidence 899999999999973 233 356678899999999999982 34447889999999999999996
Q ss_pred CCchhhhcccCCCcEEeccccccccc----CCcccc--CCCCCCEEEccCCcccc----cCCcch-hcccccceEeeccc
Q 003156 338 GPIPQVIRNCTSLYLLSLSHNHLSGS----IPKSIS--NLNKLKILKLEFNELSG----EIPQEL-GKLASLLAVNVSYN 406 (843)
Q Consensus 338 ~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~l~ls~N 406 (843)
+.+|..+..+++|+.|+|++|+|++. +|..+. .+++|+.|+|++|+|++ .+|..+ .++++|+.|++++|
T Consensus 234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N 313 (386)
T 2ca6_A 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313 (386)
T ss_dssp HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTS
T ss_pred HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCC
Confidence 57888999999999999999999866 567774 49999999999999997 488887 67899999999999
Q ss_pred cceecCC
Q 003156 407 RLIGRLP 413 (843)
Q Consensus 407 ~l~~~~p 413 (843)
++++..|
T Consensus 314 ~l~~~~~ 320 (386)
T 2ca6_A 314 RFSEEDD 320 (386)
T ss_dssp BSCTTSH
T ss_pred cCCcchh
Confidence 9886543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=211.26 Aligned_cols=195 Identities=17% Similarity=0.170 Sum_probs=106.9
Q ss_pred CCCEEECCCCCCccccCCCcCccccCCccCCEEecCCcc-CcccCchhhhcCCCCCEEEcCC-CcccccCCCCCCCCCCC
Q 003156 52 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNL-FSGSIPQGVAALHYLKELLLQG-NQFSGPLPADIGFCPHL 129 (843)
Q Consensus 52 ~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L 129 (843)
+|++|+|++|+|++.+. ..|..+++|++|++++|+ ++...+..|.++++|++|+|++ |.+++..+..|.++++|
T Consensus 32 ~l~~L~l~~n~l~~i~~----~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L 107 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPS----HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107 (239)
T ss_dssp TCCEEEEESCCCSEECT----TTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTC
T ss_pred cccEEEEeCCcceEECH----HHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCC
Confidence 56666666666654332 235556666666666664 5555555566666666666665 66665555555566666
Q ss_pred cEEEccCCcccccCCchhhcccCCc---EEEeecC-cccccCCCCccCCCCcc-EEEcccCCcCCCCCCCCCCCCCCcEE
Q 003156 130 TTLDLSNNLFTGQLPVSLRLLNSMI---FISVSNN-TLTGDIPHWIGNISTLE-FLDFSNNHLTGSLPSSLFNCKKLSVI 204 (843)
Q Consensus 130 ~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~i~~~~~~~~~~l~~L~~L 204 (843)
++|++++|.+++ +|. |..+++|+ .|++++| ++++..+..|.++++|+ +|++++|+++...+..|.. ++|+.|
T Consensus 108 ~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L 184 (239)
T 2xwt_C 108 KFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAV 184 (239)
T ss_dssp CEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEE
T ss_pred CEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEE
Confidence 666666666654 333 55555555 6666666 56555555566666666 6666666665332223333 566666
Q ss_pred EecCCc-CCCCCCchhhcc--CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCC
Q 003156 205 RLRGNS-LNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 262 (843)
Q Consensus 205 ~L~~N~-l~~~~p~~~~~~--~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n 262 (843)
++++|+ +++..+..+... +|+.|++++|++.+ +|.. .+++|+.|+++++
T Consensus 185 ~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--------~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--------GLEHLKELIARNT 236 (239)
T ss_dssp ECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--------TCTTCSEEECTTC
T ss_pred EcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--------HhccCceeeccCc
Confidence 666663 553333333333 46666666666652 2221 2455666665554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-22 Score=206.49 Aligned_cols=180 Identities=19% Similarity=0.170 Sum_probs=126.1
Q ss_pred CCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCE
Q 003156 28 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKE 107 (843)
Q Consensus 28 ~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 107 (843)
+.++++++++.++.++.... ++|++|+|++|.+++..+ ..|..+++|++|+|++|++++..+..|..+++|++
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~---~~l~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 87 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIP---ADTEKLDLQSTGLATLSD----ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT 87 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCC---TTCCEEECTTSCCCCCCT----TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCeEEecCCCCccccCCCCC---CCCCEEEccCCCcCccCH----hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCE
Confidence 45566666666666555432 456666666666664322 24556666666666666666666666677777777
Q ss_pred EEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCc
Q 003156 108 LLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHL 187 (843)
Q Consensus 108 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i 187 (843)
|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus 88 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 167 (251)
T 3m19_A 88 LGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQL 167 (251)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcC
Confidence 77777777766666667777777777777777766666677777777777777777766666778888888888888888
Q ss_pred CCCCCCCCCCCCCCcEEEecCCcCCCC
Q 003156 188 TGSLPSSLFNCKKLSVIRLRGNSLNGN 214 (843)
Q Consensus 188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (843)
++..+..|..+++|+.|+|++|++.+.
T Consensus 168 ~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 168 QSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 877677788888888888888888765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-22 Score=205.37 Aligned_cols=180 Identities=22% Similarity=0.179 Sum_probs=165.7
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
+.+.+++++++++ .+|.... ++|++|+|++|.|.++.+..|.++++|++|+|++|.|++.+ +..|..+++|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~ 86 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS----AGVFDDLTELG 86 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC----TTTTTTCTTCC
T ss_pred CCeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC----HhHhccCCcCC
Confidence 4688999999999 8997653 68999999999999999999999999999999999998644 34678899999
Q ss_pred EEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 162 (843)
+|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 87 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 99999999998888899999999999999999998888888999999999999999998888899999999999999999
Q ss_pred ccccCCCCccCCCCccEEEcccCCcCCC
Q 003156 163 LTGDIPHWIGNISTLEFLDFSNNHLTGS 190 (843)
Q Consensus 163 l~~~~p~~~~~l~~L~~L~L~~N~i~~~ 190 (843)
+++..+..|..+++|++|+|++|.++..
T Consensus 167 l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 167 LQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9988888999999999999999999853
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-23 Score=218.97 Aligned_cols=153 Identities=24% Similarity=0.298 Sum_probs=102.9
Q ss_pred cCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccC---CC-CCCccccccceEEEccCCcccccCCc----cccc
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS---RI-PPELGYFHSLIHLDLRNNALYGSIPQ----EVCE 322 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~---~~-~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~ 322 (843)
+++|++|+|++|++.+..+..++.+++|++|+|++|++.+ .. +..+..+++|++|+|++|+++ .++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 3456666666666655555666666666666666666543 11 122355667777777777775 2222 2456
Q ss_pred cCCCcEEEcCCCCCCCCchhhhccc---CCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccc
Q 003156 323 SRSLGILQLDGNSLTGPIPQVIRNC---TSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLL 399 (843)
Q Consensus 323 l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 399 (843)
+++|++|+|++|++++..|..+..+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 7788888888888887767766666 58888888888888 6676664 7888888888888853 33 56778888
Q ss_pred eEeeccccce
Q 003156 400 AVNVSYNRLI 409 (843)
Q Consensus 400 ~l~ls~N~l~ 409 (843)
.|++++|+++
T Consensus 298 ~L~L~~N~l~ 307 (310)
T 4glp_A 298 NLTLDGNPFL 307 (310)
T ss_dssp CEECSSTTTS
T ss_pred EEECcCCCCC
Confidence 8888888776
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.7e-23 Score=219.73 Aligned_cols=225 Identities=20% Similarity=0.189 Sum_probs=148.6
Q ss_pred CCCcEEEccCcccccccc---ccccCCCCCCEEECCCCCCccccCCCcCccc--cCCccCCEEecCCccCcccCc----h
Q 003156 27 ASLRYLSLAGNILQGPIG---KIFNYCSSLNTLNLSNNHFSGDLDFASGYGI--WSLKRLRTLDLSHNLFSGSIP----Q 97 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~---~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~ 97 (843)
..++.|.+.++.+....- ..+..+++|++|+|++|.+++..+. .+ ..+++|++|+|++|.+.+..+ .
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~----~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~ 139 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPP----LPLEATGLALSSLRLRNVSWATGRSWLAEL 139 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCC----CSSSCCCBCCSSCEEESCCCSSTTSSHHHH
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhh----hhhhccCCCCCEEEeecccccchhhhhHHH
Confidence 346677777766642110 0122345677777777777654332 23 567777777777777775433 3
Q ss_pred hhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccc---cC-CchhhcccCCcEEEeecCcccccCCC----
Q 003156 98 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG---QL-PVSLRLLNSMIFISVSNNTLTGDIPH---- 169 (843)
Q Consensus 98 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~-~~~~~~l~~L~~L~L~~N~l~~~~p~---- 169 (843)
.+..+++|++|+|++|++++..+..|+.+++|++|+|++|++.+ .. +..+..+++|++|+|++|+++. ++.
T Consensus 140 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~ 218 (310)
T 4glp_A 140 QQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAA 218 (310)
T ss_dssp HTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHH
T ss_pred HhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHH
Confidence 34467777777777777777777777777777777777777653 11 2234567777777777777752 222
Q ss_pred CccCCCCccEEEcccCCcCCCCCCCCCCC---CCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCC
Q 003156 170 WIGNISTLEFLDFSNNHLTGSLPSSLFNC---KKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSS 246 (843)
Q Consensus 170 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~ 246 (843)
.++++++|++|+|++|++++..|..+..+ ++|++|+|++|.++ .+|..+. .+|+.|++++|++.+. |.
T Consensus 219 l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~l~~~-~~------ 289 (310)
T 4glp_A 219 LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNRLNRA-PQ------ 289 (310)
T ss_dssp HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCCCCSC-CC------
T ss_pred HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCcCCCC-ch------
Confidence 24567778888888888776667666665 57888888888877 5666554 4678888888887743 21
Q ss_pred cccccCccCEEeCCCCccce
Q 003156 247 SSTLFQTLRILDLSSNNLVG 266 (843)
Q Consensus 247 ~~~~l~~L~~L~L~~n~l~~ 266 (843)
...+++|+.|+|++|++++
T Consensus 290 -~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 290 -PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp -TTSCCCCSCEECSSTTTSC
T ss_pred -hhhCCCccEEECcCCCCCC
Confidence 1346889999999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-22 Score=211.68 Aligned_cols=124 Identities=23% Similarity=0.342 Sum_probs=67.6
Q ss_pred CccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEc
Q 003156 252 QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL 331 (843)
Q Consensus 252 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 331 (843)
++|++|+|++|++++. +. +..+++|++|++++|.+++..+ +..+++|++|++++|++++. +. +..+++|+.|++
T Consensus 107 ~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 107 QSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKA 180 (308)
T ss_dssp TTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEEC
Confidence 3444444444444432 21 4555555555555555554322 55555555666666655532 22 555666666666
Q ss_pred CCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 332 DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 332 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
++|.+++..+ +..+++|+.|+|++|++++.. .+..+++|+.|+|++|+++
T Consensus 181 ~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred CCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 6666664332 566666666666666666333 2566666666666666665
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-22 Score=216.65 Aligned_cols=200 Identities=14% Similarity=0.082 Sum_probs=132.3
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCE-
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT- 83 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~- 83 (843)
++++.++++++ +||..+ .+++++|+|++|+|+.+++++|.++++|++|+|++|++.+.. ...+|.++++|++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i---~~~~f~~L~~l~~~ 84 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI---EADVFSNLPKLHEI 84 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEE---CTTSBCSCTTCCEE
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCcc---ChhHhhcchhhhhh
Confidence 46777888888 788665 357888888888888888888888888888888888875432 2335667777664
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccC-CcccccCCchhhccc-CCcEEEeecC
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN-NLFTGQLPVSLRLLN-SMIFISVSNN 161 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N 161 (843)
+.++.|+|....|+.|..+++|++|++++|+++...+..+....++..|++++ |++..+.+..|..+. .++.|+|++|
T Consensus 85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N 164 (350)
T 4ay9_X 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164 (350)
T ss_dssp EEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred hcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence 55566777766677777777777777777777766665666666677777754 456655555565554 4666666666
Q ss_pred cccccCCCCccCCCCccEEEccc-CCcCCCCCCCCCCCCCCcEEEecCCcCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+|+.+.+..| ...+|++|++++ |.++.+.++.|..+++|+.|+|++|+|+
T Consensus 165 ~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 165 GIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp CCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred cccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 6664333333 345566666653 5555443445566666666666666665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-24 Score=228.17 Aligned_cols=249 Identities=20% Similarity=0.186 Sum_probs=173.1
Q ss_pred CcEEEccCCcccccCCchhhcc--cCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCC-CCCCCCCCCCCcEEE
Q 003156 129 LTTLDLSNNLFTGQLPVSLRLL--NSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGS-LPSSLFNCKKLSVIR 205 (843)
Q Consensus 129 L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~ 205 (843)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 556666666554 3445555 6666777777766655444 44567777777777776643 556666777777777
Q ss_pred ecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCC-cccee-CCccccCCCCCcEEEc
Q 003156 206 LRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN-NLVGD-IPAEMGLFANLRYLNL 283 (843)
Q Consensus 206 L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L 283 (843)
|++|.+++..+..+. .+++|++|+|++| .+++. ++..+..+++|++|++
T Consensus 125 L~~~~l~~~~~~~l~-----------------------------~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l 175 (336)
T 2ast_B 125 LEGLRLSDPIVNTLA-----------------------------KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 175 (336)
T ss_dssp CTTCBCCHHHHHHHT-----------------------------TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC
T ss_pred CcCcccCHHHHHHHh-----------------------------cCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcC
Confidence 777766543333222 1456777777776 45542 4555667777888888
Q ss_pred CCC-cccCC-CCCCccccc-cceEEEccCC--ccc-ccCCccccccCCCcEEEcCCCC-CCCCchhhhcccCCCcEEecc
Q 003156 284 SSN-HLRSR-IPPELGYFH-SLIHLDLRNN--ALY-GSIPQEVCESRSLGILQLDGNS-LTGPIPQVIRNCTSLYLLSLS 356 (843)
Q Consensus 284 ~~N-~l~~~-~~~~~~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls 356 (843)
++| .+++. .+..+..++ +|++|++++| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|+.|+|+
T Consensus 176 ~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~ 255 (336)
T 2ast_B 176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255 (336)
T ss_dssp CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred CCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCC
Confidence 887 77643 344566777 8888888888 444 4566777889999999999998 777788889999999999999
Q ss_pred ccc-ccccCCccccCCCCCCEEEccCCcccccCCcchhccc-ccceEeeccccceecCCC
Q 003156 357 HNH-LSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA-SLLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 357 ~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~ls~N~l~~~~p~ 414 (843)
+|. +.......++++++|+.|+|++| ++ ...+..+. .+..|++++|++++..|.
T Consensus 256 ~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 256 RCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred CCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCC
Confidence 995 33222236888999999999999 33 33455553 488888999999998884
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.7e-24 Score=228.12 Aligned_cols=128 Identities=20% Similarity=0.210 Sum_probs=80.9
Q ss_pred CCEEecCCccCcccCchhhhcC--CCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCccccc-CCchhhcccCCcEEE
Q 003156 81 LRTLDLSHNLFSGSIPQGVAAL--HYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ-LPVSLRLLNSMIFIS 157 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ 157 (843)
++.+++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 566666666654 3455555 6777777777777755544 45677777777777777644 555666666777777
Q ss_pred eecCcccccCCCCccCCCCccEEEcccC-CcCC-CCCCCCCCCCCCcEEEecCC-cCC
Q 003156 158 VSNNTLTGDIPHWIGNISTLEFLDFSNN-HLTG-SLPSSLFNCKKLSVIRLRGN-SLN 212 (843)
Q Consensus 158 L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~i~~-~~~~~~~~l~~L~~L~L~~N-~l~ 212 (843)
|++|++++..+..++.+++|++|+|++| .+++ .++..+.++++|++|++++| .++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 182 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence 7777666555556666666777777666 4543 13444555666666666666 554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-21 Score=207.69 Aligned_cols=240 Identities=17% Similarity=0.109 Sum_probs=135.3
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccC-CchhhcccCCcE-EEee
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL-PVSLRLLNSMIF-ISVS 159 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~-L~L~ 159 (843)
+.++.++++++ .+|..+ .+++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+ +.+|.+++++.. +.+.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45666677776 345433 246777777777777555566777777777777777765433 345666666554 4555
Q ss_pred cCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecC-CcCCCCCCchhhccCcceeeccCCcceecC
Q 003156 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG-NSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~ 238 (843)
.|+++...|..|.++++|++|++++|+++...+..+....++..|++.+ |.+. .++...+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~----------------- 150 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFV----------------- 150 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSST-----------------
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccchh-----------------
Confidence 6677766667777777777777777777755555555566666666654 3343 22211110
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCC-CcccCCCCCCccccccceEEEccCCcccccCC
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSS-NHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 317 (843)
.....++.|+|++|+|+...+..| ...+|++|++++ |.++.+.++.|..+++|++|+|++|+|+...+
T Consensus 151 ----------~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~ 219 (350)
T 4ay9_X 151 ----------GLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219 (350)
T ss_dssp ----------TSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred ----------hcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence 011345566666666663333333 344566666653 55555444556666666666666666663322
Q ss_pred ccccccCCCcEEEcCCC-CCCCCchhhhcccCCCcEEecccc
Q 003156 318 QEVCESRSLGILQLDGN-SLTGPIPQVIRNCTSLYLLSLSHN 358 (843)
Q Consensus 318 ~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 358 (843)
.. +.+|+.|.+.++ .++ .+| .+.++++|+.++++++
T Consensus 220 ~~---~~~L~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 220 YG---LENLKKLRARSTYNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp SS---CTTCCEEECTTCTTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred hh---hccchHhhhccCCCcC-cCC-CchhCcChhhCcCCCC
Confidence 22 233444443333 233 444 2555666666666544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.6e-22 Score=208.67 Aligned_cols=142 Identities=18% Similarity=0.100 Sum_probs=114.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----------------cChHHHHHHHHHHHhccCCCccceee
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----------------QYPEDFEREVRVLGKARHPNLISLEG 619 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~g 619 (843)
+..+.||+|+||.||+|.+ .+|+.||+|.+...... .....+.+|+.++++++ | +++.+
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 3457899999999999999 68999999998543211 01356889999999999 5 66766
Q ss_pred EEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcE
Q 003156 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 699 (843)
Q Consensus 620 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 699 (843)
++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++.+|
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEE
T ss_pred EEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEE
Confidence 5543 45699999999999987 421 23457999999999999998 999999999999999 99999
Q ss_pred EeeccCcccccccccceeccccccccccCCcccc
Q 003156 700 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733 (843)
Q Consensus 700 l~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 733 (843)
|+|||+++.. ..|+|||++
T Consensus 233 l~DFG~a~~~---------------~~~~a~e~l 251 (282)
T 1zar_A 233 IIDFPQSVEV---------------GEEGWREIL 251 (282)
T ss_dssp ECCCTTCEET---------------TSTTHHHHH
T ss_pred EEECCCCeEC---------------CCCCHHHHH
Confidence 9999999632 237888876
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.7e-21 Score=190.89 Aligned_cols=181 Identities=22% Similarity=0.191 Sum_probs=133.4
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
+.+++++++++ .+|... .++|++|++++|+++.++...|..+++|++|+|++|++++.+. ..|..+++|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L 81 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN----GVFNKLTSLTYL 81 (208)
T ss_dssp TEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT----TTTTTCTTCCEE
T ss_pred CEEEecCCCcc-CCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh----hhcCCCCCcCEE
Confidence 56778888887 777543 4578888888888888887778888888888888888775432 346677888888
Q ss_pred ecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc
Q 003156 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|.+.
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 88888887666666777888888888888887666666777788888888888877666666777777777777777665
Q ss_pred ccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCC
Q 003156 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 200 (843)
Q Consensus 165 ~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 200 (843)
+ .+++|+.|+++.|++++.+|..++.++.
T Consensus 162 ~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 162 C-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp C-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred c-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 3 3456777777777777777776665543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.4e-21 Score=217.94 Aligned_cols=189 Identities=29% Similarity=0.405 Sum_probs=119.0
Q ss_pred CCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccC
Q 003156 152 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSE 231 (843)
Q Consensus 152 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~ 231 (843)
+|+.|+|++|++++ +|..+ +++|++|+|++|.|+ .+| ..+++|+.|+|++|.|++ +|. +.
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~----------- 119 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LP----------- 119 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CC-----------
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hh-----------
Confidence 56666666666654 44433 255666666666666 344 335666666666666653 443 21
Q ss_pred CcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCc
Q 003156 232 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 311 (843)
Q Consensus 232 n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~ 311 (843)
.+|++|+|++|+|++ +|. .+++|+.|++++|.|++ +|. .+++|++|+|++|+
T Consensus 120 --------------------~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 120 --------------------ASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ 171 (571)
T ss_dssp --------------------TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred --------------------cCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence 145555555555553 333 35566666666666654 333 34566677777777
Q ss_pred ccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCC-------cEEecccccccccCCccccCCCCCCEEEccCCcc
Q 003156 312 LYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL-------YLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384 (843)
Q Consensus 312 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 384 (843)
|++ +|. |. ++|+.|+|++|.|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|
T Consensus 172 L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 172 LTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242 (571)
T ss_dssp CSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSC
T ss_pred CCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcC
Confidence 664 454 44 67777777777777 4555 443 55 88888888888 6788787888888888888888
Q ss_pred cccCCcchhcccc
Q 003156 385 SGEIPQELGKLAS 397 (843)
Q Consensus 385 ~~~~p~~~~~l~~ 397 (843)
++.+|..+..+..
T Consensus 243 ~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 243 SSRIRESLSQQTA 255 (571)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CCcCHHHHHHhhc
Confidence 8888888877655
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.4e-21 Score=193.13 Aligned_cols=158 Identities=19% Similarity=0.192 Sum_probs=133.1
Q ss_pred cCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCC-CCccccccceEEEccCCcccccCCccccccCCCcEEEcC
Q 003156 254 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIP-PELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 332 (843)
Q Consensus 254 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 332 (843)
-+.+++++|.++ .+|..+. ..+++|+|++|.|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 357888888887 4666553 456888888888887754 457888889999999999987777788899999999999
Q ss_pred CCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecC
Q 003156 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 333 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
+|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|++++|++++..
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999888888899999999999999999888888999999999999999999888889999999999999999998776
Q ss_pred CC
Q 003156 413 PV 414 (843)
Q Consensus 413 p~ 414 (843)
+.
T Consensus 170 ~l 171 (220)
T 2v70_A 170 YL 171 (220)
T ss_dssp GG
T ss_pred ch
Confidence 63
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-20 Score=186.53 Aligned_cols=133 Identities=20% Similarity=0.176 Sum_probs=67.6
Q ss_pred cCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEee
Q 003156 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159 (843)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 159 (843)
+|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444443333344444555555555555544444444445555555555555554444444555555555555
Q ss_pred cCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCC
Q 003156 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+.
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 55555444444555555555555555555444444555555555555555554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.7e-20 Score=210.18 Aligned_cols=180 Identities=31% Similarity=0.364 Sum_probs=92.4
Q ss_pred CCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCE
Q 003156 28 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKE 107 (843)
Q Consensus 28 ~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 107 (843)
+|+.|+|++|+|++++...+ ++|++|+|++|+|+.++ ..+++|++|+|++|+|++ +|. +.. +|++
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~---~~L~~L~Ls~N~l~~ip--------~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~ 124 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP---PQITVLEITQNALISLP--------ELPASLEYLDACDNRLST-LPE-LPA--SLKH 124 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC---TTCSEEECCSSCCSCCC--------CCCTTCCEEECCSSCCSC-CCC-CCT--TCCE
T ss_pred CccEEEeCCCCCCccCHhHc---CCCCEEECcCCCCcccc--------cccCCCCEEEccCCCCCC-cch-hhc--CCCE
Confidence 55555555555555544432 45555555555555322 123555555555555553 333 333 5555
Q ss_pred EEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCc
Q 003156 108 LLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHL 187 (843)
Q Consensus 108 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i 187 (843)
|+|++|.|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|++++ +|. |. ++|+.|+|++|+|
T Consensus 125 L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L 192 (571)
T 3cvr_A 125 LDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLL 192 (571)
T ss_dssp EECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCC
T ss_pred EECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCC
Confidence 5555555554 333 34555555555555554 222 34555555555555553 444 43 5555556655555
Q ss_pred CCCCCCCCCCCCCC-------cEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCC
Q 003156 188 TGSLPSSLFNCKKL-------SVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIP 239 (843)
Q Consensus 188 ~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p 239 (843)
+ .+|. +.. +| +.|+|++|.|+ .+|..++.+ +|+.|++++|.+.+.+|
T Consensus 193 ~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 193 E-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp S-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred C-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 5 3444 332 44 55666666555 455544444 45556666665555443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7.5e-20 Score=184.06 Aligned_cols=154 Identities=24% Similarity=0.333 Sum_probs=120.3
Q ss_pred CEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCC
Q 003156 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGN 334 (843)
Q Consensus 255 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 334 (843)
+.+++++|.++ .+|..+. ++|+.|++++|.|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 56777777777 4555443 57788888888887777777788888888888888888777778888888888888888
Q ss_pred CCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceec
Q 003156 335 SLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 335 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
.|+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 88866666677888888888888888877777888888888888888888877777788888888888888887654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=196.29 Aligned_cols=188 Identities=23% Similarity=0.295 Sum_probs=149.2
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
..+.+..+.+++.++ +..+++|++|++++|.+..++. +..+++|++|+|++|++++..+ +..+++|++|
T Consensus 27 ~~~~l~~~~~~~~~~---~~~l~~L~~L~l~~~~i~~~~~--~~~l~~L~~L~L~~n~l~~~~~------l~~l~~L~~L 95 (291)
T 1h6t_A 27 IKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP------LANLKNLGWL 95 (291)
T ss_dssp HHHHTTCSCTTSEEC---HHHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG------GTTCTTCCEE
T ss_pred HHHHhcCCCcccccc---hhhcCcccEEEccCCCcccChh--HhcCCCCCEEEccCCccCCCcc------cccCCCCCEE
Confidence 345667777773333 4567889999999999887754 7888999999999998885432 6778889999
Q ss_pred ecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc
Q 003156 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
+|++|.+++ ++ .+..+++|++|+|++|++++. ..+..+++|++|++++|.+++. ..+..+++|+.|++++|+++
T Consensus 96 ~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 96 FLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169 (291)
T ss_dssp ECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence 999998874 33 488889999999999988854 4577888999999999988865 67888889999999999888
Q ss_pred ccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCC
Q 003156 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 213 (843)
Q Consensus 165 ~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (843)
+..+ +..+++|++|+|++|.+++ ++ .+..+++|+.|++++|++..
T Consensus 170 ~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 170 DIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred cchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 6554 8888899999999998885 34 48888889999998888873
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-20 Score=194.69 Aligned_cols=170 Identities=22% Similarity=0.280 Sum_probs=152.2
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
|++|+.|++++|+++ .++. |..+++|++|+|++|++.++++ |..+++|++|+|++|++++.+ .+..+++
T Consensus 45 l~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~------~l~~l~~ 113 (291)
T 1h6t_A 45 LNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS------SLKDLKK 113 (291)
T ss_dssp HHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG------GGTTCTT
T ss_pred cCcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCCh------hhccCCC
Confidence 357999999999998 6764 7899999999999999998877 899999999999999998642 3778999
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
|++|+|++|++++. ..+..+++|++|+|++|++++. ..+..+++|++|++++|.+++..+ +..+++|+.|++++
T Consensus 114 L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~ 187 (291)
T 1h6t_A 114 LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187 (291)
T ss_dssp CCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCC
Confidence 99999999999853 5689999999999999999965 568899999999999999997655 99999999999999
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTG 189 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 189 (843)
|++++ ++ .+..+++|+.|++++|+++.
T Consensus 188 N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 188 NHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp SCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 99985 44 48999999999999999985
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.9e-20 Score=198.60 Aligned_cols=160 Identities=28% Similarity=0.196 Sum_probs=127.2
Q ss_pred CccCEEeCCCCccceeCCcccc-CCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEE
Q 003156 252 QTLRILDLSSNNLVGDIPAEMG-LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330 (843)
Q Consensus 252 ~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 330 (843)
+.++.|+|++|+|++..+..+. .+++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 118 (361)
T 2xot_A 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118 (361)
T ss_dssp TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence 4577888888888877777776 788888888888888887777888888888888888888877677788888888888
Q ss_pred cCCCCCCCCchhhhcccCCCcEEecccccccccCCccc---cCCCCCCEEEccCCcccccCCcchhcccc--cceEeecc
Q 003156 331 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI---SNLNKLKILKLEFNELSGEIPQELGKLAS--LLAVNVSY 405 (843)
Q Consensus 331 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~l~ls~ 405 (843)
|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..+..++. |+.|+|++
T Consensus 119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~ 198 (361)
T 2xot_A 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198 (361)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCS
T ss_pred CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecC
Confidence 88888887778888888888888888888885444444 56888888888888888666677777776 37788888
Q ss_pred ccceec
Q 003156 406 NRLIGR 411 (843)
Q Consensus 406 N~l~~~ 411 (843)
|++...
T Consensus 199 N~~~C~ 204 (361)
T 2xot_A 199 NPLECD 204 (361)
T ss_dssp SCEECC
T ss_pred CCccCC
Confidence 887643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.8e-20 Score=211.96 Aligned_cols=189 Identities=23% Similarity=0.285 Sum_probs=132.8
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCE
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~ 83 (843)
+..+.|+.+.+.+.++ +..+++|+.|++++|.|..++. |..+++|++|+|++|+|++.++ +..+++|+.
T Consensus 23 l~~l~l~~~~i~~~~~---~~~L~~L~~L~l~~n~i~~l~~--l~~l~~L~~L~Ls~N~l~~~~~------l~~l~~L~~ 91 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP------LTNLKNLGW 91 (605)
T ss_dssp HHHHHTTCSCTTSEEC---HHHHTTCCCCBCTTCCCCCCTT--GGGCTTCCEEECTTSCCCCCGG------GGGCTTCCE
T ss_pred HHHHhccCCCcccccc---hhcCCCCCEEECcCCCCCCChH--HccCCCCCEEEeeCCCCCCChh------hccCCCCCE
Confidence 3445666677763333 4567777778888887776653 6777788888888877775432 567777788
Q ss_pred EecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcc
Q 003156 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 84 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 163 (843)
|+|++|.|.+ ++ .+..+++|++|+|++|.|++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|++
T Consensus 92 L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l 165 (605)
T 1m9s_A 92 LFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 165 (605)
T ss_dssp EECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCC
T ss_pred EECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcC
Confidence 8888877764 33 577777777777777777743 3467777777777777777754 5677777777777777777
Q ss_pred cccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCC
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 213 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (843)
.+..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+
T Consensus 166 ~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 166 SDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 76555 77777777777777777753 357777777777777777763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.1e-20 Score=198.93 Aligned_cols=178 Identities=21% Similarity=0.117 Sum_probs=114.9
Q ss_pred cEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCcccc-CCccCCEEecCCccCcccCchhhhcCCCCCEE
Q 003156 30 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIW-SLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 108 (843)
Q Consensus 30 ~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (843)
+.+++++|++..++.... +.+++|+|++|+|++.+. ..|. .+++|++|+|++|+|++..+..|..+++|++|
T Consensus 21 ~~l~c~~~~l~~iP~~~~---~~l~~L~Ls~N~l~~l~~----~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 93 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLP---SYTALLDLSHNNLSRLRA----EWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYL 93 (361)
T ss_dssp TEEECCSSCCSSCCSSCC---TTCSEEECCSSCCCEECT----TSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CEEEeCCCCcCccCccCC---CCCCEEECCCCCCCccCh----hhhhhcccccCEEECCCCcCCccChhhccCCCCCCEE
Confidence 456666666666555432 346666666666664432 2344 56666666666666666555666666667777
Q ss_pred EcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCc---cCCCCccEEEcccC
Q 003156 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI---GNISTLEFLDFSNN 185 (843)
Q Consensus 109 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N 185 (843)
+|++|+|+...+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+++...+..| ..+++|+.|+|++|
T Consensus 94 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N 173 (361)
T 2xot_A 94 DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN 173 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSS
T ss_pred ECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCC
Confidence 777766666666666666777777777777766666667777777777777777764444444 56778888888888
Q ss_pred CcCCCCCCCCCCCCC--CcEEEecCCcCCCC
Q 003156 186 HLTGSLPSSLFNCKK--LSVIRLRGNSLNGN 214 (843)
Q Consensus 186 ~i~~~~~~~~~~l~~--L~~L~L~~N~l~~~ 214 (843)
+|+...+..+..++. |+.|+|++|++...
T Consensus 174 ~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 174 KLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 888655556666665 47788888888743
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-19 Score=181.04 Aligned_cols=157 Identities=24% Similarity=0.215 Sum_probs=116.0
Q ss_pred ccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcC
Q 003156 253 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 332 (843)
Q Consensus 253 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 332 (843)
+.+.++.+++.++ .+|..+. ++|++|+|++|.|+++.|..|..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 3556777777776 4555443 677777777777777777777777777777777777775555566777778888888
Q ss_pred CCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecC
Q 003156 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 333 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
+|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|++.+..
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 88877666666777788888888888877 67777777788888888888887666667777778888888888777655
Q ss_pred C
Q 003156 413 P 413 (843)
Q Consensus 413 p 413 (843)
+
T Consensus 176 ~ 176 (229)
T 3e6j_A 176 R 176 (229)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.4e-19 Score=178.45 Aligned_cols=156 Identities=17% Similarity=0.163 Sum_probs=119.2
Q ss_pred CEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCc-hhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEE
Q 003156 54 NTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP-QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTL 132 (843)
Q Consensus 54 ~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 132 (843)
+++++++|.++.++... ...+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|
T Consensus 14 ~~l~~s~n~l~~iP~~~-------~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 14 TTVDCSNQKLNKIPEHI-------PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TEEECCSSCCSSCCSCC-------CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CEeEeCCCCcccCccCC-------CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 35666666666543321 1345677777777765533 457777788888888888877777778888888888
Q ss_pred EccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCC
Q 003156 133 DLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 133 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++.
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 88888888777777888888888888888888777888888888999999999998877888888999999999999887
Q ss_pred CCCC
Q 003156 213 GNIP 216 (843)
Q Consensus 213 ~~~p 216 (843)
+..+
T Consensus 167 c~c~ 170 (220)
T 2v70_A 167 CNCY 170 (220)
T ss_dssp CSGG
T ss_pred CCCc
Confidence 6554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-19 Score=207.01 Aligned_cols=175 Identities=22% Similarity=0.268 Sum_probs=155.2
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
|++|+.|+|++|.|. .++. |..+++|+.|+|++|.|.++++ |..+++|++|+|++|+|++.+ .+..+++
T Consensus 42 L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~------~l~~l~~ 110 (605)
T 1m9s_A 42 LNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS------SLKDLKK 110 (605)
T ss_dssp HTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCT------TSTTCTT
T ss_pred CCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCCh------hhccCCC
Confidence 468999999999998 7773 7899999999999999998887 899999999999999998643 4778999
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
|+.|+|++|+|.+ + ..+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+++..| +..+++|+.|+|++
T Consensus 111 L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 184 (605)
T 1m9s_A 111 LKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 184 (605)
T ss_dssp CCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcC
Confidence 9999999999985 3 4689999999999999999965 568899999999999999997766 99999999999999
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 194 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~ 194 (843)
|++++. ..+..+++|+.|+|++|.+.+.....
T Consensus 185 N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~ 216 (605)
T 1m9s_A 185 NHISDL--RALAGLKNLDVLELFSQECLNKPINH 216 (605)
T ss_dssp SCCCBC--GGGTTCTTCSEEECCSEEEECCCCCC
T ss_pred CCCCCC--hHHccCCCCCEEEccCCcCcCCcccc
Confidence 999864 35899999999999999998643333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=8.7e-19 Score=176.29 Aligned_cols=135 Identities=17% Similarity=0.176 Sum_probs=88.3
Q ss_pred ccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEe
Q 003156 79 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 158 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 158 (843)
++|++|+|++|+|+...+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|.|+.+.+..|..+++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 34555666666655555555666666666666666666555666666666666666666666555555666666666666
Q ss_pred ecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCC
Q 003156 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 213 (843)
Q Consensus 159 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (843)
++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 6666666666667777777777777777776666667777777777777777754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.9e-18 Score=172.72 Aligned_cols=156 Identities=22% Similarity=0.184 Sum_probs=114.3
Q ss_pred CCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEE
Q 003156 53 LNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTL 132 (843)
Q Consensus 53 L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 132 (843)
-+.++.+++.++..+..+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..+++|++|
T Consensus 21 ~~~v~c~~~~l~~ip~~~-------~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGI-------PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL 93 (229)
T ss_dssp TTEEECTTSCCSSCCSCC-------CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCEeEccCCCcCccCCCC-------CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence 445666666666544321 1567777777777776666777777777777777777776655666777777777
Q ss_pred EccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCC
Q 003156 133 DLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 133 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+|++|+|++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|+...+..|..+++|+.|+|++|++.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 77777777666667777777778888888777 66777888888888888888888766677888888888888888887
Q ss_pred CCCC
Q 003156 213 GNIP 216 (843)
Q Consensus 213 ~~~p 216 (843)
+..+
T Consensus 173 c~c~ 176 (229)
T 3e6j_A 173 CECR 176 (229)
T ss_dssp TTBG
T ss_pred CCcc
Confidence 6544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.7e-21 Score=221.80 Aligned_cols=201 Identities=25% Similarity=0.256 Sum_probs=129.1
Q ss_pred CCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCc-------------CCCCCCchhhcc-Ccceee-ccCCcceecC
Q 003156 174 ISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNS-------------LNGNIPEGLFDL-GLEEID-LSENGFMGSI 238 (843)
Q Consensus 174 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~~-~L~~L~-l~~n~l~~~~ 238 (843)
+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+..|..+..+ +|+.|+ ++.|.+
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~---- 422 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL---- 422 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH----
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc----
Confidence 444555555555554 344455555555555544432 333444444443 455565 444433
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 318 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 318 (843)
.+|+.+.+++|.++...+ ..|+.|+|++|.|++ +|. |+.+++|+.|+|++|+|+ .+|.
T Consensus 423 -------------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~ 480 (567)
T 1dce_A 423 -------------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPP 480 (567)
T ss_dssp -------------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCG
T ss_pred -------------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccch
Confidence 245556666666663322 247778888888876 344 777778888888888887 6777
Q ss_pred cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccC-CccccCCCCCCEEEccCCcccccCCcc---hhc
Q 003156 319 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI-PKSISNLNKLKILKLEFNELSGEIPQE---LGK 394 (843)
Q Consensus 319 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~ 394 (843)
.++.+++|+.|+|++|.|++ +| .|+++++|+.|+|++|+|++.. |..|+.|++|+.|+|++|+|++.+|.. +..
T Consensus 481 ~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~ 558 (567)
T 1dce_A 481 ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 558 (567)
T ss_dssp GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHH
T ss_pred hhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHH
Confidence 78888888888888888875 56 6778888888888888887665 777888888888888888887655432 334
Q ss_pred ccccceEee
Q 003156 395 LASLLAVNV 403 (843)
Q Consensus 395 l~~L~~l~l 403 (843)
+++|+.||+
T Consensus 559 lp~L~~L~l 567 (567)
T 1dce_A 559 LPSVSSILT 567 (567)
T ss_dssp CTTCSEEEC
T ss_pred CcccCccCC
Confidence 677777754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=171.97 Aligned_cols=154 Identities=16% Similarity=0.245 Sum_probs=135.8
Q ss_pred cccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcE
Q 003156 249 TLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 328 (843)
Q Consensus 249 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 328 (843)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45788999999999998 566 68899999999999998764 357889999999999999999888899999999999
Q ss_pred EEcCCCCCCCCchhhhcccCCCcEEeccccc-ccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeecccc
Q 003156 329 LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH-LSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR 407 (843)
Q Consensus 329 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~ 407 (843)
|++++|.+++..|..|..+++|+.|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 9999999998889999999999999999998 65 666 69999999999999999995 44 78999999999999999
Q ss_pred cee
Q 003156 408 LIG 410 (843)
Q Consensus 408 l~~ 410 (843)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-18 Score=169.78 Aligned_cols=132 Identities=26% Similarity=0.339 Sum_probs=91.2
Q ss_pred CEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCC-CccccccceEEEccCCcccccCCccccccCCCcEEEcCC
Q 003156 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPP-ELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 333 (843)
Q Consensus 255 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 333 (843)
+.+++++|.++ .+|..+.. +|++|++++|.|+++.+. .|..+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777775 55654432 677777777777665553 366777777777777777766666777777777777777
Q ss_pred CCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCC
Q 003156 334 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIP 389 (843)
Q Consensus 334 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 389 (843)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 77776666667777777777777777776667777777777777777777765543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=6e-19 Score=182.65 Aligned_cols=169 Identities=27% Similarity=0.309 Sum_probs=107.3
Q ss_pred CCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCC
Q 003156 26 CASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYL 105 (843)
Q Consensus 26 l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 105 (843)
+.++..+++++|.+..+. .+..+++|++|++++|.|+..+ .+..+++|++|+|++|+|++..+ +..+++|
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~------~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L 87 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA------GMQFFTNLKELHLSHNQISDLSP--LKDLTKL 87 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT------TGGGCTTCCEEECCSSCCCCCGG--GTTCSSC
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch------HHhhCCCCCEEECCCCccCCChh--hccCCCC
Confidence 345556666666666555 3556666666666666665332 24556666666666666664333 6666667
Q ss_pred CEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccC
Q 003156 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 185 (843)
Q Consensus 106 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 185 (843)
++|+|++|++++. |. +.. ++|++|+|++|++++. ..+..+++|+.|+|++|++++. + .++.+++|++|+|++|
T Consensus 88 ~~L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N 160 (263)
T 1xeu_A 88 EELSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGN 160 (263)
T ss_dssp CEEECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTS
T ss_pred CEEECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCC
Confidence 7777777766643 22 222 6677777777777643 2466677777777777777643 2 4667777777777777
Q ss_pred CcCCCCCCCCCCCCCCcEEEecCCcCCC
Q 003156 186 HLTGSLPSSLFNCKKLSVIRLRGNSLNG 213 (843)
Q Consensus 186 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (843)
++++. ..+..+++|+.|++++|.+.+
T Consensus 161 ~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 161 EITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred cCcch--HHhccCCCCCEEeCCCCcccC
Confidence 77754 567777777777777777764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-21 Score=221.00 Aligned_cols=217 Identities=23% Similarity=0.198 Sum_probs=164.1
Q ss_pred CCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcE
Q 003156 124 GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 203 (843)
Q Consensus 124 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 203 (843)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|......|. .+..+.+.+..|..+.++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 55778888888888887 6677888888888888765542101110 00111233455666666777777
Q ss_pred EE-ecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEE
Q 003156 204 IR-LRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLN 282 (843)
Q Consensus 204 L~-L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 282 (843)
|+ ++.|.+. +|..+.+++|.+.... ...|+.|+|++|.|++ +|. ++.+++|+.|+
T Consensus 414 L~~l~~n~~~----------~L~~l~l~~n~i~~l~------------~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~ 469 (567)
T 1dce_A 414 VDPMRAAYLD----------DLRSKFLLENSVLKME------------YADVRVLHLAHKDLTV-LCH-LEQLLLVTHLD 469 (567)
T ss_dssp HCGGGHHHHH----------HHHHHHHHHHHHHHHH------------HTTCSEEECTTSCCSS-CCC-GGGGTTCCEEE
T ss_pred Ccchhhcccc----------hhhhhhhhcccccccC------------ccCceEEEecCCCCCC-CcC-ccccccCcEee
Confidence 76 5555442 3555666677665321 1358999999999995 676 99999999999
Q ss_pred cCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCc-hhhhcccCCCcEEeccccccc
Q 003156 283 LSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI-PQVIRNCTSLYLLSLSHNHLS 361 (843)
Q Consensus 283 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 361 (843)
|++|.|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..|+++++|+.|+|++|+|+
T Consensus 470 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp CCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 9999998 578899999999999999999996 66 8999999999999999999876 999999999999999999999
Q ss_pred ccCCcc---ccCCCCCCEEEc
Q 003156 362 GSIPKS---ISNLNKLKILKL 379 (843)
Q Consensus 362 ~~~p~~---~~~l~~L~~L~L 379 (843)
+..|.. +..+++|+.|++
T Consensus 547 ~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 547 QEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp GSSSCTTHHHHHCTTCSEEEC
T ss_pred CCccHHHHHHHHCcccCccCC
Confidence 665532 234899999975
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=9.2e-19 Score=172.09 Aligned_cols=157 Identities=24% Similarity=0.254 Sum_probs=132.9
Q ss_pred CcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc-cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecc
Q 003156 278 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ-EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 356 (843)
Q Consensus 278 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 356 (843)
-+++++++|.++. +|..+. .+|++|++++|+|++..+. .|..+++|++|+|++|.|++..|..|.++++|+.|+|+
T Consensus 10 ~~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 3789999999975 555443 3899999999999976664 48999999999999999999989999999999999999
Q ss_pred cccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCCC
Q 003156 357 HNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPL 436 (843)
Q Consensus 357 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~ 436 (843)
+|+|++..|..|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|++++..+.......+....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 99999888888999999999999999999999999999999999999999999887742221223333455666677655
Q ss_pred C
Q 003156 437 L 437 (843)
Q Consensus 437 ~ 437 (843)
.
T Consensus 167 ~ 167 (192)
T 1w8a_A 167 S 167 (192)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.6e-19 Score=207.96 Aligned_cols=191 Identities=24% Similarity=0.351 Sum_probs=118.1
Q ss_pred EcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCC
Q 003156 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260 (843)
Q Consensus 181 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~ 260 (843)
++..|.+. ..++.+..+++|+.|+|++|.+. .+|..++. +++|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~-----------------------------l~~L~~L~Ls 255 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFK-----------------------------YDFLTRLYLN 255 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGG-----------------------------CCSCSCCBCT
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcC-----------------------------CCCCCEEEee
Confidence 45556665 56777888888888888888887 56554432 4678888888
Q ss_pred CCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCc
Q 003156 261 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI 340 (843)
Q Consensus 261 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 340 (843)
+|.|+ .+|..|+.+++|++|+|++|.|+ .+|..|+.+.+|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+
T Consensus 256 ~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~ 332 (727)
T 4b8c_D 256 GNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQF 332 (727)
T ss_dssp TSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHH
T ss_pred CCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCC
Confidence 88888 78888899999999999999998 56888999999999999999998 77888999999999999999999999
Q ss_pred hhhhcccCC-CcEEecccccccccCCccccCCCCCCEEEccCC--------cccccCCcchhcccccceEeeccccceec
Q 003156 341 PQVIRNCTS-LYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN--------ELSGEIPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 341 p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N--------~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
|..+..+.. +..|+|++|.+++.+|.. |+.|++++| .|.+..+..+.++..+....+++|-+.+.
T Consensus 333 p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~ 406 (727)
T 4b8c_D 333 LKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQH 406 (727)
T ss_dssp HHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------------------------------------------CCCGG
T ss_pred hHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeeccccccc
Confidence 988876533 335889999999888864 456667776 44444455556666667777777766543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=4e-19 Score=210.31 Aligned_cols=195 Identities=22% Similarity=0.223 Sum_probs=121.0
Q ss_pred CCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCC
Q 003156 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK 106 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 106 (843)
+.+++|+|.+|.+..++. ..|+.++|+.|.|. .++++.|.+. ..++.|..+++|+
T Consensus 173 ~~~~~l~L~~n~~~~~~~------~~l~~l~Ls~~~i~------------------~~~~~~n~~~-~~~~~~~~l~~L~ 227 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQ------ALLQHKKLSQYSID------------------EDDDIENRMV-MPKDSKYDDQLWH 227 (727)
T ss_dssp --------------------------------------------------------------------------CCCCCC
T ss_pred CccceEEeeCCCCCcchh------hHhhcCccCccccc------------------Ccccccccee-cChhhhccCCCCc
Confidence 456677777777665433 23455666666543 3355566666 6788899999999
Q ss_pred EEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCC
Q 003156 107 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186 (843)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 186 (843)
.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+ .+|..|+++++|++|+|++|.
T Consensus 228 ~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 304 (727)
T 4b8c_D 228 ALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM 304 (727)
T ss_dssp EEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred EEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence 9999999998 56666778999999999999999 78889999999999999999999 779999999999999999999
Q ss_pred cCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccC--cceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCC
Q 003156 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG--LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 262 (843)
Q Consensus 187 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~--L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n 262 (843)
|+ .+|..|..+++|+.|+|++|.|++.+|..+.... ...+++++|.+.+.+|. .|+.|+++.|
T Consensus 305 l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------------~l~~l~l~~n 369 (727)
T 4b8c_D 305 VT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------------ERRFIEINTD 369 (727)
T ss_dssp CC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------------C---------
T ss_pred CC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------------ccceeEeecc
Confidence 98 6788899999999999999999988888876653 34578999999877664 4677777777
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=179.20 Aligned_cols=169 Identities=16% Similarity=0.268 Sum_probs=145.4
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
+++..++|++|.++ .++ .|..+++|++|++++|+|..++ .+..+++|++|+|++|+|++.++ +..+++|
T Consensus 19 ~~l~~l~l~~~~i~-~~~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~------l~~l~~L 87 (263)
T 1xeu_A 19 ANAVKQNLGKQSVT-DLV--SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISDLSP------LKDLTKL 87 (263)
T ss_dssp HHHHHHHHTCSCTT-SEE--CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG------GTTCSSC
T ss_pred HHHHHHHhcCCCcc-ccc--chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCCChh------hccCCCC
Confidence 34677889999998 666 3788999999999999999887 48899999999999999986533 7789999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
++|+|++|++++ ++. +.. ++|++|+|++|++++. + .+..+++|++|+|++|++++. ..+..+++|+.|+|++|
T Consensus 88 ~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N 160 (263)
T 1xeu_A 88 EELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGN 160 (263)
T ss_dssp CEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTS
T ss_pred CEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCC
Confidence 999999999985 443 333 8999999999999864 3 588999999999999999965 37899999999999999
Q ss_pred cccccCCCCccCCCCccEEEcccCCcCCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGS 190 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~ 190 (843)
++++. ..+..+++|+.|++++|.++..
T Consensus 161 ~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 161 EITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 99966 6789999999999999999854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=176.42 Aligned_cols=138 Identities=19% Similarity=0.168 Sum_probs=105.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeE--EEEEEeecCCcc-c----------------------ChHHHHHHHHHHHhcc
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRM--LAVKKLVTSDII-Q----------------------YPEDFEREVRVLGKAR 610 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~-~----------------------~~~~~~~E~~~l~~l~ 610 (843)
++..+.||+|+||.||+|.+..+|+. ||||.+...... . ....+.+|+.++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34456899999999999999557888 999987443111 0 0125789999999998
Q ss_pred CCCc--cceeeEEEcCCeeEEEEEeCCC-C----CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhh-hcCCCCeee
Q 003156 611 HPNL--ISLEGYYWTPQLKLLVSDYAPN-G----SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPPIIH 682 (843)
Q Consensus 611 h~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH 682 (843)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 333332 346899999942 4 67666443 234567899999999999999 77 9999
Q ss_pred cCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 683 YNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 683 ~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-18 Score=187.04 Aligned_cols=288 Identities=15% Similarity=0.139 Sum_probs=160.2
Q ss_pred CCCCcEEEccCccccccccccccC-CCCCCEEECCCCCCc--cccCCCcCccccCCccCCEEecCCccCcccCchhhhc-
Q 003156 26 CASLRYLSLAGNILQGPIGKIFNY-CSSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA- 101 (843)
Q Consensus 26 l~~L~~L~L~~n~i~~~~~~~f~~-l~~L~~L~Ls~N~i~--~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~- 101 (843)
+.++++|.++++ +....-..+.. +++|++|||++|+|. .... ..++.++.+.+..|. +....|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~-------~~~~~~~~~~~~~~~---I~~~aF~~~ 92 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA-------GTYPNGKFYIYMANF---VPAYAFSNV 92 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS-------SSSGGGCCEEECTTE---ECTTTTEEE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc-------ccccccccccccccc---cCHHHhccc
Confidence 457888888764 22222222333 677888888888776 2111 112224555555553 33455555
Q ss_pred -------CCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCC
Q 003156 102 -------LHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNI 174 (843)
Q Consensus 102 -------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 174 (843)
+++|++|+|.+ .++.+.+..|.+|++|++|++++|.+..+.+.+|.. +
T Consensus 93 ~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~------------------------~ 147 (329)
T 3sb4_A 93 VNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALAD------------------------S 147 (329)
T ss_dssp ETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCT------------------------T
T ss_pred ccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcC------------------------C
Confidence 66677776666 666566666666666666666666665555555544 4
Q ss_pred CCccEEEcccC----CcCCCCCCCCCCCCCCc-EEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCccc
Q 003156 175 STLEFLDFSNN----HLTGSLPSSLFNCKKLS-VIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSST 249 (843)
Q Consensus 175 ~~L~~L~L~~N----~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~ 249 (843)
.++..+.+..+ ........+|.++.+|+ .+.+.... .++..++... .
T Consensus 148 ~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~-------------------------~ 199 (329)
T 3sb4_A 148 VTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAG-------------------------L 199 (329)
T ss_dssp TCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTT-------------------------C
T ss_pred CceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhcc-------------------------c
Confidence 44444433331 11223344555666665 44443221 2233222110 0
Q ss_pred ccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCc-E
Q 003156 250 LFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLG-I 328 (843)
Q Consensus 250 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~-~ 328 (843)
...++..+.+.++-...........+++|+.|++++|.++.+.+.+|.++.+|+.|+|.+| ++...+..|.++.+|+ .
T Consensus 200 ~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~ 278 (329)
T 3sb4_A 200 QPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGT 278 (329)
T ss_dssp CGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred CccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEE
Confidence 0223334443333111111111112466777777776676666666777777777777766 6655566677777777 7
Q ss_pred EEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEc
Q 003156 329 LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 379 (843)
Q Consensus 329 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 379 (843)
|++.+ .++.+.+..|.+|++|+.|++++|+++...+.+|.++++|+.|+.
T Consensus 279 l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 279 LELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 77776 566566677777777777777777777666667777777777753
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.5e-18 Score=166.92 Aligned_cols=178 Identities=17% Similarity=0.178 Sum_probs=135.8
Q ss_pred cCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCc
Q 003156 17 PVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 96 (843)
Q Consensus 17 ~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 96 (843)
.+|+..|... ....+..+....+. ...+++|++|++++|.++..+ .+..+++|++|++++|.+. .+
T Consensus 16 ~~pd~~~~~~---~~~~~~~~~~~~i~---~~~l~~L~~L~l~~n~i~~l~------~l~~l~~L~~L~l~~n~~~--~~ 81 (197)
T 4ezg_A 16 NIPDSTFKAY---LNGLLGQSSTANIT---EAQMNSLTYITLANINVTDLT------GIEYAHNIKDLTINNIHAT--NY 81 (197)
T ss_dssp CCCCHHHHHH---HHHHHTCCTTCCCB---HHHHHTCCEEEEESSCCSCCT------TGGGCTTCSEEEEESCCCS--CC
T ss_pred ecCcHHHHHH---HHHHhCCCccccCC---hhhcCCccEEeccCCCccChH------HHhcCCCCCEEEccCCCCC--cc
Confidence 5676655432 22223333333332 356778889999998887432 3667888999999999776 33
Q ss_pred hhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc-ccccCCCCccCCC
Q 003156 97 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT-LTGDIPHWIGNIS 175 (843)
Q Consensus 97 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~ 175 (843)
..+..+++|++|+|++|.+++..+..+..+++|++|++++|.+++..+..+..+++|++|++++|+ +. .+| .+..++
T Consensus 82 ~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~ 159 (197)
T 4ezg_A 82 NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLP 159 (197)
T ss_dssp GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCS
T ss_pred hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCC
Confidence 478889999999999999987778889999999999999999988778888999999999999998 65 455 688899
Q ss_pred CccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCC
Q 003156 176 TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 176 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+|++|++++|++++ ++ .+..+++|+.|++++|++.
T Consensus 160 ~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 160 ELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp SCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 99999999999985 34 7888999999999999886
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=184.59 Aligned_cols=290 Identities=12% Similarity=0.087 Sum_probs=199.4
Q ss_pred CccCCEEecCCccCcccCchhhhc-CCCCCEEEcCCCccc--ccCCCCCCCCCCCcEEEccCCcccccCCchhhc-----
Q 003156 78 LKRLRTLDLSHNLFSGSIPQGVAA-LHYLKELLLQGNQFS--GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL----- 149 (843)
Q Consensus 78 l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----- 149 (843)
+.+|+.|.++++- .......+.. +++|++|+|++|+|. ...... ++.+..+++..|. +.+.+|.+
T Consensus 24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~---I~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANF---VPAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccc---cCHHHhccccccc
Confidence 4567777776542 2112223333 677888888888876 222222 2335566666664 44567777
Q ss_pred ---ccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcce
Q 003156 150 ---LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEE 226 (843)
Q Consensus 150 ---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~ 226 (843)
+++|+.|.|.+ +++.+.+.+|.++++|+.|++++|.++.+.+.+|.++.++..+.+..+...... . .
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~-~-----~--- 166 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK-N-----R--- 166 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS-T-----T---
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc-c-----c---
Confidence 99999999999 888788889999999999999999998888899999888877766553221000 0 0
Q ss_pred eeccCCcceecCCCCCCCCCcccccCccC-EEeCCCCc-cceeCCccccCCCCCcEEEcCCCcccCCCCCCc-cccccce
Q 003156 227 IDLSENGFMGSIPPGSSSSSSSTLFQTLR-ILDLSSNN-LVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL-GYFHSLI 303 (843)
Q Consensus 227 L~l~~n~l~~~~p~~~~~~~~~~~l~~L~-~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~ 303 (843)
+....+ .....|+ .+.+.... +.......-....++..+.+.++-.. .....+ ..+++|+
T Consensus 167 --i~~~~f--------------~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~ 229 (329)
T 3sb4_A 167 --WEHFAF--------------IEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLV 229 (329)
T ss_dssp --TTTSCE--------------EESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCC
T ss_pred --cccccc--------------ccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCe
Confidence 000011 0112233 23332211 11111111123456777777765321 111111 2378999
Q ss_pred EEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCc-EEecccccccccCCccccCCCCCCEEEccCC
Q 003156 304 HLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLY-LLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382 (843)
Q Consensus 304 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 382 (843)
.|+|++|+++...+..|.++++|+.|+|.+| ++.+.+..|.+|++|+ .|++.+ .++...+.+|.++++|+.|++++|
T Consensus 230 ~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n 307 (329)
T 3sb4_A 230 SLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGD 307 (329)
T ss_dssp EEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSS
T ss_pred EEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCC
Confidence 9999999999777788999999999999998 8877788999999999 999999 787677899999999999999999
Q ss_pred cccccCCcchhcccccceEee
Q 003156 383 ELSGEIPQELGKLASLLAVNV 403 (843)
Q Consensus 383 ~l~~~~p~~~~~l~~L~~l~l 403 (843)
+++...+.+|.++++|+.+..
T Consensus 308 ~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 308 KITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCCEECTTTTCTTCCCCEEEC
T ss_pred ccCccchhhhcCCcchhhhcc
Confidence 999888889999999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.3e-16 Score=170.03 Aligned_cols=147 Identities=11% Similarity=0.115 Sum_probs=69.8
Q ss_pred ccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCC
Q 003156 47 FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 126 (843)
Q Consensus 47 f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 126 (843)
+..+..++++.+.++ ++. +...+|.+ .+|+.+++..+ ++.+...+|.+ .+|+.+.|.. .++.+.+..|.++
T Consensus 109 ~~~~~~l~~i~ip~~-i~~----I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c 179 (401)
T 4fdw_A 109 TEILKGYNEIILPNS-VKS----IPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYC 179 (401)
T ss_dssp EEECSSCSEEECCTT-CCE----ECTTTTTT-CCCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTC
T ss_pred EEecCCccEEEECCc-cCE----ehHhhccc-CCccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCc
Confidence 334445555555442 222 22233444 24555555444 44344444544 2455555553 4444444555555
Q ss_pred CCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEe
Q 003156 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRL 206 (843)
Q Consensus 127 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 206 (843)
++|+.+++++|+++.+...+|. ..+|+.+.|.++ +..+...+|.++++|+.++|.+| ++.+...+|.+ .+|+.+.+
T Consensus 180 ~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 180 YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence 5555555555555544444444 245555555532 44444555555555555555543 33344444444 44555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-16 Score=171.40 Aligned_cols=275 Identities=9% Similarity=0.080 Sum_probs=193.7
Q ss_pred hhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhc
Q 003156 22 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA 101 (843)
Q Consensus 22 ~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 101 (843)
+|..+..++.+.+.+ .+..|....|.++ +|+.++|.+| +.. +...+|.+ .+|+.+.+.. .+..+...+|.+
T Consensus 108 ~~~~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~----I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~ 178 (401)
T 4fdw_A 108 LTEILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKS----IGDMAFFN-STVQEIVFPS-TLEQLKEDIFYY 178 (401)
T ss_dssp EEEECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCE----ECTTTTTT-CCCCEEECCT-TCCEECSSTTTT
T ss_pred EEEecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccE----ECHHhcCC-CCceEEEeCC-CccEehHHHhhC
Confidence 345567777777753 5677777788774 6888888766 553 33345666 4688888875 566666777888
Q ss_pred CCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEE
Q 003156 102 LHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 181 (843)
Q Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 181 (843)
+.+|+.++|.+|.++.+....|. +.+|+.+.|.++ ++.+...+|.++++|+.+.+..| ++.+...+|.+ .+|+.+.
T Consensus 179 c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~ 254 (401)
T 4fdw_A 179 CYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVK 254 (401)
T ss_dssp CTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEE
T ss_pred cccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEE
Confidence 88888888888888766666666 578888888744 66677778888888888888764 55566677777 7788888
Q ss_pred cccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCC
Q 003156 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSS 261 (843)
Q Consensus 182 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~ 261 (843)
| .+.++.+...+|.+|++|+.+.+.+|.+..... . .++.. .+..+++|+.++|.
T Consensus 255 l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~--------~-----------~I~~~-----aF~~c~~L~~l~l~- 308 (401)
T 4fdw_A 255 L-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPE--------A-----------MIHPY-----CLEGCPKLARFEIP- 308 (401)
T ss_dssp E-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTT--------C-----------EECTT-----TTTTCTTCCEECCC-
T ss_pred e-CCCccEEChhHhhCCCCCCEEEeCCccccCCcc--------c-----------EECHH-----HhhCCccCCeEEeC-
Confidence 8 455665667788888888888888876641000 0 01111 12235678888887
Q ss_pred CccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccC-CCcEEEcCCCCCC
Q 003156 262 NNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESR-SLGILQLDGNSLT 337 (843)
Q Consensus 262 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~ 337 (843)
+.++......|.++++|+.+.+..| ++.+...+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus 309 ~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 309 ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 4466667778888888888888655 666777888888 888888888888766666777774 6788888776544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-16 Score=171.90 Aligned_cols=332 Identities=13% Similarity=0.091 Sum_probs=182.8
Q ss_pred cCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCc
Q 003156 17 PVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 96 (843)
Q Consensus 17 ~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 96 (843)
+|...+|.+|.+|+++.|.. .++.|...+|.++++|+.++|.++ +.. +...+|.++.+|+.+.+..+ +.....
T Consensus 61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~----I~~~aF~~c~~L~~i~~p~~-l~~i~~ 133 (394)
T 4fs7_A 61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM----IGRCTFSGCYALKSILLPLM-LKSIGV 133 (394)
T ss_dssp EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE----ECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE----ccchhhcccccchhhcccCc-eeeecc
Confidence 46666677777777777753 366666777777777777777654 332 23345666666666666543 333455
Q ss_pred hhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCC
Q 003156 97 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 176 (843)
Q Consensus 97 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 176 (843)
.+|.+...++........ ......|.++++|+.+.+.++. ..+....|.+..+|+.+.+..| +..+...+|.++..
T Consensus 134 ~aF~~~~~~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~ 209 (394)
T 4fs7_A 134 EAFKGCDFKEITIPEGVT--VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL 209 (394)
T ss_dssp TTTTTCCCSEEECCTTCC--EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred eeeecccccccccCcccc--ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence 556555433333322222 2334556666666666665443 2244555555666666555544 33344455555555
Q ss_pred ccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCE
Q 003156 177 LEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256 (843)
Q Consensus 177 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~ 256 (843)
|+.+.+..+... +.+.+....+|+.+.+..+. + .+... .......|+.
T Consensus 210 L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~-~i~~~----------------------------~f~~~~~l~~ 257 (394)
T 4fs7_A 210 LENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-T-ELGKS----------------------------VFYGCTDLES 257 (394)
T ss_dssp CCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-C-EECSS----------------------------TTTTCSSCCE
T ss_pred cceeecCCCceE--eehhhcccCCCceEEECCCc-e-ecccc----------------------------ccccccccee
Confidence 555555444332 12223334455555443221 1 11110 1122345666
Q ss_pred EeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCC
Q 003156 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 336 (843)
Q Consensus 257 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 336 (843)
+.+..+... .....|.....++.+....+.+. ...|..+.+|+.+.+.++ ++......|.++.+|+.+++.++ +
T Consensus 258 ~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v 331 (394)
T 4fs7_A 258 ISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V 331 (394)
T ss_dssp EEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred EEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c
Confidence 666655443 55566666677777766665442 245666667777777554 44444556667777777777543 5
Q ss_pred CCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccce
Q 003156 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLA 400 (843)
Q Consensus 337 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 400 (843)
+.+...+|.+|++|+.+++..| ++..-..+|.++++|+.+++..+ ++ .+...|.+.++|+.
T Consensus 332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 5455566777777777777665 55455566777777777777544 32 23345555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=8.9e-17 Score=154.33 Aligned_cols=132 Identities=23% Similarity=0.169 Sum_probs=80.4
Q ss_pred CCCcEEEcCCCccc-CCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEe
Q 003156 276 ANLRYLNLSSNHLR-SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 354 (843)
Q Consensus 276 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 354 (843)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++.+|..+.++++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 33444455555666666666666543 5556666666666666666655666666666666666
Q ss_pred cccccccccC-CccccCCCCCCEEEccCCcccccCC---cchhcccccceEeeccccce
Q 003156 355 LSHNHLSGSI-PKSISNLNKLKILKLEFNELSGEIP---QELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 355 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~ls~N~l~ 409 (843)
|++|++++.. +..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666666421 1566666777777777777764444 36666777777777777654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-16 Score=152.52 Aligned_cols=138 Identities=24% Similarity=0.239 Sum_probs=123.7
Q ss_pred cCccCEEeCCCCccc-eeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEE
Q 003156 251 FQTLRILDLSSNNLV-GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 329 (843)
Q Consensus 251 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 329 (843)
.++|+.|++++|.++ +.+|..+..+++|++|++++|.|++. ..+..+++|++|++++|++++.+|..+..+++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 478999999999998 67888899999999999999999876 789999999999999999998788888889999999
Q ss_pred EcCCCCCCCCc-hhhhcccCCCcEEecccccccccCC---ccccCCCCCCEEEccCCcccccCCcc
Q 003156 330 QLDGNSLTGPI-PQVIRNCTSLYLLSLSHNHLSGSIP---KSISNLNKLKILKLEFNELSGEIPQE 391 (843)
Q Consensus 330 ~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~ 391 (843)
+|++|.+++.. +..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+. .+|.+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999999643 2789999999999999999996544 48999999999999999998 55543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=149.55 Aligned_cols=127 Identities=20% Similarity=0.236 Sum_probs=80.4
Q ss_pred CCCcEEEcCCCccc-CCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEe
Q 003156 276 ANLRYLNLSSNHLR-SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 354 (843)
Q Consensus 276 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 354 (843)
++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34455555555554 33444445555555555555555533 4566666777777777777765666666677777777
Q ss_pred ccccccccc-CCccccCCCCCCEEEccCCcccccCC---cchhcccccceEeec
Q 003156 355 LSHNHLSGS-IPKSISNLNKLKILKLEFNELSGEIP---QELGKLASLLAVNVS 404 (843)
Q Consensus 355 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~l~ls 404 (843)
+++|++++. .|..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777777642 23667777777777777777775555 467777777777765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-15 Score=165.36 Aligned_cols=323 Identities=14% Similarity=0.102 Sum_probs=236.1
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
++|+.+.|.. .++ .|...+|.+|++|+.++|..+ +..+....|.++++|+.+.+..+ +.. +...+|.+...+
T Consensus 71 ~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~----i~~~aF~~~~~~ 142 (394)
T 4fs7_A 71 RKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKS----IGVEAFKGCDFK 142 (394)
T ss_dssp TTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCE----ECTTTTTTCCCS
T ss_pred CCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eee----ecceeeeccccc
Confidence 5799999975 477 899999999999999999755 88899999999999999988765 332 333466666544
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
...... .+......+|.++.+|+.+.+.++.. .+....|.++.+|+.+++..| ++.+...+|.+...|+.+.+..+
T Consensus 143 ~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 143 EITIPE--GVTVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp EEECCT--TCCEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTT
T ss_pred ccccCc--cccccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCC
Confidence 433332 23335567899999999999987654 477788999999999999887 66677888999999999988877
Q ss_pred cccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~ 241 (843)
... +.+.+....+|+.+.+..+. +.+....|.++.+|+.+.+..+... +....+
T Consensus 219 ~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~--i~~~~F--------------------- 272 (394)
T 4fs7_A 219 LYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR--IGGSLF--------------------- 272 (394)
T ss_dssp CCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE--ECSCTT---------------------
T ss_pred ceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce--eecccc---------------------
Confidence 553 33444556789999987654 4366678899999999998776543 222111
Q ss_pred CCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCcccc
Q 003156 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 321 (843)
Q Consensus 242 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 321 (843)
.....++.+.+..+.+ ....|....+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++......|.
T Consensus 273 -------~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 340 (394)
T 4fs7_A 273 -------YNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFR 340 (394)
T ss_dssp -------TTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTT
T ss_pred -------ccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhcc
Confidence 1134455555554432 3345667778888888765 56666677888888888888654 6655567788
Q ss_pred ccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEE
Q 003156 322 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKIL 377 (843)
Q Consensus 322 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 377 (843)
++.+|+.+++..| ++.+...+|.+|++|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 341 ~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 341 GCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 8888888888776 66566778889999999998765 33 345678888877764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=4e-16 Score=153.11 Aligned_cols=128 Identities=24% Similarity=0.332 Sum_probs=84.3
Q ss_pred EEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccc
Q 003156 280 YLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359 (843)
Q Consensus 280 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 359 (843)
.+++++|.++.+ |..+. .+|++|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~~i-p~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLKVL-PKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCSSC-CSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCCcC-CCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 445555555432 22221 35666666666666 555666777777777777777776666667777777777777777
Q ss_pred ccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceec
Q 003156 360 LSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 360 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|++++|++.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 7766666677777777777777777755555677777777777777777643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-16 Score=148.46 Aligned_cols=129 Identities=19% Similarity=0.202 Sum_probs=116.8
Q ss_pred cCccCEEeCCCCccc-eeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEE
Q 003156 251 FQTLRILDLSSNNLV-GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 329 (843)
Q Consensus 251 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 329 (843)
.++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 478999999999998 78888999999999999999999876 788999999999999999998788888889999999
Q ss_pred EcCCCCCCCC-chhhhcccCCCcEEecccccccccCC---ccccCCCCCCEEEccC
Q 003156 330 QLDGNSLTGP-IPQVIRNCTSLYLLSLSHNHLSGSIP---KSISNLNKLKILKLEF 381 (843)
Q Consensus 330 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~ 381 (843)
++++|.+++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999964 34889999999999999999996655 5789999999999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.7e-16 Score=149.56 Aligned_cols=130 Identities=23% Similarity=0.196 Sum_probs=72.6
Q ss_pred cCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCC
Q 003156 254 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 333 (843)
Q Consensus 254 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 333 (843)
.+.+++++|+++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 456667777666 344332 24666666666666655555555556666666666666544444455555555555555
Q ss_pred CCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccc
Q 003156 334 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSG 386 (843)
Q Consensus 334 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 386 (843)
|.|++..+..|.++++|+.|+|++|+|++..+..+..+++|++|+|++|.+++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 55555444445555555555555555554333344555555555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-15 Score=149.52 Aligned_cols=127 Identities=20% Similarity=0.159 Sum_probs=66.5
Q ss_pred cEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEEE
Q 003156 30 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELL 109 (843)
Q Consensus 30 ~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 109 (843)
+.+++++|++..++...+ ++|++|+|++|+|+..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~---~~l~~L~L~~n~i~~ip-----~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ 84 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP---RDVTELYLDGNQFTLVP-----KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI 84 (193)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCCEEECCSSCCCSCC-----GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CEEEcCCCCCCcCCCCCC---CCCCEEECCCCcCchhH-----HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE
Confidence 344555555554444322 34555555555554222 1344555555555555555544445555555555555
Q ss_pred cCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc
Q 003156 110 LQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 110 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
|++|+|++..+..|..+++|++|+|++|.|+...+..|..+++|+.|+|++|.+.
T Consensus 85 Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 85 LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 5555555555555555555555555555555444445555555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-15 Score=147.14 Aligned_cols=135 Identities=24% Similarity=0.191 Sum_probs=116.4
Q ss_pred CCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecc
Q 003156 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 356 (843)
Q Consensus 277 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 356 (843)
..+.+++++|.++.+ |..+ .++|++|++++|++++..+..+..+++|++|++++|.+++..+..|.++++|+.|+|+
T Consensus 8 ~~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 357899999999864 3333 3689999999999997777778899999999999999997777788999999999999
Q ss_pred cccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecCCC
Q 003156 357 HNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 414 (843)
Q Consensus 357 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~ 414 (843)
+|+|++..+..|..+++|++|+|++|+|++..+..+..+++|+.|++++|++++..|.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 9999977777789999999999999999977777788899999999999999988773
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=146.83 Aligned_cols=134 Identities=17% Similarity=0.146 Sum_probs=97.4
Q ss_pred ccCCCCCcEEEcCCCcccCCCCCCccccc-cceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCC
Q 003156 272 MGLFANLRYLNLSSNHLRSRIPPELGYFH-SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 350 (843)
Q Consensus 272 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 350 (843)
+....+|+.|++++|.++.+ +. +..+. +|++|++++|.+++. ..+..+++|++|+|++|.|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 44556677777777777643 33 33333 777777777777754 567778888888888888885544556788888
Q ss_pred cEEecccccccccCCc--cccCCCCCCEEEccCCcccccCCcc----hhcccccceEeeccccceec
Q 003156 351 YLLSLSHNHLSGSIPK--SISNLNKLKILKLEFNELSGEIPQE----LGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 351 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~l~ls~N~l~~~ 411 (843)
+.|+|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|.. +..+++|+.||+++|.+...
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 88888888886 5665 7788888888888888887 45553 78888888888888876543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4.9e-17 Score=160.71 Aligned_cols=151 Identities=21% Similarity=0.256 Sum_probs=121.2
Q ss_pred CccCEEeCCCCccceeCCc------cccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCC
Q 003156 252 QTLRILDLSSNNLVGDIPA------EMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRS 325 (843)
Q Consensus 252 ~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 325 (843)
..++.++++.+.+.+..|. .+..+++|++|++++|.+++ +| .+..+++|++|++++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3445555555555555554 78888999999999999987 45 8888899999999999998 67877888899
Q ss_pred CcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCC-ccccCCCCCCEEEccCCcccccCCcc----------hhc
Q 003156 326 LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP-KSISNLNKLKILKLEFNELSGEIPQE----------LGK 394 (843)
Q Consensus 326 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~ 394 (843)
|+.|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|++|++++|++++.+|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 9999999999985 55 68899999999999999984332 47889999999999999998776653 788
Q ss_pred ccccceEeeccccce
Q 003156 395 LASLLAVNVSYNRLI 409 (843)
Q Consensus 395 l~~L~~l~ls~N~l~ 409 (843)
+++|+.|| +|.++
T Consensus 173 l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCSEEC--CGGGT
T ss_pred CCCcEEEC--CcccC
Confidence 99999887 66654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-13 Score=148.38 Aligned_cols=336 Identities=12% Similarity=0.130 Sum_probs=170.6
Q ss_pred cCChhhhhcCC-CCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccC
Q 003156 17 PVPYQLFENCA-SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 95 (843)
Q Consensus 17 ~~~~~~f~~l~-~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 95 (843)
.|...+|.++. .|+.+.+.. .++.|...+|.++++|+.+.+..|..+.. ..+...+|....+|+.+.+..+ ++.+.
T Consensus 53 ~Ig~~aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l-~~Ig~~aF~~c~~L~~i~~~~~-~~~I~ 129 (394)
T 4gt6_A 53 KIGDRVFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCV-KKIGRQAFMFCSELTDIPILDS-VTEID 129 (394)
T ss_dssp EECTTTTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCC-CEECTTTTTTCTTCCBCGGGTT-CSEEC
T ss_pred EcCHhhccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCee-eEechhhchhcccceeeccCCc-cceeh
Confidence 45555666553 466666643 35556666666666666666655432111 1123334555555555555433 33344
Q ss_pred chhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCC
Q 003156 96 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIS 175 (843)
Q Consensus 96 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 175 (843)
...|.+..+|+.+.+..+. ..+....|..+.+|+.+.+.++ ++ .+...+|.+ .
T Consensus 130 ~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~------------------------~I~~~aF~~-~ 182 (394)
T 4gt6_A 130 SEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VT------------------------AIEERAFTG-T 182 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CC------------------------EECTTTTTT-C
T ss_pred hhhhhhhccccccccccee-eeecccceecccccccccccce-ee------------------------Eeccccccc-c
Confidence 4445555555555554332 2233444445555555554433 22 233334433 3
Q ss_pred CccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCCCCCCCcccccCcc
Q 003156 176 TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 254 (843)
Q Consensus 176 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L 254 (843)
+|+.+.+..+... ....+|.++.+|+......+... .+...++.. ...... +. ..+ ....+
T Consensus 183 ~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~-~~~----------~~~~~ 244 (394)
T 4gt6_A 183 ALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYP-AIDNVLYEKSANGDYA-----LI-RYP----------SQRED 244 (394)
T ss_dssp CCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEE-----EE-ECC----------TTCCC
T ss_pred ceeEEEECCcccc-cccchhhhccccceecccccccc-cccceeeccccccccc-----cc-ccc----------ccccc
Confidence 4555555544332 44455666666666655544433 122211111 000000 00 000 01223
Q ss_pred CEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCC
Q 003156 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGN 334 (843)
Q Consensus 255 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 334 (843)
..+.+. +.++......|....+|+.+.+.++.. .+...+|.++..|+.+.+. +.++......|.++.+|+.++|..+
T Consensus 245 ~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~ 321 (394)
T 4gt6_A 245 PAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG 321 (394)
T ss_dssp SEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT
T ss_pred ceEEcC-CcceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc
Confidence 344443 233435556677777777777766543 3555677777777777775 4455455566777777777777654
Q ss_pred CCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccc
Q 003156 335 SLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 408 (843)
Q Consensus 335 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l 408 (843)
++.+...+|.+|++|+.+.+..+ ++..-..+|.++.+|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 322 -v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 322 -ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp -CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred -ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 55455667777888888877654 554556677778888888877776542 3445556677766665543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=162.95 Aligned_cols=138 Identities=13% Similarity=0.111 Sum_probs=97.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-------------cChHHH--------HHHHHHHHhccCCC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-------------QYPEDF--------EREVRVLGKARHPN 613 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~--------~~E~~~l~~l~h~n 613 (843)
.|++...||+|+||.||+|... +|+.||||.++..... ...... .+|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3667788999999999999986 7999999987432110 001111 34566666665444
Q ss_pred ccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc
Q 003156 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 614 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 693 (843)
+.-..-+... ..++||||+++++|..+.. ......++.|++.+|.|||.. +||||||||.|||++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 3222212121 2379999999988754321 123467889999999999998 999999999999998
Q ss_pred CCCC----------cEEeeccCccc
Q 003156 694 DNYN----------PRISDFGLARL 708 (843)
Q Consensus 694 ~~~~----------~kl~Dfgl~~~ 708 (843)
+++. +.|+||+-+-.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 7763 88999997643
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=5.1e-15 Score=143.13 Aligned_cols=132 Identities=19% Similarity=0.165 Sum_probs=112.2
Q ss_pred ccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEE
Q 003156 250 LFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 329 (843)
Q Consensus 250 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 329 (843)
...+|+.|++++|+++ .+|......++|++|++++|.|++. ..|..+++|++|+|++|+|++..+..+..+++|+.|
T Consensus 17 ~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 4578999999999998 4555333344999999999999876 688899999999999999996655556899999999
Q ss_pred EcCCCCCCCCchh--hhcccCCCcEEecccccccccCCcc----ccCCCCCCEEEccCCcccc
Q 003156 330 QLDGNSLTGPIPQ--VIRNCTSLYLLSLSHNHLSGSIPKS----ISNLNKLKILKLEFNELSG 386 (843)
Q Consensus 330 ~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~ 386 (843)
+|++|.|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.||+++|.+..
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 99999997 5665 8999999999999999998 56764 8999999999999999873
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=2.4e-14 Score=137.31 Aligned_cols=107 Identities=24% Similarity=0.238 Sum_probs=54.2
Q ss_pred eEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCC
Q 003156 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382 (843)
Q Consensus 303 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 382 (843)
+.+++++|+++ .+|..+ .++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 34444444444 233333 144555555555555444555555555555555555555444444455555555555555
Q ss_pred cccccCCcchhcccccceEeeccccceecC
Q 003156 383 ELSGEIPQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 383 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
+|++..+..|..+++|+.|+|++|++++..
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 555444444555555555555555554443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.49 E-value=5.9e-16 Score=152.90 Aligned_cols=157 Identities=21% Similarity=0.227 Sum_probs=127.6
Q ss_pred CcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccc
Q 003156 223 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302 (843)
Q Consensus 223 ~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 302 (843)
.++.++++.+.+.|.+|.-......+..+++|++|+|++|++++ +| .+..+++|++|++++|.|+. +|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCcC
Confidence 45666666666666555422222234567899999999999996 67 88999999999999999984 67777788999
Q ss_pred eEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCch-hhhcccCCCcEEecccccccccCCcc----------ccCC
Q 003156 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP-QVIRNCTSLYLLSLSHNHLSGSIPKS----------ISNL 371 (843)
Q Consensus 303 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l 371 (843)
++|++++|++++ +| .+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+++.+|.. +..+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 999999999996 45 68899999999999999995433 57899999999999999999776653 8899
Q ss_pred CCCCEEEccCCcccc
Q 003156 372 NKLKILKLEFNELSG 386 (843)
Q Consensus 372 ~~L~~L~L~~N~l~~ 386 (843)
++|+.|| +|.++.
T Consensus 174 ~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 174 PNLKKLD--GMPVDV 186 (198)
T ss_dssp SSCSEEC--CGGGTT
T ss_pred CCcEEEC--CcccCH
Confidence 9999987 787764
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=6.7e-14 Score=134.59 Aligned_cols=104 Identities=26% Similarity=0.236 Sum_probs=56.0
Q ss_pred cEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccc
Q 003156 279 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358 (843)
Q Consensus 279 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 358 (843)
+.+++++|.++. +|..+. .+|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 456666666643 333332 45555555555555555555555555555555555555444444555555555555555
Q ss_pred cccccCCccccCCCCCCEEEccCCccc
Q 003156 359 HLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 359 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555433334555555555555555555
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.3e-12 Score=141.81 Aligned_cols=324 Identities=12% Similarity=0.139 Sum_probs=208.5
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCcc---ccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCc
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNI---LQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 79 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~---i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~ 79 (843)
.|+.+.+-.+ ++ .|...+|.+|++|+.+.++.|. ++.|...+|.++.+|+.+.+.++ +.. +...+|....
T Consensus 65 ~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~----I~~~aF~~c~ 137 (394)
T 4gt6_A 65 VLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE----IDSEAFHHCE 137 (394)
T ss_dssp CCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE----ECTTTTTTCT
T ss_pred cCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce----ehhhhhhhhc
Confidence 3777888654 67 7999999999999999998874 78899999999999999988775 332 4445788999
Q ss_pred cCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEee
Q 003156 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159 (843)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 159 (843)
+|+.+.+..+ +..+....|....+|+.+.+..+ ++.+....|.+ .+|+.+.+..+-.. ....+|....++......
T Consensus 138 ~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~ 213 (394)
T 4gt6_A 138 ELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSD 213 (394)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEEC
T ss_pred ccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceeccc
Confidence 9999999765 44477788999999999999876 44455666654 67999988776433 556667777777766665
Q ss_pred cCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCC
Q 003156 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p 239 (843)
.+... .....+..........+ ..+.....+..+.+ |..+. .+.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~i---------p~~v~----------------~i~ 257 (394)
T 4gt6_A 214 SESYP-AIDNVLYEKSANGDYAL----------IRYPSQREDPAFKI---------PNGVA----------------RIE 257 (394)
T ss_dssp CSSSC-BSSSCEEEECTTSCEEE----------EECCTTCCCSEEEC---------CTTEE----------------EEC
T ss_pred ccccc-cccceeecccccccccc----------cccccccccceEEc---------CCcce----------------Ecc
Confidence 55443 11111111000000000 00111112222221 11100 000
Q ss_pred CCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCcc
Q 003156 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQE 319 (843)
Q Consensus 240 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 319 (843)
.. .+.....|+.+.+.++... .....|.+..+|+.+.+. +.++.+...+|.++.+|+.++|.++ ++......
T Consensus 258 ~~-----aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 329 (394)
T 4gt6_A 258 TH-----AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDA 329 (394)
T ss_dssp TT-----TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred cc-----eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhH
Confidence 00 1122455666776655443 566677777888888886 4455666678888888888888764 65555678
Q ss_pred ccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 320 VCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 320 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
|.++.+|+.+.+..+ ++.+-..+|.+|++|+.+++.+|.... ..+.....|+.+.+..|.+.
T Consensus 330 F~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 330 FAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred hhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 888899999998655 665667789999999999999887542 46777888888888777653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=129.48 Aligned_cols=107 Identities=26% Similarity=0.208 Sum_probs=78.5
Q ss_pred cEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccc
Q 003156 279 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358 (843)
Q Consensus 279 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 358 (843)
+.|++++|.++. +|..+ ..+|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 455555555554 33333 256677777777777666777778888888888888888777777788888888888888
Q ss_pred cccccCCccccCCCCCCEEEccCCcccccC
Q 003156 359 HLSGSIPKSISNLNKLKILKLEFNELSGEI 388 (843)
Q Consensus 359 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 388 (843)
+|++..+..|..+++|++|+|++|.++...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 888666667888888888888888887543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.8e-13 Score=129.28 Aligned_cols=108 Identities=22% Similarity=0.201 Sum_probs=68.5
Q ss_pred eEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCC
Q 003156 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382 (843)
Q Consensus 303 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 382 (843)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56666666665 4555443 56666666666666666666666666666666666666544445566666666666666
Q ss_pred cccccCCcchhcccccceEeeccccceecCC
Q 003156 383 ELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413 (843)
Q Consensus 383 ~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 413 (843)
+|++..+..|..+++|+.|+|++|++....+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 6665545556666666666666666664433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=5.9e-14 Score=152.25 Aligned_cols=161 Identities=21% Similarity=0.249 Sum_probs=120.0
Q ss_pred cCccCEEeCCCCccceeCCccccCC-----CCCcEEEcCCCcccCCCCCCc-cccccceEEEccCCcccccCCcccc---
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLF-----ANLRYLNLSSNHLRSRIPPEL-GYFHSLIHLDLRNNALYGSIPQEVC--- 321 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~--- 321 (843)
+++|+.|+|++|.++......+... ++|++|+|++|.|+......+ ..+.+|++|+|++|.|+......++
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4678889999988875444443332 689999999998864322222 3466899999999999754444442
Q ss_pred --ccCCCcEEEcCCCCCCCC----chhhhcccCCCcEEeccccccccc----CCccccCCCCCCEEEccCCccccc----
Q 003156 322 --ESRSLGILQLDGNSLTGP----IPQVIRNCTSLYLLSLSHNHLSGS----IPKSISNLNKLKILKLEFNELSGE---- 387 (843)
Q Consensus 322 --~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~---- 387 (843)
..++|+.|+|++|.|+.. ++..+..+++|++|+|++|.|++. ++..+...++|+.|+|++|.|++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 457899999999999753 444557789999999999999753 356677888999999999999853
Q ss_pred CCcchhcccccceEeeccccceec
Q 003156 388 IPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 388 ~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
++..+...++|+.|||++|.++..
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHH
Confidence 344556678999999999998644
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.4e-14 Score=155.35 Aligned_cols=183 Identities=18% Similarity=0.144 Sum_probs=101.1
Q ss_pred CCCcEEEccCccccccccccccC-----CCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhh--
Q 003156 27 ASLRYLSLAGNILQGPIGKIFNY-----CSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-- 99 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~~~f~~-----l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-- 99 (843)
+.|++|+|++|.|.......|.. .++|++|+|++|.|+..... .....+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~---~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~ 148 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR---TLLPVFLRARKLGLQLNSLGPEACKDLRD 148 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHH---HTHHHHHTEEEEECCSSCCCHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHH---HHHHHHHhccHhhcCCCCCCHHHHHHHHH
Confidence 45667777777665433333222 25677777777766532110 112235567777777777764333333
Q ss_pred ---hcCCCCCEEEcCCCccccc----CCCCCCCCCCCcEEEccCCcccccC----CchhhcccCCcEEEeecCccccc--
Q 003156 100 ---AALHYLKELLLQGNQFSGP----LPADIGFCPHLTTLDLSNNLFTGQL----PVSLRLLNSMIFISVSNNTLTGD-- 166 (843)
Q Consensus 100 ---~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-- 166 (843)
...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|+... +..+...++|+.|+|++|.|+..
T Consensus 149 ~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~ 228 (372)
T 3un9_A 149 LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA 228 (372)
T ss_dssp HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHH
T ss_pred HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHH
Confidence 2346677777777776532 2233345667777777777776432 34455666777777777777642
Q ss_pred --CCCCccCCCCccEEEcccCCcCCCCCCCCCCC---C--CCcEEE--ecCCcCC
Q 003156 167 --IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC---K--KLSVIR--LRGNSLN 212 (843)
Q Consensus 167 --~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l---~--~L~~L~--L~~N~l~ 212 (843)
+...+...++|++|+|++|.|++.....+..+ . .|+.+. +..|.+.
T Consensus 229 ~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 229 LALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 23344456778888888888775333333222 1 166666 5566554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.1e-12 Score=137.31 Aligned_cols=103 Identities=24% Similarity=0.171 Sum_probs=65.5
Q ss_pred EEEcCCC-cccCCCCCCccccccceEEEccC-CcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccc
Q 003156 280 YLNLSSN-HLRSRIPPELGYFHSLIHLDLRN-NALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSH 357 (843)
Q Consensus 280 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 357 (843)
.++++++ .|++ +|. +..+++|++|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 6664 444 66666667777764 666655556666666666666666666666666666666666666666
Q ss_pred ccccccCCccccCCCCCCEEEccCCccc
Q 003156 358 NHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 358 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
|+|++..+..|..++ |+.|+|.+|.|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 666644444444444 666666666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=7.7e-12 Score=135.13 Aligned_cols=105 Identities=22% Similarity=0.187 Sum_probs=65.5
Q ss_pred EEEccCC-cccccCCccccccCCCcEEEcCC-CCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccC
Q 003156 304 HLDLRNN-ALYGSIPQEVCESRSLGILQLDG-NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF 381 (843)
Q Consensus 304 ~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 381 (843)
.++++++ +|+ .+|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3466665 666 3555 66666666666664 666655556666666666666666666666666666666666666666
Q ss_pred CcccccCCcchhcccccceEeeccccceec
Q 003156 382 NELSGEIPQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 382 N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
|+|++..+..+..++ |+.|+|++|+|...
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 666654444555444 66666666666543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.27 E-value=4.1e-10 Score=123.09 Aligned_cols=302 Identities=12% Similarity=0.064 Sum_probs=165.0
Q ss_pred hhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcC
Q 003156 23 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL 102 (843)
Q Consensus 23 f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 102 (843)
|....+|+++.+. ..++.|...+|.++.+|++++|..+ ++. +...+|.+. +|+.+.+..+ +..+...+|..
T Consensus 42 ~~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~----Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~- 112 (379)
T 4h09_A 42 YKDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTS----IGDGAFADT-KLQSYTGMER-VKKFGDYVFQG- 112 (379)
T ss_dssp GGGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCE----ECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-
T ss_pred cccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceE----echhhhcCC-CCceEECCce-eeEeccceecc-
Confidence 5566677777774 3566777777777777777777654 443 333456554 5666666543 44444455554
Q ss_pred CCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccc------------cCCCC
Q 003156 103 HYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG------------DIPHW 170 (843)
Q Consensus 103 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~p~~ 170 (843)
.+|+.+.+..+. .......|.+. +|+.+.+..+ ++.+....|.....++.+.+..+.... .....
T Consensus 113 ~~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (379)
T 4h09_A 113 TDLDDFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILES 189 (379)
T ss_dssp CCCSEEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEE
T ss_pred CCcccccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecc
Confidence 367777776553 22444444443 5666655543 344555666666777766665543221 11223
Q ss_pred ccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccc
Q 003156 171 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 250 (843)
Q Consensus 171 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~ 250 (843)
+.....+..+.+..+... .....+..+.+|+.+.+..+ +. .+....+ ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~-~i~~~~f----------------------------~~ 238 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VT-TLGDGAF----------------------------YG 238 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CC-EECTTTT----------------------------TT
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccc-ee-EEccccc----------------------------cC
Confidence 445566677666554433 55667777888888876544 22 1111111 11
Q ss_pred cCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEE
Q 003156 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330 (843)
Q Consensus 251 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 330 (843)
...|+.+.+..+ ++......|....+|+.+.+..+ ++.+....|.++.+|+.+.+.++.++......|.++.+|+.+.
T Consensus 239 ~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~ 316 (379)
T 4h09_A 239 MKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVT 316 (379)
T ss_dssp CSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEE
T ss_pred CccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEE
Confidence 344555555544 44344555666666666666543 4444445566666666666665555544445555666666666
Q ss_pred cCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCC
Q 003156 331 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL 371 (843)
Q Consensus 331 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 371 (843)
|..+ ++.+-..+|.+|++|+.+.+..+ ++..-..+|.++
T Consensus 317 lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 317 LPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred cCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 6433 44344455666666666655443 332334444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.15 E-value=3.8e-09 Score=115.38 Aligned_cols=297 Identities=10% Similarity=0.029 Sum_probs=153.4
Q ss_pred ccCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEe
Q 003156 79 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 158 (843)
Q Consensus 79 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 158 (843)
.+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|.. .+|+.+.+
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~l 120 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEF 120 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEEC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccC
Confidence 3444444432 233334444555555555555432 333444444444 3444444432 33333344433 24555555
Q ss_pred ecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecC
Q 003156 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238 (843)
Q Consensus 159 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~ 238 (843)
..+- ......+|.+. +|+.+.+..+ ++.+....|..+.+++.+.+..+.................. ....
T Consensus 121 p~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 190 (379)
T 4h09_A 121 PGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTI-------LESY 190 (379)
T ss_dssp CTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSE-------EEEC
T ss_pred CCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccce-------eccc
Confidence 4432 22333444443 4555555433 33345556667777777766655433111110000000000 0000
Q ss_pred CCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCc
Q 003156 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 318 (843)
Q Consensus 239 p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 318 (843)
+ ....+..+.+..+.-. .....+....+|+.+.+..+ +..+....|..+..|+.+.+..+ ++.....
T Consensus 191 ~----------~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~ 257 (379)
T 4h09_A 191 P----------AAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF 257 (379)
T ss_dssp C----------TTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT
T ss_pred c----------ccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcc
Confidence 0 1123344444333222 44455556666777776554 33445566667777777777655 4445556
Q ss_pred cccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhccccc
Q 003156 319 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 398 (843)
Q Consensus 319 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 398 (843)
.|.++.+|+.+.+..+ ++......|.+|++|+.+.+.++.++.....+|.++.+|+.+.|..+ ++..-..+|.++.+|
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 6677777777777544 44345566777777777777777777555667777777777777644 554556677777777
Q ss_pred ceEeecc
Q 003156 399 LAVNVSY 405 (843)
Q Consensus 399 ~~l~ls~ 405 (843)
+.+.+..
T Consensus 336 ~~i~ip~ 342 (379)
T 4h09_A 336 STISYPK 342 (379)
T ss_dssp CCCCCCT
T ss_pred CEEEECC
Confidence 7776643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.8e-10 Score=118.99 Aligned_cols=138 Identities=17% Similarity=0.041 Sum_probs=107.1
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
....++.|+.+.||++.. .++.+++|....... .....+.+|+.+++.+. +..+.++++++...+..++||||++|
T Consensus 18 ~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp EEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 344577788899999975 468899999864221 22346889999999984 67788999999888889999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc-----------------------------------------
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS----------------------------------------- 675 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------------------------------------- 675 (843)
.++.+.+. +......++.+++++++.||+.
T Consensus 95 ~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 95 VLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred eehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99877632 1123457888999999999981
Q ss_pred ---------------CCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 676 ---------------FRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 676 ---------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
..+.++|+|+++.||+++++..+.|.||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=1.1e-09 Score=112.82 Aligned_cols=130 Identities=15% Similarity=0.081 Sum_probs=96.5
Q ss_pred eec-cccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCC--ccceeeEEEcCCeeEEEEEeCCCC
Q 003156 561 EVG-EGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN--LISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 561 ~ig-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.++ .|..+.||++... +|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.
T Consensus 26 ~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~ 100 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 100 (264)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred ecccCCCCceEEEEecC-CCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence 344 5556999999764 6778999986443 2245788999999996544 456888888777889999999998
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC-----------------------------------------
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF----------------------------------------- 676 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------- 676 (843)
++. ... . ....++.++++.++.||...
T Consensus 101 ~l~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 101 DLL--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp ETT--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccC--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 873 111 1 12356777888888888641
Q ss_pred --------------CCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 677 --------------RPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 677 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
.+.++|+|++|.||++++++.+.|.|||.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887767899999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.1e-09 Score=118.57 Aligned_cols=143 Identities=15% Similarity=0.208 Sum_probs=105.4
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEee--cCCcccChHHHHHHHHHHHhcc--CCCccceeeEEEcC---CeeEEEEE
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLV--TSDIIQYPEDFEREVRVLGKAR--HPNLISLEGYYWTP---QLKLLVSD 632 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lV~e 632 (843)
+.++.|.++.||++... +..+++|+.. ..........+.+|+.+++.+. +..+.++++++.+. +..++|||
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 36899999999998874 5678888775 3322222356788999999997 45678889888766 34789999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC------------------------------------
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF------------------------------------ 676 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 676 (843)
|++|..+.+. ....++..++..++.++++.|+.||...
T Consensus 122 ~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9998776431 1223677888899999999999999721
Q ss_pred -------------------CCCeeecCCCCCCEEEcCCCC--cEEeeccCccccc
Q 003156 677 -------------------RPPIIHYNLKPSNILLDDNYN--PRISDFGLARLLT 710 (843)
Q Consensus 677 -------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfgl~~~~~ 710 (843)
.+.++|+|+++.||+++.++. +.|.||+.+..-.
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 247999999999999997653 6899999987543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=1.4e-09 Score=116.69 Aligned_cols=60 Identities=27% Similarity=0.305 Sum_probs=30.4
Q ss_pred CCCccEEEcccCCcCCC----CCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCc
Q 003156 174 ISTLEFLDFSNNHLTGS----LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENG 233 (843)
Q Consensus 174 l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~ 233 (843)
+++|++|+|+.|.+++. ++..+.++++|+.|+|++|.|+...-..+...-...+++++++
T Consensus 278 ~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp GGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHCCSEEECCSBC
T ss_pred CCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHcCCEEEecCCc
Confidence 45666666666666542 2233344566666676666665322222222112345666655
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=1.6e-09 Score=114.46 Aligned_cols=185 Identities=18% Similarity=0.144 Sum_probs=119.6
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCC--ccceeeEEEcCC---eeEEEEEeC
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPN--LISLEGYYWTPQ---LKLLVSDYA 634 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~e~~ 634 (843)
.++.|.+..||++. ..+++|..... .....+.+|+++++.+. +.. +.++++.....+ ..|+|||++
T Consensus 27 ~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp EEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred ecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 58999999999863 45888875322 23467889999999884 332 334444433332 347899999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc---------------------------------------
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS--------------------------------------- 675 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------------- 675 (843)
+|.++.+.... .++..++..++.++++.++.||..
T Consensus 99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99888654332 256667777888888888888851
Q ss_pred ----------------CCCCeeecCCCCCCEEEcC--CCCcEEeeccCcccccccccceecccc---cc---------cc
Q 003156 676 ----------------FRPPIIHYNLKPSNILLDD--NYNPRISDFGLARLLTRLDKHVMSNRF---QS---------AL 725 (843)
Q Consensus 676 ----------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~---~g---------~~ 725 (843)
..+.++|+|+++.||++++ +..+.|.||+.+..-.+..+....... .+ ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 1246899999999999997 566889999998654332111000000 00 00
Q ss_pred ccCC-cccccCcCCCCCchhHHHHHHHHHHHHhCCCCC
Q 003156 726 GYVA-PELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 762 (843)
Q Consensus 726 ~y~a-PE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~ 762 (843)
++.. |+.. .......+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~---~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVL---EKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHH---HHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHH---HHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1122 2221 01123468999999999999998776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.75 E-value=3.2e-09 Score=113.95 Aligned_cols=134 Identities=17% Similarity=0.188 Sum_probs=60.7
Q ss_pred cCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCcccc--ccCCCcEEEcCC--CCCCCC-----chhh
Q 003156 273 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC--ESRSLGILQLDG--NSLTGP-----IPQV 343 (843)
Q Consensus 273 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~ 343 (843)
..+++|+.|++++|.-.. .+. +. +++|+.|+|..|.+.......++ .+++|+.|+|+. |...+. +...
T Consensus 169 ~~~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~ 245 (362)
T 2ra8_A 169 DAMPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245 (362)
T ss_dssp HTCTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG
T ss_pred hcCCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH
Confidence 444555555555542111 111 22 45555555555555432222222 455555555532 111110 0011
Q ss_pred h--cccCCCcEEecccccccccCCcccc---CCCCCCEEEccCCccccc----CCcchhcccccceEeeccccce
Q 003156 344 I--RNCTSLYLLSLSHNHLSGSIPKSIS---NLNKLKILKLEFNELSGE----IPQELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 344 ~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~ 409 (843)
+ ..+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.++
T Consensus 246 l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp SCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 1 1345666666666655533322222 355666666666666542 2333345556666666666544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.58 E-value=5.3e-09 Score=101.28 Aligned_cols=119 Identities=14% Similarity=0.112 Sum_probs=58.1
Q ss_pred cccCCCCCCEEECCCC-CCccccCCCcCccccCCccCCEEecCCccCccc----CchhhhcCCCCCEEEcCCCccccc--
Q 003156 46 IFNYCSSLNTLNLSNN-HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS----IPQGVAALHYLKELLLQGNQFSGP-- 118 (843)
Q Consensus 46 ~f~~l~~L~~L~Ls~N-~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~-- 118 (843)
.+...+.|++|+|++| .|...........+...++|++|+|++|.|... +...+...++|++|+|++|.|.+.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3444555555555555 544211111112233344555555555555421 223344445566666666665532
Q ss_pred --CCCCCCCCCCCcEEEc--cCCcccccC----CchhhcccCCcEEEeecCccc
Q 003156 119 --LPADIGFCPHLTTLDL--SNNLFTGQL----PVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 119 --~~~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 164 (843)
+...+...++|++|+| ++|.|+... ...+...++|++|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2334445556666666 556665322 233444466666666666654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.57 E-value=1.6e-08 Score=102.78 Aligned_cols=80 Identities=24% Similarity=0.341 Sum_probs=57.0
Q ss_pred cccCCCcEEEcCCCCCCC--CchhhhcccCCCcEEecccccccccCCccccCCC--CCCEEEccCCcccccCCc------
Q 003156 321 CESRSLGILQLDGNSLTG--PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN--KLKILKLEFNELSGEIPQ------ 390 (843)
Q Consensus 321 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~------ 390 (843)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456788888888888876 3456677888888888888888754 3344444 888888888888876652
Q ss_pred -chhcccccceEe
Q 003156 391 -ELGKLASLLAVN 402 (843)
Q Consensus 391 -~~~~l~~L~~l~ 402 (843)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 356777777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.55 E-value=8.8e-09 Score=99.67 Aligned_cols=120 Identities=14% Similarity=0.172 Sum_probs=79.9
Q ss_pred hhhhcCCCCcEEEccCc-ccccc----ccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCccc-
Q 003156 21 QLFENCASLRYLSLAGN-ILQGP----IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS- 94 (843)
Q Consensus 21 ~~f~~l~~L~~L~L~~n-~i~~~----~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~- 94 (843)
.++...+.|++|+|++| .|... ....+...++|++|+|++|.|...........+...++|++|+|++|.|...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34566788888888888 77542 2334566778888888888876432211223344557788888888888743
Q ss_pred ---CchhhhcCCCCCEEEc--CCCccccc----CCCCCCCCCCCcEEEccCCccc
Q 003156 95 ---IPQGVAALHYLKELLL--QGNQFSGP----LPADIGFCPHLTTLDLSNNLFT 140 (843)
Q Consensus 95 ---~~~~~~~l~~L~~L~L--~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 140 (843)
+...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3455666778888888 77887643 2334445678888888888776
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.37 E-value=3.5e-08 Score=100.20 Aligned_cols=79 Identities=29% Similarity=0.368 Sum_probs=48.3
Q ss_pred ccccceEEEccCCcccc--cCCccccccCCCcEEEcCCCCCCCCchhhhcccC--CCcEEecccccccccCCc-------
Q 003156 298 YFHSLIHLDLRNNALYG--SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCT--SLYLLSLSHNHLSGSIPK------- 366 (843)
Q Consensus 298 ~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~------- 366 (843)
.+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 34556666666666654 3345555667777777777777643 2344444 777777777777765552
Q ss_pred cccCCCCCCEEE
Q 003156 367 SISNLNKLKILK 378 (843)
Q Consensus 367 ~~~~l~~L~~L~ 378 (843)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 356677777765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=3.3e-06 Score=87.14 Aligned_cols=136 Identities=19% Similarity=0.162 Sum_probs=97.9
Q ss_pred eeccccce-EEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 561 EVGEGVFG-TVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 561 ~ig~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
.+..|..| .||+.....++..+++|+-... ....+.+|...++.+. +--+.++++++.+++..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34556555 6999887767788999986432 2456888999998884 3346778899998899999999999988
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC------------------------------------------
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF------------------------------------------ 676 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------ 676 (843)
+.+..... ......++.+++..++.||..-
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 77655431 1223345555666666665320
Q ss_pred -------------CCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 677 -------------RPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 677 -------------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
.+.++|+|+.+.||++++++.+-|.||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=7.5e-06 Score=85.97 Aligned_cols=135 Identities=18% Similarity=0.131 Sum_probs=89.9
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCC---CccceeeEEE-cCCeeEEEEEeCCC
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHP---NLISLEGYYW-TPQLKLLVSDYAPN 636 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~e~~~~ 636 (843)
.++.|....||+. |..+++|.-.. ......+.+|+++++.+.+. .+.+++.++. ..+..++||||++|
T Consensus 26 ~l~~G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 26 SLGEGFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEECSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred ecCCCcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 5788888999987 45678887421 12345788999999999653 3556666664 34557899999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc-----------------------------------------
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS----------------------------------------- 675 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------------------------------------- 675 (843)
.++.+.... .++..++..++.++++.|+.||..
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 888663221 123333334444444444444421
Q ss_pred ----------------CCCCeeecCCCCCCEEEcC---CCC-cEEeeccCcccc
Q 003156 676 ----------------FRPPIIHYNLKPSNILLDD---NYN-PRISDFGLARLL 709 (843)
Q Consensus 676 ----------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfgl~~~~ 709 (843)
..+.++|+|+++.||+++. ++. +.|.||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2346799999999999997 455 489999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=1.4e-05 Score=85.94 Aligned_cols=80 Identities=9% Similarity=0.018 Sum_probs=54.3
Q ss_pred ee-ccccceEEEEEEEC--C----CCeEEEEEEeecCCc--ccChHHHHHHHHHHHhcc-C--CCccceeeEEEcC---C
Q 003156 561 EV-GEGVFGTVYKVSFG--T----QGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKAR-H--PNLISLEGYYWTP---Q 625 (843)
Q Consensus 561 ~i-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~---~ 625 (843)
.| +.|....+|+.... . +++.+++|....... ......+.+|+.+++.+. + -.+.++++++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 57 88889999998763 1 166788887643220 101245778999988884 3 3567788887655 3
Q ss_pred eeEEEEEeCCCCCHH
Q 003156 626 LKLLVSDYAPNGSLQ 640 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~ 640 (843)
..++||||++|.++.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 468999999886653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.90 E-value=5.3e-06 Score=77.90 Aligned_cols=83 Identities=8% Similarity=0.035 Sum_probs=55.4
Q ss_pred cceEEEccCCcccccCCccccccCCCcEEEcCCCC-CCCCchhhhccc----CCCcEEeccccc-ccccCCccccCCCCC
Q 003156 301 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS-LTGPIPQVIRNC----TSLYLLSLSHNH-LSGSIPKSISNLNKL 374 (843)
Q Consensus 301 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 374 (843)
+|+.||++++.|+..--..+..+++|+.|+|++|. |++.--..+..+ ++|++|+|++|. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 56677777766665444556677777777777773 665444455543 368888888874 765555556777888
Q ss_pred CEEEccCCc
Q 003156 375 KILKLEFNE 383 (843)
Q Consensus 375 ~~L~L~~N~ 383 (843)
++|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 888887774
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.86 E-value=4.2e-06 Score=78.60 Aligned_cols=92 Identities=9% Similarity=0.061 Sum_probs=74.4
Q ss_pred CCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccc-ccccCCccccCC----CCCCEEEccCCc-ccccCC
Q 003156 316 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH-LSGSIPKSISNL----NKLKILKLEFNE-LSGEIP 389 (843)
Q Consensus 316 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p 389 (843)
+|.....-..|+.||++++.|+..--..+.++++|+.|+|++|. |+..--..++.+ ++|++|+|++|. ||..--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 34444344579999999999988777778999999999999995 776555566665 479999999985 887656
Q ss_pred cchhcccccceEeecccc
Q 003156 390 QELGKLASLLAVNVSYNR 407 (843)
Q Consensus 390 ~~~~~l~~L~~l~ls~N~ 407 (843)
..+..+++|+.|++++++
T Consensus 133 ~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHGGGCTTCCEEEEESCT
T ss_pred HHHhcCCCCCEEECCCCC
Confidence 678889999999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=3.5e-05 Score=84.27 Aligned_cols=76 Identities=17% Similarity=0.192 Sum_probs=49.5
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc------ccChHHHHHHHHHHHhccC--CCcc-ceeeEEEcCCeeEEE
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI------IQYPEDFEREVRVLGKARH--PNLI-SLEGYYWTPQLKLLV 630 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv-~l~g~~~~~~~~~lV 630 (843)
+.+|.|.++.||++....+++.++||....... ....+.+..|.++++.+.. |..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 368999999999997654678899998643211 1123567889999988742 3333 45543 34456899
Q ss_pred EEeCCCC
Q 003156 631 SDYAPNG 637 (843)
Q Consensus 631 ~e~~~~g 637 (843)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00015 Score=77.36 Aligned_cols=140 Identities=16% Similarity=0.218 Sum_probs=80.2
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-----CCCcccee-e--EEEcCCeeEEEEE
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----HPNLISLE-G--YYWTPQLKLLVSD 632 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-g--~~~~~~~~~lV~e 632 (843)
.|+.|..+.||++... +..+++|+.... ...+..|+.+++.+. .|.++... | +....+..++|||
T Consensus 39 ~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--SGAVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET--TEEEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC--CCCEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4666778999999874 445899987541 234445666665553 24443311 1 1234566789999
Q ss_pred eCCCCCHH--------------HHHhhcCCC-----C-----CCCChhHHH-----------------------------
Q 003156 633 YAPNGSLQ--------------AKLHERLPS-----T-----PPLSWTNRF----------------------------- 659 (843)
Q Consensus 633 ~~~~gsL~--------------~~l~~~~~~-----~-----~~l~~~~~~----------------------------- 659 (843)
|++|.++. ..+|..... . ....|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 122321110 0 012332211
Q ss_pred --HHHHHHHHHHHhhhh----------cCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 660 --KVILGTAKGLAHLHH----------SFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 660 --~i~~~ia~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
.+...+..++.+|+. ...+.++|+|+++.||+++.++.+.|.||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666663 124589999999999999888899999999774
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.62 E-value=1.2e-05 Score=77.11 Aligned_cols=118 Identities=13% Similarity=0.133 Sum_probs=60.7
Q ss_pred cccCCCCCCEEECCCC-CCccccCCCcCccccCCccCCEEecCCccCccc----CchhhhcCCCCCEEEcCCCccccc--
Q 003156 46 IFNYCSSLNTLNLSNN-HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS----IPQGVAALHYLKELLLQGNQFSGP-- 118 (843)
Q Consensus 46 ~f~~l~~L~~L~Ls~N-~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~-- 118 (843)
.+.+-+.|++|+|++| +|..........++..-+.|+.|+|++|+|... +...+..-+.|++|+|++|.|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3444556666666653 554221111122334445566666666666532 223344556666666666666532
Q ss_pred --CCCCCCCCCCCcEEEccCCc---ccc----cCCchhhcccCCcEEEeecCcc
Q 003156 119 --LPADIGFCPHLTTLDLSNNL---FTG----QLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 119 --~~~~~~~l~~L~~L~L~~N~---l~~----~~~~~~~~l~~L~~L~L~~N~l 163 (843)
+...+...+.|++|+|++|. +.. .+...+..-+.|+.|+++.|.+
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 22334455567777776542 231 1223455566777777766654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.61 E-value=1.3e-05 Score=76.81 Aligned_cols=117 Identities=12% Similarity=0.093 Sum_probs=65.9
Q ss_pred hcCCCCcEEEccCc-ccccc----ccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCccc----
Q 003156 24 ENCASLRYLSLAGN-ILQGP----IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS---- 94 (843)
Q Consensus 24 ~~l~~L~~L~L~~n-~i~~~----~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---- 94 (843)
.+-+.|++|+|++| +|... ....+..-+.|++|+|++|+|..........++..-+.|++|+|++|.|...
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 44566777777764 66431 2233455567777777777776443333334455556677777777777632
Q ss_pred CchhhhcCCCCCEEEcCCC---cccc----cCCCCCCCCCCCcEEEccCCccc
Q 003156 95 IPQGVAALHYLKELLLQGN---QFSG----PLPADIGFCPHLTTLDLSNNLFT 140 (843)
Q Consensus 95 ~~~~~~~l~~L~~L~L~~n---~l~~----~~~~~~~~l~~L~~L~L~~N~l~ 140 (843)
+...+..-+.|++|+|++| .+.. .+...+...+.|+.|+++.|.+.
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2234445566777777654 2331 12233444566777777766544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=7.2e-05 Score=82.33 Aligned_cols=80 Identities=13% Similarity=-0.014 Sum_probs=48.5
Q ss_pred CCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCc--CCCCCchhHHHHHHHHHH
Q 003156 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILE 754 (843)
Q Consensus 677 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Dv~S~Gvil~e 754 (843)
.+.++|+|+++.||+++.++ +++.||+.+..-.+.-+-.. ....-...|.+|+..... .......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34899999999999999776 99999999875432211100 000011346666644211 111224556688888888
Q ss_pred HHhC
Q 003156 755 LVTG 758 (843)
Q Consensus 755 lltg 758 (843)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0021 Score=67.01 Aligned_cols=137 Identities=19% Similarity=0.180 Sum_probs=92.1
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc---CCCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR---HPNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.|+.|....+|+... +++.+++|..... ....+..|+..++.+. ...+.++++++...+..++||||+++.
T Consensus 43 ~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred EeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 689999999999876 5678889986532 2567889999998884 356888898888888899999999987
Q ss_pred CHH-----------HHHhhcCC-CC-----------------CCCChhHHH---HHH--HH--------------HHH-H
Q 003156 638 SLQ-----------AKLHERLP-ST-----------------PPLSWTNRF---KVI--LG--------------TAK-G 668 (843)
Q Consensus 638 sL~-----------~~l~~~~~-~~-----------------~~l~~~~~~---~i~--~~--------------ia~-~ 668 (843)
.+. ..||.... .. ..-+|.... ++. .+ +.. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 642 12333221 00 012454322 111 11 111 1
Q ss_pred HHhhhh-cCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 669 LAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 669 l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
...|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 2256899999999999999887 8888974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00099 Score=68.96 Aligned_cols=74 Identities=20% Similarity=0.201 Sum_probs=53.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC---CCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH---PNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
+.+|.|..+.||+.+.. +|+.|++|+-.... ......|..|+..|+.+.- -.+.+++++. ..++||||+++
T Consensus 21 ~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA-DGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEET-TSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 46899999999999986 89999999864332 2334568899999998842 2344455432 24789999987
Q ss_pred CCH
Q 003156 637 GSL 639 (843)
Q Consensus 637 gsL 639 (843)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00084 Score=59.97 Aligned_cols=57 Identities=21% Similarity=0.274 Sum_probs=38.9
Q ss_pred cEEecCCCcCc-ccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCc
Q 003156 5 KFLDLSNNLLS-GPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 64 (843)
Q Consensus 5 ~~L~L~~n~i~-~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~ 64 (843)
+.++.++++++ ..+|..+ -++|++|+|++|+|+.++.+.|..+++|++|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC---CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 35677777775 3466442 245777777777777777777777777777777777643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0014 Score=58.41 Aligned_cols=55 Identities=22% Similarity=0.297 Sum_probs=25.1
Q ss_pred EEEcCCCCCC-CCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcc
Q 003156 328 ILQLDGNSLT-GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 384 (843)
Q Consensus 328 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 384 (843)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 23332221 2355555555555533333444455555555555444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.005 Score=65.08 Aligned_cols=142 Identities=11% Similarity=0.023 Sum_probs=72.6
Q ss_pred eeccccceE-EEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC--CCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 561 EVGEGVFGT-VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH--PNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 561 ~ig~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.++.|+... +|+.... +|+.+++|...... .+.+..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECT-TCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcC-CCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 465555554 6676542 36677777643321 1234556777776642 23455666543333 7899999777
Q ss_pred CHHHHHhhcC---------------------CC-CCCCChhHHH-------H-H------------HHHHHHHHHhhhh-
Q 003156 638 SLQAKLHERL---------------------PS-TPPLSWTNRF-------K-V------------ILGTAKGLAHLHH- 674 (843)
Q Consensus 638 sL~~~l~~~~---------------------~~-~~~l~~~~~~-------~-i------------~~~ia~~l~~LH~- 674 (843)
++.+++.... .. .+.++..... . + ...+...++.+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 7765543210 00 0111111000 0 0 0011112222211
Q ss_pred --cCCCCeeecCCCCCCEEEcCC----CCcEEeeccCcccc
Q 003156 675 --SFRPPIIHYNLKPSNILLDDN----YNPRISDFGLARLL 709 (843)
Q Consensus 675 --~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~~ 709 (843)
...+.++|||+.+.||+++.+ +.+.|.||+.+..-
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124479999999999999874 67899999988654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0037 Score=65.04 Aligned_cols=140 Identities=14% Similarity=0.089 Sum_probs=75.2
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCc-cceeeEEEcCCeeEEEEEeC-CC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL-ISLEGYYWTPQLKLLVSDYA-PN 636 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~-~~ 636 (843)
.+.|+.|....+|++ +.+++|...... .. ..+..+|+.+++.+....+ .+++++ +++.-++|+||+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~-~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT-EE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc-cc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 347889999999998 357888764321 11 1234568888887753333 345543 344457899999 55
Q ss_pred CCHHH------------------HHhhcCCC-CCCCCh-hHHHHHHHH--------------HHHHHH----hhhh-cCC
Q 003156 637 GSLQA------------------KLHERLPS-TPPLSW-TNRFKVILG--------------TAKGLA----HLHH-SFR 677 (843)
Q Consensus 637 gsL~~------------------~l~~~~~~-~~~l~~-~~~~~i~~~--------------ia~~l~----~LH~-~~~ 677 (843)
.++.. .+|..... ....+. .....+... +...+. .+.. ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44421 11111100 000111 111111000 111111 1111 123
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 678 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
+.++|+|+.+.||+ ..++.+.+.||..+..-
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 46899999999999 56677899999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0052 Score=67.36 Aligned_cols=71 Identities=10% Similarity=0.193 Sum_probs=48.4
Q ss_pred eeccccceEEEEEEECC-------CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCc-cceeeEEEcCCeeEEEEE
Q 003156 561 EVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL-ISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 632 (843)
.|+.|....||++.... +++.+++|+.... ...+.+..|..+++.+...++ .++++.+. + .+|+|
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 67888899999998752 2578888887321 122566689999988853333 56666543 2 38999
Q ss_pred eCCCCC
Q 003156 633 YAPNGS 638 (843)
Q Consensus 633 ~~~~gs 638 (843)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0062 Score=64.00 Aligned_cols=142 Identities=12% Similarity=0.051 Sum_probs=79.0
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCC--ccceeeE------EEcCCeeEEEEE
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN--LISLEGY------YWTPQLKLLVSD 632 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e 632 (843)
.|+.|....+|+.... +| .+++|...... ..+.+..|+.+++.+.... +.+++.. ....+..++|++
T Consensus 29 ~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT-KD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeC-Cc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 5778888999999874 34 68889875421 2245667888877774212 2233321 122355689999
Q ss_pred eCCCCCHH--------------HHHhhcCCC--CC---C---CChhHHHH------------HHHHHHHHHHhhhhc---
Q 003156 633 YAPNGSLQ--------------AKLHERLPS--TP---P---LSWTNRFK------------VILGTAKGLAHLHHS--- 675 (843)
Q Consensus 633 ~~~~gsL~--------------~~l~~~~~~--~~---~---l~~~~~~~------------i~~~ia~~l~~LH~~--- 675 (843)
|++|..+. ..+|..... .. . ..|..... +...+...+++++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 99886431 112221110 00 0 12322110 001133445555432
Q ss_pred -CCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 676 -FRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 676 -~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
..+.++|+|+.+.||+++++..+.|.||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23479999999999999987666899999775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0083 Score=64.22 Aligned_cols=142 Identities=17% Similarity=0.196 Sum_probs=82.4
Q ss_pred eeccccceEEEEEEECC-------CCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEE
Q 003156 561 EVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+..|-...+|++.... +++.+++|+... .......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 57778888899988742 357888888522 2234566779999998884 3333556665543 28999
Q ss_pred eCCCCCHHH--------------H---HhhcC-CCCCCCC--hhHHHHHHHHHHH-------------------HHHhhh
Q 003156 633 YAPNGSLQA--------------K---LHERL-PSTPPLS--WTNRFKVILGTAK-------------------GLAHLH 673 (843)
Q Consensus 633 ~~~~gsL~~--------------~---l~~~~-~~~~~l~--~~~~~~i~~~ia~-------------------~l~~LH 673 (843)
|++|.++.. . +|... +...... |.++.++..++.. .+.+|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998765421 1 12111 1112222 3444444433321 233332
Q ss_pred hc-----CCCCeeecCCCCCCEEEcCC----CCcEEeeccCccc
Q 003156 674 HS-----FRPPIIHYNLKPSNILLDDN----YNPRISDFGLARL 708 (843)
Q Consensus 674 ~~-----~~~~ivH~dlk~~Nill~~~----~~~kl~Dfgl~~~ 708 (843)
.. ....++|+|+.+.||+++.+ +.+.+.||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 23478999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.47 E-value=0.016 Score=60.96 Aligned_cols=142 Identities=15% Similarity=0.145 Sum_probs=80.8
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCC--CccceeeE-----EEcCCeeEEEEEe
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHP--NLISLEGY-----YWTPQLKLLVSDY 633 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~-----~~~~~~~~lV~e~ 633 (843)
.++ |....||++... +|+.+++|...... ...+.+..|..+++.+... .+.+++.. ....+..++||||
T Consensus 33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCT-TCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcC-CCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 456 788899987764 56679999875332 1346677888888887422 23444432 1224456789999
Q ss_pred CCCCCHH-----H---------HHhhcCC-----CCCCCChhHH----HHH---------------HHHHHHHHHhhhhc
Q 003156 634 APNGSLQ-----A---------KLHERLP-----STPPLSWTNR----FKV---------------ILGTAKGLAHLHHS 675 (843)
Q Consensus 634 ~~~gsL~-----~---------~l~~~~~-----~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~~ 675 (843)
++|.++. . .+|.... .....++... ..+ ...+...++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875431 1 1222110 0112222211 000 01111222333221
Q ss_pred ----CCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 676 ----FRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 676 ----~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
..+.++|+|+++.||+++ + .+.+.||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.41 E-value=0.027 Score=54.01 Aligned_cols=102 Identities=16% Similarity=0.099 Sum_probs=67.0
Q ss_pred CHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccccee
Q 003156 638 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 717 (843)
Q Consensus 638 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 717 (843)
||.+.|..+ +.+++++++|.++.|.+++|.-.-.+-. + ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 899999987 5789999999999999999877621101 1 1223346899999999888764 1110
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p 761 (843)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0112367888752 3457888999999999998864444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.032 Score=61.37 Aligned_cols=73 Identities=11% Similarity=0.105 Sum_probs=46.8
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCc-cceeeEEEcCCeeEEEEEeCCCCCH
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL-ISLEGYYWTPQLKLLVSDYAPNGSL 639 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 639 (843)
.|+.|-...+|++.....+..+++|+..... .. .-+..+|..+++.+...++ .++++++ ++ ..|+||++|.++
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 6888889999999985335788888763321 11 1123589999998865444 4666665 22 359999987543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.87 E-value=0.013 Score=62.96 Aligned_cols=72 Identities=7% Similarity=0.018 Sum_probs=42.5
Q ss_pred eeccccceEEEEEEECC--------CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCC-ccceeeEEEcCCeeEEEE
Q 003156 561 EVGEGVFGTVYKVSFGT--------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN-LISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~ 631 (843)
.++.|....+|++.... .++.+++|...... .. ..+...|..+++.+...+ +.++++.. . -++||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 57888888999998742 12678888764321 11 113467888888885333 34666543 2 36899
Q ss_pred EeCCCCC
Q 003156 632 DYAPNGS 638 (843)
Q Consensus 632 e~~~~gs 638 (843)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.67 E-value=0.047 Score=57.63 Aligned_cols=32 Identities=19% Similarity=0.273 Sum_probs=28.3
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 678 ~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
..++|+|+.+.||++++++.+.+.||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.58 E-value=0.23 Score=53.72 Aligned_cols=141 Identities=15% Similarity=0.206 Sum_probs=83.2
Q ss_pred eeccccceEEEEEEECCC-------CeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEE
Q 003156 561 EVGEGVFGTVYKVSFGTQ-------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+..|-...+|+...... ++.+++|+..... ...-+..+|..+++.+. +.-..++++.+ . -+.|+|
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 677788899999987521 5788888853321 11223467888888885 33234555533 2 268999
Q ss_pred eCCCCCHHH--------------H---HhhcC------C---CCCCCChhHHHHHHHHH-------------------HH
Q 003156 633 YAPNGSLQA--------------K---LHERL------P---STPPLSWTNRFKVILGT-------------------AK 667 (843)
Q Consensus 633 ~~~~gsL~~--------------~---l~~~~------~---~~~~l~~~~~~~i~~~i-------------------a~ 667 (843)
|++|.++.. . +|... + ...+.-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 1 11110 1 11111244433333222 12
Q ss_pred HHHhhhh---------------------cCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 668 GLAHLHH---------------------SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 668 ~l~~LH~---------------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
.+.+|.. .....++|+|+.+.||+ +.++.+.+.||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11236899999999999 8888999999998864
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=86.23 E-value=0.6 Score=38.91 Aligned_cols=50 Identities=18% Similarity=0.312 Sum_probs=40.5
Q ss_pred CCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCC
Q 003156 11 NNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62 (843)
Q Consensus 11 ~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~ 62 (843)
+..++ .|...+|.+|.+|+.+.|..+ ++.|...+|.++.+|+.+.+....
T Consensus 5 g~~vt-~I~~~aF~~c~~L~~i~iP~~-v~~Ig~~aF~~C~~L~~i~~~~~~ 54 (100)
T 2lz0_A 5 GEPVV-GMDKSLFAGNTVIREITVQPN-IGLLYDGMFSGCTALEKLILTGED 54 (100)
T ss_dssp CCCCC-SSCSCTTTTCTTCCCEEECTT-SSCCCTTSSTTCTTCCCEEECCSC
T ss_pred CCccC-EecHHHhcCCCCCcEEEcCCc-hheEcHHHHhccCCccEEEEcCCC
Confidence 45666 788888999999999998654 677888889999999999887754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.00 E-value=3.1 Score=44.62 Aligned_cols=30 Identities=23% Similarity=0.362 Sum_probs=25.3
Q ss_pred CeeecCCCCCCEEE------cCCCCcEEeeccCccc
Q 003156 679 PIIHYNLKPSNILL------DDNYNPRISDFGLARL 708 (843)
Q Consensus 679 ~ivH~dlk~~Nill------~~~~~~kl~Dfgl~~~ 708 (843)
.++|+|+.+.||++ +++..+++.||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.52 E-value=3.3 Score=39.79 Aligned_cols=115 Identities=12% Similarity=0.191 Sum_probs=77.8
Q ss_pred cCCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHH-hhhhcCCCCeeecCCCCC
Q 003156 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA-HLHHSFRPPIIHYNLKPS 688 (843)
Q Consensus 610 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~dlk~~ 688 (843)
.||+. -..+-.+.+...+.++.-+++.=...++. .+...+++++..++.-.. +++.. +|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 57877 33444666777777776655533344433 677889999999988777 66654 78889999
Q ss_pred CEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCc
Q 003156 689 NILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763 (843)
Q Consensus 689 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~ 763 (843)
|+++|.++.+++.-.|+-..+ +|.-+ +..-=.-.+=+++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-------------------pP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-------------------PPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-------------------SSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-------------------CCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999987765332 23211 111123346677777888777764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.56 E-value=0.16 Score=55.81 Aligned_cols=61 Identities=8% Similarity=0.092 Sum_probs=17.5
Q ss_pred CeeccccceEEEEEEECCCCeEEEE------EEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc
Q 003156 560 AEVGEGVFGTVYKVSFGTQGRMLAV------KKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT 623 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~~~~~vav------K~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 623 (843)
+.+| ||.||+|.+.....+||| |........ +....|.+|..+++..+|||+++.+++...
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3566 999999999755568888 766543322 223468889999999999999999988753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.90 E-value=2.1 Score=40.91 Aligned_cols=124 Identities=12% Similarity=0.150 Sum_probs=82.0
Q ss_pred HHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCee
Q 003156 602 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 681 (843)
Q Consensus 602 E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 681 (843)
|+..|. -.||+.+.. .+-.+.+...+.|+.-+.+.=...++ ..+...+++++..++.-..+++.. +
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~ 101 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----Y 101 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----E
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----e
Confidence 444443 268888877 45566666656566543321111232 367788999999999888777654 7
Q ss_pred ecCCCCCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCC
Q 003156 682 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 761 (843)
Q Consensus 682 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p 761 (843)
|--+.|+|++++.++.+++.-.|+...+. |.- .+...=.-.+=+++..+++++..
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~~------~~ee~fL~qyKAliiall~~K~~ 156 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVVD-------------------PLP------VSEAEFLTRYKALVICAFNEKQS 156 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTBS-------------------CCC------CCHHHHHHHHHHHHHHHHCTTCC
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCCC-------------------CCC------CCHHHHHHHHHHHHHHHHcCCCC
Confidence 88999999999999999998777643222 221 12222234577788889999888
Q ss_pred CcC
Q 003156 762 VEY 764 (843)
Q Consensus 762 ~~~ 764 (843)
|..
T Consensus 157 Fe~ 159 (215)
T 4ann_A 157 FDA 159 (215)
T ss_dssp HHH
T ss_pred HHH
Confidence 853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 843 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-09 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 2e-63
Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 27/294 (9%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVL 606
I T+ ++ +G G FGTVYK G +AVK L VT+ Q + F+ EV VL
Sbjct: 5 IPDGQITVGQR---IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
K RH N++ GY PQL +V+ + SL LH + TA
Sbjct: 59 RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTA 114
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+G+ +LH IIH +LK +NI L ++ +I DFGLA + +R + ++
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 727 YVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784
++APE + + D+Y FG+++ EL+TG+ P +N + V
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR------ 224
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838
+ P + + + +L C RP +++ ++++ LP+
Sbjct: 225 --GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 2e-54
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 42/295 (14%)
Query: 561 EVGEGVFGTVYKV-----SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
++GEG FG V++ M+AVK L DF+RE ++ + +PN++
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHER--------------------LPSTPPLSW 655
L G + L+ +Y G L L P PPLS
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 656 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715
+ + A G+A+L +H +L N L+ +N +I+DFGL+R + D +
Sbjct: 140 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775
+ ++ PE R + D++ +GV++ E+ + YG + ++
Sbjct: 197 KADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY-- 253
Query: 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ +GN+L C PE+ L + L +C +P+ RPS + +ILQ
Sbjct: 254 ---YVRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (463), Expect = 4e-52
Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 30/281 (10%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGK 608
DPE L E+G G FG VY ++A+KK+ S + +D +EVR L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
RHPN I G Y LV +Y + + PL V G +G
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQG 127
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
LA+LH +IH ++K NILL + ++ DFG A ++ +N F ++
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWM 178
Query: 729 APE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
APE L + + K D++ G+ +EL + P+ + + + L +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQ--------N 229
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+ G + E C IP RP+ +++
Sbjct: 230 ESPALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-52
Identities = 67/303 (22%), Positives = 117/303 (38%), Gaps = 35/303 (11%)
Query: 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN 613
L E +G+G FG V++ + +G +AVK + + E E+ RH N
Sbjct: 6 VLQES---IGKGRFGEVWRGKW--RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHEN 58
Query: 614 LISLEGYYWTPQLKL----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
++ LVSDY +GSL L+ ++ K+ L TA GL
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGL 113
Query: 670 AHLHHSF-----RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH--VMSNRFQ 722
AHLH +P I H +LK NIL+ N I+D GLA + N
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 723 SALGYVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-----VVIL 772
Y+APE+ + ++ DIY G++ E+ ED ++
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 773 SEHVRVLLEEGNVLDCVDPSMGDYPE--DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
S+ + + + P++ + + + + + K+ C ++R + + + L
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 831 VIK 833
+
Sbjct: 294 QLS 296
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (455), Expect = 3e-51
Identities = 64/281 (22%), Positives = 123/281 (43%), Gaps = 27/281 (9%)
Query: 562 VGEGVFGTVYKVSF---GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 618
+G G FG V G + +A+K L + + DF E ++G+ HPN+I LE
Sbjct: 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
G ++++++ NGSL + L + + ++ G A G+ +L
Sbjct: 94 GVVTKSTPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLAD---M 147
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLL---TRLDKHVMSNRFQSALGYVAPELTCQ 735
+H +L NIL++ N ++SDFGL+R L T + + + + + APE Q
Sbjct: 148 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA-IQ 206
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795
+ D++ +G+++ E+++ + N +++ +E+ L
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN-----AIEQDYRL--------P 253
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL-QVIKTP 835
P D + +L L C + RP ++V L ++I+ P
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-51
Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 35/288 (12%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
++ + LL+ +G+G FG V + +G +AVK + Q F E V+
Sbjct: 4 LNMKELKLLQT---IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ---AFLAEASVMT 55
Query: 608 KARHPNLISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
+ RH NL+ L G + L +V++Y GSL L R L K L
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
+ + +L +H +L N+L+ ++ ++SDFGL + + +
Sbjct: 114 EAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VK 165
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
+ APE + + + K D++ FG+L+ E+ + R ++ +E+G +
Sbjct: 166 WTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKM 219
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834
D D P V ++ C + RPS ++ + L+ IKT
Sbjct: 220 DAPD----GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-51
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 29/283 (10%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
+ E L+E+ +G G FG V+ + +AVK L P+ F E ++
Sbjct: 10 VPRETLKLVER---LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS--MSPDAFLAEANLMK 63
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+ +H L+ L + ++++Y NGSL L PS L+ + A+
Sbjct: 64 QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAE 120
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
G+A + IH +L+ +NIL+ D + +I+DFGLARL+ +++ + + +
Sbjct: 121 GMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKW 176
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787
APE K D++ FG+L+ E+VT R G N ++ N+
Sbjct: 177 TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----------NLER 225
Query: 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
P++ + +L +C P RP+ + +L+
Sbjct: 226 GYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-51
Identities = 63/285 (22%), Positives = 117/285 (41%), Gaps = 29/285 (10%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
IDP T +++ +G G FG V+ + +A+K + + + EDF E V+
Sbjct: 2 IDPSELTFVQE---IGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE--EDFIEEAEVMM 55
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
K HP L+ L G LV ++ +G L L + + + L +
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCE 112
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
G+A+L +IH +L N L+ +N ++SDFG+ R + D++ S + + +
Sbjct: 113 GMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKW 168
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787
+PE+ R + K D++ FGVL+ E+ + + N ++ +
Sbjct: 169 ASPEV-FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----- 222
Query: 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
P V ++ C P RP+ + +++ L I
Sbjct: 223 --------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (448), Expect = 2e-50
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 27/285 (9%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
++ T+ K +G G +G VY+ + +AVK L + E+F +E V+
Sbjct: 14 MERTDITMKHK---LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMK 68
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+ +HPNL+ L G +++++ G+L L E + +S + +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISS 126
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
+ +L + IH +L N L+ +N+ +++DFGL+RL+T D + + + +
Sbjct: 127 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKW 182
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787
APE + + K D++ FGVL+ E+ T G D V LLE+ +
Sbjct: 183 TAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRM- 235
Query: 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+ PE V +L C PS RPS AE+ Q + +
Sbjct: 236 -------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 8e-50
Identities = 61/282 (21%), Positives = 119/282 (42%), Gaps = 25/282 (8%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
++PE E E+G+G FG VYK + A K + T + ED+ E+ +L
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASC 66
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
HPN++ L ++ ++ ++ G++ A + E PL+ + V T L
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDAL 123
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
+LH IIH +LK NIL + + +++DFG++ TR + + F ++A
Sbjct: 124 NYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMA 178
Query: 730 PEL----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785
PE+ T + + K D++ G+ ++E+ P + + + +L + +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH-HELNPMRVLLKIAK-------- 229
Query: 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+P P C +R + ++++Q
Sbjct: 230 ---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 57/272 (20%), Positives = 102/272 (37%), Gaps = 22/272 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 619
+G G +G K+ + G++L K+L + + + EV +L + +HPN++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 620 YYW--TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH--HS 675
T +V +Y G L + + + L +V+ L H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
++H +LKP+N+ LD N ++ DFGLAR+L + F Y++PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMSPEQ-MN 187
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795
+ NEK DI+ G L+ EL P + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREGKFRR------------- 233
Query: 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P + ++ RPS+ E+++
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-49
Identities = 60/295 (20%), Positives = 124/295 (42%), Gaps = 24/295 (8%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
+ + LL E+G G FG+V + + + +A+K L E+ RE +++
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 64
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+ +P ++ L G L +LV + A G L L + + +N +++ +
Sbjct: 65 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSM 120
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQSALG 726
G+ +L +H +L N+LL + + +ISDFGL++ L D + + + L
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
+ APE + + + D++ +GV + E ++ + +++ +E+G +
Sbjct: 178 WYAPEC-INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGKRM 231
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRME 841
+C P + + L C + RP V Q ++ L ++E
Sbjct: 232 EC--------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 29/283 (10%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 607
IDP+ T L++ +G G FG V + +A+K + + + ++F E +V+
Sbjct: 1 IDPKDLTFLKE---LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE--DEFIEEAKVMM 54
Query: 608 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
H L+ L G + ++++Y NG L L E ++ +
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCE 111
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
+ +L +H +L N L++D ++SDFGL+R + D++ S + + +
Sbjct: 112 AMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRW 167
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787
PE+ + + K DI+ FGVL+ E+ + + N ++
Sbjct: 168 SPPEV-LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----------HIAQ 216
Query: 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ P V + C RP+ ++ +
Sbjct: 217 GLRL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-49
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 11/223 (4%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 616
EK +E+G G G V+KVS G ++A K + RE++VL + P ++
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 617 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 676
G +++ + ++ GSL L + + KV + KGL +L
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
+ I+H ++KPSNIL++ ++ DFG++ L M+N F Y++PE Q
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPER-LQG 177
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
+ + DI+ G+ ++E+ GR P+ + + L +V
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 26/290 (8%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 609
I E+L ++G+G FG V+ ++ +A+K L + PE F +E +V+ K
Sbjct: 14 IPRESL-RLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKL 69
Query: 610 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 669
RH L+ L + +V++Y GSL + + L + A G+
Sbjct: 70 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
A++ +H +L+ +NIL+ +N +++DFGLARL+ +++ + + + A
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 182
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
PE R K D++ FG+L+ EL T R G N +L + R
Sbjct: 183 PEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------- 234
Query: 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ-VIKTPLPQ 838
P + + L C P RP+ + L+ + PQ
Sbjct: 235 ------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 60/279 (21%), Positives = 116/279 (41%), Gaps = 22/279 (7%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+GEG +G V +AVK + + PE+ ++E+ + H N++ G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
++ L +Y G L ++ + + + + G+ +LH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
H ++KP N+LLD+ N +ISDFGLA + ++ + N+ L YVAPEL +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 741 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 800
E D++ G+++ ++ G P + D+ E+ L+ P +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEKKTYLN---------PWKK 231
Query: 801 VLPVLK-LALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838
+ L PS+R ++ ++ + + PL +
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKK-DRWYNKPLKK 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 70/292 (23%), Positives = 129/292 (44%), Gaps = 27/292 (9%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKV----SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV 605
I P + + +G G FG VYK S G + +A+K L + DF E +
Sbjct: 4 IHPSCV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 606 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 665
+G+ H N+I LEG + +++++Y NG+L L E+ S ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGI 119
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS-NRFQSA 724
A G+ +L +H +L NIL++ N ++SDFGL+R+L + + + +
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 725 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784
+ + APE + D++ FG+++ E++T + N ++ + +
Sbjct: 177 IRWTAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAIN------- 227
Query: 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL-QVIKTP 835
D P D + +L + C + RP A++V IL ++I+ P
Sbjct: 228 -----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-49
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 29/292 (9%)
Query: 546 LDCSIDPE--TLLEKAAEVGEGVFGTVYKVSF---GTQGRMLAVKKLVTSDII--QYPED 598
L C I + LLEK +G+G FG V + + + +AVK L + + +D
Sbjct: 1 LTCLIGEKDLRLLEK---LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 57
Query: 599 FEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR 658
F REV + H NLI L G TP +K+ V++ AP GSL +L +
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTL 113
Query: 659 FKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 718
+ + A+G+ +L IH +L N+LL +I DFGL R L + D H +
Sbjct: 114 SRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 719 NRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 778
+ + ++ + D + FGV + E+ T + G + IL + +
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK- 229
Query: 779 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ PED + + + C H P RP+ + L
Sbjct: 230 -----------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-49
Identities = 59/273 (21%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEG 619
E+G G F TVYK +A +L + + F+ E +L +HPN++
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 620 YYWTP----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
+ + + +LV++ +G+L+ L + KGL LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 676 FRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
PPIIH +LK NI + + +I D GLA L + + ++APE+
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYE 186
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794
+ + +E D+Y FG+ +LE+ T P N + V ++ + P +
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+ + C R S+ +++
Sbjct: 244 E-----------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 63/285 (22%), Positives = 120/285 (42%), Gaps = 26/285 (9%)
Query: 550 IDPETLLEKAAEVGEGVFGTVYKVSF--GTQGRMLAVKKL-VTSDIIQYPEDFEREVRVL 606
+D + L + E+G G FGTV K + + +AVK L ++ ++ E V+
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
+ +P ++ + G +LV + A G L ++ L + N +++ +
Sbjct: 63 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPL----NKYLQQNRHVKDKNIIELVHQVS 117
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQSAL 725
G+ +L S +H +L N+LL + +ISDFGL++ L + + + +
Sbjct: 118 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785
+ APE + + K D++ FGVL+ E + + G + + +LE+G
Sbjct: 175 KWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKGER 228
Query: 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ C P + L +C + +RP A V L+
Sbjct: 229 MGC--------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 36/290 (12%)
Query: 561 EVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNL 614
+G G FG V + + +AVK L S + E E++VL H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP--------------PLSWTNRFK 660
++L G L++++Y G L L + S L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 661 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720
AKG+A L IH +L NILL +I DFGLAR + +V+
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 721 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780
+ + ++APE + + D++ +G+ + EL + G + ++
Sbjct: 207 ARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK--- 262
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+ PE + + C P RP+ ++VQ+++
Sbjct: 263 ---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 53/295 (17%), Positives = 99/295 (33%), Gaps = 41/295 (13%)
Query: 561 EVGEGVFGTVYKVSFGTQGR-----MLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNL 614
+G G FG V + + +AVK L E E++++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-------------------PLSW 655
++L G L+ +Y G L L + L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 656 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715
+ AKG+ L +H +L N+L+ +I DFGLAR + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 775
V+ + + ++APE + K D++ +G+L+ E+ + G +
Sbjct: 221 VVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 776 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
++ + D P + + C RPS + L
Sbjct: 280 IQ------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 58/299 (19%), Positives = 124/299 (41%), Gaps = 33/299 (11%)
Query: 550 IDPE--TLLEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFERE 602
+ E T+ + +G+G FG VY+ V +A+K + + ++ +F E
Sbjct: 17 VAREKITMSRE---LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 603 VRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH------ERLPSTPPLSWT 656
V+ + +++ L G Q L++ + G L++ L P P S +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 657 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716
++ A G+A+L+ + +H +L N ++ +++ +I DFG+ R + D +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 717 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 776
+ + +++PE + D++ FGV++ E+ T G N +L
Sbjct: 191 KGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 248
Query: 777 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835
++ + D P++ + +L +C + P RPS E++ ++ P
Sbjct: 249 ------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 27/296 (9%)
Query: 550 IDPETLLEKAAEV-GEGVFGTVYKVSF---GTQGRMLAVKKLVTSDIIQYPEDFEREVRV 605
I P +L+ EV G G FG VY + + AVK L I F E +
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 606 LGKARHPNLISLEGYYWTPQLK-LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 664
+ HPN++SL G + L+V Y +G L+ + T + + L
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQ 138
Query: 665 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 724
AKG+ L +H +L N +LD+ + +++DFGLAR + + + N+ +
Sbjct: 139 VAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 725 --LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782
+ ++A E Q+ + K D++ FGVL+ EL+T P + + LL+
Sbjct: 196 LPVKWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQG 250
Query: 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838
+L PE P+ ++ L C RPS +E+V + I +
Sbjct: 251 RRLLQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 26/295 (8%)
Query: 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 608
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 609 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 668
+P++ L G T ++L+ P G L + E + + AKG
Sbjct: 68 VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 123
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 728
+ +L ++H +L N+L+ + +I+DFGLA+LL +K + + + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 729 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788
A E + D++ +GV + EL+T G I S +LE+G L
Sbjct: 181 ALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERL-- 232
Query: 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 843
P + V + + C SRP E++ + PQR V
Sbjct: 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD-PQRYLVI 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 9e-46
Identities = 66/269 (24%), Positives = 104/269 (38%), Gaps = 29/269 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 618
+G+G FG VY +LA+K L + + REV + RHPN++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
GY+ L+ +YAP G++ +L + I A L++ H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH---SK 125
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+IH ++KP N+LL +I+DFG + L Y+ PE+ +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEM-IEGRM 180
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 798
+EK D++ GVL E + G+ P E RV +P+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEF--------------TFPD 225
Query: 799 DEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
L H PS RP + EV++
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 71/287 (24%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 561 EVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISL 617
+GEG FG V K G + A+K++ DF E+ VL K HPN+I+L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGT 665
G L +YAP+G+L L + + LS
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 666 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 725
A+G+ +L IH +L NIL+ +NY +I+DFGL+R + +V + +
Sbjct: 137 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPV 190
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785
++A E + D++ +GVL+ E+V+ G + L +G
Sbjct: 191 RWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-----KLPQGYR 244
Query: 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
L + P + V L C P RPS A+++ L +
Sbjct: 245 L--------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-44
Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 24/277 (8%)
Query: 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 610
DP+ + ++G+G GTVY G+ +A++++ E E+ V+ + +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENK 75
Query: 611 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 670
+PN+++ Y +V +Y GSL + E + V + L
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALE 130
Query: 671 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 730
LH + +IH ++K NILL + + +++DFG +T + + ++AP
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAP 185
Query: 731 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790
E K DI+ G++ +E++ G P E+ + L E + +
Sbjct: 186 E-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLS 243
Query: 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
D C R S E++Q
Sbjct: 244 AIFRD-----------FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 8e-44
Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 37/292 (12%)
Query: 561 EVGEGVFGTVYKV-------SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHP 612
+GEG FG V + +AVK L + + D E+ ++ +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP------------PLSWTNRFK 660
N+I+L G ++ +YA G+L+ L R P LS +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 661 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 720
A+G+ +L IH +L N+L+ ++ +I+DFGLAR + +D + +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 721 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 780
+ + ++APE + D++ FGVL+ E+ T G + LL
Sbjct: 197 GRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-----LL 250
Query: 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+EG+ + D P + + + C +PS RP+ ++V+ L I
Sbjct: 251 KEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-43
Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 25/275 (9%)
Query: 561 EVGEGVFGTVYKV---SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 617
+GEG FG V++ S +A+K E F +E + + HP+++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
G + ++ + G L++ L R L + + LA+L
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLE---S 126
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
+H ++ N+L+ N ++ DFGL+R + + +++ + + ++APE
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPES-INFR 184
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 797
R D++ FGV + E++ G N ++ +E G L + P
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-----RIENGERLPMPP----NCP 235
Query: 798 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832
+ L C + PS RP E+ L I
Sbjct: 236 PT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 66/277 (23%), Positives = 103/277 (37%), Gaps = 25/277 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 618
+GEG F TV R A+K L II RE V+ + HP + L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
+ + YA NG L + + T L +LH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSALEYLH---GK 127
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
IIH +LKP NILL+++ + +I+DFG A++L+ K +N F YV+PEL
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTEKS 186
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 798
+ D++ G +I +LV G P + +I + +++ D+PE
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEY--------------DFPE 231
Query: 799 DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835
L + R E+ + P
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (390), Expect = 7e-42
Identities = 57/269 (21%), Positives = 106/269 (39%), Gaps = 24/269 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
E+G G FG V++V+ G A K ++T E +E++ + RHP L++L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ +++ ++ G L K+ + +S + + KGL H+H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMH---ENNY 145
Query: 681 IHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+H +LKP NI+ + + DFGL L ++ + APE+ +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT---AEFAAPEV-AEGKP 201
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 798
V D++ GVL L++G P GE++ L + D + E
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCD------WNMDDSAFSGISE 254
Query: 799 DEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
D P++R ++ + ++
Sbjct: 255 D----GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-40
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 23/285 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+GEG +G V +A+KK+ + Y + RE+++L + RH N+I +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
P ++ + Y + A L++ L T LS + + +GL ++H +
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQSALGYVAPELTCQSLRV 739
+H +LKPSN+LL+ + +I DFGLAR+ D + + Y APE+ S
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------------LEEGNVLD 787
+ DI+ G ++ E+++ R G+ + L+ + +L +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 788 CVDPSMGDYPEDEVLP-----VLKLALVCTCHIPSSRPSMAEVVQ 827
P P + + P L L P R + + +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-40
Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 35/289 (12%)
Query: 561 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 615
+G G FG V + + R +AVK L E+++L H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 616 -SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPP------------LSWTNRFKV 661
+L G P L ++ ++ G+L L + P L+ +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 662 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 721
AKG+ L IH +L NILL + +I DFGLAR + + +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781
+ L ++APE T + D++ FGVL+ E+ + G ++
Sbjct: 197 RLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---- 251
Query: 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
EG + P+ + + L C PS RP+ +E+V+ L
Sbjct: 252 EGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 50/289 (17%), Positives = 111/289 (38%), Gaps = 31/289 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
++G G FG V++ + + K + ++E+ +L ARH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ + + +++ ++ + +++ L+ + + L LH I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 681 IHYNLKPSNILLD--DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
H++++P NI+ + +I +FG AR L D +A Y APE+ Q
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEV-HQHDV 179
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 798
V+ D++ G L+ L++G P E N I+ + + + +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAE------YTFDEEAFKEISI 232
Query: 799 DEVLPVLKLALVCTCHIPSSRPSMAEVV------QILQVIKTPLPQRME 841
+ + SR + +E + Q ++ + T + + ++
Sbjct: 233 E----AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLK 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 2e-39
Identities = 52/267 (19%), Positives = 100/267 (37%), Gaps = 19/267 (7%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
+G G F V +++A+K + + E E+ VL K +HPN+++L+
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
Y + L+ G L ++ E+ + + ++I + +LH
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 681 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 740
LD++ ISDFGL+++ D + + GYVAPE+ Q +
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK-PYS 187
Query: 741 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 800
+ D + GV+ L+ G P Y E++ + + ++ + P D +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILK------AEYEFDSPYWDDISDS- 239
Query: 801 VLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P R + + +Q
Sbjct: 240 ---AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (367), Expect = 9e-39
Identities = 58/270 (21%), Positives = 106/270 (39%), Gaps = 26/270 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
E+G G FG V++ GR+ K + T + + E+ ++ + HP LI+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDA 94
Query: 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 680
+ +L+ ++ G L ++ +S + +GL H+H I
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMH---EHSI 148
Query: 681 IHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+H ++KP NI+ + + DFGLA +L+ + + + APE+
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEI-VDREP 204
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE-EGNVLDCVDPSMGDYP 797
V D++ GVL L++G P GED++ L R E + + V P D
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD-- 261
Query: 798 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P R ++ + ++
Sbjct: 262 ---------FIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (361), Expect = 1e-38
Identities = 70/281 (24%), Positives = 114/281 (40%), Gaps = 35/281 (12%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKL--------VTSDIIQYPEDFEREVRVLGKAR-H 611
+G GV V + + AVK + ++ + E +EV +L K H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
PN+I L+ Y T LV D G L L E+ LS K++ + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICA 125
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
LH + I+H +LKP NILLDD+ N +++DFG + +LD Y+APE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPE 179
Query: 732 LTCQSLRVN-----EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786
+ S+ N ++ D++ GV++ L+ G P + +++L + + G
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGNYQFG--- 235
Query: 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
P DY + V L P R + E +
Sbjct: 236 ---SPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 27/300 (9%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 615
+K ++GEG +G VYK G ++A+KK+ + ++ P RE+ +L + HPN++
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
L T LV ++ + + + + +GLA H
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
++H +LKP N+L++ +++DFGLAR + L Y APE+
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLG 176
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795
+ DI+ G + E+VT R G+ + L R L V+ SM D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 796 Y----------PEDEVLPVLKLALV-----CTCHIPSSRPSMAEVVQ--ILQVIKTPLPQ 838
Y +V+P L + P+ R S + Q + P+P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (352), Expect = 2e-37
Identities = 61/283 (21%), Positives = 108/283 (38%), Gaps = 27/283 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEG 619
++GEG +G VYK G A+KK+ + + P RE+ +L + +H N++ L
Sbjct: 9 KIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
T + +LV ++ + L +L G+A+ H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
++H +LKP N+L++ +I+DFGLAR + L Y AP++ S +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKY 178
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL----------LEEGNVLDCV 789
+ DI+ G + E+V G G L R+L + E D
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 790 DPSMGDYPEDEVLPVLKLALV-----CTCHIPSSRPSMAEVVQ 827
P + L L + + P+ R + + ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 28/289 (9%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ----YPEDFEREVRVLGKARHP 612
EK +GEG F TVYK +++A+KK+ + RE+++L + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 613 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 672
N+I L + LV D+ L+ ++ +L T +GL +L
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYL 116
Query: 673 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
H + I+H +LKP+N+LLD+N +++DFGLA+ + Y APEL
Sbjct: 117 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPEL 171
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792
+ D++ G ++ EL+ + G+ ++ L+ L S
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 793 MGDYPEDEVLPVLKLALV--------------CTCHIPSSRPSMAEVVQ 827
+ DY + P + L + P +R + + ++
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-36
Identities = 55/297 (18%), Positives = 114/297 (38%), Gaps = 29/297 (9%)
Query: 547 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 606
+ ID + + +G G+ G V ++ A+K ++Q REV +
Sbjct: 7 NAIIDDYKVTSQ--VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELH 58
Query: 607 GKA-RHPNLISLEGYYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV 661
+A + P+++ + Y L+V + G L +++ +R + ++
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEI 116
Query: 662 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 721
+ + + +LH I H ++KP N+L I H
Sbjct: 117 MKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
Query: 722 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781
YVAPE+ + ++ CD++ GV++ L+ G P + ++ + +S ++ +
Sbjct: 174 CYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIR 230
Query: 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ---ILQVIKTP 835
G + +P + E+ V L P+ R ++ E + I+Q K P
Sbjct: 231 MGQ-YEFPNPEWSEVSEE----VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (340), Expect = 2e-35
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 19/231 (8%)
Query: 549 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVL 606
S+ +L +G G FG V+ + GR A+K L ++ + E E +L
Sbjct: 2 SLQDFQILRT---LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 607 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 666
HP +I + G + Q ++ DY G L + L + P++ +V
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----- 113
Query: 667 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 726
L + II+ +LKP NILLD N + +I+DFG A+ + + +
Sbjct: 114 --CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP-----D 166
Query: 727 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
Y+APE+ + N+ D + FG+LI E++ G P Y + + + +
Sbjct: 167 YIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILN 215
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 35/288 (12%)
Query: 562 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 621
+G G FG VY+ G ++A+KK ++Q RE++++ K H N++ L ++
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 622 WTPQLK------LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
++ K LV DY P + H + L + + LA++H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 676 FRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
I H ++KP N+LLD D ++ DFG A+ L R + +V + Y APEL
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIF 195
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG---------NV 785
+ D++ G ++ EL+ G+ G+ V L E ++VL N
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 786 LDCVDPSMGDYPEDEVLP------VLKLALVCTCHIPSSRPSMAEVVQ 827
+ P + +P +V + L + P++R + E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (334), Expect = 4e-35
Identities = 59/275 (21%), Positives = 107/275 (38%), Gaps = 28/275 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 618
+G G V+ R +AVK L + F RE + HP ++++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 619 GYYWTP----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
L +V +Y +L+ +H P++ +VI + L H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 128
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSNRFQSALGYVAPELT 733
+ IIH ++KP+NI++ ++ DFG+AR + V + Y++PE
Sbjct: 129 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ- 185
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793
+ V+ + D+Y G ++ E++TG P G+ V + +HVR DP
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVR-----------EDPIP 233
Query: 794 GDYPEDEVLPVLK-LALVCTCHIPSSRPSMAEVVQ 827
+ + L + L P +R A ++
Sbjct: 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 58/283 (20%), Positives = 105/283 (37%), Gaps = 25/283 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 619
++GEG +GTV+K ++A+K++ D + P RE+ +L + +H N++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + LV ++ + L + KGL H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RN 121
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
++H +LKP N+L++ N ++++FGLAR + L Y P++ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799
+ D++ G + EL RP+ G D L R+L + DY
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 800 EVLPVLKLALVCTCHI---------------PSSRPSMAEVVQ 827
+ P + + P R S E +Q
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 3e-34
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLI 615
+G G FG VY G+M A+K L I + + ++ P ++
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
+ + TP + D G L L + + GL H+H+
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR----FYAAEIILGLEHMHN- 125
Query: 676 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 735
+++ +LKP+NILLD++ + RISD GLA ++ + GY+APE+ +
Sbjct: 126 --RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQK 179
Query: 736 SLRVNEKCDIYGFGVLILELVTGRRP 761
+ + D + G ++ +L+ G P
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 66/276 (23%), Positives = 106/276 (38%), Gaps = 31/276 (11%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-----YPEDFEREVRVLGKARHPNLI 615
E+G G F V K + G A K + ED EREV +L + +HPN+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 616 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 675
+L Y +L+ + G L L E+ L+ + + G+ +LH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH-- 130
Query: 676 FRPPIIHYNLKPSNILLDDNYNPR----ISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 731
I H++LKP NI+L D P+ I DFGLA ++D +VAPE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE 186
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
+ + + D++ GV+ L++G P G+ L+ NV
Sbjct: 187 I-VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLA----------NVSAVNYE 234
Query: 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+Y + P R ++ + +Q
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 65/273 (23%), Positives = 103/273 (37%), Gaps = 30/273 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISL 617
+G+G FG V+ F + A+K L ++ E E RVL A HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 618 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
+ T + V +Y G L + + GL LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHS--- 121
Query: 678 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 737
I++ +LK NILLD + + +I+DFG+ + +N F Y+APE+
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM--LGDAKTNTFCGTPDYIAPEI-LLGQ 178
Query: 738 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 797
+ N D + FGVL+ E++ G+ P + + L +R +P +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIR----------MDNPFYPRWL 226
Query: 798 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
E E +L V P R + I Q
Sbjct: 227 EKEAKDLLVKLFVRE---PEKRLGVRG--DIRQ 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-34
Identities = 62/303 (20%), Positives = 121/303 (39%), Gaps = 43/303 (14%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLI 615
EK A++G+G FG V+K G+ +A+KK++ + + +P RE+++L +H N++
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 616 SLEGYYWTPQLK--------LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 667
+L T LV D+ + + + + +V+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLN 128
Query: 668 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA--L 725
GL ++H R I+H ++K +N+L+ + +++DFGLAR + + L
Sbjct: 129 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 726 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785
Y PEL D++G G ++ E+ T + G L+ ++ G++
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLC---GSI 241
Query: 786 LDCVDPSMGDYPEDEVLPVLK---------------------LALVCTCHIPSSRPSMAE 824
V P++ +Y E L ++K L P+ R +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 825 VVQ 827
+
Sbjct: 302 ALN 304
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 2e-33
Identities = 38/279 (13%), Positives = 80/279 (28%), Gaps = 27/279 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
++G G FG +Y + G +A+K E ++ + I +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 621 YWT-PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
++V + S + + ++H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKN 123
Query: 680 IIHYNLKPSNIL---LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA-----LGYVAPE 731
IH ++KP N L I DFGLA+ H ++ Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 732 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791
T + + + D+ G +++ G P + + + E + ++
Sbjct: 184 -THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR---QKYERISEKKMSTPIEV 239
Query: 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
YP + C +P + + Q+ +
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-33
Identities = 64/285 (22%), Positives = 109/285 (38%), Gaps = 27/285 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 619
VG G +G V G G +A+KKL + + + RE+R+L RH N+I L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + +D+ +L L ++ KGL ++H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
IIH +LKP N+ ++++ +I DFGLAR + R+ Y APE+ +R
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNWMRY 196
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL------------EEGNVLD 787
+ DI+ G ++ E++TG+ G D++ L E ++V +E
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 788 CVDPSMGDYPEDEVLPVLKLALV-----CTCHIPSSRPSMAEVVQ 827
P + +L V R + E +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 62/291 (21%), Positives = 102/291 (35%), Gaps = 28/291 (9%)
Query: 557 EKAAEVGEGVFGTVYKV-SFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRV---LGKARH 611
E AE+GEG +G V+K GR +A+K++ + P REV V L H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP--STPPLSWTNRFKVILGTAKGL 669
PN++ L + + L L P + ++ +GL
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 670 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 729
LH ++H +LKP NIL+ + +++DFGLAR+ + L Y A
Sbjct: 130 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
PE+ D++ G + E+ + G +V L + + V+ G
Sbjct: 184 PEV-LLQSSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 790 DPSMGDYPEDEVLPVLKLALV-------------CTCHIPSSRPSMAEVVQ 827
D ++ V C P+ R S +
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 53/275 (19%), Positives = 94/275 (34%), Gaps = 39/275 (14%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-----IQYPEDFEREVRVLGKAR--HPN 613
+G G FG+VY + +A+K + I + EV +L K
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
+I L ++ P +L+ + L + + L + + H H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 674 HSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 732
+ ++H ++K NIL+D + ++ DFG LL K + F Y PE
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEW 180
Query: 733 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792
++ G+L+ ++V G P E+ E+ I+ V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---IIRGQV---------------- 221
Query: 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827
+ + L C PS RP+ E+
Sbjct: 222 --FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-31
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 13/219 (5%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 618
+G+G FG V V GR A+K L II E RVL RHP L +L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 619 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 678
+ T V +YA G L L T + +++ L +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA-------LEYLHSR 124
Query: 679 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 738
+++ ++K N++LD + + +I+DFGL + + F Y+APE+ +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN-D 181
Query: 739 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
D +G GV++ E++ GR P Y +D+ + +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILM 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 8e-31
Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 16/223 (7%)
Query: 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNL 614
++ +G G FG V V G A+K L ++ + E E R+L P L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 615 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 674
+ LE + +V +Y G + + L S + +LH
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLH- 158
Query: 675 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 734
+I+ +LKP N+L+D +++DFG A+ + +APE+
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI-I 210
Query: 735 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 777
S N+ D + GVLI E+ G P + + + I + V
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVS 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 63/281 (22%), Positives = 108/281 (38%), Gaps = 31/281 (11%)
Query: 561 EVGEGVFGTVYKV---SFGTQGRMLAVKKLVTSDIIQYP---EDFEREVRVLGKARH-PN 613
+G G +G V+ V S G++ A+K L + I+Q E E +VL R P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 614 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
L++L + T L+ DY G L L +R T +++L L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA-------LE 143
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
H + II+ ++K NILLD N + ++DFGL++ + + + +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793
++ D + GVL+ EL+TG P + +E R +L+
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILK------------ 250
Query: 794 GDYPEDEVLPVLKLALV--CTCHIPSSRPSMAE--VVQILQ 830
+ P + + L L+ P R +I +
Sbjct: 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (295), Expect = 8e-30
Identities = 37/281 (13%), Positives = 82/281 (29%), Gaps = 29/281 (10%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI-SLEG 619
+GEG FG +++ + + +A+K E R I ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ +LV D S + +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 680 IIHYNLKPSNILLDDNYNP-----RISDFGLARLL--TRLDKHVMSNRFQSALG---YVA 729
+++ ++KP N L+ + + DFG+ + +H+ ++ G Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 730 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789
T + + D+ G + + + G P + G ++ R+ E +
Sbjct: 182 IN-THLGREQSRRDDLEALGHVFMYFLRGSLPWQ-GLKAATNKQKYERIG--EKKQSTPL 237
Query: 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 830
+PE K + P + +
Sbjct: 238 RELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-28
Identities = 67/285 (23%), Positives = 113/285 (39%), Gaps = 27/285 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEG 619
VG G +G+V G +AVKKL I + + RE+R+L +H N+I L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 620 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 679
+ + +D L + L+ + +I +GL ++H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141
Query: 680 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 739
IIH +LKPSN+ ++++ +I DFGLAR ++ R+ Y APE+ +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRAPEIMLNWMHY 196
Query: 740 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 799
N+ DI+ G ++ EL+TGR G D++ L +R++ G L S
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 800 EVLPVLK-----------------LALVCTCHIPSSRPSMAEVVQ 827
+ L + L R + A+ +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-28
Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 21/223 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEG 619
++G G + V++ T + VK L + +RE+++L R PN+I+L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKREIKILENLRGGPNIITLAD 97
Query: 620 YYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 677
P + LV ++ N + L+ + + K L + H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 678 PPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 736
I+H ++KP N+++D ++ R+ D+GLA ++ N ++ + PEL
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDY 204
Query: 737 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
+ D++ G ++ ++ + P +G DN L +VL
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 7e-25
Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 22/226 (9%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 619
+G G G V R +A+KKL Q + + RE+ ++ H N+ISL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 620 YYWTP------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 673
+ Q LV + Q E ++ G+ HLH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136
Query: 674 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 733
IIH +LKPSNI++ + +I DFGLAR M + Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPE-V 189
Query: 734 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779
+ E DI+ G ++ E+V + G D + ++ + L
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQL 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.8 bits (242), Expect = 2e-22
Identities = 45/216 (20%), Positives = 77/216 (35%), Gaps = 18/216 (8%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 620
++G G F TV+ +A+K + + Y E E E+++L + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 621 YWTPQLKLL--VSDYAPNGSLQAKLHE----------RLPSTPPLSWTNRFKVILGTAKG 668
LKLL + PNG + E + + ++ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 669 LAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 727
L ++H R IIH ++KP N+L++ + + +A L Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 728 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 763
+PE DI+ LI EL+TG E
Sbjct: 196 RSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.1 bits (230), Expect = 9e-21
Identities = 66/376 (17%), Positives = 115/376 (30%), Gaps = 56/376 (14%)
Query: 51 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 110
+ TL +D G+ L L ++ S+N + P L L +L+
Sbjct: 44 DQVTTLQADRLGIK-SID-----GVEYLNNLTQINFSNNQLTDITP-----LKNLTKLVD 92
Query: 111 QGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW 170
+ T N + L N SN
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNT------ISD 146
Query: 171 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLS 230
I +S L L + + L N L + + N ++ E + +
Sbjct: 147 ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL-ESLIAT 205
Query: 231 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 290
N P G ++ L L L+ N L + NL L+L++N + +
Sbjct: 206 NNQISDITPLGILTN--------LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 291 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRS--------------------LGILQ 330
P L L L L N + P + + L L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 331 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQ 390
L N+++ P + + T L L ++N +S S++NL + L N++S P
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 368
Query: 391 ELGKLASLLAVNVSYN 406
L L + + ++
Sbjct: 369 -LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 86.2 bits (212), Expect = 1e-18
Identities = 43/210 (20%), Positives = 76/210 (36%), Gaps = 21/210 (10%)
Query: 102 LHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161
L L+ L+ NQ S P +G +L L L+ N +L L ++ + ++NN
Sbjct: 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD 221
++ P + ++ L L N ++ P L L+ + L N L P
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLK 307
Query: 222 LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYL 281
L + L N P S L+ L ++N + + + N+ +L
Sbjct: 308 -NLTYLTLYFNNISDISPVSS--------LTKLQRLFFANNKVSD--VSSLANLTNINWL 356
Query: 282 NLSSNHLRSRIPPELGYFHSLIHLDLRNNA 311
+ N + P L + L L + A
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.7 bits (208), Expect = 5e-18
Identities = 58/356 (16%), Positives = 109/356 (30%), Gaps = 39/356 (10%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N+ ++ SNN L+ P +N L + + N + + TL +
Sbjct: 67 NLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 123
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
L + L D+S S+ Q L L
Sbjct: 124 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
L L ++ + +NN ++ P I ++ L+ L
Sbjct: 184 SNKVSD---------------ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSL 226
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 242
+ N L +L + L+ + L N ++ P L E+ L N P
Sbjct: 227 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLT-KLTELKLGANQISNISPLAG 283
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302
++ ++ ++ + + + NL YL L N++ P + L
Sbjct: 284 LTALTNLELNENQL----------EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKL 331
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
L NN + S + ++ L N ++ P + N T + L L+
Sbjct: 332 QRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 4e-14
Identities = 36/161 (22%), Positives = 58/161 (36%), Gaps = 17/161 (10%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ N+ LDL+NN +S P L L L N + S L L
Sbjct: 240 LTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISN--------ISPLAGLTALT 288
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLP 120
N + I +LK L L L N S P V++L L+ L N+ S
Sbjct: 289 NLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--V 344
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161
+ + ++ L +N + P L L + + +++
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.3 bits (225), Expect = 1e-20
Identities = 52/273 (19%), Positives = 99/273 (36%), Gaps = 18/273 (6%)
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
+P D+ P LDL NN T + L ++ + + NN ++ P + LE
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238
L S N L ++L V + ++ GL + + E+ + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 298
+ + L + ++ N+ IP GL +L L+L N + L
Sbjct: 143 N------GAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKG 193
Query: 299 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
++L L L N++ + + L L L+ N L +P + + + ++ L +N
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 252
Query: 359 HLSG------SIPKSISNLNKLKILKLEFNELS 385
++S P + + L N +
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.5 bits (210), Expect = 1e-18
Identities = 50/288 (17%), Positives = 92/288 (31%), Gaps = 16/288 (5%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ LDL NN ++ + F+N +L L L N + F L L LS N
Sbjct: 32 DTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQG--NQFSGPLP 120
+ K L+ L + N + L+ + + L + SG
Sbjct: 91 LKELPE-------KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 121 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 180
L+ + +++ T + L S+ + + N +T + ++ L L
Sbjct: 144 GAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 181 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240
S N ++ SL N L + L N L ++ + L N
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHL 288
+T + + L SN + + F + ++ L
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNPV-QYWEIQPSTFRCVY--VRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.1 bits (183), Expect = 3e-15
Identities = 56/292 (19%), Positives = 107/292 (36%), Gaps = 28/292 (9%)
Query: 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 86
L L N + F +L+TL L NN S A L +L L L
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA----FAPLVKLERLYL 86
Query: 87 SHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN--NLFTGQLP 144
S N +P+ + L+EL + N+ + + + ++L +G
Sbjct: 87 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 145 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 204
+ + + + +I +++ +T IP G +L L N +T +SL L+ +
Sbjct: 144 GAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 205 RLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNN 263
L NS++ L + L E+ L+ N + + + ++++ L +NN
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD-------HKYIQVVYLHNNN 253
Query: 264 L------VGDIPAEMGLFANLRYLNLSSNHLR-SRIPPE-LGYFHSLIHLDL 307
+ P A+ ++L SN ++ I P + + L
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.5 bits (166), Expect = 5e-13
Identities = 29/166 (17%), Positives = 58/166 (34%), Gaps = 4/166 (2%)
Query: 248 STLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDL 307
L +LDL +N + + NL L L +N + P L L L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 308 RNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKS 367
N L + + L + + + + + + + L + + SG +
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGA 145
Query: 368 ISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 413
+ KL +++ ++ IPQ L SL +++ N++
Sbjct: 146 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDA 188
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (211), Expect = 5e-19
Identities = 60/264 (22%), Positives = 94/264 (35%), Gaps = 13/264 (4%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
+ + L N +S VP F C +L L L N+L F + L L+LS+N
Sbjct: 33 ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+D L RL TL L P L L+ L LQ N
Sbjct: 92 QLRSVDP---ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+LT L L N + + R L+S+ + + N + PH ++ L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 242
N+L+ +L + L +RL N + L++ S + S+P
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR- 267
Query: 243 SSSSSSTLFQTLRILDLSSNNLVG 266
+ L++N+L G
Sbjct: 268 --------LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (186), Expect = 8e-16
Identities = 52/265 (19%), Positives = 89/265 (33%), Gaps = 14/265 (5%)
Query: 51 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 110
++ + L N S + + + L L L N+ + L L++L L
Sbjct: 32 AASQRIFLHGNRISHVPAAS----FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 111 QGNQFSGPL-PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPH 169
N + PA L TL L P R L ++ ++ + +N L
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 170 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDL 229
++ L L N ++ + L + L N + P DLG
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 230 SENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR 289
+ ++P + + + L+ L L+ N V D A L+A L+ SS+ +
Sbjct: 208 LFANNLSALPTEALAP-----LRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVP 261
Query: 290 SRIPPELGYFHSLIHLDLRNNALYG 314
+P L L N L G
Sbjct: 262 CSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (175), Expect = 3e-14
Identities = 56/292 (19%), Positives = 90/292 (30%), Gaps = 34/292 (11%)
Query: 119 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 178
+P I + L N + S R ++ + + +N L ++ LE
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 179 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 238
LD S+N S+ + F+ L + L G
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLG----------------------RLHTLHLDRCGLQELG 121
Query: 239 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 298
P L+ L L N L NL +L L N + S
Sbjct: 122 P------GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 299 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
HSL L L N + P + L L L N+L+ + + +L L L+ N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
Query: 359 HLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410
+ L+ + +E+ +PQ L L ++ N L G
Sbjct: 236 PWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGR-DLK--RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (165), Expect = 5e-13
Identities = 48/255 (18%), Positives = 90/255 (35%), Gaps = 7/255 (2%)
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239
L ++P + I L GN ++ +L+ ++
Sbjct: 16 TSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACR----NLTILWLHSNVL 68
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
+++ + L ++ + L PA L L+L L+ P
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359
+L +L L++NAL + +L L L GN ++ + R SL L L N
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 360 LSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFP 419
++ P + +L +L L L N LS + L L +L + ++ N + ++
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248
Query: 420 TLDQSSLQGNLGICS 434
L + + CS
Sbjct: 249 WLQKFRGSSSEVPCS 263
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.4 bits (207), Expect = 3e-18
Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 27/291 (9%)
Query: 57 NLSNNHFSGDLDFASGYGIW-----SLKRLRTLDLSHNLFSG--SIPQGVAALHYLKELL 109
LS+ + D + G+ R+ LDLS IP +A L YL L
Sbjct: 23 TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82
Query: 110 LQGN-QFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 168
+ G GP+P I L L +++ +G +P L + +++ + S N L+G +P
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 169 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV-IRLRGNSLNGNIPEGLFDLGLEEI 227
I ++ L + F N ++G++P S + KL + + N L G IP +L L +
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFV 202
Query: 228 DLSENGFMGSIPPGSSSSSSSTL-----------------FQTLRILDLSSNNLVGDIPA 270
DLS N G S ++ + L LDL +N + G +P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 271 EMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 321
+ L LN+S N+L I P+ G NN P C
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 82.5 bits (202), Expect = 1e-17
Identities = 65/275 (23%), Positives = 98/275 (35%), Gaps = 14/275 (5%)
Query: 172 GNISTLEFLDFSNNHLTG--SLPSSLFNCKKLSVIRLRG--NSLNGNIPEGLFDLGLEEI 227
+ LD S +L +PSSL N L+ + + G N + P L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 228 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 287
++ G+IP + +TL LD S N L G +P + NL + N
Sbjct: 107 YITHTNVSGAIPD------FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 288 LRSRIPPELGYFHSLIH-LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN 346
+ IP G F L + + N L G IP ++ V+
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFG 218
Query: 347 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 406
+ + L L L N + G +PQ L +L L ++NVS+N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 407 RLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 441
L G +P GG D S+ N +C L C
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 62/263 (23%), Positives = 97/263 (36%), Gaps = 29/263 (11%)
Query: 7 LDLSNNLLSGPVPY-QLFENCASLRYLSLAGNI-LQGPIGKIFNYCSSLNTLNLSNNHFS 64
LDLS L P P N L +L + G L GPI + L+ L +++ +
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV- 113
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIG 124
A + +K L TLD S+N SG++P +++L L + GN+ SG +P G
Sbjct: 114 ---SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 125 FCPHLT--TLDLSNNLFTGQLPVSLRLLNSMIFISVSN---------------------N 161
L N L P L + + +S +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD 221
+G L LD NN + G+LP L K L + + N+L G IP+G
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 222 LGLEEIDLSENGFMGSIPPGSSS 244
+ + N + P + +
Sbjct: 291 QRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 3/132 (2%)
Query: 246 SSSTLFQTLRILDLSSNNLVGD--IPAEMGLFANLRYLNLSSNH-LRSRIPPELGYFHSL 302
+ T + LDLS NL IP+ + L +L + + L IPP + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG 362
+L + + + G+IP + + ++L L N+L+G +P I + +L ++ N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 363 SIPKSISNLNKL 374
+IP S + +KL
Sbjct: 164 AIPDSYGSFSKL 175
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
N+ LDL NN + G +P L L L+++ N L G I + N + +N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYAN 300
Query: 61 NHF 63
N
Sbjct: 301 NKC 303
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.3 bits (179), Expect = 2e-15
Identities = 28/187 (14%), Positives = 51/187 (27%), Gaps = 31/187 (16%)
Query: 561 EVGEGVFGTVYKVSFGTQGRMLAVKKL---------VTSDIIQYPEDFEREVRVLGKARH 611
+GEG V+ + + VK V F +
Sbjct: 7 LMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 612 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 671
L L+G + N L + + + + V+ + +A
Sbjct: 66 RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 672 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---------LLTRLDKHVMSNRFQ 722
+H I+H +L N+L+ + I DF + +L R D + F
Sbjct: 119 FYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILER-DVRNIITYFS 173
Query: 723 SALGYVA 729
Sbjct: 174 RTYRTEK 180
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (159), Expect = 2e-12
Identities = 46/272 (16%), Positives = 97/272 (35%), Gaps = 11/272 (4%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
+TLDL+ + + + + + PL + + +DLSN++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 142 -QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS--NNHLTGSLPSSLFNC 198
L L + + +S+ L+ I + + S L L+ S + +L + L +C
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 199 KKLSVI--RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
+L + + ++ + + L+ +G+ ++ S+ + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSS-NHLRSRIPPELGYFHSLIHLDLRNNALYGS 315
S L D E L++L+LS + ELG +L L + G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 316 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNC 347
+ +L LQ++ + T I N
Sbjct: 241 LQLLK---EALPHLQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 9e-11
Identities = 40/279 (14%), Positives = 79/279 (28%), Gaps = 42/279 (15%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 66
LDL+ L V +L + + + P+ + F+ + ++LSN+
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQ--GNQFSGPLPADIG 124
+ +L+ L L S I +A L L L L +
Sbjct: 62 TLHGI---LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118
Query: 125 FCPHLTTLDL-------------------------------SNNLFTGQLPVSLRLLNSM 153
C L L+L N + + R N +
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 154 IFISVSNNTLTGDIPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLN 212
+ L D ++ L+ L S + L L +++ G +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
Query: 213 GNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF 251
G + L + ++ + F P + + ++
Sbjct: 239 GTLQL--LKEALPHLQINCSHFTTIARPTIGNKKNQEIW 275
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 48/262 (18%), Positives = 88/262 (33%), Gaps = 8/262 (3%)
Query: 130 TTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG 189
TLDL+ + L L +I + + + ++ +D SN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 190 -SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSS 247
+L L C KL + L G L+ I L L ++LS + SS
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 248 STLFQT--LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 305
S L + D + ++ + L N +S + + +L+HL
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 306 DLRNNALY-GSIPQEVCESRSLGILQLDG-NSLTGPIPQVIRNCTSLYLLSLSHNHLSGS 363
DL ++ + QE + L L L + + +L L + G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 364 IPKSISNLNKLKILKLEFNELS 385
+ L L+I F ++
Sbjct: 241 LQLLKEALPHLQINCSHFTTIA 262
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 45/206 (21%), Positives = 69/206 (33%), Gaps = 12/206 (5%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 66
++ L+ +P L ++ L L+ N+L + L LNL +
Sbjct: 15 VNCDKRNLTA-LPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 126
+L L TLDLSHN G L L + N+ + +
Sbjct: 71 ------QVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPLGALRGL 123
Query: 127 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186
L L L N P L + +S++NN LT + + L+ L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 187 LTGSLPSSLFNCKKLSVIRLRGNSLN 212
L ++P F L L GN
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 6e-09
Identities = 44/208 (21%), Positives = 69/208 (33%), Gaps = 31/208 (14%)
Query: 223 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLN 282
E++ + ++PP L + IL LS N L A + + L LN
Sbjct: 11 SHLEVNCDKRNLT-ALPPD--------LPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 283 LSSN---------------------HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 321
L + +P +L LD+ N L +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 322 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF 381
L L L GN L P ++ L LSL++N+L+ ++ L L L L+
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 382 NELSGEIPQELGKLASLLAVNVSYNRLI 409
N L IP+ L + N +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 42/211 (19%), Positives = 67/211 (31%), Gaps = 14/211 (6%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+ ++ + ++P + L L N A + LT L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 137 -NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 195
L Q+ +L +L ++ +L LD S N LT +L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALT----VLDVSFNRLTSLPLGAL 120
Query: 196 FNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 255
+L + L+GN L P L E N + +P G + + L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN-----LD 175
Query: 256 ILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 286
L L N+L IP L + L N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.0 bits (129), Expect = 2e-09
Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 314
R+L L+ +L + + + +L+LS N LR+ PP L L L +N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDN--AL 55
Query: 315 SIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLS---GSIPKSISN 370
V L L L N L Q + +C L LL+L N L G +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 371 LNKLKIL 377
L + +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 3e-08
Identities = 30/122 (24%), Positives = 48/122 (39%), Gaps = 7/122 (5%)
Query: 279 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 338
R L+L+ L L + HLDL +N L P + R L +LQ N+L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 339 PIPQVIRNCTSLYLLSLSHNHL-SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLAS 397
L L +N L + + + + +L +L L+ N L + +LA
Sbjct: 58 VDGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 398 LL 399
+L
Sbjct: 115 ML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 10/125 (8%)
Query: 30 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 89
R L LA L + L+LS+N + +L+ L L S N
Sbjct: 1 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDN 53
Query: 90 LFSGSIPQGVAALHYLKELLLQGNQF-SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 148
GVA L L+ELLL N+ + CP L L+L N + + R
Sbjct: 54 ALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111
Query: 149 LLNSM 153
L +
Sbjct: 112 LAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 8e-07
Identities = 23/132 (17%), Positives = 45/132 (34%), Gaps = 14/132 (10%)
Query: 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 64
+ L L++ L+ E + +L L+ N L+ + L + +
Sbjct: 1 RVLHLAHKDLTVLCH---LEQLLLVTHLDLSHNRLRALPPALAALRC----LEVLQASDN 53
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHN-LFSGSIPQGVAALHYLKELLLQGNQFSGP---LP 120
+ + RL+ L L +N L + Q + + L L LQGN
Sbjct: 54 ALENVDGVANLP---RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
Query: 121 ADIGFCPHLTTL 132
P ++++
Sbjct: 111 RLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 6/109 (5%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 141
R L L+H + + + L + L L N+ PA + L L S+N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 142 QLPVSLRLLNSMIFISVSNNTLTG-DIPHWIGNISTLEFLDFSNNHLTG 189
V+ + + + NN L + + L L+ N L
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 106 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 165
+ L L + + +T LDLS+N P L + + N
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 166 DIPHWIGNISTLEFLDFSNNHLTG-SLPSSLFNCKKLSVIRLRGNSLNG 213
D + + + L NN L + L +C +L ++ L+GNSL
Sbjct: 59 DGVANLPRL---QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 4e-05
Identities = 26/127 (20%), Positives = 50/127 (39%), Gaps = 9/127 (7%)
Query: 156 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 215
+ +++ LT + + + + LD S+N L P +L + L V++ N+ N+
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA-LENV 58
Query: 216 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 275
L+E+ L N S S L +L+L N+L + + L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR-----LVLLNLQGNSLCQEEGIQERLA 113
Query: 276 ANLRYLN 282
L ++
Sbjct: 114 EMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 25/112 (22%), Positives = 36/112 (32%), Gaps = 10/112 (8%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
++ + LDLS+N L P L L + N L+ G L L N
Sbjct: 19 LLLVTHLDLSHNRLRALPP--ALAALRCLEVLQASDNALENVDGVANLPRL--QELLLCN 74
Query: 61 NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS---GSIPQGVAALHYLKELL 109
N + S RL L+L N G + L + +L
Sbjct: 75 NRLQQSAAIQP---LVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 55.6 bits (132), Expect = 3e-09
Identities = 38/193 (19%), Positives = 68/193 (35%), Gaps = 13/193 (6%)
Query: 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFT 140
T+D + IP+ + + ELLL N+ + G PHL L+L N T
Sbjct: 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 141 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 200
G P + + + + + N + + L+ L+ +N ++ +P S +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 201 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260
L+ + L N N N F L + L+ P + ++I DL
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---------VRDVQIKDLP 178
Query: 261 SNNLVGDIPAEMG 273
+ G
Sbjct: 179 HSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 8e-05
Identities = 30/121 (24%), Positives = 48/121 (39%), Gaps = 4/121 (3%)
Query: 255 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRI-PPELGYFHSLIHLDLRNNALY 313
+D + L +IP + + L L+ N L G L+ L+L+ N L
Sbjct: 11 TTVDCTGRGLK-EIPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 314 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 373
G P + + LQL N + ++ L L+L N +S +P S +LN
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 374 L 374
L
Sbjct: 128 L 128
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 9e-08
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG----PIGKIFNYCSSLNTLN 57
++++ LD+ LS +L + + L L I +L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 58 LSNNHFSGDLDFASGYGIWSLK-RLRTLDLSHN 89
L +N G+ + +++ L L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 1e-07
Identities = 17/80 (21%), Positives = 27/80 (33%), Gaps = 9/80 (11%)
Query: 325 SLGILQLDGNSLTG----PIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS-----NLNKLK 375
L +L L ++ + + SL L LS+N L + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 376 ILKLEFNELSGEIPQELGKL 395
L L S E+ L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 1e-07
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 5/91 (5%)
Query: 301 SLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTG----PIPQVIRNCTSLYLLSL 355
+ LD++ L + E+ + +++LD LT I +R +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 356 SHNHLSGSIPKSISNLNKLKILKLEFNELSG 386
N L + + K++ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 9/95 (9%)
Query: 47 FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA----- 101
S L L L++ S + + + LR LDLS+N + +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 102 LHYLKELLLQGNQFSGPLPADIGF----CPHLTTL 132
L++L+L +S + + P L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 10/72 (13%), Positives = 26/72 (36%), Gaps = 5/72 (6%)
Query: 81 LRTLDLSHNLFSGS-IPQGVAALHYLKELLLQGNQFSG----PLPADIGFCPHLTTLDLS 135
+++LD+ S + + + L + + L + + + + P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 136 NNLFTGQLPVSL 147
+N +
Sbjct: 64 SNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 23/117 (19%), Positives = 37/117 (31%), Gaps = 27/117 (23%)
Query: 269 PAEMGLFANLRYLNLSSNHLRSR----IPPELGYFHSLIHLDLRNNALYGSIPQEVCESR 324
+ LR L L+ + + L HSL LDL NN L + ++ ES
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES- 420
Query: 325 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL----NKLKIL 377
V + L L L + S + + L L+++
Sbjct: 421 ------------------VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 14/82 (17%), Positives = 27/82 (32%), Gaps = 10/82 (12%)
Query: 168 PHWIGNISTLEFLDFSNNHLTG----SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL- 222
S L L ++ ++ SL ++L L + L N L L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 223 -----GLEEIDLSENGFMGSIP 239
LE++ L + + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 5e-06
Identities = 17/83 (20%), Positives = 29/83 (34%), Gaps = 5/83 (6%)
Query: 254 LRILDLSSNNLVGDIPAEM-GLFANLRYLNLSSNHLRSR----IPPELGYFHSLIHLDLR 308
++ LD+ L AE+ L + + L L I L +L L+LR
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 309 NNALYGSIPQEVCESRSLGILQL 331
+N L V + ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 7e-06
Identities = 18/85 (21%), Positives = 27/85 (31%), Gaps = 5/85 (5%)
Query: 23 FENCASLRYLSLAGNILQG----PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGI-WS 77
+ + LR L LA + + SL L+LSNN +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 78 LKRLRTLDLSHNLFSGSIPQGVAAL 102
L L L +S + + AL
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 9e-06
Identities = 15/95 (15%), Positives = 30/95 (31%), Gaps = 12/95 (12%)
Query: 52 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG----SIPQGVAALHYLKE 107
+ +L++ S D +A L++ + + L + I + L E
Sbjct: 3 DIQSLDIQCEELS-DARWAELLP--LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 108 LLLQGNQFSGPLPADIG-----FCPHLTTLDLSNN 137
L L+ N+ + + L L N
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 10/94 (10%), Positives = 24/94 (25%), Gaps = 6/94 (6%)
Query: 28 SLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 86
++ L + + ++ + L + + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 87 SHNLFSGSIPQGVAAL-----HYLKELLLQGNQF 115
N V +++L LQ
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 129 LTTLDLSNNLFT-GQLPVSLRLLNSMIFISVSNNTLTGD----IPHWIGNISTLEFLDFS 183
+ +LD+ + + L LL + + + LT I + L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 184 NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 214
+N L + + +++ SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 15/95 (15%)
Query: 103 HYLKELLLQGNQFSG----PLPADIGFCPHLTTLDLSNNLFTGQ----LPVSLRLLNSMI 154
L+ L L S L A + L LDLSNN L S+R ++
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 155 -FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 188
+ + + + ++ L+ L+ L
Sbjct: 429 EQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 7/93 (7%)
Query: 177 LEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDL-----GLEEIDLS 230
++ LD L+ + + L ++ V+RL L + + L E++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 231 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNN 263
N + ++ L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPS-CKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 7e-05
Identities = 15/75 (20%), Positives = 27/75 (36%), Gaps = 8/75 (10%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQL---FENCASLRYLSLAGNILQGPIGK-----IFNYCSS 52
++ L L++ +S L SLR L L+ N L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 53 LNTLNLSNNHFSGDL 67
L L L + ++S ++
Sbjct: 428 LEQLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/104 (15%), Positives = 32/104 (30%), Gaps = 9/104 (8%)
Query: 222 LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL----VGDIPAEMGLFAN 277
L ++ +D+ + + L Q +++ L L DI + + +
Sbjct: 2 LDIQSLDIQCEEL-----SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPA 56
Query: 278 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 321
L LNL SN L + ++ +L
Sbjct: 57 LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 17/108 (15%), Positives = 27/108 (25%), Gaps = 25/108 (23%)
Query: 120 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
L L L++ + SL + +L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSL--------------------AATLLANHSLRE 401
Query: 180 LDFSNNHLTGSLPSSLF-----NCKKLSVIRLRGNSLNGNIPEGLFDL 222
LD SNN L + L L + L + + + L L
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 9/79 (11%)
Query: 251 FQTLRILDLSSNNL----VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG-----YFHS 301
LR+L L+ ++ + A + +LR L+LS+N L +L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 302 LIHLDLRNNALYGSIPQEV 320
L L L + + +
Sbjct: 428 LEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 12/61 (19%), Positives = 26/61 (42%), Gaps = 5/61 (8%)
Query: 353 LSLSHNHLSGS-IPKSISNLNKLKILKLEFNELSGE----IPQELGKLASLLAVNVSYNR 407
L + LS + + + L + ++++L+ L+ I L +L +N+ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 408 L 408
L
Sbjct: 67 L 67
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 21/82 (25%), Positives = 36/82 (43%), Gaps = 12/82 (14%)
Query: 251 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 310
+L L++S+N L+ ++PA L L S NHL + +P +L L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQ---NLKQLHVEYN 334
Query: 311 ALYGSIPQEVCESRSLGILQLD 332
L P S+ L+++
Sbjct: 335 PLR-EFPDIP---ESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 48/333 (14%), Positives = 90/333 (27%), Gaps = 24/333 (7%)
Query: 50 CSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELL 109
+ L L+N S + L +L S N + +P+ +L L
Sbjct: 37 DRQAHELELNNLGLSSLPE--------LPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 87
Query: 110 LQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT------L 163
S P L+ L + + N+ +
Sbjct: 88 NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG 223
+ + + L FL S++ + L L
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNL 283
D + + +PP + + + T S + + L
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267
Query: 284 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQV 343
N + I SL L++ NN L +P L L N L +P++
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHLAE-VPEL 322
Query: 344 IRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 376
+N L+ + +N L P ++ L++
Sbjct: 323 PQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 53/312 (16%), Positives = 98/312 (31%), Gaps = 23/312 (7%)
Query: 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164
EL L S LP PHL +L S N T +LP + L S++ + + L+
Sbjct: 40 AHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGL 224
P + + + ++ + + L
Sbjct: 95 DLPPLL--EYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 225 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 284
EE+ +N + ++S L + + + N + + E+ L +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 285 SNHLRSRIPPELGYFHSLIHLDLRNNAL--------YGSIPQEVCESRSLGILQLDGNSL 336
+N L++ + + + L N+
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 337 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 396
+ I + SL L++S+N L +P L+ L FN L+ E+P+ L
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLK 327
Query: 397 SLLAVNVSYNRL 408
L +V YN L
Sbjct: 328 QL---HVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 18/86 (20%)
Query: 224 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNL 283
LEE+++S N + +P L L S N+L ++P NL+ L++
Sbjct: 286 LEELNVSNNKLI-ELPALPPR---------LERLIASFNHL-AEVPELPQ---NLKQLHV 331
Query: 284 SSNHLRSRIPPELGYFHSLIHLDLRN 309
N LR P S+ L + +
Sbjct: 332 EYNPLRE-FPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 1e-05
Identities = 21/100 (21%), Positives = 34/100 (34%), Gaps = 16/100 (16%)
Query: 37 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 96
N I + + SL LN+SNN RL L S N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPA--------LPPRLERLIASFNHLA-EVP 320
Query: 97 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+ LK+L ++ N P + L +++
Sbjct: 321 E---LPQNLKQLHVEYNPLRE-FPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 14/82 (17%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+++ L++SNN L +L L L + N + ++ +L L++
Sbjct: 283 PPSLEELNVSNNKLI-----ELPALPPRLERLIASFN----HLAEVPELPQNLKQLHVEY 333
Query: 61 NHFSGDLDFASGYGIWSLKRLR 82
N D S++ LR
Sbjct: 334 NPLREFPDI-----PESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 16/78 (20%), Positives = 28/78 (35%), Gaps = 5/78 (6%)
Query: 274 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 333
L L L++ L S +P L L N+L +P+ +SL + +
Sbjct: 36 LDRQAHELELNNLGLSS-LPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNL 90
Query: 334 NSLTGPIPQVIRNCTSLY 351
+L+ P + S
Sbjct: 91 KALSDLPPLLEYLGVSNN 108
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.3 bits (118), Expect = 5e-07
Identities = 45/367 (12%), Positives = 94/367 (25%), Gaps = 44/367 (11%)
Query: 28 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 87
SL+ ++ + + + S+ + LS N + I S K L + S
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 88 HNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL 147
+ + + + L + CP L T+ LS+N F L
Sbjct: 68 DI--------------FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 113
Query: 148 RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 207
S + G + + N + P + +
Sbjct: 114 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 173
Query: 208 GNSLNGNIPEGLFDLGLEEIDLSENGF-MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 266
+ L ++ + + L + ++
Sbjct: 174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 233
Query: 267 DIPAEMGLFANLRYLNLSSNHLRSRIPPELG------YFHSLIHLDLRNNALYGSIPQEV 320
+ + + NLR L L+ L +R + L L L+ N + + +
Sbjct: 234 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 293
Query: 321 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL- 379
+ L L L+ N + + ++ +
Sbjct: 294 KTV-------------------IDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGR 333
Query: 380 -EFNELS 385
E +EL
Sbjct: 334 GELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 35/338 (10%), Positives = 83/338 (24%), Gaps = 34/338 (10%)
Query: 79 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP----LPADIGFCPHLTTLDL 134
K L+ ++ S+ + +KE++L GN L +I L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 135 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 194
S+ L ++ + L T + L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 195 LFNCKKLSVIRLRGNSLNGNIPEGLFDLG--LEEIDLSENGFMGSIPPGSSSSSSSTLFQ 252
+ L + + + + +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 253 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 312
L + + N + + + L L + + +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD---------------LQDNTFTHLG 231
Query: 313 YGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC------TSLYLLSLSHNHLSGSIPK 366
++ + +L L L+ L+ + + L L L +N + +
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291
Query: 367 SI-----SNLNKLKILKLEFNELSGEIPQELGKLASLL 399
++ + L L+L N S E + ++ +
Sbjct: 292 TLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 44/308 (14%), Positives = 87/308 (28%), Gaps = 24/308 (7%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGP----IGKIFNYCSSLNTLNL 58
++K ++ V L S++ + L+GN + + + L
Sbjct: 9 SLKLDAITTEDEK-SVFAVL-LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 59 SNNHFSGDLDFAS------GYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQG 112
S+ D + +L T+ LS N F + + + L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 113 NQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIG 172
+ L G +L+ N P ++ + +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 173 NISTLEFLDFSNNHLTGS--LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD-----LGLE 225
+ T++ + L L C++L V+ L+ N+ L L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 226 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP-----AEMGLFANLRY 280
E+ L++ + S L+ L L N + D +L +
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 281 LNLSSNHL 288
L L+ N
Sbjct: 307 LELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 8/84 (9%)
Query: 322 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG----SIPKSISNLNKLKIL 377
E +SL + + + V+ S+ + LS N + + ++I++ L+I
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 378 KLEFN---ELSGEIPQELGKLASL 398
+ + EIP+ L L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQA 88
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 17/76 (22%), Positives = 30/76 (39%), Gaps = 10/76 (13%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCA-----SLRYLSLAGNILQGPIGK-----IFNYC 50
N++ L L++ LLS + + + L+ L L N ++ + I
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 51 SSLNTLNLSNNHFSGD 66
L L L+ N FS +
Sbjct: 302 PDLLFLELNGNRFSEE 317
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 37/209 (17%), Positives = 72/209 (34%), Gaps = 21/209 (10%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+ +L + ++ Q L+ + +++ + I + P++T L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 196
N T P++ +F+ + + S H S + L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK------SLSLEHNGISDINGLV 131
Query: 197 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 256
+ +L + L N + L + E+ + I P + + L+
Sbjct: 132 HLPQLESLYLGNNKITDITVL--SRLTKLDTLSLEDNQISDIVPLAGLTK-------LQN 182
Query: 257 LDLSSNNLVGDIPAEMGLFANLRYLNLSS 285
L LS N++ D+ A GL NL L L S
Sbjct: 183 LYLSKNHI-SDLRALAGL-KNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 6e-06
Identities = 37/220 (16%), Positives = 72/220 (32%), Gaps = 31/220 (14%)
Query: 8 DLSNNLLSGPVP-YQLF--ENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 64
L + ++ P P Q+F + A +L + + + N +S++ + +N+
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK 59
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL---------------- 108
S GI L + L L+ N + P L
Sbjct: 60 ------SVQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKK 113
Query: 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 168
L + + G L L L + +S+ +N ++ +P
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP 173
Query: 169 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG 208
+ ++ L+ L S NH++ +L K L V+ L
Sbjct: 174 --LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 37/231 (16%), Positives = 70/231 (30%), Gaps = 23/231 (9%)
Query: 150 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 209
L + I I+ + +T + ++ + L +T + L + L+ N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 210 SLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP 269
+ P E S G S + L T
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT------------- 120
Query: 270 AEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 329
L L + + L +L +L + N S + L L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA--QVSDLTPLANLSKLTTL 178
Query: 330 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLE 380
+ D N ++ P + + +L + L +N +S P ++N + L I+ L
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 9e-06
Identities = 28/211 (13%), Positives = 61/211 (28%), Gaps = 19/211 (9%)
Query: 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 66
+ + ++ V + + LS G + G Y ++L L L +N +
Sbjct: 24 IAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQITDL 78
Query: 67 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQG----------NQFS 116
+ I L+ + + +G L + +
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 117 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 176
+ LS L L+ + + +N ++ P + ++
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPN 196
Query: 177 LEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 207
L + NN ++ P L N L ++ L
Sbjct: 197 LIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 31/219 (14%), Positives = 64/219 (29%), Gaps = 17/219 (7%)
Query: 100 AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159
AL ++ + + + +TTL T + ++ LN++I + +
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGL 219
+N +T P T L + ++ + L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 220 FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF---------QTLRILDLSSNNLVGDIPA 270
L L+ ++ + + S + L L N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 271 EMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRN 309
+ NL ++L +N + P L +L + L N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 31/223 (13%), Positives = 64/223 (28%), Gaps = 29/223 (13%)
Query: 77 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 136
+L + + + ++ Q A L + L G + + + +L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 137 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGN---------------ISTLEFLD 181
N T P+ + + +S + I ++ L L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 182 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 241
L S GN+ ++ L + +N P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 242 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 284
S + L + L +N + P + +NL + L+
Sbjct: 193 SLPN--------LIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 11/60 (18%), Positives = 22/60 (36%), Gaps = 5/60 (8%)
Query: 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSN 60
+ + L +N +S P + +L + L N + S+L + L+N
Sbjct: 172 LSKLTTLKADDNKISDISP---LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 15/61 (24%), Positives = 29/61 (47%), Gaps = 4/61 (6%)
Query: 344 IRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNV 403
+ N + L L N +S P +++L L + L+ N++S P L ++L V +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 404 S 404
+
Sbjct: 225 T 225
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 1e-05
Identities = 21/131 (16%), Positives = 44/131 (33%), Gaps = 11/131 (8%)
Query: 49 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 108
Y S L+L DL + L+ ++ + ++ + L L
Sbjct: 20 YDGSQQALDLKGLRSDPDL--------VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSL 70
Query: 109 LLQGNQFSG--PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 166
L N+ + + + P+L L+LS N + + + + + N+L+
Sbjct: 71 NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130
Query: 167 IPHWIGNISTL 177
IS +
Sbjct: 131 FRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 4e-05
Identities = 29/136 (21%), Positives = 41/136 (30%), Gaps = 15/136 (11%)
Query: 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 64
+ LDL L+ ++ + I L +LNLSNN
Sbjct: 25 QALDLKGLRS-----DPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLY 78
Query: 65 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIG 124
D + + L+ L+LS N L+EL L GN S
Sbjct: 79 RLDDMS--SIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
Query: 125 F-------CPHLTTLD 133
+ P L LD
Sbjct: 137 YISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 6e-05
Identities = 28/145 (19%), Positives = 55/145 (37%), Gaps = 6/145 (4%)
Query: 258 DLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 317
+L + + M + L LRS P+L + + L+ R++ + ++
Sbjct: 3 ELKPEQV-EQLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSS-MAATLR 58
Query: 318 QEVCESRSLGILQLDGNSLTG--PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLK 375
L L L N L + +++ +L +L+LS N L KL+
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 376 ILKLEFNELSGEIPQELGKLASLLA 400
L L+ N LS + ++++
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRE 143
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 22/89 (24%), Positives = 33/89 (37%), Gaps = 4/89 (4%)
Query: 1 MMNMKFLDLSNNLLSG-PVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 59
+ + L+LSNN L + + +L+ L+L+GN L+ L L L
Sbjct: 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLD 123
Query: 60 NNHFSGDLDFASGYG---IWSLKRLRTLD 85
N S S Y +L LD
Sbjct: 124 GNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 1e-05
Identities = 21/154 (13%), Positives = 41/154 (26%), Gaps = 6/154 (3%)
Query: 50 CSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA-LHYLKEL 108
+ L + + L + + L L + + + L L+ L
Sbjct: 7 PHGSSGLRCTRDGALDSLH-----HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 168
+ + P F P L+ L+LS N +++ L+ + N
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
Query: 169 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 202
W+ L L + S
Sbjct: 122 RWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 24/139 (17%), Positives = 42/139 (30%), Gaps = 7/139 (5%)
Query: 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 302
++ T R LDL + I ++ S N + R L
Sbjct: 9 EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRL 65
Query: 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG----PIPQVIRNCTSLYLLSLSHN 358
L + NN + L L L NSL +++ T L +L
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 359 HLSGSIPKSISNLNKLKIL 377
+ I + ++++L
Sbjct: 126 NKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 8e-04
Identities = 29/132 (21%), Positives = 48/132 (36%), Gaps = 8/132 (6%)
Query: 23 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82
+ N R L L G + I + + ++ S+N LD L+RL+
Sbjct: 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDGFPL-----LRRLK 66
Query: 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTG 141
TL +++N AL L EL+L N + LT L + N T
Sbjct: 67 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126
Query: 142 QLPVSLRLLNSM 153
+ L ++ +
Sbjct: 127 KKHYRLYVIYKV 138
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 31/221 (14%), Positives = 62/221 (28%), Gaps = 4/221 (1%)
Query: 159 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 218
+ +T +IP + L F L + L I + N + I
Sbjct: 16 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 219 LFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL 278
+F + ++ + + + Q L I + +L L
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 279 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 338
+ + N +G + L L N + ++ + D N+L
Sbjct: 133 DIQD-NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 339 PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 379
V + +L +S + + NL KL+
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 4e-05
Identities = 25/208 (12%), Positives = 46/208 (22%), Gaps = 1/208 (0%)
Query: 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 62
N L L + F L + ++ N + I
Sbjct: 30 NAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 63 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD 122
+ + + + + + + + L ++ N + +
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 123 IGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 182
+G L L+ N + NN L S LD
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 183 SNNHLTGSLPSSLFNCKKLSVIRLRGNS 210
S + L N KKL
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 7e-04
Identities = 30/239 (12%), Positives = 58/239 (24%), Gaps = 10/239 (4%)
Query: 126 CPH------LTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 179
C H + T ++P L + I + L LE
Sbjct: 1 CHHRICHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 180 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 239
++ S N + + + +F+ + N I
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINP-EAFQNLPNLQYLLISNTGIK 116
Query: 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 299
+L + L + + N + + +GL L L+ N ++
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176
Query: 300 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 358
NN L + IL + + + N L S +
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 28/195 (14%), Positives = 53/195 (27%), Gaps = 24/195 (12%)
Query: 24 ENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 83
A L + + + + TL +D G+ L L
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-----GVEYLNNLTQ 66
Query: 84 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 143
++ S+N + P + PL + ++ +
Sbjct: 67 INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 144 PVSLRLLNSMIFISVSNNTLTGDIPHW--------------IGNISTLEFLDFSNNHLTG 189
+L L + L+G + N++TLE LD S+N ++
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186
Query: 190 SLPSSLFNCKKLSVI 204
S L L +
Sbjct: 187 --ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 843 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.56 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.51 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.88 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.41 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=429.02 Aligned_cols=266 Identities=26% Similarity=0.432 Sum_probs=210.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||+||+|++. ..||||++..... ....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 44667789999999999999874 3599999865432 2345689999999999999999999998865 45789999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.++++.. ...+++..+..++.|+|+||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999864 35699999999999999999999998 9999999999999999999999999999877654
Q ss_pred ccceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
..........||+.|||||++.. ...++.++|||||||++|||+||+.||....... .+. ..+..+. ..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~----~~~~~~~----~~ 228 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QII----FMVGRGY----LS 228 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHH----HHHHHTS----CC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHH----HHHhcCC----CC
Confidence 44334456789999999998743 2357899999999999999999999997543322 111 1222222 22
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
+.+...+..++.++.+++.+||+.||++||||+|++++|+.++...|+
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence 233334556677899999999999999999999999999999887774
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=423.28 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=208.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.|+..+.||+|+||+||+|++..+|+.||||++.........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 46777899999999999999998999999999976554445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++... ..+++.++..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 86 ~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 86 SGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp TTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999998753 4699999999999999999999998 999999999999999999999999999998765444
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
........||+.|||||++.....++.++||||+||++|||+||+.||............. ..... ..
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----~~~~~--------~~ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----KEKKT--------YL 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----HTTCT--------TS
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCC--------CC
Confidence 4444567899999999998555445788999999999999999999997654333222211 11110 01
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........++.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123445678899999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=416.36 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=200.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|+||+||+|.+. +++.||||++.... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred cEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 456678999999999999997 68889999986533 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++... ...++|..++.++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999998864 35689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 795 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 795 (843)
......||+.|+|||++ ....++.++|||||||++|||+|+..|+....... .+... +..+.. ..
T Consensus 158 -~~~~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~~~~~----i~~~~~--------~~ 222 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVED----ISTGFR--------LY 222 (263)
T ss_dssp --------CTTSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-HHHHH----HHHTCC--------CC
T ss_pred -eecceecCcccCChHHh-cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-HHHHH----HHhcCC--------CC
Confidence 22446789999999998 56679999999999999999999655554332222 11111 122211 11
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 796 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 796 ~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.+..++.++.+++.+||+.||++||||+|++++|++++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 244556678999999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-50 Score=419.79 Aligned_cols=260 Identities=27% Similarity=0.352 Sum_probs=216.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||+||+|++..+|+.||||++.... ...++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 44667779999999999999998889999999986443 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|.+++... ....++|..+..++.|+|+||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999875 245789999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. .......|++.|+|||++ .+..++.++|||||||++|||++|..|+....... .+.+ .+..+..
T Consensus 170 ~-~~~~~~~g~~~y~aPE~~-~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~----~i~~~~~-------- 234 (287)
T d1opja_ 170 Y-TAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYE----LLEKDYR-------- 234 (287)
T ss_dssp S-EEETTEEECGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHH----HHHTTCC--------
T ss_pred c-eeeccccccccccChHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHH----HHhcCCC--------
Confidence 2 222445688899999988 55678999999999999999999888775443322 1111 2222211
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCC
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 835 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~ 835 (843)
...+..++.++.+++.+||+.||++||||+|+++.|+.+.+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 123455667899999999999999999999999999987543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-50 Score=421.44 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=200.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCe---EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.|+..+.||+|+||+||+|.+..+++ .||||++.........+.|.+|++++++++|||||+++|++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45667789999999999999975554 689998865554445568999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
|||++|+|.+++... ...++|.++..++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 107 Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp ECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998864 35699999999999999999999998 999999999999999999999999999987754
Q ss_pred cccce---eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCccc
Q 003156 712 LDKHV---MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 787 (843)
Q Consensus 712 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 787 (843)
..... ......||+.|||||.+ ....++.++|||||||++|||+| |+.||..... ..+.. .+..+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~----~i~~~~~-- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVIN----AIEQDYR-- 251 (299)
T ss_dssp ---------------CGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHH----HHHTTCC--
T ss_pred CCCcceeeecccccCCccccCHHHH-hcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHH----HHHcCCC--
Confidence 33221 11234578999999988 55679999999999999999998 8999965422 11111 1222211
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 788 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 788 ~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+.+++..+.+++.+||+.||++||||.||++.|+.+.+
T Consensus 252 ------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 ------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 12355667789999999999999999999999999988643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=413.58 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=209.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||+||+|.++ +++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 356777889999999999999996 67899999986543 346789999999999999999999998855 55789999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++.... ...++|..++.|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred eCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999887642 34589999999999999999999998 9999999999999999999999999999987643
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. .......||+.|+|||++ ....++.++|||||||++|||+||..|+.........+ . . +..+..
T Consensus 163 ~~-~~~~~~~gt~~y~APE~~-~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~---~-i~~~~~------- 228 (272)
T d1qpca_ 163 EY-TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-Q---N-LERGYR------- 228 (272)
T ss_dssp CE-ECCTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-H---H-HHTTCC-------
T ss_pred cc-ccccccCCcccccChHHH-hCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-H---H-HHhcCC-------
Confidence 32 223456788999999988 55678999999999999999999777665443322211 1 1 122211
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+..++.++.+++.+||+.||++||||+||++.|+.+
T Consensus 229 -~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 229 -MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 123445667789999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=414.07 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=213.9
Q ss_pred cChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 550 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 550 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
.+++++|+..+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 8 ~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 457788898899999999999999999899999999986543 3345788999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ...+++.++..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99999999999998765 34699999999999999999999999 9999999999999999999999999999765
Q ss_pred cccccceeccccccccccCCccccc----CcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
.... .......||+.|+|||++. ....++.++|||||||++|||+||+.||....... .+... .. +.
T Consensus 161 ~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i----~~-~~- 231 (288)
T d2jfla1 161 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKI----AK-SE- 231 (288)
T ss_dssp HHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHH----HH-SC-
T ss_pred CCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHH----Hc-CC-
Confidence 4322 1224568999999999873 24457899999999999999999999997543222 22111 11 11
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.....+...+.++.+++.+||+.||++|||++|++++
T Consensus 232 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 -----PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112345566788999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=414.34 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=206.6
Q ss_pred eeccccceEEEEEEECC--CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCCCC
Q 003156 561 EVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 638 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 638 (843)
+||+|+||+||+|.++. ++..||||++.........++|.+|++++++++|||||+++|++.++ ..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCc
Confidence 59999999999998753 45689999997654444457899999999999999999999999754 5789999999999
Q ss_pred HHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc-ee
Q 003156 639 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VM 717 (843)
Q Consensus 639 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~ 717 (843)
|.+++... ...+++..+..++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+++.+...... ..
T Consensus 95 L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 99998764 35699999999999999999999998 9999999999999999999999999999987654332 22
Q ss_pred ccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCCCC
Q 003156 718 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 796 (843)
Q Consensus 718 ~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 796 (843)
.....||+.|+|||++ ....++.++|||||||++|||+| |+.||...... .+. ..+..+.. ...
T Consensus 169 ~~~~~gt~~y~aPE~~-~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~----~~i~~~~~--------~~~ 233 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGKR--------MEC 233 (285)
T ss_dssp CCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHTTCC--------CCC
T ss_pred ccccccCccccChHHH-hCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCC--------CCC
Confidence 2345688999999988 55678999999999999999998 89999754322 111 12222222 223
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 797 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 797 ~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
+..++.++.++|.+||+.||++||||.+|++.|+.+.
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 5566778999999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=407.89 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=208.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.|+..+.||+|+||+||+|++..+|+.||+|++.... .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4677889999999999999999899999999986432 22345778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ..+++..+..++.|+++||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 y~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 87 YAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred ecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999875 4689999999999999999999998 9999999999999999999999999999866532
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. .....||+.|||||++ .+..++.++|||||||++|||++|+.||..... .. ..... .... .
T Consensus 160 ~----~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~---~~~~i-~~~~------~- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QE---TYKRI-SRVE------F- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HH---HHHHH-HTTC------C-
T ss_pred c----ccccCCCCcccCHHHH-cCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HH---HHHHH-HcCC------C-
Confidence 2 2446799999999998 556789999999999999999999999964321 11 11111 1111 1
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.++...+.++.+++.+||+.||++|||++|++++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1344456678899999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=414.56 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=204.4
Q ss_pred hhhcCeeccccceEEEEEEECCCC----eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQG----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
|+..+.||+|+||+||+|.++.++ ..||||++.........++|.+|+.++++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 556778999999999999986544 4799999865544444567999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+.+|++.+++... ...++|.++..++.|+|.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 89 e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 89 EYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp ECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999988775 35699999999999999999999998 999999999999999999999999999987754
Q ss_pred cccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 712 LDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 712 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.... .......||+.|||||++ ....++.++|||||||++|||++|..|+........ +.. .+..+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-~~~----~i~~~~------ 230 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMK----AINDGF------ 230 (283)
T ss_dssp -----------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH----HHHTTC------
T ss_pred CCccceEeccCCCCccccCHHHH-ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-HHH----HHhccC------
Confidence 3322 222445689999999988 556899999999999999999998777654433222 111 122221
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
....+.+++.++.+++.+||+.||++||||.||++.|+.+.+
T Consensus 231 --~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 123355667789999999999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=409.85 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=211.1
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.+.|+..+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 44567888899999999999999988999999999865442 34678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... .+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 97 Ey~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999999988763 489999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......||+.|+|||++ .+..++.++||||+||++|||+||+.||..... ...+ ......+..
T Consensus 169 ~~~--~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~----~~~~~~~~~------ 234 (293)
T d1yhwa1 169 EQS--KRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRAL----YLIATNGTP------ 234 (293)
T ss_dssp TTC--CBCCCCSCGGGCCHHHH-SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHH----HHHHHHCSC------
T ss_pred ccc--cccccccCCCccChhhh-cCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-HHHH----HHHHhCCCC------
Confidence 322 22456799999999998 556789999999999999999999999964322 1111 111222111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. ..+.....++.+++.+||+.||++|||++|++++
T Consensus 235 ~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 EL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CC-SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CC-CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1244556778999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=421.02 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=212.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCC-----eEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQG-----RMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 626 (843)
.+.|+..+.||+|+||+||+|++...+ ..||+|.+...........+.+|+.+++++ +|||||+++|++.+++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 356778889999999999999986433 379999986655455567899999999998 89999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCC-------------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCC
Q 003156 627 KLLVSDYAPNGSLQAKLHERLP-------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 687 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~ 687 (843)
.++||||+++|+|.++++.... ....++|..++.++.|+|+||+|||++ +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999987532 124589999999999999999999998 999999999
Q ss_pred CCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCC
Q 003156 688 SNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGE 766 (843)
Q Consensus 688 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~ 766 (843)
+||+++.++.+||+|||+|+...............||+.|||||++ .+..++.++|||||||++|||+| |+.||....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH-cCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999887665554444567789999999988 56679999999999999999998 899997543
Q ss_pred CchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 003156 767 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 831 (843)
Q Consensus 767 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~ 831 (843)
... .+.. .+..+.. ...+..++.++.++|.+||+.||++||||+||+++|..
T Consensus 272 ~~~-~~~~----~~~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDA-NFYK----LIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSH-HHHH----HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH-HHHH----HHhcCCC--------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 332 2222 2222211 12355566789999999999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=413.84 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=198.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc--CCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 630 (843)
+.|+..+.||+|+||+||+|++..+|+.||||.+...... ...+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 3467778999999999999999989999999998655432 234568899999999999999999999975 3457899
Q ss_pred EEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcC--CCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 631 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF--RPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
|||+++|+|.+++.........+++..++.++.|++.||+|||++. ..+||||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765434567999999999999999999999872 12499999999999999999999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
+..... ......||+.|||||++ .+..++.++|||||||++|||+||+.||..... ..+.. .+..+..
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~----~i~~~~~--- 231 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAG----KIREGKF--- 231 (269)
T ss_dssp C-------------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH----HHHHTCC---
T ss_pred cccCCC--ccccCCCCcccCCHHHH-cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHH----HHHcCCC---
Confidence 654222 22456789999999998 566789999999999999999999999964321 11111 1222221
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+...+.++.+++.+||+.||++|||++|++++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 12344556678999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=402.74 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=211.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 635 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 635 (843)
|+..+.||+|+||+||+|+++ +++.||||++.... ...++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred CEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 456778999999999999996 78899999997644 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccc
Q 003156 636 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 715 (843)
Q Consensus 636 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 715 (843)
+|+|.+++... ...+++..+.+++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+++...+....
T Consensus 83 ~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999998765 35689999999999999999999998 9999999999999999999999999999876654332
Q ss_pred eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 716 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 716 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......||+.|+|||.+ ....++.++|||||||++|||+| |+.||..... ..+.. .+..+.. .
T Consensus 157 -~~~~~~~t~~y~aPE~~-~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~----~i~~~~~--------~ 220 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAE----HIAQGLR--------L 220 (258)
T ss_dssp -CCCCSCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHH----HHHTTCC--------C
T ss_pred -eecccCCCCCcCCcHHh-cCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHHH----HHHhCCC--------C
Confidence 22456789999999988 55678999999999999999998 8999965432 11211 1222211 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..+...+.++.+++.+||+.||++||||+|++++|..+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 23445567899999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=406.23 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=201.2
Q ss_pred CeeccccceEEEEEEECC--CCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeCCC
Q 003156 560 AEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 636 (843)
Q Consensus 560 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 636 (843)
++||+|+||+||+|.+.. .++.||||++..... ....+.|.+|++++++++|||||+++|+|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 479999999999998743 457899999864432 22346799999999999999999999999654 56899999999
Q ss_pred CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccccce
Q 003156 637 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 716 (843)
Q Consensus 637 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 716 (843)
|+|.++++.. ..++|..++.++.|||+||+|||++ +||||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999874 4699999999999999999999998 99999999999999999999999999998765433322
Q ss_pred -eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCCC
Q 003156 717 -MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 794 (843)
Q Consensus 717 -~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 794 (843)
......||+.|||||.+ ....++.++|||||||++|||+| |+.||..... ..+ ...+..+.. .
T Consensus 165 ~~~~~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~----~~~i~~~~~--------~ 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEV----TAMLEKGER--------M 229 (277)
T ss_dssp EC----CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH----HHHHHTTCC--------C
T ss_pred ccccccCCCceecCchhh-cCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHH----HHHHHcCCC--------C
Confidence 22445789999999988 55678999999999999999998 8999975422 111 122222221 2
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 795 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 795 ~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
..+..++.++.++|.+||+.||++||||+||++.|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 23556667899999999999999999999999888764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=418.34 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=207.5
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.+.|+..+.||+|+||+||+|++..+|+.||+|++.........+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34577788999999999999999989999999999765444445688999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|+|.+++... ..+++..+..++.|+++||.|||+++ +|+||||||+|||+++++.+||+|||+|+.+.+.
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999875 45899999999999999999999732 8999999999999999999999999999876432
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh----------
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE---------- 782 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~---------- 782 (843)
. .....||+.|||||++ .+..++.++||||+||++|||++|+.||....................
T Consensus 159 ~----~~~~~GT~~Y~APEvl-~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 159 M----ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp T----C---CCSSCCCCHHHH-HCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred c----cccccCCccccCchHH-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 2456899999999998 556799999999999999999999999976543322111100000000
Q ss_pred CCc--cc----------------ccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNV--LD----------------CVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~--~~----------------~~d~~l~~~~-~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
... .. ......+..+ .....++.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000 00 0000000011 1234568899999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=403.26 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=199.5
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEc----CCeeEEEE
Q 003156 557 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKLLVS 631 (843)
Q Consensus 557 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 631 (843)
+..++||+|+||+||+|.+..+++.||+|++...... ...+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3455799999999999999989999999998765432 234578999999999999999999999865 34578999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc-CCCCcEEeeccCccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLT 710 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~ 710 (843)
||+++|+|.+++... ..+++..+..++.|+++||+|||++ .++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999875 4689999999999999999999988 22399999999999997 57899999999998643
Q ss_pred ccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccC
Q 003156 711 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 790 (843)
Q Consensus 711 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 790 (843)
.. ......||+.|||||++. + .++.++|||||||++|||++|+.||........ +.. .+..+...
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~-~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~----~i~~~~~~---- 231 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYR----RVTSGVKP---- 231 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHH----HHTTTCCC----
T ss_pred CC----ccCCcccCccccCHHHhC-C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHH----HHHcCCCC----
Confidence 22 124567999999999883 3 589999999999999999999999975433221 111 11111110
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 791 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 791 ~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..++.....++.+++.+||+.||++|||++|++++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11233344568899999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=412.77 Aligned_cols=265 Identities=26% Similarity=0.418 Sum_probs=215.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
+.+.|+..+.||+|+||+||+|++.. +++.||||++.........++|.+|++++++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45567888899999999999999852 4678999998655444445679999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCC--------------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCC
Q 003156 627 KLLVSDYAPNGSLQAKLHERLP--------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLK 686 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 686 (843)
.++||||+++|+|.++++.... ....++|..++.|+.|+|.||+|||+. +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 9999999999999999976421 124589999999999999999999998 99999999
Q ss_pred CCCEEEcCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCC-CCcCC
Q 003156 687 PSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR-PVEYG 765 (843)
Q Consensus 687 ~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~-p~~~~ 765 (843)
|+|||+|.++.+||+|||+++.+.............|++.|+|||.+ ....++.++|||||||++|||++|.. ||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH-ccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999877655544444566788999999988 56679999999999999999999864 55433
Q ss_pred CCchhhHHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 766 EDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 766 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
.... ... .+..+.. ...+..++.++.+++.+||+.+|++||||.||+++|+++.+
T Consensus 247 -~~~e-~~~----~v~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 -AHEE-VIY----YVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -CHHH-HHH----HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -CHHH-HHH----HHHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2221 111 1222222 23355566789999999999999999999999999998853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=409.03 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=205.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||+||+|++..+|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 34778889999999999999998899999999986532 1234577999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999999875 4689999999999999999999998 999999999999999999999999999998765
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
...........||+.|+|||++ .+..++.++||||+||++|||+||+.||..... ..+. ... ..+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~---~~i-~~~~------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIF---QKI-IKLE------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHH-HTTC-------
T ss_pred CCcccccccccCCccccCceee-ccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHH---HHH-HcCC-------
Confidence 4444344556799999999998 555789999999999999999999999975321 1111 111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 827 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~ 827 (843)
..++.....++.+++.+||+.||++|||++|+++
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1234455667889999999999999999998744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=403.53 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=206.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||+||+|+++ +++.||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 45788889999999999999997 56789999986443 346789999999999999999999999854 567899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+++|+|..++.... ...++|.+++.++.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+++.+....
T Consensus 93 ~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999999987642 34599999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
. .......||+.|+|||++ ....++.++|||||||++|||+||..|+.........+ ..+ ..+..
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~-~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~-~~i----~~~~~-------- 232 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-DQV----ERGYR-------- 232 (285)
T ss_dssp ---------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHH----HTTCC--------
T ss_pred c-eeeccccccccccChHHH-hCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH-HHH----HhcCC--------
Confidence 2 222446789999999988 56678999999999999999999877776544332222 111 11111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCC
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 837 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~ 837 (843)
...+..++.++.+++.+||+.||++||||++|++.|+.......
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 12345566789999999999999999999999999988755543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-48 Score=408.91 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=207.9
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 551 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 551 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+++..|+..+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|++++++++|||||++++++.+++..+
T Consensus 12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 5777888899999999999999999889999999998654432 22356889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+|||||++|++..++... ..+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 92 iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccc
Confidence 999999999998776653 4689999999999999999999998 999999999999999999999999999986
Q ss_pred ccccccceeccccccccccCCcccccC--cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
.... ....||+.|||||++.. ...++.++|||||||++|||++|+.||...... . ........ ..
T Consensus 165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~----~~~~i~~~-~~- 231 (309)
T d1u5ra_ 165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-S----ALYHIAQN-ES- 231 (309)
T ss_dssp SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-H----HHHHHHHS-CC-
T ss_pred cCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-H----HHHHHHhC-CC-
Confidence 5431 34579999999998743 345899999999999999999999999643221 1 11111111 11
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
+.. .+...+.++.+++.+||+.||++|||++|++++
T Consensus 232 ----~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 ----PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ----CCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 123345678899999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-48 Score=408.55 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=193.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
..+.|+..+.||+|+||+||+|++..+|+.||||.+.........+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34567888899999999999999988999999999976554444567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc---CCCCcEEeeccCccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARL 708 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~ 708 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++. +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999864 4699999999999999999999998 999999999999995 578999999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... .....||+.|||||++ .+..++.++||||+||++|||++|+.||...... .. ...... +...
T Consensus 160 ~~~~~~---~~~~~GT~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~---~~~i~~-~~~~-- 227 (307)
T d1a06a_ 160 EDPGSV---LSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KL---FEQILK-AEYE-- 227 (307)
T ss_dssp ----------------CTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---HHHHHT-TCCC--
T ss_pred ccCCCe---eeeeeeCccccCcHHH-cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HH---HHHHhc-cCCC--
Confidence 654322 2456799999999998 5567899999999999999999999999653221 11 111111 1110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.+ .......+.++.+++.+||+.||++|||++|++++
T Consensus 228 ~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FD---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 11233455678899999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=408.79 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=205.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
+.|+..+.||+|+||+||+|.+..+|+ +||+|++......+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 346778899999999999999976665 68999886655556678899999999999999999999999875 4578
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
|+||+.+|+|.+++... ...+++..++.++.|||+||+|||++ +||||||||+||+++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988875 45789999999999999999999998 9999999999999999999999999999987
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
.............||+.|+|||++ .+..++.++|||||||++|||+| |+.||...... .+... +..+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~----i~~~~~--- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI----LEKGER--- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHH----HHHTCC---
T ss_pred ccccccccccccccCccccChHHH-hcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCC---
Confidence 654444444556789999999988 55679999999999999999999 78888654322 22222 222221
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...+..++.++.+++.+||+.||++||||.|++++|+.+.
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1235566778999999999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=403.22 Aligned_cols=264 Identities=25% Similarity=0.325 Sum_probs=204.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCC-
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ- 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~- 625 (843)
.+.|+..+.||+|+||.||+|.+.. +++.||||++.........+.+.+|..++.++ +|+||+.+++++.+++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3567788899999999999999743 35789999986554444456788888888887 6899999999987654
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 693 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~ 693 (843)
..++|||||++|+|.++++.... ....+++.++..++.|+|+||+|||++ +||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 57899999999999999986421 134589999999999999999999998 999999999999999
Q ss_pred CCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCC-CCCcCCCCchhhH
Q 003156 694 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR-RPVEYGEDNVVIL 772 (843)
Q Consensus 694 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~-~p~~~~~~~~~~l 772 (843)
+++.+||+|||+|+...............||+.|+|||++ .+..++.++|||||||++|||+||. .||....... .+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHh-hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 9999999999999877655554444567899999999988 5667999999999999999999975 5675443322 12
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
. ..+..+... ..+...+.++.+++.+||+.||++||||+|++++|+.+.
T Consensus 247 ~----~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 C----RRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp H----HHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHhcCCCC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2 222222221 234455667899999999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=398.20 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=209.1
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----cChHHHHHHHHHHHhccCCCccceeeEEEcCCe
Q 003156 552 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 626 (843)
Q Consensus 552 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 626 (843)
.+++|+..+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 346688888999999999999999889999999998654322 235789999999999999999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC----CcEEee
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY----NPRISD 702 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 702 (843)
.++|||||++|+|.+++... ..+++..+..++.|++.||+|||+. +||||||||+||+++.++ .+|++|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999999875 4699999999999999999999999 999999999999998776 499999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
||+++....... .....||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ...+ ... ..
T Consensus 161 fG~a~~~~~~~~---~~~~~~t~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~----~~i-~~ 230 (293)
T d1jksa_ 161 FGLAHKIDFGNE---FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETL----ANV-SA 230 (293)
T ss_dssp CTTCEECTTSCB---CSCCCCCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHH-HT
T ss_pred hhhhhhcCCCcc---ccccCCCCcccCHHHH-cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-HHHH----HHH-Hh
Confidence 999987654322 2456789999999998 556789999999999999999999999975322 1111 111 11
Q ss_pred CCcccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 783 GNVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 783 ~~~~~~~d~~l~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. .... ..+...+.++.+++.+||+.||++|||++|++++
T Consensus 231 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 231 VN------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TC------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1111 0123345578899999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=397.56 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=199.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
.+.|+..+.||+|+||.||+|++..+ +..||||.+.........+.|.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 34677888999999999999998643 45789998865444444567999999999999999999999986 456899
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|++.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999988764 35689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 788 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 788 (843)
...... ......||+.|+|||++ ....++.++|||||||++|||+| |..||...... .+... +..+..
T Consensus 159 ~~~~~~-~~~~~~gt~~y~apE~l-~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~----i~~~~~--- 227 (273)
T d1mp8a_ 159 EDSTYY-KASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGER--- 227 (273)
T ss_dssp -------------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCC---
T ss_pred cCCcce-eccceecCcccchhhHh-ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCC---
Confidence 543322 23456788999999998 56679999999999999999998 88888654332 11111 122221
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 789 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 789 ~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
...+..++.++.+++.+||+.||++|||+.||+++|+.+.
T Consensus 228 -----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1234556678999999999999999999999999998874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=403.33 Aligned_cols=271 Identities=21% Similarity=0.332 Sum_probs=220.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCee
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 627 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 627 (843)
.+.++..+.||+|+||+||+|.+.. +++.||||++......+....|.+|++++++++|||||+++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3566778899999999999999842 35789999997554444456789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhcC------CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEe
Q 003156 628 LLVSDYAPNGSLQAKLHERL------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 701 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 701 (843)
++||||+++|+|.+++.... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999987531 2234579999999999999999999998 99999999999999999999999
Q ss_pred eccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCC-CCCcCCCCchhhHHHHHHHHH
Q 003156 702 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR-RPVEYGEDNVVILSEHVRVLL 780 (843)
Q Consensus 702 Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~-~p~~~~~~~~~~l~~~~~~~~ 780 (843)
|||+++...............+|+.|+|||.+ .+..++.++|||||||++|||+||. .||... ... +.... +
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l-~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~----~~~~~-i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNE----QVLRF-V 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHH----HHHHH-H
T ss_pred ecccceeccCCcceeeccceecccccCCHHHH-ccCCCCcccccccHHHHHHHHHhCCCCCCCCC-CHH----HHHHH-H
Confidence 99999987665555555566789999999988 5667899999999999999999985 555432 221 22222 1
Q ss_pred hhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 003156 781 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRME 841 (843)
Q Consensus 781 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~~~~ 841 (843)
..+. ....+..++..+.++|.+||+.+|++||||+||+++|+...++..+...
T Consensus 249 ~~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 249 MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred HhCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence 2222 2223455667899999999999999999999999999998776654433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=393.78 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=197.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC-CeeEEEEEeC
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-QLKLLVSDYA 634 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~ 634 (843)
++..+.||+|+||.||+|++ .|++||||++.... ..+.|.+|++++++++||||++++|+|.++ +..++||||+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred eEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 55667899999999999999 48899999995433 457899999999999999999999999654 5679999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.+++.... ...++|..++.++.|||.||+|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 9999999997641 23589999999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCCC
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 793 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 793 (843)
....+|..|+|||++ .+..++.++|||||||++|||+| |+.||..... ..+...+ ..+. .
T Consensus 158 ----~~~~~~~~y~aPE~l-~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i----~~~~--------~ 218 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV----EKGY--------K 218 (262)
T ss_dssp --------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHH----TTTC--------C
T ss_pred ----ccccccccCCChHHH-hCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCC--------C
Confidence 334678899999988 45679999999999999999998 6777654322 2222222 2111 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 794 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 794 ~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
...+...+.++.+++.+||+.||++||||.|++++|+.++.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 23455566788999999999999999999999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=399.87 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=206.7
Q ss_pred cCeeccccceEEEEEEECCCC---eEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEc-CCeeEEEEEeC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKLLVSDYA 634 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~ 634 (843)
.++||+|+||+||+|++..++ ..||||++.........++|.+|++++++++|||||+++|++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 347999999999999986432 36899998654444445789999999999999999999999876 45789999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|+|.++++.. ...+++..++.++.|+|+||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999875 45678899999999999999999998 999999999999999999999999999987654332
Q ss_pred ce--eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 715 HV--MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 715 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
.. ......||..|+|||.+ ....++.++||||||+++|||+||+.||.......... .. +..+..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~-~~----i~~g~~------- 252 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-VY----LLQGRR------- 252 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH-HH----HHTTCC-------
T ss_pred ccceecccccccccccChHHH-hcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH-HH----HHcCCC-------
Confidence 21 22345789999999988 55679999999999999999999888886543222111 11 122221
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
...+..++.++.++|.+||+.||++||||.||+++|+.+....
T Consensus 253 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 253 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1234455678899999999999999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=400.33 Aligned_cols=260 Identities=28% Similarity=0.360 Sum_probs=206.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe--EEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCeeEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 630 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 630 (843)
+.++..+.||+|+||+||+|.++.+|. .||||++.........+.|.+|+++++++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 445667789999999999999987776 47888876554444567899999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhcC------------CCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCc
Q 003156 631 SDYAPNGSLQAKLHERL------------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 698 (843)
Q Consensus 631 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 698 (843)
|||+++|+|.++++... .....++|..++.++.|+|.||.|+|+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997642 2346799999999999999999999998 99999999999999999999
Q ss_pred EEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCC-CCcCCCCchhhHHHHHH
Q 003156 699 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR-PVEYGEDNVVILSEHVR 777 (843)
Q Consensus 699 kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~-p~~~~~~~~~~l~~~~~ 777 (843)
||+|||+++....... .....||..|+|||.+ ....++.++|||||||++|||++|.. ||... .. ..+...
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l-~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~-~~~~~~-- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TC-AELYEK-- 238 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CH-HHHHHH--
T ss_pred EEcccccccccccccc---ccceecCCcccchHHh-ccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CH-HHHHHH--
Confidence 9999999986543222 2345688999999988 56678999999999999999999765 45432 21 111111
Q ss_pred HHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccC
Q 003156 778 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 834 (843)
Q Consensus 778 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~ 834 (843)
+..+. ....+...+.++.+++.+||+.||++||||+||+++|+++..
T Consensus 239 --i~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 --LPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp --GGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHhcC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 123455667789999999999999999999999999988754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.3e-47 Score=405.23 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=207.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357778899999999999999988999999999865432 2356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc--CCCCcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~ 711 (843)
|++|+|.+++... ...+++..+..++.||+.||+|||++ +||||||||+|||++ .++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999754 34699999999999999999999999 999999999999996 467899999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... .....||+.|||||++ .+..++.++||||+||++|||+||+.||.... ....+ +........ .+
T Consensus 179 ~~~---~~~~~gT~~Y~aPEv~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~----~~i~~~~~~---~~- 245 (350)
T d1koaa2 179 KQS---VKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-DDETL----RNVKSCDWN---MD- 245 (350)
T ss_dssp TSC---EEEECSCTTTCCHHHH-HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHH----HHHHHTCCC---SC-
T ss_pred ccc---cceecCcccccCHHHH-cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-HHHHH----HHHHhCCCC---CC-
Confidence 332 2456789999999998 55678999999999999999999999996432 22111 111111110 00
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.........++.+++.+||+.||++|||++|++++
T Consensus 246 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123445678899999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=398.64 Aligned_cols=265 Identities=24% Similarity=0.310 Sum_probs=217.6
Q ss_pred hhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcCCe
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQL 626 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 626 (843)
.+.++..+.||+|+||.||+|++. .+++.||||++...........|.+|+.+++++ +|||||+++|+|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 456777889999999999999873 356789999997655444556799999999999 69999999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCC--------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 627 KLLVSDYAPNGSLQAKLHERLP--------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
.++||||+++|+|.++++.... ....+++..+..++.|||+||+|||++ +||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999987531 234689999999999999999999999 99999999999999
Q ss_pred cCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhH
Q 003156 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 772 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l 772 (843)
+.++.+|++|||+++...............||+.|+|||.+ ....++.++|||||||++|||+|++.|+.........+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHh-cCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987766555565677899999999988 56678999999999999999999655554443333223
Q ss_pred HHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 773 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 773 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
.+.+ ..+.. ...+...+..+.+||.+||+.||++||||+|++++|+++.
T Consensus 258 ~~~i----~~~~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 258 YKMI----KEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHH----HHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----hcCCC--------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 2222 22211 1123445567899999999999999999999999998753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-46 Score=403.26 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=208.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457788899999999999999988999999999865432 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc--CCCCcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgl~~~~~~ 711 (843)
+++|+|.+++... ...+++.++..|+.||+.||+|||+. +||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 108 ~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999887654 35699999999999999999999998 999999999999998 678999999999987764
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... .....||+.|+|||++ .+..++.++||||+||++|||+||+.||..... ... ...... +... ..
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~----~~~i~~-~~~~--~~- 248 (352)
T d1koba_ 182 DEI---VKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LET----LQNVKR-CDWE--FD- 248 (352)
T ss_dssp TSC---EEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHH----HHHHHH-CCCC--CC-
T ss_pred CCc---eeeccCcccccCHHHH-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHH----HHHHHh-CCCC--CC-
Confidence 332 2446789999999988 566799999999999999999999999964322 111 111111 1110 00
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.......+.++.+++.+||+.||++|||++|++++
T Consensus 249 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 --EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11233455678899999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=395.53 Aligned_cols=263 Identities=26% Similarity=0.354 Sum_probs=211.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC-------CeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEcC
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQ-------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP 624 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 624 (843)
.+.|+..+.||+|+||.||+|+.... +..||||++..........++.+|...+.++ +|||||+++|+|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 45677888999999999999997533 3479999997655444457788999999888 899999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCC------------CCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEE
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 692 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 692 (843)
+..++||||+++|+|.+++..+.. ....+++.+++.++.|+|.||+|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999987532 235689999999999999999999999 99999999999999
Q ss_pred cCCCCcEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhh
Q 003156 693 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 771 (843)
Q Consensus 693 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~ 771 (843)
+.++.+||+|||+++...............+++.|+|||.+ .+..++.++|||||||++|||++ |..||..... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l-~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh-cCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--HH
Confidence 99999999999999987665544444567789999999988 55689999999999999999998 6777754322 11
Q ss_pred HHHHHHHHHhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 772 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 772 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
+...+..+.. ...+...+.++.+++.+||+.||++||||.||++.|+++.
T Consensus 246 ----~~~~i~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 ----LFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ----HHHHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHcCCC--------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1122222221 1234455667999999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=392.81 Aligned_cols=250 Identities=24% Similarity=0.282 Sum_probs=209.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|+...+|+.||||++.+.. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 34677889999999999999999899999999996542 2234577899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999875 4688999999999999999999999 999999999999999999999999999986543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. .......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ..+ .+. +..+.
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~-~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~---~~~-i~~~~------- 221 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERL---FEL-ILMEE------- 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHH-HHHCC-------
T ss_pred CC--cccccceeCHHHhhhhhc-cCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHH---HHH-HhcCC-------
Confidence 22 223457899999999998 566789999999999999999999999975432 111 111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
..++.....++.+++.+|++.||++||+ ++|+++|
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1234455667889999999999999995 8888875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=390.00 Aligned_cols=258 Identities=28% Similarity=0.399 Sum_probs=197.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCc--ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 628 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 628 (843)
+.|+..+.||+|+||+||+|++..+ +..||||++..... .+..++|.+|+.++++++|||||+++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 3467778999999999999997432 24789999865432 22346899999999999999999999999764 568
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
+||||+++|++.+++... ...+++..++.++.|+|.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999988875 34699999999999999999999998 999999999999999999999999999998
Q ss_pred ccccccce-eccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHh-CCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 709 LTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 709 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
........ ......|+..|+|||.+ ....++.++|||||||++|||+| |+.||...... +........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-----~~~~~i~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHH-hCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----HHHHHHHhCCCC-
Confidence 75543332 23445678899999988 55678999999999999999998 89999643221 112222222211
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
...+...+..+.+++.+||+.||++||||.||++.|++.
T Consensus 234 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122445556789999999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=397.37 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=201.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHH--HHHHHHhccCCCccceeeEEEcCC----eeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEGYYWTPQ----LKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~g~~~~~~----~~~l 629 (843)
+...+.||+|+||.||+|++ +|+.||||++.... .+.+.+ |+..+.+++|||||+++|+|.+.+ ..++
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 34556899999999999998 68999999985432 234444 555556789999999999998654 5789
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhc-----CCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS-----FRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
||||+++|+|.++++.. .++|..++.++.|+|.||+|+|+. ..++||||||||+|||+++++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999864 589999999999999999999973 13499999999999999999999999999
Q ss_pred Ccccccccccce--eccccccccccCCcccccCcC-----CCCCchhHHHHHHHHHHHHhCCCCCcCCCCch--------
Q 003156 705 LARLLTRLDKHV--MSNRFQSALGYVAPELTCQSL-----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV-------- 769 (843)
Q Consensus 705 l~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~-------- 769 (843)
+++......... ......||+.|+|||++.... .++.++|||||||++|||+||..|+.......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 998775533221 234567999999999874321 25678999999999999999998875432111
Q ss_pred --hhHHHHHHHHHhhCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCC
Q 003156 770 --VILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 836 (843)
Q Consensus 770 --~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~ 836 (843)
.... ....... ....+|.++. ...+....+.+++.+||+.||++||||.||+++|+++....
T Consensus 234 ~~~~~~-~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVE-EMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHH-HHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchHH-HHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1111 1111111 1223333333 23345567899999999999999999999999999886543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-45 Score=381.55 Aligned_cols=254 Identities=27% Similarity=0.338 Sum_probs=207.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccc--------ChHHHHHHHHHHHhcc-CCCccceeeEEEcC
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--------YPEDFEREVRVLGKAR-HPNLISLEGYYWTP 624 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 624 (843)
+.|+..+.||+|+||+||+|+...+|+.||||++....... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 45677889999999999999998899999999997654322 1235889999999997 99999999999999
Q ss_pred CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeecc
Q 003156 625 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 704 (843)
Q Consensus 625 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 704 (843)
+..++||||+++|+|.++++.. ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999875 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccceeccccccccccCCcccccC-----cCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQ-----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 779 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 779 (843)
+++...+... .....||..|+|||.+.. ...++.++||||+||++|||+||+.||..... .. ..+..
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-~~----~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-ML----MLRMI 227 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH----HHHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-HH----HHHHH
Confidence 9987654322 245678999999998742 33578899999999999999999999975432 11 11111
Q ss_pred HhhCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 780 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 780 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
.. +... .. .......+.++.+++.+||+.||++|||++|++++
T Consensus 228 ~~-~~~~-~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MS-GNYQ-FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HH-TCCC-CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred Hh-CCCC-CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22 2111 00 01233455678999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-45 Score=389.70 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=206.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 632 (843)
.|+..+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 3667789999999999999998899999999986532 22346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 712 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~ 712 (843)
|+++|++..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 85 YIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred ecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999875 4578888999999999999999998 9999999999999999999999999999876532
Q ss_pred ccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCCC
Q 003156 713 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 792 (843)
Q Consensus 713 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 792 (843)
. ....||+.|||||++ .+..++.++||||+||++|||+||+.||..... . +....... +..
T Consensus 158 ~-----~~~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--~---~~~~~i~~-~~~------- 218 (316)
T d1fota_ 158 T-----YTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--M---KTYEKILN-AEL------- 218 (316)
T ss_dssp B-----CCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--H---HHHHHHHH-CCC-------
T ss_pred c-----ccccCcccccCHHHH-cCCCCCchhhccccchhHHHHHhCCCCCCCcCH--H---HHHHHHHc-CCC-------
Confidence 2 356799999999988 566789999999999999999999999975322 1 11111111 111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 793 MGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 793 l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
.++...+.++.+++.+|+..||.+|| |++|+++|
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 12344456788999999999999996 89999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-45 Score=396.78 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=203.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--ccChHHHHHH---HHHHHhccCCCccceeeEEEcCCeeEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFERE---VRVLGKARHPNLISLEGYYWTPQLKLL 629 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~~l 629 (843)
.|+..+.||+|+||.||+|++..+|+.||||++..... ......+.+| +.+++.++|||||++++++.+++..++
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 36677899999999999999998999999999864321 1223344444 666677789999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.+
T Consensus 85 vmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999875 4578999999999999999999999 9999999999999999999999999999876
Q ss_pred cccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCccccc
Q 003156 710 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 789 (843)
Q Consensus 710 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 789 (843)
.... .....||+.|+|||++..+..++.++||||+||++|||+||+.||........ ....+ ...
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~----~~~----- 222 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDR----MTL----- 222 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHH----HSS-----
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH----hcc-----
Confidence 5432 24567999999999986666789999999999999999999999976433221 11111 100
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 003156 790 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 828 (843)
Q Consensus 790 d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs-----~~evl~~ 828 (843)
......+.....++.+++.+||+.||++||| ++|++++
T Consensus 223 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 -TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111234455667899999999999999999 7888864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-45 Score=384.15 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=203.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--cChHHHHHHHHHHHhccCCCccceeeEEEcCC----ee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ----LK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~ 627 (843)
+.|+..+.||+|+||+||+|++..+|+.||||.+...... ...+.|.+|++++++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4577788999999999999999889999999999654322 22357899999999999999999999997654 37
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.++
T Consensus 87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 8999999999999999875 4689999999999999999999998 99999999999999999999999999987
Q ss_pred cccccc-cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc
Q 003156 708 LLTRLD-KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 786 (843)
Q Consensus 708 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 786 (843)
...... .........||+.|+|||++ .+..++.++||||+||++|||+||+.||..... . +........+...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~----~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-V----SVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-H----HHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHH-cCCCCCcceecccchHHHHHHHhCCCCCCCcCH-H----HHHHHHHhcCCCC
Confidence 654322 22223456799999999998 566789999999999999999999999964322 1 1122222222111
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhcc
Q 003156 787 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-SMAEVVQILQVIK 833 (843)
Q Consensus 787 ~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-s~~evl~~L~~~~ 833 (843)
. .......+.++.+++.+|++.||++|| |++++++.|.+++
T Consensus 234 ~------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 012234456788999999999999999 8999999998865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=387.91 Aligned_cols=263 Identities=23% Similarity=0.253 Sum_probs=201.2
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCccc----ChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEeC
Q 003156 559 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ----YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 634 (843)
Q Consensus 559 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 634 (843)
.+.||+|+||+||+|++..+|+.||||++....... ..+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 458999999999999998899999999986443221 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCccccccccc
Q 003156 635 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 714 (843)
Q Consensus 635 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~ 714 (843)
++|++...... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98877665543 35688999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC--Ccccc----
Q 003156 715 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--NVLDC---- 788 (843)
Q Consensus 715 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~~---- 788 (843)
......||+.|+|||++.....++.++||||+||++|||+||..||... .+...+....+...... .....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-SDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC-CHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2244578999999998866667899999999999999999999998643 22223322222211100 00000
Q ss_pred cC---CCCCCC-----ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHh
Q 003156 789 VD---PSMGDY-----PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQV 831 (843)
Q Consensus 789 ~d---~~l~~~-----~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~ 831 (843)
.. ...... ......++.+++.+|++.||++|||++|+++| ++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00 000111 12334578899999999999999999999986 544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=387.71 Aligned_cols=275 Identities=24% Similarity=0.301 Sum_probs=211.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|+..+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 46667899999999999999988999999999854432 23457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+.++ +.+++... ....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 83 LHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred cCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9754 55555443 235699999999999999999999998 99999999999999999999999999998765322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc-c----c-
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV-L----D- 787 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~-~----~- 787 (843)
.......||+.|+|||.......++.++||||+||++|||++|+.||.... ....+....+........ . .
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC-HHHHHHHHHHhcCCCchhhccccccc
Confidence 223456789999999987666667899999999999999999999997532 222222222211110000 0 0
Q ss_pred -ccCCCCCC--------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCCCCC
Q 003156 788 -CVDPSMGD--------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTPLPQ 838 (843)
Q Consensus 788 -~~d~~l~~--------~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~~~~ 838 (843)
........ .......++.+++.+|++.||++|||++|++++ ++.+.+|+|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p~ 295 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCCC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCCC
Confidence 00000000 011234568899999999999999999999998 8888888773
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-45 Score=392.13 Aligned_cols=247 Identities=22% Similarity=0.276 Sum_probs=207.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
+.|+..+.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 35777889999999999999998899999999986432 2234567899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999875 4689999999999999999999998 999999999999999999999999999987653
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
.. ....||+.|||||++ .+..++.++||||+||++|||+||+.||.... ... ...... .+..
T Consensus 194 ~~-----~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~---~~~~i~-~~~~------ 255 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQ---IYEKIV-SGKV------ 255 (350)
T ss_dssp CB-----CCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH---HHHHHH-HCCC------
T ss_pred cc-----ccccCccccCCHHHH-cCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHH---HHHHHh-cCCC------
Confidence 22 346799999999998 55678999999999999999999999996432 111 111111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..+.....++.+++.+|++.||++|+ |++|+++|
T Consensus 256 ---~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 12344556788999999999999994 99999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=387.25 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=203.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC--cccChHHHHHHHHHHH-hccCCCccceeeEEEcCCeeEEEE
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLG-KARHPNLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV~ 631 (843)
.|+..+.||+|+||+||+|++..+|+.||||++.... .....+.+..|..++. .++|||||++++++.+++..++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3666789999999999999999899999999996532 2234566777777765 679999999999999999999999
Q ss_pred EeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccc
Q 003156 632 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 711 (843)
Q Consensus 632 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~ 711 (843)
||+++|+|.++++.. ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred eecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999875 4588999999999999999999999 999999999999999999999999999986543
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... ......||+.|+|||++ .+..++.++||||+||++|||+||+.||..... ..+... +..+. +
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~----i~~~~------~ 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHS----IRMDN------P 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHCC------C
T ss_pred ccc--cccccCCCCCcCCHHHH-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHH----HHcCC------C
Confidence 222 22456799999999998 566789999999999999999999999975322 111111 11111 1
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 827 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~-evl~ 827 (843)
.++...+.++.+++.+||..||++|||+. |+++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 23444556788999999999999999995 7764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=386.75 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=204.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
+.|+..+.||+|+||+||+|.+..+|+.||||.+..... ....+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 446778899999999999999998999999999965432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC--CCCcEEeeccCcccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD--NYNPRISDFGLARLLTR 711 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~ 711 (843)
|++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999864 34689999999999999999999998 9999999999999984 45799999999987654
Q ss_pred cccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcccccCC
Q 003156 712 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 791 (843)
Q Consensus 712 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 791 (843)
... .....+|+.|+|||.. .+..++.++||||+||++|||++|+.||..... ... ........... +.
T Consensus 157 ~~~---~~~~~~t~~y~ape~~-~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-~~~----~~~i~~~~~~~---~~ 224 (321)
T d1tkia_ 157 GDN---FRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQI----IENIMNAEYTF---DE 224 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHH----HHHHHHTCCCC---CH
T ss_pred CCc---ccccccccccccchhc-cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-HHH----HHHHHhCCCCC---Ch
Confidence 332 2345788999999987 566789999999999999999999999975422 111 11111111100 00
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 792 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 792 ~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........++.+++.+|+..||++|||+.|++++
T Consensus 225 ---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 ---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111234568899999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=385.19 Aligned_cols=251 Identities=20% Similarity=0.276 Sum_probs=197.5
Q ss_pred hhhhc-CeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhc-cCCCccceeeEEEc----CCeeE
Q 003156 555 LLEKA-AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT----PQLKL 628 (843)
Q Consensus 555 ~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~ 628 (843)
.|++. +.||+|+||+||+|++..+++.||||++.. .+.+.+|+.++.++ +|||||++++++.+ ....+
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 35544 459999999999999988999999999853 25678899987665 89999999999865 35679
Q ss_pred EEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC---CCCcEEeeccC
Q 003156 629 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGL 705 (843)
Q Consensus 629 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfgl 705 (843)
+|||||++|+|.+++..+. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++ ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999998652 34699999999999999999999998 9999999999999985 56799999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
|+....... .....||+.|||||++ .+..++.++||||+||++|||+||+.||........ .. .+. .. .
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~-~~~---~~--i 229 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SP-GMK---TR--I 229 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------C--C
T ss_pred eeeccCCCc---cccccCCcccCCcHHH-cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HH-HHH---HH--H
Confidence 987654332 2456799999999988 666799999999999999999999999975432111 00 000 00 0
Q ss_pred ccccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 786 LDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~-~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. ......+. .......++.+++.+|++.||++|||+.|++++
T Consensus 230 ~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 R-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp C-SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred h-cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 00001111 112445678999999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=381.12 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=199.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----cChHHHHHHHHHHHhcc--CCCccceeeEEEcCCe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKAR--HPNLISLEGYYWTPQL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~ 626 (843)
+.|+..+.||+|+||+||+|++..+|+.||||++...... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4577788999999999999999989999999998654321 12234678999999996 8999999999999999
Q ss_pred eEEEEEeCCC-CCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-CCCcEEeecc
Q 003156 627 KLLVSDYAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFG 704 (843)
Q Consensus 627 ~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg 704 (843)
.++||||+.+ +++.+++... ..+++.++..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 6888888765 4689999999999999999999998 9999999999999985 5789999999
Q ss_pred CcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC
Q 003156 705 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 784 (843)
Q Consensus 705 l~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 784 (843)
+|+...... .....||+.|+|||++.....++.++||||+||++|||+||+.||.... . ... +.
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~----i~~-~~ 220 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E----IIR-GQ 220 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HHH-CC
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------H----Hhh-cc
Confidence 998654321 2456799999999988555455778999999999999999999996421 0 111 11
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 785 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 785 ~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
. .++...+.++.+++.+||+.||++|||++|++++
T Consensus 221 ~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 V---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 1233445678899999999999999999999886
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-43 Score=371.74 Aligned_cols=263 Identities=23% Similarity=0.281 Sum_probs=201.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|+..+.||+|+||+||+|++. +|+.||||++..... ....+.+.+|+.++++++|||||++++++..++..++|+||
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4667779999999999999996 789999999865432 23457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+.++.+..+.... ..+++..+..++.|+++||+|||+. +||||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9877666665543 5699999999999999999999998 99999999999999999999999999998765322
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhC--C-----cc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--N-----VL 786 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~-----~~ 786 (843)
. ......+++.|+|||.+.....++.++||||+||++|||++|+.||..... ...+....+...... . ..
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhh
Confidence 2 223446788999999986667789999999999999999999999965422 222222221110000 0 00
Q ss_pred cccCCCCC--------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 787 DCVDPSMG--------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 787 ~~~d~~l~--------~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...+.... .........+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 1223345678899999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=371.57 Aligned_cols=269 Identities=23% Similarity=0.289 Sum_probs=202.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC-CeEEEEEEeecCCcc-cChHHHHHHHHHHHhc---cCCCccceeeEEEc----
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQ-GRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWT---- 623 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~---- 623 (843)
.+.|++.+.||+|+||+||+|++..+ ++.||||++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46688888999999999999999644 678999998654322 2334567888887766 79999999999853
Q ss_pred -CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEee
Q 003156 624 -PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 702 (843)
Q Consensus 624 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 702 (843)
....+++|||+++|++....... ...+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 23578999999888766554443 45689999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhh
Q 003156 703 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 782 (843)
Q Consensus 703 fgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 782 (843)
||+++...... ......||+.|+|||++ .+..++.++||||+||++|||+||+.||.... ....+..........
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~-~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCC
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchh-cCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCC
Confidence 99998654322 22556899999999988 56679999999999999999999999997542 222232222211110
Q ss_pred CCc-------------ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhc
Q 003156 783 GNV-------------LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVI 832 (843)
Q Consensus 783 ~~~-------------~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~ 832 (843)
... ..........+.......+.+|+.+|++.||++|||++|++++ ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 000 0000000111233445678899999999999999999999886 4444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=373.98 Aligned_cols=271 Identities=21% Similarity=0.283 Sum_probs=203.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcCC----eeEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ----LKLL 629 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 629 (843)
..|+..+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.++++++||||+++++++..+. ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 457788899999999999999988999999999965544444567899999999999999999999997643 2355
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 709 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~ 709 (843)
+++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677799999999764 489999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccc-eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCcc--
Q 003156 710 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL-- 786 (843)
Q Consensus 710 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~-- 786 (843)
...... .......||+.|+|||++.....++.++||||+||++|||++|+.||..... .......... .......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-~~~~~~~~~~-~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-LDQLNHILGI-LGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHH-HCSCCHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-HHHHHHHhhh-ccCCChhhh
Confidence 543222 2234567899999999986777789999999999999999999999965422 1111111111 0000000
Q ss_pred -----------cccCCCCCC-----CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccC
Q 003156 787 -----------DCVDPSMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 834 (843)
Q Consensus 787 -----------~~~d~~l~~-----~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~ 834 (843)
....+.... .......++.+++.+|++.||++|||++|++++ ++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 000000001 011223468899999999999999999999987 554433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=362.71 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=209.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCCeeEEEEEe
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 633 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 633 (843)
.|+..+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.++++++||||+++++++.++...++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 466778999999999999999989999999999655432 2356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcccccccc
Q 003156 634 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 713 (843)
Q Consensus 634 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~ 713 (843)
+.++++..++... ..+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.++......
T Consensus 83 ~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 83 CDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999988887654 5678999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCC-----cccc
Q 003156 714 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN-----VLDC 788 (843)
Q Consensus 714 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~-----~~~~ 788 (843)
.. .....++..|+|||.+.....++.++||||+||++|||++|+.||.........+............ ....
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 22 2344567889999988666668999999999999999999999987655444333222211111000 0000
Q ss_pred ----------cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 789 ----------VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 789 ----------~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
...............+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011111334445678899999999999999999999886
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=372.37 Aligned_cols=267 Identities=23% Similarity=0.348 Sum_probs=200.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccceeeEEEcC------CeeEE
Q 003156 556 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QLKLL 629 (843)
Q Consensus 556 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 629 (843)
|+..++||+|+||+||+|++..+|+.||||++..... .+.+|++++++++||||+++++++... ...++
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5667789999999999999998999999999965432 234799999999999999999998643 24689
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARL 708 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~ 708 (843)
||||+++|.+ +.+.........+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999986644 44433222345799999999999999999999998 999999999999999765 899999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHH-------Hh
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------LE 781 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~-------~~ 781 (843)
+...... ....||..|+|||.+.....++.++||||+||++|||++|+.||..... ...+....+.. +.
T Consensus 173 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhh
Confidence 6543322 4457889999999876667899999999999999999999999965432 22222222110 00
Q ss_pred h--CCcccccCCCCC------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccCC
Q 003156 782 E--GNVLDCVDPSMG------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 835 (843)
Q Consensus 782 ~--~~~~~~~d~~l~------~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~~ 835 (843)
. .......-+... ........++.+|+.+|++.||++|||+.|++++ ++.+..+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 0 000000001110 0123345678899999999999999999999986 5665443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-42 Score=359.78 Aligned_cols=259 Identities=14% Similarity=0.154 Sum_probs=198.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCccce-eeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL-EGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||.||+|++..+|+.||||.+..... .+++..|+++++.++|++++.. .++..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 457788899999999999999988999999998865432 2457899999999987765555 455567778899999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEc---CCCCcEEeeccCcccc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLL 709 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgl~~~~ 709 (843)
|+ +|++.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+.+
T Consensus 84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 56677766653 35689999999999999999999998 999999999999986 4567999999999987
Q ss_pred cccccc-----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhH--HHHHHHHHhh
Q 003156 710 TRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL--SEHVRVLLEE 782 (843)
Q Consensus 710 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l--~~~~~~~~~~ 782 (843)
...... .......||+.|||||.+ .+..++.++|||||||++|||+||+.||.......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHH-TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-
T ss_pred cccccccceeccccCCcCCCccccCHHHH-hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-
Confidence 543321 122456799999999988 55678999999999999999999999997643322111 111111111
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhc
Q 003156 783 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 832 (843)
Q Consensus 783 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~ 832 (843)
... .......+.++.+++..||+.+|++||+++++.+.|+.+
T Consensus 235 ~~~--------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 235 TPI--------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp SCH--------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CCh--------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 001223446788999999999999999999998888765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=361.03 Aligned_cols=277 Identities=22% Similarity=0.259 Sum_probs=203.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-ccChHHHHHHHHHHHhccCCCccceeeEEEcC-------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------- 624 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 624 (843)
-+.|+..+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4667888899999999999999988999999999855433 33457789999999999999999999998653
Q ss_pred -CeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeec
Q 003156 625 -QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 703 (843)
Q Consensus 625 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 703 (843)
+..++||||++++++...... ...++...+..++.|++.||.|||+. +|+||||||+|||++.++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 357899999988766554443 35688899999999999999999998 9999999999999999999999999
Q ss_pred cCcccccccccc--eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHh
Q 003156 704 GLARLLTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 781 (843)
Q Consensus 704 gl~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 781 (843)
|+++.+...... .......||+.|+|||++.....++.++||||+||++|||++|+.||.... ....+.... ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~i~-~~~~ 239 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALIS-QLCG 239 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHH-HHHC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-HHHHHHHHH-HhcC
Confidence 999876543221 122345689999999998666678999999999999999999999996432 222222211 1111
Q ss_pred hC--CcccccCCC-C-------CCCC--h-------hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhccCCCCC
Q 003156 782 EG--NVLDCVDPS-M-------GDYP--E-------DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 838 (843)
Q Consensus 782 ~~--~~~~~~d~~-l-------~~~~--~-------~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~~~~~~ 838 (843)
.. ......+.. . .... . .....+.+|+.+|++.||++|||++|++++=.--..+.|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 10 000000000 0 0000 0 1123467899999999999999999999884322344444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-41 Score=354.21 Aligned_cols=261 Identities=12% Similarity=0.115 Sum_probs=206.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC-CCccceeeEEEcCCeeEEEEE
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e 632 (843)
+.|+..+.||+|+||+||+|++..+|+.||||.+..... ...+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 456778899999999999999988999999998855432 3457789999999965 899999999999999999999
Q ss_pred eCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcC-----CCCcEEeeccCcc
Q 003156 633 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-----NYNPRISDFGLAR 707 (843)
Q Consensus 633 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgl~~ 707 (843)
|+ +|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 78999998775 34689999999999999999999998 9999999999999974 5789999999998
Q ss_pred cccccccc-----eeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCch-hhHHHHHHHHHh
Q 003156 708 LLTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV-VILSEHVRVLLE 781 (843)
Q Consensus 708 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~-~~l~~~~~~~~~ 781 (843)
.+...... .......||+.|||||.+ .+..++.++|||||||++|||+||+.||....... ......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHh-cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 76543211 122456799999999988 56679999999999999999999999997543321 111111111111
Q ss_pred hCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhcc
Q 003156 782 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 833 (843)
Q Consensus 782 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~L~~~~ 833 (843)
..... +.....+.++.+++..||..+|++||+++.+.+.|+.+.
T Consensus 234 ~~~~~--------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 234 STPLR--------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HSCHH--------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCChH--------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11110 112234457889999999999999999999988887653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=368.76 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=200.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcCC------
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 625 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 625 (843)
.+.|+..+.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45678888999999999999999889999999998644322 23457889999999999999999999997654
Q ss_pred eeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccC
Q 003156 626 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 705 (843)
Q Consensus 626 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl 705 (843)
..++||||+ +++|..+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 468999999 5677777765 3599999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHH-----
Q 003156 706 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL----- 780 (843)
Q Consensus 706 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~----- 780 (843)
|+...... ....||+.|+|||++.....++.++||||+||++|||++|+.||..... ...+........
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHH
Confidence 98654321 4467899999999886666789999999999999999999999965422 222221111100
Q ss_pred --hhC----------CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccC
Q 003156 781 --EEG----------NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 834 (843)
Q Consensus 781 --~~~----------~~~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~ 834 (843)
... .........+..........+.+|+.+|+..||++|||++|++++ ++.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 000 000000111111223344567899999999999999999999997 666543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=363.00 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=204.6
Q ss_pred hhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCC---cccChHHHHHHHHHHHhccC-CCccceeeEEEcCCe
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSD---IIQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~ 626 (843)
+.|+..+.||+|+||+||+|... .+|+.||||.+.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 45778889999999999999873 368999999985432 12345678899999999977 899999999999999
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+.+|+|.+++... ..+....+..++.|++.||+|+|+. +||||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999876 3567888899999999999999998 9999999999999999999999999999
Q ss_pred ccccccccceeccccccccccCCcccccCc-CCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 785 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 785 (843)
+.+...... ......|++.|+|||.+... ..++.++||||+||++|||+||+.||....... ......+......
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE-- 252 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCC--
T ss_pred hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcccCC--
Confidence 876543322 22456789999999988543 347889999999999999999999997653322 2222222222111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 003156 786 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 828 (843)
Q Consensus 786 ~~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RP-----s~~evl~~ 828 (843)
..++.....++.+++.+||+.||++|| |++|+++|
T Consensus 253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 123445667889999999999999999 58999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-41 Score=362.53 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=202.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcC--CeeEE
Q 003156 553 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTP--QLKLL 629 (843)
Q Consensus 553 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~l 629 (843)
.+.|+..+.||+|+||+||+|++..+|+.||||++... ..+.+.+|++++++++ ||||+++++++... ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 35688888999999999999999889999999998543 3567899999999995 99999999999754 45889
Q ss_pred EEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCC-CcEEeeccCccc
Q 003156 630 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARL 708 (843)
Q Consensus 630 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgl~~~ 708 (843)
||||+++|+|..+. ..+++..+..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+|+.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 99999999986653 2489999999999999999999999 999999999999999655 599999999987
Q ss_pred ccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH--------HH
Q 003156 709 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV--------LL 780 (843)
Q Consensus 709 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~--------~~ 780 (843)
...... .....+|..|+|||.+.....++.++||||+||++|||++|+.||................ ..
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred ccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 654332 2455788999999998666678999999999999999999999998765443322221111 00
Q ss_pred hhCCc------ccccCCCC--------C-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 781 EEGNV------LDCVDPSM--------G-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 781 ~~~~~------~~~~d~~l--------~-~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
..... ........ . ........++.+|+.+|++.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00000000 0 0112344578899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=356.17 Aligned_cols=260 Identities=23% Similarity=0.262 Sum_probs=189.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcC------Ce
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 626 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 626 (843)
+.|+..+.||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 4577888999999999999999989999999999754332 2335688999999999999999999999643 57
Q ss_pred eEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCc
Q 003156 627 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 706 (843)
Q Consensus 627 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~ 706 (843)
.++||||+.++ +.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 79999999765 4444443 378999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHH--------
Q 003156 707 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV-------- 778 (843)
Q Consensus 707 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~-------- 778 (843)
+...... ......+|..|+|||++ .+..++.++||||+||++|||++|+.||.... ....+....+.
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l-~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -----------------CCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHH
T ss_pred hcccccc---ccccccccccccChhhh-cCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHH
Confidence 8654322 22455788999999998 55678999999999999999999999996432 22222111111
Q ss_pred ----------HHhhCCcc----------cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 003156 779 ----------LLEEGNVL----------DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 828 (843)
Q Consensus 779 ----------~~~~~~~~----------~~~d~~l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~ 828 (843)
........ ....+...........++.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11111000 000000000122345678899999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=357.17 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=200.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-cChHHHHHHHHHHHhccCCCccceeeEEEcC-----Cee
Q 003156 554 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QLK 627 (843)
Q Consensus 554 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 627 (843)
+.|+..+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|++++++++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 4578888999999999999999889999999998654322 2335688999999999999999999998643 344
Q ss_pred EEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 628 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 628 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
++|++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 98 ~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 6778888899999999653 589999999999999999999999 99999999999999999999999999997
Q ss_pred cccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCchhhHHHHHHHHHhhCCc--
Q 003156 708 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV-- 785 (843)
Q Consensus 708 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 785 (843)
..... .....|+..|+|||.......++.++||||+||++|||++|+.||..... ........+. ......
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-~~~~~~i~~~-~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRL-VGTPGAEL 242 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHH-HCCCCHHH
T ss_pred ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHHh-cCCCChHH
Confidence 65432 24457889999999876666789999999999999999999999965322 1111111111 000000
Q ss_pred ------------ccccCCCCCC-----CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhccC
Q 003156 786 ------------LDCVDPSMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 834 (843)
Q Consensus 786 ------------~~~~d~~l~~-----~~~~~~~~l~~l~~~c~~~~P~~RPs~~evl~~--L~~~~~ 834 (843)
.... +.... .......++.+|+.+|++.||++|||++|++++ +++...
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 243 LKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HTTCCCHHHHHHHTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhccchhhhhhhhhc-ccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0000 00000 112334567899999999999999999999986 555443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-35 Score=320.09 Aligned_cols=263 Identities=20% Similarity=0.227 Sum_probs=190.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-----------CCCccceeeEEEc
Q 003156 555 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----------HPNLISLEGYYWT 623 (843)
Q Consensus 555 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 623 (843)
+|+..++||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4788889999999999999998899999999986432 22456788999988875 5789999998864
Q ss_pred --CCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCC----
Q 003156 624 --PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---- 697 (843)
Q Consensus 624 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---- 697 (843)
....++|++++..+......... .....+++..+..++.|+++||+|||+.. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccc
Confidence 35567777777665443333322 13456888999999999999999999832 8999999999999986553
Q ss_pred --cEEeeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHHHHHHhCCCCCcCCCCc-----hh
Q 003156 698 --PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-----VV 770 (843)
Q Consensus 698 --~kl~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil~elltg~~p~~~~~~~-----~~ 770 (843)
++++|||.++..... .....||+.|+|||++ ....++.++||||+||+++||++|+.||...... ..
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHH-HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhc-cccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999754422 2456789999999988 4557899999999999999999999999754221 11
Q ss_pred hHHHHHHHH-------HhhCC-cccccC-----CC---------------CCCCChhhHHHHHHHHHHccCCCCCCCCCH
Q 003156 771 ILSEHVRVL-------LEEGN-VLDCVD-----PS---------------MGDYPEDEVLPVLKLALVCTCHIPSSRPSM 822 (843)
Q Consensus 771 ~l~~~~~~~-------~~~~~-~~~~~d-----~~---------------l~~~~~~~~~~l~~l~~~c~~~~P~~RPs~ 822 (843)
.+...+... ..... .....+ .. ..........++.+++.+|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 122111110 00000 000000 00 111345667789999999999999999999
Q ss_pred HHHHHH
Q 003156 823 AEVVQI 828 (843)
Q Consensus 823 ~evl~~ 828 (843)
+|++++
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=1.8e-32 Score=290.98 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=198.0
Q ss_pred CCcEEEeecCcccc--cCCCCccCCCCccEEEccc-CCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceee
Q 003156 152 SMIFISVSNNTLTG--DIPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEID 228 (843)
Q Consensus 152 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~ 228 (843)
+++.|+|++|.+.+ .+|..++++++|++|+|++ |++++.+|..|+++++|++|+|++|.+.+..+..+.
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~-------- 122 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS-------- 122 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG--------
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccccccccc--------
Confidence 34455555555544 3455666666666666654 566656666666666666666666666544333222
Q ss_pred ccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccc-eEEEc
Q 003156 229 LSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL-IHLDL 307 (843)
Q Consensus 229 l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L 307 (843)
.+..|+.+++++|.+.+.+|..++.++.|+.+++++|.+.+.+|..+..+..+ +.+++
T Consensus 123 ---------------------~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~ 181 (313)
T d1ogqa_ 123 ---------------------QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181 (313)
T ss_dssp ---------------------GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred ---------------------chhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccc
Confidence 23456666666666666677777777777777777777777777777666654 77888
Q ss_pred cCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccccc
Q 003156 308 RNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 387 (843)
Q Consensus 308 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 387 (843)
++|++++..|..+..+..+ .+++++|...+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+|+|.
T Consensus 182 ~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~ 259 (313)
T d1ogqa_ 182 SRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp CSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEEC
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeeccc
Confidence 8888888888888777554 79999999999999999999999999999999997655 688999999999999999999
Q ss_pred CCcchhcccccceEeeccccceecCCCCCCCCCCCCCCcCCCCCCCCCCCCCCC
Q 003156 388 IPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 441 (843)
Q Consensus 388 ~p~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c 441 (843)
+|..|+++++|+.|+|++|+|+|.+|..+.+.++...++.||+.+||.|++ +|
T Consensus 260 iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 999999999999999999999999998888899999999999999998874 66
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=9.4e-30 Score=278.26 Aligned_cols=356 Identities=22% Similarity=0.250 Sum_probs=257.1
Q ss_pred ecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecC
Q 003156 8 DLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 87 (843)
Q Consensus 8 ~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~ 87 (843)
.+..+++++.++. ..+.+|++|++++|+|+.+.. +.++++|++|+|++|+|++.+ .+..+++|++|+++
T Consensus 28 ~l~~~~~~~~~~~---~~l~~l~~L~l~~~~I~~l~g--l~~L~nL~~L~Ls~N~l~~l~------~l~~L~~L~~L~L~ 96 (384)
T d2omza2 28 VLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDIT------PLKNLTKLVDILMN 96 (384)
T ss_dssp HTTCSSTTSEECH---HHHTTCCEEECCSSCCCCCTT--GGGCTTCCEEECCSSCCCCCG------GGTTCTTCCEEECC
T ss_pred HhCCCCCCCccCH---HHhCCCCEEECCCCCCCCccc--cccCCCCCEEeCcCCcCCCCc------cccCCccccccccc
Confidence 4566666655553 346678888888888877643 677888888888888877543 26678888888888
Q ss_pred CccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccC
Q 003156 88 HNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDI 167 (843)
Q Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 167 (843)
+|++.+.. .+..+++|+.|++++|.+++..+ ......+..+....|.+....+..................
T Consensus 97 ~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~----- 167 (384)
T d2omza2 97 NNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD----- 167 (384)
T ss_dssp SSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----
T ss_pred cccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----
Confidence 88887433 37788888888888888775433 3445667777777777664333322222222222222211
Q ss_pred CCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCc
Q 003156 168 PHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSS 247 (843)
Q Consensus 168 p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~ 247 (843)
...+...+.........|... ....+..+++++.+++++|.+++..| .....+|+.|++++|++... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~--------~~ 236 (384)
T d2omza2 168 LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--------GT 236 (384)
T ss_dssp CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--------GG
T ss_pred hhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCCc--------ch
Confidence 123444555666666666554 34566778888888888888875443 23334688888888887631 12
Q ss_pred ccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCc
Q 003156 248 STLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLG 327 (843)
Q Consensus 248 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 327 (843)
...+++|+.|++++|++++.. .+..+++|++|++++|++++.. .+..+..++.+++++|++++ ...+..+++++
T Consensus 237 l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~ 310 (384)
T d2omza2 237 LASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLT 310 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCS
T ss_pred hhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccC
Confidence 355788999999999998544 3778899999999999998653 47788899999999999985 34588899999
Q ss_pred EEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccc
Q 003156 328 ILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 406 (843)
Q Consensus 328 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N 406 (843)
.|++++|++++.. .+..+++|+.|++++|+|++ ++ .++++++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 311 ~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 311 YLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp EEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred eEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 9999999999654 38899999999999999984 44 58999999999999999997654 889999999999988
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=7.2e-31 Score=278.44 Aligned_cols=252 Identities=28% Similarity=0.473 Sum_probs=184.3
Q ss_pred CCcEEEccCCcccc--cCCchhhcccCCcEEEeec-CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEE
Q 003156 128 HLTTLDLSNNLFTG--QLPVSLRLLNSMIFISVSN-NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 204 (843)
Q Consensus 128 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 204 (843)
+++.|||++|.+++ .+|..++.+++|++|+|++ |++.|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 45566666666654 3456666666666666664 56666666666666666666666666666666666666666666
Q ss_pred EecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCC-cEEEc
Q 003156 205 RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL-RYLNL 283 (843)
Q Consensus 205 ~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~L 283 (843)
++++|.+.+.+|..+.. ++.|+.+++++|.+.+.+|..+..+..+ +.+++
T Consensus 131 ~l~~N~~~~~~p~~l~~-----------------------------l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~ 181 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISS-----------------------------LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181 (313)
T ss_dssp ECCSSEEESCCCGGGGG-----------------------------CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred ccccccccccCchhhcc-----------------------------Ccccceeecccccccccccccccccccccccccc
Confidence 66666666555544432 3456666666666666666666666554 66777
Q ss_pred CCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccccccc
Q 003156 284 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS 363 (843)
Q Consensus 284 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 363 (843)
++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++|+.|++++|.+.+.+| .++.+++|+.|+|++|+|+|.
T Consensus 182 ~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~ 259 (313)
T d1ogqa_ 182 SRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp CSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEEC
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeeccc
Confidence 7777776666666655444 68888888888888888888999999999999886654 588889999999999999999
Q ss_pred CCccccCCCCCCEEEccCCcccccCCcchhcccccceEeecccc-ceec
Q 003156 364 IPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR-LIGR 411 (843)
Q Consensus 364 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~-l~~~ 411 (843)
+|..|++|++|++|+|++|+|+|.+|. +++|++|+.+++++|+ ++|.
T Consensus 260 iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred CChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 999999999999999999999999885 6889999999999998 5554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.6e-28 Score=268.30 Aligned_cols=341 Identities=21% Similarity=0.233 Sum_probs=255.4
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
|.+|++|++++|+|+ .+. .++.+++|++|+|++|+|+++++ |+++++|++|++++|+|.+.. .+..+++
T Consensus 43 l~~l~~L~l~~~~I~-~l~--gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~------~l~~l~~ 111 (384)
T d2omza2 43 LDQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT------PLANLTN 111 (384)
T ss_dssp HTTCCEEECCSSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG------GGTTCTT
T ss_pred hCCCCEEECCCCCCC-Ccc--ccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc------ccccccc
Confidence 357999999999999 665 36889999999999999999875 999999999999999998643 3678999
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
|+.|++++|.+++..+ ......+..+....|.+....+.................. ...+.............
T Consensus 112 L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 184 (384)
T d2omza2 112 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISS 184 (384)
T ss_dssp CCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCS
T ss_pred cccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhhhccccccccccccc
Confidence 9999999999985433 4566788888888888764443333323333322222222 22344444555555555
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhc-cCcceeeccCCcceecCC
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGFMGSIP 239 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~L~l~~n~l~~~~p 239 (843)
|... ....+..+++++.+++++|.+++..| +..+++|+.|++++|.++. ++ .+.. .+++.|++++|.+.+..+
T Consensus 185 ~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~ 258 (384)
T d2omza2 185 NKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP 258 (384)
T ss_dssp SCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG
T ss_pred cccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCc
Confidence 5443 33446667777777777777775433 4556777777777777763 33 2333 367777777777764322
Q ss_pred CCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCcc
Q 003156 240 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQE 319 (843)
Q Consensus 240 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 319 (843)
...+++|+.|++++|++++.. .+..++.++.+++++|.+.+. ..+..+++++.|++++|++++.. .
T Consensus 259 --------~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~ 324 (384)
T d2omza2 259 --------LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--P 324 (384)
T ss_dssp --------GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--G
T ss_pred --------ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--c
Confidence 234678999999999998543 367889999999999999763 45888899999999999999653 4
Q ss_pred ccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCc
Q 003156 320 VCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNE 383 (843)
Q Consensus 320 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 383 (843)
+..+++|+.|++++|+|++ ++ .|.++++|++|+|++|+|++..| +.++++|++|+|++|.
T Consensus 325 l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 325 VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence 8899999999999999984 44 69999999999999999996554 8999999999999983
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=5.9e-26 Score=239.33 Aligned_cols=106 Identities=28% Similarity=0.256 Sum_probs=50.7
Q ss_pred CCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCE
Q 003156 28 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKE 107 (843)
Q Consensus 28 ~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 107 (843)
.++.++.++++++.+|...+ ++|++|+|++|+|+.+++ ..|.++++|++|++++|.+....|..|..+++|++
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~---~~l~~L~Ls~N~i~~l~~----~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~ 83 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEIKD----GDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 83 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC---TTCCEEECCSSCCCCBCT----TTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred cCCEEEecCCCCCccCCCCC---CCCCEEECcCCcCCCcCh----hHhhccccccccccccccccccchhhhhCCCccCE
Confidence 34555555555555554332 345555555555553322 23445555555555555555444445555555555
Q ss_pred EEcCCCcccccCCCCCCCCCCCcEEEccCCcccccC
Q 003156 108 LLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 143 (843)
Q Consensus 108 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 143 (843)
|++++|+++. +|..+ ...++.|++++|.+....
T Consensus 84 L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~ 116 (305)
T d1xkua_ 84 LYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVR 116 (305)
T ss_dssp EECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBC
T ss_pred ecccCCccCc-Cccch--hhhhhhhhccccchhhhh
Confidence 5555555542 22211 234444555555444333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=9.1e-26 Score=237.87 Aligned_cols=124 Identities=24% Similarity=0.245 Sum_probs=58.2
Q ss_pred cCCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEee
Q 003156 80 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 159 (843)
Q Consensus 80 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 159 (843)
.++.+|-++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....|..|..+++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3445555555555 2333331 345555555555554444445555555555555555554444445555555555555
Q ss_pred cCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCC
Q 003156 160 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 209 (843)
Q Consensus 160 ~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 209 (843)
+|+++ .+|..+ ...++.|++.+|.+....+..+.....+..++...|
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n 134 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSS
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccc
Confidence 55444 222221 234455555555554433333334444444444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.3e-26 Score=237.55 Aligned_cols=255 Identities=20% Similarity=0.199 Sum_probs=211.2
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
..++.++++++ ++|..++ +++++|+|++|+|+.+++..|.++++|++|++++|++..... ..+..+..++.+
T Consensus 14 ~~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~----~~~~~~~~~~~l 85 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA----AAFTGLALLEQL 85 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECT----TTTTTCTTCCEE
T ss_pred eEEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccc----cccccccccccc
Confidence 45788889998 8887653 578999999999999999999999999999999999886543 356677888888
Q ss_pred ecC-CccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcc
Q 003156 85 DLS-HNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 163 (843)
Q Consensus 85 ~L~-~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 163 (843)
+.. .|.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+++++.+..|+.+++|+.|++++|++
T Consensus 86 ~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l 165 (284)
T d1ozna_ 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (284)
T ss_dssp ECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcc
Confidence 765 5677777788899999999999999999877788888899999999999999988888899999999999999999
Q ss_pred cccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccCCcceecCCCCC
Q 003156 164 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGS 242 (843)
Q Consensus 164 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~n~l~~~~p~~~ 242 (843)
+...+.+|.++++|+.+++++|++++..|..|.++++|++|++++|.+.+..+..+... +|+.|++++|.+.+.-+.
T Consensus 166 ~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-- 243 (284)
T d1ozna_ 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-- 243 (284)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG--
T ss_pred cccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc--
Confidence 98888899999999999999999998889999999999999999999986666666555 699999999998753211
Q ss_pred CCCCcccccCccCEEeCCCCccceeCCccccC
Q 003156 243 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 274 (843)
Q Consensus 243 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 274 (843)
......++.+....+++....|..+.+
T Consensus 244 -----~~l~~~l~~~~~~~~~~~C~~p~~l~g 270 (284)
T d1ozna_ 244 -----RPLWAWLQKFRGSSSEVPCSLPQRLAG 270 (284)
T ss_dssp -----HHHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred -----hHHHHHHHhCcCCCCceEeCCchHHcC
Confidence 011234566666777777777777654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.5e-25 Score=233.31 Aligned_cols=250 Identities=21% Similarity=0.175 Sum_probs=140.5
Q ss_pred CCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcc-cCCcCCCCCCCCCCCCCCcEEEe
Q 003156 128 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS-NNHLTGSLPSSLFNCKKLSVIRL 206 (843)
Q Consensus 128 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~i~~~~~~~~~~l~~L~~L~L 206 (843)
++++|+|++|+|+.+.+.+|.++++|++|++++|++....+..+.++..++.++.. .|.++...+..|.++++|+.|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 34445555555544444444445555555555555544445555555555555443 34455444555666666666666
Q ss_pred cCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCC
Q 003156 207 RGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 286 (843)
Q Consensus 207 ~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 286 (843)
++|.+....+..+ ...++|+.+++++|++++..+..|..+++|+.|++++|
T Consensus 113 ~~n~~~~~~~~~~-----------------------------~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N 163 (284)
T d1ozna_ 113 DRCGLQELGPGLF-----------------------------RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (284)
T ss_dssp TTSCCCCCCTTTT-----------------------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCccccccccccc-----------------------------chhcccchhhhccccccccChhHhccccchhhcccccC
Confidence 6655542111111 11345556666666665555555666666666777776
Q ss_pred cccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCc
Q 003156 287 HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK 366 (843)
Q Consensus 287 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 366 (843)
.++++.+..|.++++|+++++++|++++..|..|..+++|++|++++|.+.+..+..|+++++|+.|+|++|.+...-+.
T Consensus 164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred cccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 66666666666667777777777777666666777777777777777777766666777777777777777776643221
Q ss_pred cccCCCCCCEEEccCCcccccCCcchhcccccceEeecccccee
Q 003156 367 SISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 410 (843)
Q Consensus 367 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 410 (843)
. .-...++.+....++++...|..+.+ +...+++.+.|+|
T Consensus 244 ~-~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 244 R-PLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp H-HHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred h-HHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 1 11122344455556666555655543 3344455555554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.8e-24 Score=221.07 Aligned_cols=201 Identities=24% Similarity=0.198 Sum_probs=182.5
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
..+..+|.++++++ ++|..+. ++|++|+|++|.|+++++..|.++++|++|+|++|+|+..+. +..+++|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~------~~~l~~L 79 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV------DGTLPVL 79 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC------CSCCTTC
T ss_pred CCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc------ccccccc
Confidence 34667899999999 8997642 589999999999999999999999999999999999986532 4578999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
++|+|++|+++ ..+..+..+++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|
T Consensus 80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccc
Confidence 99999999998 46778999999999999999999888888999999999999999999888889999999999999999
Q ss_pred cccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCC
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 214 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (843)
++++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++...
T Consensus 159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 999888889999999999999999999 7888899999999999999998753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=7.4e-23 Score=210.34 Aligned_cols=197 Identities=25% Similarity=0.243 Sum_probs=118.5
Q ss_pred CcEEEeecCcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCC
Q 003156 153 MIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSEN 232 (843)
Q Consensus 153 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n 232 (843)
+.+.+.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.|+ .+|.
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--------------- 72 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--------------- 72 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC---------------
T ss_pred CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc---------------
Confidence 333444444444 2333332 34555666666555444455555556666666555554 1110
Q ss_pred cceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcc
Q 003156 233 GFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 312 (843)
Q Consensus 233 ~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l 312 (843)
...+++|++|+|++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.++++|++++|.+
T Consensus 73 ---------------~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l 136 (266)
T d1p9ag_ 73 ---------------DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (266)
T ss_dssp ---------------CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred ---------------cccccccccccccccccc-ccccccccccccccccccccccceeecccccccccccccccccccc
Confidence 012455666666666665 3455566666777777777776666666666666777777777776
Q ss_pred cccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCccc
Q 003156 313 YGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 313 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
++..+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 137 ~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 6555555666667777777777776666666666777777777777776 56666666677777777777654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.88 E-value=1.1e-20 Score=202.91 Aligned_cols=179 Identities=27% Similarity=0.278 Sum_probs=95.0
Q ss_pred CccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 3 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 3 ~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
++++|||++|+++ ++|+ .+++|++|+|++|+|+.++.. +.+|++|++++|+++..... .+.|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~l~~l--------p~~L~ 101 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE----LPPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKALSDL--------PPLLE 101 (353)
T ss_dssp TCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSCCCSC--------CTTCC
T ss_pred CCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccchhhhh--------ccccc
Confidence 4667777777776 5663 245667777777777665532 34667777777666643220 13466
Q ss_pred EEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCc
Q 003156 83 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 162 (843)
Q Consensus 83 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 162 (843)
+|++++|.+.. +|. +..+++|++|++++|.+... +. ....+..+.+..+... ....+..++.++.|.+..|.
T Consensus 102 ~L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 102 YLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp EEECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSC
T ss_pred ccccccccccc-ccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceeccccccc
Confidence 66666666653 332 45566666666666666522 21 2344555555555443 23344555556666666665
Q ss_pred ccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCC
Q 003156 163 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 212 (843)
Q Consensus 163 l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 212 (843)
+.. .+.. ....+.+...++.+. ..+ .+..++.|+.+++++|...
T Consensus 174 ~~~-~~~~---~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~ 217 (353)
T d1jl5a_ 174 LKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 217 (353)
T ss_dssp CSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred ccc-cccc---ccccccccccccccc-ccc-ccccccccccccccccccc
Confidence 542 2211 122344444444443 222 2445555666665555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=1.7e-19 Score=193.34 Aligned_cols=300 Identities=26% Similarity=0.278 Sum_probs=161.4
Q ss_pred CCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCC
Q 003156 27 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK 106 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 106 (843)
.++++|+|++|+++.+++ ..++|++|+|++|+|+..+. .+.+|+.|++++|+++. +++. .+.|+
T Consensus 38 ~~l~~LdLs~~~L~~lp~----~~~~L~~L~Ls~N~l~~lp~--------~~~~L~~L~l~~n~l~~-l~~l---p~~L~ 101 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE----LPPHLESLVASCNSLTELPE--------LPQSLKSLLVDNNNLKA-LSDL---PPLLE 101 (353)
T ss_dssp HTCSEEECTTSCCSCCCS----CCTTCSEEECCSSCCSSCCC--------CCTTCCEEECCSSCCSC-CCSC---CTTCC
T ss_pred cCCCEEEeCCCCCCCCCC----CCCCCCEEECCCCCCccccc--------chhhhhhhhhhhcccch-hhhh---ccccc
Confidence 357777777777776663 24677777777777775432 13567777777777762 3321 13577
Q ss_pred EEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCC
Q 003156 107 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 186 (843)
Q Consensus 107 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 186 (843)
+|++++|.+.. +|. ++.+++|++|++++|.+.... . ....+..+.+..+... ....+..++.++.|++++|.
T Consensus 102 ~L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~-~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 102 YLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLP-D---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp EEECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSC
T ss_pred ccccccccccc-ccc-hhhhccceeeccccccccccc-c---ccccccchhhcccccc--ccccccccccceeccccccc
Confidence 77777777763 343 466777777777777665322 1 1234455555544443 23335555666666666665
Q ss_pred cCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccce
Q 003156 187 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 266 (843)
Q Consensus 187 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~ 266 (843)
+.. .+.. ....+.+...++.+. .++.. ..++.|+.+++++|...
T Consensus 174 ~~~-~~~~---~~~~~~l~~~~~~~~-~~~~~------------------------------~~l~~L~~l~l~~n~~~- 217 (353)
T d1jl5a_ 174 LKK-LPDL---PLSLESIVAGNNILE-ELPEL------------------------------QNLPFLTTIYADNNLLK- 217 (353)
T ss_dssp CSS-CCCC---CTTCCEEECCSSCCS-SCCCC------------------------------TTCTTCCEEECCSSCCS-
T ss_pred ccc-cccc---ccccccccccccccc-ccccc------------------------------ccccccccccccccccc-
Confidence 542 2211 122334444444333 22221 22456666666666654
Q ss_pred eCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcc
Q 003156 267 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN 346 (843)
Q Consensus 267 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 346 (843)
..+. ...++..+.+.+|.+... + .....+..+++..+.+.+. +. -.......++..|.+.+ + ...
T Consensus 218 ~~~~---~~~~l~~~~~~~~~~~~~-~---~~~~~l~~~~~~~~~~~~l-~~---l~~~~~~~~~~~~~~~~-~---~~~ 282 (353)
T d1jl5a_ 218 TLPD---LPPSLEALNVRDNYLTDL-P---ELPQSLTFLDVSENIFSGL-SE---LPPNLYYLNASSNEIRS-L---CDL 282 (353)
T ss_dssp SCCS---CCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSEE-SC---CCTTCCEEECCSSCCSE-E---CCC
T ss_pred cccc---cccccccccccccccccc-c---ccccccccccccccccccc-cc---ccchhcccccccCcccc-c---ccc
Confidence 2332 234566666666665432 1 1223455555555554421 10 01234455566665552 2 123
Q ss_pred cCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccce
Q 003156 347 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 347 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 409 (843)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+|+
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR 337 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence 456677777777766 45543 456667777777766 45543 345666777777765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=7.1e-22 Score=191.78 Aligned_cols=169 Identities=16% Similarity=0.067 Sum_probs=118.0
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----c------------ChHHHHHHHHHHHhccCCCccceeeE
Q 003156 558 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----Q------------YPEDFEREVRVLGKARHPNLISLEGY 620 (843)
Q Consensus 558 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~------------~~~~~~~E~~~l~~l~h~niv~l~g~ 620 (843)
+++.||+|+||+||+|... +|+.||||.+...... . ......+|...+.++.|++++..+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4668999999999999986 7999999987432110 0 01234568889999999999988765
Q ss_pred EEcCCeeEEEEEeCCCCCHHHHHhhcCCCCCCCChhHHHHHHHHHHHHHHhhhhcCCCCeeecCCCCCCEEEcCCCCcEE
Q 003156 621 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 700 (843)
Q Consensus 621 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 700 (843)
. ..++||||++++.+. .+++.....++.|++++++|||+. +|+||||||+|||+++++ +++
T Consensus 83 ~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEE
T ss_pred c----CCEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEE
Confidence 3 237999999876432 244556678999999999999998 999999999999999654 899
Q ss_pred eeccCcccccccccceeccccccccccCCcccccCcCCCCCchhHHHHHHHH
Q 003156 701 SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLI 752 (843)
Q Consensus 701 ~Dfgl~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Dv~S~Gvil 752 (843)
+|||.|+.......... ....... -.|.+ ...|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~---l~rd~~~-~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREI---LERDVRN-IITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHH---HHHHHHH-HHHHH--HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHH---HHHHHHH-HHHHH--cCCCCCcccHHHHHHHH
Confidence 99999976532111000 0000000 01112 23578889999986443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.6e-22 Score=225.61 Aligned_cols=386 Identities=19% Similarity=0.141 Sum_probs=215.5
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccc----cccccCCCCCCEEECCCCCCccccCCCcCcccc-
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPI----GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIW- 76 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~----~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~- 76 (843)
.+|+.||+++|++++..-...+..++++++|+|++|+|+... ...+..+++|++|||++|.|+..........+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 378999999999984333556788999999999999987432 345688999999999999986321100111222
Q ss_pred CCccCCEEecCCccCccc----CchhhhcCCCCCEEEcCCCcccccCC----CCC-CCCCCCcEEEccCCcccccC----
Q 003156 77 SLKRLRTLDLSHNLFSGS----IPQGVAALHYLKELLLQGNQFSGPLP----ADI-GFCPHLTTLDLSNNLFTGQL---- 143 (843)
Q Consensus 77 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~~~---- 143 (843)
...+|++|+|++|++++. ++..+..+++|++|+|++|.++.... ..+ ........+......+....
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235799999999999753 45567889999999999999864211 111 12234455555555444211
Q ss_pred CchhhcccCCcEEEeecCcccccC----CCCc-cCCCCccEEEcccCCcCCC----CCCCCCCCCCCcEEEecCCcCCCC
Q 003156 144 PVSLRLLNSMIFISVSNNTLTGDI----PHWI-GNISTLEFLDFSNNHLTGS----LPSSLFNCKKLSVIRLRGNSLNGN 214 (843)
Q Consensus 144 ~~~~~~l~~L~~L~L~~N~l~~~~----p~~~-~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 214 (843)
...+.....++.+.++++...... ...+ ........+++..+.+... ....+...+.++.+++.+|.+...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 123455677888888887664211 0011 1223566777777766521 112334567888999988876422
Q ss_pred CCc----hhhc--cCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccc-----cCCCCCcEEEc
Q 003156 215 IPE----GLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM-----GLFANLRYLNL 283 (843)
Q Consensus 215 ~p~----~~~~--~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~L 283 (843)
... .... ..++.+++++|.+........ .......+.++.+++++|.+.+.....+ .....|+.+++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~--~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l 319 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL--CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 319 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH--HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred ccchhhcccccccccccccccccccccccccccc--cccccccccccccccccccccccccchhhccccccccccccccc
Confidence 111 1111 146666666665532100000 0001123456666666666653222111 12245666666
Q ss_pred CCCcccCCCCCCc----cccccceEEEccCCccccc----CCcccc-ccCCCcEEEcCCCCCCCC----chhhhcccCCC
Q 003156 284 SSNHLRSRIPPEL----GYFHSLIHLDLRNNALYGS----IPQEVC-ESRSLGILQLDGNSLTGP----IPQVIRNCTSL 350 (843)
Q Consensus 284 ~~N~l~~~~~~~~----~~l~~L~~L~L~~n~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 350 (843)
++|.+.......+ ....+|++|+|++|+++.. ++..+. ..+.|++|+|++|.|++. ++..+..+++|
T Consensus 320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L 399 (460)
T d1z7xw1 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 399 (460)
T ss_dssp TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence 6666553322112 2334566666666666432 112221 234566666666666532 23344455666
Q ss_pred cEEecccccccccCCccc----c-CCCCCCEEEccCCcccccCC
Q 003156 351 YLLSLSHNHLSGSIPKSI----S-NLNKLKILKLEFNELSGEIP 389 (843)
Q Consensus 351 ~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~L~~N~l~~~~p 389 (843)
++|+|++|+|+......| . +...|+.|++++|.+.....
T Consensus 400 ~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp CEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred CEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence 666666666653322222 1 22356666666666554333
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=5.1e-19 Score=178.77 Aligned_cols=204 Identities=13% Similarity=0.082 Sum_probs=166.2
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
+.++.++++++ .+|..++ +++++|+|++|+|+.++...|.++++|++|+|++|.+.... .+.+|.+++++++|
T Consensus 11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i---~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI---EADVFSNLPKLHEI 83 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEE---CSSSEESCTTCCEE
T ss_pred CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhcccccccee---eccccccccccccc
Confidence 57889999999 8997765 58999999999999999999999999999999999987532 34568889999999
Q ss_pred ecCC-ccCcccCchhhhcCCCCCEEEcCCCcccccCCC-CCCCCCCCcEEEccCCcccccCCchhhccc-CCcEEEeecC
Q 003156 85 DLSH-NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPA-DIGFCPHLTTLDLSNNLFTGQLPVSLRLLN-SMIFISVSNN 161 (843)
Q Consensus 85 ~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N 161 (843)
++.+ |.+....+..|.++++|++|++++|++....+. .+..+..+..+..+++.+....+..|..++ .++.|++++|
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n 163 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 163 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred cccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccc
Confidence 9864 678878888999999999999999999754332 344567777888888888877778887765 7889999999
Q ss_pred cccccCCCCccCCCCccEE-EcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCc
Q 003156 162 TLTGDIPHWIGNISTLEFL-DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 217 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L-~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 217 (843)
+++...+..|. ..++.++ ++++|+++...+..|.++++|++|+|++|+|+ .+|.
T Consensus 164 ~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~ 218 (242)
T d1xwdc1 164 GIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS 218 (242)
T ss_dssp CCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCS
T ss_pred ccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCH
Confidence 99965555554 4555444 67888999666667899999999999999998 4544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.6e-18 Score=173.13 Aligned_cols=204 Identities=21% Similarity=0.273 Sum_probs=152.7
Q ss_pred cEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEE
Q 003156 5 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 84 (843)
Q Consensus 5 ~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L 84 (843)
..++++.+++++.++ +..+.+|++|++++|+|+.+.+ +.++++|++|+|++|++++.. .+..+++|++|
T Consensus 22 ~~~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~ls~n~i~~~~------~l~~l~~l~~l 90 (227)
T d1h6ua2 22 IKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQITDLA------PLKNLTKITEL 90 (227)
T ss_dssp HHHHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCG------GGTTCCSCCEE
T ss_pred HHHHhCCCCcCCcCC---HHHcCCcCEEECCCCCCCcchh--HhcCCCCcEeecCCceeeccc------ccccccccccc
Confidence 345677788875443 4567888888998888887743 788888999999988887532 26778888888
Q ss_pred ecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccc
Q 003156 85 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 164 (843)
Q Consensus 85 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 164 (843)
++++|.++. + ..+.++++|+.+++++|...+. ..+...+.++.++++++.+... ..+...++|+.|++++|++.
T Consensus 91 ~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred ccccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence 888888873 3 3577888888888888887643 3366778888888888887643 34677888888998888887
Q ss_pred ccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc-CcceeeccC
Q 003156 165 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSE 231 (843)
Q Consensus 165 ~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~ 231 (843)
... .++++++|++|+|++|++++. + .+.++++|++|+|++|++++ ++. +..+ +|+.|++++
T Consensus 165 ~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 165 DLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred cch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence 433 378888899999988888853 3 37888889999999988884 442 3343 688888763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=7.9e-22 Score=219.91 Aligned_cols=384 Identities=17% Similarity=0.117 Sum_probs=244.5
Q ss_pred CCCcEEEccCccccccc-cccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccC----chhhh-
Q 003156 27 ASLRYLSLAGNILQGPI-GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI----PQGVA- 100 (843)
Q Consensus 27 ~~L~~L~L~~n~i~~~~-~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~- 100 (843)
++|++||++.|+|+... ...+..+++|++|+|++|.|+.......+..+...++|++|||++|.|+... ...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 46899999999998643 4567888999999999999874221111234667899999999999986422 22222
Q ss_pred cCCCCCEEEcCCCccccc----CCCCCCCCCCCcEEEccCCcccccCCchhhc-----ccCCcEEEeecCccccc----C
Q 003156 101 ALHYLKELLLQGNQFSGP----LPADIGFCPHLTTLDLSNNLFTGQLPVSLRL-----LNSMIFISVSNNTLTGD----I 167 (843)
Q Consensus 101 ~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~ 167 (843)
...+|++|+|++|++++. ++..+..+++|++|+|++|.++......+.. ......+......+... .
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235799999999999753 3456788999999999999988533322211 11223333333333211 0
Q ss_pred CCCccCCCCccEEEcccCCcCCC----CCCCC-CCCCCCcEEEecCCcCCCCCCchhh-----ccCcceeeccCCcceec
Q 003156 168 PHWIGNISTLEFLDFSNNHLTGS----LPSSL-FNCKKLSVIRLRGNSLNGNIPEGLF-----DLGLEEIDLSENGFMGS 237 (843)
Q Consensus 168 p~~~~~l~~L~~L~L~~N~i~~~----~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~-----~~~L~~L~l~~n~l~~~ 237 (843)
-..+.....++.++++++.+... ....+ ........+.+..+.+......... ...++.+++++|.+...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 11233457789999988876521 11111 1234567888888876532111111 12588889888876321
Q ss_pred CCCCCCCCCcccccCccCEEeCCCCccceeC----CccccCCCCCcEEEcCCCcccCCCCCCc-----cccccceEEEcc
Q 003156 238 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDI----PAEMGLFANLRYLNLSSNHLRSRIPPEL-----GYFHSLIHLDLR 308 (843)
Q Consensus 238 ~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~ 308 (843)
..... .........+++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.++++
T Consensus 242 ~~~~~-~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~ 320 (460)
T d1z7xw1 242 GMAEL-CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 320 (460)
T ss_dssp HHHHH-HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred ccchh-hcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence 00000 0001122457899999999876432 2334567789999999998864211111 233578999999
Q ss_pred CCcccccCCcc----ccccCCCcEEEcCCCCCCCC----chhhhc-ccCCCcEEeccccccccc----CCccccCCCCCC
Q 003156 309 NNALYGSIPQE----VCESRSLGILQLDGNSLTGP----IPQVIR-NCTSLYLLSLSHNHLSGS----IPKSISNLNKLK 375 (843)
Q Consensus 309 ~n~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~ 375 (843)
+|.++...... +...++|+.|+|++|.|++. ++..+. ..+.|+.|+|++|.|+.. ++..+..+++|+
T Consensus 321 ~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~ 400 (460)
T d1z7xw1 321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400 (460)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred ccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCC
Confidence 99887543333 34456899999999988753 233333 466799999999998743 445566778999
Q ss_pred EEEccCCcccccCCcchh-----cccccceEeeccccceec
Q 003156 376 ILKLEFNELSGEIPQELG-----KLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 376 ~L~L~~N~l~~~~p~~~~-----~l~~L~~l~ls~N~l~~~ 411 (843)
+|+|++|+|+......+. +...|+.|++++|.+...
T Consensus 401 ~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred EEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 999999998854433332 234688999998887643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=7.9e-19 Score=170.15 Aligned_cols=177 Identities=21% Similarity=0.211 Sum_probs=141.7
Q ss_pred cCEEeCCCCccceeCCccccCCCCCcEEEcCCCcccC-CCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcC
Q 003156 254 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS-RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 332 (843)
Q Consensus 254 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 332 (843)
.+.++.++++++ .+|..+. +++++|+|++|+|++ ..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 457888888888 5676553 688999999999976 445778889999999999999998888899999999999999
Q ss_pred CCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCCcccccCCcchhcccccceEeeccccceecC
Q 003156 333 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 412 (843)
Q Consensus 333 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 412 (843)
+|+|++..|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+....+. ..-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCC
Confidence 9999988888899999999999999999988888899999999999999999854332 222334677788888888877
Q ss_pred CCCCCCCCCCCCCcCCCCCCCCCC
Q 003156 413 PVGGVFPTLDQSSLQGNLGICSPL 436 (843)
Q Consensus 413 p~~~~~~~~~~~~~~~n~~~c~~~ 436 (843)
|. .+..+.-..+..|...|..+
T Consensus 166 p~--~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PS--KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp ST--TTTTSBGGGSCTTTCCCCCC
T ss_pred Ch--hhcCCEeeecCHhhCcCCCC
Confidence 73 34455555667777777654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=2.3e-18 Score=173.96 Aligned_cols=200 Identities=13% Similarity=0.003 Sum_probs=89.4
Q ss_pred CCcEEEccCCcccccCCchhhcccCCcEEEeecCccccc-CCCCccCCCCccEEEccc-CCcCCCCCCCCCCCCCCcEEE
Q 003156 128 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD-IPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIR 205 (843)
Q Consensus 128 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~ 205 (843)
++++|||++|+|+.+.+.+|.++++|++|++++|.+... .+.+|.+++++++|.+.. |.+....+..|.++++|+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 344444444444433333444444444444444444322 233455555555555442 444444455555555666666
Q ss_pred ecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCCCCccceeCCccccCCC-CCcEEEcC
Q 003156 206 LRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA-NLRYLNLS 284 (843)
Q Consensus 206 L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~ 284 (843)
+++|.+.. .+...+ ...++.+..+...++.+....+..|..++ .++.|+++
T Consensus 110 l~~~~l~~-~~~~~~---------------------------~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~ 161 (242)
T d1xwdc1 110 ISNTGIKH-LPDVHK---------------------------IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 161 (242)
T ss_dssp EESCCCCS-CCCCTT---------------------------TCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cchhhhcc-cccccc---------------------------cccccccccccccccccccccccccccccccceeeecc
Confidence 65555542 111000 01123344444444444444444443332 45555555
Q ss_pred CCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEec
Q 003156 285 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 355 (843)
Q Consensus 285 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 355 (843)
+|+++.+.+..|....-++.+++++|+++...+..|.++++|+.|+|++|+|+...+..|.++++|+.|++
T Consensus 162 ~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 162 KNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp SSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 55555443333332222222334445555332333455555555555555555333334444444444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.9e-18 Score=168.64 Aligned_cols=181 Identities=24% Similarity=0.333 Sum_probs=141.1
Q ss_pred EecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEec
Q 003156 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 86 (843)
Q Consensus 7 L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L 86 (843)
..+..+.+++.++. ..+.+|++|++++|.|..+.+ +..+++|++|+|++|+|++..+ +..+++|++|++
T Consensus 29 ~~l~~~~~~~~~~~---~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~------~~~l~~L~~L~l 97 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP------LANLKNLGWLFL 97 (210)
T ss_dssp HHTTCSCTTSEECH---HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG------GTTCTTCCEEEC
T ss_pred HHhCcCccCCccCH---HHhcCccEEECcCCCCCCchh--HhhCCCCCEEeCCCccccCccc------cccCcccccccc
Confidence 45667777755553 346788999999999887764 7788999999999998885432 567888999999
Q ss_pred CCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccccc
Q 003156 87 SHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 166 (843)
Q Consensus 87 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 166 (843)
++|+|++ ++ .+..+++|+.|++++|.+.. + ..+..+++|+.+++++|.++. +..+..+++|+.+++++|++++.
T Consensus 98 ~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i 171 (210)
T d1h6ta2 98 DENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI 171 (210)
T ss_dssp CSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC
T ss_pred ccccccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccccc
Confidence 9998874 34 57888899999999988863 2 347788889999999998874 34577788899999999988754
Q ss_pred CCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecC
Q 003156 167 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG 208 (843)
Q Consensus 167 ~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 208 (843)
.+ ++++++|++|+|++|+|+. ++ .+.++++|++|+|++
T Consensus 172 ~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 172 VP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 32 7888899999999998884 44 588888999998864
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.8e-18 Score=172.68 Aligned_cols=204 Identities=21% Similarity=0.259 Sum_probs=105.9
Q ss_pred CcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCCCEE
Q 003156 29 LRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 108 (843)
Q Consensus 29 L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 108 (843)
+..++++.+++.++. .+..+.+|++|++.+|.|++.. .+..+++|++|++++|++.+..+ +..+++|++|
T Consensus 21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l~------~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE------GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT------TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcch------hHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 344455555555433 2344556666666666555321 24556666666666666653322 5566666666
Q ss_pred EcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcccCCcC
Q 003156 109 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 188 (843)
Q Consensus 109 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~i~ 188 (843)
++++|.++.. + .+..+++|+.+++++|...+. ..+...+.+..+.++++.+.... .+.++++|++|++++|.++
T Consensus 91 ~~~~n~~~~i-~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~ 164 (227)
T d1h6ua2 91 ELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVS 164 (227)
T ss_dssp ECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCC
T ss_pred cccccccccc-c-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccc
Confidence 6666655522 2 355566666666666555432 23444555566666665554322 2455556666666666655
Q ss_pred CCCCCCCCCCCCCcEEEecCCcCCCCCCchhhc-cCcceeeccCCcceecCCCCCCCCCcccccCccCEEeCC
Q 003156 189 GSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 260 (843)
Q Consensus 189 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~L~l~~n~l~~~~p~~~~~~~~~~~l~~L~~L~L~ 260 (843)
+. ..+.++++|+.|+|++|.+++ ++. +.. .+|+.|++++|++++. + .+..+++|+.|+++
T Consensus 165 ~~--~~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i-~-------~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 165 DL--TPLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV-S-------PLANTSNLFIVTLT 225 (227)
T ss_dssp CC--GGGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBC-G-------GGTTCTTCCEEEEE
T ss_pred cc--hhhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCC-c-------ccccCCCCCEEEee
Confidence 32 225556666666666666653 322 222 2566666666665532 1 12335556666554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.5e-18 Score=168.15 Aligned_cols=152 Identities=22% Similarity=0.288 Sum_probs=92.9
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccc-cCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
+.++.++++++ .+|..+. +++++|+|++|+|+. ..+..|.++++|++|+|++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45555555555 3333331 456666666666653 3344455666666666666666666666666666666666666
Q ss_pred CcccccCCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCccee
Q 003156 161 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMG 236 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~ 236 (843)
|+|+.+.+.+|.++++|++|+|++|+|+.+.+.+|..+++|++|+|++|.+....+...+...++.+.+..+.+..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBB
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEe
Confidence 6666666667777777777777777777666777777777777777777776544333322234444555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.6e-18 Score=166.52 Aligned_cols=164 Identities=23% Similarity=0.284 Sum_probs=142.3
Q ss_pred CCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccC
Q 003156 2 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 81 (843)
Q Consensus 2 ~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L 81 (843)
+.|+.|++++|.++ .++. ++.+++|++|+|++|+|+++++ +..+++|++|++++|+|++.+ .+..+++|
T Consensus 46 ~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~l~------~l~~l~~L 114 (210)
T d1h6ta2 46 NSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS------SLKDLKKL 114 (210)
T ss_dssp HTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG------GGTTCTTC
T ss_pred cCccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCccc--cccCccccccccccccccccc------cccccccc
Confidence 46899999999998 6653 6889999999999999998775 688999999999999998643 36789999
Q ss_pred CEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecC
Q 003156 82 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 82 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 161 (843)
+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++.. .+..+++|+.|+|++|
T Consensus 115 ~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 115 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKN 188 (210)
T ss_dssp CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred cccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCC
Confidence 999999999873 3 468999999999999999984 335778999999999999998643 4889999999999999
Q ss_pred cccccCCCCccCCCCccEEEccc
Q 003156 162 TLTGDIPHWIGNISTLEFLDFSN 184 (843)
Q Consensus 162 ~l~~~~p~~~~~l~~L~~L~L~~ 184 (843)
+++. ++ .|.++++|++|+|++
T Consensus 189 ~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 189 HISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCCB-CG-GGTTCTTCSEEEEEE
T ss_pred CCCC-Ch-hhcCCCCCCEEEccC
Confidence 9984 44 599999999999975
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.5e-18 Score=167.55 Aligned_cols=177 Identities=24% Similarity=0.282 Sum_probs=114.3
Q ss_pred EecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEec
Q 003156 7 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 86 (843)
Q Consensus 7 L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L 86 (843)
+.++.+++++.++ ...++++++|++++|+|..+.. ++.+++|++|+|++|++++.. .+.++++|++|++
T Consensus 23 ~~l~~~~~~~~~~---~~~l~~l~~L~l~~~~i~~l~~--l~~l~nL~~L~Ls~N~l~~~~------~l~~l~~L~~L~l 91 (199)
T d2omxa2 23 TVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDIT------PLKNLTKLVDILM 91 (199)
T ss_dssp HHTTCSSTTSEEC---HHHHTTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCG------GGTTCTTCCEEEC
T ss_pred HHhCCCCCCCccC---HHHhcCCCEEECCCCCCCCccc--cccCCCcCcCccccccccCcc------cccCCcccccccc
Confidence 4566666664333 2345677777777777776543 566777777777777776432 2566777777777
Q ss_pred CCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeecCccccc
Q 003156 87 SHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 166 (843)
Q Consensus 87 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 166 (843)
++|.+.. ++ .+.++++|++|++++|.+... ..+..+++|+.|++++|++... ..+..+++|+.|++.+|++++.
T Consensus 92 ~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 92 NNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC
T ss_pred ccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC
Confidence 7777763 32 367777777777777776532 2366677777777777776632 3466677777777777777643
Q ss_pred CCCCccCCCCccEEEcccCCcCCCCCCCCCCCCCCcEE
Q 003156 167 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 204 (843)
Q Consensus 167 ~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 204 (843)
. .|+++++|++|++++|++++ ++ .++.+++|+.|
T Consensus 166 ~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 166 K--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp G--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred c--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 2 26677777777777777764 22 46666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.4e-17 Score=160.48 Aligned_cols=161 Identities=20% Similarity=0.240 Sum_probs=139.1
Q ss_pred CCCccEEecCCCcCcccCChhhhhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCcc
Q 003156 1 MMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 80 (843)
Q Consensus 1 ~~~l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~ 80 (843)
+.++++|++++|+|+ .++. ++.+++|++|+|++|+|+++.+ |.++++|++|++++|.+.... .+.++++
T Consensus 39 l~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~------~l~~l~~ 107 (199)
T d2omxa2 39 LDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT------PLANLTN 107 (199)
T ss_dssp HTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG------GGTTCTT
T ss_pred hcCCCEEECCCCCCC-Cccc--cccCCCcCcCccccccccCccc--ccCCccccccccccccccccc------ccccccc
Confidence 357999999999999 6753 6889999999999999998876 899999999999999987532 3778999
Q ss_pred CCEEecCCccCcccCchhhhcCCCCCEEEcCCCcccccCCCCCCCCCCCcEEEccCCcccccCCchhhcccCCcEEEeec
Q 003156 81 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 160 (843)
Q Consensus 81 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 160 (843)
|+.|++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|++|++++|++++.. .++++++|++|++++
T Consensus 108 L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~ 181 (199)
T d2omxa2 108 LTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISS 181 (199)
T ss_dssp CSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCS
T ss_pred cccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCCc--cccCCCCCCEEECCC
Confidence 99999999998743 458899999999999999974 33 5889999999999999998643 488999999999999
Q ss_pred CcccccCCCCccCCCCccEE
Q 003156 161 NTLTGDIPHWIGNISTLEFL 180 (843)
Q Consensus 161 N~l~~~~p~~~~~l~~L~~L 180 (843)
|++++ ++ .++.+++|++|
T Consensus 182 N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 182 NKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp SCCCC-CG-GGGGCTTCSEE
T ss_pred CCCCC-Cc-cccCCCCCCcC
Confidence 99985 43 58899999886
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=6.8e-16 Score=143.90 Aligned_cols=128 Identities=20% Similarity=0.148 Sum_probs=96.1
Q ss_pred hhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcC
Q 003156 23 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL 102 (843)
Q Consensus 23 f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 102 (843)
|.++.++++|+|++|+|+.++ +.+..+++|++|+|++|+|+... .|..+++|++|++++|+++...+..+..+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~-~~~~~l~~L~~L~Ls~N~i~~l~------~~~~l~~L~~L~ls~N~i~~l~~~~~~~l 86 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRKLD------GFPLLRRLKTLLVNNNRICRIGEGLDQAL 86 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCC-CGGGGTTCCSEEECCSSCCCEEC------CCCCCSSCCEEECCSSCCCEECSCHHHHC
T ss_pred ccCcCcCcEEECCCCCCCccC-ccccccccCCEEECCCCCCCccC------CcccCcchhhhhcccccccCCCccccccc
Confidence 677888889999999998885 56778888999999999888542 36678888888998888887666677788
Q ss_pred CCCCEEEcCCCcccccCC-CCCCCCCCCcEEEccCCcccccCC---chhhcccCCcEEE
Q 003156 103 HYLKELLLQGNQFSGPLP-ADIGFCPHLTTLDLSNNLFTGQLP---VSLRLLNSMIFIS 157 (843)
Q Consensus 103 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ 157 (843)
++|++|+|++|+|+.... ..+..+++|++|++++|.++.... ..+..+++|++|+
T Consensus 87 ~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 87 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888888888874322 356677888888888888764321 2355666666655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=5.9e-15 Score=137.41 Aligned_cols=126 Identities=15% Similarity=0.120 Sum_probs=80.3
Q ss_pred ccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCc
Q 003156 272 MGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLY 351 (843)
Q Consensus 272 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 351 (843)
+.+..++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+. + +.+..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 33455666666666666543 4445556666666666666663 3 2466677777777777777754445556677777
Q ss_pred EEecccccccccCC--ccccCCCCCCEEEccCCcccccCC----cchhcccccceEe
Q 003156 352 LLSLSHNHLSGSIP--KSISNLNKLKILKLEFNELSGEIP----QELGKLASLLAVN 402 (843)
Q Consensus 352 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~l~ 402 (843)
.|+|++|+|+. ++ ..+..+++|++|++++|.++ ..| ..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 77777777763 33 35667777777777777776 333 2466777777766
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=2.1e-14 Score=127.00 Aligned_cols=101 Identities=29% Similarity=0.371 Sum_probs=55.8
Q ss_pred EEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEeccccc
Q 003156 280 YLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 359 (843)
Q Consensus 280 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 359 (843)
.|+|++|.|+.. ..+..+.+|++|++++|+|+ .+|..+..+++|+.|++++|.|++ +| .+.++++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~l--~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC--CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC--cccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 455555555432 23555555556666666555 345555566666666666666653 33 35566666666666666
Q ss_pred ccccC-CccccCCCCCCEEEccCCccc
Q 003156 360 LSGSI-PKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 360 l~~~~-p~~~~~l~~L~~L~L~~N~l~ 385 (843)
|+... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 65322 134555666666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=2.3e-15 Score=154.96 Aligned_cols=104 Identities=20% Similarity=0.181 Sum_probs=57.2
Q ss_pred CCEEEcCCCcccccCCCCCCCCCCCcEEEccCCccccc-CCchhhcccCCcEEEeecCcccccCCCCccCCCCccEEEcc
Q 003156 105 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ-LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 183 (843)
Q Consensus 105 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 183 (843)
+..+.+..+.+.... .......+|++||+++|.++.. +...+..+++|++|+|++|++.+..+..++.+++|++|+|+
T Consensus 25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 445555555544222 2233445677777777766532 23345566666666666666655555556666677777776
Q ss_pred cC-CcCCC-CCCCCCCCCCCcEEEecCC
Q 003156 184 NN-HLTGS-LPSSLFNCKKLSVIRLRGN 209 (843)
Q Consensus 184 ~N-~i~~~-~~~~~~~l~~L~~L~L~~N 209 (843)
++ .+++. +...+.++++|++|+++++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred ccccccccccchhhHHHHhccccccccc
Confidence 63 44321 1111234666777776664
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=2e-14 Score=127.02 Aligned_cols=104 Identities=25% Similarity=0.262 Sum_probs=92.5
Q ss_pred eEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCC
Q 003156 303 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382 (843)
Q Consensus 303 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 382 (843)
+.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 57999999999 555 5899999999999999999 57778999999999999999999 455 4999999999999999
Q ss_pred cccccC-CcchhcccccceEeeccccceec
Q 003156 383 ELSGEI-PQELGKLASLLAVNVSYNRLIGR 411 (843)
Q Consensus 383 ~l~~~~-p~~~~~l~~L~~l~ls~N~l~~~ 411 (843)
+|+... ...+..+++|+.|++++|+++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 999544 36789999999999999999864
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.50 E-value=1.8e-16 Score=168.88 Aligned_cols=258 Identities=20% Similarity=0.215 Sum_probs=136.9
Q ss_pred CchhhhcCCCCCEEEcCCCccccc----CCCCCCCCCCCcEEEccCCcccccC---CchhhcccCCcEEEeecCcccccC
Q 003156 95 IPQGVAALHYLKELLLQGNQFSGP----LPADIGFCPHLTTLDLSNNLFTGQL---PVSLRLLNSMIFISVSNNTLTGDI 167 (843)
Q Consensus 95 ~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~~ 167 (843)
+...+....+|++|+|++|.+... +...+...++|+.|+++++...... +..+. .+
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~-----------------~l 85 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR-----------------LL 85 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH-----------------HH
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH-----------------HH
Confidence 345566677777777777776421 2334566777888888776544211 11111 11
Q ss_pred CCCccCCCCccEEEcccCCcCCC----CCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCCCCC
Q 003156 168 PHWIGNISTLEFLDFSNNHLTGS----LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSS 243 (843)
Q Consensus 168 p~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~~~~ 243 (843)
...+..+++|++|+|++|.++.. +...+..+++|+.|++++|.+.......+.. .+..+.....
T Consensus 86 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~-~l~~~~~~~~----------- 153 (344)
T d2ca6a1 86 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR-ALQELAVNKK----------- 153 (344)
T ss_dssp HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH-HHHHHHHHHH-----------
T ss_pred HHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccc-cccccccccc-----------
Confidence 12344556677777777776643 2223345677888888887765211111110 1111111100
Q ss_pred CCCcccccCccCEEeCCCCcccee----CCccccCCCCCcEEEcCCCcccCC-----CCCCccccccceEEEccCCcccc
Q 003156 244 SSSSSTLFQTLRILDLSSNNLVGD----IPAEMGLFANLRYLNLSSNHLRSR-----IPPELGYFHSLIHLDLRNNALYG 314 (843)
Q Consensus 244 ~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~ 314 (843)
....+.|+.+++++|.+... +...+...+.|++|++++|.|... +...+..+++|+.|+|++|.++.
T Consensus 154 ----~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 229 (344)
T d2ca6a1 154 ----AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 229 (344)
T ss_dssp ----HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred ----cccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccc
Confidence 01134677777777776532 222334556777777777776531 22345556667777777776642
Q ss_pred c----CCccccccCCCcEEEcCCCCCCCCchhhh----cc--cCCCcEEeccccccccc----CCcccc-CCCCCCEEEc
Q 003156 315 S----IPQEVCESRSLGILQLDGNSLTGPIPQVI----RN--CTSLYLLSLSHNHLSGS----IPKSIS-NLNKLKILKL 379 (843)
Q Consensus 315 ~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L 379 (843)
. +...+...++|++|+|++|.|++.....+ .. .+.|++|++++|+|+.. +...+. ++++|+.|+|
T Consensus 230 ~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l 309 (344)
T d2ca6a1 230 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309 (344)
T ss_dssp HHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEEC
T ss_pred cccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEEC
Confidence 2 23344556667777777776664322222 21 24566666666666532 222221 3556666666
Q ss_pred cCCccc
Q 003156 380 EFNELS 385 (843)
Q Consensus 380 ~~N~l~ 385 (843)
++|++.
T Consensus 310 ~~N~~~ 315 (344)
T d2ca6a1 310 NGNRFS 315 (344)
T ss_dssp TTSBSC
T ss_pred CCCcCC
Confidence 666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.47 E-value=2.7e-15 Score=159.49 Aligned_cols=215 Identities=23% Similarity=0.293 Sum_probs=144.3
Q ss_pred ccCCCCccEEEcccCCcCC----------CCCCCCCCCCCCcEEEecCCcCCCCCCchhhccCcceeeccCCcceecCCC
Q 003156 171 IGNISTLEFLDFSNNHLTG----------SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 240 (843)
Q Consensus 171 ~~~l~~L~~L~L~~N~i~~----------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~n~l~~~~p~ 240 (843)
+...++|+.|+++++.... .+...+..+++|+.|+|++|.++......+...
T Consensus 55 l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~------------------ 116 (344)
T d2ca6a1 55 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF------------------ 116 (344)
T ss_dssp TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHH------------------
T ss_pred HHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhh------------------
Confidence 4455566666666554321 122335567889999999988874322222110
Q ss_pred CCCCCCcccccCccCEEeCCCCccceeCCc-------------cccCCCCCcEEEcCCCcccCCCC----CCccccccce
Q 003156 241 GSSSSSSSTLFQTLRILDLSSNNLVGDIPA-------------EMGLFANLRYLNLSSNHLRSRIP----PELGYFHSLI 303 (843)
Q Consensus 241 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~ 303 (843)
....++|+.|++++|.+...... .....+.|+.|++++|.+..... ..+...+.|+
T Consensus 117 -------l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~ 189 (344)
T d2ca6a1 117 -------LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189 (344)
T ss_dssp -------HHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred -------hcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhc
Confidence 11235677777777766421111 11345689999999999864322 2345667999
Q ss_pred EEEccCCccccc-----CCccccccCCCcEEEcCCCCCCCC----chhhhcccCCCcEEecccccccccCCcc----ccC
Q 003156 304 HLDLRNNALYGS-----IPQEVCESRSLGILQLDGNSLTGP----IPQVIRNCTSLYLLSLSHNHLSGSIPKS----ISN 370 (843)
Q Consensus 304 ~L~L~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~ 370 (843)
+|+|++|+++.. +...+...++|+.|+|++|.++.. +...+..+++|++|+|++|.|++..... +..
T Consensus 190 ~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~ 269 (344)
T d2ca6a1 190 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 269 (344)
T ss_dssp EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHT
T ss_pred ccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhh
Confidence 999999998732 334567789999999999998643 4456778999999999999998653333 332
Q ss_pred --CCCCCEEEccCCccccc----CCcchh-cccccceEeecccccee
Q 003156 371 --LNKLKILKLEFNELSGE----IPQELG-KLASLLAVNVSYNRLIG 410 (843)
Q Consensus 371 --l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~l~ls~N~l~~ 410 (843)
.+.|+.|+|++|+|+.. +...+. ++++|+.|++++|++..
T Consensus 270 ~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 270 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 46799999999999753 233343 57889999999999853
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=9.8e-15 Score=150.17 Aligned_cols=228 Identities=17% Similarity=0.194 Sum_probs=148.3
Q ss_pred ccEEecCCCcCcccCChhhhhcCCCCcEEEccCcccccc-ccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCC
Q 003156 4 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGP-IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 82 (843)
Q Consensus 4 l~~L~L~~n~i~~~~~~~~f~~l~~L~~L~L~~n~i~~~-~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~ 82 (843)
+..+.++...+. ..... .....+|++|+|++|.+... ....+.++++|++|+|++|.+++.. ...+..+++|+
T Consensus 25 ~~~lrl~~~~~~-~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~----~~~l~~~~~L~ 98 (284)
T d2astb2 25 VIAFRCPRSFMD-QPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPI----VNTLAKNSNLV 98 (284)
T ss_dssp CSEEECTTCEEC-SCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHH----HHHHTTCTTCS
T ss_pred ceEeeccccccc-cchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHH----HHHHhcCCCCc
Confidence 345566666554 22222 23456888888888887642 3455788888889988888776321 22456678888
Q ss_pred EEecCCc-cCccc-CchhhhcCCCCCEEEcCCCc-cccc-CCCCCC-CCCCCcEEEccCC--ccccc-CCchhhcccCCc
Q 003156 83 TLDLSHN-LFSGS-IPQGVAALHYLKELLLQGNQ-FSGP-LPADIG-FCPHLTTLDLSNN--LFTGQ-LPVSLRLLNSMI 154 (843)
Q Consensus 83 ~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~-~~~~~~-~l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~ 154 (843)
+|+|++| .+++. +...+.++++|++|++++|. +++. ....+. ..++|+.|+++++ .++.. +...+..+++|+
T Consensus 99 ~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~ 178 (284)
T d2astb2 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178 (284)
T ss_dssp EEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS
T ss_pred CccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccc
Confidence 8998885 55532 22334678889999998863 4321 111122 3467889998875 34322 222345678899
Q ss_pred EEEeecC-cccccCCCCccCCCCccEEEcccC-CcCCCCCCCCCCCCCCcEEEecCCcCCCCCCchhhcc--Ccceeecc
Q 003156 155 FISVSNN-TLTGDIPHWIGNISTLEFLDFSNN-HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLS 230 (843)
Q Consensus 155 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~--~L~~L~l~ 230 (843)
+|++++| .+++.....+..+++|++|+|++| .+++.....++++++|+.|+++++ ++ ...+... .+..|.+.
T Consensus 179 ~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~---d~~l~~l~~~lp~L~i~ 254 (284)
T d2astb2 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQIN 254 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEES
T ss_pred ccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CC---HHHHHHHHHhCcccccc
Confidence 9999886 466666677888899999999984 677666667788899999999887 33 1222222 46667777
Q ss_pred CCcceecCCCC
Q 003156 231 ENGFMGSIPPG 241 (843)
Q Consensus 231 ~n~l~~~~p~~ 241 (843)
.+.++...++.
T Consensus 255 ~~~ls~~~~~~ 265 (284)
T d2astb2 255 CSHFTTIARPT 265 (284)
T ss_dssp CCCSCCTTCSS
T ss_pred CccCCCCCCCc
Confidence 77777654443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=4.3e-15 Score=143.50 Aligned_cols=143 Identities=20% Similarity=0.263 Sum_probs=111.7
Q ss_pred ccCEEeCCCC--ccceeCCccccCCCCCcEEEcCCCcccCCCCCCccccccceEEEccCCcccccCCccccccCCCcEEE
Q 003156 253 TLRILDLSSN--NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 330 (843)
Q Consensus 253 ~L~~L~L~~n--~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 330 (843)
.++.+++.++ .+. .++..+..+++|++|+|++|+|+.+ +.+..+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~ 99 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc--ccccCCccccChhhcccccc-cccccccccccccccc
Confidence 3455555543 233 4556788889999999999999865 35888999999999999998 5666666677899999
Q ss_pred cCCCCCCCCchhhhcccCCCcEEecccccccccCC--ccccCCCCCCEEEccCCcccccCCcc----------hhccccc
Q 003156 331 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP--KSISNLNKLKILKLEFNELSGEIPQE----------LGKLASL 398 (843)
Q Consensus 331 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L 398 (843)
+++|+|+. + ..+.++++|+.|+|++|+|+. ++ ..+..+++|+.|+|++|++....+.. +..+++|
T Consensus 100 l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L 176 (198)
T d1m9la_ 100 ISYNQIAS-L-SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176 (198)
T ss_dssp CSEEECCC-H-HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSC
T ss_pred cccccccc-c-ccccccccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCc
Confidence 99999984 3 358889999999999999984 43 46889999999999999988655443 5678888
Q ss_pred ceEe
Q 003156 399 LAVN 402 (843)
Q Consensus 399 ~~l~ 402 (843)
+.||
T Consensus 177 ~~LD 180 (198)
T d1m9la_ 177 KKLD 180 (198)
T ss_dssp CEES
T ss_pred CEeC
Confidence 8876
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=1.4e-14 Score=139.84 Aligned_cols=109 Identities=18% Similarity=0.144 Sum_probs=56.1
Q ss_pred hhcCCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcC
Q 003156 23 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL 102 (843)
Q Consensus 23 f~~l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 102 (843)
|..+++|++|+|++|+|+.++. |.++++|++|+|++|+|+..+. .+..+++|++|++++|+|+.. ..+..+
T Consensus 44 l~~L~~L~~L~Ls~n~I~~i~~--l~~l~~L~~L~Ls~N~i~~i~~-----~~~~~~~L~~L~l~~N~i~~l--~~~~~l 114 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIKKIEN-----LDAVADTLEELWISYNQIASL--SGIEKL 114 (198)
T ss_dssp HHHTTTCCEEECSEEEESCCCC--HHHHTTCCEEECCEEEECSCSS-----HHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred HhcccccceeECcccCCCCccc--ccCCccccChhhcccccccccc-----ccccccccccccccccccccc--cccccc
Confidence 4556666666666666655532 5555666666666665553221 122234555666666655532 234555
Q ss_pred CCCCEEEcCCCcccccCC-CCCCCCCCCcEEEccCCccc
Q 003156 103 HYLKELLLQGNQFSGPLP-ADIGFCPHLTTLDLSNNLFT 140 (843)
Q Consensus 103 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 140 (843)
++|++|+|++|+|+.... ..+..+++|++|+|++|.+.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555555543211 23445555555555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=5.7e-12 Score=115.98 Aligned_cols=104 Identities=19% Similarity=0.147 Sum_probs=54.6
Q ss_pred EEEccCCcccccCCccccccCCCcEEEcCCC-CCCCCchhhhcccCCCcEEecccccccccCCccccCCCCCCEEEccCC
Q 003156 304 HLDLRNNALYGSIPQEVCESRSLGILQLDGN-SLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 382 (843)
Q Consensus 304 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 382 (843)
.++.+++.+. ..|..+..+++|+.|++++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3444444444 33444555555555555444 355444455555666666666666665544555555666666666666
Q ss_pred cccccCCcchhcccccceEeeccccce
Q 003156 383 ELSGEIPQELGKLASLLAVNVSYNRLI 409 (843)
Q Consensus 383 ~l~~~~p~~~~~l~~L~~l~ls~N~l~ 409 (843)
+|+...+..+.. .+|+.|+|++|++.
T Consensus 91 ~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCcccChhhhcc-ccccccccCCCccc
Confidence 665333333332 24556666666553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=1.2e-11 Score=113.72 Aligned_cols=107 Identities=21% Similarity=0.078 Sum_probs=79.2
Q ss_pred CCcEEEcCCCcccCCCCCCccccccceEEEccCC-cccccCCccccccCCCcEEEcCCCCCCCCchhhhcccCCCcEEec
Q 003156 277 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN-ALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 355 (843)
Q Consensus 277 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 355 (843)
..+.++++++.+.. .|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.|..|..+++|+.|+|
T Consensus 9 ~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 34556666666653 4555666777777787655 477555667888888888888888888777888888888999999
Q ss_pred ccccccccCCccccCCCCCCEEEccCCccc
Q 003156 356 SHNHLSGSIPKSISNLNKLKILKLEFNELS 385 (843)
Q Consensus 356 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 385 (843)
++|+|+ .+|.......+|+.|+|++|.+.
T Consensus 88 s~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCCCc-ccChhhhccccccccccCCCccc
Confidence 999888 45544444457999999999885
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=2.7e-09 Score=98.43 Aligned_cols=101 Identities=22% Similarity=0.177 Sum_probs=66.5
Q ss_pred cceEEEccCCcccccCCccccccCCCcEEEcCCCCCCCCc--hhhhcccCCCcEEecccccccccCCccccCCCCCCEEE
Q 003156 301 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI--PQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 378 (843)
Q Consensus 301 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 378 (843)
.+..++..++... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|+
T Consensus 43 ~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~ 121 (162)
T d1koha1 43 IDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 121 (162)
T ss_dssp CCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCC
T ss_pred chhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceee
Confidence 3334444444433 34444556788888888888888543 45577788888888888888843332344456788888
Q ss_pred ccCCcccccCCcc-------hhcccccceEe
Q 003156 379 LEFNELSGEIPQE-------LGKLASLLAVN 402 (843)
Q Consensus 379 L~~N~l~~~~p~~-------~~~l~~L~~l~ 402 (843)
|++|.++...... +..+++|+.||
T Consensus 122 L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 122 LDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 8888887654432 55677777765
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=3.6e-09 Score=97.62 Aligned_cols=89 Identities=25% Similarity=0.162 Sum_probs=47.9
Q ss_pred CCCCcEEEccCccccccccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCcccCchhhhcCCCC
Q 003156 26 CASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYL 105 (843)
Q Consensus 26 l~~L~~L~L~~n~i~~~~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 105 (843)
+..+..++..++.+.. ...++..+++|++|+|++|+|+...+. ...+..+++|+.|+|++|.|+...+-.+-...+|
T Consensus 41 ~~~~~~l~~~~~~~~~-l~~~~~~~~~L~~L~Ls~N~i~~l~~~--~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L 117 (162)
T d1koha1 41 QNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDM--SSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117 (162)
T ss_dssp TTCCCCTTSHHHHHHH-HHHHHHHCTTCCCCCCCSSCCCCCSGG--GTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred ccchhhcchhhhHhhh-hHHHHHhCCCCCEeeCCCccccCCchh--HHHHhhCCcccccccccCccccchhhhhhhcccc
Confidence 3344444444443332 234455667777777777776643221 1234456667777777777664333333344456
Q ss_pred CEEEcCCCcccc
Q 003156 106 KELLLQGNQFSG 117 (843)
Q Consensus 106 ~~L~L~~n~l~~ 117 (843)
++|++++|.+..
T Consensus 118 ~~L~L~~Npl~~ 129 (162)
T d1koha1 118 EELWLDGNSLSD 129 (162)
T ss_dssp SSCCCTTSTTSS
T ss_pred ceeecCCCCcCc
Confidence 666666666653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=1e-05 Score=80.42 Aligned_cols=129 Identities=18% Similarity=0.077 Sum_probs=88.1
Q ss_pred ceEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEEeCCCCCHHHHHhh
Q 003156 567 FGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE 645 (843)
Q Consensus 567 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 645 (843)
.+.||+... +++.+++|+..... ......+.+|..++..+. +--+.+++.+...++..++||+++++.++.+....
T Consensus 27 ~~~v~rv~~--~~~~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 27 PAKVYKLVG--ENENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp SSEEEEEEC--SSCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCcEEEEEe--CCCeEEEEEcCCCc-ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 468998864 56778888875432 223345778998888774 33356778888888888999999999877554322
Q ss_pred cCCCCCCCChhHHHHHHHHHHHHHHhhhhcC-------------------------------------------------
Q 003156 646 RLPSTPPLSWTNRFKVILGTAKGLAHLHHSF------------------------------------------------- 676 (843)
Q Consensus 646 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------------- 676 (843)
. .....++.++++.++.||+..
T Consensus 104 ~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 104 E---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp C---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred c---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 1 112234445555555555321
Q ss_pred -------CCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 677 -------RPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 677 -------~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
.+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999987777799999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.88 E-value=1.9e-06 Score=79.15 Aligned_cols=69 Identities=14% Similarity=0.129 Sum_probs=30.6
Q ss_pred hcCCCCcEEEccCc-ccccc----ccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCc
Q 003156 24 ENCASLRYLSLAGN-ILQGP----IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS 92 (843)
Q Consensus 24 ~~l~~L~~L~L~~n-~i~~~----~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 92 (843)
.+.++|++|+|+++ .+... ....+...+.|++|+|++|.+...........+...+.|++|+|++|.|.
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 34456666666653 34321 11234444555555555555543211111222333344555555555444
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.87 E-value=1.6e-06 Score=79.64 Aligned_cols=115 Identities=13% Similarity=0.106 Sum_probs=65.0
Q ss_pred cCCCCCCEEECCCC-CCccccCCCcCccccCCccCCEEecCCccCccc----CchhhhcCCCCCEEEcCCCccccc----
Q 003156 48 NYCSSLNTLNLSNN-HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS----IPQGVAALHYLKELLLQGNQFSGP---- 118 (843)
Q Consensus 48 ~~l~~L~~L~Ls~N-~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~---- 118 (843)
.+.+.|++|+|+++ .++...-.....++...++|++|+|++|.+... +...+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 44567777777763 454221111122344556677777777776532 223455566777777777776632
Q ss_pred CCCCCCCCCCCcEEEccCCccccc-------CCchhhcccCCcEEEeecCc
Q 003156 119 LPADIGFCPHLTTLDLSNNLFTGQ-------LPVSLRLLNSMIFISVSNNT 162 (843)
Q Consensus 119 ~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~ 162 (843)
+...+...++|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 223455567777777777755422 22334556677777776554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=5.9e-05 Score=74.24 Aligned_cols=74 Identities=15% Similarity=0.107 Sum_probs=51.4
Q ss_pred eeccccc-eEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccC--CCccceeeEEEcCCeeEEEEEeCCCC
Q 003156 561 EVGEGVF-GTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH--PNLISLEGYYWTPQLKLLVSDYAPNG 637 (843)
Q Consensus 561 ~ig~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~g 637 (843)
.+..|.. +.||+.... ++..+++|...... ...+..|+..++.+.. -.+.+++++..+++..++|||+++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445543 679998874 56678888754332 2346778888877743 33566788888888889999999876
Q ss_pred CH
Q 003156 638 SL 639 (843)
Q Consensus 638 sL 639 (843)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 54
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=0.0001 Score=77.49 Aligned_cols=77 Identities=17% Similarity=0.179 Sum_probs=48.7
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecC------CcccChHHHHHHHHHHHhcc-C-C-CccceeeEEEcCCeeEEEE
Q 003156 561 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTS------DIIQYPEDFEREVRVLGKAR-H-P-NLISLEGYYWTPQLKLLVS 631 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~g~~~~~~~~~lV~ 631 (843)
.||.|....||++....+++.|+||.-... .......+...|.+.++.+. + | .+.+++.+ +++..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 689999999999988766788999975321 11122345567888887773 2 3 34455543 455568999
Q ss_pred EeCCCCCH
Q 003156 632 DYAPNGSL 639 (843)
Q Consensus 632 e~~~~gsL 639 (843)
|++++..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred eccCCccc
Confidence 99977543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.41 E-value=2.1e-05 Score=71.97 Aligned_cols=120 Identities=13% Similarity=0.170 Sum_probs=75.8
Q ss_pred hhhhcCCCCcEEEccC-cccccc----ccccccCCCCCCEEECCCCCCccccCCCcCccccCCccCCEEecCCccCccc-
Q 003156 21 QLFENCASLRYLSLAG-NILQGP----IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS- 94 (843)
Q Consensus 21 ~~f~~l~~L~~L~L~~-n~i~~~----~~~~f~~l~~L~~L~Ls~N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~- 94 (843)
.+..+.+.|++|+|++ +.|+.. ....+...++|++|+|++|.++..........+...+.++.|++++|.+...
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3445668888888876 456432 2233557788888888888876432222223455667888888888887632
Q ss_pred ---CchhhhcCCCCCEEEcC--CCcccc----cCCCCCCCCCCCcEEEccCCccc
Q 003156 95 ---IPQGVAALHYLKELLLQ--GNQFSG----PLPADIGFCPHLTTLDLSNNLFT 140 (843)
Q Consensus 95 ---~~~~~~~l~~L~~L~L~--~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~ 140 (843)
+...+...++|++++|+ +|.+.. .+...+...++|++|+++.+...
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 33456667788876554 556643 23334556788888888776543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.39 E-value=6.8e-06 Score=75.36 Aligned_cols=121 Identities=14% Similarity=0.132 Sum_probs=72.5
Q ss_pred ccccccccCCCCCCEEECCC-CCCccccCCCcCccccCCccCCEEecCCccCccc----CchhhhcCCCCCEEEcCCCcc
Q 003156 41 GPIGKIFNYCSSLNTLNLSN-NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS----IPQGVAALHYLKELLLQGNQF 115 (843)
Q Consensus 41 ~~~~~~f~~l~~L~~L~Ls~-N~i~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l 115 (843)
.+...+..+.+.|++|+|++ +.|+...-.....++...++|++|+|++|.+... +...+...++++.|++++|.+
T Consensus 7 ~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~ 86 (166)
T d1io0a_ 7 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 86 (166)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence 33444556778999999987 4565322111223455678888999999888643 334556678888888888887
Q ss_pred ccc----CCCCCCCCCCCcEEEc--cCCccccc----CCchhhcccCCcEEEeecC
Q 003156 116 SGP----LPADIGFCPHLTTLDL--SNNLFTGQ----LPVSLRLLNSMIFISVSNN 161 (843)
Q Consensus 116 ~~~----~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N 161 (843)
... +...+...++|+.++| ++|.+... +...+...++|+.|+++.+
T Consensus 87 ~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 87 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred cchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 532 2234556677776555 44555431 2233344555555555444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.16 E-value=0.013 Score=59.13 Aligned_cols=136 Identities=15% Similarity=0.159 Sum_probs=76.5
Q ss_pred eEEEEEEECCCCeEEEEEEeecCCcccChHHHHHHHHHHHhccCCCc--cceee-----EEEcCCeeEEEEEeCCCCCH-
Q 003156 568 GTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL--ISLEG-----YYWTPQLKLLVSDYAPNGSL- 639 (843)
Q Consensus 568 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~e~~~~gsL- 639 (843)
-.||++... +|+.|++|...... ...+++..|...+..+....+ +..+. .....+..+.|+++++|..+
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 479999885 78889999875432 235678889998888852222 11111 12334567889999876322
Q ss_pred ----H---------HHHhhc-----CCCCCCCCh-------------------hHHHHHHHHHHHHHHhhh----hcCCC
Q 003156 640 ----Q---------AKLHER-----LPSTPPLSW-------------------TNRFKVILGTAKGLAHLH----HSFRP 678 (843)
Q Consensus 640 ----~---------~~l~~~-----~~~~~~l~~-------------------~~~~~i~~~ia~~l~~LH----~~~~~ 678 (843)
. ..+|.. .+.....++ ..+..+...+.+.++.+. +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 111110 001111111 111122222222333332 22345
Q ss_pred CeeecCCCCCCEEEcCCCCcEEeeccCccc
Q 003156 679 PIIHYNLKPSNILLDDNYNPRISDFGLARL 708 (843)
Q Consensus 679 ~ivH~dlk~~Nill~~~~~~kl~Dfgl~~~ 708 (843)
++||+|+.+.|||++++ ..+.||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45889998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.40 E-value=0.036 Score=57.35 Aligned_cols=72 Identities=10% Similarity=0.139 Sum_probs=47.4
Q ss_pred eeccccceEEEEEEECC-------CCeEEEEEEeecCCcccChHHHHHHHHHHHhcc-CCCccceeeEEEcCCeeEEEEE
Q 003156 561 EVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 632 (843)
Q Consensus 561 ~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 632 (843)
.|+.|-.=.+|++.... ..+.|.++..- . ........+|..+++.+. +.-..++++++.. .+|+|
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 68888888999998742 23456666543 2 123345678999998885 4334467776642 68999
Q ss_pred eCCCCCH
Q 003156 633 YAPNGSL 639 (843)
Q Consensus 633 ~~~~gsL 639 (843)
|+++.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9986533
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.06 E-value=0.21 Score=49.40 Aligned_cols=31 Identities=23% Similarity=0.278 Sum_probs=27.5
Q ss_pred CCCeeecCCCCCCEEEcCCCCcEEeeccCcc
Q 003156 677 RPPIIHYNLKPSNILLDDNYNPRISDFGLAR 707 (843)
Q Consensus 677 ~~~ivH~dlk~~Nill~~~~~~kl~Dfgl~~ 707 (843)
..++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4489999999999999988877899999875
|